Psyllid ID: psy18060

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------55
Protein Sequence
MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSITTIVESDSDENEEWVMFLRTCLHKLLAGSDSDTASCERSFILMLITSLRCQSCVVLGLITHILVVLIMKHEDSAHLRECLFVFYYYYFSDSEDDMYSDADLSSDDDEDKIYDEDLVLSHSSYSTYLKKKAKREAYRNDIDDEDEYS
Secondary Structure (PSIPRED)
ccccccccccEEEccccccccccEEEEEEEcccccEEEEEEEccccccHHHHHHHHHHHHHHHccccccccHHEEEEEcccEEEEEEEccccccccccccccccccccccccccccHHHHHHHHHHccccccEEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHHHHcccccccEEEEEEEEccEEEEEEEccccccHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccccccccccccccccccccHHccccccccccccHHHHHHHHHHHHHHHHcccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccEEEEEEEEccccccEEEEEEcccccEEEEEEEEcccccccccHHHHHHHHHHHccccccEccEEEEEEcccEEEEEEEcccEEHHHcccccccccccccccccccccHHHEEEEEEEEEEccEEEEEEEEcccccEEEEEEEEcccccccccHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccEEHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHcccccccEcHHHHHHHHHHHHHHHHcHHHHHHHHHHcccEEEccccccccccHHHHHHHHHHHcccccccccHHHHHHHHHccccccccHHHcccccccc
Coil and Loop (DISEMBL)
MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISksgrsgkelSSLKQECEIQkhlahpniIKFIASHETLNEFVLITEFAHMslsklgepwfhnhcqpvkmeksngaLEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISksgrsgkelSSLKQECEIQkhlahpniIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHsnrvlhrdlkpqnvllnkdGVAMLCDFGFARSMAVGTHMltsikgtplymapeliaerpydhtadlwSLGCIAyeihmghppfktVSILHLIRLLktqdvtfpsqvsETYKDLVKGLLEkdasqrlswpellhhplvkdnlsseiesqnnqdcigfdycdkrrgsrksITTIvesdsdenEEWVMFLRTCLHKllagsdsdtasCERSFILMLITSLRCQSCVVLGLITHILVVLIMKHEDSAHLRECLFVFYYYyfsdseddmysdadlssdddedkiydedlvlshSSYSTYLKKKAKREAyrndiddedeys
Flexible Loop (DISEMBL)
MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISksgrsgkelsSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISksgrsgkelsSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSITtivesdsdeneEWVMFLRTCLHKLLagsdsdtaSCERSFILMLITSLRCQSCVVLGLITHILVVLIMKHEDSAHLRECLFVFYYYYFSDSEDDMYSDADLSSDDDEDKIYDedlvlshssystylkkkakreayrndiddedeys
Low Complexity Region (SEG)
MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSITTIVESDSDENEEWVMFLRTCLHKLLAGSDSDTASCERSFILMLITSLRCQSCVVLGLITHILVVLIMKHEDSAHLRECLfvfyyyyfsdseddmysdadlssdddedkiydedlVLSHSSYSTYLKKKAKREAYRNDIDDEDEYS
Disordered region (IsUnstruct)
********EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS**************ECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS**************ECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK************QDCIGFDYCDKR******ITTIV*******EEWVMFLRTCLHKLLAGSDSDTASCERSFILMLITSLRCQSCVVLGLITHILVVLIMKHEDSAHLRECLFVFYYYYFS*********************************************************
Disordered Region (DISOPRED)
*****GA**KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS***************CEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLG***F*************GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS**************ECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN******************************************************************************************************************YYFSDS*************************L*HSSY************************
Disordered Region (DISEMBL)
********EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS**********KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS**********KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSITTIVESDSDENEEWVMFLRTCLHKLLAGSDSDTASCERSFILMLITSLRCQSCVVLGLITHILVVLIMKHEDSAHLRECLFVFYYYYFSDSEDDMYSDADLSSDDDEDKIYDEDLVLSHSSYSTYLKKKAKREAYRNDIDDEDEYS
Disordered Region (DISPRO)
*****GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS**********************PNIIKFIASHETLNEFVLITEFAHMSLSKL****************SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSITTIVESDSDENEEWVMFLRTCLHKLLAGSDSDTASCERSFILMLITSLRCQSCVVLGLITHILVVLIMKHEDSAHLRECLFVFYYYYFSDSEDDMYSDADLSSDDDEDKIYDEDLVLSHSSYSTYLKK******************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSITTIVESDSDENEEWVMFLRTCLHKLLAGSDSDTASCERSFILMLITSLRCQSCVVLGLITHILVVLIMKHEDSAHLRECLFVFYYYYFSDSEDDMYSDADLSSDDDEDKIYDEDLVLSHSSYSTYLKKKAKREAYRNDIDDEDEYS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	549	2.2.26 [Sep-21-2011]
P23647	805	Serine/threonine-protein	yes	N/A	0.469	0.320	0.538	5e-80
Q69ZM6	1316	Serine/threonine-protein	yes	N/A	0.471	0.196	0.540	1e-78
Q5RAJ5	1315	Serine/threonine-protein	yes	N/A	0.471	0.196	0.532	1e-77
Q9NRP7	1315	Serine/threonine-protein	yes	N/A	0.471	0.196	0.532	1e-77
Q2QAV0	1322	Serine/threonine-protein	yes	N/A	0.482	0.200	0.488	5e-70
Q55FT4	2247	Probable serine/threonine	yes	N/A	0.460	0.112	0.463	3e-63
Q54PX0	496	Probable serine/threonine	no	N/A	0.444	0.491	0.361	7e-40
P97477	395	Aurora kinase A OS=Mus mu	no	N/A	0.479	0.665	0.359	3e-39
P59241	397	Aurora kinase A OS=Rattus	no	N/A	0.497	0.687	0.351	5e-39
O14965	403	Aurora kinase A OS=Homo s	no	N/A	0.497	0.677	0.347	5e-38

>sp|P23647|FUSED_DROME Serine/threonine-protein kinase fused OS=Drosophila melanogaster GN=fu PE=1 SV=2

 Score =  298 bits (764), Expect = 5e-80,   Method: Compositional matrix adjust.
 Identities = 139/258 (53%), Positives = 187/258 (72%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           + +Y    L+G+GSFG V+KA   D  K VA+K+ISK GR+ KEL +L++EC+IQ  L H
Sbjct: 1   MNRYAVSSLVGQGSFGCVYKATRKDDSKVVAIKVISKRGRATKELKNLRRECDIQARLKH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           P++I+ I S E+  +  ++TEFA M L   L     + E    ++  +L+SALYYLHSNR
Sbjct: 61  PHVIEMIESFESKTDLFVVTEFALMDLHRYLSYNGAMGEEPARRVTGHLVSALYYLHSNR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           +LHRDLKPQNVLL+K+  A LCDFG AR+M +GTH+LTSIKGTPLYMAPEL+AE+PYDH 
Sbjct: 121 ILHRDLKPQNVLLDKNMHAKLCDFGLARNMTLGTHVLTSIKGTPLYMAPELLAEQPYDHH 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           AD+WSLGCIAYE   G PPF   SILHL++++K +DV +PS ++   +  ++GLLEKD  
Sbjct: 181 ADMWSLGCIAYESMAGQPPFCASSILHLVKMIKHEDVKWPSTLTSECRSFLQGLLEKDPG 240

Query: 358 QRLSWPELLHHPLVKDNL 375
            R+SW +LL HP V+  +
Sbjct: 241 LRISWTQLLCHPFVEGRI 258

Probable serine/threonine-protein kinase; maternally required for correct patterning in the posterior part of each embryonic metamere. May be involved in control of cell division during metamorphosis and ovarian development. May interact with costal-2.
Drosophila melanogaster (taxid: 7227)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q69ZM6|STK36_MOUSE Serine/threonine-protein kinase 36 OS=Mus musculus GN=Stk36 PE=1 SV=3

 Score =  294 bits (752), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 140/259 (54%), Positives = 183/259 (70%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY  + +IGEGSFG+V+K       + VALK I K GRS KEL +L++E EI + L H
Sbjct: 1   MEKYHVLEMIGEGSFGRVYKGRKKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLWH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNI+  + S ET  E V++T++A   L  +LE   KL E     I + L+SALYYLHS+R
Sbjct: 61  PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           +LHRD+KPQN+LL K G   LCDFGFAR+M+  T +LTSIKGTPLYM+PEL+ ERPYDHT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWS+GCI YE+ +G PPF T SI  L+ L+    V +PS +S  +K+ ++GLL KD  
Sbjct: 181 ADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPVRWPSTISSCFKNFLQGLLTKDPR 240

Query: 358 QRLSWPELLHHPLVKDNLS 376
           QRLSWP+LLHHP +   ++
Sbjct: 241 QRLSWPDLLHHPFIAGRVT 259

Serine/threonine protein kinase which plays an important role in the sonic hedgehog (Shh) pathway by regulating the activity of GLI transcription factors. Controls the activity of the transcriptional regulators GLI1, GLI2 and GLI3 by opposing the effect of SUFU and promoting their nuclear localization. GLI2 requires an additional function of STK36 to become transcriptionally active, but the enzyme does not need to possess an active kinase catalytic site for this to occur. Required for postnatal development, possibly by regulating the homeostasis of cerebral spinal fluid or ciliary function. Essential for construction of the central pair apparatus of motile cilia.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5RAJ5|STK36_PONAB Serine/threonine-protein kinase 36 OS=Pongo abelii GN=STK36 PE=2 SV=1

 Score =  291 bits (744), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 138/259 (53%), Positives = 183/259 (70%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY  + +IGEGSFG+V+K       + VALK I K GRS KEL +L++E EI + L H
Sbjct: 1   MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNI+  + S ET  E V++T++A   L  +LE   KL E     I + L+SALYYLHS+R
Sbjct: 61  PNIVHMLDSFETDKEVVVVTDYAEGELLQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           +LHRD+KPQN+LL K G   LCDFGFAR+M+  T +LTSIKGTPLYM+PEL+ ERPYDHT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWS+GCI YE+ +G PPF   SI  L+ L+    V +PS +S  +K+ ++GLL KD  
Sbjct: 181 ADLWSVGCILYELAVGTPPFYATSIFQLVSLILKDPVRWPSTISPCFKNFLQGLLTKDPR 240

Query: 358 QRLSWPELLHHPLVKDNLS 376
           QRLSWP+LL+HP +  +++
Sbjct: 241 QRLSWPDLLYHPFIAGHVT 259

Serine/threonine protein kinase which plays an important role in the sonic hedgehog (Shh) pathway by regulating the activity of GLI transcription factors. Controls the activity of the transcriptional regulators GLI1, GLI2 and GLI3 by opposing the effect of SUFU and promoting their nuclear localization. GLI2 requires an additional function of STK36 to become transcriptionally active, but the enzyme does not need to possess an active kinase catalytic site for this to occur. Required for postnatal development, possibly by regulating the homeostasis of cerebral spinal fluid or ciliary function. Essential for construction of the central pair apparatus of motile cilia.

Pongo abelii (taxid: 9601)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9NRP7|STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2

 Score =  291 bits (744), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 138/259 (53%), Positives = 183/259 (70%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY  + +IGEGSFG+V+K       + VALK I K GRS KEL +L++E EI + L H
Sbjct: 1   MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNI+  + S ET  E V++T++A   L  +LE   KL E     I + L+SALYYLHS+R
Sbjct: 61  PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           +LHRD+KPQN+LL K G   LCDFGFAR+M+  T +LTSIKGTPLYM+PEL+ ERPYDHT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWS+GCI YE+ +G PPF   SI  L+ L+    V +PS +S  +K+ ++GLL KD  
Sbjct: 181 ADLWSVGCILYELAVGTPPFYATSIFQLVSLILKDPVRWPSTISPCFKNFLQGLLTKDPR 240

Query: 358 QRLSWPELLHHPLVKDNLS 376
           QRLSWP+LL+HP +  +++
Sbjct: 241 QRLSWPDLLYHPFIAGHVT 259

Serine/threonine protein kinase which plays an important role in the sonic hedgehog (Shh) pathway by regulating the activity of GLI transcription factors. Controls the activity of the transcriptional regulators GLI1, GLI2 and GLI3 by opposing the effect of SUFU and promoting their nuclear localization. GLI2 requires an additional function of STK36 to become transcriptionally active, but the enzyme does not need to possess an active kinase catalytic site for this to occur. Required for postnatal development, possibly by regulating the homeostasis of cerebral spinal fluid or ciliary function. Essential for construction of the central pair apparatus of motile cilia.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2QAV0|TIO_ARATH Serine/threonine-protein kinase TIO OS=Arabidopsis thaliana GN=TIO PE=1 SV=1

 Score =  265 bits (678), Expect = 5e-70,   Method: Compositional matrix adjust.
 Identities = 130/266 (48%), Positives = 175/266 (65%), Gaps = 1/266 (0%)

Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            +E Y  I L+GEGSFG+V+K       +TVA+K I K G++ K++ SL+QE EI + L 
Sbjct: 2   GVEDYHVIELVGEGSFGRVYKGRRKYTGQTVAMKFIMKQGKTDKDIHSLRQEIEILRKLK 61

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           H NII+ + S E   EF ++TEFA   L  +LE  K L E     I   L+ AL YLHSN
Sbjct: 62  HENIIEMLDSFENAREFCVVTEFAQGELFEILEDDKCLPEEQVQAIAKQLVKALDYLHSN 121

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
           R++HRD+KPQN+L+    V  LCDFGFAR+M+  T +L SIKGTPLYMAPEL+ E+PYD 
Sbjct: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSTNTVVLRSIKGTPLYMAPELVKEQPYDR 181

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
           T DLWSLG I YE+++G PPF T S+  LIR +    V +P ++S  ++  +KGLL K+ 
Sbjct: 182 TVDLWSLGVILYELYVGQPPFYTNSVYALIRHIVKDPVKYPDEMSTYFESFLKGLLNKEP 241

Query: 357 SQRLSWPELLHHPLVKDNLSSEIESQ 382
             RL+WP L  HP VK+    E+E++
Sbjct: 242 HSRLTWPALREHPFVKET-QEEVEAR 266

Plays a role in conventional modes of cytokinesis in meristems and during male gametogenesis but also acts in nonconventional modes of cytokinesis (cellularization) during female gametogenesis. Constitutes a signaling module in association with Kinesin-12 members that is required to support phragmoplast expansion and cell-plate growth in plant cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q55FT4|TSUA_DICDI Probable serine/threonine-protein kinase tsuA OS=Dictyostelium discoideum GN=tsuA PE=1 SV=1

 Score =  243 bits (619), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 119/257 (46%), Positives = 176/257 (68%), Gaps = 4/257 (1%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + Y+ I  IGEGSFGKV+K       + VA K+ISK G++ +++ SL+QE +I K+L+HP
Sbjct: 3   DDYKLIGQIGEGSFGKVYKYRKKFTGQLVACKVISKKGKNEEDILSLRQEIDILKNLSHP 62

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           NII+FI+  E  NEF L+TE+A   LS ++ + K LS  +   I   L+ AL YLH  +V
Sbjct: 63  NIIQFISCFENKNEFTLVTEYADGDLSQIISEEKTLSVDLIQSICYQLVIALNYLHYKKV 122

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           +HRD+KPQN+L+   G   +CDFGFA++++  + +LTS+KGTPLY+APE+I E+PYD+ A
Sbjct: 123 IHRDIKPQNILITSGGQIKVCDFGFAKTISSNSILLTSLKGTPLYLAPEIIQEQPYDYKA 182

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV---KGLLEKD 355
           DLWSLG I Y+I +G PPF   S+  L+ +    ++  P ++++ Y DLV   + LL K+
Sbjct: 183 DLWSLGIILYQILVGSPPFSANSLADLVHMTLESNIEIPKELNK-YPDLVSLFRQLLCKN 241

Query: 356 ASQRLSWPELLHHPLVK 372
             +R+ WP+LL+HP VK
Sbjct: 242 PDKRIGWPDLLYHPFVK 258

Plays a role in chemotaxis and seems to be involved in polarization.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54PX0|Y4251_DICDI Probable serine/threonine-protein kinase DDB_G0284251 OS=Dictyostelium discoideum GN=DDB_G0284251 PE=3 SV=1

 Score =  165 bits (418), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 89/246 (36%), Positives = 140/246 (56%), Gaps = 2/246 (0%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G+FG+VFK ++    + VA+K I  +      L S+K E EI   L H NI+K +  
Sbjct: 42  IGRGAFGQVFKGLNGKTGEFVAIKQIDSNKIDESSLQSVKGEVEILHKLRHNNIVKVLGV 101

Query: 187 HETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
            E   +   I E+  + SL +++E+   LSE +C+  L  ++  L YLHSN+V+HRD+K 
Sbjct: 102 VEVQAQLNFILEYVENGSLRDVIEKFGPLSEELCIIYLYQMLQGLAYLHSNKVIHRDIKA 161

Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGC 305
            N+L+ K+GV  L DFG A  +   + +  S+ GTP +MAPE I        +D+WSLG 
Sbjct: 162 SNILITKEGVIKLADFGVASQIDSESQLRFSVVGTPYWMAPESIEISGCSSASDIWSLGS 221

Query: 306 IAYEIHMGHPPFKTVSIL-HLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPE 364
              E+  G+PP+ T+  +  + R++  Q   FP+ +S+ + D  +   +KD +QR +  E
Sbjct: 222 TMIELLTGNPPYYTLQPMAAMFRIVSDQHPPFPTDISKEFLDYFQQSFKKDPTQRPTAQE 281

Query: 365 LLHHPL 370
           LL HP+
Sbjct: 282 LLQHPI 287

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P97477|AURKA_MOUSE Aurora kinase A OS=Mus musculus GN=Aurka PE=1 SV=1

 Score =  163 bits (413), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 147/267 (55%), Gaps = 4/267 (1%)

Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS-SLKQECE 170
           +K    LE +     +G+G FG V+ A     K  +ALK++ K+      +   L++E E
Sbjct: 115 KKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKANVEHQLRREVE 174

Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISA 229
           IQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +A
Sbjct: 175 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 234

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L Y HS RV+HRD+KP+N+LL  +G   + DFG+  S+   +   T++ GT  Y+ PE+I
Sbjct: 235 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW--SVHAPSSRRTTMCGTLDYLPPEMI 292

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +D   DLWSLG + YE  +G PPF+  +     R +   + TFP  V+E  +DL+ 
Sbjct: 293 EGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLIS 352

Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLS 376
            LL+ +ASQRL+  E+L HP +K N S
Sbjct: 353 RLLKHNASQRLTLAEVLEHPWIKANSS 379

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity. Necessary for proper cilia disassembly prior to mitosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P59241|AURKA_RAT Aurora kinase A OS=Rattus norvegicus GN=Aurka PE=1 SV=1

 Score =  162 bits (411), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 98/279 (35%), Positives = 152/279 (54%), Gaps = 6/279 (2%)

Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K    LE +     +G+G FG V+ A     K  +ALK++ K    ++G E   L++E 
Sbjct: 117 KKRQWTLEDFDIGRPLGKGKFGNVYLAREKQSKFILALKVLFKVQLEKAGVE-HQLRREV 175

Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 176 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 235

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL  +G   + DFG+  S+   +   T++ GT  Y  PE+
Sbjct: 236 ALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW--SVHAPSSRRTTLCGTLDYQPPEM 293

Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     R +   + TFP  V+E  +DL+
Sbjct: 294 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLI 353

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ ++SQRL+  E+L HP +K N S      N+++ 
Sbjct: 354 SRLLKHNSSQRLTLAEVLEHPWIKANSSKPPTGHNSKEA 392

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (By similarity). Necessary for proper cilia disassembly prior to mitosis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O14965|AURKA_HUMAN Aurora kinase A OS=Homo sapiens GN=AURKA PE=1 SV=2

 Score =  159 bits (402), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 150/279 (53%), Gaps = 6/279 (2%)

Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 124 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 182

Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 183 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 242

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T++ GT  Y+ PE+
Sbjct: 243 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 300

Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 301 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 360

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 361 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 399

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity. Necessary for proper cilia disassembly prior to mitosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	549
350426741	790	PREDICTED: serine/threonine-protein kina	0.469	0.326	0.612	2e-90
340723596	791	PREDICTED: serine/threonine-protein kina	0.469	0.326	0.612	4e-90
307212557	765	Serine/threonine-protein kinase 36 [Harp	0.469	0.337	0.616	4e-89
328776565	788	PREDICTED: serine/threonine-protein kina	0.469	0.327	0.608	4e-89
383857621	789	PREDICTED: serine/threonine-protein kina	0.469	0.326	0.604	4e-89
380022633	790	PREDICTED: serine/threonine-protein kina	0.469	0.326	0.608	5e-89
307190607	777	Serine/threonine-protein kinase 36 [Camp	0.469	0.332	0.600	2e-87
332016959	772	Serine/threonine-protein kinase 36 [Acro	0.469	0.334	0.577	1e-85
157117068	793	serine/threonine protein kinase [Aedes a	0.462	0.320	0.568	1e-81
170029659	790	serine threonine kinase [Culex quinquefa	0.462	0.321	0.568	2e-81

>gi|350426741|ref|XP_003494529.1| PREDICTED: serine/threonine-protein kinase fused-like [Bombus impatiens]

 Score =  339 bits (870), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 158/258 (61%), Positives = 198/258 (76%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY+ +  +GEGSFG+V+KA      + VA K+I K GRS KEL SL+QECEIQ+HL H
Sbjct: 1   MEKYEVLKQVGEGSFGQVYKAKKRSDGEIVAFKVIRKRGRSFKELKSLRQECEIQRHLHH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNII+ + S ET NE V++TE+A   L  +L +  +LSE     I  +L+SALYYLHSNR
Sbjct: 61  PNIIQMLDSFETENEIVVVTEYADKELYEILGKAGRLSEQRAQVIACDLVSALYYLHSNR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           VLHRDLKPQNVLL  +GVA LCDFGFARSM+ GTH+LTSIKGTPLYMAPELI ERPYDH 
Sbjct: 121 VLHRDLKPQNVLLESNGVAKLCDFGFARSMSTGTHVLTSIKGTPLYMAPELIEERPYDHN 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWSLGCI YE+ +G PPF+T SILHL+RL++ + + +P  +S+  K  ++GLL+KD S
Sbjct: 181 ADLWSLGCIVYELVVGSPPFQTTSILHLVRLIRFEAIKWPDYISQNCKQFLQGLLQKDPS 240

Query: 358 QRLSWPELLHHPLVKDNL 375
           QRL+WP LL HP VK+ +
Sbjct: 241 QRLTWPALLDHPFVKNRI 258

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340723596|ref|XP_003400175.1| PREDICTED: serine/threonine-protein kinase fused-like [Bombus terrestris]

 Score =  338 bits (868), Expect = 4e-90,   Method: Compositional matrix adjust.
 Identities = 158/258 (61%), Positives = 198/258 (76%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY+ +  +GEGSFG+V+KA      + VA K+I K GRS KEL SL+QECEIQ+HL H
Sbjct: 1   MEKYEVLKQVGEGSFGQVYKAKKRSDGEIVAFKVIRKRGRSFKELKSLRQECEIQRHLHH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNII+ + S ET NE V++TE+A   L  +L +  +LSE     I  +L+SALYYLHSNR
Sbjct: 61  PNIIQMLDSFETENEIVVVTEYADKELYEILGKAGRLSEQRAQVIACDLVSALYYLHSNR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           VLHRDLKPQNVLL  +GVA LCDFGFARSM+ GTH+LTSIKGTPLYMAPELI ERPYDH 
Sbjct: 121 VLHRDLKPQNVLLESNGVAKLCDFGFARSMSTGTHVLTSIKGTPLYMAPELIEERPYDHN 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWSLGCI YE+ +G PPF+T SILHL+RL++ + + +P  +S+  K  ++GLL+KD S
Sbjct: 181 ADLWSLGCIVYELVVGSPPFQTTSILHLVRLIRFEAIKWPDYISQNCKQFLQGLLQKDPS 240

Query: 358 QRLSWPELLHHPLVKDNL 375
           QRL+WP LL HP VK+ +
Sbjct: 241 QRLTWPALLDHPFVKNRI 258

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307212557|gb|EFN88280.1| Serine/threonine-protein kinase 36 [Harpegnathos saltator]

 Score =  335 bits (859), Expect = 4e-89,   Method: Compositional matrix adjust.
 Identities = 159/258 (61%), Positives = 197/258 (76%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           ++KY+ +  IGEGSFG+V+KA      + VA KII K GRS KEL SL+QECEIQ+HL H
Sbjct: 1   MKKYEILRQIGEGSFGQVYKAKKRSDGEVVAFKIIRKRGRSFKELKSLRQECEIQRHLHH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNI++ I S ET NE V+ITE+A   L  +L++  +LSE     I  +L+SALYYLHSNR
Sbjct: 61  PNIVQMIDSFETDNEIVVITEYADKELYEILDKEGRLSEERAQVIACDLVSALYYLHSNR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           VLHRDLKPQNVLL  +GVA LCDFGFARSM+ GTH+LTSIKGTPLYMAPELI E PYDH 
Sbjct: 121 VLHRDLKPQNVLLEANGVAKLCDFGFARSMSTGTHVLTSIKGTPLYMAPELIEECPYDHN 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWSLGCI YE+ +G PPF+T SILHL++L++ + + +P  +S   K  ++GLL+KD S
Sbjct: 181 ADLWSLGCIIYELVVGSPPFQTTSILHLVKLIRFEAIKWPDFISSNCKSFLQGLLQKDPS 240

Query: 358 QRLSWPELLHHPLVKDNL 375
           QRL+WP LL HP VKD +
Sbjct: 241 QRLTWPALLEHPFVKDRI 258

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328776565|ref|XP_001122254.2| PREDICTED: serine/threonine-protein kinase fused [Apis mellifera]

 Score =  335 bits (858), Expect = 4e-89,   Method: Compositional matrix adjust.
 Identities = 157/258 (60%), Positives = 197/258 (76%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY+ +  +GEGSFG+V+KA      + VA K+I K GRS KEL SL+QECEIQ+ L H
Sbjct: 1   MEKYEVLKQVGEGSFGQVYKAKKRSDGEIVAFKVIRKRGRSFKELKSLRQECEIQRRLHH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNI++ + S ET NE V++TE+A   L  +L +  +LSE     I  +L+SALYYLHSNR
Sbjct: 61  PNIVQMLDSFETENEIVVVTEYADKELYEILGKAGRLSEQRAQVIACDLVSALYYLHSNR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           VLHRDLKPQNVLL  +GVA LCDFGFARSM+ GTH+LTSIKGTPLYMAPELI ERPYD+ 
Sbjct: 121 VLHRDLKPQNVLLESNGVAKLCDFGFARSMSTGTHVLTSIKGTPLYMAPELIEERPYDYN 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWSLGCI YE+ +G PPF+T SILHLIRL++ + + +P  +S+  K  ++GLL+KD S
Sbjct: 181 ADLWSLGCIVYELVVGSPPFQTTSILHLIRLIRFEAIKWPDYISQNCKQFLQGLLQKDPS 240

Query: 358 QRLSWPELLHHPLVKDNL 375
           QRL+WP LL HP VK+ L
Sbjct: 241 QRLTWPALLDHPFVKNRL 258

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383857621|ref|XP_003704303.1| PREDICTED: serine/threonine-protein kinase fused-like [Megachile rotundata]

 Score =  335 bits (858), Expect = 4e-89,   Method: Compositional matrix adjust.
 Identities = 156/258 (60%), Positives = 198/258 (76%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY+ +  +GEGSFG+V+KA      + VA K+I K GRS KEL SL+QECEIQ+HL H
Sbjct: 1   MEKYEVLKQVGEGSFGQVYKAKKRCNGEIVAFKVIRKRGRSFKELRSLRQECEIQRHLHH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNI++ + S ET NE V++TE+A   L  +L +  +LSE     I  +L+SALYYLHSNR
Sbjct: 61  PNIVQMLDSFETENEIVVVTEYADKELYEILGKAGRLSEQRAQVIACDLVSALYYLHSNR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           VLHRDLKPQNVLL  +GVA LCDFGFARSM+ GTH+LTSIKGTPLYMAPELI ERPYDH 
Sbjct: 121 VLHRDLKPQNVLLESNGVAKLCDFGFARSMSTGTHVLTSIKGTPLYMAPELIEERPYDHN 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWSLGCI YE+ +G PPF+T SILHL+RL++ + + +P  +S++ K  ++GLL+KD  
Sbjct: 181 ADLWSLGCIVYELVVGSPPFQTTSILHLVRLIRFEAIKWPDFISQSCKSFLQGLLQKDPL 240

Query: 358 QRLSWPELLHHPLVKDNL 375
           QRL+WP LL HP VK+ +
Sbjct: 241 QRLTWPALLEHPFVKNRI 258

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380022633|ref|XP_003695144.1| PREDICTED: serine/threonine-protein kinase fused-like [Apis florea]

 Score =  335 bits (858), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 157/258 (60%), Positives = 197/258 (76%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY+ +  +GEGSFG+V+KA      + VA K+I K GRS KEL SL+QECEIQ+ L H
Sbjct: 1   MEKYEVLKQVGEGSFGQVYKAKKRSDGEIVAFKVIRKRGRSFKELKSLRQECEIQRRLHH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNI++ + S ET NE V++TE+A   L  +L +  +LSE     I  +L+SALYYLHSNR
Sbjct: 61  PNIVQMLDSFETENEIVVVTEYADKELYEILGKAGRLSEQRAQVIACDLVSALYYLHSNR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           VLHRDLKPQNVLL  +GVA LCDFGFARSM+ GTH+LTSIKGTPLYMAPELI ERPYD+ 
Sbjct: 121 VLHRDLKPQNVLLESNGVAKLCDFGFARSMSTGTHVLTSIKGTPLYMAPELIEERPYDYN 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWSLGCI YE+ +G PPF+T SILHLIRL++ + + +P  +S+  K  ++GLL+KD S
Sbjct: 181 ADLWSLGCIVYELVVGSPPFQTTSILHLIRLIRFEAIKWPDYISQNCKQFLQGLLQKDPS 240

Query: 358 QRLSWPELLHHPLVKDNL 375
           QRL+WP LL HP VK+ L
Sbjct: 241 QRLTWPALLDHPFVKNRL 258

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307190607|gb|EFN74589.1| Serine/threonine-protein kinase 36 [Camponotus floridanus]

 Score =  330 bits (845), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 155/258 (60%), Positives = 199/258 (77%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           ++KY+ +  IGEGSFG+V+KA      + VA K+I K GRS KEL SL+QECEIQ+HL H
Sbjct: 1   MKKYEILKHIGEGSFGQVYKAKKRSDGEIVAFKMIRKCGRSFKELKSLRQECEIQRHLHH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNI++ + S ET NE V++TE+A   L ++L++  +LSE     I  +L+SALYYLHSNR
Sbjct: 61  PNIVQMLDSFETENEIVVVTEYADKELYDILDKEGRLSEERTQVIACDLVSALYYLHSNR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           V+HRDLKPQNVLL  +GVA LCDFGFARSM+ GTH+LTSIKGTPLYMAPELI E PYDH 
Sbjct: 121 VMHRDLKPQNVLLEANGVAKLCDFGFARSMSTGTHVLTSIKGTPLYMAPELIEEYPYDHN 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWSLGCI YE+ +G PPF+T SILHL++L++ + + +P  +S   K  ++GLL+KD S
Sbjct: 181 ADLWSLGCIVYELVVGSPPFQTNSILHLVKLIRFEAIKWPDFISLNCKSFLQGLLQKDPS 240

Query: 358 QRLSWPELLHHPLVKDNL 375
           QRL+WP+LL HP VKD +
Sbjct: 241 QRLTWPDLLKHPFVKDRI 258

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332016959|gb|EGI57768.1| Serine/threonine-protein kinase 36 [Acromyrmex echinatior]

 Score =  323 bits (829), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 149/258 (57%), Positives = 197/258 (76%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +++Y+ +  IGEGSFG+V+KA      + VA+K+I K GRS  EL SL+QECEIQ++L H
Sbjct: 1   MKRYEILKPIGEGSFGQVYKARKRVDGEFVAVKMIRKCGRSPSELKSLRQECEIQRYLQH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNI++ + S ET NE V++TE+    L+++L +  +LSE     I  +L+SALYYLHSNR
Sbjct: 61  PNIVQMLDSFETENEIVVVTEYVDKVLNDILAKEVRLSEERAQVIACDLVSALYYLHSNR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           V+HRDLKPQNVLL  +G+  LCDFGFARSM+ GTH+LTSIKGTPLYMAPEL+ E PYDH 
Sbjct: 121 VMHRDLKPQNVLLEANGITKLCDFGFARSMSTGTHVLTSIKGTPLYMAPELVEEYPYDHN 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWSLGCI YE+ +G PPF+T SILHLI+L++ +++ +P  +S   K  ++GLL+KD S
Sbjct: 181 ADLWSLGCIVYELVVGSPPFQTYSILHLIKLIRFEEIKWPDFISSICKSFLQGLLQKDPS 240

Query: 358 QRLSWPELLHHPLVKDNL 375
           QRL+WP LL HP VKD +
Sbjct: 241 QRLTWPALLQHPFVKDRI 258

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157117068|ref|XP_001658684.1| serine/threonine protein kinase [Aedes aegypti] gi|108876216|gb|EAT40441.1| AAEL007835-PA [Aedes aegypti]

 Score =  310 bits (794), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 145/255 (56%), Positives = 191/255 (74%), Gaps = 1/255 (0%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           ++KY    L+GEGSFGKV+KAI    K TVALKIISK GRSG+EL  L+ ECEIQ++L H
Sbjct: 1   MDKYAISNLVGEGSFGKVYKAIDKQNKTTVALKIISKRGRSGRELKGLRGECEIQRNLQH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNII+ + S ET NE + +TEFA   L +LL +   L E    +I  +L+SALYYLHS+R
Sbjct: 61  PNIIRMLDSFETENEIIAVTEFAKTDLHSLL-RDGSLGEPKTQKITYDLVSALYYLHSHR 119

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           +LHRDLKPQN+LL+++  A LCDFGFAR+M +GTH+LTSIKGTPLYMAPEL+  +PYDH 
Sbjct: 120 ILHRDLKPQNILLDRNMTAKLCDFGFARNMTMGTHVLTSIKGTPLYMAPELLEAKPYDHH 179

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWSLGCI YE+  G PPF + S++HL++L++ Q + +PS ++      V+GLLE+D S
Sbjct: 180 ADLWSLGCIIYEMLAGEPPFSSTSMIHLVKLIRNQYIKWPSFLTSNCISFVQGLLERDTS 239

Query: 358 QRLSWPELLHHPLVK 372
            R+ W  +++HP VK
Sbjct: 240 HRMPWTTIINHPFVK 254

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|170029659|ref|XP_001842709.1| serine threonine kinase [Culex quinquefasciatus] gi|167864028|gb|EDS27411.1| serine threonine kinase [Culex quinquefasciatus]

 Score =  309 bits (792), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 145/255 (56%), Positives = 194/255 (76%), Gaps = 1/255 (0%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           ++KY    L+GEGSFGKV+KAI  + K TVALKIISK GRSG+EL  L+ ECEIQ++L H
Sbjct: 1   MDKYAINNLVGEGSFGKVYKAIDKESKITVALKIISKRGRSGRELKGLRGECEIQRNLQH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           PNII+ + S ET +E V +TEFA   L +LL +   L E    +I  +L+SALYYLHS+R
Sbjct: 61  PNIIRMLDSFETEHEIVAVTEFARTDLHSLL-RDGSLGEPKTQKITYDLVSALYYLHSHR 119

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           +LHRDLKPQN+L++++  A LCDFGFAR+M +GTH+LTSIKGTPLYMAPEL+  +PYDH 
Sbjct: 120 ILHRDLKPQNILMDRNMTAKLCDFGFARNMTMGTHVLTSIKGTPLYMAPELLEAKPYDHH 179

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ADLWSLGCI YE+  G PPF + S++HL+RL++ Q + +PS ++      V+GLLE+D S
Sbjct: 180 ADLWSLGCIIYEMLAGEPPFSSTSMIHLVRLIRNQYIKWPSFLTTNCISFVQGLLERDPS 239

Query: 358 QRLSWPELLHHPLVK 372
            R++W ++++HP VK
Sbjct: 240 HRMAWSKIINHPFVK 254

Source: Culex quinquefasciatus

Species: Culex quinquefasciatus

Genus: Culex

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	549
FB|FBgn0001079	805	fu "fused" [Drosophila melanog	0.469	0.320	0.538	3.6e-80
UNIPROTKB|E1B793	1317	STK36 "Uncharacterized protein	0.462	0.192	0.547	1.9e-73
UNIPROTKB|E1BWJ1	1328	E1BWJ1 "Uncharacterized protei	0.462	0.191	0.559	9.5e-72
UNIPROTKB|E1BWJ2	1331	E1BWJ2 "Uncharacterized protei	0.462	0.190	0.559	9.6e-72
UNIPROTKB|C9JDA4	279	STK36 "Serine/threonine-protei	0.471	0.928	0.532	3.7e-71
MGI|MGI:1920831	1316	Stk36 "serine/threonine kinase	0.462	0.193	0.551	5.2e-71
UNIPROTKB|D4A8P3	1188	Stk36 "Protein Stk36" [Rattus	0.462	0.213	0.547	6.8e-71
UNIPROTKB|E2RCC2	1314	STK36 "Uncharacterized protein	0.462	0.193	0.547	8.5e-71
UNIPROTKB|J9JHL2	1319	STK36 "Uncharacterized protein	0.462	0.192	0.547	8.6e-71
UNIPROTKB|A8MU99	1294	STK36 "Serine/threonine-protei	0.471	0.200	0.532	3.6e-70

FB|FBgn0001079 fu "fused" [Drosophila melanogaster (taxid:7227)]

 Score = 744 (267.0 bits), Expect = 3.6e-80, Sum P(2) = 3.6e-80
 Identities = 139/258 (53%), Positives = 187/258 (72%)

Query:   118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
             + +Y    L+G+GSFG V+KA   D  K VA+K+ISK GR+ KEL +L++EC+IQ  L H
Sbjct:     1 MNRYAVSSLVGQGSFGCVYKATRKDDSKVVAIKVISKRGRATKELKNLRRECDIQARLKH 60

Query:   178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             P++I+ I S E+  +  ++TEFA M L   L     + E    ++  +L+SALYYLHSNR
Sbjct:    61 PHVIEMIESFESKTDLFVVTEFALMDLHRYLSYNGAMGEEPARRVTGHLVSALYYLHSNR 120

Query:   238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
             +LHRDLKPQNVLL+K+  A LCDFG AR+M +GTH+LTSIKGTPLYMAPEL+AE+PYDH 
Sbjct:   121 ILHRDLKPQNVLLDKNMHAKLCDFGLARNMTLGTHVLTSIKGTPLYMAPELLAEQPYDHH 180

Query:   298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
             AD+WSLGCIAYE   G PPF   SILHL++++K +DV +PS ++   +  ++GLLEKD  
Sbjct:   181 ADMWSLGCIAYESMAGQPPFCASSILHLVKMIKHEDVKWPSTLTSECRSFLQGLLEKDPG 240

Query:   358 QRLSWPELLHHPLVKDNL 375
              R+SW +LL HP V+  +
Sbjct:   241 LRISWTQLLCHPFVEGRI 258

GO:0007367 "segment polarity determination" evidence=NAS;IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS;IDA;NAS

GO:0007224 "smoothened signaling pathway" evidence=IMP;TAS

GO:0007293 "germarium-derived egg chamber formation" evidence=IMP;NAS

GO:0043234 "protein complex" evidence=IPI

GO:0007228 "positive regulation of hh target transcription factor activity" evidence=IGI;IMP

GO:0005737 "cytoplasm" evidence=TAS

GO:0035301 "Hedgehog signaling complex" evidence=IPI

GO:0042993 "positive regulation of transcription factor import into nucleus" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0005515 "protein binding" evidence=IPI

GO:0030162 "regulation of proteolysis" evidence=NAS

GO:0005524 "ATP binding" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0031647 "regulation of protein stability" evidence=IDA

GO:0031398 "positive regulation of protein ubiquitination" evidence=IMP

GO:0030514 "negative regulation of BMP signaling pathway" evidence=IGI

UNIPROTKB|E1B793 STK36 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 725 (260.3 bits), Expect = 1.9e-73, Sum P(2) = 1.9e-73
 Identities = 139/254 (54%), Positives = 180/254 (70%)

Query:   118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
             +EKY  + +IGEGSFG+V+K       + VALK I K GRS KEL +L++E EI + L H
Sbjct:     1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60

Query:   178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             PNI+  + S ET  E V++T++A   L  +LE   KL E     I + L+SALYYLHS+R
Sbjct:    61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120

Query:   238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
             +LHRD+KPQN+LL K G   LCDFGFAR+M+  T +LTSIKGTPLYM+PEL+ ERPYDHT
Sbjct:   121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180

Query:   298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
             ADLWS+GCI YE+ +G PPF T SI  L+ L+    V +P  +S  +K+ ++GLL KD  
Sbjct:   181 ADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPVRWPPTISPCFKNFLQGLLTKDPR 240

Query:   358 QRLSWPELLHHPLV 371
             QRLSWP+LLHHP +
Sbjct:   241 QRLSWPDLLHHPFI 254

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=IEA

GO:0042384 "cilium assembly" evidence=IEA

GO:0009791 "post-embryonic development" evidence=IEA

GO:0008134 "transcription factor binding" evidence=IEA

GO:0007420 "brain development" evidence=IEA

GO:0007228 "positive regulation of hh target transcription factor activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0003351 "epithelial cilium movement" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E1BWJ1 E1BWJ1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 735 (263.8 bits), Expect = 9.5e-72, P = 9.5e-72
 Identities = 142/254 (55%), Positives = 181/254 (71%)

Query:   118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
             +E+Y  + +IGEGSFG+V+K       + VALK I K GRS KEL +L++E EI + L H
Sbjct:     1 MERYHVLEVIGEGSFGRVYKGRRRCSAQVVALKFIPKVGRSEKELKNLQREIEIMRGLHH 60

Query:   178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             PNII+ + S ET  E V++T++A   L  +LE    L E     I + L+SALYYLHS+R
Sbjct:    61 PNIIQMLDSFETDKEVVMVTDYAEGELFQILEDDGSLPEDQVQTIAAQLVSALYYLHSHR 120

Query:   238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
             +LHRD+KPQN+LL KDGV  LCDFGFAR+M++ T +LTSIKGTPLYM+PEL+ ERPYDHT
Sbjct:   121 ILHRDMKPQNILLGKDGVIKLCDFGFARAMSIHTMVLTSIKGTPLYMSPELVEERPYDHT 180

Query:   298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
             ADLWS+GCI YE+ MG PPF T SI  L+ L+    V +P  +S  +K  ++GLL KD  
Sbjct:   181 ADLWSVGCILYELFMGTPPFYTSSIFQLVSLIVKDPVKWPKAISPAFKSFLQGLLMKDPH 240

Query:   358 QRLSWPELLHHPLV 371
             QRLSWPELL HP V
Sbjct:   241 QRLSWPELLSHPFV 254

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E1BWJ2 E1BWJ2 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 735 (263.8 bits), Expect = 9.6e-72, P = 9.6e-72
 Identities = 142/254 (55%), Positives = 181/254 (71%)

Query:   118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
             +E+Y  + +IGEGSFG+V+K       + VALK I K GRS KEL +L++E EI + L H
Sbjct:     1 MERYHVLEVIGEGSFGRVYKGRRRCSAQVVALKFIPKVGRSEKELKNLQREIEIMRGLHH 60

Query:   178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             PNII+ + S ET  E V++T++A   L  +LE    L E     I + L+SALYYLHS+R
Sbjct:    61 PNIIQMLDSFETDKEVVMVTDYAEGELFQILEDDGSLPEDQVQTIAAQLVSALYYLHSHR 120

Query:   238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
             +LHRD+KPQN+LL KDGV  LCDFGFAR+M++ T +LTSIKGTPLYM+PEL+ ERPYDHT
Sbjct:   121 ILHRDMKPQNILLGKDGVIKLCDFGFARAMSIHTMVLTSIKGTPLYMSPELVEERPYDHT 180

Query:   298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
             ADLWS+GCI YE+ MG PPF T SI  L+ L+    V +P  +S  +K  ++GLL KD  
Sbjct:   181 ADLWSVGCILYELFMGTPPFYTSSIFQLVSLIVKDPVKWPKAISPAFKSFLQGLLMKDPH 240

Query:   358 QRLSWPELLHHPLV 371
             QRLSWPELL HP V
Sbjct:   241 QRLSWPELLSHPFV 254

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0003351 "epithelial cilium movement" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0007228 "positive regulation of hh target transcription factor activity" evidence=IEA

GO:0007420 "brain development" evidence=IEA

GO:0008134 "transcription factor binding" evidence=IEA

GO:0009791 "post-embryonic development" evidence=IEA

GO:0042384 "cilium assembly" evidence=IEA

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=IEA

UNIPROTKB|C9JDA4 STK36 "Serine/threonine-protein kinase 36" [Homo sapiens (taxid:9606)]

 Score = 720 (258.5 bits), Expect = 3.7e-71, P = 3.7e-71
 Identities = 138/259 (53%), Positives = 183/259 (70%)

Query:   118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
             +EKY  + +IGEGSFG+V+K       + VALK I K GRS KEL +L++E EI + L H
Sbjct:     1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60

Query:   178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             PNI+  + S ET  E V++T++A   L  +LE   KL E     I + L+SALYYLHS+R
Sbjct:    61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120

Query:   238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
             +LHRD+KPQN+LL K G   LCDFGFAR+M+  T +LTSIKGTPLYM+PEL+ ERPYDHT
Sbjct:   121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180

Query:   298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
             ADLWS+GCI YE+ +G PPF   SI  L+ L+    V +PS +S  +K+ ++GLL KD  
Sbjct:   181 ADLWSVGCILYELAVGTPPFYATSIFQLVSLILKDPVRWPSTISPCFKNFLQGLLTKDPR 240

Query:   358 QRLSWPELLHHPLVKDNLS 376
             QRLSWP+LL+HP +  +++
Sbjct:   241 QRLSWPDLLYHPFIAGHVT 259

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0003351 "epithelial cilium movement" evidence=IEA

GO:0007228 "positive regulation of hh target transcription factor activity" evidence=IEA

GO:0007420 "brain development" evidence=IEA

GO:0009791 "post-embryonic development" evidence=IEA

GO:0042384 "cilium assembly" evidence=IEA

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=IEA

MGI|MGI:1920831 Stk36 "serine/threonine kinase 36" [Mus musculus (taxid:10090)]

 Score = 728 (261.3 bits), Expect = 5.2e-71, P = 5.2e-71
 Identities = 140/254 (55%), Positives = 181/254 (71%)

Query:   118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
             +EKY  + +IGEGSFG+V+K       + VALK I K GRS KEL +L++E EI + L H
Sbjct:     1 MEKYHVLEMIGEGSFGRVYKGRKKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLWH 60

Query:   178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             PNI+  + S ET  E V++T++A   L  +LE   KL E     I + L+SALYYLHS+R
Sbjct:    61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120

Query:   238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
             +LHRD+KPQN+LL K G   LCDFGFAR+M+  T +LTSIKGTPLYM+PEL+ ERPYDHT
Sbjct:   121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180

Query:   298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
             ADLWS+GCI YE+ +G PPF T SI  L+ L+    V +PS +S  +K+ ++GLL KD  
Sbjct:   181 ADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPVRWPSTISSCFKNFLQGLLTKDPR 240

Query:   358 QRLSWPELLHHPLV 371
             QRLSWP+LLHHP +
Sbjct:   241 QRLSWPDLLHHPFI 254

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003351 "epithelial cilium movement" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=ISO;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007228 "positive regulation of hh target transcription factor activity" evidence=IDA

GO:0007275 "multicellular organismal development" evidence=IEA

GO:0007420 "brain development" evidence=IMP

GO:0008134 "transcription factor binding" evidence=ISO

GO:0009791 "post-embryonic development" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030030 "cell projection organization" evidence=IEA

GO:0042384 "cilium assembly" evidence=IDA

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=IDA

GO:0046872 "metal ion binding" evidence=IEA

GO:0051090 "regulation of sequence-specific DNA binding transcription factor activity" evidence=ISO

UNIPROTKB|D4A8P3 Stk36 "Protein Stk36" [Rattus norvegicus (taxid:10116)]

 Score = 725 (260.3 bits), Expect = 6.8e-71, P = 6.8e-71
 Identities = 139/254 (54%), Positives = 181/254 (71%)

Query:   118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
             +EKY  + +IGEGSFG+V+K       + VALK I K GRS KEL +L++E EI + L H
Sbjct:     1 MEKYHVLEMIGEGSFGRVYKGRKKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLWH 60

Query:   178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             PNI+  + S ET  E V++T++A   L  +LE   KL E     I + L+SALYYLHS+R
Sbjct:    61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEEQVQAIAAQLVSALYYLHSHR 120

Query:   238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
             +LHRD+KPQN+LL K G   LCDFGFAR+M+  T +LTSIKGTPLYM+PEL+ ERPYDHT
Sbjct:   121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180

Query:   298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
             ADLWS+GCI YE+ +G PPF T SI  L+ L+    V +PS ++  +K+ ++GLL KD  
Sbjct:   181 ADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPVRWPSTITSCFKNFLQGLLTKDPR 240

Query:   358 QRLSWPELLHHPLV 371
             QRLSWP+LLHHP +
Sbjct:   241 QRLSWPDLLHHPFI 254

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E2RCC2 STK36 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 726 (260.6 bits), Expect = 8.5e-71, P = 8.5e-71
 Identities = 139/254 (54%), Positives = 180/254 (70%)

Query:   118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
             +EKY  + +IGEGSFG+V+K       + VALK I K GRS KEL +L++E EI + L H
Sbjct:     1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60

Query:   178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             PNI+  + S ET  E V++T++A   L  +LE   KL E     I + L+SALYYLHS+R
Sbjct:    61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120

Query:   238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
             +LHRD+KPQN+LL K G   LCDFGFAR+M+  T +LTSIKGTPLYM+PEL+ ERPYDHT
Sbjct:   121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180

Query:   298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
             ADLWS+GCI YE+ +G PPF T SI  L+ L+    V +P+ +S  +K  ++GLL KD  
Sbjct:   181 ADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPVRWPTTISPCFKSFLQGLLTKDPR 240

Query:   358 QRLSWPELLHHPLV 371
             QRLSWP+LLHHP +
Sbjct:   241 QRLSWPDLLHHPFI 254

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=IEA

GO:0042384 "cilium assembly" evidence=IEA

GO:0009791 "post-embryonic development" evidence=IEA

GO:0008134 "transcription factor binding" evidence=IEA

GO:0007420 "brain development" evidence=IEA

GO:0007228 "positive regulation of hh target transcription factor activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0003351 "epithelial cilium movement" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|J9JHL2 STK36 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 726 (260.6 bits), Expect = 8.6e-71, P = 8.6e-71
 Identities = 139/254 (54%), Positives = 180/254 (70%)

Query:   118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
             +EKY  + +IGEGSFG+V+K       + VALK I K GRS KEL +L++E EI + L H
Sbjct:     1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60

Query:   178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             PNI+  + S ET  E V++T++A   L  +LE   KL E     I + L+SALYYLHS+R
Sbjct:    61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120

Query:   238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
             +LHRD+KPQN+LL K G   LCDFGFAR+M+  T +LTSIKGTPLYM+PEL+ ERPYDHT
Sbjct:   121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180

Query:   298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
             ADLWS+GCI YE+ +G PPF T SI  L+ L+    V +P+ +S  +K  ++GLL KD  
Sbjct:   181 ADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPVRWPTTISPCFKSFLQGLLTKDPR 240

Query:   358 QRLSWPELLHHPLV 371
             QRLSWP+LLHHP +
Sbjct:   241 QRLSWPDLLHHPFI 254

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|A8MU99 STK36 "Serine/threonine-protein kinase 36" [Homo sapiens (taxid:9606)]

 Score = 720 (258.5 bits), Expect = 3.6e-70, P = 3.6e-70
 Identities = 138/259 (53%), Positives = 183/259 (70%)

Query:   118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
             +EKY  + +IGEGSFG+V+K       + VALK I K GRS KEL +L++E EI + L H
Sbjct:     1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60

Query:   178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             PNI+  + S ET  E V++T++A   L  +LE   KL E     I + L+SALYYLHS+R
Sbjct:    61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120

Query:   238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
             +LHRD+KPQN+LL K G   LCDFGFAR+M+  T +LTSIKGTPLYM+PEL+ ERPYDHT
Sbjct:   121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180

Query:   298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
             ADLWS+GCI YE+ +G PPF   SI  L+ L+    V +PS +S  +K+ ++GLL KD  
Sbjct:   181 ADLWSVGCILYELAVGTPPFYATSIFQLVSLILKDPVRWPSTISPCFKNFLQGLLTKDPR 240

Query:   358 QRLSWPELLHHPLVKDNLS 376
             QRLSWP+LL+HP +  +++
Sbjct:   241 QRLSWPDLLYHPFIAGHVT 259

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9NRP7	STK36_HUMAN	2, ., 7, ., 1, 1, ., 1	0.5328	0.4717	0.1969	yes	N/A
P23647	FUSED_DROME	2, ., 7, ., 1, 1, ., 1	0.5387	0.4699	0.3204	yes	N/A
Q69ZM6	STK36_MOUSE	2, ., 7, ., 1, 1, ., 1	0.5405	0.4717	0.1968	yes	N/A
Q5RAJ5	STK36_PONAB	2, ., 7, ., 1, 1, ., 1	0.5328	0.4717	0.1969	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	549
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-85
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-78
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-69
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-64
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-62
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-61
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-60
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-58
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-56
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-56
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-53
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-49
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-48
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-48
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-47
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-46
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-46
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-46
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-46
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-46
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-45
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-44
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-44
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-44
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-44
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-43
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-42
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-42
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-41
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-41
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-41
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-41
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-40
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-40
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-40
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-40
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-39
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-39
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-39
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-39
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-39
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-39
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-38
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-38
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-37
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-37
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-37
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-37
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-36
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-36
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-36
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-36
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-35
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-35
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-35
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-35
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-35
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-35
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-35
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-34
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-34
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-34
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-34
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-34
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-34
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-34
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-34
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-34
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-34
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-34
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-33
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-33
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-33
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-33
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-32
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-32
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-32
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-32
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-32
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-32
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-32
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-32
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-32
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-32
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-32
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-31
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-31
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-31
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-31
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-31
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-31
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-31
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-31
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-31
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-31
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-31
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-30
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-30
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-30
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-30
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-30
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-29
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-29
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-29
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-29
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-29
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-29
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-29
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-29
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-29
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-28
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-28
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-28
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-28
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-28
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-28
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-28
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-28
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-28
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-28
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-28
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-28
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-28
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-27
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-27
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-27
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-27
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-27
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-27
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-27
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-27
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-27
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-26
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-26
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-26
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-26
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-26
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-26
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-26
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-26
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-25
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-25
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-25
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-25
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-25
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-24
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-24
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-24
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-24
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-24
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-24
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-24
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-24
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-24
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-23
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-23
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-23
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-23
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-23
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-23
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-23
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-23
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-23
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-23
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-22
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-22
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-22
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-22
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-21
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-21
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-21
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-21
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-21
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-21
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-21
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-21
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-20
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-20
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-20
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-20
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-20
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-20
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-20
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-20
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-20
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-20
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-20
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-19
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-19
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-19
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-19
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-19
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-19
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-19
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-18
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-18
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-18
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-17
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-17
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-17
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-17
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-17
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-17
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-16
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-16
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-16
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-16
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-15
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-14
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-14
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-14
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-13
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-13
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-13
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-13
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-13
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-12
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	8e-12
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	8e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-12
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-11
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-10
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-10
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-10
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-09
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-09
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-09
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-09
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-09
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-08
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-08
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-08
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-07
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-07
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-07
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-07
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-07
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-06
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-06
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-06
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-06
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-06
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-06
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-06
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-06
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-06
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-05
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-05
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-05
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-05
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-05
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-05
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-05
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-05
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-05
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-05
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-05
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-05
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-05
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-05
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-04
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-04
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-04
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-04
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-04
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-04
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-04
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-04
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-04
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-04
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-04
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-04
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-04
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-04
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	0.001
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.001
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.001
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	0.002
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	0.002
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	0.002
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	0.002
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	0.002
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	0.002
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	0.002
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	0.002
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.003
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	0.003
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	0.003
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	0.003
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	0.003
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	0.004
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	0.004
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	0.004
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  263 bits (675), Expect = 7e-85
 Identities = 99/256 (38%), Positives = 142/256 (55%), Gaps = 7/256 (2%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ +  +GEGSFGKV+ A      K VA+K+I K     K+   + +E +I K L HPNI
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNI 59

Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           ++     E  ++  L+ E+     L +LL++R +LSE      L  ++SAL YLHS  ++
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIV 119

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTAD 299
           HRDLKP+N+LL++DG   L DFG AR +      LT+  GTP YMAPE++  + Y    D
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178

Query: 300 LWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
           +WSLG I YE+  G PPF    + + +   I   K         +S   KDL++ LL KD
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKD 238

Query: 356 ASQRLSWPELLHHPLV 371
             +RL+  E L HP  
Sbjct: 239 PEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  247 bits (633), Expect = 1e-78
 Identities = 98/260 (37%), Positives = 144/260 (55%), Gaps = 9/260 (3%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ +  +G GSFG V+KA H    K VA+KI+ K     K+  + ++E  I + L+HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           ++ I + E  +   L+ E+     L + L +   LSE    +I   ++  L YLHSN ++
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE-RPYDHTA 298
           HRDLKP+N+LL+++GV  + DFG A+ +   +  LT+  GTP YMAPE++     Y    
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180

Query: 299 DLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVKGL 351
           D+WSLG I YE+  G PPF     +  L LIR +    + F        SE  KDL+K  
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKC 240

Query: 352 LEKDASQRLSWPELLHHPLV 371
           L KD S+R +  E+L HP  
Sbjct: 241 LNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  222 bits (569), Expect = 3e-69
 Identities = 94/258 (36%), Positives = 141/258 (54%), Gaps = 6/258 (2%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           KY+ I  IG+GSFGKV+        K   LK I  S  S KE      E +I K L HPN
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 180 IIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKK----LSETICVQILSNLISALYYLH 234
           IIK+  S E   +  ++ E+A    LS  ++++KK      E   +     L  AL YLH
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S ++LHRD+KPQN+ L  +G+  L DFG ++ ++    +  ++ GTP Y++PEL   +PY
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-FPSQVSETYKDLVKGLLE 353
           ++ +D+WSLGC+ YE+     PF+  ++L L   +        PSQ S   ++LV  LL+
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQ 240

Query: 354 KDASQRLSWPELLHHPLV 371
           KD  +R S  ++L  P +
Sbjct: 241 KDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  209 bits (534), Expect = 6e-64
 Identities = 95/264 (35%), Positives = 144/264 (54%), Gaps = 16/264 (6%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           ++ +  L+G GSFG V+ A+  D  + +A+K +  SG S +EL +L++E  I   L HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 180 IIKFIASH--ETLNEFVLITEFAHM-SLSNLLEQRKKLSE-TICV---QILSNLISALYY 232
           I+++  S   E  N   +  E+    SLS+LL++  KL E  I     QIL      L Y
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE----GLAY 116

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA--VGTHMLTSIKGTPLYMAPELIA 290
           LHSN ++HRD+K  N+L++ DGV  L DFG A+ +          S++GTP +MAPE+I 
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF--KTVSILHLIRLLKTQDVT-FPSQVSETYKDL 347
              Y   AD+WSLGC   E+  G PP+      +  L ++  + +    P  +SE  KD 
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236

Query: 348 VKGLLEKDASQRLSWPELLHHPLV 371
           ++  L +D  +R +  ELL HP +
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  204 bits (520), Expect = 1e-62
 Identities = 93/247 (37%), Positives = 127/247 (51%), Gaps = 36/247 (14%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +GEG FG V+ A      K VA+KII K   S   L  L +E EI K L HPNI+K    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 187 HETLNEFVLITEFA-HMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            E  N   L+ E+    SL +LL E   KLSE   ++IL  ++  L YLHSN ++HRDLK
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 245 PQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-AERPYDHTADLWS 302
           P+N+LL+ D G   L DFG ++ +     +L +I GTP YMAPE++  +  Y   +D+WS
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW 362
           LG I YE+                                  KDL++ +L+KD  +R S 
Sbjct: 180 LGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPSA 208

Query: 363 PELLHHP 369
            E+L H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  200 bits (512), Expect = 7e-61
 Identities = 89/254 (35%), Positives = 138/254 (54%), Gaps = 6/254 (2%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
            YQ   LIG G+FG V+K ++L+    VA+K IS      + L S+ QE ++ K+L HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 180 IIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           I+K+I S ET +   +I E+A   SL  ++++     E++    +  ++  L YLH   V
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           +HRD+K  N+L  KDGV  L DFG A  +   +    S+ GTP +MAPE+I        +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTAS 180

Query: 299 DLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
           D+WSLGC   E+  G+PP+     ++ L   R+++      P  +S   KD +    +KD
Sbjct: 181 DIWSLGCTVIELLTGNPPYYDLNPMAALF--RIVQDDHPPLPEGISPELKDFLMQCFQKD 238

Query: 356 ASQRLSWPELLHHP 369
            + R +  +LL HP
Sbjct: 239 PNLRPTAKQLLKHP 252

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  198 bits (507), Expect = 4e-60
 Identities = 83/248 (33%), Positives = 128/248 (51%), Gaps = 5/248 (2%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           +G+GSFGKV      D  K  A+K++ K      KE+     E  I   + HP I+K   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 186 SHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
           + +T  +  L+ E+A    L + L +  + SE       + ++ AL YLHS  +++RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLG 304
           P+N+LL+ DG   L DFG A+ ++       +  GTP Y+APE++  + Y    D WSLG
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLG 180

Query: 305 CIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW-- 362
            + YE+  G PPF       +   +    + FP  +S   +DL+ GLL+KD ++RL    
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240

Query: 363 -PELLHHP 369
             E+  HP
Sbjct: 241 AEEIKAHP 248

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  194 bits (496), Expect = 2e-58
 Identities = 89/255 (34%), Positives = 143/255 (56%), Gaps = 8/255 (3%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
            ++ +  IG+G FG+V+KA H    K VA+K+I     S ++   +  E +I K   HPN
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL--ESKEKKEKIINEIQILKKCKHPN 58

Query: 180 IIKFIASHETLNEFVLITEFAHM-SLSNLLEQR-KKLSETICVQILSNLISALYYLHSNR 237
           I+K+  S+   +E  ++ EF    SL +LL+   + L+E+    +   L+  L YLHSN 
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           ++HRD+K  N+LL  DG   L DFG +  ++  T    ++ GTP +MAPE+I  +PYD+ 
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF---PSQVSETYKDLVKGLLEK 354
           AD+WSLG  A E+  G PP+  +  +  +  + T        P + S+ +KD +K  L+K
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237

Query: 355 DASQRLSWPELLHHP 369
           +  +R +  +LL HP
Sbjct: 238 NPEKRPTAEQLLKHP 252

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  190 bits (484), Expect = 1e-56
 Identities = 89/268 (33%), Positives = 133/268 (49%), Gaps = 19/268 (7%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
            Y+ +  IG+GSFG V K       K +  K I     + KE   L  E  I + L HPN
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 180 IIKFI-----ASHETLNEFVLITEF-AHMSLSNLL----EQRKKLSETICVQILSNLISA 229
           I+++       S++TL    ++ E+     L+ L+    ++RK + E    +IL+ L+ A
Sbjct: 61  IVRYYDRIIDRSNQTLY---IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117

Query: 230 LYYLH-----SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYM 284
           LY  H      N VLHRDLKP N+ L+ +    L DFG A+ +   +    +  GTP YM
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYM 177

Query: 285 APELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSET 343
           +PE +    YD  +D+WSLGC+ YE+    PPF   + L L   +K       P + S  
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237

Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLV 371
             +++K +L  D  +R S  ELL  PL+
Sbjct: 238 LNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  190 bits (486), Expect = 2e-56
 Identities = 91/271 (33%), Positives = 136/271 (50%), Gaps = 20/271 (7%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E Y+ +  IGEG+ G+V+KA      K VA+K +       +    +  E  I K   HP
Sbjct: 19  ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKHP 75

Query: 179 NIIKFIASHETLNEFVLITEFAHM---SLSNLLEQ-RKKLSE----TICVQILSNLISAL 230
           NI+ +  S+   +E  ++ E+  M   SL++++ Q   +++E     +C ++L      L
Sbjct: 76  NIVDYYDSYLVGDELWVVMEY--MDGGSLTDIITQNFVRMNEPQIAYVCREVLQ----GL 129

Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  V+HRD+K  N+LL+KDG   L DFGFA  +        S+ GTP +MAPE+I 
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPP---FKTVSILHLIRLLKTQDVTFPSQVSETYKDL 347
            + Y    D+WSLG +  E+  G PP      +  L LI       +  P + S  +KD 
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249

Query: 348 VKGLLEKDASQRLSWPELLHHPLVKDNLSSE 378
           +   L KD  +R S  ELL HP +K     E
Sbjct: 250 LNKCLVKDPEKRPSAEELLQHPFLKKACPKE 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  182 bits (463), Expect = 1e-53
 Identities = 86/258 (33%), Positives = 141/258 (54%), Gaps = 9/258 (3%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E +  +  +GEGS+G V+KAIH +  + VA+K++        +L  + +E  I K    P
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSP 58

Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSN 236
            I+K+  S+    +  ++ E+    S+S++++   K L+E     IL   +  L YLHSN
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
           + +HRD+K  N+LLN++G A L DFG +  +        ++ GTP +MAPE+I E  Y++
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT---QDVTFPSQVSETYKDLVKGLLE 353
            AD+WSLG  A E+  G PP+  +  +  I ++       ++ P + S  + D VK  L 
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV 238

Query: 354 KDASQRLSWPELLHHPLV 371
           KD  +R S  +LL HP +
Sbjct: 239 KDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  170 bits (434), Expect = 4e-49
 Identities = 84/273 (30%), Positives = 127/273 (46%), Gaps = 29/273 (10%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKS--GRSGKELSSLKQECEIQKHLA-HPNIIK 182
           +IGEGSF  V  A   +  K  A+KI+ K    +  K    +K E E+   L  HP IIK
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV-KYVKIEKEVLTRLNGHPGIIK 66

Query: 183 FIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
              + +       + E+A +  L   + +   L E       + ++ AL YLHS  ++HR
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHR 126

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSM--------------------AVGTHMLTSIKGTP 281
           DLKP+N+LL+KD    + DFG A+ +                            S  GT 
Sbjct: 127 DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTA 186

Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVS 341
            Y++PEL+ E+P   ++DLW+LGCI Y++  G PPF+  +     + +   + +FP    
Sbjct: 187 EYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFP 246

Query: 342 ETYKDLVKGLLEKDASQRL----SWPELLHHPL 370
              KDL++ LL  D   RL     + EL  HP 
Sbjct: 247 PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  168 bits (427), Expect = 3e-48
 Identities = 94/271 (34%), Positives = 133/271 (49%), Gaps = 33/271 (12%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E +  +  IG+GSFG+V+KAI     + VA+K+I     +  E+  ++QE +       P
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-EAEDEIEDIQQEIQFLSQCRSP 59

Query: 179 NIIKFIASHETLNEFVL--ITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
            I K+  S   L    L  I E+    S  +LL+  K L ET    IL  ++  L YLH 
Sbjct: 60  YITKYYGSF--LKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHE 116

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK-----GTPLYMAPELIA 290
              +HRD+K  N+LL+++G   L DFG +  +       T  K     GTP +MAPE+I 
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVSGQLT-----STMSKRNTFVGTPFWMAPEVIK 171

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL---------KTQDVTFPSQVS 341
           +  YD  AD+WSLG  A E+  G PP    S LH +R+L           +   F    S
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPL---SDLHPMRVLFLIPKNNPPSLEGNKF----S 224

Query: 342 ETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
           + +KD V   L KD  +R S  ELL H  +K
Sbjct: 225 KPFKDFVSLCLNKDPKERPSAKELLKHKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  168 bits (427), Expect = 4e-48
 Identities = 95/292 (32%), Positives = 139/292 (47%), Gaps = 55/292 (18%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSG---KELSSLKQECEIQK 173
           Y+K+  +GEG++G V+KA      + VALK I     + G      +E+S LK+      
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKE------ 54

Query: 174 HLAHPNIIK---FIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQ-ILSNLISA 229
            L HPNI+K    I +   L    L+ E+  M L   L++R        ++ I+  L+  
Sbjct: 55  -LKHPNIVKLLDVIHTERKL---YLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRG 110

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG--TPLYMAPE 287
           L Y HS+R+LHRDLKPQN+L+N+DGV  L DFG AR  A G  + T      T  Y APE
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR--AFGIPLRTYTHEVVTLWYRAPE 168

Query: 288 -LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH-LIRL----------------- 328
            L+  + Y    D+WS+GCI  E+  G P F   S +  L ++                 
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228

Query: 329 LKTQDVTFPSQVSETYK-----------DLVKGLLEKDASQRLSWPELLHHP 369
           L     TFP    +  +           DL+  +L+ + ++R+S  E L HP
Sbjct: 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  165 bits (421), Expect = 4e-47
 Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 37/287 (12%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ-ECEIQKHLAH 177
            KY+ + ++GEG++G V K  +    + VA+K   K     +++      E ++ + L H
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRH 59

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSN 236
            NI+    +        L+ E+   +L  LLE     L        +  L+ A+ Y HS+
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-LTSIKGTPLYMAPE-LIAERPY 294
            ++HRD+KP+N+L+++ GV  LCDFGFAR++       LT    T  Y APE L+ +  Y
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179

Query: 295 DHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIR-----LLKTQDVTF---------- 336
               D+W++GCI  E+  G P F     +  L+LI+     L  +    F          
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239

Query: 337 --------------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
                         P +VS    D +K  L  D  +RL+  ELL HP
Sbjct: 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  163 bits (416), Expect = 1e-46
 Identities = 79/260 (30%), Positives = 127/260 (48%), Gaps = 12/260 (4%)

Query: 122 QKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +++ ++G+GS G V+K  H    K  ALK I   G        L +E +  +    P ++
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPYVV 62

Query: 182 KFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQILSNLISALYYLHSNR- 237
           K   +     E  ++ E+  M   SL++LL++  K+ E +   I   ++  L YLH+ R 
Sbjct: 63  KCYGAFYKEGEISIVLEY--MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           ++HRD+KP N+L+N  G   + DFG ++ +        +  GT  YM+PE I    Y + 
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT-QDVTFPSQVSETY----KDLVKGLL 352
           AD+WSLG    E  +G  PF          L++   D   PS  +E +    +D +   L
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240

Query: 353 EKDASQRLSWPELLHHPLVK 372
           +KD  +R S  ELL HP +K
Sbjct: 241 QKDPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  164 bits (417), Expect = 1e-46
 Identities = 89/281 (31%), Positives = 133/281 (47%), Gaps = 32/281 (11%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           YQK+  IGEG++G V+KA      + VA+K I     S     +  +E ++ K L HPNI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLE-QRKKLSETICVQILSNLISALYYLHSNRVL 239
           IK +       +  L+ EF    L  L++ +++ L E++    L  L+  L + HS+ +L
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-AERPYDHTA 298
           HRDLKP+N+L+N +GV  L DFG ARS        T    T  Y APEL+  ++ Y    
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180

Query: 299 DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD---------------VTFPSQ 339
           D+WS+GCI  E+    P F   S    +  + R L T D                +FP +
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240

Query: 340 V-----------SETYKDLVKGLLEKDASQRLSWPELLHHP 369
                       S    DL+  +L  D  +R++  + L HP
Sbjct: 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP 281

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  163 bits (415), Expect = 1e-46
 Identities = 82/252 (32%), Positives = 125/252 (49%), Gaps = 12/252 (4%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG+G+FGKV      D KK  A+K ++K        + ++  E  I + L HP ++    
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 186 SHETLNEFVLITEFAHMSLSNL---LEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
           S +      L+ +   +   +L   L Q+ K SE      +  ++ AL YLHS  ++HRD
Sbjct: 68  SFQDEENMYLVVDL--LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRD 125

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           +KP N+LL++ G   + DF  A  +   T + TS  GTP YMAPE++  + Y    D WS
Sbjct: 126 IKPDNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWS 184

Query: 303 LGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQR 359
           LG  AYE   G  P++  S      +    +T DV +P+  S    D +  LLE+D  +R
Sbjct: 185 LGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKR 244

Query: 360 LSWP--ELLHHP 369
           L     +L +HP
Sbjct: 245 LGDNLKDLKNHP 256

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  163 bits (415), Expect = 3e-46
 Identities = 83/246 (33%), Positives = 126/246 (51%), Gaps = 25/246 (10%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEIQKHLAHPNI 180
           +G GSFG+V    H    K  ALKI+SK      ++  LKQ      E  I + + HP +
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSK-----AKIVKLKQVEHVLNEKRILQSIRHPFL 63

Query: 181 IKFIAS-HETLN-----EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           +    S  +  N     E+V   E         L +  +  E +     + ++ AL YLH
Sbjct: 64  VNLYGSFQDDSNLYLVMEYVPGGELFS-----HLRKSGRFPEPVARFYAAQVVLALEYLH 118

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S  +++RDLKP+N+LL+ DG   + DFGFA+ +   T+ L    GTP Y+APE+I  + Y
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC---GTPEYLAPEIILSKGY 175

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
               D W+LG + YE+  G+PPF   + + +   +    V FPS  S   KDL++ LL+ 
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQV 235

Query: 355 DASQRL 360
           D ++RL
Sbjct: 236 DLTKRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  162 bits (412), Expect = 4e-46
 Identities = 83/262 (31%), Positives = 133/262 (50%), Gaps = 15/262 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAHPNIIKFIA 185
           I +G++G+VF A         A+K+I K+    K ++  +  E +I      P ++K   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 186 SHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
           S +      L+ E+     L++LLE    L E +    ++ ++ AL YLHSN ++HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--------IKGTPLYMAPELIAERPYDH 296
           P N+L++ +G   L DFG ++   V   +  +        I GTP Y+APE+I  + +  
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS--QVSETYKDLVKGLLEK 354
           T D WSLGCI YE  +G PPF   +   + + +    + +P   +VS+   DL+  LL  
Sbjct: 181 TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP 240

Query: 355 DASQRL---SWPELLHHPLVKD 373
           D  +RL   S  E+ +HP  K 
Sbjct: 241 DPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  158 bits (402), Expect = 6e-45
 Identities = 83/264 (31%), Positives = 136/264 (51%), Gaps = 18/264 (6%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALK---IISKSGRSGKELSSLKQECEIQKHLA 176
           +++K  L+G GSFG V++ ++LD     A+K   +        + +  L+QE  +   L 
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 177 HPNIIKFIA---SHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYY 232
           HPNI++++      + L  F+   E     SL+ LL++     E +       ++  L Y
Sbjct: 61  HPNIVQYLGTEREEDNLYIFL---ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEY 117

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           LH    +HRD+K  N+L++ +GV  L DFG A+ + V      S KG+P +MAPE+IA++
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFKGSPYWMAPEVIAQQ 176

Query: 293 -PYDHTADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDL 347
             Y   AD+WSLGC   E+  G PP+       ++  + R  +   +  P  +S+  KD 
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPI--PDHLSDEAKDF 234

Query: 348 VKGLLEKDASQRLSWPELLHHPLV 371
           +   L++D S R +  ELL HP V
Sbjct: 235 ILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  157 bits (399), Expect = 4e-44
 Identities = 83/259 (32%), Positives = 139/259 (53%), Gaps = 9/259 (3%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH--- 177
           YQ++ LIG G++G V++  H+   + VALKII+       ++S +++E  +   L     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQP 61

Query: 178 PNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           PNI K+  S+       +I E+A   S+  L++    ++E     I+  ++ AL Y+H  
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKV 120

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE-RPYD 295
            V+HRD+K  N+L+   G   LCDFG A  +   +   ++  GTP +MAPE+I E + YD
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-KTQDVTFP-SQVSETYKDLVKGLLE 353
             AD+WSLG   YE+  G+PP+  V     + L+ K++      +  S+  ++ V   L+
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLD 240

Query: 354 KDASQRLSWPELLHHPLVK 372
           ++  +RLS  ELL    +K
Sbjct: 241 EEPKERLSAEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  157 bits (398), Expect = 4e-44
 Identities = 78/255 (30%), Positives = 123/255 (48%), Gaps = 14/255 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSS-LKQECEIQKHLAHPNIIKFIA 185
           +G G FG+V         +T ALK + K           +  E EI +   HP I+K   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 186 SHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
           + +      ++ E+     L  +L  R    E      ++ ++ A  YLH+  +++RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLG 304
           P+N+LL+ +G   L DFGFA+ +  G    T   GTP Y+APE+I  + YD + D WSLG
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-GTPEYVAPEIILNKGYDFSVDYWSLG 179

Query: 305 CIAYEIHMGHPPFKT-----VSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQR 359
            + YE+  G PPF       + I + I L     + FP+ + +  KDL+K LL ++  +R
Sbjct: 180 ILLYELLTGRPPFGEDDEDPMEIYNDI-LKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238

Query: 360 L-----SWPELLHHP 369
           L        ++  H 
Sbjct: 239 LGNLKGGIKDIKKHK 253

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  157 bits (399), Expect = 4e-44
 Identities = 89/278 (32%), Positives = 136/278 (48%), Gaps = 33/278 (11%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-H 177
             ++ + +IGEG++GKV+KA H    + VA+KI+       +E+   K+E  I +  + H
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEI---KEEYNILRKYSNH 62

Query: 178 PNIIKF----IASHETLNE----FVLITEF-AHMSLSNL----LEQRKKLSETICVQILS 224
           PNI  F    I  +   N+     V+  E     S+++L     ++ K+L E     IL 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVM--ELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120

Query: 225 NLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYM 284
             +  L YLH N+V+HRD+K QN+LL K+    L DFG +  +        +  GTP +M
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180

Query: 285 APELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL------KTQD 333
           APE+IA     +  YD  +D+WSLG  A E+  G PP      +H +R L          
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRALFKIPRNPPPT 237

Query: 334 VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           +  P   S+ + D +   L K+  QR    ELL HP +
Sbjct: 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  157 bits (399), Expect = 5e-44
 Identities = 92/284 (32%), Positives = 139/284 (48%), Gaps = 35/284 (12%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAHP 178
           +Y+ +  IGEG+ G VFKA   +  +TVALK +  +    G    +L+ E +  +   HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHP 59

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNR 237
            ++K +      + FVL+ E+    LS +L ++ + L E      +  L+  + Y+H+N 
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK-GTPLYMAPELI-AERPYD 295
           ++HRDLKP N+L++ DGV  + DFG AR  +     L S +  T  Y APEL+   R YD
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD---------------VTF 336
              DLW++GCI  E+  G P F   +    +  + R L T +               +TF
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239

Query: 337 PSQVSETYK-----------DLVKGLLEKDASQRLSWPELLHHP 369
           P       +           DL+KGLL  D S+RLS  E L HP
Sbjct: 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  155 bits (393), Expect = 3e-43
 Identities = 85/286 (29%), Positives = 139/286 (48%), Gaps = 38/286 (13%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAHPN 179
           Y+KI  IGEG++G+V+KA +    + VALK I  ++ + G  +++++ E ++ + L HPN
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59

Query: 180 IIKF--IASHETLNEFVLITEFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSN 236
           I++   I + +      ++ E+    L+ LL+  + K +E+     +  L+  L YLHSN
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA-VGTHMLTSIKGTPLYMAPE-LIAERPY 294
            +LHRD+K  N+L+N DGV  L DFG AR      +   T+   T  Y  PE L+    Y
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY 179

Query: 295 DHTADLWSLGCIAYEIHMGHPPFK---TVSILHLI-RLLKT------------------- 331
               D+WS+GCI  E+ +G P F+    +  L  I  L  +                   
Sbjct: 180 GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239

Query: 332 QDVTFPSQVSETYK--------DLVKGLLEKDASQRLSWPELLHHP 369
               +  ++ E +K        DL+  LL  D  +R+S  + L H 
Sbjct: 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  152 bits (385), Expect = 2e-42
 Identities = 77/257 (29%), Positives = 130/257 (50%), Gaps = 8/257 (3%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           ++ +  +G+GS+G V+K   L   +  ALK +     S KE      E  I   + HPNI
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 181 IKFIASHETLNEFVLITEFAHMS-LSNLLEQRKK----LSETICVQILSNLISALYYLHS 235
           I +  +    N+  ++ E+A    LS  + +RKK    + E    +I   L+  L  LH 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
            ++LHRDLK  N+LL  + +  + D G ++ +     M  +  GTP YMAPE+   RPY 
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYS 179

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
           + +D+WSLGC+ YE+    PPF+  S+  L  ++ + +    P   S+  ++ ++ +L+ 
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQV 239

Query: 355 DASQRLSWPELLHHPLV 371
               R +  ++L  P V
Sbjct: 240 KPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  150 bits (382), Expect = 8e-42
 Identities = 83/270 (30%), Positives = 136/270 (50%), Gaps = 24/270 (8%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + Y+ I +IG G+   V+ AI L   + VA+K I    +    +  L++E +      HP
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLE-KCQTSVDELRKEVQAMSQCNHP 59

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLE------QRKKLSETICVQILSNLISALYY 232
           N++K+  S    +E  L+  +  +S  +LL+       R  L E I   +L  ++  L Y
Sbjct: 60  NVVKYYTSFVVGDELWLVMPY--LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT----HMLTSIKGTPLYMAPEL 288
           LHSN  +HRD+K  N+LL +DG   + DFG + S+A G      +  +  GTP +MAPE+
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 289 IAERP-YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS--------Q 339
           + +   YD  AD+WS G  A E+  G  P+     + +  L+ T     PS        +
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQNDPPSLETGADYKK 235

Query: 340 VSETYKDLVKGLLEKDASQRLSWPELLHHP 369
            S++++ ++   L+KD S+R +  ELL H 
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHK 265

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  150 bits (381), Expect = 1e-41
 Identities = 84/258 (32%), Positives = 142/258 (55%), Gaps = 7/258 (2%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY +   IG+G+ G V+ AI +   + VA+K ++   +  KEL  +  E  + +   HP
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHP 76

Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+ ++ S+   +E  ++ E+ A  SL++++ +   + E     +    + AL +LHSN+
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           V+HRD+K  N+LL  DG   L DFGF   +       +++ GTP +MAPE++  + Y   
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 298 ADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
            D+WSLG +A E+  G PP+     +  L+LI    T ++  P ++S  ++D +   LE 
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 255

Query: 355 DASQRLSWPELLHHPLVK 372
           D  +R S  ELL HP +K
Sbjct: 256 DVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  148 bits (377), Expect = 3e-41
 Identities = 87/275 (31%), Positives = 131/275 (47%), Gaps = 38/275 (13%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
            E Y+ I  IG G++G V+KA  +   + VA+K+I      G +   ++QE  + K   H
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRH 59

Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQ-RKKLSET----ICVQILSNLISALY 231
           PNI+ +  S+   ++  ++ E+    SL ++ +  R  LSE     +C + L      L 
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK----GLA 115

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPEL 288
           YLH    +HRD+K  N+LL +DG   L DFG +   A  T  +    S  GTP +MAPE+
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVS---AQLTATIAKRKSFIGTPYWMAPEV 172

Query: 289 IAER---PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-----------KTQDV 334
            A      YD   D+W+LG  A E+    PP      LH +R L           K +D 
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPM---FDLHPMRALFLISKSNFPPPKLKD- 228

Query: 335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
               + S  + D +K  L KD  +R +  +LL HP
Sbjct: 229 --KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  149 bits (376), Expect = 7e-41
 Identities = 88/258 (34%), Positives = 142/258 (55%), Gaps = 7/258 (2%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY +   IG+G+ G VF AI +   + VA+K I+   +  KEL  +  E  + K L +P
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNP 76

Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+ F+ S    +E  ++ E+ A  SL++++ +   + E     +    + AL +LH+N+
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           V+HRD+K  NVLL  DG   L DFGF   +       +++ GTP +MAPE++  + Y   
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 298 ADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
            D+WSLG +A E+  G PP+     +  L+LI    T ++  P ++S  ++D +   LE 
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEM 255

Query: 355 DASQRLSWPELLHHPLVK 372
           D  +R S  ELL HP +K
Sbjct: 256 DVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  148 bits (375), Expect = 8e-41
 Identities = 92/263 (34%), Positives = 140/263 (53%), Gaps = 18/263 (6%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G+G+FGKV+KA H +     A KII     S +EL     E +I     HPNI+    +
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 187 HETLNEFVLITEF-AHMSLSNL-LEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
           +   N+  ++ EF    +L ++ LE  + L+E     +   ++ AL +LHS++V+HRDLK
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPELIA-----ERPYDH 296
             N+LL  DG   L DFG +   A     L    +  GTP +MAPE++A     + PYD+
Sbjct: 131 AGNILLTLDGDVKLADFGVS---AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILH-LIRLLKTQDVTF--PSQVSETYKDLVKGLLE 353
            AD+WSLG    E+    PP   ++ +  L+++LK++  T   PS+ S ++ D +K  L 
Sbjct: 188 KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLV 247

Query: 354 KDASQRLSWPELLHHPLVKDNLS 376
           KD   R +  ELL HP V D   
Sbjct: 248 KDPDDRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  147 bits (374), Expect = 2e-40
 Identities = 81/263 (30%), Positives = 136/263 (51%), Gaps = 18/263 (6%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           L+ + KI   GEGS G V  A      + VA+K +    +  +EL  L  E  I +   H
Sbjct: 21  LDNFVKI---GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL--LFNEVVIMRDYQH 75

Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSE----TICVQILSNLISALYY 232
           PNI++  +S+   +E  ++ EF    +L++++    +++E    T+C+ +L     AL +
Sbjct: 76  PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLK----ALSF 130

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           LH+  V+HRD+K  ++LL  DG   L DFGF   ++       S+ GTP +MAPE+I+  
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL 190

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF---PSQVSETYKDLVK 349
           PY    D+WSLG +  E+  G PP+     L  ++ ++           +VS   +  + 
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250

Query: 350 GLLEKDASQRLSWPELLHHPLVK 372
            +L +D +QR +  ELL+HP + 
Sbjct: 251 RMLVRDPAQRATAAELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  147 bits (372), Expect = 2e-40
 Identities = 89/266 (33%), Positives = 136/266 (51%), Gaps = 16/266 (6%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           ++Q+   IG G+FGKV+ A++LD  + +A+K I       K +  +  E ++ + L HPN
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 180 IIKFIASHETLNEFVLI-TEFAHM-SLSNLLEQRKKLSETICVQILSN-LISALYYLHSN 236
           ++K+    E   E V I  E+    +L  LLE  + L E   +++ +  L+  L YLHS+
Sbjct: 61  LVKYYGV-EVHREKVYIFMEYCSGGTLEELLEHGRILDEH-VIRVYTLQLLEGLAYLHSH 118

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT----HMLTSIKGTPLYMAPELIAER 292
            ++HRD+KP N+ L+ +GV  L DFG A  +   T      + S+ GTP YMAPE+I   
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 293 PYDH---TADLWSLGCIAYEIHMGHPPFKTVSILHLI--RLLKTQDVTFPS--QVSETYK 345
                   AD+WSLGC+  E+  G  P+  +     I   +        P   Q+S   K
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238

Query: 346 DLVKGLLEKDASQRLSWPELLHHPLV 371
           D +   LE D  +R +  ELL HP V
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  146 bits (370), Expect = 3e-40
 Identities = 86/250 (34%), Positives = 127/250 (50%), Gaps = 22/250 (8%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLK------QECEIQKHLAHPNI 180
           IG+G F  V+KAI L   + VALK +        E+   K      +E ++ K L HPN+
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIF-----EMMDAKARQDCLKEIDLLKQLDHPNV 64

Query: 181 IKFIASHETLNEFVLITEFAHM-SLSNLL----EQRKKLSETICVQILSNLISALYYLHS 235
           IK++AS    NE  ++ E A    LS ++    +Q++ + E    +    L SAL ++HS
Sbjct: 65  IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
            R++HRD+KP NV +   GV  L D G  R  +  T    S+ GTP YM+PE I E  Y+
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-KTQDVTFP----SQVSETYKDLVKG 350
             +D+WSLGC+ YE+     PF     ++L  L  K +   +P       SE  +DLV  
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243

Query: 351 LLEKDASQRL 360
            +  D  +R 
Sbjct: 244 CINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  146 bits (369), Expect = 3e-40
 Identities = 75/247 (30%), Positives = 123/247 (49%), Gaps = 4/247 (1%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG+GSFG VFK +    K+  A+K I  S  + +E      E  +   L    II++  S
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 187 HETLNEFVLITEFA-HMSLSNLLE-QRKK-LSETICVQILSNLISALYYLHSNRVLHRDL 243
                +  ++ E+A +  L  LL+ QR + L E    +    ++  L +LHS ++LHRD+
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDI 127

Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSL 303
           K  N+ L+      + D G A+ ++  T+   +I GTP Y++PEL  ++PY+  +D+W+L
Sbjct: 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWAL 187

Query: 304 GCIAYEIHMGHPPFKTVSILHLIR-LLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW 362
           G + YE   G  PF   +   LI  +++          S+    L+   L KD  QR   
Sbjct: 188 GVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDT 247

Query: 363 PELLHHP 369
            +LL +P
Sbjct: 248 FQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  145 bits (368), Expect = 1e-39
 Identities = 77/249 (30%), Positives = 129/249 (51%), Gaps = 15/249 (6%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEIQ 172
           +  ++I  +G G+FG+V        +   ALK+++       E+  LKQ      E  + 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP-----EVIRLKQEQHVHNEKRVL 55

Query: 173 KHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALY 231
           K ++HP II+   +        ++ E+     L + L    + S +  +   S ++ AL 
Sbjct: 56  KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE 115

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           YLHS  +++RDLKP+N+LL+K+G   L DFGFA+ +   T  L    GTP Y+APE+I  
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC---GTPEYLAPEVIQS 172

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGL 351
           + ++   D W+LG + YE+ +G+PPF   +   +   +    + FP  +    KDL+K L
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKL 232

Query: 352 LEKDASQRL 360
           L  D ++RL
Sbjct: 233 LVVDRTRRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  144 bits (365), Expect = 1e-39
 Identities = 77/259 (29%), Positives = 140/259 (54%), Gaps = 10/259 (3%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           KY+KI ++G G+FG V        +K V +K I     +  E  + + EC++ K L+HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 180 IIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKK--LSETICVQILSNLISALYYLHSN 236
           II++  +       +++ E+A   +L+  +++R    L E   +     ++ AL+++H+ 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 237 RVLHRDLKPQNVLLNK-DGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
            +LHRDLK QN+LL+K   V  + DFG ++ ++  +   T + GTP Y++PEL   +PY+
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTPCYISPELCEGKPYN 179

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP---SQVSETYKDLVKGLL 352
             +D+W+LGC+ YE+      F+  ++  L+  LK    TF     + S   + L+  +L
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALV--LKIMSGTFAPISDRYSPDLRQLILSML 237

Query: 353 EKDASQRLSWPELLHHPLV 371
             D S+R    +++  P+ 
Sbjct: 238 NLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  146 bits (371), Expect = 2e-39
 Identities = 81/293 (27%), Positives = 125/293 (42%), Gaps = 46/293 (15%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---ECEIQKHLA 176
           +Y+ +  IG G++G V  A+     + VA+K   K      +L   K+   E ++ +HL 
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLR 57

Query: 177 HPNIIKFIA-----SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
           H NII  +      S E  N+  ++TE     L  +++  + L++      L  ++  L 
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM---AVGTHMLTSIKGTPLYMAPEL 288
           YLHS  V+HRDLKP N+L+N +    +CDFG AR +         LT    T  Y APEL
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPEL 177

Query: 289 I-AERPYDHTADLWSLGCIAYEIHMGHPPFK---TVSILHLI------------------ 326
           + +   Y    D+WS+GCI  E+    P F     +  L+LI                  
Sbjct: 178 LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237

Query: 327 -------RLLKTQDVTFPSQVSETYK---DLVKGLLEKDASQRLSWPELLHHP 369
                   L K                  DL++ +L  D  +R++  E L HP
Sbjct: 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  147 bits (371), Expect = 2e-39
 Identities = 100/294 (34%), Positives = 151/294 (51%), Gaps = 32/294 (10%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHP 178
            Y+ +  +GEGSFG+V+ A     +K VALK+++K   S  KE+    +E +I   L HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 179 -NIIKFIASHETLNEFVLITEFAH-MSLSNLLEQR---KKLSETICVQILSNLISALYYL 233
            NI+K     +      L+ E+    SL +LL++      LSE+  + IL+ ++SAL YL
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 234 HSNRVLHRDLKPQNVLLNKDG-VAMLCDFGFARSMA------VGTHMLTSIKGTPLYMAP 286
           HS  ++HRD+KP+N+LL++DG V  L DFG A+ +           + ++  GTP YMAP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 287 ELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFK-------TVSILHLIRLLKTQDVT- 335
           E++          ++D+WSLG   YE+  G PPF+       T   L +I  L T  +  
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 336 -----FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNN 384
                 P  +S+   DL+K LL KD   RLS    L H L+      E +  + 
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291

Length = 384

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  144 bits (363), Expect = 3e-39
 Identities = 91/257 (35%), Positives = 132/257 (51%), Gaps = 8/257 (3%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E + K+  IG+GSFG+V+K I    K+ VA+KII     +  E+  ++QE  +      P
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSP 62

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            I ++  S+    +  +I E+     +  L +   L ET    IL  ++  L YLHS R 
Sbjct: 63  YITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK 122

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           +HRD+K  NVLL++ G   L DFG A  +        +  GTP +MAPE+I +  YD  A
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLL----KTQDVTFPSQVSETYKDLVKGLLEK 354
           D+WSLG  A E+  G PP    S LH +R+L    K    T   Q S+ +K+ V+  L K
Sbjct: 183 DIWSLGITAIELAKGEPPN---SDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239

Query: 355 DASQRLSWPELLHHPLV 371
           D   R +  ELL H  +
Sbjct: 240 DPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  144 bits (365), Expect = 3e-39
 Identities = 90/281 (32%), Positives = 128/281 (45%), Gaps = 32/281 (11%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           YQK+  IGEG++G V+KA      + VALK I          S+  +E  + K L HPNI
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLEQ--RKKLSETICVQILSNLISALYYLHSNRV 238
           ++ +    + N+  L+ EF  + L   ++      L   +    L  L+  + Y HS+RV
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPYDHT 297
           LHRDLKPQN+L++++G   L DFG AR+  V     T    T  Y APE L+  R Y   
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTP 180

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD--------------VTFPSQ 339
            D+WS+GCI  E+    P F   S    +  + R L T D               TFP  
Sbjct: 181 VDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKW 240

Query: 340 VSETYKDLVKGL-----------LEKDASQRLSWPELLHHP 369
             +    +V  L           L  D ++R+S    L HP
Sbjct: 241 ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  142 bits (359), Expect = 2e-38
 Identities = 88/263 (33%), Positives = 137/263 (52%), Gaps = 12/263 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E ++ I  +G+G+FGKV+KA + +     A K+I    +S +EL     E +I     HP
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT--KSEEELEDYMVEIDILASCDHP 62

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSN--LLEQRKKLSETICVQILSNLISALYYLHSN 236
           NI+K + +    N   ++ EF      +  +LE  + L+E     +    + AL YLH N
Sbjct: 63  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-----AE 291
           +++HRDLK  N+L   DG   L DFG +           S  GTP +MAPE++      +
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH-LIRLLKTQDVTF--PSQVSETYKDLV 348
           RPYD+ AD+WSLG    E+    PP   ++ +  L+++ K++  T   PS+ S  +KD +
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242

Query: 349 KGLLEKDASQRLSWPELLHHPLV 371
           K  LEK+   R +  +LL HP V
Sbjct: 243 KKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  142 bits (359), Expect = 2e-38
 Identities = 83/258 (32%), Positives = 142/258 (55%), Gaps = 7/258 (2%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY +   IG+G+ G V+ AI +   + VA+K ++   +  KEL  +  E  + +   +P
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNP 76

Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+ ++ S+   +E  ++ E+ A  SL++++ +   + E     +    + AL +LHSN+
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           V+HRD+K  N+LL  DG   L DFGF   +       +++ GTP +MAPE++  + Y   
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 298 ADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
            D+WSLG +A E+  G PP+     +  L+LI    T ++  P ++S  ++D +   LE 
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEM 255

Query: 355 DASQRLSWPELLHHPLVK 372
           D  +R S  ELL HP +K
Sbjct: 256 DVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  139 bits (353), Expect = 2e-37
 Identities = 88/290 (30%), Positives = 139/290 (47%), Gaps = 42/290 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAH 177
           ++Y+K+  I EG++G V++A      + VALK +  +  + G  ++SL+ E  I   L H
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63

Query: 178 PNI--IKFIASHETLNEFVLITEFAHMSLSNLLEQRKK---LSETICVQILSNLISALYY 232
           PNI  +K +     L++  ++ E+    L +L+E  K+    SE  C  ++  L+S + +
Sbjct: 64  PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC--LMLQLLSGVAH 121

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAE 291
           LH N +LHRDLK  N+LLN  G+  +CDFG AR         T +  T  Y APE L+  
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKT---------------Q 332
           + Y    D+WS+GCI  E+    P F   S    +  + +LL T               +
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241

Query: 333 DVTFPSQ-------------VSETYKDLVKGLLEKDASQRLSWPELLHHP 369
             TF                +S+   DL+  LL  D ++R+S  + L HP
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 3e-37
 Identities = 76/256 (29%), Positives = 134/256 (52%), Gaps = 11/256 (4%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIIS---KSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           L+G+G+FG+V+    +D  + +A+K +     S  + KE+++L+ E ++ K+L H  I++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
           +           +  E+    S+ + L+    L+ET+  +    ++  + YLHSN ++HR
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAV----GTHMLTSIKGTPLYMAPELIAERPYDHT 297
           D+K  N+L +  G   L DFG ++ +      GT M  S+ GTP +M+PE+I+   Y   
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM-KSVTGTPYWMSPEVISGEGYGRK 187

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT--FPSQVSETYKDLVKGLLEKD 355
           AD+WS+GC   E+    PP+     +  I  + TQ      PS VS   ++ ++    ++
Sbjct: 188 ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVEN 247

Query: 356 ASQRLSWPELLHHPLV 371
           A +R S  ELL H  V
Sbjct: 248 AKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  138 bits (348), Expect = 4e-37
 Identities = 84/265 (31%), Positives = 135/265 (50%), Gaps = 15/265 (5%)

Query: 121 YQKICLIGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           + K  ++G+G++G V+  +     L   K V L   S    + KE   L++E ++ K L 
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDT-SNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 177 HPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           H NI++++ +    N   +  EF    S+S++L +   L E +  +    ++  + YLH+
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV----GTH--MLTSIKGTPLYMAPELI 289
           N V+HRD+K  NV+L  +G+  L DFG AR +A     GTH  ML S+ GTP +MAPE+I
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS---QVSETYKD 346
            E  Y   +D+WS+GC  +E+  G PP  ++  L  +  +       P      S    D
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAID 240

Query: 347 LVKGLLEKDASQRLSWPELLHHPLV 371
            V   L +D  +R S  +LL H  +
Sbjct: 241 FVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  138 bits (350), Expect = 6e-37
 Identities = 90/306 (29%), Positives = 140/306 (45%), Gaps = 53/306 (17%)

Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKH 174
             L  Y+ +  +GEG+FG+V+KA  +   + VALK I+  + + G  +++L+ E +I K 
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKK 63

Query: 175 LAHPNIIKFI--------ASHETLNEFVLITEFAHMSLSNLLE-QRKKLSETICVQILSN 225
           L HPN++  I         S        ++T +    LS LLE    KL+E+     +  
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQ 123

Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-----------AVGTHML 274
           L+  + YLH N +LHRD+K  N+L++  G+  + DFG AR               GT   
Sbjct: 124 LLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183

Query: 275 TSIKGTPLYMAPELIA-ERPYDHTADLWSLGCIAYEIHMGHPPFKTVS---ILHLI-RLL 329
           T++  T  Y  PEL+  ER Y    D+W +GC+  E+    P  +  S    LHLI +L 
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243

Query: 330 KT---------------QDV----TFPSQVSETYK-------DLVKGLLEKDASQRLSWP 363
            T               + V     +P  + E +        DL+  LL  D  +RL+  
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTAS 303

Query: 364 ELLHHP 369
           + L HP
Sbjct: 304 DALEHP 309

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  137 bits (345), Expect = 1e-36
 Identities = 86/257 (33%), Positives = 130/257 (50%), Gaps = 2/257 (0%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E + K+  IG+GSFG+VFK I    +K VA+KII     +  E+  ++QE  +      P
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSP 62

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            + K+  S+    +  +I E+     +  L +   L ET    IL  ++  L YLHS + 
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           +HRD+K  NVLL++ G   L DFG A  +        +  GTP +MAPE+I +  YD  A
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           D+WSLG  A E+  G PP   +  + ++ L+ K    T     S+  K+ V+  L K+ S
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 242

Query: 358 QRLSWPELLHHPLVKDN 374
            R +  ELL H  +   
Sbjct: 243 FRPTAKELLKHKFIVRF 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  136 bits (345), Expect = 2e-36
 Identities = 90/294 (30%), Positives = 138/294 (46%), Gaps = 54/294 (18%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSG------KELSSLKQECEIQK 173
           Y+++  IGEG++G V+KA  L+  + VALK +       G      +E++ LKQ      
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE---- 56

Query: 174 HLAHPNIIKFI---ASHETLNEFV--LITEFAHMSLSNLLEQRKK--LSETICVQILSNL 226
              HPNI++ +       T  E    L+ E     L+  L +  K  L       ++  L
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116

Query: 227 ISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR----SMAVGTHMLTSIKGTPL 282
           +  + +LHS+R++HRDLKPQN+L+  DG   + DFG AR     MA     LTS+  T  
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-----LTSVVVTLW 171

Query: 283 YMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLIRLLKTQD-- 333
           Y APE++ +  Y    D+WS+GCI  E+    P F+  S       I  +I L   ++  
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231

Query: 334 -------VTFPS-----------QVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
                   +FPS           ++ E   DL+K +L  +  +R+S  E L HP
Sbjct: 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  135 bits (341), Expect = 7e-36
 Identities = 90/293 (30%), Positives = 140/293 (47%), Gaps = 51/293 (17%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALK---------IISKSGRSGKELSSLKQEC 169
           EKY+K+  IGEGS+G VFK  + +  + VA+K         +I K     +E+  LKQ  
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL--REIRMLKQ-- 56

Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQR-KKLSETICVQILSNLIS 228
                L HPN++  I       +  L+ E+   ++ N LE+  + + E +  +I+   + 
Sbjct: 57  -----LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQ 111

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           A+ + H +  +HRD+KP+N+L+ K G   LCDFGFAR +       T    T  Y APEL
Sbjct: 112 AVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL 171

Query: 289 I-AERPYDHTADLWSLGCIAYEIHMGHP--PFKT-VSILHLIR------------LLKTQ 332
           +  +  Y    D+W++GC+  E+  G P  P K+ V  L+LIR            +  T 
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231

Query: 333 D----VTFPS------------QVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
                ++ P              +S      +KG L+ D ++RLS  ELL HP
Sbjct: 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  135 bits (340), Expect = 9e-36
 Identities = 79/258 (30%), Positives = 141/258 (54%), Gaps = 7/258 (2%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY +   IG+G+ G V+ A+ +   + VA++ ++   +  KEL  +  E  + +   +P
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77

Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+ ++ S+   +E  ++ E+ A  SL++++ +   + E     +    + AL +LHSN+
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           V+HRD+K  N+LL  DG   L DFGF   +       +++ GTP +MAPE++  + Y   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 298 ADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
            D+WSLG +A E+  G PP+     +  L+LI    T ++  P ++S  ++D +   L+ 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256

Query: 355 DASQRLSWPELLHHPLVK 372
           D  +R S  ELL H  +K
Sbjct: 257 DVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  135 bits (342), Expect = 1e-35
 Identities = 77/250 (30%), Positives = 133/250 (53%), Gaps = 7/250 (2%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQ-KHLAHPNIIKFI 184
           IG+GSFGKV  A H    K  A+K++ K      KE   +  E  +  K++ HP ++   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 185 ASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            S +T ++   + ++ +   L   L++ +   E       + + SAL YLHS  +++RDL
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSL 303
           KP+N+LL+  G  +L DFG  +     +   ++  GTP Y+APE++ ++PYD T D W L
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCL 182

Query: 304 GCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL--- 360
           G + YE+  G PPF +     +   +  + +     +S + + L++GLL+KD ++RL   
Sbjct: 183 GAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242

Query: 361 -SWPELLHHP 369
             + E+ +H 
Sbjct: 243 DDFLEIKNHV 252

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  134 bits (338), Expect = 3e-35
 Identities = 73/211 (34%), Positives = 117/211 (55%), Gaps = 16/211 (7%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAHP 178
           KY+K+  IG+G+FG+VFKA H   K+ VALK ++ ++ + G  +++L+ E +I + L H 
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHE 71

Query: 179 NIIKFIASHETL--------NEFVLITEFAHMSLSNLLEQRK-KLSETICVQILSNLISA 229
           N++  I    T           F L+ EF    L+ LL  +  K + +   +++  L++ 
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT----HMLTSIKGTPLYMA 285
           LYY+H N++LHRD+K  N+L+ KDG+  L DFG AR+ ++      +  T+   T  Y  
Sbjct: 132 LYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 286 PE-LIAERPYDHTADLWSLGCIAYEIHMGHP 315
           PE L+ ER Y    D+W  GCI  E+    P
Sbjct: 192 PELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  133 bits (336), Expect = 3e-35
 Identities = 91/281 (32%), Positives = 132/281 (46%), Gaps = 32/281 (11%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L HPNI
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLE--QRKKLSETICVQILSNLISALYYLHSNRV 238
           +K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS+RV
Sbjct: 62  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPYDHT 297
           LHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE L+  + Y   
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 181

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKT----QDVTFPS-------------- 338
            D+WSLGCI  E+      F   S I  L R+ +T     +V +P               
Sbjct: 182 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKW 241

Query: 339 ----------QVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
                      + E  +DL+  +L  D ++R+S    L HP
Sbjct: 242 ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  131 bits (332), Expect = 7e-35
 Identities = 79/268 (29%), Positives = 131/268 (48%), Gaps = 17/268 (6%)

Query: 120 KYQKICLIGEGSFGKVFKAIH-----LDLKKTVALKIISKSG--RSGKELSSLKQECEIQ 172
           K+ K  LIG GSFG V+  ++     L   K V L  +S S   R    L +L +E  + 
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 173 KHLAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALY 231
           K L H NI++++ S    +   +  E+    S++ LL       ET+    +  ++  L 
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR-------SMAVGTHMLTSIKGTPLYM 284
           YLH+  ++HRD+K  N+L++  G   + DFG ++       S         S++G+  +M
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR-PSLQGSVFWM 179

Query: 285 APELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQDVTFPSQVSET 343
           APE++ +  Y   AD+WSLGC+  E+  G  PF   + L  I ++ +      PS +S  
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239

Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLV 371
             D ++   E D ++R +  ELL HP +
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  132 bits (332), Expect = 8e-35
 Identities = 86/260 (33%), Positives = 131/260 (50%), Gaps = 8/260 (3%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E + K+  IG+GSFG+VFK I    ++ VA+KII     +  E+  ++QE  +      P
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSP 62

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            + K+  S+    +  +I E+     +  L +     E     +L  ++  L YLHS + 
Sbjct: 63  YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK 122

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           +HRD+K  NVLL++ G   L DFG A  +        +  GTP +MAPE+I +  YD  A
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLL----KTQDVTFPSQVSETYKDLVKGLLEK 354
           D+WSLG  A E+  G PP    S +H +R+L    K    T   + S+ +K+ +   L K
Sbjct: 183 DIWSLGITAIELAKGEPP---NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239

Query: 355 DASQRLSWPELLHHPLVKDN 374
           D S R +  ELL H  +  N
Sbjct: 240 DPSFRPTAKELLKHKFIVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  133 bits (337), Expect = 9e-35
 Identities = 95/313 (30%), Positives = 144/313 (46%), Gaps = 59/313 (18%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKII-------SKSGRSGKELSSLKQECE 170
           L KY+ +  +G+G++G V+KAI    K+ VALK I       + + R+ +E+  L++  +
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD 65

Query: 171 IQKHLAHPNIIKFIASHETLN--EFVLITEFAHMSLSNLLEQRKKLSETICVQ-ILSNLI 227
                 HPNI+K +   +  N  +  L+ E+    L  ++  R  + E +  + I+  L+
Sbjct: 66  ------HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVI--RANILEDVHKRYIMYQLL 117

Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA-----VGTHMLTSIKGTPL 282
            AL Y+HS  V+HRDLKP N+LLN D    L DFG ARS++         +LT    T  
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 283 YMAPE-LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL------------ 329
           Y APE L+    Y    D+WS+GCI  E+ +G P F   S L+ +  +            
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237

Query: 330 --------------------KTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
                               K  D   P    +   DL+K LL  + ++RL+  E L HP
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDAL-DLLKKLLVFNPNKRLTAEEALEHP 296

Query: 370 LVKD--NLSSEIE 380
            V    N S E  
Sbjct: 297 YVAQFHNPSDEPV 309

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  131 bits (331), Expect = 9e-35
 Identities = 81/243 (33%), Positives = 121/243 (49%), Gaps = 10/243 (4%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISK-SGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG G F +V++A  L  +K VALK +        K      +E ++ K L HPN+IK++ 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 186 SHETLNEFVLITEFAHM-SLSNLL----EQRKKLSETICVQILSNLISALYYLHSNRVLH 240
           S    NE  ++ E A    LS ++    +Q++ + E    +    L SA+ ++HS RV+H
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADL 300
           RD+KP NV +   GV  L D G  R  +  T    S+ GTP YM+PE I E  Y+  +D+
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 189

Query: 301 WSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDLVKGLLEKDA 356
           WSLGC+ YE+     PF    +       K +   +P       SE  ++LV   +  D 
Sbjct: 190 WSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDP 249

Query: 357 SQR 359
            QR
Sbjct: 250 DQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  132 bits (332), Expect = 1e-34
 Identities = 92/274 (33%), Positives = 140/274 (51%), Gaps = 20/274 (7%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E ++ I  +G+G+FGKV+KA + +     A K+I    +S +EL     E EI     HP
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHP 69

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSN--LLEQRKKLSE----TICVQILSNLISALYY 232
            I+K + +     +  ++ EF      +  +LE  + L+E     IC Q+L     AL Y
Sbjct: 70  YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE----ALQY 125

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI--- 289
           LHS +++HRDLK  NVLL  DG   L DFG +           S  GTP +MAPE++   
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 290 --AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH-LIRLLKTQDVTF--PSQVSETY 344
              + PYD+ AD+WSLG    E+    PP   ++ +  L+++ K++  T   PS+ S  +
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245

Query: 345 KDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSE 378
           +D +K  L+K    R S  +LL HP V    S+ 
Sbjct: 246 RDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  130 bits (329), Expect = 2e-34
 Identities = 84/261 (32%), Positives = 137/261 (52%), Gaps = 18/261 (6%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIIS---KSGRSGKELSSLKQECEIQ--KHLAHPNI 180
           L+G+G+FG+V+    +D  + +A K +    +S  + KE+S+L  ECEIQ  K+L H  I
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSAL--ECEIQLLKNLQHERI 66

Query: 181 IKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           +++        E  L     +M   S+ + L+    L+E++  +    ++  + YLHSN 
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV----GTHMLTSIKGTPLYMAPELIAERP 293
           ++HRD+K  N+L +  G   L DFG ++ +      GT +  S+ GTP +M+PE+I+   
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI-RSVTGTPYWMSPEVISGEG 185

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT--FPSQVSETYKDLVKGL 351
           Y   AD+WSLGC   E+    PP+     +  I  + TQ      PS +SE  +D + G 
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GC 244

Query: 352 LEKDASQRLSWPELLHHPLVK 372
           +  +A  R S  ELL HP  +
Sbjct: 245 IFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  132 bits (334), Expect = 2e-34
 Identities = 82/259 (31%), Positives = 130/259 (50%), Gaps = 17/259 (6%)

Query: 110 KMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQE 168
           K + S+  L  ++    +G GSFG+V  A H    +  A+K + K      K++  + QE
Sbjct: 9   KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQE 68

Query: 169 CEIQKHLAHPNIIKFIASHETLN------EFVLITE-FAHMSLSNLLEQRKKLSETICVQ 221
             I   L+HP I+  + S +  N      EFV+  E F H      L +  +    +   
Sbjct: 69  KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTH------LRKAGRFPNDVAKF 122

Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
             + L+ A  YLHS  +++RDLKP+N+LL+  G   + DFGFA+ +   T  L    GTP
Sbjct: 123 YHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC---GTP 179

Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVS 341
            Y+APE+I  + +    D W++G + YE   G+PPF   +   +   +    + FP+   
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD 239

Query: 342 ETYKDLVKGLLEKDASQRL 360
              +DLVKGLL+ D ++RL
Sbjct: 240 GRARDLVKGLLQTDHTKRL 258

Length = 329

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  130 bits (329), Expect = 3e-34
 Identities = 84/285 (29%), Positives = 130/285 (45%), Gaps = 33/285 (11%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           EKY+ + L+GEGS+G V K  H +  + VA+K   +S           +E  + K L H 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           N++  I          L+ EF  H  L +L +    L E+   + L  ++  + + HS+ 
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP-YDH 296
           ++HRD+KP+N+L+++ GV  LCDFGFAR++A    + T    T  Y APEL+     Y  
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKT---------------QDVTFP 337
             D+W++GC+  E+  G P F   S    + H+I+ L                   +  P
Sbjct: 181 AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240

Query: 338 S------------QVSETYKDLVKGLLEKDASQRLSWPELLHHPL 370
                        ++S    DL K  L  D   R S  +LLHH  
Sbjct: 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  130 bits (328), Expect = 3e-34
 Identities = 77/258 (29%), Positives = 118/258 (45%), Gaps = 17/258 (6%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G+ G V K +H    K +A+K I            + +E +I      P I+ F  +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 187 HETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNL----ISALYYLHSNR-VLHR 241
                +  +  E  +M   +L +  K++   I  +IL  +    +  L YLH    ++HR
Sbjct: 68  FYNNGDISICME--YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLW 301
           D+KP N+L+N  G   LCDFG +  + V +   T + GT  YMAPE I    Y   +D+W
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFV-GTSSYMAPERIQGNDYSVKSDIW 183

Query: 302 SLGCIAYEIHMGHPPFK-----TVSILHLI-RLLKTQDVTFPSQV-SETYKDLVKGLLEK 354
           SLG    E+  G  P+         I  L+  ++       PS   S  ++D V   L K
Sbjct: 184 SLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIK 243

Query: 355 DASQRLSWPELLHHPLVK 372
           D  +R S+ ELL HP +K
Sbjct: 244 DPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  129 bits (326), Expect = 4e-34
 Identities = 73/256 (28%), Positives = 130/256 (50%), Gaps = 4/256 (1%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           KY K+  IGEGSFGK       +  K   +K I+ S  S KE    ++E  +  ++ HPN
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 180 IIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKL--SETICVQILSNLISALYYLHSN 236
           I+++  S E      ++ ++     L   +  ++ +   E   +     +  AL ++H  
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
           ++LHRD+K QN+ L KDG   L DFG AR +     +  +  GTP Y++PE+   RPY++
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            +D+W+LGC+ YE+      F+  ++ +L+ ++++       S  S   ++LV  L +++
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRN 240

Query: 356 ASQRLSWPELLHHPLV 371
              R S   +L    +
Sbjct: 241 PRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  129 bits (325), Expect = 4e-34
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 13/254 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G+GS+G+V    H    K   +K ++    S +E  + +QE ++   L HPNI+ +  S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 187 HETLNEFVLIT-------EFAHMSLSNLLEQRKKL-SETICVQILSNLISALYYLHSNRV 238
            E  +  + I        +  H     L EQ+ KL  E   V+    +  AL YLH   +
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYH----KLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           LHRDLK QNV L +  +  + D G AR +     M +++ GTP YM+PEL + +PY++ +
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKS 183

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           D+W+LGC  YE+      F    +  L+ R+++ +    P   S    +L+  +L K   
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPE 243

Query: 358 QRLSWPELLHHPLV 371
           +R S   +L  P +
Sbjct: 244 KRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  129 bits (325), Expect = 6e-34
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 4/254 (1%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y  I ++G+G+FG+       +    V  K ++ +  S KE      E  I   L HPNI
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 181 IKFIASHETLNEFVLITEFAHM-SLSNLLEQRKK--LSETICVQILSNLISALYYLHSNR 237
           I +       N  ++  E+A+  +L + + ++K     E + +  L  ++SA+ Y+H   
Sbjct: 62  IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           +LHRD+K  N+ L K G+  L DFG ++ +     M  ++ GTP YM+PEL     Y+  
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFK 181

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-FPSQVSETYKDLVKGLLEKDA 356
           +D+W+LGC+ YE+      F   + L+L+  +   + T   S  S     LV  LL++D 
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDP 241

Query: 357 SQRLSWPELLHHPL 370
            +R +  E+L  PL
Sbjct: 242 EKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  129 bits (327), Expect = 7e-34
 Identities = 87/278 (31%), Positives = 133/278 (47%), Gaps = 30/278 (10%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKEL-SSLKQECEIQKHLAH 177
           EK  ++  +GEG+ G V K    +     ALK I+       +L   + +E EI K    
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITT--DPNPDLQKQILRELEINKSCKS 58

Query: 178 PNIIK----FIASHETLNEFVLITEFAHM-SLSNLLEQRKKL----SETICVQILSNLIS 228
           P I+K    F+    +     +  E+    SL ++ ++ KK      E +  +I  +++ 
Sbjct: 59  PYIVKYYGAFLDESSS--SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
            L YLHS +++HRD+KP N+LL + G   LCDFG   S  +   +  +  GT  YMAPE 
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGV--SGELVNSLAGTFTGTSFYMAPER 174

Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL--IRLLKTQDVTFPSQV------ 340
           I  +PY  T+D+WSLG    E+     PF       L  I LL +  V  P+        
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPNPELKDEPG 233

Query: 341 -----SETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                SE +KD +K  LEKD ++R +  ++L HP +K 
Sbjct: 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  130 bits (328), Expect = 7e-34
 Identities = 85/284 (29%), Positives = 131/284 (46%), Gaps = 35/284 (12%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHL 175
           +Y+K   +GEG++  V+KA   +  + VA+K I     K  + G   ++L+ E ++ + L
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQEL 59

Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYLH 234
            HPNII  +      +   L+ EF    L  +++ +   L+       +   +  L YLH
Sbjct: 60  KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-AERP 293
           SN +LHRDLKP N+L+  DGV  L DFG ARS       +T    T  Y APEL+   R 
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH 179

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSIL----HLIRLLKT------QDVT-------- 335
           Y    D+WS+GCI  E+ +  P     S +     +   L T        VT        
Sbjct: 180 YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239

Query: 336 --FP--------SQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
             FP           S+   DL++ LL  + ++R++  + L HP
Sbjct: 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  129 bits (326), Expect = 7e-34
 Identities = 91/283 (32%), Positives = 129/283 (45%), Gaps = 33/283 (11%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
            Y KI  IGEG++G V+K  +    + VA+K I          S+  +E  + K L HPN
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 180 IIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK---LSETICVQILSNLISALYYLHSN 236
           I+         +   LI EF  M L   L+   K   +   +    L  ++  + + HS 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPYD 295
           RVLHRDLKPQN+L++  GV  L DFG AR+  +   + T    T  Y APE L+    Y 
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYS 180

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLK-----TQDV------------TFP 337
              D+WS+G I  E+    P F   S I  L R+ +     T+DV            TFP
Sbjct: 181 TPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP 240

Query: 338 SQVSETYKDLVKG-------LLEK----DASQRLSWPELLHHP 369
                + +  VK        LLEK    D ++R+S  + L+HP
Sbjct: 241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  128 bits (323), Expect = 1e-33
 Identities = 80/254 (31%), Positives = 127/254 (50%), Gaps = 10/254 (3%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKI---ISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +G+GSFG V+            LK+   I     +  E     QE ++   L HP I+KF
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 184 IASHETLNEFVLITEFAH-----MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            AS    + F +ITE+         L  L    K LSE    +    L+  ++Y+H  R+
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           LHRDLK +N+ L K+ +  + DFG +R +     + T+  GTP YM+PE +  + YD  +
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKS 186

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           D+WSLGCI YE+      F+  + L + +R+++    + P   S     +++ +L KD S
Sbjct: 187 DIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPS 246

Query: 358 QRLSWPELLHHPLV 371
            R S  E+L +P +
Sbjct: 247 LRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  126 bits (318), Expect = 5e-33
 Identities = 83/260 (31%), Positives = 135/260 (51%), Gaps = 18/260 (6%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIIS---KSGRSGKELSSLKQECEIQ--KHLAHPNI 180
           L+G+G+FG+V+     D  + +A+K +    +S  + KE+++L  ECEIQ  K+L H  I
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNAL--ECEIQLLKNLLHERI 66

Query: 181 IKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           +++        E  L     HM   S+ + L+    L+E +  +    ++  + YLHSN 
Sbjct: 67  VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV----GTHMLTSIKGTPLYMAPELIAERP 293
           ++HRD+K  N+L +  G   L DFG ++ +      GT M  S+ GTP +M+PE+I+   
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK-SVTGTPYWMSPEVISGEG 185

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFPSQVSETYKDLVKGL 351
           Y   AD+WS+GC   E+    PP+     +  I  + TQ  +   P  VS+  +D +K +
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRI 245

Query: 352 LEKDASQRLSWPELLHHPLV 371
              +A  R S  ELL H  V
Sbjct: 246 F-VEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 6e-33
 Identities = 78/252 (30%), Positives = 125/252 (49%), Gaps = 5/252 (1%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG+GSFGKV +    D ++  ALK I K+   S  E++    E  +   +  P I+    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 186 SHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
           S ++  +  L+  F +   L + L++  +   +      + L+ AL  LH   V++RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLG 304
           P+N+LL+  G   LCDFG  +          +  GTP Y+APEL+    Y    D W+LG
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLG 180

Query: 305 CIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW-- 362
            + YE+  G PPF   ++  + R +  + + FP       KDL+ GLL +D ++RL +  
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNG 240

Query: 363 -PELLHHPLVKD 373
             E+ +HP    
Sbjct: 241 AQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  127 bits (319), Expect = 9e-33
 Identities = 81/258 (31%), Positives = 136/258 (52%), Gaps = 10/258 (3%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           LE Y KI   GEGS G V  A      + VA+K++    +  +EL  L  E  I +   H
Sbjct: 23  LENYIKI---GEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQH 77

Query: 178 PNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N+++   S+    E  ++ EF    +L++++ Q  +L+E     +  +++ AL YLHS 
Sbjct: 78  QNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ 136

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
            V+HRD+K  ++LL  DG   L DFGF   ++       S+ GTP +MAPE+I+  PY  
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---DVTFPSQVSETYKDLVKGLLE 353
             D+WSLG +  E+  G PP+ + S +  ++ L+      +    ++S   +D ++ +L 
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256

Query: 354 KDASQRLSWPELLHHPLV 371
           ++  +R +  ELL HP +
Sbjct: 257 REPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  127 bits (319), Expect = 1e-32
 Identities = 72/238 (30%), Positives = 131/238 (55%), Gaps = 3/238 (1%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKHLAHPNIIKF 183
           +IG+GSFGKV  A H   +K  A+K++ K    +  +E   + +   + K++ HP ++  
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 184 IASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
             S +T ++   + ++ +   L   L++ +   E       + + SAL YLHS  +++RD
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LKP+N+LL+  G  +L DFG  +         ++  GTP Y+APE++ ++PYD T D W 
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 181

Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
           LG + YE+  G PPF + +   +   +  + +     ++ + + L++GLL+KD ++RL
Sbjct: 182 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  125 bits (314), Expect = 2e-32
 Identities = 79/259 (30%), Positives = 129/259 (49%), Gaps = 9/259 (3%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y+ I  IGEGSFGK++ A      +   +K I  +    KE  + K+E  +   + HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 180 IIKFIASHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLIS---ALYYLH 234
           I+ F AS +      ++ E+      +  +  QR  L      QILS  +     L ++H
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED--QILSWFVQISLGLKHIH 118

Query: 235 SNRVLHRDLKPQNVLLNKDG-VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
             ++LHRD+K QN+ L+K+G VA L DFG AR +     +  +  GTP Y++PE+   RP
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP 178

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLL 352
           Y++  D+WSLGC+ YE+     PF+  ++  L+ ++ +          S   + L+  L 
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238

Query: 353 EKDASQRLSWPELLHHPLV 371
           +     R S   +L  P +
Sbjct: 239 KVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  124 bits (314), Expect = 2e-32
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 17/222 (7%)

Query: 122 QKICLIGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
                +GEG+FG+V+K             VA+K + K   S +++    +E  I + L H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLI----SALYYL 233
           PN++K +          ++ E+  M   +LL   +K    + +  L +        + YL
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEY--MEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIA 290
            S   +HRDL  +N L+ ++ V  + DFG +R   +        +G  L   +MAPE + 
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMAPESLK 176

Query: 291 ERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKT 331
           E  +   +D+WS G + +EI  +G  P+  +S   ++  LK 
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN 218

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  124 bits (315), Expect = 3e-32
 Identities = 80/288 (27%), Positives = 129/288 (44%), Gaps = 46/288 (15%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ I  +G+G+FG V+ A + +  + VA+K + K   S +E  +L++   ++K   HPNI
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 181 IKFIASHETL---NEFVLITEFAHMSLSNLLEQR--KKLSETICVQILSNLISALYYLHS 235
           +K     E     +E   + E+   +L  L++ R  K  SE++   I+  ++  L ++H 
Sbjct: 61  VKL---KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFAR---SMAVGTHMLTSIKGTPLYMAPELIAER 292
           +   HRDLKP+N+L++   V  + DFG AR   S        T    T  Y APE++   
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEILLRS 173

Query: 293 P-YDHTADLWSLGCIAYEIHMGHPPF----------KTVSIL---------HLIRLLKTQ 332
             Y    D+W+LGCI  E++   P F          K  S+L            +L    
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233

Query: 333 DVTFP-----------SQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
              FP              S    DL+K +L  D  +R +  + L HP
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  123 bits (311), Expect = 4e-32
 Identities = 74/251 (29%), Positives = 127/251 (50%), Gaps = 5/251 (1%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  + ++GEGSFG+     H++  +  A+K I +  +S   +   ++E  +   + HPN
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLLAKMKHPN 59

Query: 180 IIKFIASHETLNEFVLITEFAHMS--LSNLLEQRKKL-SETICVQILSNLISALYYLHSN 236
           I+ F  S E      ++ E+      +  +  QR KL  E   +Q    +   + ++H  
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
           RVLHRD+K +N+ L ++G   L DFG AR +        +  GTP Y+ PE+    PY++
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            +D+WSLGCI YE+     PF+  S  +LI ++ +      PS  S   + L+K + +++
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN 239

Query: 356 ASQRLSWPELL 366
              R S   +L
Sbjct: 240 PRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  124 bits (313), Expect = 5e-32
 Identities = 83/253 (32%), Positives = 132/253 (52%), Gaps = 13/253 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IGEGS G V  A      K VA+K +    +  +EL  L  E  I +   H N++    S
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL--LFNEVVIMRDYHHENVVDMYNS 87

Query: 187 HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
           +   +E  ++ EF    +L++++   +   E I    LS ++ AL YLH+  V+HRD+K 
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSYLHNQGVIHRDIKS 146

Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGC 305
            ++LL  DG   L DFGF   ++       S+ GTP +MAPE+I+  PY    D+WSLG 
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 206

Query: 306 IAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK--DLVKGLLE----KDASQR 359
           +  E+  G PP+     L  +R ++      P +V +++K   +++G L+    ++ SQR
Sbjct: 207 MVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDLMLVREPSQR 263

Query: 360 LSWPELLHHPLVK 372
            +  ELL HP +K
Sbjct: 264 ATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  123 bits (311), Expect = 5e-32
 Identities = 82/248 (33%), Positives = 127/248 (51%), Gaps = 15/248 (6%)

Query: 114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQ 172
           +N  +EK      IG G F +V++A  L     VALK +        K  +   +E ++ 
Sbjct: 2   ANFRIEKK-----IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL 56

Query: 173 KHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLL----EQRKKLSETICVQILSNLI 227
           K L HPN+IK+ AS    NE  ++ E A    LS ++    +Q++ + E    +    L 
Sbjct: 57  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
           SAL ++HS RV+HRD+KP NV +   GV  L D G  R  +  T    S+ GTP YM+PE
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPF--KTVSILHLIRLLKTQDVTFPSQVSETYK 345
            I E  Y+  +D+WSLGC+ YE+     PF    +++  L +  K +   +P   S+ Y 
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--KIEQCDYPPLPSDHYS 234

Query: 346 DLVKGLLE 353
           + ++ L+ 
Sbjct: 235 EELRQLVN 242

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  123 bits (311), Expect = 7e-32
 Identities = 69/263 (26%), Positives = 123/263 (46%), Gaps = 19/263 (7%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKE----LSSLKQECEIQKHLAH 177
           LIG+G++G+V+ A+++   + +A+K +    + +GR        + +L+ E E  K L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            NI++++    T     +  E+    S+ + L    +  E +       ++  L YLHS 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSM--AVGTHMLTSIKGTPLYMAPELI--AER 292
            +LHRDLK  N+L++ DG+  + DFG ++            S++G+  +MAPE+I    +
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ 187

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------SQVSETYKD 346
            Y    D+WSLGC+  E+  G  P+     +  +  L  +    P        +S    D
Sbjct: 188 GYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALD 247

Query: 347 LVKGLLEKDASQRLSWPELLHHP 369
            +      +   R +  ELL HP
Sbjct: 248 FLNACFTINPDNRPTARELLQHP 270

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  124 bits (312), Expect = 7e-32
 Identities = 87/283 (30%), Positives = 133/283 (46%), Gaps = 34/283 (12%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHP 178
           KY+K+  IGEG++G VFKA + +  + VALK +       G   S+L++ C + K L H 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHK 59

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNR 237
           NI++      +  +  L+ E+    L    +     +   I    +  L+  L + HS+ 
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPYDH 296
           VLHRDLKPQN+L+NK+G   L DFG AR+  +     ++   T  Y  P+ L   + Y  
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 179

Query: 297 TADLWSLGCIAYEI-HMGHPPFKTVSI---LHLI-RLLKT-------------QDVTFPS 338
           + D+WS GCI  E+ + G P F    +   L  I RLL T                 +P 
Sbjct: 180 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239

Query: 339 Q------------VSETYKDLVKGLLEKDASQRLSWPELLHHP 369
                        ++ T +DL++ LL  +  QR+S  E L HP
Sbjct: 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  124 bits (313), Expect = 7e-32
 Identities = 85/260 (32%), Positives = 126/260 (48%), Gaps = 11/260 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 177
           + +  +  IG GSFG V+ A  +   + VA+K +S SG+   E    + +E    + L H
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSN 236
           PN I++   +   +   L+ E+   S S++LE  KK L E     I    +  L YLHS+
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA---ERP 293
             +HRD+K  N+LL + G   L DFG A  ++       S  GTP +MAPE+I    E  
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQ 190

Query: 294 YDHTADLWSLGCIAYEIHMGHPP-FKTVSILHLIRLLKTQDVTFPS-QVSETYKDLVKGL 351
           YD   D+WSLG    E+    PP F   ++  L  + +    T  S   S+ +++ V   
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC 250

Query: 352 LEKDASQRLSWPELLHHPLV 371
           L+K    R S  ELL H  V
Sbjct: 251 LQKIPQDRPSSEELLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  125 bits (314), Expect = 8e-32
 Identities = 76/237 (32%), Positives = 121/237 (51%), Gaps = 2/237 (0%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAHPNIIKFI 184
           L+G+G+FGKV         K  A+KI+ K     K E++    E  + K+  HP +    
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 185 ASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            S +T +    + E+ +   L   L + +  SE       + ++SAL YLHS ++++RDL
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSL 303
           K +N++L+KDG   + DFG  +        + +  GTP Y+APE++ +  Y    D W L
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 304 GCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
           G + YE+  G  PF       L  L+  +D+ FP  +S   K L+ GLL KD ++RL
Sbjct: 182 GVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  123 bits (311), Expect = 9e-32
 Identities = 85/283 (30%), Positives = 135/283 (47%), Gaps = 36/283 (12%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           ++++  +GEG++  V+K  +    + VALK I      G   S+  +E  + K L H NI
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP-STAIREISLMKELKHENI 60

Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLE---QRKKLSETICVQILSNLISALYYLHSNR 237
           ++      T N+ +L+ E+    L   ++    R  L           L+  + + H NR
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPYDH 296
           VLHRDLKPQN+L+NK G   L DFG AR+  +  +  ++   T  Y AP+ L+  R Y  
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKT-QDVTFP--SQVSETYK---- 345
           + D+WS+GCI  E+  G P F   +    +L + R++ T  + T+P  SQ+ E YK    
Sbjct: 181 SIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE-YKPTFP 239

Query: 346 -------------------DLVKGLLEKDASQRLSWPELLHHP 369
                              DL+  LL+ +   R+S  + L HP
Sbjct: 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  122 bits (309), Expect = 1e-31
 Identities = 80/264 (30%), Positives = 124/264 (46%), Gaps = 22/264 (8%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKS---GRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +G+G FG+V         K  A K + K     R G++++    E +I + ++   I+  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN--EKKILEKVSSRFIVSL 58

Query: 184 IASHETLNEFVLITEFA-----HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
             + ET ++  L+            + N+ E      E   +   + +I  L +LH  R+
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRRI 116

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           ++RDLKP+NVLL+  G   + D G A  +  G  +     GTP YMAPE++    YD + 
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA-GTPGYMAPEVLQGEVYDFSV 175

Query: 299 DLWSLGCIAYEIHMGHPPFK----TVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
           D ++LGC  YE+  G  PF+     V    L R      V +P + S   KDL + LL+K
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235

Query: 355 DASQRL-----SWPELLHHPLVKD 373
           D  +RL     S  E+  HPL KD
Sbjct: 236 DPEKRLGCRGGSADEVREHPLFKD 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  121 bits (307), Expect = 2e-31
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 22/224 (9%)

Query: 122 QKICLIGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +    +GEG+FG+V+K       +     VA+K + K G S +E     +E  I K L+H
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLSH 60

Query: 178 PNIIKFIA--SHETLNEFVLITEF-AHMSLSNLLEQRK-KLSETICVQILSNLISALYYL 233
           PNI++ +   +        ++TE+     L + L +   KL+    +Q+   +   + YL
Sbjct: 61  PNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------VGTHMLTSIKGTPLYMAPE 287
            S   +HRDL  +N L+ ++ V  + DFG +R +               IK    +MAPE
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPE 174

Query: 288 LIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLK 330
            + +  +   +D+WS G + +EI  +G  P+  +S   ++ LL+
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218

Length = 258

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  124 bits (313), Expect = 2e-31
 Identities = 78/289 (26%), Positives = 135/289 (46%), Gaps = 42/289 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++YQ +  +G G++G+V  A      + VA+K +S+  +S        +E  + KH+ H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +      +S E   +  L+T      L+N+++ +K   + I   ++  ++  L Y
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILRGLKY 133

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 134 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNW 190

Query: 293 -PYDHTADLWSLGCIAYEIHMGHPPFK-TVSILHLIRLLK---TQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G   F  +  I  L R++    T D     ++ SE+ ++
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN 250

Query: 347 LVKG----------------------LLEK----DASQRLSWPELLHHP 369
            ++                       LLEK    D  +R++  E L HP
Sbjct: 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  121 bits (307), Expect = 2e-31
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 19/221 (8%)

Query: 127 IGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +GEG+FG+V+K            VA+K + K   S +E     +E  + K L HPN+++ 
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 184 IASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILS--NLISALY-------YL 233
           +          L+ E+     L + L + + +  +     LS  +L+S          YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIA 290
            S + +HRDL  +N L+ +D V  + DFG +R +    +      G  L   +MAPE + 
Sbjct: 122 ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK-TGGKLPIRWMAPESLK 180

Query: 291 ERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLK 330
           +  +   +D+WS G + +EI  +G  P+  +S   ++  L+
Sbjct: 181 DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  121 bits (306), Expect = 3e-31
 Identities = 82/265 (30%), Positives = 129/265 (48%), Gaps = 30/265 (11%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G+G++G V+ A  L  +  +A+K I +  R  + +  L +E  +  +L H NI++++ 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 186 SHETLNEFVLI--TEFAHMSLSNLLEQR---KKLSETICVQILSNLISALYYLHSNRVLH 240
           S ++ N F  I   +    SLS LL  +    K +E   +     ++  L YLH N+++H
Sbjct: 73  S-DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 241 RDLKPQNVLLNK-DGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI--AERPYDHT 297
           RD+K  NVL+N   GV  + DFG ++ +A       +  GT  YMAPE+I    R Y   
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAP 191

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF-----------PSQVSETYKD 346
           AD+WSLGC   E+  G PPF        I L + Q   F           P  +S   K+
Sbjct: 192 ADIWSLGCTIVEMATGKPPF--------IELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243

Query: 347 LVKGLLEKDASQRLSWPELLHHPLV 371
            +    E D  +R S  +LL  P +
Sbjct: 244 FILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  122 bits (309), Expect = 3e-31
 Identities = 87/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)

Query: 106 CQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSS 164
           C+ V          +++K+  IGEG++G V++A      + VALK +   + R G  +SS
Sbjct: 3   CRSVT---------EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS 53

Query: 165 LKQECEIQKHLAHPNII--KFIASHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQ 221
           L+ E  +  +L HPNI+  K +   + L+   L+ E+    L++LL+      SE+    
Sbjct: 54  LR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC 112

Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
           ++  L+  L YLH N ++HRDLK  N+LL   G   + DFG AR+  +    +T    T 
Sbjct: 113 LMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL 172

Query: 282 LYMAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIRLLKT----- 331
            Y APEL+     Y    D+W++GCI  E+    P     S +     +I+LL T     
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232

Query: 332 ----------QDVTFPSQ-----------VSETYKDLVKGLLEKDASQRLSWPELLHHPL 370
                        T P Q           +SE    L+  LL  D  +R +  E L    
Sbjct: 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Query: 371 VKDN 374
            K+ 
Sbjct: 293 FKEK 296

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 4e-31
 Identities = 83/291 (28%), Positives = 126/291 (43%), Gaps = 45/291 (15%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSL-KQECEIQKHLAH 177
           + ++ I +IG G+FG+V+     D  +  A+K++ KS    +   +  + E +I      
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLISALYYLH 234
           P I+K   S +      L+ E+  M    L NLL ++    E      ++ L+ AL  +H
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEY--MPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH 118

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA-------------------------- 268
               +HRD+KP N+L++ DG   L DFG  + M                           
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178

Query: 269 ---VGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF--KTVSI- 322
                     S  GTP Y+APE++   PY    D WSLG I YE+  G PPF   T+   
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238

Query: 323 -LHLIRLLKTQDVTFPSQ--VSETYKDLVKGLLEKDASQRL-SWPELLHHP 369
              +I   ++  + FP    VS    DL+  LL  D   RL S+ E+  HP
Sbjct: 239 YNKIINWKES--LRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHP 286

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (309), Expect = 4e-31
 Identities = 82/260 (31%), Positives = 131/260 (50%), Gaps = 15/260 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAH---PNIIK 182
           IG+G+FG+V++    D ++  A+K++SK    + KE++    E  I         P I+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 183 FIASHETLNEFVLITEFAHMSLSNL---LEQRKKLSETICVQILSNLISALYYLHSNRVL 239
              S +T ++  L+T++  MS   L   L++  + SE      ++ L+ AL +LH   ++
Sbjct: 61  LKFSFQTDSDLYLVTDY--MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPYDHTA 298
           +RDLKP+N+LL+  G   LCDFG +++         +  GT  Y+APE L+ E+ Y    
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQV-SETYKDLVKGLLEKDAS 357
           D WSLG + +E+  G  PF       + R +    V FP  V S+  +  VKGLL ++  
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238

Query: 358 QRL----SWPELLHHPLVKD 373
            RL       EL  HP   D
Sbjct: 239 HRLGAHRDAVELKEHPFFAD 258

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  122 bits (306), Expect = 5e-31
 Identities = 80/249 (32%), Positives = 128/249 (51%), Gaps = 7/249 (2%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IGEGS G V  A      K VA+K +    +  +EL  L  E  I +   H N+++   S
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNS 85

Query: 187 HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
           +   +E  ++ EF    +L++++   +   E I    L+ ++ AL  LH+  V+HRD+K 
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLKALSVLHAQGVIHRDIKS 144

Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGC 305
            ++LL  DG   L DFGF   ++       S+ GTP +MAPELI+  PY    D+WSLG 
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGI 204

Query: 306 IAYEIHMGHPPFKTVSILHLIRLLKTQ---DVTFPSQVSETYKDLVKGLLEKDASQRLSW 362
           +  E+  G PP+     L  +++++      +    +VS + K  +  LL +D +QR + 
Sbjct: 205 MVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATA 264

Query: 363 PELLHHPLV 371
            ELL HP +
Sbjct: 265 AELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  122 bits (307), Expect = 5e-31
 Identities = 76/244 (31%), Positives = 127/244 (52%), Gaps = 7/244 (2%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISK----SGRSGKELSSLKQECEIQKHLAHPNII 181
           +IG+GSFGKV  A      K  A+K++ K    + +  K +  + +   + K++ HP ++
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLV 59

Query: 182 KFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
               S +T  +   + +F +   L   L++ +   E       + + SAL YLHS  +++
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADL 300
           RDLKP+N+LL+  G  +L DFG  +     +   T+  GTP Y+APE+I ++PYD+T D 
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179

Query: 301 WSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
           W LG + YE+  G PPF    +  +   +  + +      S T   +++ LLEKD  +RL
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL 239

Query: 361 SWPE 364
              E
Sbjct: 240 GAKE 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 8e-31
 Identities = 83/263 (31%), Positives = 126/263 (47%), Gaps = 21/263 (7%)

Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G LE Y+K+  +GEGS+  V+K       + VALK I      G   ++++ E  + K L
Sbjct: 2   GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDL 60

Query: 176 AHPNIIKF---IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQI-LSNLISALY 231
            H NI+     I + +TL    L+ E+    L   ++          V++ L  L+  L 
Sbjct: 61  KHANIVTLHDIIHTKKTLT---LVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIA 290
           Y H  RVLHRDLKPQN+L+++ G   L DFG AR+ +V +   ++   T  Y  P+ L+ 
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG 177

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI----LHLI-RLLKTQDVTFPSQVSETYK 345
              Y  + D+W +GCI YE+  G P F   +     LH I R+L T     P++  ET+ 
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT-----PTE--ETWP 230

Query: 346 DLVKGLLEKDASQRLSWPELLHH 368
            +      K  S     P  L +
Sbjct: 231 GVSSNPEFKPYSFPFYPPRPLIN 253

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  120 bits (303), Expect = 8e-31
 Identities = 72/265 (27%), Positives = 126/265 (47%), Gaps = 15/265 (5%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLA 176
           + K   +G G+F   ++A  +     +A+K ++     S    + + +L++E  +   L 
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 177 HPNIIKFI-ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           HP+II+ + A+ E  +  + +   A  S+S+LL +     E + +     L+  L YLH 
Sbjct: 62  HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121

Query: 236 NRVLHRDLKPQNVLLNKDGVAM-LCDFGFARSMA---VGTHMLT-SIKGTPLYMAPELIA 290
           N+++HRD+K  N+L++  G  + + DFG A  +A    G       + GT  +MAPE++ 
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQDVT----FPSQVSETYK 345
              Y  + D+WS+GC+  E+    PP+       HL  + K    T     P  +S   +
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241

Query: 346 DLVKGLLEKDASQRLSWPELLHHPL 370
           D+    LE     R    ELL HP+
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHPV 266

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  121 bits (305), Expect = 1e-30
 Identities = 74/238 (31%), Positives = 123/238 (51%), Gaps = 3/238 (1%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKII-SKSGRSGKELSSLKQECEIQ-KHLAHPNIIKF 183
           +IG+GSFGKV  A         A+K++  K+    KE + +  E  +  K+L HP ++  
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 184 IASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
             S +T  +   + ++ +   L   L++ +   E       + + SA+ YLHS  +++RD
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LKP+N+LL+  G  +L DFG  +         ++  GTP Y+APE++ + PYD T D W 
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWC 181

Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
           LG + YE+  G PPF +  +  +   +  + +  P   +    DL+ GLL KD  +RL
Sbjct: 182 LGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  119 bits (301), Expect = 1e-30
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 14/216 (6%)

Query: 127 IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +GEG+FG+V+K             VA+K + K   S +++    +E  I + L HPNI+K
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 183 FIASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLI----SALYYLHSNR 237
            +         +++ E+  M   +LL+  RK   + + +  L +        + YL S  
Sbjct: 66  LLGVCTEEEPLMIVMEY--MPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDH 296
            +HRDL  +N L+ ++ V  + DFG +R +    +        P+ +MAPE + E  +  
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183

Query: 297 TADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKT 331
            +D+WS G + +EI  +G  P+  +S   ++  LK 
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK 219

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 2e-30
 Identities = 83/277 (29%), Positives = 133/277 (48%), Gaps = 39/277 (14%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---ECEIQKHLAH 177
           ++KI L+G+G  G+VF        K  ALK++ K      + + +K+   E EI   L H
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKK--EMIKRNKVKRVLTEQEILATLDH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLH 234
           P +    AS +T     L+ ++     L  LL+++  K LSE +     + ++ AL YLH
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT------------------- 275
              +++RDLKP+N+LL++ G  ML DF  ++   V    ++                   
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 276 ----------SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL 325
                     S  GT  Y+APE+I+   +    D W+LG + YE+  G  PFK  +    
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240

Query: 326 IRLLKTQDVTFPSQ--VSETYKDLVKGLLEKDASQRL 360
              +  ++VTFP    VS + +DL++ LL KD S+RL
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRL 277

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  120 bits (302), Expect = 4e-30
 Identities = 68/251 (27%), Positives = 122/251 (48%), Gaps = 29/251 (11%)

Query: 126 LIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEI-QKHL-----A 176
           ++G+GSFGKV  A   +LK T    A+K++ K       L     EC + +K +      
Sbjct: 2   VLGKGSFGKVLLA---ELKGTDELYAVKVLKK----DVILQDDDVECTMTEKRVLALAGK 54

Query: 177 HPNIIKFIASHETLNEFVLITEFA-------HMSLSNLLEQRKKLSETICVQILSNLISA 229
           HP + +  +  +T +    + E+        H+      ++  +  E       + ++  
Sbjct: 55  HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHI------QRSGRFDEPRARFYAAEIVLG 108

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L +LH   +++RDLK  NVLL+ +G   + DFG  +   +G    ++  GTP Y+APE++
Sbjct: 109 LQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL 168

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
           + +PY    D W+LG + YE+  G  PF+      L + +   +V +P  +S+  K ++K
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILK 228

Query: 350 GLLEKDASQRL 360
             L K+  +RL
Sbjct: 229 SFLTKNPEKRL 239

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  119 bits (299), Expect = 7e-30
 Identities = 73/237 (30%), Positives = 121/237 (51%), Gaps = 2/237 (0%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAHPNIIKFI 184
           L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++  HP +    
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 185 ASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + +T +    + E+A+   L   L + +  +E       + ++SAL YLHS  V++RD+
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121

Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSL 303
           K +N++L+KDG   + DFG  +        + +  GTP Y+APE++ +  Y    D W L
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 304 GCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
           G + YE+  G  PF       L  L+  +++ FP  +S   K L+ GLL+KD  QRL
Sbjct: 182 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  119 bits (299), Expect = 8e-30
 Identities = 77/250 (30%), Positives = 131/250 (52%), Gaps = 24/250 (9%)

Query: 126 LIGEGSFGKVFKAIHL---DLKKTVALKIISKSG--RSGKELSSLKQECEIQKHLAHPNI 180
           ++G+G +GKVF+   +   D  K  A+K++ K+   R+ K+ +  K E  I + + HP I
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLEQRKK----LSETICVQILSNLISALYYLHSN 236
           +  I + +T  +  LI E+  +S   L    ++    + +T C   LS +  AL +LH  
Sbjct: 63  VDLIYAFQTGGKLYLILEY--LSGGELFMHLEREGIFMEDTACF-YLSEISLALEHLHQQ 119

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
            +++RDLKP+N+LL+  G   L DFG  +       +  +  GT  YMAPE++    +  
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGK 179

Query: 297 TADLWSLGCIAYEIHMGHPPF------KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
             D WSLG + Y++  G PPF      KT+      ++LK + +  P  ++   +DL+K 
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENRKKTID-----KILKGK-LNLPPYLTPEARDLLKK 233

Query: 351 LLEKDASQRL 360
           LL+++ S RL
Sbjct: 234 LLKRNPSSRL 243

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  117 bits (294), Expect = 1e-29
 Identities = 76/261 (29%), Positives = 129/261 (49%), Gaps = 11/261 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E ++ I  IG G++G V+KA +++  +  A+K+I      G++ + ++QE  + K   H 
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL--EPGEDFAVVQQEIIMMKDCKHS 66

Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+ +  S+   ++  +  EF    SL ++      LSE+    +    +  LYYLHS  
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA-ERP--Y 294
            +HRD+K  N+LL  +G   L DFG +  +        S  GTP +MAPE+ A ER   Y
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS-----QVSETYKDLVK 349
           +   D+W++G  A E+    PP   +  +  + L+   +   P      + S ++   VK
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246

Query: 350 GLLEKDASQRLSWPELLHHPL 370
             L K+  +R +  +LL HP 
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  118 bits (298), Expect = 1e-29
 Identities = 77/237 (32%), Positives = 121/237 (51%), Gaps = 2/237 (0%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAHPNIIKFI 184
           L+G+G+FGKV         K  A+KI+ K     K E++    E  + ++  HP +    
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 185 ASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            S +T +    + E+A+   L   L + +  SE       + ++SAL YLHS  V++RDL
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121

Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSL 303
           K +N++L+KDG   + DFG  +        + +  GTP Y+APE++ +  Y    D W L
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 304 GCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
           G + YE+  G  PF       L  L+  +++ FP  +S   K L+ GLL+KD  QRL
Sbjct: 182 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  118 bits (297), Expect = 2e-29
 Identities = 76/238 (31%), Positives = 122/238 (51%), Gaps = 3/238 (1%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAHPNIIKFI 184
           L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++  HP +    
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 185 ASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNR-VLHRD 242
            S +T +    + E+A+   L   L + +  SE       + ++SAL YLHS + V++RD
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LK +N++L+KDG   + DFG  +        + +  GTP Y+APE++ +  Y    D W 
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 181

Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
           LG + YE+  G  PF       L  L+  +++ FP  +S   K L+ GLL+KD  QRL
Sbjct: 182 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  117 bits (293), Expect = 2e-29
 Identities = 79/268 (29%), Positives = 138/268 (51%), Gaps = 20/268 (7%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPN 179
           ++ + L+G G++G+V+K  H+   +  A+K++  +G   +E+   KQE   ++K+  H N
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI---KQEINMLKKYSHHRN 64

Query: 180 IIKFIASHETLN------EFVLITEFAHM-SLSNLLEQRK--KLSETICVQILSNLISAL 230
           I  +  +    N      +  L+ EF    S+++L++  K   L E     I   ++  L
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124

Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LH ++V+HRD+K QNVLL ++    L DFG +  +        +  GTP +MAPE+IA
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184

Query: 291 --ERP---YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF--PSQVSET 343
             E P   YD  +DLWSLG  A E+  G PP   +  +  + L+           + S+ 
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 244

Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLV 371
           ++  ++  L K+ SQR +  +L+ HP +
Sbjct: 245 FQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  117 bits (293), Expect = 2e-29
 Identities = 84/290 (28%), Positives = 137/290 (47%), Gaps = 22/290 (7%)

Query: 102 FHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE 161
           F  +   + +E      + ++ I  IG+G++GKV+K  +       A+KI+       +E
Sbjct: 5   FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE 64

Query: 162 LSSLKQECEIQKHLA-HPNIIKFI-----ASHETLNEFVLITEFAHMS-----LSNLLEQ 210
           + +   E  I + L  HPN++KF      A      +  L+ E  +       +  LL  
Sbjct: 65  IEA---EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121

Query: 211 RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG 270
            ++L E +   IL   +  L +LH+NR++HRD+K  N+LL  +G   L DFG +  +   
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Query: 271 THMLTSIKGTPLYMAPELIA-ERPYDHT----ADLWSLGCIAYEIHMGHPP-FKTVSILH 324
                +  GTP +MAPE+IA E+ YD++     D+WSLG  A E+  G PP F    +  
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241

Query: 325 LIRLLKTQDVTF--PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
           L ++ +    T   P +   ++   +   L KD   R S   LL HP +K
Sbjct: 242 LFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  116 bits (292), Expect = 3e-29
 Identities = 79/284 (27%), Positives = 137/284 (48%), Gaps = 34/284 (11%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           K++ + ++GEG++G V K  H + K+ VA+K    S  + +   +  +E ++ + L   N
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 180 IIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQ-ILSNLISALYYLHSNRV 238
           I++   +     +  L+ E+   ++  LLE+         V+  +  LI A+++ H N +
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-LTSIKGTPLYMAPELIAERPYDHT 297
           +HRD+KP+N+L++ + V  LCDFGFAR+++ G++   T    T  Y +PEL+   PY   
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRL-----------------------LKTQD 333
            D+WS+GCI  E+  G P F   S I  L  +                       L+   
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPA 241

Query: 334 VTFPSQVSETYK--------DLVKGLLEKDASQRLSWPELLHHP 369
           V  P  +   Y         DL+K LL+ + + R    + L+HP
Sbjct: 242 VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  117 bits (293), Expect = 5e-29
 Identities = 84/253 (33%), Positives = 127/253 (50%), Gaps = 11/253 (4%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+ A +    + VA+K +S SG+   E    + +E +  + L HPN I++  
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 186 SHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +   +   L+ E+   S S+LLE  KK L E     I    +  L YLHS+ ++HRD+K
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTADLW 301
             N+LL + G   L DFG A   +       S  GTP +MAPE+I    E  YD   D+W
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVW 204

Query: 302 SLGCIAYEIHMGHPP-FKTVSILHLIRLLKTQDVTFPS-QVSETYKDLVKGLLEKDASQR 359
           SLG    E+    PP F   ++  L  + +    T  S + +++++  V   L+K   +R
Sbjct: 205 SLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQER 264

Query: 360 LSWPELLHHPLVK 372
            +  ELL H  V+
Sbjct: 265 PASAELLRHDFVR 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  117 bits (294), Expect = 5e-29
 Identities = 71/208 (34%), Positives = 100/208 (48%), Gaps = 11/208 (5%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
            +YQ +  IGEG++G V  A H      VA+K IS          +L+ E +I +   H 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHE 63

Query: 179 NIIKFIA-----SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
           NII  +      S E+ N+  ++ E     L  L+ + + LS       L  ++  L Y+
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLI-KTQHLSNDHIQYFLYQILRGLKYI 122

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA---VGTHMLTSIKGTPLYMAPE-LI 289
           HS  VLHRDLKP N+LLN +    +CDFG AR        T  LT    T  Y APE ++
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPF 317
             + Y    D+WS+GCI  E+    P F
Sbjct: 183 NSKGYTKAIDIWSVGCILAEMLSNRPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  115 bits (291), Expect = 6e-29
 Identities = 83/285 (29%), Positives = 136/285 (47%), Gaps = 41/285 (14%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ--KHLA-H 177
           Y+ +  IGEG+F +V KA      K  A+K + K  +S +++++L+   EIQ  + L+ H
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR---EIQALRRLSPH 57

Query: 178 PNIIKFIASH--ETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLH 234
           PNI++ I            L+ E   M+L  L++ RK+ L E      +  L+ +L ++H
Sbjct: 58  PNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERP 293
            N + HRD+KP+N+L+  D +  L DFG  R +       T    T  Y APE L+ +  
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIY-SKPPYTEYISTRWYRAPECLLTDGY 175

Query: 294 YDHTADLWSLGCIAYEIHMGHPPF------KTVSILHLI------RLLKTQ------DVT 335
           Y    D+W++GC+ +EI    P F        ++ +H +       +LK        +  
Sbjct: 176 YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235

Query: 336 FPSQ-----------VSETYKDLVKGLLEKDASQRLSWPELLHHP 369
           FPS+            S    DL+K LL  D  +R++  + L HP
Sbjct: 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  114 bits (286), Expect = 1e-28
 Identities = 76/260 (29%), Positives = 132/260 (50%), Gaps = 18/260 (6%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIIS---KSGRSGKELSSLKQECEIQ--KHLAHPNI 180
           L+G G+FG+V+     D  + +A+K +     S  + KE+++L  ECEIQ  K+L H  I
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNAL--ECEIQLLKNLRHDRI 66

Query: 181 IKF---IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           +++   +   E     + +      S+ + L+    L+E +  +    ++  + YLHSN 
Sbjct: 67  VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM 126

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV----GTHMLTSIKGTPLYMAPELIAERP 293
           ++HRD+K  N+L +  G   L DFG ++ +      GT  + S+ GTP +M+PE+I+   
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG-IKSVTGTPYWMSPEVISGEG 185

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT--FPSQVSETYKDLVKGL 351
           Y   AD+WS+ C   E+    PP+     +  I  + TQ      P  VS+  +D +K +
Sbjct: 186 YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQI 245

Query: 352 LEKDASQRLSWPELLHHPLV 371
             ++  +R +   LL HP V
Sbjct: 246 FVEE-KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  115 bits (288), Expect = 2e-28
 Identities = 83/249 (33%), Positives = 125/249 (50%), Gaps = 11/249 (4%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+ A  +   + VA+K +S SG+ S ++   + +E    + L HPN I++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 186 SHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +   +   L+ E+   S S+LLE  KK L E     +    +  L YLHS+ ++HRD+K
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTADLW 301
             N+LL++ G+  L DFG A  MA          GTP +MAPE+I    E  YD   D+W
Sbjct: 143 AGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVW 198

Query: 302 SLGCIAYEIHMGHPP-FKTVSILHLIRLLKTQDVTFPS-QVSETYKDLVKGLLEKDASQR 359
           SLG    E+    PP F   ++  L  + + +     S   SE +++ V   L+K    R
Sbjct: 199 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258

Query: 360 LSWPELLHH 368
            +   LL H
Sbjct: 259 PTSEVLLKH 267

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  114 bits (287), Expect = 2e-28
 Identities = 86/252 (34%), Positives = 131/252 (51%), Gaps = 11/252 (4%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+ A  +   + VA+K +S SG+ S ++   + +E +  + + HPN I++  
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 186 SHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +   +   L+ E+   S S+LLE  KK L E     I    +  L YLHS+ ++HRD+K
Sbjct: 93  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 152

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTADLW 301
             N+LL + G   L DFG A S+A   +   S  GTP +MAPE+I    E  YD   D+W
Sbjct: 153 AGNILLTEPGQVKLADFGSA-SIASPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVW 208

Query: 302 SLGCIAYEIHMGHPP-FKTVSILHLIRLLKTQDVTFPS-QVSETYKDLVKGLLEKDASQR 359
           SLG    E+    PP F   ++  L  + + +  T  S + S+ +++ V   L+K    R
Sbjct: 209 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDR 268

Query: 360 LSWPELLHHPLV 371
            +  ELL H  V
Sbjct: 269 PTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  113 bits (285), Expect = 3e-28
 Identities = 81/267 (30%), Positives = 134/267 (50%), Gaps = 28/267 (10%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIA 185
           IG+G++GKVFK ++       A+KI+       +E+ +   E  I K L+ HPN++KF  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA---EYNILKALSDHPNVVKFYG 82

Query: 186 SH-----ETLNEFVLITEFAHM-SLSNL----LEQRKKLSETICVQILSNLISALYYLHS 235
            +     +  ++  L+ E  +  S+++L    L++ +++ E I   IL   +  L +LH 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA----- 290
           N+ +HRD+K  N+LL  +G   L DFG +  +        +  GTP +MAPE+IA     
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL------KTQDVTFPSQVSETY 344
           +  YD   D+WSLG  A E+  G PP   ++ LH +R L          +  P   S  +
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPP---LADLHPMRALFKIPRNPPPTLHQPELWSNEF 259

Query: 345 KDLVKGLLEKDASQRLSWPELLHHPLV 371
            D ++  L KD  +R +  +LL H  +
Sbjct: 260 NDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  114 bits (286), Expect = 3e-28
 Identities = 77/215 (35%), Positives = 121/215 (56%), Gaps = 20/215 (9%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLK---KTVALKIIS-KSGRSGKELSSLKQECEIQKH 174
           ++Y+ +  IGEG++GKVFKA   DLK   + VALK +  ++G  G  LS+++ E  + +H
Sbjct: 1   QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRH 57

Query: 175 LA---HPNIIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKL---SETICVQIL 223
           L    HPN+++      ++  +   +  L+ E     L+  L++  +    +ETI   ++
Sbjct: 58  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI-KDMM 116

Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLY 283
             L+  L +LHS+RV+HRDLKPQN+L+   G   L DFG AR  +     LTS+  T  Y
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWY 175

Query: 284 MAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFK 318
            APE++ +  Y    DLWS+GCI  E+    P F+
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  115 bits (289), Expect = 3e-28
 Identities = 79/282 (28%), Positives = 131/282 (46%), Gaps = 23/282 (8%)

Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQEC---EIQK 173
           +L + +++  IG G+ G V+K IH    +  ALK+I        E +  +Q C   EI +
Sbjct: 72  SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY----GNHEDTVRRQICREIEILR 127

Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
            + HPN++K     +   E  ++ EF  M   +L E      E     +   ++S + YL
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEF--MDGGSL-EGTHIADEQFLADVARQILSGIAYL 184

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI---- 289
           H   ++HRD+KP N+L+N      + DFG +R +A       S  GT  YM+PE I    
Sbjct: 185 HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244

Query: 290 AERPYDHTA-DLWSLGCIAYEIHMGHPPFKT------VSILHLIRLLKTQDVTFPSQVSE 342
               YD  A D+WSLG    E ++G  PF         S++  I +  +Q    P+  S 
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM--SQPPEAPATASR 302

Query: 343 TYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNN 384
            ++  +   L+++ ++R S  +LL HP +      + +   N
Sbjct: 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPN 344

Length = 353

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 4e-28
 Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 5/199 (2%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPN 179
           +Q +  +G+G +G+VF A   D  + VALK + KS      E+  +  E +I        
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 180 IIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           ++K + + +      L  E+        LL     LSE      ++ +  A+  LH    
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           +HRDLKP+N L++  G   L DFG ++ +    +   S+ G+P YMAPE++  + YD T 
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN---SVVGSPDYMAPEVLRGKGYDFTV 179

Query: 299 DLWSLGCIAYEIHMGHPPF 317
           D WSLGC+ YE   G PPF
Sbjct: 180 DYWSLGCMLYEFLCGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  113 bits (285), Expect = 6e-28
 Identities = 67/242 (27%), Positives = 113/242 (46%), Gaps = 11/242 (4%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHL-----AHPN 179
           ++G+GSFGKV  A      +  A+K + K       L     EC  +++ +      HP 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKD----VVLEDDDVECTMVERRVLALAWEHPF 57

Query: 180 IIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           +     + +T      + E+ +   L   ++   +  E       + +I  L +LH   +
Sbjct: 58  LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           ++RDLK  NVLL+KDG   + DFG  +    G    ++  GTP Y+APE++  + Y+ + 
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D WS G + YE+ +G  PF       L   +      FP  +S+  KD +  L E+D ++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237

Query: 359 RL 360
           RL
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 6e-28
 Identities = 71/257 (27%), Positives = 127/257 (49%), Gaps = 14/257 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAH-PNIIKFI 184
           I +G+FG V+ A         A+K++ KS   +  +++++K E  I       P + K  
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 185 ASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            S ++ +   L+ E+ +    ++L++    L E    Q ++ ++  +  LH   ++HRD+
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123

Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSL 303
           KP+N+L+++ G   L DFG +R+            GTP Y+APE I     D  +D WSL
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRN----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSL 179

Query: 304 GCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETY----KDLVKGLLEKDASQR 359
           GC+ +E   G+PPF   +   +   + ++ + +P +V E       DL+  LL  D ++R
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239

Query: 360 LS---WPELLHHPLVKD 373
           L    + E+  HP  K 
Sbjct: 240 LGANGYQEIKSHPFFKS 256

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  113 bits (285), Expect = 6e-28
 Identities = 72/242 (29%), Positives = 121/242 (50%), Gaps = 11/242 (4%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI--QKHLAHPNIIKF 183
           ++G+GSFGKV  A      +  A+KI+ K       +     EC +  ++ LA P    F
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKD----VIIQDDDVECTMVEKRVLALPGKPPF 62

Query: 184 IAS----HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           +       +T++    + E+ +   L   ++Q  K  E   V   + +   L++LHS  +
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           ++RDLK  NV+L+ +G   + DFG  +    G     +  GTP Y+APE+IA +PY  + 
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D W+ G + YE+  G PPF       L + +   +V++P  +S+    + KGLL K  ++
Sbjct: 183 DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAK 242

Query: 359 RL 360
           RL
Sbjct: 243 RL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  118 bits (296), Expect = 7e-28
 Identities = 91/300 (30%), Positives = 139/300 (46%), Gaps = 35/300 (11%)

Query: 108 PVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ 167
           P K +     L +Y+ I  IG G FG+VF   H   ++    K IS  G   +E S L  
Sbjct: 2   PGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI 61

Query: 168 ECEIQKHLAHPNIIKFIAS--HETLNEFVLITEFAHM-----SLSNLLEQRKKLSETICV 220
           E  + + L H NI+++I    ++   +  ++ EF        ++    +   K+ E   V
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 221 QILSNLISALYYLHS-------NRVLHRDLKPQNVL-----------------LNKDGVA 256
            I   L+ AL Y H+        RVLHRDLKPQN+                  LN   +A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 257 MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGH 314
            + DFG ++++ + + M  S  GTP Y +PEL+    + YD  +D+W+LGCI YE+  G 
Sbjct: 182 KIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Query: 315 PPF-KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
            PF K  +   LI  LK          S+    L+K LL   A +R S  + L + ++K+
Sbjct: 241 TPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300

Length = 1021

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  112 bits (282), Expect = 8e-28
 Identities = 92/297 (30%), Positives = 140/297 (47%), Gaps = 50/297 (16%)

Query: 92  MSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIH-----LDLKKT 146
            SLS+L +  F  +C+ VK            K+ LI +G FGKV    H     L ++K 
Sbjct: 4   KSLSELVQ--FLKNCEIVK------------KLKLI-DGKFGKVSVLKHKPTQKLFVQKI 48

Query: 147 VALKIISKSGRSGKELSSLKQECEIQKHL---AHPNIIKFIASHETLNEFVLITEF-AHM 202
           +  K  +                E   H     +PN IK   S  TL   VLI ++    
Sbjct: 49  IKAKNFN--------------AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDG 94

Query: 203 SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN--KDGVAMLCD 260
            L +LL++  KLSE    +I+  L+ AL  LH + ++H D+K +NVL +  KD +  LCD
Sbjct: 95  DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRI-YLCD 153

Query: 261 FGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV 320
           +G  + +   +       GT  Y +PE I    YD + D W++G + YE+  G  PFK  
Sbjct: 154 YGLCKIIGTPSCY----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209

Query: 321 S--ILHLIRLLKTQ--DVTFPSQVSETYKDLVKGLLEKDASQRL-SWPELLHHPLVK 372
               L L  LLK Q   + F   VS+   D V+ +L+ + + RL ++ E++ HP +K
Sbjct: 210 EDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  112 bits (282), Expect = 8e-28
 Identities = 75/264 (28%), Positives = 119/264 (45%), Gaps = 19/264 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKS---GRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +G+G FG+V         K  A K ++K     R G E + +++    + H     I+  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF--IVSL 58

Query: 184 IASHETLNEFVLITEFAH-----MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
             + +T  +  L+    +       + N+ E+     E       + +IS L +LH  R+
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           ++RDLKP+NVLL+ DG   + D G A  +  G        GTP +MAPEL+    YD + 
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178

Query: 299 DLWSLGCIAYEIHMGHPPFKT----VSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
           D ++LG   YE+     PF+     V    L + +    VT+P + S   K   + LL K
Sbjct: 179 DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAK 238

Query: 355 DASQRLSW-----PELLHHPLVKD 373
           D  +RL +       L  HPL +D
Sbjct: 239 DPEKRLGFRDGNCDGLRTHPLFRD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  112 bits (280), Expect = 1e-27
 Identities = 88/286 (30%), Positives = 128/286 (44%), Gaps = 33/286 (11%)

Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G LE Y K+  +GEG++  VFK      +  VALK I      G   ++++ E  + K+L
Sbjct: 2   GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNL 60

Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQI-LSNLISALYYLH 234
            H NI+       T     L+ E+    L   L+    L     V+I +  L+  L Y H
Sbjct: 61  KHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERP 293
             ++LHRDLKPQN+L+N+ G   L DFG AR+ +V T   ++   T  Y  P+ L+    
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSI---LHLI-RLLKT---------------QDV 334
           Y    D+W +GCI YE+  G P F   ++   LHLI RLL T               +  
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240

Query: 335 TFPSQVSETYK-----------DLVKGLLEKDASQRLSWPELLHHP 369
            FP   ++              DL+  LL  +   R+S    L H 
Sbjct: 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  111 bits (279), Expect = 2e-27
 Identities = 85/267 (31%), Positives = 129/267 (48%), Gaps = 29/267 (10%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKII--SKSGRSGKELSSLKQECEIQKHLAH 177
           +YQ+I  +G G+ G V+KA HL  ++ +A+K+I    +    K++ S   E EI      
Sbjct: 4   QYQEI--LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMS---ELEILYKCDS 58

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           P II F  +    N   + TEF        L+  +K+ E +  +I   ++  L YL S +
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMD---GGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK 115

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK----GTPLYMAPELIAERP 293
           +LHRD+KP N+L+N  G   LCDFG      V T ++ SI     GT  YMAPE I+   
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFG------VSTQLVNSIAKTYVGTNAYMAPERISGEQ 169

Query: 294 YDHTADLWSLGCIAYEIHMGHPP----FKTVSILHLIRLLK-TQDVTFP----SQVSETY 344
           Y   +D+WSLG    E+ +G  P     K    L  ++LL+   D   P     Q SE +
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229

Query: 345 KDLVKGLLEKDASQRLSWPELLHHPLV 371
              +   + K   +R +   L+ HP +
Sbjct: 230 VHFITQCMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  111 bits (278), Expect = 2e-27
 Identities = 82/289 (28%), Positives = 133/289 (46%), Gaps = 42/289 (14%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQK--HLA 176
           +Y+ +  IG G++G V+KA        VALK +  ++   G  LS++++   +++     
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 177 HPNIIKFI---ASHETLNEFVLITEFAHMS--LSNLLEQRKKLS---ETICVQILSNLIS 228
           HPNI++ +   A+  T  E  +   F H+   L   L++        ETI   ++   + 
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETI-KDLMRQFLR 119

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-LTSIKGTPLYMAPE 287
            L +LH+N ++HRDLKP+N+L+   G   L DFG AR  +    M LT +  T  Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRAPE 177

Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPF-------KTVSILHLIRLLKTQ----DVTF 336
           ++ +  Y    D+WS+GCI  E+    P F       +   I  LI L        DVT 
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237

Query: 337 P----------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
           P                 ++ E+   L+  +L  +  +R+S    L HP
Sbjct: 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  111 bits (279), Expect = 3e-27
 Identities = 80/279 (28%), Positives = 130/279 (46%), Gaps = 23/279 (8%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI-QKHLA 176
           L   + +  IG G+ G+V+K         +A+K + ++G   +E   +  + ++  K   
Sbjct: 14  LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHD 72

Query: 177 HPNIIK----FIASHETLNEFVLI-TEFAHMSLSNLLEQRKK-LSETICVQILSNLISAL 230
            P I+K    FI   +     V I  E     L  LL++ +  + E I  ++   ++ AL
Sbjct: 73  CPYIVKCYGYFITDSD-----VFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKAL 127

Query: 231 YYLHSNR-VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           +YL     V+HRD+KP N+LL+  G   LCDFG +  + V +   T   G   YMAPE I
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL-VDSKAKTRSAGCAAYMAPERI 186

Query: 290 AERP----YDHTADLWSLGCIAYEIHMGHPPFK--TVSILHLIRLLKTQDVTFPS--QVS 341
                   YD  AD+WSLG    E+  G  P+K        L ++L+ +  + P     S
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246

Query: 342 ETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
             +   V   L KD  +R  + ELL HP ++   ++E++
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVD 285

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  111 bits (278), Expect = 5e-27
 Identities = 71/249 (28%), Positives = 121/249 (48%), Gaps = 25/249 (10%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI--QKHLA----HPN 179
           ++G+GSFGKV  A      +  A+K++ K       L     +C +  ++ LA    HP 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKD----VILQDDDVDCTMTEKRILALAAKHPF 57

Query: 180 IIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           +       +T +    + E+ +   L   +++ +K  E       + +  AL +LH + V
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGV 117

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           ++RDLK  N+LL+ +G   L DFG  +   +     T+  GTP Y+APE++ E  Y  + 
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177

Query: 299 DLWSLGCIAYEIHMGHPPFKT-------VSILHLIRLLKTQDVTFPSQVSETYKDLVKGL 351
           D W+LG + YE+  G PPF+         SILH        DV +P  +S+    ++K  
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILH-------DDVLYPVWLSKEAVSILKAF 230

Query: 352 LEKDASQRL 360
           + K+ ++RL
Sbjct: 231 MTKNPNKRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  110 bits (276), Expect = 6e-27
 Identities = 87/286 (30%), Positives = 132/286 (46%), Gaps = 33/286 (11%)

Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G LE Y K+  +GEG++  V+K         VALK I      G   ++++ E  + K L
Sbjct: 3   GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDL 61

Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQI-LSNLISALYYLH 234
            H NI+       T     L+ E+    L   L+          V++ L  L+  L Y H
Sbjct: 62  KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERP 293
             +VLHRDLKPQN+L+N+ G   L DFG AR+ ++ T   ++   T  Y  P+ L+    
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSI---LHLI-RLLKT-QDVTFPSQVS-ETYK-- 345
           Y    D+W +GCI YE+  G P F   ++   LH I R+L T  + T+P  +S E +K  
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241

Query: 346 ----------------------DLVKGLLEKDASQRLSWPELLHHP 369
                                 +L+  LL+ +  +R+S  E + HP
Sbjct: 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  110 bits (277), Expect = 7e-27
 Identities = 71/239 (29%), Positives = 122/239 (51%), Gaps = 4/239 (1%)

Query: 126 LIGEGSFGKVF---KAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           ++G+GSFGKVF   K    D  +  A+K++ K+    ++    K E +I   + HP I+K
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 183 FIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
              + +T  +  LI +F     L   L +    +E      L+ L  AL +LHS  +++R
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 122

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLW 301
           DLKP+N+LL+++G   L DFG ++          S  GT  YMAPE++  R +  +AD W
Sbjct: 123 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 182

Query: 302 SLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
           S G + +E+  G  PF+       + ++    +  P  +S   + L++ L +++ + RL
Sbjct: 183 SFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRL 241

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  110 bits (275), Expect = 7e-27
 Identities = 72/211 (34%), Positives = 106/211 (50%), Gaps = 9/211 (4%)

Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           GA   Y  +  +GEGS+  V+K I     + VALK+IS     G   ++++ E  + K L
Sbjct: 2   GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGL 60

Query: 176 AHPNII---KFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQI-LSNLISALY 231
            H NI+     I + ETL  FV   E+ H  L+  + Q         V++ +  L+  L 
Sbjct: 61  KHANIVLLHDIIHTKETLT-FVF--EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA 117

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIA 290
           Y+H   +LHRDLKPQN+L++  G   L DFG AR+ ++ +   +S   T  Y  P+ L+ 
Sbjct: 118 YIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLG 177

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVS 321
              Y    D+W  GCI  E+  G P F  VS
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  109 bits (275), Expect = 9e-27
 Identities = 87/293 (29%), Positives = 132/293 (45%), Gaps = 41/293 (13%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +++Y+K+  IGEG++G V+KA      +T+ALK I          S+  +E  + K + H
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 178 PNIIKFIASHETLNEFVLITEF------AHMSLSNLLEQRKKLSETICVQILSNLISALY 231
            NI++      +     L+ E+       HM  S    +  +L +T   QIL      + 
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILR----GIA 116

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAM-LCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LI 289
           Y HS+RVLHRDLKPQN+L+++   A+ L DFG AR+  +     T    T  Y APE L+
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD------------ 333
             R Y    D+WS+GCI  E+    P F   S    +  + R+L T +            
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236

Query: 334 --VTFPSQVSETYK-----------DLVKGLLEKDASQRLSWPELLHHPLVKD 373
               FP    +              DL+  +L  D S+R++    L H   KD
Sbjct: 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289

Length = 294

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  110 bits (276), Expect = 1e-26
 Identities = 82/288 (28%), Positives = 126/288 (43%), Gaps = 39/288 (13%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           KY  I  IG G++G V  A + +  + VA+K I+ +  +  +     +E ++ +HL H N
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 180 IIKFI-----ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           +I           E  N+  ++ E     L  ++   + LS+  C   L  L+  L Y+H
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE-RP 293
           S  VLHRDLKP N+LLN +    +CDFG AR+ +     +T    T  Y APEL+     
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE 185

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIRLLKTQDVT-------------- 335
           Y    D+WS+GCI  E+    P F     +H    +  LL +                  
Sbjct: 186 YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYI 245

Query: 336 --------------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
                         FP   +    DL++ +L  D S+R++  E L HP
Sbjct: 246 RSLPYTPRQSFARLFP-HANPLAIDLLEKMLVFDPSKRITVEEALAHP 292

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  108 bits (272), Expect = 2e-26
 Identities = 89/291 (30%), Positives = 141/291 (48%), Gaps = 21/291 (7%)

Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G +E Y K+  +GEG++  VFK      +  VALK I      G   ++++ E  + K L
Sbjct: 3   GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDL 61

Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQI-LSNLISALYYLH 234
            H NI+       T     L+ E+    L   ++    +     V+I L  ++  L Y H
Sbjct: 62  KHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERP 293
             +VLHRDLKPQN+L+N+ G   L DFG AR+ +V T   ++   T  Y  P+ L+    
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSI---LHLI-RLLKTQDVTFPSQVSETYKDLVK 349
           Y    D+W +GCI +E+  G P F   ++   LHLI RLL T     P++  ET+     
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGT-----PTE--ETW----P 230

Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGF-DYCDKRRGS 399
           G+   D  +  ++P+    PL+  N +  ++++  +    F  Y  K+R S
Sbjct: 231 GISSNDEFKNYNFPKYKPQPLI--NHAPRLDTEGIELLTKFLQYESKKRIS 279

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  108 bits (270), Expect = 2e-26
 Identities = 80/273 (29%), Positives = 142/273 (52%), Gaps = 30/273 (10%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPN 179
           ++ + ++G G++G+V+K  H+   +  A+K++  +    +E+   K E   ++K+  H N
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEI---KLEINMLKKYSHHRN 74

Query: 180 IIKFIAS--------HETLNEFVLITEFAHM-SLSNLLEQRK--KLSETICVQILSNLIS 228
           I  +  +        H+  ++  L+ EF    S+++L++  K   L E     I   ++ 
Sbjct: 75  IATYYGAFIKKSPPGHD--DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
            L +LH+++V+HRD+K QNVLL ++    L DFG +  +        +  GTP +MAPE+
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 192

Query: 289 IA--ERP---YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQV--- 340
           IA  E P   YD+ +D+WSLG  A E+  G PP   +  +H +R L       P ++   
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPP---LCDMHPMRALFLIPRNPPPKLKSK 249

Query: 341 --SETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
             S+ + D ++G L K+   R S  +LL HP +
Sbjct: 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  109 bits (273), Expect = 3e-26
 Identities = 73/261 (27%), Positives = 127/261 (48%), Gaps = 17/261 (6%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH----LA--HPN 179
           ++G+GSFGKV  A   +  +  A+K++ K       L     EC + +     LA  HP 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKD----VILQDDDVECTMTEKRILSLARNHPF 57

Query: 180 IIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           + +     +T +    + EF +   L   +++ ++  E       + + SAL +LH   +
Sbjct: 58  LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI 117

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           ++RDLK  NVLL+ +G   L DFG  +         ++  GTP Y+APE++ E  Y  + 
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D W++G + YE+  GH PF+  +   L   +   +V +P+ +S+   D++K  + K+ + 
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237

Query: 359 RLSWPEL------LHHPLVKD 373
           RL    L      L HP  K+
Sbjct: 238 RLGSLTLGGEEAILRHPFFKE 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  107 bits (269), Expect = 3e-26
 Identities = 77/260 (29%), Positives = 132/260 (50%), Gaps = 25/260 (9%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDL-KKTVALKIIS-------KSGR-SGKELSSLKQECE- 170
           Y  +  +G G+FG V+K    +  +  +ALK I+       K  R   K +  +  E   
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 171 IQKHLAHPNIIKFIASHETLNE----FVLITEFAHMSL----SNLLEQRKKLSETICVQI 222
           I++ L HPNI+++   ++T  E    ++++       L    ++L E++++ +E     I
Sbjct: 62  IKEQLRHPNIVRY---YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118

Query: 223 LSNLISALYYLH-SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              ++ AL YLH   R++HRDL P N++L +D    + DFG A+     +  LTS+ GT 
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-LTSVVGTI 177

Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL-IRLLKTQDVTFPSQV 340
           LY  PE++   PY   AD+W+ GCI Y++    PPF + ++L L  ++++      P  +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Query: 341 -SETYKDLVKGLLEKDASQR 359
            SE   D++   L  DA  R
Sbjct: 238 YSEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  107 bits (269), Expect = 5e-26
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 34/279 (12%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFI 184
            IG G+FG V K +H      +A+K I  S    KE   L  + + + +    P I+KF 
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 185 ASHETLNEFV--LITEFAHMSLSNL-----LEQRKKLSETICVQILSNLISALYYLHSN- 236
            +     E    +  E   +SL           +  + E I  +I    + AL YL    
Sbjct: 70  GA--LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT------PLYMAPELIA 290
           +++HRD+KP N+LL+++G   LCDFG +        ++ SI  T      P YMAPE I 
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGIS------GQLVDSIAKTRDAGCRP-YMAPERID 180

Query: 291 ---ERPYDHTADLWSLGCIAYEIHMGHPPF-KTVSILHLIRLLKTQDV-----TFPSQVS 341
                 YD  +D+WSLG   YE+  G  P+ K  S+   +  +   D      +   + S
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240

Query: 342 ETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
            ++ + +   L KD S+R  + ELL HP +KD     ++
Sbjct: 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVD 279

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  108 bits (271), Expect = 6e-26
 Identities = 74/249 (29%), Positives = 122/249 (48%), Gaps = 16/249 (6%)

Query: 119 EKYQKICLIGEGSFGKVFKAIH-------LDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           E +  I  +G GSFG+V  A +       + +K+    KII +     K++  +  E +I
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ-----KQVDHVFSERKI 84

Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISAL 230
             ++ HP  +    S +  +   L+ EF         L + K+    +     + ++   
Sbjct: 85  LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YL S  +++RDLKP+N+LL+KDG   + DFGFA+ +   T+ L    GTP Y+APE++ 
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC---GTPEYIAPEILL 201

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
              +   AD W+LG   YEI +G PPF     L + + +    + FP  +    K L+K 
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKK 261

Query: 351 LLEKDASQR 359
           LL  D ++R
Sbjct: 262 LLSHDLTKR 270

Length = 340

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  108 bits (270), Expect = 8e-26
 Identities = 81/289 (28%), Positives = 135/289 (46%), Gaps = 42/289 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A    L++ VA+K +S+  +S        +E  + KH+ H 
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  NE  L+T      L+N++ + +KLS+     ++  L+  L Y
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIV-KCQKLSDEHVQFLIYQLLRGLKY 133

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP NV +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ---ADDEMTGYVATRWYRAPEIMLNW 190

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPF------------------------KTVSILHLIR 327
             Y+ T D+WS+GCI  E+  G   F                        K +S  H  +
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250

Query: 328 LLKTQDVTFPSQVSETYK-------DLVKGLLEKDASQRLSWPELLHHP 369
            +++        + + ++       DL++ +L  D+ +R+S  E L HP
Sbjct: 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  106 bits (265), Expect = 1e-25
 Identities = 75/257 (29%), Positives = 122/257 (47%), Gaps = 11/257 (4%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ I  +G G++G V+KA +L   +  A+KII      G + S ++QE  + K   H NI
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL--EPGDDFSLIQQEIFMVKECKHCNI 68

Query: 181 IKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           + +  S+ +  +  +  E+    SL ++      LSE     +    +  L YLHS   +
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM 128

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP---YDH 296
           HRD+K  N+LL  +G   L DFG A  +        S  GTP +MAPE+ A      Y+ 
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP-----SQVSETYKDLVKGL 351
             D+W++G  A E+    PP   +  +  + L+   +   P     ++ S T+ + VK  
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKIS 248

Query: 352 LEKDASQRLSWPELLHH 368
           L K+  +R +   LL H
Sbjct: 249 LTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  107 bits (269), Expect = 1e-25
 Identities = 80/265 (30%), Positives = 128/265 (48%), Gaps = 29/265 (10%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAHPNIIKFI 184
           L+G G FG+V            A+K++ KS    +E +S  ++E +I      P I +  
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 185 ASHETLNEFVLITEFAH----MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
            + +  +   L+ E+      +SL N  E   +  E +    L+ L+ A++ +H    +H
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMGYVH 125

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK-GTPLYMAPELI------AERP 293
           RD+KP+NVL+++ G   L DFG A  +     + + +  GTP Y+APE++       +  
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185

Query: 294 YDHTADLWSLGCIAYEIHMGHPPF------KTVS-ILHLIRLLKTQDVTFPS--QVSETY 344
           Y    D WSLG IAYE+  G  PF      KT + I++  R LK     FP   +VS  +
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK-----FPEDPKVSSDF 240

Query: 345 KDLVKGLLEKDASQRLSWPELLHHP 369
            DL++ LL     +RL +  L  HP
Sbjct: 241 LDLIQSLL-CGQKERLGYEGLCCHP 264

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  107 bits (269), Expect = 1e-25
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 31/236 (13%)

Query: 111 MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ--- 167
               + +    QK   +GEG++GKV KA      K VA+K + K      +++  +Q   
Sbjct: 1   NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVG 59

Query: 168 ----------ECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSET 217
                     E +I   + H NI+  +  +   +   L+ +     L  +++++ +L+E+
Sbjct: 60  MCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTES 119

Query: 218 ICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM---- 273
               IL  +++ L  LH    +HRDL P N+ +N  G+  + DFG AR      +     
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 274 ----------LTSIKGTPLYMAPELI--AERPYDHTADLWSLGCIAYEIHMGHPPF 317
                     +TS   T  Y APEL+  AE+ Y    D+WS+GCI  E+  G P F
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLTGKPLF 234

Length = 335

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  107 bits (268), Expect = 1e-25
 Identities = 77/298 (25%), Positives = 125/298 (41%), Gaps = 48/298 (16%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---ECEIQKHL 175
            +Y+ I  IG G++G V  AI     K VA+K   K   +    +  K+   E +I +H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK---KIPHAFDVPTLAKRTLRELKILRHF 61

Query: 176 AHPNIIK----FIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
            H NII              +  ++ +     L +++   + L+E      L  L+  L 
Sbjct: 62  KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLK 121

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA-----VGTHMLTSIKGTPLYMAP 286
           Y+HS  V+HRDLKP N+L+N+D    + DFG AR ++         M T    T  Y AP
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM-TEYVATRWYRAP 180

Query: 287 ELIAERP-YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT------QDVTFPSQ 339
           EL+   P Y    D+WS+GCI  E+      F   + +H ++L+ +      ++V     
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240

Query: 340 VSETYK-------------------------DLVKGLLEKDASQRLSWPELLHHPLVK 372
                K                         DL+  +L+ D  +R++  + L HP + 
Sbjct: 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  104 bits (262), Expect = 4e-25
 Identities = 80/294 (27%), Positives = 131/294 (44%), Gaps = 45/294 (15%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAH 177
           + Y+K+  IGEG++GKV+KA   +  K VALK    +    G   ++L+ E  + + L+ 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSE 59

Query: 178 -PNIIKFIASHETLNE-----FVLITEFAHMSL-----SNLLEQRKKLSETICVQILSNL 226
              I++ +       +       L+ E+    L     SN     + L        +  L
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 227 ISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           +  + + H + V+HRDLKPQN+L++K  G+  + D G  R+ ++     T    T  Y A
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179

Query: 286 PE-LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKT--------- 331
           PE L+    Y    D+WS+GCI  E+    P F   S    +LH+ +LL T         
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239

Query: 332 --------------QDVT--FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
                         QD++   P  +S    DL++ +L  D ++R+S    L HP
Sbjct: 240 SKLRDWHEFPQWKPQDLSRAVP-DLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  104 bits (260), Expect = 1e-24
 Identities = 78/277 (28%), Positives = 125/277 (45%), Gaps = 56/277 (20%)

Query: 125 CLIGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
             +GEG+FG+V KA  + L       TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 179 NIIKFIASHETLNEFVLITEFAH-----------------MSLSNLLEQRKKLSETICVQ 221
           NII  +          ++ E+A                   S  +     + L++   V 
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
               +   + +L S + +HRDL  +NVL+ +D V  + DFG AR      H +   + T 
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKTT 192

Query: 281 ----PL-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLK---- 330
               P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK    
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR 252

Query: 331 -------TQDV---------TFPSQVSETYKDLVKGL 351
                  TQ++           PSQ   T+K LV+ L
Sbjct: 253 MEKPQNCTQELYHLMRDCWHEVPSQ-RPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  104 bits (262), Expect = 1e-24
 Identities = 82/289 (28%), Positives = 127/289 (43%), Gaps = 43/289 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+Y  +  +G G++G V  AI     + VA+K +S+  +S        +E  + KH+ H 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S +   +F L+  +    L  ++     LSE     ++  ++  L Y
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH--PLSEDKVQYLVYQMLCGLKY 132

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE+I   
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH---ADAEMTGYVVTRWYRAPEVILNW 189

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQDVTFPSQV---------- 340
             Y+ T D+WS+GCI  E+  G   FK    L  L ++LK   V  P  V          
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS 249

Query: 341 --------------------SETYKDLVKGLLEKDASQRLSWPELLHHP 369
                               S    DL++ +LE D  +RL+  E L HP
Sbjct: 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHP 298

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  104 bits (261), Expect = 1e-24
 Identities = 87/293 (29%), Positives = 129/293 (44%), Gaps = 49/293 (16%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
            +Y  +  +G G+FG V  A      + VA+K I K   +        +E ++ KHL H 
Sbjct: 10  NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69

Query: 179 NIIK----FIASHETLNEFVLITEFAHMSLSNLLEQR---KKLSETICVQILSNLISALY 231
           NII     FI+  E   +   +TE     L  LL  R   K+  +    QIL      L 
Sbjct: 70  NIISLSDIFISPLE---DIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILR----GLK 122

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIA 290
           Y+HS  V+HRDLKP N+L+N++    +CDFG AR   +    +T    T  Y APE ++ 
Sbjct: 123 YVHSAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYVSTRYYRAPEIMLT 179

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF------------------------KTVSILHLI 326
            + YD   D+WS GCI  E+  G P F                         T+   + +
Sbjct: 180 WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239

Query: 327 RLLKTQDVTFPSQVSETYK-------DLVKGLLEKDASQRLSWPELLHHPLVK 372
           R +++     P   SE +K       DL++ +L  D  +R+S  E L HP + 
Sbjct: 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  103 bits (259), Expect = 2e-24
 Identities = 70/242 (28%), Positives = 121/242 (50%), Gaps = 11/242 (4%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI--QKHLAH----PN 179
           ++G+GSFGKV  A      +  A+KI+ K       +     EC +  ++ LA     P 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKD----VVIQDDDVECTMVEKRVLALQDKPPF 62

Query: 180 IIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           + +  +  +T++    + E+ +   L   ++Q  K  E   V   + +   L++LH   +
Sbjct: 63  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           ++RDLK  NV+L+ +G   + DFG  +   V      +  GTP Y+APE+IA +PY  + 
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D W+ G + YE+  G PPF       L + +   +V++P  +S+    + KGL+ K  S+
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSK 242

Query: 359 RL 360
           RL
Sbjct: 243 RL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  102 bits (256), Expect = 2e-24
 Identities = 80/271 (29%), Positives = 127/271 (46%), Gaps = 34/271 (12%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH----PNII 181
           +IG G FG+V+     D  K  A+K + K     K+  +L     I   L      P I+
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 182 KFIASHETLNEFVLITEFAHMSLSNL---LEQRKKLSETICVQILSNLISALYYLHSNRV 238
               +  T ++   I +   M+  +L   L Q    SE       + +I  L ++H+  V
Sbjct: 61  CMSYAFHTPDKLSFILDL--MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFV 118

Query: 239 LHRDLKPQNVLLNKDG------VAMLCDFGFARSMA-VGTHMLTSIKGTPLYMAPELIAE 291
           ++RDLKP N+LL++ G      + + CDF   +  A VGTH          YMAPE++ +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG---------YMAPEVLQK 169

Query: 292 -RPYDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDL 347
              YD +AD +SLGC+ +++  GH PF   KT     + R+  T  V  P   S   + L
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 229

Query: 348 VKGLLEKDASQRLSW-----PELLHHPLVKD 373
           ++GLL++D ++RL        E+  HP  + 
Sbjct: 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  102 bits (256), Expect = 2e-24
 Identities = 73/263 (27%), Positives = 128/263 (48%), Gaps = 17/263 (6%)

Query: 127 IGEGSFGKVF---KAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKHL-AHPNI 180
           +G G++GKVF   K    D  K  A+K++ K+   +  K     + E ++ + +   P +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 181 IKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           +    + +T  +  LI ++ +   L   L QR+  +E+     ++ ++ AL +LH   ++
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGII 127

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT-SIKGTPLYMAPELI--AERPYDH 296
           +RD+K +N+LL+ +G  +L DFG ++           S  GT  YMAPE+I      +D 
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDK 187

Query: 297 TADLWSLGCIAYEIHMGHPPFKT----VSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL 352
             D WSLG + +E+  G  PF       S   + R +      FP  +S   +D ++ LL
Sbjct: 188 AVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLL 247

Query: 353 EKDASQRLSW---PELLHHPLVK 372
           EKD  +RL      E+ +HP  +
Sbjct: 248 EKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  105 bits (263), Expect = 3e-24
 Identities = 73/215 (33%), Positives = 116/215 (53%), Gaps = 14/215 (6%)

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQ------ILSNLISA 229
           H  I+K     ++ ++ +LI E+   S  +L +Q +++L E +  Q      +   ++ A
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYG--SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA 181

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR--SMAVGTHMLTSIKGTPLYMAPE 287
           L  +HS +++HRDLK  N+ L   G+  L DFGF++  S +V   + +S  GTP Y+APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKD 346
           L   + Y   AD+WSLG I YE+   H PFK  S   ++ ++L  +   FP  VS   K 
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301

Query: 347 LVKGLLEKDASQRLSWPELLHHPLVK--DNLSSEI 379
           L+  LL K+ + R +  +LLH   +K   NL  +I
Sbjct: 302 LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDI 336

Length = 478

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  102 bits (257), Expect = 4e-24
 Identities = 68/220 (30%), Positives = 105/220 (47%), Gaps = 10/220 (4%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y+   +IG+GS+G V  AI     + VA+K I+       + + + +E ++ + L HP+
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 180 I--IKFI---ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           I  IK I    S     +  ++ E     L  +++    L+       L  L+ AL Y+H
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM---AVGTHMLTSIKGTPLYMAPELIAE 291
           +  V HRDLKP+N+L N D    +CDFG AR            T    T  Y APEL   
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180

Query: 292 --RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
               Y    D+WS+GCI  E+  G P F   +++H + L+
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI 220

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  102 bits (255), Expect = 6e-24
 Identities = 67/242 (27%), Positives = 118/242 (48%), Gaps = 11/242 (4%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI--QKHLAHPNIIKF 183
           ++G+GSFGKV  A      +  A+KI+ K       +     EC +  ++ LA      F
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKD----VVIQDDDVECTMVEKRVLALSGKPPF 62

Query: 184 I----ASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           +    +  +T++    + E+ +   L   ++Q  +  E   V   + +   L++LHS  +
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           ++RDLK  NV+L+ +G   + DFG  +          +  GTP Y+APE+IA +PY  + 
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D W+ G + YE+  G  PF+      L + +   +V +P  +S+    + KGL+ K   +
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 242

Query: 359 RL 360
           RL
Sbjct: 243 RL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  101 bits (253), Expect = 1e-23
 Identities = 75/288 (26%), Positives = 132/288 (45%), Gaps = 29/288 (10%)

Query: 126 LIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECE-IQKHL-----A 176
           ++G+GSFGKVF A   +LK T    A+K + K       L     EC  ++K +      
Sbjct: 2   MLGKGSFGKVFLA---ELKGTNQFFAIKALKKD----VVLMDDDVECTMVEKRVLSLAWE 54

Query: 177 HPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           HP +     + +T      + E+ +   L   ++   K          + +I  L +LHS
Sbjct: 55  HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS 114

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
             +++RDLK  N+LL+ DG   + DFG  +   +G     +  GTP Y+APE++  + Y+
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            + D WS G + YE+ +G  PF       L + ++  +  +P  ++   KD++  L  ++
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234

Query: 356 ASQRLSWP-ELLHHPLVKDNLSSEIES-----------QNNQDCIGFD 391
             +RL    ++  HP  ++   S +E            ++  DC  FD
Sbjct: 235 PERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFD 282

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  101 bits (252), Expect = 1e-23
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 9/207 (4%)

Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G  + Y+K+  +GEGS+  V+K       K VALK+I      G   ++++ E  + K L
Sbjct: 2   GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGL 60

Query: 176 AHPNII---KFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQI-LSNLISALY 231
            H NI+     I + ETL    L+ E+ H  L   +++         V++ L  L+  L 
Sbjct: 61  KHANIVLLHDIIHTKETLT---LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIA 290
           Y+H   +LHRDLKPQN+L++  G   L DFG AR+ +V +H  ++   T  Y  P+ L+ 
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG 177

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
              Y    D+W +GCI  E+  G   F
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  101 bits (253), Expect = 2e-23
 Identities = 93/326 (28%), Positives = 147/326 (45%), Gaps = 46/326 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++Y+ +  +G G++G V  A+       VA+K + +  +S        +E  + KH+ H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S +  ++F L+  F    L  L++  +KLSE     ++  ++  L Y
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKY 133

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +H+  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE+I   
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT---DSEMTGYVVTRWYRAPEVILNW 190

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-FPSQ------VSETY 344
             Y  T D+WS+GCI  E+  G P FK     HL +L++   VT  PS+       SE  
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHD--HLDQLMEIMKVTGTPSKEFVQKLQSEDA 248

Query: 345 KDLVKGL----------------------LEK----DASQRLSWPELLHHPLVKDNLSSE 378
           K+ VK L                      LEK    DA  R++  E L HP  ++    E
Sbjct: 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308

Query: 379 IESQNNQDCIGFDYCDKRRGSRKSIT 404
            E++       FD  D+     K +T
Sbjct: 309 DETEAPPYDDSFDEVDQSLEEWKRLT 334

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  100 bits (250), Expect = 2e-23
 Identities = 70/255 (27%), Positives = 129/255 (50%), Gaps = 16/255 (6%)

Query: 121 YQKICLIGEGSFGKVF---KAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKHL 175
           ++ + ++G G++GKVF   K    D  K  A+K++ K+   +  K     + E ++ +H+
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 176 AH-PNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYL 233
              P ++    + +T  +  LI ++ +   L   L QR++  E         ++ AL +L
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS-MAVGTHMLTSIKGTPLYMAPELIA-- 290
           H   +++RD+K +N+LL+ +G  +L DFG ++           S  GT  YMAP+++   
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTV-----SILHLIRLLKTQDVTFPSQVSETYK 345
           +  +D   D WS+G + YE+  G  PF TV     S   + R +   +  +P ++S   K
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPF-TVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240

Query: 346 DLVKGLLEKDASQRL 360
           D+++ LL KD  +RL
Sbjct: 241 DIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  100 bits (250), Expect = 2e-23
 Identities = 86/273 (31%), Positives = 135/273 (49%), Gaps = 38/273 (13%)

Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG FG+V   +AI LD +K      VA+K++ KS  + K+LS L  E E+ K +  H 
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 84

Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETIC-------VQILS--NLIS 228
           NII  + +        +I E+A   +L   L  R+      C        + LS  +L+S
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
             Y       YL S + +HRDL  +NVL+ +D V  + DFG AR +    H +   K T 
Sbjct: 145 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKKTT 200

Query: 281 ----PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLKT-QD 333
               P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  V +  L +LLK    
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 260

Query: 334 VTFPSQVSETYKDLVKGLLEKDASQRLSWPELL 366
           +  PS  +     +++       SQR ++ +L+
Sbjct: 261 MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 99.2 bits (247), Expect = 3e-23
 Identities = 77/263 (29%), Positives = 125/263 (47%), Gaps = 19/263 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G+G++G V+K +H     T+A+K I       K  + +  E +I      P I+ F  +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYGA 67

Query: 187 HETLNEFVLITEFAHM-SLSNLL---EQRKKLSETICVQILSNLISALYYL-HSNRVLHR 241
                   +  E+    SL  L       + + E +  +I   ++  L +L   + ++HR
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHR 127

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI------AERPYD 295
           D+KP NVL+N +G   LCDFG + ++ V +   T+I G   YMAPE I          Y 
Sbjct: 128 DVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNI-GCQSYMAPERIKSGGPNQNPTYT 185

Query: 296 HTADLWSLGCIAYEIHMG---HPPFKTVSIL-HLIRLLKTQDVTFPSQVSETYKDLVKGL 351
             +D+WSLG    E+ +G   +PP    +I   L  ++     T PS  S+  +D V   
Sbjct: 186 VQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKC 245

Query: 352 LEKDASQRLSWPELLHHP-LVKD 373
           L K  ++R ++ +LL HP LVK 
Sbjct: 246 LNKIPNRRPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 48/295 (16%)

Query: 126 LIGEGSFGK--VFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           LIG+       V  A H      VA+K I+    S ++L  L+QE    + L HPNI+ +
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 184 IASHETLNEFVLITEF-AHMSLSNLLEQRKK--LSETICVQILSNLISALYYLHSNRVLH 240
           + S    +E  +++   A+ S  +LL+      L E     IL ++++AL Y+HS   +H
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLY-------MAPELIAE-- 291
           R +K  ++LL+ DG  +L    ++ SM         +   P         ++PE++ +  
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFK-TVSILHLIRLLK--------------TQDVTF 336
           + Y+  +D++S+G  A E+  GH PFK   +   L+  ++               +D   
Sbjct: 185 QGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244

Query: 337 PSQV-------------------SETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
            S+                    SE +   V+  L++D   R S  +LL+H   K
Sbjct: 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 99.7 bits (248), Expect = 7e-23
 Identities = 78/289 (26%), Positives = 131/289 (45%), Gaps = 42/289 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N+++  +KL++     ++  ++  L Y
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 135

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNW 192

Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTF----PSQVSET 343
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T          S+ +  
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 252

Query: 344 Y-----------------------KDLVKGLLEKDASQRLSWPELLHHP 369
           Y                        DL++ +L  D+ +R++  + L H 
Sbjct: 253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 98.3 bits (245), Expect = 7e-23
 Identities = 81/273 (29%), Positives = 130/273 (47%), Gaps = 23/273 (8%)

Query: 122 QKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH-PNI 180
           + I  +G G++G V K  H+     +A+K I  +  S +E   L  + +I       P  
Sbjct: 4   EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYT 62

Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS----NLISALYYLHSN 236
           + F  +     +  +  E    SL    ++      TI   IL     +++ AL YLHS 
Sbjct: 63  VTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122

Query: 237 -RVLHRDLKPQNVLLNKDGVAMLCDFGFA----RSMAVGTHMLTSIKGTPLYMAPELI-- 289
             V+HRD+KP NVL+N++G   LCDFG +     S+A      T   G   YMAPE I  
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK-----TIDAGCKPYMAPERINP 177

Query: 290 --AERPYDHTADLWSLGCIAYEIHMGHPPFKT--VSILHLIRLLKTQDVTFPSQ-VSETY 344
              ++ YD  +D+WSLG    E+  G  P+ +       L ++++      P++  S  +
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237

Query: 345 KDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS 377
           +D V   L+K+  +R ++PELL HP  + +LS 
Sbjct: 238 QDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 99.4 bits (248), Expect = 8e-23
 Identities = 79/296 (26%), Positives = 133/296 (44%), Gaps = 47/296 (15%)

Query: 121 YQKICLIGEGSFGKVFKA--IHLDLKKTVALKIISKSGRSGKELSSLK--QECEIQKHL- 175
           Y+ I  +G+G++G V  A       ++TVA+K I+      K++ + +  +E ++ +H  
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV--FSKKILAKRALRELKLLRHFR 59

Query: 176 AHPNIIKF----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
            H NI       I      NE  L  E     L  ++   + L++      +  ++  L 
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG----THMLTSIKGTPLYMAPE 287
           Y+HS  VLHRDLKP N+L+N D    +CDFG AR  +         +T    T  Y APE
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 288 -LIAERPYDHTADLWSLGCIAYEIHMGHPPFK----TVSILHLIRLLKTQD--------- 333
            +++ + Y    D+WS+GCI  E+    P FK       +  ++++L T D         
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239

Query: 334 -------VTFPSQVSETYK-----------DLVKGLLEKDASQRLSWPELLHHPLV 371
                   + P+   + ++           DL++ LL  D ++R+S  E L HP +
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 97.8 bits (243), Expect = 1e-22
 Identities = 77/251 (30%), Positives = 119/251 (47%), Gaps = 25/251 (9%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH----PNII 181
           +IG G FG+V+     D  K  A+K + K     K+  +L     I   L      P I+
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 182 KFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
               +  T ++   I +  +   L   L Q    SE       + +I  L ++H+  V++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSM-------AVGTHMLTSIKGTPLYMAPELIAE-R 292
           RDLKP N+LL++ G   + D G A          +VGTH          YMAPE++ +  
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG---------YMAPEVLQKGT 171

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
            YD +AD +SLGC+ +++  GH PF   KT     + R+  T +V  P   S   K L++
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLE 231

Query: 350 GLLEKDASQRL 360
           GLL++D S+RL
Sbjct: 232 GLLQRDVSKRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 98.1 bits (244), Expect = 1e-22
 Identities = 81/276 (29%), Positives = 130/276 (47%), Gaps = 42/276 (15%)

Query: 127 IGEGSFGKVFKAIHLDLKK-------TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG FG+V +A    + K       TVA+K++ K   + K+L+ L  E E+ K +  H 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLISEMELMKLIGKHK 78

Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRK-----------KLSETICVQILSNL 226
           NII  +          +I E+A   +L   L  R+           K+ E        +L
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS--FKDL 136

Query: 227 ISALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG 279
           +S  Y       YL S R +HRDL  +NVL+ +D V  + DFG AR    G H +   K 
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKK 192

Query: 280 T-----PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLKT- 331
           T     P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LL+  
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG 252

Query: 332 QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH 367
             +  PS  +     L++       +QR ++ +L+ 
Sbjct: 253 HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 77/274 (28%), Positives = 124/274 (45%), Gaps = 29/274 (10%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E  + I  +G G+ G V K  H+     +A K++    +S      L+ E +I      P
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR-ELQIMHECRSP 63

Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHS-N 236
            I+ F  +    N   +  EF    SL  + ++   +   I  +I   ++  L YL++ +
Sbjct: 64  YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK----GTPLYMAPELIAER 292
           R++HRD+KP N+L+N  G   LCDFG      V   ++ SI     GT  YM+PE I   
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFG------VSGELINSIADTFVGTSTYMSPERIQGG 177

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFK-----------TVSILHLI-RLLKTQDVTFPS-Q 339
            Y   +D+WSLG    E+ +G  PF             + IL L+ ++++      PS  
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237

Query: 340 VSETYKDLVKGLLEKDASQRLSWPELLH--HPLV 371
             E  +D V   L KD ++R + P+ L    P +
Sbjct: 238 FPEDLRDFVDACLLKDPTERPT-PQQLCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 71/278 (25%), Positives = 127/278 (45%), Gaps = 23/278 (8%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAH 177
           E ++ I LI  G++G V+   H + ++  A+K I+K     + ++  +  E +I     +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           P ++    S ET     ++ E+      + LL+    L   +     +  + AL YLH+ 
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARS--MAVGTHML-------------TSIKGTP 281
            ++HRDLKP N+L+   G   L DFG ++   M++ T++                + GTP
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180

Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP---S 338
            Y+APE+I  + Y    D W++G I YE  +G  PF   +   L   + + D+ +P    
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240

Query: 339 QVSETYKDLVKGLLEKDASQRL---SWPELLHHPLVKD 373
            +    +DL+  LL ++  +RL      E+  H     
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 22/219 (10%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKT--VALKII--SKSGRSGKELSSLKQECEIQKHL 175
           KY+    IG G++G+V+KA   + K     A+K     K   +G   S+ + E  + + L
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLREL 59

Query: 176 AHPNIIKF---IASHETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLI 227
            H N++        H   + ++L  ++A   L  +++     +R  +  ++   +L  ++
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLF-DYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118

Query: 228 SALYYLHSNRVLHRDLKPQNVLL----NKDGVAMLCDFGFARSMAVGTHMLTSIKG---T 280
           + ++YLHSN VLHRDLKP N+L+     + GV  + D G AR        L  +     T
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178

Query: 281 PLYMAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFK 318
             Y APEL+   R Y    D+W++GCI  E+    P FK
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 32/211 (15%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
            IG+G FG V    +    + VA+K +           +   E  +   L HPN+++ + 
Sbjct: 13  TIGKGEFGDVMLGDYR--GQKVAVKCLK---DDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 186 SHETLNEFVLITEFAHMSLSNLLE-------------QRKKLSETICVQILSNLISALYY 232
                N   ++TE+  M+  +L++             Q+   +  +C          + Y
Sbjct: 68  VVLQGNPLYIVTEY--MAKGSLVDYLRSRGRAVITLAQQLGFALDVC--------EGMEY 117

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           L     +HRDL  +NVL+++D VA + DFG A+  + G     S K    + APE + E+
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---QDSGKLPVKWTAPEALREK 174

Query: 293 PYDHTADLWSLGCIAYEIH-MGHPPFKTVSI 322
            +   +D+WS G + +EI+  G  P+  + +
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 95.7 bits (238), Expect = 1e-21
 Identities = 67/256 (26%), Positives = 117/256 (45%), Gaps = 30/256 (11%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-----AHPNI 180
           +IG GS+ KV        ++  A+K+I K   +  E     Q    +KH+      HP +
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQ---TEKHVFETASNHPFL 58

Query: 181 IKFIASHETLNEFVLITEFA-------HMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
           +   +  +T +    + EF        HM      ++++KL E       + +  AL +L
Sbjct: 59  VGLHSCFQTESRLFFVIEFVSGGDLMFHM------QRQRKLPEEHARFYSAEISLALNFL 112

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           H   +++RDLK  NVLL+ +G   L D+G  +         ++  GTP Y+APE++    
Sbjct: 113 HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED 172

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSIL---------HLIRLLKTQDVTFPSQVSETY 344
           Y  + D W+LG + +E+  G  PF  V +          +L +++  + +  P  +S   
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232

Query: 345 KDLVKGLLEKDASQRL 360
             ++KG L KD  +RL
Sbjct: 233 SSVLKGFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 66/245 (26%), Positives = 119/245 (48%), Gaps = 17/245 (6%)

Query: 126 LIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEI--QKHLA---- 176
           ++G+GSFGKV  A   +LK      A+K + K       L     EC +  ++ LA    
Sbjct: 2   VLGKGSFGKVLLA---ELKGKGEYFAVKALKKD----VVLIDDDVECTMVEKRVLALAWE 54

Query: 177 HPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           +P +     + +T      + EF +   L   ++ + +          + ++  L +LHS
Sbjct: 55  NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS 114

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
             +++RDLK  NV+L++DG   + DFG  +    G +  ++  GTP Y+APE++    Y 
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            + D WS G + YE+ +G  PF       L   ++     +P  +++  KD+++ L E+D
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234

Query: 356 ASQRL 360
            ++RL
Sbjct: 235 PTRRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 93.8 bits (233), Expect = 2e-21
 Identities = 62/252 (24%), Positives = 123/252 (48%), Gaps = 14/252 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 71  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188

Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P        +L++   + + S 
Sbjct: 189 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSD 248

Query: 359 RLSWPELLHHPL 370
           R S+ E +H   
Sbjct: 249 RPSFAE-IHQAF 259

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 95.6 bits (238), Expect = 2e-21
 Identities = 77/307 (25%), Positives = 124/307 (40%), Gaps = 58/307 (18%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           L++YQ +  IG G+ G V  A      + VA+K +S+  ++        +E  + K + H
Sbjct: 15  LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNH 74

Query: 178 PNIIKFI------ASHETLNEFVLITEFAHMSLS---NLLEQRKKLSETICVQILSNLIS 228
            NII  +       S E   +  L+ E    +L     +    +++S      +L  ++ 
Sbjct: 75  KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLC 129

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
            + +LHS  ++HRDLKP N+++  D    + DFG AR+      M+T    T  Y APE+
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEV 188

Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPF----------KTVSIL-----HLIRLLKTQ- 332
           I    Y    D+WS+GCI  E+  G   F          K +  L       +  L+   
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248

Query: 333 --------------------DVTFPSQVSETYK-------DLVKGLLEKDASQRLSWPEL 365
                               DV FP       K       DL+  +L  D  +R+S  + 
Sbjct: 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308

Query: 366 LHHPLVK 372
           L HP + 
Sbjct: 309 LQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 79/267 (29%), Positives = 129/267 (48%), Gaps = 20/267 (7%)

Query: 126 LIGEGSFGKVF---KAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKHLAH-PN 179
           ++G G++GKVF   K    D  K  A+K++ K+   +  K +   + E  + +H+   P 
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 180 IIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           ++    + +T  +  LI ++ +   +   L QR   SE         +I AL +LH   +
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGI 126

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT-SIKGTPLYMAPELI-AERPYDH 296
           ++RD+K +N+LL+ +G  +L DFG ++         T S  GT  YMAPE+I  +  +  
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGK 186

Query: 297 TADLWSLGCIAYEIHMGHPPF-----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGL 351
             D WSLG + +E+  G  PF     +        R+LK  D  FPS +    +DL+  L
Sbjct: 187 AVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-DPPFPSFIGPEAQDLLHKL 245

Query: 352 LEKDASQRL-SWP----ELLHHPLVKD 373
           L KD  +RL + P    E+  HP  K 
Sbjct: 246 LRKDPKKRLGAGPQGASEIKEHPFFKG 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 83/303 (27%), Positives = 128/303 (42%), Gaps = 52/303 (17%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 177
           + ++ I +IG G+FG+V      D     A+K + KS    KE ++ ++ E +I     +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           P ++K   S +  N   LI E+     +  LL ++   +E      ++  I A+  +H  
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFG------------FARSMAVGTHMLT--------- 275
             +HRD+KP N+LL+  G   L DFG            F R +                 
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR-ILSHALPSNFLDFISKPM 179

Query: 276 ------------------SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
                             S  GTP Y+APE+  +  Y+   D WSLG I YE+ +G+PPF
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239

Query: 318 ---KTVSILHLIRLLKTQDVTFPSQV--SETYKDLVKGLLEKDASQRLSWP---ELLHHP 369
                      I   K + + FP +V  S   KDL+K L   +A +RL      E+  HP
Sbjct: 240 CSDNPQETYRKIINWK-ETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHP 297

Query: 370 LVK 372
             K
Sbjct: 298 FFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 72/232 (31%), Positives = 114/232 (49%), Gaps = 29/232 (12%)

Query: 127 IGEGSFGKVFKAIHLDLKK-------TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG FG+V  A  L + K       TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 81

Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I E+A   +L   L  R+         I           +L+S
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141

Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +  +  +  T+    
Sbjct: 142 CTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201

Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 93.4 bits (232), Expect = 4e-21
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 10/161 (6%)

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L  LH  R+++RDLKP+N+LL+  G   + D G A  +  G  +   + GT  YMAPE++
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAPEVV 173

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFK----TVSILHLIRLLKTQDVTFPSQVSETYK 345
               Y  + D W LGC+ YE+  G  PF+     V    + R +K     +  + SE  +
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233

Query: 346 DLVKGLLEKDASQRL-----SWPELLHHPLVKDNLSSEIES 381
            + + LL KD   RL        E+  HP  +      +E+
Sbjct: 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 96.1 bits (239), Expect = 4e-21
 Identities = 75/282 (26%), Positives = 138/282 (48%), Gaps = 24/282 (8%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY    ++G G+ G V  A  +   +  A+K++   G S  + +  + E     +    
Sbjct: 32  KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFF 91

Query: 179 NIIK----FIASHETLNEFV----LITEFAHM-SLSNLLEQRKKLSET--------ICVQ 221
           +I+K    F        E V    L+ ++A+   L   ++ R K + T        + +Q
Sbjct: 92  SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151

Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR--SMAVGTHMLTSIKG 279
           +L     A++++HS  ++HRD+K  N+LL  +G+  L DFGF++  +  V   +  +  G
Sbjct: 152 VLL----AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207

Query: 280 TPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQDVTFPS 338
           TP Y+APE+   +PY   AD++SLG + YE+     PF   ++  ++ + L  +    P 
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267

Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
            +S   +++V  LL  D  +R S  +LL+ P+ K  +S  +E
Sbjct: 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLE 309

Length = 496

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 94.3 bits (234), Expect = 5e-21
 Identities = 82/302 (27%), Positives = 130/302 (43%), Gaps = 51/302 (16%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           L++YQ++  IG G+ G V  A    L   VA+K +S+  ++        +E  + K + H
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79

Query: 178 PNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
            NII  +      ++L EF    L+ E    +L  ++    +L       +L  ++  + 
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIK 137

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           +LHS  ++HRDLKP N+++  D    + DFG AR+ A    M+T    T  Y APE+I  
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTPYVVTRYYRAPEVILG 196

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFK----------------TVSILHLIRLLKT---- 331
             Y    D+WS+GCI  E+  G   F+                T S   + RL  T    
Sbjct: 197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256

Query: 332 ----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHHP 369
                            D  FPS+       +   +DL+  +L  D  +R+S  E L HP
Sbjct: 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316

Query: 370 LV 371
            +
Sbjct: 317 YI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 82/273 (30%), Positives = 120/273 (43%), Gaps = 31/273 (11%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  +G GS G VF A+  D  K VA+K I       + +    +E +I + L H N
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL--TDPQSVKHALREIKIIRRLDHDN 63

Query: 180 IIKF--------------IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN 225
           I+K               + S   LN   ++ E+    L+N+LEQ   LSE      +  
Sbjct: 64  IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQ 122

Query: 226 LISALYYLHSNRVLHRDLKPQNVLLN-KDGVAMLCDFGFARSMAVG-TH--MLTSIKGTP 281
           L+  L Y+HS  VLHRDLKP NV +N +D V  + DFG AR +    +H   L+    T 
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 282 LYMAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRL-LKTQDVTFPSQ 339
            Y +P L+ +   Y    D+W+ GCI  E+  G P F     L  ++L L++  V     
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242

Query: 340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
            +E        LL    S   +       PL  
Sbjct: 243 RNE--------LLNVIPSFVRNDGGEPRRPLRD 267

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 93.2 bits (231), Expect = 1e-20
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 9/199 (4%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 178 PNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
            NII  +      ++L EF    L+ E    +L  +++   +L       +L  ++  + 
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIK 133

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I  
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILG 192

Query: 292 RPYDHTADLWSLGCIAYEI 310
             Y    D+WS+GCI  E+
Sbjct: 193 MGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 60/192 (31%), Positives = 92/192 (47%), Gaps = 10/192 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           IG G FG+V +   L L       VA+K + K+G S K+      E  I     HPNII+
Sbjct: 12  IGGGEFGEVCRG-RLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 183 FIASHETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLH 240
                      ++ITE+  + SL   L E   K +    V +L  + S + YL     +H
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVH 129

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSM--AVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           RDL  +N+L+N + V  + DFG +R +  +  T+     K    + APE IA R +   +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSAS 189

Query: 299 DLWSLGCIAYEI 310
           D+WS G + +E+
Sbjct: 190 DVWSFGIVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 75/270 (27%), Positives = 118/270 (43%), Gaps = 34/270 (12%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKS---GRSGKELSSLKQECEIQKHLAHPNIIK 182
           ++G+G FG+V         K  A K + K     R G+ ++    E +I + +    ++ 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL--NEKQILEKVNSRFVVS 64

Query: 183 FIASHETLNEFVLITEFA----------HMSLSNLLEQRKKL-SETICVQILSNLISALY 231
              ++ET +   L+              HM  +   E R    +  IC          L 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC--------GLE 116

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
            LH  R+++RDLKP+N+LL+  G   + D G A  +  G  +   + GT  YMAPE++  
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKN 175

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDL 347
             Y  + D W+LGC+ YE+  G  PF    K +    + RL+K     +  + S   + L
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235

Query: 348 VKGLLEKDASQRL-----SWPELLHHPLVK 372
            K LL KD  +RL        E+  HPL K
Sbjct: 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 35/273 (12%)

Query: 127 IGEGSFGKVFKAIHLDLK-----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG FGKV KA    LK      TVA+K++ K   S  EL  L  E  + K + HP++I
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML-KENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALY--------- 231
           K   +       +LI E+A + SL + L + +K+  +      +   S L          
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 232 ---------------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS 276
                          YL   +++HRDL  +NVL+ +     + DFG +R +      +  
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR 186

Query: 277 IKG-TPL-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKT-Q 332
            KG  P+ +MA E + +  Y   +D+WS G + +EI  +G  P+  ++   L  LLKT  
Sbjct: 187 SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY 246

Query: 333 DVTFPSQVSETYKDLVKGLLEKDASQRLSWPEL 365
            +  P   SE   +L+    +++  +R ++ ++
Sbjct: 247 RMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 29/221 (13%)

Query: 126 LIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
            +G+GSFG V +            VA+K + KS +    +    +E  I   L H N+I+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 183 F---IASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETI------CVQILSNLISALYY 232
               + +H  +    ++TE A + SL + L +       I       VQI     + + Y
Sbjct: 61  LYGVVLTHPLM----MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRY 112

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI--KGTPL-YMAPELI 289
           L S R +HRDL  +N+LL  D    + DFG  R++               P  + APE +
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172

Query: 290 AERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS---ILHLI 326
             R + H +D+W  G   +E+   G  P+  +S   IL  I
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 67/245 (27%), Positives = 115/245 (46%), Gaps = 6/245 (2%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQE---CEIQKHLA 176
           ++ + ++G G FGKV  A +    +  A+K + K     + E+ SL  E    E      
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           HP ++   A  +T +    + E+A      +       SE   V   + ++  L YLH N
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN 120

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARS-MAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           ++++RDLK  N+LL+ +G   + DFG  +  M  G    T   GTP ++APE++ E  Y 
Sbjct: 121 KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEVLTETSYT 179

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
              D W LG + YE+ +G  PF       +   +   +V +P  +S     +++ LL ++
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRN 239

Query: 356 ASQRL 360
             +RL
Sbjct: 240 PERRL 244

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 72/247 (29%), Positives = 118/247 (47%), Gaps = 18/247 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKS---GRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +G+G FG+V      +  K  A K + K     +SG++++ L  E EI + +  P I+  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL--EKEILEKVNSPFIVNL 58

Query: 184 IASHETLNEFVLITEFAH-----MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
             + E+     L+    +       + N+ E+  ++   I     + +   + +LHS  +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYS--AQITCGILHLHSMDI 116

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           ++RD+KP+NVLL+  G   L D G A  +  G   +T   GT  YMAPE++ E PY +  
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 299 DLWSLGCIAYEIHMGHPPFK----TVSILHLIRLLKTQDVTFPSQ-VSETYKDLVKGLLE 353
           D +++GC  YE+  G  PFK     V+   L R     +V F  Q  +E  KD+ +  L 
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235

Query: 354 KDASQRL 360
           K    RL
Sbjct: 236 KKPEDRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 76/238 (31%), Positives = 117/238 (49%), Gaps = 41/238 (17%)

Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG FG+V   +AI +D  K     TVA+K++     + K+LS L  E E+ K +  H 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHK 78

Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRK-----------KLSETICVQILSNL 226
           NII  + +        ++ E+A   +L   L  R+           KL E        +L
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT--FKDL 136

Query: 227 ISALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG 279
           +S  Y       YL S + +HRDL  +NVL+ +D V  + DFG AR +    H +   K 
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV----HNIDYYKK 192

Query: 280 T-----PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           T     P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 92.0 bits (228), Expect = 4e-20
 Identities = 80/302 (26%), Positives = 131/302 (43%), Gaps = 51/302 (16%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82

Query: 178 PNIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
            NII  +       S E   +  ++ E    +L  +++   +L       +L  ++  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIK 140

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILG 199

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL----HLIRLLKT---------------- 331
             Y    D+WS+GCI  E+  G   F     +     +I  L T                
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259

Query: 332 ----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHHP 369
                            DV FP+        +   +DL+  +L  DAS+R+S  E L HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319

Query: 370 LV 371
            +
Sbjct: 320 YI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 90.1 bits (223), Expect = 5e-20
 Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 10/159 (6%)

Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLY 283
           + L   L  L   R+++RDLKP+N+LL+  G   + D G A  +  G  +   + GT  Y
Sbjct: 109 AELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGY 167

Query: 284 MAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT----VSILHLIRLLKTQDVTFPSQ 339
           MAPE+I    Y  + D W LGC+ YE+  G  PF+     V    + R +K     +  +
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227

Query: 340 VSETYKDLVKGLLEKDASQRLSW-----PELLHHPLVKD 373
            SE  K + + LL K+  +RL         +  HP+ K+
Sbjct: 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 92.0 bits (228), Expect = 6e-20
 Identities = 84/291 (28%), Positives = 138/291 (47%), Gaps = 50/291 (17%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           +IG GSFG V++AI +D  + VA+K + +  +         +E  I K+L H NII    
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKNLNHINIIFLKD 126

Query: 186 SHET-------LNEFV-LITEFAHMSLSNLLEQRKKLSETI---CVQILS-NLISALYYL 233
            + T        N F+ ++ EF   ++   ++   + +  +    V++ S  L  AL Y+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAM-LCDFGFARSMAVGTHMLTSIKGTPLYMAPEL-IAE 291
           HS  + HRDLKPQN+L++ +   + LCDFG A+++  G   ++ I  +  Y APEL +  
Sbjct: 187 HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI-CSRFYRAPELMLGA 245

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKT-------------QDV 334
             Y    DLWSLGCI  E+ +G+P F   S    ++ +I++L T              D+
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305

Query: 335 TFPSQVSETYK------------DLVKGLLEKDASQRLSWPELLHHPLVKD 373
            FP    +  K            + +   L+ +  +RL+  E L  P   D
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356

Length = 440

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 89.8 bits (223), Expect = 8e-20
 Identities = 69/218 (31%), Positives = 101/218 (46%), Gaps = 21/218 (9%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLA 176
           ++K+  I  IGEG++G+V+KA   D  + VALK +   + + G  +++++ E +I + L 
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLN 64

Query: 177 HPNIIKFIASHETLNE-------------FVLITEFAHMSLSNLLEQRK-KLSETICVQI 222
           H NI+      E + +             F L+ E+    L  LLE      SE      
Sbjct: 65  HRNIVNL---KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121

Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL 282
           +  L+  L Y H    LHRD+K  N+LLN  G   L DFG AR          + K   L
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181

Query: 283 -YMAPE-LIAERPYDHTADLWSLGCIAYEIHMGHPPFK 318
            Y  PE L+ E  Y    D+WS GCI  E+    P F+
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 90.1 bits (223), Expect = 9e-20
 Identities = 61/245 (24%), Positives = 121/245 (49%), Gaps = 10/245 (4%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSGKELSSLKQECEI-QKHLAHPNIIKF 183
           +IG GS+ KV         +  A+K++ K      +++  ++ E  + ++  ++P ++  
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 184 IASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
            +  +T +   L+ E+ +   L   +++++KL E       + +  AL +LH   +++RD
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LK  NVLL+ DG   L D+G  +         ++  GTP Y+APE++    Y  + D W+
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181

Query: 303 LGCIAYEIHMGHPPFKTVSI-------LHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
           LG + +E+  G  PF  ++         +L +++  + +  P  +S     ++KG L KD
Sbjct: 182 LGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKD 241

Query: 356 ASQRL 360
             +RL
Sbjct: 242 PKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 70/272 (25%), Positives = 127/272 (46%), Gaps = 30/272 (11%)

Query: 126 LIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKHL-----AH 177
           +IG GS+ KV   + + LKKT    A+K++ K   +  E     Q    +KH+      H
Sbjct: 2   VIGRGSYAKV---LLVRLKKTERIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQASNH 55

Query: 178 PNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           P ++   +  +T +    + E+ +   L   +++++KL E       + +  AL YLH  
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
            +++RDLK  NVLL+ +G   L D+G  +         ++  GTP Y+APE++    Y  
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSIL---------HLIRLLKTQDVTFPSQVSETYKDL 347
           + D W+LG + +E+  G  PF  V            +L +++  + +  P  +S     +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 235

Query: 348 VKGLLEKDASQRL------SWPELLHHPLVKD 373
           +K  L KD  +RL       + ++  HP  ++
Sbjct: 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 30/272 (11%)

Query: 122 QKICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +KI ++GEG FGKV    +   +    + VA+K + K     +  S  K+E  I K L H
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINILKTLYH 65

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLE--QRKKLSETICVQILSNLISALYYLHS 235
            NI+K+           L     ++ L +L +   + KL+    +     +   + YLHS
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK---GTPLY-MAPELIAE 291
              +HRDL  +NVLL+ D +  + DFG A+++  G H    ++    +P++  A E + E
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG-HEYYRVREDGDSPVFWYAVECLKE 184

Query: 292 RPYDHTADLWSLGCIAYEIHMGH------PPFK----------TVSILHLIRLL-KTQDV 334
             + + +D+WS G   YE+ + H      PP K           ++++ LI LL +   +
Sbjct: 185 NKFSYASDVWSFGVTLYEL-LTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243

Query: 335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELL 366
             P    +    L+K   E +A  R ++  L+
Sbjct: 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 91.8 bits (228), Expect = 2e-19
 Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 17/229 (7%)

Query: 147 VALKII-SKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM--- 202
           VA+K++ + +     + +  ++E  +   L HPNI+  + S E      L   F ++   
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGR 64

Query: 203 SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV---AMLC 259
           +L  +L     L      +++  ++ AL   H+  ++HRDLKPQN+++++ GV   A + 
Sbjct: 65  TLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVL 124

Query: 260 DFGF------ARSMAVGTHMLTS-IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM 312
           DFG        R   V T   T+ + GTP Y APE +   P    +DL++ G I  E   
Sbjct: 125 DFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184

Query: 313 GHPPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKDLVKGLLEKDASQR 359
           G    +  S+  ++ + L   DV+ P  +       +++  L KD  QR
Sbjct: 185 GQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 34/81 (41%), Positives = 50/81 (61%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
           YQ   LIG G+FG V+K ++L+    VA+K IS      + L S+ QE ++ K+L HPN
Sbjct: 1  NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 70 IIKFIASHETLNEFVLITEFA 90
          I+K+I S ET +   +I E+A
Sbjct: 61 IVKYIGSIETSDSLYIILEYA 81

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 88.9 bits (220), Expect = 4e-19
 Identities = 73/271 (26%), Positives = 119/271 (43%), Gaps = 41/271 (15%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 177
           + ++ + +IG G+FG+V      D     A+KI+ K+    KE ++ ++ E +I      
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
             ++K   S +      LI EF     +  LL ++  LSE      ++  + A+  +H  
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---------TH--------------- 272
             +HRD+KP N+LL+  G   L DFG    +            TH               
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 273 -----------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS 321
                      +  S  GTP Y+APE+  +  Y+   D WSLG I YE+ +G+PPF + +
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 322 ILHLIRLLKT--QDVTFPSQV--SETYKDLV 348
                R +    + + FP +V  SE  KDL+
Sbjct: 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 88.8 bits (220), Expect = 5e-19
 Identities = 78/307 (25%), Positives = 130/307 (42%), Gaps = 57/307 (18%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAH 177
           E +  + +IG+G+FG+V      D  K  A+K + KS    K +L+ +K E ++      
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           P ++    S +      LI EF     L  +L +    SE +    ++  + A+  +H  
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFA----------------------------RSMA 268
             +HRD+KP N+L+++ G   L DFG +                             S+A
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 269 VGTHMLT-------------------SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYE 309
           V +  LT                   S  GTP Y+APE+  ++ Y    D WSLG I +E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Query: 310 IHMGHPPFKTVSILHLIRLLKT--QDVTFPSQVSETY--KDLVKGLLEKDASQRL---SW 362
             +G PPF + +     R +    + + FP  +  +   +DL++ L+  +A  RL     
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAENRLGRGGA 299

Query: 363 PELLHHP 369
            E+  HP
Sbjct: 300 HEIKSHP 306

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 10/159 (6%)

Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLY 283
           + ++  L  LH    ++RDLKP+N+LL+  G   + D G A  +  G  +   + GT  Y
Sbjct: 109 AEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGY 167

Query: 284 MAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT----VSILHLIRLLKTQDVTFPSQ 339
           MAPE++  + Y  + D W LGC+ YE+  G  PF+     V    + R +   +  + ++
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227

Query: 340 VSETYKDLVKGLLEKDASQRLSWP-----ELLHHPLVKD 373
            SE  K + K LL KD  QRL        E+  HP  ++
Sbjct: 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 87.4 bits (216), Expect = 6e-19
 Identities = 70/216 (32%), Positives = 104/216 (48%), Gaps = 29/216 (13%)

Query: 125 CLIGEGSFGKVFKAIHLDLK--KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII- 181
           C +G G++G V+KA   D K  K  ALK I  +G S     S  +E  + + L HPN+I 
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIA 62

Query: 182 --KFIASHETLNEFVL----------ITEFAHMSLSNLLEQRKKLSETICVQILSNLISA 229
             K   SH     ++L          I +F   S +N  ++  +L  ++   +L  ++  
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN--KKPMQLPRSMVKSLLYQILDG 120

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGV----AMLCDFGFARSMAVGTHMLTSIKG---TPL 282
           ++YLH+N VLHRDLKP N+L+  +G       + D GFAR        L  +     T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 283 YMAPE-LIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
           Y APE L+  R Y    D+W++GCI  E+    P F
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 87.4 bits (216), Expect = 8e-19
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 35/215 (16%)

Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + +++I  +G G+ G V K              IHL++K  +  +II       +EL  L
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII-------RELQVL 57

Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++ K++ E I  ++
Sbjct: 58  -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKEAKRIPEEILGKV 108

Query: 223 LSNLISALYYL-HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              ++  L YL   ++++HRD+KP N+L+N  G   LCDFG +  +     M  S  GT 
Sbjct: 109 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR 166

Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPP 316
            YM+PE +    Y   +D+WS+G    E+ +G  P
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 86.3 bits (214), Expect = 9e-19
 Identities = 72/269 (26%), Positives = 120/269 (44%), Gaps = 35/269 (13%)

Query: 127 IGEGSFGKVFKA-----IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG+FGKVF          + K+ VA+K + K   S       ++E E+  +  H NI+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNFQHENIV 71

Query: 182 KFIA---------------SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNL 226
           KF                  H  LN+F+         L +      +L+ +  +QI   +
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 227 ISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTSIKGT 280
            S + YL S   +HRDL  +N L+  D V  + DFG +R +       VG H +  I+  
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR-- 189

Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLKTQDVTFPSQ 339
             +M PE I  R +   +D+WS G + +EI   G  P+  +S   +I  +    +    +
Sbjct: 190 --WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPR 247

Query: 340 V--SETYKDLVKGLLEKDASQRLSWPELL 366
              SE Y D++ G  ++D  QR++  ++ 
Sbjct: 248 TCPSEVY-DIMLGCWKRDPQQRINIKDIH 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 84.9 bits (211), Expect = 1e-18
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 1/80 (1%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 70
          Y+ +  +GEGSFGKV+ A      K VA+K+I K     K+   + +E +I K L HPNI
Sbjct: 1  YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNI 59

Query: 71 IKFIASHETLNEFVLITEFA 90
          ++     E  ++  L+ E+ 
Sbjct: 60 VRLYDVFEDEDKLYLVMEYC 79

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 87.4 bits (216), Expect = 1e-18
 Identities = 87/358 (24%), Positives = 148/358 (41%), Gaps = 63/358 (17%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 177
           E ++ + +IG G+FG+V      D     A+KI+ K+    KE +  ++ E +I      
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
             ++K   S +      LI EF     +  LL ++  L+E      ++  + A+  +H  
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---------THMLTS----------- 276
             +HRD+KP N+LL+  G   L DFG    +             H L S           
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 277 ---------------IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS 321
                            GTP Y+APE+  +  Y+   D WSLG I YE+ +G+PPF + +
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 322 ILHLIRLLKT--QDVTFPSQV--SETYKDLV-------------KGLLEKDAS---QRLS 361
                + +    + + FP +V  SE  KDL+              G+ E   +   + + 
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVD 300

Query: 362 WPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSITTIVESDSD-ENEEWV 418
           W  +   P     +  EI+S +  D   FD        + ++ T    ++D +N++WV
Sbjct: 301 WEHIRERPAA---IPIEIKSID--DTSNFDEFPDSDILKPTVATSNHPETDYKNKDWV 353

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 9/202 (4%)

Query: 126 LIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
            IGEG FG V++ +++  +     VA+K   K+  S        QE  I +   HP+I+K
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKT-CKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 183 FIASHETLNEFVLITEFAHM-SLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLH 240
            I      N   ++ E A +  L + L+  K  L     +     L +AL YL S R +H
Sbjct: 72  LIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVH 130

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTAD 299
           RD+  +NVL++      L DFG +R +   ++   S    P+ +MAPE I  R +   +D
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASD 190

Query: 300 LWSLGCIAYEIHM-GHPPFKTV 320
           +W  G   +EI M G  PF+ V
Sbjct: 191 VWMFGVCMWEILMLGVKPFQGV 212

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 35/215 (16%)

Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + ++KI  +G G+ G VFK              IHL++K  +  +II       +EL  L
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII-------RELQVL 57

Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++  ++ E I  ++
Sbjct: 58  -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPEQILGKV 108

Query: 223 LSNLISALYYL-HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              +I  L YL   ++++HRD+KP N+L+N  G   LCDFG +  +     M  S  GT 
Sbjct: 109 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR 166

Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPP 316
            YM+PE +    Y   +D+WS+G    E+ +G  P
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 69/216 (31%), Positives = 103/216 (47%), Gaps = 29/216 (13%)

Query: 125 CLIGEGSFGKVFKAIHLDLK--KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII- 181
           C +G G++G V+KA   D K  +  ALK I  +G S     S  +E  + + L HPN+I 
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVIS 62

Query: 182 --KFIASHETLNEFVL----------ITEFAHMSLSNLLEQRKKLSETICVQILSNLISA 229
             K   SH     ++L          I +F   S +N  ++  +L   +   +L  ++  
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN--KKPVQLPRGMVKSLLYQILDG 120

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGV----AMLCDFGFARSMAVGTHMLTSIKG---TPL 282
           ++YLH+N VLHRDLKP N+L+  +G       + D GFAR        L  +     T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 283 YMAPE-LIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
           Y APE L+  R Y    D+W++GCI  E+    P F
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 12/201 (5%)

Query: 127 IGEGSFGKVFKAIHLDLK---KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +G G+FG V K ++L        VA+K + +   +  +   L+ E  +   L HP I++ 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR-EASVMAQLDHPCIVRL 61

Query: 184 IASHETLNE-FVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
           I       E  +L+ E A +  L   L++R+++  +   ++   +   + YL S   +HR
Sbjct: 62  IGV--CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT--PL-YMAPELIAERPYDHTA 298
           DL  +NVLL     A + DFG +R++  G+    +      PL + APE I    +   +
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKS 179

Query: 299 DLWSLGCIAYEIH-MGHPPFK 318
           D+WS G   +E    G  P+ 
Sbjct: 180 DVWSYGVTLWEAFSYGAKPYG 200

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 69/262 (26%), Positives = 124/262 (47%), Gaps = 28/262 (10%)

Query: 122 QKICLIGEGSFGKVFKAIHLDLKKT----VALKII-SKSGRSGKELSSLKQECEIQKHLA 176
           +KI ++G G+FG V+K + +   +     VA+K++  ++     +   +  E  +   + 
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK--EILDEAYVMASVD 67

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--------CVQILSNLIS 228
           HP++++ +    + ++  LIT+   M L  LL+  +   + I        CVQI      
Sbjct: 68  HPHVVRLLGICLS-SQVQLITQL--MPLGCLLDYVRNHKDNIGSQYLLNWCVQI----AK 120

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG-THMLTSIKGTPL-YMAP 286
            + YL   R++HRDL  +NVL+       + DFG A+ + V            P+ +MA 
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 287 ELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL-KTQDVTFPSQVS-ET 343
           E I  R Y H +D+WS G   +E+   G  P++ +  + +  LL K + +  P   + + 
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240

Query: 344 YKDLVKGLLEKDASQRLSWPEL 365
           Y  LVK  +  DA  R ++ EL
Sbjct: 241 YMVLVKCWMI-DAESRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 43/219 (19%)

Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + ++K+  +G G+ G V K              IHL++K  +  +II       +EL  L
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQII-------RELKVL 53

Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++  ++ E I  +I
Sbjct: 54  -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPENILGKI 104

Query: 223 LSNLISALYYLHSNR-VLHRDLKPQNVLLNKDGVAMLCDFGFA----RSMAVGTHMLTSI 277
              ++  L YL     ++HRD+KP N+L+N  G   LCDFG +     SMA       S 
Sbjct: 105 SIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA------NSF 158

Query: 278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPP 316
            GT  YM+PE +    Y   +D+WSLG    E+ +G  P
Sbjct: 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 29/231 (12%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG FGKV      D         VA+K ++ SG   +  S  ++E EI + L H NI+
Sbjct: 12  LGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHENIV 69

Query: 182 KF--IASHETLNEFVLITEFAHM-SLSNLL-EQRKKLSETICVQILSNLISALYYLHSNR 237
           K+  +          LI E+    SL + L   R +++    +   S +   + YL S R
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPL-YMAPELIAERPY 294
            +HRDL  +N+L+  + +  + DFG A+ +              +P+ + APE +    +
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF 189

Query: 295 DHTADLWSLGCIAYEI-----HMGHPPFK----------TVSILHLIRLLK 330
              +D+WS G   YE+         PP +           + +  L+ LLK
Sbjct: 190 SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 50/190 (26%), Positives = 89/190 (46%), Gaps = 12/190 (6%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V++ +  +  + VA+KI+        +    ++E +  K L H ++I   A 
Sbjct: 14  LGSGYFGEVWEGLWKNRVR-VAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAV 70

Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                   +ITE   M   +LL      + + L     + +   +   + YL     +HR
Sbjct: 71  CSVGEPVYIITEL--MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N+L+ +D V  + DFG AR +    + L+S K  P  + APE  +   +   +D+
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVY-LSSDKKIPYKWTAPEAASHGTFSTKSDV 187

Query: 301 WSLGCIAYEI 310
           WS G + YE+
Sbjct: 188 WSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 84.3 bits (208), Expect = 1e-17
 Identities = 87/339 (25%), Positives = 152/339 (44%), Gaps = 34/339 (10%)

Query: 80  LNEFVLITEFAHMSLSKLGEPWFHNHCQPVK-MEKSNGALEKYQKICLIGEGSFGKVFKA 138
           LN  VL  +F  +  +K  + + + + + V+ + K     E Y  + +IG G+FG+V   
Sbjct: 3   LNSLVLDLDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLV 62

Query: 139 IHLDLKKTVALKIISKSGRSGKELSSL-KQECEIQKHLAHPNIIKFIASHETLNEFVLIT 197
            H   +K  A+K++SK     +  S+   +E +I      P +++   + +      ++ 
Sbjct: 63  RHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122

Query: 198 EF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVA 256
           E+     L NL+     + E       + ++ AL  +HS  ++HRD+KP N+LL+K G  
Sbjct: 123 EYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 181

Query: 257 MLCDFGFARSM-AVGTHMLTSIKGTPLYMAPELIAERP----YDHTADLWSLGCIAYEIH 311
            L DFG    M   G     +  GTP Y++PE++  +     Y    D WS+G   +E+ 
Sbjct: 182 KLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Query: 312 MGHPPFKTVSILHLIRLL--KTQDVTFP--SQVSETYKDLVKGLLEKDASQRLSW---PE 364
           +G  PF   S++     +      + FP   ++S+  K+L+   L  D   RL      E
Sbjct: 242 VGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFL-TDREVRLGRNGVEE 300

Query: 365 LLHHPLVKDN-----------------LSSEIESQNNQD 386
           +  HP  K++                 LSS+I+S N  D
Sbjct: 301 IKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDD 339

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 81/315 (25%), Positives = 141/315 (44%), Gaps = 39/315 (12%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSL-KQECEIQKHLAH 177
           E Y+ + +IG G+FG+V    H   +K  A+K++SK     +  S+   +E +I      
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           P +++   + +      ++ E+     L NL+     + E       + ++ AL  +HS 
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 161

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGTPLYMAPELIAERP-- 293
             +HRD+KP N+LL+K G   L DFG    M   G     +  GTP Y++PE++  +   
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 294 --YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFP--SQVSETYKDL 347
             Y    D WS+G   YE+ +G  PF   S++     +      +TFP  + +S+  K+L
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281

Query: 348 VKGLLEKDASQRL---SWPELLHHPLVKDN-----------------LSSEIESQNNQDC 387
           +   L  D   RL      E+  H   K++                 LSS+I++ N    
Sbjct: 282 ICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSN---- 336

Query: 388 IGFDYCDKRRGSRKS 402
             FD  ++ +G  ++
Sbjct: 337 --FDDIEEDKGEEET 349

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 38/270 (14%)

Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG+FGKVF A   +L  T     VA+K +     + ++    ++E E+  +L H +I+
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQREAELLTNLQHEHIV 70

Query: 182 KFIASHETLNEFVLITEF-AHMSLSNLL----------------EQRKKLSETICVQILS 224
           KF       +  +++ E+  H  L+  L                + + +L  +  + I S
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 225 NLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTSIK 278
            + S + YL S   +HRDL  +N L+  + +  + DFG +R +       VG H +  I+
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190

Query: 279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVTFP 337
               +M PE I  R +   +D+WS G I +EI   G  P+  +S   +I  +    V   
Sbjct: 191 ----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 246

Query: 338 SQV--SETYKDLVKGLLEKDASQRLSWPEL 365
            +V   E Y D++ G  +++  QRL+  E+
Sbjct: 247 PRVCPKEVY-DIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 10/208 (4%)

Query: 122 QKICLIGEGSFGKVFKAI-HLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPN 179
           QK+  IG G FG+VF+ I  +  +K VA+ I + K G + K+      E  I    +H N
Sbjct: 10  QKV--IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 180 IIKFIASHETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNR 237
           II+           ++ITE+  + +L   L +   + S    V +L  + + + YL    
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSM---AVGTHMLTSIKGTPLYMAPELIAERPY 294
            +HRDL  +N+L+N +    + DFG +R +     GT+  +  K    + APE IA R +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187

Query: 295 DHTADLWSLGCIAYEI-HMGHPPFKTVS 321
              +D+WS G + +E+   G  P+  +S
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERPYWDMS 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 83.7 bits (207), Expect = 2e-17
 Identities = 77/335 (22%), Positives = 131/335 (39%), Gaps = 62/335 (18%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAHPN 179
           + KI  IG G+FG+V     +D     A+K + K+    + + + +K E +I     +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 180 IIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           ++K   S +  +    + ++     + +LL +     E +    ++ L  A+  +H    
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGF---------ARSMAVGTHM---------------- 273
           +HRD+KP N+L+++DG   L DFG          ++    G H                 
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 274 --LTSIK----------------GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHP 315
             L  ++                GTP Y+APE++    Y    D WS+G I YE+ +G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 316 PF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           PF       + L +I    T  +   +++S    DL+  L    A  RL           
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLG---------- 291

Query: 372 KDNLSSEIESQNNQDCIGFDYCDKRRGSRKSITTI 406
             N + EI++      I F     RR     I  I
Sbjct: 292 -KNGADEIKAHPFFKGIDFAS-LIRRQKAPYIPKI 324

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 63/195 (32%), Positives = 92/195 (47%), Gaps = 15/195 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---ECEIQKHLAHPNIIKF 183
           IG G+FG V+        K VALK   K     + L S K+   E ++     H N++  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALK---KMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64

Query: 184 IASHETLN-----EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           +   +  +     E  ++TE     L  ++   + LS       L  ++  L YLHS  +
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGI 124

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPE-LIAERPYD 295
           LHRD+KP N+L+N + V  +CDFG AR        HM   +  T  Y APE L+  R Y 
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEILMGSRHYT 183

Query: 296 HTADLWSLGCIAYEI 310
              D+WS+GCI  E+
Sbjct: 184 SAVDIWSVGCIFAEL 198

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 82.5 bits (204), Expect = 5e-17
 Identities = 86/303 (28%), Positives = 135/303 (44%), Gaps = 39/303 (12%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLK-QECEIQKHLA 176
            E +  I +IG G+FG+V    H   K+  A+K++SK     +  S+   +E +I  H  
Sbjct: 42  AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101

Query: 177 HPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQILSNLISALYYL 233
              I++   + +      ++ E+  M    L NL+     + E       + ++ AL  +
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEY--MPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDAI 158

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGTPLYMAPELIAER 292
           HS   +HRD+KP N+LL+K G   L DFG    M A G     +  GTP Y++PE++  +
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 293 ----PYDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPS--QVSET 343
                Y    D WS+G   YE+ +G  PF     V     I   K   +TFP   ++S+ 
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS-LTFPDDIEISKQ 277

Query: 344 YKDLVKGLLEKDASQRL---SWPELLHHPLVKDN-----------------LSSEIESQN 383
            KDL+   L  D   RL      E+  HP  K++                 LSS+I++ N
Sbjct: 278 AKDLICAFL-TDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSN 336

Query: 384 NQD 386
             D
Sbjct: 337 FDD 339

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 51/261 (19%), Positives = 115/261 (44%), Gaps = 21/261 (8%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++    + +  L  E  + K     +++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN-EASVMKEFNCHHVV 72

Query: 182 KFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALY--------- 231
           + +    T    +++ E  A   L + L  R+  +E         L   +          
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 232 -YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT-PL-YMAPEL 288
            YL + + +HRDL  +N ++ +D    + DFG  R +    +     KG  P+ +MAPE 
Sbjct: 133 AYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 192

Query: 289 IAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSETYKD 346
           + +  +   +D+WS G + +E+  +   P++ +S   +++ +        P    +   +
Sbjct: 193 LKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLE 252

Query: 347 LVKGLLEKDASQRLSWPELLH 367
           L++   + +   R ++ E++ 
Sbjct: 253 LMRMCWQYNPKMRPTFLEIVS 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 82.7 bits (204), Expect = 5e-17
 Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 21/236 (8%)

Query: 151 IISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV-LITEFAHMSLSNLLE 209
           ++ K+G+ G   +    E  I + + HP+II+   +  T N+F  LI       L   L 
Sbjct: 120 VVIKAGQRGGTAT----EAHILRAINHPSIIQLKGTF-TYNKFTCLILPRYKTDLYCYLA 174

Query: 210 QRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA-RSMA 268
            ++ ++    + I  +++ A+ YLH NR++HRD+K +N+ +N  G   L DFG A   + 
Sbjct: 175 AKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234

Query: 269 VGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF----------- 317
           +  +      GT    APEL+A  PY    D+WS G + +E+   H              
Sbjct: 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD 294

Query: 318 KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ---RLSWPELLHHPL 370
               I  +IR   T    FP        ++  GL +K + +   R  W  L   P+
Sbjct: 295 SDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPI 350

Length = 391

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 1/88 (1%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 70
          Y+ +  +G GSFG V+KA H    K VA+KI+ K     K+  + ++E  I + L+HPNI
Sbjct: 1  YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 71 IKFIASHETLNEFVLITEFA-HMSLSKL 97
          ++ I + E  +   L+ E+     L   
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDY 88

Length = 260

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 80.9 bits (199), Expect = 1e-16
 Identities = 68/248 (27%), Positives = 124/248 (50%), Gaps = 14/248 (5%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAH 177
           E ++ + +IG G+FG+V      +  K  A+KI++K     + E +  ++E ++  +  +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHS 235
             I     + +  N   L+ ++     L  LL +   +L E +    L+ ++ A+  +H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFA-RSMAVGTHMLTSIKGTPLYMAPELI----- 289
              +HRD+KP N+L++ +G   L DFG   + M  GT   +   GTP Y++PE++     
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQD-VTFPSQ---VSETY 344
            +  Y    D WSLG   YE+  G  PF   S++    +++  ++   FP+Q   VSE  
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240

Query: 345 KDLVKGLL 352
           KDL++ L+
Sbjct: 241 KDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 16/197 (8%)

Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A    L K+     VA+K++  +  S  E  +L  E +I  HL  H NI
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS-SEREALMSELKIMSHLGNHENI 101

Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQRKK--LSETICVQILSNLISALYYLHSNR 237
           +  + +       ++ITE+  +  L N L ++++  L+    +     +   + +L S  
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL-YMAPELIAERP 293
            +HRDL  +NVLL    +  +CDFG AR +   ++ +  +KG    P+ +MAPE I    
Sbjct: 162 CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV--VKGNARLPVKWMAPESIFNCV 219

Query: 294 YDHTADLWSLGCIAYEI 310
           Y   +D+WS G + +EI
Sbjct: 220 YTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 15/224 (6%)

Query: 126 LIGEGSFGKVFKAIHLDL----KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +IG G FG+V +   L L    +  VA+K + KSG + K+      E  I     HPNII
Sbjct: 11  VIGAGEFGEVCRG-RLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 182 KFIASHETLNEFVLITEF-AHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVL 239
                       ++ITEF  + +L + L Q   + +    V +L  + + + YL     +
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPL---YMAPELIAERPY 294
           HRDL  +N+L+N + V  + DFG +R +   T     TS  G  +   + APE IA R +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188

Query: 295 DHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDVTFP 337
              +D+WS G + +E+   G  P+  +S   +I  ++ QD   P
Sbjct: 189 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLP 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 5/187 (2%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           L+G+G+FG+VFK   L  K  VA+K   +      ++  L  E  I K   HPNI+K I 
Sbjct: 2   LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFL-SEARILKQYDHPNIVKLIG 59

Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
                    ++ E       LS L +++ +L     V+   +  + + YL S   +HRDL
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119

Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWS 302
             +N L+ ++ V  + DFG +R    G +  + +K  P+ + APE +    Y   +D+WS
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWS 179

Query: 303 LGCIAYE 309
            G + +E
Sbjct: 180 YGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 34/82 (41%), Positives = 41/82 (50%), Gaps = 2/82 (2%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
          +GEG FG V+ A      K VA+KII K   S   L  L +E EI K L HPNI+K    
Sbjct: 1  LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 77 HETLNEFVLITEFA-HMSLSKL 97
           E  N   L+ E+    SL  L
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDL 81

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 43/268 (16%)

Query: 127 IGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG+FGKVF A   +L     K  VA+K + ++  S ++    ++E E+   L H +I+
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ--DFQREAELLTVLQHQHIV 70

Query: 182 KFIA---------------SHETLNEFVLITEFAHMSLSNLLEQRK-----KLSETICVQ 221
           +F                  H  LN F+     +H   + +L   +     +L+    + 
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLR----SHGPDAKILAGGEDVAPGQLTLGQMLA 126

Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLT 275
           I S + S + YL S   +HRDL  +N L+ +  V  + DFG +R +       VG   + 
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIR-LLKTQD 333
            I+    +M PE I  R +   +D+WS G + +EI   G  P+  +S    I  + + ++
Sbjct: 187 PIR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE 242

Query: 334 VTFPSQVSETYKDLVKGLLEKDASQRLS 361
           +  P         +++G  +++  QR+ 
Sbjct: 243 LERPRTCPPEVYAIMQGCWQREPQQRMV 270

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 67/248 (27%), Positives = 118/248 (47%), Gaps = 14/248 (5%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAH 177
           + ++ I +IG G+FG+V        ++  A+KI++K     + E +  ++E  +  +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHS 235
             I     + +  N   L+ ++     L  LL +   +L E +    ++ ++ A++ +H 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK-GTPLYMAPELIAER-- 292
              +HRD+KP NVLL+ +G   L DFG    M     + +S+  GTP Y++PE++     
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 293 ---PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFPSQ---VSETY 344
               Y    D WSLG   YE+  G  PF   S++     +   +    FPS    VSE  
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240

Query: 345 KDLVKGLL 352
           KDL++ L+
Sbjct: 241 KDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 31/214 (14%)

Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           IG+G+FG+VF+A    L        VA+K++ K   S    +  ++E  +     HPNI+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDHPNIV 71

Query: 182 KFIASHETLNEFVLITEF-AHMSLSNLLEQRK----------------------KLSETI 218
           K +          L+ E+ A+  L+  L  R                        LS T 
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 219 CVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSI 277
            + I   + + + YL   + +HRDL  +N L+ ++ V  + DFG +R++ +   +  +  
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191

Query: 278 KGTPL-YMAPELIAERPYDHTADLWSLGCIAYEI 310
              P+ +M PE I    Y   +D+W+ G + +EI
Sbjct: 192 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 12/201 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G FG V+    L+ K+ VA+K I +   S ++     +E ++   L+HP +++    
Sbjct: 12  IGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDF---IEEAQVMMKLSHPKLVQLYGV 67

Query: 187 HETLNEFVLITEF-AHMSLSNLLE-QRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
               +   L+ EF  H  LS+ L  QR K S+   + +  ++   + YL S+ V+HRDL 
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLA 127

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADLW 301
            +N L+ ++ V  + DFG  R   V     TS  GT     + +PE+ +   Y   +D+W
Sbjct: 128 ARNCLVGENQVVKVSDFGMTR--FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185

Query: 302 SLGCIAYEIHM-GHPPFKTVS 321
           S G + +E+   G  P++  S
Sbjct: 186 SFGVLMWEVFSEGKTPYENRS 206

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 69/248 (27%), Positives = 123/248 (49%), Gaps = 14/248 (5%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAH 177
           + ++ + +IG G+FG+V      +  +  A+KI++K     + E +  ++E ++  +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 178 PNIIKF-IASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHS 235
             I     A  +  N ++++  +    L  LL +   +L E +    L+ ++ A+  +H 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFA-RSMAVGTHMLTSIKGTPLYMAPELI----- 289
              +HRD+KP NVLL+K+G   L DFG   R +A GT       GTP Y++PE++     
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQD-VTFPSQ---VSETY 344
            +  Y    D WSLG   YE+  G  PF   S++    +++  ++   FP     VSE  
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240

Query: 345 KDLVKGLL 352
           KDL++ L+
Sbjct: 241 KDLIRRLI 248

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 77.3 bits (190), Expect = 6e-16
 Identities = 67/249 (26%), Positives = 118/249 (47%), Gaps = 23/249 (9%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG+G FG V    +   K  VA+K I     +     +   E  +   L H N+++ +  
Sbjct: 14  IGKGEFGDVMLGDYRGNK--VAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLLGV 67

Query: 187 -HETLNEFVLITEF-AHMSLSNLLEQRKK--LSETICVQILSNLISALYYLHSNRVLHRD 242
             E      ++TE+ A  SL + L  R +  L     ++   ++  A+ YL +N  +HRD
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD 127

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL-YMAPELIAERPYDHTA 298
           L  +NVL+++D VA + DFG        T   +S + T   P+ + APE + E+ +   +
Sbjct: 128 LAARNVLVSEDNVAKVSDFGL-------TKEASSTQDTGKLPVKWTAPEALREKKFSTKS 180

Query: 299 DLWSLGCIAYEIH-MGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
           D+WS G + +EI+  G  P+  + +  ++ R+ K   +  P        D++K     DA
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDA 240

Query: 357 SQRLSWPEL 365
           + R S+ +L
Sbjct: 241 ATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 77.3 bits (190), Expect = 6e-16
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 24/205 (11%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IGEG FG V +  +   K  VA+K I    +      +  +E  +   L H N+++ +  
Sbjct: 14  IGEGEFGAVLQGEYTGQK--VAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 187 --HETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILS---NLISALYYLHSNRVLH 240
             H  L    ++ E  +  +L N L  R +   ++ +Q+L    ++   + YL S +++H
Sbjct: 68  ILHNGLY---IVMELMSKGNLVNFLRTRGRALVSV-IQLLQFSLDVAEGMEYLESKKLVH 123

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFAR--SMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           RDL  +N+L+++DGVA + DFG AR  SM V    L  +K T    APE +  + +   +
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-PVKWT----APEALKHKKFSSKS 178

Query: 299 DLWSLGCIAYEI-HMGHPPFKTVSI 322
           D+WS G + +E+   G  P+  +S+
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSL 203

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 77.8 bits (191), Expect = 7e-16
 Identities = 64/247 (25%), Positives = 115/247 (46%), Gaps = 37/247 (14%)

Query: 127 IGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG+FGKVF A   +L     K  VA+K +  +  + ++     +E E+  +L H +I+
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK--DFHREAELLTNLQHEHIV 70

Query: 182 KFIASHETLNEFVLITEF-AHMSLSNLLEQR-------------KKLSETICVQILSNLI 227
           KF       +  +++ E+  H  L+  L                 +L+++  + I   + 
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTSIKGTP 281
           + + YL S   +HRDL  +N L+ ++ +  + DFG +R +       VG H +  I+   
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR--- 187

Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDV-----T 335
            +M PE I  R +   +D+WSLG + +EI   G  P+  +S   +I  +    V     T
Sbjct: 188 -WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRT 246

Query: 336 FPSQVSE 342
            P +V +
Sbjct: 247 CPKEVYD 253

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 12/201 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V        K  VA+K+I +   S  +     +E ++   L+HPN+++    
Sbjct: 12  LGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFI---EEAKVMMKLSHPNLVQLYGV 67

Query: 187 HETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   ++TE+ A+  L N L E++ KL     + + S++  A+ YL SN  +HRDL 
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLA 127

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT--PL-YMAPELIAERPYDHTADLW 301
            +N L+ +D V  + DFG AR   V     TS +GT  P+ +  PE+     +   +D+W
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185

Query: 302 SLGCIAYEIH-MGHPPFKTVS 321
           S G + +E+   G  P++  S
Sbjct: 186 SFGVLMWEVFSEGKMPYERFS 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 10/191 (5%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
            IG+G+FG V+K + L     VA+K   +S           QE EI K   HPNI+K I 
Sbjct: 2   KIGKGNFGDVYKGV-LKGNTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 186 SHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISA---LYYLHSNRVLHR 241
                    ++ E   +   +LL   RKK +     ++L   + A   + YL S   +HR
Sbjct: 60  VCVQKQPIYIVMEL--VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHR 117

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS-IKGTPL-YMAPELIAERPYDHTAD 299
           DL  +N L+ ++ V  + DFG +R    G + ++  +K  P+ + APE +    Y   +D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177

Query: 300 LWSLGCIAYEI 310
           +WS G + +E 
Sbjct: 178 VWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 38/272 (13%)

Query: 126 LIGEGSFGKVFKAIHLDLKK------TVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           ++GEG FG V +     L +       VA+K +     +  E+     E    K   HPN
Sbjct: 6   ILGEGEFGSVMEG---QLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 180 IIKFI------ASHETLNEFVLITEF-------AHMSLSNLLEQRKKLSETICVQILSNL 226
           ++K I      +S + + + ++I  F       + +  S L    +KL     ++ + ++
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 227 ISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-LTSIKGTPL-YM 284
              + YL +   +HRDL  +N +L +D    + DFG ++ +  G +     I   P+ ++
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 285 APELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVS-------ILHLIRLLKTQDVTF 336
           A E +A+R Y   +D+W+ G   +EI   G  P+  V        + H  RL + +D   
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC-- 240

Query: 337 PSQVSETYKDLVKGLLEKDASQRLSWPELLHH 368
              + E Y DL+      D   R ++ +L   
Sbjct: 241 ---LDELY-DLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 77.2 bits (190), Expect = 3e-15
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 16/228 (7%)

Query: 120 KYQKICLIGEGSFGKVFKAI-HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +Y  +  +  GS G+VF    H D ++    K+I K+   GK       E +I K ++H 
Sbjct: 93  QYNILSSLTPGSEGEVFVCTKHGDEQRK---KVIVKAVTGGKTPGR---EIDILKTISHR 146

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            II  I ++   +   ++       L   +++   L     + I   L+ AL YLH   +
Sbjct: 147 AIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGI 206

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
           +HRD+K +N+ L++   A+L DFG A        T       GT    +PEL+A  PY  
Sbjct: 207 IHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA 266

Query: 297 TADLWSLGCIAYEIHMGHPPF-----KTVS--ILHLIRLLKTQDVTFP 337
             D+WS G + +E+ + +        K+ S  +  +IR ++   + FP
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314

Length = 392

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 56/225 (24%), Positives = 104/225 (46%), Gaps = 22/225 (9%)

Query: 125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKS---GRSGKELSSLKQECEIQKHLAHPNI- 180
            L+ EG+FG++F  I +D K     ++  K+     S  +++ L QE  +   L+H NI 
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 181 -IKFIASHETLNEFVLITEFAHMSLSNL--LEQRKKLSETICVQILS---------NLIS 228
            I  +   +    FVL   + +M+  NL    Q+ +L E    Q LS          +  
Sbjct: 72  PILHVCIEDGEPPFVL---YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-HMLTSIKGTPL-YMAP 286
            + YLH   V+H+D+  +N +++++    + D   +R +     H L   +  P+ +MA 
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188

Query: 287 ELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLK 330
           E +  + Y   +D+WS G + +E+  +G  P+  +    +   LK
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 20/194 (10%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V+        K VA+K + K G    E  +  QE +I K L H  +++  A 
Sbjct: 14  LGAGQFGEVWMGTWNGTTK-VAVKTL-KPGTMSPE--AFLQEAQIMKKLRHDKLVQLYAV 69

Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                   ++TE+  MS  +LL+     + KKL     V + + +   + YL S   +HR
Sbjct: 70  CSEEEPIYIVTEY--MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHR 127

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS-----IKGTPLYMAPELIAERPYDH 296
           DL  +N+L+ ++ V  + DFG AR +    +         IK T    APE      +  
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRFTI 183

Query: 297 TADLWSLGCIAYEI 310
            +D+WS G +  EI
Sbjct: 184 KSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.9 bits (184), Expect = 5e-15
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 7/192 (3%)

Query: 126 LIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +IG G FG+V    + L  K+ + + I + K+G + K+      E  I     HPNII  
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 184 IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVLHR 241
                     +++TE+  + SL   L +       I  V +L  + S + YL     +HR
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHR 130

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTA 298
           DL  +N+L+N + V  + DFG +R +        + +G  +   + APE IA R +   +
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190

Query: 299 DLWSLGCIAYEI 310
           D+WS G + +E+
Sbjct: 191 DVWSYGIVMWEV 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 14/210 (6%)

Query: 127 IGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +G G FG V    HL   +    VA+K I++   S ++     +E ++   L+HP +++ 
Sbjct: 12  LGSGQFGVV----HLGKWRAQIKVAIKAINEGAMSEEDFI---EEAKVMMKLSHPKLVQL 64

Query: 184 IASHETLNEFVLITEF-AHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHR 241
                      ++TEF  +  L N L QR+ KLS+ + + +  ++   + YL  N  +HR
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L++  GV  + DFG  R +    +  +S    P+ +  PE+     Y   +D+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLIRLL 329
           WS G + +E+   G  PF+  S   ++ ++
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 74.1 bits (182), Expect = 8e-15
 Identities = 56/250 (22%), Positives = 116/250 (46%), Gaps = 19/250 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V K      +  VA+K+I +   S  E     +E ++   L+H  +++    
Sbjct: 12  LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMKLSHEKLVQLYGV 67

Query: 187 HETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   ++TE+ ++  L N L E  K+   +  +++  ++   + YL S + +HRDL 
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLA 127

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADLW 301
            +N L++  G   + DFG +R   V     TS  G+     +  PE++    +   +D+W
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185

Query: 302 SLGCIAYEIH-MGHPPFKTVS----ILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
           + G + +E++ +G  P++  +    +  + + L+   +  P   SE    ++     + A
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR---LYRPHLASEKVYAIMYSCWHEKA 242

Query: 357 SQRLSWPELL 366
            +R ++ +LL
Sbjct: 243 EERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 74.2 bits (182), Expect = 8e-15
 Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 10/200 (5%)

Query: 127 IGEGSFGKVFKAIHLDLK--KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K ++   K  KTVA+KI+            L +E  + + L +P I++ I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 185 ASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E  + ++L+ E A +  L+  L++ K ++E    +++  +   + YL     +HRDL
Sbjct: 63  GICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121

Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL-YMAPELIAERPYDHTAD 299
             +NVLL     A + DFG ++++    +   + K     P+ + APE +    +   +D
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKA-KTHGKWPVKWYAPECMNYYKFSSKSD 180

Query: 300 LWSLGCIAYE-IHMGHPPFK 318
           +WS G + +E    G  P+K
Sbjct: 181 VWSFGVLMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 6/200 (3%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G+FG+VF          VA+K   ++     +   L QE  I K  +HPNI++ I  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFL-QEARILKQYSHPNIVRLIGV 61

Query: 187 HETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   ++ E       L+ L  +  +L     +Q++ N  + + YL S   +HRDL 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLT-SIKGTPL-YMAPELIAERPYDHTADLWS 302
            +N L+ +  V  + DFG +R    G +  T  +K  P+ + APE +    Y   +D+WS
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWS 181

Query: 303 LGCIAYE-IHMGHPPFKTVS 321
            G + +E   +G  P+  +S
Sbjct: 182 FGILLWEAFSLGAVPYANLS 201

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 73.3 bits (181), Expect = 2e-14
 Identities = 33/81 (40%), Positives = 42/81 (51%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
          KY+ I  IG+GSFGKV+        K   LK I  S  S KE      E +I K L HPN
Sbjct: 1  KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 70 IIKFIASHETLNEFVLITEFA 90
          IIK+  S E   +  ++ E+A
Sbjct: 61 IIKYYESFEEKGKLCIVMEYA 81

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 29/216 (13%)

Query: 126 LIGEGSFGKVFKA-IHLD-LKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIK 182
           +IGEG+FG+V +A I  D LK   A+K++ K   S  +      E E+   L  HPNII 
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKML-KEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 183 FIASHETLNEFVLITEFAHMSLSNLLEQRKK-------------------LSETICVQIL 223
            + + E      +  E+A     NLL+  +K                   L+    +Q  
Sbjct: 68  LLGACENRGYLYIAIEYA--PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL- 282
           S++ + + YL   + +HRDL  +NVL+ ++  + + DFG +R   V  ++  ++   P+ 
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV--YVKKTMGRLPVR 183

Query: 283 YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPF 317
           +MA E +    Y   +D+WS G + +EI  +G  P+
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 75.0 bits (184), Expect = 2e-14
 Identities = 72/318 (22%), Positives = 132/318 (41%), Gaps = 56/318 (17%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAHPN 179
           + KI  +G G+FG+V  A  +D K   A+K + K     + +++ +K E +I     +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 180 IIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           +++   S +  +    + ++     + +LL +     E +    ++ L  A+  +H    
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGF---------ARSMAVGTH----------------- 272
           +HRD+KP N+L+++DG   L DFG          ++    G H                 
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 273 ---------------------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH 311
                                +  S+ GTP Y+APE++    Y    D WS+G I YE+ 
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 312 MGHPPFKTVSILH----LIRLLKTQDVTFPSQVSETYKDLVKGLLE--KDASQRLSWPEL 365
           +G PPF   + L     +I    +  +   +++S    DL+  L    +D   +    E+
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEI 302

Query: 366 LHHPLVKD-NLSSEIESQ 382
             HP  K  + SS++  Q
Sbjct: 303 KAHPFFKTIDFSSDLRQQ 320

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 28/272 (10%)

Query: 122 QKICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           ++I  +GEG FGKV    +     +  + VA+K + K    G  ++ LK+E EI ++L H
Sbjct: 7   KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYH 65

Query: 178 PNIIKF--IASHETLNEFVLITEF-AHMSLSNLLEQRK-KLSETICVQILSNLISALYYL 233
            NI+K+  I + +  N   LI EF    SL   L + K K++    ++    +   + YL
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT---SIKGTPLYMAPELIA 290
            S + +HRDL  +NVL+  +    + DFG  +++       T    +     + APE + 
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 291 ERPYDHTADLWSLGCIAYE---------------IHMGHPPFKTVSILHLIRLLKT-QDV 334
           +  +   +D+WS G   YE               + M  P    +++  L+R+L+  + +
Sbjct: 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245

Query: 335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELL 366
             P    E    L++   E   S+R ++  L+
Sbjct: 246 PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 18/212 (8%)

Query: 127 IGEGSFGKVFKAI--HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +GEG FG V +      D    VA+K +  +  +  E+     E    K   HPN+++ I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 185 ------ASHETLNEFVLITEF-------AHMSLSNLLEQRKKLSETICVQILSNLISALY 231
                    E     V+I  F       + +  S L +  + L   + V+ ++++ S + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS-IKGTPL-YMAPELI 289
           YL S   +HRDL  +N +LN++    + DFG ++ +  G +     I   P+ ++A E +
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186

Query: 290 AERPYDHTADLWSLGCIAYEIHM-GHPPFKTV 320
           A+R Y   +D+WS G   +EI   G  P+  V
Sbjct: 187 ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 74.2 bits (182), Expect = 5e-14
 Identities = 56/184 (30%), Positives = 86/184 (46%), Gaps = 13/184 (7%)

Query: 130 GSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET 189
           GS G VF++ H D  + V +K       +G   SS+  E  + + L+HP ++  +     
Sbjct: 180 GSEGCVFESSHPDYPQRVVVK-------AGWYASSV-HEARLLRRLSHPAVLALLDVRVV 231

Query: 190 LNEFVLITEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNV 248
                L+       L   L  R + L       +   L+SA+ Y+H   ++HRD+K +NV
Sbjct: 232 GGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENV 291

Query: 249 LLNKDGVAMLCDFG---FARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGC 305
           L+N      L DFG   FAR  +  T     I GT    APE++A  PY  + D+WS G 
Sbjct: 292 LVNGPEDICLGDFGAACFARG-SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGL 350

Query: 306 IAYE 309
           + +E
Sbjct: 351 VIFE 354

Length = 461

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 71.8 bits (176), Expect = 5e-14
 Identities = 62/263 (23%), Positives = 117/263 (44%), Gaps = 30/263 (11%)

Query: 126 LIGEGSFGKVFKAIHLDL------KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
            +G G+FG+V++    D+         VA+K + K G + +E     +E  +  +  HPN
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPN 60

Query: 180 IIKFIASHETLNEFV-LITEFAHMSLSNLLEQRKK----------LSETICVQILSNLIS 228
           I+K +     LNE   +I E   M   +LL   +           L+    + I  ++  
Sbjct: 61  IVKLLGVC-LLNEPQYIIME--LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDG-----VAMLCDFGFARSMAVGTHMLTSIKGT-PL 282
              YL     +HRDL  +N L+++ G     V  + DFG AR +    +     +G  P+
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 283 -YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQD-VTFPSQ 339
            +MAPE + +  +   +D+WS G + +EI  +G  P+  ++   +++ +     +  P  
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237

Query: 340 VSETYKDLVKGLLEKDASQRLSW 362
             +    L+     +D S+R ++
Sbjct: 238 CPDKIYQLMTNCWAQDPSERPTF 260

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 61/234 (26%), Positives = 109/234 (46%), Gaps = 29/234 (12%)

Query: 124 ICLIGEGSFGKVFKAIHLDLK----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           I  +G+G+FG V    +  L+    + VA+K +  S  + + L   ++E EI K L H N
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDN 66

Query: 180 IIKF--IASHETLNEFVLITEF-AHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHS 235
           I+K+  +          L+ E+  + SL + L++ R++L     +   S +   + YL S
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLY-MAPELIAER 292
            R +HRDL  +N+L+  +    + DFG  + +      + +     +P++  APE + E 
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186

Query: 293 PYDHTADLWSLGCIAYEI----------------HMGHPPFKTVSILHLIRLLK 330
            +   +D+WS G + YE+                 MG+     + + HLI LLK
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 71.5 bits (175), Expect = 8e-14
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 16/200 (8%)

Query: 122 QKICLIGEGSFGKVFKAIHL----DLKKTVALKII-SKSGRSGKELSSLKQECEIQKHLA 176
           +K+ L+G G FG V K I +     +K  VA+K I  +SGR  +    +         L 
Sbjct: 10  RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLD 67

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           H  I++ +          L+T+     L +LL+  ++  +++  Q L N    +   +YY
Sbjct: 68  HAYIVRLLGICPG-ASLQLVTQL--SPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKGTPLYMAPELIA 290
           L  +R++HR+L  +N+LL  D +  + DFG A  +      +  +  K    +MA E I 
Sbjct: 125 LEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y H +D+WS G   +E+
Sbjct: 185 FGRYTHQSDVWSYGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 71.9 bits (176), Expect = 9e-14
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 14/201 (6%)

Query: 120 KYQKICLIGEGSFGKVFKAIHL----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           +++KI ++G G+FG V+K + +     +K  VA+K + +   S K    +  E  +   +
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASV 66

Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALY 231
            +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + 
Sbjct: 67  DNPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELI 289
           YL   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Query: 290 AERPYDHTADLWSLGCIAYEI 310
             R Y H +D+WS G   +E+
Sbjct: 184 LHRIYTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 73.3 bits (180), Expect = 1e-13
 Identities = 69/228 (30%), Positives = 104/228 (45%), Gaps = 39/228 (17%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLK----QECEIQK 173
           +++Y  I LIG+G  G+V+ A      + VALK I +   S   L  LK    +E +I  
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPL--LKKRFLREAKIAA 57

Query: 174 HLAHPNIIKFIASHETLNEFVLITE--FAHMSLSNLLEQ-------RKKLSETICV---- 220
            L HP I+  + S  +  + V  T       +L +LL+         K+L+E   V    
Sbjct: 58  DLIHPGIVP-VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116

Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK-- 278
            I   + + + Y+HS  VLHRDLKP N+LL   G  ++ D+G A    +    L  I   
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 279 ----------------GTPLYMAPELIAERPYDHTADLWSLGCIAYEI 310
                           GTP YMAPE +   P   + D+++LG I Y++
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)

Query: 126 LIGEGSFGKVFKA-IHLD-LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH-PNIIK 182
           +IGEG+FG+V KA I  D L+   A+K + K   S  +      E E+   L H PNII 
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 183 FIASHETLNEFVLITEFAHMSLSNLLEQRKK-------------------LSETICVQIL 223
            + + E      L  E+A     NLL+  +K                   LS    +   
Sbjct: 61  LLGACEHRGYLYLAIEYA--PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL- 282
           +++   + YL   + +HRDL  +N+L+ ++ VA + DFG +R   V  ++  ++   P+ 
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKKTMGRLPVR 176

Query: 283 YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPF 317
           +MA E +    Y   +D+WS G + +EI  +G  P+
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 10/200 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K ++   KK   VA+K++ K+         + +E EI   L +P I++ I
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 185 ASHETLNEFVLITEFAHMSLSN--LLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
              E     +L+ E A     N  L  ++ +++ +  V+++  +   + YL     +HRD
Sbjct: 62  GVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT--PL-YMAPELIAERPYDHTAD 299
           L  +NVLL     A + DFG ++++        +      PL + APE I  R +   +D
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSD 180

Query: 300 LWSLGCIAYE-IHMGHPPFK 318
           +WS G   +E    G  P+K
Sbjct: 181 VWSYGITMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 77/321 (23%), Positives = 136/321 (42%), Gaps = 62/321 (19%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAHPN 179
           + KI  +G G+FG+V  A  +D     A+K + K     + +++ +K E +I     +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 180 IIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           ++K   S +  +    + ++     + +LL + +   E +    ++ L  A+  +H    
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGF---------ARSMAVGTH----------------- 272
           +HRD+KP N+L++ DG   L DFG          ++    G+H                 
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 273 ---------------------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH 311
                                +  S+ GTP Y+APE++  + Y    D WS+G I +E+ 
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 312 MGHPPF----KTVSILHLIRLLKTQDVTFPSQV--SETYKDLVKGLLEKDASQRL---SW 362
           +G PPF     T + L +I    T  +  P QV  S    DL+   L   A +RL     
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHI--PPQVKLSPEAVDLI-TKLCCSAEERLGRNGA 299

Query: 363 PELLHHPLVKD-NLSSEIESQ 382
            ++  HP   + + SS+I +Q
Sbjct: 300 DDIKAHPFFSEVDFSSDIRTQ 320

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 70.5 bits (172), Expect = 3e-13
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 17/221 (7%)

Query: 122 QKICLIGEGSFGKVFKAIHL----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +++ ++G G+FG V+K I +     +K  VA+KI++++    K       E  I   + H
Sbjct: 10  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDH 68

Query: 178 PNIIKFIASHETLNEFV-LITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           P++++ +     L+  + L+T+   M    LL+   +  + I  Q+L N    +   + Y
Sbjct: 69  PHLVRLLGV--CLSPTIQLVTQL--MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG AR +        +  G  P+ +MA E I 
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
            R + H +D+WS G   +E+   G  P+  +    +  LL+
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 14/184 (7%)

Query: 130 GSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET 189
           GS G+VF A        V LKI    G+ G  L     E  + +++ HP++I+   +  +
Sbjct: 77  GSEGRVFVATKPGQPDPVVLKI----GQKGTTL----IEAMLLQNVNHPSVIRMKDTLVS 128

Query: 190 LNEFVLITEFAHMSLSNLLEQRKK---LSETICVQILSNLISALYYLHSNRVLHRDLKPQ 246
                ++       L   L +R +   + + + ++    ++  L YLH+ R++HRD+K +
Sbjct: 129 GAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIE--KQILEGLRYLHAQRIIHRDVKTE 186

Query: 247 NVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCI 306
           N+ +N      + D G A+   V       + GT    APE++A   Y+  AD+WS G +
Sbjct: 187 NIFINDVDQVCIGDLGAAQ-FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIV 245

Query: 307 AYEI 310
            +E+
Sbjct: 246 LFEM 249

Length = 357

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 53/193 (27%), Positives = 91/193 (47%), Gaps = 18/193 (9%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V++ +  +    VA+K + K G    +      E +I K L HP +I+  A 
Sbjct: 14  LGAGQFGEVWEGL-WNNTTPVAVKTL-KPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 187 HETLNEFVLI-TEFAHMSLSNLLEQRKKLSETIC-----VQILSNLISALYYLHSNRVLH 240
             TL E + I TE   M   +LLE  +  +         + + + + S + YL +   +H
Sbjct: 70  C-TLEEPIYIVTEL--MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIH 126

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHT 297
           RDL  +NVL+ ++ +  + DFG AR   +   +  + +G      + APE      +   
Sbjct: 127 RDLAARNVLVGENNICKVADFGLAR--VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184

Query: 298 ADLWSLGCIAYEI 310
           +D+WS G +  EI
Sbjct: 185 SDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 28/214 (13%)

Query: 127 IGEGSFGKVFKA--IHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++      D       VA+K + +S     E   L  E  I     H NI+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-EALIMSKFNHQNIV 72

Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLI-------SALYYL 233
           + I  S E L  F+L+   A   L + L + +   E      + +L+           YL
Sbjct: 73  RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSM------AVGTHMLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG AR +        G   +  IK    +M
Sbjct: 133 EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK----WM 188

Query: 285 APELIAERPYDHTADLWSLGCIAYEI-HMGHPPF 317
            PE   +  +    D+WS G + +EI  +G+ P+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 69.1 bits (170), Expect = 4e-13
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 3/91 (3%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
          ++ +  L+G GSFG V+ A+  D  + +A+K +  SG S +EL +L++E  I   L HPN
Sbjct: 1  EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 70 IIKFIAS--HETLNEFVLITEFAHM-SLSKL 97
          I+++  S   E  N   +  E+    SLS L
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSL 91

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 27/220 (12%)

Query: 120 KYQKICLIGEGSFGKVFKA-IHLD-LKKTVALKIISKSGRSGKELSSLKQECEIQKHLA- 176
           K+Q +  IGEG+FG+V KA I  D L+   A+K + K   S  +      E E+   L  
Sbjct: 10  KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 66

Query: 177 HPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKL------------SETICVQIL 223
           HPNII  + + E      L  E+A H +L + L + + L            + T+  Q L
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 224 ----SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG 279
               +++   + YL   + +HRDL  +N+L+ ++ VA + DFG +R   V  ++  ++  
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKKTMGR 184

Query: 280 TPL-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPF 317
            P+ +MA E +    Y   +D+WS G + +EI  +G  P+
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 80/351 (22%), Positives = 152/351 (43%), Gaps = 57/351 (16%)

Query: 16  LIGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHL-AHPN 69
           ++G G+FGKV +     L ++     VA+K++  + RS  E  +L  E +I  HL  H N
Sbjct: 44  ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS-SEKQALMSELKIMTHLGPHLN 102

Query: 70  IIKFIASHETLNEFVLITEFAHMS-----LSKLGEPWFHNHCQPVKMEKS----NGALEK 120
           I+  + +        +ITE+         L K  + +   H +  K +      N A E 
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADES 162

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPN 179
            +   ++   + G      ++D+K+    + +        E+    +  +IQ+     P 
Sbjct: 163 TRSYVILSFENKGD-----YMDMKQADTTQYVPML-----EIKEASKYSDIQRSNYDRP- 211

Query: 180 IIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
                AS++  N+    +E  ++   +  E    L+    +     +   + +L S   +
Sbjct: 212 -----ASYKGSND----SEVKNLLSDDGSE---GLTTLDLLSFTYQVARGMEFLASKNCV 259

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL----YMAPELIAERPYD 295
           HRDL  +NVLL +  +  +CDFG AR +   ++ ++  KG+      +MAPE I +  Y 
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS--KGSTFLPVKWMAPESIFDNLYT 317

Query: 296 HTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
             +D+WS G + +EI  +G  P+  + +          D TF +++   Y+
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTPYPGMIV----------DSTFYNKIKSGYR 358

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 70.9 bits (173), Expect = 5e-13
 Identities = 72/311 (23%), Positives = 121/311 (38%), Gaps = 61/311 (19%)

Query: 110 KMEKSNGALEKYQKICLIGEGSFGKVF---------------KAIHLDLKKTVALKIISK 154
           K++  +  L  ++ I  +  G+FGK+F                    +  K    ++I+K
Sbjct: 139 KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAK 198

Query: 155 SGRSGKELSS-LKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLL----- 208
             ++G   +  L+ E      L H NI+K      +     +IT+     L + +     
Sbjct: 199 RVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF 258

Query: 209 --EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS 266
             + R  L +T    I+  L+ A+ Y+H  +++HRD+K +N+ LN DG  +L DFG A  
Sbjct: 259 DWKDRPLLKQT--RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316

Query: 267 MA----------VGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEI------ 310
                       VGT    S         PE++A   Y    D+WS G I  ++      
Sbjct: 317 FEKEREAFDYGWVGTVATNS---------PEILAGDGYCEITDIWSCGLILLDMLSHDFC 367

Query: 311 ---HMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS------QRLS 361
                G  P K   +L +I  L   D  FP    + +  +    ++          + L 
Sbjct: 368 PIGDGGGKPGK--QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLG 425

Query: 362 WPELLHHPLVK 372
            P    +PLVK
Sbjct: 426 LPADFEYPLVK 436

Length = 501

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 96/379 (25%), Positives = 161/379 (42%), Gaps = 85/379 (22%)

Query: 17  IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHP-NI 70
           +G G+FG+V +A    + K     TVA+K++ K G +  E  +L  E +I  H+ H  N+
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNV 73

Query: 71  IKFI-ASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLI-G 128
           +  + A  +     ++I EF            F N    ++ ++      K +      G
Sbjct: 74  VNLLGACTKPGGPLMVIVEFCK----------FGNLSNYLRSKRGEFVPYKTKDARFRQG 123

Query: 129 EGSFGKVFKAIHLDLKKTVALKIISKSGRSG-------KELSSLKQECEIQKHLAHPNII 181
           +  +G     I  DLK+   L  I+ S  S        K LS +++E   Q+        
Sbjct: 124 KSGYG----DISEDLKRR--LDSITSSQSSASSGFVEEKSLSDVEEEEAEQE-------- 169

Query: 182 KFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                                   +L ++   L + IC      +   + +L S + +HR
Sbjct: 170 ------------------------DLYKKVLTLEDLICYSF--QVAKGMEFLASRKCIHR 203

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL-YMAPELIAERPYDHT 297
           DL  +N+LL+++ V  +CDFG AR +      +   KG    PL +MAPE I +R Y   
Sbjct: 204 DLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGDARLPLKWMAPETIFDRVYTIQ 261

Query: 298 ADLWSLGCIAYEI-HMGHPPFKTVSI-------LHLIRLLKTQDVTFPSQVSETYKDLVK 349
           +D+WS G + +EI  +G  P+  V I       L     ++  D T P ++ +T  D   
Sbjct: 262 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP-EMYQTMLDCWH 320

Query: 350 GLLEKDASQRLSWPELLHH 368
           G    + SQR ++ EL+ H
Sbjct: 321 G----EPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 66/261 (25%), Positives = 119/261 (45%), Gaps = 22/261 (8%)

Query: 122 QKICLIGEGSFGKVFKAIHL----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +K+ ++G G+FG V+K I +    ++K  VA+K++ +   S K    +  E  +   +  
Sbjct: 10  KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVGS 68

Query: 178 PNIIKFIASHETLNEFVLITEFAHMS--LSNLLEQRKKLSE----TICVQILSNLISALY 231
           P + + +    T +   L+T+       L  + E + ++        CVQI       + 
Sbjct: 69  PYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI----AKGMS 123

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELI 289
           YL   R++HRDL  +NVL+       + DFG AR + +      +  G  P+ +MA E I
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 290 AERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVS-ETYKD 346
             R + H +D+WS G   +E+   G  P+  +    +  LL K + +  P   + + Y  
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMI 243

Query: 347 LVKGLLEKDASQRLSWPELLH 367
           +VK     D+  R  + EL+ 
Sbjct: 244 MVK-CWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 29/210 (13%)

Query: 127 IGEGSFGKVFKAIHLDLK------KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           +GEG+FGKV+K   L          +VA+K + ++    K     +QE E+   L HPNI
Sbjct: 13  LGEGAFGKVYKG-ELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNI 70

Query: 181 IKFIA---------------SHETLNEFVLITEFAH---MSLSNLLEQRKKLSETICVQI 222
           +  +                +H  L+EF L+    H    + S     +  L  +  + I
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEF-LVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-LTSIKGTP 281
              + + + YL S+  +HRDL  +N L+ +     + DFG +R +    +  + S    P
Sbjct: 130 AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 282 L-YMAPELIAERPYDHTADLWSLGCIAYEI 310
           + +M PE I    +   +D+WS G + +EI
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 65.7 bits (160), Expect = 6e-12
 Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 21/240 (8%)

Query: 127 IGEGSFGKVFKA-IHLDLKKT-VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           IG G FGKV     H  + K  V +K +  S    ++L  L QE +  + L HPN+++ +
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQCL 61

Query: 185 ASHETLNEFVLITEFAHM-SLSNLL----EQRKKLSETICVQILS-NLISALYYLHSNRV 238
                   ++L+ EF  +  L N L        ++++   +Q ++  + S L +LH    
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS-IKGTPL-YMAPELIAER---- 292
           +H DL  +N  L  D    + D+G A       + +T      PL ++APEL+  R    
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL 181

Query: 293 -PYDHT--ADLWSLGCIAYEI-HMGHPPFKTVSILH-LIRLLKTQDVTFPS-QVSETYKD 346
            P D T  +++WSLG   +E+      P+  +S    L ++++ QD+  P  Q+   Y D
Sbjct: 182 LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSD 241

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 63.6 bits (155), Expect = 8e-12
 Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 24/179 (13%)

Query: 202 MSLSNLLEQRKK-LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCD 260
           +SL+++LE R + L+E    +I +  +  L  L     LHR  K  N+LL  DG+  L  
Sbjct: 1   VSLADILEVRGRPLNEE---EIWAVCLQCLGALRE---LHRQAKSGNILLTWDGLLKL-- 52

Query: 261 FGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPP---- 316
            G               +  P +MAPE+I  + Y   AD++SLG   YE      P    
Sbjct: 53  DGSVAFKTPEQS-----RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107

Query: 317 FKTVSILHLIRLLKTQDVTFPSQVSE------TYKDLVKGLLEKDASQRLSWPELLHHP 369
            +  +IL ++      D        E      +++D ++    +   +R +    L H 
Sbjct: 108 RELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 66.1 bits (161), Expect = 8e-12
 Identities = 51/184 (27%), Positives = 90/184 (48%), Gaps = 12/184 (6%)

Query: 147 VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLS 205
           V ++ I+    + + ++ L+ E  + K   HPNI+ + A+    NE  ++T F A+ S  
Sbjct: 28  VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 87

Query: 206 NLL--EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGF 263
           +L+       +SE     IL  ++ AL Y+H    +HR +K  ++L++ DG   L     
Sbjct: 88  DLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 147

Query: 264 ARSMAVGTHMLTSIKGTPLY-------MAPELIAE--RPYDHTADLWSLGCIAYEIHMGH 314
             SM      L  +   P Y       ++PE++ +  + YD  +D++S+G  A E+  GH
Sbjct: 148 NLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 207

Query: 315 PPFK 318
            PFK
Sbjct: 208 VPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 65.3 bits (159), Expect = 8e-12
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 35/222 (15%)

Query: 126 LIGEGSFGKVFKA---IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           ++G+G FG V +A         + VA+K++     S  ++    +E    K   HPN+IK
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 183 FIA---------------------SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQ 221
            I                       H  L+ F+L        +S + E+   L     V+
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL--------MSRIGEEPFTLPLQTLVR 117

Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT-SIKGT 280
            + ++ S + YL S   +HRDL  +N +LN++    + DFG ++ +  G +         
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTV 320
           P+ ++A E +A+  Y   +D+W+ G   +EI   G  P+  V
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 2/80 (2%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
           ++ +  IG+G FG+V+KA H    K VA+K+I     S ++   +  E +I K   HPN
Sbjct: 1  LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL--ESKEKKEKIINEIQILKKCKHPN 58

Query: 70 IIKFIASHETLNEFVLITEF 89
          I+K+  S+   +E  ++ EF
Sbjct: 59 IVKYYGSYLKKDELWIVMEF 78

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 7/96 (7%)

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL-YMAPE 287
           +L S + +HRDL  +N+LL+++ V  +CDFG AR +      +   KG+   PL +MAPE
Sbjct: 189 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGSARLPLKWMAPE 246

Query: 288 LIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSI 322
            I ++ Y   +D+WS G + +EI  +G  P+  V I
Sbjct: 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 30/235 (12%)

Query: 127 IGEGSFGKVFKAIHL------DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           +GE  FGKV+K  HL      +  + VA+K + K    G      K E  ++  L HPNI
Sbjct: 13  LGEDRFGKVYKG-HLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 181 IKFI---------------ASHETLNEFVLITEFAHMSLSNLLEQR---KKLSETICVQI 222
           +  +                SH  L+EF L+    H  + +  + +     L     V I
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEF-LVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGTP 281
           ++ + + + +L S+ V+H+DL  +NVL+       + D G  R + A   + L      P
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 282 L-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDV 334
           + +M+PE I    +   +D+WS G + +E+   G  P+   S   +I +++ + V
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 78/331 (23%), Positives = 130/331 (39%), Gaps = 96/331 (29%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS---KSGRSGKELSSLKQECEIQKHL 175
           ++++ + L+GEG+FGKV +A     K+  A+KI+    K  R  K         EIQ   
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK--------IEIQ--- 177

Query: 176 AHPNIIKFIASHETLNEFVLI-------TEFAHMS---------LSNLLEQRKKLSETIC 219
                ++ +   +  + F L+        E  HM          L + + +    S    
Sbjct: 178 ----FMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHL 233

Query: 220 VQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAM----------------LCDFG 262
            QI+     AL Y H+   ++H DLKP+N+L+      +                +CD G
Sbjct: 234 AQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293

Query: 263 FARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT--- 319
                    H  T+I  T  Y +PE++    + ++ D+WS+GCI YE++ G   + T   
Sbjct: 294 ---GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350

Query: 320 VSILHLI--------------------RLLKT-----QDVTFPSQVSETYK--------- 345
           +  LHL+                    RLL       +  T P  ++   +         
Sbjct: 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR 410

Query: 346 -----DLVKGLLEKDASQRLSWPELLHHPLV 371
                DL+ GLL  D  +RL+  ++  HP V
Sbjct: 411 DDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441

Length = 467

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 10/209 (4%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V+ A +    K VA+K +     S   + +   E  + K L H  ++K  A 
Sbjct: 14  LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 187 HETLNEFVLITEFAHM-SLSNLL--EQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
             T     +ITEF    SL + L  ++  K      +   + +   + ++     +HRDL
Sbjct: 70  -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128

Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWS 302
           +  N+L++   V  + DFG AR +    +        P+ + APE I    +   +D+WS
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188

Query: 303 LGCIAYEI-HMGHPPFKTVSILHLIRLLK 330
            G +  EI   G  P+  +S   +IR L+
Sbjct: 189 FGILLMEIVTYGRIPYPGMSNPEVIRALE 217

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 60/243 (24%), Positives = 111/243 (45%), Gaps = 19/243 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 185
           +G+G FG+V+     +    VA+K + K G    E  +  QE ++ K L H  +++  A 
Sbjct: 14  LGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAV 69

Query: 186 -SHETLNEFVLITEFAHMSLSNLLEQRKKLSETIC-----VQILSNLISALYYLHSNRVL 239
            S E +    ++TE+  MS  +LL+  K            V + + + S + Y+     +
Sbjct: 70  VSEEPI---YIVTEY--MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTA 298
           HRDL+  N+L+ ++ V  + DFG AR +    +        P+ + APE      +   +
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 299 DLWSLGCIAYEIHM-GHPPFK-TVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
           D+WS G +  E+   G  P+   V+   L ++ +   +  P +  E+  DL+     K+ 
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 244

Query: 357 SQR 359
            +R
Sbjct: 245 EER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 48/188 (25%), Positives = 88/188 (46%), Gaps = 8/188 (4%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V+   + +  K VA+K +     S   + +  +E  + K L H  +++  A 
Sbjct: 14  LGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 187 HETLNEFVLITEF-AHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDL 243
                   +ITE+ A  SL + L+  +  K+     +   + +   + Y+     +HRDL
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDL 129

Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWS 302
           +  NVL+++  +  + DFG AR +    +        P+ + APE I    +   +D+WS
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189

Query: 303 LGCIAYEI 310
            G + YEI
Sbjct: 190 FGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 14/206 (6%)

Query: 127 IGEG--SFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           IG G  +   V+ A H      V ++I      + + L +L+ E  +     HPNI+   
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 185 ASHETLNEFVLITEF-AHMSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHR 241
               T +   +I+ F A+ S ++LL+    + +SE +   IL   +  L YLH N  +HR
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHR 125

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLY-------MAPELIAE--R 292
           ++K  ++L++ DG+  L       S+         +   P +       ++PEL+ +   
Sbjct: 126 NIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY 185

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFK 318
            Y+  +D++S+G  A E+  G  PF+
Sbjct: 186 GYNVKSDIYSVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 61.4 bits (150), Expect = 2e-10
 Identities = 27/90 (30%), Positives = 53/90 (58%), Gaps = 4/90 (4%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAHPN 69
          Y+KI  IGEG++G+V+KA +    + VALK I  ++ + G  +++++ E ++ + L HPN
Sbjct: 1  YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59

Query: 70 IIKF--IASHETLNEFVLITEFAHMSLSKL 97
          I++   I + +      ++ E+    L+ L
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGL 89

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 24/82 (29%), Positives = 44/82 (53%), Gaps = 2/82 (2%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
           E Y+ I  IG G++G V+KA  +   + VA+K+I      G +   ++QE  + K   H
Sbjct: 2  QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRH 59

Query: 68 PNIIKFIASHETLNEFVLITEF 89
          PNI+ +  S+   ++  ++ E+
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEY 81

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 55/238 (23%), Positives = 101/238 (42%), Gaps = 36/238 (15%)

Query: 127 IGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GE +FGK++K  HL     D  + VA+K + K   + ++    +QE  +   L HPNI+
Sbjct: 13  LGECAFGKIYKG-HLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 182 KFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETIC-----------------VQIL 223
             +          ++ E+     L   L  R   S+  C                 + I 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTSI 277
             + + + YL S+  +H+DL  +N+L+ +     + D G +R +       V    L  I
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190

Query: 278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDV 334
           +    +M PE I    +   +D+WS G + +EI   G  P+   S   +I +++ + +
Sbjct: 191 R----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 50/214 (23%), Positives = 101/214 (47%), Gaps = 20/214 (9%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++    D+ K      VA+K +++S  S +E      E  + K     +++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 72

Query: 182 KFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI----------CVQILSNLISAL 230
           + +         +++ E  AH  L + L   +  +E             +Q+ + +   +
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPEL 288
            YL++ + +HRDL  +N ++  D    + DFG  R +    +     KG  P+ +MAPE 
Sbjct: 133 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 192

Query: 289 IAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVS 321
           + +  +  ++D+WS G + +EI  +   P++ +S
Sbjct: 193 LKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 7/96 (7%)

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL-YMAPE 287
           +L S + +HRDL  +N+LL+++ V  +CDFG AR +      +   KG    PL +MAPE
Sbjct: 188 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGDARLPLKWMAPE 245

Query: 288 LIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSI 322
            I ++ Y   +D+WS G + +EI  +G  P+  V I
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 49/224 (21%), Positives = 104/224 (46%), Gaps = 24/224 (10%)

Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ I   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 72

Query: 182 KFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI-------------CVQILSNLIS 228
           + +         ++I E   M+  +L    + L   +              +Q+   +  
Sbjct: 73  RLLGVVSQGQPTLVIMEL--MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAP 286
            + YL++N+ +HRDL  +N ++ +D    + DFG  R +    +     KG  P+ +M+P
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 287 ELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           E + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 23/81 (28%), Positives = 43/81 (53%), Gaps = 4/81 (4%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          E +  +  +GEGS+G V+KAIH +  + VA+K++        +L  + +E  I K    P
Sbjct: 3  EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSP 58

Query: 69 NIIKFIASHETLNEFVLITEF 89
           I+K+  S+    +  ++ E+
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEY 79

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 5e-10
 Identities = 31/87 (35%), Positives = 44/87 (50%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 70
          YQK+  IGEG++G V+KA      + VA+K I     S     +  +E ++ K L HPNI
Sbjct: 1  YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 71 IKFIASHETLNEFVLITEFAHMSLSKL 97
          IK +       +  L+ EF    L KL
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKL 87

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 61.4 bits (149), Expect = 7e-10
 Identities = 42/141 (29%), Positives = 71/141 (50%), Gaps = 2/141 (1%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH-PNIIKFIA 185
           I  G+FGKV+     +  K  A+K++ K+    K +    Q       L+  P I+    
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 186 SHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
           S ++ N   L+ E+     + +LL       E + V+ +S +  AL YLH + ++HRDLK
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131

Query: 245 PQNVLLNKDGVAMLCDFGFAR 265
           P N+L++ +G   L DFG ++
Sbjct: 132 PDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 48/188 (25%), Positives = 87/188 (46%), Gaps = 9/188 (4%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V+   +    K VA+K + K G       +   E  + K L HP +++  A 
Sbjct: 14  LGAGQFGEVWMGYYNGHTK-VAIKSL-KQGS--MSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 187 HETLNEFVLITEF-AHMSLSNLL--EQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
             T     +ITE+  + SL + L   +  KL+    + + + +   + ++     +HRDL
Sbjct: 70  -VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128

Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWS 302
           +  N+L+++     + DFG AR +    +        P+ + APE I    +   +D+WS
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188

Query: 303 LGCIAYEI 310
            G +  EI
Sbjct: 189 FGILLTEI 196

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 3/81 (3%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          E Y+ +  IGEG+ G+V+KA      K VA+K +       +    +  E  I K   HP
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKHP 75

Query: 69 NIIKFIASHETLNEFVLITEF 89
          NI+ +  S+   +E  ++ E+
Sbjct: 76 NIVDYYDSYLVGDELWVVMEY 96

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 12/113 (10%)

Query: 6   GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKH 64
             L  Y+ +  +GEG+FG+V+KA  +   + VALK I+  + + G  +++L+ E +I K 
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKK 63

Query: 65  LAHPNIIKFI--------ASHETLNEFVLITEFAHMSLSK-LGEPWFH-NHCQ 107
           L HPN++  I         S        ++T +    LS  L  P       Q
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ 116

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 7/91 (7%)

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL-YMAPE 287
           +L S   +HRDL  +N+LL    +  +CDFG AR +   ++ +  +KG    P+ +MAPE
Sbjct: 229 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV--VKGNARLPVKWMAPE 286

Query: 288 LIAERPYDHTADLWSLGCIAYEI-HMGHPPF 317
            I    Y   +D+WS G + +EI  +G  P+
Sbjct: 287 SIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 19/243 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 185
           +G+G FG+V+        K VA+K + K G    E  +  QE +I K L H  ++   A 
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTL-KPGTMMPE--AFLQEAQIMKKLRHDKLVPLYAV 69

Query: 186 -SHETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVL 239
            S E +    ++TEF  M   +LL+       K L     V + + +   + Y+     +
Sbjct: 70  VSEEPI---YIVTEF--MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTA 298
           HRDL+  N+L+  + V  + DFG AR +    +        P+ + APE      +   +
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 299 DLWSLGCIAYE-IHMGHPPFK-TVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
           D+WS G +  E +  G  P+   V+   L ++ +   +  P    E+  +L+K   +KD 
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDP 244

Query: 357 SQR 359
            +R
Sbjct: 245 DER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 57.5 bits (140), Expect = 4e-09
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 20/97 (20%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSG---KELSSLKQECEIQK 63
          Y+K+  +GEG++G V+KA      + VALK I     + G      +E+S LK+      
Sbjct: 1  YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKE------ 54

Query: 64 HLAHPNIIK---FIASHETLNEFVLITEFAHMSLSKL 97
           L HPNI+K    I +   L    L+ E+  M L K 
Sbjct: 55 -LKHPNIVKLLDVIHTERKL---YLVFEYCDMDLKKY 87

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 22/65 (33%), Positives = 31/65 (47%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
           Y+ +  IG+GSFG V K       K +  K I     + KE   L  E  I + L HPN
Sbjct: 1  DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 70 IIKFI 74
          I+++ 
Sbjct: 61 IVRYY 65

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 57.2 bits (138), Expect = 6e-09
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 35/216 (16%)

Query: 127 IGEGSFGKV----------FKAIHLDLKKT------VALKIISKSGRSGKELSSLKQECE 170
           +GEG FG+V          F      L  +      VA+K++ +          LK E +
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK-EIK 71

Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFA-----HMSLSNLLEQRKKLSETICVQILSN 225
           I   L  PNII+ +A   T +   +ITE+      +  LS    Q       +     S 
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 226 LI-------SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK 278
           LI       S + YL S   +HRDL  +N L+ K+    + DFG +R++  G +    I+
Sbjct: 132 LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY--RIQ 189

Query: 279 GTPL----YMAPELIAERPYDHTADLWSLGCIAYEI 310
           G  +    +M+ E I    +   +D+W+ G   +EI
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E  Q I  +G G FG+V+        K VA+K + K G    E  S  +E +I K L H 
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTL-KPGTMSPE--SFLEEAQIMKKLRHD 61

Query: 179 NIIKFIA--SHETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALY 231
            +++  A  S E +    ++TE+  MS  +LL+     + + L     V + + + + + 
Sbjct: 62  KLVQLYAVVSEEPI---YIVTEY--MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIA 290
           Y+     +HRDL+  N+L+    V  + DFG AR +    +        P+ + APE   
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176

Query: 291 ERPYDHTADLWSLGCIAYE-IHMGHPPF 317
              +   +D+WS G +  E +  G  P+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 56.4 bits (137), Expect = 9e-09
 Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 5/68 (7%)

Query: 12 QKICLIGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
          +    +GEG+FG+V+K       +     VA+K + K G S +E     +E  I K L+H
Sbjct: 2  ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLSH 60

Query: 68 PNIIKFIA 75
          PNI++ + 
Sbjct: 61 PNIVRLLG 68

Length = 258

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 39/143 (27%), Positives = 74/143 (51%), Gaps = 9/143 (6%)

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL-YMAPE 287
           +L S   +HRDL  +NVL+ +  +  +CDFG AR +   ++ ++  KG+   PL +MAPE
Sbjct: 254 FLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS--KGSTFLPLKWMAPE 311

Query: 288 LIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLI--RLLKTQDVTFPSQVSETY 344
            I    Y   +D+WS G + +EI  +G  P+  + +       + +   +  P+  S+  
Sbjct: 312 SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEI 371

Query: 345 KDLVKGLLEKDASQRLSWPELLH 367
            ++++   E+    R  + +L+H
Sbjct: 372 YEIMQKCWEEKFEIRPDFSQLVH 394

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 48/217 (22%), Positives = 98/217 (45%), Gaps = 18/217 (8%)

Query: 122 QKICLIGEGSFGKVF--KAIHLDLKKTVALKIISKSGRSGKE---LSSLKQECEIQKHLA 176
           Q+I  +G G FG+VF  KA  ++ +    L ++ K+ +  K+    S  ++E ++ + L+
Sbjct: 8   QEITTLGRGEFGEVFLAKAKGIEEEGGETL-VLVKALQKTKDENLQSEFRRELDMFRKLS 66

Query: 177 HPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETI---------CVQILSNL 226
           H N+++ +          +I E+  +  L   L   K   E +          V + + +
Sbjct: 67  HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 227 ISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMA 285
              + +L + R +HRDL  +N L++      +     ++ +    +        PL ++A
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186

Query: 286 PELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVS 321
           PE + E  +   +D+WS G + +E+   G  PF  +S
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 2/87 (2%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAHP 68
          +Y+ +  IGEG+ G VFKA   +  +TVALK +  +    G    +L+ E +  +   HP
Sbjct: 1  RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHP 59

Query: 69 NIIKFIASHETLNEFVLITEFAHMSLS 95
           ++K +      + FVL+ E+    LS
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSDLS 86

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 34/98 (34%), Positives = 56/98 (57%), Gaps = 7/98 (7%)

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL-YMA 285
           + +L S   +HRD+  +NVLL    VA +CDFG AR +   ++ +  +KG    P+ +MA
Sbjct: 225 MDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV--VKGNARLPVKWMA 282

Query: 286 PELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSI 322
           PE I +  Y   +D+WS G + +EI  +G  P+  + +
Sbjct: 283 PESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 11/193 (5%)

Query: 126 LIGEGSFGKVFKA-IHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           ++G G FG++ +  + L  K+   VA+  + ++G S K+      E        H NI++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLH 240
                   N  +++TE+ ++ +L + L + + +L     + +L  L S + YL     +H
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVH 130

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFA---RSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           + L    VL+N D V  +  F      +S A+ T M  S K   L+ APE I    +   
Sbjct: 131 KGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTM--SGKSPVLWAAPEAIQYHHFSSA 188

Query: 298 ADLWSLGCIAYEI 310
           +D+WS G + +E+
Sbjct: 189 SDVWSFGIVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 26/222 (11%)

Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG+G FG V+    +D    K   A+K +++     +E+    +E  I K  +HPN++ 
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL-EEVEQFLKEGIIMKDFSHPNVLS 60

Query: 183 FIA---SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLIS-------ALYY 232
            +      E     VL     +M   +L    +  +    V+   +LI         + Y
Sbjct: 61  LLGICLPSEGSPLVVL----PYMKHGDLRNFIRSETHNPTVK---DLIGFGLQVAKGMEY 113

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA----VGTHMLTSIKGTPLYMAPEL 288
           L S + +HRDL  +N +L++     + DFG AR +        H  T  K    +MA E 
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 289 IAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLL 329
           +  + +   +D+WS G + +E+   G PP+  V    +   L
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL 215

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 17/212 (8%)

Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG G FGKV    ++        +    +   S +E     +E +  + L H N+++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 186 SHETLNEFVLITEFAHM-SLSNLLEQRKKLSETIC-----VQILSNLISALYYLHSNRVL 239
               +  ++L+ EF  +  L   L   +K            ++   +   L +LH N  +
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI 122

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS-IKGTPL-YMAPELIAE-----R 292
           H DL  +N LL  D    + D+G + +     + +T      PL ++APEL+ E      
Sbjct: 123 HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLL 182

Query: 293 PYDHT--ADLWSLGCIAYEI-HMGHPPFKTVS 321
             D T  +++WSLG   +E+  +G  P++ +S
Sbjct: 183 VVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 44/220 (20%)

Query: 127 IGEGSFGKVFKAIHL------------------DLKKTVALKIISKSGRSGKELSSLKQE 168
           +GEG FG+V    HL                       VA+K++            LK E
Sbjct: 13  LGEGQFGEV----HLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK-E 67

Query: 169 CEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI------CVQ 221
            +I   L +PNII+ +    + +   +ITE+  +  L+  L QR+  S          V 
Sbjct: 68  IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 222 ILSNLI-------SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML 274
           I +NL+       S + YL S   +HRDL  +N L+       + DFG +R++  G +  
Sbjct: 128 I-ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY- 185

Query: 275 TSIKGTPL----YMAPELIAERPYDHTADLWSLGCIAYEI 310
             I+G  +    +MA E I    +   +D+W+ G   +E+
Sbjct: 186 -RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 32/86 (37%), Positives = 47/86 (54%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 70
          +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L HPNI
Sbjct: 2  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 71 IKFIASHETLNEFVLITEFAHMSLSK 96
          +K +    T N+  L+ EF H  L K
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQDLKK 87

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 58/240 (24%), Positives = 107/240 (44%), Gaps = 22/240 (9%)

Query: 127 IGEGSFGKV-FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG G FGKV    I+ D      +    K+  S KE +   Q+ +  + L HPNI++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 186 SHETLNEFVLITEFAHM-SLSNLLEQRKKL---SETICVQILSNLISA-LYYLHSNRVLH 240
                  ++L+ E+  +  L + L Q +     S+ + +Q ++  I+A + ++H +  LH
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLH 122

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIAER-----P 293
            DL  +N  L  D    + D+G   S     ++ T      PL ++APEL+ E       
Sbjct: 123 SDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLIT 182

Query: 294 YDHT--ADLWSLGCIAYEIH----MGHPPFKTVSILHLIRLLKTQDVTFPS-QVSETYKD 346
            + T  +++W+LG   +E+       +       +L+   ++K Q V     Q+   Y +
Sbjct: 183 AEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN--HVIKDQQVKLFKPQLELPYSE 240

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 53.7 bits (130), Expect = 5e-08
 Identities = 22/82 (26%), Positives = 37/82 (45%), Gaps = 5/82 (6%)

Query: 17 IGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
          +GEG+FG+V+K            VA+K + K   S +E     +E  + K L HPN+++ 
Sbjct: 3  LGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 74 IASHETLNEFVLITEFA-HMSL 94
          +          L+ E+     L
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDL 83

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 25/81 (30%), Positives = 44/81 (54%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
          KY+KI ++G G+FG V        +K V +K I     +  E  + + EC++ K L+HPN
Sbjct: 1  KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 70 IIKFIASHETLNEFVLITEFA 90
          II++  +       +++ E+A
Sbjct: 61 IIEYYENFLEDKALMIVMEYA 81

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 52.9 bits (128), Expect = 9e-08
 Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 5/78 (6%)

Query: 17 IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
          +GEG+FG+V+K             VA+K + K   S +++    +E  I + L HPNI+K
Sbjct: 7  LGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 73 FIASHETLNEFVLITEFA 90
           +         +++ E+ 
Sbjct: 66 LLGVCTEEEPLMIVMEYM 83

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 23/66 (34%), Positives = 38/66 (57%), Gaps = 4/66 (6%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-H 67
            ++ + +IGEG++GKV+KA H    + VA+KI+       +E   +K+E  I +  + H
Sbjct: 6  GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE---IKEEYNILRKYSNH 62

Query: 68 PNIIKF 73
          PNI  F
Sbjct: 63 PNIATF 68

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 30/86 (34%), Positives = 45/86 (52%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 70
          YQK+  IGEG++G V+KA      + VALK I          S+  +E  + K L HPNI
Sbjct: 1  YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 71 IKFIASHETLNEFVLITEFAHMSLSK 96
          ++ +    + N+  L+ EF  + L K
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKK 86

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 27/92 (29%), Positives = 47/92 (51%), Gaps = 5/92 (5%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHL 65
          +Y+K   +GEG++  V+KA   +  + VA+K I     K  + G   ++L+ E ++ + L
Sbjct: 1  RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQEL 59

Query: 66 AHPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
           HPNII  +      +   L+ EF    L K+
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFMETDLEKV 91

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 52.9 bits (128), Expect = 1e-07
 Identities = 20/83 (24%), Positives = 37/83 (44%), Gaps = 5/83 (6%)

Query: 12 QKICLIGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
               +GEG+FG+V+K             VA+K + K   S +++    +E  I + L H
Sbjct: 2  TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60

Query: 68 PNIIKFIASHETLNEFVLITEFA 90
          PN++K +          ++ E+ 
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYM 83

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 3/97 (3%)

Query: 277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF 336
           I GTP Y+APEL+  +P+    D W+LG   +E   G PPF   +   + + +  +D+ +
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPW 599

Query: 337 P---SQVSETYKDLVKGLLEKDASQRLSWPELLHHPL 370
           P    ++S   ++ ++ LL  D ++R    EL  HPL
Sbjct: 600 PEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 19/220 (8%)

Query: 144 KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII---KFIASHETLNEFVLITEFA 200
           ++T  LK + KS    +E  ++   C        PN++   K+I S +++  F+++    
Sbjct: 18  QQTFILKGLRKSSEYSRERLTIIPHCV-------PNMVCLHKYIVSEDSV--FLVLQHAE 68

Query: 201 HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCD 260
              L + + +   + E    +  + ++ AL  LH   ++ RDL P N+LL+  G   L  
Sbjct: 69  GGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTY 128

Query: 261 FGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV 320
           F     +              +Y APE+          D WSLG I +E+  G    KT+
Sbjct: 129 FSRWSEVE---DSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTG----KTL 181

Query: 321 SILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
              H   +     +  P  VSE  + L++ LL+ + ++RL
Sbjct: 182 VECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 52.8 bits (125), Expect = 3e-07
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHP 68
           Y+ +  +GEGSFG+V+ A     +K VALK+++K   S  KE+    +E +I   L HP
Sbjct: 1  SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 69 -NIIKFIASHETLNEFVLITEFAH-MSLSKL 97
           NI+K     +      L+ E+    SL  L
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDL 88

Length = 384

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 26/66 (39%), Positives = 45/66 (68%), Gaps = 2/66 (3%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAHP 68
          KY+K+  IG+G+FG+VFKA H   K+ VALK ++ ++ + G  +++L+ E +I + L H 
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHE 71

Query: 69 NIIKFI 74
          N++  I
Sbjct: 72 NVVNLI 77

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 55/234 (23%), Positives = 101/234 (43%), Gaps = 59/234 (25%)

Query: 127 IGEGSFGKVFKAIHL----------------DLKK----TVALKII----SKSGRSGKEL 162
           +GEG FG+V    HL                +++K     VA+KI+    +K+ R+    
Sbjct: 13  LGEGQFGEV----HLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN---- 64

Query: 163 SSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF-------AHMSLSNLLEQRKK-- 213
               +E +I   L  PNII+ +      +   +ITE+         +S  +L ++ +   
Sbjct: 65  -DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123

Query: 214 -----------LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFG 262
                      +S +  + +   + S + YL S   +HRDL  +N L+ ++    + DFG
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFG 183

Query: 263 FARSMAVGTHMLTSIKGTPL----YMAPELIAERPYDHTADLWSLGCIAYEIHM 312
            +R++  G +    I+G  +    +MA E I    +   +D+W+ G   +EI M
Sbjct: 184 MSRNLYAGDYY--RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 5e-07
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 14/92 (15%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSG------KELSSLKQECEIQK 63
          Y+++  IGEG++G V+KA  L+  + VALK +       G      +E++ LKQ      
Sbjct: 1  YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE---- 56

Query: 64 HLAHPNIIKFI---ASHETLNEFVLITEFAHM 92
             HPNI++ +       T  E  L   F H+
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV 88

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 30/79 (37%), Positives = 41/79 (51%), Gaps = 6/79 (7%)

Query: 17 IGEGSFGKVFKAIHLDLK-----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 71
          +GEG FGKV KA    LK      TVA+K++ K   S  EL  L  E  + K + HP++I
Sbjct: 8  LGEGEFGKVVKATAFRLKGRAGYTTVAVKML-KENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 72 KFIASHETLNEFVLITEFA 90
          K   +       +LI E+A
Sbjct: 67 KLYGACSQDGPLLLIVEYA 85

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 2/88 (2%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHP 68
          KY+K+  IGEG++G VFKA + +  + VALK +       G   S+L++ C + K L H 
Sbjct: 1  KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHK 59

Query: 69 NIIKFIASHETLNEFVLITEFAHMSLSK 96
          NI++      +  +  L+ E+    L K
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCDQDLKK 87

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 50.5 bits (121), Expect = 8e-07
 Identities = 29/80 (36%), Positives = 42/80 (52%), Gaps = 11/80 (13%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLK------QECEIQKHLAHPNI 70
          IG+G F  V+KAI L   + VALK +        E+   K      +E ++ K L HPN+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIF-----EMMDAKARQDCLKEIDLLKQLDHPNV 64

Query: 71 IKFIASHETLNEFVLITEFA 90
          IK++AS    NE  ++ E A
Sbjct: 65 IKYLASFIENNELNIVLELA 84

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.2 bits (120), Expect = 9e-07
 Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 24/205 (11%)

Query: 127 IGEGSFGKVFKAIHLDL-------KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +G+G+F K+FK I  ++       K  V LK++ KS R+  E  S  +   +   L+H +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE--SFFEAASMMSQLSHKH 60

Query: 180 IIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETIC-VQILSNLISALYYLHSNR 237
           ++         +E +++ E+    SL   L++ K L      +++   L  AL++L    
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 238 VLHRDLKPQNVLLNKDGVAM--------LCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           + H ++  +NVLL ++            L D G + ++     +L  I     ++ PE I
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP----WVPPECI 176

Query: 290 AE-RPYDHTADLWSLGCIAYEIHMG 313
              +     AD WS G   +EI  G
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 20/87 (22%), Positives = 40/87 (45%), Gaps = 2/87 (2%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ-ECEIQKHLAH 67
           KY+ + ++GEG++G V K  +    + VA+K   K     +++      E ++ + L H
Sbjct: 1  NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRH 59

Query: 68 PNIIKFIASHETLNEFVLITEFAHMSL 94
           NI+    +        L+ E+   +L
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTL 86

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 27/95 (28%), Positives = 48/95 (50%), Gaps = 10/95 (10%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALK---IISKSGRSGKELSSLKQECEIQKHLA 66
          +++K  L+G GSFG V++ ++LD     A+K   +        + +  L+QE  +   L 
Sbjct: 1  RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 67 HPNIIKFIA---SHETLNEFVLITEFAHM-SLSKL 97
          HPNI++++      + L  F+   E     SL+KL
Sbjct: 61 HPNIVQYLGTEREEDNLYIFL---ELVPGGSLAKL 92

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 50.2 bits (121), Expect = 1e-06
 Identities = 30/109 (27%), Positives = 50/109 (45%), Gaps = 14/109 (12%)

Query: 10  KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---ECEIQKHLA 66
           +Y+ +  IG G++G V  A+     + VA+K   K      +L   K+   E ++ +HL 
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLR 57

Query: 67  HPNIIKFIA-----SHETLNEFVLITEFAHMSLSKL---GEPWFHNHCQ 107
           H NII  +      S E  N+  ++TE     L K+    +P   +H Q
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQ 106

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 25/80 (31%), Positives = 41/80 (51%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
          KY K+  IGEGSFGK       +  K   +K I+ S  S KE    ++E  +  ++ HPN
Sbjct: 1  KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 70 IIKFIASHETLNEFVLITEF 89
          I+++  S E      ++ ++
Sbjct: 61 IVQYQESFEENGNLYIVMDY 80

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 49.4 bits (119), Expect = 2e-06
 Identities = 24/75 (32%), Positives = 37/75 (49%), Gaps = 1/75 (1%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIA 75
          +G+GSFGKV      D  K  A+K++ K      KE+     E  I   + HP I+K   
Sbjct: 1  LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 76 SHETLNEFVLITEFA 90
          + +T  +  L+ E+A
Sbjct: 61 AFQTEEKLYLVLEYA 75

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 49.1 bits (118), Expect = 2e-06
 Identities = 17/62 (27%), Positives = 29/62 (46%), Gaps = 1/62 (1%)

Query: 12 QKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 71
          +++ ++G+GS G V+K  H    K  ALK I   G        L +E +  +    P ++
Sbjct: 4  ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPYVV 62

Query: 72 KF 73
          K 
Sbjct: 63 KC 64

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 29/87 (33%), Positives = 40/87 (45%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
           Y KI  IGEG++G V+K  +    + VA+K I          S+  +E  + K L HPN
Sbjct: 1  DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 70 IIKFIASHETLNEFVLITEFAHMSLSK 96
          I+         +   LI EF  M L K
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKK 87

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 7/94 (7%)

Query: 6  GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 65
          G LE Y+K+  +GEGS+  V+K       + VALK I      G   ++++ E  + K L
Sbjct: 2  GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDL 60

Query: 66 AHPNIIKF---IASHETLNEFVLITEFAHMSLSK 96
           H NI+     I + +TL    L+ E+    L +
Sbjct: 61 KHANIVTLHDIIHTKKTLT---LVFEYLDTDLKQ 91

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 7/83 (8%)

Query: 15 CLIGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 68
            +GEG+FG+V KA  + L       TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 69 NIIKFIASHETLNEFVLITEFAH 91
          NII  +          ++ E+A 
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAA 99

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 48.7 bits (117), Expect = 3e-06
 Identities = 23/64 (35%), Positives = 31/64 (48%), Gaps = 4/64 (6%)

Query: 16 LIGEGSFGKVFKAIHLDLKKTVALKIISKS--GRSGKELSSLKQECEIQKHLA-HPNIIK 72
          +IGEGSF  V  A   +  K  A+KI+ K    +  K    +K E E+   L  HP IIK
Sbjct: 8  IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV-KYVKIEKEVLTRLNGHPGIIK 66

Query: 73 FIAS 76
             +
Sbjct: 67 LYYT 70

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 1/68 (1%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          E +  +  IG+GSFG+V+KAI     + VA+K+I     +  E+  ++QE +       P
Sbjct: 1  ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-EAEDEIEDIQQEIQFLSQCRSP 59

Query: 69 NIIKFIAS 76
           I K+  S
Sbjct: 60 YITKYYGS 67

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 49/225 (21%)

Query: 127 IGEGSFGKV-----FKAIHLDLKKT-----------VALKIISKSGRSGKELSSLKQECE 170
           +GEG FG+V             K             VA+K++ +   S        +E +
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAREDFLKEVK 71

Query: 171 IQKHLAHPNIIKFIA-------------SHET--LNEFVLITEFAHMSLSNLLEQRKKLS 215
           I   L+ PNI + +                E   LN+F+          S L    K LS
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET---SGLACNSKSLS 128

Query: 216 ET----ICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT 271
            +    +  QI     S + YL S   +HRDL  +N L+ K+    + DFG +R++    
Sbjct: 129 FSTLLYMATQI----ASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 272 HMLTSIKG-TPL---YMAPELIAERPYDHTADLWSLGCIAYEIHM 312
           +    ++G  PL   +MA E +    +   +D+W+ G   +EI  
Sbjct: 185 YY--RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 4/84 (4%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH--- 67
          YQ++ LIG G++G V++  H+   + VALKII+       ++S +++E  +   L     
Sbjct: 3  YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQP 61

Query: 68 PNIIKFIASHETLNEFVLITEFAH 91
          PNI K+  S+       +I E+A 
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAE 85

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 22/81 (27%), Positives = 40/81 (49%), Gaps = 1/81 (1%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          + Y+ I +IG G+   V+ AI L   + VA+K I    +    +  L++E +      HP
Sbjct: 1  DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLE-KCQTSVDELRKEVQAMSQCNHP 59

Query: 69 NIIKFIASHETLNEFVLITEF 89
          N++K+  S    +E  L+  +
Sbjct: 60 NVVKYYTSFVVGDELWLVMPY 80

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 21/64 (32%), Positives = 39/64 (60%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
          ++Q+   IG G+FGKV+ A++LD  + +A+K I       K +  +  E ++ + L HPN
Sbjct: 1  RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 70 IIKF 73
          ++K+
Sbjct: 61 LVKY 64

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 7/87 (8%)

Query: 10 KYQKICLIGEGSFGKVFKAIH-----LDLKKTVALKIISKSG--RSGKELSSLKQECEIQ 62
          K+ K  LIG GSFG V+  ++     L   K V L  +S S   R    L +L +E  + 
Sbjct: 1  KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 63 KHLAHPNIIKFIASHETLNEFVLITEF 89
          K L H NI++++ S    +   +  E+
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEY 87

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 29/94 (30%), Positives = 43/94 (45%), Gaps = 6/94 (6%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           +YQ +  IGEG++G V  A H      VA+K IS          +L+ E +I +   H 
Sbjct: 5  PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHE 63

Query: 69 NIIKFIA-----SHETLNEFVLITEFAHMSLSKL 97
          NII  +      S E+ N+  ++ E     L KL
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKL 97

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 11/94 (11%)

Query: 190 LNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVL 249
           L EF++    A   + + + Q K+    I   ++  +++ L  LH   ++HRD+KP+N+L
Sbjct: 287 LEEFMM----AGKKIPDNMPQDKRDINVI-KGVMRQVLTGLRKLHRIGIVHRDIKPENLL 341

Query: 250 LNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLY 283
           +  DG   + DFG A  M  G      I   PLY
Sbjct: 342 VTVDGQVKIIDFGAAVDMCTG------INFNPLY 369

Length = 507

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 46.3 bits (109), Expect = 2e-05
 Identities = 27/81 (33%), Positives = 45/81 (55%), Gaps = 2/81 (2%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          +KY +   IG+G+ G VF AI +   + VA+K I+   +  KEL  +  E  + K L +P
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNP 76

Query: 69 NIIKFIASHETLNEFVLITEF 89
          NI+ F+ S    +E  ++ E+
Sbjct: 77 NIVNFLDSFLVGDELFVVMEY 97

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 25/80 (31%), Positives = 41/80 (51%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
          +Y+ I  IGEGSFGK++ A      +   +K I  +    KE  + K+E  +   + HPN
Sbjct: 1  RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 70 IIKFIASHETLNEFVLITEF 89
          I+ F AS +      ++ E+
Sbjct: 61 IVTFFASFQENGRLFIVMEY 80

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 46.0 bits (110), Expect = 2e-05
 Identities = 26/90 (28%), Positives = 48/90 (53%), Gaps = 6/90 (6%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 70
          Y+ I  +G+G+FG V+ A + +  + VA+K + K   S +E  +L++   ++K   HPNI
Sbjct: 1  YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 71 IKFIASHETL---NEFVLITEFAHMSLSKL 97
          +K     E     +E   + E+   +L +L
Sbjct: 61 VKL---KEVFRENDELYFVFEYMEGNLYQL 87

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 21/82 (25%), Positives = 44/82 (53%), Gaps = 8/82 (9%)

Query: 16 LIGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKE----LSSLKQECEIQKHLAH 67
          LIG+G++G+V+ A+++   + +A+K +    + +GR        + +L+ E E  K L H
Sbjct: 8  LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 68 PNIIKFIASHETLNEFVLITEF 89
           NI++++    T     +  E+
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEY 89

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 30/144 (20%), Positives = 61/144 (42%), Gaps = 11/144 (7%)

Query: 124 ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII-- 181
           I L+  G   +V+  +     +   LKI     +        ++E  I + LA   +   
Sbjct: 3   IKLLKGGLTNRVYL-LGTK-DEDYVLKINPSREKGAD----REREVAILQLLARKGLPVP 56

Query: 182 KFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
           K +AS E+     L+ E+        L++  +  +    + L+ L++ L+ L    + H 
Sbjct: 57  KVLASGESDGWSYLLMEWIE---GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113

Query: 242 DLKPQNVLLNKDGVAMLCDFGFAR 265
           DL P N+L++   +  + D+ +A 
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 45.6 bits (109), Expect = 3e-05
 Identities = 22/66 (33%), Positives = 31/66 (46%), Gaps = 11/66 (16%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEIQKHLAHPNI 70
          +G GSFG+V    H    K  ALKI+SK      ++  LKQ      E  I + + HP +
Sbjct: 9  LGTGSFGRVMLVRHKGSGKYYALKILSK-----AKIVKLKQVEHVLNEKRILQSIRHPFL 63

Query: 71 IKFIAS 76
          +    S
Sbjct: 64 VNLYGS 69

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 25/73 (34%), Positives = 38/73 (52%), Gaps = 2/73 (2%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
          +G+G+FGKV+KA H +     A KII     S +EL     E +I     HPNI+    +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 77 HETLNEFVLITEF 89
          +   N+  ++ EF
Sbjct: 71 YFYENKLWILIEF 83

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 22/74 (29%), Positives = 35/74 (47%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
          IG+GSFG VFK +    K+  A+K I  S  + +E      E  +   L    II++  S
Sbjct: 8  IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 77 HETLNEFVLITEFA 90
               +  ++ E+A
Sbjct: 68 FLDKGKLNIVMEYA 81

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 27/75 (36%), Positives = 39/75 (52%), Gaps = 18/75 (24%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALK---------IISKSGRSGKELSSLKQEC 59
          EKY+K+  IGEGS+G VFK  + +  + VA+K         +I K     +E+  LKQ  
Sbjct: 1  EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL--REIRMLKQ-- 56

Query: 60 EIQKHLAHPNIIKFI 74
               L HPN++  I
Sbjct: 57 -----LKHPNLVNLI 66

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 29/90 (32%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPN 69
          ++K+  IGEG++G V++A      + VALK +   + R G  +SSL+ E  +  +L HPN
Sbjct: 9  FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPN 67

Query: 70 II--KFIASHETLNEFVLITEFAHMSLSKL 97
          I+  K +   + L+   L+ E+    L+ L
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASL 97

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)

Query: 6  GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 65
          GA   Y  +  +GEGS+  V+K I     + VALK+IS     G   ++++ E  + K L
Sbjct: 2  GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGL 60

Query: 66 AHPNII---KFIASHETLNEFVLITEFAHMSLSK 96
           H NI+     I + ETL  FV   E+ H  L++
Sbjct: 61 KHANIVLLHDIIHTKETLT-FVF--EYMHTDLAQ 91

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 44.9 bits (107), Expect = 5e-05
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAH 67
          ++Y+K+  I EG++G V++A      + VALK +  +  + G  ++SL+ E  I   L H
Sbjct: 5  DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63

Query: 68 PNI--IKFIASHETLNEFVLITEFAHMSLSKLGE 99
          PNI  +K +     L++  ++ E+    L  L E
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLME 97

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 18/58 (31%), Positives = 29/58 (50%), Gaps = 1/58 (1%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKF 73
          IG+G+FGKV      D KK  A+K ++K        + ++  E  I + L HP ++  
Sbjct: 8  IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 23/80 (28%), Positives = 39/80 (48%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 70
          ++ +  +G+GS+G V+K   L   +  ALK +     S KE      E  I   + HPNI
Sbjct: 2  FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 71 IKFIASHETLNEFVLITEFA 90
          I +  +    N+  ++ E+A
Sbjct: 62 ISYKEAFLDGNKLCIVMEYA 81

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 44.9 bits (106), Expect = 6e-05
 Identities = 23/81 (28%), Positives = 45/81 (55%), Gaps = 2/81 (2%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          +KY +   IG+G+ G V+ AI +   + VA+K ++   +  KEL  +  E  + +   HP
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHP 76

Query: 69 NIIKFIASHETLNEFVLITEF 89
          NI+ ++ S+   +E  ++ E+
Sbjct: 77 NIVNYLDSYLVGDELWVVMEY 97

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 44.7 bits (105), Expect = 7e-05
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 6/95 (6%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           E+YQ +  +G G++G V  A    L++ VA+K +S+  +S        +E  + KH+ H 
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 69  NIIKFI------ASHETLNEFVLITEFAHMSLSKL 97
           N+I  +       S E  NE  L+T      L+ +
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNI 109

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 18/76 (23%), Positives = 34/76 (44%), Gaps = 1/76 (1%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAHPNIIKFIA 75
          I +G++G+VF A         A+K+I K+    K ++  +  E +I      P ++K   
Sbjct: 1  ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 76 SHETLNEFVLITEFAH 91
          S +      L+ E+  
Sbjct: 61 SFQGKKNLYLVMEYLP 76

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 20/88 (22%), Positives = 39/88 (44%), Gaps = 11/88 (12%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEIQ 62
          +  ++I  +G G+FG+V        +   ALK+++       E+  LKQ      E  + 
Sbjct: 1  DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP-----EVIRLKQEQHVHNEKRVL 55

Query: 63 KHLAHPNIIKFIASHETLNEFVLITEFA 90
          K ++HP II+   +        ++ E+ 
Sbjct: 56 KEVSHPFIIRLFWTEHDQRFLYMLMEYV 83

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 8/92 (8%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ--KHLA-H 67
          Y+ +  IGEG+F +V KA      K  A+K + K  +S +++++L+   EIQ  + L+ H
Sbjct: 1  YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR---EIQALRRLSPH 57

Query: 68 PNIIKFIASH--ETLNEFVLITEFAHMSLSKL 97
          PNI++ I            L+ E   M+L +L
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFELMDMNLYEL 89

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 2/81 (2%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          E ++ I  +G+G+FGKV+KA + +     A K+I    +S +EL     E +I     HP
Sbjct: 5  EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT--KSEEELEDYMVEIDILASCDHP 62

Query: 69 NIIKFIASHETLNEFVLITEF 89
          NI+K + +    N   ++ EF
Sbjct: 63 NIVKLLDAFYYENNLWILIEF 83

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 18/61 (29%), Positives = 39/61 (63%), Gaps = 3/61 (4%)

Query: 16 LIGEGSFGKVFKAIHLDLKKTVALKIIS---KSGRSGKELSSLKQECEIQKHLAHPNIIK 72
          L+G+G+FG+V+    +D  + +A+K +     S  + KE+++L+ E ++ K+L H  I++
Sbjct: 9  LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 73 F 73
          +
Sbjct: 69 Y 69

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 1/81 (1%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          E + K+  IG+GSFG+VFK I    +K VA+KII     +  E+  ++QE  +      P
Sbjct: 4  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSP 62

Query: 69 NIIKFIASHETLNEFVLITEF 89
           + K+  S+    +  +I E+
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEY 83

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 22/81 (27%), Positives = 45/81 (55%), Gaps = 2/81 (2%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          E ++ I  IG G++G V+KA +++  +  A+K+I      G++ + ++QE  + K   H 
Sbjct: 9  EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL--EPGEDFAVVQQEIIMMKDCKHS 66

Query: 69 NIIKFIASHETLNEFVLITEF 89
          NI+ +  S+   ++  +  EF
Sbjct: 67 NIVAYFGSYLRRDKLWICMEF 87

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 24/89 (26%), Positives = 46/89 (51%), Gaps = 6/89 (6%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQK--HLA 66
          +Y+ +  IG G++G V+KA        VALK +  ++   G  LS++++   +++     
Sbjct: 1  QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 67 HPNIIKFI---ASHETLNEFVLITEFAHM 92
          HPNI++ +   A+  T  E  +   F H+
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV 89

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 24/95 (25%), Positives = 44/95 (46%), Gaps = 6/95 (6%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           E+Y  +  +G G++G V  AI     + VA+K +S+  +S        +E  + KH+ H 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 69  NIIKFI------ASHETLNEFVLITEFAHMSLSKL 97
           N+I  +       S +   +F L+  +    L K+
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI 109

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 6/82 (7%)

Query: 208 LEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN-KDGVAMLCDFGFARS 266
           LE+  K+ +TI  QIL  L      LHS  ++HRD+KPQN++ +   G   + D G A  
Sbjct: 250 LERENKIIQTIMRQILFALDG----LHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAAD 305

Query: 267 MAVGTHMLTS-IKGTPLYMAPE 287
           + VG + +       P Y APE
Sbjct: 306 LRVGINYIPKEFLLDPRYAAPE 327

Length = 566

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 26/75 (34%), Positives = 39/75 (52%), Gaps = 1/75 (1%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISK-SGRSGKELSSLKQECEIQKHLAHPNIIKFIA 75
          IG G F +V++A  L  +K VALK +        K      +E ++ K L HPN+IK++ 
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 76 SHETLNEFVLITEFA 90
          S    NE  ++ E A
Sbjct: 70 SFIEDNELNIVLELA 84

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 43.6 bits (102), Expect = 3e-04
 Identities = 24/67 (35%), Positives = 35/67 (52%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
          L +Y+ I  IG G FG+VF   H   ++    K IS  G   +E S L  E  + + L H
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71

Query: 68 PNIIKFI 74
           NI+++I
Sbjct: 72 KNIVRYI 78

Length = 1021

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 25/89 (28%), Positives = 45/89 (50%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
          +++Y+K+  IGEG++G V+KA      +T+ALK I          S+  +E  + K + H
Sbjct: 1  MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 68 PNIIKFIASHETLNEFVLITEFAHMSLSK 96
           NI++      +     L+ E+  + L K
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKK 89

Length = 294

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 1/81 (1%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          E + K+  IG+GSFG+V+K I    K+ VA+KII     +  E+  ++QE  +      P
Sbjct: 4  ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSP 62

Query: 69 NIIKFIASHETLNEFVLITEF 89
           I ++  S+    +  +I E+
Sbjct: 63 YITRYYGSYLKGTKLWIIMEY 83

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 42.7 bits (101), Expect = 4e-04
 Identities = 23/95 (24%), Positives = 45/95 (47%), Gaps = 6/95 (6%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           ++YQ +  +G G++G+V  A      + VA+K +S+  +S        +E  + KH+ H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 69  NIIKFI------ASHETLNEFVLITEFAHMSLSKL 97
           N+I  +      +S E   +  L+T      L+ +
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNI 109

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 42.4 bits (99), Expect = 4e-04
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 7/94 (7%)

Query: 6  GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 65
          G  + Y+K+  +GEGS+  V+K       K VALK+I      G   ++++ E  + K L
Sbjct: 2  GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGL 60

Query: 66 AHPNII---KFIASHETLNEFVLITEFAHMSLSK 96
           H NI+     I + ETL    L+ E+ H  L +
Sbjct: 61 KHANIVLLHDIIHTKETLT---LVFEYVHTDLCQ 91

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 17/74 (22%), Positives = 31/74 (41%), Gaps = 5/74 (6%)

Query: 16 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 75
           IG+G FG V    +    + VA+K +           +   E  +   L HPN+++ + 
Sbjct: 13 TIGKGEFGDVMLGDYR--GQKVAVKCLK---DDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 76 SHETLNEFVLITEF 89
               N   ++TE+
Sbjct: 68 VVLQGNPLYIVTEY 81

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 25/80 (31%), Positives = 37/80 (46%), Gaps = 9/80 (11%)

Query: 17 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 71
          +GEG FGKV      D         VA+K ++ SG   +  S  ++E EI + L H NI+
Sbjct: 12 LGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHENIV 69

Query: 72 KF--IASHETLNEFVLITEF 89
          K+  +          LI E+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEY 89

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 25/81 (30%), Positives = 38/81 (46%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          EKY+ + L+GEGS+G V K  H +  + VA+K   +S           +E  + K L H 
Sbjct: 1  EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 69 NIIKFIASHETLNEFVLITEF 89
          N++  I          L+ EF
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEF 81

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 28/72 (38%), Positives = 46/72 (63%), Gaps = 10/72 (13%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLK---KTVALKIIS-KSGRSGKELSSLKQECEIQKH 64
          ++Y+ +  IGEG++GKVFKA   DLK   + VALK +  ++G  G  LS+++ E  + +H
Sbjct: 1  QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRH 57

Query: 65 L---AHPNIIKF 73
          L    HPN+++ 
Sbjct: 58 LETFEHPNVVRL 69

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 1/81 (1%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          E + K+  IG+GSFG+VFK I    ++ VA+KII     +  E+  ++QE  +      P
Sbjct: 4  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSP 62

Query: 69 NIIKFIASHETLNEFVLITEF 89
           + K+  S+    +  +I E+
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEY 83

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 41.1 bits (97), Expect = 8e-04
 Identities = 17/61 (27%), Positives = 25/61 (40%), Gaps = 1/61 (1%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSS-LKQECEIQKHLAHPNIIKFIA 75
          +G G FG+V         +T ALK + K           +  E EI +   HP I+K   
Sbjct: 1  LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 76 S 76
          +
Sbjct: 61 T 61

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 31/109 (28%), Positives = 44/109 (40%), Gaps = 29/109 (26%)

Query: 17  IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
           IG G FG+V +   L L       VA+K + K+G S K+      E  I     HPNII+
Sbjct: 12  IGGGEFGEVCRG-RLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 73  FIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKY 121
                      ++ITE+                     ME  NG+L+K+
Sbjct: 70  LEGVVTKSRPVMIITEY---------------------ME--NGSLDKF 95

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 41.4 bits (97), Expect = 8e-04
 Identities = 28/103 (27%), Positives = 44/103 (42%), Gaps = 10/103 (9%)

Query: 17  IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 71
           IG+G+FG+VF+A    L        VA+K++ K   S    +  ++E  +     HPNI+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDHPNIV 71

Query: 72  KFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKS 114
           K +          L+ E+  M+   L E  F  H  P      
Sbjct: 72  KLLGVCAVGKPMCLLFEY--MAYGDLNE--FLRHRSPRAQCSL 110

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 16/73 (21%), Positives = 29/73 (39%), Gaps = 1/73 (1%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
          +G G+ G V K +H    K +A+K I            + +E +I      P I+ F  +
Sbjct: 9  LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 77 HETLNEFVLITEF 89
               +  +  E+
Sbjct: 68 FYNNGDISICMEY 80

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 22/76 (28%), Positives = 36/76 (47%), Gaps = 2/76 (2%)

Query: 16 LIGEGSFGK--VFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
          LIG+       V  A H      VA+K I+    S ++L  L+QE    + L HPNI+ +
Sbjct: 5  LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 74 IASHETLNEFVLITEF 89
          + S    +E  +++  
Sbjct: 65 VTSFIVDSELYVVSPL 80

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 49/230 (21%), Positives = 88/230 (38%), Gaps = 30/230 (13%)

Query: 127 IGEGSFGKVFKAIHL---DLKKT-------VALKIISKSGRSGKELSSLKQECEIQKHLA 176
           +G+G+F  ++K +     DL          V LK++    R             +   L+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETAS---LMSQLS 59

Query: 177 HPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETIC-VQILSNLISALYYLH 234
           H +++K         E +++ E+     L   L + K        + +   L SAL+YL 
Sbjct: 60  HKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE 118

Query: 235 SNRVLHRDLKPQNVLLNKDGVAM-------LCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
             +++H ++  +N+L+ + G+         L D G   ++      +  I     ++APE
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP----WIAPE 174

Query: 288 LI--AERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDV 334
            I   +      AD WS G    EI   G  P  T+S     R  + Q  
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 40.3 bits (95), Expect = 0.002
 Identities = 25/81 (30%), Positives = 44/81 (54%), Gaps = 13/81 (16%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKII-------SKSGRSGKELSSLKQECE 60
          L KY+ +  +G+G++G V+KAI    K+ VALK I       + + R+ +E+  L++  +
Sbjct: 6  LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD 65

Query: 61 IQKHLAHPNIIKFIASHETLN 81
                HPNI+K +   +  N
Sbjct: 66 ------HPNIVKLLNVIKAEN 80

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 22/63 (34%), Positives = 40/63 (63%), Gaps = 7/63 (11%)

Query: 16 LIGEGSFGKVFKAIHLDLKKTVALKIIS---KSGRSGKELSSLKQECEIQ--KHLAHPNI 70
          L+G+G+FG+V+     D  + +A+K +    +S  + KE+++L  ECEIQ  K+L H  I
Sbjct: 9  LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNAL--ECEIQLLKNLLHERI 66

Query: 71 IKF 73
          +++
Sbjct: 67 VQY 69

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 21/70 (30%), Positives = 36/70 (51%), Gaps = 1/70 (1%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 67
          + +  +  IG GSFG V+ A  +   + VA+K +S SG+   E    + +E    + L H
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 68 PNIIKFIASH 77
          PN I++   +
Sbjct: 75 PNTIEYKGCY 84

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 24/86 (27%), Positives = 43/86 (50%), Gaps = 1/86 (1%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 70
          ++++  +GEG++  V+K  +    + VALK I      G   S+  +E  + K L H NI
Sbjct: 2  FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP-STAIREISLMKELKHENI 60

Query: 71 IKFIASHETLNEFVLITEFAHMSLSK 96
          ++      T N+ +L+ E+    L K
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKK 86

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 20/71 (28%), Positives = 41/71 (57%), Gaps = 3/71 (4%)

Query: 16 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 75
          ++G+G++G V+ A  L  +  +A+K I +  R  + +  L +E  +  +L H NI++++ 
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 76 SHETLNEFVLI 86
          S ++ N F  I
Sbjct: 73 S-DSENGFFKI 82

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 1/84 (1%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAHPNIIKFIA 75
           IG GSFG V+ A +    + VA+K +S SG+   E    + +E +  + L HPN I++  
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 76  SHETLNEFVLITEFAHMSLSKLGE 99
            +   +   L+ E+   S S L E
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLE 112

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 24/77 (31%), Positives = 41/77 (53%), Gaps = 3/77 (3%)

Query: 16 LIGEGSFGKVF---KAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
          ++G+GSFGKVF   K    D  +  A+K++ K+    ++    K E +I   + HP I+K
Sbjct: 3  VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 73 FIASHETLNEFVLITEF 89
             + +T  +  LI +F
Sbjct: 63 LHYAFQTEGKLYLILDF 79

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 29/84 (34%), Positives = 46/84 (54%), Gaps = 7/84 (8%)

Query: 12 QKICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
          ++I  +GEG FGKV    +     +  + VA+K + K    G  ++ LK+E EI ++L H
Sbjct: 7  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYH 65

Query: 68 PNIIKF--IASHETLNEFVLITEF 89
           NI+K+  I + +  N   LI EF
Sbjct: 66 ENIVKYKGICTEDGGNGIKLIMEF 89

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 24/76 (31%), Positives = 35/76 (46%), Gaps = 3/76 (3%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKI---ISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
          +G+GSFG V+            LK+   I     +  E     QE ++   L HP I+KF
Sbjct: 8  LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 74 IASHETLNEFVLITEF 89
           AS    + F +ITE+
Sbjct: 68 HASFLERDAFCIITEY 83

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 6/88 (6%)

Query: 4  SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQ 62
          +N  +EK      IG G F +V++A  L     VALK +        K  +   +E ++ 
Sbjct: 2  ANFRIEKK-----IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL 56

Query: 63 KHLAHPNIIKFIASHETLNEFVLITEFA 90
          K L HPN+IK+ AS    NE  ++ E A
Sbjct: 57 KQLNHPNVIKYYASFIEDNELNIVLELA 84

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 25/86 (29%), Positives = 43/86 (50%), Gaps = 7/86 (8%)

Query: 7   ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQEC---EIQK 63
           +L + +++  IG G+ G V+K IH    +  ALK+I        E +  +Q C   EI +
Sbjct: 72  SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY----GNHEDTVRRQICREIEILR 127

Query: 64  HLAHPNIIKFIASHETLNEFVLITEF 89
            + HPN++K     +   E  ++ EF
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEF 153

Length = 353

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 2/66 (3%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLA 66
          ++K+  I  IGEG++G+V+KA   D  + VALK +   + + G  +++++ E +I + L 
Sbjct: 6  VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLN 64

Query: 67 HPNIIK 72
          H NI+ 
Sbjct: 65 HRNIVN 70

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 39.3 bits (92), Expect = 0.003
 Identities = 20/62 (32%), Positives = 31/62 (50%), Gaps = 4/62 (6%)

Query: 16 LIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
           IGEG FG V++ +++  +     VA+K   K+  S        QE  I +   HP+I+K
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 73 FI 74
           I
Sbjct: 72 LI 73

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 23/63 (36%), Positives = 40/63 (63%), Gaps = 7/63 (11%)

Query: 16 LIGEGSFGKVFKAIHLDLKKTVALKIIS---KSGRSGKELSSLKQECEIQ--KHLAHPNI 70
          L+G+G+FG+V+    +D  + +A K +    +S  + KE+S+L  ECEIQ  K+L H  I
Sbjct: 9  LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSAL--ECEIQLLKNLQHERI 66

Query: 71 IKF 73
          +++
Sbjct: 67 VQY 69

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 1/84 (1%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIA 75
           IG GSFG V+ A  +   + VA+K +S SG+ S ++   + +E    + L HPN I++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 76  SHETLNEFVLITEFAHMSLSKLGE 99
            +   +   L+ E+   S S L E
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLE 106

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 23/79 (29%), Positives = 42/79 (53%), Gaps = 2/79 (2%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 70
          Y+ I  +G G++G V+KA +L   +  A+KII      G + S ++QE  + K   H NI
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL--EPGDDFSLIQQEIFMVKECKHCNI 68

Query: 71 IKFIASHETLNEFVLITEF 89
          + +  S+ +  +  +  E+
Sbjct: 69 VAYFGSYLSREKLWICMEY 87

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 23/59 (38%), Positives = 30/59 (50%), Gaps = 2/59 (3%)

Query: 16 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 74
           IG+G+FG V+K + L     VA+K   +S           QE EI K   HPNI+K I
Sbjct: 2  KIGKGNFGDVYKGV-LKGNTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	549
KOG0575|consensus	592		100.0
KOG0598|consensus	357		100.0
KOG0581|consensus	364		100.0
KOG0615|consensus	475		100.0
KOG0597|consensus	808		100.0
KOG0593|consensus	396		100.0
KOG0616|consensus	355		100.0
KOG0592|consensus	604		100.0
KOG0595|consensus	429		100.0
KOG0583|consensus	370		100.0
KOG0605|consensus	550		100.0
KOG0591|consensus	375		100.0
KOG0588|consensus	786		100.0
KOG0033|consensus	355		100.0
KOG0694|consensus	694		100.0
KOG0661|consensus	538		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0659|consensus	318		100.0
KOG0600|consensus	560		100.0
KOG0198|consensus	313		100.0
KOG0580|consensus	281		100.0
KOG0585|consensus	576		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0660|consensus	359		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0663|consensus	419		100.0
KOG0582|consensus	516		100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0578|consensus	550		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0032|consensus	382		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0611|consensus	668		100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0610|consensus	459		100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0201|consensus	467		100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0192|consensus	362		100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0594|consensus	323		100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0599|consensus	411		100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG4717|consensus	864		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG1035|consensus	1351		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0658|consensus	364		100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0589|consensus	426		100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0986|consensus	591		100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0690|consensus	516		100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0574|consensus	502		100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0667|consensus	586		100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0577|consensus	948		100.0
KOG0579|consensus	1187		100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0197|consensus	468		100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0607|consensus	463		100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG4236|consensus	888		100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0604|consensus	400		100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0662|consensus	292		100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0603|consensus	612		100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0612|consensus	1317		100.0
KOG0586|consensus	596		100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0696|consensus	683		100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG4721|consensus	904		100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0983|consensus	391		100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0596|consensus	677		100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0584|consensus	632		100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG4279|consensus	1226		100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0614|consensus	732		100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG1989|consensus	738		100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4645|consensus	1509		100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0194|consensus	474		100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0193|consensus	678		100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0666|consensus	438		100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG2345|consensus	302		100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG1187|consensus	361		100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0695|consensus	593		100.0
KOG1026|consensus	774		100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0608|consensus	1034		100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0669|consensus	376		100.0
KOG0587|consensus	953		100.0
KOG1095|consensus	1025		100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1006|consensus	361		100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0671|consensus	415		100.0
KOG1151|consensus	775		100.0
KOG0665|consensus	369		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4250|consensus	732		100.0
KOG4257|consensus	974		100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0670|consensus	752		100.0
KOG4278|consensus	1157		100.0
KOG1290|consensus	590		100.0
KOG0196|consensus	996		100.0
KOG0199|consensus	1039		100.0
KOG0664|consensus	449		100.0
KOG1094|consensus	807		100.0
KOG0668|consensus	338		100.0
KOG0576|consensus	829		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027|consensus	903		100.0
KOG0200|consensus	609		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0984|consensus	282		100.0
KOG1152|consensus	772		100.0
KOG1025|consensus	1177		99.97
KOG3653|consensus	534		99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG2052|consensus	513		99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1167|consensus	418		99.97
KOG1345|consensus	378		99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1024|consensus	563		99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG0590|consensus	601		99.94
KOG1164|consensus	322		99.94
KOG0603|consensus	612		99.93
KOG1033|consensus	516		99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG0606|consensus	1205		99.91
KOG1163|consensus	341		99.91
KOG1165|consensus	449		99.9
KOG1240|consensus	1431		99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG4158|consensus	598		99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG0195|consensus	448		99.82
PRK10345	210	hypothetical protein; Provisional	99.82
KOG1166|consensus	974		99.79
smart00090	237	RIO RIO-like kinase.	99.79
KOG0590|consensus	601		99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
KOG0601|consensus	524		99.78
KOG0576|consensus	829		99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
KOG1023|consensus	484		99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
KOG0601|consensus	524		99.66
KOG0606|consensus	1205		99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG0595|consensus	429		99.6
KOG0600|consensus	560		99.53
KOG0659|consensus	318		99.52
KOG0593|consensus	396		99.51
KOG0597|consensus	808		99.51
KOG0591|consensus	375		99.5
KOG0598|consensus	357		99.49
KOG0605|consensus	550		99.46
KOG0575|consensus	592		99.43
KOG0615|consensus	475		99.42
KOG1243|consensus	690		99.41
KOG0661|consensus	538		99.41
KOG0662|consensus	292		99.41
KOG0663|consensus	419		99.4
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.39
KOG1266|consensus	458		99.39
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.38
KOG0611|consensus	668		99.37
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.32
KOG0580|consensus	281		99.31
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.31
KOG0616|consensus	355		99.28
KOG0581|consensus	364		99.26
KOG0594|consensus	323		99.25
KOG0694|consensus	694		99.24
KOG0660|consensus	359		99.24
KOG0585|consensus	576		99.22
KOG0032|consensus	382		99.2
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.2
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.19
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.18
KOG0586|consensus	596		99.18
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.18
KOG0589|consensus	426		99.18
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.18
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.17
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.16
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.15
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.14
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.14
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.13
KOG0583|consensus	370		99.12
KOG0201|consensus	467		99.12
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.12
KOG1026|consensus	774		99.11
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.11
KOG0582|consensus	516		99.1
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.1
KOG4236|consensus	888		99.1
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.1
KOG0577|consensus	948		99.09
KOG0192|consensus	362		99.09
KOG0690|consensus	516		99.09
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.09
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.09
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.08
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.08
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.08
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.07
KOG1187|consensus	361		99.07
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.07
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.07

>KOG0575|consensus

Probab=100.00  E-value=7.7e-58  Score=480.46  Aligned_cols=256  Identities=34%  Similarity=0.612  Sum_probs=244.4

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+.. ......+.+.+|++|.++|+|||||+++++|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            67999999999999999999999999999999998754 34455678899999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |+|. ++|..++++++.++|.+++.++.||+.||.|||++||||||||..|+||+++..|||||||+|..+..+.....+
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T  177 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT  177 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence            9998 799999999999999999999999999999999999999999999999999999999999999999877667788


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCc
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      .||||.|.|||++....+++.+||||+||++|-||+|++||...+..+++.+|+...+.+|..+|.++++||.+||++||
T Consensus       178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P  257 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNP  257 (592)
T ss_pred             ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCcccCcc
Q psy18060        357 SQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       357 ~~Rps~~elL~Hpw~~~~  374 (549)
                      .+|||+.+||.|+||+..
T Consensus       258 ~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  258 SERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             ccCCCHHHHhcCHhhhCC
Confidence            999999999999999543

>KOG0598|consensus

Probab=100.00  E-value=3.1e-56  Score=445.37  Aligned_cols=269  Identities=33%  Similarity=0.541  Sum_probs=248.1

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ....++|++++.||+|+||+|++++.++|++.||+|++++.... .++.+....|..||..++||+||+++..|++.+.+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            45578999999999999999999999999999999999887643 34678899999999999999999999999999999


Q ss_pred             EEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      |+|+||++| .|..+|++.+.|+|..++.++.+|+.||.|||++|||||||||+||||+.+|+++|+|||+++.......
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999985 8999999999999999999999999999999999999999999999999999999999999987655555


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc-cCCHHHHHHHHHh
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS-QVSETYKDLVKGL  351 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~dlI~~~  351 (549)
                      ...++|||+.|||||++.+.+|+.++|+||||+++|+|++|.+||.+.+....++.|..++...++ .++++++++++++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~L  260 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKL  260 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHH
Confidence            667789999999999999999999999999999999999999999999999999999999855555 4999999999999


Q ss_pred             chhCcCCCC----CHHHHhcCcccCcccchhhhhcc
Q psy18060        352 LEKDASQRL----SWPELLHHPLVKDNLSSEIESQN  383 (549)
Q Consensus       352 L~~dP~~Rp----s~~elL~Hpw~~~~~~~~~~~~~  383 (549)
                      |++||.+|.    .+.+|.+||||.+..+..+....
T Consensus       261 L~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~  296 (357)
T KOG0598|consen  261 LKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKK  296 (357)
T ss_pred             hccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcC
Confidence            999999996    58999999999998887665443

>KOG0581|consensus

Probab=100.00  E-value=5.8e-56  Score=443.57  Aligned_cols=257  Identities=29%  Similarity=0.519  Sum_probs=235.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-EEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-EFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~i  195 (549)
                      ...+.+.+..||+|..|+||+|.|+.|++.+|+|++. ....+...+.+.+|+++++..+||+||.+|+.|.... .++|
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence            3457788999999999999999999999999999993 4456677889999999999999999999999999988 5999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      +||||+ |+|..+++..++++|.....++.++++||.|||+ ++||||||||+|||++.+|.|||||||.++.+...  .
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~  233 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--I  233 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--h
Confidence            999999 6999999999999999999999999999999995 89999999999999999999999999999887654  5


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcC-CCCCCcc-CCHHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV-----SILHLIRLLKTQ-DVTFPSQ-VSETYKD  346 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~~d  346 (549)
                      .++++||..|||||.+.+..|+.++||||||++++||.+|+.||...     ...+++..|..+ ++.+|.. +|+++++
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~  313 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS  313 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence            67889999999999999999999999999999999999999999874     677888888874 4567776 9999999


Q ss_pred             HHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        347 LVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      ||..||++||..|||+.|+++|||+++...
T Consensus       314 FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  314 FVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            999999999999999999999999986544

>KOG0615|consensus

Probab=100.00  E-value=1.3e-56  Score=451.12  Aligned_cols=258  Identities=33%  Similarity=0.535  Sum_probs=229.7

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh-----HHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-----KELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      ..+.|.+.+.||+|+||.|-+|..++||+.||||++++.....     .....+.+|++||++|+|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4567999999999999999999999999999999998765322     12345689999999999999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC---CcEEEeecccceec
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD---GVAMLCDFGFARSM  267 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~---g~vKL~DFGla~~~  267 (549)
                      ..||||||++ |+|.+.+-.++.+.|...+.+++|++.|+.|||++||+||||||+|||++.+   ..+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            9999999998 5899999999999999999999999999999999999999999999999877   68999999999988


Q ss_pred             ccCcccccccCCCCcccccccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCCCCC----cc
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAERP---YDHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQDVTFP----SQ  339 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~~~---y~~ksDIwSlGvil~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~  339 (549)
                      +.+ ....+.||||.|.|||++.+..   +..++|+|||||+||-+|+|.+||...... ...+.|..+.+.+-    ..
T Consensus       330 g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  330 GEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR  408 (475)
T ss_pred             ccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence            744 5668899999999999997654   345889999999999999999999876544 47788888877654    35


Q ss_pred             CCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       340 ~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +|+++.+||++||..||++|||+.|+|+||||++..
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            899999999999999999999999999999998653

>KOG0597|consensus

Probab=100.00  E-value=3.9e-55  Score=453.05  Aligned_cols=257  Identities=52%  Similarity=0.873  Sum_probs=250.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+...+.++...+.+|++|++.++|||||.|+++|++..++++|+
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            46788899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        198 EFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       198 E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      |||.|+|+.+|...+.++|+.++.++.|++.||.|||+.+|+|||+||.|||+...|.+|+||||+|+.+..++...++.
T Consensus        81 e~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi  160 (808)
T KOG0597|consen   81 EYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI  160 (808)
T ss_pred             hhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999988889999


Q ss_pred             CCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcC
Q psy18060        278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS  357 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~  357 (549)
                      .|||.|||||...+++|+..+|+||||||+|||++|++||-..+..+..+.|...+...|+..|..+..|++.+|.+||.
T Consensus       161 kGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~  240 (808)
T KOG0597|consen  161 KGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPA  240 (808)
T ss_pred             cCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCcccCcc
Q psy18060        358 QRLSWPELLHHPLVKDN  374 (549)
Q Consensus       358 ~Rps~~elL~Hpw~~~~  374 (549)
                      +|+||.+++.|||.+..
T Consensus       241 ~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  241 QRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             hcccHHHHhcChHHhhh
Confidence            99999999999999864

>KOG0593|consensus

Probab=100.00  E-value=7.4e-55  Score=423.15  Aligned_cols=262  Identities=31%  Similarity=0.563  Sum_probs=234.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +++|+.+..+|+|+||+|++|+++.||+.||||.+..+..++...+...+|+++|++++|||+|.++++|.....+++|+
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            46789999999999999999999999999999999887777777778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |||+.++.+-|+.. ..+++..++.++.|++.|+.|||++++|||||||+||||+.+|.+||||||+|+....+....|.
T Consensus        81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence            99999988888775 46999999999999999999999999999999999999999999999999999998866677889


Q ss_pred             cCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-------------------CCC
Q psy18060        277 IKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-------------------VTF  336 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-------------------~~~  336 (549)
                      .+.|.||+|||.+.+ .+|+.++||||+||++.||++|.+.|++.+..+++..|...-                   +.+
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            999999999999987 889999999999999999999999999998777766654210                   112


Q ss_pred             C------------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccchhh
Q psy18060        337 P------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       337 p------------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~~~  379 (549)
                      |            +.++.-+.||+++||..||.+|++.+|+|.||+|.+....+.
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~~  295 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIEREL  295 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHHHH
Confidence            2            246778889999999999999999999999999966654433

>KOG0616|consensus

Probab=100.00  E-value=1.1e-53  Score=414.36  Aligned_cols=265  Identities=29%  Similarity=0.510  Sum_probs=246.5

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ..+++|++++.||.|+||.|.+++++.+|..||+|++++... .-+..+...+|..+|+.+.||+++++++.+.+.+.+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            567889999999999999999999999999999999987542 3345678889999999999999999999999999999


Q ss_pred             EEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      +||||.+| .|..++++.++|++..++.++.||+.||+|||+++|++|||||+|||||++|.+||+|||+|+.....   
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence            99999985 79999999999999999999999999999999999999999999999999999999999999987633   


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhch
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ..+.||||.|+|||++...+|+.++|.|||||++|||+.|.+||...++..++++|..+.+.+|+.+++.+++||+++|+
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~  277 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQ  277 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHh
Confidence            46789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hCcCCCC-----CHHHHhcCcccCcccchhhhhcc
Q psy18060        354 KDASQRL-----SWPELLHHPLVKDNLSSEIESQN  383 (549)
Q Consensus       354 ~dP~~Rp-----s~~elL~Hpw~~~~~~~~~~~~~  383 (549)
                      +|-.+|.     ...+|..||||++..+..+..+.
T Consensus       278 vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~  312 (355)
T KOG0616|consen  278 VDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRK  312 (355)
T ss_pred             hhhHhhhcCcCCCccccccCcccccccHHHHhhcc
Confidence            9999994     56899999999988777665443

>KOG0592|consensus

Probab=100.00  E-value=2.6e-53  Score=439.68  Aligned_cols=266  Identities=31%  Similarity=0.539  Sum_probs=243.5

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNE  192 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  192 (549)
                      .....+|.+++.||.|+|++|++|+.+.+++.||||++.+.-. ..+....+..|-..|.+| .||.|+++|..|++...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            4467889999999999999999999999999999999976542 223345677888899999 89999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +|+|+||++ |+|.++|.+.+.|++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||.|+.+.+..
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            999999998 7999999999999999999999999999999999999999999999999999999999999998775421


Q ss_pred             c-----------c--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc
Q psy18060        272 H-----------M--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS  338 (549)
Q Consensus       272 ~-----------~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~  338 (549)
                      .           .  ..+++||..|.+||++.....+..+|||+||||||.|+.|++||.+.+..-++++|....+.||+
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~  308 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE  308 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence            1           1  15589999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccchhhh
Q psy18060        339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       339 ~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~~~~  380 (549)
                      .+++.+.+||+++|..||.+|+|++||.+||||.+..+..+-
T Consensus       309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw  350 (604)
T KOG0592|consen  309 GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW  350 (604)
T ss_pred             CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence            999999999999999999999999999999999987665543

>KOG0595|consensus

Probab=100.00  E-value=8e-53  Score=424.30  Aligned_cols=259  Identities=36%  Similarity=0.637  Sum_probs=240.0

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ....+|.+.+.||+|+||+||+|+++.++..||||.+.+...+.+..+.+..|+.||+.++|||||+++++.+..+.+|+
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            45678999999999999999999999999999999999887788889999999999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC------CcEEEeecccceecc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD------GVAMLCDFGFARSMA  268 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~------g~vKL~DFGla~~~~  268 (549)
                      |||||+ |+|..+|++++.++|..++.++.||+.||++||+++||||||||+||||+..      -.+||+|||+|+.+.
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            999999 6999999999999999999999999999999999999999999999999875      468999999999987


Q ss_pred             cCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---CCccCCHHHH
Q psy18060        269 VGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT---FPSQVSETYK  345 (549)
Q Consensus       269 ~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~  345 (549)
                      ++ ....+.||+|.|||||++..+.|+.|+|+||+|+|+|+|++|++||...+..+....+..+.-.   +|..+++...
T Consensus       167 ~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~  245 (429)
T KOG0595|consen  167 PG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLR  245 (429)
T ss_pred             ch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchh
Confidence            55 4567889999999999999999999999999999999999999999999999999888776533   3456788888


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +++...|+++|..|.+..+.+.|+++....
T Consensus       246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  246 ELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            999999999999999999999999997654

>KOG0583|consensus

Probab=100.00  E-value=2e-51  Score=430.36  Aligned_cols=258  Identities=33%  Similarity=0.556  Sum_probs=237.9

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCC
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS---GKELSSLKQECEIQKHLA-HPNIIKFIASHETLN  191 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~  191 (549)
                      ....+|.+.+.||+|+||+|+.|.+..++..||+|++.+....   ......+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567899999999999999999999999999999987664221   134556778999999998 999999999999999


Q ss_pred             EEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC-CcEEEeecccceeccc
Q psy18060        192 EFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAV  269 (549)
Q Consensus       192 ~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~-g~vKL~DFGla~~~~~  269 (549)
                      .+|+|||||.| +|.+++.+.++++|.+++.+++||+.|++|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            99999999985 999999999999999999999999999999999999999999999999999 9999999999988743


Q ss_pred             CcccccccCCCCcccccccccCCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccC-CHHHHH
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERP-YD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQV-SETYKD  346 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~-y~-~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~~~d  346 (549)
                      ......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...+...|..+.+.+|..+ |+++++
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~  253 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARS  253 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHH
Confidence            335668889999999999999877 86 789999999999999999999999999999999999999999999 999999


Q ss_pred             HHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        347 LVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      |+.+||..||.+|+|+.+|+.||||+.
T Consensus       254 Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  254 LIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999986

>KOG0605|consensus

Probab=100.00  E-value=1.9e-51  Score=426.20  Aligned_cols=264  Identities=30%  Similarity=0.505  Sum_probs=237.7

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ...++|++++.||+|+||.||+|+.+.||..||+|++.++.. .......++.|-.+|....+|.||++|.+|++.+++|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            367899999999999999999999999999999999988763 4456788999999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceeccc----
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV----  269 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~----  269 (549)
                      |||||++ |++..+|.+.+.|+|..+++++.+++.|++-||+.|+|||||||+|+|||..|++||+|||++.....    
T Consensus       218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            9999988 58999999999999999999999999999999999999999999999999999999999999852210    


Q ss_pred             ------------------Cc-c------------------------cccccCCCCcccccccccCCCCCcchhhHHHHHH
Q psy18060        270 ------------------GT-H------------------------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCI  306 (549)
Q Consensus       270 ------------------~~-~------------------------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvi  306 (549)
                                        .. .                        ...+.+|||.|||||++.+.+|+..+|+||||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                              00 0                        0123579999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCc--cCCHHHHHHHHHhchhCcCCCCC---HHHHhcCcccCcccchhh
Q psy18060        307 AYEIHMGHPPFKTVSILHLIRLLKTQD--VTFPS--QVSETYKDLVKGLLEKDASQRLS---WPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       307 l~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~dlI~~~L~~dP~~Rps---~~elL~Hpw~~~~~~~~~  379 (549)
                      +||||.|.+||.+.++.++.++|....  +.+|.  .++++++|||.+||. ||.+|+.   ++||.+||||++..+..+
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l  456 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHL  456 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchh
Confidence            999999999999999999999998776  56665  478999999999999 9999986   899999999998876655


Q ss_pred             h
Q psy18060        380 E  380 (549)
Q Consensus       380 ~  380 (549)
                      .
T Consensus       457 ~  457 (550)
T KOG0605|consen  457 R  457 (550)
T ss_pred             h
Confidence            3

>KOG0591|consensus

Probab=100.00  E-value=2.4e-53  Score=409.03  Aligned_cols=255  Identities=35%  Similarity=0.566  Sum_probs=231.6

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEE-EEeeCC-
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA-SHETLN-  191 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~-  191 (549)
                      ......+|++++.||+|+||.||++.+..+|..+|.|.+.-...+.+..+.+..|+.+|++|+|||||++++ .+...+ 
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            345567899999999999999999999999999999999866678888899999999999999999999998 454444 


Q ss_pred             EEEEEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--CccccccCCcEEEecCCcEEEeecc
Q psy18060        192 EFVLITEFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHS--NR--VLHRDLKPQNVLLNKDGVAMLCDFG  262 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~--~g--IiHrDIKP~NILl~~~g~vKL~DFG  262 (549)
                      .++||||+|+ |+|.+.|+.    ++.++|..++.++.|++.||..||+  .+  |+||||||.||||+.+|.|||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            4899999998 799999864    4569999999999999999999999  44  9999999999999999999999999


Q ss_pred             cceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CC-ccC
Q psy18060        263 FARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-FP-SQV  340 (549)
Q Consensus       263 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~  340 (549)
                      +++.+...+....+.+|||+||+||.+...+|++|+||||+||++|||+.-++||.+.+..++.++|.+++.+ .| ..+
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~Y  253 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHY  253 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHh
Confidence            9999987777778899999999999999999999999999999999999999999999999999999999775 56 578


Q ss_pred             CHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        341 SETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       341 s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      |..+..+|..|+.+||..||+.     +|++.+
T Consensus       254 S~~l~~li~~ci~vd~~~RP~t-----~~~v~d  281 (375)
T KOG0591|consen  254 STDLRELINMCIAVDPEQRPDT-----VPYVQD  281 (375)
T ss_pred             hhHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence            9999999999999999999986     555544

>KOG0588|consensus

Probab=100.00  E-value=8.5e-52  Score=436.09  Aligned_cols=262  Identities=29%  Similarity=0.515  Sum_probs=243.4

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecC-CCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ...+.-|++++.||.|+.|.|-.|++..||+.+|||++.+. ..+......+.+|+-||+.+.||||+++|+++++..++
T Consensus         8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen    8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL   87 (786)
T ss_pred             cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence            34556689999999999999999999999999999999876 34444567889999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      |+|.||+. |.|++++..+++++|.+++.+++||+.|+.|||..+|+||||||+|+||+.++.+||+|||+|..-.++ .
T Consensus        88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-k  166 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-K  166 (786)
T ss_pred             EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC-c
Confidence            99999988 579999999999999999999999999999999999999999999999999999999999999755444 5


Q ss_pred             cccccCCCCcccccccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHh
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~-~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      ...+.||+|.|.|||++.+.+|+ .++||||+|||||.||||+.||.+.+...++.+++.+.+.+|..+|+++++||.+|
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~m  246 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRM  246 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHH
Confidence            67888999999999999999985 78999999999999999999999999999999999999999999999999999999


Q ss_pred             chhCcCCCCCHHHHhcCcccCcccch
Q psy18060        352 LEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                      |.+||.+|+|.+||++|||+......
T Consensus       247 l~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  247 LDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             hccCccccccHHHHhhCchhhcCCCC
Confidence            99999999999999999999876543

>KOG0033|consensus

Probab=100.00  E-value=3e-52  Score=394.40  Aligned_cols=256  Identities=29%  Similarity=0.514  Sum_probs=236.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .+.|++.+.||+|.|+.|++|.+..||+.+|+|++.....+....+.+.+|++|-+.|+|||||++.+........|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            35688899999999999999999999999999999776666667889999999999999999999999999999999999


Q ss_pred             ecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC---CcEEEeecccceecccCccc
Q psy18060        198 EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD---GVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       198 E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~---g~vKL~DFGla~~~~~~~~~  273 (549)
                      |++.| +|..-|-++.-++|..+-..++||+.||.|+|.+||||||+||+|+++...   .-+||||||+|.... +...
T Consensus        90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~  168 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEA  168 (355)
T ss_pred             ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Cccc
Confidence            99986 788888888888999999999999999999999999999999999999654   369999999999888 4456


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHHHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLVK  349 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dlI~  349 (549)
                      ...++|||.|||||++...+|+.++|||+.|||||-|+.|.+||.+.+...+++.|..+.+.+|+    .+++++++||+
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr  248 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR  248 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence            67889999999999999999999999999999999999999999999999999999999888774    68999999999


Q ss_pred             HhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        350 GLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      +||..||.+|+|+.|.|+|||+++-
T Consensus       249 rML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  249 RMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHhccChhhhccHHHHhCCchhcch
Confidence            9999999999999999999999864

>KOG0694|consensus

Probab=100.00  E-value=4.6e-50  Score=426.09  Aligned_cols=269  Identities=24%  Similarity=0.433  Sum_probs=245.4

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNE  192 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  192 (549)
                      .-.+++|.++++||+|+||+|+++..+.+++.||||++++.. ....+.+....|.+|+... +||.+++++.+|++.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            456889999999999999999999999999999999998876 3455677888999998888 49999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        193 FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +|+||||+.|+-.-++.+.+.|+|..++.++..++.||+|||++|||+||||.+|||||.+|++||+|||+++..-....
T Consensus       444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence            99999999863344445567899999999999999999999999999999999999999999999999999986553445


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhc
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ..+++||||.|||||++.++.|+.++|+|||||+|||||.|+.||.+.+..++...|....+.+|..+|.++.++++++|
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll  603 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLL  603 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHh
Confidence            66889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhCcCCCCCH-----HHHhcCcccCcccchhhhhcc
Q psy18060        353 EKDASQRLSW-----PELLHHPLVKDNLSSEIESQN  383 (549)
Q Consensus       353 ~~dP~~Rps~-----~elL~Hpw~~~~~~~~~~~~~  383 (549)
                      .++|++|+.+     ++|..||||+...+..+....
T Consensus       604 ~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~  639 (694)
T KOG0694|consen  604 RKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRR  639 (694)
T ss_pred             ccCcccccCCCCCCchhhhhCCccccCCHHHHhhcc
Confidence            9999999975     789999999998887775543

>KOG0661|consensus

Probab=100.00  E-value=1.2e-50  Score=414.21  Aligned_cols=259  Identities=29%  Similarity=0.465  Sum_probs=228.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCC-EEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLN-EFV  194 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-~~~  194 (549)
                      .+++|.+++.||.|+||.||+|+.+.++..||||.+.+...+-++ ..-.+|++.|++++ ||||+++.+++.+.+ .+|
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            467899999999999999999999999999999999776544333 34468999999998 999999999998877 999


Q ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      +||||++.+|.++++.+ +.|+|..++.|+.||++||+|+|.+|+.|||+||+|||+..+..+||+|||+||..... ..
T Consensus        87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-pP  165 (538)
T KOG0661|consen   87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-PP  165 (538)
T ss_pred             eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-CC
Confidence            99999999999999876 45999999999999999999999999999999999999998899999999999988654 46


Q ss_pred             ccccCCCCccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------C
Q psy18060        274 LTSIKGTPLYMAPELIA-ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-------------------D  333 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~-~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-------------------~  333 (549)
                      .|..+.|.||+|||++. .+.|+.++||||+|||++|+++-++.|+|.+..+.+.+|..-                   .
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence            78889999999999974 577999999999999999999999999999888887776420                   1


Q ss_pred             CCCC-----------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        334 VTFP-----------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       334 ~~~p-----------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                      +.+|           +++++++.++|.+||..||.+||||.|+|+||||+.....
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence            1222           2478999999999999999999999999999999865443

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.9e-49  Score=407.44  Aligned_cols=264  Identities=30%  Similarity=0.493  Sum_probs=237.9

Q ss_pred             cccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       113 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      .+...+++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++...+
T Consensus        12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   91 (329)
T PTZ00263         12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN   91 (329)
T ss_pred             cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence            345567889999999999999999999999999999999975432 2233467889999999999999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      .+|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999987 589999999889999999999999999999999999999999999999999999999999999876432


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~  350 (549)
                         ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..+...+|..+++.+++||.+
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  248 (329)
T PTZ00263        172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG  248 (329)
T ss_pred             ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence               23457999999999999999999999999999999999999999999988888889888888899999999999999


Q ss_pred             hchhCcCCCCC-----HHHHhcCcccCcccchhh
Q psy18060        351 LLEKDASQRLS-----WPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       351 ~L~~dP~~Rps-----~~elL~Hpw~~~~~~~~~  379 (549)
                      ||+.||.+||+     ++++++||||.+......
T Consensus       249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~  282 (329)
T PTZ00263        249 LLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKL  282 (329)
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHH
Confidence            99999999997     799999999987554433

>KOG0659|consensus

Probab=100.00  E-value=1.3e-49  Score=380.92  Aligned_cols=256  Identities=30%  Similarity=0.476  Sum_probs=227.6

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .+|...+.+|+|.||.||+|++..||+.||||.+..............+|++.|+.++||||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            56888999999999999999999999999999998765444445567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      |++.+|...|+.+ ..++..+++.++.+++.||+|||++.|+||||||.|+|++.+|.+||+|||+|+...+.....+..
T Consensus        82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~  161 (318)
T KOG0659|consen   82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ  161 (318)
T ss_pred             eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc
Confidence            9999999999875 468999999999999999999999999999999999999999999999999999998776666666


Q ss_pred             CCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----------C---------C
Q psy18060        278 KGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-----------T---------F  336 (549)
Q Consensus       278 ~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-----------~---------~  336 (549)
                      +-|.||+|||.+.| ..|+..+||||.|||+.||+-|.+-|++.+..+++..|...-.           .         +
T Consensus       162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~  241 (318)
T KOG0659|consen  162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF  241 (318)
T ss_pred             eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC
Confidence            89999999999876 6799999999999999999999999999888777776632100           0         1


Q ss_pred             C--------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        337 P--------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       337 p--------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      |        +..++++.||+.+||..||.+|+|+.|+|+||||+..
T Consensus       242 P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  242 PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence            1        1357788999999999999999999999999999863

>KOG0600|consensus

Probab=100.00  E-value=8.8e-50  Score=410.50  Aligned_cols=256  Identities=31%  Similarity=0.466  Sum_probs=227.6

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--CEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--NEFV  194 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~  194 (549)
                      ..+.|+.++.||+|.||.||+|++..+|+.||+|.+..............+||.||++|+||||+++.+.....  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            45679999999999999999999999999999999987665555666788999999999999999999987665  6899


Q ss_pred             EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-c
Q psy18060        195 LITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-H  272 (549)
Q Consensus       195 iV~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-~  272 (549)
                      +|+||++.+|..++.. .-+|++.+++.++.||+.||+|||++||+|||||.+|||||.+|.+||+|||+|+...... .
T Consensus       195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~  274 (560)
T KOG0600|consen  195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA  274 (560)
T ss_pred             EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence            9999999999999887 4579999999999999999999999999999999999999999999999999999776543 3


Q ss_pred             cccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------CCCCC----
Q psy18060        273 MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----------DVTFP----  337 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~----------~~~~p----  337 (549)
                      ..|+.+-|+||+|||.+.+ ..|+.++|+||+||||.||++|++.|++.+..+++..|..-          ...+|    
T Consensus       275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~  354 (560)
T KOG0600|consen  275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI  354 (560)
T ss_pred             ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence            4788899999999999877 57999999999999999999999999999988888776321          00122    


Q ss_pred             ---------------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        338 ---------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       338 ---------------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                                     ..+++.+.+|+..||..||.+|.||.++|+|+||+
T Consensus       355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence                           13688899999999999999999999999999994

>KOG0198|consensus

Probab=100.00  E-value=1.5e-49  Score=402.49  Aligned_cols=257  Identities=33%  Similarity=0.588  Sum_probs=220.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC--EEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN--EFVL  195 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~i  195 (549)
                      ..+|...+.||+|+||.||++.+.++|...|||.+.....  ...+.+.+|+++|++++|||||++++......  .++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            4568889999999999999999999999999999876522  22678999999999999999999999754443  6899


Q ss_pred             EEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec-CCcEEEeecccceeccc---
Q psy18060        196 ITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK-DGVAMLCDFGFARSMAV---  269 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~-~g~vKL~DFGla~~~~~---  269 (549)
                      .|||+. |+|.+++.+.+ +++|..++.+.+||+.||.|||++|||||||||+|||++. +|.+||+|||+++....   
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            999998 69999999877 7999999999999999999999999999999999999999 79999999999987653   


Q ss_pred             CcccccccCCCCcccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC--CCCCccCCHHHH
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERP-YDHTADLWSLGCIAYEIHMGHPPFKT-VSILHLIRLLKTQD--VTFPSQVSETYK  345 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~-y~~ksDIwSlGvil~eLltG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~  345 (549)
                      .........||+.|||||++..+. ...++|||||||++.||+||.+||.. ......+-.+....  +.+|+.+|++++
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~  253 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK  253 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence            112234578999999999998632 33599999999999999999999987 44444444444333  568889999999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      +||.+|+.+||.+||||.++|+|||++....
T Consensus       254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  254 DFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999976543

>KOG0580|consensus

Probab=100.00  E-value=5.1e-50  Score=378.77  Aligned_cols=259  Identities=33%  Similarity=0.550  Sum_probs=240.3

Q ss_pred             cccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       113 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      .....+++|++.+.||+|.||.||.|+.++++-.+|+|++.++.. .......+.+|+.|.+.|+||||+++|++|.+..
T Consensus        16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~   95 (281)
T KOG0580|consen   16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK   95 (281)
T ss_pred             ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence            356778999999999999999999999999999999999987653 2223467899999999999999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        192 EFVLITEFAH-MSLSNLLE--QRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~--~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                      .+|+++||.. |.|.+.|.  ...++++..++.++.|++.||.|||..+||||||||+|+|++.+|.+||+|||.+-...
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999987 78999998  56789999999999999999999999999999999999999999999999999985443


Q ss_pred             cCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHH
Q psy18060        269 VGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV  348 (549)
Q Consensus       269 ~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI  348 (549)
                        .....+.|||..|.|||+..+..++.++|+|++|+++||++.|.+||...+..+.+++|...+..+|+.++.+++|+|
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI  253 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLI  253 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHH
Confidence              345678899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      .+||.++|.+|.+..|++.|||+..
T Consensus       254 ~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  254 SRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHhccCccccccHHHHhhhHHHHh
Confidence            9999999999999999999999864

>KOG0585|consensus

Probab=100.00  E-value=3.5e-49  Score=402.96  Aligned_cols=265  Identities=32%  Similarity=0.535  Sum_probs=228.7

Q ss_pred             ccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC------------hHHHHHHHHHHHHHHhcCCCC
Q psy18060        112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS------------GKELSSLKQECEIQKHLAHPN  179 (549)
Q Consensus       112 ~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------------~~~~~~~~~Ei~il~~l~hpn  179 (549)
                      ......++.|++++.||+|.||.|-+|++..+++.||||++.+....            ....+.+.+|+.||+++.|||
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            44566789999999999999999999999999999999999765421            112457899999999999999


Q ss_pred             eeEEEEEEee--CCEEEEEEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcE
Q psy18060        180 IIKFIASHET--LNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVA  256 (549)
Q Consensus       180 Iv~l~~~~~~--~~~~~iV~E~~~gsL~~~l~~~~~-l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~v  256 (549)
                      ||+++++..+  .+.+|||+|||...-..+.-..+. +++.++++++++++.||+|||.+|||||||||+|+||+.+|+|
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence            9999999855  467999999998432333333444 9999999999999999999999999999999999999999999


Q ss_pred             EEeecccceecccC-----cccccccCCCCcccccccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy18060        257 MLCDFGFARSMAVG-----THMLTSIKGTPLYMAPELIAERP----YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIR  327 (549)
Q Consensus       257 KL~DFGla~~~~~~-----~~~~~~~~GT~~Y~APE~l~~~~----y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~  327 (549)
                      ||+|||.+.....+     .......+|||.|||||...++.    .+.+.||||+||+||+|+.|+.||.+....++..
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~  329 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD  329 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence            99999999766322     12234468999999999987632    3578999999999999999999999999999999


Q ss_pred             HHhcCCCCCCcc--CCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        328 LLKTQDVTFPSQ--VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       328 ~i~~~~~~~p~~--~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      +|...++.+|..  +.+.++|+|.+||++||.+|++..+|..|||......
T Consensus       330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            999999999965  7999999999999999999999999999999987643

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.5e-48  Score=403.22  Aligned_cols=255  Identities=31%  Similarity=0.497  Sum_probs=229.5

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-C
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-M  202 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-g  202 (549)
                      +.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...+.+|+||||+. |
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999975432 23344567889999999999999999999999999999999998 5


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCc
Q psy18060        203 SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL  282 (549)
Q Consensus       203 sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~  282 (549)
                      +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++............+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            89999998889999999999999999999999999999999999999999999999999998754333333455679999


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCC--
Q psy18060        283 YMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL--  360 (549)
Q Consensus       283 Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rp--  360 (549)
                      |+|||++.+..++.++|||||||++|||++|+.||...+.......+......+|..+++++.+||.+||+.||.+||  
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  240 (323)
T cd05571         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG  240 (323)
T ss_pred             ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCC
Confidence            999999999999999999999999999999999999999888888888888889999999999999999999999999  


Q ss_pred             ---CHHHHhcCcccCcccchhh
Q psy18060        361 ---SWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       361 ---s~~elL~Hpw~~~~~~~~~  379 (549)
                         ++.++++||||....+...
T Consensus       241 ~~~~~~~ll~h~~f~~~~~~~~  262 (323)
T cd05571         241 GPEDAKEIMEHRFFASINWQDV  262 (323)
T ss_pred             CCCCHHHHHcCCCcCCCCHHHH
Confidence               8999999999987655444

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0660|consensus

Probab=100.00  E-value=3.6e-49  Score=393.32  Aligned_cols=261  Identities=30%  Similarity=0.490  Sum_probs=228.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-----CCEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-----LNEF  193 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~  193 (549)
                      ..|..++.||+|+||.|+.+.++.+|+.||||.+.....+.-..+...+|+++++.++|+||+.+.+.+..     .+.+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            45666899999999999999999999999999998766666677788999999999999999999998754     4579


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceeccc--Cc
Q psy18060        194 VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV--GT  271 (549)
Q Consensus       194 ~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~--~~  271 (549)
                      |+|+|+++.+|.+.|+.+..+++..+..++.||+.||+|+|+.||+||||||+|+|++.+..+||||||+|+....  ..
T Consensus       102 YiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~  181 (359)
T KOG0660|consen  102 YLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED  181 (359)
T ss_pred             EEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence            9999999999999999998899999999999999999999999999999999999999999999999999998753  23


Q ss_pred             ccccccCCCCccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------
Q psy18060        272 HMLTSIKGTPLYMAPELIA-ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ------------------  332 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~-~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~------------------  332 (549)
                      ...|..+.|.||+|||++. ...|+.++||||+|||+.||++|++.|++.+..+.+..|..-                  
T Consensus       182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar  261 (359)
T KOG0660|consen  182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR  261 (359)
T ss_pred             cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence            4457888999999999974 578999999999999999999999999998776666655321                  


Q ss_pred             -----CCCCC--------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccchhh
Q psy18060        333 -----DVTFP--------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       333 -----~~~~p--------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~~~  379 (549)
                           -+..|        ++.++.+.+|+.+||..||.+|+|++|+|.|||+.....+..
T Consensus       262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d  321 (359)
T KOG0660|consen  262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED  321 (359)
T ss_pred             HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence                 01111        367899999999999999999999999999999987655444

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-48  Score=396.28  Aligned_cols=256  Identities=29%  Similarity=0.480  Sum_probs=232.1

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            468999999999999999999999999999999975432 2234456889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||+. |+|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....   ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~~  157 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TWT  157 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---ccc
Confidence            9987 589999999889999999999999999999999999999999999999999999999999999765432   234


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCc
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..+...+|..+++.++++|.+||+.||
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (291)
T cd05612         158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDR  237 (291)
T ss_pred             ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCH
Confidence            57999999999999989999999999999999999999999999988888888888888999999999999999999999


Q ss_pred             CCCCC-----HHHHhcCcccCcccch
Q psy18060        357 SQRLS-----WPELLHHPLVKDNLSS  377 (549)
Q Consensus       357 ~~Rps-----~~elL~Hpw~~~~~~~  377 (549)
                      .+||+     ++++++||||......
T Consensus       238 ~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         238 TRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             HHccCCccCCHHHHhcCccccCCCHH
Confidence            99995     9999999999865443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0663|consensus

Probab=100.00  E-value=3.3e-49  Score=388.27  Aligned_cols=260  Identities=28%  Similarity=0.451  Sum_probs=227.4

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEE--eeCCE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASH--ETLNE  192 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~~  192 (549)
                      ..+++.|+.+..|++|+||.||+|+++.|++.||+|+++-......-.-...+|+.+|.+.+|||||.+-.+.  .+-+.
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            4567889999999999999999999999999999999875432222122457899999999999999998875  44567


Q ss_pred             EEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 FVLITEFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +|||||||..+|..++...+ +|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||||||+||..+...
T Consensus       152 iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  152 IYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            99999999999999999876 89999999999999999999999999999999999999999999999999999998887


Q ss_pred             ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------
Q psy18060        272 HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ------------------  332 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~------------------  332 (549)
                      ...|..+-|.||+|||.+.+ ..|+.++|+||+|||+.||+++++.|++.+..+++.+|..-                  
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            77888999999999999876 56999999999999999999999999999888887776321                  


Q ss_pred             -CCCCCc-------------cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        333 -DVTFPS-------------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       333 -~~~~p~-------------~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                       ...+|+             .+++...+|++.+|..||.+|.||.|.|+|+||.+.
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence             011111             156888999999999999999999999999999874

>KOG0582|consensus

Probab=100.00  E-value=8.4e-48  Score=390.74  Aligned_cols=262  Identities=30%  Similarity=0.494  Sum_probs=229.9

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .....+.|++.+.||.|..++||+|+...++..||||++.....+.. .+.+.+|++.++.++||||++++.+|..+..+
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            34456889999999999999999999999999999999987665444 78999999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        194 VLITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      |+||.|+. |++.++++..  ..++|..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+...
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            99999998 7999999874  46999999999999999999999999999999999999999999999999987655433


Q ss_pred             ccc----ccccCCCCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-------
Q psy18060        271 THM----LTSIKGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP-------  337 (549)
Q Consensus       271 ~~~----~~~~~GT~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p-------  337 (549)
                      ...    .+++.|||+|||||++..  ..|++|+||||||++..||.+|..||...++...+-.-.++.++.|       
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence            221    156789999999999643  6799999999999999999999999999988877655445544322       


Q ss_pred             ---ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        338 ---SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       338 ---~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                         ..++..++.+|..||++||.+|||+.++|+|+||+....
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence               246788999999999999999999999999999987543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-48  Score=396.09  Aligned_cols=251  Identities=31%  Similarity=0.516  Sum_probs=226.8

Q ss_pred             EecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CCH
Q psy18060        127 IGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSL  204 (549)
Q Consensus       127 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL  204 (549)
                      ||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++...+.+|+||||+. |+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999999999999999997542 233345677889999999999999999999999999999999998 589


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCccc
Q psy18060        205 SNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYM  284 (549)
Q Consensus       205 ~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~  284 (549)
                      .+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++............+||+.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            99999888999999999999999999999999999999999999999999999999999976443333345567999999


Q ss_pred             ccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCC---C
Q psy18060        285 APELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL---S  361 (549)
Q Consensus       285 APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rp---s  361 (549)
                      |||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++++||.+||+.||.+||   +
T Consensus       161 aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~  240 (312)
T cd05585         161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNG  240 (312)
T ss_pred             CHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence            9999999999999999999999999999999999999888888888888889999999999999999999999997   5


Q ss_pred             HHHHhcCcccCcccch
Q psy18060        362 WPELLHHPLVKDNLSS  377 (549)
Q Consensus       362 ~~elL~Hpw~~~~~~~  377 (549)
                      +.|+++||||.+....
T Consensus       241 ~~e~l~hp~~~~~~~~  256 (312)
T cd05585         241 AQEIKNHPFFSQLSWK  256 (312)
T ss_pred             HHHHHcCCCcCCCCHH
Confidence            7999999999876443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0578|consensus

Probab=100.00  E-value=7.3e-49  Score=409.75  Aligned_cols=255  Identities=32%  Similarity=0.568  Sum_probs=231.7

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      -...|.....||+|+.|.||.+....+++.||||.+.......+  +.+.+|+.+|+..+|||||++++.|--.+.+|+|
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            34678888999999999999999999999999999987655443  5689999999999999999999999888999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||++ |+|.+.+... .++|.+++.|++++++||+|||.+||+|||||.+|||++.+|.+||+|||++..+........
T Consensus       349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence            99998 5788887654 599999999999999999999999999999999999999999999999999988877766778


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCccCCHHHHHHHHHhc
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD---VTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~dlI~~~L  352 (549)
                      +.+|||+|||||+.....|++++||||||++++||+-|++||-..++...+.+|.+..   +..|..+|+.+++|+.+||
T Consensus       428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL  507 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCL  507 (550)
T ss_pred             cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHh
Confidence            8899999999999999999999999999999999999999999888877777776543   3466789999999999999


Q ss_pred             hhCcCCCCCHHHHhcCcccCcc
Q psy18060        353 EKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       353 ~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      +.||.+|++|.|||+||||+..
T Consensus       508 ~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  508 VVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             hcchhcCCCHHHHhcChhhhhc
Confidence            9999999999999999999543

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.5e-47  Score=387.30  Aligned_cols=254  Identities=30%  Similarity=0.458  Sum_probs=217.0

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      .+++|++.+.||.|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            457899999999999999999999999999999998654322 2234567899999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..........
T Consensus        82 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~  161 (288)
T cd07871          82 FEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS  161 (288)
T ss_pred             EeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence            9999999999987654 579999999999999999999999999999999999999999999999999976544333344


Q ss_pred             ccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-------------------CC
Q psy18060        276 SIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-------------------VT  335 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-------------------~~  335 (549)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+....                   ..
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            5678999999999865 568999999999999999999999998877665554432110                   00


Q ss_pred             C-----------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        336 F-----------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       336 ~-----------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      +           .+.+++++++||.+||+.||.+|||++|+++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            1           12467899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-47  Score=398.62  Aligned_cols=262  Identities=29%  Similarity=0.459  Sum_probs=234.3

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCC-ceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLK-KTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~-~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      .....++|++.+.||+|+||.||+|.+..++ ..||+|.+.+... .......+.+|+.+++.++||||+++++++...+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            3345678999999999999999999876654 6899999875432 2334567789999999999999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      .+|+||||+. |+|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            9999999997 689999999889999999999999999999999999999999999999999999999999999876432


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~  350 (549)
                         ..+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+..+...+|..+++.++++|++
T Consensus       185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  261 (340)
T PTZ00426        185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKK  261 (340)
T ss_pred             ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence               24567999999999999988999999999999999999999999999988888888888888899999999999999


Q ss_pred             hchhCcCCCC-----CHHHHhcCcccCcccchh
Q psy18060        351 LLEKDASQRL-----SWPELLHHPLVKDNLSSE  378 (549)
Q Consensus       351 ~L~~dP~~Rp-----s~~elL~Hpw~~~~~~~~  378 (549)
                      ||+.||.+|+     |++++++||||.+..+..
T Consensus       262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~  294 (340)
T PTZ00426        262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS  294 (340)
T ss_pred             HcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence            9999999995     899999999998765443

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.1e-47  Score=395.73  Aligned_cols=255  Identities=30%  Similarity=0.507  Sum_probs=228.3

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-C
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-M  202 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-g  202 (549)
                      +.||+|+||.||++.+..+++.||+|++.+... .......+.+|+++++.++||||+++++++...+.+++||||+. |
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999975432 23345677889999999999999999999999999999999997 5


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCc
Q psy18060        203 SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL  282 (549)
Q Consensus       203 sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~  282 (549)
                      +|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++............+||+.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            89999988888999999999999999999999999999999999999999999999999998754333233345679999


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCC--
Q psy18060        283 YMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL--  360 (549)
Q Consensus       283 Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rp--  360 (549)
                      |+|||++.+..++.++|||||||++|+|++|+.||...+.......+......+|..+++++.+||.+||++||.+||  
T Consensus       161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  240 (328)
T cd05593         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGG  240 (328)
T ss_pred             ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence            999999999899999999999999999999999999988888888888888889999999999999999999999997  


Q ss_pred             ---CHHHHhcCcccCcccchhh
Q psy18060        361 ---SWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       361 ---s~~elL~Hpw~~~~~~~~~  379 (549)
                         ++.|+++||||.+......
T Consensus       241 ~~~~~~~il~h~~~~~~~~~~~  262 (328)
T cd05593         241 GPDDAKEIMRHSFFTGVNWQDV  262 (328)
T ss_pred             CCCCHHHHhcCCCcCCCCHHHH
Confidence               8999999999987654433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.6e-47  Score=393.12  Aligned_cols=254  Identities=29%  Similarity=0.491  Sum_probs=227.6

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-C
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-M  202 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-g  202 (549)
                      +.||+|+||.||++.+..+|+.||+|++.... ........+.+|+++++.++||||+++++++...+.+|+||||+. |
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997542 223345567789999999999999999999999999999999998 5


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCc
Q psy18060        203 SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL  282 (549)
Q Consensus       203 sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~  282 (549)
                      +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.............||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            89999988889999999999999999999999999999999999999999999999999998754333333345679999


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCC--
Q psy18060        283 YMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL--  360 (549)
Q Consensus       283 Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rp--  360 (549)
                      |+|||++.+..++.++|||||||++|+|++|+.||...+.......+......+|..+++++.++|.+||..||.+||  
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  240 (323)
T cd05595         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG  240 (323)
T ss_pred             cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCC
Confidence            999999999999999999999999999999999999998888888888888888999999999999999999999998  


Q ss_pred             ---CHHHHhcCcccCcccchh
Q psy18060        361 ---SWPELLHHPLVKDNLSSE  378 (549)
Q Consensus       361 ---s~~elL~Hpw~~~~~~~~  378 (549)
                         ++.++++||||....+..
T Consensus       241 ~~~~~~~~l~h~~~~~~~~~~  261 (323)
T cd05595         241 GPSDAKEVMEHRFFLSINWQD  261 (323)
T ss_pred             CCCCHHHHHcCCCcCCCCHHH
Confidence               899999999998765443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0032|consensus

Probab=100.00  E-value=7e-47  Score=396.30  Aligned_cols=259  Identities=34%  Similarity=0.575  Sum_probs=235.6

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh-HHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCC
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHLA-HPNIIKFIASHETLN  191 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~  191 (549)
                      .......|++.+.||+|.||.||+|+.+.||+.+|+|.+.+..... .....+.+|++||+++. |||||.++++|++.+
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            3445567999999999999999999999999999999998765432 24568899999999998 999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC----CcEEEeeccccee
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD----GVAMLCDFGFARS  266 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~----g~vKL~DFGla~~  266 (549)
                      .+++|||+|. |.|.+.|... .++|..+..++.|++.|++|||+.||+||||||+|+|+...    +.+|++|||+|..
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            9999999998 5899999877 59999999999999999999999999999999999999643    4799999999998


Q ss_pred             cccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCH
Q psy18060        267 MAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSE  342 (549)
Q Consensus       267 ~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~  342 (549)
                      ... .......+||+.|+|||++...+|+..+||||+||++|.|++|.+||.+.+.......+..+.+.++    +.++.
T Consensus       189 ~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  189 IKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             ccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            876 4566788999999999999999999999999999999999999999999999998889998877665    46799


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+++||++||..||.+|+|+.++|+|||++..
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            99999999999999999999999999998754

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.4e-47  Score=382.49  Aligned_cols=261  Identities=26%  Similarity=0.410  Sum_probs=224.2

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+.+.... ......+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            378899999999999999999999999999998754322 2233457789999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        199 FAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       199 ~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |+. |+|..++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  159 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVR  159 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-eec
Confidence            997 5898887643  468999999999999999999999999999999999999999999999999998754332 234


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCCCCccCCHHHHHHHHHh
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI----LHLIRLLKTQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.....    ......+......++..+++++.+||.+|
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  239 (285)
T cd05631         160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML  239 (285)
T ss_pred             CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence            55799999999999999999999999999999999999999987543    23334444555667788999999999999


Q ss_pred             chhCcCCCCC-----HHHHhcCcccCcccchhhhh
Q psy18060        352 LEKDASQRLS-----WPELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       352 L~~dP~~Rps-----~~elL~Hpw~~~~~~~~~~~  381 (549)
                      |+.||.+||+     ++++++||||.+.....+..
T Consensus       240 l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~  274 (285)
T cd05631         240 LTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEA  274 (285)
T ss_pred             hhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHh
Confidence            9999999997     89999999999876655543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5e-47  Score=392.52  Aligned_cols=257  Identities=30%  Similarity=0.473  Sum_probs=214.5

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-----CEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-----NEFV  194 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~  194 (549)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            58999999999999999999999999999999875433333445678999999999999999999887433     3589


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc---
Q psy18060        195 LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT---  271 (549)
Q Consensus       195 iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~---  271 (549)
                      +||||++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......   
T Consensus        81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  160 (338)
T cd07859          81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA  160 (338)
T ss_pred             EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence            99999999999999988899999999999999999999999999999999999999999999999999997643221   


Q ss_pred             ccccccCCCCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Q psy18060        272 HMLTSIKGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT------------------  331 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~------------------  331 (549)
                      .......||+.|+|||++.+  ..++.++|||||||++|+|++|++||.+.+.......+..                  
T Consensus       161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  240 (338)
T cd07859         161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA  240 (338)
T ss_pred             ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence            12244579999999999865  6789999999999999999999999987654433221110                  


Q ss_pred             ---------C-CCCC---CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        332 ---------Q-DVTF---PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       332 ---------~-~~~~---p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                               . ...+   .+.+++.+.++|.+||+.||.+|||+.|+++||||++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                     0 0000   0246788999999999999999999999999999976433

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.2e-46  Score=388.98  Aligned_cols=260  Identities=27%  Similarity=0.500  Sum_probs=230.8

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCC-CeeEEEEEEeeCCEEEEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP-NIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~iV~  197 (549)
                      +|++++.||+|+||.||+|.+..+++.||+|++.+... .......+..|..++..+.|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            48899999999999999999999999999999975422 223456678899999999765 5888999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||+. |+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...........
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            9997 589999998889999999999999999999999999999999999999999999999999998754333333445


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCc
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+++.+||.+||
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (324)
T cd05587         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP  240 (324)
T ss_pred             ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            67999999999999999999999999999999999999999999988888888888888899999999999999999999


Q ss_pred             CCCCCH-----HHHhcCcccCcccchhh
Q psy18060        357 SQRLSW-----PELLHHPLVKDNLSSEI  379 (549)
Q Consensus       357 ~~Rps~-----~elL~Hpw~~~~~~~~~  379 (549)
                      .+|+++     +++++||||........
T Consensus       241 ~~R~~~~~~~~~~~~~hp~~~~~~~~~~  268 (324)
T cd05587         241 AKRLGCGPTGERDIREHAFFRRIDWEKL  268 (324)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence            999986     89999999987655443

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.8e-47  Score=386.20  Aligned_cols=257  Identities=28%  Similarity=0.426  Sum_probs=214.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            357899999999999999999999999999999998754322 2223567899999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||++++|.+++..+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..........
T Consensus        82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          82 FEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             EECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence            999999999888764 5689999999999999999999999999999999999999999999999999976543333345


Q ss_pred             ccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhc---CC-----------------
Q psy18060        276 SIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSI-LHLIRLLKT---QD-----------------  333 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~-~~~~~~i~~---~~-----------------  333 (549)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...+..+..   .+                 
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE  241 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence            5678999999999865 4588999999999999999999999987532 222222210   00                 


Q ss_pred             -C--CCCc---------cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        334 -V--TFPS---------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       334 -~--~~p~---------~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                       .  ..|.         ..++.+++||.+||+.||.+|||+.|+++||||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence             0  0010         245788999999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.9e-47  Score=390.21  Aligned_cols=261  Identities=25%  Similarity=0.469  Sum_probs=231.2

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++.+... ..........|..++..+ .||+|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            48899999999999999999999999999999976432 222344566777887776 6899999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||++ |+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            9997 689999988889999999999999999999999999999999999999999999999999999765433333456


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCc
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+++.+||++||
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  240 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP  240 (323)
T ss_pred             CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCH
Confidence            68999999999999999999999999999999999999999999998888888888888999999999999999999999


Q ss_pred             CCCCCH-----HHHhcCcccCcccchhhh
Q psy18060        357 SQRLSW-----PELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       357 ~~Rps~-----~elL~Hpw~~~~~~~~~~  380 (549)
                      .+|+++     .++++||||+...+....
T Consensus       241 ~~R~~~~~~~~~~i~~h~~~~~~~~~~~~  269 (323)
T cd05616         241 GKRLGCGPEGERDIKEHAFFRYIDWEKLE  269 (323)
T ss_pred             HhcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            999984     899999999876554443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.1e-47  Score=391.42  Aligned_cols=255  Identities=27%  Similarity=0.494  Sum_probs=227.2

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.++.+++.||+|++.+... .......+..|..++..+ +||||+++++++...+.+|+||||++ 
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999875321 223345667788888776 69999999999999999999999998 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      |+|..++.+...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.............||+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            58999999888999999999999999999999999999999999999999999999999999876443333345567999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCC
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS  361 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps  361 (549)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.++|.+||+.||.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~  240 (320)
T cd05590         161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLG  240 (320)
T ss_pred             cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence            99999999999999999999999999999999999999999998998988888888899999999999999999999999


Q ss_pred             H------HHHhcCcccCcccchhh
Q psy18060        362 W------PELLHHPLVKDNLSSEI  379 (549)
Q Consensus       362 ~------~elL~Hpw~~~~~~~~~  379 (549)
                      +      +++++||||....+...
T Consensus       241 ~~~~~~~~~~~~h~~f~~~~~~~~  264 (320)
T cd05590         241 SLTLGGEEAILRHPFFKELDWEKL  264 (320)
T ss_pred             CCCCCCHHHHHcCCCcCCCCHHHH
Confidence            8      99999999987655443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.3e-47  Score=382.86  Aligned_cols=253  Identities=29%  Similarity=0.532  Sum_probs=215.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36999999999999999999999999999999997654444445677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-cccc
Q psy18060        199 FAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-MLTS  276 (549)
Q Consensus       199 ~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~  276 (549)
                      |+.+++.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE  160 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence            999766555544 45799999999999999999999999999999999999999999999999999987643221 2234


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-------------------CCC-
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-------------------VTF-  336 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-------------------~~~-  336 (549)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+....                   ..+ 
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (287)
T cd07848         161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP  240 (287)
T ss_pred             cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccC
Confidence            579999999999998889999999999999999999999998876544333222110                   001 


Q ss_pred             ------------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        337 ------------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       337 ------------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                  +..+|+++.+||.+||++||.+|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                        12368889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.2e-46  Score=395.37  Aligned_cols=260  Identities=27%  Similarity=0.443  Sum_probs=224.4

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+... .......+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            468999999999999999999999999999999975432 2233467788999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-----
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-----  271 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-----  271 (549)
                      ||+. |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++......     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            9997 5899999988899999999999999999999999999999999999999999999999999987543210     


Q ss_pred             ------------------------------ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q psy18060        272 ------------------------------HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS  321 (549)
Q Consensus       272 ------------------------------~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~  321 (549)
                                                    ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                                          01124579999999999999999999999999999999999999999988


Q ss_pred             HHHHHHHHhcC--CCCCCc--cCCHHHHHHHHHhchhCcC---CCCCHHHHhcCcccCcccchhh
Q psy18060        322 ILHLIRLLKTQ--DVTFPS--QVSETYKDLVKGLLEKDAS---QRLSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       322 ~~~~~~~i~~~--~~~~p~--~~s~~~~dlI~~~L~~dP~---~Rps~~elL~Hpw~~~~~~~~~  379 (549)
                      .......+...  ...+|+  .++++++++|.+|+. +|.   .||+++||++||||++..+..+
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~  304 (363)
T cd05628         241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHI  304 (363)
T ss_pred             HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHH
Confidence            88888777653  344554  478999999999765 444   5689999999999998765554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.4e-47  Score=389.14  Aligned_cols=254  Identities=25%  Similarity=0.454  Sum_probs=224.1

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+|+.||+|.+.+... ..........|..++..+ +||||+++++++...+.+|+||||+. 
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999975321 122344566777777654 89999999999999999999999998 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      |+|..++.....+++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.........+..+||+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            58999998888999999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCC
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS  361 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps  361 (549)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...+.....+.+......+|..++++++++|.+||+.||.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~  240 (316)
T cd05620         161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLG  240 (316)
T ss_pred             CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999999999999999999999999999999999988888888887777888889999999999999999999999


Q ss_pred             H-HHHhcCcccCcccchh
Q psy18060        362 W-PELLHHPLVKDNLSSE  378 (549)
Q Consensus       362 ~-~elL~Hpw~~~~~~~~  378 (549)
                      + +++++||||.......
T Consensus       241 ~~~~~~~h~~f~~~~~~~  258 (316)
T cd05620         241 VVGNIRGHPFFKTINWTA  258 (316)
T ss_pred             ChHHHHcCCCcCCCCHHH
Confidence            8 5899999998765443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0611|consensus

Probab=100.00  E-value=5.4e-48  Score=386.56  Aligned_cols=256  Identities=29%  Similarity=0.507  Sum_probs=236.6

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ..-.+|++.+.||+|.||+|-+|.....|+.||||.+.+... +....-.+++|++||+.|+||||+++|++|++.+.+.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            345779999999999999999999999999999999988764 4455678899999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      |||||.. |.|.+++..++.++|.+++.+++||+.|+.|||+++++|||||.+|||+|+++.+||+|||++..+... ..
T Consensus       130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kf  208 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KF  208 (668)
T ss_pred             EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cH
Confidence            9999987 689999999999999999999999999999999999999999999999999999999999999877654 56


Q ss_pred             ccccCCCCcccccccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhc
Q psy18060        274 LTSIKGTPLYMAPELIAERPYD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~-~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L  352 (549)
                      .+++||+|.|.+||++.+.+|. +.+|-|||||+||-|..|.+||.+.+...+++.|..+.+.-|.. |..+.-||+.||
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmL  287 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWML  287 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHH
Confidence            7899999999999999999985 67999999999999999999999999999999999988765544 667889999999


Q ss_pred             hhCcCCCCCHHHHhcCcccCc
Q psy18060        353 EKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       353 ~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      .+||.+|.|+++|..|=|+.=
T Consensus       288 mVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  288 MVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             hcCcccchhHHHHhhhheeec
Confidence            999999999999999999863

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.3e-47  Score=392.53  Aligned_cols=253  Identities=30%  Similarity=0.502  Sum_probs=226.9

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-C
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-M  202 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-g  202 (549)
                      +.||+|+||.||++.+..+++.||+|++.+... .......+.+|+++++.++||||+++++++...+.+|+||||+. |
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999975432 22344567789999999999999999999999999999999998 5


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        203 SLSNLLEQRKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       203 sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      +|..++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+++.............||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            899999888899999999999999999999997 7999999999999999999999999999876433333344567999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCC-
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL-  360 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rp-  360 (549)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||.+||++||.+|+ 
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  240 (325)
T cd05594         161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLG  240 (325)
T ss_pred             ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCC
Confidence            9999999999999999999999999999999999999998888888888888889999999999999999999999997 


Q ss_pred             ----CHHHHhcCcccCcccch
Q psy18060        361 ----SWPELLHHPLVKDNLSS  377 (549)
Q Consensus       361 ----s~~elL~Hpw~~~~~~~  377 (549)
                          ++.++++||||.+....
T Consensus       241 ~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         241 GGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             CCCCCHHHHhcCCCcCCCCHH
Confidence                89999999999876544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-46  Score=389.10  Aligned_cols=255  Identities=27%  Similarity=0.462  Sum_probs=227.5

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+++.||+|++.+... .......+..|.+++..+ +||||+++++++...+.+|+||||++ 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            369999999999999999999999999975421 223345667788888866 79999999999999999999999998 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      ++|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            58999999888999999999999999999999999999999999999999999999999999876543333345567999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCC-
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL-  360 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rp-  360 (549)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...+.......+......+|..+++++.++|.+||++||.+|| 
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~  240 (321)
T cd05591         161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLG  240 (321)
T ss_pred             cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence            9999999999999999999999999999999999999999999999998888888888999999999999999999999 


Q ss_pred             ------CHHHHhcCcccCcccchhh
Q psy18060        361 ------SWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       361 ------s~~elL~Hpw~~~~~~~~~  379 (549)
                            +++++++||||....+...
T Consensus       241 ~~~~~~~~~~~~~hp~~~~~~~~~~  265 (321)
T cd05591         241 CVASQGGEDAIKQHPFFKEIDWVLL  265 (321)
T ss_pred             CCCCCCCHHHHhcCCccCCCCHHHH
Confidence                  8999999999987655444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.6e-46  Score=388.20  Aligned_cols=256  Identities=26%  Similarity=0.462  Sum_probs=225.2

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHH---HhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQ---KHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      |++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|++++   +.++||||+++++++...+.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            6789999999999999999999999999999975431 223345666776665   456799999999999999999999


Q ss_pred             EecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||+.| +|...+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..........
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence            999984 78877754 5799999999999999999999999999999999999999999999999999875433333345


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhC
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD  355 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~d  355 (549)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++.+.++|.+||+.|
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d  239 (324)
T cd05589         160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRN  239 (324)
T ss_pred             ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            56899999999999999999999999999999999999999999998888888888888889999999999999999999


Q ss_pred             cCCCC-----CHHHHhcCcccCcccch
Q psy18060        356 ASQRL-----SWPELLHHPLVKDNLSS  377 (549)
Q Consensus       356 P~~Rp-----s~~elL~Hpw~~~~~~~  377 (549)
                      |.+||     ++.++++||||++....
T Consensus       240 P~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         240 PERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             HhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence            99999     69999999999876443

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-46  Score=388.21  Aligned_cols=253  Identities=25%  Similarity=0.474  Sum_probs=226.3

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|..+++.+ +||||+++++++...+.+|+||||+. 
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997643 1223445667888888887 79999999999999999999999997 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      |+|...+.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            58999998888999999999999999999999999999999999999999999999999999875433333334567999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCC
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS  361 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps  361 (549)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++.+.+||.+||..||.+|||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s  240 (318)
T cd05570         161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLG  240 (318)
T ss_pred             cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999999999999999999999999999999999998888888888888888899999999999999999999999


Q ss_pred             H-----HHHhcCcccCcccch
Q psy18060        362 W-----PELLHHPLVKDNLSS  377 (549)
Q Consensus       362 ~-----~elL~Hpw~~~~~~~  377 (549)
                      +     .++++||||+...+.
T Consensus       241 ~~~~~~~~ll~~~~~~~~~~~  261 (318)
T cd05570         241 CLPTGEQDIKGHPFFREIDWD  261 (318)
T ss_pred             CCCCCHHHHhcCCCcCCCCHH
Confidence            9     999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-46  Score=387.69  Aligned_cols=255  Identities=26%  Similarity=0.469  Sum_probs=223.0

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHh-cCCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKH-LAHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+++.||+|++.+... ..........|..++.. .+||||+++++++...+.+|+||||++ 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            369999999999999999999999999975421 12233445566666665 489999999999999999999999997 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      |+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            58999999888999999999999999999999999999999999999999999999999999976543333445568999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCC
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS  361 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps  361 (549)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..++.++.++|.+||..||.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~  240 (316)
T cd05592         161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLG  240 (316)
T ss_pred             cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999998999999999999999999999999999998888888887777788899999999999999999999998


Q ss_pred             H-HHHhcCcccCcccchhh
Q psy18060        362 W-PELLHHPLVKDNLSSEI  379 (549)
Q Consensus       362 ~-~elL~Hpw~~~~~~~~~  379 (549)
                      + .++++||||........
T Consensus       241 ~~~~l~~h~~~~~~~~~~~  259 (316)
T cd05592         241 VDGDIRQHPFFRGIDWERL  259 (316)
T ss_pred             ChHHHHcCcccCCCCHHHH
Confidence            6 58999999987654433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-46  Score=387.25  Aligned_cols=256  Identities=30%  Similarity=0.493  Sum_probs=226.9

Q ss_pred             EEEEecCCcEEEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        124 ICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGR--SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       124 ~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++.||+|+||.||++...   .+++.||+|++.+...  .......+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            367999999999999864   4688999999975421  22334567889999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      |+. ++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++............
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            998 5899999988899999999999999999999999999999999999999999999999999987654333334556


Q ss_pred             CCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcC
Q psy18060        278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDAS  357 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~  357 (549)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..+...+|+.+++.+.+||.+||++||.
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  240 (323)
T cd05584         161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS  240 (323)
T ss_pred             CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHh
Confidence            79999999999998889999999999999999999999999999888888888888888999999999999999999999


Q ss_pred             CCC-----CHHHHhcCcccCcccchhh
Q psy18060        358 QRL-----SWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       358 ~Rp-----s~~elL~Hpw~~~~~~~~~  379 (549)
                      +||     +++++++||||........
T Consensus       241 ~R~~~~~~~~~~l~~h~~~~~~~~~~~  267 (323)
T cd05584         241 SRLGAGPGDAAEVQSHPFFRHVNWDDL  267 (323)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence            999     8999999999987544333

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0610|consensus

Probab=100.00  E-value=4.8e-47  Score=382.51  Aligned_cols=265  Identities=32%  Similarity=0.462  Sum_probs=238.4

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .-.+++|++++.||+|.-|+||+|..+.++..+|+|++.+... ..+.......|..||+.++||.++.+|+.|+..+..
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            3456789999999999999999999999999999999988663 355567788899999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceeccc-
Q psy18060        194 VLITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV-  269 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~-  269 (549)
                      +++||||. |+|..+++++  +.|++..++.++.+++.||+|||-.|||.|||||+||||.++|+|-|.||-++..... 
T Consensus       153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999998 5899988775  4699999999999999999999999999999999999999999999999988742210 


Q ss_pred             --------------------------------C-c----------------------ccccccCCCCcccccccccCCCC
Q psy18060        270 --------------------------------G-T----------------------HMLTSIKGTPLYMAPELIAERPY  294 (549)
Q Consensus       270 --------------------------------~-~----------------------~~~~~~~GT~~Y~APE~l~~~~y  294 (549)
                                                      . .                      ....+++||-.|.|||++.+..+
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                      11235689999999999999999


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHhchhCcCCCCC----HHHHhcC
Q psy18060        295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS--QVSETYKDLVKGLLEKDASQRLS----WPELLHH  368 (549)
Q Consensus       295 ~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dlI~~~L~~dP~~Rps----~~elL~H  368 (549)
                      +.++|+|+|||++|||+.|..||.+.+..+++.+|..+++.+|.  .++..++|||+++|.+||.+|+.    |+||.+|
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence            99999999999999999999999999999999999999999884  57899999999999999999998    9999999


Q ss_pred             cccCcccchhh
Q psy18060        369 PLVKDNLSSEI  379 (549)
Q Consensus       369 pw~~~~~~~~~  379 (549)
                      |||++..+.-+
T Consensus       393 pFF~gVnWaLi  403 (459)
T KOG0610|consen  393 PFFEGVNWALI  403 (459)
T ss_pred             ccccCCChhhe
Confidence            99999887744

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-46  Score=393.18  Aligned_cols=258  Identities=30%  Similarity=0.480  Sum_probs=224.3

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            469999999999999999999999999999999975432 2234456788999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc----
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH----  272 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~----  272 (549)
                      ||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+.....    
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            9997 58999999888999999999999999999999999999999999999999999999999999875432110    


Q ss_pred             ----------------------------------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q psy18060        273 ----------------------------------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFK  318 (549)
Q Consensus       273 ----------------------------------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~  318 (549)
                                                        ...+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence                                              0113469999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHhcCC--CCCCc--cCCHHHHHHHHHhchhCcCCCCC---HHHHhcCcccCcccch
Q psy18060        319 TVSILHLIRLLKTQD--VTFPS--QVSETYKDLVKGLLEKDASQRLS---WPELLHHPLVKDNLSS  377 (549)
Q Consensus       319 ~~~~~~~~~~i~~~~--~~~p~--~~s~~~~dlI~~~L~~dP~~Rps---~~elL~Hpw~~~~~~~  377 (549)
                      ..+.......+....  ..+|.  .+++++++||.+||. +|.+|++   +.|+++||||+.....
T Consensus       241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            988887777765433  23343  479999999999996 9999998   9999999999876543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0201|consensus

Probab=100.00  E-value=1.2e-48  Score=396.68  Aligned_cols=256  Identities=34%  Similarity=0.556  Sum_probs=232.4

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ..|..++.||+|+||.||+|.+..+++.||+|++.... ...+...+.+|+.++.++++|||.++|+++-.+..++|+||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            34777899999999999999999999999999997643 34456788999999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      ||+ |++.+.++..+.+.|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+........++
T Consensus        92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence            998 5899999988888999999999999999999999999999999999999999999999999998887665556788


Q ss_pred             CCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHhchhCc
Q psy18060        278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      +|||+|||||++.+..|+.|+||||||++++||++|.+|+....++..+..|.... +.+...+|+.+++||..||.+||
T Consensus       172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P  251 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNP  251 (467)
T ss_pred             cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCc
Confidence            99999999999999999999999999999999999999999988877766665443 33445799999999999999999


Q ss_pred             CCCCCHHHHhcCcccCccc
Q psy18060        357 SQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       357 ~~Rps~~elL~Hpw~~~~~  375 (549)
                      +.||||.++|+|+|++...
T Consensus       252 ~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  252 EFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             ccCcCHHHHhhhHHHHhcC
Confidence            9999999999999998743

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-46  Score=392.20  Aligned_cols=259  Identities=31%  Similarity=0.526  Sum_probs=228.1

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.++..++||||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            4699999999999999999999999999999999764322 234567889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-----
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-----  271 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-----  271 (549)
                      ||+. ++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            9997 5899999988899999999999999999999999999999999999999999999999999997654332     


Q ss_pred             ------------------------ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy18060        272 ------------------------HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIR  327 (549)
Q Consensus       272 ------------------------~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~  327 (549)
                                              .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  240 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN  240 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence                                    12334579999999999999999999999999999999999999999988877777


Q ss_pred             HHhc--CCCCCCc--cCCHHHHHHHHHhchhCcCCCCC-HHHHhcCcccCcccchh
Q psy18060        328 LLKT--QDVTFPS--QVSETYKDLVKGLLEKDASQRLS-WPELLHHPLVKDNLSSE  378 (549)
Q Consensus       328 ~i~~--~~~~~p~--~~s~~~~dlI~~~L~~dP~~Rps-~~elL~Hpw~~~~~~~~  378 (549)
                      .+..  ....+|.  .+++++.+||.+||. ||.+||+ +.++++||||++.....
T Consensus       241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~  295 (350)
T cd05573         241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWEN  295 (350)
T ss_pred             HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHH
Confidence            7766  3444554  359999999999997 9999999 99999999998765443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0192|consensus

Probab=100.00  E-value=2.5e-46  Score=389.10  Aligned_cols=247  Identities=28%  Similarity=0.525  Sum_probs=218.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCce-EEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-EEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKT-VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-EFVLI  196 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~-vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~iV  196 (549)
                      ....+.+.||+|+||+||+|.++  |+. ||+|++..........+.+.+|+.++.+++|||||++++++.... .+.||
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence            34455666999999999999988  566 999999877666555789999999999999999999999998877 79999


Q ss_pred             EecCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccccCCcEEEecCC-cEEEeecccceecccCc
Q psy18060        197 TEFAH-MSLSNLLEQ--RKKLSETICVQILSNLISALYYLHSNR-VLHRDLKPQNVLLNKDG-VAMLCDFGFARSMAVGT  271 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g-IiHrDIKP~NILl~~~g-~vKL~DFGla~~~~~~~  271 (549)
                      |||+. |+|.+++..  .+.++...+..|+.||+.|++|||+++ ||||||||+|||++.++ ++||||||+++......
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            99998 799999988  678999999999999999999999999 99999999999999998 99999999998776543


Q ss_pred             ccccccCCCCccccccccc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCccCCHHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIA--ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLK--TQDVTFPSQVSETYKDL  347 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~--~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dl  347 (549)
                      ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.+....+....+.  ...+.+|..+++.+..+
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l  278 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSL  278 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence            3445578999999999999  6699999999999999999999999999998866666654  33456677899999999


Q ss_pred             HHHhchhCcCCCCCHHHHhc
Q psy18060        348 VKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~  367 (549)
                      |.+||..||..||++.+++.
T Consensus       279 ~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  279 MERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHhCCCCCCcCCCHHHHHH
Confidence            99999999999999998864

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.6e-46  Score=386.37  Aligned_cols=255  Identities=30%  Similarity=0.519  Sum_probs=223.5

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHH-HHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECE-IQKHLAHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|.. +++.++||||+++++.+...+.+|+||||+. 
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            469999999999999999999999999975432 1222334444444 5678999999999999999999999999998 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++............+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            58999999888999999999999999999999999999999999999999999999999999875433333345567999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCC
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS  361 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps  361 (549)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+++.+++.+.++|.+||+.||.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (323)
T cd05575         161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLG  240 (323)
T ss_pred             hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCC
Confidence            99999999999999999999999999999999999999998888888888888888889999999999999999999999


Q ss_pred             H----HHHhcCcccCcccchhh
Q psy18060        362 W----PELLHHPLVKDNLSSEI  379 (549)
Q Consensus       362 ~----~elL~Hpw~~~~~~~~~  379 (549)
                      +    .++++||||.......+
T Consensus       241 ~~~~~~~il~~~~~~~~~~~~~  262 (323)
T cd05575         241 AKDDFLEIKNHVFFSSINWDDL  262 (323)
T ss_pred             CCCCHHHHHcCCCcCCCCHHHH
Confidence            7    69999999987654443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.5e-46  Score=393.51  Aligned_cols=256  Identities=27%  Similarity=0.455  Sum_probs=220.7

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            58999999999999999999999999999999875432 23345678899999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC-------
Q psy18060        199 FAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG-------  270 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~-------  270 (549)
                      |++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....       
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~  161 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  161 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence            997 589999988888999999999999999999999999999999999999999999999999997532100       


Q ss_pred             ----------------------------------------cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHH
Q psy18060        271 ----------------------------------------THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEI  310 (549)
Q Consensus       271 ----------------------------------------~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eL  310 (549)
                                                              .....+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el  241 (382)
T cd05625         162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  241 (382)
T ss_pred             cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence                                                    0001235799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHhcC--CCCCC--ccCCHHHHHHHHHhchhCcCCCCC---HHHHhcCcccCcccc
Q psy18060        311 HMGHPPFKTVSILHLIRLLKTQ--DVTFP--SQVSETYKDLVKGLLEKDASQRLS---WPELLHHPLVKDNLS  376 (549)
Q Consensus       311 ltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~dlI~~~L~~dP~~Rps---~~elL~Hpw~~~~~~  376 (549)
                      ++|++||.+.+.......+...  ...+|  ..+++++.++|.+|+ .+|.+|++   +.++++||||+....
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            9999999988877766666542  23333  468999999999986 59999997   999999999987544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-46  Score=386.68  Aligned_cols=257  Identities=30%  Similarity=0.465  Sum_probs=225.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.++..++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            369999999999999999999999999999999975432 1234467889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....   ....
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~  157 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANS  157 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCC
Confidence            9997 58999999888999999999999999999999999999999999999999999999999999976543   3355


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCC------ccCCHHHHHHH
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFP------SQVSETYKDLV  348 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~p------~~~s~~~~dlI  348 (549)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ...|      ..+++++.+||
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li  237 (333)
T cd05600         158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI  237 (333)
T ss_pred             cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence            679999999999999999999999999999999999999999988877766665422  1122      14689999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCcccchh
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKDNLSSE  378 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~~~~~~  378 (549)
                      .+||..+|.+||++.++++||||.+.....
T Consensus       238 ~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~  267 (333)
T cd05600         238 TKLINDPSRRFGSLEDIKNHPFFKEVDWNE  267 (333)
T ss_pred             HHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence            999999999999999999999998754433

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0594|consensus

Probab=100.00  E-value=8.3e-47  Score=377.29  Aligned_cols=258  Identities=31%  Similarity=0.487  Sum_probs=225.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCC-eeEEEEEEeeCC-----
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN-IIKFIASHETLN-----  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~-----  191 (549)
                      +..|..+++||+|+||+||+|+.+.+|+.||+|.+......+.......+|+.+++.++|+| ||++++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            56788888999999999999999999999999999866543233456689999999999999 999999998777     


Q ss_pred             -EEEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        192 -EFVLITEFAHMSLSNLLEQRK----KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       192 -~~~iV~E~~~gsL~~~l~~~~----~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                       .+++|+||++.+|..+++...    .++...++.+++||+.||+|||++||+||||||+||||+++|.+||+|||+|+.
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence             899999999999999998865    588889999999999999999999999999999999999999999999999998


Q ss_pred             cccCcccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------
Q psy18060        267 MAVGTHMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-------------  332 (549)
Q Consensus       267 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-------------  332 (549)
                      ...+....+..++|.+|+|||++.+. .|+..+||||+|||++||+++++.|++.+..+++..|..-             
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~  249 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS  249 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence            87666667888999999999999875 7999999999999999999999999999887777666321             


Q ss_pred             -----CCCCC------------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        333 -----DVTFP------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       333 -----~~~~p------------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                           ...+|            +..++...+++.+||+.+|.+|.|+..+|.||||.+..
T Consensus       250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence                 00111            11335888999999999999999999999999998653

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.3e-46  Score=386.01  Aligned_cols=253  Identities=26%  Similarity=0.474  Sum_probs=220.2

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+++.||+|++.+... .......+..|..++..+ +||||+++++++...+.+|+||||++ 
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            469999999999999999999999999976432 233456678899999888 79999999999999999999999997 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            58999998888999999999999999999999999999999999999999999999999999875332223345568999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhcCCCCCCccCCHHHHHHHHHhc
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV---------SILHLIRLLKTQDVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L  352 (549)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...         ......+.+......+|..+++++.++|.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  240 (329)
T cd05588         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFL  240 (329)
T ss_pred             cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            999999999999999999999999999999999999632         12234555667777888899999999999999


Q ss_pred             hhCcCCCCC------HHHHhcCcccCcccch
Q psy18060        353 EKDASQRLS------WPELLHHPLVKDNLSS  377 (549)
Q Consensus       353 ~~dP~~Rps------~~elL~Hpw~~~~~~~  377 (549)
                      ..||.+|||      ++++++||||......
T Consensus       241 ~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~  271 (329)
T cd05588         241 NKDPKERLGCHPQTGFRDIKSHPFFRNIDWD  271 (329)
T ss_pred             ccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence            999999997      7899999999765443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7e-46  Score=392.17  Aligned_cols=258  Identities=25%  Similarity=0.433  Sum_probs=220.4

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .|++++.||+|+||+||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            58999999999999999999999999999999976432 33445678899999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc------
Q psy18060        199 FAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT------  271 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~------  271 (549)
                      |++ |+|.+++.+...+++..++.++.||+.||+|||+.||+||||||+|||++.+|.+||+|||+++......      
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~  161 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ  161 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence            997 5899999988899999999999999999999999999999999999999999999999999975321000      


Q ss_pred             -----------------------------------------ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHH
Q psy18060        272 -----------------------------------------HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEI  310 (549)
Q Consensus       272 -----------------------------------------~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eL  310 (549)
                                                               ....+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el  241 (381)
T cd05626         162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM  241 (381)
T ss_pred             ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence                                                     001245799999999999998999999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHHhc--hhCcCCCCCHHHHhcCcccCcccch
Q psy18060        311 HMGHPPFKTVSILHLIRLLKT--QDVTFPS--QVSETYKDLVKGLL--EKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       311 ltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dlI~~~L--~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                      ++|+.||...+.......+..  ....+|.  .+++++.+||.+|+  ..+|..|+++.++++||||.+....
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~  314 (381)
T cd05626         242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS  314 (381)
T ss_pred             HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence            999999998877666555543  2233443  58999999999965  4555569999999999999876543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.1e-46  Score=382.88  Aligned_cols=255  Identities=25%  Similarity=0.470  Sum_probs=223.5

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHh-cCCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKH-LAHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+++.||+|++..... ..........|..++.. ++||||+++++++.+.+.+++||||+. 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999975421 11223455667777776 489999999999999999999999997 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      |+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.............||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            68999999888899999999999999999999999999999999999999999999999999875433333344567999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCC
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS  361 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps  361 (549)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..++.+++++|.+||++||.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~  240 (316)
T cd05619         161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLG  240 (316)
T ss_pred             cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCC
Confidence            99999999999999999999999999999999999999988888888877777788889999999999999999999999


Q ss_pred             HH-HHhcCcccCcccchhh
Q psy18060        362 WP-ELLHHPLVKDNLSSEI  379 (549)
Q Consensus       362 ~~-elL~Hpw~~~~~~~~~  379 (549)
                      +. ++++||||........
T Consensus       241 ~~~~l~~h~~~~~~~~~~~  259 (316)
T cd05619         241 VKGDIRQHPFFREIDWSAL  259 (316)
T ss_pred             ChHHHHcCcccCCCCHHHH
Confidence            96 8999999988655444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0599|consensus

Probab=100.00  E-value=1.9e-47  Score=366.59  Aligned_cols=257  Identities=31%  Similarity=0.510  Sum_probs=232.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC------ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR------SGKELSSLKQECEIQKHL-AHPNIIKFIASHET  189 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  189 (549)
                      ...+|.--++||.|..+.|-+|.++.+++.+|+|++.....      .....++-.+|+.||+++ .||+|+++.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            34567778899999999999999999999999999865431      122245567899999998 69999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                      +..+++|+|+|+ |.|+++|.....++|...+.|++|++.|+.|||.++||||||||+|||++++-.+||+|||+|+.+.
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence            999999999998 8899999999999999999999999999999999999999999999999999999999999999988


Q ss_pred             cCcccccccCCCCccccccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----c
Q psy18060        269 VGTHMLTSIKGTPLYMAPELIA------ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----S  338 (549)
Q Consensus       269 ~~~~~~~~~~GT~~Y~APE~l~------~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  338 (549)
                      ++ ......||||+|.|||.+.      ...|+..+|+||+|||+|-|+.|.+||......-.++.|..+.+.|.    .
T Consensus       175 ~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa  253 (411)
T KOG0599|consen  175 PG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA  253 (411)
T ss_pred             Cc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence            77 4568889999999999984      35688999999999999999999999999999999999999988775    3


Q ss_pred             cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       339 ~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ++|...+|||.+||+.||.+|+|++|+|.||||...
T Consensus       254 dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  254 DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            689999999999999999999999999999999654

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.1e-45  Score=381.91  Aligned_cols=261  Identities=26%  Similarity=0.484  Sum_probs=230.1

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCEEEEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +|+..+.||+|+||.||+|.+..+++.||+|++.+... .......+..|..++..+. ||+|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47889999999999999999999999999999975421 2233456777888888885 577888999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||++ |+|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            9997 589999998889999999999999999999999999999999999999999999999999998764433333345


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCc
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+++.+||+++|
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p  240 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP  240 (323)
T ss_pred             ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCH
Confidence            67999999999999989999999999999999999999999999988888888888888899999999999999999999


Q ss_pred             CCCCC-----HHHHhcCcccCcccchhhh
Q psy18060        357 SQRLS-----WPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       357 ~~Rps-----~~elL~Hpw~~~~~~~~~~  380 (549)
                      .+|++     .+++++||||....+....
T Consensus       241 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~  269 (323)
T cd05615         241 SKRLGCGPEGERDIREHAFFRRIDWDKLE  269 (323)
T ss_pred             hhCCCCCCCCHHHHhcCcccCCCCHHHHh
Confidence            99997     4799999999876554443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG4717|consensus

Probab=100.00  E-value=6.6e-47  Score=387.77  Aligned_cols=256  Identities=31%  Similarity=0.509  Sum_probs=239.4

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .-|.+.+.||+|.|++|-+|++.-||..||||++.+...+.-....+.+|++.|+.++|||||++|++......+|+|+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            44888899999999999999999999999999999988877777889999999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe-cCCcEEEeecccceecccCccccc
Q psy18060        199 FAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN-KDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       199 ~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~-~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      +-+ |+|+++|.++ ..++|..+++++.||+.|+.|||+..+|||||||+|+.+- .-|.|||+|||++..+.++ ...+
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL~  176 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKLT  176 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-chhh
Confidence            987 5999999775 5799999999999999999999999999999999998765 5599999999999988877 4568


Q ss_pred             ccCCCCcccccccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchh
Q psy18060        276 SIKGTPLYMAPELIAERPYD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~-~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      +.||+..|-|||++.+..|+ +++||||||||||.|.+|++||...+..+.+.+|..+.+..|..+|.++++||..||.+
T Consensus       177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvR  256 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVR  256 (864)
T ss_pred             cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhc
Confidence            88999999999999999998 56899999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCCCHHHHhcCcccCccc
Q psy18060        355 DASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       355 dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ||++|.|.+||..|+|++...
T Consensus       257 dPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  257 DPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             CchhhccHHHHhccccccCCC
Confidence            999999999999999998653

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-46  Score=392.71  Aligned_cols=257  Identities=28%  Similarity=0.469  Sum_probs=221.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|.+++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            468999999999999999999999999999999865432 2334567889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-----
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-----  271 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-----  271 (549)
                      ||+. |+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++......     
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            9997 6899999988899999999999999999999999999999999999999999999999999986321100     


Q ss_pred             -------c-----------------------------------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHH
Q psy18060        272 -------H-----------------------------------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYE  309 (549)
Q Consensus       272 -------~-----------------------------------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~e  309 (549)
                             .                                   .....+||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE  240 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence                   0                                   0012469999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHhcC--CCCCCc--cCCHHHHHHHHHhchhCcCCC---CCHHHHhcCcccCcccc
Q psy18060        310 IHMGHPPFKTVSILHLIRLLKTQ--DVTFPS--QVSETYKDLVKGLLEKDASQR---LSWPELLHHPLVKDNLS  376 (549)
Q Consensus       310 LltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~dlI~~~L~~dP~~R---ps~~elL~Hpw~~~~~~  376 (549)
                      |++|.+||...+.......+...  ...+|.  .+++++++||.+||. +|.+|   +|+.|++.||||++...
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            99999999988877777766543  334454  579999999999997 77765   59999999999987544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-45  Score=374.32  Aligned_cols=252  Identities=32%  Similarity=0.502  Sum_probs=210.4

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcC-CCceEEEEEEecCCCChHHHHHHHHHHHHHHhc---CCCCeeEEEEEEe-----e
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLD-LKKTVALKIISKSGRSGKELSSLKQECEIQKHL---AHPNIIKFIASHE-----T  189 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~-----~  189 (549)
                      ++|++.+.||+|+||.||+|.+.. ++..+|+|.+..............+|+.+++.+   .||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            468999999999999999999854 468899999876543333334456677777665   6999999999874     3


Q ss_pred             CCEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceec
Q psy18060        190 LNEFVLITEFAHMSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       190 ~~~~~iV~E~~~gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~  267 (549)
                      ...+++|||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            4568999999999999999764  45899999999999999999999999999999999999999999999999999766


Q ss_pred             ccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-------------
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-------------  334 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-------------  334 (549)
                      ... .......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.....             
T Consensus       161 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         161 SFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             cCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence            543 233456799999999999888999999999999999999999999998877666555432100             


Q ss_pred             --------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        335 --------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       335 --------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                    .+.+.+++.++++|.+||+.||++|||+.|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                          0113467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-46  Score=385.83  Aligned_cols=254  Identities=29%  Similarity=0.449  Sum_probs=226.6

Q ss_pred             EEEecCCcEEEEEEEE---cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC
Q psy18060        125 CLIGEGSFGKVFKAIH---LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~---~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~  201 (549)
                      +.||+|+||.||++.+   ..+|+.||+|++.+..........+.+|++++++++||||+++++++...+.+|+||||+.
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999876   3578999999997644333334566789999999999999999999999999999999997


Q ss_pred             -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCC
Q psy18060        202 -MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT  280 (549)
Q Consensus       202 -gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT  280 (549)
                       |+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~  161 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT  161 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCC
Confidence             6899999888889999999999999999999999999999999999999999999999999997665443334556899


Q ss_pred             CcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCC
Q psy18060        281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL  360 (549)
Q Consensus       281 ~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rp  360 (549)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+......+|..+++.+.++|.+||+.||.+||
T Consensus       162 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~  241 (318)
T cd05582         162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRL  241 (318)
T ss_pred             hhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcC
Confidence            99999999998889999999999999999999999999999888888888888888999999999999999999999999


Q ss_pred             C-----HHHHhcCcccCcccchh
Q psy18060        361 S-----WPELLHHPLVKDNLSSE  378 (549)
Q Consensus       361 s-----~~elL~Hpw~~~~~~~~  378 (549)
                      |     +.+++.||||.......
T Consensus       242 ~a~~~~~~~~~~~~~~~~~~~~~  264 (318)
T cd05582         242 GAGPDGVEEIKRHPFFSTIDWNK  264 (318)
T ss_pred             CCCCCCHHHHhCCCCcCCCCHHH
Confidence            9     67799999998764433

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.2e-45  Score=382.77  Aligned_cols=252  Identities=25%  Similarity=0.463  Sum_probs=219.2

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.++.++ +||||+++++++...+.+++||||+. 
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999976432 233455677888888776 89999999999999999999999998 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.............||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            58999998888999999999999999999999999999999999999999999999999999875433333345568999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhc
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT---------VSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L  352 (549)
                      .|+|||++.+..++.++|||||||++|+|++|+.||..         .........+......+|..++..+.++|.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L  240 (329)
T cd05618         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL  240 (329)
T ss_pred             cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence            99999999999999999999999999999999999952         122334455667777889999999999999999


Q ss_pred             hhCcCCCCC------HHHHhcCcccCcccc
Q psy18060        353 EKDASQRLS------WPELLHHPLVKDNLS  376 (549)
Q Consensus       353 ~~dP~~Rps------~~elL~Hpw~~~~~~  376 (549)
                      ..||.+|||      +.++++||||+...+
T Consensus       241 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         241 NKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             cCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            999999998      579999999987544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.3e-46  Score=388.86  Aligned_cols=260  Identities=28%  Similarity=0.488  Sum_probs=225.1

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            368999999999999999999999999999999975332 2334567888999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-----
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-----  271 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-----  271 (549)
                      ||++ |+|.+++.+++.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++......     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            9997 5899999988899999999999999999999999999999999999999999999999999986542110     


Q ss_pred             ------------------------------ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q psy18060        272 ------------------------------HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS  321 (549)
Q Consensus       272 ------------------------------~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~  321 (549)
                                                    ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                                          01124579999999999999999999999999999999999999999988


Q ss_pred             HHHHHHHHhcC--CCCCCc--cCCHHHHHHHHHhchhCcCCCCC---HHHHhcCcccCcccchhh
Q psy18060        322 ILHLIRLLKTQ--DVTFPS--QVSETYKDLVKGLLEKDASQRLS---WPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       322 ~~~~~~~i~~~--~~~~p~--~~s~~~~dlI~~~L~~dP~~Rps---~~elL~Hpw~~~~~~~~~  379 (549)
                      .......+...  ...+|+  .++++++++|.+|+. ||.+|++   +.++++||||++..+...
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~  304 (360)
T cd05627         241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHI  304 (360)
T ss_pred             HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHH
Confidence            88877777653  234454  478999999999874 9999984   799999999998765544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG1035|consensus

Probab=100.00  E-value=1.1e-46  Score=418.76  Aligned_cols=352  Identities=24%  Similarity=0.350  Sum_probs=229.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .++|+.+++||+||||.||||+++.+|+.||||+|+... +.....++.||+++|++|+|||||+||.+|.+...-..++
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            567999999999999999999999999999999998876 5556678999999999999999999999997755444444


Q ss_pred             hhhh---cccccC----CCCccccCCCccccc----------cccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEE
Q psy18060         88 EFAH---MSLSKL----GEPWFHNHCQPVKME----------KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK  150 (549)
Q Consensus        88 ey~~---~sLskl----g~p~~~~~~~~~~~~----------~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK  150 (549)
                      +-..   .+++.-    ..+..-  .++.+.+          ........|.--...+.|+.-.--.-.+. .|...  -
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~--~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~de-dg~~~--S  631 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIR--YQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDE-DGRNL--S  631 (1351)
T ss_pred             cccccchhhhcccCCCcccceee--eccCCCcccCcchhhccccCccccccccccccccccCCcccccccc-ccccc--c
Confidence            3321   111111    110000  0000000          00000000100001111100000000000 00000  0


Q ss_pred             EEecCCCChHHHHHHHHHHHHHHh--cCCCCeeEEEEEEeeCCEEEEEEecCCCCHHHHHHhcCCCC--HHHHHHHHHHH
Q psy18060        151 IISKSGRSGKELSSLKQECEIQKH--LAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLS--ETICVQILSNL  226 (549)
Q Consensus       151 ~i~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~~~~iV~E~~~gsL~~~l~~~~~l~--e~~~~~i~~qI  226 (549)
                      ..+.........+....+-.+.++  ..-|+     -..+....+||.||||..++.+++-.++.+.  ....+++++||
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~-----~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreI  706 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPM-----VPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREI  706 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccc-----cccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHH
Confidence            000000000000001111111111  11222     1223345689999999987666665555554  77899999999


Q ss_pred             HHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc------------------cCcccccccCCCCccccccc
Q psy18060        227 ISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------------------VGTHMLTSIKGTPLYMAPEL  288 (549)
Q Consensus       227 l~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~------------------~~~~~~~~~~GT~~Y~APE~  288 (549)
                      +.||.|+|++|||||||||.|||++.++.|||+|||+|+...                  .+....|+.+||..|+|||+
T Consensus       707 lEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  707 LEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            999999999999999999999999999999999999998621                  11124577899999999999


Q ss_pred             ccCC---CCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCCccC----CHHHHHHHHHhchhCcCCCC
Q psy18060        289 IAER---PYDHTADLWSLGCIAYEIHMGHPPFKT-VSILHLIRLLKTQDVTFPSQV----SETYKDLVKGLLEKDASQRL  360 (549)
Q Consensus       289 l~~~---~y~~ksDIwSlGvil~eLltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~~----s~~~~dlI~~~L~~dP~~Rp  360 (549)
                      +.+.   +|+.|+|+||||||++||+   +||.+ +....++..+..+.++.|+.+    -+.-..+|.+||++||.+||
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRP  863 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRP  863 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCC
Confidence            9764   4999999999999999998   47865 466677777877766665322    24456899999999999999


Q ss_pred             CHHHHhcCcccCc
Q psy18060        361 SWPELLHHPLVKD  373 (549)
Q Consensus       361 s~~elL~Hpw~~~  373 (549)
                      ||.|+|++.||-.
T Consensus       864 tA~eLL~s~llpp  876 (1351)
T KOG1035|consen  864 TATELLNSELLPP  876 (1351)
T ss_pred             CHHHHhhccCCCc
Confidence            9999999999973

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2e-45  Score=380.74  Aligned_cols=255  Identities=24%  Similarity=0.451  Sum_probs=221.7

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.++.++ .||||+++++++...+.+|+||||+. 
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999976432 233456678899998888 69999999999999999999999997 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            58999998888999999999999999999999999999999999999999999999999999875433333345568999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchh
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV-------SILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~-------~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...       ........+...+..+|..+++.+.++|.+||.+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~  240 (327)
T cd05617         161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK  240 (327)
T ss_pred             ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence            999999999999999999999999999999999999532       2334555666677788889999999999999999


Q ss_pred             CcCCCCC------HHHHhcCcccCcccchhh
Q psy18060        355 DASQRLS------WPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       355 dP~~Rps------~~elL~Hpw~~~~~~~~~  379 (549)
                      ||.+|++      ++++++||||....+...
T Consensus       241 dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~  271 (327)
T cd05617         241 DPKERLGCQPQTGFSDIKSHTFFRSIDWDLL  271 (327)
T ss_pred             CHHHcCCCCCCCCHHHHHcCCCCCCCCHHHH
Confidence            9999998      469999999987655443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.9e-45  Score=381.00  Aligned_cols=258  Identities=29%  Similarity=0.460  Sum_probs=221.3

Q ss_pred             ceeEEEEEecCCcEEEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGR--SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF  193 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  193 (549)
                      +|++.+.||+|+||.||++.+.   .+++.||+|++.+...  .......+.+|+.+++.+ +||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4889999999999999998764   4789999999975321  223345678899999999 599999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-  271 (549)
                      ++||||+. |+|.+++.++..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... 
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            99999998 5899999988899999999999999999999999999999999999999999999999999997654322 


Q ss_pred             ccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCCCCCCccCCHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSETYKD  346 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~d  346 (549)
                      ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...    ........+......+|..+++.+.+
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD  240 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            223356799999999999765 4789999999999999999999999642    34445555666667788889999999


Q ss_pred             HHHHhchhCcCCCC-----CHHHHhcCcccCcccch
Q psy18060        347 LVKGLLEKDASQRL-----SWPELLHHPLVKDNLSS  377 (549)
Q Consensus       347 lI~~~L~~dP~~Rp-----s~~elL~Hpw~~~~~~~  377 (549)
                      +|.+||+.||.+||     +++++++||||++....
T Consensus       241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  276 (332)
T cd05614         241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE  276 (332)
T ss_pred             HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            99999999999999     78899999999875443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.6e-46  Score=390.83  Aligned_cols=257  Identities=26%  Similarity=0.439  Sum_probs=220.6

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            369999999999999999999999999999999865321 1223456789999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC------
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG------  270 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~------  270 (549)
                      ||+. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......      
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            9997 689999998888999999999999999999999999999999999999999999999999997432100      


Q ss_pred             -------------------------------------cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhC
Q psy18060        271 -------------------------------------THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMG  313 (549)
Q Consensus       271 -------------------------------------~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG  313 (549)
                                                           .......+||+.|||||++.+..++.++|||||||++|+|++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G  240 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG  240 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence                                                 0001235799999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhcCC--CCCC--ccCCHHHHHHHHHhchhCcCCCC---CHHHHhcCcccCcccc
Q psy18060        314 HPPFKTVSILHLIRLLKTQD--VTFP--SQVSETYKDLVKGLLEKDASQRL---SWPELLHHPLVKDNLS  376 (549)
Q Consensus       314 ~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~dlI~~~L~~dP~~Rp---s~~elL~Hpw~~~~~~  376 (549)
                      +.||.+.+.......+....  ..+|  ..+++++.++|.+|+ .+|.+|+   |+.++++||||+....
T Consensus       241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence            99999888777666655432  2233  368999999999976 5999999   9999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-45  Score=381.79  Aligned_cols=255  Identities=30%  Similarity=0.508  Sum_probs=222.1

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHH-HHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQE-CEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E-i~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+++.||+|++.+.... ......+..| ..+++.+.||||+++++++...+.+|+||||+. 
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999753211 1122233344 345788899999999999999999999999998 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++............+||+
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            58999999888899999999999999999999999999999999999999999999999999976433333345567999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCC
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS  361 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps  361 (549)
                      .|+|||++.+..++.++|||||||++|+|++|++||...+.......+......+++.+++.+.++|.+||++||.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (325)
T cd05602         161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLG  240 (325)
T ss_pred             cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence            99999999999999999999999999999999999999988888888888877888899999999999999999999998


Q ss_pred             HH----HHhcCcccCcccchhh
Q psy18060        362 WP----ELLHHPLVKDNLSSEI  379 (549)
Q Consensus       362 ~~----elL~Hpw~~~~~~~~~  379 (549)
                      +.    ++++|+||....+..+
T Consensus       241 ~~~~~~~i~~~~~~~~~~~~~~  262 (325)
T cd05602         241 AKDDFMEIKNHIFFSPINWDDL  262 (325)
T ss_pred             CCCCHHHHhcCcccCCCCHHHH
Confidence            75    8999999987655444

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.2e-45  Score=387.18  Aligned_cols=259  Identities=28%  Similarity=0.453  Sum_probs=223.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            45789999999999999999999999999999999975322 22234457789999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-c
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-M  273 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~  273 (549)
                      ||||+. |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....... .
T Consensus       121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence            999997 589998865 4689999999999999999999999999999999999999999999999999987643321 2


Q ss_pred             ccccCCCCcccccccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCc--cCCHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAER----PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFPS--QVSETYK  345 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~----~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~  345 (549)
                      ....+||+.|+|||++.+.    .++.++|||||||++|+|++|++||...+.......+....  ..+|.  .+|.+++
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  279 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK  279 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHH
Confidence            3456799999999998653    47899999999999999999999999988887777776543  44554  5799999


Q ss_pred             HHHHHhchhCcCC--CCCHHHHhcCcccCcccc
Q psy18060        346 DLVKGLLEKDASQ--RLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       346 dlI~~~L~~dP~~--Rps~~elL~Hpw~~~~~~  376 (549)
                      +||.+||+.+|.+  |+|+.++++||||++..+
T Consensus       280 ~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         280 DLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             HHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence            9999999999987  999999999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0658|consensus

Probab=100.00  E-value=1.9e-46  Score=374.39  Aligned_cols=253  Identities=31%  Similarity=0.500  Sum_probs=216.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-----E
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----E  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~  192 (549)
                      .-.|...+.+|+|+||.||+|....+++.+|||.+-....-      -.+|+++|+.++|||||++..+|....     .
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            34588899999999999999999999999999998654332      246899999999999999988874322     3


Q ss_pred             EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC-CcEEEeecccceec
Q psy18060        193 FVLITEFAHMSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSM  267 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~-g~vKL~DFGla~~~  267 (549)
                      ..+||||++.+|.+.++.    +.+++...++-+..||++||.|||+.||+||||||+|||+|.+ |.+||||||.|+..
T Consensus        97 lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen   97 LNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            468999999999999985    5789999999999999999999999999999999999999976 99999999999988


Q ss_pred             ccCcccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--------------  332 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--------------  332 (549)
                      ..+.. ..+...|.+|+|||.+.+ ..|+.+.||||.||++.||+-|++.|++.+...++..|..-              
T Consensus       177 ~~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  177 VKGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             ccCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence            76643 366778999999999876 57999999999999999999999999998877776655321              


Q ss_pred             ---CCC------------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        333 ---DVT------------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       333 ---~~~------------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                         ...            +....++++.+|+.++|+.+|.+|.++.|++.||||......
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence               011            223578999999999999999999999999999999765443

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.8e-45  Score=370.69  Aligned_cols=252  Identities=29%  Similarity=0.428  Sum_probs=216.5

Q ss_pred             EecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CCH
Q psy18060        127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSL  204 (549)
Q Consensus       127 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL  204 (549)
                      ||+|+||+||+|.+..+++.+|+|.+.+.... ......+..|+++++.++||||+++.+++...+.+++||||++ |+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999999999999998754322 2234567789999999999999999999999999999999997 589


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCC
Q psy18060        205 SNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT  280 (549)
Q Consensus       205 ~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT  280 (549)
                      ...+..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..............||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            877743    3569999999999999999999999999999999999999999999999999998765544444456799


Q ss_pred             CcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCc
Q psy18060        281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI----LHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       281 ~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||.....    ......+......+|+.+++.+.+++.+||+.||
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP  240 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence            999999999999999999999999999999999999976532    2333444455566778899999999999999999


Q ss_pred             CCCC-----CHHHHhcCcccCcccchh
Q psy18060        357 SQRL-----SWPELLHHPLVKDNLSSE  378 (549)
Q Consensus       357 ~~Rp-----s~~elL~Hpw~~~~~~~~  378 (549)
                      .+||     +++++++||||++..+..
T Consensus       241 ~~R~~~~~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         241 EKRLGFRDGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             HHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence            9999     889999999998755443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-45  Score=381.75  Aligned_cols=255  Identities=31%  Similarity=0.503  Sum_probs=223.1

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHH-HHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECE-IQKHLAHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+|+.+|+|++.+... .......+..|.. +++.++||||+++++++...+.+|+||||+. 
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            469999999999999999999999999975421 2223344455554 5778999999999999999999999999998 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      |+|..++.+...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            58999998888999999999999999999999999999999999999999999999999999875433333345667999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCC
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS  361 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps  361 (549)
                      .|+|||++.+..++.++|||||||++|+|++|..||...+.......+......+++..+..+.++|.+||+++|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~  240 (325)
T cd05604         161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLG  240 (325)
T ss_pred             hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCC
Confidence            99999999999999999999999999999999999999998888888888887788889999999999999999999998


Q ss_pred             H----HHHhcCcccCcccchhh
Q psy18060        362 W----PELLHHPLVKDNLSSEI  379 (549)
Q Consensus       362 ~----~elL~Hpw~~~~~~~~~  379 (549)
                      +    .++++||||........
T Consensus       241 ~~~~~~~i~~h~~f~~~~~~~~  262 (325)
T cd05604         241 AKEDFLEIQEHPFFESLSWTDL  262 (325)
T ss_pred             CCCCHHHHhcCCCcCCCCHHHH
Confidence            7    58999999987654443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0589|consensus

Probab=100.00  E-value=1.9e-46  Score=389.31  Aligned_cols=259  Identities=33%  Similarity=0.565  Sum_probs=241.8

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE-EEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE-FVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~i  195 (549)
                      .+++|..++.+|+|+||.++.++++..++.+++|.+.-...+....+...+|+.++++++|||||.+.+.|..++. ++|
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            3578999999999999999999999999999999998888777777889999999999999999999999988888 999


Q ss_pred             EEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        196 ITEFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ||+||+ |+|.+.|.+.+  .|+|+.+..|+.|++.|++|||+++|+|||||+.|||++.++.|||+|||+|+.+.+...
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            999998 58999997654  589999999999999999999999999999999999999999999999999999988765


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHh
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~  351 (549)
                      ...+..|||.||+||++.+.+|+.|+|||||||++|||++-+++|.+.+...++.+|..+. .++|..++.+++.+|..|
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~  241 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSM  241 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHH
Confidence            6778899999999999999999999999999999999999999999999999999988776 567889999999999999


Q ss_pred             chhCcCCCCCHHHHhcCcccCccc
Q psy18060        352 LEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      |.++|..||++.++|.+|.+....
T Consensus       242 l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  242 LRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             hhcCCccCCCHHHHhhChhhhhHH
Confidence            999999999999999999987554

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.8e-45  Score=383.16  Aligned_cols=257  Identities=27%  Similarity=0.416  Sum_probs=215.0

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC----
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN----  191 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----  191 (549)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.+++.++||||+++++++...+    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3468899999999999999999999999999999999765444445567789999999999999999999886443    


Q ss_pred             --EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceeccc
Q psy18060        192 --EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV  269 (549)
Q Consensus       192 --~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~  269 (549)
                        .+|+||||++++|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876          98 FQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             cceeEEEEeCCCcCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence              579999999999888775  3589999999999999999999999999999999999999999999999999976543


Q ss_pred             CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------------------
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLK-------------------  330 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~-------------------  330 (549)
                      . ...+...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.                   
T Consensus       176 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (359)
T cd07876         176 N-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR  254 (359)
T ss_pred             C-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            2 22345679999999999999999999999999999999999999998765433222111                   


Q ss_pred             ---cCCCC--------------------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        331 ---TQDVT--------------------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       331 ---~~~~~--------------------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                         .....                    .+...++.+++||.+||+.||.+|||+.|+|+||||....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence               01000                    0112467889999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-45  Score=388.85  Aligned_cols=250  Identities=25%  Similarity=0.341  Sum_probs=210.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ...+|++++.||+|+||.||+|.+..+++.||+|....        ..+.+|+++++.++||||+++++++......++|
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            34679999999999999999999999999999997532        3457899999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC-ccccc
Q psy18060        197 TEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG-THMLT  275 (549)
Q Consensus       197 ~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~-~~~~~  275 (549)
                      ||++.++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... .....
T Consensus       162 ~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~  241 (391)
T PHA03212        162 LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY  241 (391)
T ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999999653321 12234


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhc-----------------
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLIRLLKT-----------------  331 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~-------~~~~~~~i~~-----------------  331 (549)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|..||....       ....+..+..                 
T Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~  321 (391)
T PHA03212        242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL  321 (391)
T ss_pred             cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence            5679999999999999999999999999999999999998875321       1111111100                 


Q ss_pred             ---------CCC----CCC-----ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        332 ---------QDV----TFP-----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       332 ---------~~~----~~p-----~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                               ...    ..|     ..++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                     000    001     1246789999999999999999999999999999763

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6e-45  Score=373.32  Aligned_cols=258  Identities=28%  Similarity=0.476  Sum_probs=217.9

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ..+++|.+.+.||+|+||.||+|.+..+++.+|+|.+...... .....+.+|+.+++.++||||+++++++...+..++
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            3457899999999999999999999999999999998754322 223456789999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||||++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus        82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            99999999998887654 58999999999999999999999999999999999999999999999999997654433333


Q ss_pred             cccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------CC
Q psy18060        275 TSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-------------------DV  334 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-------------------~~  334 (549)
                      ....+|+.|+|||++.+ ..++.++|||||||++|+|+||++||.+.+..+....+...                   ..
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            44568999999999865 56899999999999999999999999887665444333210                   00


Q ss_pred             CCC-----------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        335 TFP-----------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       335 ~~p-----------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+|           +.++++++++|.+||+.||.+|||+.|+++||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            111           2468899999999999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.1e-45  Score=379.15  Aligned_cols=254  Identities=30%  Similarity=0.485  Sum_probs=222.2

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHH-HHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQEC-EIQKHLAHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+++.||+|++.+... .......+.+|. .+++.++||||+++++++...+..|+||||++ 
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999975432 122233444554 46788999999999999999999999999998 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            58999998888899999999999999999999999999999999999999999999999999875433333345567999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCC
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS  361 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps  361 (549)
                      .|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+|+..+..+.++|.+||++||.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (321)
T cd05603         161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLG  240 (321)
T ss_pred             ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCC
Confidence            99999999998999999999999999999999999999998888888888888888899999999999999999999997


Q ss_pred             H----HHHhcCcccCcccchh
Q psy18060        362 W----PELLHHPLVKDNLSSE  378 (549)
Q Consensus       362 ~----~elL~Hpw~~~~~~~~  378 (549)
                      +    .++++||||.......
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~  261 (321)
T cd05603         241 AKADFLEIKNHVFFSPINWDD  261 (321)
T ss_pred             CCCCHHHHhCCCCcCCCCHHH
Confidence            6    5999999998755443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3e-45  Score=385.87  Aligned_cols=255  Identities=27%  Similarity=0.417  Sum_probs=218.8

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-----EEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----EFV  194 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~  194 (549)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++...+     .+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999999999999999998654444445567889999999999999999999988776     789


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-cc
Q psy18060        195 LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-HM  273 (549)
Q Consensus       195 iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-~~  273 (549)
                      +||||+.++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~  160 (372)
T cd07853          81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH  160 (372)
T ss_pred             EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999997654322 22


Q ss_pred             ccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Q psy18060        274 LTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT---------------------  331 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~---------------------  331 (549)
                      .+...+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+..                     
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  240 (372)
T cd07853         161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI  240 (372)
T ss_pred             CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHH
Confidence            3445689999999998764 589999999999999999999999988776655544321                     


Q ss_pred             --CCC---------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        332 --QDV---------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       332 --~~~---------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                        ...         .++...++++.+||.+||+.||.+|||+.|+++||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence              111         1223468899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.1e-45  Score=394.51  Aligned_cols=251  Identities=31%  Similarity=0.471  Sum_probs=209.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC------
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------  190 (549)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++||||+++++++...      
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            3467999999999999999999999999999999885432      2235799999999999999998876332      


Q ss_pred             --CEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-cEEEeeccc
Q psy18060        191 --NEFVLITEFAHMSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-VAMLCDFGF  263 (549)
Q Consensus       191 --~~~~iV~E~~~gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-~vKL~DFGl  263 (549)
                        ..+++||||++++|.+++..    ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus       138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence              24679999999998887753    46799999999999999999999999999999999999998665 799999999


Q ss_pred             ceecccCcccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------
Q psy18060        264 ARSMAVGTHMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----------  332 (549)
Q Consensus       264 a~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~----------  332 (549)
                      |+...... ......||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+....+..+...          
T Consensus       218 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        218 AKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             chhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            98765432 2345678999999999865 46999999999999999999999999987665444433210          


Q ss_pred             -------CC------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        333 -------DV------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       333 -------~~------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                             ..            .+|...|+++.+||.+||++||.+|||+.|+|+||||.+.
T Consensus       297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence                   01            1344578899999999999999999999999999999754

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.2e-45  Score=385.05  Aligned_cols=258  Identities=26%  Similarity=0.459  Sum_probs=221.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ..++|++.+.||+|+||.||++.+..+++.+|+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            34679999999999999999999999999999999975322 22234567889999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-c
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-M  273 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~  273 (549)
                      ||||+. |+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|........ .
T Consensus       121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence            999997 5899988654 689999999999999999999999999999999999999999999999999987643222 2


Q ss_pred             ccccCCCCcccccccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCc--cCCHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAER----PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFPS--QVSETYK  345 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~----~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~  345 (549)
                      ..+.+||+.|+|||++.+.    .++.++|||||||++|+|++|+.||.+.+.......+....  +.+|.  .+++.++
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~  279 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK  279 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence            2456799999999999654    37899999999999999999999999988887777776533  44554  4699999


Q ss_pred             HHHHHhchhCcCC--CCCHHHHhcCcccCccc
Q psy18060        346 DLVKGLLEKDASQ--RLSWPELLHHPLVKDNL  375 (549)
Q Consensus       346 dlI~~~L~~dP~~--Rps~~elL~Hpw~~~~~  375 (549)
                      ++|.+||+.+|.+  |+|+.|+++||||+...
T Consensus       280 ~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         280 NLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             HHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence            9999999865543  89999999999998643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6e-45  Score=368.28  Aligned_cols=251  Identities=29%  Similarity=0.462  Sum_probs=208.6

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc---CCCCeeEEEEEEee-----CC
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL---AHPNIIKFIASHET-----LN  191 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~~  191 (549)
                      +|++.+.||+|+||.||+|.++.+++.||+|.+..............+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            58899999999999999999999999999999875432222223445677766655   79999999998754     34


Q ss_pred             EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceeccc
Q psy18060        192 EFVLITEFAHMSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV  269 (549)
Q Consensus       192 ~~~iV~E~~~gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~  269 (549)
                      .++++||++.++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~  160 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC  160 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence            58999999999999998764  3589999999999999999999999999999999999999999999999999976643


Q ss_pred             CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------C----
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-----------V----  334 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-----------~----  334 (549)
                      . ...+...||+.|+|||++.+..++.++|||||||++|+|++|++||.+.........+....           .    
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07863         161 Q-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR  239 (288)
T ss_pred             c-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence            3 22344578999999999998899999999999999999999999998876655544432100           0    


Q ss_pred             ------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        335 ------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       335 ------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                  ...+.+++.+.++|.+||++||.+|||+.|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                        0113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.5e-44  Score=374.58  Aligned_cols=254  Identities=25%  Similarity=0.442  Sum_probs=219.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++++.||+|+||.||++.+..++..+|+|.+... ........+.+|+++++.++||||+++++++...+.+++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            46799999999999999999999999999999998753 23444567899999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      ||+. ++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||+++.....  ...
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  160 (331)
T cd06649          83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN  160 (331)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--ccc
Confidence            9998 58999999888899999999999999999999986 6999999999999999999999999998765432  234


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------------------------
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLK-------------------------  330 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~-------------------------  330 (549)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.                         
T Consensus       161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd06649         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV  240 (331)
T ss_pred             cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccc
Confidence            5579999999999999899999999999999999999999997765544332211                         


Q ss_pred             ---------------------cC-CCCCC-ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        331 ---------------------TQ-DVTFP-SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       331 ---------------------~~-~~~~p-~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                           .. ....+ ..+++++++||.+||++||++|||+.++++||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                 11 01111 2468899999999999999999999999999999754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.4e-45  Score=379.97  Aligned_cols=258  Identities=28%  Similarity=0.458  Sum_probs=223.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            368999999999999999999999999999999976432 2334567889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-cc
Q psy18060        198 EFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-ML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~  274 (549)
                      ||+. |+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            9997 6899999876 6899999999999999999999999999999999999999999999999999987654322 22


Q ss_pred             cccCCCCccccccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCC--ccCCHHH
Q psy18060        275 TSIKGTPLYMAPELIA------ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFP--SQVSETY  344 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~------~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~  344 (549)
                      ....||+.|+|||++.      +..++.++|||||||++|+|++|+.||...+.......+....  ..+|  ..+++.+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            3457999999999986      4568899999999999999999999999888777777665432  2334  3579999


Q ss_pred             HHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        345 KDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                      .+||.+||+ +|.+|||++++++||||......
T Consensus       241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         241 LDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             HHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence            999999998 99999999999999999875443

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.8e-45  Score=381.11  Aligned_cols=255  Identities=28%  Similarity=0.438  Sum_probs=215.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC------
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------  190 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            46789999999999999999999999999999999976544445556778899999999999999999887543      


Q ss_pred             CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        191 NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       191 ~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      ..+|+||||++++|.+.+..  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       102 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  179 (364)
T cd07875         102 QDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  179 (364)
T ss_pred             CeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence            35799999999999888854  5889999999999999999999999999999999999999999999999999765433


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV----------------  334 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~----------------  334 (549)
                       ...+...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....                
T Consensus       180 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (364)
T cd07875         180 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  258 (364)
T ss_pred             -CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence             223455799999999999999999999999999999999999999988776555444322100                


Q ss_pred             ------C--------------C------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        335 ------T--------------F------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       335 ------~--------------~------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                            .              +      +...+..+++||.+||+.||.+|||+.|+|+||||...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                  0              0      01135678999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0986|consensus

Probab=100.00  E-value=1.1e-46  Score=382.27  Aligned_cols=284  Identities=27%  Similarity=0.406  Sum_probs=253.3

Q ss_pred             CCCccccCCCccccccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcC
Q psy18060         98 GEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLA  176 (549)
Q Consensus        98 g~p~~~~~~~~~~~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~  176 (549)
                      .+.++++.+|+.+++......+.|...++||+||||.|+-|+.+.||+.||.|.+.+.... .......++|-+|+++++
T Consensus       164 ~S~yf~rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~  243 (591)
T KOG0986|consen  164 ESDYFTRFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS  243 (591)
T ss_pred             HHHHHHHHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc
Confidence            3455678889999999888889999999999999999999999999999999988664321 223356688999999999


Q ss_pred             CCCeeEEEEEEeeCCEEEEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC
Q psy18060        177 HPNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD  253 (549)
Q Consensus       177 hpnIv~l~~~~~~~~~~~iV~E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~  253 (549)
                      .|.||.+-..|++.+.+++||..++ |+|.-+|-+.+  .|+|..+..++.+|+.||++||+++||.|||||+|||+|+.
T Consensus       244 s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~  323 (591)
T KOG0986|consen  244 SPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH  323 (591)
T ss_pred             cCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC
Confidence            9999999999999999999999998 58999988765  89999999999999999999999999999999999999999


Q ss_pred             CcEEEeecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH
Q psy18060        254 GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLL  329 (549)
Q Consensus       254 g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~----~~~~~~~~i  329 (549)
                      |+|+|+|+|+|..+..+ ...+..+||.+|||||++.+..|+..+|+|||||++|||+.|+.||...    ..+++-+++
T Consensus       324 GhvRISDLGLAvei~~g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~  402 (591)
T KOG0986|consen  324 GHVRISDLGLAVEIPEG-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT  402 (591)
T ss_pred             CCeEeeccceEEecCCC-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH
Confidence            99999999999888655 4556679999999999999999999999999999999999999999754    345677778


Q ss_pred             hcCCCCCCccCCHHHHHHHHHhchhCcCCCCC-----HHHHhcCcccCcccchhhhhc
Q psy18060        330 KTQDVTFPSQVSETYKDLVKGLLEKDASQRLS-----WPELLHHPLVKDNLSSEIESQ  382 (549)
Q Consensus       330 ~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps-----~~elL~Hpw~~~~~~~~~~~~  382 (549)
                      .+.+..+|..+|++++++.+.+|++||.+|+.     ++++.+||||++..+..++..
T Consensus       403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleag  460 (591)
T KOG0986|consen  403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAG  460 (591)
T ss_pred             hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhcc
Confidence            88888999999999999999999999999985     579999999999877766544

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-45  Score=380.99  Aligned_cols=252  Identities=31%  Similarity=0.518  Sum_probs=218.2

Q ss_pred             EecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc---CCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL---AHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       127 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      ||+|+||.||+|.+..+++.||+|++.+... ..........|..++...   .||||+++++++...+.+|+||||+. 
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            6999999999999999999999999865322 122233445566676655   69999999999999999999999997 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            58999999888999999999999999999999999999999999999999999999999999876543333445678999


Q ss_pred             cccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc-cCCHHHHHHHHHhchhCcCCC
Q psy18060        282 LYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS-QVSETYKDLVKGLLEKDASQR  359 (549)
Q Consensus       282 ~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~dlI~~~L~~dP~~R  359 (549)
                      .|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+..+...+|. .+++++.+||.+||.+||.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R  240 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR  240 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence            99999998754 5899999999999999999999999999888888888877777775 479999999999999999999


Q ss_pred             C----CHHHHhcCcccCcccchh
Q psy18060        360 L----SWPELLHHPLVKDNLSSE  378 (549)
Q Consensus       360 p----s~~elL~Hpw~~~~~~~~  378 (549)
                      |    ++.++++||||.+..+..
T Consensus       241 ~~~~~~~~~ll~h~~~~~~~~~~  263 (330)
T cd05586         241 LGAHRDAVELKEHPFFADIDWDL  263 (330)
T ss_pred             CCCCCCHHHHhcCccccCCCHHH
Confidence            8    689999999998765433

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.4e-45  Score=379.43  Aligned_cols=256  Identities=27%  Similarity=0.428  Sum_probs=215.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC------
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------  190 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|.+............+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            46889999999999999999999999999999999976554455556778899999999999999999987543      


Q ss_pred             CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        191 NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       191 ~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      ...|+||||++++|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        95 ~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~  172 (355)
T cd07874          95 QDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_pred             ceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence            35799999999998888754  5889999999999999999999999999999999999999999999999999765433


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------------
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT-------------------  331 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~-------------------  331 (549)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..                   
T Consensus       173 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (355)
T cd07874         173 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_pred             -cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence             223456799999999999999999999999999999999999999987764433322110                   


Q ss_pred             ---CC-----CC---------------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        332 ---QD-----VT---------------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       332 ---~~-----~~---------------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                         ..     ..               .+...+..+++||.+||+.||.+|||+.|+|+||||....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence               00     00               1122456789999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-44  Score=364.88  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=221.9

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh-HHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .|++.+.||+|+||.||++.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4889999999999999999999999999999987543222 223456789999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        199 FAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       199 ~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |+. |+|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||+++...... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  159 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIR  159 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-ccc
Confidence            997 5898887653  469999999999999999999999999999999999999999999999999997754332 224


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCCCCCccCCHHHHHHHHHh
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIRLLKTQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      ...||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+...    ....+......+|..+++.+.+||.+|
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (285)
T cd05605         160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL  239 (285)
T ss_pred             cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence            4579999999999998889999999999999999999999998765433    233344445566778999999999999


Q ss_pred             chhCcCCCC-----CHHHHhcCcccCcccchhh
Q psy18060        352 LEKDASQRL-----SWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       352 L~~dP~~Rp-----s~~elL~Hpw~~~~~~~~~  379 (549)
                      |..||.+||     +++++++||||........
T Consensus       240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~  272 (285)
T cd05605         240 LTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL  272 (285)
T ss_pred             ccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHH
Confidence            999999999     8999999999987655544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.8e-44  Score=391.50  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=207.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCC------CCeeEEEEEEeeC-
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH------PNIIKFIASHETL-  190 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~-  190 (549)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++....   ........|+++++.+.|      ++++++++++... 
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            478999999999999999999999999999999996432   223345667777777654      4588888888654 


Q ss_pred             CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCC---------------
Q psy18060        191 NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDG---------------  254 (549)
Q Consensus       191 ~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g---------------  254 (549)
                      ..+++||++++++|.+++.+++.+++..++.++.||+.||+|||+ .|||||||||+|||++.++               
T Consensus       205 ~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        205 GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            578999999999999999988899999999999999999999998 5999999999999998765               


Q ss_pred             -cEEEeecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Q psy18060        255 -VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD  333 (549)
Q Consensus       255 -~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~  333 (549)
                       .+||+|||.+....   ...+..+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+....
T Consensus       285 ~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  361 (467)
T PTZ00284        285 CRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL  361 (467)
T ss_pred             ceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence             49999999875432   23356789999999999999999999999999999999999999998877655444332211


Q ss_pred             CCCCc------------------------------------------cCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        334 VTFPS------------------------------------------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       334 ~~~p~------------------------------------------~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      ..+|.                                          ..++.+.+||.+||+.||.+|||++|+|+||||
T Consensus       362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~  441 (467)
T PTZ00284        362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV  441 (467)
T ss_pred             CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence            11110                                          013567799999999999999999999999999


Q ss_pred             Ccccc
Q psy18060        372 KDNLS  376 (549)
Q Consensus       372 ~~~~~  376 (549)
                      .....
T Consensus       442 ~~~~~  446 (467)
T PTZ00284        442 LKYYP  446 (467)
T ss_pred             cccCC
Confidence            86543

>KOG0690|consensus

Probab=100.00  E-value=2.4e-46  Score=366.18  Aligned_cols=264  Identities=29%  Similarity=0.473  Sum_probs=245.0

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ..+++|..+++||+|.||+|-+|+.+.+++.||+|++++.- ....+...-..|-++|+..+||.+..+..+|+..++++
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            36789999999999999999999999999999999998754 34555667778899999999999999999999999999


Q ss_pred             EEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      +||||++| .|.-+|.+.+.|+|..++.+-..|+.||.|||+++||.||||.+|+|+|.+|++||+|||+++.--.....
T Consensus       245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence            99999985 79999999899999999999999999999999999999999999999999999999999999765555566


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhch
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ..++||||.|.|||++....|+.++|+|.+||++|||++|+.||...+...+.+.|....+.||..++++++.|+..+|.
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~  404 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLK  404 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhh
Confidence            78899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hCcCCCCC-----HHHHhcCcccCcccchhh
Q psy18060        354 KDASQRLS-----WPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       354 ~dP~~Rps-----~~elL~Hpw~~~~~~~~~  379 (549)
                      +||.+|+.     +.||.+|+||....+...
T Consensus       405 kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~  435 (516)
T KOG0690|consen  405 KDPKKRLGGGPDDAKEIMRHRFFASVDWEAT  435 (516)
T ss_pred             cChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence            99999986     789999999998766544

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.8e-45  Score=360.62  Aligned_cols=251  Identities=36%  Similarity=0.603  Sum_probs=216.7

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecC
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA  200 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~  200 (549)
                      |++.+.||+|+||+||++.+..+++.||+|++..............+|+.+++.++||||+++++++......+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            78999999999999999999999999999999876544444444566999999999999999999999999999999999


Q ss_pred             CC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCC
Q psy18060        201 HM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG  279 (549)
Q Consensus       201 ~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~G  279 (549)
                      .+ +|.+++...+.+++..+..++.||+.||.+||++||+||||||+||+++.++.++|+|||.+..............+
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  160 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG  160 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            97 99999998889999999999999999999999999999999999999999999999999999764333334456679


Q ss_pred             CCccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCCC----ccCCHHHHHHHHHh
Q psy18060        280 TPLYMAPELIA-ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI---LHLIRLLKTQDVTFP----SQVSETYKDLVKGL  351 (549)
Q Consensus       280 T~~Y~APE~l~-~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~---~~~~~~i~~~~~~~p----~~~s~~~~dlI~~~  351 (549)
                      |+.|+|||++. +..++.++||||||+++|+|++|..||.....   ..............+    ...++.+.++|.+|
T Consensus       161 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  240 (260)
T PF00069_consen  161 TPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKM  240 (260)
T ss_dssp             SGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHH
Confidence            99999999998 88899999999999999999999999998733   333333222211111    12248999999999


Q ss_pred             chhCcCCCCCHHHHhcCccc
Q psy18060        352 LEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~  371 (549)
                      |+.||.+|||+.++++||||
T Consensus       241 l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  241 LSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             SSSSGGGSTTHHHHHTSGGG
T ss_pred             ccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0574|consensus

Probab=100.00  E-value=1.5e-47  Score=371.10  Aligned_cols=257  Identities=32%  Similarity=0.554  Sum_probs=233.5

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      +-|.++.+||+|+||.||++.++.+|+.+|||.+...    ..++.+.+|+.|+++.+.|++|++|+++.....++||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            4488999999999999999999999999999998653    456788999999999999999999999998899999999


Q ss_pred             cCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        199 FAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       199 ~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||+ |+..+.++. +++++|.++..+++..+.||+|||...-||||||..|||++.+|..||+|||.|..+.......++
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            999 899999986 467999999999999999999999999999999999999999999999999999877665566688


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---CCccCCHHHHHHHHHhch
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT---FPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~dlI~~~L~  353 (549)
                      ..|||.|||||++..-.|+.++||||||++..||.-|++||....+...+-.|.+.+++   -|..||.++.|||++||.
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi  268 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI  268 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence            89999999999999999999999999999999999999999998888887777766543   245689999999999999


Q ss_pred             hCcCCCCCHHHHhcCcccCcccchhh
Q psy18060        354 KDASQRLSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~~~~~~~~~  379 (549)
                      ++|++|.|+.++++|||+++...-.+
T Consensus       269 K~PE~R~TA~~L~~H~FiknA~g~~I  294 (502)
T KOG0574|consen  269 KKPEERKTALRLCEHTFIKNAPGCDI  294 (502)
T ss_pred             CCHHHHHHHHHHhhhhhhcCCCcccH
Confidence            99999999999999999998755443

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.5e-44  Score=379.20  Aligned_cols=259  Identities=27%  Similarity=0.443  Sum_probs=221.2

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|++.+... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            345789999999999999999999999999999999875321 2223456788999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-c
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-H  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-~  272 (549)
                      +||||++ |+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... .
T Consensus       120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            9999997 589998865 468999999999999999999999999999999999999999999999999998764322 1


Q ss_pred             cccccCCCCcccccccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCC--ccCCHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAER----PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFP--SQVSETY  344 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~----~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~  344 (549)
                      .....+||+.|+|||++.+.    .++.++|||||||++|+|++|..||...+.......+....  ..+|  ..+++.+
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  278 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence            23456799999999998653    37899999999999999999999999998888887776543  3344  3689999


Q ss_pred             HHHHHHhchhCcCC--CCCHHHHhcCcccCccc
Q psy18060        345 KDLVKGLLEKDASQ--RLSWPELLHHPLVKDNL  375 (549)
Q Consensus       345 ~dlI~~~L~~dP~~--Rps~~elL~Hpw~~~~~  375 (549)
                      +++|.+||..+|.+  |++++++++||||++..
T Consensus       279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             HHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            99999999844433  78999999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-44  Score=376.41  Aligned_cols=255  Identities=30%  Similarity=0.493  Sum_probs=213.8

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC------
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------  190 (549)
                      ..++|++++.||+|+||.||+|.+..+++.||+|.+............+.+|+++++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            35789999999999999999999999999999999876443333445677899999999999999999877533      


Q ss_pred             CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        191 NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       191 ~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      ...|++|++++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        93 ~~~~~~~~~~~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~  171 (343)
T cd07878          93 NEVYLVTNLMGADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE  171 (343)
T ss_pred             CcEEEEeecCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence            4579999999999988775 457999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----------------
Q psy18060        271 THMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD----------------  333 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~----------------  333 (549)
                         .+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....                
T Consensus       172 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07878         172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA  248 (343)
T ss_pred             ---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence               345679999999999876 568999999999999999999999998876554444332110                


Q ss_pred             -------CCCC--------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        334 -------VTFP--------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       334 -------~~~p--------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                             ...|        ...++.+.+||.+||..||.+|||+.|++.||||....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence                   0011        13567789999999999999999999999999998643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.3e-44  Score=364.16  Aligned_cols=258  Identities=29%  Similarity=0.487  Sum_probs=218.1

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ..+++|.+.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..++
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            3567899999999999999999999999999999998654322 223456789999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||||++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        82 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          82 VFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             EEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence            9999999999988764 568999999999999999999999999999999999999999999999999997654433333


Q ss_pred             cccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------CC
Q psy18060        275 TSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-------------------DV  334 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-------------------~~  334 (549)
                      ....+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+...                   ..
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence            44567899999999865 45789999999999999999999999987765554332210                   00


Q ss_pred             CCC-----------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        335 TFP-----------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       335 ~~p-----------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ..|           ..+++.+++||.+||+.||.+|||++|+++||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            111           2468899999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-44  Score=369.09  Aligned_cols=261  Identities=26%  Similarity=0.442  Sum_probs=219.8

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+.. ........+.+|+.++..++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46999999999999999999999999999999997532 22234456788999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-cc
Q psy18060        198 EFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-ML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~  274 (549)
                      ||+. |+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            9986 689999976 46799999999999999999999999999999999999999999999999999876643322 12


Q ss_pred             cccCCCCcccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCC---ccCCHHH
Q psy18060        275 TSIKGTPLYMAPELIAE-----RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFP---SQVSETY  344 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~-----~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~~  344 (549)
                      ....||+.|+|||++..     ..++.++|||||||++|+|++|+.||...+..+....+....  ..+|   ..+++.+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            23469999999999863     457889999999999999999999999888777776665432  2333   3479999


Q ss_pred             HHHHHHhchhCcC--CCCCHHHHhcCcccCcccchhh
Q psy18060        345 KDLVKGLLEKDAS--QRLSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       345 ~dlI~~~L~~dP~--~Rps~~elL~Hpw~~~~~~~~~  379 (549)
                      +++|.+||..++.  .|+++.++++||||.+..+...
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~  277 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNI  277 (331)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHH
Confidence            9999999876444  3889999999999987644333

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.5e-44  Score=359.40  Aligned_cols=252  Identities=31%  Similarity=0.471  Sum_probs=213.0

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.+.||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            48899999999999999999999999999999875443333446678899999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        200 AHMSLSNLLEQR---KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       200 ~~gsL~~~l~~~---~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      +.++|.+++...   ..+++..++.++.||+.||+|||++||+||||||+||+++.+|.++|+|||++............
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (285)
T cd07861          81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH  160 (285)
T ss_pred             CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence            999999888653   46899999999999999999999999999999999999999999999999999766544333344


Q ss_pred             cCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------------
Q psy18060        277 IKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-----------------------  332 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-----------------------  332 (549)
                      ..+++.|+|||++.+ ..++.++|||||||++|+|+||++||.+.+.......+...                       
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
T cd07861         161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP  240 (285)
T ss_pred             CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcc
Confidence            567899999998865 45789999999999999999999999876543322211100                       


Q ss_pred             C------CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        333 D------VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       333 ~------~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      .      ......+++++.++|.+||+.||.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            0      00123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.1e-43  Score=350.45  Aligned_cols=252  Identities=30%  Similarity=0.529  Sum_probs=221.7

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-CCEEEEEEe
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-LNEFVLITE  198 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iV~E  198 (549)
                      .|++.+.||+|++|.||++.+..+++.+|+|.+............+.+|+.+++.++|||++++++.+.. ...++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4899999999999999999999999999999997655555566778999999999999999999988764 446899999


Q ss_pred             cCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        199 FAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       199 ~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |++ ++|.+++...  ..+++.++..++.|++.||.+||++||+||||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            997 5899998763  4589999999999999999999999999999999999999999999999999987654433445


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHhchh
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dlI~~~L~~  354 (549)
                      ...|++.|+|||++.+..++.++|||||||++++|++|+.||...+.......+..+.. ..|..+++.+.+++.+||+.
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  240 (257)
T cd08223         161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSK  240 (257)
T ss_pred             cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhcc
Confidence            56789999999999999999999999999999999999999998877666665555443 45667899999999999999


Q ss_pred             CcCCCCCHHHHhcCccc
Q psy18060        355 DASQRLSWPELLHHPLV  371 (549)
Q Consensus       355 dP~~Rps~~elL~Hpw~  371 (549)
                      +|.+|||+.++++||||
T Consensus       241 ~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         241 RPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CcccCCCHHHHhcCCCC
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.8e-44  Score=388.42  Aligned_cols=262  Identities=26%  Similarity=0.427  Sum_probs=228.4

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC---
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN---  191 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---  191 (549)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++.....+......+.+|+.++..++|+||++++..+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            33457899999999999999999999999999999999876666666778889999999999999999987764322   


Q ss_pred             -----EEEEEEecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeec
Q psy18060        192 -----EFVLITEFAH-MSLSNLLEQR----KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDF  261 (549)
Q Consensus       192 -----~~~iV~E~~~-gsL~~~l~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DF  261 (549)
                           .+++||||+. |+|.+++..+    ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence                 3689999998 6999998753    46899999999999999999999999999999999999999999999999


Q ss_pred             ccceecccC--cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCc
Q psy18060        262 GFARSMAVG--THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPS  338 (549)
Q Consensus       262 Gla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~p~  338 (549)
                      |+++.....  .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..+.. .+|+
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  267 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP  267 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence            999765432  1223456799999999999999999999999999999999999999999888877777665543 4678


Q ss_pred             cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       339 ~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      .+++++.+++.+||+.||.+||++.++++|||++....
T Consensus       268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~  305 (496)
T PTZ00283        268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS  305 (496)
T ss_pred             CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence            89999999999999999999999999999999876543

>KOG0667|consensus

Probab=100.00  E-value=1.6e-44  Score=383.72  Aligned_cols=251  Identities=29%  Similarity=0.475  Sum_probs=217.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-C-----CCeeEEEEEEeeCC
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-H-----PNIIKFIASHETLN  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~~~~~  191 (549)
                      -.+|.+++.||+|+||.|-+|.+..|++.||||++++.   ..-......|+.||..|+ |     -|+|+++++|...+
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            34899999999999999999999999999999999754   334566678999999996 3     38999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC--cEEEeecccceec
Q psy18060        192 EFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG--VAMLCDFGFARSM  267 (549)
Q Consensus       192 ~~~iV~E~~~gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g--~vKL~DFGla~~~  267 (549)
                      ++|||+|++..+|.++|+.++  +|+...++.|+.||+.||..||+.||||+|||||||||.+.+  .|||+|||+|+..
T Consensus       262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999999999999999999864  689999999999999999999999999999999999997654  7999999999876


Q ss_pred             ccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---------------  332 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~---------------  332 (549)
                      ...   ..+.+.+.+|+|||++.+.+|+.+.||||||||++||++|.+.|++.+..+++..|..-               
T Consensus       342 ~q~---vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~  418 (586)
T KOG0667|consen  342 SQR---VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA  418 (586)
T ss_pred             CCc---ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence            532   34778899999999999999999999999999999999999999998887777766310               


Q ss_pred             -------------------------------------CCCCCc-----------cCCHHHHHHHHHhchhCcCCCCCHHH
Q psy18060        333 -------------------------------------DVTFPS-----------QVSETYKDLVKGLLEKDASQRLSWPE  364 (549)
Q Consensus       333 -------------------------------------~~~~p~-----------~~s~~~~dlI~~~L~~dP~~Rps~~e  364 (549)
                                                           ....|+           .-...+.+||++||..||..|+|+.|
T Consensus       419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q  498 (586)
T KOG0667|consen  419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ  498 (586)
T ss_pred             ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence                                                 000110           11346789999999999999999999


Q ss_pred             HhcCcccCcc
Q psy18060        365 LLHHPLVKDN  374 (549)
Q Consensus       365 lL~Hpw~~~~  374 (549)
                      +|+||||+..
T Consensus       499 al~Hpfl~~~  508 (586)
T KOG0667|consen  499 ALNHPFLTGT  508 (586)
T ss_pred             HhcCcccccc
Confidence            9999999853

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-43  Score=349.61  Aligned_cols=252  Identities=29%  Similarity=0.479  Sum_probs=225.5

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+............+.+|+++++.++||||+++++.+...+..+++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            47889999999999999999999999999999976555566677889999999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        200 AH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       200 ~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      +. ++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++...........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  160 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT  160 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence            87 5899999774  57899999999999999999999999999999999999999999999999999876554433445


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHhchhC
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSETYKDLVKGLLEKD  355 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dlI~~~L~~d  355 (549)
                      ..|++.|+|||++.+..++.++|+|||||++++|++|+.||...+.......+..+.. .++..+++.+.++|.+||+.+
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  240 (256)
T cd08529         161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD  240 (256)
T ss_pred             cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCC
Confidence            6789999999999998899999999999999999999999998887777776665543 344578999999999999999


Q ss_pred             cCCCCCHHHHhcCccc
Q psy18060        356 ASQRLSWPELLHHPLV  371 (549)
Q Consensus       356 P~~Rps~~elL~Hpw~  371 (549)
                      |++||++.++++|||+
T Consensus       241 p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         241 YRQRPDTFQLLRNPSL  256 (256)
T ss_pred             cccCcCHHHHhhCCCC
Confidence            9999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.6e-43  Score=359.21  Aligned_cols=259  Identities=31%  Similarity=0.516  Sum_probs=233.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|+||.||++.+..+++.+|+|.+.+... .......+.+|+++++.+.||||+++++++...+.+++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            468999999999999999999999999999999875432 2234567889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||++ ++|.+++.....+++..+..++.||+.||.|||+.||+||||+|+|||++.+|.+||+|||+++.....   ...
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~  157 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYT  157 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCC
Confidence            9995 799999999889999999999999999999999999999999999999999999999999999776533   244


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCc
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      ..|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+..+...+|..+++.++++|.+||+.||
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  237 (290)
T cd05580         158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDL  237 (290)
T ss_pred             CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCH
Confidence            57899999999998888899999999999999999999999988887777777777888888999999999999999999


Q ss_pred             CCCC-----CHHHHhcCcccCcccchhhh
Q psy18060        357 SQRL-----SWPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       357 ~~Rp-----s~~elL~Hpw~~~~~~~~~~  380 (549)
                      .+|+     +++|+++||||....+....
T Consensus       238 ~~R~~~~~~~~~~l~~~~~~~~~~~~~~~  266 (290)
T cd05580         238 TKRLGNLKNGVNDIKNHPWFAGIDWIALL  266 (290)
T ss_pred             HHccCcccCCHHHHHcCcccccCCHHHHh
Confidence            9999     89999999999876654443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.8e-44  Score=362.61  Aligned_cols=252  Identities=31%  Similarity=0.493  Sum_probs=212.1

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|++.+.||+|+||.||+|.+..+|+.+|+|.+............+.+|+.+++.++||||+++++++.+.+.+++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            58899999999999999999999999999999976443333345677899999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccC
Q psy18060        200 AHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK  278 (549)
Q Consensus       200 ~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~  278 (549)
                      ++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.............
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (284)
T cd07839          81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV  160 (284)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCc
Confidence            99999988865 56799999999999999999999999999999999999999999999999999986654433344556


Q ss_pred             CCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhcC----------------C----C--
Q psy18060        279 GTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPF-KTVSILHLIRLLKTQ----------------D----V--  334 (549)
Q Consensus       279 GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf-~~~~~~~~~~~i~~~----------------~----~--  334 (549)
                      +++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+.......+...                .    .  
T Consensus       161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd07839         161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY  240 (284)
T ss_pred             cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCC
Confidence            89999999998664 4789999999999999999998885 444443333332110                0    0  


Q ss_pred             -------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        335 -------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       335 -------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                             ...+.+++++.++|.+||+.||.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                   0113468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-43  Score=352.02  Aligned_cols=253  Identities=29%  Similarity=0.514  Sum_probs=221.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS---GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ++|.+.+.||+|++|.||+|.+..+++.+|+|.+......   ......+.+|++++++++||||+++++++...+.+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4689999999999999999999999999999998754322   2234578899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ++|++. ++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++.........
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            999997 5899999988889999999999999999999999999999999999999999999999999997654322111


Q ss_pred             ---cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHHH
Q psy18060        275 ---TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFPSQVSETYKDLVK  349 (549)
Q Consensus       275 ---~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dlI~  349 (549)
                         ....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...  ...+|..+++.+.++|.
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  241 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR  241 (263)
T ss_pred             ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHH
Confidence               3356889999999999988999999999999999999999999877665555444333  34567788999999999


Q ss_pred             HhchhCcCCCCCHHHHhcCccc
Q psy18060        350 GLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      +||..+|.+|||+.++++||||
T Consensus       242 ~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         242 RTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-43  Score=368.24  Aligned_cols=261  Identities=26%  Similarity=0.441  Sum_probs=221.1

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++.+... .......+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            468999999999999999999999999999999865321 2223445788999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-cc
Q psy18060        198 EFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-ML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~  274 (549)
                      ||+. |+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            9987 689999987 46799999999999999999999999999999999999999999999999999876533222 22


Q ss_pred             cccCCCCccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCC---ccCCHHH
Q psy18060        275 TSIKGTPLYMAPELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFP---SQVSETY  344 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~-----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~~  344 (549)
                      ...+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+.......+....  ..+|   ..+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            3457999999999985     3568899999999999999999999999998888887776543  2333   3579999


Q ss_pred             HHHHHHhchhCcCC--CCCHHHHhcCcccCcccchhh
Q psy18060        345 KDLVKGLLEKDASQ--RLSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       345 ~dlI~~~L~~dP~~--Rps~~elL~Hpw~~~~~~~~~  379 (549)
                      ++||.+||..+|.+  |+++.++++||||.+.....+
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~  277 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI  277 (332)
T ss_pred             HHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHH
Confidence            99999999765544  789999999999987654433

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.4e-44  Score=373.18  Aligned_cols=255  Identities=28%  Similarity=0.453  Sum_probs=213.1

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ....+|+.++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+++++.++||||+++++++...+.+++
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence            34677899999999999999999999999999999986532 33345678899999999999999999999999999999


Q ss_pred             EEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||||+.+ +|.+    ....++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus       150 v~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        150 LLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             EEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            9999985 6653    3456788889999999999999999999999999999999999999999999998765443334


Q ss_pred             cccCCCCcccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh-cCCCCCCccCCHHHH
Q psy18060        275 TSIKGTPLYMAPELIAE-----RPYDHTADLWSLGCIAYEIHMGHPPFKTVSI---LHLIRLLK-TQDVTFPSQVSETYK  345 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~-----~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~---~~~~~~i~-~~~~~~p~~~s~~~~  345 (549)
                      ....||+.|+|||++..     ...+.++|||||||++|+|++|+.||.....   ......+. ......+..++++++
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  305 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR  305 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence            55679999999998843     2345689999999999999999999974332   22222222 233445678899999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +||.+||+.||.+|||+.|+++||||....
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            999999999999999999999999998653

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-43  Score=368.36  Aligned_cols=261  Identities=26%  Similarity=0.424  Sum_probs=221.9

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+.. ........+.+|..++..+.||||+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46999999999999999999999999999999987532 22233456788999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-cc
Q psy18060        198 EFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-ML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~  274 (549)
                      ||+. |+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++....... ..
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            9987 689999987 46799999999999999999999999999999999999999999999999999976653322 22


Q ss_pred             cccCCCCcccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCc---cCCHHH
Q psy18060        275 TSIKGTPLYMAPELIAE-----RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFPS---QVSETY  344 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~-----~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~~  344 (549)
                      ...+||+.|+|||++.+     +.++.++|||||||++|+|++|+.||...+.......+....  ..+|+   .+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            33579999999999865     568899999999999999999999999888877777765543  33443   468999


Q ss_pred             HHHHHHhchhCcCC--CCCHHHHhcCcccCcccchhh
Q psy18060        345 KDLVKGLLEKDASQ--RLSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       345 ~dlI~~~L~~dP~~--Rps~~elL~Hpw~~~~~~~~~  379 (549)
                      +++|.+||..++.+  |++++++++||||+...+...
T Consensus       241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~  277 (331)
T cd05624         241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI  277 (331)
T ss_pred             HHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence            99999999876654  568999999999987654433

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-43  Score=366.68  Aligned_cols=254  Identities=26%  Similarity=0.449  Sum_probs=216.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++...+.+++||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            367999999999999999999999999999999986542 3344567889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      ||+. ++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++......  ...
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  160 (333)
T cd06650          83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN  160 (333)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--ccc
Confidence            9997 59999999888899999999999999999999985 7999999999999999999999999998755322  224


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------------------
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL--------------------------  329 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i--------------------------  329 (549)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+                          
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (333)
T cd06650         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS  240 (333)
T ss_pred             cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhh
Confidence            457999999999999888999999999999999999999999765443332111                          


Q ss_pred             ------------------hcC-CCCCC-ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        330 ------------------KTQ-DVTFP-SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       330 ------------------~~~-~~~~p-~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                        ... ...++ ..++.++++||.+||++||.+|||+.|++.||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                              111 11111 1367899999999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-43  Score=383.02  Aligned_cols=256  Identities=29%  Similarity=0.440  Sum_probs=224.0

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCC-CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDL-KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ....|.+.+.||+|+||.||+|....+ +..+|+|.+...  .......+.+|+.+++.++|||||++++++...+.+||
T Consensus        65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            345599999999999999999998877 788999976433  23344567889999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        196 ITEFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      ||||+. |+|.+++..    +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            999997 689888754    356899999999999999999999999999999999999999999999999999876433


Q ss_pred             c--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHHH
Q psy18060        271 T--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSETYKDL  347 (549)
Q Consensus       271 ~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dl  347 (549)
                      .  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..+.. .+|..+++++.++
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  302 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKAL  302 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHH
Confidence            2  123456799999999999999999999999999999999999999999888887777765544 3567899999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      |.+||.+||.+|||+.+++.|||++..
T Consensus       303 i~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        303 LDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            999999999999999999999999643

>KOG0577|consensus

Probab=100.00  E-value=3.5e-45  Score=380.16  Aligned_cols=253  Identities=33%  Similarity=0.515  Sum_probs=227.0

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .|.-++.||.|+||.||-+++..+.+.||||.++-+. .+...++.+.+|+++|++++|||++.+-++|-.....|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3667889999999999999999999999999998665 455668899999999999999999999999999889999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      ||-|+-.+++.- .+++-|.++..|+.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|..+.+    .+++
T Consensus       107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----AnsF  182 (948)
T KOG0577|consen  107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----ANSF  182 (948)
T ss_pred             HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc----hhcc
Confidence            999998888875 46799999999999999999999999999999999999999999999999999977654    4778


Q ss_pred             CCCCccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCC-ccCCHHHHHHHHHhc
Q psy18060        278 KGTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-VTFP-SQVSETYKDLVKGLL  352 (549)
Q Consensus       278 ~GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~dlI~~~L  352 (549)
                      +|||+|||||++.   .+.|+.++||||||+++.||.-.++|+.+.+-...+..|.... +.++ +.||..+..||..||
T Consensus       183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CL  262 (948)
T KOG0577|consen  183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL  262 (948)
T ss_pred             cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence            9999999999984   4789999999999999999999999999888877776665543 3444 469999999999999


Q ss_pred             hhCcCCCCCHHHHhcCcccCcccc
Q psy18060        353 EKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       353 ~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      ++-|..|||.+++|+|+|+.....
T Consensus       263 qKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  263 QKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             hhCcccCCcHHHHhhcchhccCCC
Confidence            999999999999999999986543

>KOG0579|consensus

Probab=100.00  E-value=3.3e-45  Score=382.01  Aligned_cols=255  Identities=32%  Similarity=0.538  Sum_probs=226.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      +.|.++..||.|+||.||+|.++.++-..|.|+|..  .+..++..+.-|+.||...+||+||++++.|...+.++|..|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            458899999999999999999999999999999854  346677888999999999999999999999988899999999


Q ss_pred             cCCCCHHH-HH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        199 FAHMSLSN-LL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       199 ~~~gsL~~-~l-~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||+|.--+ ++ .-...+++.++..+++|++.||.|||+++|||||||..|||++.+|.++|+|||.+...........+
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence            99976444 33 34578999999999999999999999999999999999999999999999999988654444445567


Q ss_pred             cCCCCcccccccc-----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---CCccCCHHHHHHH
Q psy18060        277 IKGTPLYMAPELI-----AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT---FPSQVSETYKDLV  348 (549)
Q Consensus       277 ~~GT~~Y~APE~l-----~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~dlI  348 (549)
                      +.|||+|||||+.     +..+|+.++||||||++|.||..+.+|-...++..++-+|....++   -|+.|+..+.||+
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfL  269 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFL  269 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHH
Confidence            8999999999986     4578999999999999999999999999999999998888766543   4678999999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      .+||.+||..||++.++|+|||+.+..
T Consensus       270 k~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  270 KRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHHHhcCCccCCCHHHHhhCcccccCC
Confidence            999999999999999999999998653

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-43  Score=372.43  Aligned_cols=251  Identities=24%  Similarity=0.377  Sum_probs=209.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHL--DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ..+|.+++.||+|+||.||+|...  .++..+|+|.+...       ....+|+++++.++||||+++++++......++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            457999999999999999999754  34678999988643       234679999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--c
Q psy18060        196 ITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--M  273 (549)
Q Consensus       196 V~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--~  273 (549)
                      +||++.++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.......  .
T Consensus       164 v~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        164 VMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             EehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence            99999999999998788899999999999999999999999999999999999999999999999999976543321  2


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HhcCCC------------
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI---LHLIRL----LKTQDV------------  334 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~---~~~~~~----i~~~~~------------  334 (549)
                      .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+...   ...+..    +...+.            
T Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  323 (392)
T PHA03207        244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK  323 (392)
T ss_pred             ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence            2345799999999999999999999999999999999999999976432   111111    111111            


Q ss_pred             -------------CCC-----ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        335 -------------TFP-----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       335 -------------~~p-----~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                                   ..|     ..++.++++||.+||+.||++|||+.|+|.||||....
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                         111     13467889999999999999999999999999997643

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-43  Score=362.59  Aligned_cols=244  Identities=28%  Similarity=0.468  Sum_probs=194.6

Q ss_pred             EEEEecCCcEEEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--CCEEEEEEec
Q psy18060        124 ICLIGEGSFGKVFKAIHL--DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--LNEFVLITEF  199 (549)
Q Consensus       124 ~~~iG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~iV~E~  199 (549)
                      .+.||+|+||.||+|.++  .+++.+|+|.+......    ..+.+|+++++.++||||+++++++..  ...++++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            468999999999999965  46788999998654322    346789999999999999999998843  4578999999


Q ss_pred             CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE----ecCCcEEEeeccccee
Q psy18060        200 AHMSLSNLLEQR---------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL----NKDGVAMLCDFGFARS  266 (549)
Q Consensus       200 ~~gsL~~~l~~~---------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl----~~~g~vKL~DFGla~~  266 (549)
                      ++++|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+|+.
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            999999888642         258999999999999999999999999999999999999    4557899999999986


Q ss_pred             cccCc---ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHhcC-
Q psy18060        267 MAVGT---HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSI---------LHLIRLLKTQ-  332 (549)
Q Consensus       267 ~~~~~---~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~---------~~~~~~i~~~-  332 (549)
                      .....   .......||+.|+|||++.+ ..++.++||||+||++|+|++|++||.....         ......+... 
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            64321   12244678999999999876 4589999999999999999999999964321         0111111000 


Q ss_pred             ---------------------------CCC----------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        333 ---------------------------DVT----------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       333 ---------------------------~~~----------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                                 ...          .....+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                       000          001235678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6e-43  Score=352.66  Aligned_cols=253  Identities=32%  Similarity=0.566  Sum_probs=213.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++.+......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46899999999999999999999999999999987544333334567889999999999999999999999999999999


Q ss_pred             cCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~gs-L~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      |++++ |..++.....+++..++.++.||+.||.|||+.|++||||||+||+++.+|.++|+|||++.............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY  160 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence            99965 55555566679999999999999999999999999999999999999999999999999998765443333445


Q ss_pred             CCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------CCCCC
Q psy18060        278 KGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-------------------DVTFP  337 (549)
Q Consensus       278 ~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~p  337 (549)
                      .++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+...                   ....|
T Consensus       161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07847         161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP  240 (286)
T ss_pred             ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence            68899999999866 55889999999999999999999999887654443332110                   00001


Q ss_pred             ------------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        338 ------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       338 ------------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                  +.++..+.+||.+||+.+|.+|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                        2468889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.9e-43  Score=355.43  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=216.4

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .|+..+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++||+|+.+++.+...+.+++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            377889999999999999999999999999998754322 2233456789999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        199 FAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       199 ~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |+. ++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... ...
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  159 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIK  159 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-ccc
Confidence            987 5899888654  358999999999999999999999999999999999999999999999999987654332 223


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHH-HHhcCCCCCCccCCHHHHHHHHHh
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL---HLIR-LLKTQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~---~~~~-~i~~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      ...||+.|+|||++.+..++.++||||+||++|+|++|+.||......   .... ........++..+++++.+|+.+|
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (285)
T cd05630         160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML  239 (285)
T ss_pred             CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence            457999999999999989999999999999999999999999865321   1121 122223345677899999999999


Q ss_pred             chhCcCCCCC-----HHHHhcCcccCcccc
Q psy18060        352 LEKDASQRLS-----WPELLHHPLVKDNLS  376 (549)
Q Consensus       352 L~~dP~~Rps-----~~elL~Hpw~~~~~~  376 (549)
                      |+.||.+|||     ++|+++||||+....
T Consensus       240 l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         240 LCKDPKERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             hhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence            9999999999     899999999976433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.3e-43  Score=354.21  Aligned_cols=252  Identities=27%  Similarity=0.414  Sum_probs=210.3

Q ss_pred             EecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CCH
Q psy18060        127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSL  204 (549)
Q Consensus       127 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL  204 (549)
                      ||+|+||.||++..+.+|+.||+|.+...... .........|+++++.++||||+++++++.....+++||||+. ++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999999999999999998653321 1223445679999999999999999999999999999999997 589


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCc
Q psy18060        205 SNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL  282 (549)
Q Consensus       205 ~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~  282 (549)
                      .+++...  ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++....... ......||+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~  159 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG  159 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCC
Confidence            8887654  358899999999999999999999999999999999999999999999999997665432 2344579999


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCCCC-ccCCHHHHHHHHHhchhCcC
Q psy18060        283 YMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFP-SQVSETYKDLVKGLLEKDAS  357 (549)
Q Consensus       283 Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~----~~~~~~~i~~~~~~~p-~~~s~~~~dlI~~~L~~dP~  357 (549)
                      |+|||++.+..++.++|||||||++|+|++|+.||....    .......+......++ ..++++++++|.+||++||.
T Consensus       160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~  239 (277)
T cd05607         160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE  239 (277)
T ss_pred             ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence            999999988889999999999999999999999997643    2333344443333333 46899999999999999999


Q ss_pred             CCCCH----HHHhcCcccCcccchhh
Q psy18060        358 QRLSW----PELLHHPLVKDNLSSEI  379 (549)
Q Consensus       358 ~Rps~----~elL~Hpw~~~~~~~~~  379 (549)
                      +||++    ++++.||||+....+..
T Consensus       240 ~R~~~~~~~~~~~~h~~f~~~~~~~~  265 (277)
T cd05607         240 DRLGSREKNDDPRKHEFFKTINFPRL  265 (277)
T ss_pred             hCCCCccchhhhhcChhhcCCCHHHH
Confidence            99999    67889999987544443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-42  Score=352.96  Aligned_cols=259  Identities=26%  Similarity=0.400  Sum_probs=221.1

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .|+..+.||+|+||+||++.+..+++.+|+|.+...... ......+.+|+++++.++||||+.+.+.+...+..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            377889999999999999999999999999998654322 2233456789999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        199 FAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       199 ~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |+. ++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  159 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIR  159 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-ccc
Confidence            998 5888887653  469999999999999999999999999999999999999999999999999987654332 224


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCCCCCccCCHHHHHHHHHh
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI----RLLKTQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~----~~i~~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      ...||+.|+|||++.+..++.++|+|||||++|+|++|..||.........    ..+......++..+++++.+|+.+|
T Consensus       160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML  239 (285)
T ss_pred             CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence            457999999999999889999999999999999999999999877654332    3333444456678899999999999


Q ss_pred             chhCcCCCCC-----HHHHhcCcccCcccchhh
Q psy18060        352 LEKDASQRLS-----WPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       352 L~~dP~~Rps-----~~elL~Hpw~~~~~~~~~  379 (549)
                      |+.||.+|||     +.+++.||||+.......
T Consensus       240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~  272 (285)
T cd05632         240 LTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL  272 (285)
T ss_pred             ccCCHhHcCCCcccChHHHHcChhhhcCCHHHH
Confidence            9999999999     889999999988755443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0197|consensus

Probab=100.00  E-value=7.9e-44  Score=371.12  Aligned_cols=244  Identities=25%  Similarity=0.412  Sum_probs=215.0

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .+.+++++.||+|.||.||.|.... ...||+|.+.....+.   ..+.+|+++|++|+|+|||++++++...+.+||||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            3456788899999999999999874 4579999997654333   46779999999999999999999999988999999


Q ss_pred             ecCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        198 EFAH-MSLSNLLEQ--RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||+. |+|.++|+.  +..+...+...++.|||+|++||+++++|||||...|||+++++.+||+|||+|+....+....
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            9998 899999997  5678999999999999999999999999999999999999999999999999999554433222


Q ss_pred             c-ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHh
Q psy18060        275 T-SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       275 ~-~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~  351 (549)
                      . ...-...|+|||.+..+.++.|||||||||+||||+| |+.||.+.+..+.++.+..+ +++.|+.+|+++.+++..|
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C  440 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC  440 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence            1 1223456999999999999999999999999999998 99999999999999999876 4667889999999999999


Q ss_pred             chhCcCCCCCHHHH
Q psy18060        352 LEKDASQRLSWPEL  365 (549)
Q Consensus       352 L~~dP~~Rps~~el  365 (549)
                      |..+|++|||++.+
T Consensus       441 W~~~P~~RPtF~~L  454 (468)
T KOG0197|consen  441 WHEDPEDRPTFETL  454 (468)
T ss_pred             hhCCcccCCCHHHH
Confidence            99999999999755

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.6e-43  Score=351.39  Aligned_cols=251  Identities=29%  Similarity=0.516  Sum_probs=215.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....  ......+.+|+.+++.++||||+++++.+...+..+++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            357899999999999999999999999999999986542  233456788999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||++ ++|.+++...+.+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++............
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06645          86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS  165 (267)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence            9998 589999998889999999999999999999999999999999999999999999999999998766543333345


Q ss_pred             cCCCCccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-----ccCCHHHHHHH
Q psy18060        277 IKGTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP-----SQVSETYKDLV  348 (549)
Q Consensus       277 ~~GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~dlI  348 (549)
                      ..||+.|+|||++.   ...++.++|+|||||++|+|++|..||...................+     ..++..+.++|
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  245 (267)
T cd06645         166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV  245 (267)
T ss_pred             ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHH
Confidence            57999999999974   45688999999999999999999999976654443333322222211     24788999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPL  370 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw  370 (549)
                      .+||+.+|++|||+.++++|||
T Consensus       246 ~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         246 KMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHccCCchhCcCHHHHhcCCC
Confidence            9999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.1e-43  Score=357.73  Aligned_cols=258  Identities=29%  Similarity=0.459  Sum_probs=217.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--CEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--NEFV  194 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~  194 (549)
                      .+++|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.++++++||||+++++++...  +.++
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            56789999999999999999999999999999999875433222233456799999999999999999998654  5689


Q ss_pred             EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      +||||++++|.+++.. ...+++.++..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus        85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            9999999999999876 367899999999999999999999999999999999999999999999999999876544333


Q ss_pred             ccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------C
Q psy18060        274 LTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-------------------D  333 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-------------------~  333 (549)
                      .+...+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+...                   .
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK  244 (309)
T ss_pred             CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence            344456888999999865 56899999999999999999999999988877666554331                   0


Q ss_pred             CCCC-----------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        334 VTFP-----------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       334 ~~~p-----------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ...+           ...++++.+||.+||+.||.+|||+.+++.||||++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            0111           1258889999999999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-42  Score=346.35  Aligned_cols=252  Identities=29%  Similarity=0.557  Sum_probs=219.0

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh-------HHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-------KELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      +|.+...||+|++|.||+|.+..+++.+|+|.+.......       .....+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999999889999999986543321       223568899999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      .+++|||++ ++|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            999999997 4899999988889999999999999999999999999999999999999999999999999987664221


Q ss_pred             c------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHH
Q psy18060        272 H------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETY  344 (549)
Q Consensus       272 ~------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  344 (549)
                      .      ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+....+..+... ...+|..++..+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA  240 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHH
Confidence            1      112345889999999999888999999999999999999999999887665555444333 345677889999


Q ss_pred             HHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        345 KDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      .++|.+||+.||.+||++.++++||||
T Consensus       241 ~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         241 IDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.8e-43  Score=352.56  Aligned_cols=252  Identities=33%  Similarity=0.499  Sum_probs=213.1

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|+.++.||.|++|.||+|.+..+++.||+|.+............+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            48899999999999999999999999999999875443333445788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        200 AHMSLSNLLEQ--RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       200 ~~gsL~~~l~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      ++++|.+++..  ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.+||+|||+++............
T Consensus        81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (284)
T cd07860          81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE  160 (284)
T ss_pred             cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence            99899998865  3568999999999999999999999999999999999999999999999999987665443333445


Q ss_pred             CCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-C-----------------C----
Q psy18060        278 KGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-D-----------------V----  334 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-~-----------------~----  334 (549)
                      .+++.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+.......+... .                 .    
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd07860         161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK  240 (284)
T ss_pred             cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccc
Confidence            678999999988664 4688999999999999999999999877654333222110 0                 0    


Q ss_pred             -------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        335 -------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       335 -------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                             ...+.++++++++|.+||+.||.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                   0123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.4e-43  Score=348.35  Aligned_cols=251  Identities=29%  Similarity=0.456  Sum_probs=214.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ..+|++.+.||+|+||.||+|.+..+++.+|+|++.....  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            4579999999999999999999999999999999865422  23456789999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||++ ++|.+++..+..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++............
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06646          86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS  165 (267)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence            9998 589999988888999999999999999999999999999999999999999999999999999876533322344


Q ss_pred             cCCCCccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCccCCHHHHHHH
Q psy18060        277 IKGTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-----FPSQVSETYKDLV  348 (549)
Q Consensus       277 ~~GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~dlI  348 (549)
                      ..|++.|+|||.+.   ...++.++|+||+||++|+|++|+.||...........+......     .+..++..+.+||
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  245 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFV  245 (267)
T ss_pred             cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHH
Confidence            56899999999984   355788999999999999999999999766544433333222222     1235789999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPL  370 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw  370 (549)
                      .+||+.+|.+|||++++++|+|
T Consensus       246 ~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         246 KISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-43  Score=351.84  Aligned_cols=254  Identities=33%  Similarity=0.553  Sum_probs=221.5

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||.|+||.||+|.+..++..+|+|.+...  .......+.+|+.+++.++||||+++++.+......++|||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            5699999999999999999999989999999998653  33445678899999999999999999999999999999999


Q ss_pred             cCCC-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        199 FAHM-SLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       199 ~~~g-sL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++............
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence            9985 899988764 56999999999999999999999999999999999999999999999999998665433333345


Q ss_pred             cCCCCccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCccCCHHHHHHH
Q psy18060        277 IKGTPLYMAPELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---TFPSQVSETYKDLV  348 (549)
Q Consensus       277 ~~GT~~Y~APE~l~-----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~dlI  348 (549)
                      ..||+.|+|||++.     +..++.++|+|||||++|+|++|++||...+.......+.....   ..|..++.++.++|
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFL  242 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHH
Confidence            57899999999974     34578899999999999999999999998877776666655432   34567899999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+||+.+|.+|||+.++++||||.+.
T Consensus       243 ~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         243 KSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHhccChhhCcCHHHHhcChhhccc
Confidence            99999999999999999999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2e-42  Score=343.53  Aligned_cols=252  Identities=29%  Similarity=0.520  Sum_probs=223.3

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|++.+.||+|+||.||++.+..+++.||+|.+............+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            58899999999999999999999999999999976554555566889999999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        200 AH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       200 ~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      +. ++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++............
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART  160 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence            97 58999987643  5799999999999999999999999999999999999999999999999999766543333334


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHhchhC
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLLEKD  355 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~L~~d  355 (549)
                      ..|++.|+|||++.+..++.++|+|||||++++|++|+.||...+.......+..+. ...|..++.++.++|.+||..+
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  240 (256)
T cd08218         161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRN  240 (256)
T ss_pred             ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCC
Confidence            568999999999998889999999999999999999999999888777766655443 3456778999999999999999


Q ss_pred             cCCCCCHHHHhcCccc
Q psy18060        356 ASQRLSWPELLHHPLV  371 (549)
Q Consensus       356 P~~Rps~~elL~Hpw~  371 (549)
                      |.+||++.++++||||
T Consensus       241 p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         241 PRDRPSVNSILEKNFI  256 (256)
T ss_pred             hhhCcCHHHHhhCcCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=354.69  Aligned_cols=261  Identities=33%  Similarity=0.505  Sum_probs=226.9

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh-HHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+.+..... .....+.+|+++++.+.||||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36899999999999999999999999999999997654332 34567889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--
Q psy18060        198 EFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--  272 (549)
Q Consensus       198 E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--  272 (549)
                      ||+. ++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.+|.++|+|||++........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            9987 5899998764  5689999999999999999999999999999999999999999999999999865432110  


Q ss_pred             ---------------------------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy18060        273 ---------------------------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL  325 (549)
Q Consensus       273 ---------------------------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~  325 (549)
                                                 ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                       11234689999999999988899999999999999999999999998887777


Q ss_pred             HHHHhcCCCCCCcc--CCHHHHHHHHHhchhCcCCCCC----HHHHhcCcccCcccchhh
Q psy18060        326 IRLLKTQDVTFPSQ--VSETYKDLVKGLLEKDASQRLS----WPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       326 ~~~i~~~~~~~p~~--~s~~~~dlI~~~L~~dP~~Rps----~~elL~Hpw~~~~~~~~~  379 (549)
                      ...+......+|..  +++.+.++|.+||..||.+|||    ++|+++||||+....+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~  300 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI  300 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhc
Confidence            77766666555544  6999999999999999999999    999999999987655444

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-43  Score=368.58  Aligned_cols=247  Identities=26%  Similarity=0.383  Sum_probs=203.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ..+|++++.||+|+||.||+|.+..++..||+|+....        ....|+.++++++||||+++++++...+..++||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            35699999999999999999999999999999985432        2246899999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |++.++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus       137 e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~  215 (357)
T PHA03209        137 PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLG  215 (357)
T ss_pred             EccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-ccccc
Confidence            9999999998865 456999999999999999999999999999999999999999999999999998754322 22345


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCH----------HHHHHHHh---cCCCCCC-----
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF-KTVSI----------LHLIRLLK---TQDVTFP-----  337 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf-~~~~~----------~~~~~~i~---~~~~~~p-----  337 (549)
                      ..||+.|+|||++.+..++.++|||||||++|||+++..|+ .....          ......+.   ..+..+|     
T Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  295 (357)
T PHA03209        216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS  295 (357)
T ss_pred             ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence            67999999999999999999999999999999999855444 32110          11111111   0111111     


Q ss_pred             -------------------------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        338 -------------------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       338 -------------------------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                                               ..++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                     135667788999999999999999999999999975

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.8e-42  Score=342.50  Aligned_cols=252  Identities=34%  Similarity=0.590  Sum_probs=223.4

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe--eCCEEEEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE--TLNEFVLIT  197 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~iV~  197 (549)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+............+.+|+++++.++||||+++++.+.  .....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            488999999999999999999999999999999776666666778889999999999999999998774  345689999


Q ss_pred             ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCccccccCCcEEEecCCcEEEeecccceec
Q psy18060        198 EFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLH-----SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       198 E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH-----~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~  267 (549)
                      ||++ ++|.+++..    ...+++..++.++.||+.||.|||     +.+++||||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9997 589999876    357899999999999999999999     899999999999999999999999999999876


Q ss_pred             ccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHH
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSETYKD  346 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~d  346 (549)
                      ...........|++.|+|||++.+..++.++|+||||+++++|++|+.||...+.......+..+.. .+|..++..+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNE  240 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence            5544334456799999999999988899999999999999999999999998887777776665543 466788999999


Q ss_pred             HHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        347 LVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      ++.+||+.+|.+|||+.+|++|||+
T Consensus       241 l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         241 VIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHccCCcccCCCHHHHhhCCCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=348.19  Aligned_cols=256  Identities=33%  Similarity=0.554  Sum_probs=223.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|+++++.++||||+++++.+.....+++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            36888999999999999999999999999999987543 23445678899999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      |+. ++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++............
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF  158 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence            987 5899998865 89999999999999999999999999999999999999999999999999998776543334556


Q ss_pred             CCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCcc-CCHHHHHHHHHhchhC
Q psy18060        278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-VTFPSQ-VSETYKDLVKGLLEKD  355 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~dlI~~~L~~d  355 (549)
                      .|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.... ...+.. +++.+.+++.+||..+
T Consensus       159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~  238 (274)
T cd06609         159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKD  238 (274)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCC
Confidence            78999999999998889999999999999999999999998877666555554442 233334 7899999999999999


Q ss_pred             cCCCCCHHHHhcCcccCcccc
Q psy18060        356 ASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       356 P~~Rps~~elL~Hpw~~~~~~  376 (549)
                      |.+|||++++++||||.....
T Consensus       239 p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         239 PKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             hhhCcCHHHHhhChhhcCCCc
Confidence            999999999999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=343.23  Aligned_cols=250  Identities=30%  Similarity=0.516  Sum_probs=218.6

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+.....  .....+.+|+.+++.++||||+++++.+...+.++++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            579999999999999999999999999999999975432  245788999999999999999999999999999999999


Q ss_pred             cCCC-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        199 FAHM-SLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       199 ~~~g-sL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++............
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence            9985 899988776 78999999999999999999999999999999999999999999999999998766543333345


Q ss_pred             cCCCCcccccccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCccCCHHHHHHH
Q psy18060        277 IKGTPLYMAPELIAER---PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-----FPSQVSETYKDLV  348 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~---~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~dlI  348 (549)
                      ..|+..|+|||.+.+.   .++.++|+|||||++|+|++|++||...+.......+......     .+..++.++.+|+
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI  240 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence            6789999999999776   7899999999999999999999999887766555544443221     2345678999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPL  370 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw  370 (549)
                      .+||..+|.+|||+.+++.|||
T Consensus       241 ~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         241 KKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.1e-42  Score=349.96  Aligned_cols=259  Identities=32%  Similarity=0.516  Sum_probs=220.9

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ...+.|++++.||.|+||.||+|.+..+++.+|+|.+...  +......+.+|+.+++.++||||+++++.+...+.+++
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            3447799999999999999999999999999999998653  34456778899999999999999999999999999999


Q ss_pred             EEecCCC-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        196 ITEFAHM-SLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       196 V~E~~~g-sL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      ||||+++ +|..++.+ ...+++..+..++.|++.||.|||+.|++||||||+||+++.+|.++|+|||++.........
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            9999985 67777654 457899999999999999999999999999999999999999999999999998765433333


Q ss_pred             ccccCCCCccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCccCCHHHH
Q psy18060        274 LTSIKGTPLYMAPELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---TFPSQVSETYK  345 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~-----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~  345 (549)
                      .....|++.|+|||++.     ...++.++|||||||++|+|++|.+||...+.......+.....   ..|..++.++.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR  246 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence            34556899999999984     34578899999999999999999999988776665555543322   23557889999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      ++|.+||..+|.+||+++++++||||.....
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         247 DFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             HHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            9999999999999999999999999975433

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.9e-42  Score=340.14  Aligned_cols=252  Identities=30%  Similarity=0.495  Sum_probs=225.3

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|+.++.||.|+||.||.+....+++.+++|.+.....+......+.+|+.++++++||||+++++++.+.+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            58999999999999999999999999999999876655556667788999999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        200 AH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       200 ~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ++ ++|.+++.+.  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||+++...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET  160 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence            97 5899999875  46899999999999999999999999999999999999999999999999999876544333455


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCccCCHHHHHHHHHhchhC
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-FPSQVSETYKDLVKGLLEKD  355 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~dlI~~~L~~d  355 (549)
                      ..|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+..+... .+..++.++.++|.+||..+
T Consensus       161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  240 (256)
T cd08221         161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD  240 (256)
T ss_pred             cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccC
Confidence            67999999999998888999999999999999999999999988887777776655432 34567999999999999999


Q ss_pred             cCCCCCHHHHhcCccc
Q psy18060        356 ASQRLSWPELLHHPLV  371 (549)
Q Consensus       356 P~~Rps~~elL~Hpw~  371 (549)
                      |.+|||+.++++|||+
T Consensus       241 p~~R~s~~~ll~~~~l  256 (256)
T cd08221         241 PEKRPTADEVLDQPLL  256 (256)
T ss_pred             cccCCCHHHHhhCcCC
Confidence            9999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-42  Score=359.37  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=207.0

Q ss_pred             EEEEEecC--CcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecC
Q psy18060        123 KICLIGEG--SFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA  200 (549)
Q Consensus       123 ~~~~iG~G--~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~  200 (549)
                      ++++||+|  +||+||++.++.+|+.||+|.+............+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  7899999999999999999999765444555667888999999999999999999999999999999999


Q ss_pred             C-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-----
Q psy18060        201 H-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-----  272 (549)
Q Consensus       201 ~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-----  272 (549)
                      . |+|.+++..+  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||.+........     
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            8 6899998753  4589999999999999999999999999999999999999999999999986543321100     


Q ss_pred             --cccccCCCCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------------
Q psy18060        273 --MLTSIKGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV--------------  334 (549)
Q Consensus       273 --~~~~~~GT~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~--------------  334 (549)
                        ......++..|+|||++.+  ..++.++|||||||++|+|++|+.||..............+..              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL  241 (327)
T ss_pred             ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence              1122356788999999975  4689999999999999999999999986554333222211110              


Q ss_pred             --------------------------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        335 --------------------------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       335 --------------------------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                                      +....+++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                            0112357789999999999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.3e-42  Score=348.94  Aligned_cols=252  Identities=33%  Similarity=0.560  Sum_probs=216.7

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecC
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA  200 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~  200 (549)
                      |++.+.||+|+||.||+|.+..++..+|+|.+...  .......+.+|+++++.++||||+++++.+...+..++||||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            68889999999999999999999999999998643  2345567889999999999999999999999999999999999


Q ss_pred             CC-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccC
Q psy18060        201 HM-SLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK  278 (549)
Q Consensus       201 ~g-sL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~  278 (549)
                      ++ +|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..............
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  164 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI  164 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence            84 78777754 46799999999999999999999999999999999999999999999999999876543333334457


Q ss_pred             CCCccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCccCCHHHHHHHHH
Q psy18060        279 GTPLYMAPELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD---VTFPSQVSETYKDLVKG  350 (549)
Q Consensus       279 GT~~Y~APE~l~-----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~dlI~~  350 (549)
                      ||+.|+|||++.     +..++.++|||||||++|+|++|++||...+.......+....   ...|..++.++.+||.+
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (282)
T cd06643         165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKK  244 (282)
T ss_pred             ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHH
Confidence            899999999983     4557889999999999999999999998877666555544332   23456789999999999


Q ss_pred             hchhCcCCCCCHHHHhcCcccCcc
Q psy18060        351 LLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ||..||.+||++.++++||||+..
T Consensus       245 ~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         245 CLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HccCChhhCcCHHHHhcCCCEecc
Confidence            999999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.4e-42  Score=350.53  Aligned_cols=254  Identities=33%  Similarity=0.572  Sum_probs=221.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ..+|++.+.||.|++|.||+|.+..+++.+|+|.+.....  .....+.+|+.+++.++||||+++++++...+.+++|+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            3669999999999999999999999999999999865432  23456789999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||+. ++|..++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++............
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            9997 588888865 46899999999999999999999999999999999999999999999999998766544333345


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCCccCCHHHHHHHHHhch
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---DVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ..|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...   ....|..+++.+.++|.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE  254 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence            57899999999999888999999999999999999999999988776555444332   223456789999999999999


Q ss_pred             hCcCCCCCHHHHhcCcccCcc
Q psy18060        354 KDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .||.+|||+.++++||||...
T Consensus       255 ~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         255 MDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             cChhhCCCHHHHhhChHhhhc
Confidence            999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-42  Score=361.13  Aligned_cols=249  Identities=26%  Similarity=0.460  Sum_probs=204.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeC-
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIH-----LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETL-  190 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-  190 (549)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+ +||||+++++++... 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            35799999999999999999975     234568999998643 2334456788999999999 899999999987654 


Q ss_pred             CEEEEEEecCC-CCHHHHHHhc----------------------------------------------------------
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQR----------------------------------------------------------  211 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~----------------------------------------------------------  211 (549)
                      ..++++|||++ |+|.+++...                                                          
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46899999998 6899998753                                                          


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--cccccCCCCcccc
Q psy18060        212 ----KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMA  285 (549)
Q Consensus       212 ----~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~A  285 (549)
                          ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  ......+|+.|+|
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence                2377888899999999999999999999999999999999999999999999976533211  1123346788999


Q ss_pred             cccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhcC-CCCCCccCCHHHHHHHHHhchhCcCCCCCH
Q psy18060        286 PELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILH-LIRLLKTQ-DVTFPSQVSETYKDLVKGLLEKDASQRLSW  362 (549)
Q Consensus       286 PE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~  362 (549)
                      ||++.+..++.++|||||||++|||++ |..||.+..... ....+..+ ....|..+++.+.+++.+||+.||.+|||+
T Consensus       245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  324 (338)
T cd05102         245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTF  324 (338)
T ss_pred             cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence            999999899999999999999999997 999998765432 33333333 334567889999999999999999999999


Q ss_pred             HHHhc
Q psy18060        363 PELLH  367 (549)
Q Consensus       363 ~elL~  367 (549)
                      .|+++
T Consensus       325 ~el~~  329 (338)
T cd05102         325 SALVE  329 (338)
T ss_pred             HHHHH
Confidence            99875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.5e-43  Score=346.92  Aligned_cols=251  Identities=33%  Similarity=0.525  Sum_probs=223.6

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+.+... .......+.+|++++++++||||+++++.+...+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            48899999999999999999999999999999976543 22456788999999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      |+. ++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~  159 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTST  159 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-ccccc
Confidence            997 5899999888889999999999999999999999999999999999999999999999999987665432 23445


Q ss_pred             CCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCCCCccCCHHHHHHHHHhchh
Q psy18060        278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      .|+..|+|||++.+..++.++|+||||+++|+|++|..||...+   ...............|..+++.+.++|.+||+.
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (258)
T cd05578         160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER  239 (258)
T ss_pred             CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccC
Confidence            68999999999988889999999999999999999999998776   445444444456677888999999999999999


Q ss_pred             CcCCCCCH--HHHhcCccc
Q psy18060        355 DASQRLSW--PELLHHPLV  371 (549)
Q Consensus       355 dP~~Rps~--~elL~Hpw~  371 (549)
                      ||.+||++  .|+++||||
T Consensus       240 ~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         240 DPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ChhHcCCccHHHHhcCCCC
Confidence            99999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.2e-42  Score=352.47  Aligned_cols=253  Identities=27%  Similarity=0.468  Sum_probs=216.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+... ........+.+|+++++.++||||+++++.+...+.++++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            3689999999999999999999999999999998653 233445668899999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        199 FAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |++ ++|.+++.+.+.+++..+..++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++......  ....
T Consensus        80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~  157 (308)
T cd06615          80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS  157 (308)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--cccc
Confidence            997 5899999988889999999999999999999998 59999999999999999999999999998765332  2345


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------------
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ------------------------  332 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~------------------------  332 (549)
                      ..|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+...                        
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence            57899999999998888999999999999999999999999765543333222111                        


Q ss_pred             -------------CCCCC-ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        333 -------------DVTFP-SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       333 -------------~~~~p-~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                   .+..| ..++.++.+||.+||..+|.+|||+.++++||||.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                         11111 1367889999999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3e-42  Score=349.72  Aligned_cols=254  Identities=27%  Similarity=0.424  Sum_probs=211.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCE-----
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNE-----  192 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~-----  192 (549)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3689999999999999999999999999999998654333333456788999999994 6999999999876655     


Q ss_pred             EEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec-CCcEEEeeccccee
Q psy18060        193 FVLITEFAHMSLSNLLEQR-----KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK-DGVAMLCDFGFARS  266 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~-~g~vKL~DFGla~~  266 (549)
                      .|++|||++++|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            8999999999999988653     35799999999999999999999999999999999999998 88999999999976


Q ss_pred             cccCcccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------
Q psy18060        267 MAVGTHMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD------------  333 (549)
Q Consensus       267 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~------------  333 (549)
                      ........+...+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....            
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            5443333344467899999998865 457999999999999999999999998876655443332100            


Q ss_pred             --------CC--------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        334 --------VT--------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       334 --------~~--------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                              ..        ..+.+++++.+||.+||.+||.+|||+.|++.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                    00        0134789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.3e-42  Score=350.59  Aligned_cols=238  Identities=19%  Similarity=0.294  Sum_probs=207.7

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh-HHHHHHHHHHHHHHhcCCCCeeEEEEEEee----CCEEEEEEec
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHLAHPNIIKFIASHET----LNEFVLITEF  199 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~iV~E~  199 (549)
                      ..||+|++|.||+|..  +|+.||+|.+....... .....+.+|+.++++++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5799999999999987  58999999997654332 234678899999999999999999999866    4578999999


Q ss_pred             CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        200 AH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       200 ~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      +. |+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+|||++.+|.+||+|||+++.....   ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~  180 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKN  180 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---cccc
Confidence            98 58999999888999999999999999999999984 9999999999999999999999999999765432   2345


Q ss_pred             CCCCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHhch
Q psy18060        278 KGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       278 ~GT~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      .||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+..+....+...  .+.+|...++++++++.+||+
T Consensus       181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~  260 (283)
T PHA02988        181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS  260 (283)
T ss_pred             cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence            68999999999976  68999999999999999999999999998888877776433  345566789999999999999


Q ss_pred             hCcCCCCCHHHHhc
Q psy18060        354 KDASQRLSWPELLH  367 (549)
Q Consensus       354 ~dP~~Rps~~elL~  367 (549)
                      .||.+|||+.|+++
T Consensus       261 ~dp~~Rps~~ell~  274 (283)
T PHA02988        261 HDSIKRPNIKEILY  274 (283)
T ss_pred             CCcccCcCHHHHHH
Confidence            99999999999975

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-42  Score=391.46  Aligned_cols=263  Identities=34%  Similarity=0.540  Sum_probs=220.2

Q ss_pred             cccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--C
Q psy18060        113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--L  190 (549)
Q Consensus       113 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~  190 (549)
                      .....+.+|.+++.||+|+||.||+|.+..++..+|+|++............+..|+.+++.+.|||||+++++|..  .
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            34456688999999999999999999999999999999998765555666788999999999999999999998854  4


Q ss_pred             CEEEEEEecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-------CCccccccCCcEEEec------
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQR----KKLSETICVQILSNLISALYYLHSN-------RVLHRDLKPQNVLLNK------  252 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~----~~l~e~~~~~i~~qIl~aL~yLH~~-------gIiHrDIKP~NILl~~------  252 (549)
                      ..+||||||+. ++|.++|...    ..+++..++.|+.||+.||.|||+.       +||||||||+||||+.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            57899999998 5999998753    5799999999999999999999984       4999999999999964      


Q ss_pred             -----------CCcEEEeecccceecccCcccccccCCCCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q psy18060        253 -----------DGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKT  319 (549)
Q Consensus       253 -----------~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~  319 (549)
                                 .+.+||+|||+++...... ......||+.|+|||++.+  ..++.++||||||||||+|+||..||..
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                       2358999999998664332 2345579999999999854  4589999999999999999999999976


Q ss_pred             CCH-HHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        320 VSI-LHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       320 ~~~-~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      .+. ...+..+...+.......++++.+||..||..+|.+||++.|+|.|||++....
T Consensus       246 ~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        246 ANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             CCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            554 344444444332223467899999999999999999999999999999986543

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.9e-42  Score=346.52  Aligned_cols=256  Identities=30%  Similarity=0.509  Sum_probs=210.5

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHH-HHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI-QKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|+||.||++.+..+|+.||+|.+......... ..+..|+.+ ++.++||||+++++++...+.+|++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            3689999999999999999999999999999998765433333 344445554 67779999999999999999999999


Q ss_pred             ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        198 EFAHMSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       198 E~~~gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ||++|+|.+++..    ...+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++..... .
T Consensus        80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~  158 (283)
T cd06617          80 EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-V  158 (283)
T ss_pred             hhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc-c
Confidence            9999999888764    24689999999999999999999998 9999999999999999999999999998765432 1


Q ss_pred             cccccCCCCcccccccccC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCCCCC-ccCCHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAE----RPYDHTADLWSLGCIAYEIHMGHPPFKTVS--ILHLIRLLKTQDVTFP-SQVSETYK  345 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~----~~y~~ksDIwSlGvil~eLltG~~Pf~~~~--~~~~~~~i~~~~~~~p-~~~s~~~~  345 (549)
                      ..+...|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||....  .......+......+| ..+|+++.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  238 (283)
T cd06617         159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ  238 (283)
T ss_pred             ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHH
Confidence            2233568999999998864    457899999999999999999999997532  2233222322333343 35799999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      ++|.+||..+|.+|||+.+++.||||.....
T Consensus       239 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         239 DFVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence            9999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.4e-42  Score=349.36  Aligned_cols=261  Identities=26%  Similarity=0.462  Sum_probs=224.4

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+...+.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            368999999999999999999999999999999876432 2234457789999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-----
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-----  271 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-----  271 (549)
                      ||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.+|.++|+|||+++......     
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            9997 5899999988889999999999999999999999999999999999999999999999999986321100     


Q ss_pred             ----------ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---
Q psy18060        272 ----------HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS---  338 (549)
Q Consensus       272 ----------~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~---  338 (549)
                                .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+.......|.   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE  240 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence                      0112245788999999998888999999999999999999999999988888777776665444332   


Q ss_pred             cCCHHHHHHHHHhchhCcCCCCC---HHHHhcCcccCcccchhh
Q psy18060        339 QVSETYKDLVKGLLEKDASQRLS---WPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       339 ~~s~~~~dlI~~~L~~dP~~Rps---~~elL~Hpw~~~~~~~~~  379 (549)
                      .+++++.++|.+||+.+|.+||+   +.++++||||........
T Consensus       241 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~  284 (305)
T cd05609         241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL  284 (305)
T ss_pred             cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence            57899999999999999999998   799999999976554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.9e-42  Score=349.40  Aligned_cols=255  Identities=29%  Similarity=0.536  Sum_probs=219.8

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ...+|++.+.||+|+||.||+|.+..+++.+|+|.+......  ....+.+|+.+++.+.||||+++++.+......++|
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            346799999999999999999999999999999998764432  235678999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||+. ++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...........
T Consensus        96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            99997 589998864 4689999999999999999999999999999999999999999999999999876554433334


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCCccCCHHHHHHHHHhc
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---DVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ...|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...   ....|..+++.+.++|.+||
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence            457899999999998888999999999999999999999999877664443333222   22345678899999999999


Q ss_pred             hhCcCCCCCHHHHhcCcccCcc
Q psy18060        353 EKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       353 ~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ..+|.+|||+.++++||||...
T Consensus       255 ~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         255 DMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             cCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.4e-42  Score=344.94  Aligned_cols=250  Identities=30%  Similarity=0.542  Sum_probs=211.8

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeC------C
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETL------N  191 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~------~  191 (549)
                      ..|++.+.||+|+||.||+|.+..+++.+|+|.+.....   ....+.+|+.+++.+ +||||+++++.+...      .
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            568888999999999999999999999999999875432   235678899999998 799999999988642      4


Q ss_pred             EEEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        192 EFVLITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                      .+|++|||++ ++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||++++++.++|+|||++....
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            6899999998 5899998864  468999999999999999999999999999999999999999999999999997654


Q ss_pred             cCcccccccCCCCccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCccCC
Q psy18060        269 VGTHMLTSIKGTPLYMAPELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV--TFPSQVS  341 (549)
Q Consensus       269 ~~~~~~~~~~GT~~Y~APE~l~-----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s  341 (549)
                      ..........|++.|+|||++.     +..++.++|||||||++|+|++|+.||...........+.....  ..+..++
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS  242 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcC
Confidence            3333345567999999999985     34588899999999999999999999987666555544433321  2234678


Q ss_pred             HHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        342 ETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       342 ~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      +.+.+|+.+||..+|.+|||+.+++.||||
T Consensus       243 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.9e-42  Score=349.27  Aligned_cols=257  Identities=29%  Similarity=0.456  Sum_probs=215.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +++|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+++++.++||||+++++++...+..++||
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            36799999999999999999999999999999998665433334456788999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec-CCcEEEeecccceecccCcccc
Q psy18060        198 EFAHMSLSNLLEQRKK--LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK-DGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       198 E~~~gsL~~~l~~~~~--l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~-~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||++++|.+++.....  +++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++..........
T Consensus        81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence            9999999988876543  578889999999999999999999999999999999985 4579999999997654433333


Q ss_pred             cccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C-----------------
Q psy18060        275 TSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---D-----------------  333 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~---~-----------------  333 (549)
                      +...|++.|+|||++.+ ..++.++|||||||++|+|+||++||...+..+....+...   +                 
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA  240 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence            44568899999999865 45789999999999999999999999877665544433210   0                 


Q ss_pred             -CC--------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        334 -VT--------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       334 -~~--------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                       ..        ..+.+++++.++|.+||+.+|.+||++.+++.||||.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence             00        123578899999999999999999999999999999764

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.3e-42  Score=343.43  Aligned_cols=248  Identities=30%  Similarity=0.514  Sum_probs=219.9

Q ss_pred             EecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CCH
Q psy18060        127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSL  204 (549)
Q Consensus       127 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL  204 (549)
                      ||.|++|.||+|.+..+++.+|+|++.+... .......+.+|+++++.++||||+++++.+.+.+.++++|||+. ++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6999999999999999999999999976543 23345678999999999999999999999999999999999987 699


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCccc
Q psy18060        205 SNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYM  284 (549)
Q Consensus       205 ~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~  284 (549)
                      .+++.+...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||+++...... ......|++.|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~  159 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYV  159 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCcc
Confidence            9999988889999999999999999999999999999999999999999999999999998765432 223457899999


Q ss_pred             ccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHh--cCCCCCCccCCHHHHHHHHHhchhCcCCCC
Q psy18060        285 APELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS--ILHLIRLLK--TQDVTFPSQVSETYKDLVKGLLEKDASQRL  360 (549)
Q Consensus       285 APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rp  360 (549)
                      |||.+.+..++.++|+||||+++|+|++|..||....  .......+.  .....+|...++++.++|.+||..+|.+||
T Consensus       160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  239 (262)
T cd05572         160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL  239 (262)
T ss_pred             ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence            9999988889999999999999999999999998776  666666665  445567777899999999999999999999


Q ss_pred             C-----HHHHhcCcccCccc
Q psy18060        361 S-----WPELLHHPLVKDNL  375 (549)
Q Consensus       361 s-----~~elL~Hpw~~~~~  375 (549)
                      +     ++|+++||||++..
T Consensus       240 ~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         240 GNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             CCcccCHHHHhcChhhhCCC
Confidence            9     99999999998653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-42  Score=372.82  Aligned_cols=248  Identities=27%  Similarity=0.365  Sum_probs=207.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|....        ..+.+|++++++++|||||++++++...+..++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            3469999999999999999999999999999996422        23468999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--cc
Q psy18060        198 EFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--ML  274 (549)
Q Consensus       198 E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--~~  274 (549)
                      |++.++|..++..+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  ..
T Consensus       240 e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        240 PKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             EccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence            99999999988764 4699999999999999999999999999999999999999999999999999976543211  22


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHhcCCC---CCC------
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV--------SILHLIRLLKTQDV---TFP------  337 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~--------~~~~~~~~i~~~~~---~~p------  337 (549)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..|+...        ....+.+.+.....   .+|      
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            3457999999999999999999999999999999999987655322        12233333322111   011      


Q ss_pred             -------------------------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        338 -------------------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       338 -------------------------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                                               ..+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                     024568899999999999999999999999999964

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.9e-42  Score=351.42  Aligned_cols=255  Identities=30%  Similarity=0.482  Sum_probs=215.6

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--CEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--NEFV  194 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~  194 (549)
                      .+++|++.+.||.|+||.||+|.+..+++.+|+|.+............+.+|+.++++++||||+++++++...  +..|
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            34679999999999999999999999999999999976543333334567899999999999999999998777  8899


Q ss_pred             EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      +||||++++|.+++.... .+++..++.++.||+.||+|||++|++||||||+|||++.+|.++|+|||++.........
T Consensus        83 lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          83 MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             EEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence            999999999999987654 5899999999999999999999999999999999999999999999999999876544333


Q ss_pred             ccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------------
Q psy18060        274 LTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--------------------  332 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--------------------  332 (549)
                      .....+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||...+.......+...                    
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
T cd07843         163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK  242 (293)
T ss_pred             cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence            3445688999999998654 4689999999999999999999999887665554433210                    


Q ss_pred             -----------CCCCCcc-CCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        333 -----------DVTFPSQ-VSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       333 -----------~~~~p~~-~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                 ...+|.. +++.+.++|++||+.+|++|||+.|++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                       0112222 58899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.9e-42  Score=346.05  Aligned_cols=253  Identities=34%  Similarity=0.537  Sum_probs=215.6

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|++.+.||+|+||.||+|.+..+|+.+|+|++............+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            58899999999999999999999999999999987654445556788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-ccccc
Q psy18060        200 AHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-MLTSI  277 (549)
Q Consensus       200 ~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~~  277 (549)
                      ++++|.+++.. ...+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........ .....
T Consensus        81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (286)
T cd07832          81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ  160 (286)
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence            97799999865 45699999999999999999999999999999999999999999999999999876654321 23345


Q ss_pred             CCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------CCC--
Q psy18060        278 KGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-------------------DVT--  335 (549)
Q Consensus       278 ~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-------------------~~~--  335 (549)
                      .|+..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+...                   ...  
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07832         161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP  240 (286)
T ss_pred             cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCC
Confidence            68999999999865 44689999999999999999999999877655544433211                   000  


Q ss_pred             ---------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        336 ---------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       336 ---------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                               ..+..+..+.++|.+||..+|.+|||++++++||||.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                     1124578999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.1e-42  Score=360.34  Aligned_cols=257  Identities=27%  Similarity=0.418  Sum_probs=215.1

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC------
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------  190 (549)
                      ...+|++.+.||+|+||.||+|.+..+++.+|+|.+.+..........+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            35789999999999999999999999999999999875444444455677899999999999999999987543      


Q ss_pred             CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        191 NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       191 ~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      ...|+||||+.++|.+.+...  +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        94 ~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  171 (353)
T cd07850          94 QDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  171 (353)
T ss_pred             CcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence            357999999999999988754  999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ------------------  332 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~------------------  332 (549)
                      . ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...                  
T Consensus       172 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T cd07850         172 F-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN  250 (353)
T ss_pred             C-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence            2 234456899999999999999999999999999999999999999877654433332110                  


Q ss_pred             ----CC--------------CC-------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        333 ----DV--------------TF-------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       333 ----~~--------------~~-------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                          ..              .+       +...++.+.++|.+||+.||.+|||+.|+|.||||+....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence                00              00       1134667899999999999999999999999999975443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4e-42  Score=350.68  Aligned_cols=256  Identities=31%  Similarity=0.523  Sum_probs=209.5

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC----
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN----  191 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----  191 (549)
                      ..+++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|++++++++||||+++++++....    
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            3457899999999999999999999999999999998654333222345568999999999999999999876543    


Q ss_pred             ----EEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        192 ----EFVLITEFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       192 ----~~~iV~E~~~gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                          ..++||||++++|.+.+.... .+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus        89 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          89 RYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             CCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence                469999999999998887653 789999999999999999999999999999999999999999999999999976


Q ss_pred             cccCcc----cccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-------
Q psy18060        267 MAVGTH----MLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-------  334 (549)
Q Consensus       267 ~~~~~~----~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-------  334 (549)
                      ......    ......++..|+|||++.+. .++.++||||||+++|+|++|++||.+.+.......+.....       
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW  248 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            543221    12334678899999988654 478899999999999999999999988766544333222100       


Q ss_pred             ------------CCC-------------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        335 ------------TFP-------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       335 ------------~~p-------------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                  .+|             ...+..+.+||.+||..||.+|||++|+++||||
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                        011             1135678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-42  Score=347.71  Aligned_cols=254  Identities=29%  Similarity=0.474  Sum_probs=210.0

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      .+++|++.+.||+|++|.||+|.++.+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            4578999999999999999999999899999999987543221 223456899999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++..........
T Consensus        82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  161 (291)
T cd07844          82 FEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS  161 (291)
T ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence            999999999988764 4689999999999999999999999999999999999999999999999999875543322233


Q ss_pred             ccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcC-------------------CC
Q psy18060        276 SIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQ-------------------DV  334 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~-~~~~~~~i~~~-------------------~~  334 (549)
                      ...+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.. ..+....+...                   ..
T Consensus       162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07844         162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY  241 (291)
T ss_pred             ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence            3457889999999865 558999999999999999999999997655 22222211100                   00


Q ss_pred             C-----------CCccCC--HHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        335 T-----------FPSQVS--ETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       335 ~-----------~p~~~s--~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      .           ..+.++  +.+.+++.+||+.+|.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0           001234  888999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.7e-42  Score=349.72  Aligned_cols=253  Identities=31%  Similarity=0.518  Sum_probs=213.6

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+............+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46899999999999999999999999999999986644333334567889999999999999999999999999999999


Q ss_pred             cCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      |+.+ +|..+......+++.++..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..........+..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY  160 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence            9996 566666666679999999999999999999999999999999999999999999999999998765444444556


Q ss_pred             CCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-------------------CC--
Q psy18060        278 KGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-------------------VT--  335 (549)
Q Consensus       278 ~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-------------------~~--  335 (549)
                      .|+..|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+....                   ..  
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07846         161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP  240 (286)
T ss_pred             cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence            78999999999865 457889999999999999999999998766443333222100                   00  


Q ss_pred             ----------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        336 ----------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       336 ----------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                .++.++..+.+|+.+||..+|.+||++.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                      123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0607|consensus

Probab=100.00  E-value=1.3e-43  Score=346.60  Aligned_cols=251  Identities=33%  Similarity=0.544  Sum_probs=221.8

Q ss_pred             EEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        124 ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       124 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      .+.||+|+|+.|-.|....++..||||++.+.  .......+.+|++++.+. .|+||++++++|++.+.+|+|||-+. 
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G  160 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG  160 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence            36799999999999999999999999999875  455667889999999888 59999999999999999999999988 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC---cEEEeecccceeccc-------Cc
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAV-------GT  271 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g---~vKL~DFGla~~~~~-------~~  271 (549)
                      |+|..+|.++..|+|.++.+++++|+.||.+||.+||.||||||+|||.....   -||||||.+...+..       .+
T Consensus       161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence            58999999999999999999999999999999999999999999999997654   489999998754322       12


Q ss_pred             ccccccCCCCccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHhc
Q psy18060        272 HMLTSIKGTPLYMAPELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTV---------------SILHLIRLLKT  331 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~-----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~---------------~~~~~~~~i~~  331 (549)
                      ....+.+|+..|||||+..     ...|+.++|.||||||||-||+|.+||.+.               -...+++.|+.
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE  320 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE  320 (463)
T ss_pred             ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence            3345678999999999862     356999999999999999999999999763               15677788999


Q ss_pred             CCCCCCc----cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        332 QDVTFPS----QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       332 ~~~~~p~----~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      +.+.||+    .+|.+++++|..+|.+||.+|.++.++++|||+.....
T Consensus       321 GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  321 GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            9999996    48999999999999999999999999999999986543

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.9e-42  Score=349.74  Aligned_cols=257  Identities=30%  Similarity=0.455  Sum_probs=217.4

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS---GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+......   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            488899999999999999999999999999999765433   22345667899999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||+.++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++..........
T Consensus        81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (298)
T cd07841          81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT  160 (298)
T ss_pred             EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccc
Confidence            9999889999998766 799999999999999999999999999999999999999999999999999987655433334


Q ss_pred             ccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------------------
Q psy18060        276 SIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD---------------------  333 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~---------------------  333 (549)
                      ...+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+....                     
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T cd07841         161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK  240 (298)
T ss_pred             ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccccc
Confidence            4567889999999854 567899999999999999999998888766554444332110                     


Q ss_pred             --CC-----CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        334 --VT-----FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       334 --~~-----~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                        ..     .....+..+.++|.+||+++|.+|||+.|++.||||.+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         241 PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence              00     11345788999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1e-41  Score=344.04  Aligned_cols=249  Identities=30%  Similarity=0.499  Sum_probs=210.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|++++++++||||+++++.+...+..++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            36888999999999999999999999999999987542 33445678899999999999999999999999999999999


Q ss_pred             cCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      |+++ +|..+    ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......  ..+..
T Consensus        80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~  153 (279)
T cd06619          80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTY  153 (279)
T ss_pred             cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCC
Confidence            9985 56433    45789999999999999999999999999999999999999999999999999765432  23456


Q ss_pred             CCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCC-CCC-CccCCHHHHHHH
Q psy18060        278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLIRLLKTQD-VTF-PSQVSETYKDLV  348 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~-------~~~~~~~i~~~~-~~~-p~~~s~~~~dlI  348 (549)
                      .||+.|+|||++.+..++.++|+|||||++|+|++|+.||....       .......+.... ... ....++++.++|
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI  233 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence            79999999999998889999999999999999999999996532       122222222222 222 235789999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+||+.+|.+||+++++++||||...
T Consensus       234 ~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         234 TQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHhhCChhhCCCHHHHhcCcccccc
Confidence            99999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-41  Score=337.68  Aligned_cols=251  Identities=29%  Similarity=0.558  Sum_probs=221.8

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+.....+......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            58999999999999999999999999999999987665556677899999999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-cEEEeecccceecccCccccc
Q psy18060        200 AH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-VAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       200 ~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-~vKL~DFGla~~~~~~~~~~~  275 (549)
                      ++ ++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++....... ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-ccc
Confidence            97 5899999764  3589999999999999999999999999999999999998654 68999999998765432 223


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHhchh
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      ...|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.... ..+|..+++.+.+++.+||..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  239 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL  239 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccC
Confidence            4568999999999998889999999999999999999999999887766666655443 346677899999999999999


Q ss_pred             CcCCCCCHHHHhcCccc
Q psy18060        355 DASQRLSWPELLHHPLV  371 (549)
Q Consensus       355 dP~~Rps~~elL~Hpw~  371 (549)
                      +|.+|||+.|+++||||
T Consensus       240 ~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         240 DPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ChhhCCCHHHHhhCCCC
Confidence            99999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG4236|consensus

Probab=100.00  E-value=8.7e-44  Score=365.61  Aligned_cols=247  Identities=32%  Similarity=0.568  Sum_probs=224.2

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCCCCH
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSL  204 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~gsL  204 (549)
                      +.||+|.||+||-|.++++|+.||||++.+.....+..+.+++|+.||+++.||.||.+-..|++.+.+++|||-+.|+.
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            68999999999999999999999999999988877777899999999999999999999999999999999999999997


Q ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC---CcEEEeecccceecccCcccccccCC
Q psy18060        205 SNLLEQ--RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD---GVAMLCDFGFARSMAVGTHMLTSIKG  279 (549)
Q Consensus       205 ~~~l~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~---g~vKL~DFGla~~~~~~~~~~~~~~G  279 (549)
                      ...|-.  .+++++...++++.||+.||.|||-+||+|+||||+|||+.+.   ..+||||||+||.++.. ....+.+|
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsVVG  728 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSVVG  728 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhhcC
Confidence            777643  5789999999999999999999999999999999999999765   37999999999988754 45677899


Q ss_pred             CCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHHHHHHHhchhC
Q psy18060        280 TPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLVKGLLEKD  355 (549)
Q Consensus       280 T~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dlI~~~L~~d  355 (549)
                      ||.|.|||++.+..|+..-|+||+|||+|--++|..||....  ++-..|++..+.+|+    .+++++.|||+.+|+..
T Consensus       729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVk  806 (888)
T KOG4236|consen  729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVK  806 (888)
T ss_pred             CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999999999997653  334456666665554    58999999999999999


Q ss_pred             cCCCCCHHHHhcCcccCcc
Q psy18060        356 ASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       356 P~~Rps~~elL~Hpw~~~~  374 (549)
                      -.+|.|+...|.|||+++.
T Consensus       807 m~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  807 MRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHhcchHhhccchhhhcc
Confidence            9999999999999999876

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.8e-42  Score=340.91  Aligned_cols=249  Identities=35%  Similarity=0.605  Sum_probs=217.8

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||+|+||.||+|.+..++..+|+|.+....    ....+.+|+.+++.++||||+++++.+......|+++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            56899999999999999999999989999999986532    25688999999999999999999999999999999999


Q ss_pred             cCCC-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        199 FAHM-SLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       199 ~~~g-sL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ++++ +|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++............
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT  158 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence            9984 89999875 457899999999999999999999999999999999999999999999999998776544323344


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCccCCHHHHHHHHHhch
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD---VTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+....   ...+..+++.+.++|.+||+
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (256)
T cd06612         159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV  238 (256)
T ss_pred             ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHh
Confidence            568999999999998899999999999999999999999998876655444433222   23345678899999999999


Q ss_pred             hCcCCCCCHHHHhcCccc
Q psy18060        354 KDASQRLSWPELLHHPLV  371 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~  371 (549)
                      .||.+|||+.|++.||||
T Consensus       239 ~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         239 KDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             cChhhCcCHHHHhcCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.8e-42  Score=341.72  Aligned_cols=253  Identities=30%  Similarity=0.543  Sum_probs=215.4

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--CCEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLAHPNIIKFIASHET--LNEF  193 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~  193 (549)
                      .+|+..+.||+|+||.||+|.+..++..||+|.+.....   .......+.+|+.+++.++||||+++++++..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            368899999999999999999999999999999865432   22344678899999999999999999998865  4678


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-  271 (549)
                      +++|||++ ++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++...... 
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            99999997 5899999888889999999999999999999999999999999999999999999999999987653211 


Q ss_pred             --ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHH
Q psy18060        272 --HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFPSQVSETYKDL  347 (549)
Q Consensus       272 --~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dl  347 (549)
                        .......|+..|+|||++.+..++.++||||+||++|+|++|+.||...........+...  ...+|..+++.++++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF  241 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence              1122346889999999999888999999999999999999999999877655555444332  234566788999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      + +||..+|.+|||++|+++||||+
T Consensus       242 i-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         242 L-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             H-HHhcCChhhCcCHHHHhcCcccc
Confidence            9 67778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.6e-42  Score=349.73  Aligned_cols=256  Identities=30%  Similarity=0.551  Sum_probs=220.2

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|.+......  ....+.+|+.+++.++||||+++++.+...+..++
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence            3447899999999999999999999999999999998754332  23567889999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||||++ ++|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++..........
T Consensus        94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence            999997 589988864 568999999999999999999999999999999999999999999999999997765443334


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCCccCCHHHHHHHHHh
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---DVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~dlI~~~  351 (549)
                      ....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+...   ....|..+++.+.+|+.+|
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  252 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC  252 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence            4567899999999999888999999999999999999999999876654433222221   2234567889999999999


Q ss_pred             chhCcCCCCCHHHHhcCcccCcc
Q psy18060        352 LEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      |..+|.+||++.++++||||...
T Consensus       253 l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         253 LEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             ccCChhhCcCHHHHhcCchhccc
Confidence            99999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.2e-42  Score=339.92  Aligned_cols=252  Identities=31%  Similarity=0.545  Sum_probs=217.0

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||.|+||.||+|....++..+|+|++....... ....+.+|+.+++.++||||+++++.+...+..+++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            46899999999999999999998899999999987544333 56788999999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc-
Q psy18060        199 FAH-MSLSNLLEQR---KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-  273 (549)
Q Consensus       199 ~~~-gsL~~~l~~~---~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~-  273 (549)
                      ++. ++|.+++...   ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++......... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            997 5899998764   45899999999999999999999999999999999999999999999999998766543222 


Q ss_pred             ---ccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCC-----ccCCHH
Q psy18060        274 ---LTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFP-----SQVSET  343 (549)
Q Consensus       274 ---~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~p-----~~~s~~  343 (549)
                         .....|+..|+|||++... .++.++|+|||||++|+|++|+.||...+.......+..... .++     ..+++.
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS  239 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHH
Confidence               2344689999999998766 789999999999999999999999988766555544433321 122     257899


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      +.+++.+||..||.+|||+.++++||||
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         240 FRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-41  Score=339.55  Aligned_cols=253  Identities=28%  Similarity=0.517  Sum_probs=215.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC---CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--CCEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG---RSGKELSSLKQECEIQKHLAHPNIIKFIASHET--LNEF  193 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~  193 (549)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+....   ........+.+|+.+++.+.||||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57899999999999999999999999999999886432   123345678899999999999999999998865  3568


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-  271 (549)
                      +++|||++ ++|.+++.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++...... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            89999997 5899999888889999999999999999999999999999999999999999999999999987553211 


Q ss_pred             --ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHH
Q psy18060        272 --HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFPSQVSETYKDL  347 (549)
Q Consensus       272 --~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dl  347 (549)
                        .......||..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...  ....|..++..+.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF  241 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence              1123346899999999998888999999999999999999999999877655555444433  233566788999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      |.+||. +|++||+++++++|||+.
T Consensus       242 i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         242 LKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHhc-ChhhCCCHHHHhcCcccC
Confidence            999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0604|consensus

Probab=100.00  E-value=9.6e-44  Score=345.10  Aligned_cols=251  Identities=32%  Similarity=0.538  Sum_probs=218.3

Q ss_pred             ccccceeEE-EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee----
Q psy18060        116 GALEKYQKI-CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET----  189 (549)
Q Consensus       116 ~~~~~y~~~-~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----  189 (549)
                      ..+++|.+. ++||-|-.|.|-.|.++.|++.+|+|++...       ...++|+++.-.. .|||||+++++|++    
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            345666654 5799999999999999999999999998643       2346788876554 79999999998754    


Q ss_pred             CCEEEEEEecCCC-CHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC---CcEEEeeccc
Q psy18060        190 LNEFVLITEFAHM-SLSNLLEQRKK--LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD---GVAMLCDFGF  263 (549)
Q Consensus       190 ~~~~~iV~E~~~g-sL~~~l~~~~~--l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~---g~vKL~DFGl  263 (549)
                      ...+.+|||++.| .|+..|+.++.  |+|.++..|+.||+.|+.|||+.+|.||||||+|+|.+..   ..+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            4678999999985 79999998765  9999999999999999999999999999999999999765   4799999999


Q ss_pred             ceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCCCCc-
Q psy18060        264 ARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFPS-  338 (549)
Q Consensus       264 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~----~~~~~~~i~~~~~~~p~-  338 (549)
                      |+..... ....+.|-||+|.|||++...+|+..+|+||+||++|-|++|.+||....    ......+|..+.+.||. 
T Consensus       211 AK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  211 AKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             ccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            9876543 34577899999999999999999999999999999999999999996543    34566789999999984 


Q ss_pred             ---cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        339 ---QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       339 ---~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                         .+|+.++++|+++|..+|.+|.|+++++.|||+...
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence               579999999999999999999999999999999754

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-42  Score=346.22  Aligned_cols=251  Identities=33%  Similarity=0.508  Sum_probs=213.3

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecC
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA  200 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~  200 (549)
                      |++.+.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            57789999999999999999999999999998765433333456788999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccC
Q psy18060        201 HMSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK  278 (549)
Q Consensus       201 ~gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~  278 (549)
                      +++|.+++....  .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++.........+...
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  160 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV  160 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccc
Confidence            999999998766  799999999999999999999999999999999999999999999999999976644333334446


Q ss_pred             CCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------------
Q psy18060        279 GTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-------------------------  332 (549)
Q Consensus       279 GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-------------------------  332 (549)
                      +++.|+|||++.+. .++.++|||||||++|+|++|++||...+.......+...                         
T Consensus       161 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd07835         161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKW  240 (283)
T ss_pred             cccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccc
Confidence            78999999988654 5789999999999999999999999877654433222110                         


Q ss_pred             C----CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        333 D----VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       333 ~----~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      .    ....+.+++.+.++|.+||+.+|.+|||++|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         241 ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            0    01124577899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0662|consensus

Probab=100.00  E-value=2e-43  Score=320.77  Aligned_cols=257  Identities=31%  Similarity=0.507  Sum_probs=225.5

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .+|...++||+|.||+|++++++.+++.||+|.+.....+....+...+|+.+++.++|.|||++++.....+.+.+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            45777889999999999999999999999999998776665666788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      +|..+|..+... ++.++.+.++.++.|++.||.++|++++.||||||+|+||+.+|.+|++|||+|+.++.+.......
T Consensus        82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae  161 (292)
T KOG0662|consen   82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE  161 (292)
T ss_pred             HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence            999999999876 6779999999999999999999999999999999999999999999999999999888776666677


Q ss_pred             CCCCcccccccccCCC-CCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--------------------CC
Q psy18060        278 KGTPLYMAPELIAERP-YDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD--------------------VT  335 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~-y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~--------------------~~  335 (549)
                      +-|.+|++|.++.+.+ |+...|+||.|||+.|+.. |++.|++.+..+.+.+|...-                    +.
T Consensus       162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~  241 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI  241 (292)
T ss_pred             eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence            8899999999998754 8999999999999999985 889999999888877763210                    00


Q ss_pred             CCc---------cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        336 FPS---------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       336 ~p~---------~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +|.         .++..-+++++++|.-+|.+|+++++.++||||.+..
T Consensus       242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            111         2334557999999999999999999999999998753

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-41  Score=340.43  Aligned_cols=251  Identities=31%  Similarity=0.576  Sum_probs=215.4

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR----SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      +|++.+.||+|+||.||+|.. .+++.+|+|.+.....    .......+.+|+.+++.++||||+++++++...+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            477889999999999999986 4688999999865332    12234568899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC----
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG----  270 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~----  270 (549)
                      +|||+. ++|.+++.+...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++......    
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            999997 589999988888999999999999999999999999999999999999999999999999998754211    


Q ss_pred             --cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCCccCCHHHH
Q psy18060        271 --THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---DVTFPSQVSETYK  345 (549)
Q Consensus       271 --~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~  345 (549)
                        ........||..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...   ....|..++.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI  239 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence              11223456899999999999888999999999999999999999999877655544433332   2345677899999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      ++|.+||+++|.+||++.++++||||
T Consensus       240 ~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         240 DFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.4e-42  Score=353.27  Aligned_cols=244  Identities=29%  Similarity=0.473  Sum_probs=193.9

Q ss_pred             EEEEecCCcEEEEEEEEcC--CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe--eCCEEEEEEec
Q psy18060        124 ICLIGEGSFGKVFKAIHLD--LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE--TLNEFVLITEF  199 (549)
Q Consensus       124 ~~~iG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~iV~E~  199 (549)
                      .+.||+|+||.||+|....  ++..||+|.+.....    ...+.+|+.+++.++||||+++++++.  ....++++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            4689999999999998654  567899999865432    234678999999999999999999884  35678999999


Q ss_pred             CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE----ecCCcEEEeeccccee
Q psy18060        200 AHMSLSNLLEQR---------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL----NKDGVAMLCDFGFARS  266 (549)
Q Consensus       200 ~~gsL~~~l~~~---------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl----~~~g~vKL~DFGla~~  266 (549)
                      ++++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++.
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            999998887532         248899999999999999999999999999999999999    4567999999999986


Q ss_pred             cccCcc---cccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHhc--
Q psy18060        267 MAVGTH---MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL---------HLIRLLKT--  331 (549)
Q Consensus       267 ~~~~~~---~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~---------~~~~~i~~--  331 (549)
                      ......   ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||......         .....+..  
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            643321   2234578999999999876 45899999999999999999999999653211         00000000  


Q ss_pred             --------------------------CCC----------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        332 --------------------------QDV----------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       332 --------------------------~~~----------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                                ...          ..+...+..+.++|.+||+.||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                                      000          0011235678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0603|consensus

Probab=100.00  E-value=3.5e-43  Score=371.90  Aligned_cols=242  Identities=32%  Similarity=0.437  Sum_probs=208.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh-cCCCCeeEEEEEEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH-LAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      .+.|.+...+|.|+|+.|-.|.+..+++.+++|++.+....      ..+|+.++.. -+||||+++.+.+.+....|+|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeeee
Confidence            46788888899999999999999999999999999876221      2345655444 4899999999999999999999


Q ss_pred             EecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE-ecCCcEEEeecccceecccCcccc
Q psy18060        197 TEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL-NKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       197 ~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl-~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||.+.| -|.+.+...+.+. .++..|++||+.|+.|||++|+|||||||+|||+ ++.|+++|+|||.++.....   .
T Consensus       395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~  470 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---C  470 (612)
T ss_pred             ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---h
Confidence            999986 4666666655555 7888999999999999999999999999999999 58899999999999876543   3


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCCCCCccCCHHHHHHHHHhch
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQDVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      .+.+-|..|.|||++....|++++||||||++||+||+|+.||...+.. ++..++..+  .+...+|+++++||++||+
T Consensus       471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~--~~s~~vS~~AKdLl~~LL~  548 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP--KFSECVSDEAKDLLQQLLQ  548 (612)
T ss_pred             cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC--ccccccCHHHHHHHHHhcc
Confidence            4556788999999999999999999999999999999999999876655 555555433  4457899999999999999


Q ss_pred             hCcCCCCCHHHHhcCccc
Q psy18060        354 KDASQRLSWPELLHHPLV  371 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~  371 (549)
                      .||.+||++.+++.|||+
T Consensus       549 ~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  549 VDPALRLGADEIGAHPWF  566 (612)
T ss_pred             CChhhCcChhhhccCcch
Confidence            999999999999999999

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-41  Score=344.24  Aligned_cols=255  Identities=30%  Similarity=0.506  Sum_probs=214.4

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeC---
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETL---  190 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~---  190 (549)
                      ....++|.+.+.||+|+||.||+|....+++.+|+|++.....   ....+.+|+.+++++ +|||++++++++...   
T Consensus        18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            3446789999999999999999999999999999999865322   234567899999998 899999999988643   


Q ss_pred             --CEEEEEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccc
Q psy18060        191 --NEFVLITEFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGF  263 (549)
Q Consensus       191 --~~~~iV~E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGl  263 (549)
                        +..++||||++ ++|.+++..    ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~  174 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV  174 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence              35899999997 589988763    35789999999999999999999999999999999999999999999999999


Q ss_pred             ceecccCcccccccCCCCcccccccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---C
Q psy18060        264 ARSMAVGTHMLTSIKGTPLYMAPELIAER-----PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---T  335 (549)
Q Consensus       264 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---~  335 (549)
                      +..............|+..|+|||++...     .++.++|||||||++|+|++|++||...........+.....   .
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  254 (291)
T cd06639         175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL  254 (291)
T ss_pred             chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence            87665433333445789999999998543     368999999999999999999999988776655555543322   2


Q ss_pred             CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        336 FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       336 ~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      .|..++..+.++|.+||+.+|.+||++.|+++||||+
T Consensus       255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            3556788999999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0612|consensus

Probab=100.00  E-value=6.5e-44  Score=393.99  Aligned_cols=264  Identities=30%  Similarity=0.460  Sum_probs=234.7

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      -..++|.++++||+|+||.|..++++.|++.||+|++++-... .....-|..|-.+|..-+.+-|++++..|++.+++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            3457899999999999999999999999999999999873321 234467888999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc-cCcc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA-VGTH  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~-~~~~  272 (549)
                      +||||++ |+|..++.+..+++|..+++++..|+.||.-||+.|+|||||||.|||||..|++||+|||.+-.+. .+.-
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            9999976 6999999998899999999999999999999999999999999999999999999999999886665 3444


Q ss_pred             cccccCCCCccccccccc----C-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCC--ccCCHH
Q psy18060        273 MLTSIKGTPLYMAPELIA----E-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFP--SQVSET  343 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~----~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~  343 (549)
                      .....+|||.|.+||++.    + +.|+..+|+||+||++|||+.|..||...+..+++.+|..-  .+.||  ..+|++
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee  311 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE  311 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence            455678999999999984    2 56999999999999999999999999999999999998765  56788  569999


Q ss_pred             HHHHHHHhchhCcCCCCC---HHHHhcCcccCcccchhhh
Q psy18060        344 YKDLVKGLLEKDASQRLS---WPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps---~~elL~Hpw~~~~~~~~~~  380 (549)
                      +++||.+++. +|..|.+   ++++..||||.+..+..+.
T Consensus       312 akdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR  350 (1317)
T KOG0612|consen  312 AKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIR  350 (1317)
T ss_pred             HHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhh
Confidence            9999999886 6778888   9999999999998885553

>KOG0586|consensus

Probab=100.00  E-value=7.2e-43  Score=367.78  Aligned_cols=264  Identities=31%  Similarity=0.493  Sum_probs=246.5

Q ss_pred             cccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       113 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ........|.+.+.||+|.|++|..+.+..++..||||.+.+...+......+.+|+++|..++|||||+++.+.+....
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            34556778999999999999999999999999999999999998888877789999999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +|+||||+. |.++++|.+++.+.+..++.++.|++.|++|||+++|+|||||++||||+.+-.+||+|||++..+..+ 
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-  208 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-  208 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-
Confidence            999999987 689999999999999999999999999999999999999999999999999999999999999988754 


Q ss_pred             ccccccCCCCcccccccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~-~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~  350 (549)
                      ....++||++.|.|||++.+.+|+ +.+|+||+|+++|.|+.|..||.+.+..........+.+.+|-.++.++.++|++
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk  288 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK  288 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence            567889999999999999998875 7899999999999999999999999998888888888888888899999999999


Q ss_pred             hchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        351 LLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                      +|.++|.+|++.++++.|+|+......
T Consensus       289 ~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  289 FLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             hhccCccccCCHHHhhhhcccchhhhh
Confidence            999999999999999999999765544

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-41  Score=336.75  Aligned_cols=251  Identities=32%  Similarity=0.588  Sum_probs=218.5

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      +|+..+.||+|++|.||+|....++..|++|.+.....   .......+.+|+.+++.++||||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            46778899999999999999998899999999875432   234456788999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||++ ++|.+++.+...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAK  159 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-ccc
Confidence            99997 4899999888889999999999999999999999999999999999999999999999999987654432 234


Q ss_pred             ccCCCCcccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCCCCCccCCHHHHHHHHHhc
Q psy18060        276 SIKGTPLYMAPELIAERP-YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT--QDVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~-y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ...|++.|+|||.+.... ++.++|+|||||++|+|++|+.||...........+..  ....+|..+++.+.+++.+||
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  239 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL  239 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence            567899999999987766 89999999999999999999999987765544444433  223456678999999999999


Q ss_pred             hhCcCCCCCHHHHhcCccc
Q psy18060        353 EKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       353 ~~dP~~Rps~~elL~Hpw~  371 (549)
                      +.+|.+|||+.+++.|||+
T Consensus       240 ~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         240 QRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             hcCcccCcCHHHHhcCCCC
Confidence            9999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.7e-41  Score=344.15  Aligned_cols=254  Identities=29%  Similarity=0.429  Sum_probs=208.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            347799999999999999999999999999999998654322 2223567899999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||++++|.+.+..+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||+++..........
T Consensus        82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          82 FEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             EecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence            999998888777653 5688899999999999999999999999999999999999999999999999876543333334


Q ss_pred             ccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcC---------------------
Q psy18060        276 SIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQ---------------------  332 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~-~~~~~i~~~---------------------  332 (549)
                      ...+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.. +.+..+...                     
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE  241 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence            4568999999999865 45889999999999999999999999765432 221111100                     


Q ss_pred             --CCCCCc---------cCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        333 --DVTFPS---------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       333 --~~~~p~---------~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                        ....+.         ..++.+.+++.+||..||.+|||+.|++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence              000000         135788999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.8e-42  Score=342.23  Aligned_cols=253  Identities=27%  Similarity=0.504  Sum_probs=215.3

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC----hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS----GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      +|+..+.||+|++|.||++.+..+++.+|+|.+......    ......+.+|+++++.++||||+++++++...+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999999999999999998754321    2235678899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-cEEEeecccceecccCcc-
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-VAMLCDFGFARSMAVGTH-  272 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-~vKL~DFGla~~~~~~~~-  272 (549)
                      ||||+. ++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||.+........ 
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999988 58999998888899999999999999999999999999999999999998776 599999999876643211 


Q ss_pred             ---cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh--cCCCCCCccCCHHH
Q psy18060        273 ---MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL---HLIRLLK--TQDVTFPSQVSETY  344 (549)
Q Consensus       273 ---~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~---~~~~~i~--~~~~~~p~~~s~~~  344 (549)
                         ......||..|+|||++.+..++.++|+|||||++++|++|..||...+..   .....+.  .....+|..+++++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL  240 (268)
T ss_pred             CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence               112346889999999998888999999999999999999999999754432   2222221  22345667789999


Q ss_pred             HHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        345 KDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      .+++.+||..+|.+|||+.++++||||+
T Consensus       241 ~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         241 RDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.2e-41  Score=336.21  Aligned_cols=248  Identities=29%  Similarity=0.523  Sum_probs=218.5

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+...+.+|++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            58899999999999999999999999999999865432 33456778899999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        200 AH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       200 ~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ++ ++|.+++...  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++...........
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            97 5899888653  45899999999999999999999999999999999999999999999999999876544333445


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHhchhC
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSETYKDLVKGLLEKD  355 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dlI~~~L~~d  355 (549)
                      ..|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..+.. ..|..++..+.++|.+||+.|
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  239 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN  239 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCC
Confidence            6799999999999988899999999999999999999999998887777666655543 356778999999999999999


Q ss_pred             cCCCCCHHHHhcC
Q psy18060        356 ASQRLSWPELLHH  368 (549)
Q Consensus       356 P~~Rps~~elL~H  368 (549)
                      |.+|||+.+++.-
T Consensus       240 P~~Rp~~~~il~~  252 (255)
T cd08219         240 PRSRPSATTILSR  252 (255)
T ss_pred             cccCCCHHHHhhc
Confidence            9999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.6e-42  Score=356.96  Aligned_cols=260  Identities=28%  Similarity=0.461  Sum_probs=216.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe----eCCEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE----TLNEFV  194 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~~  194 (549)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++.    ....++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            6799999999999999999999999999999998765433344566778999999999999999988775    335689


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--
Q psy18060        195 LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--  272 (549)
Q Consensus       195 iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--  272 (549)
                      +||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........  
T Consensus        85 lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  164 (334)
T cd07855          85 VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH  164 (334)
T ss_pred             EEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCC
Confidence            999999999999998888899999999999999999999999999999999999999999999999999976543221  


Q ss_pred             --cccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Q psy18060        273 --MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT------------------  331 (549)
Q Consensus       273 --~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~------------------  331 (549)
                        ......|+..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+..                  
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~  244 (334)
T cd07855         165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRV  244 (334)
T ss_pred             CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhH
Confidence              1234578999999999865 5689999999999999999999999987654433322111                  


Q ss_pred             ------CC--CCC-----CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccchh
Q psy18060        332 ------QD--VTF-----PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSE  378 (549)
Q Consensus       332 ------~~--~~~-----p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~~  378 (549)
                            ..  ...     .+..++++.++|.+||+.+|.+|||+.+++.||||.......
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         245 RKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             HHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                  00  011     134689999999999999999999999999999998654433

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.4e-41  Score=342.07  Aligned_cols=248  Identities=30%  Similarity=0.490  Sum_probs=207.2

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeC--CEEEEEE
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETL--NEFVLIT  197 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~iV~  197 (549)
                      |++.+.||+|+||.||+|.+..+++.+|+|.+.+....... ....+|+.++.++. ||||+++++++.+.  +.+++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            67889999999999999999999999999998754332222 23356888888885 99999999999877  8899999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||++++|.+.+..+ ..+++..+..++.|++.||.|||+.|++||||||+||+++. +.+||+|||+++...... ..+.
T Consensus        80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~~~~  157 (282)
T cd07831          80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-PYTE  157 (282)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-CcCC
Confidence            99999999888764 57899999999999999999999999999999999999999 999999999997664332 2234


Q ss_pred             cCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------CCCCCC
Q psy18060        277 IKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT------------------QDVTFP  337 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~------------------~~~~~p  337 (549)
                      ..+|+.|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..+....+..                  ....+|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP  237 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence            568999999998644 5578999999999999999999999988776554443321                  011111


Q ss_pred             -----------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        338 -----------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       338 -----------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                 +.++..+.++|.+||.++|.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                       2468999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-42  Score=344.57  Aligned_cols=253  Identities=31%  Similarity=0.546  Sum_probs=214.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+++++.+.||||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36999999999999999999999999999999987544444445678999999999999999999999999999999999


Q ss_pred             cCCCCHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-cccc
Q psy18060        199 FAHMSLSNL-LEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-MLTS  276 (549)
Q Consensus       199 ~~~gsL~~~-l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~  276 (549)
                      |+++++... +.+...+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++........ ....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD  160 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence            999765544 45556799999999999999999999999999999999999999999999999999877654432 3345


Q ss_pred             cCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------C---
Q psy18060        277 IKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-------------------D---  333 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-------------------~---  333 (549)
                      ..++..|+|||++.+. .++.++||||||+++|+|++|++||.+.+.......+...                   .   
T Consensus       161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07833         161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF  240 (288)
T ss_pred             cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence            6789999999999887 8899999999999999999999999876554433322110                   0   


Q ss_pred             ----------CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        334 ----------VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       334 ----------~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                ..+|..+++++.+||.+||..+|.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                      01233458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0696|consensus

Probab=100.00  E-value=2e-43  Score=354.48  Aligned_cols=269  Identities=26%  Similarity=0.494  Sum_probs=242.0

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ..+|..+.+||+|+||+|.++..+.+.+.||||++++... .....+--..|-++|... +-|.+++++.+|++-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            4679999999999999999999999999999999977542 111222234566666655 67899999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||||++ |+|--.|++-++|.|..+..++.+|+-||-+||++|||.||||..|||++.+|++||+|||+++.--.+....
T Consensus       428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TT  507 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTT  507 (683)
T ss_pred             EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcce
Confidence            999998 5899999999999999999999999999999999999999999999999999999999999997655555666


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchh
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      .++||||.|+|||++..++|+.++|+||+||+||||+.|++||.+.+..++.+.|......+|..+|.++.++.+..|.+
T Consensus       508 kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK  587 (683)
T KOG0696|consen  508 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTK  587 (683)
T ss_pred             eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhc
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCCCH-----HHHhcCcccCcccchhhhhccCcc
Q psy18060        355 DASQRLSW-----PELLHHPLVKDNLSSEIESQNNQD  386 (549)
Q Consensus       355 dP~~Rps~-----~elL~Hpw~~~~~~~~~~~~~~~~  386 (549)
                      .|.+|+.+     .+|..||||+...+..++....+.
T Consensus       588 ~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqP  624 (683)
T KOG0696|consen  588 HPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQP  624 (683)
T ss_pred             CCccccCCCCccccchhhCcchhhccHHHHhhccCCC
Confidence            99999975     789999999999888887665554

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-41  Score=342.74  Aligned_cols=251  Identities=29%  Similarity=0.479  Sum_probs=212.7

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|++.+.||.|++|.||+|.+..+|..||+|.+...... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            588999999999999999999999999999998764322 2235567899999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        200 AHMSLSNLLEQR---KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       200 ~~gsL~~~l~~~---~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      +.++|.+++...   ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++...........
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (284)
T cd07836          80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN  159 (284)
T ss_pred             CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence            999999988764   35899999999999999999999999999999999999999999999999999765443333344


Q ss_pred             cCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------CCC--
Q psy18060        277 IKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ------------------DVT--  335 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~------------------~~~--  335 (549)
                      ..+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...                  ...  
T Consensus       160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07836         160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP  239 (284)
T ss_pred             ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence            568899999999865 45789999999999999999999999877655444332210                  000  


Q ss_pred             ---------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        336 ---------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       336 ---------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                               +.+..++.+.++|.+||+.||.+||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                     112457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.1e-42  Score=356.41  Aligned_cols=257  Identities=30%  Similarity=0.494  Sum_probs=215.8

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-----CEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-----NEF  193 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~  193 (549)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            579999999999999999999999999999999875433333445677899999999999999999877543     358


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        194 VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       194 ~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      |++|||++++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++........
T Consensus        85 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  164 (337)
T cd07858          85 YIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF  164 (337)
T ss_pred             EEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCccc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999766543333


Q ss_pred             ccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Q psy18060        274 LTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT---------------------  331 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~---------------------  331 (549)
                      .....||..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+..                     
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (337)
T cd07858         165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY  244 (337)
T ss_pred             ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHH
Confidence            345578999999998865 5689999999999999999999999987654333222210                     


Q ss_pred             ------C-CC---CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        332 ------Q-DV---TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       332 ------~-~~---~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                            . ..   ...+.+++++.++|.+||+.+|.+|||++++++||||....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         245 IRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             HHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence                  0 00   01235789999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.7e-41  Score=335.97  Aligned_cols=254  Identities=30%  Similarity=0.529  Sum_probs=224.6

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||+|++|.||+|.+..+++.+|+|.+...... .....+.+|+.+++.++||||+++++.+...+..+++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            3688999999999999999999999999999998765432 445778999999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        199 FAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |++ ++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++............
T Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  159 (264)
T cd06623          80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT  159 (264)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence            998 6899999988899999999999999999999999 99999999999999999999999999999877654443345


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcC-CCCCCcc-CCHHHHHHHHHh
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV---SILHLIRLLKTQ-DVTFPSQ-VSETYKDLVKGL  351 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~dlI~~~  351 (549)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|+.||...   ...+....+... ....+.. ++..+.++|.+|
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  239 (264)
T cd06623         160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC  239 (264)
T ss_pred             eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHH
Confidence            57899999999999889999999999999999999999999776   455555555433 2334555 899999999999


Q ss_pred             chhCcCCCCCHHHHhcCcccCc
Q psy18060        352 LEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      |..+|.+|||+.++++|||++.
T Consensus       240 l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         240 LQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             ccCChhhCCCHHHHHhCHHHHh
Confidence            9999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=339.10  Aligned_cols=252  Identities=34%  Similarity=0.549  Sum_probs=213.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCC----
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLN----  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~----  191 (549)
                      ..++|++.+.||+|++|.||+|.+..+++.+++|++.....   ....+.+|+.+++++ .||||+++++++....    
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            34789999999999999999999998999999999875432   345788999999998 7999999999986544    


Q ss_pred             --EEEEEEecCCC-CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccc
Q psy18060        192 --EFVLITEFAHM-SLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA  264 (549)
Q Consensus       192 --~~~iV~E~~~g-sL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla  264 (549)
                        .+++||||+.+ +|.+++..    ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence              58999999985 89888865    357999999999999999999999999999999999999999999999999998


Q ss_pred             eecccCcccccccCCCCcccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CC
Q psy18060        265 RSMAVGTHMLTSIKGTPLYMAPELIAE-----RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---TF  336 (549)
Q Consensus       265 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~  336 (549)
                      ..............|++.|+|||++..     ..++.++|||||||++|+|++|+.||...........+.....   ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS  240 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence            766543333455678999999998753     3478899999999999999999999987665555544444322   22


Q ss_pred             CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        337 PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       337 p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      +..+++.+++||.+||..||.+|||+.++++|||+
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            33478899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.5e-41  Score=336.76  Aligned_cols=252  Identities=30%  Similarity=0.544  Sum_probs=219.8

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|.+.+.||+|+||.||+|....++..+|+|.+............+.+|+.+++.++||||+++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            58899999999999999999999999999999876544444556788999999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-cEEEeecccceecccCccccc
Q psy18060        200 AH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-VAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       200 ~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-~vKL~DFGla~~~~~~~~~~~  275 (549)
                      +. ++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            97 58999987643  479999999999999999999999999999999999999886 469999999977654433334


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHhchh
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dlI~~~L~~  354 (549)
                      ...|++.|+|||++.+..++.++|+|||||++++|++|..||...+.......+..... ..++.++..+.++|.+||..
T Consensus       161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  240 (257)
T cd08225         161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKV  240 (257)
T ss_pred             ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhcc
Confidence            45689999999999888899999999999999999999999988777666655544432 34567889999999999999


Q ss_pred             CcCCCCCHHHHhcCccc
Q psy18060        355 DASQRLSWPELLHHPLV  371 (549)
Q Consensus       355 dP~~Rps~~elL~Hpw~  371 (549)
                      +|.+|||+.++++||||
T Consensus       241 ~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         241 SPRDRPSITSILKRPFL  257 (257)
T ss_pred             ChhhCcCHHHHhhCCCC
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.1e-41  Score=342.03  Aligned_cols=257  Identities=30%  Similarity=0.515  Sum_probs=213.5

Q ss_pred             ccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEe--
Q psy18060        112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHE--  188 (549)
Q Consensus       112 ~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~--  188 (549)
                      .......++|++.+.||+|+||.||+|.+..+++.+|+|+.....   .....+.+|+.+++.+ +||||+++++++.  
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            334456688999999999999999999999999999999876432   2234677899999999 7999999999873  


Q ss_pred             ---eCCEEEEEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEee
Q psy18060        189 ---TLNEFVLITEFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCD  260 (549)
Q Consensus       189 ---~~~~~~iV~E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~D  260 (549)
                         ..+.+++||||++ ++|.+++..    ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence               4467899999997 589888753    35689999999999999999999999999999999999999999999999


Q ss_pred             cccceecccCcccccccCCCCccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--
Q psy18060        261 FGFARSMAVGTHMLTSIKGTPLYMAPELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--  333 (549)
Q Consensus       261 FGla~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--  333 (549)
                      ||+++.............||+.|+|||++.     +..++.++|||||||++|+|++|+.||...........+....  
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  247 (286)
T cd06638         168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP  247 (286)
T ss_pred             CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence            999987654333334457999999999975     3458899999999999999999999998776544443332221  


Q ss_pred             -CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        334 -VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       334 -~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                       ...|..++..+.++|.+||+.||.+|||+.|+++||||
T Consensus       248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence             22345678899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.6e-41  Score=335.42  Aligned_cols=252  Identities=33%  Similarity=0.595  Sum_probs=217.3

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+............+.+|+.+++.++||||+++++.+...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            58899999999999999999998999999999987655445678899999999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc----
Q psy18060        200 AH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML----  274 (549)
Q Consensus       200 ~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~----  274 (549)
                      +. ++|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++..........    
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~  160 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV  160 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence            98 5899999888789999999999999999999999999999999999999999999999999987764332211    


Q ss_pred             cccCCCCcccccccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc-CCCCCCcc--CCHHHHHH
Q psy18060        275 TSIKGTPLYMAPELIAERP---YDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKT-QDVTFPSQ--VSETYKDL  347 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~---y~~ksDIwSlGvil~eLltG~~Pf~~~~-~~~~~~~i~~-~~~~~p~~--~s~~~~dl  347 (549)
                      ....+++.|+|||++.+..   ++.++||||||+++|+|++|+.||...+ .......+.. ....+|..  +++.+.+|
T Consensus       161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (264)
T cd06626         161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF  240 (264)
T ss_pred             cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHH
Confidence            2356889999999997765   8899999999999999999999997653 2222222322 23344544  48999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCccc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      |.+||+.+|.+|||+.+++.|||+
T Consensus       241 i~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         241 LDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHccCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8e-42  Score=342.72  Aligned_cols=253  Identities=33%  Similarity=0.561  Sum_probs=226.1

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ++|.+.+.||+|+||.||+|....+++.+|+|++.+... .......+.+|..+++++. ||||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            468999999999999999999999999999999876432 2334467888999999998 99999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc----
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT----  271 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~----  271 (549)
                      ||++. ++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.+|.++|+|||++.......    
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            99995 7999999998899999999999999999999999999999999999999999999999999987654322    


Q ss_pred             ----------------ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Q psy18060        272 ----------------HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT  335 (549)
Q Consensus       272 ----------------~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~  335 (549)
                                      .......|+..|+|||++.+..++.++|+||||++++++++|+.||...+.......+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS  240 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence                            1122346789999999998888999999999999999999999999988877777777777778


Q ss_pred             CCccCCHHHHHHHHHhchhCcCCCCCH----HHHhcCccc
Q psy18060        336 FPSQVSETYKDLVKGLLEKDASQRLSW----PELLHHPLV  371 (549)
Q Consensus       336 ~p~~~s~~~~dlI~~~L~~dP~~Rps~----~elL~Hpw~  371 (549)
                      +|..+++.+.+||.+||+.+|.+|||+    +++++||||
T Consensus       241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            888999999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8e-42  Score=345.35  Aligned_cols=253  Identities=26%  Similarity=0.485  Sum_probs=215.3

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++++.||+|+||.||+|.+..++..||+|.+... ........+.+|+.++++++||||+++++.+...+.+++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            3688999999999999999999999999999998653 234445678899999999999999999999999999999999


Q ss_pred             cCCC-CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        199 FAHM-SLSNLLEQR---KKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       199 ~~~g-sL~~~l~~~---~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      |++| +|..++...   ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++......  .
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--L  157 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--c
Confidence            9985 788888763   379999999999999999999997 59999999999999999999999999998765322  2


Q ss_pred             ccccCCCCcccccccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---Hhc-CCCCCCccCCHH
Q psy18060        274 LTSIKGTPLYMAPELIAER------PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRL---LKT-QDVTFPSQVSET  343 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~------~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~---i~~-~~~~~p~~~s~~  343 (549)
                      .....|++.|+|||++.+.      .++.++|+|||||++|+|++|+.||...........   +.. .....|+.++++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD  237 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence            2345688999999998543      358899999999999999999999976554443322   222 234566779999


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      +.+||.+||+.+|.+||++.+++.||||...
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             HHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            9999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.1e-41  Score=341.19  Aligned_cols=254  Identities=33%  Similarity=0.548  Sum_probs=221.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ..|+..+.||.|+||.||+|.+..++..+|+|.+.... .......+.+|+.+++.+.||||+++++.+.+.+..++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            35778899999999999999999999999999987542 23445788899999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      |++ ++|.+++.. .++++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.............
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence            997 589998875 578999999999999999999999999999999999999999999999999997765443333445


Q ss_pred             CCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhchhCc
Q psy18060        278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      .++..|+|||++.+..++.++|+|||||++|+|++|+.||...........+... ....+..++..+.+++.+||..+|
T Consensus       162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  241 (277)
T cd06640         162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDP  241 (277)
T ss_pred             cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCc
Confidence            6889999999998888999999999999999999999999887766665554333 233455678899999999999999


Q ss_pred             CCCCCHHHHhcCcccCcc
Q psy18060        357 SQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       357 ~~Rps~~elL~Hpw~~~~  374 (549)
                      .+||++.++++||||...
T Consensus       242 ~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         242 SFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             ccCcCHHHHHhChHhhhc
Confidence            999999999999999654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.9e-41  Score=342.00  Aligned_cols=252  Identities=29%  Similarity=0.510  Sum_probs=211.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEe------e
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHE------T  189 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~------~  189 (549)
                      ....|++.+.||+|+||.||+|.+..+++.+|+|++....   .....+..|+.+++.+ +||||+++++++.      .
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            4467999999999999999999999999999999986532   3345678899999888 7999999999874      3


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                      .+.++++|||++ |+|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            467899999998 5899998763  4588999999999999999999999999999999999999999999999999876


Q ss_pred             cccCcccccccCCCCccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-C-CCcc
Q psy18060        267 MAVGTHMLTSIKGTPLYMAPELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-T-FPSQ  339 (549)
Q Consensus       267 ~~~~~~~~~~~~GT~~Y~APE~l~-----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~  339 (549)
                      ............|++.|+|||++.     +..++.++|||||||++|+|++|..||...........+..... . .+..
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  250 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK  250 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccc
Confidence            543322334567999999999985     35688899999999999999999999987665544443333221 1 2235


Q ss_pred             CCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       340 ~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      ++.++.+||.+||+.||.+|||+.|+++||||
T Consensus       251 ~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            88999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-41  Score=330.94  Aligned_cols=252  Identities=35%  Similarity=0.589  Sum_probs=224.6

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|.+.+.||+|++|.||++.+..+++.||+|.+............+.+|+++++.+.|||++++++++...+..+++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            47889999999999999999999999999999987665555667899999999999999999999999999999999999


Q ss_pred             CCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccC
Q psy18060        200 AHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK  278 (549)
Q Consensus       200 ~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~  278 (549)
                      +.+ +|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..............
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  160 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV  160 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence            985 8999999888999999999999999999999999999999999999999999999999999987765444334567


Q ss_pred             CCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcCCCCCCccCCHHHHHHHHHhchhCcC
Q psy18060        279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDAS  357 (549)
Q Consensus       279 GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i-~~~~~~~p~~~s~~~~dlI~~~L~~dP~  357 (549)
                      |+..|+|||...+..++.++||||||+++|+|++|..||...+.......+ ......+|..+++.+.+++.+||..+|+
T Consensus       161 ~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  240 (254)
T cd06627         161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPN  240 (254)
T ss_pred             cchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChh
Confidence            899999999998888999999999999999999999999876654443333 3444556778999999999999999999


Q ss_pred             CCCCHHHHhcCccc
Q psy18060        358 QRLSWPELLHHPLV  371 (549)
Q Consensus       358 ~Rps~~elL~Hpw~  371 (549)
                      +|||+.+++.||||
T Consensus       241 ~R~~~~~~l~~~~~  254 (254)
T cd06627         241 LRPTAKQLLKHPWI  254 (254)
T ss_pred             hCcCHHHHhcCCCC
Confidence            99999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.5e-41  Score=338.86  Aligned_cols=249  Identities=20%  Similarity=0.340  Sum_probs=212.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEc---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ..+|++.+.||+|+||.||+|.+.   ..+..+|+|.+... .+......+.+|+.++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG-CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC-CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            356999999999999999999765   44678999998654 23344567889999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +||||++ |+|.+++... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+........
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence            9999998 5899888764 5789999999999999999999999999999999999999999999999998765432211


Q ss_pred             c-ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHH
Q psy18060        273 M-LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVK  349 (549)
Q Consensus       273 ~-~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~  349 (549)
                      . .....+++.|+|||.+.+..++.++|||||||++|++++ |..||...+.......+..+ ..+.|..++..+.+++.
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  242 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLML  242 (266)
T ss_pred             hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence            1 112345678999999999999999999999999999775 99999998888777776654 33556788999999999


Q ss_pred             HhchhCcCCCCCHHHHhc
Q psy18060        350 GLLEKDASQRLSWPELLH  367 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~  367 (549)
                      +||+.+|.+|||+.+|++
T Consensus       243 ~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         243 DCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHcCCCchhCCCHHHHHH
Confidence            999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.7e-41  Score=341.60  Aligned_cols=249  Identities=30%  Similarity=0.431  Sum_probs=206.5

Q ss_pred             EEecCCcEEEEEEEEcCCCceEEEEEEecCCCChH-HHHHHHHHHHHH---HhcCCCCeeEEEEEEeeCCEEEEEEecCC
Q psy18060        126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQ---KHLAHPNIIKFIASHETLNEFVLITEFAH  201 (549)
Q Consensus       126 ~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~iV~E~~~  201 (549)
                      .||+|+||.||++.+..+++.+|+|.+.+...... ......+|..++   ....||||+.+++.+...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            38999999999999999999999999876443211 122334444433   34479999999999999999999999988


Q ss_pred             -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCC
Q psy18060        202 -MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT  280 (549)
Q Consensus       202 -gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT  280 (549)
                       ++|.+++..++.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......  ......||
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~  158 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT  158 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCCC
Confidence             589999998889999999999999999999999999999999999999999999999999998755432  22344699


Q ss_pred             Cccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCc
Q psy18060        281 PLYMAPELIA-ERPYDHTADLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       281 ~~Y~APE~l~-~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      +.|+|||.+. +..++.++||||+||++|+|++|..||....   ..............+|+.+++++.++|.+||..||
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  238 (279)
T cd05633         159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV  238 (279)
T ss_pred             cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence            9999999986 4668999999999999999999999997542   22333333344556778899999999999999999


Q ss_pred             CCCC-----CHHHHhcCcccCcccc
Q psy18060        357 SQRL-----SWPELLHHPLVKDNLS  376 (549)
Q Consensus       357 ~~Rp-----s~~elL~Hpw~~~~~~  376 (549)
                      .+||     |++++++||||++...
T Consensus       239 ~~R~~~~~~~~~~~~~h~~~~~~~~  263 (279)
T cd05633         239 SKRLGCLGRGAQEVKEHVFFKGIDW  263 (279)
T ss_pred             HHhcCCCCCCHHHHHhCccccCCCH
Confidence            9999     6999999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.1e-41  Score=341.28  Aligned_cols=249  Identities=31%  Similarity=0.462  Sum_probs=213.6

Q ss_pred             EecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CCH
Q psy18060        127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSL  204 (549)
Q Consensus       127 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL  204 (549)
                      ||+|+||.||+|.+..+|+.+|+|.+...... ......+.+|+++++.++||||+++++.+...+..|+||||++ ++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999998754322 2234456789999999999999999999999999999999998 589


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCc
Q psy18060        205 SNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL  282 (549)
Q Consensus       205 ~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~  282 (549)
                      .+++.+..  .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+...... .......|+..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~  159 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPG  159 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCC
Confidence            99998765  7999999999999999999999999999999999999999999999999998765432 22234568889


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCC
Q psy18060        283 YMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI----LHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ  358 (549)
Q Consensus       283 Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~  358 (549)
                      |+|||++.+..++.++|||||||++|+|++|+.||.....    ......+.......|+.+++.+.++|.+||+.+|.+
T Consensus       160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  239 (277)
T cd05577         160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK  239 (277)
T ss_pred             cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence            9999999888899999999999999999999999976543    333334444555677788999999999999999999


Q ss_pred             CC-----CHHHHhcCcccCcccc
Q psy18060        359 RL-----SWPELLHHPLVKDNLS  376 (549)
Q Consensus       359 Rp-----s~~elL~Hpw~~~~~~  376 (549)
                      ||     ++.+++.||||.+...
T Consensus       240 R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         240 RLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             ccCCCcccHHHHHhChhhhcCCh
Confidence            99     8889999999976544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.8e-41  Score=342.07  Aligned_cols=250  Identities=22%  Similarity=0.402  Sum_probs=216.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCC-----ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLK-----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      .++|++.+.||+|+||.||+|.....+     ..+|+|.+... ........+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            457899999999999999999876555     67999998643 233445678899999999999999999999998899


Q ss_pred             EEEEEecCC-CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQR----------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV  255 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~  255 (549)
                      .+++|||+. ++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||++++++.
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence            999999987 6899999765                45788899999999999999999999999999999999999999


Q ss_pred             EEEeecccceecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC
Q psy18060        256 AMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ  332 (549)
Q Consensus       256 vKL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~  332 (549)
                      ++|+|||+++......  .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+..+
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR  242 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999997653321  12234457889999999988889999999999999999998 99999998888888777655


Q ss_pred             C-CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        333 D-VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       333 ~-~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      . ...|..+|+++.+++.+||+.||.+||++.||+++
T Consensus       243 ~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         243 QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            4 34567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.1e-42  Score=341.00  Aligned_cols=252  Identities=30%  Similarity=0.508  Sum_probs=217.8

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|+..+.||+|++|.||++.+..+++.+|+|.+..... ......+.+|+++++.+.||||+++++.+...+.+++++|+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            57788899999999999999999999999999876533 34456788999999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        200 AH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       200 ~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ++ ++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~  158 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KT  158 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--hc
Confidence            99 6899999876 789999999999999999999999 9999999999999999999999999999876543221  22


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcC-CCCCCcc-CCHHHHHHHH
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV-----SILHLIRLLKTQ-DVTFPSQ-VSETYKDLVK  349 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~~dlI~  349 (549)
                      ..|+..|+|||.+.+..++.++|||||||++|+|++|..||...     ........+... ....|.. +++++.++|.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN  238 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHH
Confidence            67899999999999889999999999999999999999999754     233333333333 2334444 8999999999


Q ss_pred             HhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        350 GLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      +||..||.+|||+.+++.||||+..
T Consensus       239 ~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         239 LCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.7e-42  Score=353.08  Aligned_cols=257  Identities=29%  Similarity=0.470  Sum_probs=221.3

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-----EEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----EFV  194 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~  194 (549)
                      +|++.+.||.|++|.||+|.+..+++.+|+|.+............+.+|+.+++.++||||+++++++...+     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            588999999999999999999999999999998765433445567889999999999999999999887765     789


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc---
Q psy18060        195 LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT---  271 (549)
Q Consensus       195 iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~---  271 (549)
                      ++|||++++|.+++..+..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......   
T Consensus        81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~  160 (330)
T cd07834          81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK  160 (330)
T ss_pred             EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999998765442   


Q ss_pred             ccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---------------
Q psy18060        272 HMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT---------------  335 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~---------------  335 (549)
                      .......+|+.|+|||++.+. .++.++|+|||||++|+|++|++||.+.+.......+......               
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  240 (330)
T cd07834         161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR  240 (330)
T ss_pred             ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchh
Confidence            123445689999999999877 7899999999999999999999999887766555444321100               


Q ss_pred             ----------------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        336 ----------------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       336 ----------------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                                      ..+.+++.+.++|.+||+++|.+|||+++++.||||.+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                            11346889999999999999999999999999999986544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.7e-41  Score=343.44  Aligned_cols=247  Identities=22%  Similarity=0.353  Sum_probs=204.8

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcC----------------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLD----------------LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK  182 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~  182 (549)
                      ++|.+.+.||+|+||.||+|.+..                ++..||+|.+... ........+.+|++++.+++||||++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            578999999999999999997543                3447999998653 23444567889999999999999999


Q ss_pred             EEEEEeeCCEEEEEEecCC-CCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q psy18060        183 FIASHETLNEFVLITEFAH-MSLSNLLEQRK-------------------KLSETICVQILSNLISALYYLHSNRVLHRD  242 (549)
Q Consensus       183 l~~~~~~~~~~~iV~E~~~-gsL~~~l~~~~-------------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrD  242 (549)
                      +++++...+..++||||+. |+|.+++....                   .+++..+..++.||+.||.|||+.||+|||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d  163 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD  163 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            9999999999999999997 58999986532                   367788999999999999999999999999


Q ss_pred             ccCCcEEEecCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh--CCCCCC
Q psy18060        243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM--GHPPFK  318 (549)
Q Consensus       243 IKP~NILl~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt--G~~Pf~  318 (549)
                      |||+|||++.++.+||+|||+++.......  ......++..|+|||++.+..++.++|||||||++|+|++  |..||.
T Consensus       164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  243 (304)
T cd05096         164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG  243 (304)
T ss_pred             cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence            999999999999999999999976543321  1223346788999999988889999999999999999986  678888


Q ss_pred             CCCHHHHHHHHhc--------CCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHh
Q psy18060        319 TVSILHLIRLLKT--------QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELL  366 (549)
Q Consensus       319 ~~~~~~~~~~i~~--------~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL  366 (549)
                      ..+.......+..        .....|+.+++.+.+++.+||+.||.+|||+.+|.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         244 ELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             cCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            7766655543321        11234567899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.7e-41  Score=340.29  Aligned_cols=252  Identities=29%  Similarity=0.441  Sum_probs=211.0

Q ss_pred             EEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHH-HHHHHHH---HHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC
Q psy18060        126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQE---CEIQKHLAHPNIIKFIASHETLNEFVLITEFAH  201 (549)
Q Consensus       126 ~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-~~~~~~E---i~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~  201 (549)
                      .||+|+||.||+|.+..+++.||+|.+.+....... .....+|   .++++...||+|+.+++.+...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999999999999999998764322111 1122333   334555689999999999999999999999997


Q ss_pred             -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCC
Q psy18060        202 -MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT  280 (549)
Q Consensus       202 -gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT  280 (549)
                       ++|..++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.....  ......||
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~  158 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT  158 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCCC
Confidence             589999988888999999999999999999999999999999999999999999999999998755432  22345799


Q ss_pred             CcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCc
Q psy18060        281 PLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTV---SILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       281 ~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      ..|+|||++.+ ..++.++||||+||++|+|++|+.||...   ........+......+|..+++++.+++.+||..+|
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p  238 (278)
T cd05606         159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV  238 (278)
T ss_pred             cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence            99999999875 46899999999999999999999999876   444444455555667788889999999999999999


Q ss_pred             CCCC-----CHHHHhcCcccCcccchhh
Q psy18060        357 SQRL-----SWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       357 ~~Rp-----s~~elL~Hpw~~~~~~~~~  379 (549)
                      .+||     ++.++++||||++......
T Consensus       239 ~~R~~~~~~~~~~ll~~~~~~~~~~~~~  266 (278)
T cd05606         239 NRRLGCLGRGAQEVKEHPFFRSLDWQMV  266 (278)
T ss_pred             HhccCCCCCCHHHHHhCccccCCCchHh
Confidence            9999     9999999999987654433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.7e-41  Score=330.88  Aligned_cols=252  Identities=37%  Similarity=0.626  Sum_probs=225.2

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|.+.+.||.|+||.||++.+..++..+|+|++............+.+|+++++.++|||++++.+.+......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            58899999999999999999999999999999987655556667889999999999999999999999999999999999


Q ss_pred             CCC-CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        200 AHM-SLSNLLEQR----KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       200 ~~g-sL~~~l~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      +++ +|.+++...    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  160 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA  160 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence            985 899999874    679999999999999999999999999999999999999999999999999997765443233


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhch
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ....|++.|+|||.+.+..++.++|+||+|+++++|++|..||...+.......+... ...+|..++..+.+++.+||.
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  240 (258)
T cd08215         161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQ  240 (258)
T ss_pred             cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence            4457899999999998888999999999999999999999999888877776665544 334566889999999999999


Q ss_pred             hCcCCCCCHHHHhcCccc
Q psy18060        354 KDASQRLSWPELLHHPLV  371 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~  371 (549)
                      .+|.+|||+.++++||||
T Consensus       241 ~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         241 KDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CChhhCcCHHHHhcCCCC
Confidence            999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG4721|consensus

Probab=100.00  E-value=3.2e-43  Score=364.34  Aligned_cols=240  Identities=28%  Similarity=0.495  Sum_probs=214.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++...-++.||+|+.|.||.|+..  ++.||||.+...         -+.+|+-|++|+||||+.|.++|...-.++|||
T Consensus       123 Fe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM  191 (904)
T KOG4721|consen  123 FEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM  191 (904)
T ss_pred             HHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence            444556788999999999999887  789999987532         235788899999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |||. |.|..+|+..+.++......|..+|+.|++|||.+.|||||||.-||||+.+..|||+|||.++.+... ...-+
T Consensus       192 EfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMS  270 (904)
T KOG4721|consen  192 EFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMS  270 (904)
T ss_pred             eccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhh
Confidence            9998 789999999999999999999999999999999999999999999999999999999999999877543 34467


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHhchh
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      ++||..|||||++.+.+.+.|+|||||||+|||||||..||...+...++--+-..  .++.|..+|+.++-||++||..
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS  350 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence            89999999999999999999999999999999999999999988777666544333  3456789999999999999999


Q ss_pred             CcCCCCCHHHHhcCc
Q psy18060        355 DASQRLSWPELLHHP  369 (549)
Q Consensus       355 dP~~Rps~~elL~Hp  369 (549)
                      .|.+||++.+||.|=
T Consensus       351 KpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  351 KPRNRPSFRQILLHL  365 (904)
T ss_pred             CCCCCccHHHHHHHH
Confidence            999999999999993

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-40  Score=329.01  Aligned_cols=252  Identities=35%  Similarity=0.624  Sum_probs=222.5

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--CEEEEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--NEFVLIT  197 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~iV~  197 (549)
                      +|...+.||+|++|.||+|.+..++..+++|++..........+.+.+|+.++++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            47888999999999999999999999999999977655456678889999999999999999999999888  8899999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--cc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--ML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--~~  274 (549)
                      |+++ ++|.+++.+...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+........  ..
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT  160 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence            9995 68999999888999999999999999999999999999999999999999999999999999987765432  13


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHh--cCCCCCCccCCHHHHHHHHHh
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLK--TQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      ....++..|+|||.+.+..++.++||||||+++++|++|..||.... .......+.  .....+|..+++.+++||.+|
T Consensus       161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~  240 (260)
T cd06606         161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC  240 (260)
T ss_pred             cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHh
Confidence            44578999999999988889999999999999999999999998765 333333333  233456778899999999999


Q ss_pred             chhCcCCCCCHHHHhcCccc
Q psy18060        352 LEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~  371 (549)
                      |+.+|.+||++.++++||||
T Consensus       241 l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         241 LRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.1e-41  Score=342.83  Aligned_cols=254  Identities=32%  Similarity=0.506  Sum_probs=218.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ...|+..+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356999999999999999999999999999999986543 2334456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||+.|+|.+.+.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......    .
T Consensus        94 ~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----~  169 (307)
T cd06607          94 MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----N  169 (307)
T ss_pred             HHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----C
Confidence            99999998888764 457899999999999999999999999999999999999999999999999998765432    3


Q ss_pred             ccCCCCccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCC-CccCCHHHHHHHHH
Q psy18060        276 SIKGTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-VTF-PSQVSETYKDLVKG  350 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~-p~~~s~~~~dlI~~  350 (549)
                      ...|++.|+|||++.   ...++.++||||||+++|+|++|+.||...+.......+.... ... +..+++.+.++|.+
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  249 (307)
T cd06607         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS  249 (307)
T ss_pred             CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHH
Confidence            456889999999874   4568899999999999999999999998887766655544332 222 24578899999999


Q ss_pred             hchhCcCCCCCHHHHhcCcccCccc
Q psy18060        351 LLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ||..+|.+||++.+++.||||....
T Consensus       250 ~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         250 CLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HhcCChhhCcCHHHHhcChhhcccC
Confidence            9999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.2e-41  Score=335.68  Aligned_cols=249  Identities=30%  Similarity=0.519  Sum_probs=208.8

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecC
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA  200 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~  200 (549)
                      ......||+|+||.||+|.+..++..+|+|.+....  ......+.+|+.+++.++||||+++++++...+..++++||+
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            334468999999999999999999999999886542  334567889999999999999999999999999999999998


Q ss_pred             C-CCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec-CCcEEEeecccceecccCccccc
Q psy18060        201 H-MSLSNLLEQR-KKL--SETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK-DGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       201 ~-gsL~~~l~~~-~~l--~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~-~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      . ++|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++...........
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence            7 5899999764 445  88889999999999999999999999999999999976 67999999999876643333334


Q ss_pred             ccCCCCcccccccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH--HhcCCCCCCccCCHHHHHHHHH
Q psy18060        276 SIKGTPLYMAPELIAER--PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL-IRL--LKTQDVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~--~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~-~~~--i~~~~~~~p~~~s~~~~dlI~~  350 (549)
                      ...|++.|+|||++.+.  .++.++|+||||+++|+|++|+.||........ ...  .......+|..+++++++|+.+
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  247 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR  247 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence            45689999999998654  378999999999999999999999976532211 111  1223345677889999999999


Q ss_pred             hchhCcCCCCCHHHHhcCccc
Q psy18060        351 LLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      ||+.+|.+|||+.|++.||||
T Consensus       248 ~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         248 CFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0983|consensus

Probab=100.00  E-value=1.8e-42  Score=332.47  Aligned_cols=258  Identities=27%  Similarity=0.498  Sum_probs=216.6

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~i  195 (549)
                      .+++.+.+..||.|+.|+||+++.+.+|...|||.+.+... .++.+.++..+.++..- .+|.||+++++|-.+..++|
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I  168 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI  168 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence            34556778889999999999999999999999999987654 44556677777765554 59999999999999988999


Q ss_pred             EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        196 ITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       196 V~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      .||.+..-+..+++. .++++|..+-.+...++.||.||.. +||||||+||+|||+|..|.+||||||++.++... ..
T Consensus       169 cMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-kA  247 (391)
T KOG0983|consen  169 CMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-KA  247 (391)
T ss_pred             HHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc-cc
Confidence            999988666666655 3579999999999999999999975 59999999999999999999999999999877654 33


Q ss_pred             ccccCCCCccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCC-CCCCc--cCCHHHHH
Q psy18060        274 LTSIKGTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQD-VTFPS--QVSETYKD  346 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~-~~~~~~~i~~~~-~~~p~--~~s~~~~d  346 (549)
                      .+...|-+.|||||.+.   ..+|+..+||||||++++||.||+.||.+.+ .-+.+.++.+.. +.+|.  .+|+.+++
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~  327 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQS  327 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHH
Confidence            45567999999999984   4579999999999999999999999999853 345555555433 33342  48999999


Q ss_pred             HHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        347 LVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      |+..||++|+.+||...++|+|||+.....
T Consensus       328 fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  328 FVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             HHHHHhhcCcccCcchHHHhcCcceeecch
Confidence            999999999999999999999999986543

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-41  Score=350.18  Aligned_cols=258  Identities=30%  Similarity=0.481  Sum_probs=211.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-----CE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-----NE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~  192 (549)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            3679999999999999999999999999999999864322 23345677899999999999999999876443     35


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        193 FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      .++++||++++|.+.+. ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~lv~e~~~~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          83 VYIVQELMETDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             EEEEehhcccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence            89999999999988875 45799999999999999999999999999999999999999999999999999876543211


Q ss_pred             ---cccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------
Q psy18060        273 ---MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT-----------------  331 (549)
Q Consensus       273 ---~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~-----------------  331 (549)
                         ......||+.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+..                 
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR  241 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence               1234578999999998754 5689999999999999999999999987654333222110                 


Q ss_pred             -------CC--CC-----CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        332 -------QD--VT-----FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       332 -------~~--~~-----~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                             .+  ..     ..+..++++.++|.+||+.+|.+|||+.|+++||||......
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                   00  00     113467889999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-41  Score=336.00  Aligned_cols=248  Identities=33%  Similarity=0.559  Sum_probs=219.9

Q ss_pred             EecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CCH
Q psy18060        127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSL  204 (549)
Q Consensus       127 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL  204 (549)
                      ||.|+||.||++.+..+++.+|+|.+..... .......+.+|+++++.+.||||+++++.+...+..|++||++. ++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999999999999999865432 23445678899999999999999999999999999999999997 589


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--------cccc
Q psy18060        205 SNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--------MLTS  276 (549)
Q Consensus       205 ~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--------~~~~  276 (549)
                      .+++.+.+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........        ....
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            99999878899999999999999999999999999999999999999999999999999875433211        2234


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccC--CHHHHHHHHHhchh
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQV--SETYKDLVKGLLEK  354 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~dlI~~~L~~  354 (549)
                      ..+++.|+|||...+..++.++||||||+++|+|++|..||...........+..+...+|...  ++.+.+++.+||+.
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  240 (265)
T cd05579         161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP  240 (265)
T ss_pred             cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcC
Confidence            5688899999999888899999999999999999999999999888888888877766666655  99999999999999


Q ss_pred             CcCCCCCH---HHHhcCcccCcc
Q psy18060        355 DASQRLSW---PELLHHPLVKDN  374 (549)
Q Consensus       355 dP~~Rps~---~elL~Hpw~~~~  374 (549)
                      +|.+|||+   .++++||||++.
T Consensus       241 ~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         241 DPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             CHhhcCCCccHHHHhcCccccCC
Confidence            99999999   999999999754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.3e-41  Score=336.62  Aligned_cols=252  Identities=27%  Similarity=0.508  Sum_probs=212.5

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC--------hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--------GKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      +|.+.+.||+|+||.||+|.+..+++.+|+|.+......        ....+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            478889999999999999999999999999988643211        112356788999999999999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      ..++||||+. ++|.+++.+...+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            9999999997 589999998888999999999999999999999999999999999999999999999999998765322


Q ss_pred             c--ccccccCCCCcccccccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCC----ccC
Q psy18060        271 T--HMLTSIKGTPLYMAPELIAERP--YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFP----SQV  340 (549)
Q Consensus       271 ~--~~~~~~~GT~~Y~APE~l~~~~--y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p----~~~  340 (549)
                      .  .......|+..|+|||.+....  ++.++|+||||+++|+|++|..||...+.......+...  ...+|    ..+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence            1  1123456889999999987654  889999999999999999999999766655444333222  22233    246


Q ss_pred             CHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        341 SETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       341 s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      +.++.++|.+||.++|.+|||+.++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.8e-41  Score=343.16  Aligned_cols=255  Identities=29%  Similarity=0.488  Sum_probs=210.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|...+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++. ||||+++++++...+..+++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            4566778999999999999999999999999998754333 44567888999999986 999999999998888999999


Q ss_pred             ecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        198 EFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       198 E~~~gsL~~~l~-----~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ||+.++|.++..     ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++......
T Consensus        83 e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             ecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            999887666543     246799999999999999999999975 99999999999999999999999999997654322


Q ss_pred             ccccccCCCCcccccccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcC-CCCCC----ccCCH
Q psy18060        272 HMLTSIKGTPLYMAPELIAER---PYDHTADLWSLGCIAYEIHMGHPPFKTVSI-LHLIRLLKTQ-DVTFP----SQVSE  342 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~---~y~~ksDIwSlGvil~eLltG~~Pf~~~~~-~~~~~~i~~~-~~~~p----~~~s~  342 (549)
                       ......||+.|+|||++.+.   .++.++|||||||++|+|++|+.||..... ......+..+ ...++    ..+++
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd06616         163 -AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSP  241 (288)
T ss_pred             -ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence             22344689999999999765   689999999999999999999999976542 1222222222 12222    24789


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ++.+||.+||+++|.+|||+++++.||||....
T Consensus       242 ~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         242 SFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-41  Score=345.78  Aligned_cols=255  Identities=31%  Similarity=0.484  Sum_probs=217.8

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      +.|.....||+|+||.||++.+..++..||+|.+....  ......+.+|+.+++.+.||||+++++.+...+..++|||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            44566778999999999999999999999999986532  3345668899999999999999999999999999999999


Q ss_pred             cCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      |+++ +|.+++. +..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.............
T Consensus       100 ~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         100 FLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            9985 7888775 4578999999999999999999999999999999999999999999999999987654333333445


Q ss_pred             CCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCccCCHHHHHHHHHhchh
Q psy18060        278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD---VTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      .||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+....   ...+...++.+.+++.+||..
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  258 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR  258 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccC
Confidence            78999999999988889999999999999999999999998877766655544321   122235789999999999999


Q ss_pred             CcCCCCCHHHHhcCcccCcccc
Q psy18060        355 DASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       355 dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      ||.+|||++++++||||.....
T Consensus       259 ~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         259 EPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             ChhHCcCHHHHhhChhhhccCC
Confidence            9999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-40  Score=338.31  Aligned_cols=253  Identities=29%  Similarity=0.493  Sum_probs=219.0

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      .|...+.||+|++|.||++.+..+++.+|+|.+....  ......+.+|+.+++.+.||||+++++++...+..++++||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            4555689999999999999999899999999986432  23345678999999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccC
Q psy18060        200 AH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK  278 (549)
Q Consensus       200 ~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~  278 (549)
                      +. ++|.+++.. .++++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||.+..............
T Consensus        98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  176 (285)
T cd06648          98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV  176 (285)
T ss_pred             cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence            97 589999887 6799999999999999999999999999999999999999999999999998876543333334456


Q ss_pred             CCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---CCccCCHHHHHHHHHhchhC
Q psy18060        279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT---FPSQVSETYKDLVKGLLEKD  355 (549)
Q Consensus       279 GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~dlI~~~L~~d  355 (549)
                      |++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+......   .+..+++.+.+||.+||+.+
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  256 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRD  256 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccC
Confidence            899999999998888999999999999999999999999888777776666554322   22347899999999999999


Q ss_pred             cCCCCCHHHHhcCcccCccc
Q psy18060        356 ASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       356 P~~Rps~~elL~Hpw~~~~~  375 (549)
                      |.+|||+.++++||||....
T Consensus       257 p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         257 PAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             hhhCcCHHHHccCcccccCC
Confidence            99999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-41  Score=344.40  Aligned_cols=252  Identities=29%  Similarity=0.467  Sum_probs=206.0

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcC--CCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--CEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLD--LKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--NEFV  194 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~  194 (549)
                      +|++.+.||+|+||.||+|.+..  ++..||+|.+.... ........+.+|+.+++.++||||+++++++...  +.++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48899999999999999999988  89999999987643 1122235667899999999999999999999887  8899


Q ss_pred             EEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec----CCcEEEeecccce
Q psy18060        195 LITEFAHMSLSNLLEQR-----KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK----DGVAMLCDFGFAR  265 (549)
Q Consensus       195 iV~E~~~gsL~~~l~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~----~g~vKL~DFGla~  265 (549)
                      +||||++++|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||+++.    +|.+||+|||+++
T Consensus        81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~  160 (316)
T cd07842          81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR  160 (316)
T ss_pred             EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence            99999999888887542     26899999999999999999999999999999999999999    8999999999997


Q ss_pred             ecccCcc---cccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHH---
Q psy18060        266 SMAVGTH---MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH---------LIRLL---  329 (549)
Q Consensus       266 ~~~~~~~---~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~---------~~~~i---  329 (549)
                      .......   ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.....         ....+   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd07842         161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV  240 (316)
T ss_pred             ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence            6543221   1234568899999998866 458999999999999999999999997654321         00000   


Q ss_pred             -----------------------hcCCCCCC-----------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        330 -----------------------KTQDVTFP-----------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       330 -----------------------~~~~~~~p-----------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                             ......++           ...+..+.+++.+||+.||.+|||+.|++.||||
T Consensus       241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                                   00001111           1467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.5e-41  Score=356.87  Aligned_cols=251  Identities=25%  Similarity=0.417  Sum_probs=207.8

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET  189 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  189 (549)
                      ...++|++.+.||+|+||.||+|.+..+     +..||+|.+..... ......+.+|+.+++.+ .|||||++++++..
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            3456899999999999999999986544     35799999975432 33456788999999999 89999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhc---------------------------------------------------------
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQR---------------------------------------------------------  211 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~---------------------------------------------------------  211 (549)
                      .+.+++||||+. |+|.+++...                                                         
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999998 6899988642                                                         


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--cccc
Q psy18060        212 -------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--MLTS  276 (549)
Q Consensus       212 -------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--~~~~  276 (549)
                                   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  ....
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                         1367888999999999999999999999999999999999999999999999976543321  1122


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHhch
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ--DVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ..+++.|||||++.+..++.++|||||||++|+|++ |+.||...........+...  ....|...++++.+++.+||+
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  353 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN  353 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence            335678999999998899999999999999999997 99999876554433333222  334556679999999999999


Q ss_pred             hCcCCCCCHHHHhc
Q psy18060        354 KDASQRLSWPELLH  367 (549)
Q Consensus       354 ~dP~~Rps~~elL~  367 (549)
                      .||.+|||+.++++
T Consensus       354 ~dp~~RPs~~~l~~  367 (374)
T cd05106         354 LEPTERPTFSQISQ  367 (374)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-41  Score=350.14  Aligned_cols=255  Identities=28%  Similarity=0.457  Sum_probs=213.6

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-----
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----  191 (549)
                      ..++|++++.||+|+||.||+|.+..++..||+|.+............+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            356799999999999999999999999999999998654433444456789999999999999999999886543     


Q ss_pred             -EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        192 -EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       192 -~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                       .+++|||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus        93 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  171 (343)
T cd07880          93 HDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE  171 (343)
T ss_pred             ceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence             4689999998889888764 57999999999999999999999999999999999999999999999999999765432


Q ss_pred             cccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---------------
Q psy18060        271 THMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---------------  334 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---------------  334 (549)
                         .....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......+.....               
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07880         172 ---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA  248 (343)
T ss_pred             ---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence               234568999999999876 4588999999999999999999999987765443333221100               


Q ss_pred             ----------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        335 ----------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       335 ----------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                                      .+.+.+++.+.++|.+||..||.+|||+.+++.||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence                            01235788899999999999999999999999999998653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-41  Score=334.12  Aligned_cols=247  Identities=28%  Similarity=0.468  Sum_probs=210.3

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHH-HHhcCCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEI-QKHLAHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+..+++.+|+|.+.+.... ......+..|..+ .....|||++++++++...+.+|++|||++ 
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5689999999999999999999999998754321 2222334445444 445689999999999999999999999997 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                      ++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++....    .....|++
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~  157 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTP  157 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCc
Confidence            58999999888899999999999999999999999999999999999999999999999999875432    23446889


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHHHHHhchhCcC
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDLVKGLLEKDAS  357 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dlI~~~L~~dP~  357 (549)
                      .|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.......+    ..+++.+.++|.+||+.+|.
T Consensus       158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  237 (260)
T cd05611         158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA  237 (260)
T ss_pred             CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence            99999999888899999999999999999999999998888777776655543333    35789999999999999999


Q ss_pred             CCCCH---HHHhcCcccCccc
Q psy18060        358 QRLSW---PELLHHPLVKDNL  375 (549)
Q Consensus       358 ~Rps~---~elL~Hpw~~~~~  375 (549)
                      +|||+   +|++.||||++..
T Consensus       238 ~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         238 KRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HccCCCcHHHHHcChHhhcCC
Confidence            99955   7999999997643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.5e-41  Score=336.68  Aligned_cols=244  Identities=30%  Similarity=0.498  Sum_probs=204.1

Q ss_pred             cceeEEEEE--ecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEE
Q psy18060        119 EKYQKICLI--GEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       119 ~~y~~~~~i--G~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ++|.+.+.+  |+|+||.||++.++.++..+|+|.+.......       .|+.....+ +||||+++++++...+..++
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            456666665  99999999999999999999999986543221       122222222 79999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-cEEEeecccceecccCccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-VAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-~vKL~DFGla~~~~~~~~~  273 (549)
                      ||||++ ++|.+++..+..+++.++..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++.....   
T Consensus        87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---  163 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---  163 (267)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence            999997 69999999888999999999999999999999999999999999999999998 9999999998765432   


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCCCCCccCCHHHHHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIRLLKTQDVTFPSQVSETYKDLVK  349 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~dlI~  349 (549)
                       ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......    ............++.+++.+.+||.
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  242 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQ  242 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHH
Confidence             23468999999999998889999999999999999999999997553321    1222223444566689999999999


Q ss_pred             HhchhCcCCCCC-HHHHhcCcccCc
Q psy18060        350 GLLEKDASQRLS-WPELLHHPLVKD  373 (549)
Q Consensus       350 ~~L~~dP~~Rps-~~elL~Hpw~~~  373 (549)
                      +||+.+|.+||+ ++|+|+||||+.
T Consensus       243 ~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        243 SMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHhccChhhCCchHHHHhcCCcccC
Confidence            999999999996 599999999963

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-41  Score=342.89  Aligned_cols=253  Identities=34%  Similarity=0.550  Sum_probs=218.0

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      .|+..+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.+.||||+++++++...+..++||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            46677889999999999999999999999999865432 33456789999999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccC
Q psy18060        200 AH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK  278 (549)
Q Consensus       200 ~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~  278 (549)
                      ++ ++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..............
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhccc
Confidence            98 488888764 5789999999999999999999999999999999999999999999999999976654333334456


Q ss_pred             CCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhchhCcC
Q psy18060        279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLEKDAS  357 (549)
Q Consensus       279 GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~  357 (549)
                      |+..|+|||++.+..++.++|+|||||++|+|++|+.||...........+... ...++..++..+.++|.+||+.+|.
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  242 (277)
T cd06642         163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPR  242 (277)
T ss_pred             CcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcc
Confidence            899999999999888999999999999999999999999876655554444333 2334456789999999999999999


Q ss_pred             CCCCHHHHhcCcccCcc
Q psy18060        358 QRLSWPELLHHPLVKDN  374 (549)
Q Consensus       358 ~Rps~~elL~Hpw~~~~  374 (549)
                      +|||+.++++||||...
T Consensus       243 ~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         243 FRPTAKELLKHKFITRY  259 (277)
T ss_pred             cCcCHHHHHHhHHHHHH
Confidence            99999999999999754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-41  Score=335.97  Aligned_cols=254  Identities=32%  Similarity=0.588  Sum_probs=217.4

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC---CCCeeEEEEEEeeCCEEEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA---HPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~iV  196 (549)
                      .|+..+.||+|+||.||+|.+..+++.+|+|.+.... .......+.+|+.+++.+.   |||++++++++......+++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            4778899999999999999999999999999986542 2334566788999999986   99999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||+. ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++...........
T Consensus        81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06917          81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS  159 (277)
T ss_pred             EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence            99997 489988865 4799999999999999999999999999999999999999999999999999987655443344


Q ss_pred             ccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCc-cCCHHHHHHHHHhc
Q psy18060        276 SIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-VTFPS-QVSETYKDLVKGLL  352 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~p~-~~s~~~~dlI~~~L  352 (549)
                      ...|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+.... ..++. .++.++.+++.+||
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  239 (277)
T cd06917         160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACL  239 (277)
T ss_pred             cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHc
Confidence            5579999999999865 457899999999999999999999998877766554443332 22333 37889999999999


Q ss_pred             hhCcCCCCCHHHHhcCcccCccc
Q psy18060        353 EKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       353 ~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ..||.+||++.+++.||||+...
T Consensus       240 ~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         240 DEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             CCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999997643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.3e-40  Score=335.43  Aligned_cols=254  Identities=34%  Similarity=0.544  Sum_probs=220.6

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      -|++.+.||+|+||.||+|.+..++..+|+|.+..... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            47788999999999999999998999999999865432 33456788999999999999999999999999999999999


Q ss_pred             CCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccC
Q psy18060        200 AHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK  278 (549)
Q Consensus       200 ~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~  278 (549)
                      +++ +|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..............
T Consensus        84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06641          84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence            984 78888864 5689999999999999999999999999999999999999999999999999876654333334456


Q ss_pred             CCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHhchhCcC
Q psy18060        279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLLEKDAS  357 (549)
Q Consensus       279 GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~L~~dP~  357 (549)
                      |+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.... ..++..++.++.+++.+||+.+|.
T Consensus       163 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  242 (277)
T cd06641         163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS  242 (277)
T ss_pred             CCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChh
Confidence            8999999999988888999999999999999999999998877666665554432 335567899999999999999999


Q ss_pred             CCCCHHHHhcCcccCccc
Q psy18060        358 QRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       358 ~Rps~~elL~Hpw~~~~~  375 (549)
                      +||++.++++||||....
T Consensus       243 ~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         243 FRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             hCcCHHHHHhCHHHhhhh
Confidence            999999999999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-41  Score=338.46  Aligned_cols=251  Identities=33%  Similarity=0.504  Sum_probs=215.8

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecC
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA  200 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~  200 (549)
                      |++.+.||+|++|.||+|.+..+++.+|+|.+............+.+|+++++.++||||+++++.+...+..+++|||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56788999999999999999989999999998765544344567888999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCC
Q psy18060        201 HMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG  279 (549)
Q Consensus       201 ~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~G  279 (549)
                      +++|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||.+..............+
T Consensus        81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (283)
T cd05118          81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV  160 (283)
T ss_pred             CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccC
Confidence            99999888764 57999999999999999999999999999999999999999999999999999877654323344568


Q ss_pred             CCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-------------------CC----
Q psy18060        280 TPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-------------------VT----  335 (549)
Q Consensus       280 T~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-------------------~~----  335 (549)
                      +..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.+..+...-                   ..    
T Consensus       161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05118         161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK  240 (283)
T ss_pred             cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccc
Confidence            8899999998776 78999999999999999999999998877655544432110                   00    


Q ss_pred             -------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        336 -------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       336 -------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                             ..+.++.++.+||.+||++||.+||++.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                   112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=330.83  Aligned_cols=252  Identities=27%  Similarity=0.510  Sum_probs=217.0

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC---CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--CEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG---RSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--NEF  193 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~  193 (549)
                      .+|.+.+.||+|+||.||+|.+..+++.+|+|.+....   ........+.+|+++++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46999999999999999999999999999999885432   2234456788999999999999999999988654  568


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC--
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--  270 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~--  270 (549)
                      +++|||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            89999987 589999988888999999999999999999999999999999999999999999999999999765321  


Q ss_pred             -cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHH
Q psy18060        271 -THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFPSQVSETYKDL  347 (549)
Q Consensus       271 -~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dl  347 (549)
                       ....+...|+..|+|||++.+..++.++|+|||||++|+|++|+.||...........+...  ...+|..+++.+.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  241 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF  241 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence             11123456899999999998888999999999999999999999999887666655555433  234678899999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCccc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      |.+||+ +|..|||+.+++.|||.
T Consensus       242 i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         242 LKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHhc-CcccCccHHHHhcCCCC
Confidence            999999 57999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-41  Score=339.04  Aligned_cols=254  Identities=28%  Similarity=0.456  Sum_probs=216.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++++.||+|+||.||++.+..+++.+|+|++.... .......+.+|+++++.++||||+++++.+...+.+++||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            467899999999999999999999999999999986543 2334567889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      ||++ ++|.+++.+.+.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++......  ...
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~~  160 (284)
T cd06620          83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IAD  160 (284)
T ss_pred             ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--ccC
Confidence            9998 5899999888889999999999999999999997 59999999999999999999999999998655322  123


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHhcC-CCCCCc-cCCH
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL-----------HLIRLLKTQ-DVTFPS-QVSE  342 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~-----------~~~~~i~~~-~~~~p~-~~s~  342 (549)
                      ...||..|+|||++.+..++.++|||||||++|+|++|..||......           .....+... ...++. .++.
T Consensus       161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd06620         161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE  240 (284)
T ss_pred             ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence            457899999999998888999999999999999999999999865431           222223222 223333 3788


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ++.+|+.+||+.||.+|||+.|+++||||...
T Consensus       241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            99999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0596|consensus

Probab=100.00  E-value=6.4e-42  Score=354.96  Aligned_cols=253  Identities=29%  Similarity=0.509  Sum_probs=213.9

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ..|++++.||+||.+.||++.... .+.||+|.+.....+......+.+|+..|.+| .|.+||++|++-..++.+|+||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            569999999999999999998765 56678887776677788899999999999999 5899999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCH-HHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--cc
Q psy18060        198 EFAHMSLSNLLEQRKKLSE-TICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--ML  274 (549)
Q Consensus       198 E~~~gsL~~~l~~~~~l~e-~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--~~  274 (549)
                      |+-+.+|..+|+++....+ -.++.+..|++.|+.++|.+||||.||||.|+|+- .|.+||+|||+|..+..++-  ..
T Consensus       440 E~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~k  518 (677)
T KOG0596|consen  440 ECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVK  518 (677)
T ss_pred             ecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccceee
Confidence            9988899999998765433 57899999999999999999999999999999994 57999999999988875532  23


Q ss_pred             cccCCCCcccccccccCCC-----------CCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCC--CCCCccC
Q psy18060        275 TSIKGTPLYMAPELIAERP-----------YDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQD--VTFPSQV  340 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~-----------y~~ksDIwSlGvil~eLltG~~Pf~~~~-~~~~~~~i~~~~--~~~p~~~  340 (549)
                      .+.+||+.|||||.+....           .+.++||||||||||+|+.|++||..-. ...-+..|....  ++||..-
T Consensus       519 dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~  598 (677)
T KOG0596|consen  519 DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIP  598 (677)
T ss_pred             ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCC
Confidence            4568999999999985432           5578999999999999999999997643 344444555443  3566544


Q ss_pred             CHH-HHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        341 SET-YKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       341 s~~-~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      +.. +.++++.||++||++|||+.++|+|||+..
T Consensus       599 ~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  599 ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            443 999999999999999999999999999986

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-40  Score=331.71  Aligned_cols=241  Identities=24%  Similarity=0.433  Sum_probs=207.7

Q ss_pred             EEecCCcEEEEEEEE--cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-C
Q psy18060        126 LIGEGSFGKVFKAIH--LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-M  202 (549)
Q Consensus       126 ~iG~G~fg~Vy~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-g  202 (549)
                      .||+|+||.||+|..  ..++..+|+|++............+.+|+.+++.+.||||+++++++. .+..++||||++ +
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999964  456789999998765555555678899999999999999999999875 456789999988 5


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc---ccccCC
Q psy18060        203 SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM---LTSIKG  279 (549)
Q Consensus       203 sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~---~~~~~G  279 (549)
                      +|.+++.....+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||+++........   .....+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  160 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW  160 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence            89999988888999999999999999999999999999999999999999999999999999876543221   122234


Q ss_pred             CCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHhchhCcC
Q psy18060        280 TPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLLEKDAS  357 (549)
Q Consensus       280 T~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~L~~dP~  357 (549)
                      ++.|+|||.+....++.++|+|||||++|||++ |+.||...........+..+. ...|..++++++++|.+||+.||.
T Consensus       161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~  240 (257)
T cd05116         161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVD  240 (257)
T ss_pred             CccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCch
Confidence            678999999988889999999999999999998 999999888777777776543 456778999999999999999999


Q ss_pred             CCCCHHHHhc
Q psy18060        358 QRLSWPELLH  367 (549)
Q Consensus       358 ~Rps~~elL~  367 (549)
                      +||++.+|..
T Consensus       241 ~Rp~~~~i~~  250 (257)
T cd05116         241 ERPGFAVVEL  250 (257)
T ss_pred             hCcCHHHHHH
Confidence            9999988854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.3e-40  Score=330.85  Aligned_cols=250  Identities=32%  Similarity=0.512  Sum_probs=212.4

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999999999999999886533 23444567889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        198 EFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       198 E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ||++ ++|.+++..    ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            9998 589888753    34589999999999999999999999999999999999999999999999999887654333


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCC-CC-CccCCHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS--ILHLIRLLKTQDV-TF-PSQVSETYKDLV  348 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~--~~~~~~~i~~~~~-~~-p~~~s~~~~dlI  348 (549)
                      ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||....  .......+..... +. +..++..+.++|
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV  241 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence            3344578999999999988889999999999999999999999996543  3444444443321 22 235788999999


Q ss_pred             HHhchhCcCCCCCHHHHhcC
Q psy18060        349 KGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~H  368 (549)
                      .+||..+|.+|||+.++++.
T Consensus       242 ~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         242 SMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHCCCCcccCcCHHHHHHH
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.7e-41  Score=348.18  Aligned_cols=258  Identities=27%  Similarity=0.454  Sum_probs=214.0

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC------
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------  190 (549)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.++++++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            34789999999999999999999999999999999876443333445678899999999999999999987543      


Q ss_pred             CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        191 NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       191 ~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      ...|+++++++++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++.... 
T Consensus        95 ~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-  172 (345)
T cd07877          95 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  172 (345)
T ss_pred             ccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-
Confidence            34789999998899888765 4699999999999999999999999999999999999999999999999999876532 


Q ss_pred             cccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----------------
Q psy18060        271 THMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD----------------  333 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~----------------  333 (549)
                        ......||+.|+|||.+.+ ..++.++|||||||++|+|++|++||...+.......+....                
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (345)
T cd07877         173 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  250 (345)
T ss_pred             --cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence              2234568999999999866 568899999999999999999999998766544433321110                


Q ss_pred             -------CCC--------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccchh
Q psy18060        334 -------VTF--------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSE  378 (549)
Q Consensus       334 -------~~~--------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~~  378 (549)
                             ...        ....++.+.+||.+||+.||.+|||+.+++.||||++...+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence                   001        113578899999999999999999999999999998755433

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8e-41  Score=341.26  Aligned_cols=255  Identities=30%  Similarity=0.516  Sum_probs=209.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-------
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-------  189 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-------  189 (549)
                      .+++|.+.+.||+|+||.||+|.+..+++.+|+|.+..............+|+++++.++||||+++++.+..       
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            4688999999999999999999999999999999986543322223456789999999999999999987643       


Q ss_pred             -CCEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceec
Q psy18060        190 -LNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       190 -~~~~~iV~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~  267 (549)
                       ...+++||||+.++|...+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus        86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence             235799999999988888765 457999999999999999999999999999999999999999999999999999765


Q ss_pred             ccCcc-----------cccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--
Q psy18060        268 AVGTH-----------MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--  333 (549)
Q Consensus       268 ~~~~~-----------~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--  333 (549)
                      .....           ..+...||+.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+....  
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT  245 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            43211           1233457889999998865 458999999999999999999999998877655544432110  


Q ss_pred             ---------------------CCCC-------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        334 ---------------------VTFP-------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       334 ---------------------~~~p-------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                           ...|       ..+++.+.+||.+||+.||.+|||+.|++.||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                                 0001       1345788899999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7e-41  Score=353.47  Aligned_cols=250  Identities=25%  Similarity=0.433  Sum_probs=206.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCC
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIH-----LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLN  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~  191 (549)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++..... ......+.+|+.+++.+ +||||+++++++...+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            35799999999999999999974     34567899999865432 23446788999999999 8999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhcC----------------------------------------------------------
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRK----------------------------------------------------------  212 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~----------------------------------------------------------  212 (549)
                      ..++||||+. |+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999998 68999886532                                                          


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc--
Q psy18060        213 -----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--  273 (549)
Q Consensus       213 -----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~--  273 (549)
                                       .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........  
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence                             3678889999999999999999999999999999999999999999999999866433211  


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHhcC-CCCCCccCCHHHHHHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSIL-HLIRLLKTQ-DVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~dlI~~  350 (549)
                      .....++..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+..+ ....|...+.++.++|.+
T Consensus       273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  352 (375)
T cd05104         273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKS  352 (375)
T ss_pred             cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHH
Confidence            122345677999999999999999999999999999998 89999876543 333333333 223456678999999999


Q ss_pred             hchhCcCCCCCHHHHhcC
Q psy18060        351 LLEKDASQRLSWPELLHH  368 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~H  368 (549)
                      ||+.||.+|||+.|+++.
T Consensus       353 cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         353 CWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HccCChhHCcCHHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0584|consensus

Probab=100.00  E-value=4.8e-42  Score=361.90  Aligned_cols=249  Identities=26%  Similarity=0.433  Sum_probs=218.4

Q ss_pred             eEEEEEecCCcEEEEEEEEcCCCceEEEEEEecC--CCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE--EEEEE
Q psy18060        122 QKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS--GRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE--FVLIT  197 (549)
Q Consensus       122 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--~~iV~  197 (549)
                      +...+||+|+|-+||+|.+..+|-.||.-.++..  ..++...+.+..|+.+|+.|+||||+++|.+|.+.+.  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            3457899999999999999999999998665433  3456667899999999999999999999999977654  88999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCccccccCCcEEEecC-CcEEEeecccceecccCccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN--RVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~--gIiHrDIKP~NILl~~~-g~vKL~DFGla~~~~~~~~~  273 (549)
                      |++. |+|+.++++.++++...++.|++||+.||.|||++  .|||||||..||||+.+ |.|||+|+|+|+.+....  
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--  200 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence            9987 89999999999999999999999999999999998  59999999999999876 899999999998776442  


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCC--CCccCCHHHHHHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV-SILHLIRLLKTQDVT--FPSQVSETYKDLVKG  350 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~-~~~~~~~~i~~~~~~--~p~~~s~~~~dlI~~  350 (549)
                      .....|||.|||||++. ..|+..+||||||+++.||.|+.+||... ++.++++++..+..+  +...-.+++++||.+
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek  279 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK  279 (632)
T ss_pred             cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH
Confidence            34578999999999998 67999999999999999999999999886 567777887776432  334457899999999


Q ss_pred             hchhCcCCCCCHHHHhcCcccCcc
Q psy18060        351 LLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ||.. ...|||+.|+|.||||...
T Consensus       280 Cl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  280 CLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HhcC-chhccCHHHHhhChhhccc
Confidence            9999 8899999999999999875

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=328.74  Aligned_cols=243  Identities=25%  Similarity=0.438  Sum_probs=214.8

Q ss_pred             EEEecCCcEEEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC
Q psy18060        125 CLIGEGSFGKVFKAIHLDL---KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~  201 (549)
                      +.||+|+||.||+|.....   +..+|+|.+....... ....+.+|+.+++.+.||||+++++++.....++++|||+.
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            4689999999999999866   8899999987654333 46788999999999999999999999999999999999995


Q ss_pred             -CCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        202 -MSLSNLLEQR---------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       202 -gsL~~~l~~~---------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                       ++|.+++...         ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+.......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence             7999999885         779999999999999999999999999999999999999999999999999998765432


Q ss_pred             --ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHH
Q psy18060        272 --HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDL  347 (549)
Q Consensus       272 --~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dl  347 (549)
                        .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+..+ ....|..+|+++.++
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYEL  239 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHH
Confidence              22344567899999999988889999999999999999999 69999998888877777643 345677889999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcC
Q psy18060        348 VKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~H  368 (549)
                      +.+||..+|.+|||+.+++++
T Consensus       240 i~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         240 MLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHccCCcccCcCHHHHHHh
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-40  Score=345.33  Aligned_cols=258  Identities=28%  Similarity=0.421  Sum_probs=214.4

Q ss_pred             ccceeE-EEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHH------------HHHHHHHHHHHHhcCCCCeeEEE
Q psy18060        118 LEKYQK-ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE------------LSSLKQECEIQKHLAHPNIIKFI  184 (549)
Q Consensus       118 ~~~y~~-~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~------------~~~~~~Ei~il~~l~hpnIv~l~  184 (549)
                      .++|.. .+.||.|+||.||+|.+..+++.||+|.+.........            ...+.+|+.+++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356654 57799999999999999999999999998654322100            12467899999999999999999


Q ss_pred             EEEeeCCEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccc
Q psy18060        185 ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA  264 (549)
Q Consensus       185 ~~~~~~~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla  264 (549)
                      +++...+..+++||++.|+|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus        87 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            99999999999999999999999998888999999999999999999999999999999999999999999999999999


Q ss_pred             eeccc--------------CcccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy18060        265 RSMAV--------------GTHMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL  329 (549)
Q Consensus       265 ~~~~~--------------~~~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i  329 (549)
                      +....              .....+...+++.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+..+....+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            76541              11122334578899999998764 4789999999999999999999999888766555443


Q ss_pred             hcC---CC-------------------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        330 KTQ---DV-------------------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       330 ~~~---~~-------------------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ...   +.                         ...+..++.+.++|.+||+.+|.+|||++|++.||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            210   00                         00124578899999999999999999999999999998653

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=329.10  Aligned_cols=245  Identities=34%  Similarity=0.565  Sum_probs=221.2

Q ss_pred             EecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CCH
Q psy18060        127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSL  204 (549)
Q Consensus       127 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL  204 (549)
                      ||+|+||.||++.+..+++.+|+|.+.+... .......+..|+.+++.+.||||+++++.+...+..+++||++. ++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999999998899999999876543 22345678899999999999999999999999999999999995 799


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCccc
Q psy18060        205 SNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYM  284 (549)
Q Consensus       205 ~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~  284 (549)
                      .+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............|+..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            99999888899999999999999999999999999999999999999999999999999977654333345567899999


Q ss_pred             ccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCCH--
Q psy18060        285 APELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW--  362 (549)
Q Consensus       285 APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~--  362 (549)
                      |||...+...+.++|+||||+++|+|++|..||...+.......+......+|...++.+.++|.+||..||.+|||+  
T Consensus       161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            999998888899999999999999999999999988877777777777778888899999999999999999999999  


Q ss_pred             -HHHhcCccc
Q psy18060        363 -PELLHHPLV  371 (549)
Q Consensus       363 -~elL~Hpw~  371 (549)
                       .++++||||
T Consensus       241 ~~~l~~~~~f  250 (250)
T cd05123         241 AEEIKAHPFF  250 (250)
T ss_pred             HHHHHhCCCC
Confidence             999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.6e-41  Score=349.03  Aligned_cols=256  Identities=28%  Similarity=0.472  Sum_probs=215.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE----
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE----  192 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----  192 (549)
                      ..++|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.+.||||+++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3467999999999999999999999999999999986543333344567789999999999999999887765544    


Q ss_pred             --EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        193 --FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       193 --~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                        .++|+|+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++......
T Consensus        93 ~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (343)
T cd07851          93 QDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE  171 (343)
T ss_pred             ccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence              899999999999998875 57999999999999999999999999999999999999999999999999999765432


Q ss_pred             cccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--------------
Q psy18060        271 THMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT--------------  335 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~--------------  335 (549)
                         .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+......              
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07851         172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA  248 (343)
T ss_pred             ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence               344568999999999865 46789999999999999999999999887766555444321100              


Q ss_pred             -----------------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        336 -----------------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       336 -----------------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                                       ....+++.+.+||.+||..+|.+|||+.+|++||||.....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence                             01246889999999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=334.02  Aligned_cols=251  Identities=32%  Similarity=0.506  Sum_probs=212.8

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--CEEEEEEe
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--NEFVLITE  198 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~iV~E  198 (549)
                      |++.+.||+|++|.||+|.+..+++.+|+|.+............+.+|+.+++.+.|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            6788999999999999999999999999999987543333445678899999999999999999999887  88999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-cccc
Q psy18060        199 FAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-MLTS  276 (549)
Q Consensus       199 ~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~  276 (549)
                      |++++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||++++++.+||+|||++........ ..+.
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (287)
T cd07840          81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN  160 (287)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence            9999999998765 5799999999999999999999999999999999999999999999999999986654321 2234


Q ss_pred             cCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---------------------
Q psy18060        277 IKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---------------------  334 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---------------------  334 (549)
                      ..++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.....                     
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (287)
T cd07840         161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP  240 (287)
T ss_pred             cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence            467889999998764 4688999999999999999999999988776555544332100                     


Q ss_pred             --C--------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        335 --T--------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       335 --~--------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                        .        +...+++.+.+++.+||..+|.+||++.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              0        001138899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.2e-40  Score=330.99  Aligned_cols=248  Identities=23%  Similarity=0.439  Sum_probs=214.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ..+|.+.+.||+|+||.||+|....+++.+|+|.+...   ......+.+|+++++.++||||+++++++...+.++++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            35688999999999999999999999999999998643   223456889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        198 EFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||++ ++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++..........
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            9987 6899998764  358999999999999999999999999999999999999999999999999997765432211


Q ss_pred             -cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHh
Q psy18060        275 -TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       275 -~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~  351 (549)
                       ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+... ....|..+++++.++|.+|
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  241 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRAC  241 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence             12234667999999998899999999999999999998 99999988887777776554 4456778999999999999


Q ss_pred             chhCcCCCCCHHHHhcC
Q psy18060        352 LEKDASQRLSWPELLHH  368 (549)
Q Consensus       352 L~~dP~~Rps~~elL~H  368 (549)
                      |+.+|.+|||+.++++.
T Consensus       242 l~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         242 WQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             ccCCcccCCCHHHHHHH
Confidence            99999999999998653

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG4279|consensus

Probab=100.00  E-value=3.1e-42  Score=363.11  Aligned_cols=248  Identities=31%  Similarity=0.578  Sum_probs=217.7

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CC
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MS  203 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gs  203 (549)
                      -+||+|.||+||.|++..|....|||.+..  .+....+.+..|+.+.+.|+|.|||++.|++..++.+-|.||-.+ |+
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            369999999999999999999999999854  334556788999999999999999999999999999999999876 69


Q ss_pred             HHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec-CCcEEEeecccceecccCcccccccCC
Q psy18060        204 LSNLLEQR-KKL--SETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK-DGVAMLCDFGFARSMAVGTHMLTSIKG  279 (549)
Q Consensus       204 L~~~l~~~-~~l--~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~-~g~vKL~DFGla~~~~~~~~~~~~~~G  279 (549)
                      |.++|+.. +++  +|..+..+.+||++||.|||++.|||||||-.|+|++. .|.+||.|||.+++...-+....++.|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            99999864 666  88899999999999999999999999999999999975 699999999999988766566678899


Q ss_pred             CCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHH-HhcCCCCCCccCCHHHHHHHHHhchh
Q psy18060        280 TPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTVS--ILHLIRL-LKTQDVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       280 T~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~~~--~~~~~~~-i~~~~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      |..|||||++..  ..|+.++|||||||++.||.||++||....  ....++. +-...+++|..+|.+++.||.+|+.+
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep  818 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP  818 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence            999999999954  569999999999999999999999997543  2222221 23345678899999999999999999


Q ss_pred             CcCCCCCHHHHhcCcccCcc
Q psy18060        355 DASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       355 dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ||.+||+|.++|..||++..
T Consensus       819 d~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  819 DPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CcccCccHHHhccCcccccC
Confidence            99999999999999999876

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-40  Score=334.78  Aligned_cols=249  Identities=25%  Similarity=0.407  Sum_probs=214.0

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      .++|.+.+.||+|+||.||+|.+..     ++..+|+|.+..... ......+.+|+++++.+.||||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            4568899999999999999998753     357899999865432 3345688999999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEE
Q psy18060        193 FVLITEFAH-MSLSNLLEQRK--------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAM  257 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~--------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vK  257 (549)
                      .+++|||+. ++|.+++...+              .+++..+..++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k  162 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK  162 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence            999999987 58999997642              478899999999999999999999999999999999999999999


Q ss_pred             EeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCC
Q psy18060        258 LCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDV  334 (549)
Q Consensus       258 L~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~~  334 (549)
                      |+|||+++.......  ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+..+..
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~  242 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL  242 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence            999999976432211  1123346788999999999999999999999999999998 9999998888888887776654


Q ss_pred             C-CCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        335 T-FPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       335 ~-~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      . .|..++..+.+++.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         243 LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3 45678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-40  Score=334.06  Aligned_cols=250  Identities=32%  Similarity=0.511  Sum_probs=210.0

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc---CCCCeeEEEEEEeeCCE-----
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL---AHPNIIKFIASHETLNE-----  192 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~-----  192 (549)
                      |++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.+   .||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6789999999999999999998899999999975443333334566777777665   69999999999987776     


Q ss_pred             EEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        193 FVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      ++++||+++++|.+++....  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~  160 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE  160 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence            99999999999999887753  5899999999999999999999999999999999999999999999999999776543


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CC----------
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-----VT----------  335 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-----~~----------  335 (549)
                      . ......+++.|+|||++.+..++.++|+|||||++|+|++|.+||...+..+....+....     ..          
T Consensus       161 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07838         161 M-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS  239 (287)
T ss_pred             c-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence            2 2233458899999999998889999999999999999999999998877666555443210     00          


Q ss_pred             -C-----------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        336 -F-----------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       336 -~-----------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                       +           .+.+++.+.++|.+||+.||.+||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence             0           01356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-41  Score=367.71  Aligned_cols=261  Identities=23%  Similarity=0.318  Sum_probs=200.6

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCc-eEEEEEE--------------ec-CCCChHHHHHHHHHHHHHHhcCCCC
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKK-TVALKII--------------SK-SGRSGKELSSLKQECEIQKHLAHPN  179 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~-~vAvK~i--------------~~-~~~~~~~~~~~~~Ei~il~~l~hpn  179 (549)
                      ...++|++++.||+|+||.||+|..+.... ..+.|.+              .+ ..........+.+|+.+++.++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999987654322 2222211              11 0112223456789999999999999


Q ss_pred             eeEEEEEEeeCCEEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC
Q psy18060        180 IIKFIASHETLNEFVLITEFAHMSLSNLLEQR-----KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG  254 (549)
Q Consensus       180 Iv~l~~~~~~~~~~~iV~E~~~gsL~~~l~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g  254 (549)
                      ||++++++...+..|++++++.++|..++...     .......++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            99999999999999999999999988877542     2345667889999999999999999999999999999999999


Q ss_pred             cEEEeecccceecccCcc-cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCC-CCCC--CH-HHHHHHH
Q psy18060        255 VAMLCDFGFARSMAVGTH-MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPP-FKTV--SI-LHLIRLL  329 (549)
Q Consensus       255 ~vKL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~P-f~~~--~~-~~~~~~i  329 (549)
                      .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..| |...  .. ....+.+
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            999999999987654322 22346799999999999999999999999999999999998754 4322  12 2222211


Q ss_pred             hc---CCCCCC----------------------------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        330 KT---QDVTFP----------------------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       330 ~~---~~~~~p----------------------------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      ..   ....+|                            ..++..+.++|.+||+.||.+|||+.|+|.||||.....
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~  462 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE  462 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence            10   000111                            135667888999999999999999999999999987543

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.5e-40  Score=327.54  Aligned_cols=250  Identities=30%  Similarity=0.529  Sum_probs=221.9

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+............+.+|+++++.++||||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            48899999999999999999999999999999977655555566778899999999999999999999888999999999


Q ss_pred             CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        200 AH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       200 ~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ++ ++|.+++.+    ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++......  ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~  158 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA  158 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence            87 589998876    356899999999999999999999999999999999999999999999999999776543  22


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHhch
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dlI~~~L~  353 (549)
                      ....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+..... ..+..++.++.+++.+||.
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  238 (256)
T cd08530         159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ  238 (256)
T ss_pred             ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcC
Confidence            335689999999999999999999999999999999999999998887776666655443 3556789999999999999


Q ss_pred             hCcCCCCCHHHHhcCccc
Q psy18060        354 KDASQRLSWPELLHHPLV  371 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~  371 (549)
                      .+|.+|||+.++++||++
T Consensus       239 ~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         239 VKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CCcccCCCHHHHhcCCCC
Confidence            999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.5e-40  Score=338.35  Aligned_cols=255  Identities=31%  Similarity=0.441  Sum_probs=212.6

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-----
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----  191 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+++++.++||||+++++++....     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            457899999999999999999999999999999999765433333456778999999999999999999886554     


Q ss_pred             -----EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccce
Q psy18060        192 -----EFVLITEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       192 -----~~~iV~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                           .+++++||++++|...+... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|||++.
T Consensus        85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~  164 (302)
T cd07864          85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR  164 (302)
T ss_pred             cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence                 78999999999888887764 469999999999999999999999999999999999999999999999999997


Q ss_pred             ecccCcc-cccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CC------
Q psy18060        266 SMAVGTH-MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---DV------  334 (549)
Q Consensus       266 ~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~---~~------  334 (549)
                      ....... ......+++.|+|||++.+ ..++.++|||||||++++|++|++||...+.......+...   +.      
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD  244 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence            6644322 2223356888999998864 45789999999999999999999999877665544443221   00      


Q ss_pred             ---------------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        335 ---------------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       335 ---------------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                                           .....++..+.++|.+||..+|.+|||+.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                 0112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.2e-41  Score=341.72  Aligned_cols=253  Identities=30%  Similarity=0.515  Sum_probs=217.3

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ..|.....||+|+||.||++.+..+++.||+|.+.....  .....+.+|+.+++.+.||||+++++.+...+..+++||
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence            345556689999999999999998999999999865332  234567889999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      |++ ++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.............
T Consensus        99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659          99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence            998 478887654 578999999999999999999999999999999999999999999999999987654433333456


Q ss_pred             CCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCccCCHHHHHHHHHhchh
Q psy18060        278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---TFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~dlI~~~L~~  354 (549)
                      .|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.....   ..+..+++.+.++|.+||+.
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  257 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR  257 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence            799999999999988899999999999999999999999988777666666544332   22346789999999999999


Q ss_pred             CcCCCCCHHHHhcCcccCcc
Q psy18060        355 DASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       355 dP~~Rps~~elL~Hpw~~~~  374 (549)
                      +|.+||++.++++||||.+.
T Consensus       258 ~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         258 EPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             CcccCcCHHHHhhChhhccC
Confidence            99999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.7e-40  Score=333.47  Aligned_cols=257  Identities=20%  Similarity=0.365  Sum_probs=214.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      ..++|++.+.||+|+||.||+|..+.     .+..||+|.+..... ......+.+|+.+++.++||||+++++++...+
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35689999999999999999997653     345799998764432 233446788999999999999999999999889


Q ss_pred             EEEEEEecCC-CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEee
Q psy18060        192 EFVLITEFAH-MSLSNLLEQR----------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCD  260 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~----------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~D  260 (549)
                      ..++||||+. |+|.+++...          ..++...+..++.|++.||.|||++||+||||||+|||++.++.++|+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence            9999999987 6999999753          2346678889999999999999999999999999999999999999999


Q ss_pred             cccceecccCccc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCC
Q psy18060        261 FGFARSMAVGTHM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTF  336 (549)
Q Consensus       261 FGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~  336 (549)
                      ||+++........  .....++..|+|||.+.++.++.++|||||||++|||++ |..||.+.+..+....+..+. ...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ  242 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9998765332111  122345678999999998889999999999999999998 899999888877777665443 345


Q ss_pred             CccCCHHHHHHHHHhchhCcCCCCCHHHHhc------CcccCcc
Q psy18060        337 PSQVSETYKDLVKGLLEKDASQRLSWPELLH------HPLVKDN  374 (549)
Q Consensus       337 p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~------Hpw~~~~  374 (549)
                      |...++.+.+++.+||+.||.+|||+.++++      ||||.+.
T Consensus       243 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         243 PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            6678899999999999999999999999986      9998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.1e-40  Score=327.53  Aligned_cols=246  Identities=24%  Similarity=0.414  Sum_probs=211.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|+||.||++..+. +..+|+|.+......   ...+.+|+.+++.++||||+++++++...+..+++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            3568999999999999999998764 567999987644322   346788999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc-c
Q psy18060        198 EFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-L  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~-~  274 (549)
                      ||+. |+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++........ .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence            9997 6899998754 46899999999999999999999999999999999999999999999999998765432211 1


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHhc
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~L  352 (549)
                      ....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+..+. ...|...+..+.+++.+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~  238 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCW  238 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            22345668999999988889999999999999999999 999999988888877776653 3346668899999999999


Q ss_pred             hhCcCCCCCHHHHhc
Q psy18060        353 EKDASQRLSWPELLH  367 (549)
Q Consensus       353 ~~dP~~Rps~~elL~  367 (549)
                      +.+|.+|||+.++++
T Consensus       239 ~~~p~~Rps~~~l~~  253 (256)
T cd05114         239 HEKPEGRPTFAELLR  253 (256)
T ss_pred             cCCcccCcCHHHHHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.5e-40  Score=328.05  Aligned_cols=242  Identities=24%  Similarity=0.387  Sum_probs=205.8

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CC
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MS  203 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gs  203 (549)
                      +.||+|+||.||+|.+..+++.+|+|.+... ........+.+|+++++.+.||||+++++++...+..++||||+. ++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            3689999999999999999999999987643 334445678899999999999999999999999999999999987 58


Q ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc--cccCCC
Q psy18060        204 LSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML--TSIKGT  280 (549)
Q Consensus       204 L~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~--~~~~GT  280 (549)
                      |.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........  ....++
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            999997644 58999999999999999999999999999999999999999999999999987654321111  111234


Q ss_pred             CcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhchhCcCC
Q psy18060        281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLEKDASQ  358 (549)
Q Consensus       281 ~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~  358 (549)
                      ..|+|||.+.++.++.++|||||||++|+|++ |..||...+.......+... ....|..++..+.+++.+||+.+|.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  239 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ  239 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhh
Confidence            56999999998889999999999999999997 99999887776665555443 34566778999999999999999999


Q ss_pred             CCCHHHHhc
Q psy18060        359 RLSWPELLH  367 (549)
Q Consensus       359 Rps~~elL~  367 (549)
                      |||+.++++
T Consensus       240 Rps~~~~~~  248 (252)
T cd05084         240 RPSFSTVHQ  248 (252)
T ss_pred             CcCHHHHHH
Confidence            999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.2e-40  Score=332.38  Aligned_cols=251  Identities=21%  Similarity=0.363  Sum_probs=211.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      ..++|++.+.||+|+||.||+|.+..     ++..+|+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34679999999999999999998642     35679999885432 2334456889999999999999999999999989


Q ss_pred             EEEEEEecCC-CCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEee
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRK----------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCD  260 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~----------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~D  260 (549)
                      ..++||||+. ++|.+++.+..          .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence            9999999987 58999987532          357788899999999999999999999999999999999999999999


Q ss_pred             cccceecccCccc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCC
Q psy18060        261 FGFARSMAVGTHM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTF  336 (549)
Q Consensus       261 FGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~  336 (549)
                      ||+++........  .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.... ...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  242 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK  242 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            9998765432211  122345788999999998889999999999999999998 799999888877777665543 345


Q ss_pred             CccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        337 PSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       337 p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      |..+++.+.+++.+||+.||.+|||+.|++++
T Consensus       243 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         243 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            67789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.3e-40  Score=334.60  Aligned_cols=247  Identities=25%  Similarity=0.420  Sum_probs=211.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ++|.+.+.||+|+||.||++.+.     .++..+|+|.+...  .......+.+|+.+++++.||||+++++++...+.+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            56899999999999999999853     34566899988653  234456788999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEe
Q psy18060        194 VLITEFAH-MSLSNLLEQRK-------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLC  259 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~-------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~  259 (549)
                      +++|||+. ++|.+++...+             .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~  162 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG  162 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence            99999987 68999997543             48999999999999999999999999999999999999999999999


Q ss_pred             ecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CC
Q psy18060        260 DFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VT  335 (549)
Q Consensus       260 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~  335 (549)
                      |||+++.......  ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+..+. ..
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~  242 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ  242 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999976533211  1122345778999999998889999999999999999998 999999888877777776664 34


Q ss_pred             CCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        336 FPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       336 ~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .+..+++++.+++.+||+.||.+|||+.+++.
T Consensus       243 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         243 RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            56678999999999999999999999999843

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.9e-40  Score=334.18  Aligned_cols=256  Identities=34%  Similarity=0.564  Sum_probs=223.1

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      .....|+....||+|++|.||+|.+..++..+|+|++.....   ....+.+|+.+++.++||||+++++.+...+..++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            455668999999999999999999998899999999975433   45677899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        196 ITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      ++||++ ++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus        93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence            999998 69999999877 8999999999999999999999999999999999999999999999999988655433333


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-C--CCccCCHHHHHHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-T--FPSQVSETYKDLVKG  350 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~--~p~~~s~~~~dlI~~  350 (549)
                      .....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+..... .  .+..++..++++|.+
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK  252 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence            3445688999999999888899999999999999999999999998776655555443322 1  223488999999999


Q ss_pred             hchhCcCCCCCHHHHhcCcccCcc
Q psy18060        351 LLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ||+.+|.+|||+.+++.||||+..
T Consensus       253 ~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         253 CLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HhccChhhCcCHHHHhhChHhhcc
Confidence            999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.3e-40  Score=333.32  Aligned_cols=250  Identities=21%  Similarity=0.384  Sum_probs=212.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEc----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHL----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      +.+|++.+.||+|+||.||+|...    .++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            467899999999999999999853    356789999986532 334456788999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc
Q psy18060        194 VLITEFAH-MSLSNLLEQR-----------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV  255 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~-----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~  255 (549)
                      +++|||++ ++|.+++..+                 ..+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence            99999998 5899998533                 24788889999999999999999999999999999999999999


Q ss_pred             EEEeecccceecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC
Q psy18060        256 AMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ  332 (549)
Q Consensus       256 vKL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~  332 (549)
                      +||+|||+++......  .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+...
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  242 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR  242 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999997654321  11233456778999999988889999999999999999998 99999888777766666544


Q ss_pred             C-CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        333 D-VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       333 ~-~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      . ...|..+++.+.+++.+||+.||.+||++.+|+++
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         243 QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            3 34567789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.8e-40  Score=345.55  Aligned_cols=253  Identities=32%  Similarity=0.471  Sum_probs=208.5

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--------
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--------  190 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--------  190 (549)
                      .+|.+.+.||.|+||.||+|.+..+++.||+|.+.....  .....+.+|+.+++.++||||+++++++...        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            679999999999999999999999999999999865432  3446788999999999999999998765443        


Q ss_pred             ------CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec-CCcEEEeeccc
Q psy18060        191 ------NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK-DGVAMLCDFGF  263 (549)
Q Consensus       191 ------~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~-~g~vKL~DFGl  263 (549)
                            ...++||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          83 GSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             ccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence                  35799999999999888864 57999999999999999999999999999999999999985 45789999999


Q ss_pred             ceecccCcc---cccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------
Q psy18060        264 ARSMAVGTH---MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD------  333 (549)
Q Consensus       264 a~~~~~~~~---~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~------  333 (549)
                      ++.......   ..+...||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+....      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE  241 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            976542211   1123467899999998754 568899999999999999999999998776544443322110      


Q ss_pred             -------------------CC-----CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        334 -------------------VT-----FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       334 -------------------~~-----~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                         ..     +.+.++.++.+||.+||+.||.+|||+.+++.||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                               00     113578899999999999999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.7e-40  Score=342.66  Aligned_cols=255  Identities=29%  Similarity=0.478  Sum_probs=210.1

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCC--CceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee----CCE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDL--KKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET----LNE  192 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~~  192 (549)
                      +|.+.+.||+|+||.||++.+..+  +..||+|.+............+.+|+.+++.+ .||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            488999999999999999999988  89999999875433333345678899999998 59999999986432    356


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        193 FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +|++|++++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~  160 (332)
T cd07857          81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG  160 (332)
T ss_pred             EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence            78999999999999998888999999999999999999999999999999999999999999999999999976543211


Q ss_pred             ----cccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Q psy18060        273 ----MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---------------  332 (549)
Q Consensus       273 ----~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~---------------  332 (549)
                          ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+...               
T Consensus       161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd07857         161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP  240 (332)
T ss_pred             cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhh
Confidence                1234578999999998765 56899999999999999999999999876544333221110               


Q ss_pred             -------------CCCC---CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        333 -------------DVTF---PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       333 -------------~~~~---p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                   ...+   .+..+..+.+|+.+||+.||.+|||+.+++.|||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence                         0011   12457899999999999999999999999999999644

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.4e-40  Score=331.91  Aligned_cols=256  Identities=30%  Similarity=0.513  Sum_probs=213.1

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--CCEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--LNEFVLI  196 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~iV  196 (549)
                      ++|...+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++.++||||+++++++..  .+.+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            368899999999999999999999999999999875433 2445678899999999999999999998754  4478999


Q ss_pred             EecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        197 TEFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      |||++ ++|.+++..    ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            99997 589887653    3458999999999999999999999999999999999999999999999999987654322


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCC-CCCC------cc
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV-----SILHLIRLLKTQD-VTFP------SQ  339 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~-----~~~~~~~~i~~~~-~~~p------~~  339 (549)
                        .....++..|+|||.+.+..++.++|||||||++|+|++|..||...     ...+....+.... ..++      ..
T Consensus       160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd06621         160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK  237 (287)
T ss_pred             --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence              22446888999999999889999999999999999999999999765     2334444443322 1121      13


Q ss_pred             CCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       340 ~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                      +++.+.+||.+||..+|.+|||+.|++.||||+....+
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence            56789999999999999999999999999999765443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=335.44  Aligned_cols=251  Identities=35%  Similarity=0.557  Sum_probs=214.8

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecC
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA  200 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~  200 (549)
                      |+..+.||+|++|.||+|....+++.+|+|.+............+.+|+.+++.++||||+++++++...+..++|||++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            56778999999999999999999999999999765433334456778999999999999999999999889999999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCC
Q psy18060        201 HMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG  279 (549)
Q Consensus       201 ~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~G  279 (549)
                      +++|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||+++.............+
T Consensus        81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  160 (282)
T cd07829          81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV  160 (282)
T ss_pred             CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcccc
Confidence            99999999886 58999999999999999999999999999999999999999999999999999876544333344567


Q ss_pred             CCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------CCCC----
Q psy18060        280 TPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ------------------DVTF----  336 (549)
Q Consensus       280 T~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~------------------~~~~----  336 (549)
                      +..|+|||.+.+. .++.++|||||||++|+|++|++||...+.......+...                  ...+    
T Consensus       161 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd07829         161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP  240 (282)
T ss_pred             CcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccC
Confidence            8889999998766 7899999999999999999999999887655544433210                  0001    


Q ss_pred             -------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        337 -------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       337 -------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                             .+.++..+.++|.+||..+|.+||++.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         241 PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                   12347889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.8e-40  Score=338.01  Aligned_cols=254  Identities=31%  Similarity=0.554  Sum_probs=217.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ..+|.+.+.||+|+||.||++....++..+|+|.+.....  .....+.+|+.+++.++||||+++++.+...+..|+|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            4689999999999999999999988899999999864322  23456788999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||+. ++|.+++.+ ..+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++............
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             ecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence            9997 589998875 46889999999999999999999999999999999999999999999999998766544333445


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-C--CCCCccCCHHHHHHHHHhch
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-D--VTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-~--~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+... .  ...+..++..++++|.+||.
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE  254 (293)
T ss_pred             ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHcc
Confidence            57899999999998888999999999999999999999999877654443332221 1  12334578899999999999


Q ss_pred             hCcCCCCCHHHHhcCcccCcc
Q psy18060        354 KDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+|.+||++.+++.||||+..
T Consensus       255 ~~p~~Rp~~~~il~h~~~~~~  275 (293)
T cd06647         255 MDVEKRGSAKELLQHPFLKIA  275 (293)
T ss_pred             CChhhCcCHHHHhcCHHHhcC
Confidence            999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.7e-40  Score=331.15  Aligned_cols=247  Identities=24%  Similarity=0.378  Sum_probs=208.1

Q ss_pred             eEEEEEecCCcEEEEEEEEcCCCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee------CCEE
Q psy18060        122 QKICLIGEGSFGKVFKAIHLDLKK--TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET------LNEF  193 (549)
Q Consensus       122 ~~~~~iG~G~fg~Vy~~~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~~~  193 (549)
                      .+.+.||+|+||.||+|....++.  .+|+|.+............+.+|+.+++.++||||+++++.+..      ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            467889999999999999887765  58999987655555667788999999999999999999987632      2246


Q ss_pred             EEEEecCC-CCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        194 VLITEFAH-MSLSNLLEQ------RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~------~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                      +++|||+. |+|.+++..      ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence            89999987 689888742      23488999999999999999999999999999999999999999999999999987


Q ss_pred             cccCccc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCH
Q psy18060        267 MAVGTHM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSE  342 (549)
Q Consensus       267 ~~~~~~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~  342 (549)
                      .......  .....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+..+. ...++.++.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLD  241 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            6433211  122346778999999999999999999999999999999 899999888777777776654 345678899


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .+.++|.+||+.||.+|||+.+++++
T Consensus       242 ~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         242 GLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-40  Score=345.45  Aligned_cols=253  Identities=30%  Similarity=0.491  Sum_probs=210.8

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC------CE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------NE  192 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~~  192 (549)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+.+..........+.+|+.+++.+.||||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            679999999999999999999999999999999876433333345678899999999999999999988654      34


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        193 FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +++||||+..+|..++  ...+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++....   
T Consensus        95 ~~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~---  169 (342)
T cd07879          95 FYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA---  169 (342)
T ss_pred             EEEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC---
Confidence            6999999988887765  34689999999999999999999999999999999999999999999999999876532   


Q ss_pred             cccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------------
Q psy18060        273 MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD------------------  333 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~------------------  333 (549)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....                  
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (342)
T cd07879         170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS  249 (342)
T ss_pred             CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence            2234568899999999866 468999999999999999999999999877554443322210                  


Q ss_pred             -----CCC--------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        334 -----VTF--------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       334 -----~~~--------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                           ...        .+..++.+.+||.+||+.||.+||++.+++.||||.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                 001        1246788999999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-40  Score=330.43  Aligned_cols=249  Identities=20%  Similarity=0.378  Sum_probs=213.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCC-----ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLK-----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      .++|++.+.||+|+||.||+|.....+     ..+|+|.+.... .......+.+|+.+++.+.||||+++++++.....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            467999999999999999999876543     789999986443 23344577899999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeec
Q psy18060        193 FVLITEFAH-MSLSNLLEQRK----------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDF  261 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~----------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DF  261 (549)
                      .++||||+. ++|.+++....          .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df  163 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF  163 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence            999999997 69999986532          3678899999999999999999999999999999999999999999999


Q ss_pred             ccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCC
Q psy18060        262 GFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFP  337 (549)
Q Consensus       262 Gla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  337 (549)
                      |+++.......  ......+|..|+|||.+.+..++.++|||||||++|+|++ |..||...+.....+.+... ....|
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  243 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP  243 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence            99876543221  1233457889999999988889999999999999999998 99999988888777777644 34567


Q ss_pred             ccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        338 SQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       338 ~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ..++..+.+++.+||+.+|.+|||+.+++.
T Consensus       244 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         244 ENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-40  Score=328.27  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=213.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDL---KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .++|++.+.||+|+||.||+|.+..+   ...+|+|.+.... .......+.+|+.+++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            35689999999999999999988654   4579999886543 3444567888999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ++|||+. ++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus        82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            9999997 5899998764 4689999999999999999999999999999999999999999999999999987642221


Q ss_pred             c--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHH
Q psy18060        273 M--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLV  348 (549)
Q Consensus       273 ~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI  348 (549)
                      .  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+... ..+.|..+++.+.+++
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  241 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLM  241 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            1  122345678999999998889999999999999999998 99999888877777776654 3345567899999999


Q ss_pred             HHhchhCcCCCCCHHHHhcC
Q psy18060        349 KGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~H  368 (549)
                      .+||+.+|.+||++.+++++
T Consensus       242 ~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         242 LDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-40  Score=345.79  Aligned_cols=257  Identities=34%  Similarity=0.520  Sum_probs=214.1

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee--CCEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET--LNEF  193 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--~~~~  193 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|.+............+.+|+.+++++ +||||+++++++..  ...+
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            45789999999999999999999998999999999865433334445677899999999 99999999998754  3468


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc--
Q psy18060        194 VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--  271 (549)
Q Consensus       194 ~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~--  271 (549)
                      ++||||++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.......  
T Consensus        85 ~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          85 YLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN  163 (337)
T ss_pred             EEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence            999999999999998776 88999999999999999999999999999999999999999999999999997654332  


Q ss_pred             ---ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------
Q psy18060        272 ---HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--------------  333 (549)
Q Consensus       272 ---~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--------------  333 (549)
                         .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+....              
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP  243 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence               12234568999999998754 557899999999999999999999998765544333321110              


Q ss_pred             -------------C----CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        334 -------------V----TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       334 -------------~----~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                   .    ...+.++.++.++|.+||+.+|.+|||+.++++|||+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                         0    0112368899999999999999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.8e-40  Score=321.15  Aligned_cols=248  Identities=35%  Similarity=0.613  Sum_probs=216.2

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      +|...+.||+|++|.||++.+..+++.+++|++.....  .....+.+|+.+++.++||||+++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            47889999999999999999998999999999876433  3456788999999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        200 AH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       200 ~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      ++ ++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........ ....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~  157 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTM  157 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccce
Confidence            98 6899998876 6899999999999999999999999999999999999999999999999999977654432 3455


Q ss_pred             CCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCc--cCCHHHHHHHHHhchh
Q psy18060        278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-DVTFPS--QVSETYKDLVKGLLEK  354 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-~~~~p~--~~s~~~~dlI~~~L~~  354 (549)
                      .|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ....+.  .++..+.++|.+||+.
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence            7899999999998888999999999999999999999999887555444443322 222332  3489999999999999


Q ss_pred             CcCCCCCHHHHhcCcc
Q psy18060        355 DASQRLSWPELLHHPL  370 (549)
Q Consensus       355 dP~~Rps~~elL~Hpw  370 (549)
                      ||.+|||+.++++|||
T Consensus       238 ~p~~R~t~~~~l~~~~  253 (253)
T cd05122         238 NPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ChhhCCCHHHHhcCCC
Confidence            9999999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-40  Score=329.37  Aligned_cols=248  Identities=23%  Similarity=0.382  Sum_probs=210.2

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE-----
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDL---KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE-----  192 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-----  192 (549)
                      |.+.+.||+|+||.||+|....+   +..+|+|.+............+.+|+.+++.++||||+++++.+.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56788999999999999987653   4789999997655555566788999999999999999999998755443     


Q ss_pred             -EEEEEecCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccc
Q psy18060        193 -FVLITEFAH-MSLSNLLEQR------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA  264 (549)
Q Consensus       193 -~~iV~E~~~-gsL~~~l~~~------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla  264 (549)
                       .+++|||+. ++|..++...      ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence             799999987 6898888542      36899999999999999999999999999999999999999999999999999


Q ss_pred             eecccCccc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccC
Q psy18060        265 RSMAVGTHM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQV  340 (549)
Q Consensus       265 ~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  340 (549)
                      +........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+..+ ....|..+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC  240 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCC
Confidence            876433211  122345678999999988889999999999999999999 99999988877777766544 34567789


Q ss_pred             CHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        341 SETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       341 s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ++.+.+++.+||+.||.+|||+.|++++
T Consensus       241 ~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         241 LDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.9e-40  Score=325.92  Aligned_cols=249  Identities=34%  Similarity=0.550  Sum_probs=212.6

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|++++++++||||+++++.+...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            579999999999999999999999999999999875432 3334567889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        198 EFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       198 E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ||++ ++|.+++..    ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            9998 589998864    34589999999999999999999999999999999999999999999999999876654433


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCC-CCCCc-cCCHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS--ILHLIRLLKTQD-VTFPS-QVSETYKDLV  348 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~--~~~~~~~i~~~~-~~~p~-~~s~~~~dlI  348 (549)
                      ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||....  .......+..+. .+.|. .++..+.++|
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  241 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV  241 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence            3345578999999999998889999999999999999999999996543  334444444332 22343 6888999999


Q ss_pred             HHhchhCcCCCCCHHHHhc
Q psy18060        349 KGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~  367 (549)
                      .+||..+|.+|||+.+|++
T Consensus       242 ~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         242 SRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHcCCCcccCCCHHHHHH
Confidence            9999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5e-40  Score=334.62  Aligned_cols=260  Identities=28%  Similarity=0.484  Sum_probs=212.7

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  193 (549)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|.+....... ....+..|+.++... .||||+++++++......
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            335577999999999999999999999999999999997654332 334455666666555 599999999999999999


Q ss_pred             EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      |++|||++++|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++.......
T Consensus        90 ~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          90 FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             EEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            99999999888888765 4578999999999999999999997 599999999999999999999999999987654322


Q ss_pred             ccccccCCCCcccccccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCC-CCCC--ccCCHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAER----PYDHTADLWSLGCIAYEIHMGHPPFKTVSI-LHLIRLLKTQD-VTFP--SQVSET  343 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~----~y~~ksDIwSlGvil~eLltG~~Pf~~~~~-~~~~~~i~~~~-~~~p--~~~s~~  343 (549)
                       ......+++.|+|||.+.+.    .++.++||||||+++|+|++|+.||..... .+....+.... ...+  ..++++
T Consensus       170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (296)
T cd06618         170 -AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD  248 (296)
T ss_pred             -cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence             22334588899999998654    388999999999999999999999976432 23333333322 2233  247899


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      +.+|+.+||..||.+||++++++.||||.....
T Consensus       249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            999999999999999999999999999986544

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.9e-40  Score=330.66  Aligned_cols=250  Identities=21%  Similarity=0.360  Sum_probs=212.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      .++|.+.+.||+|++|.||+|.+..     ++..||+|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3669999999999999999999987     77889999886432 23344568889999999999999999999988888


Q ss_pred             EEEEEecCC-CCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC---cEEEeec
Q psy18060        193 FVLITEFAH-MSLSNLLEQRK-------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG---VAMLCDF  261 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~-------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g---~vKL~DF  261 (549)
                      .+++|||+. ++|.+++...+       .+++..+..++.||+.||+|||++|++||||||+||+++.++   .+||+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df  163 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF  163 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence            999999996 68999997653       489999999999999999999999999999999999998765   5999999


Q ss_pred             ccceecccCccc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCC
Q psy18060        262 GFARSMAVGTHM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFP  337 (549)
Q Consensus       262 Gla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  337 (549)
                      |+++........  .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+... ....|
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~  243 (277)
T cd05036         164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP  243 (277)
T ss_pred             ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            999866322111  112234567999999998899999999999999999997 99999988877766665433 44567


Q ss_pred             ccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        338 SQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       338 ~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ..++..+.+++.+||+.+|.+|||+.++++|
T Consensus       244 ~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         244 KGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            7889999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-39  Score=334.53  Aligned_cols=251  Identities=31%  Similarity=0.512  Sum_probs=215.3

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      |...+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.+++.++|||++++++++.+.+..|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            6677889999999999999999999999999875433 333446788899999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccC
Q psy18060        200 AHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK  278 (549)
Q Consensus       200 ~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~  278 (549)
                      +.++|.+.+.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....    .+...
T Consensus       103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~~~~  178 (313)
T cd06633         103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANSFV  178 (313)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CCCcc
Confidence            99998888865 45689999999999999999999999999999999999999999999999998864322    23457


Q ss_pred             CCCccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCccCCHHHHHHHHHhch
Q psy18060        279 GTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT--FPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       279 GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~dlI~~~L~  353 (549)
                      |+..|+|||++.   ...++.++|||||||++|+|++|..||...+.......+.....+  ....++..+++|+.+||+
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  258 (313)
T cd06633         179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ  258 (313)
T ss_pred             ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence            899999999984   456889999999999999999999999887766655554433221  224578899999999999


Q ss_pred             hCcCCCCCHHHHhcCcccCccc
Q psy18060        354 KDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ++|.+||++.+++.||||....
T Consensus       259 ~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         259 KIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             CChhhCcCHHHHhcCcccCCCc
Confidence            9999999999999999998644

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.1e-40  Score=334.33  Aligned_cols=248  Identities=24%  Similarity=0.397  Sum_probs=209.0

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKK--TVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ++|++.+.||+|+||.||+|....++.  .+++|.+... ......+.+.+|+.++.++ +||||+++++++...+.+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            578999999999999999999877765  4688877532 2334456788999999999 79999999999999899999


Q ss_pred             EEecCC-CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEE
Q psy18060        196 ITEFAH-MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAML  258 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL  258 (549)
                      +|||++ ++|.+++.+..                .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence            999987 69999997642                4788999999999999999999999999999999999999999999


Q ss_pred             eecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCC
Q psy18060        259 CDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTF  336 (549)
Q Consensus       259 ~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~  336 (549)
                      +|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+..+ ....
T Consensus       161 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (297)
T cd05089         161 ADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK  239 (297)
T ss_pred             CCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            9999986432111 1111223557999999988889999999999999999997 99999988887777766554 2345


Q ss_pred             CccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        337 PSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       337 p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      |..+++.+.+|+.+||+.+|.+|||++++++.
T Consensus       240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            66789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8e-40  Score=331.69  Aligned_cols=260  Identities=27%  Similarity=0.472  Sum_probs=219.3

Q ss_pred             ceeEEEEEecCCcEEEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGR--SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF  193 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  193 (549)
                      +|++.+.||+|+||.||+|...   .+|..||+|++.....  .......+.+|+++++.+ +||||+.++++++....+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4789999999999999999874   4789999999875332  122345678899999999 699999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-  271 (549)
                      |+||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            99999998 5899999988889999999999999999999999999999999999999999999999999997654322 


Q ss_pred             ccccccCCCCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCCCCCCccCCHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSETYK  345 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~  345 (549)
                      .......|+..|+|||.+.+  ..++.++||||||+++|+|++|..||...    ........+......+|..+++.+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK  240 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence            12234568999999999865  35788999999999999999999999643    3344444555555667788999999


Q ss_pred             HHHHHhchhCcCCCC-----CHHHHhcCcccCcccchhh
Q psy18060        346 DLVKGLLEKDASQRL-----SWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       346 dlI~~~L~~dP~~Rp-----s~~elL~Hpw~~~~~~~~~  379 (549)
                      +++.+||+.||.+||     ++.+++.||||....+...
T Consensus       241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~  279 (290)
T cd05613         241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL  279 (290)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence            999999999999997     8899999999987665433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.1e-40  Score=329.83  Aligned_cols=249  Identities=32%  Similarity=0.514  Sum_probs=211.0

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .+|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.+++.+.||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            568899999999999999999999999999998865432 3334567889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        198 EFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       198 E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ||+. ++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            9998 489998864    34689999999999999999999999999999999999999999999999999876654333


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCC-CC-CccCCHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI--LHLIRLLKTQDV-TF-PSQVSETYKDLV  348 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~--~~~~~~i~~~~~-~~-p~~~s~~~~dlI  348 (549)
                      ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+...  ......+..... +. +..+++.+++++
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV  241 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence            33445799999999999888899999999999999999999999975533  343444433322 12 245889999999


Q ss_pred             HHhchhCcCCCCCHHHHhc
Q psy18060        349 KGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~  367 (549)
                      .+||..||.+|||+.+|++
T Consensus       242 ~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         242 NMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHhcCCCcccCCCHHHHHH
Confidence            9999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.2e-40  Score=329.86  Aligned_cols=247  Identities=22%  Similarity=0.391  Sum_probs=215.0

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ..+|++.+.||.|+||.||+|.+.. +..+|+|.+....  ......+.+|+.+++.++||||+++++++...+.++++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            3568999999999999999999988 8899999986543  223457889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        198 EFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||++ ++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.+..........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~  161 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS  161 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence            9998 5999999763  468999999999999999999999999999999999999999999999999997765433333


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhc
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+... ....|..+++.+.+++.+||
T Consensus       162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  241 (261)
T cd05148         162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECW  241 (261)
T ss_pred             cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHc
Confidence            34456778999999988889999999999999999998 89999988877777766543 34456788999999999999


Q ss_pred             hhCcCCCCCHHHHhc
Q psy18060        353 EKDASQRLSWPELLH  367 (549)
Q Consensus       353 ~~dP~~Rps~~elL~  367 (549)
                      +.||.+|||+.++++
T Consensus       242 ~~~p~~Rpt~~~l~~  256 (261)
T cd05148         242 AAEPEDRPSFKALRE  256 (261)
T ss_pred             CCCchhCcCHHHHHH
Confidence            999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-40  Score=325.66  Aligned_cols=241  Identities=23%  Similarity=0.410  Sum_probs=206.1

Q ss_pred             EEEecCCcEEEEEEEEcCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC
Q psy18060        125 CLIGEGSFGKVFKAIHLDLK---KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~  201 (549)
                      +.||+|+||.||+|....++   ..+|+|.+...... .....+.+|+++++.+.||||+++++++. .+..+++|||+.
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            46999999999999876555   78999998765443 44567889999999999999999999876 456799999987


Q ss_pred             -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc---cc
Q psy18060        202 -MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT---SI  277 (549)
Q Consensus       202 -gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~---~~  277 (549)
                       ++|.+++.++..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++..........   ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~  158 (257)
T cd05060          79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG  158 (257)
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence             68999999888899999999999999999999999999999999999999999999999999987654332211   12


Q ss_pred             CCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHhchhC
Q psy18060        278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLLEKD  355 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~L~~d  355 (549)
                      .++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+.... ...|..+++.++++|.+||..+
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  238 (257)
T cd05060         159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYR  238 (257)
T ss_pred             cccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCC
Confidence            23567999999998899999999999999999998 999999888777776665543 3456778999999999999999


Q ss_pred             cCCCCCHHHHhc
Q psy18060        356 ASQRLSWPELLH  367 (549)
Q Consensus       356 P~~Rps~~elL~  367 (549)
                      |.+||++.++++
T Consensus       239 p~~Rp~~~~l~~  250 (257)
T cd05060         239 PEDRPTFSELES  250 (257)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.2e-39  Score=335.55  Aligned_cols=250  Identities=32%  Similarity=0.506  Sum_probs=216.0

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .|...+.||+|+||.||++.+..++..+|+|.+..... .......+.+|+++++.++|||++++++++...+..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            37888999999999999999999999999999875432 33445678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        199 FAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       199 ~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      |+.|+|.+.+.. ...+++.++..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....    ....
T Consensus       106 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~~~~  181 (317)
T cd06635         106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----ANSF  181 (317)
T ss_pred             CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----cccc
Confidence            999998888765 45689999999999999999999999999999999999999999999999999865432    2345


Q ss_pred             CCCCccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-C-CCccCCHHHHHHHHHhc
Q psy18060        278 KGTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-T-FPSQVSETYKDLVKGLL  352 (549)
Q Consensus       278 ~GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~dlI~~~L  352 (549)
                      .|++.|+|||++.   .+.++.++|||||||++|+|++|+.||...+.......+..... . .+..+++.++++|.+||
T Consensus       182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  261 (317)
T cd06635         182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL  261 (317)
T ss_pred             cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHc
Confidence            6899999999973   45688999999999999999999999988776666655544432 2 23467899999999999


Q ss_pred             hhCcCCCCCHHHHhcCcccCc
Q psy18060        353 EKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       353 ~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      +.+|.+||++.++++|||+..
T Consensus       262 ~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         262 QKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             cCCcccCcCHHHHHhChhhhc
Confidence            999999999999999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=324.76  Aligned_cols=246  Identities=22%  Similarity=0.386  Sum_probs=210.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|++|.||+|.... ++.||+|.+.....   ..+.+.+|+.++++++||||+++++++...+..+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            3569999999999999999998754 57899999865432   2356788999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc-
Q psy18060        198 EFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-  273 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~-  273 (549)
                      |++. ++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++........ 
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05068          81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA  160 (261)
T ss_pred             ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence            9995 79999997754  6899999999999999999999999999999999999999999999999999876532111 


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHh
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~  351 (549)
                      .....++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+... ....+..++..+.+++.+|
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDC  240 (261)
T ss_pred             cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence            111223457999999998889999999999999999999 99999988877777666544 3345567899999999999


Q ss_pred             chhCcCCCCCHHHHhc
Q psy18060        352 LEKDASQRLSWPELLH  367 (549)
Q Consensus       352 L~~dP~~Rps~~elL~  367 (549)
                      |+.+|.+||++.++++
T Consensus       241 l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         241 WKEDPDDRPTFETLQW  256 (261)
T ss_pred             hhcCcccCCCHHHHHH
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.3e-40  Score=336.09  Aligned_cols=249  Identities=26%  Similarity=0.390  Sum_probs=209.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCce--EEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~  194 (549)
                      .++|++.+.||+|+||.||+|.++.++..  +|+|.+... ........+.+|+.++.++ +||||+++++++...+.+|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            46799999999999999999998877765  466766432 2344456788899999999 8999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEE
Q psy18060        195 LITEFAH-MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAM  257 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vK  257 (549)
                      +||||+. ++|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence            9999997 68999997543                478999999999999999999999999999999999999999999


Q ss_pred             EeecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCC
Q psy18060        258 LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVT  335 (549)
Q Consensus       258 L~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~  335 (549)
                      |+|||+++...... ......++..|+|||++.+..++.++|||||||++|+|+| |..||...+..+....+... ...
T Consensus       165 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~  243 (303)
T cd05088         165 IADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE  243 (303)
T ss_pred             eCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCC
Confidence            99999986432111 1122234677999999988889999999999999999998 99999888777776666544 234


Q ss_pred             CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        336 FPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       336 ~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .|..+++.+.+++.+||+.+|.+||++.+++.+
T Consensus       244 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         244 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            556688999999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-39  Score=337.90  Aligned_cols=256  Identities=30%  Similarity=0.471  Sum_probs=212.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-CCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-LNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~i  195 (549)
                      ..++|++.+.||.|+||.||+|.+..+++.+|+|.+.+..........+.+|+.+++.++||||+++++++.. .+..++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            3567999999999999999999999999999999986544333344667889999999999999999998865 567899


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        196 ITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       196 V~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      +|||++++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||+++.....   ..
T Consensus        88 v~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---~~  163 (328)
T cd07856          88 VTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MT  163 (328)
T ss_pred             EeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---cC
Confidence            999999899888764 46889999999999999999999999999999999999999999999999998754322   23


Q ss_pred             ccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------------
Q psy18060        276 SIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT-----------------------  331 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~-----------------------  331 (549)
                      ...+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...........+..                       
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd07856         164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ  243 (328)
T ss_pred             CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence            4568899999999865 5689999999999999999999999987654322211110                       


Q ss_pred             -C--CCCCC-----ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        332 -Q--DVTFP-----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       332 -~--~~~~p-----~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                       .  ....|     +.+++.+.++|.+||+.+|.+|||+++++.||||.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence             0  00111     346889999999999999999999999999999975433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.5e-40  Score=329.12  Aligned_cols=245  Identities=32%  Similarity=0.531  Sum_probs=206.0

Q ss_pred             eEEEEEecCCcEEEEEEEEc----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        122 QKICLIGEGSFGKVFKAIHL----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       122 ~~~~~iG~G~fg~Vy~~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .+.+.||.|+||.||+|...    ..+..|+||.+.. .........+.+|++++++++||||+++++++...+..++||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence            46789999999999999988    4567899999954 344455788999999999999999999999999888899999


Q ss_pred             ecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc--c
Q psy18060        198 EFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--H  272 (549)
Q Consensus       198 E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~--~  272 (549)
                      ||+. |+|.++|...  ..+++..+..|+.||+.||.|||+++++||||+|+|||++.++.+||+|||++.......  .
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9998 6999999987  679999999999999999999999999999999999999999999999999998763221  1


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKG  350 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~  350 (549)
                      ......+...|+|||.+.+..++.++||||||+++|||++ |+.||...+.......+..+. ...|..++..+.++|.+
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  240 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQ  240 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHH
Confidence            1233456778999999988889999999999999999999 789999998888877775543 34566789999999999


Q ss_pred             hchhCcCCCCCHHHHhc
Q psy18060        351 LLEKDASQRLSWPELLH  367 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~  367 (549)
                      ||..+|.+|||+.++++
T Consensus       241 C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  241 CWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HT-SSGGGS--HHHHHH
T ss_pred             HcCCChhhCcCHHHHHh
Confidence            99999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0614|consensus

Probab=100.00  E-value=2.6e-42  Score=354.07  Aligned_cols=270  Identities=28%  Similarity=0.458  Sum_probs=245.1

Q ss_pred             ccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q psy18060        112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETL  190 (549)
Q Consensus       112 ~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  190 (549)
                      +..+..+++.+++..||-||||.|-++........+|+|++++.. ...+..+.+..|-+||...++|.||++|-.|.+.
T Consensus       413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~  492 (732)
T KOG0614|consen  413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS  492 (732)
T ss_pred             hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence            445667788999999999999999998877666679999998755 3445567888999999999999999999999999


Q ss_pred             CEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceeccc
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV  269 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~  269 (549)
                      ..+|+.||-|- |.|+..++.++.|.+..+++++..+++|++|||++|||.|||||+|.+++.+|.+||.|||+|+.++.
T Consensus       493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            99999999875 68999999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHH
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFPSQVSETYKDL  347 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dl  347 (549)
                      +.. ..++||||.|.|||++.+..++.++|.||||+++|||++|.+||.+.++..+++.|..+  .+.+|..++..+.++
T Consensus       573 g~K-TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L  651 (732)
T KOG0614|consen  573 GRK-TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL  651 (732)
T ss_pred             CCc-eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence            754 46789999999999999999999999999999999999999999999999999999876  367899999999999


Q ss_pred             HHHhchhCcCCCCC-----HHHHhcCcccCcccchhhhhc
Q psy18060        348 VKGLLEKDASQRLS-----WPELLHHPLVKDNLSSEIESQ  382 (549)
Q Consensus       348 I~~~L~~dP~~Rps-----~~elL~Hpw~~~~~~~~~~~~  382 (549)
                      |+++...+|..|+.     +.+|.+|.||.++.+..+...
T Consensus       652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~  691 (732)
T KOG0614|consen  652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSR  691 (732)
T ss_pred             HHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhc
Confidence            99999999999987     789999999998877666443

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-39  Score=325.32  Aligned_cols=247  Identities=20%  Similarity=0.359  Sum_probs=210.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|+||.||.+.... +..+|+|.+......   ...+.+|+.+++.++||||+++++++...+.++++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            4578999999999999999997764 456999988654332   356788999999999999999999999888899999


Q ss_pred             ecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc-c
Q psy18060        198 EFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-L  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~-~  274 (549)
                      ||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||.++........ .
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            9997 5899999764 46899999999999999999999999999999999999999999999999998765433211 1


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHhc
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDV-TFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dlI~~~L  352 (549)
                      ....++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+..... ..+...+..+.+++.+||
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  238 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW  238 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence            12235677999999988889999999999999999998 9999988877776666655433 345667899999999999


Q ss_pred             hhCcCCCCCHHHHhcC
Q psy18060        353 EKDASQRLSWPELLHH  368 (549)
Q Consensus       353 ~~dP~~Rps~~elL~H  368 (549)
                      ..+|.+|||+.+++.+
T Consensus       239 ~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         239 HEKAEERPTFQQLLSS  254 (256)
T ss_pred             CCCcccCCCHHHHHHh
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.5e-40  Score=341.19  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=204.7

Q ss_pred             EEEecC--CcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEG--SFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G--~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      ..||+|  +||+||++.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..++||||+. 
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999999999999999987665555666788999999999999999999999999999999999998 


Q ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc------
Q psy18060        202 MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM------  273 (549)
Q Consensus       202 gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~------  273 (549)
                      ++|.+++.+.  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++++|||.+.........      
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD  163 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence            5899998874  35899999999999999999999999999999999999999999999999865332211100      


Q ss_pred             -ccccCCCCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------
Q psy18060        274 -LTSIKGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV----------------  334 (549)
Q Consensus       274 -~~~~~GT~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~----------------  334 (549)
                       .....++..|+|||++.+  ..++.++|||||||++|+|++|+.||.................                
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd08226         164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM  243 (328)
T ss_pred             ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence             011235667999999976  4578999999999999999999999987654443322211110                


Q ss_pred             -------------------------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        335 -------------------------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       335 -------------------------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                                                     ..+..+++.+.+||.+||+.||.+|||+.|+++||||....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                           01123577899999999999999999999999999997544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1e-39  Score=334.20  Aligned_cols=250  Identities=30%  Similarity=0.468  Sum_probs=212.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLD-------LKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET  189 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  189 (549)
                      .++|.+.+.||+|+||.||++.+..       +...+|+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            3679999999999999999998643       23469999987542 334456788899999999 79999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK  252 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~  252 (549)
                      .+..|+||||++ |+|.+++..+.                .+++.++..++.|++.||+|||++|++||||||+|||++.
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~  175 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  175 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence            999999999998 59999997642                4788899999999999999999999999999999999999


Q ss_pred             CCcEEEeecccceecccCccc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy18060        253 DGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLL  329 (549)
Q Consensus       253 ~g~vKL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i  329 (549)
                      ++.+||+|||+++........  .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus       176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~  255 (307)
T cd05098         176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  255 (307)
T ss_pred             CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            999999999998765432111  112234578999999998889999999999999999998 89999988887777766


Q ss_pred             hcCC-CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        330 KTQD-VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       330 ~~~~-~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .... ...|..++.++.+++.+||..+|.+|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         256 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            5554 35667889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-40  Score=325.46  Aligned_cols=246  Identities=24%  Similarity=0.399  Sum_probs=210.0

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|.+.+....   ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            45889999999999999999876 4678999998654332   2457789999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc-c
Q psy18060        199 FAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML-T  275 (549)
Q Consensus       199 ~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~-~  275 (549)
                      |++ ++|.+++..+ ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++......... .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            997 5899999764 468999999999999999999999999999999999999999999999999987654322111 1


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhch
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+... ....|..+++++.+++.+||.
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  239 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWH  239 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence            1223457999999998889999999999999999998 89999888877777766554 345667789999999999999


Q ss_pred             hCcCCCCCHHHHhcC
Q psy18060        354 KDASQRLSWPELLHH  368 (549)
Q Consensus       354 ~dP~~Rps~~elL~H  368 (549)
                      .+|++|||+.++++.
T Consensus       240 ~~p~~Rpt~~~~l~~  254 (256)
T cd05059         240 EKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-39  Score=325.15  Aligned_cols=246  Identities=22%  Similarity=0.367  Sum_probs=210.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|+||.||+|... .+..+|+|.+....   .....+.+|+.+++.++||||+++++.+...+..+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            467999999999999999999865 46779999876432   23467889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc-
Q psy18060        198 EFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-  273 (549)
Q Consensus       198 E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~-  273 (549)
                      ||+. ++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++........ 
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            9987 6999998753  46889999999999999999999999999999999999999999999999999876433211 


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHh
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~  351 (549)
                      .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+... ..+.+..++.++.+++.+|
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTC  240 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            123346678999999988889999999999999999998 99999988877777766544 2334456899999999999


Q ss_pred             chhCcCCCCCHHHHhc
Q psy18060        352 LEKDASQRLSWPELLH  367 (549)
Q Consensus       352 L~~dP~~Rps~~elL~  367 (549)
                      |..+|++|||++++++
T Consensus       241 l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         241 WKEKAEERPTFDYLQS  256 (261)
T ss_pred             ccCCcccCcCHHHHHH
Confidence            9999999999998864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.1e-40  Score=332.35  Aligned_cols=250  Identities=22%  Similarity=0.392  Sum_probs=213.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      +.+|++.+.||+|+||.||+|.+..+     ++.||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            45688899999999999999987543     5789999987543 23344678899999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQR----------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV  255 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~  255 (549)
                      .++++||+. ++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+|||+++++.
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence            999999987 5899888532                34788889999999999999999999999999999999999999


Q ss_pred             EEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC
Q psy18060        256 AMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ  332 (549)
Q Consensus       256 vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~  332 (549)
                      +||+|||+++.......  ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+...
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR  242 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999876543221  1233456788999999988889999999999999999998 89999988888888877766


Q ss_pred             CC-CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        333 DV-TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       333 ~~-~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .. ..|..++..+.+++.+||+.+|.+||++.+|+..
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         243 QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            53 3567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.5e-40  Score=336.05  Aligned_cols=249  Identities=22%  Similarity=0.391  Sum_probs=208.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCce----EEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKT----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ..+|++.+.||+|+||.||+|.+..++..    ||+|.+... ........+.+|+.+++.++||||+++++++... ..
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            35699999999999999999998766654    899998643 2334456788999999999999999999998765 46


Q ss_pred             EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ++++||+. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence            78888877 6899999874 468999999999999999999999999999999999999999999999999998765432


Q ss_pred             ccc--cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHH
Q psy18060        272 HML--TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDL  347 (549)
Q Consensus       272 ~~~--~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dl  347 (549)
                      ...  ....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+... ..+.|+.++..+.++
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI  243 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence            211  22334678999999999999999999999999999997 99999988776655544433 234456788999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcC
Q psy18060        348 VKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~H  368 (549)
                      +.+||..+|.+|||+.+++.+
T Consensus       244 i~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         244 MVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.7e-39  Score=327.43  Aligned_cols=248  Identities=22%  Similarity=0.378  Sum_probs=209.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCce----EEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKT----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ..+|++.+.||+|+||.||+|.+..++..    ||+|.+... ........+.+|+.+++.+.||||+++++++... ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence            35789999999999999999998777764    799988643 3344456788999999999999999999988754 46


Q ss_pred             EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ++++|+++ |+|.+++..+ +.+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||+++......
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence            78999887 6899999764 569999999999999999999999999999999999999999999999999998765332


Q ss_pred             cc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHH
Q psy18060        272 HM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDL  347 (549)
Q Consensus       272 ~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dl  347 (549)
                      ..  .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+... ..+.+..++..+.++
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMI  243 (279)
T ss_pred             ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHH
Confidence            21  122235678999999998899999999999999999998 99999887776666655554 234556789999999


Q ss_pred             HHHhchhCcCCCCCHHHHhc
Q psy18060        348 VKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~  367 (549)
                      +.+||..||++||++.+++.
T Consensus       244 i~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         244 MVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.8e-40  Score=333.89  Aligned_cols=252  Identities=30%  Similarity=0.484  Sum_probs=215.3

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecC
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA  200 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~  200 (549)
                      |.....||+|+||.||++....+++.+|+|.+....  ......+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            334467999999999999999999999999885432  234566889999999999999999999999999999999999


Q ss_pred             CC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCC
Q psy18060        201 HM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG  279 (549)
Q Consensus       201 ~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~G  279 (549)
                      ++ +|.+++. +..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++..............|
T Consensus       100 ~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  178 (292)
T cd06657         100 EGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG  178 (292)
T ss_pred             CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence            85 7887764 457899999999999999999999999999999999999999999999999998765443333344568


Q ss_pred             CCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCccCCHHHHHHHHHhchhCc
Q psy18060        280 TPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD---VTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       280 T~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      |+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+....   ......+++.+.+++.+||+.+|
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P  258 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP  258 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence            999999999988889999999999999999999999998877666555553322   12234678999999999999999


Q ss_pred             CCCCCHHHHhcCcccCccc
Q psy18060        357 SQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       357 ~~Rps~~elL~Hpw~~~~~  375 (549)
                      .+||++.+++.||||....
T Consensus       259 ~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         259 AQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             ccCcCHHHHhcChHHhccC
Confidence            9999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1989|consensus

Probab=100.00  E-value=1.3e-40  Score=363.90  Aligned_cols=243  Identities=30%  Similarity=0.527  Sum_probs=208.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEE-Eee------C
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIAS-HET------L  190 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~~------~  190 (549)
                      .++++.+.|.+|||+.||.|.+...|..||+|++-..  +....+.+.+|+.+|++|. |||||.+++. ...      .
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            4578999999999999999999998899999998654  6677899999999999996 9999999993 211      1


Q ss_pred             CEEEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccCCcEEEecCCcEEEeecccce
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNR--VLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~g--IiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                      -.++|.||||. |+|-+++.++  ..|+|.++++|+.|+++|+.+||..+  |||||||-|||||+.+|..||||||.|+
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            35789999999 6999999854  56999999999999999999999997  9999999999999999999999999987


Q ss_pred             ecccCccc---------ccccCCCCcccccccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Q psy18060        266 SMAVGTHM---------LTSIKGTPLYMAPELI---AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD  333 (549)
Q Consensus       266 ~~~~~~~~---------~~~~~GT~~Y~APE~l---~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~  333 (549)
                      ........         .-....|+.|+|||++   .+.+.+.|+|||||||+||.|+..+.||......    .|..+.
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng~  270 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNGN  270 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEecc
Confidence            54322111         0112468999999997   5678999999999999999999999999876443    355677


Q ss_pred             CCCCc--cCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        334 VTFPS--QVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       334 ~~~p~--~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      +.+|+  .++..+++||..||+.||.+||++.|++.
T Consensus       271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence            77775  78999999999999999999999988875

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1e-39  Score=331.36  Aligned_cols=249  Identities=21%  Similarity=0.346  Sum_probs=210.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCC----------------ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCee
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLK----------------KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII  181 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~----------------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv  181 (549)
                      .++|++.+.||+|+||.||+|.+..++                ..+|+|.+.... .......+.+|+++++.++||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence            467999999999999999999876544                457999987543 234556788999999999999999


Q ss_pred             EEEEEEeeCCEEEEEEecCC-CCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEE
Q psy18060        182 KFIASHETLNEFVLITEFAH-MSLSNLLEQRK-----------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVL  249 (549)
Q Consensus       182 ~l~~~~~~~~~~~iV~E~~~-gsL~~~l~~~~-----------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NIL  249 (549)
                      ++++++...+..+++||++. ++|.+++....           .+++..+..++.|++.||.|||+.||+||||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            99999999899999999987 58999998765           6899999999999999999999999999999999999


Q ss_pred             EecCCcEEEeecccceecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCHHHH
Q psy18060        250 LNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM--GHPPFKTVSILHL  325 (549)
Q Consensus       250 l~~~g~vKL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt--G~~Pf~~~~~~~~  325 (549)
                      ++.++.++|+|||+++......  .......+|+.|+|||++.+..++.++|||||||++|+|++  |..||...+....
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV  242 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence            9999999999999997654322  11233456788999999988889999999999999999998  7889988776666


Q ss_pred             HHHHhcC--------CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        326 IRLLKTQ--------DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       326 ~~~i~~~--------~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      +..+...        ....|..+|+++.+++.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            5554322        12344567899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1e-39  Score=331.18  Aligned_cols=251  Identities=29%  Similarity=0.492  Sum_probs=213.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETL  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  190 (549)
                      ..++|++.+.||+|+||.||++.....     ...+|+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            346799999999999999999987644     3689999987543 334456788999999999 899999999999999


Q ss_pred             CEEEEEEecCC-CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQR----------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD  253 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~  253 (549)
                      +.++++|||+. |+|..++..+                ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED  168 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence            99999999987 6899998653                358899999999999999999999999999999999999999


Q ss_pred             CcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q psy18060        254 GVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLK  330 (549)
Q Consensus       254 g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~  330 (549)
                      +.+||+|||+++.......  ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  248 (293)
T cd05053         169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK  248 (293)
T ss_pred             CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999986643221  1122335678999999988889999999999999999997 999999888877777665


Q ss_pred             cCC-CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        331 TQD-VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       331 ~~~-~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .+. ...|...+..+.+|+.+||..||++|||+.+++++
T Consensus       249 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         249 EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            543 34566788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.5e-39  Score=333.65  Aligned_cols=252  Identities=32%  Similarity=0.501  Sum_probs=215.3

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ..|...+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+++++.++|||++++++++...+..++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34778899999999999999999999999999987532 23344566788999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||+.|+|.+.+.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......    +.
T Consensus        95 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----~~  170 (308)
T cd06634          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NX  170 (308)
T ss_pred             EccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----cc
Confidence            9999998888764 456899999999999999999999999999999999999999999999999998765432    34


Q ss_pred             cCCCCccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCccCCHHHHHHHHHh
Q psy18060        277 IKGTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT--FPSQVSETYKDLVKGL  351 (549)
Q Consensus       277 ~~GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~dlI~~~  351 (549)
                      ..|++.|+|||.+.   ...++.++|||||||++|+|++|..||...+.......+......  .+..++..+.++|.+|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  250 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence            56899999999974   356788999999999999999999999877655554444433322  2346889999999999


Q ss_pred             chhCcCCCCCHHHHhcCcccCcc
Q psy18060        352 LEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      |..+|.+||+++++++|||+...
T Consensus       251 l~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         251 LQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             hhCCcccCCCHHHHhhCcccccc
Confidence            99999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-39  Score=321.43  Aligned_cols=242  Identities=24%  Similarity=0.416  Sum_probs=212.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||.|+||.||+|...  ++.+|+|.+.....   ....+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            467899999999999999999875  78999999865432   4567889999999999999999999999889999999


Q ss_pred             ecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        198 EFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      |+++ ++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.++......   
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            9998 59999998765  69999999999999999999999999999999999999999999999999997764321   


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhc
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ....++..|+|||++.+..++.++||||||+++|+|++ |..||...+.......+... ....|..+++.+.++|.+||
T Consensus       157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (256)
T cd05039         157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCW  236 (256)
T ss_pred             ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHh
Confidence            23345667999999988889999999999999999997 99999988877777666544 33456778999999999999


Q ss_pred             hhCcCCCCCHHHHhc
Q psy18060        353 EKDASQRLSWPELLH  367 (549)
Q Consensus       353 ~~dP~~Rps~~elL~  367 (549)
                      ..+|.+|||+.+++.
T Consensus       237 ~~~p~~Rp~~~~l~~  251 (256)
T cd05039         237 ELDPAKRPTFKQLRE  251 (256)
T ss_pred             ccChhhCcCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.8e-39  Score=366.93  Aligned_cols=250  Identities=26%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++++.+.+..+++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            4689999999999999999999999999999999875432 233456788999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccc
Q psy18060        197 TEFAH-MSLSNLLEQR-----------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA  264 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~-----------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla  264 (549)
                      |||++ ++|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            99998 5899988642           23456678899999999999999999999999999999999999999999999


Q ss_pred             eecccCc------------------ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy18060        265 RSMAVGT------------------HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI  326 (549)
Q Consensus       265 ~~~~~~~------------------~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~  326 (549)
                      +......                  ......+||+.|||||++.+..++.++|||||||++|+|+||..||...+.....
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            7652110                  0112346999999999999999999999999999999999999999876544332


Q ss_pred             HHHh-cCCCCC--CccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        327 RLLK-TQDVTF--PSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       327 ~~i~-~~~~~~--p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .... ..+...  ...+|+.+.+++.+||+.||.+||+..+.+.
T Consensus       241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2211 111111  2367899999999999999999987655543

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.5e-39  Score=324.13  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=211.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ..+|++.+.||+|+||.||+|.+..++.   .+|+|.+.... .......+.+|+.+++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            3578999999999999999998865543   69999886532 3444568899999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ++|||++ ++|.+++... ..+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++........
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            9999997 5899999765 4689999999999999999999999999999999999999999999999999987654321


Q ss_pred             cc---cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHH
Q psy18060        273 ML---TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDL  347 (549)
Q Consensus       273 ~~---~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dl  347 (549)
                      ..   ....++..|+|||.+.+..++.++|+|||||++|++++ |..||......+....+... ..+.+..+++.+.++
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQL  241 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHH
Confidence            11   12233568999999998889999999999999999886 99999888777766666544 234456789999999


Q ss_pred             HHHhchhCcCCCCCHHHHhc
Q psy18060        348 VKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~  367 (549)
                      +.+||+++|.+||++.++++
T Consensus       242 i~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         242 MLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHcccCchhCCCHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8.1e-40  Score=340.43  Aligned_cols=249  Identities=26%  Similarity=0.456  Sum_probs=204.5

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee-CC
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET-LN  191 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-~~  191 (549)
                      ++|++.+.||+|+||.||+|....     +++.||+|.+.... .......+.+|+.+++.+ +||||+++++++.. ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            579999999999999999997543     45789999986533 334456778899999999 89999999998754 45


Q ss_pred             EEEEEEecCC-CCHHHHHHhc-----------------------------------------------------------
Q psy18060        192 EFVLITEFAH-MSLSNLLEQR-----------------------------------------------------------  211 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~-----------------------------------------------------------  211 (549)
                      .++++|||+. ++|.+++...                                                           
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            7899999998 5899888642                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--cccccCCCCcccccc
Q psy18060        212 --KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPE  287 (549)
Q Consensus       212 --~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE  287 (549)
                        ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+.....  ......++..|+|||
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  245 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  245 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence              2578899999999999999999999999999999999999999999999999987643221  122344677899999


Q ss_pred             cccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHhcC-CCCCCccCCHHHHHHHHHhchhCcCCCCCHHH
Q psy18060        288 LIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQ-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPE  364 (549)
Q Consensus       288 ~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~-~~~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~e  364 (549)
                      ++.+..++.++|||||||++|+|++ |..||.+....+. ...+..+ ....|...++++.+++.+||+.+|.+||++.|
T Consensus       246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e  325 (337)
T cd05054         246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSE  325 (337)
T ss_pred             HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999999999999999999998 9999987543332 2333322 23345678999999999999999999999999


Q ss_pred             HhcC
Q psy18060        365 LLHH  368 (549)
Q Consensus       365 lL~H  368 (549)
                      +++|
T Consensus       326 ll~~  329 (337)
T cd05054         326 LVEI  329 (337)
T ss_pred             HHHH
Confidence            9876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.9e-39  Score=328.24  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=211.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ..+|.+.+.||+|+||.||+|.+..     ++..+++|.+....  ......+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            3568899999999999999997543     45668999875432  3344678899999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV  255 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~  255 (549)
                      .++||||++ ++|.+++..+.                .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            999999987 68999997643                3889999999999999999999999999999999999999999


Q ss_pred             EEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC
Q psy18060        256 AMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ  332 (549)
Q Consensus       256 vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~  332 (549)
                      ++|+|||+++.......  ......|++.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+..+
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  241 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG  241 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence            99999999976543221  1233456788999999998899999999999999999998 99999888887777776665


Q ss_pred             CC-CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        333 DV-TFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       333 ~~-~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .. ..+..+|..+.+++.+||+.+|.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            44 345668999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.6e-39  Score=321.47  Aligned_cols=245  Identities=22%  Similarity=0.379  Sum_probs=208.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+......   ...+.+|+.+++.++||||+++++++. .+..+++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            356999999999999999999865 4778999998754432   346788999999999999999999874 45689999


Q ss_pred             ecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-c
Q psy18060        198 EFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-M  273 (549)
Q Consensus       198 E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~  273 (549)
                      |++. ++|.+++...  ..+++.++..++.|++.||+|||+.|++||||||+||++++++.++|+|||++........ .
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05067          80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence            9987 6899998753  4689999999999999999999999999999999999999999999999999976652221 1


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHh
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~  351 (549)
                      .....++..|+|||++.+..++.++|||||||++|+|++ |++||.+.+.......+... ....|...+.++.+++.+|
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLC  239 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            223346778999999998889999999999999999998 99999988877777666544 3345567889999999999


Q ss_pred             chhCcCCCCCHHHHhc
Q psy18060        352 LEKDASQRLSWPELLH  367 (549)
Q Consensus       352 L~~dP~~Rps~~elL~  367 (549)
                      |..+|++|||+++++.
T Consensus       240 l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         240 WKEKPEERPTFEYLRS  255 (260)
T ss_pred             ccCChhhCCCHHHHHH
Confidence            9999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.8e-39  Score=321.53  Aligned_cols=241  Identities=25%  Similarity=0.439  Sum_probs=207.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEE-eeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASH-ETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~iV  196 (549)
                      ..+|++.+.||+|+||.||++...  +..+|+|.+....    ....+.+|+.+++.+.|||++++++++ ...+..+++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            467999999999999999999765  7889999985432    245678999999999999999999875 455678999


Q ss_pred             EecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        197 TEFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      |||++ ++|.+++.++.  .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......  
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99997 59999998654  48899999999999999999999999999999999999999999999999987654321  


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHh
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~  351 (549)
                       ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+..+ ....++.+++.+.+++.+|
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (256)
T cd05082         157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQC  235 (256)
T ss_pred             -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence             23345678999999998889999999999999999997 99999988887777766544 3345677899999999999


Q ss_pred             chhCcCCCCCHHHHhc
Q psy18060        352 LEKDASQRLSWPELLH  367 (549)
Q Consensus       352 L~~dP~~Rps~~elL~  367 (549)
                      |..+|.+|||+.++++
T Consensus       236 l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         236 WHLDAATRPSFLQLRE  251 (256)
T ss_pred             hcCChhhCcCHHHHHH
Confidence            9999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-39  Score=324.75  Aligned_cols=251  Identities=31%  Similarity=0.552  Sum_probs=213.4

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC---CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG---RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      +|.+.+.||+|+||.||++.+..++..+++|++....   ........+..|+.+++.++||||+++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5889999999999999999998887777777765422   2222334566789999999999999999999888899999


Q ss_pred             EecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        197 TEFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      |||+. ++|.+++..    ...+++..+..++.|++.||.|||++|++||||||+||+++. +.++|+|||+++......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            99998 588888753    456999999999999999999999999999999999999975 679999999997765443


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~  350 (549)
                      .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..+ ....|..++.++.++|.+
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQS  239 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHH
Confidence            3344566899999999998888999999999999999999999999887776666655444 334566789999999999


Q ss_pred             hchhCcCCCCCHHHHhcCccc
Q psy18060        351 LLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      ||..+|.+||++.++++||||
T Consensus       240 ~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         240 MLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4645|consensus

Probab=100.00  E-value=6.5e-42  Score=382.42  Aligned_cols=256  Identities=30%  Similarity=0.542  Sum_probs=225.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      -+|+..-.||.|.||.||.|.+..+|...|+|.+.......+....+.+|.+++..++|||+|++|++-...+..+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            45677788999999999999999999999999987655556667788999999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc----c
Q psy18060        199 FAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH----M  273 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~----~  273 (549)
                      ||. |+|.++++..+..+|...+.+..|++.|+.|||+.|||||||||+||||+.+|.+|++|||.|..+.+...    .
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            998 69999999888899999999999999999999999999999999999999999999999999987765431    2


Q ss_pred             ccccCCCCcccccccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcC-CCCCCccCCHHHHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAER---PYDHTADLWSLGCIAYEIHMGHPPFKTVSI-LHLIRLLKTQ-DVTFPSQVSETYKDLV  348 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~---~y~~ksDIwSlGvil~eLltG~~Pf~~~~~-~~~~~~i~~~-~~~~p~~~s~~~~dlI  348 (549)
                      .....|||.|||||++.+.   ....++|||||||++.||.||+.||...+. -++......+ .+++|..+|++.++||
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            3456899999999999653   467889999999999999999999987653 3444444444 4568888999999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+||+.||.+|.++.|++.|.|-+..
T Consensus      1475 e~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             HHHHhcCchhhhHHHHHHHhhccccc
Confidence            99999999999999999999987643

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.1e-39  Score=331.03  Aligned_cols=250  Identities=29%  Similarity=0.469  Sum_probs=211.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLD-------LKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET  189 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  189 (549)
                      .++|.+.+.||+|+||.||+|.+..       ....+|+|.+.... .......+.+|+++++.+ .||||+++++++..
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3678999999999999999997642       34569999986532 344566788999999999 69999999999998


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQR----------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK  252 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~  252 (549)
                      .+.++++|||+. |+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~  169 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE  169 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence            889999999987 6899999764                24788899999999999999999999999999999999999


Q ss_pred             CCcEEEeecccceecccCccc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy18060        253 DGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLL  329 (549)
Q Consensus       253 ~g~vKL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i  329 (549)
                      ++.+||+|||+++........  .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~  249 (314)
T cd05099         170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL  249 (314)
T ss_pred             CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999999765432111  112234567999999998889999999999999999999 99999998888877777


Q ss_pred             hcCC-CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        330 KTQD-VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       330 ~~~~-~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ..+. ...|..++.++.+++.+||..+|.+|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         250 REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            6553 34567789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.2e-39  Score=327.53  Aligned_cols=247  Identities=27%  Similarity=0.431  Sum_probs=208.7

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      +|++.+.||+|+||.||+|....     ....+|+|.+.... .......+.+|+.+++.+.||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            47889999999999999998753     23568888876433 3344567889999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEE
Q psy18060        195 LITEFAH-MSLSNLLEQR------------------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVL  249 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~------------------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NIL  249 (549)
                      ++|||+. ++|.+++...                        ..+++..+..++.|++.||.|||+.||+||||||+|||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            9999998 6899998642                        24788899999999999999999999999999999999


Q ss_pred             EecCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy18060        250 LNKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLI  326 (549)
Q Consensus       250 l~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~  326 (549)
                      +++++.+||+|||+++.......  ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+..+....
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  239 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF  239 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999976533221  1123346778999999988889999999999999999998 99999988888777


Q ss_pred             HHHhcC-CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        327 RLLKTQ-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       327 ~~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ..+... ....|..++.++.+|+.+||+.+|.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            766543 33456778999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.1e-39  Score=326.14  Aligned_cols=247  Identities=24%  Similarity=0.396  Sum_probs=209.5

Q ss_pred             cceeEEEEEecCCcEEEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .++...+.||+|+||.||++...     .++..+|+|.+...  .......+.+|+++++.+.||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            46788999999999999999643     34668999987643  334456789999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEE
Q psy18060        194 VLITEFAH-MSLSNLLEQRK---------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAM  257 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~---------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vK  257 (549)
                      +++|||+. ++|.+++....               .+++..+..++.||+.||+|||++|++||||||+|||+++++.+|
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k  162 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK  162 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence            99999987 68999987643               478999999999999999999999999999999999999999999


Q ss_pred             EeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-C
Q psy18060        258 LCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-D  333 (549)
Q Consensus       258 L~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~  333 (549)
                      |+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+..+ .
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  242 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE  242 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc
Confidence            999999976543221  1122345788999999998889999999999999999998 99999887777766666544 3


Q ss_pred             CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        334 VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       334 ~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ...|..+++.+.++|.+||+.||.+||++.+|++
T Consensus       243 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         243 LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            4556778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4e-39  Score=321.12  Aligned_cols=244  Identities=23%  Similarity=0.370  Sum_probs=207.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|+||.||+|... .+..+|+|.+......   ...+.+|+.++++++|||++++++++.. +..+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT   79 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence            457899999999999999999766 4667999998764433   2467899999999999999999998754 5578999


Q ss_pred             ecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc-
Q psy18060        198 EFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-  273 (549)
Q Consensus       198 E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~-  273 (549)
                      ||+. ++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++......... 
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            9997 5899998763  35899999999999999999999999999999999999999999999999999765432211 


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHh
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~  351 (549)
                      .....++..|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+... ..+.|...+..+.+++.+|
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQC  239 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence            122335667999999988889999999999999999999 99999988877777766544 3445677899999999999


Q ss_pred             chhCcCCCCCHHHHh
Q psy18060        352 LEKDASQRLSWPELL  366 (549)
Q Consensus       352 L~~dP~~Rps~~elL  366 (549)
                      |.++|.+|||+.++.
T Consensus       240 l~~~p~~Rpt~~~l~  254 (260)
T cd05070         240 WKKDPEERPTFEYLQ  254 (260)
T ss_pred             cccCcccCcCHHHHH
Confidence            999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.7e-39  Score=344.09  Aligned_cols=250  Identities=25%  Similarity=0.420  Sum_probs=206.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETL  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~  190 (549)
                      ..++|++.+.||+|+||.||+|.+...     +..||+|++.... .......+.+|+++++.+. ||||+++++++...
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            356799999999999999999987533     3469999986543 2334567899999999996 99999999999999


Q ss_pred             CEEEEEEecCC-CCHHHHHHhc----------------------------------------------------------
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQR----------------------------------------------------------  211 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~----------------------------------------------------------  211 (549)
                      +..|||||||. |+|.++|.++                                                          
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999998 6899888653                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC
Q psy18060        212 --------------------------------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD  253 (549)
Q Consensus       212 --------------------------------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~  253 (549)
                                                            ..+++..+..++.||+.||+|||+.||+||||||+|||++.+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~  273 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence                                                  236778889999999999999999999999999999999999


Q ss_pred             CcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHH
Q psy18060        254 GVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLL  329 (549)
Q Consensus       254 g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~-~~~i  329 (549)
                      +.+||+|||+++.......  ......+++.|+|||++.+..++.++|||||||++|+|++ |..||........ ...+
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~  353 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI  353 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence            9999999999976543221  1223356788999999998889999999999999999997 9999987644332 3333


Q ss_pred             hcC-CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        330 KTQ-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       330 ~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ..+ ....|..+++.+.+++.+||+.||.+|||+.++.+
T Consensus       354 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         354 KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333 33456678999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.6e-39  Score=362.21  Aligned_cols=149  Identities=28%  Similarity=0.470  Sum_probs=136.8

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      .+++|.+++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.++..++||||+++++++...+.+|+
T Consensus         2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence            3678999999999999999999999999999999997643 234445678899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccce
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                      ||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999996 6899999888889999999999999999999999999999999999999999999999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=326.86  Aligned_cols=249  Identities=29%  Similarity=0.475  Sum_probs=208.4

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCEEEEEEec
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      |.+.+.||+|++|.||+|....+++.+|+|.+...... .......+|+..++.+. ||||+++++.+...+..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            67889999999999999999999999999998654332 22234456889999998 99999999999999999999999


Q ss_pred             CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        200 AHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       200 ~~gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      ++|+|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++...... ..+..
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~  158 (283)
T cd07830          80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYTDY  158 (283)
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcCCC
Confidence            9999999998765  78999999999999999999999999999999999999999999999999997664332 23445


Q ss_pred             CCCCccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------CCC--
Q psy18060        278 KGTPLYMAPELIA-ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-------------------DVT--  335 (549)
Q Consensus       278 ~GT~~Y~APE~l~-~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-------------------~~~--  335 (549)
                      .|+..|+|||++. +..++.++|+||||+++++|++|++||...+.......+...                   ...  
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07830         159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP  238 (283)
T ss_pred             CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence            6899999999884 456889999999999999999999999877655444332210                   000  


Q ss_pred             ---------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        336 ---------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       336 ---------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                               ..+..++.+.++|.+||+.+|.+|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                     011236889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.8e-39  Score=321.66  Aligned_cols=245  Identities=23%  Similarity=0.374  Sum_probs=207.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|+||.||+|.+..+ ..+|+|.+......   ...+.+|+++++.++||||+++++.+.. +..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   79 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence            45699999999999999999988765 45999998754332   2467889999999999999999998754 5579999


Q ss_pred             ecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        198 EFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||+. |+|.+++.+.  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||.++.........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            9998 5999999763  358999999999999999999999999999999999999999999999999997665332211


Q ss_pred             -cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHh
Q psy18060        275 -TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       275 -~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~  351 (549)
                       ....++..|+|||+..+..++.++|||||||++|+|++ |..||.+.........+... ....+..+++.+.+++.+|
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  239 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC  239 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence             22346678999999988889999999999999999999 89999888777776666543 2344567899999999999


Q ss_pred             chhCcCCCCCHHHHhc
Q psy18060        352 LEKDASQRLSWPELLH  367 (549)
Q Consensus       352 L~~dP~~Rps~~elL~  367 (549)
                      |+++|.+||++.+++.
T Consensus       240 l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         240 WRKEPEERPTFEYLQA  255 (262)
T ss_pred             ccCCcccCCCHHHHHH
Confidence            9999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.3e-39  Score=329.37  Aligned_cols=251  Identities=25%  Similarity=0.423  Sum_probs=209.0

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIH-----LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET  189 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  189 (549)
                      -..++|.+.+.||+|+||.||++.+     ..++..+|+|.+.... .......+.+|+.+++++ +||||+++++++..
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            3446799999999999999999975     3345679999986543 234456788999999999 79999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                      .+..+++|||+. |+|.+++....  .+++.++..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++.
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999987 68999997643  389999999999999999999999999999999999999999999999999976


Q ss_pred             cccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCccCC
Q psy18060        267 MAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ--DVTFPSQVS  341 (549)
Q Consensus       267 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s  341 (549)
                      ......  ......+++.|+|||++.+..++.++||||+||++|+|++ |..||...............  ....|...+
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAP  270 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCC
Confidence            543221  1122346788999999998889999999999999999998 99999877655444333322  223455689


Q ss_pred             HHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        342 ETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       342 ~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      +++.+++.+||.++|++|||+.|+++
T Consensus       271 ~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         271 AEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0194|consensus

Probab=100.00  E-value=5.2e-40  Score=347.22  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=217.0

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCc---e-EEEEEEecC-CCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKK---T-VALKIISKS-GRSGKELSSLKQECEIQKHLAHPNIIKFIASHE  188 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~-vAvK~i~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  188 (549)
                      +.-.-++-.+.+.||+|+||.||+|..+..+.   . ||+|..... .........+.+|++++++++|||||++||+..
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            33334455666999999999999998776432   3 899998753 356677889999999999999999999999999


Q ss_pred             eCCEEEEEEecCC-CCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        189 TLNEFVLITEFAH-MSLSNLLEQRKK-LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       189 ~~~~~~iV~E~~~-gsL~~~l~~~~~-l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                      ....++||||+|. |+|.++|++.+. ++..+...++.+.+.||+|||++++|||||..+|+|++.++.+||+|||+++.
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence            9999999999998 599999999874 99999999999999999999999999999999999999999999999999875


Q ss_pred             cccCccccc-ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCccCCH
Q psy18060        267 MAVGTHMLT-SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD--VTFPSQVSE  342 (549)
Q Consensus       267 ~~~~~~~~~-~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~  342 (549)
                      ...- .... ...-...|+|||.+....|+.++||||+||++||+++ |..||.+....++...|....  .+.|...|.
T Consensus       312 ~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~  390 (474)
T KOG0194|consen  312 GSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPK  390 (474)
T ss_pred             Ccce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHH
Confidence            5311 1111 2235678999999999999999999999999999998 889999999999999884433  445667888


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ++..++.+|+..+|++|||+.++.+
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHhccCChhhccCHHHHHH
Confidence            9999999999999999999988754

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.6e-39  Score=333.30  Aligned_cols=244  Identities=27%  Similarity=0.447  Sum_probs=198.9

Q ss_pred             CcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CCHHHHHH
Q psy18060        131 SFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSLSNLLE  209 (549)
Q Consensus       131 ~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL~~~l~  209 (549)
                      ++|.||.+....+++.||+|++............+.+|+.+++.++||||+++++++...+..+++|||++ ++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            44555666666789999999998764555667789999999999999999999999999999999999998 68999987


Q ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-------cccccCCC
Q psy18060        210 QR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-------MLTSIKGT  280 (549)
Q Consensus       210 ~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-------~~~~~~GT  280 (549)
                      ..  ..+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||.+........       ......++
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN  171 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence            64  4689999999999999999999999999999999999999999999999998865432211       12334578


Q ss_pred             CcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhcC-------------------------
Q psy18060        281 PLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQ-------------------------  332 (549)
Q Consensus       281 ~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~-~~i~~~-------------------------  332 (549)
                      ..|+|||++.+  ..++.++|+||+||++|+|++|+.||...+..... ..+...                         
T Consensus       172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
T cd08216         172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE  251 (314)
T ss_pred             ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccccc
Confidence            88999999865  45889999999999999999999999876543332 222110                         


Q ss_pred             --------CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        333 --------DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       333 --------~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                              ....+..+++++.+|+.+||+.||.+|||+.++|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence                    000112345788999999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.6e-39  Score=321.04  Aligned_cols=240  Identities=23%  Similarity=0.423  Sum_probs=202.1

Q ss_pred             EEecCCcEEEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-C
Q psy18060        126 LIGEGSFGKVFKAIHL--DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-M  202 (549)
Q Consensus       126 ~iG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-g  202 (549)
                      .||+|+||.||+|.+.  .++..+|+|++... ........+.+|+.+++.++||||++++++++. ...++||||++ +
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            3899999999999765  44567999998654 233445678899999999999999999998864 56899999997 5


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc---cccC
Q psy18060        203 SLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIK  278 (549)
Q Consensus       203 sL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~---~~~~  278 (549)
                      +|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.........   +...
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            89999875 4578999999999999999999999999999999999999999999999999997654332211   1223


Q ss_pred             CCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhchhCc
Q psy18060        279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       279 GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      +++.|+|||++.+..++.++|||||||++|+|++ |..||...........+..+ ....|...++++.++|.+||..+|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~  239 (257)
T cd05115         160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKW  239 (257)
T ss_pred             CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence            4578999999988889999999999999999996 99999988877777666554 345677889999999999999999


Q ss_pred             CCCCCHHHHhc
Q psy18060        357 SQRLSWPELLH  367 (549)
Q Consensus       357 ~~Rps~~elL~  367 (549)
                      ++||++.+|.+
T Consensus       240 ~~Rp~~~~i~~  250 (257)
T cd05115         240 EDRPNFAKVEE  250 (257)
T ss_pred             hhCcCHHHHHH
Confidence            99999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-39  Score=318.73  Aligned_cols=247  Identities=24%  Similarity=0.377  Sum_probs=211.8

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|.+.+.||+|+||.||+|.... +..+|+|.+......   ...+.+|+.+++.++||||+++++++......+++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            34679999999999999999998764 577999998754332   35678899999999999999999999988899999


Q ss_pred             EecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-
Q psy18060        197 TEFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-  272 (549)
                      ||++. ++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....... 
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            99987 58999997653  689999999999999999999999999999999999999999999999999876643211 


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~  350 (549)
                      ......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+.......+... ....|...++++.+++.+
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  239 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQ  239 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            1122235678999999998889999999999999999998 99999988887777776554 334566789999999999


Q ss_pred             hchhCcCCCCCHHHHhc
Q psy18060        351 LLEKDASQRLSWPELLH  367 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~  367 (549)
                      ||+.+|.+||+++++++
T Consensus       240 ~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         240 CWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HcccCcccCCCHHHHHH
Confidence            99999999999998863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.1e-39  Score=326.17  Aligned_cols=260  Identities=27%  Similarity=0.471  Sum_probs=217.3

Q ss_pred             ceeEEEEEecCCcEEEEEEEEc---CCCceEEEEEEecCCCC--hHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGRS--GKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF  193 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  193 (549)
                      +|++.+.||+|++|.||++...   .++..+|+|.+.+....  ......+.+|++++..+ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4789999999999999999854   45788999998754321  22345678899999999 699999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ++||||+. ++|.+++.....+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||+++.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            99999997 58999998888899999999999999999999999999999999999999999999999999876543321


Q ss_pred             -cccccCCCCcccccccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCCCCccCCHHHH
Q psy18060        273 -MLTSIKGTPLYMAPELIAERP--YDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFPSQVSETYK  345 (549)
Q Consensus       273 -~~~~~~GT~~Y~APE~l~~~~--y~~ksDIwSlGvil~eLltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~  345 (549)
                       ......|++.|+|||.+.+..  ++.++|+||||+++|+|++|..||....    .......+.......|..+++.+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  240 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR  240 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence             123346899999999987654  7889999999999999999999996432    334444455555667778999999


Q ss_pred             HHHHHhchhCcCCCCC---HHHHhcCcccCcccchhh
Q psy18060        346 DLVKGLLEKDASQRLS---WPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps---~~elL~Hpw~~~~~~~~~  379 (549)
                      ++|.+||+.||.+|||   +.++|+||||+...+..+
T Consensus       241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~  277 (288)
T cd05583         241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL  277 (288)
T ss_pred             HHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH
Confidence            9999999999999998   567899999987665444

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-39  Score=328.16  Aligned_cols=253  Identities=28%  Similarity=0.454  Sum_probs=214.3

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEc-------CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHL-------DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIAS  186 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~  186 (549)
                      .....+|.+.+.||+|+||.||+|...       ..+..+|+|.+... ........+.+|+.+++.+ .||||++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            344678999999999999999999753       23457999988643 2334456788999999999 89999999999


Q ss_pred             EeeCCEEEEEEecCC-CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEE
Q psy18060        187 HETLNEFVLITEFAH-MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVL  249 (549)
Q Consensus       187 ~~~~~~~~iV~E~~~-gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NIL  249 (549)
                      +......+++|||+. |+|.+++.++.                .++...+..++.||+.||.|||++||+||||||+||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  169 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL  169 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence            999999999999997 59999997642                4677889999999999999999999999999999999


Q ss_pred             EecCCcEEEeecccceecccCccc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy18060        250 LNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLI  326 (549)
Q Consensus       250 l~~~g~vKL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~  326 (549)
                      ++.++.+||+|||+++........  .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  249 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  249 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            999999999999999876532211  122346778999999988889999999999999999998 89999998888888


Q ss_pred             HHHhcCC-CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        327 RLLKTQD-VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       327 ~~i~~~~-~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ..+.... ...|..++..+.+++.+||..+|.+|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            7776543 34566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.4e-39  Score=319.61  Aligned_cols=249  Identities=24%  Similarity=0.401  Sum_probs=210.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .++|+..+.||+|+||.||+|....++.   .+|+|.+.... .......+.+|+++++.+.||||+++.+++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            3568889999999999999999876654   69999886432 3344567889999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +||||++ ++|.+++... +.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            9999998 5899998764 5789999999999999999999999999999999999999999999999999976643221


Q ss_pred             cc-c--ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHH
Q psy18060        273 ML-T--SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDL  347 (549)
Q Consensus       273 ~~-~--~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dl  347 (549)
                      .. +  ...+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+.... .+.+...+..+.++
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l  242 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQL  242 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence            11 1  1223457999999988889999999999999999997 999998888777777765542 23345678999999


Q ss_pred             HHHhchhCcCCCCCHHHHhc
Q psy18060        348 VKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~  367 (549)
                      +.+||+.+|.+||++.++++
T Consensus       243 i~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         243 MLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0193|consensus

Probab=100.00  E-value=2.6e-40  Score=346.71  Aligned_cols=252  Identities=27%  Similarity=0.443  Sum_probs=217.0

Q ss_pred             ccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       112 ~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      +.+.-..+...+...||+|+||+||+|.+-   ..||||++.....++...+.|++|+..+++-+|.||+-|.|++-...
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            344445567788999999999999999886   46999999988888889999999999999999999999999998776


Q ss_pred             EEEEEEecCCC-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc-
Q psy18060        192 EFVLITEFAHM-SLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA-  268 (549)
Q Consensus       192 ~~~iV~E~~~g-sL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~-  268 (549)
                      . .||+.+|+| +|..+|... .+|.....+.|++||++|+.|||.++|||||||..|||+.+++.|||+|||++.... 
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence            6 899999998 799998754 568899999999999999999999999999999999999999999999999986432 


Q ss_pred             -cCcccccccCCCCcccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCcc
Q psy18060        269 -VGTHMLTSIKGTPLYMAPELIAE---RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-----FPSQ  339 (549)
Q Consensus       269 -~~~~~~~~~~GT~~Y~APE~l~~---~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~  339 (549)
                       .+........|...|||||++.-   .+|++.+|||||||++|||+||..||......+++-.+..+...     .-.+
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~  620 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN  620 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence             23344556678899999999853   57999999999999999999999999977777766665555221     1245


Q ss_pred             CCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        340 VSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       340 ~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .++++++|+..||..+++.||.+.+||.
T Consensus       621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  621 CPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            7889999999999999999999999876

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.3e-39  Score=320.47  Aligned_cols=249  Identities=26%  Similarity=0.407  Sum_probs=211.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ..+|++.+.||+|+||.||+|....+++   .||+|.+... ........+..|+.+++.+.||||+++++++......+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            3568999999999999999999887665   5999998653 23445678899999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +||||++ ++|.+++... +.+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            9999997 5899998764 5689999999999999999999999999999999999999999999999999876543221


Q ss_pred             c--ccc-cC--CCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHH
Q psy18060        273 M--LTS-IK--GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYK  345 (549)
Q Consensus       273 ~--~~~-~~--GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  345 (549)
                      .  ... ..  ++..|+|||++.+..++.++|||||||++|||++ |..||...+.......+... ..+.|..++..+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALH  241 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHH
Confidence            1  111 11  2457999999998899999999999999999886 99999988877777666433 3345567899999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhc
Q psy18060        346 DLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      +++.+||..+|.+||++.+++.
T Consensus       242 ~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         242 QLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.2e-38  Score=317.95  Aligned_cols=244  Identities=23%  Similarity=0.368  Sum_probs=206.0

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||+|++|.||+|.+..+ ..+|+|.+.....   ....+.+|+++++.+.|||++++++++.. +..+++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence            5689999999999999999987664 4699998764332   23567889999999999999999988754 56789999


Q ss_pred             cCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc-c
Q psy18060        199 FAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-L  274 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~-~  274 (549)
                      |+. ++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||+++........ .
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence            998 58999997643  4789999999999999999999999999999999999999999999999999766433211 1


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhc
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ....++..|+|||...+..++.++|||||||++|+|++ |..||.+....+....+... ....|...+..+.+++.+||
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCW  240 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence            22346778999999988889999999999999999999 99999988777777666544 23456678999999999999


Q ss_pred             hhCcCCCCCHHHHhc
Q psy18060        353 EKDASQRLSWPELLH  367 (549)
Q Consensus       353 ~~dP~~Rps~~elL~  367 (549)
                      .+||.+||+++++++
T Consensus       241 ~~~p~~Rp~~~~i~~  255 (260)
T cd05069         241 KKDPDERPTFEYIQS  255 (260)
T ss_pred             cCCcccCcCHHHHHH
Confidence            999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.1e-39  Score=322.80  Aligned_cols=248  Identities=23%  Similarity=0.387  Sum_probs=206.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCce----EEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKT----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ..+|++.+.||+|+||.||+|.+..++..    +++|.+... ........+..|+.+++.+.||||+++++++.. ...
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            35788999999999999999998877764    666766432 223345677888889999999999999998754 456


Q ss_pred             EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ++++|++. |+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            78889876 7999999764 578999999999999999999999999999999999999999999999999998664332


Q ss_pred             c--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHHH
Q psy18060        272 H--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDV-TFPSQVSETYKDL  347 (549)
Q Consensus       272 ~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dl  347 (549)
                      .  ..+...|+..|+|||++.+..++.++|||||||++|||++ |..||.+.........+..+.. ..|..++..+.++
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMV  243 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHH
Confidence            1  1233457788999999998889999999999999999998 9999998877766666655432 3345678899999


Q ss_pred             HHHhchhCcCCCCCHHHHhc
Q psy18060        348 VKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~  367 (549)
                      +.+||..||.+|||+.|+++
T Consensus       244 i~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         244 MVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999866

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7e-39  Score=324.43  Aligned_cols=249  Identities=24%  Similarity=0.403  Sum_probs=211.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ..+|++.+.||+|+||.||+|.+..     ++..+|+|.+... ........+.+|+.+++.+.||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            3568999999999999999998743     5788999998643 233445678899999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEE
Q psy18060        193 FVLITEFAH-MSLSNLLEQRK----------------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVL  249 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~----------------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NIL  249 (549)
                      .+++|||++ ++|.+++....                      .+++..+..++.||+.||.|||++|++||||||+|||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil  162 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL  162 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence            999999988 58999987532                      3788889999999999999999999999999999999


Q ss_pred             EecCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy18060        250 LNKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLI  326 (549)
Q Consensus       250 l~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~  326 (549)
                      ++.++.++|+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+..
T Consensus       163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~  242 (288)
T cd05050         163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI  242 (288)
T ss_pred             ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999876532211  1122345677999999988889999999999999999997 88999888888877


Q ss_pred             HHHhcCCC-CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        327 RLLKTQDV-TFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       327 ~~i~~~~~-~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ..+..+.. ..|..++.++.+|+.+||+.+|.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         243 YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            77765543 346678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0666|consensus

Probab=100.00  E-value=7.7e-41  Score=326.19  Aligned_cols=258  Identities=30%  Similarity=0.480  Sum_probs=206.6

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-CC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-LN  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~  191 (549)
                      .+..|+.+..||+|.||.||+|..++++.    .+|+|.+...+.....-...-+|+.+++.++||||+.+..+|-. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            35679999999999999999997766644    68999986553222222455789999999999999999998866 77


Q ss_pred             EEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC----CcEEEeecc
Q psy18060        192 EFVLITEFAHMSLSNLLEQR-----KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD----GVAMLCDFG  262 (549)
Q Consensus       192 ~~~iV~E~~~gsL~~~l~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~----g~vKL~DFG  262 (549)
                      .+++++||++.+|+.+|+-+     +.++...++.|+.||+.|+.|||++=|+||||||.|||+..+    |.|||+|||
T Consensus       102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            89999999999999999743     358999999999999999999999999999999999999887    899999999


Q ss_pred             cceecccCcccc---cccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHH
Q psy18060        263 FARSMAVGTHML---TSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSI---------LHLIRLL  329 (549)
Q Consensus       263 la~~~~~~~~~~---~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~---------~~~~~~i  329 (549)
                      +||.+...-...   ...+-|.+|+|||.+.+ ..||.++||||+|||+.||+|-++.|.+...         ...+.+|
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            999876543322   34567999999999877 5699999999999999999998888865321         1112222


Q ss_pred             hc----C---CC----CCCc--------------------------cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        330 KT----Q---DV----TFPS--------------------------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       330 ~~----~---~~----~~p~--------------------------~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      ..    .   ..    .+|.                          .-++.+.+|+.+||+.||.+|+|++++|+|+||.
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~  341 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT  341 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence            10    0   00    0110                          1245578999999999999999999999999998


Q ss_pred             cc
Q psy18060        373 DN  374 (549)
Q Consensus       373 ~~  374 (549)
                      ..
T Consensus       342 ~d  343 (438)
T KOG0666|consen  342 ED  343 (438)
T ss_pred             cC
Confidence            65

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-38  Score=315.59  Aligned_cols=246  Identities=24%  Similarity=0.436  Sum_probs=212.5

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCC----ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLK----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      +++.+.||.|+||.||+|.+..++    ..+|+|.+.... .......+.+|+.+++.+.||||+++++++...+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            356789999999999999998766    889999986543 223567889999999999999999999999998999999


Q ss_pred             EecCC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        197 TEFAH-MSLSNLLEQRKK--LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~--l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      ||++. ++|.+++.....  +++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            99997 589999986554  999999999999999999999999999999999999999999999999999776543221


Q ss_pred             cc-ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHH
Q psy18060        274 LT-SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKG  350 (549)
Q Consensus       274 ~~-~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~  350 (549)
                      .. ...+++.|+|||.+.+..++.++|||||||++++|++ |.+||...+.......+.... ...+...+.++.+++.+
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  239 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQ  239 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence            11 2237789999999988889999999999999999998 899998888777777765543 34556789999999999


Q ss_pred             hchhCcCCCCCHHHHhc
Q psy18060        351 LLEKDASQRLSWPELLH  367 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~  367 (549)
                      ||..+|.+|||+.|+++
T Consensus       240 ~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      240 CWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HCcCChhhCcCHHHHHh
Confidence            99999999999999975

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.8e-39  Score=317.93  Aligned_cols=241  Identities=24%  Similarity=0.413  Sum_probs=205.8

Q ss_pred             EEEecCCcEEEEEEEEcC-CCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC
Q psy18060        125 CLIGEGSFGKVFKAIHLD-LKK--TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~  201 (549)
                      +.||+|++|.||+|.+.. .+.  .+|+|.+...... ...+.+.+|+.++++++||||+++++.+.. ...+++|||+.
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            368999999999998765 333  5899998765443 556788999999999999999999999888 88999999997


Q ss_pred             -CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc---ccc
Q psy18060        202 -MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH---MLT  275 (549)
Q Consensus       202 -gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~---~~~  275 (549)
                       ++|.+++.++.  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.......   ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence             69999998764  689999999999999999999999999999999999999999999999999987644221   112


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHhc
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ--DVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ...++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+...  ....|...|..+.+++.+||
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  238 (257)
T cd05040         159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW  238 (257)
T ss_pred             CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence            3457788999999998889999999999999999998 99999888777766665532  23345668899999999999


Q ss_pred             hhCcCCCCCHHHHhc
Q psy18060        353 EKDASQRLSWPELLH  367 (549)
Q Consensus       353 ~~dP~~Rps~~elL~  367 (549)
                      +.+|.+|||+.++++
T Consensus       239 ~~~p~~Rps~~~~~~  253 (257)
T cd05040         239 AHNPADRPTFAALRE  253 (257)
T ss_pred             CCCcccCCCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-39  Score=316.50  Aligned_cols=241  Identities=25%  Similarity=0.399  Sum_probs=206.1

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CC
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MS  203 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gs  203 (549)
                      +.||+|+||.||+|.+.. ++.+|+|.+...... .....+.+|+++++++.||||+++++++...+..++|||++. ++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            368999999999999887 999999998764432 345678899999999999999999999999999999999987 58


Q ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc--cccCCC
Q psy18060        204 LSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML--TSIKGT  280 (549)
Q Consensus       204 L~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~--~~~~GT  280 (549)
                      |.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.........  ....++
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            9999866 3568999999999999999999999999999999999999999999999999987654222111  112345


Q ss_pred             CcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhchhCcCC
Q psy18060        281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLEKDASQ  358 (549)
Q Consensus       281 ~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~  358 (549)
                      ..|+|||.+.++.++.++|+|||||++|+|++ |..||...........+... ....|...+.++.+++.+||..+|.+
T Consensus       159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  238 (251)
T cd05041         159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN  238 (251)
T ss_pred             eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence            67999999988889999999999999999999 89999888776666666543 33456678999999999999999999


Q ss_pred             CCCHHHHhc
Q psy18060        359 RLSWPELLH  367 (549)
Q Consensus       359 Rps~~elL~  367 (549)
                      |||+.|+++
T Consensus       239 Rp~~~ell~  247 (251)
T cd05041         239 RPSFSEIYN  247 (251)
T ss_pred             CcCHHHHHH
Confidence            999999975

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-39  Score=321.55  Aligned_cols=240  Identities=27%  Similarity=0.415  Sum_probs=202.0

Q ss_pred             EEecCCcEEEEEEEEcCCCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        126 LIGEGSFGKVFKAIHLDLKK--TVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       126 ~iG~G~fg~Vy~~~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      .||+|+||.||+|....++.  .+|+|.+... ........+.+|+.+++++ .||||+++++++...+.++++|||+. 
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            58999999999999988776  4688877532 2334456788999999999 89999999999999999999999987 


Q ss_pred             CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccce
Q psy18060        202 MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       202 gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                      |+|.+++..+.                .+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+++
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence            69999997643                47889999999999999999999999999999999999999999999999986


Q ss_pred             ecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHH
Q psy18060        266 SMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSET  343 (549)
Q Consensus       266 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  343 (549)
                      ...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+... ....|..++.+
T Consensus       161 ~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (270)
T cd05047         161 GQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE  239 (270)
T ss_pred             ccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHH
Confidence            332111 1112234667999999988889999999999999999997 99999888777777666544 33456678899


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      +.+++.+||..+|.+|||+.+++.
T Consensus       240 ~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         240 VYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             HHHHHHHHcccChhhCCCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-39  Score=326.31  Aligned_cols=248  Identities=22%  Similarity=0.341  Sum_probs=205.5

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCC--------------ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLK--------------KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI  184 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~--------------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~  184 (549)
                      .+|++.+.||+|+||.||+|.+..++              ..||+|.+... ........+.+|++++++++||||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            57999999999999999999875432              35899998653 3344556789999999999999999999


Q ss_pred             EEEeeCCEEEEEEecCC-CCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe
Q psy18060        185 ASHETLNEFVLITEFAH-MSLSNLLEQRK------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN  251 (549)
Q Consensus       185 ~~~~~~~~~~iV~E~~~-gsL~~~l~~~~------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~  251 (549)
                      +++...+..++||||+. ++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~  163 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG  163 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence            99999999999999998 58999986532            368888999999999999999999999999999999999


Q ss_pred             cCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCHHHHHH
Q psy18060        252 KDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM--GHPPFKTVSILHLIR  327 (549)
Q Consensus       252 ~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt--G~~Pf~~~~~~~~~~  327 (549)
                      .++.+||+|||+++.......  ......+++.|+|||++.+..++.++|||||||++|+|++  |..||...+......
T Consensus       164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~  243 (295)
T cd05097         164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE  243 (295)
T ss_pred             CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence            999999999999976543221  1123345778999999988889999999999999999988  778998776665554


Q ss_pred             HHhc--------CCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        328 LLKT--------QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       328 ~i~~--------~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .+..        .....++..++.+.+|+.+||+.||.+|||+.+|++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         244 NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            4321        112335568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.7e-38  Score=314.19  Aligned_cols=242  Identities=23%  Similarity=0.376  Sum_probs=204.8

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CC
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MS  203 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gs  203 (549)
                      +.||+|+||.||+|... .+..+|+|.+.... .......+.+|+++++.++||||+++++++...+..++||||+. ++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            36899999999999865 58899999986543 33344568899999999999999999999999999999999987 58


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc-cccCCCC
Q psy18060        204 LSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML-TSIKGTP  281 (549)
Q Consensus       204 L~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~-~~~~GT~  281 (549)
                      |.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ....+++
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI  158 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence            99988754 468999999999999999999999999999999999999999999999999987654322111 1223466


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhchhCcCCC
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLEKDASQR  359 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~R  359 (549)
                      .|+|||++.+..++.++||||||+++|++++ |..||...........+... ....|..++..+.+++.+||..+|++|
T Consensus       159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  238 (250)
T cd05085         159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR  238 (250)
T ss_pred             cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence            7999999988889999999999999999998 99999988777766666544 234566789999999999999999999


Q ss_pred             CCHHHHhcC
Q psy18060        360 LSWPELLHH  368 (549)
Q Consensus       360 ps~~elL~H  368 (549)
                      ||+.++++.
T Consensus       239 p~~~~l~~~  247 (250)
T cd05085         239 PKFSELQKE  247 (250)
T ss_pred             CCHHHHHHH
Confidence            999998753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-38  Score=330.91  Aligned_cols=250  Identities=28%  Similarity=0.469  Sum_probs=211.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCC-------CceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDL-------KKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET  189 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  189 (549)
                      ..+|++.+.||+|+||.||+|.+...       +..+|+|.+... ........+.+|+++++++ .||||+++++++..
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            35799999999999999999986432       236899987643 3344567888999999999 89999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK  252 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~  252 (549)
                      .+.++++|||++ |+|.+++.++.                .++...+..++.|++.||.|||++||+||||||+|||++.
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~  169 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence            999999999997 59999997642                3677888999999999999999999999999999999999


Q ss_pred             CCcEEEeecccceecccCccc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy18060        253 DGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLL  329 (549)
Q Consensus       253 ~g~vKL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i  329 (549)
                      ++.+||+|||+++........  .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  249 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL  249 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            999999999999765432211  122334567999999999999999999999999999998 89999998888887777


Q ss_pred             hcCC-CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        330 KTQD-VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       330 ~~~~-~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .... ...|...+.++.+++.+||..+|.+|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         250 KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            6543 34566789999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=324.89  Aligned_cols=248  Identities=16%  Similarity=0.226  Sum_probs=194.8

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCC---CceEEEEEEecCCCChHHH---------HHHHHHHHHHHhcCCCCeeEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDL---KKTVALKIISKSGRSGKEL---------SSLKQECEIQKHLAHPNIIKFIAS  186 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~---------~~~~~Ei~il~~l~hpnIv~l~~~  186 (549)
                      .+|++.+.||+|+||.||+|.+..+   +..+|+|+...........         .....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5799999999999999999998877   6677887654322111000         011223344556789999999987


Q ss_pred             EeeCC----EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecc
Q psy18060        187 HETLN----EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFG  262 (549)
Q Consensus       187 ~~~~~----~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFG  262 (549)
                      +....    ..+++++++..++.+.+......++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFG  171 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYG  171 (294)
T ss_pred             eeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcC
Confidence            65443    34788888888888888776668899999999999999999999999999999999999999999999999


Q ss_pred             cceecccCc-------ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-H--------HHH
Q psy18060        263 FARSMAVGT-------HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI-L--------HLI  326 (549)
Q Consensus       263 la~~~~~~~-------~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~-~--------~~~  326 (549)
                      +|+......       .......||+.|+|||+..+..++.++|||||||++|+|++|+.||.+... .        +..
T Consensus       172 la~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~  251 (294)
T PHA02882        172 IASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFI  251 (294)
T ss_pred             CceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHH
Confidence            998664221       112334699999999999999999999999999999999999999987632 1        222


Q ss_pred             HHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        327 RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       327 ~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ..+..+... ++..++.+.++++.|+..+|.+||+++++++
T Consensus       252 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        252 KRLHEGKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhhhhhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            333333332 3456899999999999999999999999864

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.4e-38  Score=320.72  Aligned_cols=249  Identities=20%  Similarity=0.355  Sum_probs=210.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcC----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-CCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLD----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-LNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~  192 (549)
                      .++|++.+.||+|+||.||+|.+..    ++..+|+|.+... ........+.+|+.+++.+.||||+++++++.. ...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            4679999999999999999999876    3578999987643 344556778899999999999999999998655 567


Q ss_pred             EEEEEecCC-CCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccc
Q psy18060        193 FVLITEFAH-MSLSNLLEQR--------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGF  263 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~--------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGl  263 (549)
                      .+++++++. ++|.+++...        ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~  163 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL  163 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence            889999987 6899998763        4589999999999999999999999999999999999999999999999999


Q ss_pred             ceecccCccc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCcc
Q psy18060        264 ARSMAVGTHM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQ  339 (549)
Q Consensus       264 a~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  339 (549)
                      ++.+......  .....++..|+|||++.+..++.++|||||||++|++++ |+.||...+..+....+... ....+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  243 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPIN  243 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCc
Confidence            9865433211  122346778999999988889999999999999999999 99999988877776665544 2234556


Q ss_pred             CCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        340 VSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       340 ~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      +++++.+++.+||..+|++|||+.++++
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         244 CPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            7899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-38  Score=319.82  Aligned_cols=249  Identities=22%  Similarity=0.385  Sum_probs=212.6

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ++|++++.||+|+||.||+|..+.+     .+.+|+|.+.... .......+.+|++++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            6789999999999999999997643     4679999875432 233456789999999999999999999999988899


Q ss_pred             EEEEecCC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccc
Q psy18060        194 VLITEFAH-MSLSNLLEQRK---------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGF  263 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~---------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGl  263 (549)
                      ++||||++ ++|.+++....         .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~  163 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL  163 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence            99999998 69999998765         689999999999999999999999999999999999999999999999999


Q ss_pred             ceecccCc-ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCC--CCcc
Q psy18060        264 ARSMAVGT-HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVT--FPSQ  339 (549)
Q Consensus       264 a~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~--~p~~  339 (549)
                      ++...... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+..+...  .+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  243 (275)
T cd05046         164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG  243 (275)
T ss_pred             ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCC
Confidence            86543221 11233456778999999988889999999999999999998 88999887777777777655433  3567


Q ss_pred             CCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        340 VSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       340 ~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +++.+.+++.+||+.+|.+|||+.|++.+
T Consensus       244 ~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         244 CPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            89999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-38  Score=324.63  Aligned_cols=248  Identities=23%  Similarity=0.363  Sum_probs=204.1

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcC----------------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLD----------------LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK  182 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~  182 (549)
                      ++|++.+.||+|+||.||++.+..                ++..+|+|.+... ........+.+|+++++.++||||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            469999999999999999986432                3456899998643 23344567889999999999999999


Q ss_pred             EEEEEeeCCEEEEEEecCC-CCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE
Q psy18060        183 FIASHETLNEFVLITEFAH-MSLSNLLEQRK-----------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL  250 (549)
Q Consensus       183 l~~~~~~~~~~~iV~E~~~-gsL~~~l~~~~-----------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl  250 (549)
                      +++++...+..+++|||+. ++|.+++....           .+++..+..++.|++.||+|||+.|++||||||+|||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili  163 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence            9999999999999999987 69999987643           36778899999999999999999999999999999999


Q ss_pred             ecCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCHHHHH
Q psy18060        251 NKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM--GHPPFKTVSILHLI  326 (549)
Q Consensus       251 ~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt--G~~Pf~~~~~~~~~  326 (549)
                      +.++.++|+|||+++.......  ......+++.|+|||+..++.++.++|||||||++|||++  |..||...+..+..
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05095         164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI  243 (296)
T ss_pred             cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence            9999999999999976543221  1122344678999999888889999999999999999998  78999877665554


Q ss_pred             HHHh--------cCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        327 RLLK--------TQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       327 ~~i~--------~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ....        ....+.|..+++.+.+|+.+||+.||.+|||+.+|++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         244 ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4321        1122345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.4e-38  Score=314.29  Aligned_cols=247  Identities=25%  Similarity=0.436  Sum_probs=210.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ..+|++.+.||+|+||.||++.+.. +..+|+|.+......   ...+.+|+++++.+.||||+++++++......+++|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            3578999999999999999998764 678999988654332   245788999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc-c
Q psy18060        198 EFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-L  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~-~  274 (549)
                      ||+. ++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++........ .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            9987 5899988764 46899999999999999999999999999999999999999999999999998765432111 1


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhc
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+..+ ....|...++.+.+++.+||
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  238 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCW  238 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHc
Confidence            12235678999999988889999999999999999998 99999988877777776554 23345667999999999999


Q ss_pred             hhCcCCCCCHHHHhcC
Q psy18060        353 EKDASQRLSWPELLHH  368 (549)
Q Consensus       353 ~~dP~~Rps~~elL~H  368 (549)
                      +.+|.+|||+.+++++
T Consensus       239 ~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         239 KERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ccChhhCCCHHHHHHh
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.6e-39  Score=318.14  Aligned_cols=228  Identities=23%  Similarity=0.305  Sum_probs=194.9

Q ss_pred             CCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CCHHHHH
Q psy18060        130 GSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSLSNLL  208 (549)
Q Consensus       130 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL~~~l  208 (549)
                      |.+|.||++.+..+++.||+|.+....       ...+|...+....||||+++++++...+..+++|||+. |+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            889999999999999999999997542       12334455556679999999999999999999999998 5899999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCccccccc
Q psy18060        209 EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL  288 (549)
Q Consensus       209 ~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~  288 (549)
                      .+...+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||.+......   .....++..|+|||.
T Consensus        77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~  153 (237)
T cd05576          77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEV  153 (237)
T ss_pred             HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCcc
Confidence            88888999999999999999999999999999999999999999999999999987655432   233456788999999


Q ss_pred             ccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCCH-----H
Q psy18060        289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW-----P  363 (549)
Q Consensus       289 l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~-----~  363 (549)
                      +.+..++.++|+||+||++|+|++|+.||.......    .......+|+.+++.++++|.+||+.||.+||++     +
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~  229 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE  229 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence            988889999999999999999999999886543211    0112335677899999999999999999999986     9


Q ss_pred             HHhcCccc
Q psy18060        364 ELLHHPLV  371 (549)
Q Consensus       364 elL~Hpw~  371 (549)
                      ++++||||
T Consensus       230 ~~~~h~~~  237 (237)
T cd05576         230 DIKSHPFF  237 (237)
T ss_pred             HHHcCCCC
Confidence            99999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=318.87  Aligned_cols=247  Identities=23%  Similarity=0.428  Sum_probs=210.3

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .+|++.+.||+|+||.||+|.+..++.    .+|+|.+..... ......+.+|+.+++.+.||||+++++++.. ...+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            578999999999999999999877665    589998765432 3445678899999999999999999999877 6789


Q ss_pred             EEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ++|||+. |+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~  164 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK  164 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence            9999987 6899998874 4689999999999999999999999999999999999999999999999999987653322


Q ss_pred             ccc--ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHH
Q psy18060        273 MLT--SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLV  348 (549)
Q Consensus       273 ~~~--~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI  348 (549)
                      ...  ...++..|+|||.+....++.++|+|||||++|++++ |+.||.+....+....+..+. ...|...+..+.+++
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (279)
T cd05057         165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVL  244 (279)
T ss_pred             ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            111  1224567999999988889999999999999999998 999999988877776665543 445667889999999


Q ss_pred             HHhchhCcCCCCCHHHHhc
Q psy18060        349 KGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~  367 (549)
                      .+||..+|..|||+.++++
T Consensus       245 ~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         245 VKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHcCCChhhCCCHHHHHH
Confidence            9999999999999998854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG2345|consensus

Probab=100.00  E-value=2.7e-40  Score=314.06  Aligned_cols=251  Identities=28%  Similarity=0.441  Sum_probs=205.5

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe-----eC
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE-----TL  190 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~  190 (549)
                      -+.++|++.+.||+|||+.||.+.+..++..||+|++...+  .+..+..++|+...++++||||++++++..     ..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            34578999999999999999999999999999999997754  456778899999999999999999887642     23


Q ss_pred             CEEEEEEecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccCCcEEEecCCcEEEeeccc
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQR----KKLSETICVQILSNLISALYYLHSNR--VLHRDLKPQNVLLNKDGVAMLCDFGF  263 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~----~~l~e~~~~~i~~qIl~aL~yLH~~g--IiHrDIKP~NILl~~~g~vKL~DFGl  263 (549)
                      ...||++.|.. |+|.+.|...    ..++|.++..|+.+|+.||++||+..  +.||||||.|||+++.+.++|.|||.
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence            45899999765 8999998753    35899999999999999999999998  99999999999999999999999999


Q ss_pred             ceecccCc---------ccccccCCCCccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Q psy18060        264 ARSMAVGT---------HMLTSIKGTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI--LHLIRLL  329 (549)
Q Consensus       264 a~~~~~~~---------~~~~~~~GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~--~~~~~~i  329 (549)
                      ++...-..         +...+...|..|+|||.+.   +...+.++|||||||+||+|+.|..||...-.  ..+.-.+
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv  255 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV  255 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence            87553211         1122345789999999984   45578999999999999999999999953211  0111122


Q ss_pred             hcCCCCCC--ccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        330 KTQDVTFP--SQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       330 ~~~~~~~p--~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .++.+.+|  +.+|+.+.++|+.||++||.+||++.+++.+
T Consensus       256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            34445555  3489999999999999999999999999865

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.1e-38  Score=316.46  Aligned_cols=248  Identities=29%  Similarity=0.418  Sum_probs=208.8

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDL---KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      .+|.+.+.||+|+||.||+|.+...   ...+|+|..... ......+.+.+|+.+++.+.||||+++++++.+ ...++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            5688999999999999999987654   346899987543 224455678899999999999999999998875 45789


Q ss_pred             EEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-
Q psy18060        196 ITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-  272 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-  272 (549)
                      ||||+. ++|.+++.+.. .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++....... 
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  163 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY  163 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence            999997 68999998744 589999999999999999999999999999999999999999999999999876543321 


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~  350 (549)
                      ..+...+++.|+|||.+....++.++|||||||++|+|++ |..||...+..+....+..+ ....|+.+++.+.++|.+
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  243 (270)
T cd05056         164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK  243 (270)
T ss_pred             ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence            1122234567999999988889999999999999999986 99999988877766666554 345677889999999999


Q ss_pred             hchhCcCCCCCHHHHhcC
Q psy18060        351 LLEKDASQRLSWPELLHH  368 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~H  368 (549)
                      ||..+|.+|||+.+++..
T Consensus       244 ~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         244 CWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HcCCChhhCcCHHHHHHH
Confidence            999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-38  Score=319.96  Aligned_cols=245  Identities=28%  Similarity=0.421  Sum_probs=198.0

Q ss_pred             eeEEEEEecCCcEEEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--CCEEE
Q psy18060        121 YQKICLIGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--LNEFV  194 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~  194 (549)
                      |++.+.||+|+||+||++.    ...++..+|+|.+.... .......+.+|+++++.++||||+++++++..  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            3899999999999998764    34567889999986542 22344677889999999999999999998755  34689


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      ++|||+. ++|.+++... .+++.+++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++........
T Consensus        85 lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  163 (283)
T cd05080          85 LIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY  163 (283)
T ss_pred             EEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence            9999998 5899988764 6999999999999999999999999999999999999999999999999999766433211


Q ss_pred             ---ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHhc-CCC
Q psy18060        274 ---LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL---------------HLIRLLKT-QDV  334 (549)
Q Consensus       274 ---~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~---------------~~~~~i~~-~~~  334 (549)
                         .....++..|+|||++.+..++.++|||||||++|+|++|..||......               .....+.. ...
T Consensus       164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (283)
T cd05080         164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL  243 (283)
T ss_pred             hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCC
Confidence               12234567799999998888999999999999999999999998643211               11111111 112


Q ss_pred             CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       335 ~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      +.|..++.++.+++.+||+.+|.+|||+.+++.
T Consensus       244 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            335678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.6e-39  Score=321.57  Aligned_cols=236  Identities=21%  Similarity=0.353  Sum_probs=197.1

Q ss_pred             EEecCCcEEEEEEEEcCCCce-------EEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        126 LIGEGSFGKVFKAIHLDLKKT-------VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       126 ~iG~G~fg~Vy~~~~~~~~~~-------vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .||+|+||.||+|.+..++..       +|+|.+....  ....+.+.+|+.+++.+.||||+++++++...+..++|||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            589999999999998665443       8888875422  2344577889999999999999999999999889999999


Q ss_pred             cCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc--------EEEeecccceecc
Q psy18060        199 FAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV--------AMLCDFGFARSMA  268 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~--------vKL~DFGla~~~~  268 (549)
                      |++ |+|.+++..++ .+++..+..++.||+.||+|||++||+||||||+||+++.++.        ++++|||++....
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence            998 58999997654 5899999999999999999999999999999999999987764        6999999886553


Q ss_pred             cCcccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHH
Q psy18060        269 VGTHMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMG-HPPFKTVSILHLIRLLKTQDVTFPSQVSETYKD  346 (549)
Q Consensus       269 ~~~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~d  346 (549)
                      ..    ....+++.|+|||++.+ ..++.++|||||||++|+|++| .+||...+....... ......+|...++++.+
T Consensus       160 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  234 (258)
T cd05078         160 PK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDRHQLPAPKWTELAN  234 (258)
T ss_pred             Cc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHccccCCCCCcHHHHH
Confidence            22    33468899999999976 4589999999999999999998 577776665544433 33445677778899999


Q ss_pred             HHHHhchhCcCCCCCHHHHhcC
Q psy18060        347 LVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +|.+||+.||.+|||++++++.
T Consensus       235 li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         235 LINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHhccChhhCCCHHHHHHh
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2e-38  Score=337.38  Aligned_cols=252  Identities=26%  Similarity=0.419  Sum_probs=208.1

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEee
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHET  189 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~  189 (549)
                      ...++|.+.+.||+|+||.||+|.+.     .++..||+|++..... ......+.+|++++..+. ||||+++++++..
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            34456888999999999999999864     3456899999975432 333456889999999997 9999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhcC--------------------------------------------------------
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQRK--------------------------------------------------------  212 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~~--------------------------------------------------------  212 (549)
                      .+..++||||+. |+|.+++.+.+                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            899999999998 69999986532                                                        


Q ss_pred             ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE
Q psy18060        213 ------------------------------------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL  250 (549)
Q Consensus       213 ------------------------------------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl  250 (549)
                                                                .+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl  272 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI  272 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence                                                      25667788999999999999999999999999999999


Q ss_pred             ecCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy18060        251 NKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIR  327 (549)
Q Consensus       251 ~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~  327 (549)
                      +.++.+||+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+...
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~  352 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY  352 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence            9999999999999976532211  1223457888999999998889999999999999999998 899998765544433


Q ss_pred             H-HhcC-CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        328 L-LKTQ-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       328 ~-i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      . +..+ ....|..++.++.+++.+||..+|.+||++.+|++.
T Consensus       353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3 3322 334567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG1187|consensus

Probab=100.00  E-value=4.3e-39  Score=336.46  Aligned_cols=257  Identities=27%  Similarity=0.422  Sum_probs=205.5

Q ss_pred             ccccccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q psy18060        108 PVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASH  187 (549)
Q Consensus       108 ~~~~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~  187 (549)
                      .+.........++|.....||+|+||.||+|.... +..||||.+.......  ...+.+|+.++.+++|||+|+++|+|
T Consensus        64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34555566677889989999999999999998876 4899999886644322  34599999999999999999999999


Q ss_pred             eeCC-EEEEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CCccccccCCcEEEecCCcEEEee
Q psy18060        188 ETLN-EFVLITEFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSN---RVLHRDLKPQNVLLNKDGVAMLCD  260 (549)
Q Consensus       188 ~~~~-~~~iV~E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~---gIiHrDIKP~NILl~~~g~vKL~D  260 (549)
                      .+.+ ..+||+||+. |+|.++|....  .++|....+|+.+++.||+|||+.   .||||||||+|||||++...||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9888 5999999987 89999998765  899999999999999999999986   399999999999999999999999


Q ss_pred             cccceeccc-CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------HHHHH-HHHhcC
Q psy18060        261 FGFARSMAV-GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS------ILHLI-RLLKTQ  332 (549)
Q Consensus       261 FGla~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~------~~~~~-~~i~~~  332 (549)
                      ||+|+.... .....+...||.+|+|||++..+..+.|+|||||||+|.||+||+.|.....      ..... ..+..+
T Consensus       221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~  300 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG  300 (361)
T ss_pred             ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence            999966543 3222222279999999999999999999999999999999999998886432      11111 112221


Q ss_pred             C------CCCC-ccCC--HH---HHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        333 D------VTFP-SQVS--ET---YKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       333 ~------~~~p-~~~s--~~---~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .      ..+. ...+  ..   +..+..+|++.+|..||++.|+++
T Consensus       301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            1      1111 2233  23   446677999999999999998743

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.3e-38  Score=313.47  Aligned_cols=243  Identities=22%  Similarity=0.394  Sum_probs=199.0

Q ss_pred             EEEecCCcEEEEEEEEcC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe-eCCEEEEEEecC
Q psy18060        125 CLIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE-TLNEFVLITEFA  200 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~iV~E~~  200 (549)
                      +.||+|+||.||+|.+..   .+..+|+|.+... ........+.+|+.+++.++||||+++++++. ..+..+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            368999999999998653   3457999987542 23344567888999999999999999999764 455678999998


Q ss_pred             C-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc----ccc
Q psy18060        201 H-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT----HML  274 (549)
Q Consensus       201 ~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~----~~~  274 (549)
                      . ++|.+++.+. ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++......    ...
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            7 6999999764 456788888999999999999999999999999999999999999999999997553211    111


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHhc
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~L  352 (549)
                      ....+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+.......+..+. ...|..+++.+.+++.+||
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  239 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCW  239 (262)
T ss_pred             ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHc
Confidence            23346778999999988889999999999999999999 577888777766666655443 3345567899999999999


Q ss_pred             hhCcCCCCCHHHHhcC
Q psy18060        353 EKDASQRLSWPELLHH  368 (549)
Q Consensus       353 ~~dP~~Rps~~elL~H  368 (549)
                      ..+|++||++.++++.
T Consensus       240 ~~~p~~Rp~~~~il~~  255 (262)
T cd05058         240 HPKPEMRPTFSELVSR  255 (262)
T ss_pred             CCChhhCCCHHHHHHH
Confidence            9999999999999764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-38  Score=331.02  Aligned_cols=250  Identities=27%  Similarity=0.454  Sum_probs=203.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee-C
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIH-----LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET-L  190 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-~  190 (549)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|.+.... .......+.+|+.++..+ +||||+++++++.. .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            45799999999999999999984     3457889999986543 234456788999999999 68999999997754 4


Q ss_pred             CEEEEEEecCC-CCHHHHHHhcC---------------------------------------------------------
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQRK---------------------------------------------------------  212 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~~---------------------------------------------------------  212 (549)
                      ..++++|||++ |+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            56899999998 58999986531                                                         


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--cccccCCC
Q psy18060        213 ----------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--MLTSIKGT  280 (549)
Q Consensus       213 ----------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT  280 (549)
                                .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  ......++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence                      367778889999999999999999999999999999999999999999999876532211  11223456


Q ss_pred             CcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhcC-CCCCCccCCHHHHHHHHHhchhCcC
Q psy18060        281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILH-LIRLLKTQ-DVTFPSQVSETYKDLVKGLLEKDAS  357 (549)
Q Consensus       281 ~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~  357 (549)
                      +.|+|||++.+..++.++|||||||++|+|++ |..||....... ....+..+ ....|...++++.+++.+||+.||.
T Consensus       245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~  324 (343)
T cd05103         245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS  324 (343)
T ss_pred             cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            78999999988889999999999999999997 999998754332 22333222 3345566789999999999999999


Q ss_pred             CCCCHHHHhcC
Q psy18060        358 QRLSWPELLHH  368 (549)
Q Consensus       358 ~Rps~~elL~H  368 (549)
                      +|||+.+|++|
T Consensus       325 ~Rps~~eil~~  335 (343)
T cd05103         325 QRPTFSELVEH  335 (343)
T ss_pred             hCcCHHHHHHH
Confidence            99999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.9e-38  Score=311.67  Aligned_cols=246  Identities=23%  Similarity=0.363  Sum_probs=207.7

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||++.... +..+|+|.+...   ......+.+|+++++.++||||+++++.+.. ...+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            35789999999999999999998654 567999987643   2234578889999999999999999999877 678999


Q ss_pred             EecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        197 TEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      |||++ ++|.+++.+.  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||.+.........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            99997 6999999763  45788889999999999999999999999999999999999999999999998765432211


Q ss_pred             -ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHH
Q psy18060        274 -LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKG  350 (549)
Q Consensus       274 -~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~  350 (549)
                       .....++..|+|||++.+..++.++|+|||||++|++++ |..||...+.......+.... ...+...+.++.+++.+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  238 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR  238 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHH
Confidence             122345677999999988889999999999999999998 999999888777776665542 33456789999999999


Q ss_pred             hchhCcCCCCCHHHHhc
Q psy18060        351 LLEKDASQRLSWPELLH  367 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~  367 (549)
                      ||.++|++||++.++++
T Consensus       239 ~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         239 CWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HcccCcccCcCHHHHHH
Confidence            99999999999988753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.3e-38  Score=319.09  Aligned_cols=248  Identities=25%  Similarity=0.416  Sum_probs=202.6

Q ss_pred             ceeEEEEEecCCcEEEEEEEE----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--CEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIH----LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--NEF  193 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~  193 (549)
                      .|++++.||+|+||.||.|..    ..++..||+|.+.... .......+.+|+.+++.+.||||+++++++...  ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            478999999999999999974    4568899999986442 334456789999999999999999999988765  568


Q ss_pred             EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ++||||+. ++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++......
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence            99999997 5899999765 358999999999999999999999999999999999999999999999999998664332


Q ss_pred             c---cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHhcC-
Q psy18060        272 H---MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV---------------SILHLIRLLKTQ-  332 (549)
Q Consensus       272 ~---~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~---------------~~~~~~~~i~~~-  332 (549)
                      .   ......|+..|+|||++.+..++.++|||||||++|+|++|..|+...               ........+... 
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK  243 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence            1   112345777899999998888999999999999999999987665321               111122222222 


Q ss_pred             CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        333 DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       333 ~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ..+.+..+++.+.+|+.+||+.+|.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            233456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.9e-38  Score=322.13  Aligned_cols=249  Identities=23%  Similarity=0.403  Sum_probs=207.0

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ..+|+..+.||+|+||.||+|.+..++.    .+|+|.+.... .......+.+|+.+++.+.||||+++++++... ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            3568899999999999999999887776    46888876432 233344678999999999999999999988654 46


Q ss_pred             EEEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ++++||+. |+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence            78899987 68999987654 68999999999999999999999999999999999999999999999999998664332


Q ss_pred             cc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHH
Q psy18060        272 HM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDL  347 (549)
Q Consensus       272 ~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dl  347 (549)
                      ..  .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..+. ...++..+..+.++
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV  243 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence            21  223345778999999998899999999999999999997 999998877666555554432 33456688999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcC
Q psy18060        348 VKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~H  368 (549)
                      +.+||..+|++||++.++++.
T Consensus       244 i~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         244 MVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999998775

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.4e-38  Score=312.50  Aligned_cols=240  Identities=25%  Similarity=0.430  Sum_probs=205.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|+||.||++..  +++.+|+|.+....    ....+.+|+.+++.++||||+++++++... ..+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            46799999999999999999864  58889999986432    235678999999999999999999998654 479999


Q ss_pred             ecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        198 EFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||+. ++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.....   .
T Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~  154 (254)
T cd05083          78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---V  154 (254)
T ss_pred             ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---C
Confidence            9987 59999997653  5899999999999999999999999999999999999999999999999998754322   1


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHhc
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~L  352 (549)
                      .....+..|+|||.+.+..++.++|+|||||++|+|++ |++||...+.......+..+. ...+..+++.+.+++.+||
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  234 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCW  234 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHc
Confidence            22345678999999988889999999999999999997 999999888877766665542 3345678999999999999


Q ss_pred             hhCcCCCCCHHHHhc
Q psy18060        353 EKDASQRLSWPELLH  367 (549)
Q Consensus       353 ~~dP~~Rps~~elL~  367 (549)
                      ..+|.+||++.+++.
T Consensus       235 ~~~p~~Rp~~~~l~~  249 (254)
T cd05083         235 ETEPKKRPSFHKLRE  249 (254)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999865

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-38  Score=315.93  Aligned_cols=236  Identities=20%  Similarity=0.337  Sum_probs=192.7

Q ss_pred             EEecCCcEEEEEEEEcCC------------CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        126 LIGEGSFGKVFKAIHLDL------------KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       126 ~iG~G~fg~Vy~~~~~~~------------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .||+|+||.||+|.....            ...+|+|.+....  ......+.+|+.+++.++||||+++++++......
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            589999999999985422            2358888865432  23345778899999999999999999999988889


Q ss_pred             EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc-------EEEeecccc
Q psy18060        194 VLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV-------AMLCDFGFA  264 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~-------vKL~DFGla  264 (549)
                      +++|||++ ++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.       ++++|||++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~  159 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP  159 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence            99999998 4787777653 56899999999999999999999999999999999999987664       899999998


Q ss_pred             eecccCcccccccCCCCccccccccc-CCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcCCCCCCccCCH
Q psy18060        265 RSMAVGTHMLTSIKGTPLYMAPELIA-ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLKTQDVTFPSQVSE  342 (549)
Q Consensus       265 ~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~y~~ksDIwSlGvil~eLl-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  342 (549)
                      ......    ....||..|+|||.+. +..++.++|||||||++|+|+ +|..||......+... +...........++
T Consensus       160 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~  234 (262)
T cd05077         160 ITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTPSCK  234 (262)
T ss_pred             ccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCCCChH
Confidence            655322    3346888999999986 567899999999999999997 5899998766554433 22333334445678


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ++.++|.+||+.||.+||++.+|+++
T Consensus       235 ~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         235 ELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            89999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.7e-38  Score=316.37  Aligned_cols=247  Identities=26%  Similarity=0.421  Sum_probs=199.9

Q ss_pred             cceeEEEEEecCCcEEEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--CCE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--LNE  192 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~  192 (549)
                      .+|++.+.||+|+||.||+|.    ...++..||+|.+...  .......+.+|+++++.++||||+++++++..  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            468999999999999999997    3457889999998653  23445678899999999999999999987643  346


Q ss_pred             EEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        193 FVLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      +++||||+. ++|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            899999997 6999999764 46899999999999999999999999999999999999999999999999999876433


Q ss_pred             ccc---ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhc
Q psy18060        271 THM---LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL----------------HLIRLLKT  331 (549)
Q Consensus       271 ~~~---~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~----------------~~~~~i~~  331 (549)
                      ...   .....++..|+|||++.+..++.++|||||||++|||++|..|+......                .....+..
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN  241 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence            211   11123445699999999888999999999999999999988776433211                11111111


Q ss_pred             C-CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        332 Q-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       332 ~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      . ..+.+..++.++.+++.+||..+|++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1 22345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.7e-38  Score=314.99  Aligned_cols=240  Identities=23%  Similarity=0.352  Sum_probs=192.6

Q ss_pred             EEecCCcEEEEEEEEcC--CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-C
Q psy18060        126 LIGEGSFGKVFKAIHLD--LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-M  202 (549)
Q Consensus       126 ~iG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-g  202 (549)
                      .||+|+||.||+|....  ....+|+|.+... ........+.+|+.+++.++||||+++++.+......++||||+. |
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            58999999999996533  3456888877543 233445677889999999999999999999999999999999998 5


Q ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--ccc
Q psy18060        203 SLSNLLEQRK-----KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--MLT  275 (549)
Q Consensus       203 sL~~~l~~~~-----~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--~~~  275 (549)
                      +|.+++....     .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD  160 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence            9999997643     246778899999999999999999999999999999999999999999999865433211  112


Q ss_pred             ccCCCCccccccccc-------CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh-cCCCC-----CCccCC
Q psy18060        276 SIKGTPLYMAPELIA-------ERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLK-TQDVT-----FPSQVS  341 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~-------~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~-~~~~~-----~p~~~s  341 (549)
                      ...+++.|+|||++.       ...++.++|||||||++|+|++ |..||...........+. .....     .+..++
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd05042         161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS  240 (269)
T ss_pred             CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence            334677899999874       2457889999999999999999 889998877665554432 22222     234678


Q ss_pred             HHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        342 ETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       342 ~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      +.+.+++..|+ .||.+|||+++|++
T Consensus       241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         241 DRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             HHHHHHHHHHh-cCcccccCHHHHHH
Confidence            99999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.8e-38  Score=315.06  Aligned_cols=248  Identities=24%  Similarity=0.369  Sum_probs=206.2

Q ss_pred             eeEEEEEecCCcEEEEEEEEcC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC------
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN------  191 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------  191 (549)
                      |.+.+.||+|+||.||+|....   +++.+|+|++..........+.+.+|+++++.++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5678899999999999998643   5788999999765555556677889999999999999999999875432      


Q ss_pred             EEEEEEecCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccc
Q psy18060        192 EFVLITEFAH-MSLSNLLEQR------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA  264 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla  264 (549)
                      ..+++++|+. |+|.+++...      ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            2478889887 6888877432      24788999999999999999999999999999999999999999999999999


Q ss_pred             eecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccC
Q psy18060        265 RSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQV  340 (549)
Q Consensus       265 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  340 (549)
                      +....+..  ......+++.|++||.+.+..++.++|||||||++|+|++ |++||...+.......+... ....+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC  240 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence            86643321  1223345678999999998889999999999999999999 99999888877766665544 33455678


Q ss_pred             CHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        341 SETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       341 s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ++.+.+++.+||+.+|.+|||+.+++.+
T Consensus       241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         241 LEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.6e-38  Score=317.16  Aligned_cols=236  Identities=20%  Similarity=0.300  Sum_probs=193.0

Q ss_pred             EEecCCcEEEEEEEEcCC------------------------CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCee
Q psy18060        126 LIGEGSFGKVFKAIHLDL------------------------KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII  181 (549)
Q Consensus       126 ~iG~G~fg~Vy~~~~~~~------------------------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv  181 (549)
                      .||+|+||.||+|....+                        ...+|+|++....  ......+.+|+.+++.+.||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence            589999999999975322                        2357888875432  22345677889999999999999


Q ss_pred             EEEEEEeeCCEEEEEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-----
Q psy18060        182 KFIASHETLNEFVLITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-----  254 (549)
Q Consensus       182 ~l~~~~~~~~~~~iV~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-----  254 (549)
                      ++++++......++||||++ |+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+     
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            99999999999999999998 578888865 46789999999999999999999999999999999999998654     


Q ss_pred             --cEEEeecccceecccCcccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHh
Q psy18060        255 --VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK  330 (549)
Q Consensus       255 --~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLl-tG~~Pf~~~~~~~~~~~i~  330 (549)
                        .+|++|||++......    ....+++.|+|||.+.+ ..++.++|||||||++|||+ +|+.||...........+.
T Consensus       160 ~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  235 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE  235 (274)
T ss_pred             cceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH
Confidence              4899999988644321    23357888999998865 56899999999999999985 7999998776655444332


Q ss_pred             cCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        331 TQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       331 ~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                       ....+|...++.+.++|.+||+.+|.+|||+.+++++
T Consensus       236 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         236 -KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             3334556677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.5e-38  Score=312.24  Aligned_cols=234  Identities=22%  Similarity=0.375  Sum_probs=193.6

Q ss_pred             EEEecCCcEEEEEEEEcCCC----------ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        125 CLIGEGSFGKVFKAIHLDLK----------KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~----------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      +.||+|+||.||+|.+..++          ..+++|.+.....   ....+.+|+.+++.++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            36899999999999998776          3477787654322   14678899999999999999999999877 7789


Q ss_pred             EEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-------cEEEeecccce
Q psy18060        195 LITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-------VAMLCDFGFAR  265 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-------~vKL~DFGla~  265 (549)
                      +||||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||++.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999998 58999998766 799999999999999999999999999999999999999887       79999999997


Q ss_pred             ecccCcccccccCCCCcccccccccCC--CCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCccCCH
Q psy18060        266 SMAVGTHMLTSIKGTPLYMAPELIAER--PYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVTFPSQVSE  342 (549)
Q Consensus       266 ~~~~~~~~~~~~~GT~~Y~APE~l~~~--~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  342 (549)
                      ....    .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||...+.......... ....|...+.
T Consensus       157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~  231 (259)
T cd05037         157 TVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLPMPDCA  231 (259)
T ss_pred             cccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCCCCCch
Confidence            6543    1234577889999999776  78999999999999999999 6888877654443333322 2223333458


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .+.++|.+||..+|.+|||+.++++
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         232 ELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.6e-38  Score=314.52  Aligned_cols=241  Identities=23%  Similarity=0.418  Sum_probs=203.0

Q ss_pred             EEecCCcEEEEEEEEcCCC------ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        126 LIGEGSFGKVFKAIHLDLK------KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       126 ~iG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      .||+|+||.||+|.....+      ..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            6899999999999876544      689999886532 223456788899999999999999999999988999999999


Q ss_pred             CC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-----cEEEeeccccee
Q psy18060        200 AH-MSLSNLLEQR-------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-----VAMLCDFGFARS  266 (549)
Q Consensus       200 ~~-gsL~~~l~~~-------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-----~vKL~DFGla~~  266 (549)
                      ++ ++|.+++...       ..+++..+..++.|++.||.|||+.|++||||||+||+++.++     .++|+|||+++.
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            87 6899998752       3478899999999999999999999999999999999999887     899999999876


Q ss_pred             cccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCH
Q psy18060        267 MAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSE  342 (549)
Q Consensus       267 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~  342 (549)
                      ......  ......++..|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+... ....+..+|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPD  240 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchH
Confidence            533211  1122345788999999999899999999999999999998 99999888777766665543 3455677899


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .+.++|.+||.++|.+||++.++++
T Consensus       241 ~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         241 KIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999865

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0695|consensus

Probab=100.00  E-value=3.5e-39  Score=316.79  Aligned_cols=267  Identities=23%  Similarity=0.438  Sum_probs=234.5

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCC
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLN  191 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~  191 (549)
                      +.-.+++|.++++||+|+|++|.++++++|.+.||+|++++.-. ..+..+-+..|-.+..+. +||.+|-++.+|++..
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            34457899999999999999999999999999999999987543 333455666676666665 7999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      .+++|.||.+ |+|--+++++++++|+.++.+...|+.||.|||++|||.||||..|+|++..|++||+|+|+++.--.+
T Consensus       325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            9999999998 589989999999999999999999999999999999999999999999999999999999999765555


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHhcCCCCCCccCCH
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT--------VSILHLIRLLKTQDVTFPSQVSE  342 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~--------~~~~~~~~~i~~~~~~~p~~~s~  342 (549)
                      .....++||||.|.|||++.+..|++.+|+|+|||+++||+.|+.||.-        .+..-+.+.|....+.+|..+|-
T Consensus       405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsv  484 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSV  484 (593)
T ss_pred             CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeeh
Confidence            5667889999999999999999999999999999999999999999952        23344566778888899999999


Q ss_pred             HHHHHHHHhchhCcCCCCC------HHHHhcCcccCcccchhhh
Q psy18060        343 TYKDLVKGLLEKDASQRLS------WPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps------~~elL~Hpw~~~~~~~~~~  380 (549)
                      .+..+++..|.+||..|+.      ..++..||||+...+..++
T Consensus       485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le  528 (593)
T KOG0695|consen  485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE  528 (593)
T ss_pred             hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh
Confidence            9999999999999999975      5799999999976665443

>KOG1026|consensus

Probab=100.00  E-value=7.4e-39  Score=348.74  Aligned_cols=247  Identities=24%  Similarity=0.432  Sum_probs=215.9

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .+.+..+.||+|+||+||+|..-.     ....||||.++.. .+......|++|+.++..++|||||+++|++..++.+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            456678899999999999997542     3467999999654 3444678999999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEE
Q psy18060        194 VLITEFAH-MSLSNLLEQRK--------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAML  258 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~--------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL  258 (549)
                      ++|+||+. |+|.++|..+.              +++..+...|+.||+.|+.||-++.+|||||...|+|+.++-.|||
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI  644 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI  644 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence            99999998 89999997542              2788899999999999999999999999999999999999999999


Q ss_pred             eecccceecccCccc-cc-ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCC-
Q psy18060        259 CDFGFARSMAVGTHM-LT-SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDV-  334 (549)
Q Consensus       259 ~DFGla~~~~~~~~~-~~-~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~~-  334 (549)
                      +|||+++..-..... .. .-.-..+|||||.+..++|+.+|||||+||+|||+++ |+.||.+.+..++++.|..+.. 
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL  724 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLL  724 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcc
Confidence            999999876433211 11 1123567999999999999999999999999999997 9999999999999999998875 


Q ss_pred             CCCccCCHHHHHHHHHhchhCcCCCCCHHHHh
Q psy18060        335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELL  366 (549)
Q Consensus       335 ~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL  366 (549)
                      .-|.++|.++.+|+..||+.+|.+||++.||-
T Consensus       725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  725 SCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            45689999999999999999999999999873

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.2e-37  Score=311.80  Aligned_cols=248  Identities=29%  Similarity=0.553  Sum_probs=209.9

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcC-CCceEEEEEEecCC--------CChHHHHHHHHHHHHHHh-cCCCCeeEEEEEEee
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLD-LKKTVALKIISKSG--------RSGKELSSLKQECEIQKH-LAHPNIIKFIASHET  189 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~--------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~  189 (549)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....        ........+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999987 68899999886432        223345567788888765 799999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcEEEeeccc
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGF  263 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~vKL~DFGl  263 (549)
                      .+..+++|||+. ++|.+++..    ...+++..++.++.|++.||.|||+ .|++||||+|+|||++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            999999999987 488888743    3568999999999999999999996 6899999999999999999999999999


Q ss_pred             ceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CC-ccCC
Q psy18060        264 ARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-FP-SQVS  341 (549)
Q Consensus       264 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s  341 (549)
                      +....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+...... .+ ..++
T Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd08528         161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS  239 (269)
T ss_pred             eeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence            97765432 334567899999999999888999999999999999999999999888877776666554432 22 2578


Q ss_pred             HHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        342 ETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       342 ~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +.+.++|.+||+.||.+||++.|+..+
T Consensus       240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         240 EDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            999999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0608|consensus

Probab=100.00  E-value=6.8e-39  Score=335.41  Aligned_cols=260  Identities=27%  Similarity=0.462  Sum_probs=221.6

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .-|..++.||-|+||.|.++...+|...||+|.+.+.. ........++.|-.||...+++-||++|.+|++.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            34889999999999999999999999999999997754 33445667889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc--c-----
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA--V-----  269 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~--~-----  269 (549)
                      +|+. |++-.+|-+.+.|.|..+++++.++..|+++.|+.|+|||||||.|||||.+|++||+|||+++-+.  .     
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence            9988 5899999999999999999999999999999999999999999999999999999999999985321  1     


Q ss_pred             --Ccc---------------------------------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q psy18060        270 --GTH---------------------------------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGH  314 (549)
Q Consensus       270 --~~~---------------------------------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~  314 (549)
                        +.+                                 ...+.+||+.|+|||++....|+..+|+||.|||||||+.|+
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence              000                                 012357999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhcCC--CCCC--ccCCHHHHHHHHHhchhCcCCCCC---HHHHhcCcccCcccchhh
Q psy18060        315 PPFKTVSILHLIRLLKTQD--VTFP--SQVSETYKDLVKGLLEKDASQRLS---WPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       315 ~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~dlI~~~L~~dP~~Rps---~~elL~Hpw~~~~~~~~~  379 (549)
                      +||-..++.+...++.+..  +.+|  .++|.++.++|.++. .++..|+.   ++||..||||+......+
T Consensus       869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfssl  939 (1034)
T KOG0608|consen  869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSL  939 (1034)
T ss_pred             CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHhh
Confidence            9998877766665554432  2334  579999999998854 46777874   678999999997655443

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-37  Score=312.00  Aligned_cols=241  Identities=22%  Similarity=0.326  Sum_probs=192.9

Q ss_pred             EEEecCCcEEEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHL--DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|...  .++..+|+|.+..... ......+.+|+.+++.++||||+++++++......++||||++ 
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            35899999999999754  3456799998865432 3334568889999999999999999999998889999999998 


Q ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--cc
Q psy18060        202 MSLSNLLEQRK-----KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--ML  274 (549)
Q Consensus       202 gsL~~~l~~~~-----~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--~~  274 (549)
                      |+|.+++....     ..++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.......  ..
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            68999987532     356778889999999999999999999999999999999999999999999865432211  11


Q ss_pred             cccCCCCcccccccccCC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc-CCCC-----CCccC
Q psy18060        275 TSIKGTPLYMAPELIAER-------PYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKT-QDVT-----FPSQV  340 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~-------~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~-~~~~-----~p~~~  340 (549)
                      ....|++.|+|||++.+.       .++.++|||||||++|+|++ |+.||......+....... ....     .+...
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL  239 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence            234578889999998542       35789999999999999996 9999987766555433222 1121     12246


Q ss_pred             CHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        341 SETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       341 s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ++.+.+++.+|+ .+|.+|||+++|+.
T Consensus       240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         240 SDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            889999999999 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0669|consensus

Probab=100.00  E-value=1.1e-40  Score=316.86  Aligned_cols=260  Identities=31%  Similarity=0.524  Sum_probs=213.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-------
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-------  189 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-------  189 (549)
                      ....|....+||+|.||.|++|+.+++|+.||+|++--......-.....+|+++|..++|+|++.+++.|..       
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            3456888899999999999999999999999998753221111112344689999999999999998875532       


Q ss_pred             -CCEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceec
Q psy18060        190 -LNEFVLITEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       190 -~~~~~iV~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~  267 (549)
                       ...+|+||.+|..+|..+|... .+++..+++.++.+++.||.|+|++.|+|||+||+|+||+.+|.+||+|||+++.+
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f  174 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF  174 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence             2358999999999999999876 68999999999999999999999999999999999999999999999999999766


Q ss_pred             ccCc----ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C-------
Q psy18060        268 AVGT----HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--D-------  333 (549)
Q Consensus       268 ~~~~----~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~-------  333 (549)
                      ....    ...+..+-|.+|++||.+.+ ..|+.+.|||+.|||+.||+||.+-+.+.+..+.+..|..-  .       
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP  254 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP  254 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence            4322    22455677999999999876 67999999999999999999999999999887777665321  0       


Q ss_pred             ----------C---CCCc-------------cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        334 ----------V---TFPS-------------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       334 ----------~---~~p~-------------~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                                +   ++|.             .-.+++.+|+.++|..||.+|+.+.++++|.||.....
T Consensus       255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence                      0   1111             01457889999999999999999999999999975443

>KOG0587|consensus

Probab=100.00  E-value=3.1e-38  Score=342.31  Aligned_cols=258  Identities=32%  Similarity=0.543  Sum_probs=225.8

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEe----
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHE----  188 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~----  188 (549)
                      .....+.|++...||.|.+|.||++.++++++..|+|+......   ....++.|.+|++.+ .|||++.+|++|.    
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            34445679999999999999999999999999999999875432   335667888999888 6999999999884    


Q ss_pred             -eCCEEEEEEecCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccc
Q psy18060        189 -TLNEFVLITEFAH-MSLSNLLEQ--RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA  264 (549)
Q Consensus       189 -~~~~~~iV~E~~~-gsL~~~l~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla  264 (549)
                       .++.+|||||||+ ||.-++++.  ..++.|..+..|++.++.||.+||++.++|||||=.|||++.+|.|||+|||.+
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence             3568999999999 588888765  467899999999999999999999999999999999999999999999999999


Q ss_pred             eecccCcccccccCCCCcccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---C
Q psy18060        265 RSMAVGTHMLTSIKGTPLYMAPELIAE-----RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT---F  336 (549)
Q Consensus       265 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~  336 (549)
                      ..........++.+|||+|||||++..     ..|+..+|+||||++..||.-|.+|+-..-+...+-.|...+++   -
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr  250 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR  250 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence            988777677788899999999999843     45888999999999999999999999988888777766555432   3


Q ss_pred             CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        337 PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       337 p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      |..|++++.+||..||.+|..+||+..++|+|||++..
T Consensus       251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            56799999999999999999999999999999999854

>KOG1095|consensus

Probab=100.00  E-value=5.2e-38  Score=353.13  Aligned_cols=249  Identities=24%  Similarity=0.415  Sum_probs=217.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCc-----eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      -..-.+.+.||+|.||.||.|.......     .||+|.+.+. .+......|.+|..+|+.++|||||+++|++-+...
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            3456788999999999999998765443     3999998654 345667899999999999999999999999988999


Q ss_pred             EEEEEecCC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccc
Q psy18060        193 FVLITEFAH-MSLSNLLEQR-------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA  264 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~-------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla  264 (549)
                      .+|++|||. |+|..+|++.       ..++..+...++.||++|.+||+++++|||||..+|+||+....|||+|||+|
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence            999999987 6999999875       34889999999999999999999999999999999999999999999999999


Q ss_pred             eecccCcccccccC--CCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHH-HHhcCCCCCCccC
Q psy18060        265 RSMAVGTHMLTSIK--GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIR-LLKTQDVTFPSQV  340 (549)
Q Consensus       265 ~~~~~~~~~~~~~~--GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~-~i~~~~~~~p~~~  340 (549)
                      +.+-..........  -...|||||.+..+.++.|+|||||||+|||++| |..||...+..++.. ....++++.|+.+
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~C  929 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYC  929 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCC
Confidence            95543322222211  2357999999999999999999999999999998 999999999888887 5666778889999


Q ss_pred             CHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        341 SETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       341 s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      |..+.++|..||+.+|++||++..|++
T Consensus       930 P~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  930 PEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ChHHHHHHHHHccCChhhCccHHHHHh
Confidence            999999999999999999999999987

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-37  Score=313.31  Aligned_cols=248  Identities=27%  Similarity=0.434  Sum_probs=204.3

Q ss_pred             cceeEEEEEecCCcEEEEEEEEc----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--CCE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHL----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--LNE  192 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~  192 (549)
                      ..|++.+.||+|+||.||+|...    .++..+|+|.+...... .....+.+|+++++.+.||||+++++++..  ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            46788899999999999999864    34789999999765433 345688999999999999999999998876  567


Q ss_pred             EEEEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        193 FVLITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      .+++|||+. ++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            899999997 58999997754 6899999999999999999999999999999999999999999999999999876532


Q ss_pred             ccc---ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHhcC
Q psy18060        271 THM---LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL---------------HLIRLLKTQ  332 (549)
Q Consensus       271 ~~~---~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~---------------~~~~~i~~~  332 (549)
                      ...   .....++..|+|||.+.+..++.++|||||||++++|++|..||......               .....+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG  242 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence            211   11234566799999998888999999999999999999999998653221               122222222


Q ss_pred             -CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        333 -DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       333 -~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                       ....|..++.++.+++.+||..+|.+|||+.|++.
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             22344567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1006|consensus

Probab=100.00  E-value=1.6e-39  Score=311.18  Aligned_cols=256  Identities=30%  Similarity=0.476  Sum_probs=211.8

Q ss_pred             eEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHH-HHhcCCCCeeEEEEEEeeCCEEEEEEecC
Q psy18060        122 QKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI-QKHLAHPNIIKFIASHETLNEFVLITEFA  200 (549)
Q Consensus       122 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~iV~E~~  200 (549)
                      +-+..||.|+||+|++-.++.+|+..|||.++.... .++...++.|... ++.-++||||++|+.....+..||.||++
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            345679999999999999999999999999976544 4556677777775 45558999999999988888889999999


Q ss_pred             CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        201 HMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       201 ~gsL~~~l~-----~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      .-||..+.+     +...++|..+..|....+.||+||... .|||||+||+|||++..|.|||||||++..+..+ -..
T Consensus       146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-iAk  224 (361)
T KOG1006|consen  146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-IAK  224 (361)
T ss_pred             hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH-HHh
Confidence            987665543     356799999999999999999999764 8999999999999999999999999998765433 223


Q ss_pred             cccCCCCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCCC---CCc---cCCHHHH
Q psy18060        275 TSIKGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVT---FPS---QVSETYK  345 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~~~-~~~~~~~i~~~~~~---~p~---~~s~~~~  345 (549)
                      +.-.|-..|||||.+..  ..|+.++|+||||++|||+.||..|+...+ ..+.+..+..+.++   ++.   .++..+.
T Consensus       225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~  304 (361)
T KOG1006|consen  225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMV  304 (361)
T ss_pred             hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHH
Confidence            44578899999999943  459999999999999999999999998764 44555556666543   222   3789999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcCcccCcccchhh
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~~~  379 (549)
                      .||+-||.+|-..||+..+++++||.+.......
T Consensus       305 ~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~  338 (361)
T KOG1006|consen  305 RFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGP  338 (361)
T ss_pred             HHHHHHhhcccccCcchhhhhcCchhhhhhhcCC
Confidence            9999999999999999999999999987654433

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.4e-37  Score=307.81  Aligned_cols=240  Identities=20%  Similarity=0.318  Sum_probs=191.6

Q ss_pred             EEecCCcEEEEEEEEcCCC--ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-C
Q psy18060        126 LIGEGSFGKVFKAIHLDLK--KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-M  202 (549)
Q Consensus       126 ~iG~G~fg~Vy~~~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-g  202 (549)
                      .||+|+||.||++.....+  ..+++|.+.... .......+.+|+.+++.++||||+++++.+......++||||+. |
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            5899999999999754332  345666654432 23445678999999999999999999999999999999999998 5


Q ss_pred             CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc--ccccc
Q psy18060        203 SLSNLLEQR----KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTS  276 (549)
Q Consensus       203 sL~~~l~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~--~~~~~  276 (549)
                      +|.+++.+.    ..+++..+..++.||+.||+|||+.|++||||||+|||++.++.++|+|||++.......  .....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  160 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD  160 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence            999999764    346777888999999999999999999999999999999999999999999986432211  11234


Q ss_pred             cCCCCcccccccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC------CCCCccCCH
Q psy18060        277 IKGTPLYMAPELIAE-------RPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD------VTFPSQVSE  342 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~-------~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~  342 (549)
                      ..|++.|+|||++..       ..++.++|||||||++|||++ |..||...+..+....+....      ..++..+++
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd05086         161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE  240 (268)
T ss_pred             CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence            568899999999743       345789999999999999997 678998777766665543321      223345789


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .+.+++..|| .+|.+||++++|++
T Consensus       241 ~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         241 RWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHHHHHHHHh-hCcccCCCHHHHHH
Confidence            9999999999 68999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0671|consensus

Probab=100.00  E-value=9.1e-39  Score=319.94  Aligned_cols=254  Identities=26%  Similarity=0.430  Sum_probs=210.0

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC--CCC----eeEEEEEEe
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA--HPN----IIKFIASHE  188 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpn----Iv~l~~~~~  188 (549)
                      .....+|.++..+|+|.||.|-+|.+..++..+|+|+++..   .+..++.+-|+++++++.  .|+    +|++.+||.
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            33468899999999999999999999999999999999653   233456677899999983  232    688889999


Q ss_pred             eCCEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec--------------
Q psy18060        189 TLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK--------------  252 (549)
Q Consensus       189 ~~~~~~iV~E~~~gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~--------------  252 (549)
                      -.++.+||+|.++-|+.+.+..++  +++...++.++.||+.++++||+.+++|-||||+|||+.+              
T Consensus       162 yrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  162 YRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             ccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence            999999999999989999998864  6899999999999999999999999999999999999943              


Q ss_pred             ------CCcEEEeecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--
Q psy18060        253 ------DGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH--  324 (549)
Q Consensus       253 ------~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~--  324 (549)
                            +..|+++|||.|+....   ..++.+.|..|+|||++.+-+++.++||||+||||+||+||...|++.+..+  
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             eeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                  22589999999976542   2367789999999999999999999999999999999999999999877444  


Q ss_pred             -HHHHHhcC------------------CCCCCcc-------------------------CCHHHHHHHHHhchhCcCCCC
Q psy18060        325 -LIRLLKTQ------------------DVTFPSQ-------------------------VSETYKDLVKGLLEKDASQRL  360 (549)
Q Consensus       325 -~~~~i~~~------------------~~~~p~~-------------------------~s~~~~dlI~~~L~~dP~~Rp  360 (549)
                       ..++|...                  .+..|..                         .-.++.|||++||..||.+|+
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence             33333211                  1111110                         112467999999999999999


Q ss_pred             CHHHHhcCcccCcc
Q psy18060        361 SWPELLHHPLVKDN  374 (549)
Q Consensus       361 s~~elL~Hpw~~~~  374 (549)
                      |+.|+|.||||+..
T Consensus       399 Tl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  399 TLREALSHPFFARL  412 (415)
T ss_pred             cHHHHhcCHHhhcC
Confidence            99999999999753

>KOG1151|consensus

Probab=100.00  E-value=1.8e-38  Score=321.02  Aligned_cols=259  Identities=29%  Similarity=0.482  Sum_probs=217.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHH-----HHHHHHHHHHHHhcCCCCeeEEEEEEe-eC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-----LSSLKQECEIQKHLAHPNIIKFIASHE-TL  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~  190 (549)
                      ..++|-++..||+|||+.||++.+....+.||+|+-........+     .....+|..|.+.|.||.||++|++|. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            346799999999999999999999999999999997554432222     345668999999999999999999985 55


Q ss_pred             CEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCccccccCCcEEEec---CCcEEEeecccc
Q psy18060        191 NEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSN--RVLHRDLKPQNVLLNK---DGVAMLCDFGFA  264 (549)
Q Consensus       191 ~~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~--gIiHrDIKP~NILl~~---~g~vKL~DFGla  264 (549)
                      +.++-|+|||+| +|.-+|++++-++|.+++.|+.||+.||.||.+.  .|||-||||.|||+-.   -|.+||+|||++
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            678999999998 7999999999999999999999999999999976  6999999999999954   378999999999


Q ss_pred             eecccCcc-------cccccCCCCccccccccc----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHH---HH
Q psy18060        265 RSMAVGTH-------MLTSIKGTPLYMAPELIA----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIR---LL  329 (549)
Q Consensus       265 ~~~~~~~~-------~~~~~~GT~~Y~APE~l~----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~-~~~~---~i  329 (549)
                      +.+..+..       ......||.||++||.+.    ..+.+.|+||||+|||+|.++.|+.||...... .+++   .+
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            98865432       234568999999999984    345789999999999999999999999765432 2222   23


Q ss_pred             hcCCCCCC--ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        330 KTQDVTFP--SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       330 ~~~~~~~p--~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ....+.||  +.++.++++||++||+...++|..+.++..||+|....
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~  748 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI  748 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence            44455666  56999999999999999999999999999999997643

>KOG0665|consensus

Probab=100.00  E-value=1.6e-37  Score=304.74  Aligned_cols=253  Identities=28%  Similarity=0.449  Sum_probs=216.3

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC----
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN----  191 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----  191 (549)
                      ....+|.-++.+|.|.- .|.-+.+.-+++.||+|.+.....+........+|...+..++|+||++++.+|....    
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            34567888999999999 7888889899999999998776555555667789999999999999999999985543    


Q ss_pred             --EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceeccc
Q psy18060        192 --EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV  269 (549)
Q Consensus       192 --~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~  269 (549)
                        .+|+|||++..+|...+.  ..++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+....
T Consensus        93 ~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   93 FQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             HHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence              579999999999999987  5678888999999999999999999999999999999999999999999999987665


Q ss_pred             CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----------------
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD----------------  333 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~----------------  333 (549)
                      . -..+..+.|.+|+|||++.+..|...+||||+||++.||++|+..|++.+..+...++...-                
T Consensus       171 ~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  171 D-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             c-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            4 45677889999999999999889999999999999999999999999877665554442110                


Q ss_pred             -----------C----CCCc-----------cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        334 -----------V----TFPS-----------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       334 -----------~----~~p~-----------~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                                 .    .+|+           .-+..+++++.+||..||++|.|++++|+|||++
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                       0    1121           1234678999999999999999999999999998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.4e-36  Score=292.43  Aligned_cols=239  Identities=41%  Similarity=0.683  Sum_probs=210.3

Q ss_pred             CcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCCC-CHHHHHH
Q psy18060        131 SFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLE  209 (549)
Q Consensus       131 ~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~g-sL~~~l~  209 (549)
                      +||.||+|....+++.+|+|++........ ...+.+|++.+++++||||+++++.+......++++|++++ +|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            589999999998899999999876443221 57889999999999999999999999988999999999986 9999998


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCcccccccc
Q psy18060        210 QRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI  289 (549)
Q Consensus       210 ~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l  289 (549)
                      ....+++..+..++.+++.||.|||+.|++|+||+|.||+++.++.++|+|||.+....... ......|+..|+|||.+
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHH
Confidence            87779999999999999999999999999999999999999999999999999998765432 33455689999999999


Q ss_pred             cCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCCcc---CCHHHHHHHHHhchhCcCCCCCHHHH
Q psy18060        290 AERPYDHTADLWSLGCIAYEIHMGHPPFKT-VSILHLIRLLKTQDVTFPSQ---VSETYKDLVKGLLEKDASQRLSWPEL  365 (549)
Q Consensus       290 ~~~~y~~ksDIwSlGvil~eLltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~dlI~~~L~~dP~~Rps~~el  365 (549)
                      .+..++.++||||||+++++|++|..||.. .........+.......+..   ++.++.+++.+||..+|.+||++.++
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  238 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA  238 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence            888899999999999999999999999988 66666666666555443333   88999999999999999999999999


Q ss_pred             hcCccc
Q psy18060        366 LHHPLV  371 (549)
Q Consensus       366 L~Hpw~  371 (549)
                      ++||||
T Consensus       239 ~~~~~~  244 (244)
T smart00220      239 LQHPFF  244 (244)
T ss_pred             hhCCCC
Confidence            999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4250|consensus

Probab=100.00  E-value=2.3e-37  Score=330.19  Aligned_cols=240  Identities=33%  Similarity=0.510  Sum_probs=197.3

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC------E
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN------E  192 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------~  192 (549)
                      ..|..-+.||+|+||.||+++++.+|..||||.+.+.. .....+...+|++++++++|||||++.++-++..      .
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            44667788999999999999999999999999997754 3345677889999999999999999998865543      4


Q ss_pred             EEEEEecCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC--C--cEEEeecccc
Q psy18060        193 FVLITEFAH-MSLSNLLEQ---RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD--G--VAMLCDFGFA  264 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~---~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~--g--~vKL~DFGla  264 (549)
                      ..++||||. |||+..+++   ..+++|.+...++..+..||.|||++||+||||||.||++-..  |  .-||+|||.|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            679999998 699999975   4579999999999999999999999999999999999999533  3  5799999999


Q ss_pred             eecccCcccccccCCCCccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcC-------
Q psy18060        265 RSMAVGTHMLTSIKGTPLYMAPELIA-ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI----LHLIRLLKTQ-------  332 (549)
Q Consensus       265 ~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~----~~~~~~i~~~-------  332 (549)
                      +....+. ..++.+||+.|.+||++. .+.|+..+|.|||||++|++.||..||.....    .++.-.+.++       
T Consensus       172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i  250 (732)
T KOG4250|consen  172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI  250 (732)
T ss_pred             ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence            9887664 678999999999999998 48899999999999999999999999954321    2233222221       


Q ss_pred             --------------CCCCCccCCHH----HHHHHHHhchhCcCCCC
Q psy18060        333 --------------DVTFPSQVSET----YKDLVKGLLEKDASQRL  360 (549)
Q Consensus       333 --------------~~~~p~~~s~~----~~dlI~~~L~~dP~~Rp  360 (549)
                                    .+++|..+++.    +...+..+|..+|.+|.
T Consensus       251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                          12334444443    34678889999999998

>KOG4257|consensus

Probab=100.00  E-value=1.8e-36  Score=317.01  Aligned_cols=242  Identities=28%  Similarity=0.431  Sum_probs=207.0

Q ss_pred             EEEEEecCCcEEEEEEEEcCC----CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        123 KICLIGEGSFGKVFKAIHLDL----KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       123 ~~~~iG~G~fg~Vy~~~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      +.+.||.|.||.||+|.....    +-.||||.-+.. ......+.|.+|.-+|++++||||++++|++.+ ...+||||
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            345799999999999976433    235888887553 334446789999999999999999999999975 46899999


Q ss_pred             cCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        199 FAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ++. |.|+.+|+.++ .++......++.||+.||.|||+.++|||||...|||+.....|||+|||++|.+........+
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS  550 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS  550 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcc
Confidence            998 88999998764 5899999999999999999999999999999999999999999999999999988755433222


Q ss_pred             -cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhch
Q psy18060        277 -IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       277 -~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~  353 (549)
                       ..-..-|||||-+.-..++.++|||-|||++||++. |..||.+....+.+-.|.++ +++.|+++|+.+..++.+||.
T Consensus       551 ~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWa  630 (974)
T KOG4257|consen  551 RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWA  630 (974)
T ss_pred             ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhc
Confidence             122456999999999999999999999999999885 99999998888887777666 467889999999999999999


Q ss_pred             hCcCCCCCHHHHh
Q psy18060        354 KDASQRLSWPELL  366 (549)
Q Consensus       354 ~dP~~Rps~~elL  366 (549)
                      .+|.+||++.|+.
T Consensus       631 yeP~kRPrftei~  643 (974)
T KOG4257|consen  631 YEPSKRPRFTEIK  643 (974)
T ss_pred             cCcccCCcHHHHH
Confidence            9999999987653

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=8.8e-36  Score=329.17  Aligned_cols=254  Identities=23%  Similarity=0.326  Sum_probs=178.4

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCC----CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEE-----
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDL----KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS-----  186 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-----  186 (549)
                      ...++|++.+.||+|+||.||+|.+..+    +..||+|.+......    ....++  .++...+.+++.+...     
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            3567899999999999999999999998    899999987643211    111111  1112222222222211     


Q ss_pred             -EeeCCEEEEEEecCC-CCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCcccccc
Q psy18060        187 -HETLNEFVLITEFAH-MSLSNLLEQRKK--------------------LSETICVQILSNLISALYYLHSNRVLHRDLK  244 (549)
Q Consensus       187 -~~~~~~~~iV~E~~~-gsL~~~l~~~~~--------------------l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIK  244 (549)
                       .......++||||++ ++|.+++.....                    ..+..+..++.||+.||.|||++||+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             245567899999998 589998875421                    1234467899999999999999999999999


Q ss_pred             CCcEEEec-CCcEEEeecccceecccCc-ccccccCCCCcccccccccCC----------------------CCCcchhh
Q psy18060        245 PQNVLLNK-DGVAMLCDFGFARSMAVGT-HMLTSIKGTPLYMAPELIAER----------------------PYDHTADL  300 (549)
Q Consensus       245 P~NILl~~-~g~vKL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~----------------------~y~~ksDI  300 (549)
                      |+|||++. ++.+||+|||+|+....+. .......||+.|||||++...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 5899999999998654322 233556899999999976322                      24456799


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----------CC----------ccCCHHHHHHHHHhchhCcCCC
Q psy18060        301 WSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-----------FP----------SQVSETYKDLVKGLLEKDASQR  359 (549)
Q Consensus       301 wSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~-----------~p----------~~~s~~~~dlI~~~L~~dP~~R  359 (549)
                      |||||++|||+++..|+... .......+......           .+          ...+....+||.+||++||.+|
T Consensus       363 wSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            99999999999977665432 11111112111110           00          1123345689999999999999


Q ss_pred             CCHHHHhcCcccCcccc
Q psy18060        360 LSWPELLHHPLVKDNLS  376 (549)
Q Consensus       360 ps~~elL~Hpw~~~~~~  376 (549)
                      ||+.|+|+||||.....
T Consensus       442 ~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        442 ISAKAALAHPYFDREGL  458 (566)
T ss_pred             CCHHHHhCCcCcCCCCc
Confidence            99999999999986543

>KOG0670|consensus

Probab=100.00  E-value=5.6e-37  Score=315.57  Aligned_cols=250  Identities=28%  Similarity=0.462  Sum_probs=213.6

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC------CCCeeEEEEEEeeCCE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA------HPNIIKFIASHETLNE  192 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~~~~~~~~  192 (549)
                      .+|.+....|+|-|++|..|.+...|+.||||+|....   -....=+.|++||++|+      --|+++++..|...++
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            67899999999999999999999999999999997643   22344578999999995      2378999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC-CcEEEeecccceecc
Q psy18060        193 FVLITEFAHMSLSNLLEQRK---KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMA  268 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~-g~vKL~DFGla~~~~  268 (549)
                      +|||+|.+..+|.++|++.+   .+....++.++.|+..||..|...||+|.||||.|||+++. ..+||||||.|...+
T Consensus       509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~  588 (752)
T KOG0670|consen  509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFAS  588 (752)
T ss_pred             eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccc
Confidence            99999999999999999854   58888999999999999999999999999999999999876 578999999997665


Q ss_pred             cCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc----------
Q psy18060        269 VGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----------  338 (549)
Q Consensus       269 ~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~----------  338 (549)
                      ..  ..+.+.-+.+|.|||++.|-+|+...|+||+||+||||+||+..|++.+..++++........+|.          
T Consensus       589 en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~d  666 (752)
T KOG0670|consen  589 EN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKD  666 (752)
T ss_pred             cc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhh
Confidence            33  334455677899999999999999999999999999999999999999888887765332222221          


Q ss_pred             --------------------------------------------------cCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        339 --------------------------------------------------QVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       339 --------------------------------------------------~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                                                                        .+-..+++|+.+||..||++|.|+.|+|.|
T Consensus       667 qHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  667 QHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             hhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence                                                              012457899999999999999999999999


Q ss_pred             cccCc
Q psy18060        369 PLVKD  373 (549)
Q Consensus       369 pw~~~  373 (549)
                      |||+.
T Consensus       747 pFi~~  751 (752)
T KOG0670|consen  747 PFITE  751 (752)
T ss_pred             CcccC
Confidence            99964

>KOG4278|consensus

Probab=100.00  E-value=6.5e-36  Score=312.19  Aligned_cols=242  Identities=24%  Similarity=0.462  Sum_probs=216.6

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecC
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA  200 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~  200 (549)
                      ..+-.+||.|.||.||.|.+++-...||||.++..   ..+...|+.|+.+|+.++|||+|++.++|...-.+|||+||+
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            45567899999999999999999999999998643   356788999999999999999999999999999999999997


Q ss_pred             C-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccccc
Q psy18060        201 H-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       201 ~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                      . |+|.++|+.-  ..++.-...+++.||..|+.||..+++|||||...|.|+.++..||++|||+++.+..++  .+..
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT--YTAH  423 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT--YTAH  423 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc--eecc
Confidence            6 8999999863  457888889999999999999999999999999999999999999999999999987654  3444


Q ss_pred             CC---CCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhc
Q psy18060        278 KG---TPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       278 ~G---T~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L  352 (549)
                      .|   ..-|.|||-+....++.|+|||+|||+|||+.| |..||++.+..+++..+..+ +..-|..+++...+|++.||
T Consensus       424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW  503 (1157)
T KOG4278|consen  424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACW  503 (1157)
T ss_pred             cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHh
Confidence            45   455999999998899999999999999999998 99999999999999888665 45678899999999999999


Q ss_pred             hhCcCCCCCHHHHhc
Q psy18060        353 EKDASQRLSWPELLH  367 (549)
Q Consensus       353 ~~dP~~Rps~~elL~  367 (549)
                      +..|.+||++.|+-+
T Consensus       504 ~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  504 NWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             cCCcccCccHHHHHH
Confidence            999999999988743

>KOG1290|consensus

Probab=100.00  E-value=2.9e-35  Score=301.81  Aligned_cols=253  Identities=24%  Similarity=0.388  Sum_probs=200.0

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-----C---CCeeEEEEEEe--
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-----H---PNIIKFIASHE--  188 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~l~~~~~--  188 (549)
                      .+|.+.++||.|.|++||+|.+..+.+.||+|+.+...   .-.+....||++|++++     |   .+||++++.|.  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            68999999999999999999999999999999986432   33456788999999883     3   36999999885  


Q ss_pred             --eCCEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecC----------
Q psy18060        189 --TLNEFVLITEFAHMSLSNLLEQR--KKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKD----------  253 (549)
Q Consensus       189 --~~~~~~iV~E~~~gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~----------  253 (549)
                        ++.++++|+|+++.+|..+|...  +.++...+++|++||+.||.|||.+ ||||-||||+|||+..+          
T Consensus       155 GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~  234 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDARE  234 (590)
T ss_pred             CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhh
Confidence              45689999999999999999864  6799999999999999999999986 99999999999999320          


Q ss_pred             --------------------------------------------------------------------------------
Q psy18060        254 --------------------------------------------------------------------------------  253 (549)
Q Consensus       254 --------------------------------------------------------------------------------  253 (549)
                                                                                                      
T Consensus       235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~  314 (590)
T KOG1290|consen  235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES  314 (590)
T ss_pred             hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence                                                                                            


Q ss_pred             ----------------------------------------------------------------------------CcEE
Q psy18060        254 ----------------------------------------------------------------------------GVAM  257 (549)
Q Consensus       254 ----------------------------------------------------------------------------g~vK  257 (549)
                                                                                                  -.||
T Consensus       315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK  394 (590)
T KOG1290|consen  315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK  394 (590)
T ss_pred             chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence                                                                                        0145


Q ss_pred             EeecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-------HH---HHHH
Q psy18060        258 LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-------IL---HLIR  327 (549)
Q Consensus       258 L~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~-------~~---~~~~  327 (549)
                      |+|||-|+-..   ...|.-..|..|+|||++.+..|+..+||||++|++|||+||.+.|...+       ..   .+++
T Consensus       395 IaDlGNACW~~---khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~E  471 (590)
T KOG1290|consen  395 IADLGNACWVH---KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIME  471 (590)
T ss_pred             Eeeccchhhhh---hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHH
Confidence            55555554322   22344567899999999999999999999999999999999999996532       11   1222


Q ss_pred             HHh--------cC------------------------------CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCc
Q psy18060        328 LLK--------TQ------------------------------DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHP  369 (549)
Q Consensus       328 ~i~--------~~------------------------------~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hp  369 (549)
                      .+-        .+                              .+.+|..-..++.+|+.-||+.+|++||||.++|+||
T Consensus       472 LLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hP  551 (590)
T KOG1290|consen  472 LLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHP  551 (590)
T ss_pred             HHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCc
Confidence            110        01                              1112222345678999999999999999999999999


Q ss_pred             ccCcccch
Q psy18060        370 LVKDNLSS  377 (549)
Q Consensus       370 w~~~~~~~  377 (549)
                      |+.....+
T Consensus       552 wLn~~~~~  559 (590)
T KOG1290|consen  552 WLNPVAGP  559 (590)
T ss_pred             cccCCCCC
Confidence            99876553

>KOG0196|consensus

Probab=100.00  E-value=3.3e-36  Score=322.38  Aligned_cols=265  Identities=26%  Similarity=0.431  Sum_probs=228.7

Q ss_pred             ccCCCccccccccccc---------cceeEEEEEecCCcEEEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHH
Q psy18060        103 HNHCQPVKMEKSNGAL---------EKYQKICLIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECE  170 (549)
Q Consensus       103 ~~~~~~~~~~~~~~~~---------~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~Ei~  170 (549)
                      +....|...++.+...         ....+.++||.|.||.|++|+.+..++   .||||.++. ....+....|+.|+.
T Consensus       604 k~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAs  682 (996)
T KOG0196|consen  604 KTYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEAS  682 (996)
T ss_pred             eeecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhh
Confidence            3344555555444333         445788999999999999999887764   599999854 456677789999999


Q ss_pred             HHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcE
Q psy18060        171 IQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNV  248 (549)
Q Consensus       171 il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NI  248 (549)
                      ||.++.||||+++-++......+.||+|||. |+|..+|+++ +.|+..++.-+++.|+.|++||-++|+|||||...||
T Consensus       683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNI  762 (996)
T KOG0196|consen  683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNI  762 (996)
T ss_pred             hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhhe
Confidence            9999999999999999999999999999997 8999999876 6799999999999999999999999999999999999


Q ss_pred             EEecCCcEEEeecccceecccCccc-ccccCC--CCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy18060        249 LLNKDGVAMLCDFGFARSMAVGTHM-LTSIKG--TPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILH  324 (549)
Q Consensus       249 Ll~~~g~vKL~DFGla~~~~~~~~~-~~~~~G--T~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~  324 (549)
                      |++.+-.+|++|||++|....+... .++.-|  ..+|.|||.+..++++.++||||+|+++||.++ |..||...+..+
T Consensus       763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd  842 (996)
T KOG0196|consen  763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD  842 (996)
T ss_pred             eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence            9999999999999999987654422 233323  467999999999999999999999999999775 999999999999


Q ss_pred             HHHHHhcC-CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        325 LIRLLKTQ-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       325 ~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .++.|..+ +++.|..+|..+.+|+..||++|-..||++.||+.+
T Consensus       843 VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  843 VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            99998766 455667899999999999999999999999999865

>KOG0199|consensus

Probab=100.00  E-value=1.3e-35  Score=314.11  Aligned_cols=253  Identities=23%  Similarity=0.416  Sum_probs=217.4

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCC-c--eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLK-K--TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~-~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      +...+.+.||+|.||.|++|.+...+ +  .||||.+....... ....|.+|+.+|.+|+|||++++|++.-+ ..+.+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            34567789999999999999886543 2  58999997655443 67889999999999999999999999876 67889


Q ss_pred             EEecCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        196 ITEFAH-MSLSNLLEQ--RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      |||++. |+|.+.|.+  +..|.......++.||+.|+.||.++++|||||...|+|+-....|||||||+.+.++.+..
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            999998 799999987  34588888899999999999999999999999999999999999999999999998876543


Q ss_pred             ccc---ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHH
Q psy18060        273 MLT---SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDL  347 (549)
Q Consensus       273 ~~~---~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dl  347 (549)
                      ...   ...-...|+|||.+...+++.++|||++||++|||+| |..||.+....+++++|..+ .++.|+.+|+.+.++
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~i  347 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQI  347 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHH
Confidence            321   1223456999999999999999999999999999997 89999999999999998754 356778999999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      +..||+.+|++|||+..|...-++..
T Consensus       348 mk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  348 MKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             HHHhccCCccccccHHHHHHhHHHHh
Confidence            99999999999999988865544443

>KOG0664|consensus

Probab=100.00  E-value=2.9e-37  Score=296.40  Aligned_cols=253  Identities=27%  Similarity=0.450  Sum_probs=213.8

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-----EEEE
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----EFVL  195 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~i  195 (549)
                      .+-.+.||-|+||.||.+.+..+|+.+|+|.+.....+-..-..+-+|++++..++|.|++...+..+..+     .+|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34457899999999999999999999999998765544445567789999999999999999887665443     4688


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-ccc
Q psy18060        196 ITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-HML  274 (549)
Q Consensus       196 V~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-~~~  274 (549)
                      ++|++..+|..+|-.-..++...++-++.||+.||+|||+.||.||||||.|+|++.+..+||||||+|+...... ...
T Consensus       135 ~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM  214 (449)
T KOG0664|consen  135 LTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM  214 (449)
T ss_pred             HHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence            9999999999999988899999999999999999999999999999999999999999999999999999876543 223


Q ss_pred             cccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----------------------
Q psy18060        275 TSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT----------------------  331 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~----------------------  331 (549)
                      +..+-|-+|+|||++.+ ..|+.++||||+|||+.||+..+..|...++.+.++.|..                      
T Consensus       215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L  294 (449)
T KOG0664|consen  215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL  294 (449)
T ss_pred             HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence            55567899999999977 5699999999999999999999999998888777776632                      


Q ss_pred             -CCCCCCc-----------cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        332 -QDVTFPS-----------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       332 -~~~~~p~-----------~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                       +....|+           .-..+..+++.++|..||.+|.+.++.+.|+++..
T Consensus       295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence             1111121           12346778999999999999999999999999864

>KOG1094|consensus

Probab=100.00  E-value=2.2e-35  Score=307.41  Aligned_cols=246  Identities=23%  Similarity=0.358  Sum_probs=209.8

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      ...+.++||+|-||.|.+|.-.. +..||+|.++... .....+.|.+|+++|.+++|||||.+.++|..++.+++++||
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             heehhhhhcCcccceeEEEEecC-ceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            34677899999999999998654 6899999997543 344568899999999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc--c
Q psy18060        200 AH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--L  274 (549)
Q Consensus       200 ~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~--~  274 (549)
                      ++ |+|.+++..+.  .........|+.||+.|++||.+.++|||||.|.|+|++.++++||||||++|.+-.+...  .
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq  696 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ  696 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence            87 89999999873  3345556779999999999999999999999999999999999999999999876544322  1


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHhc----C----CCCCCccCCHHH
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH--MGHPPFKTVSILHLIRLLKT----Q----DVTFPSQVSETY  344 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLl--tG~~Pf~~~~~~~~~~~i~~----~----~~~~p~~~s~~~  344 (549)
                      ...+-...|||||.+.-++++.++|+|++|+++||++  +...||...+..+..+....    +    -+..|+.++..+
T Consensus       697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~l  776 (807)
T KOG1094|consen  697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGL  776 (807)
T ss_pred             cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHH
Confidence            2234567899999999999999999999999999987  57899999888887776432    1    234677899999


Q ss_pred             HHHHHHhchhCcCCCCCHHHHhc
Q psy18060        345 KDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .++|.+||.++-.+|||++++..
T Consensus       777 yelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  777 YELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHHHhchhhhcCCCHHHHHH
Confidence            99999999999999999999854

>KOG0668|consensus

Probab=100.00  E-value=7.7e-36  Score=280.50  Aligned_cols=250  Identities=26%  Similarity=0.457  Sum_probs=206.0

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeC--CE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETL--NE  192 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~  192 (549)
                      +..++|++.+.+|+|.|+.|+.|.+..+++.++||+++..     ....+.+|++||+.|. ||||+++++...+.  ..
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            4678899999999999999999999999999999998653     3457899999999997 99999999987554  45


Q ss_pred             EEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC-CcEEEeecccceecccC
Q psy18060        193 FVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVG  270 (549)
Q Consensus       193 ~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~-g~vKL~DFGla~~~~~~  270 (549)
                      ..+++|+.+. +...+   ...++...++.++.|++.||.|||++||+|||+||.|++|+.. -.++|+|+|+|....++
T Consensus       110 paLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            6799999875 44433   3468888999999999999999999999999999999999976 47999999999988766


Q ss_pred             cccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHh-------------cCCCC
Q psy18060        271 THMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFK-TVSILHLIRLLK-------------TQDVT  335 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~-~~~~~~~~~~i~-------------~~~~~  335 (549)
                      . ..+-.+.+.+|--||.+.. +.|+..-|+|||||++..|++.+.||. +.+..+++.+|.             .-.+.
T Consensus       187 ~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  187 K-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             c-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            4 3455678899999999865 668999999999999999999999984 333333333221             11111


Q ss_pred             CCc------------------------cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        336 FPS------------------------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       336 ~p~------------------------~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      +++                        -+++++.||+.++|..|-+.||||.|++.||||...
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            211                        257999999999999999999999999999999753

>KOG0576|consensus

Probab=100.00  E-value=9.1e-37  Score=322.14  Aligned_cols=263  Identities=29%  Similarity=0.505  Sum_probs=235.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      -.++|.++..+|+|.||.||+++++.+++..|+|+++...  ....+.+.+|+-+++..+|||||.+++.+-..+.++|+
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            3467999999999999999999999999999999997643  34456788999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      ||||+ |+|.+.-.--+.++|.++..+++..++||+|||++|=+|||||-.|||+++.|.||++|||.+..++.......
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            99999 58999888889999999999999999999999999999999999999999999999999999987766555667


Q ss_pred             ccCCCCcccccccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-----ccCCHHHHHH
Q psy18060        276 SIKGTPLYMAPELI---AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP-----SQVSETYKDL  347 (549)
Q Consensus       276 ~~~GT~~Y~APE~l---~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~dl  347 (549)
                      ++.|||+|||||+.   ..+.|+..+|||++|+...|+---++|....-+.+......+..+..|     ..+++.+-+|
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence            88999999999986   467799999999999999999988999888888888887777665554     3689999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccCcccchhhhh
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~~~~~~~~~~  381 (549)
                      ++.+|.++|++|||++-+|+|||+..........
T Consensus       251 vK~altknpKkRptaeklL~h~fvs~~l~~rl~~  284 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAI  284 (829)
T ss_pred             HHHHhcCCCccCCChhhheeceeeccchhhHHHH
Confidence            9999999999999999999999998775544433

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.7e-34  Score=308.48  Aligned_cols=259  Identities=23%  Similarity=0.349  Sum_probs=187.9

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEc----------------CCCceEEEEEEecCCCChH------------HHHHHH
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHL----------------DLKKTVALKIISKSGRSGK------------ELSSLK  166 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~----------------~~~~~vAvK~i~~~~~~~~------------~~~~~~  166 (549)
                      ....++|.+.++||+|+||.||+|...                ..++.||||.+........            ......
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            345778999999999999999999752                2346799999864321100            011223


Q ss_pred             HHHHHHHhcCCCCe-----eEEEEEEee--------CCEEEEEEecCC-CCHHHHHHhcC--------------------
Q psy18060        167 QECEIQKHLAHPNI-----IKFIASHET--------LNEFVLITEFAH-MSLSNLLEQRK--------------------  212 (549)
Q Consensus       167 ~Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~iV~E~~~-gsL~~~l~~~~--------------------  212 (549)
                      .|+.++.+++|.++     +++++++..        ....++||||++ ++|.+++....                    
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46667777766554     566666532        346799999998 58988886421                    


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc-cccCCCCcccccc
Q psy18060        213 ----KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML-TSIKGTPLYMAPE  287 (549)
Q Consensus       213 ----~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~-~~~~GT~~Y~APE  287 (549)
                          .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....+.... ....+|+.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence                23566788999999999999999999999999999999999999999999997654332111 1223589999999


Q ss_pred             cccCCC--------------------CC--cchhhHHHHHHHHHHHhCCC-CCCCCCH-----------HHHHHHHhcCC
Q psy18060        288 LIAERP--------------------YD--HTADLWSLGCIAYEIHMGHP-PFKTVSI-----------LHLIRLLKTQD  333 (549)
Q Consensus       288 ~l~~~~--------------------y~--~ksDIwSlGvil~eLltG~~-Pf~~~~~-----------~~~~~~i~~~~  333 (549)
                      ++....                    |+  .+.||||+||++++|++|.. ||.....           ....+.+....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            985422                    22  24799999999999999875 7754211           11112222333


Q ss_pred             CCCC--ccCCHHHHHHHHHhchhCc---CCCCCHHHHhcCcccCc
Q psy18060        334 VTFP--SQVSETYKDLVKGLLEKDA---SQRLSWPELLHHPLVKD  373 (549)
Q Consensus       334 ~~~p--~~~s~~~~dlI~~~L~~dP---~~Rps~~elL~Hpw~~~  373 (549)
                      +.++  +..++.+++|+.+||.++|   .+|+|++|+|+||||..
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            3333  5678999999999999876   68999999999999964

>KOG1027|consensus

Probab=100.00  E-value=2.5e-35  Score=318.55  Aligned_cols=241  Identities=31%  Similarity=0.488  Sum_probs=197.1

Q ss_pred             EEEecCCcEE-EEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEEecCCC
Q psy18060        125 CLIGEGSFGK-VFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLITEFAHM  202 (549)
Q Consensus       125 ~~iG~G~fg~-Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~E~~~g  202 (549)
                      +++|.|+-|+ ||+|...  |+.||||++-.     .......+|+..++.- .|||||++|+.-.+....||..|+|..
T Consensus       515 eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~  587 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE--GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC  587 (903)
T ss_pred             HHcccCCCCcEEEEEeeC--CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence            5688998885 5899876  78999998854     3345678999998887 699999999999999999999999999


Q ss_pred             CHHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec---CC--cEEEeecccceecccCccc
Q psy18060        203 SLSNLLEQRK-K---LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK---DG--VAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       203 sL~~~l~~~~-~---l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~---~g--~vKL~DFGla~~~~~~~~~  273 (549)
                      +|.++++... .   ......+.++.|++.||++||+.+||||||||.||||+.   ++  .++|+|||+++.+..+...
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS  667 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS  667 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence            9999998741 1   111345788999999999999999999999999999986   34  6899999999988765433


Q ss_pred             ---ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcCCCCCC---ccCCHHHHH
Q psy18060        274 ---LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMG-HPPFKTVSILHLIRLLKTQDVTFP---SQVSETYKD  346 (549)
Q Consensus       274 ---~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~~d  346 (549)
                         ..+..||-+|+|||++....-+.++|||||||++|..++| ..||...-  +....|.++...+-   +....++.+
T Consensus       668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~d~eA~d  745 (903)
T KOG1027|consen  668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEPLPDCEAKD  745 (903)
T ss_pred             hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeeccCchHHHHH
Confidence               3456799999999999988888899999999999999985 99996532  22334555544322   111228999


Q ss_pred             HHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        347 LVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ||.+||.++|..||+|.+||.||+|=+.
T Consensus       746 LI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  746 LISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             HHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            9999999999999999999999999654

>KOG0200|consensus

Probab=100.00  E-value=4.3e-33  Score=310.52  Aligned_cols=246  Identities=29%  Similarity=0.497  Sum_probs=210.7

Q ss_pred             eeEEEEEecCCcEEEEEEEEc---C----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCE
Q psy18060        121 YQKICLIGEGSFGKVFKAIHL---D----LKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNE  192 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~---~----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  192 (549)
                      ..+.+.||+|.||.|++|...   .    ....||||........ .....+..|+++++.+ .||||+.+.+++...+.
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            355669999999999999643   1    1457999998766554 6678899999999998 69999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV  255 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~  255 (549)
                      +++|+||+. |+|.++++.++                .++..+...++.||+.|++||++.++|||||...|||++.+..
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~  456 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV  456 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence            999999998 89999998766                3888999999999999999999999999999999999999999


Q ss_pred             EEEeecccceecccCcccc-cccCC--CCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHh
Q psy18060        256 AMLCDFGFARSMAVGTHML-TSIKG--TPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVS-ILHLIRLLK  330 (549)
Q Consensus       256 vKL~DFGla~~~~~~~~~~-~~~~G--T~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~-~~~~~~~i~  330 (549)
                      +||+|||+|+......... ....|  ...|||||.+....|+.++||||+||+|||++| |..||++.. .....+.+.
T Consensus       457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~  536 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLK  536 (609)
T ss_pred             EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHh
Confidence            9999999998655433322 22233  334999999999999999999999999999998 899999866 666677777


Q ss_pred             cCC-CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        331 TQD-VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       331 ~~~-~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .+. ...|..+++++.++++.||..+|.+||++.++..
T Consensus       537 ~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  537 EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            764 4678889999999999999999999999988754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.1e-33  Score=330.31  Aligned_cols=236  Identities=21%  Similarity=0.279  Sum_probs=187.8

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ..+.....||+|+||.||+|.+..++..||+|.+......      ...|++++++++|||||++++++.+.+..++|||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            3456677899999999999999989999999998643221      1346888999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        199 FAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLH---SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      |++ |+|.++++   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++..+++ ||.+.....    .
T Consensus       764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~  835 (968)
T PLN00113        764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----D  835 (968)
T ss_pred             CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----C
Confidence            997 68999986   4889999999999999999999   6699999999999999998888775 666543321    1


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhc---------CC----CCC
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-----ILHLIRLLKT---------QD----VTF  336 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~-----~~~~~~~i~~---------~~----~~~  336 (549)
                      ....||+.|||||++.+..++.++|||||||++|||+||+.||....     .....+....         ..    ...
T Consensus       836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (968)
T PLN00113        836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV  915 (968)
T ss_pred             CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence            23368999999999999999999999999999999999999985321     1111111100         00    011


Q ss_pred             CccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        337 PSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       337 p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +.....++.+++.+||+.||.+|||+.|+++.
T Consensus       916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            11123356789999999999999999999765

>KOG0984|consensus

Probab=100.00  E-value=1.5e-33  Score=261.56  Aligned_cols=211  Identities=27%  Similarity=0.457  Sum_probs=176.6

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHH-HhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ-KHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      ...+..||+|++|.|-+.++..+|...|+|.+... .+.+....+.+|+.+. +...+|.+|.||+.......++|.||.
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            44567899999999999999999999999999654 3445566778888874 556899999999998888899999999


Q ss_pred             CCCCHHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        200 AHMSLSNL----LEQRKKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       200 ~~gsL~~~----l~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      +.-||..+    +++.+.++|..+-+|+..++.||.|||++ .+||||+||+||||+.+|.|||||||++..+..+.. .
T Consensus       127 M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-k  205 (282)
T KOG0984|consen  127 MDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-K  205 (282)
T ss_pred             hhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH-H
Confidence            99877655    45677899999999999999999999987 899999999999999999999999999976654321 2


Q ss_pred             cccCCCCccccccccc----CCCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCC
Q psy18060        275 TSIKGTPLYMAPELIA----ERPYDHTADLWSLGCIAYEIHMGHPPFKTV-SILHLIRLLKTQD  333 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~-~~~~~~~~i~~~~  333 (549)
                      +-..|-..|||||.+.    ...|+.++||||||+++.||.+++.||... ++-+++..+...+
T Consensus       206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            3246788899999984    347999999999999999999999999754 5666666655443

>KOG1152|consensus

Probab=100.00  E-value=8.8e-34  Score=295.37  Aligned_cols=202  Identities=29%  Similarity=0.487  Sum_probs=179.7

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChH------HHHHHHHHHHHHHhcC---CCCeeEEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK------ELSSLKQECEIQKHLA---HPNIIKFIAS  186 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~---hpnIv~l~~~  186 (549)
                      ....+|..++.+|.|+||.|+.|.++.+...|+||.+.+.+.-..      .+-.+-.|++||..++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            345679999999999999999999999999999999987653211      1234567999999997   9999999999


Q ss_pred             EeeCCEEEEEEecCC-C-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccc
Q psy18060        187 HETLNEFVLITEFAH-M-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA  264 (549)
Q Consensus       187 ~~~~~~~~iV~E~~~-g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla  264 (549)
                      |++.+.+||+||.-+ | +|+++|+....++|.+++.|++|++.|+++||++||||||||-+|+.++.+|.+||+|||.|
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence            999999999999876 4 89999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eecccCcccccccCCCCcccccccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCC
Q psy18060        265 RSMAVGTHMLTSIKGTPLYMAPELIAERPYD-HTADLWSLGCIAYEIHMGHPPFKT  319 (549)
Q Consensus       265 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~-~ksDIwSlGvil~eLltG~~Pf~~  319 (549)
                      .....+  ....++||..|.|||++.+.+|- ..-|||+||++||-+.....||.+
T Consensus       718 a~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  718 AYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            766554  34667899999999999998885 568999999999999999999853

>KOG1025|consensus

Probab=99.97  E-value=6.1e-32  Score=290.50  Aligned_cols=244  Identities=25%  Similarity=0.409  Sum_probs=211.2

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      .+..++||+|+||+||+|.+...|+    +||+|++... ...+...++..|+-+|.+++|||++++++++.... +.||
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            3456789999999999999876665    5888887543 33444578899999999999999999999987665 7889


Q ss_pred             EecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        197 TEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ++|++ |+|.++++.+ ..+..+....|..||++|+.|||.++++||||...|+|+..-..|||.|||+|+...+.....
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            99998 7999999864 568889999999999999999999999999999999999999999999999999887665444


Q ss_pred             cccCC--CCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHH
Q psy18060        275 TSIKG--TPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKG  350 (549)
Q Consensus       275 ~~~~G--T~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~  350 (549)
                      +...|  .+-|||=|.+....|+.++||||+||++||++| |..|+.+.+..++-..+..+. +.-|+.++.++.-++.+
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvk  935 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVK  935 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHH
Confidence            43333  456999999999999999999999999999997 999999999888888776653 56678999999999999


Q ss_pred             hchhCcCCCCCHHHHh
Q psy18060        351 LLEKDASQRLSWPELL  366 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL  366 (549)
                      ||..|+..||+++++.
T Consensus       936 Cwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  936 CWMIDADSRPTFKELA  951 (1177)
T ss_pred             HhccCcccCccHHHHH
Confidence            9999999999998774

>KOG3653|consensus

Probab=99.97  E-value=1.1e-31  Score=275.03  Aligned_cols=238  Identities=30%  Similarity=0.458  Sum_probs=189.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh--cCCCCeeEEEEEEeeCC----
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH--LAHPNIIKFIASHETLN----  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~----  191 (549)
                      ....++++.||+|+||.||+|...  ++.||||++..     ...+.+.+|-.|.+.  +.|+||++|++.-....    
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            556778899999999999999876  69999999864     455678888888765  58999999998876555    


Q ss_pred             EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccccccCCcEEEecCCcEEEeec
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN---------RVLHRDLKPQNVLLNKDGVAMLCDF  261 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~---------gIiHrDIKP~NILl~~~g~vKL~DF  261 (549)
                      .++||++|-+ |+|.++|+.+ .+++....+++..+++||+|||+.         +|+|||||..|||+..+++..|+||
T Consensus       282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            7899999977 8999999864 799999999999999999999974         6999999999999999999999999


Q ss_pred             ccceecccCccc--ccccCCCCcccccccccCCC-CC-----cchhhHHHHHHHHHHHhCC------------CCCC---
Q psy18060        262 GFARSMAVGTHM--LTSIKGTPLYMAPELIAERP-YD-----HTADLWSLGCIAYEIHMGH------------PPFK---  318 (549)
Q Consensus       262 Gla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~-y~-----~ksDIwSlGvil~eLltG~------------~Pf~---  318 (549)
                      |+|..+.++...  .-..+||.+|||||++.+.- ..     .+.||||+|.+||||++.-            .||.   
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            999887654322  23468999999999997632 22     3589999999999999732            2342   


Q ss_pred             --CCCHHHHHHHH--hcCCCCCCccC-----CHHHHHHHHHhchhCcCCCCCHH
Q psy18060        319 --TVSILHLIRLL--KTQDVTFPSQV-----SETYKDLVKGLLEKDASQRLSWP  363 (549)
Q Consensus       319 --~~~~~~~~~~i--~~~~~~~p~~~-----s~~~~dlI~~~L~~dP~~Rps~~  363 (549)
                        ..+..+.....  ...++.+|+.+     ..-+++.+..||..||+.|+|+.
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence              12333333332  34455566543     34678999999999999999984

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.2e-30  Score=245.33  Aligned_cols=211  Identities=43%  Similarity=0.721  Sum_probs=187.8

Q ss_pred             EecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CCHH
Q psy18060        127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSLS  205 (549)
Q Consensus       127 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL~  205 (549)
                      ||+|++|.||++....+++.+++|+........ ....+.+|++.++.+.|++|+++++++......+++||+++ ++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999998889999999987643221 34678999999999999999999999999899999999999 6999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec-CCcEEEeecccceecccCcccccccCCCCcc
Q psy18060        206 NLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK-DGVAMLCDFGFARSMAVGTHMLTSIKGTPLY  283 (549)
Q Consensus       206 ~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~-~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y  283 (549)
                      +++... ..+++..+..++.+++.+|++||+.|++|+||+|.||+++. ++.++|+|||.+..............++..|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            999876 57899999999999999999999999999999999999999 8999999999997765443223445688899


Q ss_pred             cccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCCH
Q psy18060        284 MAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW  362 (549)
Q Consensus       284 ~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~  362 (549)
                      ++||.+... .++.++|+|++|+++++|                               ..+.+++.+|+..+|.+||++
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~~  208 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPSA  208 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcCH
Confidence            999999876 788999999999999999                               778899999999999999999


Q ss_pred             HHHhcCc
Q psy18060        363 PELLHHP  369 (549)
Q Consensus       363 ~elL~Hp  369 (549)
                      .++++|+
T Consensus       209 ~~l~~~~  215 (215)
T cd00180         209 KEILEHL  215 (215)
T ss_pred             HHHhhCC
Confidence            9999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG2052|consensus

Probab=99.97  E-value=5.4e-31  Score=268.20  Aligned_cols=240  Identities=27%  Similarity=0.432  Sum_probs=187.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh--cCCCCeeEEEEEEeeC----C
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH--LAHPNIIKFIASHETL----N  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~----~  191 (549)
                      -...++.+.||+|.||.||+|.++  |+.||||++...     +..+..+|.+|.+.  |+|+||+.|++....+    .
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             hheeEEEEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            366789999999999999999998  899999999643     23456677777665  5999999999876443    3


Q ss_pred             EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccccccCCcEEEecCCcEEEeecc
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN--------RVLHRDLKPQNVLLNKDGVAMLCDFG  262 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~--------gIiHrDIKP~NILl~~~g~vKL~DFG  262 (549)
                      .++||++|-+ |||.++|.. ..++.....+++..++.||++||..        .|.|||||..|||+..+|..-|+|+|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            5899999976 899999987 6899999999999999999999964        49999999999999999999999999


Q ss_pred             cceecccCcc----cccccCCCCcccccccccCCC----C-C-cchhhHHHHHHHHHHHh-----C-----CCCCCC---
Q psy18060        263 FARSMAVGTH----MLTSIKGTPLYMAPELIAERP----Y-D-HTADLWSLGCIAYEIHM-----G-----HPPFKT---  319 (549)
Q Consensus       263 la~~~~~~~~----~~~~~~GT~~Y~APE~l~~~~----y-~-~ksDIwSlGvil~eLlt-----G-----~~Pf~~---  319 (549)
                      +|-.....+.    ..+..+||.+|||||++...-    + + .-+||||||.++||+..     |     ++||..   
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            9976554322    245678999999999995431    1 1 24899999999999974     2     578854   


Q ss_pred             --CCHHHHHHHHh--cCCCCCCccCC--H---HHHHHHHHhchhCcCCCCCHHHH
Q psy18060        320 --VSILHLIRLLK--TQDVTFPSQVS--E---TYKDLVKGLLEKDASQRLSWPEL  365 (549)
Q Consensus       320 --~~~~~~~~~i~--~~~~~~p~~~s--~---~~~dlI~~~L~~dP~~Rps~~el  365 (549)
                        .+.++..+.+.  ..++.+|..+.  +   .+.++++.||..||.-|.|+--|
T Consensus       442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence              23344433332  23344454332  2   34588999999999999998554

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.4e-29  Score=244.81  Aligned_cols=212  Identities=36%  Similarity=0.592  Sum_probs=184.1

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecC
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA  200 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~  200 (549)
                      |.+.+.||+|++|.||++.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+...+..++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            56788999999999999999988999999998764332 24578889999999999999999999998889999999999


Q ss_pred             CC-CHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-cccccc
Q psy18060        201 HM-SLSNLLEQRKK-LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-HMLTSI  277 (549)
Q Consensus       201 ~g-sL~~~l~~~~~-l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~~  277 (549)
                      .+ +|.+++..... +++..+..++.|++.+|.+||+.|++|+||+|.||+++.++.++|+|||.+....... ......
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            86 99999988777 8999999999999999999999999999999999999999999999999998765432 122445


Q ss_pred             CCCCcccccccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHhcCC
Q psy18060        278 KGTPLYMAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFKT--VSILHLIRLLKTQD  333 (549)
Q Consensus       278 ~GT~~Y~APE~l-~~~~y~~ksDIwSlGvil~eLltG~~Pf~~--~~~~~~~~~i~~~~  333 (549)
                      .++..|++||.+ ....++.++|+|+||+++++|++|+.||..  .+.....+.+..+.
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            688899999998 777788899999999999999999999977  44446666666654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.5e-31  Score=307.96  Aligned_cols=195  Identities=16%  Similarity=0.232  Sum_probs=148.1

Q ss_pred             CCeeEEEEEE-------eeCCEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEE
Q psy18060        178 PNIIKFIASH-------ETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVL  249 (549)
Q Consensus       178 pnIv~l~~~~-------~~~~~~~iV~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NIL  249 (549)
                      +||++++++|       .....++.+||+++++|.++|.. ...+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL  112 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV  112 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence            4677777766       23346788899999999999975 356999999999999999999999999999999999999


Q ss_pred             Eec-------------------CCcEEEeecccceecccCc----------------ccccccCCCCcccccccccCCCC
Q psy18060        250 LNK-------------------DGVAMLCDFGFARSMAVGT----------------HMLTSIKGTPLYMAPELIAERPY  294 (549)
Q Consensus       250 l~~-------------------~g~vKL~DFGla~~~~~~~----------------~~~~~~~GT~~Y~APE~l~~~~y  294 (549)
                      |+.                   ++.+||+|||+++......                .......||++|||||++.+..|
T Consensus       113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~  192 (793)
T PLN00181        113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSS  192 (793)
T ss_pred             EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCC
Confidence            964                   3456677777765421100                00112468999999999999999


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       295 ~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      +.++|||||||+||||++|.+|+.....  ....+.....+ .+....+...+++.+||.++|.+|||+.|+++||||..
T Consensus       193 ~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        193 NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence            9999999999999999999988764321  12222111111 11112456679999999999999999999999999975


Q ss_pred             c
Q psy18060        374 N  374 (549)
Q Consensus       374 ~  374 (549)
                      .
T Consensus       271 ~  271 (793)
T PLN00181        271 P  271 (793)
T ss_pred             h
Confidence            3

>KOG1167|consensus

Probab=99.97  E-value=2.4e-31  Score=269.93  Aligned_cols=250  Identities=28%  Similarity=0.430  Sum_probs=196.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  193 (549)
                      ...|..+.+||.|+|+.||++.+..   .+..||+|.+...+    ..+.+.+|+++|..+ -+.||+++.+++..++..
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            3568899999999999999998887   78899999987643    235688999999998 589999999999999999


Q ss_pred             EEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC-CcEEEeecccceecc---
Q psy18060        194 VLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMA---  268 (549)
Q Consensus       194 ~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~-g~vKL~DFGla~~~~---  268 (549)
                      .+||||.+. ...+++.   .++-.+++.+++.++.||.++|.+|||||||||+|+|.+.. +.-.|.|||+|....   
T Consensus       111 ~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             EEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            999999885 5665554   46788999999999999999999999999999999999865 678899999995110   


Q ss_pred             --------------c--Cc-------------------------ccccccCCCCcccccccccC-CCCCcchhhHHHHHH
Q psy18060        269 --------------V--GT-------------------------HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCI  306 (549)
Q Consensus       269 --------------~--~~-------------------------~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvi  306 (549)
                                    +  +.                         .......||++|+|||++.. +..+.++||||.|||
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                          0  00                         00123469999999999865 556889999999999


Q ss_pred             HHHHHhCCCCCCCCC-----HHHHHH-----------------------------------------HHhcCCC------
Q psy18060        307 AYEIHMGHPPFKTVS-----ILHLIR-----------------------------------------LLKTQDV------  334 (549)
Q Consensus       307 l~eLltG~~Pf~~~~-----~~~~~~-----------------------------------------~i~~~~~------  334 (549)
                      +..+++++.||-...     ..++..                                         .+...+.      
T Consensus       268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~  347 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE  347 (418)
T ss_pred             eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence            999999999994211     011000                                         0000000      


Q ss_pred             CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       335 ~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ...+..+..+.+|+.+||..||.+|+|++++|+||||.+.
T Consensus       348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             cccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence            0011245688999999999999999999999999999843

>KOG1345|consensus

Probab=99.96  E-value=3.6e-30  Score=247.63  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=198.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEE-EeeCCEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIAS-HETLNEFV  194 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~-~~~~~~~~  194 (549)
                      ..+.|.+.+.+|+|.||.+-+|.|+.++..+++|.+..+.   .....+.+|..---.| .|.||+.-|++ |+..+.++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            3467999999999999999999999999999999997653   3455677776654444 68999998864 78888899


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC--CcEEEeecccceecccCc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD--GVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~--g~vKL~DFGla~~~~~~~  271 (549)
                      +++||++ |+|..-+.. ..+.|...+.++.|+++|+.|||++++||||||.+||||-..  -+|||||||..+..+...
T Consensus        99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence            9999999 899987765 568999999999999999999999999999999999999543  489999999987654322


Q ss_pred             ccccccCCCCcccccccccC---C--CCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCCCCCCc---
Q psy18060        272 HMLTSIKGTPLYMAPELIAE---R--PYDHTADLWSLGCIAYEIHMGHPPFKTVS-----ILHLIRLLKTQDVTFPS---  338 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~---~--~y~~ksDIwSlGvil~eLltG~~Pf~~~~-----~~~~~~~i~~~~~~~p~---  338 (549)
                      .   ...-+..|.|||....   .  ..++.+|+|.||+++|.++||.+||+...     -.+............|.   
T Consensus       178 ~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~  254 (378)
T KOG1345|consen  178 K---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN  254 (378)
T ss_pred             h---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc
Confidence            1   1223556889997632   2  24677999999999999999999997432     22333444444445564   


Q ss_pred             cCCHHHHHHHHHhchhCcCCC---CCHHHHhcCcccCccc
Q psy18060        339 QVSETYKDLVKGLLEKDASQR---LSWPELLHHPLVKDNL  375 (549)
Q Consensus       339 ~~s~~~~dlI~~~L~~dP~~R---ps~~elL~Hpw~~~~~  375 (549)
                      .+++.+..+.++-|.++|++|   -++......-|....+
T Consensus       255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i  294 (378)
T KOG1345|consen  255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI  294 (378)
T ss_pred             ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence            478999999999999999999   5666667777775443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=4.5e-29  Score=234.27  Aligned_cols=158  Identities=26%  Similarity=0.330  Sum_probs=130.7

Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCC
Q psy18060        202 MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT  280 (549)
Q Consensus       202 gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT  280 (549)
                      |+|.+++..+ ..+++.+++.++.||+.||.|||+++      ||+|||++.++.+|+  ||+++.....     ...||
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence            6899999874 45999999999999999999999998      999999999999999  9998766432     22689


Q ss_pred             CcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCCC-------CCccCCH--HHHHHHHH
Q psy18060        281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI-LHLIRLLKTQDVT-------FPSQVSE--TYKDLVKG  350 (549)
Q Consensus       281 ~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~-~~~~~~i~~~~~~-------~p~~~s~--~~~dlI~~  350 (549)
                      +.|||||++.+..|+.++|||||||++|||++|+.||..... ......+......       .+..++.  ++.++|.+
T Consensus        68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  147 (176)
T smart00750       68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV  147 (176)
T ss_pred             ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence            999999999999999999999999999999999999976543 2222222222111       1223444  69999999


Q ss_pred             hchhCcCCCCCHHHHhcCcccC
Q psy18060        351 LLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      ||..+|.+|||+.|+++|+|+.
T Consensus       148 cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      148 CASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHhcccccccCHHHHHHHHHHH
Confidence            9999999999999999999985

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024|consensus

Probab=99.96  E-value=1.7e-28  Score=246.13  Aligned_cols=248  Identities=19%  Similarity=0.347  Sum_probs=206.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCC-----ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe-eCCE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLK-----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE-TLNE  192 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~  192 (549)
                      .+++....+-+|.||.||.|.++...     +.+-+|.+.. ..++-....+.+|.-++..+.|||+.++.++.. +...
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            45777788999999999999776432     3355565543 234455678889999999999999999998764 4455


Q ss_pred             EEEEEecCC-CCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccc
Q psy18060        193 FVLITEFAH-MSLSNLLEQ--------RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGF  263 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~--------~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGl  263 (549)
                      .+.++.+.+ |+|..+|..        .+.++..+...++.|++.|++|||+.||||.||...|.+|++.-.|||+|=.+
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaL  442 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSAL  442 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchh
Confidence            667777777 789999873        13477888899999999999999999999999999999999999999999999


Q ss_pred             ceecccCcccc--cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCcc
Q psy18060        264 ARSMAVGTHML--TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQ  339 (549)
Q Consensus       264 a~~~~~~~~~~--~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  339 (549)
                      +|..-+.....  .+...+..||+||.+....|+.++|+|||||+||||+| |+.|+...++.+....++.+ ++.-|-+
T Consensus       443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~N  522 (563)
T KOG1024|consen  443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFN  522 (563)
T ss_pred             ccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCC
Confidence            99876543221  11234567999999999999999999999999999998 99999999999999888876 4567889


Q ss_pred             CCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        340 VSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       340 ~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      +|+++..++.-||...|++||+.+|+..
T Consensus       523 CPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  523 CPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            9999999999999999999999999854

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=6.6e-26  Score=226.85  Aligned_cols=250  Identities=37%  Similarity=0.599  Sum_probs=208.8

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChH-HHHHHHHHHHHHHhcCCC-CeeEEEEEEeeCCEEEEEEe
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAHP-NIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~iV~E  198 (549)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+........ ....+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            778899999999999999887   7889999876654432 567889999999999988 79999999987777899999


Q ss_pred             cCCC-CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-cEEEeecccceecccCcc-
Q psy18060        199 FAHM-SLSNLLEQRK---KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-VAMLCDFGFARSMAVGTH-  272 (549)
Q Consensus       199 ~~~g-sL~~~l~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-~vKL~DFGla~~~~~~~~-  272 (549)
                      ++.+ ++.+++....   .+++.....++.|++.++.|+|+.|++||||||+||+++..+ .++++|||.++....... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            9985 7887777765   799999999999999999999999999999999999999998 799999999975544321 


Q ss_pred             -----cccccCCCCcccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCC-CCcc
Q psy18060        273 -----MLTSIKGTPLYMAPELIAE---RPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVT-FPSQ  339 (549)
Q Consensus       273 -----~~~~~~GT~~Y~APE~l~~---~~y~~ksDIwSlGvil~eLltG~~Pf~~~~----~~~~~~~i~~~~~~-~p~~  339 (549)
                           ......||+.|+|||.+.+   ..++...|+||+|++++++++|..||....    .......+...... ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 2466789999999999987   578899999999999999999999987765    34555555444432 2221


Q ss_pred             C--------CHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        340 V--------SETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       340 ~--------s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      .        ...+.+++.+++..+|..|.+..+...++|...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            1        157899999999999999999999988866654

>KOG0590|consensus

Probab=99.94  E-value=1.3e-28  Score=272.21  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=200.2

Q ss_pred             EEEEEecCCcEEEEEEEEcCCCceEEEEEEe----cCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        123 KICLIGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       123 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~----~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ....+|.|++|.|+.+......+.++.|...    ...........+..|..+-..+.|||++.......+....+-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4567999999988888777777777776543    111111222236778888889999999877665555555555599


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC--c--ccc
Q psy18060        199 FAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--T--HML  274 (549)
Q Consensus       199 ~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~--~--~~~  274 (549)
                      ||+++|+..+.....++..++..++.|++.||+|||+.||.||||||+|++++.+|.+||+|||.+.....+  .  ...
T Consensus       402 ~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~  481 (601)
T KOG0590|consen  402 YCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHES  481 (601)
T ss_pred             cccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhh
Confidence            999999999998889999999999999999999999999999999999999999999999999998654332  1  345


Q ss_pred             cccCCCCcccccccccCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-------HhcCCCCCCccCCHHH
Q psy18060        275 TSIKGTPLYMAPELIAERPYDH-TADLWSLGCIAYEIHMGHPPFKTVSILHLI--RL-------LKTQDVTFPSQVSETY  344 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~-ksDIwSlGvil~eLltG~~Pf~~~~~~~~~--~~-------i~~~~~~~p~~~s~~~  344 (549)
                      ...+|+..|+|||++.+..|++ .+||||.|+++..|.+|+.||......+..  ..       +..+...+...++...
T Consensus       482 ~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~  561 (601)
T KOG0590|consen  482 SGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRET  561 (601)
T ss_pred             cCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhH
Confidence            6778999999999999999985 589999999999999999999765443221  11       1111122224578889


Q ss_pred             HHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        345 KDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      +.+|.+||++||.+|.|+++|++.+||+..
T Consensus       562 ~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  562 RIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             HHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            999999999999999999999999999864

>KOG1164|consensus

Probab=99.94  E-value=2.9e-25  Score=229.87  Aligned_cols=247  Identities=24%  Similarity=0.301  Sum_probs=195.5

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCC-ceEEEEEEecCCCChHHHHHHHHHHHHHHhcC----CCCeeEEEEEE-eeCCEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLK-KTVALKIISKSGRSGKELSSLKQECEIQKHLA----HPNIIKFIASH-ETLNEF  193 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~----hpnIv~l~~~~-~~~~~~  193 (549)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|+.........  ..+..|..++..+.    .+++..+++.. .....-
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            8999999999999999999988775 6799998766432211  15677888888876    36899999998 577788


Q ss_pred             EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC-----CcEEEeeccccee
Q psy18060        194 VLITEFAHMSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-----GVAMLCDFGFARS  266 (549)
Q Consensus       194 ~iV~E~~~gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~-----g~vKL~DFGla~~  266 (549)
                      +|||++++.+|.++....  +.|+...+..++.|++.+|++||+.|++||||||+|+++...     ..+.|.|||+|+.
T Consensus        97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            999999999999988654  579999999999999999999999999999999999999865     3689999999983


Q ss_pred             cc---cCcc------c-ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hcCC
Q psy18060        267 MA---VGTH------M-LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL---KTQD  333 (549)
Q Consensus       267 ~~---~~~~------~-~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i---~~~~  333 (549)
                      ..   ....      . .....||..|+++....+...+.+.|+||++.++.+++.|..||............   ....
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~  256 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL  256 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence            22   1110      1 12355999999999999999999999999999999999999999776532222221   1111


Q ss_pred             C-C-CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        334 V-T-FPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       334 ~-~-~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      . . +....+.++.++...+-..+...+|....+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  257 LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            1 1 233456788888888888899999998776544

>KOG0603|consensus

Probab=99.93  E-value=1.6e-27  Score=253.08  Aligned_cols=241  Identities=28%  Similarity=0.397  Sum_probs=210.4

Q ss_pred             EecCCcEEEEEEE---EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCEEEEEEecCCC
Q psy18060        127 IGEGSFGKVFKAI---HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVLITEFAHM  202 (549)
Q Consensus       127 iG~G~fg~Vy~~~---~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iV~E~~~g  202 (549)
                      +|+|+||.|+++.   -...+..||+|+..+.............|..++...+ ||.+|++...++.....++++++..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6999999999764   3445778999998765433222225566778888886 99999999999999999999999885


Q ss_pred             -CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCC
Q psy18060        203 -SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP  281 (549)
Q Consensus       203 -sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~  281 (549)
                       .|...+.+...+.+...+.+...++.|++++|+.||++||+|++||+++.+|++++.|||+++..-.....    |||.
T Consensus        82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cgt~  157 (612)
T KOG0603|consen   82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CGTY  157 (612)
T ss_pred             chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----ccch
Confidence             89999999999999999999999999999999999999999999999999999999999999876543322    8999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCC
Q psy18060        282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS  361 (549)
Q Consensus       282 ~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps  361 (549)
                      .|||||++.  .+..++|.||+|+++++|+||..||.+    ++...|....+.+|..++..+++++..++.++|.+|..
T Consensus       158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg  231 (612)
T KOG0603|consen  158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLG  231 (612)
T ss_pred             hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhc
Confidence            999999998  578899999999999999999999998    77778888888999999999999999999999999986


Q ss_pred             H-----HHHhcCcccCcccch
Q psy18060        362 W-----PELLHHPLVKDNLSS  377 (549)
Q Consensus       362 ~-----~elL~Hpw~~~~~~~  377 (549)
                      .     .|+++|+||....+.
T Consensus       232 ~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  232 AGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             cCcchhHHHhccchheeeeHh
Confidence            4     799999999876544

>KOG1033|consensus

Probab=99.93  E-value=6.3e-27  Score=244.35  Aligned_cols=357  Identities=21%  Similarity=0.257  Sum_probs=220.9

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc----
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE----   82 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~----   82 (549)
                      ..++|+....+|.|+||+|+.+..+.++-.+|||.|...... ....+..+|..-+..+.||+|+.++..|.....    
T Consensus        47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e-~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~~~~~q  125 (516)
T KOG1033|consen   47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNRE-ESRSRVLREVSSLAEFEHPGIKRYFHAWYERPPLGWQ  125 (516)
T ss_pred             hhccccccccccccCccccCCccccccchhhHHHHhcccchh-hhhhhhhccccchhhhcccchhhheeceecCCCCccc
Confidence            346789999999999999999999988889999999765432 234567889999999999999999988854321    


Q ss_pred             ----eehhhhhh---hcccccCCCC-------------------ccccCCCcccccc-----------------------
Q psy18060         83 ----FVLITEFA---HMSLSKLGEP-------------------WFHNHCQPVKMEK-----------------------  113 (549)
Q Consensus        83 ----~~lv~ey~---~~sLsklg~p-------------------~~~~~~~~~~~~~-----------------------  113 (549)
                          .-+.-++-   .+++.++...                   .++...+..+.+.                       
T Consensus       126 e~~d~~~l~~~~~~~~~~l~sl~~~~~~~~q~~~~~~~~~A~e~s~~~~~~~v~~~~~s~s~~~~~s~s~~~~~~~~~rk  205 (516)
T KOG1033|consen  126 EEMDLKLLDDETSSERSNLPSLSERRTSKRQTAELPRVSAAAESSFHVFRAIVPVENQSHSQESSSSISQHNGSRSEFRK  205 (516)
T ss_pred             chhhhhhhhccCCcchhccccccchhccchhhhhcccccccchhhhccccccCchhhcccCcccccchhhcccchhhhhh
Confidence                11111110   1112111000                   0000000111000                       


Q ss_pred             ---------------------ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC------------CCh-
Q psy18060        114 ---------------------SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG------------RSG-  159 (549)
Q Consensus       114 ---------------------~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~------------~~~-  159 (549)
                                           .........-....+.++++.+.++........+-.|......            ... 
T Consensus       206 ~s~~k~~~~~~~~~tdsd~~ed~~~~~~s~~~~~~~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~  285 (516)
T KOG1033|consen  206 TSVSKASRFEGPDCTDSDLEEDEMQGSDSKESSRHEESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL  285 (516)
T ss_pred             hhhccccccCCCccccccccccccccCcccCcccccccccccccccccccccCCchhhhhcccchhhhhccchhhhccch
Confidence                                 0000000001112333334444444333222333222221110            000 


Q ss_pred             HHHHHHHHHHHHHHh-cCCCCeeEEE------EEE-----eeCCEEEEEEecCC-CCHHHHHHhcCC---CCHHHHHHHH
Q psy18060        160 KELSSLKQECEIQKH-LAHPNIIKFI------ASH-----ETLNEFVLITEFAH-MSLSNLLEQRKK---LSETICVQIL  223 (549)
Q Consensus       160 ~~~~~~~~Ei~il~~-l~hpnIv~l~------~~~-----~~~~~~~iV~E~~~-gsL~~~l~~~~~---l~e~~~~~i~  223 (549)
                      .......+++..+.. ..|+..+..-      ...     ....++||.|++|. .+|.+||..+..   -+......++
T Consensus       286 ~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~  365 (516)
T KOG1033|consen  286 CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIF  365 (516)
T ss_pred             hhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHH
Confidence            001111122222222 2344433321      011     11235899999998 689999986543   5667788999


Q ss_pred             HHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc------ccccccCCCCcccccccccCCCCCcc
Q psy18060        224 SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT------HMLTSIKGTPLYMAPELIAERPYDHT  297 (549)
Q Consensus       224 ~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~------~~~~~~~GT~~Y~APE~l~~~~y~~k  297 (549)
                      .|+..|++|   +|.+|||+||.||++..++.+||+|||+........      ...+...||.+||+||++.+..|+.+
T Consensus       366 ~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k  442 (516)
T KOG1033|consen  366 KQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK  442 (516)
T ss_pred             Hhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh
Confidence            999999999   999999999999999999999999999987765432      23466789999999999999999999


Q ss_pred             hhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCC--CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        298 ADLWSLGCIAYEIHMGHPPFKTV-SILHLIRLLKTQDVT--FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       298 sDIwSlGvil~eLltG~~Pf~~~-~~~~~~~~i~~~~~~--~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      +||||||+||+||+.   +|.+. .......-+..+.++  +..+.| .-..|+.+||...|.+||++.+.--|+|.
T Consensus       443 vdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  443 VDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             cchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            999999999999997   23221 222333334444332  112233 34589999999999999998888888875

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.2e-24  Score=226.72  Aligned_cols=176  Identities=18%  Similarity=0.215  Sum_probs=134.8

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcC-CCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhcCCCCeeE-EEEEEee
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLD-LKKTVALKIISKSGR---SGKELSSLKQECEIQKHLAHPNIIK-FIASHET  189 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~~  189 (549)
                      .....+|.+.+.||+|+||+||+|.+.. +++.+|||.+.....   .......+.+|+++++.+.|+|++. +++.   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            3446779999999999999999998876 677789998753211   2334567899999999999999985 5442   


Q ss_pred             CCEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccc-cCCcEEEecCCcEEEeecccceec
Q psy18060        190 LNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL-KPQNVLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       190 ~~~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDI-KP~NILl~~~g~vKL~DFGla~~~  267 (549)
                       +..|+||||+.| +|. .+.   ...   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus        91 -~~~~LVmE~~~G~~L~-~~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLH-LAR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             -CCcEEEEEccCCCCHH-HhC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence             457999999986 575 221   111   1467899999999999999999999 999999999999999999999866


Q ss_pred             ccCc--------ccccccCCCCcccccccccCCC------CCcchhhH
Q psy18060        268 AVGT--------HMLTSIKGTPLYMAPELIAERP------YDHTADLW  301 (549)
Q Consensus       268 ~~~~--------~~~~~~~GT~~Y~APE~l~~~~------y~~ksDIw  301 (549)
                      ....        ...++..+++.|+|||.+....      .+..+|-|
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            4322        1124567899999999985422      23346766

>KOG0606|consensus

Probab=99.91  E-value=1.2e-24  Score=241.28  Aligned_cols=274  Identities=27%  Similarity=0.434  Sum_probs=204.2

Q ss_pred             CCCCccccccccccccceehhhhhhhcccccCCCCccccCCCccccccccccccceeEEEEEecCCcEEEEEEEEcCCCc
Q psy18060         66 AHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKK  145 (549)
Q Consensus        66 ~HpnIV~l~~~~~~~~~~~lv~ey~~~sLsklg~p~~~~~~~~~~~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~  145 (549)
                      +-|...+++++ + .+.+|...+...+--.+   |.-...............-.+|..++.|..|+||.||.++|+.+.+
T Consensus        35 ~~~~parllec-e-peefy~lle~aeg~~~~---p~~~~s~~~~~as~~~p~e~df~~IklisngAygavylvrh~~trq  109 (1205)
T KOG0606|consen   35 KSPSPARLLEC-E-PEEFYHLLEAAEGHARK---PMTDESPESRGASRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQ  109 (1205)
T ss_pred             ccCCchhhccC-C-HHHHHHHHHhhhccccC---CCCCCCcccccccccCCCccccceeEeeccCCCCceeeeecccccc
Confidence            45667788887 4 77777777665433221   1111111100011233445779999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHH
Q psy18060        146 TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN  225 (549)
Q Consensus       146 ~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~q  225 (549)
                      .+|+|+ .+..       .+.+  .|+.....|.+|                    |+-...++..+.++...       
T Consensus       110 rfa~ki-Nkq~-------lilR--nilt~a~npfvv--------------------gDc~tllk~~g~lPvdm-------  152 (1205)
T KOG0606|consen  110 RFAMKI-NKQN-------LILR--NILTFAGNPFVV--------------------GDCATLLKNIGPLPVDM-------  152 (1205)
T ss_pred             chhhcc-cccc-------hhhh--ccccccCCccee--------------------chhhhhcccCCCCcchh-------
Confidence            999954 3321       1111  033334455544                    45555555556666443       


Q ss_pred             HHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC-------------c--ccccccCCCCccccccccc
Q psy18060        226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG-------------T--HMLTSIKGTPLYMAPELIA  290 (549)
Q Consensus       226 Il~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~-------------~--~~~~~~~GT~~Y~APE~l~  290 (549)
                       +.+++|||+-||+|||+||+|.+|+.-|++|++|||+++.....             .  -.....||||.|+|||++.
T Consensus       153 -vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil  231 (1205)
T KOG0606|consen  153 -VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL  231 (1205)
T ss_pred             -hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence             78999999999999999999999999999999999998642110             0  1124569999999999999


Q ss_pred             CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---cCCHHHHHHHHHhchhCcCCCC---CHHH
Q psy18060        291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS---QVSETYKDLVKGLLEKDASQRL---SWPE  364 (549)
Q Consensus       291 ~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~~dlI~~~L~~dP~~Rp---s~~e  364 (549)
                      .+.|+..+|+|++|+|+||.+-|..||.+.++++++.......+.+|.   .++++++++|.++|+.+|..|.   ++-+
T Consensus       232 rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e  311 (1205)
T KOG0606|consen  232 RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALE  311 (1205)
T ss_pred             hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence            999999999999999999999999999999999999988877777774   4789999999999999999997   4678


Q ss_pred             HhcCcccCcccchhhhhc
Q psy18060        365 LLHHPLVKDNLSSEIESQ  382 (549)
Q Consensus       365 lL~Hpw~~~~~~~~~~~~  382 (549)
                      +.+|+||+...+..+-++
T Consensus       312 vk~h~ff~~LDw~~llRq  329 (1205)
T KOG0606|consen  312 VKQHGFFQLLDWKSLLRQ  329 (1205)
T ss_pred             hhhccceeecccchhhhh
Confidence            999999998776644333

>KOG1163|consensus

Probab=99.91  E-value=1.5e-23  Score=199.19  Aligned_cols=242  Identities=19%  Similarity=0.295  Sum_probs=198.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~i  195 (549)
                      ...+|.+++.||+|+||.+|.|....+|..||||+-+.....    ..+.-|.++.+.|+ .+.|+.+..+..+.+.-.+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            357799999999999999999999999999999997654332    34677889988886 4788888888888888899


Q ss_pred             EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC---CcEEEeecccceecccC-
Q psy18060        196 ITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD---GVAMLCDFGFARSMAVG-  270 (549)
Q Consensus       196 V~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~---g~vKL~DFGla~~~~~~-  270 (549)
                      ||++.+.+|.+++.- .+.|+...+.-++-|++.-++|+|.+++|||||||+|.|+.-+   ..+.++|||+|+..... 
T Consensus        89 VMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   89 VMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             eeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            999999999988864 4679999999999999999999999999999999999999643   46899999999765422 


Q ss_pred             ------cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCCCC----
Q psy18060        271 ------THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDVTFP----  337 (549)
Q Consensus       271 ------~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~---~~~~~~~i~~~~~~~p----  337 (549)
                            ........||..|.+=....+...+...|+=|+|.+|..+..|..||++..   ..+-.++|.......|    
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~L  248 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVL  248 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHH
Confidence                  122355679999999877777777888999999999999999999998864   4455566666555544    


Q ss_pred             -ccCCHHHHHHHHHhchhCcCCCCCH
Q psy18060        338 -SQVSETYKDLVKGLLEKDASQRLSW  362 (549)
Q Consensus       338 -~~~s~~~~dlI~~~L~~dP~~Rps~  362 (549)
                       ..+|.++.-.+.-|-..--+.-|..
T Consensus       249 C~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  249 CKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             hCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence             4688899988888877766666764

>KOG1165|consensus

Probab=99.90  E-value=1.3e-22  Score=200.47  Aligned_cols=241  Identities=22%  Similarity=0.327  Sum_probs=196.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      --.|++.++||+|+||..+.|.+.-+++.||||.-...+..    -.+..|.+..+.| ..++|++.|.+...+.+-.+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            35799999999999999999999999999999986554332    3567788888888 579999999999888888999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-----cEEEeecccceecccC
Q psy18060        197 TEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-----VAMLCDFGFARSMAVG  270 (549)
Q Consensus       197 ~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-----~vKL~DFGla~~~~~~  270 (549)
                      +|+++-+|.++++- .++|+...+..++.|++.-++|+|++.+|.|||||+|+||...|     .+.|+|||+|+.....
T Consensus       103 idLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  103 IDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             hhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence            99999999998875 56799999999999999999999999999999999999997543     6889999999876432


Q ss_pred             c-------ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCCCCC---
Q psy18060        271 T-------HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV---SILHLIRLLKTQDVTFP---  337 (549)
Q Consensus       271 ~-------~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~---~~~~~~~~i~~~~~~~p---  337 (549)
                      .       ....+..||..||+=..-.+...+..-|+=|||-+++..|.|..||.+.   +..+-+++|-......|   
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~  262 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV  262 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH
Confidence            1       2235678999999988888888999999999999999999999999874   55666777755443333   


Q ss_pred             --ccCCHHHHHHHHHhchhCcCCCCCH
Q psy18060        338 --SQVSETYKDLVKGLLEKDASQRLSW  362 (549)
Q Consensus       338 --~~~s~~~~dlI~~~L~~dP~~Rps~  362 (549)
                        .++|.++...+.-.-..+-..-|..
T Consensus       263 Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  263 LCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             HHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence              3567776666655544444444543

>KOG1240|consensus

Probab=99.89  E-value=6.6e-24  Score=235.35  Aligned_cols=236  Identities=23%  Similarity=0.317  Sum_probs=184.5

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC--CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++...+.||++.|=+|.+|++.+ |. ++||++-+..  .+-........|++ ...+++||.+.+.-+-......|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            57778999999999999998875 44 9999987654  22233344445555 56679999999988877778889999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc---cc
Q psy18060        198 EFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH---ML  274 (549)
Q Consensus       198 E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~---~~  274 (549)
                      +|...+|.+.|..++-+...+.+.|+.||+.||..+|..||+|||||.+||||+.-+-+.|+||..-+..--..+   ..
T Consensus       101 qyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  101 QYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             HHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            999999999999998899999999999999999999999999999999999999999999999986543211110   11


Q ss_pred             ----cccCCCCcccccccccCC----------C-CCcchhhHHHHHHHHHHHh-CCCCCCCC-----------CHHHHHH
Q psy18060        275 ----TSIKGTPLYMAPELIAER----------P-YDHTADLWSLGCIAYEIHM-GHPPFKTV-----------SILHLIR  327 (549)
Q Consensus       275 ----~~~~GT~~Y~APE~l~~~----------~-y~~ksDIwSlGvil~eLlt-G~~Pf~~~-----------~~~~~~~  327 (549)
                          -+...-.+|.|||.+...          + .+++.||||+||+++||++ |++||.-.           .++..++
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le  260 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLE  260 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHH
Confidence                111233569999988541          1 5678999999999999997 78888421           2222222


Q ss_pred             HHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        328 LLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       328 ~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .|          -+..++++|..|++.||.+|.+|++.|+.
T Consensus       261 ~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  261 KI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            22          23468899999999999999999999985

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.7e-22  Score=193.34  Aligned_cols=140  Identities=22%  Similarity=0.176  Sum_probs=108.8

Q ss_pred             EEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHH------------------------HHHHHHHHHHHHhcCCCC
Q psy18060        124 ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE------------------------LSSLKQECEIQKHLAHPN  179 (549)
Q Consensus       124 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~------------------------~~~~~~Ei~il~~l~hpn  179 (549)
                      .+.||+|+||.||+|.+. +|+.||+|++.........                        .....+|++++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999987 8999999999754321111                        122345999999998777


Q ss_pred             eeEEEEEEeeCCEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCccccccCCcEEEecCCcEE
Q psy18060        180 IIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYL-HSNRVLHRDLKPQNVLLNKDGVAM  257 (549)
Q Consensus       180 Iv~l~~~~~~~~~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yL-H~~gIiHrDIKP~NILl~~~g~vK  257 (549)
                      +........ .+ .+|||||++| ++...+.....+++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            643322222 22 3899999996 4544444457899999999999999999999 799999999999999998 57899


Q ss_pred             Eeecccceec
Q psy18060        258 LCDFGFARSM  267 (549)
Q Consensus       258 L~DFGla~~~  267 (549)
                      |+|||+|...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=3.9e-22  Score=200.19  Aligned_cols=233  Identities=24%  Similarity=0.359  Sum_probs=152.0

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCC---C-------CeeEEEE--
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAH---P-------NIIKFIA--  185 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~h---p-------nIv~l~~--  185 (549)
                      ......+.||.|+++.||.+.+..||+.+|+|+...... .....+.+++|.-....+.+   |       .++-.++  
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            346778999999999999999999999999999765543 23345666666544433222   1       1111111  


Q ss_pred             -------EEeeC---C-----EEEEEEecCCCCHHHHHH---hcCCCC----HHHHHHHHHHHHHHHHHHHhCCCccccc
Q psy18060        186 -------SHETL---N-----EFVLITEFAHMSLSNLLE---QRKKLS----ETICVQILSNLISALYYLHSNRVLHRDL  243 (549)
Q Consensus       186 -------~~~~~---~-----~~~iV~E~~~gsL~~~l~---~~~~l~----e~~~~~i~~qIl~aL~yLH~~gIiHrDI  243 (549)
                             ++...   .     +.+++|.-+.++|.+++.   ......    -.....+..|++..+++||+.|++|+||
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                   11111   1     235677778888877754   333321    1223456689999999999999999999


Q ss_pred             cCCcEEEecCCcEEEeecccceecccCcccccccCCCCcccccccccC--------CCCCcchhhHHHHHHHHHHHhCCC
Q psy18060        244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE--------RPYDHTADLWSLGCIAYEIHMGHP  315 (549)
Q Consensus       244 KP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~y~~ksDIwSlGvil~eLltG~~  315 (549)
                      +|+|+|++.+|.+.|+||+.....+...   .....+..|.|||....        ..++.+.|.|+||+++|.|.+|..
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            9999999999999999999876654321   11345678999998743        357899999999999999999999


Q ss_pred             CCCCCCHHHHHH-HHhcCCCCCCccCCHHHHHHHHHhchhCcCCC
Q psy18060        316 PFKTVSILHLIR-LLKTQDVTFPSQVSETYKDLVKGLLEKDASQR  359 (549)
Q Consensus       316 Pf~~~~~~~~~~-~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~R  359 (549)
                      ||.......... ....+     .++|+.++.||.++|++||.+|
T Consensus       249 Pf~~~~~~~~~~~~f~~C-----~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEWDFSRC-----RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGGGGTTS-----S---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccccchhc-----CCcCHHHHHHHHHHccCCcccC
Confidence            998654332221 11111     2688999999999999999988

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=4.9e-22  Score=193.90  Aligned_cols=170  Identities=15%  Similarity=0.155  Sum_probs=131.3

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChH-HHHH------HHHHHHHHHhcCCCCeeEEEEEEeeC-
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSS------LKQECEIQKHLAHPNIIKFIASHETL-  190 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~------~~~Ei~il~~l~hpnIv~l~~~~~~~-  190 (549)
                      .+|++.+.+|.|+||.||.+..  ++..+|+|++........ ....      +.+|++.+.++.||+|+....++... 
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            6799999999999999999654  467899999965432222 2222      67999999999999999988876533 


Q ss_pred             -------CEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecc
Q psy18060        191 -------NEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFG  262 (549)
Q Consensus       191 -------~~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFG  262 (549)
                             +..+|+|||++| +|.++.    .+++.    ...+++.+|..||+.|++||||||+||+++.+| ++|+|||
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg  179 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS  179 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence                   357899999997 787763    23332    456999999999999999999999999999999 9999999


Q ss_pred             cceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHH
Q psy18060        263 FARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH  311 (549)
Q Consensus       263 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLl  311 (549)
                      ..+........            ..+.....|+.++|+||||+++..+.
T Consensus       180 ~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        180 GKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence            87644221110            11344556788999999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.8e-21  Score=184.94  Aligned_cols=141  Identities=20%  Similarity=0.152  Sum_probs=111.1

Q ss_pred             EEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh----------------------H--HHHHHHHHHHHHHhcCCCC
Q psy18060        124 ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----------------------K--ELSSLKQECEIQKHLAHPN  179 (549)
Q Consensus       124 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----------------------~--~~~~~~~Ei~il~~l~hpn  179 (549)
                      .+.||+|++|.||+|.+. +|+.||||++.......                      .  .......|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 89999999997653110                      0  0123467899999999998


Q ss_pred             eeEEEEEEeeCCEEEEEEecCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcEE
Q psy18060        180 IIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAM  257 (549)
Q Consensus       180 Iv~l~~~~~~~~~~~iV~E~~~gs-L~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~vK  257 (549)
                      +..........  .++||||++|. +.........+++..+..++.|++.+|.+||+ +||+||||||+|||++ ++.++
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            75433332222  48999999864 43332344678889999999999999999999 9999999999999998 88999


Q ss_pred             Eeecccceecc
Q psy18060        258 LCDFGFARSMA  268 (549)
Q Consensus       258 L~DFGla~~~~  268 (549)
                      |+|||+|+...
T Consensus       158 liDFG~a~~~~  168 (190)
T cd05145         158 IIDVSQAVELD  168 (190)
T ss_pred             EEEcccceecC
Confidence            99999997664

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158|consensus

Probab=99.84  E-value=9.3e-21  Score=191.18  Aligned_cols=248  Identities=28%  Similarity=0.368  Sum_probs=175.7

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCc-----------------------------------eEEEEEEecCCC-
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKK-----------------------------------TVALKIISKSGR-  157 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~-----------------------------------~vAvK~i~~~~~-  157 (549)
                      +.-.+++|++...||+|....||.+.....|.                                   +.|||.+-.-.. 
T Consensus       152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~  231 (598)
T KOG4158|consen  152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD  231 (598)
T ss_pred             cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence            33457889999999999999999887543211                                   135665533221 


Q ss_pred             --ChHHHHHHHHHHH------HH--------Hh--------cCCCCeeEEEEEEee------------------------
Q psy18060        158 --SGKELSSLKQECE------IQ--------KH--------LAHPNIIKFIASHET------------------------  189 (549)
Q Consensus       158 --~~~~~~~~~~Ei~------il--------~~--------l~hpnIv~l~~~~~~------------------------  189 (549)
                        +...++.+-+|.-      .+        +.        -+|||||++...|.+                        
T Consensus       232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g  311 (598)
T KOG4158|consen  232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG  311 (598)
T ss_pred             CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence              1222233333311      11        11        269999998765432                        


Q ss_pred             ---CCEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe--cCC--cEEEeecc
Q psy18060        190 ---LNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN--KDG--VAMLCDFG  262 (549)
Q Consensus       190 ---~~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~--~~g--~vKL~DFG  262 (549)
                         ...+|+||.-...+|+.++..+ ..+....+-++.|+++|+.|||++||.|||+|..|||+.  +++  .+.|+|||
T Consensus       312 ~g~~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG  390 (598)
T KOG4158|consen  312 AGEPKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG  390 (598)
T ss_pred             cCCCceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence               2358999998889999999865 466677788999999999999999999999999999994  343  57899999


Q ss_pred             cceecccCc------ccccccCCCCcccccccccCCC-----C-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH
Q psy18060        263 FARSMAVGT------HMLTSIKGTPLYMAPELIAERP-----Y-DHTADLWSLGCIAYEIHMGHPPFKTVSILHL--IRL  328 (549)
Q Consensus       263 la~~~~~~~------~~~~~~~GT~~Y~APE~l~~~~-----y-~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~--~~~  328 (549)
                      ++-......      ...-..-|...-||||+....+     . -.|+|.|+.|.+.||+++...||........  ...
T Consensus       391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y  470 (598)
T KOG4158|consen  391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY  470 (598)
T ss_pred             eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence            863322110      0112335788899999986432     1 2579999999999999999999976432211  111


Q ss_pred             HhcCCCCCCccCCHHHHHHHHHhchhCcCCCCCH
Q psy18060        329 LKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW  362 (549)
Q Consensus       329 i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~  362 (549)
                      ...+-+.+|+.+++.+++++..+|++||.+|++.
T Consensus       471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             hhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence            2233456788999999999999999999999996

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.1e-19  Score=174.09  Aligned_cols=186  Identities=14%  Similarity=0.070  Sum_probs=138.1

Q ss_pred             eEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChH--HHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCEEEEEEe
Q psy18060        122 QKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK--ELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       122 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      .+...|++|+||+|+.+..  .+..++.+.+.-......  ....+.+|+++|+++. |+++++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567899999999997754  467777666654332111  1225789999999995 5889999886    34689999


Q ss_pred             cCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccc-cCCcEEEecCCcEEEeecccceecccCccc---
Q psy18060        199 FAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL-KPQNVLLNKDGVAMLCDFGFARSMAVGTHM---  273 (549)
Q Consensus       199 ~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDI-KP~NILl~~~g~vKL~DFGla~~~~~~~~~---  273 (549)
                      |+.| +|...+..      . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........   
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            9887 57543321      1 2357889999999999999999999 799999999999999999999855433210   


Q ss_pred             ----------ccccCCCCcccccccccCC-CCC-cchhhHHHHHHHHHHHhCCCCCCCC
Q psy18060        274 ----------LTSIKGTPLYMAPELIAER-PYD-HTADLWSLGCIAYEIHMGHPPFKTV  320 (549)
Q Consensus       274 ----------~~~~~GT~~Y~APE~l~~~-~y~-~ksDIwSlGvil~eLltG~~Pf~~~  320 (549)
                                ......++.|++|+...-- ..+ ...+.++.|+-+|.++|+..|..+.
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                      0112368888999865321 223 5678899999999999999987654

>KOG0195|consensus

Probab=99.82  E-value=7.9e-21  Score=183.29  Aligned_cols=238  Identities=19%  Similarity=0.374  Sum_probs=191.5

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ....++.+|.+...|..|+|++.  |..+++|++.....+....+.+..|.-.++.+.||||+.+++.+...-++.++..
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence            33456667888999999999987  5566778876655555555678888889999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC-Cc-cccccCCcEEEecCCcEEE--eecccceecccCc
Q psy18060        199 FAH-MSLSNLLEQRKK--LSETICVQILSNLISALYYLHSNR-VL-HRDLKPQNVLLNKDGVAML--CDFGFARSMAVGT  271 (549)
Q Consensus       199 ~~~-gsL~~~l~~~~~--l~e~~~~~i~~qIl~aL~yLH~~g-Ii-HrDIKP~NILl~~~g~vKL--~DFGla~~~~~~~  271 (549)
                      |++ |+|.++|.....  .+..++.+++.+++.|+.|||+.. ++ ---|....+++|++-+.+|  +|--++-      
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------  341 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------  341 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------
Confidence            998 799999987644  577889999999999999999973 33 4568888999999876654  3322221      


Q ss_pred             ccccccCCCCcccccccccCCCCC---cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYD---HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFPSQVSETYKD  346 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~---~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~d  346 (549)
                       ......-.|.||+||.+...+-+   .++|+|||++++|||.|...||...++.+.--+|...  +..+|+.++.....
T Consensus       342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~k  420 (448)
T KOG0195|consen  342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNK  420 (448)
T ss_pred             -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHH
Confidence             11222346889999999765533   5799999999999999999999999988877665433  46789999999999


Q ss_pred             HHHHhchhCcCCCCCHHHH
Q psy18060        347 LVKGLLEKDASQRLSWPEL  365 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~el  365 (549)
                      +++-|+..||.+||.+..+
T Consensus       421 lm~icmnedpgkrpkfdmi  439 (448)
T KOG0195|consen  421 LMNICMNEDPGKRPKFDMI  439 (448)
T ss_pred             HHHHHhcCCCCcCCCccee
Confidence            9999999999999998665

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.6e-19  Score=175.07  Aligned_cols=133  Identities=26%  Similarity=0.414  Sum_probs=106.3

Q ss_pred             EEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-----CCCCeeEEEEEEeeCC---EEE-
Q psy18060        124 ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-----AHPNIIKFIASHETLN---EFV-  194 (549)
Q Consensus       124 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~-  194 (549)
                      .+.||+|+||.||.  +..++.. +||++.....  .....+.+|+.+++.+     .||||+++++++++..   .++ 
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            46899999999995  6666555 6998865332  2345789999999999     6799999999998874   333 


Q ss_pred             EEEecCC---CCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCccccccCCcEEEecC----CcEEEeecccc
Q psy18060        195 LITEFAH---MSLSNLLEQRKKLSETICVQILSNLISAL-YYLHSNRVLHRDLKPQNVLLNKD----GVAMLCDFGFA  264 (549)
Q Consensus       195 iV~E~~~---gsL~~~l~~~~~l~e~~~~~i~~qIl~aL-~yLH~~gIiHrDIKP~NILl~~~----g~vKL~DFGla  264 (549)
                      +||||++   ++|.+++++ ..+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+||+.+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            7899955   599999976 457766  35688888888 99999999999999999999743    37999995544

>KOG1166|consensus

Probab=99.79  E-value=4.9e-19  Score=200.38  Aligned_cols=193  Identities=26%  Similarity=0.382  Sum_probs=157.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC---CCCeeEEEEEEeeCCEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA---HPNIIKFIASHETLNEF  193 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~  193 (549)
                      ..+.|.+-+.||+|+||.||+|.+.+ |+.||+|+-+......--+     -.+++.+|+   -|.|..+...+.-.+.-
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            34679999999999999999999988 9999999976654321111     123333443   23455555555556667


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec-------CCcEEEeecccce
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK-------DGVAMLCDFGFAR  265 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~-------~g~vKL~DFGla~  265 (549)
                      ++|+||.+ |+|.+++...+.++|..+..++.|++..++.||..+|||+||||.|.||..       .-.++|+|||.|-
T Consensus       770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            89999988 899999998899999999999999999999999999999999999999953       2369999999997


Q ss_pred             eccc--CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q psy18060        266 SMAV--GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHP  315 (549)
Q Consensus       266 ~~~~--~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~  315 (549)
                      .+..  +....+..++|-.+-.+|+..|.+++..+|.|.|+.+++.||+|++
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            6642  2234567789999999999999999999999999999999999975

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=5.7e-19  Score=174.76  Aligned_cols=143  Identities=20%  Similarity=0.168  Sum_probs=112.8

Q ss_pred             eeEEEEEecCCcEEEEEEE-EcCCCceEEEEEEecCCCCh--------------------H--HHHHHHHHHHHHHhcCC
Q psy18060        121 YQKICLIGEGSFGKVFKAI-HLDLKKTVALKIISKSGRSG--------------------K--ELSSLKQECEIQKHLAH  177 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~-~~~~~~~vAvK~i~~~~~~~--------------------~--~~~~~~~Ei~il~~l~h  177 (549)
                      |.+.+.||+|++|.||+|. +..+|+.||+|++.......                    .  ....+..|+.++..+.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            6788899999999999998 77789999999987542110                    0  11245689999999975


Q ss_pred             C--CeeEEEEEEeeCCEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccccCCcEEEecC
Q psy18060        178 P--NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNR-VLHRDLKPQNVLLNKD  253 (549)
Q Consensus       178 p--nIv~l~~~~~~~~~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~g-IiHrDIKP~NILl~~~  253 (549)
                      .  .+++.++.   . ..++||||++| +|.........+.+..+..++.||+.+|.+||+.| |+||||||+||+++ +
T Consensus       110 ~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~  184 (237)
T smart00090      110 AGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D  184 (237)
T ss_pred             cCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence            3  34455543   2 34899999997 56655544556777778899999999999999999 99999999999999 8


Q ss_pred             CcEEEeecccceecc
Q psy18060        254 GVAMLCDFGFARSMA  268 (549)
Q Consensus       254 g~vKL~DFGla~~~~  268 (549)
                      +.++|+|||.|....
T Consensus       185 ~~i~LiDFg~a~~~~  199 (237)
T smart00090      185 GKVVIIDVSQSVELD  199 (237)
T ss_pred             CCEEEEEChhhhccC
Confidence            899999999986543

>KOG0590|consensus

Probab=99.78  E-value=1.3e-20  Score=208.72  Aligned_cols=256  Identities=28%  Similarity=0.394  Sum_probs=207.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEc-CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHL-DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~i  195 (549)
                      ...|.+.+.||+|+|+.|-.+... .+...+|.|.+...............|..+...+. |+|++.+++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            556888899999999999877663 44556777877665444444556667888888886 9999999999999999999


Q ss_pred             EEecCCC-CHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCccccccCCcEEEecCC-cEEEeecccceeccc-
Q psy18060        196 ITEFAHM-SLSNLL-EQRK-KLSETICVQILSNLISALYYLH-SNRVLHRDLKPQNVLLNKDG-VAMLCDFGFARSMAV-  269 (549)
Q Consensus       196 V~E~~~g-sL~~~l-~~~~-~l~e~~~~~i~~qIl~aL~yLH-~~gIiHrDIKP~NILl~~~g-~vKL~DFGla~~~~~-  269 (549)
                      .+++..| ++..-+ .... ..+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|..... 
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            9999774 788887 5554 6788888999999999999999 99999999999999999999 999999999987654 


Q ss_pred             C--cccccccCC-CCcccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHhcC---CCCCCccC
Q psy18060        270 G--THMLTSIKG-TPLYMAPELIAERP-YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI--RLLKTQ---DVTFPSQV  340 (549)
Q Consensus       270 ~--~~~~~~~~G-T~~Y~APE~l~~~~-y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~--~~i~~~---~~~~p~~~  340 (549)
                      .  .......+| ++.|+|||...+.. .....|+||+|+++.-+++|..||.........  ..+...   .......+
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI  258 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence            2  223345678 99999999998854 467799999999999999999999765433221  111111   23344678


Q ss_pred             CHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        341 SETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       341 s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      +....+++.+++..+|..|.+.+++..+||+..
T Consensus       259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ChhhhhcccccccCCchhccccccccccccccc
Confidence            899999999999999999999999999999987

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3.5e-18  Score=165.40  Aligned_cols=135  Identities=19%  Similarity=0.254  Sum_probs=111.2

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChH------HHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK------ELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      +.||+|++|.||+|..  .+..+++|..........      ....+.+|+.++..+.|++|+....++...+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  577899998654322111      12457789999999999988776666666677899999


Q ss_pred             cCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        199 FAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       199 ~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                      |++| +|.+++.....    ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||.++.
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9986 89988875432    7788999999999999999999999999999999 78999999998865

>KOG0601|consensus

Probab=99.78  E-value=2.1e-19  Score=191.47  Aligned_cols=357  Identities=21%  Similarity=0.193  Sum_probs=255.4

Q ss_pred             Ceeeeeeecc--cCceEEEEEEE--CCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC-CCCcccccccccccccee
Q psy18060         10 KYQKICLIGE--GSFGKVFKAIH--LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFV   84 (549)
Q Consensus        10 ~y~~~~~IG~--G~fG~V~~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~   84 (549)
                      .|.....+|.  |.+|.||.+..  ..++..+|+|+=+...........-.+|......++ |+|.++.+..|+.....+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3566788999  99999999998  889999999994332221122223346776666776 999999999999988888


Q ss_pred             hhhhhhhcccccCCCCcc------------------------ccCCC-----ccccc------c-ccccccceeEEEEEe
Q psy18060         85 LITEFAHMSLSKLGEPWF------------------------HNHCQ-----PVKME------K-SNGALEKYQKICLIG  128 (549)
Q Consensus        85 lv~ey~~~sLsklg~p~~------------------------~~~~~-----~~~~~------~-~~~~~~~y~~~~~iG  128 (549)
                      +-.|++..++...-..+.                        +.|.+     ....+      . ......+|..+..||
T Consensus       195 iqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~  274 (524)
T KOG0601|consen  195 IQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS  274 (524)
T ss_pred             eeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEcc
Confidence            888877655433211110                        01111     01111      1 122346788999999


Q ss_pred             cCCcEEEEEEEEc-CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEEecCC-CCHH
Q psy18060        129 EGSFGKVFKAIHL-DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLITEFAH-MSLS  205 (549)
Q Consensus       129 ~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL~  205 (549)
                      .|.|+.|+.+..+ .++..|++|...+..........-..|+.+...+ .|.+++..+..+......||-.|||. +++.
T Consensus       275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~  354 (524)
T KOG0601|consen  275 DGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSS  354 (524)
T ss_pred             CCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchh
Confidence            9999999988755 6788999998876544333333334566666555 68899998888877788889999997 4544


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC-CcEEEeecccceecccCcccccccCCCCccc
Q psy18060        206 NLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYM  284 (549)
Q Consensus       206 ~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~-g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~  284 (549)
                      ..+.-...+.+...+.+..|++.|+.++|+..++|+|+||+||++..+ +..+++|||.++.+...   .....++-+++
T Consensus       355 l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~  431 (524)
T KOG0601|consen  355 LRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS---SGVFHHIDRLY  431 (524)
T ss_pred             hhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee---ccccccccccc
Confidence            444434467888899999999999999999999999999999999886 78889999998754321   12222333444


Q ss_pred             --ccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCCH
Q psy18060        285 --APELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW  362 (549)
Q Consensus       285 --APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~  362 (549)
                        +|+......+..++|++|||..+.+.++|...-.....   ...|..+.....+..+..++.+.+.++.+++..||.+
T Consensus       432 p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~  508 (524)
T KOG0601|consen  432 PIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSA  508 (524)
T ss_pred             ccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccCCCchHHhhhhhhhhhcCCccccchhh
Confidence              55556677889999999999999999998743222221   1223445555556666899999999999999999999


Q ss_pred             HHHhcCcccC
Q psy18060        363 PELLHHPLVK  372 (549)
Q Consensus       363 ~elL~Hpw~~  372 (549)
                      .++..|+=|.
T Consensus       509 ~~l~~~~~~~  518 (524)
T KOG0601|consen  509 VELSLHSEFY  518 (524)
T ss_pred             hhhcccchhh
Confidence            9988886553

>KOG0576|consensus

Probab=99.76  E-value=9.2e-21  Score=201.41  Aligned_cols=349  Identities=19%  Similarity=0.260  Sum_probs=243.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      .-++|+.+..+|+|+||.||||+++.+++..|+|.++....  .....+.+||-+++..+|||||.|++.+.....+++.
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            34689999999999999999999999999999999976532  2345677899999999999999999999999999999


Q ss_pred             hhhhh-cccccC--------------------------------------------------------------------
Q psy18060         87 TEFAH-MSLSKL--------------------------------------------------------------------   97 (549)
Q Consensus        87 ~ey~~-~sLskl--------------------------------------------------------------------   97 (549)
                      ||||. +||..+                                                                    
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            99994 233221                                                                    


Q ss_pred             ---CCCccc--------------cCCCc--------------------------cccc-------cccccccceeEEEEE
Q psy18060         98 ---GEPWFH--------------NHCQP--------------------------VKME-------KSNGALEKYQKICLI  127 (549)
Q Consensus        98 ---g~p~~~--------------~~~~~--------------------------~~~~-------~~~~~~~~y~~~~~i  127 (549)
                         |.|++-              ..|+-                          +-|.       .-.....-+......
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence               111110              00000                          0000       000111122333447


Q ss_pred             ecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCC-eeEEEEEEeeCCEEEEEEecCCCC--H
Q psy18060        128 GEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN-IIKFIASHETLNEFVLITEFAHMS--L  204 (549)
Q Consensus       128 G~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~iV~E~~~gs--L  204 (549)
                      ++|++++++|.+...+...+ .+.+...       -...-++++|.+++||| .+..++.++.++...++|+++.+.  .
T Consensus       251 vK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence            78888888888777655544 6666443       23456788999999999 777778888888899999999743  1


Q ss_pred             HHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCcc
Q psy18060        205 SNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLY  283 (549)
Q Consensus       205 ~~~l-~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y  283 (549)
                      .... ...-.+.+.+...+.+.-..+|++||+..=+|||    ||+.++ +.++.+|||.+..+.... ..++..+|+.+
T Consensus       323 ~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~  396 (829)
T KOG0576|consen  323 ALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEP  396 (829)
T ss_pred             cccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccccCCCCCCC
Confidence            1111 0111244455566677778899999998778999    777755 679999999987765443 45667899999


Q ss_pred             cccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-----ccCCHHHH-HHHHHhchhCcC
Q psy18060        284 MAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP-----SQVSETYK-DLVKGLLEKDAS  357 (549)
Q Consensus       284 ~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~-dlI~~~L~~dP~  357 (549)
                      +|||+.....+....|.|++|+-..++.-|-+|-...  ......+..++ .-|     ..+++... ++...|+...|.
T Consensus       397 ~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p-~s~~L~~~~aw~~~~~~~~~~~~~~g~P~  473 (829)
T KOG0576|consen  397 LAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGP-NSPMLTDKSAWSPVFHRDFPAPCLNGLPP  473 (829)
T ss_pred             CCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCC-CccccchhhhcCcccccCCcccccCCCCC
Confidence            9999999999999999999999888888887775441  11111111111 000     11222222 488889999999


Q ss_pred             CCCCHHHHhcCcccCcc
Q psy18060        358 QRLSWPELLHHPLVKDN  374 (549)
Q Consensus       358 ~Rps~~elL~Hpw~~~~  374 (549)
                      .|+....++.|.+|...
T Consensus       474 ~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  474 TPKVHMGACFSKVFNGC  490 (829)
T ss_pred             CCcchhhHHHHHHhccC
Confidence            99999999998888653

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=1.9e-17  Score=158.88  Aligned_cols=132  Identities=16%  Similarity=0.262  Sum_probs=103.7

Q ss_pred             EEecCCcEEEEEEEEcCCCceEEEEEEecCCC-Ch-----HHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SG-----KELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       126 ~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      .||+|+||.||+|..  ++..+++|....... ..     .....+.+|+++++.+.|+++......+...+..+++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            379999999999984  478899998654321 11     1235677899999999888755444344455567899999


Q ss_pred             CCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceec
Q psy18060        200 AHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       200 ~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~  267 (549)
                      ++| +|.+++.....       .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||+++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            985 78888765321       7899999999999999999999999999999 889999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=2.2e-17  Score=158.85  Aligned_cols=138  Identities=20%  Similarity=0.165  Sum_probs=107.1

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChH--------------------HHHHHHHHHHHHHhcCCC--
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK--------------------ELSSLKQECEIQKHLAHP--  178 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--------------------~~~~~~~Ei~il~~l~hp--  178 (549)
                      |.+.+.||+|+||.||++... +|+.+|||++........                    .......|..++..+.++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            677889999999999999875 699999999765331100                    112356788889888777  


Q ss_pred             CeeEEEEEEeeCCEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEE
Q psy18060        179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAM  257 (549)
Q Consensus       179 nIv~l~~~~~~~~~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vK  257 (549)
                      .++..++.    ...+++|||++| +|......      .....++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence            44555542    345899999986 66654321      34567889999999999999999999999999999999999


Q ss_pred             Eeecccceeccc
Q psy18060        258 LCDFGFARSMAV  269 (549)
Q Consensus       258 L~DFGla~~~~~  269 (549)
                      |+|||++.....
T Consensus       166 liDfg~~~~~~~  177 (198)
T cd05144         166 IIDWPQMVSTDH  177 (198)
T ss_pred             EEECCccccCCC
Confidence            999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023|consensus

Probab=99.72  E-value=2.6e-17  Score=175.29  Aligned_cols=196  Identities=27%  Similarity=0.370  Sum_probs=155.9

Q ss_pred             HHhcCCCCeeEEEEEEeeCCEEEEEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC-ccccccCCcE
Q psy18060        172 QKHLAHPNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRV-LHRDLKPQNV  248 (549)
Q Consensus       172 l~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gI-iHrDIKP~NI  248 (549)
                      |+.+.|.|+.+|++.+.+....++|.+||. |+|.+.+.. ...+++.....++++|+.||+|||+..| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            356889999999999999999999999998 899999987 4568888889999999999999999866 9999999999


Q ss_pred             EEecCCcEEEeecccceeccc--CcccccccCCCCcccccccccCCC-------CCcchhhHHHHHHHHHHHhCCCCCCC
Q psy18060        249 LLNKDGVAMLCDFGFARSMAV--GTHMLTSIKGTPLYMAPELIAERP-------YDHTADLWSLGCIAYEIHMGHPPFKT  319 (549)
Q Consensus       249 Ll~~~g~vKL~DFGla~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~-------y~~ksDIwSlGvil~eLltG~~Pf~~  319 (549)
                      +++..-.+||+|||+......  .........-...|.|||.+....       -+.+.||||+|++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999866532  111111122345599999997632       46679999999999999999999975


Q ss_pred             C----CHHHHHHHHhc-CCC-CCCc-----cCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        320 V----SILHLIRLLKT-QDV-TFPS-----QVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       320 ~----~~~~~~~~i~~-~~~-~~p~-----~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .    .+.+++..+.. +.. ..|.     ..++++..++..||..+|..||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            2    33456666655 322 1221     34567889999999999999999988743

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=1.3e-16  Score=176.36  Aligned_cols=141  Identities=18%  Similarity=0.250  Sum_probs=111.3

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CCh-----HHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSG-----KELSSLKQECEIQKHLAHPNIIKFIASHET  189 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  189 (549)
                      .....|...+.||+|+||.||++....  ..+++|...... ...     .....+.+|+++++.++|++++....++..
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~  407 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD  407 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence            334556678999999999999998754  344555432211 111     123567899999999999999887777666


Q ss_pred             CCEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceec
Q psy18060        190 LNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       190 ~~~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~  267 (549)
                      ....++||||++| +|.+++.        ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            6678899999985 8988875        356789999999999999999999999999999 6789999999998653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2.2e-16  Score=149.83  Aligned_cols=137  Identities=23%  Similarity=0.244  Sum_probs=98.7

Q ss_pred             EEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHH----------------------HHHHHHHHHhcCCC--C
Q psy18060        124 ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSS----------------------LKQECEIQKHLAHP--N  179 (549)
Q Consensus       124 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~----------------------~~~Ei~il~~l~hp--n  179 (549)
                      .+.||+|+||.||+|.+. +++.||||++............                      ...|...+..+.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999877 7899999998754322111111                      13566666666443  2


Q ss_pred             eeEEEEEEeeCCEEEEEEecCCC-CHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcE
Q psy18060        180 IIKFIASHETLNEFVLITEFAHM-SLS-NLLEQRKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVA  256 (549)
Q Consensus       180 Iv~l~~~~~~~~~~~iV~E~~~g-sL~-~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~v  256 (549)
                      +++.++..    ..+++|||++| ++. ..+.... .. ..+..++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus        81 ~~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEecC----CCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            45555432    35899999986 221 2222111 11 6678899999999999999 9999999999999999 8999


Q ss_pred             EEeecccceecc
Q psy18060        257 MLCDFGFARSMA  268 (549)
Q Consensus       257 KL~DFGla~~~~  268 (549)
                      +|+|||.+....
T Consensus       154 ~liDfg~a~~~~  165 (187)
T cd05119         154 YIIDVPQAVEID  165 (187)
T ss_pred             EEEECccccccc
Confidence            999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601|consensus

Probab=99.66  E-value=7e-17  Score=172.21  Aligned_cols=254  Identities=23%  Similarity=0.285  Sum_probs=197.7

Q ss_pred             cceeEEEEEec--CCcEEEEEEEE--cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEE
Q psy18060        119 EKYQKICLIGE--GSFGKVFKAIH--LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF  193 (549)
Q Consensus       119 ~~y~~~~~iG~--G~fg~Vy~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  193 (549)
                      +.+.+...+|.  |.+|.||.+..  ..++..+|+|.-......+.....-.+|..-..++ .|+|.++.+..++..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45777888999  99999999988  88899999998544332222222234455555555 599999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCCccccccCCcEEEecC-CcEEEeecccceec
Q psy18060        194 VLITEFAHMSLSNLLEQRKK-LSETICVQILSNLIS----ALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSM  267 (549)
Q Consensus       194 ~iV~E~~~gsL~~~l~~~~~-l~e~~~~~i~~qIl~----aL~yLH~~gIiHrDIKP~NILl~~~-g~vKL~DFGla~~~  267 (549)
                      ++.+|+|+.+|..+...... +++..++..+.+...    ||.++|+.+++|-|+||.||++..+ ...+++|||+...+
T Consensus       194 fiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i  273 (524)
T KOG0601|consen  194 FIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI  273 (524)
T ss_pred             eeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEc
Confidence            99999999999888877655 889999999999999    9999999999999999999999999 78999999999887


Q ss_pred             ccCccccc-----ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCCCCCccC
Q psy18060        268 AVGTHMLT-----SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV--SILHLIRLLKTQDVTFPSQV  340 (549)
Q Consensus       268 ~~~~~~~~-----~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~--~~~~~~~~i~~~~~~~p~~~  340 (549)
                      ..+.....     ...|...|++||.+.+. ++.+.|++|+|.+..+..+|..+....  +....++... -+.++-...
T Consensus       274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~~~~~  351 (524)
T KOG0601|consen  274 SDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEFCEGG  351 (524)
T ss_pred             cCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-CchhhhcCc
Confidence            76542222     22578889999988764 789999999999999999887766544  2222211111 011122334


Q ss_pred             CHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        341 SETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       341 s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      +..+...+..|++.+|..|++++.++.|+++...
T Consensus       352 s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  352 SSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             chhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            5666679999999999999999999999999854

>KOG0606|consensus

Probab=99.65  E-value=4.1e-17  Score=181.84  Aligned_cols=270  Identities=24%  Similarity=0.357  Sum_probs=217.3

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      .....+.+.+.+-+-+|+++.+..+.-..+|...++|+...... -....+....+-.++-...+|.++.....+.....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            44677888999999999999999988888887777766543211 11112233344444444567888877766667788


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC-
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG-  270 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~-  270 (549)
                      .+++++|.+ ++|...+...+..++.-++..+..+.++++|||+..+.|||++|.|+++..+|..+++|||.....+.- 
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            999999997 589999888888888888999999999999999999999999999999999999999999844321100 


Q ss_pred             ---------c---------------------ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q psy18060        271 ---------T---------------------HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV  320 (549)
Q Consensus       271 ---------~---------------------~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~  320 (549)
                               .                     .......||+.|.+||.+.+......+|+|++|++++|.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                     0                     0012346899999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhcCCCCCCc---cCCHHHHHHHHHhchhCcCCCCCHH---HHhcCcccCcccchhhhhcc
Q psy18060        321 SILHLIRLLKTQDVTFPS---QVSETYKDLVKGLLEKDASQRLSWP---ELLHHPLVKDNLSSEIESQN  383 (549)
Q Consensus       321 ~~~~~~~~i~~~~~~~p~---~~s~~~~dlI~~~L~~dP~~Rps~~---elL~Hpw~~~~~~~~~~~~~  383 (549)
                      .+.+..+.|.......|.   ..+.++++++.+.|..+|.+|.++.   ++-.||||++..+..+..+.
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQK 1107 (1205)
T ss_pred             chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccccc
Confidence            999999999888777664   5789999999999999999999987   99999999988776555443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=3.4e-15  Score=148.02  Aligned_cols=135  Identities=22%  Similarity=0.257  Sum_probs=103.5

Q ss_pred             EEEe-cCCcEEEEEEEEcCCCceEEEEEEecCCC-----------ChHHHHHHHHHHHHHHhcCCCCe--eEEEEEEeeC
Q psy18060        125 CLIG-EGSFGKVFKAIHLDLKKTVALKIISKSGR-----------SGKELSSLKQECEIQKHLAHPNI--IKFIASHETL  190 (549)
Q Consensus       125 ~~iG-~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-----------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~  190 (549)
                      ..|| .||.|+||.+...  +..+++|.......           +......+.+|+.++..+.|++|  +..++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4677 7888888888664  77899998854321           11223567889999999998875  6666654332


Q ss_pred             -C---EEEEEEecCCC--CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccc
Q psy18060        191 -N---EFVLITEFAHM--SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA  264 (549)
Q Consensus       191 -~---~~~iV~E~~~g--sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla  264 (549)
                       .   ..++|||+++|  +|.+++.. ..+++..    +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence             2   23599999985  78888765 4566543    568999999999999999999999999999999999999987


Q ss_pred             ee
Q psy18060        265 RS  266 (549)
Q Consensus       265 ~~  266 (549)
                      +.
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            54

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=1.7e-15  Score=136.56  Aligned_cols=131  Identities=26%  Similarity=0.286  Sum_probs=109.5

Q ss_pred             EEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCC--CCeeEEEEEEeeCCEEEEEEecC
Q psy18060        123 KICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH--PNIIKFIASHETLNEFVLITEFA  200 (549)
Q Consensus       123 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~iV~E~~  200 (549)
                      +++.||+|+++.||++....  ..+++|.......    ...+.+|+.+++.+.+  +++++++.+....+..+++||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            45789999999999998753  7899999865432    3567889999999976  58999999888778899999999


Q ss_pred             CC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        201 HM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSN---RVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       201 ~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                      .| .+..+       +......++.+++.+|.+||..   +++||||+|+||+++..+.+++.|||.++.
T Consensus        76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            86 34432       5566677899999999999985   799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0595|consensus

Probab=99.60  E-value=8.8e-16  Score=156.37  Aligned_cols=93  Identities=31%  Similarity=0.412  Sum_probs=84.9

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      .....+|...+.||+|+||+||+|+++.++..||||.|.++....+..+.+..||++|++++|||||.++++.++.+.+|
T Consensus         6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~   85 (429)
T KOG0595|consen    6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY   85 (429)
T ss_pred             ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence            35677899999999999999999999999999999999988777777788999999999999999999999999999999


Q ss_pred             hhhhhhh-cccccC
Q psy18060         85 LITEFAH-MSLSKL   97 (549)
Q Consensus        85 lv~ey~~-~sLskl   97 (549)
                      +|||||. ++|+.+
T Consensus        86 lVMEyC~gGDLs~y   99 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDY   99 (429)
T ss_pred             EEEEeCCCCCHHHH
Confidence            9999997 677643

>KOG0600|consensus

Probab=99.53  E-value=2.9e-15  Score=155.90  Aligned_cols=93  Identities=32%  Similarity=0.433  Sum_probs=83.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc--ccee
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--NEFV   84 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~   84 (549)
                      ..+.|+.++.||+|+||.||+|++..||+.||+|++..............|||.||++|+|||||+|.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            35679999999999999999999999999999999998776666667889999999999999999999988766  6899


Q ss_pred             hhhhhhhcccccCCC
Q psy18060         85 LITEFAHMSLSKLGE   99 (549)
Q Consensus        85 lv~ey~~~sLsklg~   99 (549)
                      +|+||+..+|+.+..
T Consensus       195 lVFeYMdhDL~GLl~  209 (560)
T KOG0600|consen  195 LVFEYMDHDLSGLLS  209 (560)
T ss_pred             EEEecccchhhhhhc
Confidence            999999999887754

>KOG0659|consensus

Probab=99.52  E-value=8.8e-15  Score=141.62  Aligned_cols=90  Identities=29%  Similarity=0.475  Sum_probs=80.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +.+|..++.||+|+||.||+|++..||+.||||+|+........-....|||++|+.++|||||.+.++|.+...+.+|+
T Consensus         1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            35799999999999999999999999999999999877654444467889999999999999999999999999999999


Q ss_pred             hhhhcccccC
Q psy18060         88 EFAHMSLSKL   97 (549)
Q Consensus        88 ey~~~sLskl   97 (549)
                      ||+..+|...
T Consensus        81 Efm~tdLe~v   90 (318)
T KOG0659|consen   81 EFMPTDLEVV   90 (318)
T ss_pred             EeccccHHHH
Confidence            9998877554

>KOG0593|consensus

Probab=99.51  E-value=7.3e-15  Score=144.43  Aligned_cols=86  Identities=28%  Similarity=0.429  Sum_probs=76.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      |++|+.+-++|+|+||+||||+++.||+.||||+.--+..+....+-.+|||++|++|+|||+|++.++|.....+++|+
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            68899999999999999999999999999999998654444444455789999999999999999999999999999999


Q ss_pred             hhhhcc
Q psy18060         88 EFAHMS   93 (549)
Q Consensus        88 ey~~~s   93 (549)
                      |||..+
T Consensus        81 E~~dhT   86 (396)
T KOG0593|consen   81 EYCDHT   86 (396)
T ss_pred             eecchH
Confidence            999654

>KOG0597|consensus

Probab=99.51  E-value=8.7e-15  Score=153.75  Aligned_cols=90  Identities=42%  Similarity=0.661  Sum_probs=85.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      |++|-+.+.||+|+||+||||+.+.|++.||||.|.|.....+++..+.+|++|+++|+|||||.++++|++...+++|.
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            57899999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             hhhhcccccC
Q psy18060         88 EFAHMSLSKL   97 (549)
Q Consensus        88 ey~~~sLskl   97 (549)
                      ||+.|+|..+
T Consensus        81 e~a~g~L~~i   90 (808)
T KOG0597|consen   81 EYAVGDLFTI   90 (808)
T ss_pred             hhhhhhHHHH
Confidence            9999988654

>KOG0591|consensus

Probab=99.50  E-value=2.7e-15  Score=146.13  Aligned_cols=92  Identities=36%  Similarity=0.449  Sum_probs=82.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccc-ccccccc-e
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA-SHETLNE-F   83 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~-~~~~~~~-~   83 (549)
                      ..+.+|+++++||+|+||.||+|++..+|+.||.|.|.....+.++++.+..||.+|++|+|||||++++ .|.+.+. +
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence            4567799999999999999999999999999999999876678888889999999999999999999998 7777766 9


Q ss_pred             ehhhhhh-hcccccC
Q psy18060         84 VLITEFA-HMSLSKL   97 (549)
Q Consensus        84 ~lv~ey~-~~sLskl   97 (549)
                      +++||+| +++|+..
T Consensus        96 nivmE~c~~GDLsqm  110 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQM  110 (375)
T ss_pred             HHHHHhhcccCHHHH
Confidence            9999999 5777664

>KOG0598|consensus

Probab=99.49  E-value=1.7e-14  Score=145.68  Aligned_cols=87  Identities=31%  Similarity=0.484  Sum_probs=80.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ...++|+++++||+|+||+||.++.+.|++.||+|+|+|+.. ..++.+....|..||.+++||+||+++.+|++...+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            457899999999999999999999999999999999998874 4457788999999999999999999999999999999


Q ss_pred             hhhhhhhc
Q psy18060         85 LITEFAHM   92 (549)
Q Consensus        85 lv~ey~~~   92 (549)
                      +|+||..+
T Consensus       102 lVld~~~G  109 (357)
T KOG0598|consen  102 LVLDYLNG  109 (357)
T ss_pred             EEEeccCC
Confidence            99999864

>KOG0605|consensus

Probab=99.46  E-value=4.3e-14  Score=148.35  Aligned_cols=87  Identities=25%  Similarity=0.386  Sum_probs=80.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ...++|+++++||+||||.||+|+-+.||+.||+|+++|+.+ ...+++.++.|..||...++|+||+||.+|++...+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            357899999999999999999999999999999999998874 4567789999999999999999999999999999999


Q ss_pred             hhhhhhhc
Q psy18060         85 LITEFAHM   92 (549)
Q Consensus        85 lv~ey~~~   92 (549)
                      +||||.+|
T Consensus       218 LiMEylPG  225 (550)
T KOG0605|consen  218 LIMEYLPG  225 (550)
T ss_pred             EEEEecCC
Confidence            99999964

>KOG0575|consensus

Probab=99.43  E-value=1.4e-13  Score=146.63  Aligned_cols=88  Identities=31%  Similarity=0.529  Sum_probs=79.0

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      ..|+..+.||+|||+.||.+++..+|+.||+|+|+++.. .....+.+.+||+|+++|+|||||+++++|++.+++|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            459999999999999999999999999999999998763 4456788999999999999999999999999999999999


Q ss_pred             hhhh-ccccc
Q psy18060         88 EFAH-MSLSK   96 (549)
Q Consensus        88 ey~~-~sLsk   96 (549)
                      |+|+ ++|..
T Consensus        98 ELC~~~sL~e  107 (592)
T KOG0575|consen   98 ELCHRGSLME  107 (592)
T ss_pred             EecCCccHHH
Confidence            9995 44433

>KOG0615|consensus

Probab=99.42  E-value=1.9e-13  Score=139.49  Aligned_cols=84  Identities=31%  Similarity=0.433  Sum_probs=73.2

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChh-----hhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-----ELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      +.|.+.+.||+|+||.|.+|..+.||+.||||+|++......     -...+.+|++||++|+|||||++++.|+.....
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            457889999999999999999999999999999988764321     123467999999999999999999999999999


Q ss_pred             ehhhhhhhc
Q psy18060         84 VLITEFAHM   92 (549)
Q Consensus        84 ~lv~ey~~~   92 (549)
                      |+||||+.+
T Consensus       252 YmVlE~v~G  260 (475)
T KOG0615|consen  252 YMVLEYVEG  260 (475)
T ss_pred             EEEEEEecC
Confidence            999999853

>KOG1243|consensus

Probab=99.41  E-value=3.7e-12  Score=137.65  Aligned_cols=169  Identities=21%  Similarity=0.298  Sum_probs=128.5

Q ss_pred             EEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCCCCHHHHHHhcCCCCH
Q psy18060        137 KAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSE  216 (549)
Q Consensus       137 ~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~gsL~~~l~~~~~l~e  216 (549)
                      .|..+.++..+.|...+....  .......+-++-++.++||||+++++.++..+.+|||+|-+. .|..++++.+   .
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~-Pl~~~lk~l~---~  103 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR-PLETVLKELG---K  103 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc-cHHHHHHHhH---H
Confidence            466677788888888865433  334567788899999999999999999999999999999874 4556665533   6


Q ss_pred             HHHHHHHHHHHHHHHHHH-hCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCcccccccccCCCCC
Q psy18060        217 TICVQILSNLISALYYLH-SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD  295 (549)
Q Consensus       217 ~~~~~i~~qIl~aL~yLH-~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~  295 (549)
                      .....-+.||+.||.+|| ..+++|++|.-.-|+++..|.+||++|-++..............---.|..|+.+....  
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence            677788999999999998 56899999999999999999999999998754432211111111122356666543322  


Q ss_pred             cchhhHHHHHHHHHHHhC
Q psy18060        296 HTADLWSLGCIAYEIHMG  313 (549)
Q Consensus       296 ~ksDIwSlGvil~eLltG  313 (549)
                      -..|.|-|||++++++.|
T Consensus       182 ~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhhHHHHHHHHhCc
Confidence            457999999999999998

>KOG0661|consensus

Probab=99.41  E-value=3.4e-14  Score=147.07  Aligned_cols=91  Identities=29%  Similarity=0.393  Sum_probs=82.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC-CCCcccccccccccc-ce
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLN-EF   83 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~-~~   83 (549)
                      ..+++|.+++.||.|+||.||+|+.+.+|+.||||+++++..+.++... +||++.|++|+ |||||++++++.+.. .+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            5678999999999999999999999999999999999888777666555 48999999999 999999999998877 99


Q ss_pred             ehhhhhhhcccccC
Q psy18060         84 VLITEFAHMSLSKL   97 (549)
Q Consensus        84 ~lv~ey~~~sLskl   97 (549)
                      ++||||+.++|..+
T Consensus        86 ~fVfE~Md~NLYqL   99 (538)
T KOG0661|consen   86 YFVFEFMDCNLYQL   99 (538)
T ss_pred             eeeHHhhhhhHHHH
Confidence            99999999998765

>KOG0662|consensus

Probab=99.41  E-value=9.2e-14  Score=127.40  Aligned_cols=90  Identities=32%  Similarity=0.459  Sum_probs=82.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +.+|...+.||+|+||+||+|+++.|++.||+|.++....++......+|||.+|+.|+|.|||+++++......+.+|+
T Consensus         1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            45788999999999999999999999999999999887766666778899999999999999999999999999999999


Q ss_pred             hhhhcccccC
Q psy18060         88 EFAHMSLSKL   97 (549)
Q Consensus        88 ey~~~sLskl   97 (549)
                      +||+.+|.|+
T Consensus        81 e~cdqdlkky   90 (292)
T KOG0662|consen   81 EFCDQDLKKY   90 (292)
T ss_pred             HHhhHHHHHH
Confidence            9999888765

>KOG0663|consensus

Probab=99.40  E-value=1.1e-13  Score=137.78  Aligned_cols=91  Identities=23%  Similarity=0.375  Sum_probs=78.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccc--ccccee
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE--TLNEFV   84 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~--~~~~~~   84 (549)
                      ..++|+.+..|++|+||.||+|+++.|++.||+|+++.........-..+|||.+|.+++|||||.+..+..  +.+.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            457899999999999999999999999999999999877644444456789999999999999999988763  456799


Q ss_pred             hhhhhhhcccccC
Q psy18060         85 LITEFAHMSLSKL   97 (549)
Q Consensus        85 lv~ey~~~sLskl   97 (549)
                      +||||+..+|..+
T Consensus       154 ~VMe~~EhDLksl  166 (419)
T KOG0663|consen  154 IVMEYVEHDLKSL  166 (419)
T ss_pred             eeHHHHHhhHHHH
Confidence            9999999888665

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.39  E-value=2.3e-12  Score=138.67  Aligned_cols=139  Identities=23%  Similarity=0.309  Sum_probs=95.2

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh----------------------------HHH----------HHHH
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----------------------------KEL----------SSLK  166 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----------------------------~~~----------~~~~  166 (549)
                      +.||.|++|.||+|..+ +|+.||||+........                            ...          -.+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            67999999999999875 58999999986432100                            000          0133


Q ss_pred             HHHHHHHhc----C-CCCe--eEEEEEEeeCCEEEEEEecCCC-CHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q psy18060        167 QECEIQKHL----A-HPNI--IKFIASHETLNEFVLITEFAHM-SLSNLLEQR-KKLSETICVQILSNLIS-ALYYLHSN  236 (549)
Q Consensus       167 ~Ei~il~~l----~-hpnI--v~l~~~~~~~~~~~iV~E~~~g-sL~~~l~~~-~~l~e~~~~~i~~qIl~-aL~yLH~~  236 (549)
                      +|++.+.++    . +|+|  ++.+.  ......+|||||++| +|.+..... ....   ...++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence            455555544    2 3433  23332  223346899999986 677765432 1222   2345556655 47889999


Q ss_pred             CCccccccCCcEEEecCCcEEEeecccceeccc
Q psy18060        237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV  269 (549)
Q Consensus       237 gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~  269 (549)
                      |++|+|+||.||+++.+|.++++|||++.....
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            999999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266|consensus

Probab=99.39  E-value=5e-13  Score=132.99  Aligned_cols=200  Identities=20%  Similarity=0.270  Sum_probs=143.5

Q ss_pred             HHHhcCCCCeeEEEEEEeeC-----CEEEEEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CC
Q psy18060        171 IQKHLAHPNIIKFIASHETL-----NEFVLITEFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSN--RV  238 (549)
Q Consensus       171 il~~l~hpnIv~l~~~~~~~-----~~~~iV~E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~--gI  238 (549)
                      -+-++.|.|||+++.++.+.     ....++.||+. |+|..+|++    ...+.....++|+-||+.||.|||+.  .|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            34456799999998877543     34678899987 789988875    34588888999999999999999987  59


Q ss_pred             ccccccCCcEEEecCCcEEEeecccceecccC-----cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhC
Q psy18060        239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG-----THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMG  313 (549)
Q Consensus       239 iHrDIKP~NILl~~~g~vKL~DFGla~~~~~~-----~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG  313 (549)
                      +|+++...-|++..+|.+||+--.... ..+.     ........|-++|.|||.-...+.+.++|||++|....+|..|
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            999999999999999999985322211 1100     0011123467889999988777888999999999999999887


Q ss_pred             CCCC-CCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        314 HPPF-KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       314 ~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ..-- .+.+....-..+....+-+.   ..--++++.+||+..|+.||++.+++.||.+-+.
T Consensus       279 Eiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             eeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            6432 22211111112211111111   1223478999999999999999999999988654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.38  E-value=5e-13  Score=145.89  Aligned_cols=144  Identities=17%  Similarity=0.223  Sum_probs=96.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC---------------------------C-h----HHHHH-
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---------------------------S-G----KELSS-  164 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---------------------------~-~----~~~~~-  164 (549)
                      ...|.. +.||+|++|.||+|..+.+|+.||||+..+.-.                           . .    +-... 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            456776 789999999999999998899999999975310                           0 0    00111 


Q ss_pred             -----HHHHHHHHHhc----CCCCeeEEEEEEee-CCEEEEEEecCCC-CHHHH--HHhcC----CCCHHHHHHHHHHHH
Q psy18060        165 -----LKQECEIQKHL----AHPNIIKFIASHET-LNEFVLITEFAHM-SLSNL--LEQRK----KLSETICVQILSNLI  227 (549)
Q Consensus       165 -----~~~Ei~il~~l----~hpnIv~l~~~~~~-~~~~~iV~E~~~g-sL~~~--l~~~~----~l~e~~~~~i~~qIl  227 (549)
                           +.+|+..+.++    .+.+.+.+-.++.+ ....+|||||+.| .+.+.  +...+    .+.+..+..++.|++
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence                 23344444443    24333333333322 3456899999986 67664  33332    244444555555554


Q ss_pred             HHHHHHHhCCCccccccCCcEEEecCC----cEEEeecccceeccc
Q psy18060        228 SALYYLHSNRVLHRDLKPQNVLLNKDG----VAMLCDFGFARSMAV  269 (549)
Q Consensus       228 ~aL~yLH~~gIiHrDIKP~NILl~~~g----~vKL~DFGla~~~~~  269 (549)
                             ..|++|+|+||.||+++.+|    .++++|||++.....
T Consensus       278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   58999999999999999888    999999999987754

>KOG0611|consensus

Probab=99.37  E-value=1.4e-13  Score=139.76  Aligned_cols=83  Identities=30%  Similarity=0.512  Sum_probs=77.1

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .+|++.+.||+|+||+|-+|+....|+.||||-|++... ++.++..++|||+||+.|+|||||.+|++|+..+.+.+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            469999999999999999999999999999999998774 5557788999999999999999999999999999999999


Q ss_pred             hhhh
Q psy18060         88 EFAH   91 (549)
Q Consensus        88 ey~~   91 (549)
                      ||..
T Consensus       133 EYaS  136 (668)
T KOG0611|consen  133 EYAS  136 (668)
T ss_pred             EecC
Confidence            9974

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.32  E-value=1.6e-11  Score=117.48  Aligned_cols=139  Identities=17%  Similarity=0.173  Sum_probs=101.1

Q ss_pred             EEEecCCcEEEEEEEEcC------CCceEEEEEEecCCC-----------C---------hHHHHHH----HHHHHHHHh
Q psy18060        125 CLIGEGSFGKVFKAIHLD------LKKTVALKIISKSGR-----------S---------GKELSSL----KQECEIQKH  174 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~-----------~---------~~~~~~~----~~Ei~il~~  174 (549)
                      ..||.|-=+.||.|....      .+..+|+|+......           .         ......+    ++|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997653      357899998753210           0         1112233    389999998


Q ss_pred             cCC--CCeeEEEEEEeeCCEEEEEEecCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCccccccCCcEEE
Q psy18060        175 LAH--PNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYL-HSNRVLHRDLKPQNVLL  250 (549)
Q Consensus       175 l~h--pnIv~l~~~~~~~~~~~iV~E~~~gs-L~~~l~~~~~l~e~~~~~i~~qIl~aL~yL-H~~gIiHrDIKP~NILl  250 (549)
                      +..  -+++..+++    ..-+|||||++++ +....-+...+++.++..+..|++.+|..| |+.||||+||+|.|||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~  158 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW  158 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            843  456667764    3457999999863 322222233566667788899999999999 89999999999999999


Q ss_pred             ecCCcEEEeecccceecc
Q psy18060        251 NKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       251 ~~~g~vKL~DFGla~~~~  268 (549)
                      + +|.+.|+|||.|-...
T Consensus       159 ~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         159 H-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             E-CCcEEEEECCCceeCC
Confidence            6 5789999999886554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0580|consensus

Probab=99.31  E-value=3.5e-13  Score=128.88  Aligned_cols=87  Identities=32%  Similarity=0.432  Sum_probs=78.6

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChh-hhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      ..++++|++.+.||+|.||.||+|+.+.++-.||+|++.|++.... ..+++.|||+|.+.|+||||+++|+.|.+...+
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            4578899999999999999999999999999999999988774333 346799999999999999999999999999999


Q ss_pred             ehhhhhhh
Q psy18060         84 VLITEFAH   91 (549)
Q Consensus        84 ~lv~ey~~   91 (549)
                      |+++||..
T Consensus        98 yLilEya~  105 (281)
T KOG0580|consen   98 YLILEYAP  105 (281)
T ss_pred             EEEEEecC
Confidence            99999974

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.31  E-value=8.5e-12  Score=116.08  Aligned_cols=126  Identities=29%  Similarity=0.300  Sum_probs=93.4

Q ss_pred             EEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCe-eEEEEEEeeCCEEEEEEecCCC
Q psy18060        124 ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI-IKFIASHETLNEFVLITEFAHM  202 (549)
Q Consensus       124 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~iV~E~~~g  202 (549)
                      ++.++.|.++.||++...  +..|++|.......   ....+.+|+.+++.+.+.++ ++++....  ...++|||+++|
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence            467899999999999865  78899998754321   12245788888888865444 45555543  234799999987


Q ss_pred             -CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ccccccCCcEEEecCCcEEEeecccce
Q psy18060        203 -SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV-----LHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       203 -sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gI-----iHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                       ++...        ......++.+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence             44432        11123467799999999999985     9999999999998 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0616|consensus

Probab=99.28  E-value=2e-12  Score=127.12  Aligned_cols=87  Identities=20%  Similarity=0.372  Sum_probs=80.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ..+++|+.+++||.|+||+|.+++++.+|..||+|++++... ..++.+...+|..+|+.+.||++|+++++|.+...+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            567899999999999999999999999999999999988763 4567788999999999999999999999999999999


Q ss_pred             hhhhhhhc
Q psy18060         85 LITEFAHM   92 (549)
Q Consensus        85 lv~ey~~~   92 (549)
                      +||+|..+
T Consensus       121 mvmeyv~G  128 (355)
T KOG0616|consen  121 MVMEYVPG  128 (355)
T ss_pred             EEEeccCC
Confidence            99999854

>KOG0581|consensus

Probab=99.26  E-value=4.8e-12  Score=128.11  Aligned_cols=90  Identities=24%  Similarity=0.354  Sum_probs=77.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc-ceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-EFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~l   85 (549)
                      .+++.+.+..||+|+.|+||||+|+.|++.||+|.|... .+....+++.||++++++.+||+||.+|++|.... .+++
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence            345788899999999999999999999999999999433 34455678999999999999999999999999988 4999


Q ss_pred             hhhhhh-cccccC
Q psy18060         86 ITEFAH-MSLSKL   97 (549)
Q Consensus        86 v~ey~~-~sLskl   97 (549)
                      +|||+. +||.++
T Consensus       156 ~mEYMDgGSLd~~  168 (364)
T KOG0581|consen  156 CMEYMDGGSLDDI  168 (364)
T ss_pred             ehhhcCCCCHHHH
Confidence            999984 566544

>KOG0594|consensus

Probab=99.25  E-value=2.3e-12  Score=129.91  Aligned_cols=90  Identities=32%  Similarity=0.406  Sum_probs=80.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCC-cccccccccccc-----
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN-IIKFIASHETLN-----   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-IV~l~~~~~~~~-----   81 (549)
                      ++.|+.++.||+|+||+||+|+.+.+|+.||+|+|......+.......|||.+|+.|+|+| ||.+++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            66799999999999999999999999999999999877654455677899999999999999 999999998777     


Q ss_pred             -ceehhhhhhhcccccC
Q psy18060         82 -EFVLITEFAHMSLSKL   97 (549)
Q Consensus        82 -~~~lv~ey~~~sLskl   97 (549)
                       .+++|++|..++|.++
T Consensus        90 ~~l~lvfe~~d~DL~~y  106 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKY  106 (323)
T ss_pred             ceEEEEEEeecccHHHH
Confidence             8999999999888765

>KOG0694|consensus

Probab=99.24  E-value=1e-11  Score=134.05  Aligned_cols=88  Identities=24%  Similarity=0.395  Sum_probs=79.8

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcC-CCCccccccccccccc
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNE   82 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~   82 (549)
                      ...+++|.++++||+|+||+|++|..+.+++.||||.++|... ...+++....|.+|+...+ ||++++++.+|++.+.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            3467899999999999999999999999999999999998774 5567888999999998776 9999999999999999


Q ss_pred             eehhhhhhhc
Q psy18060         83 FVLITEFAHM   92 (549)
Q Consensus        83 ~~lv~ey~~~   92 (549)
                      +++||||..+
T Consensus       444 l~fvmey~~G  453 (694)
T KOG0694|consen  444 LFFVMEYVAG  453 (694)
T ss_pred             EEEEEEecCC
Confidence            9999999854

>KOG0660|consensus

Probab=99.24  E-value=5.3e-12  Score=127.32  Aligned_cols=91  Identities=25%  Similarity=0.344  Sum_probs=80.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc-----cc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-----LN   81 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~   81 (549)
                      ....|..++.||+|+||.|++|.++.||+.||||+|.....+....++..||+++|+.++|+|||.+++.+..     .+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456777899999999999999999999999999998777667777899999999999999999999998854     56


Q ss_pred             ceehhhhhhhcccccC
Q psy18060         82 EFVLITEFAHMSLSKL   97 (549)
Q Consensus        82 ~~~lv~ey~~~sLskl   97 (549)
                      .+|+|++++..+|.++
T Consensus       100 DvYiV~elMetDL~~i  115 (359)
T KOG0660|consen  100 DVYLVFELMETDLHQI  115 (359)
T ss_pred             eeEEehhHHhhHHHHH
Confidence            7999999998887765

>KOG0585|consensus

Probab=99.22  E-value=8.6e-12  Score=129.39  Aligned_cols=86  Identities=30%  Similarity=0.447  Sum_probs=74.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh------------hhhhhHHHHHHHHHhcCCCCcccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG------------KELSSLKQECEIQKHLAHPNIIKF   73 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~------------~~~~~~~~Ei~il~~l~HpnIV~l   73 (549)
                      ..+++|++++.||+|.||+|.+|++..+++.||||+++|.....            ...+++.+||.||++|+|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            45789999999999999999999999999999999998764211            134689999999999999999999


Q ss_pred             ccccccc--cceehhhhhhh
Q psy18060         74 IASHETL--NEFVLITEFAH   91 (549)
Q Consensus        74 ~~~~~~~--~~~~lv~ey~~   91 (549)
                      +++..+.  +.+|+|+|||.
T Consensus       174 iEvLDDP~s~~~YlVley~s  193 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCS  193 (576)
T ss_pred             EEeecCcccCceEEEEEecc
Confidence            9998654  57999999985

>KOG0032|consensus

Probab=99.20  E-value=1.6e-11  Score=129.40  Aligned_cols=84  Identities=29%  Similarity=0.449  Sum_probs=76.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC-hhhhhhHHHHHHHHHhcC-CCCccccccccccccceeh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~l   85 (549)
                      .+.|++.+.||+|+||.||+|+++.||+.||+|.|++.... ....+.+.+|+.||++|. |||||.++++|++...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            45799999999999999999999999999999999887643 234568999999999999 9999999999999999999


Q ss_pred             hhhhhh
Q psy18060         86 ITEFAH   91 (549)
Q Consensus        86 v~ey~~   91 (549)
                      |||++.
T Consensus       114 vmEL~~  119 (382)
T KOG0032|consen  114 VMELCE  119 (382)
T ss_pred             EEEecC
Confidence            999986

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.20  E-value=2.9e-11  Score=122.61  Aligned_cols=90  Identities=29%  Similarity=0.383  Sum_probs=77.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      +.+++|++++.||+|+||.||+|.++.+++.||+|+++..... .....+.+|+.+++.++||||+++++++.+....++
T Consensus         2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            3578899999999999999999999999999999999754322 223467789999999999999999999999999999


Q ss_pred             hhhhhhccccc
Q psy18060         86 ITEFAHMSLSK   96 (549)
Q Consensus        86 v~ey~~~sLsk   96 (549)
                      +|||+.++|..
T Consensus        81 v~e~~~~~l~~   91 (288)
T cd07871          81 VFEYLDSDLKQ   91 (288)
T ss_pred             EEeCCCcCHHH
Confidence            99998776543

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.19  E-value=2.7e-11  Score=128.25  Aligned_cols=87  Identities=20%  Similarity=0.334  Sum_probs=76.0

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +.|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|+++++.++|||||++++++.+...++++|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            368999999999999999999999999999999976543 3344567899999999999999999999999999999999


Q ss_pred             hhhhc-ccc
Q psy18060         88 EFAHM-SLS   95 (549)
Q Consensus        88 ey~~~-sLs   95 (549)
                      ||+.+ +|.
T Consensus        81 E~~~gg~L~   89 (381)
T cd05626          81 DYIPGGDMM   89 (381)
T ss_pred             ecCCCCcHH
Confidence            99853 443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.18  E-value=3.4e-11  Score=121.55  Aligned_cols=85  Identities=22%  Similarity=0.420  Sum_probs=75.2

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE   88 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~e   88 (549)
                      ++|++.+.||+|+||.||+|+++.+++.||||++..........+.+.+|+++++.++||||+++++++.....+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999999999999999997654433345678899999999999999999999999999999999


Q ss_pred             hhhcc
Q psy18060         89 FAHMS   93 (549)
Q Consensus        89 y~~~s   93 (549)
                      |+..+
T Consensus        81 ~~~~~   85 (287)
T cd07848          81 YVEKN   85 (287)
T ss_pred             cCCCC
Confidence            98654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0586|consensus

Probab=99.18  E-value=2.7e-11  Score=129.45  Aligned_cols=312  Identities=23%  Similarity=0.289  Sum_probs=184.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      .....|.+.+.||+|.||+|.+|++..||..||||.|++...+..-++.+.||+++|..|+|||||+++.+.++...+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            44567999999999999999999999999999999999988776666779999999999999999999999999999999


Q ss_pred             hhhhhhc-cccc-----------CCCCccc----------cCC-CccccccccccccceeEEEEEecCCcEEEEEEEEc-
Q psy18060         86 ITEFAHM-SLSK-----------LGEPWFH----------NHC-QPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHL-  141 (549)
Q Consensus        86 v~ey~~~-sLsk-----------lg~p~~~----------~~~-~~~~~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~-  141 (549)
                      ||||+.+ .+..           .....+.          ..+ ....+.. .+.+=.....-.|+.++|++++.--.. 
T Consensus       133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~-eNilL~~~mnikIaDfgfS~~~~~~~~l  211 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKA-ENILLDENMNIKIADFGFSTFFDYGLML  211 (596)
T ss_pred             EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccch-hhcccccccceeeeccccceeecccccc
Confidence            9999732 1111           1111111          000 0001111 111122233367999999999863211 


Q ss_pred             ---CCCceEEEEEEecCCC-ChHHHH--------------HHHHHHHHHHhcCCCCeeEEEEEE----eeCCE---EEEE
Q psy18060        142 ---DLKKTVALKIISKSGR-SGKELS--------------SLKQECEIQKHLAHPNIIKFIASH----ETLNE---FVLI  196 (549)
Q Consensus       142 ---~~~~~vAvK~i~~~~~-~~~~~~--------------~~~~Ei~il~~l~hpnIv~l~~~~----~~~~~---~~iV  196 (549)
                         ..-.+||.+.+..... ...+.+              .+..+-+.++.++++.++.-+...    .+.+.   -+||
T Consensus       212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lv  291 (596)
T KOG0586|consen  212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLV  291 (596)
T ss_pred             cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhc
Confidence               1134677776643321 111111              112233344555566555444321    00000   0112


Q ss_pred             EecCC-CCHHHHHHhcC---CCCHHHHHHHHHH---HHHHHHHHHhCCCccccccCCcEEEecCC---------------
Q psy18060        197 TEFAH-MSLSNLLEQRK---KLSETICVQILSN---LISALYYLHSNRVLHRDLKPQNVLLNKDG---------------  254 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~---~l~e~~~~~i~~q---Il~aL~yLH~~gIiHrDIKP~NILl~~~g---------------  254 (549)
                      .+-.. +++.+..+.+-   .+.+.........   +...-.+.|-..+.|++++-+++|..+..               
T Consensus       292 l~Pskr~~~dqim~~~W~n~~~~~~~l~p~~e~~~~~~~~~r~~~m~~~G~~~~~i~~sL~~~k~d~i~a~y~ll~~~~~  371 (596)
T KOG0586|consen  292 LNPSKRGPCDQIMKDRWRNDLLEARLLAPLIERSTPFILAKRILHMNSIGHRRLKIEESLAKQKFDDINATYLLLGYRKQ  371 (596)
T ss_pred             cCccccCCHHHhhhhcccchhhhhhhhhcccccCccchhhHHHHHHHhhccchhhHHHHHhhhhHHHHHHHHhhcchhhh
Confidence            11111 23333332211   1111111222222   45556667778889999999988876431               


Q ss_pred             -cEEEeecccceecccCcccccccCCCCcccccccccCCCCC-cchhhHHHHHHHHHHHhC-CCCCCCC
Q psy18060        255 -VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD-HTADLWSLGCIAYEIHMG-HPPFKTV  320 (549)
Q Consensus       255 -~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~-~ksDIwSlGvil~eLltG-~~Pf~~~  320 (549)
                       ...++|++.. ..... ......++++.+..++.+....+. .-.+-|+.|.+.+..+.. +.|+...
T Consensus       372 ~s~~~~~~~~~-~~~~~-~~~~~~~~s~~~~~~d~~~p~~~~~~~~~~~~~~~~~~s~~~e~~~~a~~~  438 (596)
T KOG0586|consen  372 RSIESADFGLK-TIELN-YMCSARCGSPDYVSVDRLMPVPYDGHLTDTWDGSVILYSLLDEDRLPARDL  438 (596)
T ss_pred             ccchhhhcCCC-ccccc-cccccccCCCCcccccccCCCCcccccccccccCccchhhhhcccCCCCCc
Confidence             3456677652 22211 333444677777788877766554 447899999999998876 6666543

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.18  E-value=2.9e-11  Score=126.88  Aligned_cols=87  Identities=24%  Similarity=0.374  Sum_probs=75.3

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      ++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+|..++||||+++++.+.+...++++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            479999999999999999999999999999999976432 2234456889999999999999999999999999999999


Q ss_pred             hhhh-cccc
Q psy18060         88 EFAH-MSLS   95 (549)
Q Consensus        88 ey~~-~sLs   95 (549)
                      ||+. ++|.
T Consensus        81 E~~~~g~L~   89 (364)
T cd05599          81 EYLPGGDMM   89 (364)
T ss_pred             CCCCCcHHH
Confidence            9984 3443

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0589|consensus

Probab=99.18  E-value=1.2e-11  Score=129.78  Aligned_cols=89  Identities=26%  Similarity=0.424  Sum_probs=81.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc-eeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE-FVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~-~~l   85 (549)
                      .+++|..++.||+|+||.+++++++..++.||+|+|.....+..+++...+|+.+++++.|||||.+.++|+..+. +++
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            4789999999999999999999999999999999999888777777788999999999999999999999998888 999


Q ss_pred             hhhhhhc-ccc
Q psy18060         86 ITEFAHM-SLS   95 (549)
Q Consensus        86 v~ey~~~-sLs   95 (549)
                      +|+|+.| ++.
T Consensus        82 vm~Y~eGg~l~   92 (426)
T KOG0589|consen   82 VMEYCEGGDLA   92 (426)
T ss_pred             EEeecCCCCHH
Confidence            9999964 443

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.18  E-value=3.9e-11  Score=122.51  Aligned_cols=88  Identities=28%  Similarity=0.387  Sum_probs=76.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++++.||+|+||.||+|+++.+|+.||||++...... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            467899999999999999999999999999999999754322 2234567899999999999999999999999999999


Q ss_pred             hhhhhcccc
Q psy18060         87 TEFAHMSLS   95 (549)
Q Consensus        87 ~ey~~~sLs   95 (549)
                      |||++++|.
T Consensus        82 ~e~~~~~l~   90 (303)
T cd07869          82 FEYVHTDLC   90 (303)
T ss_pred             EECCCcCHH
Confidence            999987654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.17  E-value=3.5e-11  Score=124.73  Aligned_cols=88  Identities=27%  Similarity=0.347  Sum_probs=76.6

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      .-.+++|++.+.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            3457889999999999999999999999999999999976432 223446788999999999999999999999999999


Q ss_pred             ehhhhhhhc
Q psy18060         84 VLITEFAHM   92 (549)
Q Consensus        84 ~lv~ey~~~   92 (549)
                      +++|||+.+
T Consensus        94 ~lv~e~~~~  102 (329)
T PTZ00263         94 YFLLEFVVG  102 (329)
T ss_pred             EEEEcCCCC
Confidence            999999753

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.16  E-value=3.7e-11  Score=126.85  Aligned_cols=87  Identities=26%  Similarity=0.373  Sum_probs=75.6

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      ++|++++.||+|+||.||+|.++.+|+.||||++.+... .......+.+|+++++.++|||||++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            479999999999999999999999999999999976432 2334567889999999999999999999999999999999


Q ss_pred             hhhh-cccc
Q psy18060         88 EFAH-MSLS   95 (549)
Q Consensus        88 ey~~-~sLs   95 (549)
                      ||+. ++|.
T Consensus        81 E~~~gg~L~   89 (377)
T cd05629          81 EFLPGGDLM   89 (377)
T ss_pred             eCCCCCcHH
Confidence            9984 4553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.15  E-value=4.3e-11  Score=121.69  Aligned_cols=83  Identities=20%  Similarity=0.340  Sum_probs=73.0

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      ++|++++.||+|+||.||+|.++.+|+.||||++.+... .....+.+.+|+++++.++||||+++++.+.+...++++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            479999999999999999999999999999999976432 2234466889999999999999999999999999999999


Q ss_pred             hhhh
Q psy18060         88 EFAH   91 (549)
Q Consensus        88 ey~~   91 (549)
                      ||+.
T Consensus        81 e~~~   84 (291)
T cd05612          81 EYVP   84 (291)
T ss_pred             eCCC
Confidence            9874

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.14  E-value=4.7e-11  Score=126.32  Aligned_cols=84  Identities=20%  Similarity=0.330  Sum_probs=74.2

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +.|++++.||+|+||.||+|+++.+++.||||++.+... .......+.+|+.+++.++|||||++++.+.+...+++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            369999999999999999999999999999999976532 2334567889999999999999999999999999999999


Q ss_pred             hhhhc
Q psy18060         88 EFAHM   92 (549)
Q Consensus        88 ey~~~   92 (549)
                      ||+.+
T Consensus        81 E~~~g   85 (382)
T cd05625          81 DYIPG   85 (382)
T ss_pred             eCCCC
Confidence            99853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.14  E-value=4.8e-11  Score=125.88  Aligned_cols=87  Identities=20%  Similarity=0.310  Sum_probs=75.0

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++.+.+.+.++++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            479999999999999999999999999999999975432 2223456889999999999999999999999999999999


Q ss_pred             hhhh-cccc
Q psy18060         88 EFAH-MSLS   95 (549)
Q Consensus        88 ey~~-~sLs   95 (549)
                      ||+. ++|.
T Consensus        81 E~~~~g~L~   89 (376)
T cd05598          81 DYIPGGDMM   89 (376)
T ss_pred             eCCCCCcHH
Confidence            9984 4453

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.13  E-value=6.6e-11  Score=124.36  Aligned_cols=84  Identities=24%  Similarity=0.358  Sum_probs=74.0

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.++..++||||+++++.+.+...+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            579999999999999999999999999999999976532 2233457889999999999999999999999999999999


Q ss_pred             hhhhc
Q psy18060         88 EFAHM   92 (549)
Q Consensus        88 ey~~~   92 (549)
                      ||+.+
T Consensus        81 E~~~g   85 (363)
T cd05628          81 EFLPG   85 (363)
T ss_pred             cCCCC
Confidence            99853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0583|consensus

Probab=99.12  E-value=7.6e-11  Score=124.15  Aligned_cols=87  Identities=33%  Similarity=0.434  Sum_probs=75.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC---hhhhhhHHHHHHHHHhcC-CCCcccccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS---GKELSSLKQECEIQKHLA-HPNIIKFIASHETLN   81 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~   81 (549)
                      ....+|.+.+.||+|+||+|++|.+..+|..||||+++++...   ....+.+.||+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999999999999999988775321   123456779999999999 999999999999999


Q ss_pred             ceehhhhhhhc
Q psy18060         82 EFVLITEFAHM   92 (549)
Q Consensus        82 ~~~lv~ey~~~   92 (549)
                      .+|+||||+.+
T Consensus        94 ~~~ivmEy~~g  104 (370)
T KOG0583|consen   94 KIYIVMEYCSG  104 (370)
T ss_pred             eEEEEEEecCC
Confidence            99999999865

>KOG0201|consensus

Probab=99.12  E-value=5.3e-11  Score=122.69  Aligned_cols=86  Identities=34%  Similarity=0.477  Sum_probs=77.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ..-..|+.++.||+|+||.||+|.+..|++.||||+|+.... ..+++.+.+|+.+|+++++|||.++|+++..+..+++
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence            344578999999999999999999999999999999987643 3456788999999999999999999999999999999


Q ss_pred             hhhhhhc
Q psy18060         86 ITEFAHM   92 (549)
Q Consensus        86 v~ey~~~   92 (549)
                      +|||+.|
T Consensus        89 iMey~~g   95 (467)
T KOG0201|consen   89 IMEYCGG   95 (467)
T ss_pred             HHHHhcC
Confidence            9999965

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.12  E-value=8.8e-11  Score=121.44  Aligned_cols=87  Identities=23%  Similarity=0.364  Sum_probs=72.1

Q ss_pred             CeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc-----ccee
Q psy18060         10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-----NEFV   84 (549)
Q Consensus        10 ~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~   84 (549)
                      +|++.+.||+|+||.||+|+++.+|+.||||++............+.+|+++++.++||||+++++++...     ..++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            58999999999999999999999999999999975433333445688999999999999999999887432     3479


Q ss_pred             hhhhhhhccccc
Q psy18060         85 LITEFAHMSLSK   96 (549)
Q Consensus        85 lv~ey~~~sLsk   96 (549)
                      ++|||+.++|..
T Consensus        81 lv~e~~~~~L~~   92 (338)
T cd07859          81 VVFELMESDLHQ   92 (338)
T ss_pred             EEEecCCCCHHH
Confidence            999998766543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG1026|consensus

Probab=99.11  E-value=1.4e-11  Score=136.06  Aligned_cols=90  Identities=24%  Similarity=0.414  Sum_probs=75.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEECC-----CCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      ...+-+..+.||+|+||+||+|+...     +.+.||||.++.. .+....+.|.||+++|+.++|||||+|+|++..++
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            34567788999999999999998642     3468999999654 34445678999999999999999999999999999


Q ss_pred             ceehhhhhh-hcccccC
Q psy18060         82 EFVLITEFA-HMSLSKL   97 (549)
Q Consensus        82 ~~~lv~ey~-~~sLskl   97 (549)
                      .+++|+||+ |++|.++
T Consensus       563 P~~MvFEYm~~GDL~eF  579 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEF  579 (774)
T ss_pred             eeEEEEEecccccHHHH
Confidence            999999998 7777654

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.11  E-value=1.3e-10  Score=119.04  Aligned_cols=89  Identities=28%  Similarity=0.383  Sum_probs=76.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ..+++|++++.||+|+||.||+|+++.+++.||||+++..... .....+.+|+++++.++||||+++++++......++
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            4578999999999999999999999999999999999755432 223457789999999999999999999999999999


Q ss_pred             hhhhhhcccc
Q psy18060         86 ITEFAHMSLS   95 (549)
Q Consensus        86 v~ey~~~sLs   95 (549)
                      +|||+.++|.
T Consensus        82 v~e~~~~~l~   91 (309)
T cd07872          82 VFEYLDKDLK   91 (309)
T ss_pred             EEeCCCCCHH
Confidence            9999876553

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0582|consensus

Probab=99.10  E-value=1.1e-10  Score=120.53  Aligned_cols=91  Identities=25%  Similarity=0.353  Sum_probs=80.0

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ....+.|++.++||.|+-+.||+|+++.+++.||||+|+...-+ .++..+++|+..|+.++|||||+++.+|...+.+|
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            35677899999999999999999999999999999999876533 34778999999999999999999999999999999


Q ss_pred             hhhhhhh-ccccc
Q psy18060         85 LITEFAH-MSLSK   96 (549)
Q Consensus        85 lv~ey~~-~sLsk   96 (549)
                      +||-|+. +|+..
T Consensus       101 vVmpfMa~GS~ld  113 (516)
T KOG0582|consen  101 VVMPFMAGGSLLD  113 (516)
T ss_pred             EeehhhcCCcHHH
Confidence            9999874 45443

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.10  E-value=1.3e-10  Score=122.43  Aligned_cols=87  Identities=22%  Similarity=0.245  Sum_probs=74.0

Q ss_pred             CeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc-----cee
Q psy18060         10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----EFV   84 (549)
Q Consensus        10 ~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~   84 (549)
                      +|++++.||+|+||.||+|.+..+|+.||||++............+.+|+++++.++||||+++++++....     .+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478999999999999999999999999999999765433334567889999999999999999999987766     789


Q ss_pred             hhhhhhhccccc
Q psy18060         85 LITEFAHMSLSK   96 (549)
Q Consensus        85 lv~ey~~~sLsk   96 (549)
                      ++++|+.++|..
T Consensus        81 lv~e~~~~~l~~   92 (372)
T cd07853          81 VVTELMQSDLHK   92 (372)
T ss_pred             EEeeccccCHHH
Confidence            999998766543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG4236|consensus

Probab=99.10  E-value=7.9e-11  Score=123.28  Aligned_cols=84  Identities=31%  Similarity=0.465  Sum_probs=74.8

Q ss_pred             eee--eeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhhh
Q psy18060         11 YQK--ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE   88 (549)
Q Consensus        11 y~~--~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~e   88 (549)
                      |++  -++||+|.||+||-|.++.||+.||||+|+|-....+...+++.|+.||.+++||-||.+-..|++.+.+++|||
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME  643 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME  643 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence            444  468999999999999999999999999999876544444789999999999999999999999999999999999


Q ss_pred             hhhccc
Q psy18060         89 FAHMSL   94 (549)
Q Consensus        89 y~~~sL   94 (549)
                      -.|+++
T Consensus       644 Kl~GDM  649 (888)
T KOG4236|consen  644 KLHGDM  649 (888)
T ss_pred             hhcchH
Confidence            888764

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.10  E-value=1.1e-10  Score=120.94  Aligned_cols=88  Identities=23%  Similarity=0.312  Sum_probs=75.5

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      ++|++++.||+|+||.||+|++..+|+.||||++++... .......+.+|+.++..++||||+++++.+.+...++++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            479999999999999999999999999999999976532 2234467889999999999999999999999999999999


Q ss_pred             hhhh-ccccc
Q psy18060         88 EFAH-MSLSK   96 (549)
Q Consensus        88 ey~~-~sLsk   96 (549)
                      ||+. ++|..
T Consensus        81 e~~~g~~L~~   90 (333)
T cd05600          81 EYVPGGDFRT   90 (333)
T ss_pred             eCCCCCCHHH
Confidence            9984 45543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0577|consensus

Probab=99.09  E-value=4.9e-11  Score=126.30  Aligned_cols=90  Identities=30%  Similarity=0.418  Sum_probs=79.1

Q ss_pred             CeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhhh
Q psy18060         10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE   88 (549)
Q Consensus        10 ~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~e   88 (549)
                      .|.=++.||.|+||-||-|++..|.+.||||+++.+.. +.+--+.++.|++.|.+|+|||+|.+.++|-.....|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            46778899999999999999999999999999987764 33334678999999999999999999999999999999999


Q ss_pred             hhhcccccCCC
Q psy18060         89 FAHMSLSKLGE   99 (549)
Q Consensus        89 y~~~sLsklg~   99 (549)
                      ||-+|-+++-+
T Consensus       107 YClGSAsDlle  117 (948)
T KOG0577|consen  107 YCLGSASDLLE  117 (948)
T ss_pred             HHhccHHHHHH
Confidence            99988777643

>KOG0192|consensus

Probab=99.09  E-value=6.8e-11  Score=123.76  Aligned_cols=88  Identities=30%  Similarity=0.478  Sum_probs=73.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCce-EEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc-ceeh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKT-VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-EFVL   85 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~-vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~l   85 (549)
                      .++....+.||+|+||+||+|.++.  +. ||||++.....+....+.|.+|+.+|++|+|||||.++|++.+.. .+.+
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            4456667779999999999999984  55 999999876554444678999999999999999999999998887 7999


Q ss_pred             hhhhhh-cccccC
Q psy18060         86 ITEFAH-MSLSKL   97 (549)
Q Consensus        86 v~ey~~-~sLskl   97 (549)
                      ||||+. ++|..+
T Consensus       118 VtEy~~~GsL~~~  130 (362)
T KOG0192|consen  118 VTEYMPGGSLSVL  130 (362)
T ss_pred             EEEeCCCCcHHHH
Confidence            999984 566554

>KOG0690|consensus

Probab=99.09  E-value=3e-11  Score=120.05  Aligned_cols=87  Identities=23%  Similarity=0.364  Sum_probs=79.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCC-CChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ..|++|+.+++||+|+||+|-+|+.+.+|+.||||+++|.- ....++...+.|-++|...+||++..+..+|++...++
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            36889999999999999999999999999999999998765 35566777888999999999999999999999999999


Q ss_pred             hhhhhhhc
Q psy18060         85 LITEFAHM   92 (549)
Q Consensus        85 lv~ey~~~   92 (549)
                      +||||..+
T Consensus       245 FVMeyanG  252 (516)
T KOG0690|consen  245 FVMEYANG  252 (516)
T ss_pred             EEEEEccC
Confidence            99999854

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.09  E-value=1.7e-10  Score=117.52  Aligned_cols=89  Identities=28%  Similarity=0.381  Sum_probs=77.0

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ..+++|++++.||+|+||.||+|+++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++......++
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            4578999999999999999999999999999999999754422 223457789999999999999999999999999999


Q ss_pred             hhhhhhcccc
Q psy18060         86 ITEFAHMSLS   95 (549)
Q Consensus        86 v~ey~~~sLs   95 (549)
                      ++||+.++|.
T Consensus        82 v~e~~~~~l~   91 (301)
T cd07873          82 VFEYLDKDLK   91 (301)
T ss_pred             EEeccccCHH
Confidence            9999876653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.09  E-value=1.9e-10  Score=120.60  Aligned_cols=90  Identities=26%  Similarity=0.345  Sum_probs=75.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc-----
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-----   80 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----   80 (549)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++.+..........+.+|+.+++.++||||+++++++...     
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            346899999999999999999999999999999999976544444456788999999999999999999987543     


Q ss_pred             -cceehhhhhhhcccc
Q psy18060         81 -NEFVLITEFAHMSLS   95 (549)
Q Consensus        81 -~~~~lv~ey~~~sLs   95 (549)
                       ..++++|||+.+++.
T Consensus        98 ~~~~~lv~e~~~~~l~  113 (359)
T cd07876          98 FQDVYLVMELMDANLC  113 (359)
T ss_pred             cceeEEEEeCCCcCHH
Confidence             347899999876653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.08  E-value=9.3e-11  Score=115.98  Aligned_cols=85  Identities=32%  Similarity=0.480  Sum_probs=74.3

Q ss_pred             eeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhhhhh
Q psy18060         11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA   90 (549)
Q Consensus        11 y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~ey~   90 (549)
                      |++++.||+|+||+||+|++..+++.||+|++..............+|+.++++++||||+++++.+.+....+++|+++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            78999999999999999999999999999999876544444444567999999999999999999999999999999998


Q ss_pred             hc-ccc
Q psy18060         91 HM-SLS   95 (549)
Q Consensus        91 ~~-sLs   95 (549)
                      .+ +|.
T Consensus        81 ~~~~L~   86 (260)
T PF00069_consen   81 PGGSLQ   86 (260)
T ss_dssp             TTEBHH
T ss_pred             cccccc
Confidence            76 554

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.08  E-value=1.4e-10  Score=120.82  Aligned_cols=83  Identities=24%  Similarity=0.446  Sum_probs=73.7

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      ++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|++++..++||||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            479999999999999999999999999999999976542 2234567889999999999999999999999999999999


Q ss_pred             hhhh
Q psy18060         88 EFAH   91 (549)
Q Consensus        88 ey~~   91 (549)
                      ||+.
T Consensus        81 e~~~   84 (350)
T cd05573          81 EYMP   84 (350)
T ss_pred             cCCC
Confidence            9984

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.08  E-value=1.3e-10  Score=122.64  Aligned_cols=92  Identities=22%  Similarity=0.276  Sum_probs=77.4

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          4 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         4 ~~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      ..-..++|++.+.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+++.++||||+++++++.+...
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            34456789999999999999999999999999999999976432 22233557789999999999999999999999999


Q ss_pred             eehhhhhhh-cccc
Q psy18060         83 FVLITEFAH-MSLS   95 (549)
Q Consensus        83 ~~lv~ey~~-~sLs   95 (549)
                      +++||||+. ++|.
T Consensus       118 ~~lv~Ey~~gg~L~  131 (370)
T cd05596         118 LYMVMEYMPGGDLV  131 (370)
T ss_pred             EEEEEcCCCCCcHH
Confidence            999999984 4443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.07  E-value=1.5e-10  Score=120.00  Aligned_cols=87  Identities=18%  Similarity=0.279  Sum_probs=74.8

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      ++|++++.||+|+||.||+|+++.+++.||||++.+... .....+.+.+|+.++..++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            579999999999999999999999999999999976432 2334456888999999999999999999999999999999


Q ss_pred             hhhh-cccc
Q psy18060         88 EFAH-MSLS   95 (549)
Q Consensus        88 ey~~-~sLs   95 (549)
                      ||+. ++|.
T Consensus        81 e~~~g~~L~   89 (331)
T cd05597          81 DYYVGGDLL   89 (331)
T ss_pred             ecCCCCcHH
Confidence            9974 4443

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG1187|consensus

Probab=99.07  E-value=9.4e-11  Score=123.13  Aligned_cols=90  Identities=31%  Similarity=0.464  Sum_probs=74.8

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc-c
Q psy18060          4 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-E   82 (549)
Q Consensus         4 ~~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~   82 (549)
                      +..+.++|..-..||+|+||.||+|.... |..||||++.......  ...|.+|++++++++|||+|+|+|+|.+.+ .
T Consensus        70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~  146 (361)
T KOG1187|consen   70 LRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH  146 (361)
T ss_pred             HHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence            34566889999999999999999998765 4899999887654332  234999999999999999999999999888 4


Q ss_pred             eehhhhhhh-ccccc
Q psy18060         83 FVLITEFAH-MSLSK   96 (549)
Q Consensus        83 ~~lv~ey~~-~sLsk   96 (549)
                      ..+|+||+. +||..
T Consensus       147 ~~LVYEym~nGsL~d  161 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLED  161 (361)
T ss_pred             EEEEEEccCCCCHHH
Confidence            999999985 56644

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.07  E-value=1.3e-10  Score=122.73  Aligned_cols=92  Identities=21%  Similarity=0.309  Sum_probs=77.6

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          4 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         4 ~~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      .....++|++.+.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+...
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            34456789999999999999999999999999999999976432 22334567889999999999999999999999999


Q ss_pred             eehhhhhhh-cccc
Q psy18060         83 FVLITEFAH-MSLS   95 (549)
Q Consensus        83 ~~lv~ey~~-~sLs   95 (549)
                      +++||||+. ++|.
T Consensus       118 ~~lv~Ey~~gg~L~  131 (370)
T cd05621         118 LYMVMEYMPGGDLV  131 (370)
T ss_pred             EEEEEcCCCCCcHH
Confidence            999999984 4553

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=1.5e-09  Score=101.27  Aligned_cols=132  Identities=20%  Similarity=0.248  Sum_probs=95.1

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEE-EecCCCChHH-----HHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKI-ISKSGRSGKE-----LSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~-i~~~~~~~~~-----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ..+++|+=+.++.+...  |..+++|. +++.-..+..     ...-.+|++++.++.--.|..-+=++.+.+...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            35788999999988654  44566664 3332222221     2345689999998865555443333445566679999


Q ss_pred             cCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        199 FAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       199 ~~~gs-L~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                      |.+|. |.+.+...       ...++..+-.-+.-||..||+|+||.++||++..++ +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99985 67788765       245677777888899999999999999999997765 99999999864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	549
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-41
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-41
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-40
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-40
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-40
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-40
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-40
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-40
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-40
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-40
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-40
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-40
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-39
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-39
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-39
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-39
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-39
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-39
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-39
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-39
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-39
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-39
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-39
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-39
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-39
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-39
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-38
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-38
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-38
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-38
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-38
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-38
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-36
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-35
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-35
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-35
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-35
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-35
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-34
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-34
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-34
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-34
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-33
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-33
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-33
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-33
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-33
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-33
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-33
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-33
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-33
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-33
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-33
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-33
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-33
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-32
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-32
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-32
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-32
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-32
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-31
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-31
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-31
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-31
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-31
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-31
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-31
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-31
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-31
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-31
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-31
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-31
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-31
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-31
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-31
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-31
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-30
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-30
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-30
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-30
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-30
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-30
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-30
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-30
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-30
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-30
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-30
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-30
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-30
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-30
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-30
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-30
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-30
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-30
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-30
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-30
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-30
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-30
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-30
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-30
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-30
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-30
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-30
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-30
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-30
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-30
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-30
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-30
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-30
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-30
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-30
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-30
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-30
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-30
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-30
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-30
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-30
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-30
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-30
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-30
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-30
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-30
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-30
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-30
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-30
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-30
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-30
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-30
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-29
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-29
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-29
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-29
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-29
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-29
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-29
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-29
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-29
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-29
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-29
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-29
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-29
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-29
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-29
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-29
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-29
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-29
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-29
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-29
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-29
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-29
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-29
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-29
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-29
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-29
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-29
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-29
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-29
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-29
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-29
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-29
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-29
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-29
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-29
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-29
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-29
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-29
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-29
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-29
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-29
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-29
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-29
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-29
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-29
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-29
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-29
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-29
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-29
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-29
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-29
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-29
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-29
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-29
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-29
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-29
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-29
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-29
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-29
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-29
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-29
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-29
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-29
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-28
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-28
3soa_A	444	Full-Length Human Camkii Length = 444		1e-28
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-28
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-28
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-28
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-28
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-28
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-28
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-28
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-28
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-28
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-28
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-28
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-28
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-28
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-28
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-28
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-28
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-28
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-28
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-28
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-28
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-28
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-28
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-28
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-28
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-28
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-28
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-28
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-28
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-28
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-28
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-28
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-28
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-28
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-28
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-28
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-27
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-27
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-27
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-27
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-27
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-27
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-27
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-27
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-27
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-27
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-27
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-27
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-27
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-27
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-27
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-27
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-27
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-27
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-27
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-27
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-27
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-27
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-27
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-27
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-27
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-27
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-27
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-27
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-27
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-27
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-27
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-27
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-27
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-27
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-27
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-27
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-26
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-26
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-26
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-26
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-26
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-26
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-26
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-26
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-26
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-26
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-26
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-26
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-26
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-26
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-26
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-26
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-26
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-26
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-26
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-26
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-26
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-26
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-26
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-26
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-26
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-26
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-26
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-26
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-26
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-26
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-26
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-26
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-26
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-26
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-26
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-25
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-25
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-25
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-25
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-25
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-25
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-25
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-25
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-25
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-25
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-25
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-25
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-25
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-25
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-25
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-25
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-25
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		9e-25
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-24
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-24
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-24
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-24
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-24
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-24
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-24
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-24
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-24
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-24
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-24
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-24
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-24
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-24
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-24
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-24
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-24
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-24
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-24
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-24
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-24
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-24
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-24
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-24
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-24
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-24
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-24
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-24
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-24
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-24
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-24
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-23
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-23
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-23
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-23
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-23
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-23
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-23
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-23
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-23
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-23
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-23
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-23
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-23
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-22
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-22
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-22
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-22
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-22
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-22
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-22
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-22
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-22
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-22
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-22
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-22
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-22
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-22
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-22
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-22
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-22
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-22
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-22
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-22
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-22
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-21
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-21
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-21
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-21
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-21
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-21
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-21
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-21
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-21
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-21
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-21
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-21
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-21
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-21
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-21
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-21
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-21
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-21
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-21
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-21
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-21
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-21
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-21
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-21
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-21
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-21
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-21
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-21
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-21
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-21
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-21
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-21
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-21
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-21
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-21
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-21
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-21
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-21
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-21
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-21
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-21
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-21
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-21
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-21
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-21
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-21
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-21
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-21
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-21
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-21
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-21
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-21
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-21
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-21
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-21
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-21
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-21
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-21
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-21
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-21
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-21
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-21
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-21
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-21
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-21
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-21
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-21
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-21
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-21
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-21
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-21
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-21
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-21
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-20
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-20
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-20
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-20
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-20
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-20
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-20
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-20
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-20
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-20
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-20
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-20
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-20
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-20
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-20
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-20
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-20
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-20
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-20
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-20
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-20
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-20
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-20
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-20
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-20
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-20
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-20
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-20
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-20
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-20
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-20
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-20
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-20
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-20
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-20
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-20
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-20
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-20
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-20
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-20
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-20
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-20
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-20
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-20
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-20
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-20
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-20
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-20
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-20
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-20
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-20
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-20
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-20
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-20
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-20
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-20
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-20
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-20
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-20
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-20
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		9e-20
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-20
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-19
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-19
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-19
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-19
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-19
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-19
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-19
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-19
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-19
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-19
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-19
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-19
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-19
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-19
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-19
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-19
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-19
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-19
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-19
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-19
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-19
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-19
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-19
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-19
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-19
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-19
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-19
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-19
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-19
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-19
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-19
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-19
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-19
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-19
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-19
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-19
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-19
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-19
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-19
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-19
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-19
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-19
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-19
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-19
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-19
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-19
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-19
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-19
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-19
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-19
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-19
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-19
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-19
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-19
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-19
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-19
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-19
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-18
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-18
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-18
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-18
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-18
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-18
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-18
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-18
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-18
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-18
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-18
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-18
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-18
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-18
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-18
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-18
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-18
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-18
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-18
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-18
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-18
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-18
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-18
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-18
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-18
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-18
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-18
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-18
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-18
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-18
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-18
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-18
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-18
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-18
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-18
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-18
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-18
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-18
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-18
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-18
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-18
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-18
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-17
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-17
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-17
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-17
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-17
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-17
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-17
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-17
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-17
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-17
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-17
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-17
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-17
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-17
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-17
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-17
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-17
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-17
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-17
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-17
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-17
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-17
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-17
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-17
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-17
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-17
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-17
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-17
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-17
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-17
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-17
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-17
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-17
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-17
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-17
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-17
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-17
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-17
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-17
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-16
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-16
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-16
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-16
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-16
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-16
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-16
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-16
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-16
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		5e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-16
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-16
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-16
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		7e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-16
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-16
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-16
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-16
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-15
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-15
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-14
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-14
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-14
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-14
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-14
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-14
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-14
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-14
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-14
3iok_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-14
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-14
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-14
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-14
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-13
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-13
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		4e-13
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-13
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-13
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-12
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-12
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-12
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-12
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-12
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-12
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-11
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-11
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-11
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-11
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		6e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-10
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-10
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-10

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 149/267 (55%), Gaps = 6/267 (2%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECE 170
           K    LE +     +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E E
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVE 64
Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISA 229
           IQ HL HPNI++            LI E+A + ++   L++  +  E      ++ L +A
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L Y HS RV+HRD+KP+N+LL  +G   + DFG+  S+   +   T++ GT  Y+ PE+I
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMI 182
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +D   DLWSLG + YE  +G PPF+  +     R +   + TFP  V+E  +DL+ 
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLIS 242
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLS 376
            LL+ +ASQRL+  E+L HP +K N S
Sbjct: 243 RLLKHNASQRLTLAEVLEHPWIKANSS 269

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  165 bits (417), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 98/279 (35%), Positives = 150/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 60
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S    +   T++ GT  Y+ PE+
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SCHAPSSRRTTLSGTLDYLPPEM 178
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S    SQN +  
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNSQNKESA 277

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 148/267 (55%), Gaps = 6/267 (2%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECE 170
           K    LE +     +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E E
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVE 64
Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISA 229
           IQ HL HPNI++            LI E+A + ++   L++  +  E      ++ L +A
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L Y HS RV+HRD+KP+N+LL  +G   + DFG+  S+   +    ++ GT  Y+ PE+I
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW--SVHAPSSRRDTLCGTLDYLPPEMI 182
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +D   DLWSLG + YE  +G PPF+  +     R +   + TFP  V+E  +DL+ 
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLIS 242
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLS 376
            LL+ +ASQRL+  E+L HP +K N S
Sbjct: 243 RLLKHNASQRLTLAEVLEHPWIKANSS 269

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  162 bits (411), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 150/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 64
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T++ GT  Y+ PE+
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 182
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 281

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  162 bits (410), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 150/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 62
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T++ GT  Y+ PE+
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 180
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 279

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  162 bits (410), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 149/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 64
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T++ GT  Y+ PE 
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEX 182
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 243 SRLLKHNPSQRPXLREVLEHPWITANSSKPSNCQNKESA 281

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  162 bits (410), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 150/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 18  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 76
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 77  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 136
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T++ GT  Y+ PE+
Sbjct: 137 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 194
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 254
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 255 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 293

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  162 bits (409), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 97/277 (35%), Positives = 149/277 (53%), Gaps = 6/277 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 59
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T + GT  Y+ PE+
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEM 177
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQ 385
             LL+ + SQR    E+L HP +  N S     QN +
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  162 bits (409), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 149/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 60
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T + GT  Y+ PE+
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEM 178
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  162 bits (409), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 97/278 (34%), Positives = 148/278 (53%), Gaps = 6/278 (2%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECE 170
           K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E E
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVE 60
Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISA 229
           IQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +A
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T + GT  Y+ PE+I
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMI 178
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+ 
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 238
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
            LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 276

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  161 bits (408), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 150/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 85
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 86  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 145
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T++ GT  Y+ PE+
Sbjct: 146 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 203
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 263
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 264 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 302

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  161 bits (408), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 149/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 64
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T + GT  Y+ PE+
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEM 182
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 281

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  161 bits (407), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 96/274 (35%), Positives = 148/274 (54%), Gaps = 6/274 (2%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKH 174
           ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E EIQ H
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYL 233
           L HPNI++            LI E+A + ++   L++  K  E      ++ L +AL Y 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T++ GT  Y+ PE+I  R 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+  LL+
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 242
Query: 354 KDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
            + SQR    E+L HP +  N S     QN +  
Sbjct: 243 HNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 276

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 148/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 64
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A    +   L++  K  E      ++ L +
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELAN 124
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T++ GT  Y+ PE+
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 182
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 281

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 96/279 (34%), Positives = 150/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 61
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + +FG+  S+   +   T++ GT  Y+ PE+
Sbjct: 122 ALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW--SVHAPSSRRTTLCGTLDYLPPEM 179
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 239
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 240 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 278

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  160 bits (405), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/274 (35%), Positives = 147/274 (53%), Gaps = 6/274 (2%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKH 174
           ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E EIQ H
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYL 233
           L HPNI++            LI E+A + ++   L++  K  E      ++ L +AL Y 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T + GT  Y+ PE+I  R 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTELCGTLDYLPPEMIEGRM 182
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+  LL+
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 242
Query: 354 KDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
            + SQR    E+L HP +  N S     QN +  
Sbjct: 243 HNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 276

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  160 bits (405), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/279 (34%), Positives = 149/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 60
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +    ++ GT  Y+ PE+
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDTLCGTLDYLPPEM 178
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/280 (34%), Positives = 148/280 (52%), Gaps = 6/280 (2%)
Query: 111 MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQE 168
           M     ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E
Sbjct: 3   MGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRRE 61
Query: 169 CEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLI 227
            EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
           +AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +    ++ GT  Y+ PE
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPE 179
Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDL 347
           +I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 348 VKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
           +  LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 279

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  159 bits (403), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 95/268 (35%), Positives = 147/268 (54%), Gaps = 6/268 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 62
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T++ GT  Y+ PE+
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 180
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLS 376
             LL+ + SQR    E+L HP +  N S
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 96/279 (34%), Positives = 146/279 (52%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 64
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A    +   L++  K  E      ++ L +
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELAN 124
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +     + GT  Y+ PE+
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLXGTLDYLPPEM 182
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 281

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 96/279 (34%), Positives = 148/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 61
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +     + GT  Y+ PE+
Sbjct: 122 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEM 179
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 239
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 240 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 278

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  159 bits (402), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 146/267 (54%), Gaps = 6/267 (2%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECE 170
           K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E E
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVE 59
Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISA 229
           IQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +A
Sbjct: 60  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 119
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T++ GT  Y+ PE+I
Sbjct: 120 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMI 177
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+ 
Sbjct: 178 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 237
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLS 376
            LL+ + SQR    E+L HP +  N S
Sbjct: 238 RLLKHNPSQRPMLREVLEHPWITANSS 264

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  159 bits (401), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 146/267 (54%), Gaps = 6/267 (2%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECE 170
           K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E E
Sbjct: 6   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVE 64
Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISA 229
           IQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +A
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 124
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T++ GT  Y+ PE+I
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMI 182
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+ 
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 242
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLS 376
            LL+ + SQR    E+L HP +  N S
Sbjct: 243 RLLKHNPSQRPMLREVLEHPWITANSS 269

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  158 bits (400), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 96/279 (34%), Positives = 148/279 (53%), Gaps = 6/279 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 85
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 86  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 145
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +     + GT  Y+ PE+
Sbjct: 146 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDDLCGTLDYLPPEM 203
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 263
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDC 387
             LL+ + SQR    E+L HP +  N S     QN +  
Sbjct: 264 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 302

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  158 bits (399), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 145/267 (54%), Gaps = 6/267 (2%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECE 170
           K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E E
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVE 60
Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISA 229
           IQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +A
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T + GT  Y+ PE+I
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTXLCGTLDYLPPEMI 178
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+ 
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 238
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLS 376
            LL+ + SQR    E+L HP +  N S
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSS 265

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  158 bits (399), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 94/263 (35%), Positives = 145/263 (55%), Gaps = 6/263 (2%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKH 174
           ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E EIQ H
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 61
Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYL 233
           L HPNI++            LI E+A + ++   L++  K  E      ++ L +AL Y 
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 121
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T++ GT  Y+ PE+I  R 
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM 179
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+  LL+
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 239
Query: 354 KDASQRLSWPELLHHPLVKDNLS 376
            + SQR    E+L HP +  N S
Sbjct: 240 HNPSQRPMLREVLEHPWITANSS 262

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  157 bits (397), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 94/268 (35%), Positives = 147/268 (54%), Gaps = 6/268 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 62
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + +FG+  S+   +   T++ GT  Y+ PE+
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW--SVHAPSSRRTTLCGTLDYLPPEM 180
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLS 376
             LL+ + SQR    E+L HP +  N S
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 145/267 (54%), Gaps = 6/267 (2%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECE 170
           K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E E
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVE 60
Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISA 229
           IQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +A
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +    ++ GT  Y+ PE+I
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEMI 178
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+ 
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 238
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLS 376
            LL+ + SQR    E+L HP +  N S
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSS 265

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 94/268 (35%), Positives = 145/268 (54%), Gaps = 6/268 (2%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQEC 169
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREV 62
Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           EIQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           AL Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +     + GT  Y+ PE+
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEM 180
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           I  R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLS 376
             LL+ + SQR    E+L HP +  N S
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 144/267 (53%), Gaps = 6/267 (2%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECE 170
           K   ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E E
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVE 60
Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISA 229
           IQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +A
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +     + GT  Y+ PE+I
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEMI 178
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+ 
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 238
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLS 376
            LL+ + SQR    E+L HP +  N S
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSS 265

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  155 bits (392), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 146/267 (54%), Gaps = 6/267 (2%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECE 170
           K   ALE ++    +G+G FG V+ A   + K  +ALK++ K+   ++G E   L++E E
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVE-HQLRREVE 60
Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISA 229
           IQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +A
Sbjct: 61  IQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L Y HS +V+HRD+KP+N+LL   G   + DFG+  S+   +    ++ GT  Y+ PE+I
Sbjct: 121 LSYCHSKKVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEMI 178
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+ 
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLIS 238
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLS 376
            LL+ + SQR    E+L HP +  N S
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSS 265

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  155 bits (391), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 143/263 (54%), Gaps = 6/263 (2%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKH 174
           ALE ++    +G+G FG V+ A     K  +ALK++ K+   ++G E   L++E EIQ H
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYL 233
           L HPNI++            LI E+A + ++   L++  K  E      ++ L +AL Y 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS RV+HRD+KP+N+LL   G   + DFG+  S+   +     + GT  Y+ PE+I  R 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDDLCGTLDYLPPEMIEGRM 185
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+  LL+
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 245
Query: 354 KDASQRLSWPELLHHPLVKDNLS 376
            + SQR    E+L HP +  N S
Sbjct: 246 HNPSQRPMLREVLEHPWITANSS 268

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  148 bits (373), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 87/251 (34%), Positives = 135/251 (53%), Gaps = 9/251 (3%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +GEGS+G V+KAIH +  + VA+K +        +L  + +E  I +    P+++K+  S
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 187 HETLNEFVLITEF-AHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSNRVLHRDLK 244
           +    +  ++ E+    S+S+++  R K L+E     IL + +  L YLH  R +HRD+K
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIK 152
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLG 304
             N+LLN +G A L DFG A  +         + GTP +MAPE+I E  Y+  AD+WSLG
Sbjct: 153 AGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 305 CIAYEIHMGHPPFKTVSILHLIRLLKTQ-DVTF--PSQVSETYKDLVKGLLEKDASQRLS 361
             A E+  G PP+  +  +  I ++ T    TF  P   S+ + D VK  L K   QR +
Sbjct: 213 ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT 272
Query: 362 WPELLHHPLVK 372
             +LL HP V+
Sbjct: 273 ATQLLQHPFVR 283

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 12/261 (4%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           ++ I  +G+G+FGKV+KA + +     A K+I    +S +EL     E +I     HPNI
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNI 96
Query: 181 IKFIASHETLNEFVLITEFAHMSLSN--LLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           +K + +    N   ++ EF      +  +LE  + L+E+    +    + AL YLH N++
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 156
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-----AERP 293
           +HRDLK  N+L   DG   L DFG +           S  GTP +MAPE++      +RP
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILH-LIRLLKTQDVTF--PSQVSETYKDLVKG 350
           YD+ AD+WSLG    E+    PP   ++ +  L+++ K++  T   PS+ S  +KD +K 
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 276
Query: 351 LLEKDASQRLSWPELLHHPLV 371
            LEK+   R +  +LL HP V
Sbjct: 277 CLEKNVDARWTTSQLLQHPFV 297

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 145/268 (54%), Gaps = 10/268 (3%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+Y  +C++G+GSFG+V K      ++  A+K+I+K+    K+ S++ +E E+ K L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 179 NIIKFIASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+K     E  + F ++ E +    L + + +RK+ SE    +I+  + S + Y+H + 
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 238 VLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           ++HRDLKP+N+LL    KD    + DFG +      T M   I GT  Y+APE++    Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAPEVL-RGTY 199
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDLVKG 350
           D   D+WS G I Y +  G PPF   +   +++ ++T    F       +S+  KDL++ 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 351 LLEKDASQRLSWPELLHHPLVKDNLSSE 378
           +L    S R++  + L HP ++   S E
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSEE 287

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 12/261 (4%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           ++ I  +G+G+FGKV+KA + +     A K+I    +S +EL     E +I     HPNI
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNI 96
Query: 181 IKFIASHETLNEFVLITEFAHMSLSN--LLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           +K + +    N   ++ EF      +  +LE  + L+E+    +    + AL YLH N++
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 156
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-----AERP 293
           +HRDLK  N+L   DG   L DFG +           S  GTP +MAPE++      +RP
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILH-LIRLLKTQDVTF--PSQVSETYKDLVKG 350
           YD+ AD+WSLG    E+    PP   ++ +  L+++ K++  T   PS+ S  +KD +K 
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 276
Query: 351 LLEKDASQRLSWPELLHHPLV 371
            LEK+   R +  +LL HP V
Sbjct: 277 CLEKNVDARWTTSQLLQHPFV 297

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  145 bits (366), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 143/262 (54%), Gaps = 10/262 (3%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+Y  +C++G+GSFG+V K      ++  A+K+I+K+    K+ S++ +E E+ K L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 179 NIIKFIASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+K     E  + F ++ E +    L + + +RK+ SE    +I+  + S + Y+H + 
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 238 VLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           ++HRDLKP+N+LL    KD    + DFG +      T M   I GT  Y+APE++    Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAPEVL-RGTY 199
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDLVKG 350
           D   D+WS G I Y +  G PPF   +   +++ ++T    F       +S+  KDL++ 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 351 LLEKDASQRLSWPELLHHPLVK 372
           +L    S R++  + L HP ++
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQ 281

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  145 bits (365), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 143/262 (54%), Gaps = 10/262 (3%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+Y  +C++G+GSFG+V K      ++  A+K+I+K+    K+ S++ +E E+ K L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 179 NIIKFIASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+K     E  + F ++ E +    L + + +RK+ SE    +I+  + S + Y+H + 
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 238 VLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           ++HRDLKP+N+LL    KD    + DFG +      T M   I GT  Y+APE++    Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAPEVL-RGTY 199
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDLVKG 350
           D   D+WS G I Y +  G PPF   +   +++ ++T    F       +S+  KDL++ 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 351 LLEKDASQRLSWPELLHHPLVK 372
           +L    S R++  + L HP ++
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQ 281

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 136/261 (52%), Gaps = 12/261 (4%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           ++ I  +G+G+FGKV+KA + +     A K+I    +S +EL     E +I     HPNI
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNI 96
Query: 181 IKFIASHETLNEFVLITEFAHMSLSN--LLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           +K + +    N   ++ EF      +  +LE  + L+E+    +    + AL YLH N++
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 156
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-----AERP 293
           +HRDLK  N+L   DG   L DFG +              GTP +MAPE++      +RP
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILH-LIRLLKTQDVTF--PSQVSETYKDLVKG 350
           YD+ AD+WSLG    E+    PP   ++ +  L+++ K++  T   PS+ S  +KD +K 
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 276
Query: 351 LLEKDASQRLSWPELLHHPLV 371
            LEK+   R +  +LL HP V
Sbjct: 277 CLEKNVDARWTTSQLLQHPFV 297

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 135/269 (50%), Gaps = 6/269 (2%)
Query: 109 VKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLK 166
            +M K    ++ +  +  +G+G FG V+ A     K  +ALK++ KS   + G E   L+
Sbjct: 4   AEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-HQLR 62
Query: 167 QECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSN 225
           +E EIQ HL HPNI++            L+ EFA    L   L++  +  E      +  
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           L  AL+Y H  +V+HRD+KP+N+L+   G   + DFG+  S+   +     + GT  Y+ 
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRXMCGTLDYLP 180
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + +D   DLW  G + YE  +G PPF + S     R +   D+ FP  +S+  K
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 240
Query: 346 DLVKGLLEKDASQRLSWPELLHHPLVKDN 374
           DL+  LL     QRL    ++ HP VK N
Sbjct: 241 DLISKLLRYHPPQRLPLKGVMEHPWVKAN 269

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  141 bits (356), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 144/267 (53%), Gaps = 18/267 (6%)
Query: 119 EKYQKICLIGEGSFGKVF----KAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH 174
           E YQ++  +G G++G+V     K  H++     A+KII K+  S    S L +E  + K 
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVER----AIKIIRKTSVSTSSNSKLLEEVAVLKL 92
Query: 175 LAHPNIIKFIASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
           L HPNI+K     E    + L+ E +    L + +  R K +E     I+  ++S + YL
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152
Query: 234 HSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           H + ++HRDLKP+N+LL    KD +  + DFG +        M   + GT  Y+APE++ 
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-GTAYYIAPEVLR 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKD 346
           ++ YD   D+WS+G I + +  G+PPF   +   ++R ++    TF S     VSE  KD
Sbjct: 212 KK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270
Query: 347 LVKGLLEKDASQRLSWPELLHHPLVKD 373
           L+K +L+ D+ +R+S  + L HP +K+
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWIKE 297

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 134/269 (49%), Gaps = 6/269 (2%)
Query: 109 VKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLK 166
            +M K    ++ +     +G+G FG V+ A     K  +ALK++ KS   + G E   L+
Sbjct: 5   AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-HQLR 63
Query: 167 QECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSN 225
           +E EIQ HL HPNI++            L+ EFA    L   L++  +  E      +  
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 123
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           L  AL+Y H  +V+HRD+KP+N+L+   G   + DFG+  S+   +     + GT  Y+ 
Sbjct: 124 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRXMCGTLDYLP 181
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + +D   DLW  G + YE  +G PPF + S     R +   D+ FP  +S+  K
Sbjct: 182 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 241
Query: 346 DLVKGLLEKDASQRLSWPELLHHPLVKDN 374
           DL+  LL     QRL    ++ HP VK N
Sbjct: 242 DLISKLLRYHPPQRLPLKGVMEHPWVKAN 270

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/254 (31%), Positives = 144/254 (56%), Gaps = 10/254 (3%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G G+F +V  A     +K VA+K I+K    GKE  S++ E  +   + HPNI+    
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVLHKIKHPNIVALDD 83
Query: 186 SHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E+     LI +  +   L + + ++   +E    +++  ++ A+ YLH   ++HRDLK
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 245 PQNVL---LNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLW 301
           P+N+L   L++D   M+ DFG ++    G+ +L++  GTP Y+APE++A++PY    D W
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCW 202
Query: 302 SLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQ---DVTFPSQVSETYKDLVKGLLEKDAS 357
           S+G IAY +  G+PPF   +   L  ++LK +   D  +   +S++ KD ++ L+EKD  
Sbjct: 203 SIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPE 262
Query: 358 QRLSWPELLHHPLV 371
           +R +  + L HP +
Sbjct: 263 KRFTCEQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/254 (31%), Positives = 144/254 (56%), Gaps = 10/254 (3%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G G+F +V  A     +K VA+K I+K    GKE  S++ E  +   + HPNI+    
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVLHKIKHPNIVALDD 83
Query: 186 SHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E+     LI +  +   L + + ++   +E    +++  ++ A+ YLH   ++HRDLK
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 245 PQNVL---LNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLW 301
           P+N+L   L++D   M+ DFG ++    G+ +L++  GTP Y+APE++A++PY    D W
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCW 202
Query: 302 SLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQ---DVTFPSQVSETYKDLVKGLLEKDAS 357
           S+G IAY +  G+PPF   +   L  ++LK +   D  +   +S++ KD ++ L+EKD  
Sbjct: 203 SIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPE 262
Query: 358 QRLSWPELLHHPLV 371
           +R +  + L HP +
Sbjct: 263 KRFTCEQALQHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/259 (31%), Positives = 146/259 (56%), Gaps = 10/259 (3%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G G+F +V  A     +K VA+K I+K    GKE  S++ E  +   + HPNI+    
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVLHKIKHPNIVALDD 83
Query: 186 SHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E+     LI +  +   L + + ++   +E    +++  ++ A+ YLH   ++HRDLK
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 245 PQNVL---LNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLW 301
           P+N+L   L++D   M+ DFG ++    G+ +L++  GTP Y+APE++A++PY    D W
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCW 202
Query: 302 SLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQ---DVTFPSQVSETYKDLVKGLLEKDAS 357
           S+G IAY +  G+PPF   +   L  ++LK +   D  +   +S++ KD ++ L+EKD  
Sbjct: 203 SIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPE 262
Query: 358 QRLSWPELLHHPLVKDNLS 376
           +R +  + L HP +  + +
Sbjct: 263 KRFTCEQALQHPWIAGDTA 281

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 140/258 (54%), Gaps = 7/258 (2%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY +   IG+G+ G V+ A+ +   + VA++ ++   +  KEL  +  E  + +   +P
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77
Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+ ++ S+   +E  ++ E+ A  SL++++ +   + E     +    + AL +LHSN+
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           V+HRD+K  N+LL  DG   L DFGF   +       + + GTP +MAPE++  + Y   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 298 ADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
            D+WSLG +A E+  G PP+     +  L+LI    T ++  P ++S  ++D +   LE 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 256
Query: 355 DASQRLSWPELLHHPLVK 372
           D  +R S  ELL H  +K
Sbjct: 257 DVEKRGSAKELLQHQFLK 274

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/254 (31%), Positives = 144/254 (56%), Gaps = 10/254 (3%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G G+F +V  A     +K VA+K I+K    GKE  S++ E  +   + HPNI+    
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNIVALDD 83
Query: 186 SHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E+     LI +  +   L + + ++   +E    +++  ++ A+ YLH   ++HRDLK
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 245 PQNVL---LNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLW 301
           P+N+L   L++D   M+ DFG ++    G+ +L++  GTP Y+APE++A++PY    D W
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCW 202
Query: 302 SLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQ---DVTFPSQVSETYKDLVKGLLEKDAS 357
           S+G IAY +  G+PPF   +   L  ++LK +   D  +   +S++ KD ++ L+EKD  
Sbjct: 203 SIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPE 262
Query: 358 QRLSWPELLHHPLV 371
           +R +  + L HP +
Sbjct: 263 KRFTCEQALQHPWI 276

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  139 bits (349), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 141/258 (54%), Gaps = 7/258 (2%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY +   IG+G+ G V+ A+ +   + VA++ ++   +  KEL  +  E  + +   +P
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77
Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+ ++ S+   +E  ++ E+ A  SL++++ +   + E     +    + AL +LHSN+
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           V+HRD+K  N+LL  DG   L DFGF   +       +++ GTP +MAPE++  + Y   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 298 ADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
            D+WSLG +A E+  G PP+     +  L+LI    T ++  P ++S  ++D +   L+ 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 355 DASQRLSWPELLHHPLVK 372
           D  +R S  ELL H  +K
Sbjct: 257 DVEKRGSAKELLQHQFLK 274

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 91/257 (35%), Positives = 130/257 (50%), Gaps = 8/257 (3%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E + K+  IG+GSFG+V+K I    K+ VA+KII        E+  ++QE  +      P
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSP 77
Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            I ++  S+    +  +I E+     +  L +   L ET    IL  ++  L YLHS R 
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK 137
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           +HRD+K  NVLL++ G   L DFG A  +           GTP +MAPE+I +  YD  A
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKA 197
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLL----KTQDVTFPSQVSETYKDLVKGLLEK 354
           D+WSLG  A E+  G PP    S LH +R+L    K    T   Q S+ +K+ V+  L K
Sbjct: 198 DIWSLGITAIELAKGEPP---NSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNK 254
Query: 355 DASQRLSWPELLHHPLV 371
           D   R +  ELL H  +
Sbjct: 255 DPRFRPTAKELLKHKFI 271

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  138 bits (348), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 95/302 (31%), Positives = 156/302 (51%), Gaps = 17/302 (5%)
Query: 98  GEPWFHNHCQPVKMEKSNGAL--EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS 155
           G P  H H  P    + + A+  ++Y+   ++G+GSFG+V         +  A+K+ISK 
Sbjct: 26  GGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 85
Query: 156 GRSGK-ELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE-FAHMSLSNLLEQRKK 213
               K +  SL +E ++ K L HPNI+K     E    F L+ E +    L + +  RK+
Sbjct: 86  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 145
Query: 214 LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVG 270
            SE    +I+  ++S + Y+H N+++HRDLKP+N+LL   +KD    + DFG +      
Sbjct: 146 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 205
Query: 271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLK 330
             M   I GT  Y+APE++    YD   D+WS G I Y +  G PPF   +   +++ ++
Sbjct: 206 KKMKDKI-GTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 263
Query: 331 TQDVTFP----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV----KDNLSSEIESQ 382
               TF      +VSE+ KDL++ +L    S R+S  + L H  +    K+ +S ++ S 
Sbjct: 264 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSL 323
Query: 383 NN 384
           +N
Sbjct: 324 DN 325

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  138 bits (348), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 140/258 (54%), Gaps = 7/258 (2%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY +   IG+G+ G V+ A+ +   + VA++ ++   +  KEL  +  E  + +   +P
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 78
Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+ ++ S+   +E  ++ E+ A  SL++++ +   + E     +    + AL +LHSN+
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           V+HRD+K  N+LL  DG   L DFGF   +       + + GTP +MAPE++  + Y   
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 298 ADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
            D+WSLG +A E+  G PP+     +  L+LI    T ++  P ++S  ++D +   LE 
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 257
Query: 355 DASQRLSWPELLHHPLVK 372
           D  +R S  EL+ H  +K
Sbjct: 258 DVEKRGSAKELIQHQFLK 275

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  138 bits (348), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 95/302 (31%), Positives = 156/302 (51%), Gaps = 17/302 (5%)
Query: 98  GEPWFHNHCQPVKMEKSNGAL--EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS 155
           G P  H H  P    + + A+  ++Y+   ++G+GSFG+V         +  A+K+ISK 
Sbjct: 27  GGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 86
Query: 156 GRSGK-ELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE-FAHMSLSNLLEQRKK 213
               K +  SL +E ++ K L HPNI+K     E    F L+ E +    L + +  RK+
Sbjct: 87  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 146
Query: 214 LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVG 270
            SE    +I+  ++S + Y+H N+++HRDLKP+N+LL   +KD    + DFG +      
Sbjct: 147 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 206
Query: 271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLK 330
             M   I GT  Y+APE++    YD   D+WS G I Y +  G PPF   +   +++ ++
Sbjct: 207 KKMKDKI-GTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 264
Query: 331 TQDVTFP----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV----KDNLSSEIESQ 382
               TF      +VSE+ KDL++ +L    S R+S  + L H  +    K+ +S ++ S 
Sbjct: 265 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSL 324
Query: 383 NN 384
           +N
Sbjct: 325 DN 326

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  138 bits (347), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 140/258 (54%), Gaps = 7/258 (2%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY +   IG+G+ G V+ A+ +   + VA++ ++   +  KEL  +  E  + +   +P
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77
Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+ ++ S+   +E  ++ E+ A  SL++++ +   + E     +    + AL +LHSN+
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           V+HRD+K  N+LL  DG   L DFGF   +       + + GTP +MAPE++  + Y   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 298 ADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
            D+WSLG +A E+  G PP+     +  L+LI    T ++  P ++S  ++D +   L+ 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 355 DASQRLSWPELLHHPLVK 372
           D  +R S  ELL H  +K
Sbjct: 257 DVEKRGSAKELLQHQFLK 274

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 142/265 (53%), Gaps = 5/265 (1%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKHL 175
           +E ++   L+G+GSF  V++A  +     VA+K+I K    ++G  +  ++ E +I   L
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM-VQRVQNEVKIHCQL 68
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQR-KKLSETICVQILSNLISALYYL 233
            HP+I++     E  N   L+ E  H   ++  L+ R K  SE      +  +I+ + YL
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+ +LHRDL   N+LL ++    + DFG A  + +      ++ GTP Y++PE+     
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           +   +D+WSLGC+ Y + +G PPF T ++ + +  +   D   PS +S   KDL+  LL 
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLR 248
Query: 354 KDASQRLSWPELLHHPLVKDNLSSE 378
           ++ + RLS   +L HP +  N S++
Sbjct: 249 RNPADRLSLSSVLDHPFMSRNSSTK 273

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 141/258 (54%), Gaps = 7/258 (2%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY +   IG+G+ G V+ A+ +   + VA++ ++   +  KEL  +  E  + +   +P
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 78
Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+ ++ S+   +E  ++ E+ A  SL++++ +   + E     +    + AL +LHSN+
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           V+HR++K  N+LL  DG   L DFGF   +       +++ GTP +MAPE++  + Y   
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 197
Query: 298 ADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
            D+WSLG +A E+  G PP+     +  L+LI    T ++  P ++S  ++D +   LE 
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 257
Query: 355 DASQRLSWPELLHHPLVK 372
           D  +R S  EL+ H  +K
Sbjct: 258 DVEKRGSAKELIQHQFLK 275

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  136 bits (342), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 79/253 (31%), Positives = 139/253 (54%), Gaps = 10/253 (3%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G+F +V  A      K  A+K I K    GKE SS++ E  + + + H NI+     
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKE-SSIENEIAVLRKIKHENIVALEDI 88
Query: 187 HETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
           +E+ N   L+ +  +   L + + ++   +E     ++  ++ A+YYLH   ++HRDLKP
Sbjct: 89  YESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKP 148
Query: 246 QNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           +N+L    +++   M+ DFG ++    G  M T+  GTP Y+APE++A++PY    D WS
Sbjct: 149 ENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTAC-GTPGYVAPEVLAQKPYSKAVDCWS 207
Query: 303 LGCIAYEIHMGHPPFKTVSILHLI-RLLKTQ---DVTFPSQVSETYKDLVKGLLEKDASQ 358
           +G IAY +  G+PPF   +   L  ++LK +   D  +   +S++ KD ++ L+EKD ++
Sbjct: 208 IGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNK 267
Query: 359 RLSWPELLHHPLV 371
           R +  +   HP +
Sbjct: 268 RYTCEQAARHPWI 280

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 142/265 (53%), Gaps = 11/265 (4%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS-SLKQECEIQKH 174
           G  ++YQ++  +G G++G+V            A+KII KS  +    S +L  E  + K 
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 175 LAHPNIIKFIASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
           L HPNI+K     E    + L+ E +    L + +  R+K SE     I+  ++S   YL
Sbjct: 61  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 234 HSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           H + ++HRDLKP+N+LL   ++D +  + DFG +    VG  M   + GT  Y+APE++ 
Sbjct: 121 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-GTAYYIAPEVLR 179
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKD 346
           ++ YD   D+WS G I Y +  G+PPF   +   +++ ++    +F     +QVS+  K 
Sbjct: 180 KK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQ 238
Query: 347 LVKGLLEKDASQRLSWPELLHHPLV 371
           LVK +L  + S+R+S  E L+HP +
Sbjct: 239 LVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 154/297 (51%), Gaps = 17/297 (5%)
Query: 103 HNHCQPVKMEKSNGAL--EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK 160
           H H  P    + + A+  ++Y+   ++G+GSFG+V         +  A+K+ISK     K
Sbjct: 8   HLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK 67
Query: 161 -ELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETI 218
            +  SL +E ++ K L HPNI+K     E    F L+ E +    L + +  RK+ SE  
Sbjct: 68  TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 127
Query: 219 CVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLT 275
             +I+  ++S + Y+H N+++HRDLKP+N+LL   +KD    + DFG +        M  
Sbjct: 128 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187
Query: 276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT 335
            I GT  Y+APE++    YD   D+WS G I Y +  G PPF   +   +++ ++    T
Sbjct: 188 KI-GTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 336 FP----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV----KDNLSSEIESQNN 384
           F      +VSE+ KDL++ +L    S R+S  + L H  +    K+ +S ++ S +N
Sbjct: 246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDN 302

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 142/266 (53%), Gaps = 11/266 (4%)
Query: 115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS-SLKQECEIQK 173
            G  ++YQ++  +G G++G+V            A+KII KS  +    S +L  E  + K
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 174 HLAHPNIIKFIASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
            L HPNI+K     E    + L+ E +    L + +  R+K SE     I+  ++S   Y
Sbjct: 77  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTY 136
Query: 233 LHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           LH + ++HRDLKP+N+LL   ++D +  + DFG +    VG  M   + GT  Y+APE++
Sbjct: 137 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-GTAYYIAPEVL 195
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYK 345
            ++ YD   D+WS G I Y +  G+PPF   +   +++ ++    +F     +QVS+  K
Sbjct: 196 RKK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAK 254
Query: 346 DLVKGLLEKDASQRLSWPELLHHPLV 371
            LVK +L  + S+R+S  E L+HP +
Sbjct: 255 QLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 90/258 (34%), Positives = 132/258 (51%), Gaps = 4/258 (1%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E + K+  IG+GSFG+VFK I    +K VA+KII        E+  ++QE  +      P
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSP 65
Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
            + K+  S+    +  +I E+    S  +LLE    L ET    IL  ++  L YLHS +
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK 124
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
            +HRD+K  NVLL++ G   L DFG A  +        +  GTP +MAPE+I +  YD  
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 184
Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDA 356
           AD+WSLG  A E+  G PP   +  + ++ L+ K    T     S+  K+ V+  L K+ 
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 244
Query: 357 SQRLSWPELLHHPLVKDN 374
           S R +  ELL H  +  N
Sbjct: 245 SFRPTAKELLKHKFILRN 262

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 90/258 (34%), Positives = 132/258 (51%), Gaps = 4/258 (1%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E + K+  IG+GSFG+VFK I    +K VA+KII        E+  ++QE  +      P
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSP 85
Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
            + K+  S+    +  +I E+    S  +LLE    L ET    IL  ++  L YLHS +
Sbjct: 86  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK 144
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
            +HRD+K  NVLL++ G   L DFG A  +        +  GTP +MAPE+I +  YD  
Sbjct: 145 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 204
Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDA 356
           AD+WSLG  A E+  G PP   +  + ++ L+ K    T     S+  K+ V+  L K+ 
Sbjct: 205 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 264
Query: 357 SQRLSWPELLHHPLVKDN 374
           S R +  ELL H  +  N
Sbjct: 265 SFRPTAKELLKHKFILRN 282

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/258 (34%), Positives = 131/258 (50%), Gaps = 4/258 (1%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E + K+  IG+GSFG+VFK I    +K VA+KII        E+  ++QE  +      P
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSP 80
Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
            + K+  S+    +  +I E+    S  +LLE    L ET    IL  ++  L YLHS +
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK 139
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
            +HRD+K  NVLL++ G   L DFG A  +           GTP +MAPE+I +  YD  
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSK 199
Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDA 356
           AD+WSLG  A E+  G PP   +  + ++ L+ K    T     S+  K+ V+  L K+ 
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 357 SQRLSWPELLHHPLVKDN 374
           S R +  ELL H  +  N
Sbjct: 260 SFRPTAKELLKHKFILRN 277

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 132/251 (52%), Gaps = 6/251 (2%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G+G FG V+ A        VALK++ KS   + G E   L++E EIQ HL HPNI++  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVE-HQLRREIEIQAHLHHPNILRLY 89
Query: 185 ASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
                     LI E+A    L   L++     E     I+  L  AL Y H  +V+HRD+
Sbjct: 90  NYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDI 149
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSL 303
           KP+N+LL   G   + DFG+  S+   +    ++ GT  Y+ PE+I  R ++   DLW +
Sbjct: 150 KPENLLLGLKGELKIADFGW--SVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCI 207
Query: 304 GCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWP 363
           G + YE+ +G+PPF++ S     R +   D+ FP+ V    +DL+  LL  + S+RL   
Sbjct: 208 GVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRHNPSERLPLA 267
Query: 364 ELLHHPLVKDN 374
           ++  HP V+ N
Sbjct: 268 QVSAHPWVRAN 278

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/258 (34%), Positives = 131/258 (50%), Gaps = 4/258 (1%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E + K+  IG+GSFG+VFK I    +K VA+KII        E+  ++QE  +      P
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSP 65
Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
            + K+  S+    +  +I E+    S  +LLE    L ET    IL  ++  L YLHS +
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK 124
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
            +HRD+K  NVLL++ G   L DFG A  +           GTP +MAPE+I +  YD  
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSK 184
Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDA 356
           AD+WSLG  A E+  G PP   +  + ++ L+ K    T     S+  K+ V+  L K+ 
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 244
Query: 357 SQRLSWPELLHHPLVKDN 374
           S R +  ELL H  +  N
Sbjct: 245 SFRPTAKELLKHKFILRN 262

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 143/265 (53%), Gaps = 4/265 (1%)
Query: 114 SNGA-LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSS-LKQECEI 171
           ++GA +  YQ +  +GEGSFGKV  A H    + VALKII+K   +  ++   +++E   
Sbjct: 8   ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 67
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
            + L HP+IIK     ++ +E +++ E+A   L + + QR K+SE    +    +ISA+ 
Sbjct: 68  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE 127
Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           Y H ++++HRDLKP+N+LL++     + DFG +  M  G  + TS  G+P Y APE+I+ 
Sbjct: 128 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAPEVISG 186
Query: 292 RPY-DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
           + Y     D+WS G I Y +     PF   SI  L + +     T P  +S     L+K 
Sbjct: 187 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKR 246
Query: 351 LLEKDASQRLSWPELLHHPLVKDNL 375
           +L  +   R+S  E++     K +L
Sbjct: 247 MLIVNPLNRISIHEIMQDDWFKVDL 271

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 143/265 (53%), Gaps = 4/265 (1%)
Query: 114 SNGA-LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSS-LKQECEI 171
           ++GA +  YQ +  +GEGSFGKV  A H    + VALKII+K   +  ++   +++E   
Sbjct: 7   ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 66
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
            + L HP+IIK     ++ +E +++ E+A   L + + QR K+SE    +    +ISA+ 
Sbjct: 67  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE 126
Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           Y H ++++HRDLKP+N+LL++     + DFG +  M  G  + TS  G+P Y APE+I+ 
Sbjct: 127 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAPEVISG 185
Query: 292 RPY-DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
           + Y     D+WS G I Y +     PF   SI  L + +     T P  +S     L+K 
Sbjct: 186 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKR 245
Query: 351 LLEKDASQRLSWPELLHHPLVKDNL 375
           +L  +   R+S  E++     K +L
Sbjct: 246 MLIVNPLNRISIHEIMQDDWFKVDL 270

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 143/266 (53%), Gaps = 4/266 (1%)
Query: 114 SNGA-LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSS-LKQECEI 171
           ++GA +  YQ +  +GEGSFGKV  A H    + VALKII+K   +  ++   +++E   
Sbjct: 2   ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 61
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
            + L HP+IIK     ++ +E +++ E+A   L + + QR K+SE    +    +ISA+ 
Sbjct: 62  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE 121
Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           Y H ++++HRDLKP+N+LL++     + DFG +  M  G  + TS  G+P Y APE+I+ 
Sbjct: 122 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAPEVISG 180
Query: 292 RPY-DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
           + Y     D+WS G I Y +     PF   SI  L + +     T P  +S     L+K 
Sbjct: 181 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKR 240
Query: 351 LLEKDASQRLSWPELLHHPLVKDNLS 376
           +L  +   R+S  E++     K +L 
Sbjct: 241 MLIVNPLNRISIHEIMQDDWFKVDLP 266

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 86/258 (33%), Positives = 138/258 (53%), Gaps = 3/258 (1%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSS-LKQECEIQKHLAHPN 179
           YQ +  +GEGSFGKV  A H    + VALKII+K   +  ++   +++E    + L HP+
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 180 IIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           IIK     ++ +E +++ E+A   L + + QR K+SE    +    +ISA+ Y H ++++
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIV 125
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY-DHTA 298
           HRDLKP+N+LL++     + DFG +  M  G  + TS  G+P Y APE+I+ + Y     
Sbjct: 126 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAPEVISGKLYAGPEV 184
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D+WS G I Y +     PF   SI  L + +     T P  +S     L+K +L  +   
Sbjct: 185 DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 244
Query: 359 RLSWPELLHHPLVKDNLS 376
           R+S  E++     K +L 
Sbjct: 245 RISIHEIMQDDWFKVDLP 262

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 141/264 (53%), Gaps = 23/264 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISK--SGRSGKELSSLKQECEIQKHLAHPNIIKF- 183
           +GEGSF    K +H    +  A+KIISK     + KE+++LK  CE      HPNI+K  
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKL-CE-----GHPNIVKLH 72
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              H+ L+ F+++       L   ++++K  SET    I+  L+SA+ ++H   V+HRDL
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDL 132
Query: 244 KPQNVLLNKDGVAM---LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADL 300
           KP+N+L   +   +   + DFGFAR        L +   T  Y APEL+ +  YD + DL
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDL 192
Query: 301 WSLGCIAYEIHMGHPPFKT-------VSILHLIRLLKTQDVTFPSQ----VSETYKDLVK 349
           WSLG I Y +  G  PF++        S + +++ +K  D +F  +    VS+  KDL++
Sbjct: 193 WSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQ 252
Query: 350 GLLEKDASQRLSWPELLHHPLVKD 373
           GLL  D ++RL    L ++  ++D
Sbjct: 253 GLLTVDPNKRLKMSGLRYNEWLQD 276

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 137/263 (52%), Gaps = 12/263 (4%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E ++ +  +G+G+FGKV+KA + +     A K+I    +S +EL     E EI     HP
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYIVEIEILATCDHP 76
Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSN--LLEQRKKLSETICVQILSNLISALYYLHSN 236
            I+K + ++    +  ++ EF      +  +LE  + L+E     +   ++ AL +LHS 
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-----AE 291
           R++HRDLK  NVL+  +G   L DFG +           S  GTP +MAPE++      +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH-LIRLLKTQDVTF--PSQVSETYKDLV 348
            PYD+ AD+WSLG    E+    PP   ++ +  L+++ K+   T   PS+ S  ++D +
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256
Query: 349 KGLLEKDASQRLSWPELLHHPLV 371
           K  L+K+   R S  +LL HP V
Sbjct: 257 KIALDKNPETRPSAAQLLEHPFV 279

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 95/290 (32%), Positives = 137/290 (47%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 180
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 151/299 (50%), Gaps = 13/299 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKEL-SSLKQECEIQKHLAHPNIIKFIA 185
           +GEGSFGKV  A H   ++ VALK IS+      ++   +++E    K L HP+IIK   
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 186 SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
              T  + V++ E+A   L + + ++K+++E    +    +I A+ Y H ++++HRDLKP
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKP 136
Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY-DHTADLWSLG 304
           +N+LL+ +    + DFG +  M  G  + TS  G+P Y APE+I  + Y     D+WS G
Sbjct: 137 ENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 305 CIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPE 364
            + Y + +G  PF    I +L + + +     P  +S   + L++ ++  D  QR++  E
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQE 255
Query: 365 LLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRK------SITTIVES-DSDENEE 416
           +   P    NL   +        +   Y D R  S+       S   IVE+  SDEN E
Sbjct: 256 IRRDPWFNVNLPDYLRPMEE---VQGSYADSRIVSKLGEAMGFSEDYIVEALRSDENNE 311

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 134/251 (53%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H +     A+KI+ K     +++  LKQ      E  I
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 95
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
           Q+ +  P ++K   S +  +   ++ E+A    + + L +  + SE       + ++   
Sbjct: 96  QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---GTPEYLAPEIIL 212
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 273 LLQVDLTKRFG 283

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  131 bits (330), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 137/263 (52%), Gaps = 12/263 (4%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E ++ +  +G+G+FGKV+KA + +     A K+I    +S +EL     E EI     HP
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYIVEIEILATCDHP 68
Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSN--LLEQRKKLSETICVQILSNLISALYYLHSN 236
            I+K + ++    +  ++ EF      +  +LE  + L+E     +   ++ AL +LHS 
Sbjct: 69  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA-----E 291
           R++HRDLK  NVL+  +G   L DFG +           S  GTP +MAPE++      +
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH-LIRLLKTQDVTF--PSQVSETYKDLV 348
            PYD+ AD+WSLG    E+    PP   ++ +  L+++ K+   T   PS+ S  ++D +
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 248
Query: 349 KGLLEKDASQRLSWPELLHHPLV 371
           K  L+K+   R S  +LL HP V
Sbjct: 249 KIALDKNPETRPSAAQLLEHPFV 271

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 139/263 (52%), Gaps = 11/263 (4%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAH 177
           ++Y+   ++G+GSFG+V         +  A+K+ISK     K +  SL +E ++ K L H
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 178 PNIIKFIASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           PNI+K     E    F L+ E +    L + +  RK+ SE    +I+  ++S + Y+H N
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 151
Query: 237 RVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           +++HRDLKP+N+LL   +KD    + DFG +        M   I GT  Y+APE++    
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-GTAYYIAPEVL-HGT 209
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDLVK 349
           YD   D+WS G I Y +  G PPF   +   +++ ++    TF      +VSE+ KDL++
Sbjct: 210 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 269
Query: 350 GLLEKDASQRLSWPELLHHPLVK 372
            +L    S R+S  + L H  ++
Sbjct: 270 KMLTYVPSMRISARDALDHEWIQ 292

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 145/274 (52%), Gaps = 10/274 (3%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHL 175
           +L+ +Q +  +G GSFG+V         +  A+K++ K      K++     E  +   +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP II+   + +   +  +I ++     L +LL + ++    +     + +  AL YLH
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S  +++RDLKP+N+LL+K+G   + DFGFA+ +   T+ L    GTP Y+APE+++ +PY
Sbjct: 124 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC---GTPDYIAPEVVSTKPY 180
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
           + + D WS G + YE+  G+ PF   + +     +   ++ FP   +E  KDL+  L+ +
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR 240
Query: 355 DASQRL-----SWPELLHHPLVKDNLSSEIESQN 383
           D SQRL        ++ +HP  K+ +  ++ S+N
Sbjct: 241 DLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRN 274

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 134/251 (53%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + ++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 136/259 (52%), Gaps = 12/259 (4%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G G+F +VF        K  ALK I KS       SSL+ E  + K + H NI+    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 186 SHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E+   + L+ +      L + + +R   +E     ++  ++SA+ YLH N ++HRDLK
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK 133
Query: 245 PQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLW 301
           P+N+L     ++   M+ DFG ++    G  ++++  GTP Y+APE++A++PY    D W
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCW 191
Query: 302 SLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLVKGLLEKDAS 357
           S+G I Y +  G+PPF   +   L   +K     F S     +SE+ KD +  LLEKD +
Sbjct: 192 SIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPN 251
Query: 358 QRLSWPELLHHPLVKDNLS 376
           +R +  + L HP +  N +
Sbjct: 252 ERYTCEKALSHPWIDGNTA 270

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/302 (31%), Positives = 153/302 (50%), Gaps = 27/302 (8%)
Query: 103 HNHCQPVKMEKSNGAL--EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK 160
           H H  P    + + A+  ++Y+   ++G+GSFG+V         +  A+K+ISK     K
Sbjct: 8   HLHATPGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK 67
Query: 161 -ELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETI 218
            +  SL +E ++ K L HPNI K     E    F L+ E +    L + +  RK+ SE  
Sbjct: 68  TDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 127
Query: 219 CVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLT 275
             +I+  ++S + Y H N+++HRDLKP+N+LL   +KD    + DFG +      TH   
Sbjct: 128 AARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS------THFEA 181
Query: 276 SIK-----GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLK 330
           S K     GT  Y+APE++    YD   D+WS G I Y +  G PPF   +   +++ ++
Sbjct: 182 SKKXKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240
Query: 331 TQDVTFP----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV----KDNLSSEIESQ 382
               TF      +VSE+ KDL++  L    S R+S  + L H  +    K+ +S ++ S 
Sbjct: 241 KGKYTFELPQWKKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQTYTKEQISVDVPSL 300
Query: 383 NN 384
           +N
Sbjct: 301 DN 302

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 134/251 (53%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+A    + + L +  + SE       + ++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+++++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 129/252 (51%), Gaps = 2/252 (0%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL 175
            +++Y +   +G+G F K ++   +D K+  A K++ KS      +   +  E  I K L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLH 234
            +P+++ F    E  +   ++ E     SL  L ++RK ++E      +   I  + YLH
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           +NRV+HRDLK  N+ LN D    + DFG A  +        ++ GTP Y+APE++ ++ +
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
               D+WSLGCI Y + +G PPF+T  +      +K  + + P  ++     L++ +L  
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHA 279
Query: 355 DASQRLSWPELL 366
           D + R S  ELL
Sbjct: 280 DPTLRPSVAELL 291

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 137/290 (47%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF  M L + ++      +   +    L  L+  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  IG GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  IG GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 135/288 (46%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 181
Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS-------- 341
            TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S        
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 342 ----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                           E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 135/288 (46%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y 
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 188
Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS-------- 341
            TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S        
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 248
Query: 342 ----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                           E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 249 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  IG GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 2/252 (0%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL 175
            +++Y +   +G+G F K ++   +D K+  A K++ KS      +   +  E  I K L
Sbjct: 24  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 83
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLH 234
            +P+++ F    E  +   ++ E     SL  L ++RK ++E      +   I  + YLH
Sbjct: 84  DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 143
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           +NRV+HRDLK  N+ LN D    + DFG A  +         + GTP Y+APE++ ++ +
Sbjct: 144 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
               D+WSLGCI Y + +G PPF+T  +      +K  + + P  ++     L++ +L  
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHA 263
Query: 355 DASQRLSWPELL 366
           D + R S  ELL
Sbjct: 264 DPTLRPSVAELL 275

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 137/290 (47%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF  M L + ++      +   +    L  L+  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 134/251 (53%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+A    + + L +  + SE       + ++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+++++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 2/252 (0%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL 175
            +++Y +   +G+G F K ++   +D K+  A K++ KS      +   +  E  I K L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLH 234
            +P+++ F    E  +   ++ E     SL  L ++RK ++E      +   I  + YLH
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           +NRV+HRDLK  N+ LN D    + DFG A  +         + GTP Y+APE++ ++ +
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
               D+WSLGCI Y + +G PPF+T  +      +K  + + P  ++     L++ +L  
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHA 279
Query: 355 DASQRLSWPELL 366
           D + R S  ELL
Sbjct: 280 DPTLRPSVAELL 291

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 183
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 243
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 244 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 84/260 (32%), Positives = 130/260 (50%), Gaps = 8/260 (3%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E + K+  IG+GSFG+VFK I    ++ VA+KII        E+  ++QE  +       
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSS 81
Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            + K+  S+   ++  +I E+     +  L +     E     +L  ++  L YLHS + 
Sbjct: 82  YVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK 141
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           +HRD+K  NVLL++ G   L DFG A  +        +  GTP +MAPE+I +  YD  A
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 201
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLL----KTQDVTFPSQVSETYKDLVKGLLEK 354
           D+WSLG  A E+  G PP    S +H +R+L    K    T     ++++K+ +   L K
Sbjct: 202 DIWSLGITAIELAKGEPP---NSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNK 258
Query: 355 DASQRLSWPELLHHPLVKDN 374
           D S R +  ELL H  +  N
Sbjct: 259 DPSFRPTAKELLKHKFIVKN 278

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  129 bits (324), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 95
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---GTPEYLAPEIIL 212
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 273 LLQVDLTKRFG 283

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  129 bits (324), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 94/289 (32%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L 
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLH 234
           HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S+RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 295 DHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------- 341
             TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S       
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 342 -----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                            E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 95
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 212
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 273 LLQVDLTKRFG 283

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 80
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 81  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 140
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---GTPEYLAPEIIL 197
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 257
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 258 LLQVDLTKRFG 268

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 135/288 (46%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS-------- 341
            TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S        
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 342 ----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                           E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 2/252 (0%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL 175
            +++Y +   +G+G F K ++   +D K+  A K++ KS      +   +  E  I K L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLH 234
            +P+++ F    E  +   ++ E     SL  L ++RK ++E      +   I  + YLH
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           +NRV+HRDLK  N+ LN D    + DFG A  +         + GTP Y+APE++ ++ +
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
               D+WSLGCI Y + +G PPF+T  +      +K  + + P  ++     L++ +L  
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHA 279
Query: 355 DASQRLSWPELL 366
           D + R S  ELL
Sbjct: 280 DPTLRPSVAELL 291

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 135/288 (46%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS-------- 341
            TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S        
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 342 ----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                           E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  129 bits (323), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 135/288 (46%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y 
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 188
Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS-------- 341
            TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S        
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 248
Query: 342 ----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                           E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 249 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  129 bits (323), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 135/288 (46%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS-------- 341
            TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S        
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 342 ----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                           E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  129 bits (323), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 110
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 170
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 171 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC---GTPEYLA 227
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 287
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 288 DLLRNLLQVDLTKRFG 303

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  129 bits (323), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 135/288 (46%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y 
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 185
Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS-------- 341
            TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S        
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 245
Query: 342 ----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                           E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 246 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 128/245 (52%), Gaps = 4/245 (1%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFI 184
            +G+G F K F+    D K+  A KI+ KS      +   +  E  I + LAH +++ F 
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 185 ASHETLNEFVLIT-EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
              E  N+FV +  E     SL  L ++RK L+E      L  ++    YLH NRV+HRD
Sbjct: 88  GFFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 146
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LK  N+ LN+D    + DFG A  +        ++ GTP Y+APE+++++ +    D+WS
Sbjct: 147 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWS 206
Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW 362
           +GCI Y + +G PPF+T  +      +K  + + P  ++     L++ +L+ D + R + 
Sbjct: 207 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTI 266
Query: 363 PELLH 367
            ELL+
Sbjct: 267 NELLN 271

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 128/245 (52%), Gaps = 4/245 (1%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFI 184
            +G+G F K F+    D K+  A KI+ KS      +   +  E  I + LAH +++ F 
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 185 ASHETLNEFVLIT-EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
              E  N+FV +  E     SL  L ++RK L+E      L  ++    YLH NRV+HRD
Sbjct: 84  GFFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 142
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LK  N+ LN+D    + DFG A  +        ++ GTP Y+APE+++++ +    D+WS
Sbjct: 143 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWS 202
Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW 362
           +GCI Y + +G PPF+T  +      +K  + + P  ++     L++ +L+ D + R + 
Sbjct: 203 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTI 262
Query: 363 PELLH 367
            ELL+
Sbjct: 263 NELLN 267

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 135/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 1   GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 128/245 (52%), Gaps = 4/245 (1%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFI 184
            +G+G F K F+    D K+  A KI+ KS      +   +  E  I + LAH +++ F 
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 185 ASHETLNEFVLIT-EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
              E  N+FV +  E     SL  L ++RK L+E      L  ++    YLH NRV+HRD
Sbjct: 84  GFFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 142
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LK  N+ LN+D    + DFG A  +        ++ GTP Y+APE+++++ +    D+WS
Sbjct: 143 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWS 202
Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW 362
           +GCI Y + +G PPF+T  +      +K  + + P  ++     L++ +L+ D + R + 
Sbjct: 203 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTI 262
Query: 363 PELLH 367
            ELL+
Sbjct: 263 NELLN 267

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  128 bits (322), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 93/290 (32%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKP+N+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 130/246 (52%), Gaps = 5/246 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHLA 176
           L+++++I  +G GSFG+V    H++     A+KI+ K      KE+     E  I + + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHS 235
            P ++K   S +  +   ++ E+A    + + L +  + SE       + ++    YLHS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
             +++RDLKP+N+++++ G   + DFG A+ +   T  L    GTP Y+APE+I  + Y+
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC---GTPEYLAPEIILSKGYN 216
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
              D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ LL+ D
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 356 ASQRLS 361
            ++R  
Sbjct: 277 LTKRFG 282

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  128 bits (322), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 95
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P + K   S +  +   ++ E+A    + + L +  + SE       + ++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+++++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 212
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 273 LLQVDLTKRFG 283

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  128 bits (321), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 95
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P + K   S +  +   ++ E+A    + + L +  + SE       + ++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+++++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 212
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 273 LLQVDLTKRFG 283

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  128 bits (321), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 93/290 (32%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKP+N+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 122 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  128 bits (321), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 134/287 (46%), Gaps = 32/287 (11%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHSN 236
           NI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
           RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y  
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 297 TA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS--------- 341
           TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S         
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 342 ---------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                          E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  128 bits (321), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 36  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 90
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 207
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 268 DLLRNLLQVDLTKRFG 283

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+A    + + L +  +  E       + ++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+++++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/291 (31%), Positives = 141/291 (48%), Gaps = 33/291 (11%)
Query: 115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH 174
            G +EKYQK+  +GEG++G V+KA      + VALK I          S+  +E  + K 
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQI-LSNLISALYYL 233
           L HPNI+  I    +     L+ EF    L  +L++ K   +   ++I L  L+  + + 
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAER 292
           H +R+LHRDLKPQN+L+N DG   L DFG AR+  +     T    T  Y AP+ L+  +
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFPSQVSE------ 342
            Y  + D+WS+GCI  E+  G P F  V+    +  +  +L T +     QV E      
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 343 -TYK-------------------DLVKGLLEKDASQRLSWPELLHHPLVKD 373
            T++                   DL+  +L  D ++R+S  + ++HP  KD
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 130/246 (52%), Gaps = 5/246 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHLA 176
           L+++++I  +G GSFG+V    H++     A+KI+ K      KE+     E  I + + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHS 235
            P ++K   S +  +   ++ E+A    + + L +  + SE       + ++    YLHS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
             +++RDLKP+N+++++ G   + DFG A+ +   T  L    GTP Y+APE+I  + Y+
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC---GTPEYLAPEIILSKGYN 216
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
              D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ LL+ D
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 356 ASQRLS 361
            ++R  
Sbjct: 277 LTKRFG 282

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 93/289 (32%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           ++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLH 234
           HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    Y
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 295 DHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------- 341
             TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S       
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 342 -----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                            E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H +     A+KI+ K     +++  LKQ      E  I
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 95
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+A    + + L +  + SE       + ++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+++++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 212
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 273 LLQVDLTKRFG 283

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 142/302 (47%), Gaps = 33/302 (10%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           ++EKY+ + L+GEGS+G V K  + D  + VA+K   +S           +E ++ K L 
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 177 HPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           H N++  +   +    + L+ EF  H  L +L      L   +  + L  +I+ + + HS
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPY 294
           + ++HRD+KP+N+L+++ GV  LCDFGFAR++A    +      T  Y APE L+ +  Y
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKT---------------QDVT 335
               D+W++GC+  E+ MG P F   S    + H++  L                   V 
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 336 FP------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQN 383
            P             ++SE   DL K  L  D  +R    ELLHH   + +  +E  SQ 
Sbjct: 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQE 322
Query: 384 NQ 385
            Q
Sbjct: 323 LQ 324

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 22  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 76
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 77  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 136
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 137 IVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 193
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 253
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 254 DLLRNLLQVDLTKRFG 269

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/291 (31%), Positives = 141/291 (48%), Gaps = 33/291 (11%)
Query: 115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH 174
            G +EKYQK+  +GEG++G V+KA      + VALK I          S+  +E  + K 
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQI-LSNLISALYYL 233
           L HPNI+  I    +     L+ EF    L  +L++ K   +   ++I L  L+  + + 
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAER 292
           H +R+LHRDLKPQN+L+N DG   L DFG AR+  +     T    T  Y AP+ L+  +
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFPSQVSE------ 342
            Y  + D+WS+GCI  E+  G P F  V+    +  +  +L T +     QV E      
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 343 -TYK-------------------DLVKGLLEKDASQRLSWPELLHHPLVKD 373
            T++                   DL+  +L  D ++R+S  + ++HP  KD
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 127/245 (51%), Gaps = 4/245 (1%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFI 184
            +G+G F K F+    D K+  A KI+ KS      +   +  E  I + LAH +++ F 
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 185 ASHETLNEFVLIT-EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
              E  N+FV +  E     SL  L ++RK L+E      L  ++    YLH NRV+HRD
Sbjct: 82  GFFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 140
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LK  N+ LN+D    + DFG A  +         + GTP Y+APE+++++ +    D+WS
Sbjct: 141 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWS 200
Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW 362
           +GCI Y + +G PPF+T  +      +K  + + P  ++     L++ +L+ D + R + 
Sbjct: 201 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTI 260
Query: 363 PELLH 367
            ELL+
Sbjct: 261 NELLN 265

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H +     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 93/290 (32%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF  M L   ++      +   +    L  L+  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKP+N+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 93/290 (32%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ EF  M L   ++      +   +    L  L+  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKP+N+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 123 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 127/245 (51%), Gaps = 4/245 (1%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFI 184
            +G+G F K F+    D K+  A KI+ KS      +   +  E  I + LAH +++ F 
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 185 ASHETLNEFVLIT-EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
              E  N+FV +  E     SL  L ++RK L+E      L  ++    YLH NRV+HRD
Sbjct: 106 GFFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 164
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LK  N+ LN+D    + DFG A  +         + GTP Y+APE+++++ +    D+WS
Sbjct: 165 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWS 224
Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW 362
           +GCI Y + +G PPF+T  +      +K  + + P  ++     L++ +L+ D + R + 
Sbjct: 225 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTI 284
Query: 363 PELLH 367
            ELL+
Sbjct: 285 NELLN 289

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H +     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H +     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 95
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  +  E       + ++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 155
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 212
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 273 LLQVDLTKRFG 283

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  +  E       + ++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H +     A+KI+ K     +++  LKQ      E  I
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 95
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 212
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 273 LLQVDLTKRFG 283

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/289 (32%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           ++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLH 234
           HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    Y
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 295 DHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------- 341
             TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S       
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 342 -----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                            E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H +     A+KI+ K     +++  LKQ      E  I
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 95
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 212
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 273 LLQVDLTKRFG 283

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H +     A+KI+ K     +++  LKQ      E  I
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 115
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 232
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 292
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 293 LLQVDLTKRFG 303

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  +  E       + ++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 211
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 272 LLQVDLTKRFG 282

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/289 (32%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           ++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLH 234
           HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    Y
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 295 DHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------- 341
             TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S       
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 342 -----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                            E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 127/245 (51%), Gaps = 4/245 (1%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFI 184
            +G+G F K F+    D K+  A KI+ KS      +   +  E  I + LAH +++ F 
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 185 ASHETLNEFVLIT-EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
              E  N+FV +  E     SL  L ++RK L+E      L  ++    YLH NRV+HRD
Sbjct: 108 GFFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 166
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LK  N+ LN+D    + DFG A  +         + GTP Y+APE+++++ +    D+WS
Sbjct: 167 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWS 226
Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSW 362
           +GCI Y + +G PPF+T  +      +K  + + P  ++     L++ +L+ D + R + 
Sbjct: 227 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTI 286
Query: 363 PELLH 367
            ELL+
Sbjct: 287 NELLN 291

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H +     A+KI+ K     +++  LKQ      E  I
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 95
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 212
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 273 LLQVDLTKRFG 283

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+++++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/289 (32%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           ++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLH 234
           HPNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    Y
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 295 DHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------- 341
             TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S       
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 342 -----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                            E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H +     A+KI+ K     +++  LKQ      E  I
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 87
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 147
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 204
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 264
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 265 LLQVDLTKRFG 275

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 16/283 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++YQ    +G+G+F  V + + +   +  A KII+    S ++   L++E  I + L HP
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 179 NIIKFIASHETLNE----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           NI++    H++++E    +++        L   +  R+  SE      +  ++ ++ + H
Sbjct: 64  NIVRL---HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH 120
Query: 235 SNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
            N ++HRDLKP+N+LL   +K     L DFG A  +           GTP Y++PE++ +
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDL 347
            PY    D+W+ G I Y + +G+PPF       L + +K     FPS     V+   KDL
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 348 VKGLLEKDASQRLSWPELLHHPLV--KDNLSSEIESQNNQDCI 388
           +  +L  + ++R++  E L HP +  +  ++S +  Q   DC+
Sbjct: 241 INKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCL 283

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 16/283 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++YQ    +G+G+F  V + + +   +  A KII+    S ++   L++E  I + L HP
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 179 NIIKFIASHETLNE----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           NI++    H++++E    +++        L   +  R+  SE      +  ++ ++ + H
Sbjct: 64  NIVRL---HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH 120
Query: 235 SNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
            N ++HRDLKP+N+LL   +K     L DFG A  +           GTP Y++PE++ +
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDL 347
            PY    D+W+ G I Y + +G+PPF       L + +K     FPS     V+   KDL
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 348 VKGLLEKDASQRLSWPELLHHPLV--KDNLSSEIESQNNQDCI 388
           +  +L  + ++R++  E L HP +  +  ++S +  Q   DC+
Sbjct: 241 INKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCL 283

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/288 (32%), Positives = 134/288 (46%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VAL  I     +    S+  +E  + K L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS-------- 341
            TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S        
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 342 ----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                           E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 92/288 (31%), Positives = 139/288 (48%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY  +  IGEG++G V+KA + +  +T ALK I          S+  +E  I K L H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQ-ILSNLISALYYLHSN 236
            NI+K      T    VL+ E     L  LL+  +   E++  +  L  L++ + Y H  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPYD 295
           RVLHRDLKPQN+L+N++G   + DFG AR+  +     T    T  Y AP+ L+  + Y 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFPSQVSETYK------ 345
            T D+WS+GCI  E+  G P F  VS    ++ + R+L T +      V+E  K      
Sbjct: 180 TTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 346 -------------------DLVKGLLEKDASQRLSWPELLHHPLVKDN 374
                              DL+  +L+ D +QR++  + L H   K+N
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/288 (32%), Positives = 134/288 (46%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VAL  I     +    S+  +E  + K L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS-------- 341
            TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S        
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 342 ----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                           E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 144/285 (50%), Gaps = 20/285 (7%)
Query: 114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQ--- 167
           ++G  E Y+   ++G G    V + IH    K  A+KII  +G    S +E+  L++   
Sbjct: 12  THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL 71
Query: 168 -ECEIQKHLA-HPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILS 224
            E +I + ++ HPNII+   ++ET   F L+ +      L + L ++  LSE    +I+ 
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 225 NLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYM 284
            L+  +  LH   ++HRDLKP+N+LL+ D    L DFGF+  +  G   L S+ GTP Y+
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLRSVCGTPSYL 190
Query: 285 APELIA-----ERP-YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS 338
           APE+I        P Y    D+WS G I Y +  G PPF     + ++R++ + +  F S
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250
Query: 339 ----QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEI 379
                 S+T KDLV   L     +R +  E L HP  +  +  E+
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 143/287 (49%), Gaps = 16/287 (5%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           ++EKY ++  IGEGSFGK       +  +   +K I+ S  S KE    ++E  +  ++ 
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK 81
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLIS---ALY 231
           HPNI+++  S E      ++ ++         +  Q+  L +    QIL   +    AL 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE--DQILDWFVQICLALK 139
Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           ++H  ++LHRD+K QN+ L KDG   L DFG AR +     +  +  GTP Y++PE+   
Sbjct: 140 HVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS---QVSETYKDLV 348
           +PY++ +D+W+LGC+ YE+      F+  S+ +L+  LK    +FP      S   + LV
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV--LKIISGSFPPVSLHYSYDLRSLV 257
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDK 395
             L +++   R S   +L     K  ++  IE   +   I  ++C K
Sbjct: 258 SQLFKRNPRDRPSVNSILE----KGFIAKRIEKFLSPQLIAEEFCLK 300

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + +E       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 92/288 (31%), Positives = 139/288 (48%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY  +  IGEG++G V+KA + +  +T ALK I          S+  +E  I K L H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQ-ILSNLISALYYLHSN 236
            NI+K      T    VL+ E     L  LL+  +   E++  +  L  L++ + Y H  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPYD 295
           RVLHRDLKPQN+L+N++G   + DFG AR+  +     T    T  Y AP+ L+  + Y 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFPSQVSETYK------ 345
            T D+WS+GCI  E+  G P F  VS    ++ + R+L T +      V+E  K      
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 346 -------------------DLVKGLLEKDASQRLSWPELLHHPLVKDN 374
                              DL+  +L+ D +QR++  + L H   K+N
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/288 (32%), Positives = 134/288 (46%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    Y 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS-------- 341
            TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S        
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 342 ----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                           E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 92/288 (31%), Positives = 139/288 (48%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY  +  IGEG++G V+KA + +  +T ALK I          S+  +E  I K L H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQ-ILSNLISALYYLHSN 236
            NI+K      T    VL+ E     L  LL+  +   E++  +  L  L++ + Y H  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPYD 295
           RVLHRDLKPQN+L+N++G   + DFG AR+  +     T    T  Y AP+ L+  + Y 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFPSQVSETYK------ 345
            T D+WS+GCI  E+  G P F  VS    ++ + R+L T +      V+E  K      
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 346 -------------------DLVKGLLEKDASQRLSWPELLHHPLVKDN 374
                              DL+  +L+ D +QR++  + L H   K+N
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/288 (32%), Positives = 134/288 (46%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    Y 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS-------- 341
            TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S        
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 342 ----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                           E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + Y++  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 132/262 (50%), Gaps = 9/262 (3%)
Query: 108 PVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLK 166
           PV  E  +   + ++ +  IG+GSFGKV      D KK  A+K ++K       E+ ++ 
Sbjct: 4   PVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF 63
Query: 167 QECEIQKHLAHPNIIKFIASHETLNE-FVLITEFAHMSLSNLLEQRKKLSETICVQILSN 225
           +E +I + L HP ++    S +   + F+++       L   L+Q     E      +  
Sbjct: 64  KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE 123
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           L+ AL YL + R++HRD+KP N+LL++ G   + DF  A  +   T  +T++ GT  YMA
Sbjct: 124 LVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMA 182
Query: 286 PELIAERP---YDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQ 339
           PE+ + R    Y    D WSLG  AYE+  G  P+    + S   ++   +T  VT+PS 
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA 242
Query: 340 VSETYKDLVKGLLEKDASQRLS 361
            S+    L+K LLE +  QR S
Sbjct: 243 WSQEMVSLLKKLLEPNPDQRFS 264

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H++     A+KI+ K     +++  LKQ      E  I
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 95
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P + K   S +  +   ++ E+A    + + L +  +  E       + ++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 155
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+++++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 212
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 273 LLQVDLTKRFG 283

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 92/289 (31%), Positives = 136/289 (47%), Gaps = 32/289 (11%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           ++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLH 234
           HPNI+K +    T N+  L+ EF H  L + ++      +   +    L  L+  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S+RVLHRDLKP+N+L+N +G   L DFG AR+  V          T  Y APE++    Y
Sbjct: 121 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 295 DHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------- 341
             TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S       
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 342 -----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                            E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 133/256 (51%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  +  E       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 93/288 (32%), Positives = 134/288 (46%), Gaps = 32/288 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ E  H  L   ++      +   +    L  L+  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS-------- 341
            TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S        
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 342 ----------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                           E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 133/256 (51%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  +  E       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 133/256 (51%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 30  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 84
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  +  E       + 
Sbjct: 85  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 144
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 145 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 201
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 261
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 262 DLLRNLLQVDLTKRFG 277

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 133/256 (51%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  +  E       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 126/259 (48%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISK----SGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K       K  A K I K    S R G     +++E  I + + HPNII 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                E   + VLI E  +   L + L +++ L+E    Q L  ++  ++YLHS R+ H 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHF 132
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      L DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNYEPLGLE 191
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    D  + S  SE  KD ++ LL 
Sbjct: 192 ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLV 251
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L H  +K
Sbjct: 252 KDPKRRMTIAQSLEHSWIK 270

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 133/256 (51%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 110
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  +  E       + 
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 170
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 171 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 227
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 287
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 288 DLLRNLLQVDLTKRFG 303

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  125 bits (314), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 138/281 (49%), Gaps = 16/281 (5%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           YQ    +G+G+F  V + + +   +  A KII+    S ++   L++E  I + L HPNI
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 181 IKFIASHETLNE----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           ++    H++++E    +++        L   +  R+  SE      +  ++ A+ + H  
Sbjct: 84  VRL---HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 140
Query: 237 RVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
            V+HRDLKP+N+LL    K     L DFG A  +           GTP Y++PE++ + P
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVK 349
           Y    DLW+ G I Y + +G+PPF       L + +K     FPS     V+   KDL+ 
Sbjct: 201 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 260
Query: 350 GLLEKDASQRLSWPELLHHPLV--KDNLSSEIESQNNQDCI 388
            +L  + S+R++  E L HP +  +  ++S +  Q   DC+
Sbjct: 261 KMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCL 301

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  125 bits (314), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 133/256 (51%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           P +I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  125 bits (314), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 131/251 (52%), Gaps = 15/251 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ------ECEI 171
           L+++++I  +G GSFG+V    H +     A+KI+ K     +++  LKQ      E  I
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 87
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            + +  P ++K   S +  +   ++ E+     + + L +  +  E       + ++   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 147
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+APE+I 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIL 204
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ 
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 264
Query: 351 LLEKDASQRLS 361
           LL+ D ++R  
Sbjct: 265 LLQVDLTKRFG 275

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  125 bits (314), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 105/324 (32%), Positives = 159/324 (49%), Gaps = 55/324 (16%)
Query: 111 MEKSN--GALEKYQKICLIGEGSFGKVFKAIHLDLK---KTVALKIIS-KSGRSGKELSS 164
           MEK     A ++Y+ +  IGEG++GKVFKA   DLK   + VALK +  ++G  G  LS+
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLST 58
Query: 165 LKQECEIQKHLA---HPNIIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKL-- 214
           ++ E  + +HL    HPN+++      ++  +   +  L+ E     L+  L++  +   
Sbjct: 59  IR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117
Query: 215 -SETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM 273
            +ETI   ++  L+  L +LHS+RV+HRDLKPQN+L+   G   L DFG AR  +     
Sbjct: 118 PTETI-KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMA 175
Query: 274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLI 326
           LTS+  T  Y APE++ +  Y    DLWS+GCI  E+    P F+  S       IL +I
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 327 RLLK----TQDVTFPSQ----------------VSETYKDLVKGLLEKDASQRLSWPELL 366
            L       +DV  P Q                + E  KDL+   L  + ++R+S    L
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295
Query: 367 HHPLVKD------NLSSEIESQNN 384
            HP  +D      NL S +    N
Sbjct: 296 SHPYFQDLERCKENLDSHLPPSQN 319

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  125 bits (314), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 125/259 (48%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISK----SGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K       K  A K I K    S R G     +++E  I + + HPNII 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                E   + VLI E  +   L + L +++ L+E    Q L  ++  ++YLHS R+ H 
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHF 153
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      L DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 154 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNYEPLGLE 212
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    D  + S  SE  KD ++ LL 
Sbjct: 213 ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLV 272
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R+   + L H  +K
Sbjct: 273 KDPKRRMXIAQSLEHSWIK 291

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  125 bits (314), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 143/285 (50%), Gaps = 20/285 (7%)
Query: 114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQ--- 167
           ++G  E Y+   ++G G    V + IH    K  A+KII  +G    S +E+  L++   
Sbjct: 12  THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL 71
Query: 168 -ECEIQKHLA-HPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILS 224
            E +I + ++ HPNII+   ++ET   F L+ +      L + L ++  LSE    +I+ 
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 225 NLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYM 284
            L+  +  LH   ++HRDLKP+N+LL+ D    L DFGF+  +  G   L  + GTP Y+
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYL 190
Query: 285 APELIA-----ERP-YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS 338
           APE+I        P Y    D+WS G I Y +  G PPF     + ++R++ + +  F S
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250
Query: 339 ----QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEI 379
                 S+T KDLV   L     +R +  E L HP  +  +  E+
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  125 bits (313), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 125/259 (48%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISK----SGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K       K  A K I K    S R G     +++E  I + + HPNII 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                E   + VLI E  +   L + L +++ L+E    Q L  ++  ++YLHS R+ H 
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHF 139
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      L DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 140 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNYEPLGLE 198
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    D  + S  SE  KD ++ LL 
Sbjct: 199 ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLV 258
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R+   + L H  +K
Sbjct: 259 KDPKRRMXIAQSLEHSWIK 277

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  125 bits (313), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 124/243 (51%), Gaps = 10/243 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG G F +V++A  L     VALK +        K  +   +E ++ K L HPN+IK+ A
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 186 SHETLNEFVLITEFAHMS-LSNLLE----QRKKLSETICVQILSNLISALYYLHSNRVLH 240
           S    NE  ++ E A    LS +++    Q++ + E    +    L SAL ++HS RV+H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMH 159
Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADL 300
           RD+KP NV +   GV  L D G  R  +  T    S+ GTP YM+PE I E  Y+  +D+
Sbjct: 160 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 219
Query: 301 WSLGCIAYEIHMGHPPF--KTVSILHLIRLLKTQDV-TFPSQ-VSETYKDLVKGLLEKDA 356
           WSLGC+ YE+     PF    +++  L + ++  D    PS   SE  + LV   +  D 
Sbjct: 220 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP 279
Query: 357 SQR 359
            +R
Sbjct: 280 EKR 282

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 133/256 (51%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP Y+A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++   
Sbjct: 267 DLLRNLLQVDLTKAFG 282

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 127/258 (49%), Gaps = 14/258 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    S++ R G     +++E  I + + HPNII 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + VLI E  +   L + L Q++ LSE      +  ++  + YLH+ ++ H 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 242 DLKPQNVLLNKDGVAM----LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    + +    L DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNYEPLGLE 198
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    D  F SQ SE  KD ++ LL 
Sbjct: 199 ADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLV 258
Query: 354 KDASQRLSWPELLHHPLV 371
           K+  +RL+  E L HP +
Sbjct: 259 KETRKRLTIQEALRHPWI 276

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 148/302 (49%), Gaps = 18/302 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ    +G+G+F  V + + +   +  A  II+    S ++   L++E  I + L HP
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 179 NIIKFIASHETLNE----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           NI++    H++++E    +++        L   +  R+  SE      +  ++ A+ + H
Sbjct: 71  NIVRL---HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 235 SNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
              V+HR+LKP+N+LL    K     L DFG A  +           GTP Y++PE++ +
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDL 347
            PY    DLW+ G I Y + +G+PPF       L + +K     FPS     V+   KDL
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247
Query: 348 VKGLLEKDASQRLSWPELLHHPLV--KDNLSSEIESQNNQDCIGFDYCDKRRGSRKSITT 405
           +  +L  + S+R++  E L HP +  +  ++S +  Q   DC+     + RR  + +I T
Sbjct: 248 INKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCL--KKFNARRKLKGAILT 305
Query: 406 IV 407
           ++
Sbjct: 306 VM 307

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 133/256 (51%), Gaps = 15/256 (5%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ----- 167
           ++   L+++ +I  +G GSFG+V    H +     A+KI+ K     +++  LKQ     
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTL 89
Query: 168 -ECEIQKHLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSN 225
            E  I + +  P ++K   S +  +   ++ E+ A   + + L +  + SE       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           ++    YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP  +A
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEALA 206
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE+I  + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   K
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 346 DLVKGLLEKDASQRLS 361
           DL++ LL+ D ++R  
Sbjct: 267 DLLRNLLQVDLTKRFG 282

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 101/307 (32%), Positives = 154/307 (50%), Gaps = 49/307 (15%)
Query: 111 MEKSN--GALEKYQKICLIGEGSFGKVFKAIHLDLK---KTVALKIIS-KSGRSGKELSS 164
           MEK     A ++Y+ +  IGEG++GKVFKA   DLK   + VALK +  ++G  G  LS+
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLST 58
Query: 165 LKQECEIQKHLA---HPNIIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKL-- 214
           ++ E  + +HL    HPN+++      ++  +   +  L+ E     L+  L++  +   
Sbjct: 59  IR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117
Query: 215 -SETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM 273
            +ETI   ++  L+  L +LHS+RV+HRDLKPQN+L+   G   L DFG AR  +     
Sbjct: 118 PTETI-KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMA 175
Query: 274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLI 326
           LTS+  T  Y APE++ +  Y    DLWS+GCI  E+    P F+  S       IL +I
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 327 RLLK----TQDVTFPSQ----------------VSETYKDLVKGLLEKDASQRLSWPELL 366
            L       +DV  P Q                + E  KDL+   L  + ++R+S    L
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295
Query: 367 HHPLVKD 373
            HP  +D
Sbjct: 296 SHPYFQD 302

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 134/264 (50%), Gaps = 18/264 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISK------SGRSGKELSSLKQECEIQKHLAHPNI 180
           +G G+ G+V  A      K VA+KIISK      S R      +++ E EI K L HP I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
           IK     +  + ++++       L + +   K+L E  C      ++ A+ YLH N ++H
Sbjct: 78  IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 137
Query: 241 RDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL---IAERPY 294
           RDLKP+NVLL+   +D +  + DFG ++ +   T ++ ++ GTP Y+APE+   +    Y
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 295 DHTADLWSLGCIAYEIHMGHPPFK----TVSILHLIRLLKTQDVT-FPSQVSETYKDLVK 349
           +   D WSLG I +    G+PPF      VS+   I   K   +    ++VSE   DLVK
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 256
Query: 350 GLLEKDASQRLSWPELLHHPLVKD 373
            LL  D   R +  E L HP ++D
Sbjct: 257 KLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 134/264 (50%), Gaps = 18/264 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISK------SGRSGKELSSLKQECEIQKHLAHPNI 180
           +G G+ G+V  A      K VA+KIISK      S R      +++ E EI K L HP I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
           IK     +  + ++++       L + +   K+L E  C      ++ A+ YLH N ++H
Sbjct: 78  IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 137
Query: 241 RDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL---IAERPY 294
           RDLKP+NVLL+   +D +  + DFG ++ +   T ++ ++ GTP Y+APE+   +    Y
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 295 DHTADLWSLGCIAYEIHMGHPPFK----TVSILHLIRLLKTQDVT-FPSQVSETYKDLVK 349
           +   D WSLG I +    G+PPF      VS+   I   K   +    ++VSE   DLVK
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 256
Query: 350 GLLEKDASQRLSWPELLHHPLVKD 373
            LL  D   R +  E L HP ++D
Sbjct: 257 KLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 134/264 (50%), Gaps = 18/264 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISK------SGRSGKELSSLKQECEIQKHLAHPNI 180
           +G G+ G+V  A      K VA+KIISK      S R      +++ E EI K L HP I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
           IK     +  + ++++       L + +   K+L E  C      ++ A+ YLH N ++H
Sbjct: 78  IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 137
Query: 241 RDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL---IAERPY 294
           RDLKP+NVLL+   +D +  + DFG ++ +   T ++ ++ GTP Y+APE+   +    Y
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 295 DHTADLWSLGCIAYEIHMGHPPFK----TVSILHLIRLLKTQDVT-FPSQVSETYKDLVK 349
           +   D WSLG I +    G+PPF      VS+   I   K   +    ++VSE   DLVK
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 256
Query: 350 GLLEKDASQRLSWPELLHHPLVKD 373
            LL  D   R +  E L HP ++D
Sbjct: 257 KLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 134/264 (50%), Gaps = 18/264 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISK------SGRSGKELSSLKQECEIQKHLAHPNI 180
           +G G+ G+V  A      K VA+KIISK      S R      +++ E EI K L HP I
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
           IK     +  + ++++       L + +   K+L E  C      ++ A+ YLH N ++H
Sbjct: 77  IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 136
Query: 241 RDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL---IAERPY 294
           RDLKP+NVLL+   +D +  + DFG ++ +   T ++ ++ GTP Y+APE+   +    Y
Sbjct: 137 RDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGY 195
Query: 295 DHTADLWSLGCIAYEIHMGHPPFK----TVSILHLIRLLKTQDVT-FPSQVSETYKDLVK 349
           +   D WSLG I +    G+PPF      VS+   I   K   +    ++VSE   DLVK
Sbjct: 196 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 255
Query: 350 GLLEKDASQRLSWPELLHHPLVKD 373
            LL  D   R +  E L HP ++D
Sbjct: 256 KLLVVDPKARFTTEEALRHPWLQD 279

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 130/239 (54%), Gaps = 3/239 (1%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKHLAHPNIIKF 183
           +IG+GSFGKV  A H   +   A+K++ K    +  +E   + +   + K++ HP ++  
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 184 IASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
             S +T ++   + ++ +   L   L++ +   E       + + SAL YLHS  +++RD
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 164
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LKP+N+LL+  G  +L DFG  +         ++  GTP Y+APE++ ++PYD T D W 
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 224
Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS 361
           LG + YE+  G PPF + +   +   +  + +     ++ + + L++GLL+KD ++RL 
Sbjct: 225 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLG 283

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 126/251 (50%), Gaps = 2/251 (0%)
Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEI 171
           ++   +  +  + L+G+G+FGKV         +  A+KI+ K     K E++    E  +
Sbjct: 2   RAKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 61
Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
            ++  HP +     + +T +    + E+A+   L   L + +  +E       + ++SAL
Sbjct: 62  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 121
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLHS  V++RD+K +N++L+KDG   + DFG  +        + +  GTP Y+APE++ 
Sbjct: 122 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 181
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
           +  Y    D W LG + YE+  G  PF       L  L+  +++ FP  +S   K L+ G
Sbjct: 182 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 241
Query: 351 LLEKDASQRLS 361
           LL+KD  QRL 
Sbjct: 242 LLKKDPKQRLG 252

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 124/247 (50%), Gaps = 2/247 (0%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHL 175
            +  +  + L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++ 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP +     + +T +    + E+A+   L   L + +  +E       + ++SAL YLH
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S  V++RD+K +N++L+KDG   + DFG  +        + +  GTP Y+APE++ +  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
               D W LG + YE+  G  PF       L  L+  +++ FP  +S   K L+ GLL+K
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 355 DASQRLS 361
           D  QRL 
Sbjct: 243 DPKQRLG 249

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 134/290 (46%), Gaps = 32/290 (11%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G++E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
            HPNI+K +    T N+  L+ E     L   ++      +   +    L  L+  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS+RVLHRDLKPQN+L+N +G   L DFG AR+  V          T  Y APE++    
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 294 YDHTA-DLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD-VTFPSQVS------ 341
           Y  TA D+WSLGCI  E+      F   S    +  + R L T D V +P   S      
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 342 ------------------ETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                             E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 134/264 (50%), Gaps = 18/264 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISK------SGRSGKELSSLKQECEIQKHLAHPNI 180
           +G G+ G+V  A      K VA+KIISK      S R      +++ E EI K L HP I
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
           IK     +  + ++++       L + +   K+L E  C      ++ A+ YLH N ++H
Sbjct: 84  IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 143
Query: 241 RDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL---IAERPY 294
           RDLKP+NVLL+   +D +  + DFG ++ +   T ++ ++ GTP Y+APE+   +    Y
Sbjct: 144 RDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGY 202
Query: 295 DHTADLWSLGCIAYEIHMGHPPFK----TVSILHLIRLLKTQDVT-FPSQVSETYKDLVK 349
           +   D WSLG I +    G+PPF      VS+   I   K   +    ++VSE   DLVK
Sbjct: 203 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 262
Query: 350 GLLEKDASQRLSWPELLHHPLVKD 373
            LL  D   R +  E L HP ++D
Sbjct: 263 KLLVVDPKARFTTEEALRHPWLQD 286

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 124/247 (50%), Gaps = 2/247 (0%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHL 175
            +  +  + L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++ 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP +     + +T +    + E+A+   L   L + +  +E       + ++SAL YLH
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S  V++RD+K +N++L+KDG   + DFG  +        + +  GTP Y+APE++ +  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
               D W LG + YE+  G  PF       L  L+  +++ FP  +S   K L+ GLL+K
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 355 DASQRLS 361
           D  QRL 
Sbjct: 243 DPKQRLG 249

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 87/264 (32%), Positives = 134/264 (50%), Gaps = 18/264 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISK------SGRSGKELSSLKQECEIQKHLAHPNI 180
           +G G+ G+V  A      K VA++IISK      S R      +++ E EI K L HP I
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
           IK     +  + ++++       L + +   K+L E  C      ++ A+ YLH N ++H
Sbjct: 217 IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 276
Query: 241 RDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL---IAERPY 294
           RDLKP+NVLL+   +D +  + DFG ++ +   T ++ ++ GTP Y+APE+   +    Y
Sbjct: 277 RDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGY 335
Query: 295 DHTADLWSLGCIAYEIHMGHPPFK----TVSILHLIRLLKTQDVT-FPSQVSETYKDLVK 349
           +   D WSLG I +    G+PPF      VS+   I   K   +    ++VSE   DLVK
Sbjct: 336 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 395
Query: 350 GLLEKDASQRLSWPELLHHPLVKD 373
            LL  D   R +  E L HP ++D
Sbjct: 396 KLLVVDPKARFTTEEALRHPWLQD 419

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/234 (34%), Positives = 118/234 (50%), Gaps = 3/234 (1%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ +  IG+G+F KV  A H+   + VA+KII K+  +   L  L +E  I K L HPNI
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 181 IKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           +K     ET     LI E+A    + + L    ++ E         ++SA+ Y H  R++
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT-A 298
           HRDLK +N+LL+ D    + DFGF+    VG   L +  G+P Y APEL   + YD    
Sbjct: 134 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDTFCGSPPYAAPELFQGKKYDGPEV 192
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL 352
           D+WSLG I Y +  G  PF   ++  L   +       P  +S   ++L+K  L
Sbjct: 193 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 246

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 123/247 (49%), Gaps = 2/247 (0%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHL 175
            +  +  + L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++ 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP +     + +T +    + E+A+   L   L + +  +E       + ++SAL YLH
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S  V++RD+K +N++L+KDG   + DFG  +        +    GTP Y+APE++ +  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
               D W LG + YE+  G  PF       L  L+  +++ FP  +S   K L+ GLL+K
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 355 DASQRLS 361
           D  QRL 
Sbjct: 243 DPKQRLG 249

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 87/264 (32%), Positives = 134/264 (50%), Gaps = 18/264 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISK------SGRSGKELSSLKQECEIQKHLAHPNI 180
           +G G+ G+V  A      K VA++IISK      S R      +++ E EI K L HP I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
           IK     +  + ++++       L + +   K+L E  C      ++ A+ YLH N ++H
Sbjct: 203 IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262
Query: 241 RDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL---IAERPY 294
           RDLKP+NVLL+   +D +  + DFG ++ +   T ++ ++ GTP Y+APE+   +    Y
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGY 321
Query: 295 DHTADLWSLGCIAYEIHMGHPPFK----TVSILHLIRLLKTQDVT-FPSQVSETYKDLVK 349
           +   D WSLG I +    G+PPF      VS+   I   K   +    ++VSE   DLVK
Sbjct: 322 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 381
Query: 350 GLLEKDASQRLSWPELLHHPLVKD 373
            LL  D   R +  E L HP ++D
Sbjct: 382 KLLVVDPKARFTTEEALRHPWLQD 405

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/248 (32%), Positives = 124/248 (50%), Gaps = 3/248 (1%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ +  IG+G+F KV  A H+   + VA+KII K+  +   L  L +E  I K L HPNI
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 181 IKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           +K     ET     LI E+A    + + L    ++ E         ++SA+ Y H  R++
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT-A 298
           HRDLK +N+LL+ D    + DFGF+    VG   L +  G P Y APEL   + YD    
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAAPELFQGKKYDGPEV 195
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D+WSLG I Y +  G  PF   ++  L   +       P  +S   ++L+K  L  +  +
Sbjct: 196 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIK 255
Query: 359 RLSWPELL 366
           R +  +++
Sbjct: 256 RGTLEQIM 263

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 138/276 (50%), Gaps = 20/276 (7%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQ----E 168
           G  E Y+   ++G G    V + IH    K  A+KII  +G    S +E+  L++    E
Sbjct: 1   GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 60
Query: 169 CEIQKHLA-HPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNL 226
            +I + ++ HPNII+   ++ET   F L+ +      L + L ++  LSE    +I+  L
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 227 ISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
           +  +  LH   ++HRDLKP+N+LL+ D    L DFGF+  +  G   L  + GTP Y+AP
Sbjct: 121 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAP 179
Query: 287 ELIA-----ERP-YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS-- 338
           E+I        P Y    D+WS G I Y +  G PPF     + ++R++ + +  F S  
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 239
Query: 339 --QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
               S+T KDLV   L     +R +  E L HP  +
Sbjct: 240 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 275

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 123/247 (49%), Gaps = 2/247 (0%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHL 175
            +  +  + L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++ 
Sbjct: 8   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP +     + +T +    + E+A+   L   L + +  +E       + ++SAL YLH
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 127
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S  V++RD+K +N++L+KDG   + DFG  +        +    GTP Y+APE++ +  Y
Sbjct: 128 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 187
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
               D W LG + YE+  G  PF       L  L+  +++ FP  +S   K L+ GLL+K
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 247
Query: 355 DASQRLS 361
           D  QRL 
Sbjct: 248 DPKQRLG 254

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 123/247 (49%), Gaps = 2/247 (0%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHL 175
            +  +  + L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++ 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP +     + +T +    + E+A+   L   L + +  +E       + ++SAL YLH
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S  V++RD+K +N++L+KDG   + DFG  +        +    GTP Y+APE++ +  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
               D W LG + YE+  G  PF       L  L+  +++ FP  +S   K L+ GLL+K
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 355 DASQRLS 361
           D  QRL 
Sbjct: 243 DPKQRLG 249

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 123/247 (49%), Gaps = 2/247 (0%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHL 175
            +  +  + L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++ 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP +     + +T +    + E+A+   L   L + +  +E       + ++SAL YLH
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S  V++RD+K +N++L+KDG   + DFG  +        +    GTP Y+APE++ +  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
               D W LG + YE+  G  PF       L  L+  +++ FP  +S   K L+ GLL+K
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 355 DASQRLS 361
           D  QRL 
Sbjct: 243 DPKQRLG 249

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPAFVAPEIVNYEPLGLE 197
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 258 KDPKKRMTIQDSLQHPWIK 276

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 149/297 (50%), Gaps = 22/297 (7%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPN 179
           ++ + L+G G++G+V+K  H+   +  A+K++  +G    E   +KQE   ++K+  H N
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRN 82
Query: 180 IIKFIASHETLN------EFVLITEF-AHMSLSNLLEQRK--KLSETICVQILSNLISAL 230
           I  +  +    N      +  L+ EF    S+++L++  K   L E     I   ++  L
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LH ++V+HRD+K QNVLL ++    L DFG +  +        +  GTP +MAPE+IA
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 291 --ERP---YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF--PSQVSET 343
             E P   YD  +DLWSLG  A E+  G PP   +  +  + L+           + S+ 
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 262
Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSR 400
           ++  ++  L K+ SQR +  +L+ HP ++D  +        +D I  D   K+RG +
Sbjct: 263 FQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHI--DRTKKKRGEK 317

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 132/253 (52%), Gaps = 13/253 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IGEGS G V  A      K VA+K +    +  +EL  L  E  I +   H N++   +S
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL--LFNEVVIMRDYHHDNVVDMYSS 110
Query: 187 HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
           +   +E  ++ EF    +L++++   +   E I    LS ++ AL YLH+  V+HRD+K 
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSYLHNQGVIHRDIKS 169
Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGC 305
            ++LL  DG   L DFGF   ++        + GTP +MAPE+I+  PY    D+WSLG 
Sbjct: 170 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGI 229
Query: 306 IAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK--DLVKGLLE----KDASQR 359
           +  E+  G PP+     L  +R ++    + P +V + +K   +++G L+    ++ SQR
Sbjct: 230 MVIEMIDGEPPYFNEPPLQAMRRIRD---SLPPRVKDLHKVSSVLRGFLDLMLVREPSQR 286
Query: 360 LSWPELLHHPLVK 372
            +  ELL HP +K
Sbjct: 287 ATAQELLGHPFLK 299

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 197
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 258 KDPKKRMTIQDSLQHPWIK 276

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 141/295 (47%), Gaps = 16/295 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    S++ R G     +++E  I + + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + VLI E  +   L + L Q++ LSE      +  ++  + YLH+ ++ H 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 242 DLKPQNVLLNKDGVAM----LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    + +    L DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNYEPLGLE 198
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    D  F SQ SE  KD ++ LL 
Sbjct: 199 ADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLV 258
Query: 354 KDASQRLSWPELLHHPLVK--DNLSSEIESQNNQDCIGFDYCDKRRGSRKSITTI 406
           K+  +RL+  E L HP +   DN  + +  ++  +   F     RR S+ + + +
Sbjct: 259 KETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRSKLAFSIV 313

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 197
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 258 KDPKKRMTIQDSLQHPWIK 276

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 126/248 (50%), Gaps = 3/248 (1%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHL 175
            + +++ + L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++ 
Sbjct: 149 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP +     S +T +    + E+A+   L   L + +  SE       + ++SAL YLH
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 268
Query: 235 SNR-VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           S + V++RDLK +N++L+KDG   + DFG  +        + +  GTP Y+APE++ +  
Sbjct: 269 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 328
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           Y    D W LG + YE+  G  PF       L  L+  +++ FP  +    K L+ GLL+
Sbjct: 329 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLK 388
Query: 354 KDASQRLS 361
           KD  QRL 
Sbjct: 389 KDPKQRLG 396

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 197
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 258 KDPKKRMTIQDSLQHPWIK 276

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 100/303 (33%), Positives = 152/303 (50%), Gaps = 49/303 (16%)
Query: 111 MEKSN--GALEKYQKICLIGEGSFGKVFKAIHLDLK---KTVALKIIS-KSGRSGKELSS 164
           MEK     A ++Y+ +  IGEG++GKVFKA   DLK   + VALK +  ++G  G  LS+
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLST 58
Query: 165 LKQECEIQKHLA---HPNIIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKL-- 214
           ++ E  + +HL    HPN+++      ++  +   +  L+ E     L+  L++  +   
Sbjct: 59  IR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117
Query: 215 -SETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM 273
            +ETI   ++  L+  L +LHS+RV+HRDLKPQN+L+   G   L DFG AR  +     
Sbjct: 118 PTETIK-DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMA 175
Query: 274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLI 326
           LTS+  T  Y APE++ +  Y    DLWS+GCI  E+    P F+  S       IL +I
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 327 RLLK----TQDVTFPSQ----------------VSETYKDLVKGLLEKDASQRLSWPELL 366
            L       +DV  P Q                + E  KDL+   L  + ++R+S    L
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295
Query: 367 HHP 369
            HP
Sbjct: 296 SHP 298

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 197
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 258 KDPKKRMTIQDSLQHPWIK 276

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 197
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 258 KDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 197
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 258 KDPKKRMTIQDSLQHPWIK 276

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 126/248 (50%), Gaps = 3/248 (1%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHL 175
            + +++ + L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++ 
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP +     S +T +    + E+A+   L   L + +  SE       + ++SAL YLH
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 235 SNR-VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           S + V++RDLK +N++L+KDG   + DFG  +        + +  GTP Y+APE++ +  
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           Y    D W LG + YE+  G  PF       L  L+  +++ FP  +    K L+ GLL+
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLK 385
Query: 354 KDASQRLS 361
           KD  QRL 
Sbjct: 386 KDPKQRLG 393

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 196
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 197 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 256
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 257 KDPKKRMTIQDSLQHPWIK 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 197
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 258 KDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 197
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 258 KDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 197
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 258 KDPKKRMTIQDSLQHPWIK 276

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 134/279 (48%), Gaps = 5/279 (1%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ +  IG+G+F KV  A H+   K VA+KII K+  +   L  L +E  I K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 181 IKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           +K     ET     L+ E+A    + + L    ++ E         ++SA+ Y H   ++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT-A 298
           HRDLK +N+LL+ D    + DFGF+     G   L +  G+P Y APEL   + YD    
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYDGPEV 194
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D+WSLG I Y +  G  PF   ++  L   +       P  +S   ++L+K  L  + S+
Sbjct: 195 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSK 254
Query: 359 RLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRR 397
           R +  +++    +  N+  E +          DY D RR
Sbjct: 255 RGTLEQIMKDRWM--NVGHEDDELKPYVAPLPDYKDPRR 291

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 196
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 197 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 256
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 257 KDPKKRMTIQDSLQHPWIK 275

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 128/259 (49%), Gaps = 12/259 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG GS+G+V  A+    +   A K I K     +++   KQE EI K L HPNII+   +
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKY--FVEDVDRFKQEIEIMKSLDHPNIIRLYET 91
Query: 187 HETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
            E   +  L+ E      L   +  ++   E+   +I+ +++SA+ Y H   V HRDLKP
Sbjct: 92  FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKP 151
Query: 246 QNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           +N L    + D    L DFG A     G  M T + GTP Y++P+++ E  Y    D WS
Sbjct: 152 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-GTPYYVSPQVL-EGLYGPECDEWS 209
Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVKGLLEKDASQ 358
            G + Y +  G+PPF   +   ++  ++    TFP +    VS   + L++ LL K   Q
Sbjct: 210 AGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQ 269
Query: 359 RLSWPELLHHPLVKDNLSS 377
           R++  + L H   +  LSS
Sbjct: 270 RITSLQALEHEWFEKQLSS 288

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 197
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 258 KDPKKRMTIQDSLQHPWIK 276

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 138/290 (47%), Gaps = 35/290 (12%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY+KI  IGEGS+G VFK  + D  + VA+K   +S           +E  + K L H
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 178 PNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           PN++  +          L+ E+  H  L  L   ++ + E +   I    + A+ + H +
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPYD 295
             +HRD+KP+N+L+ K  V  LCDFGFAR +   +        T  Y +PE L+ +  Y 
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 296 HTADLWSLGCIAYEIHMGHP--PFKT-VSILHLIRL------------------------ 328
              D+W++GC+  E+  G P  P K+ V  L+LIR                         
Sbjct: 182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241
Query: 329 -----LKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                ++  ++ FP+ +S     L+KG L  D ++RL+  +LLHHP  ++
Sbjct: 242 PDPEDMEPLELKFPN-ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 39/280 (13%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSG------------------------RSGKEL 162
           IG+GS+G V  A + +     A+K++SK                          +    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 163 SSLKQECEIQKHLAHPNIIKFIASHETLNE------FVLITEFAHMSLSNLLEQRKKLSE 216
             + QE  I K L HPN++K +   +  NE      F L+ +   M +  L    K LSE
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSE 136
Query: 217 TICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS 276
                   +LI  + YLH  +++HRD+KP N+L+ +DG   + DFG +        +L++
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 277 IKGTPLYMAPELIAE--RPYDHTA-DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD 333
             GTP +MAPE ++E  + +   A D+W++G   Y    G  PF    I+ L   +K+Q 
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQA 256
Query: 334 VTFPSQ--VSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           + FP Q  ++E  KDL+  +L+K+   R+  PE+  HP V
Sbjct: 257 LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 128/259 (49%), Gaps = 12/259 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG GS+G+V  A+    +   A K I K     +++   KQE EI K L HPNII+   +
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKY--FVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 187 HETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
            E   +  L+ E      L   +  ++   E+   +I+ +++SA+ Y H   V HRDLKP
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKP 134
Query: 246 QNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           +N L    + D    L DFG A     G  M T + GTP Y++P+++ E  Y    D WS
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-GTPYYVSPQVL-EGLYGPECDEWS 192
Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVKGLLEKDASQ 358
            G + Y +  G+PPF   +   ++  ++    TFP +    VS   + L++ LL K   Q
Sbjct: 193 AGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQ 252
Query: 359 RLSWPELLHHPLVKDNLSS 377
           R++  + L H   +  LSS
Sbjct: 253 RITSLQALEHEWFEKQLSS 271

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 124/248 (50%), Gaps = 3/248 (1%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ +  IG+G+F KV  A H+   K VA+KII K+  +   L  L +E  I K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 181 IKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           +K     ET     L+ E+A    + + L    ++ E         ++SA+ Y H   ++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT-A 298
           HRDLK +N+LL+ D    + DFGF+     G   L +  G+P Y APEL   + YD    
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYDGPEV 194
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D+WSLG I Y +  G  PF   ++  L   +       P  +S   ++L+K  L  + S+
Sbjct: 195 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSK 254
Query: 359 RLSWPELL 366
           R +  +++
Sbjct: 255 RGTLEQIM 262

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 126/251 (50%), Gaps = 3/251 (1%)
Query: 114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQ 172
           S   + +++ + L+G+G+FGKV         +  A+KI+ K     K E++    E  + 
Sbjct: 3   SRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 62
Query: 173 KHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALY 231
           ++  HP +     S +T +    + E+A+   L   L + +  SE       + ++SAL 
Sbjct: 63  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 122
Query: 232 YLHSNR-VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           YLHS + V++RDLK +N++L+KDG   + DFG  +        +    GTP Y+APE++ 
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 182
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
           +  Y    D W LG + YE+  G  PF       L  L+  +++ FP  +    K L+ G
Sbjct: 183 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 242
Query: 351 LLEKDASQRLS 361
           LL+KD  QRL 
Sbjct: 243 LLKKDPKQRLG 253

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 125/248 (50%), Gaps = 3/248 (1%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHL 175
            + +++ + L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++ 
Sbjct: 7   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP +     S +T +    + E+A+   L   L + +  SE       + ++SAL YLH
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 126
Query: 235 SNR-VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           S + V++RDLK +N++L+KDG   + DFG  +        +    GTP Y+APE++ +  
Sbjct: 127 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND 186
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           Y    D W LG + YE+  G  PF       L  L+  +++ FP  +    K L+ GLL+
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLK 246
Query: 354 KDASQRLS 361
           KD  QRL 
Sbjct: 247 KDPKQRLG 254

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 125/248 (50%), Gaps = 3/248 (1%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHL 175
            + +++ + L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++ 
Sbjct: 8   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP +     S +T +    + E+A+   L   L + +  SE       + ++SAL YLH
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 127
Query: 235 SNR-VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           S + V++RDLK +N++L+KDG   + DFG  +        +    GTP Y+APE++ +  
Sbjct: 128 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND 187
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           Y    D W LG + YE+  G  PF       L  L+  +++ FP  +    K L+ GLL+
Sbjct: 188 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLK 247
Query: 354 KDASQRLS 361
           KD  QRL 
Sbjct: 248 KDPKQRLG 255

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    +KS R G     +++E  I K + HPN+I 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + +LI E  A   L + L +++ L+E    + L  +++ +YYLHS ++ H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 242 DLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 197
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    +  + S  S   KD ++ LL 
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257
Query: 354 KDASQRLSWPELLHHPLVK 372
           KD  +R++  + L HP +K
Sbjct: 258 KDPKKRMTIQDSLQHPWIK 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 125/258 (48%), Gaps = 14/258 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    S++ R G     +++E  I + + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 183 FIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + VLI E      L + L Q++ LSE      +  ++  + YLH+ ++ H 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 242 DLKPQNVLLNKDGVAM----LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    + +    L DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNYEPLGLE 198
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    D  F SQ SE  KD ++ LL 
Sbjct: 199 ADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLV 258
Query: 354 KDASQRLSWPELLHHPLV 371
           K+  +RL+  E L HP +
Sbjct: 259 KETRKRLTIQEALRHPWI 276

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 123/248 (49%), Gaps = 3/248 (1%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ +  IG+G+F KV  A H+   K VA+KII K+  +   L  L +E  I K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 181 IKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           +K     ET     L+ E+A    + + L    ++ E         ++SA+ Y H   ++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT-A 298
           HRDLK +N+LL+ D    + DFGF+     G   L +  G P Y APEL   + YD    
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQGKKYDGPEV 194
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D+WSLG I Y +  G  PF   ++  L   +       P  +S   ++L+K  L  + S+
Sbjct: 195 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSK 254
Query: 359 RLSWPELL 366
           R +  +++
Sbjct: 255 RGTLEQIM 262

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 135/272 (49%), Gaps = 19/272 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR--SGKELSSLKQECEIQKHL- 175
           +KY    +IG G    V + +H       A+KI+  +    S ++L  +++    + H+ 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 176 ----AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
                HP+II  I S+E+ +   L+ +      L + L ++  LSE     I+ +L+ A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI- 289
            +LH+N ++HRDLKP+N+LL+ +    L DFGF+  +  G   L  + GTP Y+APE++ 
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELCGTPGYLAPEILK 272
Query: 290 -----AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QV 340
                    Y    DLW+ G I + +  G PPF     + ++R++      F S      
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332
Query: 341 SETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
           S T KDL+  LL+ D   RL+  + L HP  +
Sbjct: 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 124/248 (50%), Gaps = 3/248 (1%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ +  IG+G+F KV  A H+   K VA++II K+  +   L  L +E  I K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 181 IKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           +K     ET     L+ E+A    + + L    ++ E         ++SA+ Y H   ++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT-A 298
           HRDLK +N+LL+ D    + DFGF+     G   L +  G+P Y APEL   + YD    
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYDGPEV 194
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D+WSLG I Y +  G  PF   ++  L   +       P  +S   ++L+K  L  + S+
Sbjct: 195 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSK 254
Query: 359 RLSWPELL 366
           R +  +++
Sbjct: 255 RGTLEQIM 262

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 129/250 (51%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 35  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 179 NIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A    L   + +     ET      + ++SAL YLH   
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML--TSIKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +      S  GT  Y++PEL+ E+   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 273 ATKRLGCEEM 282

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G+G+F  V + +H       A KII+    S ++   L++E  I + L HPNI++    
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL--- 70
Query: 187 HETLNE----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
           H+++ E    +++        L   +  R+  SE      +  ++ ++ Y HSN ++HR+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 243 LKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTAD 299
           LKP+N+LL    K     L DFG A  +   +       GTP Y++PE++ + PY    D
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVD 189
Query: 300 LWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVKGLLEKD 355
           +W+ G I Y + +G+PPF       L   +K     +PS     V+   K L+  +L  +
Sbjct: 190 IWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN 249
Query: 356 ASQRLSWPELLHHPLV--KDNLSSEIESQNNQDCI 388
             +R++  + L  P +  ++ ++S I  Q+  DC+
Sbjct: 250 PKKRITADQALKVPWICNRERVASAIHRQDXVDCL 284

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 123/248 (49%), Gaps = 3/248 (1%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ +  IG+G+F KV  A H+   K VA++II K+  +   L  L +E  I K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 181 IKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           +K     ET     L+ E+A    + + L    ++ E         ++SA+ Y H   ++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT-A 298
           HRDLK +N+LL+ D    + DFGF+     G   L    G+P Y APEL   + YD    
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDEFCGSPPYAAPELFQGKKYDGPEV 194
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D+WSLG I Y +  G  PF   ++  L   +       P  +S   ++L+K  L  + S+
Sbjct: 195 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSK 254
Query: 359 RLSWPELL 366
           R +  +++
Sbjct: 255 RGTLEQIM 262

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G+G+F  V + +H       A KII+    S ++   L++E  I + L HPNI++    
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL--- 93
Query: 187 HETLNE----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
           H+++ E    +++        L   +  R+  SE      +  ++ ++ Y HSN ++HR+
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 153
Query: 243 LKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTAD 299
           LKP+N+LL    K     L DFG A  +   +       GTP Y++PE++ + PY    D
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVD 212
Query: 300 LWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVKGLLEKD 355
           +W+ G I Y + +G+PPF       L   +K     +PS     V+   K L+  +L  +
Sbjct: 213 IWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN 272
Query: 356 ASQRLSWPELLHHPLV--KDNLSSEIESQNNQDCI 388
             +R++  + L  P +  ++ ++S I  Q+  DC+
Sbjct: 273 PKKRITADQALKVPWICNRERVASAIHRQDTVDCL 307

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 130/250 (52%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 32  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML--TSIKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +      S  GT  Y++PEL+ E+   
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 269
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 270 ATKRLGCEEM 279

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 140/295 (47%), Gaps = 16/295 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    S++ R G     +++E  I + + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + VLI E  +   L + L Q++ LSE      +  ++  + YLH+ ++ H 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 242 DLKPQNVLLNKDGVAM----LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    + +    L DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNYEPLGLE 198
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    D  F S  SE  KD ++ LL 
Sbjct: 199 ADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLV 258
Query: 354 KDASQRLSWPELLHHPLVK--DNLSSEIESQNNQDCIGFDYCDKRRGSRKSITTI 406
           K+  +RL+  E L HP +   DN  + +  ++  +   F     RR S+ + + +
Sbjct: 259 KETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRSKLAFSIV 313

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 134/274 (48%), Gaps = 17/274 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G+G+F  V + +H       A KII+    S ++   L++E  I + L HPNI++    
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL--- 69
Query: 187 HETLNE----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
           H+++ E    +++        L   +  R+  SE      +  ++ ++ Y HSN ++HR+
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 129
Query: 243 LKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTAD 299
           LKP+N+LL    K     L DFG A  +   +       GTP Y++PE++ + PY    D
Sbjct: 130 LKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVD 188
Query: 300 LWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVKGLLEKD 355
           +W+ G I Y + +G+PPF       L   +K     +PS     V+   K L+  +L  +
Sbjct: 189 IWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN 248
Query: 356 ASQRLSWPELLHHPLV--KDNLSSEIESQNNQDC 387
             +R++  + L  P +  ++ ++S I  Q+  DC
Sbjct: 249 PKKRITADQALKVPWICNRERVASAIHRQDXVDC 282

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 80/241 (33%), Positives = 118/241 (48%), Gaps = 3/241 (1%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ +  IG+G+F KV  A H+   K VA+KII K+  +   L  L +E  I K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 181 IKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           +K     ET     L+ E+A    + + L    +  E         ++SA+ Y H   ++
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT-A 298
           HRDLK +N+LL+ D    + DFGF+     G + L +  G P Y APEL   + YD    
Sbjct: 136 HRDLKAENLLLDADXNIKIADFGFSNEFTFG-NKLDAFCGAPPYAAPELFQGKKYDGPEV 194
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D+WSLG I Y +  G  PF   ++  L   +       P   S   ++L+K  L  + S+
Sbjct: 195 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLKKFLILNPSK 254
Query: 359 R 359
           R
Sbjct: 255 R 255

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/319 (28%), Positives = 160/319 (50%), Gaps = 35/319 (10%)
Query: 119 EKYQKICLIGEGSFGKVF---KAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQK 173
           E ++ + ++G+G +GKVF   K    +  K  A+K++ K+   R+ K+ +  K E  I +
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK----LSETICVQILSNLISA 229
            + HP I+  I + +T  +  LI E+  +S   L  Q ++    + +T C   L+ +  A
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEY--LSGGELFMQLEREGIFMEDTACF-YLAEISMA 133
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L +LH   +++RDLKP+N++LN  G   L DFG  +       +  +  GT  YMAPE++
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
               ++   D WSLG + Y++  G PPF   +    I  +    +  P  +++  +DL+K
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253
Query: 350 GLLEKDASQRL-SWP----ELLHHPLVK-----DNLSSEIES------QNNQDCIGFDYC 393
            LL+++A+ RL + P    E+  HP  +     + L+ ++E       Q+ +D   FD  
Sbjct: 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFD-- 311
Query: 394 DKRRGSRKSITTIVESDSD 412
                S+ +  T V+S  D
Sbjct: 312 -----SKFTRQTPVDSPDD 325

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 80/241 (33%), Positives = 119/241 (49%), Gaps = 3/241 (1%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ +  IG+G+F KV  A H+   K VA+KII K+  +   L  L +E  I K L HPNI
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 181 IKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
           +K     ET     L+ E+A    + + L     + E         ++SA+ Y H   ++
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT-A 298
           HRDLK +N+LL+ D    + DFGF+     G   L +  G+P Y APEL   + YD    
Sbjct: 129 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYDGPEV 187
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D+WSLG I Y +  G  PF   ++  L   +       P  +S   ++L+K  L  + S+
Sbjct: 188 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSK 247
Query: 359 R 359
           R
Sbjct: 248 R 248

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 130/250 (52%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 36  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML--TSIKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +      S  GT  Y++PEL+ E+   
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 273
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 274 ATKRLGCEEM 283

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 125/258 (48%), Gaps = 14/258 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    S++ R G     +++E  I + + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + VLI E  +   L + L Q++ LSE      +  ++  + YLH+ ++ H 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 242 DLKPQNVLLNKDGVAM----LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    + +    L DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNYEPLGLE 198
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    D  F S  SE  KD ++ LL 
Sbjct: 199 ADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLV 258
Query: 354 KDASQRLSWPELLHHPLV 371
           K+  +RL+  E L HP +
Sbjct: 259 KETRKRLTIQEALRHPWI 276

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 90/319 (28%), Positives = 159/319 (49%), Gaps = 35/319 (10%)
Query: 119 EKYQKICLIGEGSFGKVF---KAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQK 173
           E ++ + ++G+G +GKVF   K    +  K  A+K++ K+   R+ K+ +  K E  I +
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK----LSETICVQILSNLISA 229
            + HP I+  I + +T  +  LI E+  +S   L  Q ++    + +T C   L+ +  A
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEY--LSGGELFMQLEREGIFMEDTACF-YLAEISMA 133
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L +LH   +++RDLKP+N++LN  G   L DFG  +       +     GT  YMAPE++
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEIL 193
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
               ++   D WSLG + Y++  G PPF   +    I  +    +  P  +++  +DL+K
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253
Query: 350 GLLEKDASQRL-SWP----ELLHHPLVK-----DNLSSEIES------QNNQDCIGFDYC 393
            LL+++A+ RL + P    E+  HP  +     + L+ ++E       Q+ +D   FD  
Sbjct: 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFD-- 311
Query: 394 DKRRGSRKSITTIVESDSD 412
                S+ +  T V+S  D
Sbjct: 312 -----SKFTRQTPVDSPDD 325

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  118 bits (296), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 130/250 (52%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 33  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML--TSIKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +      +  GT  Y++PEL+ E+   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 271 ATKRLGCEEM 280

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  118 bits (295), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 130/250 (52%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 17  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 254
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 255 ATKRLGCEEM 264

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  118 bits (295), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 140/283 (49%), Gaps = 16/283 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + YQ    +G+G+F  V + +     +  A KII+    S ++   L++E  I + L HP
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 179 NIIKFIASHETLNE----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           NI++    H++++E    +++        L   +  R+  SE      +  ++ ++ ++H
Sbjct: 91  NIVRL---HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIH 147
Query: 235 SNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
            + ++HRDLKP+N+LL    K     L DFG A  +           GTP Y++PE++ +
Sbjct: 148 QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK 207
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDL 347
            PY    D+W+ G I Y + +G+PPF       L + +K     FPS     V+   K+L
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 267
Query: 348 VKGLLEKDASQRLSWPELLHHPLV--KDNLSSEIESQNNQDCI 388
           +  +L  + ++R++  + L HP V  +  ++S +  Q   +C+
Sbjct: 268 INQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECL 310

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 138/289 (47%), Gaps = 34/289 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLA 176
           ++KY+K+  IGEG++G VFKA + +  + VALK +       G   S+L++ C + K L 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELK 59
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHS 235
           H NI++      +  +  L+ EF    L    +     L   I    L  L+  L + HS
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPY 294
             VLHRDLKPQN+L+N++G   L +FG AR+  +     ++   T  Y  P+ L   + Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 295 DHTADLWSLGCIAYEI-HMGHPPFKTVSI----LHLIRLLKTQ-DVTFPS---------- 338
             + D+WS GCI  E+ + G P F    +      + RLL T  +  +PS          
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 339 --------------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                         +++ T +DL++ LL+ +  QR+S  E L HP   D
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 127/244 (52%), Gaps = 4/244 (1%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFI 184
           ++GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP  +K  
Sbjct: 14  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 73
Query: 185 ASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + +   +      +A +  L   + +     ET      + ++SAL YLH   ++HRDL
Sbjct: 74  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 133
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYDHTADLW 301
           KP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+    ++DLW
Sbjct: 134 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLW 193
Query: 302 SLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS 361
           +LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  DA++RL 
Sbjct: 194 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLG 253
Query: 362 WPEL 365
             E+
Sbjct: 254 CEEM 257

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 130/250 (52%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 32  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 269
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 270 ATKRLGCEEM 279

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 130/250 (52%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 33  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 271 ATKRLGCEEM 280

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 127/244 (52%), Gaps = 4/244 (1%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFI 184
           ++GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP  +K  
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 185 ASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + +   +      +A +  L   + +     ET      + ++SAL YLH   ++HRDL
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 134
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYDHTADLW 301
           KP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+    ++DLW
Sbjct: 135 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLW 194
Query: 302 SLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS 361
           +LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  DA++RL 
Sbjct: 195 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLG 254
Query: 362 WPEL 365
             E+
Sbjct: 255 CEEM 258

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 134/260 (51%), Gaps = 14/260 (5%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           L+ Y KI   GEGS G V  A      + VA+K++    +  +EL  L  E  I +   H
Sbjct: 47  LDSYVKI---GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQH 101
Query: 178 PNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N+++   S+    E  ++ EF    +L++++ Q  +L+E     +   ++ AL YLH+ 
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
            V+HRD+K  ++LL  DG   L DFGF   ++        + GTP +MAPE+I+   Y  
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYAT 220
Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS-----QVSETYKDLVKGL 351
             D+WSLG +  E+  G PP+ + S +  ++ L+  D   P      +VS   +D ++ +
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR--DSPPPKLKNSHKVSPVLRDFLERM 278
Query: 352 LEKDASQRLSWPELLHHPLV 371
           L +D  +R +  ELL HP +
Sbjct: 279 LVRDPQERATAQELLDHPFL 298

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 11/251 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IGEGS G V  A      K VA+K +    +  +EL  L  E  I +   H N+++   S
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNS 94
Query: 187 HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
           +   +E  ++ EF    +L++++   +   E I    L+ ++ AL  LH+  V+HRD+K 
Sbjct: 95  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKS 153
Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGC 305
            ++LL  DG   L DFGF   ++        + GTP +MAPELI+  PY    D+WSLG 
Sbjct: 154 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGI 213
Query: 306 IAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS-----QVSETYKDLVKGLLEKDASQRL 360
           +  E+  G PP+     L  +++++  D   P      +VS + K  +  LL +D +QR 
Sbjct: 214 MVIEMVDGEPPYFNEPPLKAMKMIR--DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 271
Query: 361 SWPELLHHPLV 371
           +  ELL HP +
Sbjct: 272 TAAELLKHPFL 282

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 125/258 (48%), Gaps = 14/258 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G F  V K          A K I    S++ R G     +++E  I + + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 183 FIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
               +E   + VLI E  +   L + L Q++ LSE      +  ++  + YLH+ ++ H 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 242 DLKPQNVLLNKDGVAM----LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           DLKP+N++L    + +    L DFG A  +  G     +I GTP ++APE++   P    
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNYEPLGLE 198
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WS+G I Y +  G  PF    K  ++ ++  +    D  F S  SE  KD ++ LL 
Sbjct: 199 ADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLV 258
Query: 354 KDASQRLSWPELLHHPLV 371
           K+  +RL+  E L HP +
Sbjct: 259 KETRKRLTIQEALRHPWI 276

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 11/251 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IGEGS G V  A      K VA+K +    +  +EL  L  E  I +   H N+++   S
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNS 96
Query: 187 HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
           +   +E  ++ EF    +L++++   +   E I    L+ ++ AL  LH+  V+HRD+K 
Sbjct: 97  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKS 155
Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGC 305
            ++LL  DG   L DFGF   ++        + GTP +MAPELI+  PY    D+WSLG 
Sbjct: 156 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGI 215
Query: 306 IAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS-----QVSETYKDLVKGLLEKDASQRL 360
           +  E+  G PP+     L  +++++  D   P      +VS + K  +  LL +D +QR 
Sbjct: 216 MVIEMVDGEPPYFNEPPLKAMKMIR--DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 273
Query: 361 SWPELLHHPLV 371
           +  ELL HP +
Sbjct: 274 TAAELLKHPFL 284

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 130/250 (52%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 33  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 271 ATKRLGCEEM 280

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 130/250 (52%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 35  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 273 ATKRLGCEEM 282

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 127/244 (52%), Gaps = 4/244 (1%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFI 184
           ++GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP  +K  
Sbjct: 16  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 75
Query: 185 ASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + +   +      +A +  L   + +     ET      + ++SAL YLH   ++HRDL
Sbjct: 76  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 135
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYDHTADLW 301
           KP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+    ++DLW
Sbjct: 136 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLW 195
Query: 302 SLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS 361
           +LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  DA++RL 
Sbjct: 196 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLG 255
Query: 362 WPEL 365
             E+
Sbjct: 256 CEEM 259

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 11/251 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IGEGS G V  A      K VA+K +    +  +EL  L  E  I +   H N+++   S
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNS 89
Query: 187 HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
           +   +E  ++ EF    +L++++   +   E I    L+ ++ AL  LH+  V+HRD+K 
Sbjct: 90  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKS 148
Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGC 305
            ++LL  DG   L DFGF   ++        + GTP +MAPELI+  PY    D+WSLG 
Sbjct: 149 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGI 208
Query: 306 IAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS-----QVSETYKDLVKGLLEKDASQRL 360
           +  E+  G PP+     L  +++++  D   P      +VS + K  +  LL +D +QR 
Sbjct: 209 MVIEMVDGEPPYFNEPPLKAMKMIR--DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 266
Query: 361 SWPELLHHPLV 371
           +  ELL HP +
Sbjct: 267 TAAELLKHPFL 277

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 130/250 (52%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 35  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 273 ATKRLGCEEM 282

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 11/251 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IGEGS G V  A      K VA+K +    +  +EL  L  E  I +   H N+++   S
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNS 85
Query: 187 HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
           +   +E  ++ EF    +L++++   +   E I    L+ ++ AL  LH+  V+HRD+K 
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKS 144
Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGC 305
            ++LL  DG   L DFGF   ++        + GTP +MAPELI+  PY    D+WSLG 
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGI 204
Query: 306 IAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS-----QVSETYKDLVKGLLEKDASQRL 360
           +  E+  G PP+     L  +++++  D   P      +VS + K  +  LL +D +QR 
Sbjct: 205 MVIEMVDGEPPYFNEPPLKAMKMIR--DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 262
Query: 361 SWPELLHHPLV 371
           +  ELL HP +
Sbjct: 263 TAAELLKHPFL 273

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 137/289 (47%), Gaps = 34/289 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLA 176
           ++KY+K+  IGEG++G VFKA + +  + VALK +       G   S+L++ C + K L 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELK 59
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHS 235
           H NI++      +  +  L+ EF    L    +     L   I    L  L+  L + HS
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPY 294
             VLHRDLKPQN+L+N++G   L DFG AR+  +     ++   T  Y  P+ L   + Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 295 DHTADLWSLGCIAYEI-HMGHPPFKTVSI----LHLIRLLKTQ-DVTFPS---------- 338
             + D+WS GCI  E+ +   P F    +      + RLL T  +  +PS          
Sbjct: 180 STSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 339 --------------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                         +++ T +DL++ LL+ +  QR+S  E L HP   D
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 130/250 (52%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 36  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 273
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 274 ATKRLGCEEM 283

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 130/250 (52%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 38  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP+      +DLV+ LL  D
Sbjct: 216 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVLD 275
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 276 ATKRLGCEEM 285

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 71/193 (36%), Positives = 101/193 (52%), Gaps = 3/193 (1%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG+G+F KV  A H+   + VA+KII K+  +   L  L +E  I K L HPNI+K    
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 187 HETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
            ET     L+ E+A    + + L    ++ E         ++SA+ Y H   ++HRDLK 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKA 142
Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT-ADLWSLG 304
           +N+LL+ D    + DFGF+    VG   L +  G+P Y APEL   + YD    D+WSLG
Sbjct: 143 ENLLLDGDMNIKIADFGFSNEFTVGNK-LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 305 CIAYEIHMGHPPF 317
            I Y +  G  PF
Sbjct: 202 VILYTLVSGSLPF 214

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 130/250 (52%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 35  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 273 ATKRLGCEEM 282

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 127/244 (52%), Gaps = 4/244 (1%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFI 184
           ++GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP  +K  
Sbjct: 17  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 76
Query: 185 ASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + +   +      +A +  L   + +     ET      + ++SAL YLH   ++HRDL
Sbjct: 77  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 136
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYDHTADLW 301
           KP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+    ++DLW
Sbjct: 137 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLW 196
Query: 302 SLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS 361
           +LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  DA++RL 
Sbjct: 197 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLG 256
Query: 362 WPEL 365
             E+
Sbjct: 257 CEEM 260

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 148/304 (48%), Gaps = 25/304 (8%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS----GRSGKELSSLKQ------- 167
           E Y K+  +G G++G+V      +     A+K+I KS    GR   +  ++++       
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 168 ECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQ---RKKLSETICVQILS 224
           E  + K L HPNIIK     E    F L+TEF       L EQ   R K  E     I+ 
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGG--ELFEQIINRHKFDECDAANIMK 153
Query: 225 NLISALYYLHSNRVLHRDLKPQNVLL-NKDGV--AMLCDFGFARSMAVGTHMLTSIKGTP 281
            ++S + YLH + ++HRD+KP+N+LL NK+ +    + DFG + S     + L    GT 
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS-SFFSKDYKLRDRLGTA 212
Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP---- 337
            Y+APE++ ++ Y+   D+WS G I Y +  G+PPF   +   +I+ ++     F     
Sbjct: 213 YYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 338 SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRR 397
             +S+  K+L+K +L  D ++R +  E L+   +K   ++  +S     C       K  
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFE 331
Query: 398 GSRK 401
           GS+K
Sbjct: 332 GSQK 335

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 11/251 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IGEGS G V  A      K VA+K +    +  +EL  L  E  I +   H N+++   S
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNS 216
Query: 187 HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
           +   +E  ++ EF    +L++++   +   E I    L+ ++ AL  LH+  V+HRD+K 
Sbjct: 217 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKS 275
Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGC 305
            ++LL  DG   L DFGF   ++        + GTP +MAPELI+  PY    D+WSLG 
Sbjct: 276 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGI 335
Query: 306 IAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS-----QVSETYKDLVKGLLEKDASQRL 360
           +  E+  G PP+     L  +++++  D   P      +VS + K  +  LL +D +QR 
Sbjct: 336 MVIEMVDGEPPYFNEPPLKAMKMIR--DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 393
Query: 361 SWPELLHHPLV 371
           +  ELL HP +
Sbjct: 394 TAAELLKHPFL 404

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 11/251 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IGEGS G V  A      K VA+K +    +  +EL  L  E  I +   H N+++   S
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNS 139
Query: 187 HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
           +   +E  ++ EF    +L++++   +   E I    L+ ++ AL  LH+  V+HRD+K 
Sbjct: 140 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKS 198
Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGC 305
            ++LL  DG   L DFGF   ++        + GTP +MAPELI+  PY    D+WSLG 
Sbjct: 199 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGI 258
Query: 306 IAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS-----QVSETYKDLVKGLLEKDASQRL 360
           +  E+  G PP+     L  +++++  D   P      +VS + K  +  LL +D +QR 
Sbjct: 259 MVIEMVDGEPPYFNEPPLKAMKMIR--DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 316
Query: 361 SWPELLHHPLV 371
           +  ELL HP +
Sbjct: 317 TAAELLKHPFL 327

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 129/250 (51%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 40  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K     +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 217
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 218 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 277
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 278 ATKRLGCEEM 287

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 129/250 (51%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 35  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   +   +   +  FP +     +DLV+ LL  D
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 273 ATKRLGCEEM 282

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 19/280 (6%)
Query: 111 MEKSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISK---SGRSGKELSSLK 166
           M   +   E   ++C +IG+G+F  V + I+ +  +  A+KI+     +   G     LK
Sbjct: 15  MADDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK 74
Query: 167 QECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNL-LEQRKK------LSETIC 219
           +E  I   L HP+I++ + ++ +     ++ EF  M  ++L  E  K+       SE + 
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEF--MDGADLCFEIVKRADAGFVYSEAVA 132
Query: 220 VQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTS 276
              +  ++ AL Y H N ++HRD+KP+NVLL          L DFG A  +     +   
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG 192
Query: 277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF 336
             GTP +MAPE++   PY    D+W  G I + +  G  PF          ++K +    
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 252
Query: 337 PSQ---VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
           P Q   +SE+ KDLV+ +L  D ++R++  E L+HP +K+
Sbjct: 253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/252 (32%), Positives = 127/252 (50%), Gaps = 11/252 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+ A  +   + VA+K +S SG+ S ++   + +E    + L HPN I++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 186 SHETLNEFVLITEFAHMSLSNLLE-QRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +   +   L+ E+   S S+LLE  +K L E     +    +  L YLHS+ ++HRD+K
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI---AERPYDHTADLW 301
             N+LL++ G+  L DFG A  MA     +    GTP +MAPE+I    E  YD   D+W
Sbjct: 143 AGNILLSEPGLVKLGDFGSASIMAPANXFV----GTPYWMAPEVILAMDEGQYDGKVDVW 198
Query: 302 SLGCIAYEIHMGHPP-FKTVSILHLIRLLKTQDVTFPS-QVSETYKDLVKGLLEKDASQR 359
           SLG    E+    PP F   ++  L  + + +     S   SE +++ V   L+K    R
Sbjct: 199 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
Query: 360 LSWPELLHHPLV 371
            +   LL H  V
Sbjct: 259 PTSEVLLKHRFV 270

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/252 (32%), Positives = 127/252 (50%), Gaps = 11/252 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+ A  +   + VA+K +S SG+ S ++   + +E    + L HPN I++  
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 186 SHETLNEFVLITEFAHMSLSNLLE-QRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +   +   L+ E+   S S+LLE  +K L E     +    +  L YLHS+ ++HRD+K
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI---AERPYDHTADLW 301
             N+LL++ G+  L DFG A  MA     +    GTP +MAPE+I    E  YD   D+W
Sbjct: 182 AGNILLSEPGLVKLGDFGSASIMAPANXFV----GTPYWMAPEVILAMDEGQYDGKVDVW 237
Query: 302 SLGCIAYEIHMGHPP-FKTVSILHLIRLLKTQDVTFPS-QVSETYKDLVKGLLEKDASQR 359
           SLG    E+    PP F   ++  L  + + +     S   SE +++ V   L+K    R
Sbjct: 238 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 297
Query: 360 LSWPELLHHPLV 371
            +   LL H  V
Sbjct: 298 PTSEVLLKHRFV 309

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 129/250 (51%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF     A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 33  KFGKI--LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL  D
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 271 ATKRLGCEEM 280

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 129/250 (51%), Gaps = 6/250 (2%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 178
           K+ KI  +GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L HP
Sbjct: 35  KFGKI--LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
             +K   + +   +      +A +  L   + +     ET      + ++SAL YLH   
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYD 295
           ++HRDLKP+N+LLN+D    + DFG A+ ++  +    +    GT  Y++PEL+ E+   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            ++DLW+LGCI Y++  G PPF+  +   +   +   +  FP +     +DLV+ LL  D
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 356 ASQRLSWPEL 365
           A++RL   E+
Sbjct: 273 ATKRLGCEEM 282

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 140/277 (50%), Gaps = 26/277 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ-KHLAHPNIIKFIA 185
           IG GS+ +  + +H       A+K+I KS R   E      E EI  ++  HPNII    
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE------EIEILLRYGQHPNIITLKD 88
Query: 186 SHETLNEFVLITEFAHMSLSNLLE---QRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
            ++      L+TE   M    LL+   ++K  SE     +L  +   + YLHS  V+HRD
Sbjct: 89  VYDDGKHVYLVTEL--MRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRD 146
Query: 243 LKPQNVL-LNKDGVA---MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           LKP N+L +++ G      +CDFGFA+ +     +L +   T  ++APE++  + YD   
Sbjct: 147 LKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGC 206
Query: 299 DLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFP----SQVSETYKDLVKGL 351
           D+WSLG + Y +  G+ PF    + +   ++  + +   T      + VSET KDLV  +
Sbjct: 207 DIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKM 266
Query: 352 LEKDASQRLSWPELLHHPLV--KDNLS-SEIESQNNQ 385
           L  D  QRL+  ++L HP V  KD L  S++  Q+ Q
Sbjct: 267 LHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQ 303

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 137/283 (48%), Gaps = 16/283 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++YQ    IG+G+F  V + + L      A KII+    S ++   L++E  I + L H 
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHS 63
Query: 179 NIIKFIASHETLNE----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           NI++    H++++E    +++        L   +  R+  SE      +  ++ A+ + H
Sbjct: 64  NIVRL---HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 120
Query: 235 SNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
              V+HRDLKP+N+LL    K     L DFG A  +           GTP Y++PE++ +
Sbjct: 121 QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDL 347
             Y    D+W+ G I Y + +G+PPF       L + +K     FPS     V+   K+L
Sbjct: 181 EAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 240
Query: 348 VKGLLEKDASQRLSWPELLHHPLV--KDNLSSEIESQNNQDCI 388
           +  +L  + ++R++  E L HP V  +  ++S +  Q   +C+
Sbjct: 241 INQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECL 283

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 138/276 (50%), Gaps = 24/276 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ-KHLAHPNIIKFIA 185
           IG GS+ +  + +H       A+K+I KS R   E      E EI  ++  HPNII    
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE------EIEILLRYGQHPNIITLKD 88
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            ++      L+TE       L  +L Q K  SE     +L  +   + YLHS  V+HRDL
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQ-KFFSEREASFVLHTIGKTVEYLHSQGVVHRDL 147
Query: 244 KPQNVL-LNKDGVA---MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTAD 299
           KP N+L +++ G      +CDFGFA+ +     +L +   T  ++APE++  + YD   D
Sbjct: 148 KPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCD 207
Query: 300 LWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFP----SQVSETYKDLVKGLL 352
           +WSLG + Y +  G+ PF    + +   ++  + +   T      + VSET KDLV  +L
Sbjct: 208 IWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKML 267
Query: 353 EKDASQRLSWPELLHHPLV--KDNLS-SEIESQNNQ 385
             D  QRL+  ++L HP V  KD L  S++  Q+ Q
Sbjct: 268 HVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQ 303

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  115 bits (287), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 137/283 (48%), Gaps = 38/283 (13%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFI 184
           L+GEG++ KV  A+ L   K  A+KII K  ++G   S + +E E + +   + NI++ I
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEK--QAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 185 ASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E    F L+ E     S+   ++++K  +E    +++ ++ +AL +LH+  + HRDL
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDL 137
Query: 244 KPQNVLL---NKDGVAMLCDFGFARSM-------AVGTHMLTSIKGTPLYMAPELI---- 289
           KP+N+L     K     +CDF     M        + T  LT+  G+  YMAPE++    
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFT 197
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKT---------------VSILHLIRLLKTQD 333
                YD   DLWSLG + Y +  G+PPF                 V    L   ++   
Sbjct: 198 DQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 257
Query: 334 VTFPSQ----VSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
             FP +    +S   KDL+  LL +DA QRLS  ++L HP V+
Sbjct: 258 YEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 139/268 (51%), Gaps = 26/268 (9%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G G  GKV +  H    +  ALK++  S ++ +E+    Q          P+I+  + 
Sbjct: 17  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQAS------GGPHIVCILD 70
Query: 186 SHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRV 238
            +E ++       +++       L + +++R  +  +E    +I+ ++ +A+ +LHS+ +
Sbjct: 71  VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 130
Query: 239 LHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
            HRD+KP+N+L     KD V  L DFGFA+      + L +   TP Y+APE++    YD
Sbjct: 131 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTPYYVAPEVLGPEKYD 188
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFP----SQVSETYKDL 347
            + D+WSLG I Y +  G PPF + +       + R ++     FP    S+VSE  K L
Sbjct: 189 KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQL 248
Query: 348 VKGLLEKDASQRLSWPELLHHPLVKDNL 375
           ++ LL+ D ++RL+  + ++HP +  ++
Sbjct: 249 IRLLLKTDPTERLTITQFMNHPWINQSM 276

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 139/268 (51%), Gaps = 26/268 (9%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G G  GKV +  H    +  ALK++  S ++ +E+    Q          P+I+  + 
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQAS------GGPHIVCILD 89
Query: 186 SHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRV 238
            +E ++       +++       L + +++R  +  +E    +I+ ++ +A+ +LHS+ +
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 239 LHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
            HRD+KP+N+L     KD V  L DFGFA+      + L +   TP Y+APE++    YD
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTPYYVAPEVLGPEKYD 207
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFP----SQVSETYKDL 347
            + D+WSLG I Y +  G PPF + +       + R ++     FP    S+VSE  K L
Sbjct: 208 KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQL 267
Query: 348 VKGLLEKDASQRLSWPELLHHPLVKDNL 375
           ++ LL+ D ++RL+  + ++HP +  ++
Sbjct: 268 IRLLLKTDPTERLTITQFMNHPWINQSM 295

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 130/254 (51%), Gaps = 4/254 (1%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           +G G+FGKV    H      VA+KI+++   RS   +  +K+E +  K   HP+IIK   
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 186 SHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
              T  +F ++ E+     L + + +  ++ E    ++   ++SA+ Y H + V+HRDLK
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY-DHTADLWSL 303
           P+NVLL+    A + DFG +  M+ G  + TS  G+P Y APE+I+ R Y     D+WS 
Sbjct: 139 PENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 304 GCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWP 363
           G I Y +  G  PF    +  L + ++      P  ++ +   L+  +L+ D  +R +  
Sbjct: 198 GVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIK 257
Query: 364 ELLHHPLVKDNLSS 377
           ++  H   K +L S
Sbjct: 258 DIREHEWFKQDLPS 271

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 114/213 (53%), Gaps = 16/213 (7%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLA 176
           + KY+K+  IG+G+FG+VFKA H    + VALK ++ ++ + G  +++L+ E +I + L 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLK 75
Query: 177 HPNIIKFI--------ASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLI 227
           H N++  I          +       L+ +F    L+ LL     K + +   +++  L+
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG----THMLTSIKGTPLY 283
           + LYY+H N++LHRD+K  NVL+ +DGV  L DFG AR+ ++      +   +   T  Y
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 284 MAPE-LIAERPYDHTADLWSLGCIAYEIHMGHP 315
             PE L+ ER Y    DLW  GCI  E+    P
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 114/213 (53%), Gaps = 16/213 (7%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLA 176
           + KY+K+  IG+G+FG+VFKA H    + VALK ++ ++ + G  +++L+ E +I + L 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLK 75
Query: 177 HPNIIKFI--------ASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLI 227
           H N++  I          +       L+ +F    L+ LL     K + +   +++  L+
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG----THMLTSIKGTPLY 283
           + LYY+H N++LHRD+K  NVL+ +DGV  L DFG AR+ ++      +   +   T  Y
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 284 MAPE-LIAERPYDHTADLWSLGCIAYEIHMGHP 315
             PE L+ ER Y    DLW  GCI  E+    P
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 132/291 (45%), Gaps = 42/291 (14%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +++++  +G G++  V+K ++      VALK +      G   ++++ E  + K L H N
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKELKHEN 64
Query: 180 IIKFIASHETLNEFVLITEFAHMSLSNLLEQR------KKLSETICVQILSNLISALYYL 233
           I++      T N+  L+ EF    L   ++ R      + L   +       L+  L + 
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAER 292
           H N++LHRDLKPQN+L+NK G   L DFG AR+  +  +  +S   T  Y AP+ L+  R
Sbjct: 125 HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSR 184
Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-----KTQDVTFPS--------- 338
            Y  + D+WS GCI  E+  G P F   +    ++L+        +  +PS         
Sbjct: 185 TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP 244
Query: 339 -----------QVSETYK---------DLVKGLLEKDASQRLSWPELLHHP 369
                      QV + +          D + GLL+ +   RLS  + LHHP
Sbjct: 245 NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 17/268 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E Y+ +  IG GS+G+  K       K +  K +     +  E   L  E  + + L HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 179 NIIKFIAS--HETLNEFVLITEFAHMS-----LSNLLEQRKKLSETICVQILSNLISALY 231
           NI+++       T     ++ E+         ++   ++R+ L E   +++++ L  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 232 YLH-----SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
             H      + VLHRDLKP NV L+      L DFG AR +   T    +  GTP YM+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 185
Query: 287 ELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL---IRLLKTQDVTFPSQVSET 343
           E +    Y+  +D+WSLGC+ YE+    PPF   S   L   IR  K + +  P + S+ 
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--PYRYSDE 243
Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLV 371
             +++  +L      R S  E+L +PL+
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 17/268 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E Y+ +  IG GS+G+  K       K +  K +     +  E   L  E  + + L HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 179 NIIKFIAS--HETLNEFVLITEFAHMS-----LSNLLEQRKKLSETICVQILSNLISALY 231
           NI+++       T     ++ E+         ++   ++R+ L E   +++++ L  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 232 YLH-----SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
             H      + VLHRDLKP NV L+      L DFG AR +   T    +  GTP YM+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 287 ELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL---IRLLKTQDVTFPSQVSET 343
           E +    Y+  +D+WSLGC+ YE+    PPF   S   L   IR  K + +  P + S+ 
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--PYRYSDE 243
Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLV 371
             +++  +L      R S  E+L +PL+
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 114/213 (53%), Gaps = 16/213 (7%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLA 176
           + KY+K+  IG+G+FG+VFKA H    + VALK ++ ++ + G  +++L+ E +I + L 
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLK 74
Query: 177 HPNIIKFI--------ASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLI 227
           H N++  I          +       L+ +F    L+ LL     K + +   +++  L+
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG----THMLTSIKGTPLY 283
           + LYY+H N++LHRD+K  NVL+ +DGV  L DFG AR+ ++      +   +   T  Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 284 MAPE-LIAERPYDHTADLWSLGCIAYEIHMGHP 315
             PE L+ ER Y    DLW  GCI  E+    P
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 114/213 (53%), Gaps = 16/213 (7%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLA 176
           + KY+K+  IG+G+FG+VFKA H    + VALK ++ ++ + G  +++L+ E +I + L 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLK 75
Query: 177 HPNIIKFI--------ASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLI 227
           H N++  I          +       L+ +F    L+ LL     K + +   +++  L+
Sbjct: 76  HENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG----THMLTSIKGTPLY 283
           + LYY+H N++LHRD+K  NVL+ +DGV  L DFG AR+ ++      +   +   T  Y
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 284 MAPE-LIAERPYDHTADLWSLGCIAYEIHMGHP 315
             PE L+ ER Y    DLW  GCI  E+    P
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 124/256 (48%), Gaps = 15/256 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G+G+F  V + +H       A KII+    S ++   L++E  I + L HPNI++    
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL--- 70
Query: 187 HETLNE----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
           H+++ E    +++        L   +  R+  SE      +  ++ ++ Y HSN ++HR+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 243 LKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTAD 299
           LKP+N+LL    K     L DFG A  +   +       GTP Y++PE++ + PY    D
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVD 189
Query: 300 LWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVKGLLEKD 355
           +W+ G I Y + +G+PPF       L   +K     +PS     V+   K L+  +L  +
Sbjct: 190 IWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN 249
Query: 356 ASQRLSWPELLHHPLV 371
             +R++  + L  P +
Sbjct: 250 PKKRITADQALKVPWI 265

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 136/302 (45%), Gaps = 36/302 (11%)
Query: 109 VKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQE 168
           V    S  ++++Y++I  +GEG++G+V+KAI     +TVA+K I           +  +E
Sbjct: 24  VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE 83
Query: 169 CEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLIS 228
             + K L H NII+  +     +   LI E+A   L   +++   +S  +    L  LI+
Sbjct: 84  VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 229 ALYYLHSNRVLHRDLKPQNVLL-----NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLY 283
            + + HS R LHRDLKPQN+LL     ++  V  + DFG AR+  +     T    T  Y
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203
Query: 284 MAPE-LIAERPYDHTADLWSLGCIAYEIHMGHP--P--------FKTVSILHL------- 325
             PE L+  R Y  + D+WS+ CI  E+ M  P  P        FK   +L L       
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263
Query: 326 -IRLLKTQDVTFPSQVSETYKDLV------------KGLLEKDASQRLSWPELLHHPLVK 372
            +  L     +FP    +T K ++              +LE D  +R+S    L HP   
Sbjct: 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323
Query: 373 DN 374
            N
Sbjct: 324 HN 325

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 144/279 (51%), Gaps = 28/279 (10%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++       ++E E+
Sbjct: 61  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVEL 113
Query: 172 QKHLAH-PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L        +++       L + ++ R  +  +E    +I+
Sbjct: 114 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 173
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+      + LT+   T
Sbjct: 174 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYT 232
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
           P Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +KT+       F
Sbjct: 233 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 292
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR++  E ++HP +
Sbjct: 293 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 144/279 (51%), Gaps = 28/279 (10%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++       ++E E+
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVEL 107
Query: 172 QKHLAH-PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L        +++       L + ++ R  +  +E    +I+
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 167
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+      + LT+   T
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYT 226
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
           P Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +KT+       F
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR++  E ++HP +
Sbjct: 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 4/254 (1%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           +G G+FGKV    H      VA+KI+++   RS   +  +K+E +  K   HP+IIK   
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 186 SHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
              T  +F ++ E+     L + + +  ++ E    ++   ++SA+ Y H + V+HRDLK
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY-DHTADLWSL 303
           P+NVLL+    A + DFG +  M+ G  +  S  G+P Y APE+I+ R Y     D+WS 
Sbjct: 139 PENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC-GSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 304 GCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWP 363
           G I Y +  G  PF    +  L + ++      P  ++ +   L+  +L+ D  +R +  
Sbjct: 198 GVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIK 257
Query: 364 ELLHHPLVKDNLSS 377
           ++  H   K +L S
Sbjct: 258 DIREHEWFKQDLPS 271

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 144/279 (51%), Gaps = 28/279 (10%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++       ++E E+
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVEL 63
Query: 172 QKHLAH-PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L        +++       L + ++ R  +  +E    +I+
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+      + LT+   T
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYT 182
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
           P Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +KT+       F
Sbjct: 183 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 242
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR++  E ++HP +
Sbjct: 243 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 144/279 (51%), Gaps = 28/279 (10%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++       ++E E+
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVEL 63
Query: 172 QKHLAH-PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L        +++       L + ++ R  +  +E    +I+
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+      + LT+   T
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYT 182
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
           P Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +KT+       F
Sbjct: 183 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 242
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR++  E ++HP +
Sbjct: 243 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 144/279 (51%), Gaps = 28/279 (10%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++       ++E E+
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVEL 61
Query: 172 QKHLAH-PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L        +++       L + ++ R  +  +E    +I+
Sbjct: 62  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 121
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+      + LT+   T
Sbjct: 122 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYT 180
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
           P Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +KT+       F
Sbjct: 181 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 240
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR++  E ++HP +
Sbjct: 241 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 144/279 (51%), Gaps = 28/279 (10%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++       ++E E+
Sbjct: 10  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVEL 62
Query: 172 QKHLAH-PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L        +++       L + ++ R  +  +E    +I+
Sbjct: 63  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 122
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+      + LT+   T
Sbjct: 123 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYT 181
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
           P Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +KT+       F
Sbjct: 182 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 241
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR++  E ++HP +
Sbjct: 242 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 144/279 (51%), Gaps = 28/279 (10%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++       ++E E+
Sbjct: 16  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVEL 68
Query: 172 QKHLAH-PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L        +++       L + ++ R  +  +E    +I+
Sbjct: 69  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 128
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+      + LT+   T
Sbjct: 129 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYT 187
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
           P Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +KT+       F
Sbjct: 188 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 247
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR++  E ++HP +
Sbjct: 248 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 144/279 (51%), Gaps = 28/279 (10%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++       ++E E+
Sbjct: 17  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVEL 69
Query: 172 QKHLAH-PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L        +++       L + ++ R  +  +E    +I+
Sbjct: 70  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 129
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+      + LT+   T
Sbjct: 130 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYT 188
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
           P Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +KT+       F
Sbjct: 189 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 248
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR++  E ++HP +
Sbjct: 249 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 144/279 (51%), Gaps = 28/279 (10%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++       ++E E+
Sbjct: 25  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVEL 77
Query: 172 QKHLAH-PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L        +++       L + ++ R  +  +E    +I+
Sbjct: 78  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 137
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+      + LT+   T
Sbjct: 138 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYT 196
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
           P Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +KT+       F
Sbjct: 197 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 256
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR++  E ++HP +
Sbjct: 257 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 144/279 (51%), Gaps = 28/279 (10%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++       ++E E+
Sbjct: 15  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVEL 67
Query: 172 QKHLAH-PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L        +++       L + ++ R  +  +E    +I+
Sbjct: 68  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 127
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+      + LT+   T
Sbjct: 128 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYT 186
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
           P Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +KT+       F
Sbjct: 187 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 246
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR++  E ++HP +
Sbjct: 247 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 127/246 (51%), Gaps = 4/246 (1%)
Query: 120 KYQKICLIGEGSFGKVF---KAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           +++ + ++G+GSFGKVF   K    D ++  A+K++ K+    ++    K E +I   + 
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 85
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           HP I+K   + +T  +  LI +F     L   L +    +E      L+ L  AL +LHS
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 145
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
             +++RDLKP+N+LL+++G   L DFG ++          S  GT  YMAPE++  R + 
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 205
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            +AD WS G + +E+  G  PF+       + ++    +  P  +S   + L++ L +++
Sbjct: 206 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRN 265
Query: 356 ASQRLS 361
            + RL 
Sbjct: 266 PANRLG 271

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 127/246 (51%), Gaps = 4/246 (1%)
Query: 120 KYQKICLIGEGSFGKVF---KAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           +++ + ++G+GSFGKVF   K    D ++  A+K++ K+    ++    K E +I   + 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           HP I+K   + +T  +  LI +F     L   L +    +E      L+ L  AL +LHS
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
             +++RDLKP+N+LL+++G   L DFG ++          S  GT  YMAPE++  R + 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            +AD WS G + +E+  G  PF+       + ++    +  P  +S   + L++ L +++
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRN 264
Query: 356 ASQRLS 361
            + RL 
Sbjct: 265 PANRLG 270

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G+G++G V+    L  +  +A+K I +  R  +    L +E  + KHL H NI++++ 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 186 SHETLNEFV--LITEFAHMSLSNLLEQR----KKLSETICVQILSNLISALYYLHSNRVL 239
           S  + N F+   + +    SLS LL  +    K   +TI       ++  L YLH N+++
Sbjct: 87  SF-SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLKYLHDNQIV 144
Query: 240 HRDLKPQNVLLNK-DGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP--YDH 296
           HRD+K  NVL+N   GV  + DFG ++ +A       +  GT  YMAPE+I + P  Y  
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 297 TADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL 352
            AD+WSLGC   E+  G PPF    +  + +  + + K      P  +S   K  +    
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP-EIPESMSAEAKAFILKCF 263
Query: 353 EKDASQRLSWPELL 366
           E D  +R    +LL
Sbjct: 264 EPDPDKRACANDLL 277

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 124/245 (50%), Gaps = 4/245 (1%)
Query: 121 YQKICLIGEGSFGKVF---KAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           ++ + ++G+GSFGKVF   K    D     A+K++ K+    ++    K E +I   + H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 178 PNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           P ++K   + +T  +  LI +F     L   L +    +E      L+ L   L +LHS 
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSL 149
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
            +++RDLKP+N+LL+++G   L DFG ++          S  GT  YMAPE++  + + H
Sbjct: 150 GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSH 209
Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
           +AD WS G + +E+  G  PF+       + L+    +  P  +S   + L++ L +++ 
Sbjct: 210 SADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRALFKRNP 269
Query: 357 SQRLS 361
           + RL 
Sbjct: 270 ANRLG 274

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 127/246 (51%), Gaps = 4/246 (1%)
Query: 120 KYQKICLIGEGSFGKVF---KAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           +++ + ++G+GSFGKVF   K    D ++  A+K++ K+    ++    K E +I   + 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           HP I+K   + +T  +  LI +F     L   L +    +E      L+ L  AL +LHS
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
             +++RDLKP+N+LL+++G   L DFG ++          S  GT  YMAPE++  R + 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            +AD WS G + +E+  G  PF+       + ++    +  P  +S   + L++ L +++
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRN 264
Query: 356 ASQRLS 361
            + RL 
Sbjct: 265 PANRLG 270

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/336 (25%), Positives = 142/336 (42%), Gaps = 44/336 (13%)
Query: 64  HLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQK 123
           HL      +F+ S      F+   ++  +    +GE WF +                   
Sbjct: 153 HLGQAPFQEFLDS----KYFLRFLQWKWLEAQPMGEDWFLD------------------- 189
Query: 124 ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
             ++G G FG+VF      +K T  L    K  +   +     Q   ++K +      +F
Sbjct: 190 FRVLGRGGFGEVFAC---QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 184 IAS----HETLNEFVLITEFAHMS-----LSNLLEQRKKLSETICVQILSNLISALYYLH 234
           I S     ET  +  L+    +       + N+ E      E   +   + ++S L +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
              +++RDLKP+NVLL+ DG   + D G A  +  G        GTP +MAPEL+    Y
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKT----VSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
           D + D ++LG   YE+     PF+     V    L + +  Q VT+P + S   KD  + 
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 351 LLEKDASQRLSWPE-----LLHHPLVKDNLSSEIES 381
           LL+KD  +RL + +     L  HPL +D    ++E+
Sbjct: 427 LLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEA 462

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++       ++E E+
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVEL 61
Query: 172 QKHLAH-PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L        +++       L + ++ R  +  +E    +I+
Sbjct: 62  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 121
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+      + LT    T
Sbjct: 122 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTEPCYT 180
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
           P Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +KT+       F
Sbjct: 181 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 240
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR++  E ++HP +
Sbjct: 241 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 127/261 (48%), Gaps = 25/261 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ-KHLAHPNIIKFIA 185
           IG GS+    + IH       A+KII KS R   E      E EI  ++  HPNII    
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------EIEILLRYGQHPNIITLKD 83
Query: 186 SHETLNEFVLITEFAHMSLSNLLE---QRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
            ++      ++TE   M    LL+   ++K  SE     +L  +   + YLH+  V+HRD
Sbjct: 84  VYDDGKYVYVVTEL--MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 243 LKPQNVLL-----NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           LKP N+L      N + +  +CDFGFA+ +     +L +   T  ++APE++  + YD  
Sbjct: 142 LKPSNILYVDESGNPESI-RICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAA 200
Query: 298 ADLWSLGCIAYEIHMGHPPFKTVS------ILHLIRLLK-TQDVTFPSQVSETYKDLVKG 350
            D+WSLG + Y +  G+ PF          IL  I   K +    + + VS+T KDLV  
Sbjct: 201 CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSK 260
Query: 351 LLEKDASQRLSWPELLHHPLV 371
           +L  D  QRL+   +L HP +
Sbjct: 261 MLHVDPHQRLTAALVLRHPWI 281

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 140/281 (49%), Gaps = 19/281 (6%)
Query: 111 MEKSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISK---SGRSGKELSSLK 166
           M   +   E   ++C +IG+G F  V + I+ +  +  A+KI+     +   G     LK
Sbjct: 15  MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK 74
Query: 167 QECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNL-LEQRKK------LSETIC 219
           +E  I   L HP+I++ + ++ +     ++ EF  M  ++L  E  K+       SE + 
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEF--MDGADLCFEIVKRADAGFVYSEAVA 132
Query: 220 VQILSNLISALYYLHSNRVLHRDLKPQNVLL-NKDGVAMLCDFGFARSMAVGTHMLTSIK 278
              +  ++ AL Y H N ++HRD+KP  VLL +K+  A +   GF  ++ +G   L +  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 279 --GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF 336
             GTP +MAPE++   PY    D+W  G I + +  G  PF          ++K +    
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 252
Query: 337 PSQ---VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN 374
           P Q   +SE+ KDLV+ +L  D ++R++  E L+HP +K+ 
Sbjct: 253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 140/281 (49%), Gaps = 19/281 (6%)
Query: 111 MEKSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISK---SGRSGKELSSLK 166
           M   +   E   ++C +IG+G F  V + I+ +  +  A+KI+     +   G     LK
Sbjct: 17  MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK 76
Query: 167 QECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNL-LEQRKK------LSETIC 219
           +E  I   L HP+I++ + ++ +     ++ EF  M  ++L  E  K+       SE + 
Sbjct: 77  REASICHMLKHPHIVELLETYSSDGMLYMVFEF--MDGADLCFEIVKRADAGFVYSEAVA 134
Query: 220 VQILSNLISALYYLHSNRVLHRDLKPQNVLL-NKDGVAMLCDFGFARSMAVGTHMLTSIK 278
              +  ++ AL Y H N ++HRD+KP  VLL +K+  A +   GF  ++ +G   L +  
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 279 --GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF 336
             GTP +MAPE++   PY    D+W  G I + +  G  PF          ++K +    
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 254
Query: 337 PSQ---VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN 374
           P Q   +SE+ KDLV+ +L  D ++R++  E L+HP +K+ 
Sbjct: 255 PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 295

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 126/255 (49%), Gaps = 18/255 (7%)
Query: 125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
            ++G+G++G V+    L  +  +A+K I +  R  +    L +E  + KHL H NI++++
Sbjct: 14  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 185 ASHETLNEFV--LITEFAHMSLSNLLEQR----KKLSETICVQILSNLISALYYLHSNRV 238
            S  + N F+   + +    SLS LL  +    K   +TI       ++  L YLH N++
Sbjct: 72  GSF-SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT-KQILEGLKYLHDNQI 129
Query: 239 LHRDLKPQNVLLNK-DGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP--YD 295
           +HRD+K  NVL+N   GV  + DFG ++ +A       +  GT  YMAPE+I + P  Y 
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 296 HTADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGL 351
             AD+WSLGC   E+  G PPF    +  + +  + + K      P  +S   K  +   
Sbjct: 190 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP-EIPESMSAEAKAFILKC 248
Query: 352 LEKDASQRLSWPELL 366
            E D  +R    +LL
Sbjct: 249 FEPDPDKRACANDLL 263

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 140/285 (49%), Gaps = 19/285 (6%)
Query: 116 GALEKY---QKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ 172
           GA+  +    K  ++G G FG+V K         +A KII   G   KE   +K E  + 
Sbjct: 83  GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE--EVKNEISVM 140
Query: 173 KHLAHPNIIKFIASHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISAL 230
             L H N+I+   + E+ N+ VL+ E+         ++++   L+E   +  +  +   +
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGI 200
Query: 231 YYLHSNRVLHRDLKPQNVL-LNKDGVAM-LCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
            ++H   +LH DLKP+N+L +N+D   + + DFG AR       +  +  GTP ++APE+
Sbjct: 201 RHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEV 259
Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPF------KTVSILHLIRLLKTQDVTFPSQVSE 342
           +         D+WS+G IAY +  G  PF      +T++ +   R    +D  F   +SE
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR-WDLEDEEF-QDISE 317
Query: 343 TYKDLVKGLLEKDASQRLSWPELLHHPLVKDN-LSSEIESQNNQD 386
             K+ +  LL K+ S R+S  E L HP + D+ L S + +Q  ++
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKN 362

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 126/268 (47%), Gaps = 17/268 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E Y+ +  IG GS+G+  K       K +  K +     +  E   L  E  + + L HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 179 NIIKF---IASHETLNEFVLITEFAHMSLSNLL----EQRKKLSETICVQILSNLISALY 231
           NI+++   I        ++++       L++++    ++R+ L E   +++++ L  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 232 YLH-----SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
             H      + VLHRDLKP NV L+      L DFG AR +           GTP YM+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSP 185
Query: 287 ELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL---IRLLKTQDVTFPSQVSET 343
           E +    Y+  +D+WSLGC+ YE+    PPF   S   L   IR  K + +  P + S+ 
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--PYRYSDE 243
Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLV 371
             +++  +L      R S  E+L +PL+
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 17/270 (6%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH-- 174
            ++ ++ I ++G+GSFGKV  A   +     A+K++ K       L     EC + +   
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD----VILQDDDVECTMTEKRI 76
Query: 175 --LA--HPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISA 229
             LA  HP + +     +T +    + EF +   L   +++ ++  E       + +ISA
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA 136
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L +LH   +++RDLK  NVLL+ +G   L DFG  +          +  GTP Y+APE++
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
            E  Y    D W++G + YE+  GH PF+  +   L   +   +V +P+ + E    ++K
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILK 256
Query: 350 GLLEKDASQRL------SWPELLHHPLVKD 373
             + K+ + RL          +L HP  K+
Sbjct: 257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 136/317 (42%), Gaps = 40/317 (12%)
Query: 83  FVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLD 142
           F+   ++  +    +GE WF +                     ++G G FG+VF      
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLD-------------------FRVLGRGGFGEVFAC---Q 205
Query: 143 LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS----HETLNEFVLITE 198
           +K T  L    K  +   +     Q   ++K +      +FI S     ET  +  L+  
Sbjct: 206 MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265
Query: 199 FAHMS-----LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD 253
             +       + N+ E      E   +   + ++S L +LH   +++RDLKP+NVLL+ D
Sbjct: 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD 325
Query: 254 GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMG 313
           G   + D G A  +  G        GTP +MAPEL+    YD + D ++LG   YE+   
Sbjct: 326 GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
Query: 314 HPPFKT----VSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPE----- 364
             PF+     V    L + +  Q VT+P + S   KD  + LL+KD  +RL + +     
Sbjct: 386 RGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDG 445
Query: 365 LLHHPLVKDNLSSEIES 381
           L  HPL +D    ++E+
Sbjct: 446 LRTHPLFRDISWRQLEA 462

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 136/317 (42%), Gaps = 40/317 (12%)
Query: 83  FVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLD 142
           F+   ++  +    +GE WF +                     ++G G FG+VF      
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLD-------------------FRVLGRGGFGEVFAC---Q 205
Query: 143 LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS----HETLNEFVLITE 198
           +K T  L    K  +   +     Q   ++K +      +FI S     ET  +  L+  
Sbjct: 206 MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265
Query: 199 FAHMS-----LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD 253
             +       + N+ E      E   +   + ++S L +LH   +++RDLKP+NVLL+ D
Sbjct: 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD 325
Query: 254 GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMG 313
           G   + D G A  +  G        GTP +MAPEL+    YD + D ++LG   YE+   
Sbjct: 326 GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
Query: 314 HPPFKT----VSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPE----- 364
             PF+     V    L + +  Q VT+P + S   KD  + LL+KD  +RL + +     
Sbjct: 386 RGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDG 445
Query: 365 LLHHPLVKDNLSSEIES 381
           L  HPL +D    ++E+
Sbjct: 446 LRTHPLFRDISWRQLEA 462

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 136/317 (42%), Gaps = 40/317 (12%)
Query: 83  FVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLD 142
           F+   ++  +    +GE WF +                     ++G G FG+VF      
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLD-------------------FRVLGRGGFGEVFAC---Q 205
Query: 143 LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS----HETLNEFVLITE 198
           +K T  L    K  +   +     Q   ++K +      +FI S     ET  +  L+  
Sbjct: 206 MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265
Query: 199 FAHMS-----LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD 253
             +       + N+ E      E   +   + ++S L +LH   +++RDLKP+NVLL+ D
Sbjct: 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD 325
Query: 254 GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMG 313
           G   + D G A  +  G        GTP +MAPEL+    YD + D ++LG   YE+   
Sbjct: 326 GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
Query: 314 HPPFKT----VSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPE----- 364
             PF+     V    L + +  Q VT+P + S   KD  + LL+KD  +RL + +     
Sbjct: 386 RGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDG 445
Query: 365 LLHHPLVKDNLSSEIES 381
           L  HPL +D    ++E+
Sbjct: 446 LRTHPLFRDISWRQLEA 462

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFIA 185
           IG G   KVF+ ++ + K+  A+K ++      + L S + E   + K   H + I  + 
Sbjct: 64  IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 186 SHETLNEFV-LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E  ++++ ++ E  ++ L++ L+++K +          N++ A++ +H + ++H DLK
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPLYMAPELIAERPYDH------ 296
           P N L+  DG+  L DFG A  M   T  +   S  GT  YM PE I +           
Sbjct: 183 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 241
Query: 297 -----TADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSETYKDL 347
                 +D+WSLGCI Y +  G  PF+ +    S LH I +    ++ FP    +  +D+
Sbjct: 242 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDIPEKDLQDV 300
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
           +K  L++D  QR+S PELL HP V+
Sbjct: 301 LKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFIA 185
           IG G   KVF+ ++ + K+  A+K ++      + L S + E   + K   H + I  + 
Sbjct: 64  IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 186 SHETLNEFV-LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E  ++++ ++ E  ++ L++ L+++K +          N++ A++ +H + ++H DLK
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPLYMAPELIAERPYDH------ 296
           P N L+  DG+  L DFG A  M   T  +   S  GT  YM PE I +           
Sbjct: 183 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 241
Query: 297 -----TADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSETYKDL 347
                 +D+WSLGCI Y +  G  PF+ +    S LH I +    ++ FP    +  +D+
Sbjct: 242 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDIPEKDLQDV 300
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
           +K  L++D  QR+S PELL HP V+
Sbjct: 301 LKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFIA 185
           IG G   KVF+ ++ + K+  A+K ++      + L S + E   + K   H + I  + 
Sbjct: 17  IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 186 SHETLNEFV-LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E  ++++ ++ E  ++ L++ L+++K +          N++ A++ +H + ++H DLK
Sbjct: 76  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 135
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPLYMAPELIAERPYDH------ 296
           P N L+  DG+  L DFG A  M   T  +   S  GT  YM PE I +           
Sbjct: 136 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 194
Query: 297 -----TADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSETYKDL 347
                 +D+WSLGCI Y +  G  PF+ +    S LH I +    ++ FP    +  +D+
Sbjct: 195 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDIPEKDLQDV 253
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
           +K  L++D  QR+S PELL HP V+
Sbjct: 254 LKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 123/260 (47%), Gaps = 23/260 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ-KHLAHPNIIKFIA 185
           IG GS+    + IH       A+KII KS R   E      E EI  ++  HPNII    
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE------EIEILLRYGQHPNIITLKD 83
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            ++      ++TE       L  +L Q K  SE     +L  +   + YLH+  V+HRDL
Sbjct: 84  VYDDGKYVYVVTELXKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDL 142
Query: 244 KPQNVLL-----NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           KP N+L      N + +  +CDFGFA+ +     +L +   T  ++APE++  + YD   
Sbjct: 143 KPSNILYVDESGNPESI-RICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAAC 201
Query: 299 DLWSLGCIAYEIHMGHPPFKTVS------ILHLIRLLK-TQDVTFPSQVSETYKDLVKGL 351
           D+WSLG + Y    G+ PF          IL  I   K +    + + VS+T KDLV   
Sbjct: 202 DIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKX 261
Query: 352 LEKDASQRLSWPELLHHPLV 371
           L  D  QRL+   +L HP +
Sbjct: 262 LHVDPHQRLTAALVLRHPWI 281

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFIA 185
           IG G   KVF+ ++ + K+  A+K ++      + L S + E   + K   H + I  + 
Sbjct: 36  IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 186 SHETLNEFV-LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E  ++++ ++ E  ++ L++ L+++K +          N++ A++ +H + ++H DLK
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 154
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPLYMAPELIAERPYDH------ 296
           P N L+  DG+  L DFG A  M   T  +   S  GT  YM PE I +           
Sbjct: 155 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 213
Query: 297 -----TADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSETYKDL 347
                 +D+WSLGCI Y +  G  PF+ +    S LH I +    ++ FP    +  +D+
Sbjct: 214 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDIPEKDLQDV 272
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
           +K  L++D  QR+S PELL HP V+
Sbjct: 273 LKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 124/251 (49%), Gaps = 11/251 (4%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI--QKHL 175
           L  +  + ++G+GSFGKV  A     ++  A+KI+ K       +     EC +  ++ L
Sbjct: 18  LTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKD----VVIQDDDVECTMVEKRVL 73
Query: 176 A----HPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
           A     P + +  +  +T++    + E+ +   L   ++Q  K  E   V   + +   L
Sbjct: 74  ALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGL 133
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           ++LH   +++RDLK  NV+L+ +G   + DFG  +   +         GTP Y+APE+IA
Sbjct: 134 FFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIA 193
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            +PY  + D W+ G + YE+  G PPF       L + +   +V++P  +S+    + KG
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 253
Query: 351 LLEKDASQRLS 361
           L+ K  ++RL 
Sbjct: 254 LMTKHPAKRLG 264

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFIA 185
           IG G   KVF+ ++ + K+  A+K ++      + L S + E   + K   H + I  + 
Sbjct: 20  IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 186 SHETLNEFV-LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E  ++++ ++ E  ++ L++ L+++K +          N++ A++ +H + ++H DLK
Sbjct: 79  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 138
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPLYMAPELIAERPYDH------ 296
           P N L+  DG+  L DFG A  M   T  +   S  GT  YM PE I +           
Sbjct: 139 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 197
Query: 297 -----TADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSETYKDL 347
                 +D+WSLGCI Y +  G  PF+ +    S LH I +    ++ FP    +  +D+
Sbjct: 198 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDIPEKDLQDV 256
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
           +K  L++D  QR+S PELL HP V+
Sbjct: 257 LKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFIA 185
           IG G   KVF+ ++ + K+  A+K ++      + L S + E   + K   H + I  + 
Sbjct: 16  IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 186 SHETLNEFV-LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E  ++++ ++ E  ++ L++ L+++K +          N++ A++ +H + ++H DLK
Sbjct: 75  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 134
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPLYMAPELIAERPYDH------ 296
           P N L+  DG+  L DFG A  M   T  +   S  GT  YM PE I +           
Sbjct: 135 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 193
Query: 297 -----TADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSETYKDL 347
                 +D+WSLGCI Y +  G  PF+ +    S LH I +    ++ FP    +  +D+
Sbjct: 194 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDIPEKDLQDV 252
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
           +K  L++D  QR+S PELL HP V+
Sbjct: 253 LKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 147/304 (48%), Gaps = 25/304 (8%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++Y+ +  IG G+FG           + VA+K I    R  K  +++K+E    + L HP
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIAANVKREIINHRSLRHP 75
Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQ---RKKLSETICVQILSNLISALYYLHS 235
           NI++F     T     ++ E+A  S   L E+     + SE         LIS + Y H+
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 236 NRVLHRDLKPQNVLLNKDGVAML--CDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
            +V HRDLK +N LL+      L  CDFG+++S  + +   +++ GTP Y+APE++ ++ 
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 192
Query: 294 YD-HTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLIRLLKTQDVTFPSQV--SET 343
           YD   AD+WS G   Y + +G  PF+           +H  R+L  Q    P  V  S  
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH--RILNVQ-YAIPDYVHISPE 249
Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSI 403
            + L+  +   D ++R+S PE+ +H     NL +++ + N      FD  D+   S + I
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTM-TTQFDESDQPGQSIEEI 308
Query: 404 TTIV 407
             I+
Sbjct: 309 MQII 312

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 137/293 (46%), Gaps = 18/293 (6%)
Query: 101 WFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK 160
           W   + QPV++ K +  L+ Y     +G G+FG V +          A K +     S K
Sbjct: 34  WKQYYPQPVEI-KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 92
Query: 161 ELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLE----QRKKLSE 216
           E  ++++E +    L HP ++    + E  NE V+I EF  MS   L E    +  K+SE
Sbjct: 93  E--TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF--MSGGELFEKVADEHNKMSE 148
Query: 217 TICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN--KDGVAMLCDFGFARSMAVGTHML 274
              V+ +  +   L ++H N  +H DLKP+N++    +     L DFG    +     + 
Sbjct: 149 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 208
Query: 275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT--- 331
            +  GT  + APE+   +P  +  D+WS+G ++Y +  G  PF   +    +R +K+   
Sbjct: 209 VTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 267
Query: 332 --QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQ 382
              D  F S +SE  KD ++ LL  D + R++  + L HP +    +   +SQ
Sbjct: 268 NMDDSAF-SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 319

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 137/293 (46%), Gaps = 18/293 (6%)
Query: 101 WFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK 160
           W   + QPV++ K +  L+ Y     +G G+FG V +          A K +     S K
Sbjct: 140 WKQYYPQPVEI-KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 198
Query: 161 ELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLE----QRKKLSE 216
           E  ++++E +    L HP ++    + E  NE V+I EF  MS   L E    +  K+SE
Sbjct: 199 E--TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF--MSGGELFEKVADEHNKMSE 254
Query: 217 TICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN--KDGVAMLCDFGFARSMAVGTHML 274
              V+ +  +   L ++H N  +H DLKP+N++    +     L DFG    +     + 
Sbjct: 255 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314
Query: 275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT--- 331
            +  GT  + APE+   +P  +  D+WS+G ++Y +  G  PF   +    +R +K+   
Sbjct: 315 VTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373
Query: 332 --QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQ 382
              D  F S +SE  KD ++ LL  D + R++  + L HP +    +   +SQ
Sbjct: 374 NMDDSAF-SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 425

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 132/273 (48%), Gaps = 12/273 (4%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHL- 175
           +E ++   ++G+GSFGKVF A   + KKT     I K+ +    L     EC  ++K + 
Sbjct: 17  IEDFELHKMLGKGSFGKVFLA---EFKKTNQFFAI-KALKKDVVLMDDDVECTMVEKRVL 72
Query: 176 ----AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
                HP +     + +T      + E+ +   L   ++   K   +      + +I  L
Sbjct: 73  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 132
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  +++RDLK  N+LL+KDG   + DFG  +   +G        GTP Y+APE++ 
Sbjct: 133 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILL 192
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            + Y+H+ D WS G + YE+ +G  PF       L   ++  +  +P  + +  KDL+  
Sbjct: 193 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 252
Query: 351 LLEKDASQRLS-WPELLHHPLVKDNLSSEIESQ 382
           L  ++  +RL    ++  HPL ++    E+E +
Sbjct: 253 LFVREPEKRLGVRGDIRQHPLFREINWEELERK 285

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFIA 185
           IG G   KVF+ ++ + K+  A+K ++      + L S + E   + K   H + I  + 
Sbjct: 36  IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 186 SHETLNEFV-LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E  ++++ ++ E  ++ L++ L+++K +          N++ A++ +H + ++H DLK
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 154
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPLYMAPELIAERPYDH------ 296
           P N L+  DG+  L DFG A  M      +   S  GT  YM PE I +           
Sbjct: 155 PANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 213
Query: 297 -----TADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSETYKDL 347
                 +D+WSLGCI Y +  G  PF+ +    S LH I +    ++ FP    +  +D+
Sbjct: 214 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDIPEKDLQDV 272
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
           +K  L++D  QR+S PELL HP V+
Sbjct: 273 LKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQE-CEIQKHLAHPNIIKFIA 185
           IG G   KVF+ ++ + K+  A+K ++      + L S + E   + K   H + I  + 
Sbjct: 64  IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 186 SHETLNEFV-LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            +E  ++++ ++ E  ++ L++ L+++K +          N++ A++ +H + ++H DLK
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPLYMAPELIAERPYDH------ 296
           P N L+  DG+  L DFG A  M   T  +   S  G   YM PE I +           
Sbjct: 183 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSK 241
Query: 297 -----TADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSETYKDL 347
                 +D+WSLGCI Y +  G  PF+ +    S LH I +    ++ FP    +  +D+
Sbjct: 242 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDIPEKDLQDV 300
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
           +K  L++D  QR+S PELL HP V+
Sbjct: 301 LKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 142/289 (49%), Gaps = 28/289 (9%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 177
           E+Y+ +  +G G    V+ A    L   VA+K I    R  +E L   ++E      L+H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 178 PNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            NI+  I   E  + + L+ E+    +LS  +E    LS    +   + ++  + + H  
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS-IKGTPLYMAPELIAERPYD 295
           R++HRD+KPQN+L++ +    + DFG A++++  +   T+ + GT  Y +PE       D
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 296 HTADLWSLGCIAYEIHMGHPPFK-----TVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
              D++S+G + YE+ +G PPF      +++I H+      QD + P+  ++  KD+ + 
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI------QD-SVPNVTTDVRKDIPQS 243
Query: 351 L-------LEKDASQRLSWPELLHHPLVKDNLSSEI-ESQNNQDCIGFD 391
           L        EKD + R    + +     KD+LSS + E++ N+D    D
Sbjct: 244 LSNVILRATEKDKANRYKTIQEM-----KDDLSSVLHENRANEDVYELD 287

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 128/265 (48%), Gaps = 12/265 (4%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHL-----AHPN 179
           ++G+GSFGKVF A   + KKT     I K+ +    L     EC  ++K +      HP 
Sbjct: 24  MLGKGSFGKVFLA---EFKKTNQFFAI-KALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 180 IIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           +     + +T      + E+ +   L   ++   K   +      + +I  L +LHS  +
Sbjct: 80  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           ++RDLK  N+LL+KDG   + DFG  +   +G        GTP Y+APE++  + Y+H+ 
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSV 199
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           D WS G + YE+ +G  PF       L   ++  +  +P  + +  KDL+  L  ++  +
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEK 259
Query: 359 RLS-WPELLHHPLVKDNLSSEIESQ 382
           RL    ++  HPL ++    E+E +
Sbjct: 260 RLGVRGDIRQHPLFREINWEELERK 284

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 130/285 (45%), Gaps = 33/285 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E Y K+  +GEG++  V+K         VALK I      G   ++++ E  + K L H
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKH 59
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQI-LSNLISALYYLHSN 236
            NI+       T     L+ E+    L   L+    +     V++ L  L+  L Y H  
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPYD 295
           +VLHRDLKPQN+L+N+ G   L DFG AR+ ++ T    +   T  Y  P+ L+    Y 
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179
Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSI---LHLI-RLLKT-QDVTFPSQVS----ETYK- 345
              D+W +GCI YE+  G P F   ++   LH I R+L T  + T+P  +S    +TY  
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239
Query: 346 --------------------DLVKGLLEKDASQRLSWPELLHHPL 370
                               DL+  LL+ +   R+S  + + HP 
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 126/262 (48%), Gaps = 24/262 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKS---GRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +G G+FG V    HL  +++  L+ + K+    RS   +  ++ E E+ K L HPNIIK 
Sbjct: 30  LGSGAFGDV----HLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQ-------RKKLSETICVQILSNLISALYYLHSN 236
               E  +   ++ E        LLE+        K LSE    +++  +++AL Y HS 
Sbjct: 86  FEVFEDYHNMYIVMETCEGG--ELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 237 RVLHRDLKPQNVLLNKD---GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
            V+H+DLKP+N+L           + DFG A       H  T+  GT LYMAPE+  +R 
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-TNAAGTALYMAPEVF-KRD 201
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ---VSETYKDLVKG 350
                D+WS G + Y +  G  PF   S+  + +    ++  +  +   ++    DL+K 
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQ 261
Query: 351 LLEKDASQRLSWPELLHHPLVK 372
           +L KD  +R S  ++LHH   K
Sbjct: 262 MLTKDPERRPSAAQVLHHEWFK 283

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 139/279 (49%), Gaps = 28/279 (10%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK +       ++    ++E E+
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL-------QDCPKARREVEL 107
Query: 172 QKHLAH-PNIIKFIASHETLNE----FVLITE-FAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L       +++ E      L + ++ R  +  +E    +I 
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIX 167
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+      + LT+   T
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYT 226
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
           P Y+APE++    YD + D WSLG I Y +  G+PPF +   L +    KT+       F
Sbjct: 227 PYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEF 286
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR +  E  +HP +
Sbjct: 287 PNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWI 325

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 128/270 (47%), Gaps = 30/270 (11%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           +IG G+   V  A     K+ VA+K I+   +    +  L +E +      HPNI+ +  
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLE-KCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 186 SHETLNEFVLITEFAHMSLSNLLE-----------QRKKLSETICVQILSNLISALYYLH 234
           S    +E  L+ +   +S  ++L+           +   L E+    IL  ++  L YLH
Sbjct: 81  SFVVKDELWLVMKL--LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML-----TSIKGTPLYMAPELI 289
            N  +HRD+K  N+LL +DG   + DFG +  +A G  +       +  GTP +MAPE++
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 290 AE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRL--------LKT--QDVTFPS 338
            + R YD  AD+WS G  A E+  G  P+     + ++ L        L+T  QD     
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLK 258
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHH 368
           +  ++++ ++   L+KD  +R +  ELL H
Sbjct: 259 KYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 128/270 (47%), Gaps = 30/270 (11%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           +IG G+   V  A     K+ VA+K I+   +    +  L +E +      HPNI+ +  
Sbjct: 17  VIGSGATAVVQAAYCAPKKEKVAIKRINLE-KCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 186 SHETLNEFVLITEFAHMSLSNLLE-----------QRKKLSETICVQILSNLISALYYLH 234
           S    +E  L+ +   +S  ++L+           +   L E+    IL  ++  L YLH
Sbjct: 76  SFVVKDELWLVMKL--LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 133
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML-----TSIKGTPLYMAPELI 289
            N  +HRD+K  N+LL +DG   + DFG +  +A G  +       +  GTP +MAPE++
Sbjct: 134 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 193
Query: 290 AE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRL--------LKT--QDVTFPS 338
            + R YD  AD+WS G  A E+  G  P+     + ++ L        L+T  QD     
Sbjct: 194 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLK 253
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHH 368
           +  ++++ ++   L+KD  +R +  ELL H
Sbjct: 254 KYGKSFRKMISLCLQKDPEKRPTAAELLRH 283

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 128/253 (50%), Gaps = 4/253 (1%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           +G G+FGKV    H      VA+KI+++   RS   +  +++E +  K   HP+IIK   
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 186 SHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
              T ++  ++ E+ +   L + + +  +L E    ++   ++S + Y H + V+HRDLK
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY-DHTADLWSL 303
           P+NVLL+    A + DFG +  M+ G  +  S  G+P Y APE+I+ R Y     D+WS 
Sbjct: 144 PENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC-GSPNYAAPEVISGRLYAGPEVDIWSS 202
Query: 304 GCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWP 363
           G I Y +  G  PF    +  L + +       P  ++ +   L+K +L+ D  +R +  
Sbjct: 203 GVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIK 262
Query: 364 ELLHHPLVKDNLS 376
           ++  H   K +L 
Sbjct: 263 DIREHEWFKQDLP 275

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 130/292 (44%), Gaps = 15/292 (5%)
Query: 101 WFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK 160
           W     QPV++ K     + Y  +  +G G+FG V + +     +    K I+      K
Sbjct: 34  WKKYVPQPVEV-KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK 92
Query: 161 ELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMS--LSNLLEQRKKLSETI 218
              ++K E  I   L HP +I    + E   E VLI EF         +  +  K+SE  
Sbjct: 93  --YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE 150
Query: 219 CVQILSNLISALYYLHSNRVLHRDLKPQNVL--LNKDGVAMLCDFGFARSMAVGTHMLTS 276
            +  +      L ++H + ++H D+KP+N++    K     + DFG A  +     ++  
Sbjct: 151 VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKV 209
Query: 277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF 336
              T  + APE++   P     D+W++G + Y +  G  PF     L  ++ +K  D  F
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 269
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK---DNLSSEIES 381
                S VS   KD +K LL+K+  +RL+  + L HP +K    NL+S I S
Sbjct: 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 321

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 137/280 (48%), Gaps = 24/280 (8%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++Y+ +  IG G+FG           + VA+K I    R  K   ++K+E    + L HP
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLRHP 74
Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQ---RKKLSETICVQILSNLISALYYLHS 235
           NI++F     T     ++ E+A  S   L E+     + SE         LIS + Y H+
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 132
Query: 236 NRVLHRDLKPQNVLLNKDGVAML--CDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
            +V HRDLK +N LL+      L  CDFG+++S  + +   +++ GTP Y+APE++ ++ 
Sbjct: 133 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 191
Query: 294 YD-HTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLIRLLKTQDVTFPSQV--SET 343
           YD   AD+WS G   Y + +G  PF+           +H  R+L  Q    P  V  S  
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH--RILNVQ-YAIPDYVHISPE 248
Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQN 383
            + L+  +   D ++R+S PE+ +H     NL +++ + N
Sbjct: 249 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDN 288

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V + IH D  + VA+K   +   S K       E +I K L HPN++     
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 187 HETLNEF------VLITEFAHMS-LSNLLEQRKK---LSETICVQILSNLISALYYLHSN 236
            + L +       +L  E+     L   L Q +    L E     +LS++ SAL YLH N
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 237 RVLHRDLKPQNVLLNKDGVAM---LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           R++HRDLKP+N++L      +   + D G+A+ +  G  + T   GT  Y+APEL+ ++ 
Sbjct: 142 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKK 200
Query: 294 YDHTADLWSLGCIAYEIHMGHPPF 317
           Y  T D WS G +A+E   G  PF
Sbjct: 201 YTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V + IH D  + VA+K   +   S K       E +I K L HPN++     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 187 HETLNEF------VLITEFAHMS-LSNLLEQRKK---LSETICVQILSNLISALYYLHSN 236
            + L +       +L  E+     L   L Q +    L E     +LS++ SAL YLH N
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 237 RVLHRDLKPQNVLLNKDGVAM---LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           R++HRDLKP+N++L      +   + D G+A+ +  G  + T   GT  Y+APEL+ ++ 
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKK 199
Query: 294 YDHTADLWSLGCIAYEIHMGHPPF 317
           Y  T D WS G +A+E   G  PF
Sbjct: 200 YTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/304 (28%), Positives = 145/304 (47%), Gaps = 25/304 (8%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++Y+ +  IG G+FG           + VA+K I    R  K   ++K+E    + L HP
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLRHP 75
Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQ---RKKLSETICVQILSNLISALYYLHS 235
           NI++F     T     ++ E+A  S   L E+     + SE         LIS + Y H+
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 236 NRVLHRDLKPQNVLLNKDGVAML--CDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
            +V HRDLK +N LL+      L  C FG+++S  + +   +++ GTP Y+APE++ ++ 
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 192
Query: 294 YD-HTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLIRLLKTQDVTFPSQV--SET 343
           YD   AD+WS G   Y + +G  PF+           +H  R+L  Q    P  V  S  
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH--RILNVQ-YAIPDYVHISPE 249
Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSI 403
            + L+  +   D ++R+S PE+ +H     NL +++ + N      FD  D+   S + I
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTM-TTQFDESDQPGQSIEEI 308
Query: 404 TTIV 407
             I+
Sbjct: 309 MQII 312

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 131/259 (50%), Gaps = 29/259 (11%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 186 SHETLNEFVLITE-------FAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            + T  +  ++T+       + H+  S    + KKL     + I       + YLH+  +
Sbjct: 88  -YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLHAKSI 141
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERP 293
           +HRDLK  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I      P
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLI-RLLKTQDVT-FPSQVSETYKDL 347
           Y   +D+++ G + YE+  G  P+  ++    I+ ++ R   + D++   S   +  K L
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 348 VKGLLEKDASQRLSWPELL 366
           +   L+K   +R S+P +L
Sbjct: 262 MAECLKKKRDERPSFPRIL 280

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 119/251 (47%), Gaps = 11/251 (4%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI--QKHL 175
           L  +  + ++G+GSFGKV  +      +  A+KI+ K       +     EC +  ++ L
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD----VVIQDDDVECTMVEKRVL 395
Query: 176 AHPNIIKFIAS----HETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
           A P    F+       +T++    + E+ +   L   ++Q  +  E   V   + +   L
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 455
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           ++L S  +++RDLK  NV+L+ +G   + DFG  +             GTP Y+APE+IA
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA 515
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            +PY  + D W+ G + YE+  G  PF+      L + +   +V +P  +S+    + KG
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575
Query: 351 LLEKDASQRLS 361
           L+ K   +RL 
Sbjct: 576 LMTKHPGKRLG 586

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/304 (28%), Positives = 145/304 (47%), Gaps = 25/304 (8%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++Y+ +  IG G+FG           + VA+K I    R  K   ++K+E    + L HP
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIE---RGEKIDENVKREIINHRSLRHP 75
Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQ---RKKLSETICVQILSNLISALYYLHS 235
           NI++F     T     ++ E+A  S   L E+     + SE         LIS + Y H+
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQLISGVSYAHA 133
Query: 236 NRVLHRDLKPQNVLLNKDGVAML--CDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
            +V HRDLK +N LL+      L   DFG++++  + +   +++ GTP Y+APE++ ++ 
Sbjct: 134 MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV-GTPAYIAPEVLLKKE 192
Query: 294 YD-HTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLIRLLKTQDVTFPSQV--SET 343
           YD   AD+WS G   Y + +G  PF+           +H  R+L  Q    P  V  S  
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH--RILNVQ-YAIPDYVHISPE 249
Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSI 403
            + L+  +   D ++R+S PE+ +H     NL +++ + N      FD  D+   S + I
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTM-TTQFDESDQPGQSIEEI 308
Query: 404 TTIV 407
             I+
Sbjct: 309 MQII 312

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 119/251 (47%), Gaps = 11/251 (4%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI--QKHL 175
           L  +  + ++G+GSFGKV  +      +  A+KI+ K       +     EC +  ++ L
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD----VVIQDDDVECTMVEKRVL 74
Query: 176 AHPNIIKFIAS----HETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
           A P    F+       +T++    + E+ +   L   ++Q  +  E   V   + +   L
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           ++L S  +++RDLK  NV+L+ +G   + DFG  +             GTP Y+APE+IA
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA 194
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            +PY  + D W+ G + YE+  G  PF+      L + +   +V +P  +S+    + KG
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 254
Query: 351 LLEKDASQRLS 361
           L+ K   +RL 
Sbjct: 255 LMTKHPGKRLG 265

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 131/259 (50%), Gaps = 29/259 (11%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 186 SHETLNEFVLITE-------FAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            + T  +  ++T+       + H+  S    + KKL     + I       + YLH+  +
Sbjct: 88  -YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLHAKSI 141
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERP 293
           +HRDLK  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I      P
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLI-RLLKTQDVT-FPSQVSETYKDL 347
           Y   +D+++ G + YE+  G  P+  ++    I+ ++ R   + D++   S   +  K L
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 348 VKGLLEKDASQRLSWPELL 366
           +   L+K   +R S+P +L
Sbjct: 262 MAECLKKKRDERPSFPRIL 280

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 134/271 (49%), Gaps = 18/271 (6%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V +A  H      VA+KI+ +     + ++   +E  I K L HPNI+ F+ 
Sbjct: 45  IGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 186 SHETLNEFVLITEF-AHMSLSNLLEQ---RKKLSETICVQILSNLISALYYLHSNR--VL 239
           +        ++TE+ +  SL  LL +   R++L E   + +  ++   + YLH+    ++
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTAD 299
           HRDLK  N+L++K     +CDFG +R  A          GTP +MAPE++ + P +  +D
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 300 LWSLGCIAYEIHMGHPPFKTVSILHLIRLL--KTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ++S G I +E+     P+  ++   ++  +  K + +  P  ++     +++G    +  
Sbjct: 222 VYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPW 281
Query: 358 QRLSWPELLH--HPLVKDNLSSEIESQNNQD 386
           +R S+  ++    PL+K    S +   N  D
Sbjct: 282 KRPSFATIMDLLRPLIK----SAVPPPNRSD 308

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 131/259 (50%), Gaps = 29/259 (11%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 20  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 186 SHETLNEFVLITE-------FAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            + T  +  ++T+       + H+  S    + KKL     + I       + YLH+  +
Sbjct: 76  -YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLHAKSI 129
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERP 293
           +HRDLK  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I      P
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLI-RLLKTQDVT-FPSQVSETYKDL 347
           Y   +D+++ G + YE+  G  P+  ++    I+ ++ R   + D++   S   +  K L
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 249
Query: 348 VKGLLEKDASQRLSWPELL 366
           +   L+K   +R S+P +L
Sbjct: 250 MAECLKKKRDERPSFPRIL 268

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 88/304 (28%), Positives = 144/304 (47%), Gaps = 25/304 (8%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++Y+ +  IG G+FG           + VA+K I    R  K   ++K+E    + L HP
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLRHP 75
Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQ---RKKLSETICVQILSNLISALYYLHS 235
           NI++F     T     ++ E+A  S   L E+     + SE         LIS + Y H+
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 236 NRVLHRDLKPQNVLLNKDGVAML--CDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
            +V HRDLK +N LL+      L  C FG+++S  + +    ++ GTP Y+APE++ ++ 
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV-GTPAYIAPEVLLKKE 192
Query: 294 YD-HTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLIRLLKTQDVTFPSQV--SET 343
           YD   AD+WS G   Y + +G  PF+           +H  R+L  Q    P  V  S  
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH--RILNVQ-YAIPDYVHISPE 249
Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSI 403
            + L+  +   D ++R+S PE+ +H     NL +++ + N      FD  D+   S + I
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTM-TTQFDESDQPGQSIEEI 308
Query: 404 TTIV 407
             I+
Sbjct: 309 MQII 312

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 123/254 (48%), Gaps = 19/254 (7%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++ Q +  +G G++G V  A    L++ VA+K +S+  +S        +E  + KHL H 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  +E  L+T      L+N+++  + LS+     ++  L+  L Y
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKY 146
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP NV +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 147 IHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQ---ADEEMTGYVATRWYRAPEIMLNW 203
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFP-------SQVSET 343
             Y+ T D+WS+GCI  E+  G   F     I  L R+++      P       S+ + T
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHART 263
Query: 344 YKDLVKGLLEKDAS 357
           Y   +  + +KD S
Sbjct: 264 YIQSLPPMPQKDLS 277

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 135/283 (47%), Gaps = 38/283 (13%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFI 184
           ++GEG+  +V   I+L   +  A+KII K  + G   S + +E E + +   H N+++ I
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 185 ASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E  + F L+ E     S+ + + +R+  +E     ++ ++ SAL +LH+  + HRDL
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 244 KPQNVLL---NKDGVAMLCDFGFARSM-------AVGTHMLTSIKGTPLYMAPELIAERP 293
           KP+N+L    N+     +CDFG    +        + T  L +  G+  YMAPE++    
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 294 -----YDHTADLWSLGCIAYEIHMGHPPFK---------------TVSILHLIRLLKTQD 333
                YD   DLWSLG I Y +  G+PPF                      L   ++   
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 334 VTFP----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
             FP    + +S   KDL+  LL +DA QRLS  ++L HP V+
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 135/271 (49%), Gaps = 18/271 (6%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V +A  H      VA+KI+ +     + ++   +E  I K L HPNI+ F+ 
Sbjct: 45  IGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 186 SHETLNEFVLITEF-AHMSLSNLLEQ---RKKLSETICVQILSNLISALYYLHSNR--VL 239
           +        ++TE+ +  SL  LL +   R++L E   + +  ++   + YLH+    ++
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTAD 299
           HR+LK  N+L++K     +CDFG +R  A       S  GTP +MAPE++ + P +  +D
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 300 LWSLGCIAYEIHMGHPPFKTVSILHLIRLL--KTQDVTFPSQVSETYKDLVKGLLEKDAS 357
           ++S G I +E+     P+  ++   ++  +  K + +  P  ++     +++G    +  
Sbjct: 222 VYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPW 281
Query: 358 QRLSWPELLH--HPLVKDNLSSEIESQNNQD 386
           +R S+  ++    PL+K    S +   N  D
Sbjct: 282 KRPSFATIMDLLRPLIK----SAVPPPNRSD 308

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 90/322 (27%), Positives = 144/322 (44%), Gaps = 42/322 (13%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y+ +  +G G++G V  A+       VA+K + +  +S        +E  + KH+ H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 181 IKFI---ASHETLNEFV---LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           I  +      ETL++F    L+  F    L  L++  +KL E     ++  ++  L Y+H
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIH 145
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE-RP 293
           +  ++HRDLKP N+ +N+D    + DFG AR     + M   +  T  Y APE+I     
Sbjct: 146 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMXGXVV-TRWYRAPEVILNWMR 202
Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQV-----SETYKDLV 348
           Y  T D+WS+GCI  E+  G   FK    L  ++ +     T P++      S+  K+ +
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 262
Query: 349 KGL--LEK------------------------DASQRLSWPELLHHPLVKDNLSSEIESQ 382
           KGL  LEK                        DA QR++  E L HP  +    +E E Q
Sbjct: 263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 322
Query: 383 NNQDCIGFDYCDKRRGSRKSIT 404
             +    FD  D+     K +T
Sbjct: 323 VQKYDDSFDDVDRTLDEWKRVT 344

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 137/292 (46%), Gaps = 16/292 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G+   V++      +K  ALK++ K+     +   ++ E  +   L+HPNIIK    
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 187 HETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
            ET  E  L+ E      L + + ++   SE      +  ++ A+ YLH N ++HRDLKP
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKP 176
Query: 246 QNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           +N+L      D    + DFG ++ +     ++ ++ GTP Y APE++    Y    D+WS
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSK-IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWS 235
Query: 303 LGCIAYEIHMGHPPF-KTVSILHLIRLLKTQDVTFPS----QVSETYKDLVKGLLEKDAS 357
           +G I Y +  G  PF        + R +   +  F S    +VS   KDLV+ L+  D  
Sbjct: 236 VGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPK 295
Query: 358 QRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSITTIVES 409
           +RL+  + L HP V    ++ +     Q  +     + RR  + ++  +V S
Sbjct: 296 KRLTTFQALQHPWVTGKAANFVHMDTAQKKL--QEFNARRKLKAAVKAVVAS 345

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 124/247 (50%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 147
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR  A     +T    T  Y APE++   
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA---DEMTGYVATRWYRAPEIMLNW 204
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 265 YIQSLTQ 271

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KXQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 124/247 (50%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 147
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR  A     +T    T  Y APE++   
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA---DEMTGYVATRWYRAPEIMLNW 204
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 265 YIQSLTQ 271

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 124/247 (50%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 147
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR  A     +T    T  Y APE++   
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA---DEMTGYVATRWYRAPEIMLNW 204
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 265 YIQSLTQ 271

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 123/254 (48%), Gaps = 19/254 (7%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++ Q +  +G G++G V  A    L++ VA+K +S+  +S        +E  + KHL H 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  +E  L+T      L+N++ + + LS+     ++  L+  L Y
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIV-KCQALSDEHVQFLVYQLLRGLKY 146
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP NV +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 147 IHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQ---ADEEMTGYVATRWYRAPEIMLNW 203
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFP-------SQVSET 343
             Y+ T D+WS+GCI  E+  G   F     I  L R+++      P       S+ + T
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHART 263
Query: 344 YKDLVKGLLEKDAS 357
           Y   +  + +KD S
Sbjct: 264 YIQSLPPMPQKDLS 277

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 134/259 (51%), Gaps = 14/259 (5%)
Query: 117 ALEKYQKICLIGEGSFGKVF---KAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEI 171
            +E ++ + ++G G++GKVF   K    D  K  A+K++ K+   +  K     + E ++
Sbjct: 52  GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 172 QKHLAH-PNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISA 229
            +H+   P ++    + +T  +  LI ++ +   L   L QR++ +E      +  ++ A
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS-MAVGTHMLTSIKGTPLYMAPEL 288
           L +LH   +++RD+K +N+LL+ +G  +L DFG ++  +A  T       GT  YMAP++
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 289 I--AERPYDHTADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSE 342
           +   +  +D   D WSLG + YE+  G  PF    +  S   + R +   +  +P ++S 
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 291
Query: 343 TYKDLVKGLLEKDASQRLS 361
             KDL++ LL KD  +RL 
Sbjct: 292 LAKDLIQRLLMKDPKKRLG 310

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 8/220 (3%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS----GKELSSLKQECEIQKH 174
           ++Y+K+  +GEG F  V+KA   +  + VA+K I    RS    G   ++L+ E ++ + 
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQE 68
Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYL 233
           L+HPNII  + +    +   L+ +F    L  +++     L+ +     +   +  L YL
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-AER 292
           H + +LHRDLKP N+LL+++GV  L DFG A+S             T  Y APEL+   R
Sbjct: 129 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGAR 188
Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKT 331
            Y    D+W++GCI  E+ +  P     S L  L R+ +T
Sbjct: 189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KXQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 150
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 151 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 207
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 245

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  IG G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 145
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 202
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 146
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 203
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 142
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 199
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 123/254 (48%), Gaps = 19/254 (7%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++ Q +  +G G++G V  A    L++ VA+K +S+  +S        +E  + KHL H 
Sbjct: 20  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 79
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  +E  L+T      L+N++ + + LS+     ++  L+  L Y
Sbjct: 80  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIV-KCQALSDEHVQFLVYQLLRGLKY 138
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           +HS  ++HRDLKP NV +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 139 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ---ADEEMTGYVATRWYRAPEIMLNW 195
Query: 293 P-YDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFP-------SQVSET 343
             Y+ T D+WS+GCI  E+  G   F     I  L R+++      P       S+ + T
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHART 255
Query: 344 YKDLVKGLLEKDAS 357
           Y   +  + +KD S
Sbjct: 256 YIQSLPPMPQKDLS 269

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +SK  +S        +E  + KH+ H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 152
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 209
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 269
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 270 YIQSLTQ 276

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 131/298 (43%), Gaps = 45/298 (15%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI-- 184
           +G G++G V  AI     + VA+K +S+  +S        +E  + KH+ H N+I  +  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 185 ----ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
               +S     +F L+  F    L  ++    K SE     ++  ++  L Y+HS  V+H
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVH 149
Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-AERPYDHTAD 299
           RDLKP N+ +N+D    + DFG AR        +T    T  Y APE+I +   Y+ T D
Sbjct: 150 RDLKPGNLAVNEDCELKILDFGLARH---ADAEMTGYVVTRWYRAPEVILSWMHYNQTVD 206
Query: 300 LWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQDVT----------------------- 335
           +WS+GCI  E+  G   FK    L  L ++LK   V                        
Sbjct: 207 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT 266
Query: 336 --------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQ 385
                   FP + S    DL++ +LE D  +RL+  + L HP  +     E E++  Q
Sbjct: 267 PRKDFTQLFP-RASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ 323

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R+++S  + + + + + SA+ YL     +HR
Sbjct: 78  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 256 RPSFAEIHQAFETMFQESSISDEVEKE 282

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 145
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 202
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 37/281 (13%)
Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + ++KI  +G G+ G VFK              IHL++K  +  +II       +EL  L
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------RELQVL 61
Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++  ++ E I  ++
Sbjct: 62  -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPEQILGKV 112
Query: 223 LSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              +I  L YL   ++++HRD+KP N+L+N  G   LCDFG +  +     M     GT 
Sbjct: 113 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DEMANEFVGTR 170
Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-FPSQV 340
            YM+PE +    Y   +D+WS+G    E+ +G  P   ++I  L+  +  +     PS V
Sbjct: 171 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAV 230
Query: 341 -SETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
            S  ++D V   L K+ ++R    +L+ H  +K + + E++
Sbjct: 231 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 271

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 160
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 217
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 277
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 278 YIQSLAQ 284

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 151
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 208
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 246

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 159
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 216
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 276
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 277 YIQSLAQ 283

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 118/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +AI LD  K      VA+K++ KS  + K+LS L  E E+ K +  H 
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSN---------LIS 228
           NII  + +        +I E+A   +L   L+ R+      C     N         L+S
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
             Y       YL S + +HRDL  +NVL+ +D V  + DFG AR +  +  +  T+    
Sbjct: 140 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  V +  L +LLK
Sbjct: 200 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R+++S  + + + + + SA+ YL     +HR
Sbjct: 78  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 256 RPSFAEIHQAFETMFQESSISDEVEKE 282

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N+++  +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG  R        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N+++  +KL++     ++  ++  L Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 193
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 254 YIQSLAQ 260

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 146
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 203
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 264 YIQSLAQ 270

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 118/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +AI LD  K      VA+K++ KS  + K+LS L  E E+ K +  H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSN---------LIS 228
           NII  + +        +I E+A   +L   L+ R+      C     N         L+S
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
             Y       YL S + +HRDL  +NVL+ +D V  + DFG AR +  +  +  T+    
Sbjct: 155 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 214
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  V +  L +LLK
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNA 197
Query: 293 P-YDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 258 YIQSLTQ 264

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 258 YIQSLTQ 264

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R+++S  + + + + + SA+ YL     +HR
Sbjct: 83  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 261 RPSFAEIHQAFETMFQESSISDEVEKE 287

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFI 184
           ++GEG+  +V   I+L   +  A+KII K  + G   S + +E E + +   H N+++ I
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 185 ASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E  + F L+ E     S+ + + +R+  +E     ++ ++ SAL +LH+  + HRDL
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 244 KPQNVLL---NKDGVAMLCDFGFARSM-------AVGTHMLTSIKGTPLYMAPELIAERP 293
           KP+N+L    N+     +CDF     +        + T  L +  G+  YMAPE++    
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 294 -----YDHTADLWSLGCIAYEIHMGHPPFK---------------TVSILHLIRLLKTQD 333
                YD   DLWSLG I Y +  G+PPF                      L   ++   
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 334 VTFP----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
             FP    + +S   KDL+  LL +DA QRLS  ++L HP V+
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 142
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 199
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 260 YIQSLTQ 266

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 147
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 204
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 265 YIQSLTQ 271

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 145
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 202
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 146
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 203
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 264 YIQSLTQ 270

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 142
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 199
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 139
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 140 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 196
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 234

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 151
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 208
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 268
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 269 YIQSLTQ 275

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 160
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 217
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 277
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 278 YIQSLTQ 284

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 142
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 199
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 260 YIQSLTQ 266

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 152
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 209
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 269
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 270 YIQSLTQ 276

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 152
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 209
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 269
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 270 YIQSLTQ 276

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 131/298 (43%), Gaps = 45/298 (15%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI-- 184
           +G G++G V  AI     + VA+K +S+  +S        +E  + KH+ H N+I  +  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 185 ----ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
               +S     +F L+  F    L  ++    + SE     ++  ++  L Y+HS  V+H
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVH 167
Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-AERPYDHTAD 299
           RDLKP N+ +N+D    + DFG AR        +T    T  Y APE+I +   Y+ T D
Sbjct: 168 RDLKPGNLAVNEDCELKILDFGLARH---ADAEMTGYVVTRWYRAPEVILSWMHYNQTVD 224
Query: 300 LWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQDVT----------------------- 335
           +WS+GCI  E+  G   FK    L  L ++LK   V                        
Sbjct: 225 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT 284
Query: 336 --------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQ 385
                   FP + S    DL++ +LE D  +RL+  + L HP  +     E E++  Q
Sbjct: 285 PRKDFTQLFP-RASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ 341

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGXVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 258 YIQSLTQ 264

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 163
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 220
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 280
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 281 YIQSLTQ 287

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 79  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 136
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 197 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 256
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 257 RPSFAEIHQAFETMFQESSISDEVEKE 283

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 146
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 203
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 264 YIQSLTQ 270

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 80  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 257
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 258 RPSFAEIHQAFETMFQESSISDEVEKE 284

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 159
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 216
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 276
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 277 YIQSLTQ 283

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 137
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 194
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 145
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 202
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 263 YIQSLTQ 269

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 293 P-YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 19/254 (7%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + T  +  ++T++   S    +L     K      + I       + YLH+  ++HRDL
Sbjct: 100 -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 244 KPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTA 298
           K  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I    + PY   +
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 218
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------SQVSETYKDLVKGLL 352
           D+++ G + YE+  G  P+  ++    I  +  +    P      S   +  K L+   L
Sbjct: 219 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 278
Query: 353 EKDASQRLSWPELL 366
           +K   +R  +P++L
Sbjct: 279 KKKRDERPLFPQIL 292

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 19/254 (7%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + T  +  ++T++   S    +L     K      + I       + YLH+  ++HRDL
Sbjct: 100 -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 244 KPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTA 298
           K  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I    + PY   +
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 218
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------SQVSETYKDLVKGLL 352
           D+++ G + YE+  G  P+  ++    I  +  +    P      S   +  K L+   L
Sbjct: 219 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 278
Query: 353 EKDASQRLSWPELL 366
           +K   +R  +P++L
Sbjct: 279 KKKRDERPLFPQIL 292

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N+++  +KL++     ++  ++  L Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 137
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 194
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 232

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 19/254 (7%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 36  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + T  +  ++T++   S    +L     K      + I       + YLH+  ++HRDL
Sbjct: 92  -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 150
Query: 244 KPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTA 298
           K  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I    + PY   +
Sbjct: 151 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 210
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------SQVSETYKDLVKGLL 352
           D+++ G + YE+  G  P+  ++    I  +  +    P      S   +  K L+   L
Sbjct: 211 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 270
Query: 353 EKDASQRLSWPELL 366
           +K   +R  +P++L
Sbjct: 271 KKKRDERPLFPQIL 284

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 19/254 (7%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + T  +  ++T++   S    +L     K      + I       + YLH+  ++HRDL
Sbjct: 72  -YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 244 KPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTA 298
           K  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I    + PY   +
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------SQVSETYKDLVKGLL 352
           D+++ G + YE+  G  P+  ++    I  +  +    P      S   +  K L+   L
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250
Query: 353 EKDASQRLSWPELL 366
           +K   +R  +P++L
Sbjct: 251 KKKRDERPLFPQIL 264

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 19/254 (7%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 43  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + T  +  ++T++   S    +L     K      + I       + YLH+  ++HRDL
Sbjct: 99  -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 157
Query: 244 KPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTA 298
           K  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I    + PY   +
Sbjct: 158 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 217
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------SQVSETYKDLVKGLL 352
           D+++ G + YE+  G  P+  ++    I  +  +    P      S   +  K L+   L
Sbjct: 218 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 277
Query: 353 EKDASQRLSWPELL 366
           +K   +R  +P++L
Sbjct: 278 KKKRDERPLFPQIL 291

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 118/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +AI LD  K      VA+K++ KS  + K+LS L  E E+ K +  H 
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 86
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRK----------------KLSETICVQ 221
           NII  + +        +I E+A   +L   L+ R+                +LS    V 
Sbjct: 87  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 146
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
               +   + YL S + +HRDL  +NVL+ +D V  + DFG AR +  +  +  T+    
Sbjct: 147 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 206
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  V +  L +LLK
Sbjct: 207 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 258

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N+++  +KL++     ++  ++  L Y
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 138
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 139 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 195
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 255
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 256 YIQSLTQ 262

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N+++  +KL++     ++  ++  L Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 193
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N+++   KL++     ++  ++  L Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-AKLTDDHVQFLIYQILRGLKY 136
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 193
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 254 YIQSLAQ 260

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 118/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +AI LD  K      VA+K++ KS  + K+LS L  E E+ K +  H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRK----------------KLSETICVQ 221
           NII  + +        +I E+A   +L   L+ R+                +LS    V 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
               +   + YL S + +HRDL  +NVL+ +D V  + DFG AR +  +  +  T+    
Sbjct: 155 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 214
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  V +  L +LLK
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 118/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +AI LD  K      VA+K++ KS  + K+LS L  E E+ K +  H 
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 83
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRK----------------KLSETICVQ 221
           NII  + +        +I E+A   +L   L+ R+                +LS    V 
Sbjct: 84  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 143
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
               +   + YL S + +HRDL  +NVL+ +D V  + DFG AR +  +  +  T+    
Sbjct: 144 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 203
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  V +  L +LLK
Sbjct: 204 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 255

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 118/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +AI LD  K      VA+K++ KS  + K+LS L  E E+ K +  H 
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 87
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRK----------------KLSETICVQ 221
           NII  + +        +I E+A   +L   L+ R+                +LS    V 
Sbjct: 88  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 147
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
               +   + YL S + +HRDL  +NVL+ +D V  + DFG AR +  +  +  T+    
Sbjct: 148 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 207
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  V +  L +LLK
Sbjct: 208 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 259

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 19/254 (7%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + T  +  ++T++   S    +L     K      + I       + YLH+  ++HRDL
Sbjct: 77  -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 244 KPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTA 298
           K  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I    + PY   +
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------SQVSETYKDLVKGLL 352
           D+++ G + YE+  G  P+  ++    I  +  +    P      S   +  K L+   L
Sbjct: 196 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 255
Query: 353 EKDASQRLSWPELL 366
           +K   +R  +P++L
Sbjct: 256 KKKRDERPLFPQIL 269

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 19/254 (7%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 18  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + T  +  ++T++   S    +L     K      + I       + YLH+  ++HRDL
Sbjct: 74  -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 132
Query: 244 KPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTA 298
           K  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I    + PY   +
Sbjct: 133 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 192
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------SQVSETYKDLVKGLL 352
           D+++ G + YE+  G  P+  ++    I  +  +    P      S   +  K L+   L
Sbjct: 193 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 252
Query: 353 EKDASQRLSWPELL 366
           +K   +R  +P++L
Sbjct: 253 KKKRDERPLFPQIL 266

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 19/254 (7%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + T  +  ++T++   S    +L     K      + I       + YLH+  ++HRDL
Sbjct: 77  -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 244 KPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTA 298
           K  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I    + PY   +
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------SQVSETYKDLVKGLL 352
           D+++ G + YE+  G  P+  ++    I  +  +    P      S   +  K L+   L
Sbjct: 196 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 255
Query: 353 EKDASQRLSWPELL 366
           +K   +R  +P++L
Sbjct: 256 KKKRDERPLFPQIL 269

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 140/283 (49%), Gaps = 28/283 (9%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDL-KKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           ++Y  +  IG G+FG V + +   L K+ VA+K I +     +   ++++E    + L H
Sbjct: 20  DRYDFVKDIGSGNFG-VARLMRDKLTKELVAVKYIERGAAIDE---NVQREIINHRSLRH 75
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQ---RKKLSETICVQILSNLISALYYLH 234
           PNI++F     T     +I E+A  S   L E+     + SE         L+S + Y H
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYA--SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 235 SNRVLHRDLKPQNVLLNKDGVAML--CDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           S ++ HRDLK +N LL+      L  CDFG+++S  + +   +++ GTP Y+APE++  +
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRQ 192
Query: 293 PYD-HTADLWSLGCIAYEIHMGHPPF----------KTVSILHLIRLLKTQDVTFPSQVS 341
            YD   AD+WS G   Y + +G  PF          KT+  +  ++     D+    ++S
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI----RIS 248
Query: 342 ETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNN 384
                L+  +   D + R+S PE+  H     NL +++ +++N
Sbjct: 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESN 291

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +     T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMAGFVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 258 YIQSLTQ 264

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +     T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMAGFVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 258 YIQSLAQ 264

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 19/254 (7%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + T  +  ++T++   S    +L     K      + I       + YLH+  ++HRDL
Sbjct: 72  -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 244 KPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTA 298
           K  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I    + PY   +
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------SQVSETYKDLVKGLL 352
           D+++ G + YE+  G  P+  ++    I  +  +    P      S   +  K L+   L
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250
Query: 353 EKDASQRLSWPELL 366
           +K   +R  +P++L
Sbjct: 251 KKKRDERPLFPQIL 264

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 80  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 257
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 258 RPSFAEIHQAFETMFQESSISDEVEKE 284

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 80  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 257
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 258 RPSFAEIHQAFETMFQESSISDEVEKE 284

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 129/267 (48%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R+++S  + + + + + SA+ YL     +HR
Sbjct: 76  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T    +    P+ + APE +A   +   +D+
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  +    +  LL K   +  P    E   +L++   + + S 
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 253
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 254 RPSFAEIHQAFETMFQESSISDEVEKE 280

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 91  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 148
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 149 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 208
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 209 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 268
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 269 RPSFAEIHQAFETMFQESSISDEVEKE 295

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 83  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 261 RPSFAEIHQAFETMFQESSISDEVEKE 287

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 19/254 (7%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+K+++ +  + ++L + K E  + +   H NI+ F+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + T  +  ++T++   S    +L     K      + I       + YLH+  ++HRDL
Sbjct: 72  -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 244 KPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTA 298
           K  N+ L++D    + DFG A  +S   G+H    + G+ L+MAPE+I    + PY   +
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------SQVSETYKDLVKGLL 352
           D+++ G + YE+  G  P+  ++    I  +  +    P      S   +  K L+   L
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250
Query: 353 EKDASQRLSWPELL 366
           +K   +R  +P++L
Sbjct: 251 KKKRDERPLFPQIL 264

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N+++  +KL++     ++  ++  L Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +     T  Y APE++   
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMAGFVATRWYRAPEIMLNW 193
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 254 YIQSLAQ 260

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 135/303 (44%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +LS +++   +L       +L  ++  +
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM--ELDHERMSYLLYQMLVGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFK----------------TVSILHLIRLLKT--- 331
              Y    D+WS+GCI  E+  G   F                 T S   + +L  T   
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 332 -----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 369 PLV 371
           P +
Sbjct: 319 PYI 321

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 118/236 (50%), Gaps = 37/236 (15%)
Query: 127 IGEGSFGKVF--KAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +AI LD  K      VA+K++ KS  + K+LS L  E E+ K +  H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRK----------------KLSETICVQ 221
           NII  + +        +I E+A   +L   L+ R+                +LS    V 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
               +   + YL S + +HRDL  +NVL+ +D V  + DFG AR +    H +   K T 
Sbjct: 155 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDXXKKTT 210
Query: 281 ----PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
               P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  V +  L +LLK
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 123/247 (49%), Gaps = 13/247 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 82  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 139
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 200 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 259
Query: 359 RLSWPEL 365
           R S+ E+
Sbjct: 260 RPSFAEI 266

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 118/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +AI LD  K      VA+K++ KS  + K+LS L  E E+ K +  H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRK----------------KLSETICVQ 221
           NII  + +        +I E+A   +L   L+ R+                +LS    V 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
               +   + YL S + +HRDL  +NVL+ +D V  + DFG AR +  +  +  T+    
Sbjct: 155 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 214
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  V +  L +LLK
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + D+G AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDYGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 135/303 (44%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +LS +++   +L       +L  ++  +
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFK----------------TVSILHLIRLLKT--- 331
              Y    D+WS+GCI  E+  G   F                 T S   + +L  T   
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 332 -----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 369 PLV 371
           P +
Sbjct: 319 PYI 321

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 118/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +AI LD  K      VA+K++ KS  + K+LS L  E E+ K +  H 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRK----------------KLSETICVQ 221
           NII  + +        +I E+A   +L   L+ R+                +LS    V 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
               +   + YL S + +HRDL  +NVL+ +D V  + DFG AR +  +  +  T+    
Sbjct: 196 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 255
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  V +  L +LLK
Sbjct: 256 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 123/247 (49%), Gaps = 13/247 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 78  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 359 RLSWPEL 365
           R S+ E+
Sbjct: 256 RPSFAEI 262

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 123/247 (49%), Gaps = 13/247 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 83  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 359 RLSWPEL 365
           R S+ E+
Sbjct: 261 RPSFAEI 267

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 135/303 (44%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +LS +++   +L       +L  ++  +
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFK----------------TVSILHLIRLLKT--- 331
              Y    D+WS+GCI  E+  G   F                 T S   + +L  T   
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 332 -----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 369 PLV 371
           P +
Sbjct: 319 PYI 321

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 160
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +     T  Y APE++   
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMXGXVATRWYRAPEIMLNW 217
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 277
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 278 YIQSLAQ 284

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 123/247 (49%), Gaps = 13/247 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 78  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 359 RLSWPEL 365
           R S+ E+
Sbjct: 256 RPSFAEI 262

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  +  +     +A+K +S+  +S        +E  + KH+ H 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 169
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++   
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 226
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVT----FPSQVSET 343
             Y+ T D+WS+GCI  E+  G   F        +  ++RL  T   +     PS  +  
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARN 286
Query: 344 Y-----------------------KDLVKGLLEKDASQRLSWPELLHHP 369
           Y                        DL++ +L  D  +R++  E L HP
Sbjct: 287 YINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHP 335

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 41/285 (14%)
Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + ++KI  +G G+ G VFK              IHL++K  +  +II       +EL  L
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------RELQVL 77
Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++  ++ E I  ++
Sbjct: 78  -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPEQILGKV 128
Query: 223 LSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              +I  L YL   ++++HRD+KP N+L+N  G   LCDFG +  +     M  S  GT 
Sbjct: 129 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR 186
Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF----KTVSILHLIR-LLKTQDVTF 336
            YM+PE +    Y   +D+WS+G    E+ +G  P      +++I  L+  ++       
Sbjct: 187 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKL 246
Query: 337 PSQV-SETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
           PS V S  ++D V   L K+ ++R    +L+ H  +K + + E++
Sbjct: 247 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 291

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 128/265 (48%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +    GK   +  +E +I + L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----GKAFKN--RELQIMRKLDHCNI 75
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELI 194
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +           ++P++  HP  K
Sbjct: 255 TE----------FAFPQIKAHPWTK 269

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 114/229 (49%), Gaps = 9/229 (3%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSGKELSSLKQECEIQKHLAH 177
           ++Y+   ++G G   +V  A  L L + VA+K++     R        ++E +    L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 178 PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           P I+   A+ E         ++++     ++L +++     ++    ++++++   AL +
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT---SIKGTPLYMAPELI 289
            H N ++HRD+KP N++++      + DFG AR++A   + +T   ++ GT  Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS 338
                D  +D++SLGC+ YE+  G PPF   S + +      +D   PS
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 130/267 (48%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +I EF  M+  NLL+      R+++S  + + + + + SA+ YL     +HR
Sbjct: 78  CTREPPFYIIIEF--MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 256 RPSFAEIHQAFETMFQESSISDEVEKE 282

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 163
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR        +     T  Y APE++   
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMXGYVATRWYRAPEIMLNW 220
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 258

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 130/267 (48%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +I EF  M+  NLL+      R+++S  + + + + + SA+ YL     +HR
Sbjct: 78  CTREPPFYIIIEF--MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 256 RPSFAEIHQAFETMFQESSISDEVEKE 282

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 129/267 (48%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R+++S  + + + + + SA+ YL     +HR
Sbjct: 76  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T    +    P+ + APE +A   +   +D+
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  +    +  LL K   +  P    E   +L++   + + S 
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 253
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 254 RPSFAEIHQAFETMFQESSISDEVEKE 280

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +A+ +D  K     TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I E+A   +L   L  R+         I           +L+S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +    +   +  G  
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRL 221
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/331 (26%), Positives = 144/331 (43%), Gaps = 64/331 (19%)
Query: 85  LITEFAHMSLSKLGEPW---FHNHCQPVKMEKSNGALE---------------------- 119
           L+   +HMS    G P    F   C+PV+   + G+++                      
Sbjct: 39  LVPRGSHMS----GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPD 94
Query: 120 -----KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH 174
                 Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + 
Sbjct: 95  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRK 148
Query: 175 LAHPNIIK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILS 224
           L H NI++    F +S E  +E  L  + ++   ++  +     +  +T+ V      + 
Sbjct: 149 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 208
Query: 225 NLISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLY 283
            L  +L Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y
Sbjct: 209 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YY 267
Query: 284 MAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVS 341
            APELI     Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ 
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 327
Query: 342 ETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
           E   +  +            +P++  HP  K
Sbjct: 328 EMNPNYTE----------FKFPQIKAHPWTK 348

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 123/247 (49%), Gaps = 13/247 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R+++S  + + + + + SA+ YL     +HR
Sbjct: 285 CTREPPFYIITEF--MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           +L  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 462
Query: 359 RLSWPEL 365
           R S+ E+
Sbjct: 463 RPSFAEI 469

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQK-- 173
           A  +Y+ +  IG G++G V+KA        VALK +   +G  G  +S++++   +++  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 174 HLAHPNIIKFI---ASHETLNEFVLITEFAHMS--LSNLLEQRKKL---SETICVQILSN 225
              HPN+++ +   A+  T  E  +   F H+   L   L++       +ETI   ++  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK-DLMRQ 120
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
            +  L +LH+N ++HRDLKP+N+L+   G   L DFG AR  +     L  +  T  Y A
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY-QMALAPVVVTLWYRA 179
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
           PE++ +  Y    D+WS+GCI  E+    P F
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 122/247 (49%), Gaps = 13/247 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 83  CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T    +    P+ + APE +A   +   +D+
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 359 RLSWPEL 365
           R S+ E+
Sbjct: 261 RPSFAEI 267

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +A+ +D  K     TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I E+A   +L   L  R+         I           +L+S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +    +   +  G  
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRL 221
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 109
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELI 228
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 289 TE----------FKFPQIKAHPWTK 303

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 87
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 148 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELI 206
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 266
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 267 TE----------FKFPQIKAHPWTK 281

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    +  FG AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILGFGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 258 YIQSLTQ 264

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 121/264 (45%), Gaps = 20/264 (7%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR------SGKELSSLKQECEIQ 172
           +KY  +  +G G+FG V+ A+  +  K V +K I K            +L  +  E  I 
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 173 KHLAHPNIIKFIASHETLNEFVLITE--FAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
             + H NIIK +   E    F L+ E   + + L   +++  +L E +   I   L+SA+
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YL    ++HRD+K +N+++ +D    L DFG A  +  G  +  +  GT  Y APE++ 
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLM 202
Query: 291 ERPYDHTA-DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF--PSQVSETYKDL 347
             PY     ++WSLG   Y +     PF          L +T +     P  VS+    L
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPF--------CELEETVEAAIHPPYLVSKELMSL 254
Query: 348 VKGLLEKDASQRLSWPELLHHPLV 371
           V GLL+    +R +  +L+  P V
Sbjct: 255 VSGLLQPVPERRTTLEKLVTDPWV 278

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 128/265 (48%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +    GK   +  +E +I + L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----GKAFKN--RELQIMRKLDHCNI 75
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPELI 194
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +           ++P++  HP  K
Sbjct: 255 TE----------FAFPQIKAHPWTK 269

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 94
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 155 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELI 213
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 214 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 273
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 274 TE----------FKFPQIKAHPWTK 288

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 135/303 (44%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +LS +++   +L       +L  ++  +
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFK----------------TVSILHLIRLLKT--- 331
              Y    D+WS+GCI  E+  G   F                 T S   + +L  T   
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 332 -----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 369 PLV 371
           P +
Sbjct: 319 PYI 321

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 103
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 164 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPELI 222
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 223 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 282
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 283 TE----------FKFPQIKAHPWTK 297

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQK-- 173
           A  +Y+ +  IG G++G V+KA        VALK +   +G  G  +S++++   +++  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 174 HLAHPNIIKFI---ASHETLNEFVLITEFAHMS--LSNLLEQRKKL---SETICVQILSN 225
              HPN+++ +   A+  T  E  +   F H+   L   L++       +ETI   ++  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK-DLMRQ 120
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
            +  L +LH+N ++HRDLKP+N+L+   G   L DFG AR  +     L  +  T  Y A
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY-QMALDPVVVTLWYRA 179
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
           PE++ +  Y    D+WS+GCI  E+    P F
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 11/211 (5%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQK-- 173
           A  +Y+ +  IG G++G V+KA        VALK +   +G  G  +S++++   +++  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 174 HLAHPNIIKFI---ASHETLNEFVLITEFAHMS--LSNLLEQRKK--LSETICVQILSNL 226
              HPN+++ +   A+  T  E  +   F H+   L   L++     L       ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 227 ISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
           +  L +LH+N ++HRDLKP+N+L+   G   L DFG AR  +    +   +  T  Y AP
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-TLWYRAP 180
Query: 287 ELIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
           E++ +  Y    D+WS+GCI  E+    P F
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 83
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 144 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELI 202
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 203 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 262
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 263 TE----------FKFPQIKAHPWTK 277

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 87
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 148 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELI 206
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 266
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 267 TE----------FKFPQIKAHPWTK 281

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 117/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +A+ +D  K     TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I E+A   +L   L  R+         I           +L+S
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +  +  +  T+    
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 111
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 172 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPELI 230
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 231 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 290
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 291 TE----------FKFPQIKAHPWTK 305

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 113
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 174 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPELI 232
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 233 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 292
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 293 TE----------FKFPQIKAHPWTK 307

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 11/218 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + DF  AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFYLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
             Y+ T D+WS+GCI  E+  G   F     +  ++L+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 109
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPELI 228
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 289 TE----------FKFPQIKAHPWTK 303

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 79
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 140 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELI 198
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 199 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 258
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 259 TE----------FKFPQIKAHPWTK 273

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 80
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 141 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPELI 199
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 200 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 259
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 260 TE----------FKFPQIKAHPWTK 274

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + D G AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDAGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 258 YIQSLTQ 264

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELI 194
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 255 TE----------FKFPQIKAHPWTK 269

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 122/247 (49%), Gaps = 18/247 (7%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH--PNIIKFI 184
           +G G F  V + I     +  A K + K  R     + +  E  + + LA   P +I   
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE-LAKSCPRVINLH 95
Query: 185 ASHETLNEFVLITEFAH----MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
             +E  +E +LI E+A      SL  L E  + +SE   ++++  ++  +YYLH N ++H
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVH 154
Query: 241 RDLKPQNVLLNKD---GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
            DLKPQN+LL+     G   + DFG +R +      L  I GTP Y+APE++   P    
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILNYDPITTA 213
Query: 298 ADLWSLGCIAYEIHMGHPPF----KTVSILHLIRL-LKTQDVTFPSQVSETYKDLVKGLL 352
            D+W++G IAY +     PF       + L++ ++ +   + TF S VS+   D ++ LL
Sbjct: 214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF-SSVSQLATDFIQSLL 272
Query: 353 EKDASQR 359
            K+  +R
Sbjct: 273 VKNPEKR 279

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +A+ +D  K     TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I E+A   +L   L  R+         I           +L+S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +  +     T+    
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +A+ +D  K     TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I E+A   +L   L  R+         I           +L+S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +  +     T+    
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 135/275 (49%), Gaps = 16/275 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 324 CTREPPFYIITEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 381
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           +L  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 382 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 442 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 501
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQNNQDCIGF 390
           R S+ E+         + ++S E+E +  ++ + F
Sbjct: 502 RPSFAEIHQAFETMFQESSISDEVEKELGKENLYF 536

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 76
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 137 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELI 195
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 196 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 255
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 256 TE----------FKFPQIKAHPWTK 270

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +A+ +D  K     TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I E+A   +L   L  R+         I           +L+S
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +    +   +  G  
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 88
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 149 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPELI 207
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 208 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 267
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 268 TE----------FKFPQIKAHPWTK 282

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELI 194
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 255 TE----------FKFPQIKAHPWTK 269

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 122/247 (49%), Gaps = 13/247 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +I EF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 83  CTREPPFYIIIEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 359 RLSWPEL 365
           R S+ E+
Sbjct: 261 RPSFAEI 267

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + D G AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDGGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 258 YIQSLTQ 264

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 127/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +    GK   +  +E +I + L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----GKAFKN--RELQIMRKLDHCNI 75
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPELI 194
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 255 TE----------FKFPQIKAHPWTK 269

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 140
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +HS  ++HRDLKP N+ +N+D    + D G AR        +T    T  Y APE++   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDRGLARHT---DDEMTGYVATRWYRAPEIMLNW 197
Query: 292 RPYDHTADLWSLGCIAYEIHMGH---PPFKTVSILHLI-RLLKTQDVTFPSQV-SETYKD 346
             Y+ T D+WS+GCI  E+  G    P    +  L LI RL+ T       ++ SE+ ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 347 LVKGLLE 353
            ++ L +
Sbjct: 258 YIQSLTQ 264

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 134/303 (44%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +LS +++   +L       +L  ++  +
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM--ELDHERMSYLLYQMLVGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFK----------------TVSILHLIRLLKT--- 331
              Y    D+WS+G I  E+  G   F                 T S   + +L  T   
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 332 -----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 369 PLV 371
           P +
Sbjct: 319 PYI 321

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG FG+V   +A+ +D  K     TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 88
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I E+A   +L   L  R+         I           +L+S
Sbjct: 89  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +    +   +  G  
Sbjct: 149 CTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 208
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 209 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 260

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG FG+V   +A+ +D  K     TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 93
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I E+A   +L   L  R+         I           +L+S
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +    +   +  G  
Sbjct: 154 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 213
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 214 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 265

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG FG+V   +A+ +D  K     TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 90
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I E+A   +L   L  R+         I           +L+S
Sbjct: 91  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +    +   +  G  
Sbjct: 151 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 210
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 211 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 262

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQM--ELDHERMSYLLYQMLXGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 199 GMGYKENVDIWSVGCIMGEM 218

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +E  L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPELI 194
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 255 TE----------FKFPQIKAHPWTK 269

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 113/229 (49%), Gaps = 9/229 (3%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSGKELSSLKQECEIQKHLAH 177
           ++Y+   ++G G   +V  A  L L + VA+K++     R        ++E +    L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 178 PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           P I+    + E         ++++     ++L +++     ++    ++++++   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT---SIKGTPLYMAPELI 289
            H N ++HRD+KP N++++      + DFG AR++A   + +T   ++ GT  Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS 338
                D  +D++SLGC+ YE+  G PPF   S + +      +D   PS
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 103/225 (45%), Gaps = 18/225 (8%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           +Q   L+GEG++G V  A H    + VA+K I    +    L +L+ E +I KH  H NI
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENI 71
Query: 181 IKFIA-----SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           I         S E  NE  +I E     L  ++   + LS+      +   + A+  LH 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFAR---------SMAVGTHM-LTSIKGTPLYMA 285
           + V+HRDLKP N+L+N +    +CDFG AR         S   G    +T    T  Y A
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRA 190
Query: 286 PE-LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
           PE ++    Y    D+WS GCI  E+ +  P F      H + L+
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 117/232 (50%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +A+ +D  K     TVA+K++ K   + ++LS L  E E+ K +  H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEEDLSDLVSEMEMMKMIGKHK 101
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I E+A   +L   L  R+         I           +L+S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGT 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +  +  +  T+    
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 113/229 (49%), Gaps = 9/229 (3%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSGKELSSLKQECEIQKHLAH 177
           ++Y+   ++G G   +V  A  L L + VA+K++     R        ++E +    L H
Sbjct: 29  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 88
Query: 178 PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           P I+    + E         ++++     ++L +++     ++    ++++++   AL +
Sbjct: 89  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 148
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT---SIKGTPLYMAPELI 289
            H N ++HRD+KP N++++      + DFG AR++A   + +T   ++ GT  Y++PE  
Sbjct: 149 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS 338
                D  +D++SLGC+ YE+  G PPF   S + +      +D   PS
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 257

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 103/225 (45%), Gaps = 18/225 (8%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           +Q   L+GEG++G V  A H    + VA+K I    +    L +L+ E +I KH  H NI
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENI 71
Query: 181 IKFIA-----SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           I         S E  NE  +I E     L  ++   + LS+      +   + A+  LH 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFAR---------SMAVGTHM-LTSIKGTPLYMA 285
           + V+HRDLKP N+L+N +    +CDFG AR         S   G    +T    T  Y A
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRA 190
Query: 286 PE-LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
           PE ++    Y    D+WS GCI  E+ +  P F      H + L+
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 199 GMGYKENVDIWSVGCIMGEM 218

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG FG+V   +A+ +D  K     TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I E+A   +L   L  R+         I           +L+S
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +    +   +  G  
Sbjct: 208 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 267
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 119/252 (47%), Gaps = 25/252 (9%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           +IG G FG+V+     D  K  A+K + K     K+  +L     I   L       FI 
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 186 ----SHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
               +  T ++   I +  +   L   L Q    SE       + +I  L ++H+  V++
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 241 RDLKPQNVLLNKDG------VAMLCDFGFARSMA-VGTHMLTSIKGTPLYMAPELIAER- 292
           RDLKP N+LL++ G      + + CDF   +  A VGTH          YMAPE++ +  
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG---------YMAPEVLQKGV 366
Query: 293 PYDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
            YD +AD +SLGC+ +++  GH PF   KT     + R+  T  V  P   S   + L++
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 350 GLLEKDASQRLS 361
           GLL++D ++RL 
Sbjct: 427 GLLQRDVNRRLG 438

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 119/252 (47%), Gaps = 25/252 (9%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           +IG G FG+V+     D  K  A+K + K     K+  +L     I   L       FI 
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 186 ----SHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
               +  T ++   I +  +   L   L Q    SE       + +I  L ++H+  V++
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 241 RDLKPQNVLLNKDG------VAMLCDFGFARSMA-VGTHMLTSIKGTPLYMAPELIAER- 292
           RDLKP N+LL++ G      + + CDF   +  A VGTH          YMAPE++ +  
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG---------YMAPEVLQKGV 366
Query: 293 PYDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
            YD +AD +SLGC+ +++  GH PF   KT     + R+  T  V  P   S   + L++
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 350 GLLEKDASQRLS 361
           GLL++D ++RL 
Sbjct: 427 GLLQRDVNRRLG 438

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 119/252 (47%), Gaps = 25/252 (9%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           +IG G FG+V+     D  K  A+K + K     K+  +L     I   L       FI 
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 186 ----SHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
               +  T ++   I +  +   L   L Q    SE       + +I  L ++H+  V++
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 241 RDLKPQNVLLNKDG------VAMLCDFGFARSMA-VGTHMLTSIKGTPLYMAPELIAER- 292
           RDLKP N+LL++ G      + + CDF   +  A VGTH          YMAPE++ +  
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG---------YMAPEVLQKGV 366
Query: 293 PYDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
            YD +AD +SLGC+ +++  GH PF   KT     + R+  T  V  P   S   + L++
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 350 GLLEKDASQRLS 361
           GLL++D ++RL 
Sbjct: 427 GLLQRDVNRRLG 438

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 119/252 (47%), Gaps = 25/252 (9%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           +IG G FG+V+     D  K  A+K + K     K+  +L     I   L       FI 
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 254
Query: 186 ----SHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
               +  T ++   I +  +   L   L Q    SE       + +I  L ++H+  V++
Sbjct: 255 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 314
Query: 241 RDLKPQNVLLNKDG------VAMLCDFGFARSMA-VGTHMLTSIKGTPLYMAPELIAER- 292
           RDLKP N+LL++ G      + + CDF   +  A VGTH          YMAPE++ +  
Sbjct: 315 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG---------YMAPEVLQKGV 365
Query: 293 PYDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
            YD +AD +SLGC+ +++  GH PF   KT     + R+  T  V  P   S   + L++
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 425
Query: 350 GLLEKDASQRLS 361
           GLL++D ++RL 
Sbjct: 426 GLLQRDVNRRLG 437

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 199 GMGYKENVDIWSVGCIMGEM 218

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 134/303 (44%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +L  +++   +L       +L  ++  +
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFK----------------TVSILHLIRLLKT--- 331
              Y    D+WS+GCI  E+  G   F                 T S   + +L  T   
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 332 -----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 369 PLV 371
           P +
Sbjct: 319 PYI 321

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 140/307 (45%), Gaps = 49/307 (15%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG VF+A  ++  +    K++       +EL       +I + + HPN+
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL-------QIMRIVKHPNV 94
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICVQILS----NLISAL 230
           +     F ++ +  +E  L  + E+   ++        KL +T+ + ++      L+ +L
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+   GV  L DFG A+ +  G   ++ I     Y APELI
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSR-YYRAPELI 213
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLL--------KTQDVTF 336
                Y    D+WS GC+  E+  G P F   S    ++ +I++L        KT +  +
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273
Query: 337 ---------PSQVSETYK--------DLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEI 379
                    P   S+ ++        DL+  LLE   S RL+  E L HP   +  + E 
Sbjct: 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333
Query: 380 ESQNNQD 386
              N ++
Sbjct: 334 RMPNGRE 340

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 132/313 (42%), Gaps = 64/313 (20%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHL 175
           +KY     IG+GS+G V  AI    +   A+KI++K+     + K++  +K E  + K L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHM--------------------------------- 202
            HPNI +    +E      L+ E  H                                  
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 203 -------SLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL 250
                  S+    E     QR+KL   I  QI S    AL+YLH+  + HRD+KP+N L 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFS----ALHYLHNQGICHRDIKPENFLF 201
Query: 251 --NKDGVAMLCDFGFARS---MAVGTHM-LTSIKGTPLYMAPELI--AERPYDHTADLWS 302
             NK     L DFG ++    +  G +  +T+  GTP ++APE++      Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVKGLLEKDASQ 358
            G + + + MG  PF  V+    I  +  + + F +     +S   +DL+  LL ++  +
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321
Query: 359 RLSWPELLHHPLV 371
           R      L HP +
Sbjct: 322 RFDAMRALQHPWI 334

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 129/267 (48%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +I EF  M+  NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 79  CTREPPFYIIIEF--MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 136
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T    +    P+ + APE +A   +   +D+
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++   + + S 
Sbjct: 197 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 256
Query: 359 RLSWPEL---LHHPLVKDNLSSEIESQ 382
           R S+ E+         + ++S E+E +
Sbjct: 257 RPSFAEIHQAFETMFQESSISDEVEKE 283

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 134/303 (44%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +LS +++   +L       +L  ++  +
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM--ELDHERMSYLLYQMLVGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFK----------------TVSILHLIRLLKT--- 331
              Y    D+WS+G I  E+  G   F                 T S   + +L  T   
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 332 -----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 369 PLV 371
           P +
Sbjct: 319 PYI 321

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 120/247 (48%), Gaps = 13/247 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +I EF  M+  NLL+      R+++S  + + + + + SA+ YL     +HR
Sbjct: 76  CTREPPFYIIIEF--MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ +  + DFG +R M   T    +    P+ + APE +A   +   +D+
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W+ G + +EI   G  P+  +    +  LL K   +  P    E   +L++   + + S 
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 253
Query: 359 RLSWPEL 365
           R S+ E+
Sbjct: 254 RPSFAEI 260

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 121/267 (45%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS--NLISALYYLHSNRVLHR 241
           I    T N   +I E   +       Q +K S  +   IL    L +AL YL S R +HR
Sbjct: 79  IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 137
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +NVL++ +    L DFG +R M   T+   S    P+ +MAPE I  R +   +D+
Sbjct: 138 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 197
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W  G   +EI M G  PF+ V    +I R+   + +  P     T   L+      D S+
Sbjct: 198 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 257
Query: 359 RLSWPELLHHPLVKDNLSSEIESQNNQ 385
           R  + EL      K  LS+ +E +  Q
Sbjct: 258 RPRFTEL------KAQLSTILEEEKAQ 278

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +L  +++   +L       +L  ++  +
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 140
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 199
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIRLLKT--------------- 331
              Y    D+WS+GCI  E+  G   F     +     +I  L T               
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259
Query: 332 -----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319
Query: 369 PLV 371
           P +
Sbjct: 320 PYI 322

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +A+ +D  K     TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I  +A   +L   L  R+         I           +L+S
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +    +   +  G  
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 121/267 (45%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS--NLISALYYLHSNRVLHR 241
           I    T N   +I E   +       Q +K S  +   IL    L +AL YL S R +HR
Sbjct: 82  IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 140
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +NVL++ +    L DFG +R M   T+   S    P+ +MAPE I  R +   +D+
Sbjct: 141 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 200
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W  G   +EI M G  PF+ V    +I R+   + +  P     T   L+      D S+
Sbjct: 201 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 260
Query: 359 RLSWPELLHHPLVKDNLSSEIESQNNQ 385
           R  + EL      K  LS+ +E +  Q
Sbjct: 261 RPRFTEL------KAQLSTILEEEKAQ 281

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQM--ELDHERMSYLLYQMLXGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 199 GMGYKENVDIWSVGCIMGEM 218

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 121/267 (45%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS--NLISALYYLHSNRVLHR 241
           I    T N   +I E   +       Q +K S  +   IL    L +AL YL S R +HR
Sbjct: 80  IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 138
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +NVL++ +    L DFG +R M   T+   S    P+ +MAPE I  R +   +D+
Sbjct: 139 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 198
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W  G   +EI M G  PF+ V    +I R+   + +  P     T   L+      D S+
Sbjct: 199 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 258
Query: 359 RLSWPELLHHPLVKDNLSSEIESQNNQ 385
           R  + EL      K  LS+ +E +  Q
Sbjct: 259 RPRFTEL------KAQLSTILEEEKAQ 279

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 121/267 (45%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS--NLISALYYLHSNRVLHR 241
           I    T N   +I E   +       Q +K S  +   IL    L +AL YL S R +HR
Sbjct: 74  IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 132
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +NVL++ +    L DFG +R M   T+   S    P+ +MAPE I  R +   +D+
Sbjct: 133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 192
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W  G   +EI M G  PF+ V    +I R+   + +  P     T   L+      D S+
Sbjct: 193 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 252
Query: 359 RLSWPELLHHPLVKDNLSSEIESQNNQ 385
           R  + EL      K  LS+ +E +  Q
Sbjct: 253 RPRFTEL------KAQLSTILEEEKAQ 273

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 27  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 86
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +L  +++   +L       +L  ++  +
Sbjct: 87  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 144
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 145 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 203
Query: 291 ERPYDHTADLWSLGCIAYEI---------------------HMGHP-PFKTVSILHLIRL 328
              Y    DLWS+GCI  E+                      +G P P     +   +R 
Sbjct: 204 GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRT 263
Query: 329 LKTQ--------------DVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 264 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 323
Query: 369 PLV 371
           P +
Sbjct: 324 PYI 326

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQM--ELDHERMSYLLYQMLXGI 132
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 191
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 192 GMGYKENVDIWSVGCIMGEM 211

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 37/274 (13%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++ EG F  V++A  +   +  ALK +  S    K  + +++ C ++K   HPNI++F +
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 186 --------SHETLNEFVLITEFAHMSLSNLL---EQRKKLSETICVQILSNLISALYYLH 234
                   S     EF+L+TE     L   L   E R  LS    ++I      A+ ++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 235 SNR--VLHRDLKPQNVLLNKDGVAMLCDFGFARSM-------------AVGTHMLTSIKG 279
             +  ++HRDLK +N+LL+  G   LCDFG A ++             A+    +T    
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR-NT 212
Query: 280 TPLYMAPELI---AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF 336
           TP+Y  PE+I   +  P     D+W+LGCI Y +     PF+  + L ++        + 
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV----NGKYSI 268
Query: 337 PSQVSE--TYKDLVKGLLEKDASQRLSWPELLHH 368
           P   ++   +  L++ +L+ +  +RLS  E++H 
Sbjct: 269 PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 133/293 (45%), Gaps = 51/293 (17%)
Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + ++KI  +G G+ G VFK              IHL++K  +  +II       +EL  L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------RELQVL 58
Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++  ++ E I  ++
Sbjct: 59  -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 223 LSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              +I  L YL   ++++HRD+KP N+L+N  G   LCDFG +  +     M  S  GT 
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR 167
Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMG-------------HPPFKTVSILHLIRL 328
            YM+PE +    Y   +D+WS+G    E+ +G              PP     +L  I  
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYI-- 225
Query: 329 LKTQDVTFPSQV-SETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
           +       PS V S  ++D V   L K+ ++R    +L+ H  +K + + E++
Sbjct: 226 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 278

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 121/267 (45%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS--NLISALYYLHSNRVLHR 241
           I    T N   +I E   +       Q +K S  +   IL    L +AL YL S R +HR
Sbjct: 105 IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 163
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +NVL++ +    L DFG +R M   T+   S    P+ +MAPE I  R +   +D+
Sbjct: 164 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 223
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W  G   +EI M G  PF+ V    +I R+   + +  P     T   L+      D S+
Sbjct: 224 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 283
Query: 359 RLSWPELLHHPLVKDNLSSEIESQNNQ 385
           R  + EL      K  LS+ +E +  Q
Sbjct: 284 RPRFTEL------KAQLSTILEEEKAQ 304

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +L  +++   +L       +L  ++  +
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIRLLKT--------------- 331
              Y    D+WS+GCI  E+  G   F     +     +I  L T               
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258
Query: 332 -----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 369 PLV 371
           P +
Sbjct: 319 PYI 321

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKVF--KAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V   +A+ +D  K     TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQI---------LSNLIS 228
           NII  + +        +I  +A   +L   L  R+         I           +L+S
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 229 ALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
             Y       YL S + +HRDL  +NVL+ ++ V  + DFG AR +    +   +  G  
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           P+ +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 75
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +L  +++   +L       +L  ++  +
Sbjct: 76  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 133
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 134 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 192
Query: 291 ERPYDHTADLWSLGCIAYEI---------------------HMGHP-PFKTVSILHLIRL 328
              Y    DLWS+GCI  E+                      +G P P     +   +R 
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRT 252
Query: 329 LKTQ--------------DVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 253 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 312
Query: 369 PLV 371
           P +
Sbjct: 313 PYI 315

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 102/225 (45%), Gaps = 18/225 (8%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           +Q   L+GEG++G V  A H    + VA+K I    +    L +L+ E +I KH  H NI
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENI 71
Query: 181 IKFIA-----SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           I         S E  NE  +I E     L  ++   + LS+      +   + A+  LH 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFAR---------SMAVGTHM-LTSIKGTPLYMA 285
           + V+HRDLKP N+L+N +    +CDFG AR         S   G    +     T  Y A
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 286 PE-LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
           PE ++    Y    D+WS GCI  E+ +  P F      H + L+
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 121/267 (45%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS--NLISALYYLHSNRVLHR 241
           I    T N   +I E   +       Q +K S  +   IL    L +AL YL S R +HR
Sbjct: 77  IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +NVL++ +    L DFG +R M   T+   S    P+ +MAPE I  R +   +D+
Sbjct: 136 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 195
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W  G   +EI M G  PF+ V    +I R+   + +  P     T   L+      D S+
Sbjct: 196 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 255
Query: 359 RLSWPELLHHPLVKDNLSSEIESQNNQ 385
           R  + EL      K  LS+ +E +  Q
Sbjct: 256 RPRFTEL------KAQLSTILEEEKLQ 276

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/247 (31%), Positives = 113/247 (45%), Gaps = 10/247 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS--NLISALYYLHSNRVLHR 241
           I    T N   +I E   +       Q +K S  +   IL    L +AL YL S R +HR
Sbjct: 457 IGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +NVL++ +    L DFG +R M   T+   S    P+ +MAPE I  R +   +D+
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 575
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W  G   +EI M G  PF+ V    +I R+   + +  P     T   L+      D S+
Sbjct: 576 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 635
Query: 359 RLSWPEL 365
           R  + EL
Sbjct: 636 RPRFTEL 642

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 121/267 (45%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS--NLISALYYLHSNRVLHR 241
           I    T N   +I E   +       Q +K S  +   IL    L +AL YL S R +HR
Sbjct: 77  IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +NVL++ +    L DFG +R M   T+   S    P+ +MAPE I  R +   +D+
Sbjct: 136 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 195
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W  G   +EI M G  PF+ V    +I R+   + +  P     T   L+      D S+
Sbjct: 196 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 255
Query: 359 RLSWPELLHHPLVKDNLSSEIESQNNQ 385
           R  + EL      K  LS+ +E +  Q
Sbjct: 256 RPRFTEL------KAQLSTILEEEKLQ 276

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 130/281 (46%), Gaps = 30/281 (10%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQK 173
            L+ +  + +IG GS+ KV   + + LKKT    A+K++ K   +  E     Q    +K
Sbjct: 18  GLQDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEK 71
Query: 174 HL-----AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLI 227
           H+      HP ++   +  +T +    + E+ +   L   +++++KL E       + + 
Sbjct: 72  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 131
Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
            AL YLH   +++RDLK  NVLL+ +G   L D+G  +         +   GTP Y+APE
Sbjct: 132 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 191
Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL---------HLIRLLKTQDVTFPS 338
           ++    Y  + D W+LG + +E+  G  PF  V            +L +++  + +  P 
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 251
Query: 339 QVSETYKDLVKGLLEKDASQRL------SWPELLHHPLVKD 373
            +S     ++K  L KD  +RL       + ++  HP  ++
Sbjct: 252 SMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRN 292

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 177
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 236
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 237 GMGYKENVDIWSVGCIMGEM 256

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 123/266 (46%), Gaps = 22/266 (8%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL---- 175
           +Y+   L+G+G FG VF    L  +  VA+K+I ++   G    S    C ++  L    
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 176 ----AHPNIIKFIASHETLNEFVLITE--FAHMSLSNLLEQRKKLSETICVQILSNLISA 229
                HP +I+ +   ET   F+L+ E       L + + ++  L E         +++A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 230 LYYLHSNRVLHRDLKPQNVLLN-KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           + + HS  V+HRD+K +N+L++ + G A L DFG      +     T   GT +Y  PE 
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG--SGALLHDEPYTDFDGTRVYSPPEW 209
Query: 289 IAERPYDH-TADLWSLGCIAYEIHMGHPPF-KTVSILHLIRLLKTQDVTFPSQVSETYKD 346
           I+   Y    A +WSLG + Y++  G  PF +   IL         ++ FP+ VS     
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE-------AELHFPAHVSPDCCA 262
Query: 347 LVKGLLEKDASQRLSWPELLHHPLVK 372
           L++  L    S R S  E+L  P ++
Sbjct: 263 LIRRCLAPKPSSRPSLEEILLDPWMQ 288

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 199 GMGYKENVDIWSVGCIMGEM 218

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 140
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 199
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 200 GMGYKENVDIWSVGCIMGEM 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 140
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 199
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 200 GMGYKENVDIWSVGCIMGEM 219

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 177
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 236
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 237 GMGYKENVDIWSVGCIMGEM 256

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 132
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 191
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 192 GMGYKENVDIWSVGCIMGEM 211

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 199 GMGYKENVDIWSVGCIMGEM 218

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 75
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 133
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 134 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 192
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 193 GMGYKENVDIWSVGCIMGEM 212

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 75
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 133
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 134 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 192
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 193 GMGYKENVDIWSVGCIMGEM 212

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 131/281 (46%), Gaps = 30/281 (10%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQK 173
            L+ +  + +IG GS+ KV   + + LKKT    A++++ K   +  E     Q    +K
Sbjct: 50  GLQDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ---TEK 103
Query: 174 HL-----AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLI 227
           H+      HP ++   +  +T +    + E+ +   L   +++++KL E       + + 
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
            AL YLH   +++RDLK  NVLL+ +G   L D+G  +         ++  GTP Y+APE
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL---------HLIRLLKTQDVTFPS 338
           ++    Y  + D W+LG + +E+  G  PF  V            +L +++  + +  P 
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283
Query: 339 QVSETYKDLVKGLLEKDASQRL------SWPELLHHPLVKD 373
            +S     ++K  L KD  +RL       + ++  HP  ++
Sbjct: 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + 
Sbjct: 21  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 80
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  +++   +L       +L  ++  +
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 138
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 139 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 197
Query: 291 ERPYDHTADLWSLGCIAYEI 310
              Y    D+WS+GCI  E+
Sbjct: 198 GMGYKENVDIWSVGCIMGEM 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 120/267 (44%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS--NLISALYYLHSNRVLHR 241
           I    T N   +I E   +       Q +K S  +   IL    L +AL YL S R +HR
Sbjct: 77  IGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +NVL++ +    L DFG +R M   T    S    P+ +MAPE I  R +   +D+
Sbjct: 136 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDV 195
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W  G   +EI M G  PF+ V    +I R+   + +  P     T   L+      D S+
Sbjct: 196 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 255
Query: 359 RLSWPELLHHPLVKDNLSSEIESQNNQ 385
           R  + EL      K  LS+ +E +  Q
Sbjct: 256 RPRFTEL------KAQLSTILEEEKLQ 276

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 124/265 (46%), Gaps = 30/265 (11%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 181 IK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV----QILSNLISAL 230
           ++    F +S E  +   L  + ++   ++  +     +  +T+ V      +  L  +L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 231 YYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G   ++ I     Y APELI
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELI 194
Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQDVTFPSQVSETYKDL 347
                Y  + D+WS GC+  E+ +G P F   S +  L+ ++K        Q+ E   + 
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 348 VKGLLEKDASQRLSWPELLHHPLVK 372
            +            +P++  HP  K
Sbjct: 255 TE----------FKFPQIKAHPWTK 269

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 120/267 (44%), Gaps = 16/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS--NLISALYYLHSNRVLHR 241
           I    T N   +I E   +       Q +K S  +   IL    L +AL YL S R +HR
Sbjct: 77  IGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +NVL++      L DFG +R M   T+   S    P+ +MAPE I  R +   +D+
Sbjct: 136 DIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 195
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W  G   +EI M G  PF+ V    +I R+   + +  P     T   L+      D S+
Sbjct: 196 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 255
Query: 359 RLSWPELLHHPLVKDNLSSEIESQNNQ 385
           R  + EL      K  LS+ +E +  Q
Sbjct: 256 RPRFTEL------KAQLSTILEEEKLQ 276

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 127/262 (48%), Gaps = 19/262 (7%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH-PNIIKFIA 185
           IG G++G V K +H    + +A+K I +S    KE   L  + ++    +  P I++F  
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 186 SHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNL----ISALYYLHSN-RVL 239
           +     +  +  E    S     +     L + I  +IL  +    + AL +L  N +++
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKII 148
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI----AERPYD 295
           HRD+KP N+LL++ G   LCDFG +  + V +   T   G   YMAPE I    + + YD
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPERIDPSASRQGYD 207
Query: 296 HTADLWSLGCIAYEIHMGHPPF-KTVSIL-HLIRLLKTQDVTFPS----QVSETYKDLVK 349
             +D+WSLG   YE+  G  P+ K  S+   L +++K       +    + S ++ + V 
Sbjct: 208 VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVN 267
Query: 350 GLLEKDASQRLSWPELLHHPLV 371
             L KD S+R  + ELL HP +
Sbjct: 268 LCLTKDESKRPKYKELLKHPFI 289

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 16/267 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           EKY     +G G FG V + +    KKT   K +   G    +   +K+E  I     H 
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHR 61
Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK----KLSETICVQILSNLISALYYLH 234
           NI+    S E++ E V+I EF  +S  ++ E+      +L+E   V  +  +  AL +LH
Sbjct: 62  NILHLHESFESMEELVMIFEF--ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 235 SNRVLHRDLKPQNVLLN--KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           S+ + H D++P+N++    +     + +FG AR +  G +    +   P Y APE+    
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPEVHQHD 178
Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLV 348
                 D+WSLG + Y +  G  PF   +   +I  +   + TF      ++S    D V
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238
Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNL 375
             LL K+   R++  E L HP +K  +
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKI 265

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 102
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  L+T      L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 103 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 161
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 162 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y ++  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHEN 102
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           +I        ++ E + +  ++ +     L  LL+ ++  ++ IC   L  ++  L Y+H
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-FLYQILRGLKYIH 161
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH----MLTSIKGTPLYMAPE-LI 289
           S  VLHRDLKP N+L+N      +CDFG AR +A   H     LT    T  Y APE ++
Sbjct: 162 SANVLHRDLKPSNLLINTTCDLKICDFGLAR-IADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPF 317
             + Y  + D+WS+GCI  E+    P F
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 24  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 83
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +L  +++   +L       +L  ++  +
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 141
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+     T  Y APE+I 
Sbjct: 142 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMVPFVVTRYYRAPEVIL 200
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL----HLIRLLKT--------------- 331
              Y    D+WS+GCI  E+  G   F     +     +I  L T               
Sbjct: 201 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 260
Query: 332 -----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 261 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 320
Query: 369 PLV 371
           P +
Sbjct: 321 PYI 323

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR-EIKILLRFRHEN 86
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 145
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 112/229 (48%), Gaps = 9/229 (3%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSGKELSSLKQECEIQKHLAH 177
           ++Y+   ++G G   +V  A  L   + VA+K++     R        ++E +    L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 178 PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           P I+    + E         ++++     ++L +++     ++    ++++++   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT---SIKGTPLYMAPELI 289
            H N ++HRD+KP N++++      + DFG AR++A   + +T   ++ GT  Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS 338
                D  +D++SLGC+ YE+  G PPF   S + +      +D   PS
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 105/208 (50%), Gaps = 9/208 (4%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSGKELSSLKQECEIQKHLAH 177
           ++Y+   ++G G   +V  A  L   + VA+K++     R        ++E +    L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 178 PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           P I+    + E         ++++     ++L +++     ++    ++++++   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT---SIKGTPLYMAPELI 289
            H N ++HRD+KP N++++      + DFG AR++A   + +T   ++ GT  Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPF 317
                D  +D++SLGC+ YE+  G PPF
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 130/281 (46%), Gaps = 30/281 (10%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQK 173
            L+ +  + +IG GS+ KV   + + LKKT    A+K++ K   +  E     Q    +K
Sbjct: 3   GLQDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEK 56
Query: 174 HL-----AHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLI 227
           H+      HP ++   +  +T +    + E+ +   L   +++++KL E       + + 
Sbjct: 57  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 116
Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
            AL YLH   +++RDLK  NVLL+ +G   L D+G  +         +   GTP Y+APE
Sbjct: 117 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 176
Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL---------HLIRLLKTQDVTFPS 338
           ++    Y  + D W+LG + +E+  G  PF  V            +L +++  + +  P 
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 236
Query: 339 QVSETYKDLVKGLLEKDASQRL------SWPELLHHPLVKD 373
            +S     ++K  L KD  +RL       + ++  HP  ++
Sbjct: 237 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 277

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/247 (31%), Positives = 112/247 (45%), Gaps = 10/247 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS--NLISALYYLHSNRVLHR 241
           I    T N   +I E   +       Q +K S  +   IL    L +AL YL S R +HR
Sbjct: 457 IGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +NVL++      L DFG +R M   T+   S    P+ +MAPE I  R +   +D+
Sbjct: 516 DIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 575
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           W  G   +EI M G  PF+ V    +I R+   + +  P     T   L+      D S+
Sbjct: 576 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 635
Query: 359 RLSWPEL 365
           R  + EL
Sbjct: 636 RPRFTEL 642

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +L  +++   +L       +L  ++  +
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPEVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL----HLIRLLKT--------------- 331
              Y    D+WS+GCI  E+  G   F     +     +I  L T               
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258
Query: 332 -----------------QDVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 369 PLV 371
           P +
Sbjct: 319 PYI 321

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 132/278 (47%), Gaps = 24/278 (8%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKS-GRSGKELSSLKQECEIQ 172
            L+ +  + +IG GS+ KV   + + LKKT    A+K++ K      +++  ++ E  + 
Sbjct: 7   GLQDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVF 63
Query: 173 KHLA-HPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISAL 230
           +  + HP ++   +  +T +    + E+ +   L   +++++KL E       + +  AL
Sbjct: 64  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 123
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            YLH   +++RDLK  NVLL+ +G   L D+G  +         +   GTP Y+APE++ 
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 183
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL---------HLIRLLKTQDVTFPSQVS 341
              Y  + D W+LG + +E+  G  PF  V            +L +++  + +  P  +S
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243
Query: 342 ETYKDLVKGLLEKDASQRL------SWPELLHHPLVKD 373
                ++K  L KD  +RL       + ++  HP  ++
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 126/269 (46%), Gaps = 27/269 (10%)
Query: 127 IGEGSFGKVFKA-IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           IG GSFG V+K   H D    VA+KI+     + ++  + + E  + +   H NI+ F+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD----VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 186 SHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
            + T +   ++T++   S    +L  Q  K      + I       + YLH+  ++HRD+
Sbjct: 100 -YMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDM 158
Query: 244 KPQNVLLNKDGVAMLCDFGFA--RSMAVGTHMLTSIKGTPLYMAPELIA---ERPYDHTA 298
           K  N+ L++     + DFG A  +S   G+  +    G+ L+MAPE+I      P+   +
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS 218
Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKD-------LVKGL 351
           D++S G + YE+  G  P+  ++    I  +  +    P  +S+ YK+       LV   
Sbjct: 219 DVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD-LSKLYKNCPKAMKRLVADC 277
Query: 352 LEKDASQRLSWP------ELLHHPLVKDN 374
           ++K   +R  +P      ELL H L K N
Sbjct: 278 VKKVKEERPLFPQILSSIELLQHSLPKIN 306

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 141
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 111/229 (48%), Gaps = 9/229 (3%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSGKELSSLKQECEIQKHLAH 177
           ++Y+   ++G G   +V  A  L   + VA+K++     R        ++E +    L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 178 PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           P I+    + E         ++++     ++L +++     ++    ++++++   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPELI 289
            H N ++HRD+KP N+L++      + DFG AR++A   + +    ++ GT  Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS 338
                D  +D++SLGC+ YE+  G PPF   S + +      +D   PS
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 117/248 (47%), Gaps = 27/248 (10%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L KY+ +  +G+G++G V+K+I     + VA+K I  + ++  +     +E  I   L+
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66
Query: 177 -HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQ-ILSNLISALYYLH 234
            H NI+  +      N+  +   F +M        R  + E +  Q ++  LI  + YLH
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS------------MAVGTH---------M 273
           S  +LHRD+KP N+LLN +    + DFG +RS            +++  +         +
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 274 LTSIKGTPLYMAPE-LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH-LIRLLKT 331
           LT    T  Y APE L+    Y    D+WSLGCI  EI  G P F   S ++ L R++  
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246
Query: 332 QDVTFPSQ 339
            D  FPS 
Sbjct: 247 ID--FPSN 252

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHEN 84
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 143
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 144 SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 141
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 90
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 149
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 150 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 141
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 84
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 143
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 145
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 141
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 123/265 (46%), Gaps = 12/265 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G+ G+V+K         +A+K + +SG   +    L     + K    P I++   +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 187 HETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYL-HSNRVLHRDLK 244
             T  +  +  E        L ++ +  + E I  ++   ++ ALYYL   + V+HRD+K
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK 152
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI----AERP-YDHTAD 299
           P N+LL++ G   LCDFG +  + V         G   YMAPE I      +P YD  AD
Sbjct: 153 PSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRAD 211
Query: 300 LWSLGCIAYEIHMGHPPFKT--VSILHLIRLLKTQDVTFPSQV--SETYKDLVKGLLEKD 355
           +WSLG    E+  G  P+K        L ++L+ +    P  +  S  ++  VK  L KD
Sbjct: 212 VWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKD 271
Query: 356 ASQRLSWPELLHHPLVKDNLSSEIE 380
             +R  + +LL H  +K   + E++
Sbjct: 272 HRKRPKYNKLLEHSFIKRYETLEVD 296

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK----ELSSLKQECEIQ 172
           A  +Y+ +  IG G++G V+KA        VALK +      G      +S++++   ++
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 173 K--HLAHPNIIKFI---ASHETLNEFVLITEFAHMS--LSNLLEQRKKL---SETICVQI 222
           +     HPN+++ +   A+  T  E  +   F H+   L   L++       +ETI   +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK-DL 125
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL 282
           +   +  L +LH+N ++HRDLKP+N+L+   G   L DFG AR  +     LT +  T  
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY-QMALTPVVVTLW 184
Query: 283 YMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
           Y APE++ +  Y    D+WS+GCI  E+    P F
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 80
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 139
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 115/244 (47%), Gaps = 13/244 (5%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ++  IG G+ G V  A    L   VA+K +S+  ++        +E  + K + 
Sbjct: 20  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 79
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  ++    +L       +L  ++  +
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGI 137
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A    M+T    T  Y APE+I 
Sbjct: 138 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ASTNFMMTPYVVTRYYRAPEVIL 196
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIRLLKTQDVTFPSQVSETYKD 346
              Y    D+WS+GCI  E+  G   F+    +     +I  L T    F + +  T ++
Sbjct: 197 GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRN 256
Query: 347 LVKG 350
            V+ 
Sbjct: 257 YVEN 260

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 80
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 139
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 87
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 146
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 88
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 147
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 148 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 79
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 138
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 139 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 145
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +L  +++   +L       +L  ++  +
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+     T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMEPEVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEI---------------------HMGHP-PFKTVSILHLIRL 328
              Y    DLWS+GCI  E+                      +G P P     +   +R 
Sbjct: 199 GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258
Query: 329 LKTQ--------------DVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 369 PLV 371
           P +
Sbjct: 319 PYI 321

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 102
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 161
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 162 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP- 178
           +Y+ + +IG+GSFG+V KA    + + VALK++    R  ++ +   +E  I +HL    
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA---EEIRILEHLRKQD 154
Query: 179 -----NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALY 231
                N+I  + +    N   +  E   M+L  L+++ K    S  +  +   +++  L 
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
            LH NR++H DLKP+N+LL + G + +    F  S      + T I+ +  Y APE+I  
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQ-SRFYRAPEVILG 273
Query: 292 RPYDHTADLWSLGCIAYEIHMGHP 315
             Y    D+WSLGCI  E+  G+P
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYP 297

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHEN 84
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 143
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 12/262 (4%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDL--KKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           + KY    L+GEGS+GKV + +  +   ++ V +    K  R     +++K+E ++ + L
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 176 AHPNIIKFIA--SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQ--ILSNLISALY 231
            H N+I+ +    +E   +  ++ E+    +  +L+   +    +C        LI  L 
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM---AVGTHMLTSIKGTPLYMAPEL 288
           YLHS  ++H+D+KP N+LL   G   +   G A ++   A      TS +G+P +  PE+
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEI 182
Query: 289 IA--ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKD 346
               +       D+WS G   Y I  G  PF+  +I  L   +       P        D
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 347 LVKGLLEKDASQRLSWPELLHH 368
           L+KG+LE + ++R S  ++  H
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQH 264

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP- 178
           +Y+ + +IG+GSFG+V KA    + + VALK++    R  ++ +   +E  I +HL    
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA---EEIRILEHLRKQD 154
Query: 179 -----NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALY 231
                N+I  + +    N   +  E   M+L  L+++ K    S  +  +   +++  L 
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
            LH NR++H DLKP+N+LL + G + +    F  S      + T I+ +  Y APE+I  
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQ-SRFYRAPEVILG 273
Query: 292 RPYDHTADLWSLGCIAYEIHMGHP 315
             Y    D+WSLGCI  E+  G+P
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYP 297

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 129/262 (49%), Gaps = 15/262 (5%)
Query: 122 QKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ-KHLAHPNI 180
           + I  +G G++G V K  H+   + +A+K I  +  S +E   L  + +I  + +  P  
Sbjct: 54  EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFT 112
Query: 181 IKFIASHETLNEFVLITEFAHMSLS----NLLEQRKKLSETICVQILSNLISALYYLHSN 236
           + F  +     +  +  E    SL      ++++ + + E I  +I  +++ AL +LHS 
Sbjct: 113 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 172
Query: 237 -RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI----AE 291
             V+HRD+KP NVL+N  G   +CDFG +  + V +   T   G   YMAPE I     +
Sbjct: 173 LSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKT--VSILHLIRLLKTQDVTFPS-QVSETYKDLV 348
           + Y   +D+WSLG    E+ +   P+ +       L ++++      P+ + S  + D  
Sbjct: 232 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 291
Query: 349 KGLLEKDASQRLSWPELLHHPL 370
              L+K++ +R ++PEL+ HP 
Sbjct: 292 SQCLKKNSKERPTYPELMQHPF 313

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA++ IS          +L+ E +I     H N
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 145
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 9/203 (4%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ++  IG G+ G V  A    L   VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      +TL EF    L+ E    +L  ++    +L       +L  ++  +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A    M+T    T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTPYVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEIHMG 313
              Y    D+WS+GCI  E+  G
Sbjct: 199 GMGYAANVDIWSVGCIMGELVKG 221

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 106/211 (50%), Gaps = 12/211 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V+  +      TVA+K + +      E+    +E  + K + HPN+++ +  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F ++TE+  M   NLL+      R++++  + + + + + SA+ YL     +HR
Sbjct: 97  CTLEPPFYIVTEY--MPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHR 154
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL  +N L+ ++ V  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 301 WSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           W+ G + +EI   G  P+  + +  +  LL+
Sbjct: 215 WAFGVLLWEIATYGMSPYPGIDLSQVYDLLE 245

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 110/256 (42%), Gaps = 15/256 (5%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           +IG G FGKV++A  +  +  V            + + +++QE ++   L HPNII    
Sbjct: 14  IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 186 SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV---LHRD 242
                    L+ EFA     N +   K++   I V     +   + YLH   +   +HRD
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRD 133
Query: 243 LKPQNVLL-----NKD---GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           LK  N+L+     N D    +  + DFG AR     T M  S  G   +MAPE+I    +
Sbjct: 134 LKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYAWMAPEVIRASMF 191
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF--PSQVSETYKDLVKGLL 352
              +D+WS G + +E+  G  PF+ +  L +   +    +    PS   E +  L++   
Sbjct: 192 SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCW 251
Query: 353 EKDASQRLSWPELLHH 368
             D   R S+  +L  
Sbjct: 252 NPDPHSRPSFTNILDQ 267

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEIXINKMLNH 64
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 51/303 (16%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
            L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 177 HPNIIKFI---ASHETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
           H NII  +      ++L EF    ++ E    +L  +++   +L       +L  ++  +
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
            +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+     T  Y APE+I 
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMEPEVVTRYYRAPEVIL 198
Query: 291 ERPYDHTADLWSLGCIAYEI---------------------HMGHP-PFKTVSILHLIRL 328
              Y    D+WS+GCI  E+                      +G P P     +   +R 
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRN 258
Query: 329 LKTQ--------------DVTFPSQV------SETYKDLVKGLLEKDASQRLSWPELLHH 368
                             DV FP+        +   +DL+  +L  DAS+R+S  E L H
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 369 PLV 371
           P +
Sbjct: 319 PYI 321

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICY-FLYQILRGLKYIH 145
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE ++ 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEIXINKMLNH 63
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 134/279 (48%), Gaps = 49/279 (17%)
Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++       ++E E+
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVEL 63
Query: 172 QKHLAH-PNIIKFIASHETLNE-----FVLITEFAHMSLSNLLEQR--KKLSETICVQIL 223
               +  P+I++ +  +E L        +++       L + ++ R  +  +E    +I+
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
            ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+               
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--------------- 168
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTF 336
                 E   E+ YD + D+WSLG I Y +  G+PPF +   L +   +KT+       F
Sbjct: 169 ------ETTGEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221
Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLV 371
           P    S+VSE  K L++ LL+ + +QR++  E ++HP +
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 117/252 (46%), Gaps = 22/252 (8%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G G+FG V KA      K VA+K I         +  L+Q   +     HPNI+K   
Sbjct: 15  VVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVN----HPNIVKLYG 68
Query: 186 SHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS---ALYYLHSNR---V 238
           +   LN   L+ E+A   SL N+L   + L        +S  +     + YLHS +   +
Sbjct: 69  A--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 239 LHRDLKPQNVLLNKDGVAM-LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           +HRDLKP N+LL   G  + +CDFG A    + THM T+ KG+  +MAPE+     Y   
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTA--CDIQTHM-TNNKGSAAWMAPEVFEGSNYSEK 183
Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS---QVSETYKDLVKGLLEK 354
            D++S G I +E+     PF  +       +    + T P     + +  + L+     K
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSK 243
Query: 355 DASQRLSWPELL 366
           D SQR S  E++
Sbjct: 244 DPSQRPSMEEIV 255

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 135/300 (45%), Gaps = 35/300 (11%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSL-KQECEIQKHLAH 177
           E Y+ + +IG G+FG+V    H   +K  A+K++SK     +  S+   +E +I      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           P +++   + +      ++ E+     L NL+     + E       + ++ AL  +HS 
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 192
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGTPLYMAPELI----AE 291
             +HRD+KP N+LL+K G   L DFG    M   G     +  GTP Y++PE++     +
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT--QDVTFP--SQVSETYKDL 347
             Y    D WS+G   YE+ +G  PF   S++     +      +TFP  + +S+  K+L
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 312
Query: 348 VKGLLEKDASQRL-------------------SWPELLH--HPLVKDNLSSEIESQNNQD 386
           +   L  D   RL                   +W  L     P+V D LSS+I++ N  D
Sbjct: 313 ICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPD-LSSDIDTSNFDD 370

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 117/252 (46%), Gaps = 22/252 (8%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G G+FG V KA      K VA+K I         +  L+Q   +     HPNI+K   
Sbjct: 16  VVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVN----HPNIVKLYG 69
Query: 186 SHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS---ALYYLHSNR---V 238
           +   LN   L+ E+A   SL N+L   + L        +S  +     + YLHS +   +
Sbjct: 70  A--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 239 LHRDLKPQNVLLNKDGVAM-LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           +HRDLKP N+LL   G  + +CDFG A    + THM T+ KG+  +MAPE+     Y   
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTA--CDIQTHM-TNNKGSAAWMAPEVFEGSNYSEK 184
Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS---QVSETYKDLVKGLLEK 354
            D++S G I +E+     PF  +       +    + T P     + +  + L+     K
Sbjct: 185 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSK 244
Query: 355 DASQRLSWPELL 366
           D SQR S  E++
Sbjct: 245 DPSQRPSMEEIV 256

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 135/300 (45%), Gaps = 35/300 (11%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSL-KQECEIQKHLAH 177
           E Y+ + +IG G+FG+V    H   +K  A+K++SK     +  S+   +E +I      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           P +++   + +      ++ E+     L NL+     + E       + ++ AL  +HS 
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 192
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGTPLYMAPELI----AE 291
             +HRD+KP N+LL+K G   L DFG    M   G     +  GTP Y++PE++     +
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT--QDVTFP--SQVSETYKDL 347
             Y    D WS+G   YE+ +G  PF   S++     +      +TFP  + +S+  K+L
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 312
Query: 348 VKGLLEKDASQRL-------------------SWPELLH--HPLVKDNLSSEIESQNNQD 386
           +   L  D   RL                   +W  L     P+V D LSS+I++ N  D
Sbjct: 313 ICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPD-LSSDIDTSNFDD 370

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 37/234 (15%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + Y+   LIG GS+G V+ A   +  K VA+K +++      +   + +E  I   L   
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 179 NIIKF---IASHETL--NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
            II+    I   + L  +E  ++ E A   L  L +    L+E     IL NL+    ++
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFI 147
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-------------------AVGTH-- 272
           H + ++HRDLKP N LLN+D    +CDFG AR++                     G H  
Sbjct: 148 HESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNK 207
Query: 273 ----MLTSIKGTPLYMAPELI-AERPYDHTADLWSLGCIAYEI------HMGHP 315
                LTS   T  Y APELI  +  Y ++ D+WS GCI  E+      H+ +P
Sbjct: 208 NLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNP 261

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 145
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  L     T  Y APE ++ 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 142/309 (45%), Gaps = 26/309 (8%)
Query: 85  LITEFAHMSLSKL-------GEPWFHNHCQPVKMEKSNGALE-KYQKICLIGEGSFGKVF 136
           L+   +HM LSK+         P    H   +   K    LE +YQ   L+G G FG V+
Sbjct: 14  LVPRGSHMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVY 73
Query: 137 KAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QKHLAHPNIIKFIASHETL 190
             I +     VA+K + K   S  G+  +  +   E+    +       +I+ +   E  
Sbjct: 74  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 133
Query: 191 NEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNV 248
           + FVLI E       L + + +R  L E +       ++ A+ + H+  VLHRD+K +N+
Sbjct: 134 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 193
Query: 249 LLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA-ERPYDHTADLWSLGCI 306
           L++ + G   L DFG      +   + T   GT +Y  PE I   R +  +A +WSLG +
Sbjct: 194 LIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 251
Query: 307 AYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELL 366
            Y++  G  PF+     H   +++ Q V F  +VS   + L++  L    S R ++ E+ 
Sbjct: 252 LYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQ 305
Query: 367 HHPLVKDNL 375
           +HP ++D L
Sbjct: 306 NHPWMQDVL 314

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 87
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 146
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      +CDFG AR        T  L     T  Y APE ++ 
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 135/300 (45%), Gaps = 35/300 (11%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSL-KQECEIQKHLAH 177
           E Y+ + +IG G+FG+V    H   +K  A+K++SK     +  S+   +E +I      
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           P +++   + +      ++ E+     L NL+     + E       + ++ AL  +HS 
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 187
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGTPLYMAPELI----AE 291
             +HRD+KP N+LL+K G   L DFG    M   G     +  GTP Y++PE++     +
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT--QDVTFP--SQVSETYKDL 347
             Y    D WS+G   YE+ +G  PF   S++     +      +TFP  + +S+  K+L
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 348 VKGLLEKDASQRL-------------------SWPELLH--HPLVKDNLSSEIESQNNQD 386
           +   L  D   RL                   +W  L     P+V D LSS+I++ N  D
Sbjct: 308 ICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPD-LSSDIDTSNFDD 365

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 125 HCHNXGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSXECQHLIR 236
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEIXINKMLNH 63
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 127
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 185
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIR 239
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 240 WCLALRPSDRPTFEEIQNHPWMQDVL 265

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIR 240
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 241 WCLALRPSDRPTFEEIQNHPWMQDVL 266

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIR 241
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 242 WCLALRPSDRPTFEEIQNHPWMQDVL 267

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIR 236
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIR 256
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 257 WCLALRPSDRPTFEEIQNHPWMQDVL 282

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIR 255
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 256 WCLALRPSDRPTFEEIQNHPWMQDVL 281

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIR 241
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 242 WCLALRPSDRPTFEEIQNHPWMQDVL 267

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIR 241
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 242 WCLALRPSDRPTFEEIQNHPWMQDVL 267

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIR 240
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 241 WCLALRPSDRPTFEEIQNHPWMQDVL 266

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 33/225 (14%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++Y+   LIG GS+G V +A     K+ VA+K I +      +   + +E  I   L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 179 NIIKFI-----ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
           +++K +        E  +E  ++ E A      L      L+E     +L NL+  + Y+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP------------ 281
           HS  +LHRDLKP N L+N+D    +CDFG AR++    +  + +  +P            
Sbjct: 173 HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 282 ---------------LYMAPELI-AERPYDHTADLWSLGCIAYEI 310
                           Y APELI  +  Y    D+WS+GCI  E+
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 100/213 (46%), Gaps = 28/213 (13%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF-- 183
           LIG GS+G V+ A   + +K VA+K +++      +   + +E  I   L    II+   
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 184 -IASHETL--NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
            I   + L  +E  ++ E A   L  L +    L+E     IL NL+    ++H + ++H
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIH 152
Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSM----------------AVGTH------MLTSIK 278
           RDLKP N LLN+D    +CDFG AR++                  G H       LTS  
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212
Query: 279 GTPLYMAPELI-AERPYDHTADLWSLGCIAYEI 310
            T  Y APELI  +  Y  + D+WS GCI  E+
Sbjct: 213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIR 268
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 269 WCLALRPSDRPTFEEIQNHPWMQDVL 294

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSXECQHLIR 256
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 257 WCLALRPSDRPTFEEIQNHPWMQDVL 282

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSXECQHLIR 255
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 256 WCLALRPSDRPTFEEIQNHPWMQDVL 281

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIR 283
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 284 WCLALRPSDRPTFEEIQNHPWMQDVL 309

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 221
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIR 275
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 276 WCLALRPSDRPTFEEIQNHPWMQDVL 301

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 62
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPS 210

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 64
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 151
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 209
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSXECQHLIR 263
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 264 WCLALRPSDRPTFEEIQNHPWMQDVL 289

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 64
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 64
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 64
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H N
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 180 IIKF-----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           II         + E + +  ++ +     L  LL+ +   ++ IC   L  ++  L Y+H
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 141
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPE-LIA 290
           S  VLHRDLKP N+LLN      + DFG AR        T  LT    T  Y APE ++ 
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF 317
            + Y  + D+WS+GCI  E+    P F
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 64
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 126/262 (48%), Gaps = 15/262 (5%)
Query: 122 QKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ-KHLAHPNI 180
           + I  +G G++G V K  H+   + +A+K I  +  S +E   L  + +I  + +  P  
Sbjct: 10  EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFT 68
Query: 181 IKFIASHETLNEFVLITEFAHMSLS----NLLEQRKKLSETICVQILSNLISALYYLHSN 236
           + F  +     +  +  E    SL      ++++ + + E I  +I  +++ AL +LHS 
Sbjct: 69  VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 237 -RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI----AE 291
             V+HRD+KP NVL+N  G   +CDFG +  +             P YMAPE I     +
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP-YMAPERINPELNQ 187
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKT--VSILHLIRLLKTQDVTFPS-QVSETYKDLV 348
           + Y   +D+WSLG    E+ +   P+ +       L ++++      P+ + S  + D  
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247
Query: 349 KGLLEKDASQRLSWPELLHHPL 370
              L+K++ +R ++PEL+ HP 
Sbjct: 248 SQCLKKNSKERPTYPELMQHPF 269

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 64
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 123/268 (45%), Gaps = 34/268 (12%)
Query: 121 YQKICLIGEGSFGKVFKAIH-LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +++I LIG G FG+VFKA H +D K  V  ++   + ++ +E+ +L +       L H N
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAK-------LDHVN 65
Query: 180 IIKFIASHETLNE-----------------FVLITEFAHMSLSNLLEQRK--KLSETICV 220
           I+ +    +  +                  F+ +      +L   +E+R+  KL + + +
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
           ++   +   + Y+HS ++++RDLKP N+ L       + DFG   S+        S KGT
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS-KGT 184
Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYE-IHMGHPPFKTVSILHLIRLLKTQDVTFPSQ 339
             YM+PE I+ + Y    DL++LG I  E +H+    F+T      +R     D      
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR-----DGIISDI 239
Query: 340 VSETYKDLVKGLLEKDASQRLSWPELLH 367
             +  K L++ LL K    R +  E+L 
Sbjct: 240 FDKKEKTLLQKLLSKKPEDRPNTSEILR 267

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSXECQHLIR 283
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 284 WCLALRPSDRPTFEEIQNHPWMQDVL 309

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 133/295 (45%), Gaps = 48/295 (16%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRKK------------------LSETICVQ 221
             + A  +     ++ITEF    +LS  L  ++                   L   IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
               +   + +L S + +HRDL  +N+LL++  V  +CDFG AR +      +       
Sbjct: 146 F--QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKT 331
           PL +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 332 QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            D T P ++ +T  D   G    + SQR ++ EL+ H      L + +++   QD
Sbjct: 264 PDYTTP-EMYQTMLDCWHG----EPSQRPTFSELVEH------LGNLLQANAQQD 307

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 87/341 (25%), Positives = 153/341 (44%), Gaps = 34/341 (9%)
Query: 78  ETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKS-NGALEKYQKICLIGEGSFGKVF 136
           + LN  VL  +F  +  +K  + + + + + VK  +      E Y  + +IG G+FG+V 
Sbjct: 33  DGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQ 92
Query: 137 KAIHLDLKKTVALKIISKSGRSGKELSSL-KQECEIQKHLAHPNIIKFIASHETLNEFVL 195
              H   +K  A+K++SK     +  S+   +E +I      P +++   + +      +
Sbjct: 93  LVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 152
Query: 196 ITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG 254
           + E+     L NL+     + E       + ++ AL  +HS  ++HRD+KP N+LL+K G
Sbjct: 153 VMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG 211
Query: 255 VAMLCDFGFARSM-AVGTHMLTSIKGTPLYMAPELI----AERPYDHTADLWSLGCIAYE 309
              L DFG    M   G     +  GTP Y++PE++     +  Y    D WS+G   +E
Sbjct: 212 HLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFE 271
Query: 310 IHMGHPPFKTVSILHLIRLLKT--QDVTFP--SQVSETYKDLVKGLLEKDASQRLSW--- 362
           + +G  PF   S++     +      + FP  +++S+  K+L+   L  D   RL     
Sbjct: 272 MLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFL-TDREVRLGRNGV 330
Query: 363 PELLHHPLVKDN-----------------LSSEIESQNNQD 386
            E+  HP  K++                 LSS+I+S N  D
Sbjct: 331 EEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDD 371

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   ++  Q V F  +VS   + L++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIGGQ-VFFRQRVSSECQHLIR 236
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 12/204 (5%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP- 178
           +Y+ + +IG+G FG+V KA    + + VALK++    R  ++ +   +E  I +HL    
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA---EEIRILEHLRKQD 154
Query: 179 -----NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALY 231
                N+I  + +    N   +  E   M+L  L+++ K    S  +  +   +++  L 
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
            LH NR++H DLKP+N+LL + G + +    F  S      +   I+ +  Y APE+I  
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQ-SRFYRAPEVILG 273
Query: 292 RPYDHTADLWSLGCIAYEIHMGHP 315
             Y    D+WSLGCI  E+  G+P
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYP 297

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 133/295 (45%), Gaps = 48/295 (16%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRKK------------------LSETICVQ 221
             + A  +     ++ITEF    +LS  L  ++                   L   IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
               +   + +L S + +HRDL  +N+LL++  V  +CDFG AR +      +       
Sbjct: 146 F--QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKT 331
           PL +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 332 QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            D T P ++ +T  D   G    + SQR ++ EL+ H      L + +++   QD
Sbjct: 264 PDYTTP-EMYQTMLDCWHG----EPSQRPTFSELVEH------LGNLLQANAQQD 307

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   ++  Q V F  +VS   + L++
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIGGQ-VFFRQRVSSECQHLIR 268
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 269 WCLALRPSDRPTFEEIQNHPWMQDVL 294

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   ++  Q V F  +VS   + L++
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIGGQ-VFFRQRVSSECQHLIR 269
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 270 WCLALRPSDRPTFEEIQNHPWMQDVL 295

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 133/295 (45%), Gaps = 48/295 (16%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRKK------------------LSETICVQ 221
             + A  +     ++ITEF    +LS  L  ++                   L   IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
               +   + +L S + +HRDL  +N+LL++  V  +CDFG AR +      +       
Sbjct: 146 F--QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKT 331
           PL +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 332 QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            D T P ++ +T  D   G    + SQR ++ EL+ H      L + +++   QD
Sbjct: 264 PDYTTP-EMYQTMLDCWHG----EPSQRPTFSELVEH------LGNLLQANAQQD 307

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           E+S   ++++Q   + G+G+FG V          +VA+K + +  R       + Q+  +
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAV 75
Query: 172 QKHLAHPNIIKFIASHETLNE-------FVLITEFAHMSLSNLLE---QRKKLSETICVQ 221
              L HPNI++  +   TL E         ++ E+   +L        +R+     I ++
Sbjct: 76  ---LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 222 I-LSNLISALYYLH--SNRVLHRDLKPQNVLLNK-DGVAMLCDFGFARSMAVGTHMLTSI 277
           + L  LI ++  LH  S  V HRD+KP NVL+N+ DG   LCDFG A+ ++     +  I
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 278 KGTPLYMAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFK 318
             +  Y APELI   + Y    D+WS+GCI  E+ +G P F+
Sbjct: 193 -CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   ++  Q V F  +VS   + L++
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIGGQ-VFFRQRVSSECQHLIR 268
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 269 WCLALRPSDRPTFEEIQNHPWMQDVL 294

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   ++  Q V F  +VS   + L++
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIGGQ-VFFRQRVSXECQHLIR 269
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 270 WCLALRPSDRPTFEEIQNHPWMQDVL 295

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 47/281 (16%)
Query: 121 YQKICLIGEGSFGKVFKAIH-LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +++I LIG G FG+VFKA H +D K  V  ++   + ++ +E+ +L +       L H N
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAK-------LDHVN 66
Query: 180 II-------KFIASHETLNE-----------------------FVLITEFAHMSLSNLLE 209
           I+        F    ET ++                       F+ +      +L   +E
Sbjct: 67  IVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 126
Query: 210 QRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM 267
           +R+  KL + + +++   +   + Y+HS +++HRDLKP N+ L       + DFG   S+
Sbjct: 127 KRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 268 AVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYE-IHMGHPPFKTVSILHLI 326
                  T  KGT  YM+PE I+ + Y    DL++LG I  E +H+    F+T      +
Sbjct: 187 K-NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 245
Query: 327 RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH 367
           R     D        +  K L++ LL K    R +  E+L 
Sbjct: 246 R-----DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 281

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   ++  Q V F  +VS   + L++
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIGGQ-VFFRQRVSSECQHLIR 269
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 270 WCLALRPSDRPTFEEIQNHPWMQDVL 295

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   ++  Q V F  +VS   + L++
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIGGQ-VFFRQRVSXECQHLIR 269
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 270 WCLALRPSDRPTFEEIQNHPWMQDVL 295

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 86/181 (47%), Gaps = 17/181 (9%)
Query: 201 HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCD 260
           HM  +   E R        V   + +   L  LH  R+++RDLKP+N+LL+  G   + D
Sbjct: 277 HMGQAGFPEARA-------VFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISD 329
Query: 261 FGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF--- 317
            G A  +  G  +   + GT  YMAPE++    Y  + D W+LGC+ YE+  G  PF   
Sbjct: 330 LGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388
Query: 318 -KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL-----SWPELLHHPLV 371
            K +    + RL+K     +  + S   + L   LL KD ++RL     S  E+  HPL 
Sbjct: 389 KKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 372 K 372
           K
Sbjct: 449 K 449

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   ++  Q V F  +VS   + L++
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIGGQ-VFFRQRVSXECQHLIR 268
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L    S R ++ E+ +HP ++D L
Sbjct: 269 WCLALRPSDRPTFEEIQNHPWMQDVL 294

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 126/266 (47%), Gaps = 18/266 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEI----QK 173
           +YQ   L+G G FG V+  I +     VA+K + K   S  G+  +  +   E+    + 
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +  +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSXECQHLIR 256
Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
             L      R ++ E+ +HP ++D L
Sbjct: 257 WCLALRPXDRPTFEEIQNHPWMQDVL 282

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 86/181 (47%), Gaps = 17/181 (9%)
Query: 201 HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCD 260
           HM  +   E R        V   + +   L  LH  R+++RDLKP+N+LL+  G   + D
Sbjct: 277 HMGQAGFPEAR-------AVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISD 329
Query: 261 FGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF--- 317
            G A  +  G  +   + GT  YMAPE++    Y  + D W+LGC+ YE+  G  PF   
Sbjct: 330 LGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388
Query: 318 -KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL-----SWPELLHHPLV 371
            K +    + RL+K     +  + S   + L   LL KD ++RL     S  E+  HPL 
Sbjct: 389 KKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 372 K 372
           K
Sbjct: 449 K 449

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 125/273 (45%), Gaps = 38/273 (13%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRKK--------------LSETICVQILSN 225
             + A  +     ++I EF    +LS  L  ++               L   IC      
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF--Q 152
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT-PL-Y 283
           +   + +L S + +HRDL  +N+LL++  V  +CDFG AR +      +       PL +
Sbjct: 153 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 284 MAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKTQDVT 335
           MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++  D T
Sbjct: 213 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 272
Query: 336 FPSQVSETYKDLVKGLLEKDASQRLSWPELLHH 368
            P ++ +T  D   G    + SQR ++ EL+ H
Sbjct: 273 TP-EMYQTMLDCWHG----EPSQRPTFSELVEH 300

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 35/215 (16%)
Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + ++KI  +G G+ G VFK              IHL++K  +  +II       +EL  L
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------RELQVL 85
Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++  ++ E I  ++
Sbjct: 86  -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPEQILGKV 136
Query: 223 LSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              +I  L YL   ++++HRD+KP N+L+N  G   LCDFG +  +     M  S  GT 
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR 194
Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPP 316
            YM+PE +    Y   +D+WS+G    E+ +G  P
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 134/292 (45%), Gaps = 43/292 (14%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRK------KLSETICVQILS--------- 224
             + A  +     ++I EF    +LS  L  ++      K  E +    L+         
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 225 NLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT-PL- 282
            +   + +L S + +HRDL  +N+LL++  V  +CDFG AR +      +       PL 
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 283 YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKTQDV 334
           +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++  D 
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 275
Query: 335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
           T P ++ +T  D   G    + SQR ++ EL+ H      L + +++   QD
Sbjct: 276 TTP-EMYQTMLDCWHG----EPSQRPTFSELVEH------LGNLLQANAQQD 316

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I   L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINAMLNH 64
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 11/222 (4%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++Y+ I  IG G++G V  A      + VA+K I  +           +E +I KH  H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 179 NII------KFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           NII      +    +       ++ +     L  ++   + L+       L  L+  L Y
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 173
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR----SMAVGTHMLTSIKGTPLYMAPEL 288
           +HS +V+HRDLKP N+L+N++    + DFG AR    S A   + +T    T  Y APEL
Sbjct: 174 MHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 289 -IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
            ++   Y    DLWS+GCI  E+      F   + +H ++L+
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI 275

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 35/215 (16%)
Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + ++KI  +G G+ G VFK              IHL++K  +  +II       +EL  L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------RELQVL 58
Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++  ++ E I  ++
Sbjct: 59  -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 223 LSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              +I  L YL   ++++HRD+KP N+L+N  G   LCDFG +  +     M  S  GT 
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR 167
Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPP 316
            YM+PE +    Y   +D+WS+G    E+ +G  P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 35/215 (16%)
Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + ++KI  +G G+ G VFK              IHL++K  +  +II       +EL  L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------RELQVL 58
Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++  ++ E I  ++
Sbjct: 59  -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 223 LSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              +I  L YL   ++++HRD+KP N+L+N  G   LCDFG +  +     M  S  GT 
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR 167
Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPP 316
            YM+PE +    Y   +D+WS+G    E+ +G  P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 5/208 (2%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG+ G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 63
Query: 178 PNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+ +   L + +E    + E    +    L++ + YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 295 -DHTADLWSLGCIAYEIHMGHPPFKTVS 321
                D+WS G +   +  G  P+   S
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 132/295 (44%), Gaps = 48/295 (16%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRKK------------------LSETICVQ 221
             + A  +     ++I EF    +LS  L  ++                   L   IC  
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
               +   + +L S + +HRDL  +N+LL++  V  +CDFG AR +      +       
Sbjct: 146 F--QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKT 331
           PL +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 332 QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            D T P ++ +T  D   G    + SQR ++ EL+ H      L + +++   QD
Sbjct: 264 PDYTTP-EMYQTMLDCWHG----EPSQRPTFSELVEH------LGNLLQANAQQD 307

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 35/215 (16%)
Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + ++KI  +G G+ G VFK              IHL++K  +  +II       +EL  L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------RELQVL 58
Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++  ++ E I  ++
Sbjct: 59  -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 223 LSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              +I  L YL   ++++HRD+KP N+L+N  G   LCDFG +  +     M  S  GT 
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR 167
Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPP 316
            YM+PE +    Y   +D+WS+G    E+ +G  P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 35/215 (16%)
Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + ++KI  +G G+ G VFK              IHL++K  +  +II       +EL  L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------RELQVL 58
Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++  ++ E I  ++
Sbjct: 59  -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 223 LSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              +I  L YL   ++++HRD+KP N+L+N  G   LCDFG +  +     M  S  GT 
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR 167
Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPP 316
            YM+PE +    Y   +D+WS+G    E+ +G  P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 132/295 (44%), Gaps = 48/295 (16%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRKK------------------LSETICVQ 221
             + A  +     ++I EF    +LS  L  ++                   L   IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
               +   + +L S + +HRDL  +N+LL++  V  +CDFG AR +      +       
Sbjct: 155 F--QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKT 331
           PL +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 332 QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            D T P ++ +T  D   G    + SQR ++ EL+ H      L + +++   QD
Sbjct: 273 PDYTTP-EMYQTMLDCWHG----EPSQRPTFSELVEH------LGNLLQANAQQD 316

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 11/222 (4%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++Y+ I  IG G++G V  A      + VA+K I  +           +E +I KH  H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 179 NII------KFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           NII      +    +       ++ +     L  ++   + L+       L  L+  L Y
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 174
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR----SMAVGTHMLTSIKGTPLYMAPEL 288
           +HS +V+HRDLKP N+L+N++    + DFG AR    S A   + +T    T  Y APEL
Sbjct: 175 MHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 234
Query: 289 -IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
            ++   Y    DLWS+GCI  E+      F   + +H ++L+
Sbjct: 235 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI 276

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 35/216 (16%)
Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + ++KI  +G G+ G VFK              IHL++K  +  +II       +EL  L
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------RELQVL 120
Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++  ++ E I  ++
Sbjct: 121 -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPEQILGKV 171
Query: 223 LSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              +I  L YL   ++++HRD+KP N+L+N  G   LCDFG +  +     M  S  GT 
Sbjct: 172 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR 229
Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
            YM+PE +    Y   +D+WS+G    E+ +G  P 
Sbjct: 230 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 38/270 (14%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG+FGKVF A   +L  T     VA+K +     + ++    ++E E+  +L H +I+
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQREAELLTNLQHEHIV 80
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLL----------------EQRKKLSETICVQILS 224
           KF       +  +++ E+  H  L+  L                + + +L  +  + I S
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 225 NLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTSIK 278
            + S + YL S   +HRDL  +N L+  + +  + DFG +R +       VG H +  I+
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLKTQDVTFP 337
               +M PE I  R +   +D+WS G I +EI   G  P+  +S   +I  +    V   
Sbjct: 201 ----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 256
Query: 338 SQV--SETYKDLVKGLLEKDASQRLSWPEL 365
            +V   E Y D++ G  +++  QRL+  E+
Sbjct: 257 PRVCPKEVY-DVMLGCWQREPQQRLNIKEI 285

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 31/274 (11%)
Query: 64  HLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQK 123
           HL  P +  F+  H   +    + EFA                   +++ +N +++K   
Sbjct: 13  HLKLPGLRTFVDPHTFEDPTQTVHEFAK------------------ELDATNISIDK--- 51
Query: 124 ICLIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNII 181
             ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII
Sbjct: 52  --VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVL 239
           +           +++TE+  + SL + L +       I  V +L  + S + YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL  +N+L+N + V  + DFG AR +        + +G  +   + +PE IA R +  
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 297 TADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
            +D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 131/303 (43%), Gaps = 60/303 (19%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  +G G  G VF A+  D  K VA+K I  +    + +    +E +I + L H N
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDN 69
Query: 180 IIKF--------------IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN 225
           I+K               + S   LN   ++ E+    L+N+LEQ   L E   +  +  
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQ 128
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLN-KDGVAMLCDFGFARSMAVGTHMLTSIKG----- 279
           L+  L Y+HS  VLHRDLKP N+ +N +D V  + DFG AR M    H   S KG     
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM--DPHY--SHKGHLSEG 184
Query: 280 --TPLYMAPE-LIAERPYDHTADLWSLGCIAYEIHMGHPPF-------------KTVSIL 323
             T  Y +P  L++   Y    D+W+ GCI  E+  G   F             +++ ++
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 324 H---------LIRLLKTQDVTFPSQ--------VSETYKDLVKGLLEKDASQRLSWPELL 366
           H         +I +    D+T P +        +S    D ++ +L      RL+  E L
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 367 HHP 369
            HP
Sbjct: 305 SHP 307

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 121/248 (48%), Gaps = 14/248 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAH 177
           E ++ + +IG G+FG+V      +  K  A+KI++K     + E +  ++E ++  +   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 178 PNIIKF-IASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHS 235
             I     A  +  N ++++  +    L  LL +   +L E +    L+ ++ A+  +H 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFA-RSMAVGTHMLTSIKGTPLYMAPELI----- 289
              +HRD+KP N+L++ +G   L DFG   + M  GT   +   GTP Y++PE++     
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT--QDVTFPSQ---VSETY 344
            +  Y    D WSLG   YE+  G  PF   S++     +    +   FP+Q   VSE  
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
Query: 345 KDLVKGLL 352
           KDL++ L+
Sbjct: 314 KDLIRRLI 321

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 132/295 (44%), Gaps = 48/295 (16%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRKK------------------LSETICVQ 221
             + A  +     ++I EF    +LS  L  ++                   L   IC  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
               +   + +L S + +HRDL  +N+LL++  V  +CDFG AR +      +       
Sbjct: 157 F--QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKT 331
           PL +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++ 
Sbjct: 215 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 274
Query: 332 QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            D T P ++ +T  D   G    + SQR ++ EL+ H      L + +++   QD
Sbjct: 275 PDYTTP-EMYQTMLDCWHG----EPSQRPTFSELVEH------LGNLLQANAQQD 318

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 132/295 (44%), Gaps = 48/295 (16%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRKK------------------LSETICVQ 221
             + A  +     ++I EF    +LS  L  ++                   L   IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
               +   + +L S + +HRDL  +N+LL++  V  +CDFG AR +      +       
Sbjct: 155 F--QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKT 331
           PL +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 332 QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            D T P ++ +T  D   G    + SQR ++ EL+ H      L + +++   QD
Sbjct: 273 PDYTTP-EMYQTMLDCWHG----EPSQRPTFSELVEH------LGNLLQANAQQD 316

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 132/295 (44%), Gaps = 48/295 (16%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRKK------------------LSETICVQ 221
             + A  +     ++I EF    +LS  L  ++                   L   IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
               +   + +L S + +HRDL  +N+LL++  V  +CDFG AR +      +       
Sbjct: 155 F--QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKT 331
           PL +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 332 QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            D T P ++ +T  D   G    + SQR ++ EL+ H      L + +++   QD
Sbjct: 273 PDYTTP-EMYQTMLDCWHG----EPSQRPTFSELVEH------LGNLLQANAQQD 316

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 132/295 (44%), Gaps = 48/295 (16%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRKK------------------LSETICVQ 221
             + A  +     ++I EF    +LS  L  ++                   L   IC  
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT- 280
               +   + +L S + +HRDL  +N+LL++  V  +CDFG AR +      +       
Sbjct: 192 F--QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKT 331
           PL +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++ 
Sbjct: 250 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 309
Query: 332 QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            D T P ++ +T  D   G    + SQR ++ EL+ H      L + +++   QD
Sbjct: 310 PDYTTP-EMYQTMLDCWHG----EPSQRPTFSELVEH------LGNLLQANAQQD 353

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 85/342 (24%), Positives = 149/342 (43%), Gaps = 83/342 (24%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY     +G GSFG V +   ++  K  ALK + +  R         +E +I K L H 
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN------RELDIMKVLDHV 60
Query: 179 NIIKFIASHETL-------------------------------------NEFV-LITEFA 200
           NIIK +    T                                      N+++ +I E+ 
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 201 HMSLSNLLEQRKKLSETICVQILS----NLISALYYLHSNRVLHRDLKPQNVLLN-KDGV 255
             +L  +L+   +   +I + ++S     L  A+ ++HS  + HRD+KPQN+L+N KD  
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 256 AMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL-IAERPYDHTADLWSLGCIAYEIHMGH 314
             LCDFG A+ +      +  I     Y APEL +    Y  + DLWS+GC+  E+ +G 
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAXICSR-FYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 315 PPFKT-VSILHLIRLLKTQ----------------DVTFPSQVSETYK------------ 345
           P F    SI  L+R+++                  +V FP+  ++ ++            
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 346 DLVKGLLEKDASQRLSWPELLHHPL---VKDNLSSEIESQNN 384
           DL++ +L  +   R++  E + HP    ++++  SE+++ +N
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSN 341

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQ---------ILSNLI--- 227
             + A  +     ++I EF    +LS  L  R K +E +  +          L +LI   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 228 ----SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT-PL 282
                 + +L S + +HRDL  +N+LL++  V  +CDFG AR +      +       PL
Sbjct: 155 FQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 283 -YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKTQD 333
            +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++  D
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 274
Query: 334 VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            T P ++ +T  D   G    + SQR ++ EL+ H      L + +++   QD
Sbjct: 275 YTTP-EMYQTMLDCWHG----EPSQRPTFSELVEH------LGNLLQANAQQD 316

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 123/274 (44%), Gaps = 31/274 (11%)
Query: 64  HLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQK 123
           HL  P +  F+  H   +    + EFA                   +++ +N +++K   
Sbjct: 13  HLKLPGLRTFVDPHTYEDPTQTVHEFAK------------------ELDATNISIDK--- 51
Query: 124 ICLIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNII 181
             ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII
Sbjct: 52  --VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVL 239
           +           +++TE+  + SL + L +       I  V +L  + S + YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL  +N+L+N + V  + DFG +R +        + +G  +   + +PE IA R +  
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 297 TADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
            +D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 123/274 (44%), Gaps = 31/274 (11%)
Query: 64  HLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQK 123
           HL  P +  F+  H   +    + EFA                   +++ +N +++K   
Sbjct: 13  HLKLPGLRTFVDPHTFEDPTQTVHEFAK------------------ELDATNISIDK--- 51
Query: 124 ICLIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNII 181
             ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII
Sbjct: 52  --VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVL 239
           +           +++TE+  + SL + L +       I  V +L  + S + YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFV 169
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL  +N+L+N + V  + DFG +R +        + +G  +   + +PE IA R +  
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 297 TADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
            +D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 123/274 (44%), Gaps = 31/274 (11%)
Query: 64  HLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQK 123
           HL  P +  F+  H   +    + EFA                   +++ +N +++K   
Sbjct: 13  HLKLPGLRTFVDPHTFEDPTQTVHEFAK------------------ELDATNISIDK--- 51
Query: 124 ICLIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNII 181
             ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII
Sbjct: 52  --VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVL 239
           +           +++TE+  + SL + L +       I  V +L  + S + YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL  +N+L+N + V  + DFG +R +        + +G  +   + +PE IA R +  
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 297 TADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
            +D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 122/274 (44%), Gaps = 31/274 (11%)
Query: 64  HLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQK 123
           HL  P +  F+  H   +    + EFA                   +++ +N +++K   
Sbjct: 13  HLKLPGLRTFVDPHTFEDPTQTVHEFAK------------------ELDATNISIDK--- 51
Query: 124 ICLIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNII 181
             ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII
Sbjct: 52  --VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVL 239
           +           +++TE+  + SL + L +       I  V +L  + S + YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL  +N+L+N + V  + DFG  R +        + +G  +   + +PE IA R +  
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 297 TADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
            +D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 111/240 (46%), Gaps = 17/240 (7%)
Query: 108 PVKMEKSNGALEKYQK----ICL-----IGEGSFGKVFKA-IHLDLKKTVALKIIS-KSG 156
           P   E  N A+ ++ K     C+     IG G FG+V    + +  K+ + + I + K+G
Sbjct: 9   PFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG 68
Query: 157 RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRK-KL 214
            + K+      E  I     HPNII            ++ITE+  + SL   L +   + 
Sbjct: 69  YTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF 128
Query: 215 SETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML 274
           +    V +L  + S + YL     +HRDL  +N+L+N + V  + DFG +R +       
Sbjct: 129 TVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAA 188
Query: 275 TSIKGTPL---YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLK 330
            + +G  +   + APE IA R +   +D+WS G + +E+   G  P+  +S   +I+ ++
Sbjct: 189 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 248

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 113/251 (45%), Gaps = 24/251 (9%)
Query: 108 PVKMEKSNGALEKYQK----ICL-----IGEGSFGKVFKAIHLDLKKT----VALKIISK 154
           P   E  N A+ ++ K     C+     IG G FG+V    HL L       VA+K + K
Sbjct: 13  PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSG-HLKLPGKREIFVAIKTL-K 70
Query: 155 SGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKK 213
           SG + K+      E  I     HPN+I            ++ITEF  + SL + L Q   
Sbjct: 71  SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 130
Query: 214 LSETI-CVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH 272
               I  V +L  + + + YL     +HRDL  +N+L+N + V  + DFG +R +   T 
Sbjct: 131 QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 190
Query: 273 --MLTSIKGTPL---YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLI 326
               TS  G  +   + APE I  R +   +D+WS G + +E+   G  P+  ++   +I
Sbjct: 191 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 250
Query: 327 RLLKTQDVTFP 337
             ++ QD   P
Sbjct: 251 NAIE-QDYRLP 260

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 37/257 (14%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLK--QECEIQKHL 175
           L  ++ I  +G G FG VF+A +       A+K I    R   EL+  K  +E +    L
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR---ELAREKVMREVKALAKL 60
Query: 176 AHPNIIKFI-------------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSE---TIC 219
            HP I+++               S   +  ++ +      +L + +  R  + E   ++C
Sbjct: 61  EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 220 VQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-------AVGTH 272
           + I   +  A+ +LHS  ++HRDLKP N+    D V  + DFG   +M        V T 
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 273 ML-----TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIR 327
           M      T   GT LYM+PE I    Y H  D++SLG I +E+     PF T  +  +  
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-QMERVRT 236
Query: 328 LLKTQDVTFPSQVSETY 344
           L   +++ FP   ++ Y
Sbjct: 237 LTDVRNLKFPPLFTQKY 253

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 127/275 (46%), Gaps = 49/275 (17%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           ++G G+ G +      D +     +I+ +    + +E+  L++  E      HPN+I++ 
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE------HPNVIRYF 84
Query: 185 ASHE--------------TLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISAL 230
            + +              TL E+V   +FAH+ L               + +L    S L
Sbjct: 85  CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-------------ITLLQQTTSGL 131
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGV-----AMLCDFGFARSMAVGTHML---TSIKGTPL 282
            +LHS  ++HRDLKP N+L++         AM+ DFG  + +AVG H     + + GT  
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 283 YMAPELIAERPYD---HTADLWSLGCIAYEI--HMGHPPFKTVSILHLIRLLK-TQDVTF 336
           ++APE+++E   +   +T D++S GC+ Y +     HP  K++     I L   + D   
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251
Query: 337 PSQVSETY-KDLVKGLLEKDASQRLSWPELLHHPL 370
           P +  +   ++L++ ++  D  +R S   +L HP 
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 120/251 (47%), Gaps = 20/251 (7%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAH 177
           E ++ I +IG G+FG+V      + ++  A+KI++K     + E +  ++E ++   L +
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV---LVN 146
Query: 178 PNIIKFIASHETLNE----FVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYY 232
            +     A H    +    ++++  +    L  LL +   KL E +    +  ++ A+  
Sbjct: 147 GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 206
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK-GTPLYMAPELIAE 291
           +H    +HRD+KP NVLL+ +G   L DFG    M     + +S+  GTP Y++PE++  
Sbjct: 207 IHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 266
Query: 292 RP-----YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFPS---QVS 341
                  Y    D WSLG   YE+  G  PF   S++     +   +    FPS    VS
Sbjct: 267 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVS 326
Query: 342 ETYKDLVKGLL 352
           E  KDL++ L+
Sbjct: 327 EEAKDLIQRLI 337

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 22/262 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG GSF  V+K +  +    VA   +     +  E    K+E E  K L HPNI++F  S
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 187 HETLNE----FVLITEF-AHMSLSNLLEQRK----KLSETICVQILSNLISALYYLHSNR 237
            E+  +     VL+TE     +L   L++ K    K+  + C QIL      L +LH+  
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQIL----KGLQFLHTRT 149
Query: 238 --VLHRDLKPQNVLL-NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
             ++HRDLK  N+ +    G   + D G A           ++ GTP + APE   E+ Y
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFXAPEXYEEK-Y 206
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---TFPSQVSETYKDLVKGL 351
           D + D+++ G    E      P+        I    T  V   +F        K++++G 
Sbjct: 207 DESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 266
Query: 352 LEKDASQRLSWPELLHHPLVKD 373
           + ++  +R S  +LL+H   ++
Sbjct: 267 IRQNKDERYSIKDLLNHAFFQE 288

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G+G FG+  K  H +  + + +K + +     +   +  +E ++ + L HPN++KFI 
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR--TFLKEVKVMRCLEHPNVLKFIG 74
Query: 186 SHETLNEFVLITEFAHM-SLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDL 243
                     ITE+    +L  +++    +   +  V    ++ S + YLHS  ++HRDL
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMA---VGTHMLTSIK-----------GTPLYMAPELI 289
              N L+ ++   ++ DFG AR M         L S+K           G P +MAPE+I
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 290 AERPYDHTADLWSLGCIAYEI 310
             R YD   D++S G +  EI
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEI 215

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 120/251 (47%), Gaps = 20/251 (7%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLAH 177
           E ++ I +IG G+FG+V      + ++  A+KI++K     + E +  ++E ++   L +
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV---LVN 130
Query: 178 PNIIKFIASHETLNE----FVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYY 232
            +     A H    +    ++++  +    L  LL +   KL E +    +  ++ A+  
Sbjct: 131 GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 190
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK-GTPLYMAPELIAE 291
           +H    +HRD+KP NVLL+ +G   L DFG    M     + +S+  GTP Y++PE++  
Sbjct: 191 IHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 250
Query: 292 RP-----YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFPS---QVS 341
                  Y    D WSLG   YE+  G  PF   S++     +   +    FPS    VS
Sbjct: 251 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVS 310
Query: 342 ETYKDLVKGLL 352
           E  KDL++ L+
Sbjct: 311 EEAKDLIQRLI 321

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 124/276 (44%), Gaps = 22/276 (7%)
Query: 115 NGALEKYQ-------KICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ 167
            GA E ++        I  +G G++G V K  H+   +  A+K I  +  S +E   L  
Sbjct: 23  QGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNS-QEQKRLLX 81
Query: 168 ECEIQKHLAH-PNIIKFIASHETLNEFVLITEFAHMSLS----NLLEQRKKLSETICVQI 222
           + +I       P  + F  +     +  +  E    SL      ++++ + + E I  +I
Sbjct: 82  DLDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKI 141
Query: 223 LSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
             +++ AL +LHS   V+HRD+KP NVL+N  G    CDFG +  +             P
Sbjct: 142 AVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKP 201
Query: 282 LYMAPELI----AERPYDHTADLWSLGCIAYEIHMGHPPFKT--VSILHLIRLLKTQDVT 335
            Y APE I     ++ Y   +D+WSLG    E+ +   P+ +       L ++++     
Sbjct: 202 -YXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 260
Query: 336 FPS-QVSETYKDLVKGLLEKDASQRLSWPELLHHPL 370
            P+ + S  + D     L+K++ +R ++PEL  HP 
Sbjct: 261 LPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPF 296

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 35/216 (16%)
Query: 119 EKYQKICLIGEGSFGKVFKA-------------IHLDLKKTVALKIISKSGRSGKELSSL 165
           + +++I  +G G+ G V K              IHL++K  +  +II       +EL  L
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQII-------RELQVL 68
Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQI 222
             EC        P I+ F  +  +  E  +  E  HM   SL  +L++ K++ E I  ++
Sbjct: 69  -HECN------SPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKEAKRIPEEILGKV 119
Query: 223 LSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
              ++  L YL   ++++HRD+KP N+L+N  G   LCDFG +  +     M  S  GT 
Sbjct: 120 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR 177
Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
            YMAPE +    Y   +D+WS+G    E+ +G  P 
Sbjct: 178 SYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 132/277 (47%), Gaps = 30/277 (10%)
Query: 122 QKICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +KI  +GEG FGKV    +   +    + VA+K + K+    +  S  KQE +I + L H
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYH 92
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQIL--SNLISALYYLHS 235
            +IIK+    E      L     ++ L +L +   + S  +   +L    +   + YLH+
Sbjct: 93  EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKGTPLYM-APELIAER 292
              +HRDL  +NVLL+ D +  + DFG A+++  G   + +     +P++  APE + E 
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 293 PYDHTADLWSLGCIAYEIHMGH------PPFK----------TVSILHLIRLL-KTQDVT 335
            + + +D+WS G   YE+ + H      PP K           +++L L  LL + + + 
Sbjct: 213 KFYYASDVWSFGVTLYEL-LTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP 271
Query: 336 FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
            P +       L+K   E +AS R ++  L+  P++K
Sbjct: 272 RPDKCPAEVYHLMKNCWETEASFRPTFENLI--PILK 306

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 31/274 (11%)
Query: 64  HLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQK 123
           HL  P +  ++  H   +    + EFA                   +++ +N +++K   
Sbjct: 11  HLKLPGLRTYVDPHTYEDPTQTVHEFAK------------------ELDATNISIDK--- 49
Query: 124 ICLIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNII 181
             ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII
Sbjct: 50  --VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVL 239
           +           +++TE+  + SL + L +       I  V +L  + S + YL     +
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 167
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL  +N+L+N + V  + DFG +R +        + +G  +   + +PE IA R +  
Sbjct: 168 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 227
Query: 297 TADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
            +D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 228 ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 261

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 122/274 (44%), Gaps = 31/274 (11%)
Query: 64  HLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQK 123
           HL  P +  F+  H   +    + EFA                   +++ +N +++K   
Sbjct: 13  HLKLPGLRTFVDPHTFEDPTQTVHEFAK------------------ELDATNISIDK--- 51
Query: 124 ICLIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNII 181
             ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII
Sbjct: 52  --VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 182 KFIASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVL 239
           +           +++TE   + SL + L +       I  V +L  + S + YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAV 169
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL  +N+L+N + V  + DFG +R +        + +G  +   + +PE IA R +  
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 297 TADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
            +D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 31/274 (11%)
Query: 64  HLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQK 123
           HL  P +  ++  H   +    + EFA                   +++ +N +++K   
Sbjct: 13  HLKLPGLRTYVDPHTYEDPTQTVHEFAK------------------ELDATNISIDK--- 51
Query: 124 ICLIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNII 181
             ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII
Sbjct: 52  --VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVL 239
           +           +++TE+  + SL + L +       I  V +L  + S + YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL  +N+L+N + V  + DFG +R +        + +G  +   + +PE IA R +  
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 297 TADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
            +D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G+G+   VF+  H       A+K+ +      + +    +E E+ K L H NI+K  A
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 186 SHE--TLNEFVLITEFAH-MSLSNLLEQRKK---LSETICVQILSNLISALYYLHSNRVL 239
             E  T    VLI EF    SL  +LE+      L E+  + +L +++  + +L  N ++
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 240 HRDLKPQNVL--LNKDG--VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA----- 290
           HR++KP N++  + +DG  V  L DFG AR +        S+ GT  Y+ P++       
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPDMYERAVLR 193
Query: 291 ---ERPYDHTADLWSLGCIAYEIHMGHPPFK 318
              ++ Y  T DLWS+G   Y    G  PF+
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 31/274 (11%)
Query: 64  HLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQK 123
           HL  P +  ++  H   +    + EFA                   +++ +N +++K   
Sbjct: 13  HLKLPGLRTYVDPHTFEDPTQTVHEFAK------------------ELDATNISIDK--- 51
Query: 124 ICLIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNII 181
             ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII
Sbjct: 52  --VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVL 239
           +           +++TE+  + SL + L +       I  V +L  + S + YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL  +N+L+N + V  + DFG +R +        + +G  +   + +PE IA R +  
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 297 TADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
            +D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 126 LIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII+ 
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 184 IASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVLHR 241
                     +++TE+  + SL + L +       I  V +L  + S + YL     +HR
Sbjct: 83  EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 142
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTA 298
           DL  +N+L+N + V  + DFG +R +        + +G  +   + +PE IA R +   +
Sbjct: 143 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 202
Query: 299 DLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
           D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 203 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G GSFG+V +          A+K +       +EL +          L+ P I+    +
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAG-------LSSPRIVPLYGA 134
Query: 187 ---HETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
                 +N F+ + E    SL  L++Q   L E   +  L   +  L YLH+ R+LH D+
Sbjct: 135 VREGPWVNIFMELLEGG--SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 244 KPQNVLLNKDGV-AMLCDFGFARSM---AVGTHMLTS--IKGTPLYMAPELIAERPYDHT 297
           K  NVLL+ DG  A LCDFG A  +    +G  +LT   I GT  +MAPE++  +P D  
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 252
Query: 298 ADLWSLGCIAYEIHMGHPPF 317
            D+WS  C+   +  G  P+
Sbjct: 253 VDIWSSCCMMLHMLNGCHPW 272

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS----GRSGKELSSL----KQEC 169
           +++Y+   LIG+GSFG+V KA     ++ VA+KII        ++  E+  L    K + 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 170 EIQKHLAHPNIIKFIASHETL-NEFVLITEFAHMSLSNLLEQR--KKLSETICVQILSNL 226
           E++ ++ H      +  H    N   L+ E    +L +LL     + +S  +  +    +
Sbjct: 113 EMKYYIVH------LKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 227 ISALYYLHSNR--VLHRDLKPQNVLL--NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL 282
            +AL +L +    ++H DLKP+N+LL   K     + DFG   S  +G  +   I+ +  
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQ-SRF 223
Query: 283 YMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
           Y +PE++   PYD   D+WSLGCI  E+H G P F
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 109/238 (45%), Gaps = 34/238 (14%)
Query: 127 IGEGSFGKVFKAIHLDLK-----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG FGKV KA    LK      TVA+K++ K   S  EL  L  E  + K + HP++I
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQ-----------------IL 223
           K   +       +LI E+A + SL   L + +K+                         +
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 224 SNLIS-------ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS 276
            +LIS        + YL   +++HRDL  +N+L+ +     + DFG +R +      +  
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKR 209
Query: 277 IKG-TPL-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKT 331
            +G  P+ +MA E + +  Y   +D+WS G + +EI  +G  P+  +    L  LLKT
Sbjct: 210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G GSFG+V +          A+K +       +EL +          L+ P I+    +
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAG-------LSSPRIVPLYGA 118
Query: 187 ---HETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
                 +N F+ + E    SL  L++Q   L E   +  L   +  L YLH+ R+LH D+
Sbjct: 119 VREGPWVNIFMELLEGG--SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 244 KPQNVLLNKDGV-AMLCDFGFARSM---AVGTHMLTS--IKGTPLYMAPELIAERPYDHT 297
           K  NVLL+ DG  A LCDFG A  +    +G  +LT   I GT  +MAPE++  +P D  
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 298 ADLWSLGCIAYEIHMGHPPF 317
            D+WS  C+   +  G  P+
Sbjct: 237 VDIWSSCCMMLHMLNGCHPW 256

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 109/238 (45%), Gaps = 34/238 (14%)
Query: 127 IGEGSFGKVFKAIHLDLK-----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG FGKV KA    LK      TVA+K++ K   S  EL  L  E  + K + HP++I
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQ-----------------IL 223
           K   +       +LI E+A + SL   L + +K+                         +
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 224 SNLIS-------ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS 276
            +LIS        + YL   +++HRDL  +N+L+ +     + DFG +R +      +  
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR 209
Query: 277 IKG-TPL-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKT 331
            +G  P+ +MA E + +  Y   +D+WS G + +EI  +G  P+  +    L  LLKT
Sbjct: 210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS----GRSGKELSSL----KQEC 169
           +++Y+   LIG+GSFG+V KA     ++ VA+KII        ++  E+  L    K + 
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 93
Query: 170 EIQKHLAHPNIIKFIASHETL-NEFVLITEFAHMSLSNLLEQR--KKLSETICVQILSNL 226
           E++ ++ H      +  H    N   L+ E    +L +LL     + +S  +  +    +
Sbjct: 94  EMKYYIVH------LKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 147
Query: 227 ISALYYLHSNR--VLHRDLKPQNVLL--NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL 282
            +AL +L +    ++H DLKP+N+LL   K     + DFG   S  +G  +   I+ +  
Sbjct: 148 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQ-SRF 204
Query: 283 YMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
           Y +PE++   PYD   D+WSLGCI  E+H G P F
Sbjct: 205 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 239

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 126 LIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII+ 
Sbjct: 40  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 99
Query: 184 IASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVLHR 241
                     +++TE+  + SL + L +       I  V +L  + S + YL     +HR
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 159
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTA 298
           DL  +N+L+N + V  + DFG +R +        + +G  +   + +PE IA R +   +
Sbjct: 160 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 219
Query: 299 DLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
           D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 220 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 251

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS----GRSGKELSSL----KQEC 169
           +++Y+   LIG+GSFG+V KA     ++ VA+KII        ++  E+  L    K + 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 170 EIQKHLAHPNIIKFIASHETL-NEFVLITEFAHMSLSNLLEQR--KKLSETICVQILSNL 226
           E++ ++ H      +  H    N   L+ E    +L +LL     + +S  +  +    +
Sbjct: 113 EMKYYIVH------LKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 227 ISALYYLHSNR--VLHRDLKPQNVLL--NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL 282
            +AL +L +    ++H DLKP+N+LL   K     + DFG   S  +G  +   I+ +  
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFG--SSCQLGQRIYQXIQ-SRF 223
Query: 283 YMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
           Y +PE++   PYD   D+WSLGCI  E+H G P F
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 8/213 (3%)
Query: 126 LIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +IG G FG+V    + +  K+ + + I + K+G + K+      E  I     HPNII  
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 184 IASHETLNEFVLITEFA-HMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHR 241
                     ++ITE+  + SL   L +   + +    V +L  + S + YL     +HR
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHR 134
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTA 298
           DL  +N+L+N + V  + DFG +R +        + +G  +   + APE IA R +   +
Sbjct: 135 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 194
Query: 299 DLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLK 330
           D+WS G + +E+   G  P+  +S   +I+ ++
Sbjct: 195 DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 227

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 8/213 (3%)
Query: 126 LIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +IG G FG+V    + +  K+ + + I + K+G + K+      E  I     HPNII  
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 184 IASHETLNEFVLITEFA-HMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHR 241
                     ++ITE+  + SL   L +   + +    V +L  + S + YL     +HR
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHR 140
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTA 298
           DL  +N+L+N + V  + DFG +R +        + +G  +   + APE IA R +   +
Sbjct: 141 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 200
Query: 299 DLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLK 330
           D+WS G + +E+   G  P+  +S   +I+ ++
Sbjct: 201 DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 233

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 133/277 (48%), Gaps = 30/277 (10%)
Query: 122 QKICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +KI  +GEG FGKV    +   +    + VA+K + K+    +  S  KQE +I + L H
Sbjct: 17  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADCGPQHRSGWKQEIDILRTLYH 75
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQIL--SNLISALYYLHS 235
            +IIK+    E   E  L     ++ L +L +   + S  +   +L    +   + YLHS
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKGTPLYM-APELIAER 292
              +HR+L  +NVLL+ D +  + DFG A+++  G   + +     +P++  APE + E 
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 293 PYDHTADLWSLGCIAYEIHMGH------PPFK----------TVSILHLIRLL-KTQDVT 335
            + + +D+WS G   YE+ + H      PP K           +++L L  LL + + + 
Sbjct: 196 KFYYASDVWSFGVTLYEL-LTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP 254
Query: 336 FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
            P +       L+K   E +AS R ++  L+  P++K
Sbjct: 255 RPDKCPCEVYHLMKNCWETEASFRPTFENLI--PILK 289

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 116/248 (46%), Gaps = 8/248 (3%)
Query: 126 LIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           ++GEG FG+V++ ++ + K     VA+K   K      +      E  I K+L HP+I+K
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLDHPHIVK 77
Query: 183 FIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS-NLISALYYLHSNRVLHR 241
            I   E    ++++  + +  L + LE+ K   + + + + S  +  A+ YL S   +HR
Sbjct: 78  LIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 137
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +N+L+       L DFG +R +    +   S+   P+ +M+PE I  R +   +D+
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 197
Query: 301 WSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLLEKDASQ 358
           W      +EI   G  PF  +    +I +L+  D +  P         L+    + D S 
Sbjct: 198 WMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSD 257
Query: 359 RLSWPELL 366
           R  + EL+
Sbjct: 258 RPRFTELV 265

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 116/248 (46%), Gaps = 8/248 (3%)
Query: 126 LIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           ++GEG FG+V++ ++ + K     VA+K   K      +      E  I K+L HP+I+K
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLDHPHIVK 73
Query: 183 FIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS-NLISALYYLHSNRVLHR 241
            I   E    ++++  + +  L + LE+ K   + + + + S  +  A+ YL S   +HR
Sbjct: 74  LIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 133
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +N+L+       L DFG +R +    +   S+   P+ +M+PE I  R +   +D+
Sbjct: 134 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 193
Query: 301 WSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLLEKDASQ 358
           W      +EI   G  PF  +    +I +L+  D +  P         L+    + D S 
Sbjct: 194 WMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSD 253
Query: 359 RLSWPELL 366
           R  + EL+
Sbjct: 254 RPRFTELV 261

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G GSFG+V +          A+K +       +EL +          L+ P I+    +
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAG-------LSSPRIVPLYGA 132
Query: 187 ---HETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
                 +N F+ + E    SL  L++Q   L E   +  L   +  L YLH+ R+LH D+
Sbjct: 133 VREGPWVNIFMELLEGG--SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 244 KPQNVLLNKDGV-AMLCDFGFARSM---AVGTHMLTS--IKGTPLYMAPELIAERPYDHT 297
           K  NVLL+ DG  A LCDFG A  +    +G  +LT   I GT  +MAPE++  +P D  
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 250
Query: 298 ADLWSLGCIAYEIHMGHPPF 317
            D+WS  C+   +  G  P+
Sbjct: 251 VDIWSSCCMMLHMLNGCHPW 270

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 116/248 (46%), Gaps = 8/248 (3%)
Query: 126 LIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           ++GEG FG+V++ ++ + K     VA+K   K      +      E  I K+L HP+I+K
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLDHPHIVK 89
Query: 183 FIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILS-NLISALYYLHSNRVLHR 241
            I   E    ++++  + +  L + LE+ K   + + + + S  +  A+ YL S   +HR
Sbjct: 90  LIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 149
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           D+  +N+L+       L DFG +R +    +   S+   P+ +M+PE I  R +   +D+
Sbjct: 150 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 209
Query: 301 WSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLLEKDASQ 358
           W      +EI   G  PF  +    +I +L+  D +  P         L+    + D S 
Sbjct: 210 WMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSD 269
Query: 359 RLSWPELL 366
           R  + EL+
Sbjct: 270 RPRFTELV 277

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 122/274 (44%), Gaps = 31/274 (11%)
Query: 64  HLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQK 123
           HL  P +  ++  H   +    + EFA                   +++ +N +++K   
Sbjct: 13  HLKLPGLRTYVDPHTYEDPTQTVHEFAK------------------ELDATNISIDK--- 51
Query: 124 ICLIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNII 181
             ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII
Sbjct: 52  --VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 182 KFIASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVL 239
           +           +++TE   + SL + L +       I  V +L  + S + YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL  +N+L+N + V  + DFG +R +        + +G  +   + +PE IA R +  
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 297 TADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
            +D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 108/238 (45%), Gaps = 34/238 (14%)
Query: 127 IGEGSFGKVFKAIHLDLK-----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG FGKV KA    LK      TVA+K++ K   S  EL  L  E  + K + HP++I
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQ-----------------IL 223
           K   +       +LI E+A + SL   L + +K+                         +
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 224 SNLIS-------ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS 276
            +LIS        + YL    ++HRDL  +N+L+ +     + DFG +R +      +  
Sbjct: 150 GDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKR 209
Query: 277 IKG-TPL-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKT 331
            +G  P+ +MA E + +  Y   +D+WS G + +EI  +G  P+  +    L  LLKT
Sbjct: 210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 8/212 (3%)
Query: 126 LIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           ++G G FG+V    + L  KK +++ I + K G + K+      E  I     HPNII+ 
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 184 IASHETLNEFVLITE-FAHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVLHR 241
                     +++TE   + SL + L +       I  V +L  + S + YL     +HR
Sbjct: 83  EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 142
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTA 298
           DL  +N+L+N + V  + DFG +R +        + +G  +   + +PE IA R +   +
Sbjct: 143 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 202
Query: 299 DLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL 329
           D+WS G + +E+   G  P+  +S   +I+ +
Sbjct: 203 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           ++G+G+   VF+  H       A+K+ +      + +    +E E+ K L H NI+K  A
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 186 SHE--TLNEFVLITEFAH-MSLSNLLEQRKK---LSETICVQILSNLISALYYLHSNRVL 239
             E  T    VLI EF    SL  +LE+      L E+  + +L +++  + +L  N ++
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 240 HRDLKPQNVL--LNKDG--VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA----- 290
           HR++KP N++  + +DG  V  L DFG AR +         + GT  Y+ P++       
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVXLYGTEEYLHPDMYERAVLR 193
Query: 291 ---ERPYDHTADLWSLGCIAYEIHMGHPPFK 318
              ++ Y  T DLWS+G   Y    G  PF+
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 30/277 (10%)
Query: 122 QKICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +KI  +GEG FGKV    +   +    + VA+K + K+    +  S  KQE +I + L H
Sbjct: 17  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADCGPQHRSGWKQEIDILRTLYH 75
Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQIL--SNLISALYYLHS 235
            +IIK+    E   E  L     ++ L +L +   + S  +   +L    +   + YLH+
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKGTPLYM-APELIAER 292
              +HR+L  +NVLL+ D +  + DFG A+++  G   + +     +P++  APE + E 
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 293 PYDHTADLWSLGCIAYEIHMGH------PPFK----------TVSILHLIRLL-KTQDVT 335
            + + +D+WS G   YE+ + H      PP K           +++L L  LL + + + 
Sbjct: 196 KFYYASDVWSFGVTLYEL-LTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP 254
Query: 336 FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
            P +       L+K   E +AS R ++  L+  P++K
Sbjct: 255 RPDKCPCEVYHLMKNCWETEASFRPTFENLI--PILK 289

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 29/222 (13%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A    L K      VA+K++ KS     E  +L  E +I  HL  H NI
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSN-------------- 225
           +  + +       ++ITE+  +  L N L ++ ++ ET     ++N              
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQ 172
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL 282
           +   + +L S   +HRD+  +NVLL    VA + DFG AR +   ++ +  +KG    P+
Sbjct: 173 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--VKGNARLPV 230
Query: 283 -YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI 322
            +MAPE I +  Y   +D+WS G + +EI  +G  P+  + +
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 29/222 (13%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A    L K      VA+K++ KS     E  +L  E +I  HL  H NI
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSN-------------- 225
           +  + +       ++ITE+  +  L N L ++ ++ ET     ++N              
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL 282
           +   + +L S   +HRD+  +NVLL    VA + DFG AR +   ++ +  +KG    P+
Sbjct: 173 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--VKGNARLPV 230
Query: 283 -YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI 322
            +MAPE I +  Y   +D+WS G + +EI  +G  P+  + +
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 115/245 (46%), Gaps = 15/245 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG+G FG V    +   K  VA+K I     +   L+    E  +   L H N+++ +  
Sbjct: 201 IGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLA----EASVMTQLRHSNLVQLLGV 254
Query: 187 -HETLNEFVLITEF-AHMSLSNLLEQRKK--LSETICVQILSNLISALYYLHSNRVLHRD 242
             E      ++TE+ A  SL + L  R +  L     ++   ++  A+ YL  N  +HRD
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           L  +NVL+++D VA + DFG  +     +    + K    + APE + E+ +   +D+WS
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 371
Query: 303 LGCIAYEIH-MGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
            G + +EI+  G  P+  + +  ++ R+ K   +  P        D++K     DA+ R 
Sbjct: 372 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRP 431
Query: 361 SWPEL 365
           ++ +L
Sbjct: 432 TFLQL 436

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 136/286 (47%), Gaps = 49/286 (17%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           +++I ++G+G+FG+V KA +    +  A+K I     + ++LS++  E  +   L H  +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYV 64
Query: 181 IKFIASHETLNEFVLI--------TEFAHMSL------------SNLLEQRKKLSETICV 220
           +++ A+      FV          T F  M               NL +QR +       
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE-----YW 119
Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA----RSMAV------- 269
           ++   ++ AL Y+HS  ++HRDLKP N+ +++     + DFG A    RS+ +       
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 270 ---GTHMLTSIKGTPLYMAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL 325
               +  LTS  GT +Y+A E++     Y+   D++SLG I +E  M +P    +  +++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE--MIYPFSTGMERVNI 237
Query: 326 IRLLKTQDVTFPSQVSETY----KDLVKGLLEKDASQRLSWPELLH 367
           ++ L++  + FP    +      K +++ L++ D ++R     LL+
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 136/286 (47%), Gaps = 49/286 (17%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           +++I ++G+G+FG+V KA +    +  A+K I     + ++LS++  E  +   L H  +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYV 64
Query: 181 IKFIASHETLNEFVLI--------TEFAHMSL------------SNLLEQRKKLSETICV 220
           +++ A+      FV          T F  M               NL +QR +       
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE-----YW 119
Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA----RSMAV------- 269
           ++   ++ AL Y+HS  ++HRDLKP N+ +++     + DFG A    RS+ +       
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 270 ---GTHMLTSIKGTPLYMAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL 325
               +  LTS  GT +Y+A E++     Y+   D++SLG I +E  M +P    +  +++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE--MIYPFSTGMERVNI 237
Query: 326 IRLLKTQDVTFPSQVSETY----KDLVKGLLEKDASQRLSWPELLH 367
           ++ L++  + FP    +      K +++ L++ D ++R     LL+
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 9/205 (4%)
Query: 126 LIGEGSFGKVFKAI--HLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG+V+K +      KK V + I + K+G + K+      E  I    +H NII+
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 183 FIASHETLNEFVLITEFA-HMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLH 240
                      ++ITE+  + +L   L E+  + S    V +L  + + + YL +   +H
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 170
Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHT 297
           RDL  +N+L+N + V  + DFG +R +        +  G  +   + APE I+ R +   
Sbjct: 171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 230
Query: 298 ADLWSLGCIAYEIHM-GHPPFKTVS 321
           +D+WS G + +E+   G  P+  +S
Sbjct: 231 SDVWSFGIVMWEVMTYGERPYWELS 255

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 125 CLIGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII- 181
           C +G G++G V+KA   D K     ALK I  +G S     S  +E  + + L HPN+I 
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVIS 82
Query: 182 --KFIASHETLNEFVL----------ITEFAHMSLSNLLEQRKKLSETICVQILSNLISA 229
             K   SH     ++L          I +F   S +N  ++  +L   +   +L  ++  
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN--KKPVQLPRGMVKSLLYQILDG 140
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGV----AMLCDFGFARSMAVGTHMLTSIKG---TPL 282
           ++YLH+N VLHRDLKP N+L+  +G       + D GFAR        L  +     T  
Sbjct: 141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200
Query: 283 YMAPE-LIAERPYDHTADLWSLGCIAYEIHMGHPPF 317
           Y APE L+  R Y    D+W++GCI  E+    P F
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 130/275 (47%), Gaps = 42/275 (15%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 181
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 182 KFI-ASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQ-------ILSNLI----- 227
             + A  +     ++I EF    +LS  L  R K +E +  +        L +LI     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 228 --SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL 282
               + +L S + +HRDL  +N+LL++  V  + DFG AR +      +   KG    PL
Sbjct: 153 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR--KGDARLPL 210
Query: 283 -YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-------LHLIRLLKTQD 333
            +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I       L     ++  D
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRAPD 270
Query: 334 VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH 368
            T P ++ +T  D   G    + SQR ++ EL+ H
Sbjct: 271 YTTP-EMYQTMLDCWHG----EPSQRPTFSELVEH 300

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 120/254 (47%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKA-IHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG+V +  +    KK   VA+K + K G + ++      E  I     HPNII+
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 183 FIASHETLNEFVLITEFA-HMSLSNLLE-QRKKLSETICVQILSNLISALYYLHSNRVLH 240
                      +++TEF  + +L + L     + +    V +L  + S + YL     +H
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVH 139
Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT---SIKG-TPL-YMAPELIAERPYD 295
           RDL  +N+L+N + V  + DFG +R +   +   T   S+ G  P+ + APE IA R + 
Sbjct: 140 RDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFT 199
Query: 296 HTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDVTF--PSQVSETYKDLVKGLL 352
             +D WS G + +E+   G  P+  +S   +I  ++ QD     P     +   L+    
Sbjct: 200 SASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE-QDYRLPPPPDCPTSLHQLMLDCW 258
Query: 353 EKDASQRLSWPELL 366
           +KD + R  +P+++
Sbjct: 259 QKDRNARPRFPQVV 272

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 130/274 (47%), Gaps = 17/274 (6%)
Query: 126 LIGEGSFGKVFKA-IHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG+V +  +    KK   VA+K + K G + ++      E  I     HPNII+
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 183 FIASHETLNEFVLITEFA-HMSLSNLLE-QRKKLSETICVQILSNLISALYYLHSNRVLH 240
                      +++TEF  + +L + L     + +    V +L  + S + YL     +H
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVH 141
Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT---SIKG-TPL-YMAPELIAERPYD 295
           RDL  +N+L+N + V  + DFG +R +   +   T   S+ G  P+ + APE IA R + 
Sbjct: 142 RDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFT 201
Query: 296 HTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDVTF--PSQVSETYKDLVKGLL 352
             +D WS G + +E+   G  P+  +S   +I  ++ QD     P     +   L+    
Sbjct: 202 SASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE-QDYRLPPPPDCPTSLHQLMLDCW 260
Query: 353 EKDASQRLSWPELLH--HPLVKDNLSSEIESQNN 384
           +KD + R  +P+++     ++++  S +I ++ N
Sbjct: 261 QKDRNARPRFPQVVSALDKMIRNPASLKIVAREN 294

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 115/245 (46%), Gaps = 15/245 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG+G FG V    +   K  VA+K I     +   L+    E  +   L H N+++ +  
Sbjct: 29  IGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLA----EASVMTQLRHSNLVQLLGV 82
Query: 187 -HETLNEFVLITEF-AHMSLSNLLEQRKK--LSETICVQILSNLISALYYLHSNRVLHRD 242
             E      ++TE+ A  SL + L  R +  L     ++   ++  A+ YL  N  +HRD
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           L  +NVL+++D VA + DFG  +     +    + K    + APE + E+ +   +D+WS
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 199
Query: 303 LGCIAYEIH-MGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
            G + +EI+  G  P+  + +  ++ R+ K   +  P        +++K     DA+ R 
Sbjct: 200 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 259
Query: 361 SWPEL 365
           S+ +L
Sbjct: 260 SFLQL 264

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 15/224 (6%)
Query: 126 LIGEGSFGKVFKAIHLDLKKT----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +IG G FG+V    HL L       VA+K + KSG + K+      E  I     HPN+I
Sbjct: 14  VIGAGEFGEVCSG-HLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVL 239
                       ++ITEF  + SL + L Q       I  V +L  + + + YL     +
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 131
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPL---YMAPELIAERPY 294
           HR L  +N+L+N + V  + DFG +R +   T     TS  G  +   + APE I  R +
Sbjct: 132 HRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 191
Query: 295 DHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDVTFP 337
              +D+WS G + +E+   G  P+  ++   +I  ++ QD   P
Sbjct: 192 TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLP 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G GSFG+V +          A+K +       +EL +          L  P I+    +
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAG-------LTSPRIVPLYGA 134
Query: 187 ---HETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
                 +N F+ + E    SL  L++++  L E   +  L   +  L YLHS R+LH D+
Sbjct: 135 VREGPWVNIFMELLEGG--SLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 244 KPQNVLLNKDGV-AMLCDFGFA---RSMAVGTHMLTS--IKGTPLYMAPELIAERPYDHT 297
           K  NVLL+ DG  A LCDFG A   +   +G  +LT   I GT  +MAPE++  R  D  
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAK 252
Query: 298 ADLWSLGCIAYEIHMG-HP 315
            D+WS  C+   +  G HP
Sbjct: 253 VDVWSSCCMMLHMLNGCHP 271

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G GSFG+V +          A+K +       +EL +          L  P I+    +
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAG-------LTSPRIVPLYGA 153
Query: 187 ---HETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
                 +N F+ + E    SL  L++++  L E   +  L   +  L YLHS R+LH D+
Sbjct: 154 VREGPWVNIFMELLEGG--SLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 244 KPQNVLLNKDGV-AMLCDFGFA---RSMAVGTHMLTS--IKGTPLYMAPELIAERPYDHT 297
           K  NVLL+ DG  A LCDFG A   +   +G  +LT   I GT  +MAPE++  R  D  
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAK 271
Query: 298 ADLWSLGCIAYEIHMG-HP 315
            D+WS  C+   +  G HP
Sbjct: 272 VDVWSSCCMMLHMLNGCHP 290

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 115/245 (46%), Gaps = 15/245 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG+G FG V    +   K  VA+K I     +   L+    E  +   L H N+++ +  
Sbjct: 14  IGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLA----EASVMTQLRHSNLVQLLGV 67
Query: 187 -HETLNEFVLITEF-AHMSLSNLLEQRKK--LSETICVQILSNLISALYYLHSNRVLHRD 242
             E      ++TE+ A  SL + L  R +  L     ++   ++  A+ YL  N  +HRD
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 127
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           L  +NVL+++D VA + DFG  +     +    + K    + APE + E+ +   +D+WS
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 184
Query: 303 LGCIAYEIH-MGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
            G + +EI+  G  P+  + +  ++ R+ K   +  P        +++K     DA+ R 
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 244
Query: 361 SWPEL 365
           S+ +L
Sbjct: 245 SFLQL 249

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 120/260 (46%), Gaps = 33/260 (12%)
Query: 127 IGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG+FGKVF A   +L     K  VA+K +  +  + ++     +E E+  +L H +I+
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK--DFHREAELLTNLQHEHIV 78
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQR-------------KKLSETICVQILSNLI 227
           KF       +  +++ E+  H  L+  L                 +L+++  + I   + 
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTSIKGTP 281
           + + YL S   +HRDL  +N L+ ++ +  + DFG +R +       VG H +  I+   
Sbjct: 139 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR--- 195
Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLKTQDV-TFPSQ 339
            +M PE I  R +   +D+WSLG + +EI   G  P+  +S   +I  +    V   P  
Sbjct: 196 -WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRT 254
Query: 340 VSETYKDLVKGLLEKDASQR 359
             +   +L+ G  +++   R
Sbjct: 255 CPQEVYELMLGCWQREPHMR 274

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 6/200 (3%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G+FG+VF          VA+K   ++     +   L QE  I K  +HPNI++ I  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILKQYSHPNIVRLIGV 180
Query: 187 HETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   ++ E       L+ L  +  +L     +Q++ +  + + YL S   +HRDL 
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLT-SIKGTPL-YMAPELIAERPYDHTADLWS 302
            +N L+ +  V  + DFG +R  A G +  +  ++  P+ + APE +    Y   +D+WS
Sbjct: 241 ARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300
Query: 303 LGCIAYE-IHMGHPPFKTVS 321
            G + +E   +G  P+  +S
Sbjct: 301 FGILLWETFSLGASPYPNLS 320

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 114/245 (46%), Gaps = 15/245 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG+G FG V    +   K  VA+K I     +   L+    E  +   L H N+++ +  
Sbjct: 20  IGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLA----EASVMTQLRHSNLVQLLGV 73
Query: 187 -HETLNEFVLITEF-AHMSLSNLLEQRKK--LSETICVQILSNLISALYYLHSNRVLHRD 242
             E      ++TE+ A  SL + L  R +  L     ++   ++  A+ YL  N  +HRD
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 133
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           L  +NVL+++D VA + DFG  +     +    + K    + APE + E  +   +D+WS
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKLPVKWTAPEALREAAFSTKSDVWS 190
Query: 303 LGCIAYEIH-MGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
            G + +EI+  G  P+  + +  ++ R+ K   +  P        +++K     DA+ R 
Sbjct: 191 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 250
Query: 361 SWPEL 365
           S+ +L
Sbjct: 251 SFLQL 255

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 31/224 (13%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A    L K      VA+K++ KS     E  +L  E +I  HL  H NI
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQRK----------------KLSETICVQIL 223
           +  + +       ++ITE+  +  L N L +++                +LS    +   
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFS 172
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT--- 280
           S +   + +L S   +HRD+  +NVLL    VA + DFG AR +   ++ +  +KG    
Sbjct: 173 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--VKGNARL 230
Query: 281 PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI 322
           P+ +MAPE I +  Y   +D+WS G + +EI  +G  P+  + +
Sbjct: 231 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 274

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V K      +  VA+K+I +   S  E     +E ++  +L+H  +++    
Sbjct: 17  LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKLVQLYGV 72
Query: 187 HETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   +ITE+ A+  L N L E R +      +++  ++  A+ YL S + LHRDL 
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 132
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADLW 301
            +N L+N  GV  + DFG +R +    +  TS +G+     +  PE++    +   +D+W
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 302 SLGCIAYEIH-MGHPPFKTVS 321
           + G + +EI+ +G  P++  +
Sbjct: 191 AFGVLMWEIYSLGKMPYERFT 211

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 111/228 (48%), Gaps = 35/228 (15%)
Query: 177 HPNIIKFIASHETLNEFVLIT-EFAHMSLSNLLEQRKKLSETICVQ-------ILSNLIS 228
           HPN+I++  S ET + F+ I  E  +++L +L+E +    E + +Q       +L  + S
Sbjct: 86  HPNVIRYYCS-ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 229 ALYYLHSNRVLHRDLKPQNVLLN---------KDGVA----MLCDFGFARSMAVGTHM-- 273
            + +LHS +++HRDLKPQN+L++         + G      ++ DFG  + +  G     
Sbjct: 145 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 274 --LTSIKGTPLYMAPELIAE---RPYDHTADLWSLGCIAYEI-HMGHPPF-----KTVSI 322
             L +  GT  + APEL+ E   R    + D++S+GC+ Y I   G  PF     +  +I
Sbjct: 205 XNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 264
Query: 323 LHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPL 370
           +  I  L          +     DL+  +++ D  +R +  ++L HPL
Sbjct: 265 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A    L K      VA+K++ KS     E  +L  E +I  HL  H NI
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQR----------KKLSETICVQILSNLISA 229
           +  + +       ++ITE+  +  L N L ++          + L     +   S +   
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 172
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL-YMA 285
           + +L S   +HRD+  +NVLL    VA + DFG AR +   ++ +  +KG    P+ +MA
Sbjct: 173 MAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--VKGNARLPVKWMA 230
Query: 286 PELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI 322
           PE I +  Y   +D+WS G + +EI  +G  P+  + +
Sbjct: 231 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 268

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 111/228 (48%), Gaps = 35/228 (15%)
Query: 177 HPNIIKFIASHETLNEFVLIT-EFAHMSLSNLLEQRKKLSETICVQ-------ILSNLIS 228
           HPN+I++  S ET + F+ I  E  +++L +L+E +    E + +Q       +L  + S
Sbjct: 86  HPNVIRYYCS-ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 229 ALYYLHSNRVLHRDLKPQNVLLN---------KDGVA----MLCDFGFARSMAVGTHM-- 273
            + +LHS +++HRDLKPQN+L++         + G      ++ DFG  + +  G     
Sbjct: 145 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 274 --LTSIKGTPLYMAPELIAE---RPYDHTADLWSLGCIAYEI-HMGHPPF-----KTVSI 322
             L +  GT  + APEL+ E   R    + D++S+GC+ Y I   G  PF     +  +I
Sbjct: 205 XNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 264
Query: 323 LHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPL 370
           +  I  L          +     DL+  +++ D  +R +  ++L HPL
Sbjct: 265 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 26/200 (13%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           LIG G FGKV+K +  D  K VALK   ++  S + +   + E E      HP+++  I 
Sbjct: 46  LIGHGVFGKVYKGVLRDGAK-VALK--RRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 186 SHETLNEFVLITEFA-------HMSLSNL------LEQRKKLSETICVQILSNLISALYY 232
             +  NE +LI ++        H+  S+L       EQR +    IC+         L+Y
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE----ICI----GAARGLHY 154
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA-RSMAVG-THMLTSIKGTPLYMAPELIA 290
           LH+  ++HRD+K  N+LL+++ V  + DFG + +   +G TH+   +KGT  Y+ PE   
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFI 214
Query: 291 ERPYDHTADLWSLGCIAYEI 310
           +      +D++S G + +E+
Sbjct: 215 KGRLTEKSDVYSFGVVLFEV 234

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 8/213 (3%)
Query: 126 LIGEGSFGKVFKA-IHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +IG G FG+V    + L  K+ + + I + K G + K+      E  I     HPNII  
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 184 IASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRVLHR 241
                     +++TE+  + SL   L++       I  V +L  + + + YL     +HR
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHR 148
Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTA 298
           DL  +N+L+N + V  + DFG +R +        + +G  +   + APE IA R +   +
Sbjct: 149 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSAS 208
Query: 299 DLWSLGCIAYE-IHMGHPPFKTVSILHLIRLLK 330
           D+WS G + +E +  G  P+  ++   +I+ ++
Sbjct: 209 DVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVE 241

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A    L K      VA+K++ KS     E  +L  E +I  HL  H NI
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENI 104
Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQR----------KKLSETICVQILSNLISA 229
           +  + +       ++ITE+  +  L N L ++          + L     +   S +   
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 164
Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL-YMA 285
           + +L S   +HRD+  +NVLL    VA + DFG AR +   ++ +  +KG    P+ +MA
Sbjct: 165 MAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--VKGNARLPVKWMA 222
Query: 286 PELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI 322
           PE I +  Y   +D+WS G + +EI  +G  P+  + +
Sbjct: 223 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 260

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 115/229 (50%), Gaps = 18/229 (7%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G  + YQ +  +G G + +VF+AI++   + V +KI+    ++      +K+E +I ++L
Sbjct: 34  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKN-----KIKREIKILENL 88
Query: 176 -AHPNIIKF--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
              PNII    I          L+  F H++ ++  +  + L++      +  ++ AL Y
Sbjct: 89  RGGPNIITLADIVKDPVSRTPALV--FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAM-LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
            HS  ++HRD+KP NV+++ +   + L D+G A     G      +  +  +  PEL+ +
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVD 205
Query: 292 -RPYDHTADLWSLGCIAYEIHMGHPPF-----KTVSILHLIRLLKTQDV 334
            + YD++ D+WSLGC+   +     PF         ++ + ++L T+D+
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 254

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 6/200 (3%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G+FG+VF          VA+K   ++     +   L QE  I K  +HPNI++ I  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILKQYSHPNIVRLIGV 180
Query: 187 HETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   ++ E       L+ L  +  +L     +Q++ +  + + YL S   +HRDL 
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLT-SIKGTPL-YMAPELIAERPYDHTADLWS 302
            +N L+ +  V  + DFG +R  A G    +  ++  P+ + APE +    Y   +D+WS
Sbjct: 241 ARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300
Query: 303 LGCIAYE-IHMGHPPFKTVS 321
            G + +E   +G  P+  +S
Sbjct: 301 FGILLWETFSLGASPYPNLS 320

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 109/248 (43%), Gaps = 17/248 (6%)
Query: 100 PWFHNHCQPVKMEKSNGALEKYQK----ICL-----IGEGSFGKVFKA-IHLDLKKTVAL 149
           P    +  P   E  N A+ ++ K     C+     IG G FG+V    + L  K+ VA+
Sbjct: 15  PGTKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAV 74
Query: 150 KIIS-KSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLL 208
            I + K G + K+      E  I     HPN++            +++ EF      +  
Sbjct: 75  AIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAF 134
Query: 209 EQRKKLSETIC--VQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS 266
            ++     T+   V +L  + + + YL     +HRDL  +N+L+N + V  + DFG +R 
Sbjct: 135 LRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 194
Query: 267 MAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSI 322
           +      + +  G  +   + APE I  R +   +D+WS G + +E+   G  P+  +S 
Sbjct: 195 IEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 254
Query: 323 LHLIRLLK 330
             +I+ ++
Sbjct: 255 QDVIKAIE 262

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 26/200 (13%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           LIG G FGKV+K +  D  K VALK   ++  S + +   + E E      HP+++  I 
Sbjct: 46  LIGHGVFGKVYKGVLRDGAK-VALK--RRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 186 SHETLNEFVLITEFA-------HMSLSNL------LEQRKKLSETICVQILSNLISALYY 232
             +  NE +LI ++        H+  S+L       EQR +    IC+         L+Y
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE----ICI----GAARGLHY 154
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV--GTHMLTSIKGTPLYMAPELIA 290
           LH+  ++HRD+K  N+LL+++ V  + DFG ++       TH+   +KGT  Y+ PE   
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFI 214
Query: 291 ERPYDHTADLWSLGCIAYEI 310
           +      +D++S G + +E+
Sbjct: 215 KGRLTEKSDVYSFGVVLFEV 234

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 126/275 (45%), Gaps = 36/275 (13%)
Query: 126 LIGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHL-AHPN 179
           ++G G+FGKV  A    + KT     VA+K++ +   S  E  +L  E ++   L +H N
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHEN 110
Query: 180 IIKFIASHETLNEFVLITEFA-HMSLSNLL--------------EQRKKLSETICVQILS 224
           I+  + +        LI E+  +  L N L              E +K+L E   + +L+
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 225 ---------NLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS-MAVGTHML 274
                     +   + +L     +HRDL  +NVL+    V  +CDFG AR  M+   +++
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230
Query: 275 TSIKGTPL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-LHLIRLLKT 331
                 P+ +MAPE + E  Y   +D+WS G + +EI  +G  P+  + +  +  +L++ 
Sbjct: 231 RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN 290
Query: 332 Q-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPEL 365
              +  P   +E    +++     D+ +R S+P L
Sbjct: 291 GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 8/199 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V K      +  VA+K+I +   S  E     +E ++  +L+H  +++    
Sbjct: 12  LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKLVQLYGV 67
Query: 187 HETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   +ITE+ A+  L N L E R +      +++  ++  A+ YL S + LHRDL 
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWSL 303
            +N L+N  GV  + DFG +R +    +  +     P+ +  PE++    +   +D+W+ 
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187
Query: 304 GCIAYEIH-MGHPPFKTVS 321
           G + +EI+ +G  P++  +
Sbjct: 188 GVLMWEIYSLGKMPYERFT 206

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 8/199 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V K      +  VA+K+I +   S  E     +E ++  +L+H  +++    
Sbjct: 16  LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKLVQLYGV 71
Query: 187 HETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   +ITE+ A+  L N L E R +      +++  ++  A+ YL S + LHRDL 
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 131
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWSL 303
            +N L+N  GV  + DFG +R +    +  +     P+ +  PE++    +   +D+W+ 
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 191
Query: 304 GCIAYEIH-MGHPPFKTVS 321
           G + +EI+ +G  P++  +
Sbjct: 192 GVLMWEIYSLGKMPYERFT 210

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 8/199 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V K      +  VA+K+I +   S  E     +E ++  +L+H  +++    
Sbjct: 17  LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKLVQLYGV 72
Query: 187 HETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   +ITE+ A+  L N L E R +      +++  ++  A+ YL S + LHRDL 
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 132
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWSL 303
            +N L+N  GV  + DFG +R +    +  +     P+ +  PE++    +   +D+W+ 
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 192
Query: 304 GCIAYEIH-MGHPPFKTVS 321
           G + +EI+ +G  P++  +
Sbjct: 193 GVLMWEIYSLGKMPYERFT 211

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 127/295 (43%), Gaps = 56/295 (18%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLK---------QECEIQKHLA 176
            I  GS+G V   +  +    VA+K +  +   G+ ++ L          +E  +  H  
Sbjct: 29  FISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 177 HPNIIK----FIASHE-TLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILSNLISAL 230
           HPNI+     F+   E  +++  L+TE     L+ ++ +QR  +S       + +++  L
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR---SMAVGTHMLTSIKGTPLYMAPE 287
           + LH   V+HRDL P N+LL  +    +CDF  AR   + A  TH +T       Y APE
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RWYRAPE 203
Query: 288 LIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLIRLLKTQDVT-FPS 338
           L+ + + +    D+WS GC+  E+      F+  +       I+ ++   K +DV  F S
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS 263
Query: 339 QVSETY------------------------KDLVKGLLEKDASQRLSWPELLHHP 369
             +  Y                         DL+  +LE +  +R+S  + L HP
Sbjct: 264 PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 8/199 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V K      +  VA+K+I +   S  E     +E ++  +L+H  +++    
Sbjct: 23  LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKLVQLYGV 78
Query: 187 HETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   +ITE+ A+  L N L E R +      +++  ++  A+ YL S + LHRDL 
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 138
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWSL 303
            +N L+N  GV  + DFG +R +    +  +     P+ +  PE++    +   +D+W+ 
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 198
Query: 304 GCIAYEIH-MGHPPFKTVS 321
           G + +EI+ +G  P++  +
Sbjct: 199 GVLMWEIYSLGKMPYERFT 217

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 130/282 (46%), Gaps = 31/282 (10%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 76
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 136
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYM-APELIAERPYD 295
           +HR+L  +N+L+  +    + DFG  + +      + +     +P++  APE + E  + 
Sbjct: 137 IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS 196
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 197 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 256
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLSSEI 379
              +    ++      + +QR S+ +L L    ++DN++ E 
Sbjct: 257 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGEF 298

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 127/295 (43%), Gaps = 56/295 (18%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLK---------QECEIQKHLA 176
            I  GS+G V   +  +    VA+K +  +   G+ ++ L          +E  +  H  
Sbjct: 29  FISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 177 HPNIIK----FIASHE-TLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILSNLISAL 230
           HPNI+     F+   E  +++  L+TE     L+ ++ +QR  +S       + +++  L
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR---SMAVGTHMLTSIKGTPLYMAPE 287
           + LH   V+HRDL P N+LL  +    +CDF  AR   + A  TH +T       Y APE
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RWYRAPE 203
Query: 288 LIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLIRLLKTQDVT-FPS 338
           L+ + + +    D+WS GC+  E+      F+  +       I+ ++   K +DV  F S
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS 263
Query: 339 QVSETY------------------------KDLVKGLLEKDASQRLSWPELLHHP 369
             +  Y                         DL+  +LE +  +R+S  + L HP
Sbjct: 264 PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 127/280 (45%), Gaps = 31/280 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 78
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI EF  + SL   L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 199 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 258
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLSS 377
              +    ++      + +QR S+ +L L    ++DN++ 
Sbjct: 259 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 298

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 75
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG--TPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +          +   +P++  APE + E  + 
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS 195
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 196 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 255
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLSS 377
              +    ++      + +QR S+ +L L    ++DN++ 
Sbjct: 256 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 8/199 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V K      +  VA+K+I +   S  E     +E ++  +L+H  +++    
Sbjct: 32  LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKLVQLYGV 87
Query: 187 HETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   +ITE+ A+  L N L E R +      +++  ++  A+ YL S + LHRDL 
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWSL 303
            +N L+N  GV  + DFG +R +    +  +     P+ +  PE++    +   +D+W+ 
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 207
Query: 304 GCIAYEIH-MGHPPFKTVS 321
           G + +EI+ +G  P++  +
Sbjct: 208 GVLMWEIYSLGKMPYERFT 226

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 78
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 199 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 258
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLSS 377
              +    ++      + +QR S+ +L L    ++DN++ 
Sbjct: 259 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 298

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 14/225 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G FG V     L+ K  VA+K I +   S ++     +E E+   L+HP +++    
Sbjct: 16  IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHPKLVQLYGV 71
Query: 187 HETLNEFVLITEFA-HMSLSNLLEQRKKL--SETICVQILSNLISALYYLHSNRVLHRDL 243
                   L+TEF  H  LS+ L  ++ L  +ET+    L ++   + YL    V+HRDL
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACVIHRDL 130
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADL 300
             +N L+ ++ V  + DFG  R   V     TS  GT     + +PE+ +   Y   +D+
Sbjct: 131 AARNCLVGENQVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVTFPSQVSETY 344
           WS G + +E+   G  P++  S   ++  + T    +  +++ T+
Sbjct: 189 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 233

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 80
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 140
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 141 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 200
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 201 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 260
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLSS 377
              +    ++      + +QR S+ +L L    ++DN++ 
Sbjct: 261 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 300

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 82
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 142
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 143 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 202
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 203 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 262
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLSS 377
              +    ++      + +QR S+ +L L    ++DN++ 
Sbjct: 263 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 302

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 81
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 141
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 142 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 201
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 202 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 261
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLSS 377
              +    ++      + +QR S+ +L L    ++DN++ 
Sbjct: 262 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 301

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 75
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 195
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 196 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 255
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLSS 377
              +    ++      + +QR S+ +L L    ++DN++ 
Sbjct: 256 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 179 NIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ + H+ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 237 RVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA-ERPY 294
            VLHRD+K +N+L++ + G   L DFG      +   + T   GT +Y  PE I   R +
Sbjct: 177 GVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
             +A +WSLG + Y++  G  PF+     H   +++ Q V F  +VS   + L++  L  
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ-VFFRQRVSSECQHLIRWCLAL 288
Query: 355 DASQRLSWPELLHHPLVKDNL 375
             S R ++ E+ +HP ++D L
Sbjct: 289 RPSDRPTFEEIQNHPWMQDVL 309

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 128/279 (45%), Gaps = 31/279 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 74
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 134
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 135 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 194
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 195 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 254
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLS 376
              +    ++      + +QR S+ +L L    ++DN++
Sbjct: 255 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 293

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 75
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 195
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 196 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 255
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLSS 377
              +    ++      + +QR S+ +L L    ++DN++ 
Sbjct: 256 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 79
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 139
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 140 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 199
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 200 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 259
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLSS 377
              +    ++      + +QR S+ +L L    ++DN++ 
Sbjct: 260 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 299

>pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 93
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 153
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 213
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 214 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 273
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLSS 377
              +    ++      + +QR S+ +L L    ++DN++ 
Sbjct: 274 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 313

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 39/232 (16%)
Query: 177 HPNIIKFIASHETLNEFVLIT-EFAHMSLSNLLEQRKKLSETICVQ-------ILSNLIS 228
           HPN+I++  S ET + F+ I  E  +++L +L+E +    E + +Q       +L  + S
Sbjct: 68  HPNVIRYYCS-ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 229 ALYYLHSNRVLHRDLKPQNVLLN---------KDGVA----MLCDFGFARSMAVGTHM-- 273
            + +LHS +++HRDLKPQN+L++         + G      ++ DFG  + +  G     
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 186
Query: 274 --LTSIKGTPLYMAPELIAE-------RPYDHTADLWSLGCIAYEI-HMGHPPF-----K 318
             L +  GT  + APEL+ E       R    + D++S+GC+ Y I   G  PF     +
Sbjct: 187 XNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 319 TVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPL 370
             +I+  I  L          +     DL+  +++ D  +R +  ++L HPL
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 120 KYQKICLIGEGSFGKVFKA-IHLD-LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           K+Q +  IGEG+FG+V KA I  D L+   A+K + K   S  +      E E+   L H
Sbjct: 18  KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 74
Query: 178 -PNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKL------------SETICVQIL 223
            PNII  + + E      L  E+A H +L + L + + L            + T+  Q L
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 224 ----SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG 279
               +++   + YL   + +HRDL  +N+L+ ++ VA + DFG +R   V  ++  ++  
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKKTMGR 192
Query: 280 TPL-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLI-RLLKTQDVTF 336
            P+ +MA E +    Y   +D+WS G + +EI  +G  P+  ++   L  +L +   +  
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 252
Query: 337 PSQVSETYKDLVKGLLEKDASQRLSWPELL 366
           P    +   DL++    +   +R S+ ++L
Sbjct: 253 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V K      +  VA+K+I +   S  E     +E ++  +L+H  +++    
Sbjct: 32  LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKLVQLYGV 87
Query: 187 HETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   +ITE+ A+  L N L E R +      +++  ++  A+ YL S + LHRDL 
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 245 PQNVLLNKDGVAMLCDFGFAR-------SMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
            +N L+N  GV  + DFG +R       + +VG+     ++ +P    PE++    +   
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKF--PVRWSP----PEVLMYSKFSSK 201
Query: 298 ADLWSLGCIAYEIH-MGHPPFKTVS 321
           +D+W+ G + +EI+ +G  P++  +
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFT 226

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V + ++   KK   VA+K++ K G    +   + +E +I   L +P I++ I
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 185 ASHETLNEFVLITEFAHMSLSN--LLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
              +     +L+ E A     +  L+ +R+++  +   ++L  +   + YL     +HRD
Sbjct: 77  GVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPL-YMAPELIAERPYDHTAD 299
           L  +NVLL     A + DFG ++++       T  S    PL + APE I  R +   +D
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 195
Query: 300 LWSLGCIAYE-IHMGHPPFKTV 320
           +WS G   +E +  G  P+K +
Sbjct: 196 VWSYGVTMWEALSYGQKPYKKM 217

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 185
           LIG+G FG+V+   H      VA+++I     +  +L + K+E    +   H N++ F+ 
Sbjct: 40  LIGKGRFGQVY---HGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 186 SHETLNEFVLITEF--AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
           +  +     +IT         S + + +  L      QI   ++  + YLH+  +LH+DL
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156
Query: 244 KPQNVLLNKDGVAMLCDFGF---ARSMAVGTH--MLTSIKGTPLYMAPELIAE------- 291
           K +NV  + +G  ++ DFG    +  +  G     L    G   ++APE+I +       
Sbjct: 157 KSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEE 215
Query: 292 --RPYDHTADLWSLGCIAYEIHMGHPPFKT 319
              P+   +D+++LG I YE+H    PFKT
Sbjct: 216 DKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 120 KYQKICLIGEGSFGKVFKA-IHLD-LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           K+Q +  IGEG+FG+V KA I  D L+   A+K + K   S  +      E E+   L H
Sbjct: 28  KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 84
Query: 178 -PNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKL------------SETICVQIL 223
            PNII  + + E      L  E+A H +L + L + + L            + T+  Q L
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 224 ----SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG 279
               +++   + YL   + +HRDL  +N+L+ ++ VA + DFG +R   V  ++  ++  
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKKTMGR 202
Query: 280 TPL-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLI-RLLKTQDVTF 336
            P+ +MA E +    Y   +D+WS G + +EI  +G  P+  ++   L  +L +   +  
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 262
Query: 337 PSQVSETYKDLVKGLLEKDASQRLSWPELL 366
           P    +   DL++    +   +R S+ ++L
Sbjct: 263 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 39/232 (16%)
Query: 177 HPNIIKFIASHETLNEFVLIT-EFAHMSLSNLLEQRKKLSETICVQ-------ILSNLIS 228
           HPN+I++  S ET + F+ I  E  +++L +L+E +    E + +Q       +L  + S
Sbjct: 68  HPNVIRYYCS-ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 229 ALYYLHSNRVLHRDLKPQNVLLN---------KDGVA----MLCDFGFARSMAVGTHM-- 273
            + +LHS +++HRDLKPQN+L++         + G      ++ DFG  + +  G     
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 274 --LTSIKGTPLYMAPELIAE-------RPYDHTADLWSLGCIAYEI-HMGHPPF-----K 318
             L +  GT  + APEL+ E       R    + D++S+GC+ Y I   G  PF     +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 319 TVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPL 370
             +I+  I  L          +     DL+  +++ D  +R +  ++L HPL
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           A + +    ++G G FGKV+K    D    VA+K + +    G EL   + E E+     
Sbjct: 36  ASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERXQGGELQ-FQTEVEMISMAV 93
Query: 177 HPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKK----LSETICVQILSNLISALY 231
           H N+++      T  E +L+  + A+ S+++ L +R +    L      +I       L 
Sbjct: 94  HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLA 153
Query: 232 YLHSN---RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV-GTHMLTSIKGTPLYMAPE 287
           YLH +   +++HRD+K  N+LL+++  A++ DFG A+ M     H+  +++GT  ++APE
Sbjct: 154 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPE 213
Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDL 347
            ++        D++  G +  E+  G   F       L RL    DV           D 
Sbjct: 214 YLSTGKSSEKTDVFGYGVMLLELITGQRAF------DLARLANDDDVML--------LDW 259
Query: 348 VKGLLEK 354
           VKGLL++
Sbjct: 260 VKGLLKE 266

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 10/197 (5%)
Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH---L 175
           + +Q++  +G GS+G+VFK    +  +  A+K      R  K+ +  ++  E+  H    
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA--RKLAEVGSHEKVG 114
Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLH 234
            HP  ++   + E      L TE    SL    E     L E      L + + AL +LH
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK-GTPLYMAPELIAERP 293
           S  ++H D+KP N+ L   G   L DFG    + +GT     ++ G P YMAPEL+ +  
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLL--VELGTAGAGEVQEGDPRYMAPELL-QGS 231
Query: 294 YDHTADLWSLGCIAYEI 310
           Y   AD++SLG    E+
Sbjct: 232 YGTAADVFSLGLTILEV 248

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 127/278 (45%), Gaps = 31/278 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 93
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 153
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 213
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 214 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 273
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNL 375
              +    ++      + +QR S+ +L L    ++DN+
Sbjct: 274 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 185
           +GEG F  V     L      ALK I    +  +E    ++E ++ +   HPNI++ +A 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE--EAQREADMHRLFNHPNILRLVAY 94
Query: 186 -------SHETLNEFVLITEFAHMSLSNLLEQRKK----LSETICVQILSNLISALYYLH 234
                   HE    ++L+  F   +L N +E+ K     L+E   + +L  +   L  +H
Sbjct: 95  CLRERGAKHEA---WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV---GTHMLTSIKG------TPLYMA 285
           +    HRDLKP N+LL  +G  +L D G      +   G+    +++       T  Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 286 PELIAERPY---DHTADLWSLGCIAYEIHMGHPPFKTV 320
           PEL + + +   D   D+WSLGC+ Y +  G  P+  V
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 118/264 (44%), Gaps = 35/264 (13%)
Query: 127 IGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG+FGKVF A   +L     K  VA+K + ++  S ++    ++E E+   L H +I+
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ--DFQREAELLTMLQHQHIV 77
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETIC---------------VQILSN 225
           +F          +++ E+  H  L+  L      ++ +                + + S 
Sbjct: 78  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTSIKG 279
           + + + YL     +HRDL  +N L+ +  V  + DFG +R +       VG   +  I+ 
Sbjct: 138 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR- 196
Query: 280 TPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIR-LLKTQDVTFP 337
              +M PE I  R +   +D+WS G + +EI   G  P+  +S    I  + + +++  P
Sbjct: 197 ---WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP 253
Query: 338 SQVSETYKDLVKGLLEKDASQRLS 361
                    +++G  +++  QR S
Sbjct: 254 RACPPEVYAIMRGCWQREPQQRHS 277

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 118/264 (44%), Gaps = 35/264 (13%)
Query: 127 IGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG+FGKVF A   +L     K  VA+K + ++  S ++    ++E E+   L H +I+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ--DFQREAELLTMLQHQHIV 106
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETIC---------------VQILSN 225
           +F          +++ E+  H  L+  L      ++ +                + + S 
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTSIKG 279
           + + + YL     +HRDL  +N L+ +  V  + DFG +R +       VG   +  I+ 
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR- 225
Query: 280 TPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIR-LLKTQDVTFP 337
              +M PE I  R +   +D+WS G + +EI   G  P+  +S    I  + + +++  P
Sbjct: 226 ---WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP 282
Query: 338 SQVSETYKDLVKGLLEKDASQRLS 361
                    +++G  +++  QR S
Sbjct: 283 RACPPEVYAIMRGCWQREPQQRHS 306

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 118/264 (44%), Gaps = 35/264 (13%)
Query: 127 IGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG+FGKVF A   +L     K  VA+K + ++  S ++    ++E E+   L H +I+
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ--DFQREAELLTMLQHQHIV 83
Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETIC---------------VQILSN 225
           +F          +++ E+  H  L+  L      ++ +                + + S 
Sbjct: 84  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTSIKG 279
           + + + YL     +HRDL  +N L+ +  V  + DFG +R +       VG   +  I+ 
Sbjct: 144 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR- 202
Query: 280 TPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIR-LLKTQDVTFP 337
              +M PE I  R +   +D+WS G + +EI   G  P+  +S    I  + + +++  P
Sbjct: 203 ---WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP 259
Query: 338 SQVSETYKDLVKGLLEKDASQRLS 361
                    +++G  +++  QR S
Sbjct: 260 RACPPEVYAIMRGCWQREPQQRHS 283

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 73
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 133
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 134 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 193
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKT 331
             +D+WS G + YE+         PP + +            + HLI LLK 
Sbjct: 194 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 245

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 29/232 (12%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 106
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI-CVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L++ K+  + I  +Q  S +   + YL + R 
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLY-MAPELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 226
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKT 331
             +D+WS G + YE+         PP + +            + HLI LLK 
Sbjct: 227 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 107/236 (45%), Gaps = 31/236 (13%)
Query: 126 LIGEGSFGKVFKAIHLDLKK------TVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           ++GEG FG V +    +LK+       VA+K +     S +E+     E    K  +HPN
Sbjct: 41  ILGEGEFGSVMEG---NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 180 IIKFIA-----SHETLNEFVLITEF-------AHMSLSNLLEQRKKLSETICVQILSNLI 227
           +I+ +      S + + + ++I  F        ++  S L    K +     ++ + ++ 
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS-IKGTPL-YMA 285
             + YL +   LHRDL  +N +L  D    + DFG ++ +  G +     I   P+ ++A
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 286 PELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVS-------ILHLIRLLKTQD 333
            E +A+R Y   +D+W+ G   +EI   G  P+  V        +LH  RL + +D
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPED 273

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 28/272 (10%)
Query: 122 QKICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           ++I  +GEG FGKV    +     +  + VA+K + K    G  ++ LK+E EI ++L H
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYH 82
Query: 178 PNIIKF--IASHETLNEFVLITEF-AHMSLSNLLEQRK-KLSETICVQILSNLISALYYL 233
            NI+K+  I + +  N   LI EF    SL   L + K K++    ++    +   + YL
Sbjct: 83  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPLYM-APELIA 290
            S + +HRDL  +NVL+  +    + DFG  +++       T    + +P++  APE + 
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 291 ERPYDHTADLWSLGCIAYE---------------IHMGHPPFKTVSILHLIRLLK-TQDV 334
           +  +   +D+WS G   +E               + M  P    +++  L+  LK  + +
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 262
Query: 335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELL 366
             P    +    L++   E   S R S+  L+
Sbjct: 263 PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLI 294

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 14/225 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G FG V     L+ K  VA+K I +   S ++     +E E+   L+HP +++    
Sbjct: 15  IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHPKLVQLYGV 70
Query: 187 HETLNEFVLITEFA-HMSLSNLLEQRKKL--SETICVQILSNLISALYYLHSNRVLHRDL 243
                   L+ EF  H  LS+ L  ++ L  +ET+    L ++   + YL    V+HRDL
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEASVIHRDL 129
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADL 300
             +N L+ ++ V  + DFG  R   V     TS  GT     + +PE+ +   Y   +D+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVTFPSQVSETY 344
           WS G + +E+   G  P++  S   ++  + T    +  +++ T+
Sbjct: 188 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 232

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 28/272 (10%)
Query: 122 QKICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           ++I  +GEG FGKV    +     +  + VA+K + K    G  ++ LK+E EI ++L H
Sbjct: 12  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYH 70
Query: 178 PNIIKF--IASHETLNEFVLITEF-AHMSLSNLLEQRK-KLSETICVQILSNLISALYYL 233
            NI+K+  I + +  N   LI EF    SL   L + K K++    ++    +   + YL
Sbjct: 71  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 130
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPLYM-APELIA 290
            S + +HRDL  +NVL+  +    + DFG  +++       T    + +P++  APE + 
Sbjct: 131 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 291 ERPYDHTADLWSLGCIAYE---------------IHMGHPPFKTVSILHLIRLLK-TQDV 334
           +  +   +D+WS G   +E               + M  P    +++  L+  LK  + +
Sbjct: 191 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 250
Query: 335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELL 366
             P    +    L++   E   S R S+  L+
Sbjct: 251 PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLI 282

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 39/275 (14%)
Query: 127 IGEGSFGKVFKA-----IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A     I  D   TVA+K++  S     E  +L  E ++  +L  H NI
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNI 105
Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLIS----------- 228
           +  + +       ++ITE+  +  L N L  R+K    IC +    ++            
Sbjct: 106 VNLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 229 ---------ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG 279
                     + +L S   +HRDL  +N+LL    +  +CDFG AR +   ++ +  +KG
Sbjct: 164 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV--VKG 221
Query: 280 T---PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-LHLIRLLKTQ- 332
               P+ +MAPE I    Y   +D+WS G   +E+  +G  P+  + +     +++K   
Sbjct: 222 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 281
Query: 333 DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH 367
            +  P        D++K   + D  +R ++ +++ 
Sbjct: 282 RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 133/287 (46%), Gaps = 51/287 (17%)
Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           +++I ++G+G+FG+V KA +    +  A+K I     + ++LS++  E  +   L H  +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVXLLASLNHQYV 64
Query: 181 IKFIASHETLNEFVLI--------------------TEFAHMSLSNLLEQRKKLSETICV 220
           +++ A+      FV                      T +  +   NL +QR +       
Sbjct: 65  VRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE-----YW 119
Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA----RSMAV------- 269
           ++   ++ AL Y+HS  ++HR+LKP N+ +++     + DFG A    RS+ +       
Sbjct: 120 RLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 270 ---GTHMLTSIKGTPLYMAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFKT-VSILH 324
               +  LTS  GT  Y+A E++     Y+   D +SLG I +E      PF T    ++
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERVN 236
Query: 325 LIRLLKTQDVTFPSQVSETY----KDLVKGLLEKDASQRLSWPELLH 367
           +++ L++  + FP    +      K +++ L++ D ++R     LL+
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKEL-SSLKQECEIQKHLAHPNIIKFIA 185
           +GEG FG V+K  +++       K+ +    + +EL     QE ++     H N+++ + 
Sbjct: 39  MGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 186 SHETLNEFVLITEFAHMSLSNLLEQRKKLSET------ICVQILSNLISALYYLHSNRVL 239
                ++  L+  + +M   +LL++   L  T      +  +I     + + +LH N  +
Sbjct: 98  FSSDGDDLCLV--YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMA--VGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           HRD+K  N+LL++   A + DFG AR+      T M + I GT  YMAPE +        
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL-RGEITPK 214
Query: 298 ADLWSLGCIAYEIHMGHP 315
           +D++S G +  EI  G P
Sbjct: 215 SDIYSFGVVLLEIITGLP 232

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 39/275 (14%)
Query: 127 IGEGSFGKVFKA-----IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A     I  D   TVA+K++  S     E  +L  E ++  +L  H NI
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNI 107
Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLIS----------- 228
           +  + +       ++ITE+  +  L N L  R+K    IC +    ++            
Sbjct: 108 VNLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 229 ---------ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG 279
                     + +L S   +HRDL  +N+LL    +  +CDFG AR +   ++ +  +KG
Sbjct: 166 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV--VKG 223
Query: 280 T---PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-LHLIRLLKTQ- 332
               P+ +MAPE I    Y   +D+WS G   +E+  +G  P+  + +     +++K   
Sbjct: 224 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 283
Query: 333 DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH 367
            +  P        D++K   + D  +R ++ +++ 
Sbjct: 284 RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 39/275 (14%)
Query: 127 IGEGSFGKVFKA-----IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A     I  D   TVA+K++  S     E  +L  E ++  +L  H NI
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNI 89
Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLIS----------- 228
           +  + +       ++ITE+  +  L N L  R+K    IC +    ++            
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 229 ---------ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG 279
                     + +L S   +HRDL  +N+LL    +  +CDFG AR +   ++ +  +KG
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV--VKG 205
Query: 280 T---PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-LHLIRLLKTQ- 332
               P+ +MAPE I    Y   +D+WS G   +E+  +G  P+  + +     +++K   
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265
Query: 333 DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH 367
            +  P        D++K   + D  +R ++ +++ 
Sbjct: 266 RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 120 KYQKICLIGEGSFGKVFKA-IHLD-LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           K+Q +  IGEG+FG+V KA I  D L+   A+K + K   S  +      E E+   L H
Sbjct: 25  KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 81
Query: 178 -PNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKL------------SETICVQIL 223
            PNII  + + E      L  E+A H +L + L + + L            + T+  Q L
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 224 ----SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG 279
               +++   + YL   + +HR+L  +N+L+ ++ VA + DFG +R   V  ++  ++  
Sbjct: 142 LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV--YVKKTMGR 199
Query: 280 TPL-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLI-RLLKTQDVTF 336
            P+ +MA E +    Y   +D+WS G + +EI  +G  P+  ++   L  +L +   +  
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 259
Query: 337 PSQVSETYKDLVKGLLEKDASQRLSWPELL 366
           P    +   DL++    +   +R S+ ++L
Sbjct: 260 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 14/225 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G FG V     L+ K  VA+K I +   S ++     +E E+   L+HP +++    
Sbjct: 13  IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHPKLVQLYGV 68
Query: 187 HETLNEFVLITEFA-HMSLSNLLEQRKKL--SETICVQILSNLISALYYLHSNRVLHRDL 243
                   L+ EF  H  LS+ L  ++ L  +ET+    L ++   + YL    V+HRDL
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACVIHRDL 127
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADL 300
             +N L+ ++ V  + DFG  R   V     TS  GT     + +PE+ +   Y   +D+
Sbjct: 128 AARNCLVGENQVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVTFPSQVSETY 344
           WS G + +E+   G  P++  S   ++  + T    +  +++ T+
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 14/225 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G FG V     L+ K  VA+K I +   S ++     +E E+   L+HP +++    
Sbjct: 15  IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHPKLVQLYGV 70
Query: 187 HETLNEFVLITEFA-HMSLSNLLEQRKKL--SETICVQILSNLISALYYLHSNRVLHRDL 243
                   L+ EF  H  LS+ L  ++ L  +ET+    L ++   + YL    V+HRDL
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACVIHRDL 129
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADL 300
             +N L+ ++ V  + DFG  R   V     TS  GT     + +PE+ +   Y   +D+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVTFPSQVSETY 344
           WS G + +E+   G  P++  S   ++  + T    +  +++ T+
Sbjct: 188 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 232

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 122 QKICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +KI  +GEG FGKV    +   +    + VA+K + K G   +  S  ++E EI + L H
Sbjct: 11  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KEGCGPQLRSGWQREIEILRTLYH 69
Query: 178 PNIIKFIASHETLNE--FVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLH 234
            +I+K+    E   E    L+ E+  + SL + L  R  +     +     +   + YLH
Sbjct: 70  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP-RHCVGLAQLLLFAQQICEGMAYLH 128
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKGTPLYM-APELIAE 291
           +   +HR L  +NVLL+ D +  + DFG A+++  G   + +     +P++  APE + E
Sbjct: 129 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 292 RPYDHTADLWSLGCIAYEI 310
             + + +D+WS G   YE+
Sbjct: 189 CKFYYASDVWSFGVTLYEL 207

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 14/225 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G FG V     L+ K  VA+K I +   S ++     +E E+   L+HP +++    
Sbjct: 18  IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHPKLVQLYGV 73
Query: 187 HETLNEFVLITEFA-HMSLSNLLEQRKKL--SETICVQILSNLISALYYLHSNRVLHRDL 243
                   L+ EF  H  LS+ L  ++ L  +ET+    L ++   + YL    V+HRDL
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACVIHRDL 132
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADL 300
             +N L+ ++ V  + DFG  R   V     TS  GT     + +PE+ +   Y   +D+
Sbjct: 133 AARNCLVGENQVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 190
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVTFPSQVSETY 344
           WS G + +E+   G  P++  S   ++  + T    +  +++ T+
Sbjct: 191 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 235

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 127 IGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  +  +  + VA+K +  S  + + L   ++E EI K L H NI+K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVK 78
Query: 183 F--IASHETLNEFVLITEF-AHMSLSNLLE-QRKKLSETICVQILSNLISALYYLHSNRV 238
           +  +          LI E+  + SL + L+   +++     +Q  S +   + YL + R 
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM--LTSIKGTPLYM-APELIAERPYD 295
           +HRDL  +N+L+  +    + DFG  + +        +     +P++  APE + E  + 
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 296 HTADLWSLGCIAYEIHM-----GHPPFKTVS-----------ILHLIRLLKTQD-VTFPS 338
             +D+WS G + YE+         PP + +            + HLI LLK    +  P 
Sbjct: 199 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 258
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPEL-LHHPLVKDNLSS 377
              +    ++      + +QR S+ +L L    ++DN++ 
Sbjct: 259 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 298

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 122 QKICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +KI  +GEG FGKV    +   +    + VA+K + K G   +  S  ++E EI + L H
Sbjct: 12  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KEGCGPQLRSGWQREIEILRTLYH 70
Query: 178 PNIIKFIASHETLNE--FVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLH 234
            +I+K+    E   E    L+ E+  + SL + L  R  +     +     +   + YLH
Sbjct: 71  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP-RHCVGLAQLLLFAQQICEGMAYLH 129
Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKGTPLYM-APELIAE 291
           +   +HR L  +NVLL+ D +  + DFG A+++  G   + +     +P++  APE + E
Sbjct: 130 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 292 RPYDHTADLWSLGCIAYEI 310
             + + +D+WS G   YE+
Sbjct: 190 CKFYYASDVWSFGVTLYEL 208

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 39/275 (14%)
Query: 127 IGEGSFGKVFKA-----IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A     I  D   TVA+K++  S     E  +L  E ++  +L  H NI
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNI 112
Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLIS----------- 228
           +  + +       ++ITE+  +  L N L  R+K    IC +    ++            
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 229 ---------ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG 279
                     + +L S   +HRDL  +N+LL    +  +CDFG AR +   ++ +  +KG
Sbjct: 171 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV--VKG 228
Query: 280 T---PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-LHLIRLLKTQ- 332
               P+ +MAPE I    Y   +D+WS G   +E+  +G  P+  + +     +++K   
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 288
Query: 333 DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH 367
            +  P        D++K   + D  +R ++ +++ 
Sbjct: 289 RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 109/238 (45%), Gaps = 15/238 (6%)
Query: 95  SKLGEPWF----HNHCQPVKMEKSNGALEKYQKI---CLIGEGSFGKV-FKAIHLDLKKT 146
            KL EP F    H + +P +  +S     +  +I    +IG G  G+V +  + +  ++ 
Sbjct: 18  GKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRD 77
Query: 147 VALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA-HMSL 204
           V + I + K+G + ++      E  I     HPNII+           +++TE+  + SL
Sbjct: 78  VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
Query: 205 SNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGF 263
              L     + +    V +L  + + + YL     +HRDL  +NVL++ + V  + DFG 
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 264 ARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPF 317
           +R +        +  G  +   + APE IA R +   +D+WS G + +E+   G  P+
Sbjct: 198 SRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 108/238 (45%), Gaps = 52/238 (21%)
Query: 119 EKYQKICLIGEGSFGKVFKAI-HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           E+Y+ +  +GEG+FGKV + + H   K  VALKII   G+  +E + L    EI      
Sbjct: 28  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY-REAARL----EI------ 76
Query: 178 PNIIKFIASHETLNEF--VLITEF----AHMSLS------NLLEQRKKLSETI-----CV 220
            N++K I   +  N+F  VL++++     HM ++      N  E  K+ +          
Sbjct: 77  -NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR 135
Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLLN-------------------KDGVAMLCDF 261
            +   L  AL +LH N++ H DLKP+N+L                     K+    + DF
Sbjct: 136 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 195
Query: 262 GFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT 319
           G   S        T+I  T  Y  PE+I E  +    D+WS+GCI +E + G   F+T
Sbjct: 196 G---SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 250

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 108/238 (45%), Gaps = 52/238 (21%)
Query: 119 EKYQKICLIGEGSFGKVFKAI-HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           E+Y+ +  +GEG+FGKV + + H   K  VALKII   G+  +E + L    EI      
Sbjct: 51  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY-REAARL----EI------ 99
Query: 178 PNIIKFIASHETLNEF--VLITEF----AHMSLS------NLLEQRKKLSETI-----CV 220
            N++K I   +  N+F  VL++++     HM ++      N  E  K+ +          
Sbjct: 100 -NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR 158
Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLLN-------------------KDGVAMLCDF 261
            +   L  AL +LH N++ H DLKP+N+L                     K+    + DF
Sbjct: 159 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 218
Query: 262 GFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT 319
           G   S        T+I  T  Y  PE+I E  +    D+WS+GCI +E + G   F+T
Sbjct: 219 G---SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 273

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 115/247 (46%), Gaps = 25/247 (10%)
Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           A + +    ++G G FGKV+K    D    VA+K + +    G EL   + E E+     
Sbjct: 28  ASDNFXNKNILGRGGFGKVYKGRLAD-GXLVAVKRLKEERTQGGELQ-FQTEVEMISMAV 85
Query: 177 HPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKK----LSETICVQILSNLISALY 231
           H N+++      T  E +L+  + A+ S+++ L +R +    L      +I       L 
Sbjct: 86  HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLA 145
Query: 232 YLHSN---RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV-GTHMLTSIKGTPLYMAPE 287
           YLH +   +++HRD+K  N+LL+++  A++ DFG A+ M     H+  +++G   ++APE
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPE 205
Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDL 347
            ++        D++  G +  E+  G   F       L RL    DV           D 
Sbjct: 206 YLSTGKSSEKTDVFGYGVMLLELITGQRAF------DLARLANDDDVML--------LDW 251
Query: 348 VKGLLEK 354
           VKGLL++
Sbjct: 252 VKGLLKE 258

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 112/255 (43%), Gaps = 29/255 (11%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-----KELSSLKQECEIQKHLAHPNII 181
           IG+G FG V K   +  K  VA+K +      G     ++    ++E  I  +L HPNI+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 182 KFIA----SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           K           + EFV   +  H     LL++   +  ++ ++++ ++   + Y+ +  
Sbjct: 87  KLYGLMHNPPRMVMEFVPCGDLYH----RLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 238 --VLHRDLKPQNVLL-----NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
             ++HRDL+  N+ L     N    A + DFG ++      H ++ + G   +MAPE I 
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSGLLGNFQWMAPETIG 199
Query: 291 --ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI--LHLIRLLKTQDV--TFPSQVSETY 344
             E  Y   AD +S   I Y I  G  PF   S   +  I +++ + +  T P       
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259
Query: 345 KDLVKGLLEKDASQR 359
           +++++     D  +R
Sbjct: 260 RNVIELCWSGDPKKR 274

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKEL-SSLKQECEIQKHLAHPNIIKFIA 185
           +GEG FG V+K  +++       K+ +    + +EL     QE ++     H N+++ + 
Sbjct: 39  MGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 186 SHETLNEFVLITEFAHMSLSNLLEQRKKLSET------ICVQILSNLISALYYLHSNRVL 239
                ++  L+  + +M   +LL++   L  T      +  +I     + + +LH N  +
Sbjct: 98  FSSDGDDLCLV--YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMA--VGTHMLTSIKGTPLYMAPELIAERPYDHT 297
           HRD+K  N+LL++   A + DFG AR+      T M   I GT  YMAPE +        
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL-RGEITPK 214
Query: 298 ADLWSLGCIAYEIHMGHP 315
           +D++S G +  EI  G P
Sbjct: 215 SDIYSFGVVLLEIITGLP 232

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 107/238 (44%), Gaps = 52/238 (21%)
Query: 119 EKYQKICLIGEGSFGKVFKAI-HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           E+Y+ +  +GEG+FGKV + + H   K  VALKII   G+  +E + L    EI      
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY-REAARL----EI------ 67
Query: 178 PNIIKFIASHETLNEF--VLITEF----AHMSLS------NLLEQRKK-----LSETICV 220
            N++K I   +  N+F  VL++++     HM ++      N  E  K+            
Sbjct: 68  -NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR 126
Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLLN-------------------KDGVAMLCDF 261
            +   L  AL +LH N++ H DLKP+N+L                     K+    + DF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 262 GFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT 319
           G   S        T+I  T  Y  PE+I E  +    D+WS+GCI +E + G   F+T
Sbjct: 187 G---SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 11/218 (5%)
Query: 122 QKICLIGEGSFGKVFKAIHL----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +K+ ++G G+FG V+K I +    ++K  VA+K++ +   S K    +  E  +   +  
Sbjct: 20  RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVGS 78
Query: 178 PNIIKFIASHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           P + + +    T +   L+T+       L ++ E R +L     +     +   + YL  
Sbjct: 79  PYVSRLLGICLT-STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED 137
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIAERP 293
            R++HRDL  +NVL+       + DFG AR + +      +  G  P+ +MA E I  R 
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 294 YDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           + H +D+WS G   +E+   G  P+  +    +  LL+
Sbjct: 198 FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 235

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 109/238 (45%), Gaps = 15/238 (6%)
Query: 95  SKLGEPWF----HNHCQPVKMEKSNGALEKYQKI---CLIGEGSFGKV-FKAIHLDLKKT 146
            KL EP F    H + +P +  +S     +  +I    +IG G  G+V +  + +  ++ 
Sbjct: 18  GKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRD 77
Query: 147 VALKIIS-KSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA-HMSL 204
           V + I + K+G + ++      E  I     HPNII+           +++TE+  + SL
Sbjct: 78  VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
Query: 205 SNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGF 263
              L     + +    V +L  + + + YL     +HRDL  +NVL++ + V  + DFG 
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 264 ARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPF 317
           +R +        +  G  +   + APE IA R +   +D+WS G + +E+   G  P+
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 131/277 (47%), Gaps = 26/277 (9%)
Query: 122 QKICLI---GEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQK 173
           +KI L+   G+GSFG V++    D+ K      VA+K +++S  S +E      E  + K
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMK 75
Query: 174 HLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI----------CVQI 222
                ++++ +         +++ E  AH  L + L   +  +E             +Q+
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TP 281
            + +   + YL++ + +HRDL  +N ++  D    + DFG  R +    +     KG  P
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLP 195
Query: 282 L-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQD-VTFPS 338
           + +MAPE + +  +  ++D+WS G + +EI  +   P++ +S   +++ +     +  P 
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL 375
              E   DL++   + +   R ++ E+++  L+KD+L
Sbjct: 256 NCPERVTDLMRMCWQFNPKMRPTFLEIVN--LLKDDL 290

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 17/221 (7%)
Query: 122 QKICLIGEGSFGKVFKAIHLD----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +++ ++G G+FG V+K I +     +K  VA+KI++++    K       E  I   + H
Sbjct: 18  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDH 76
Query: 178 PNIIKFIASHETLNEFV-LITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           P++++ +     L+  + L+T+   M    LLE   +  + I  Q+L N    +   + Y
Sbjct: 77  PHLVRLLGV--CLSPTIQLVTQL--MPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 132
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG AR +        +  G  P+ +MA E I 
Sbjct: 133 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
            R + H +D+WS G   +E+   G  P+  +    +  LL+
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 233

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 38/231 (16%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A    L K      VA+K++ KS     E  +L  E +I  HL  H NI
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENI 97
Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLL-----------------------EQRKKLSE 216
           +  + +       ++ITE+  +  L N L                       E  + L  
Sbjct: 98  VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLEL 157
Query: 217 TICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS 276
              +   S +   + +L S   +HRD+  +NVLL    VA + DFG AR +   ++ +  
Sbjct: 158 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-- 215
Query: 277 IKGT---PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI 322
           +KG    P+ +MAPE I +  Y   +D+WS G + +EI  +G  P+  + +
Sbjct: 216 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 266

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 39/275 (14%)
Query: 127 IGEGSFGKVFKA-----IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A     I  D   TVA+K++  S     E  +L  E ++  +L  H NI
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNI 112
Query: 181 IKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLIS----------- 228
           +  + +       ++ITE+  +  L N L  R+K    IC +    ++            
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 229 ---------ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG 279
                     + +L S   +HRDL  +N+LL    +  +CDFG AR +   ++ +  +KG
Sbjct: 171 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYV--VKG 228
Query: 280 T---PL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSI-LHLIRLLKTQ- 332
               P+ +MAPE I    Y   +D+WS G   +E+  +G  P+  + +     +++K   
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 288
Query: 333 DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH 367
            +  P        D++K   + D  +R ++ +++ 
Sbjct: 289 RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 131/277 (47%), Gaps = 26/277 (9%)
Query: 122 QKICLI---GEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQK 173
           +KI L+   G+GSFG V++    D+ K      VA+K +++S  S +E      E  + K
Sbjct: 16  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMK 74
Query: 174 HLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI----------CVQI 222
                ++++ +         +++ E  AH  L + L   +  +E             +Q+
Sbjct: 75  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 134
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TP 281
            + +   + YL++ + +HRDL  +N ++  D    + DFG  R +    +     KG  P
Sbjct: 135 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 282 L-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQD-VTFPS 338
           + +MAPE + +  +  ++D+WS G + +EI  +   P++ +S   +++ +     +  P 
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 254
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL 375
              E   DL++   + +   R ++ E+++  L+KD+L
Sbjct: 255 NCPERVTDLMRMCWQFNPKMRPTFLEIVN--LLKDDL 289

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 14/225 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G FG V     L+ K  VA+K I +   S  +     +E E+   L+HP +++    
Sbjct: 35  IGSGQFGLVHLGYWLN-KDKVAIKTIKEGSMSEDDFI---EEAEVMMKLSHPKLVQLYGV 90
Query: 187 HETLNEFVLITEFA-HMSLSNLLEQRKKL--SETICVQILSNLISALYYLHSNRVLHRDL 243
                   L+ EF  H  LS+ L  ++ L  +ET+    L ++   + YL    V+HRDL
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACVIHRDL 149
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADL 300
             +N L+ ++ V  + DFG  R   V     TS  GT     + +PE+ +   Y   +D+
Sbjct: 150 AARNCLVGENQVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 207
Query: 301 WSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVTFPSQVSETY 344
           WS G + +E+   G  P++  S   ++  + T    +  +++ T+
Sbjct: 208 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 252

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 131/277 (47%), Gaps = 26/277 (9%)
Query: 122 QKICLI---GEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQK 173
           +KI L+   G+GSFG V++    D+ K      VA+K +++S  S +E      E  + K
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMK 75
Query: 174 HLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI----------CVQI 222
                ++++ +         +++ E  AH  L + L   +  +E             +Q+
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TP 281
            + +   + YL++ + +HRDL  +N ++  D    + DFG  R +          KG  P
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 282 L-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQD-VTFPS 338
           + +MAPE + +  +  ++D+WS G + +EI  +   P++ +S   +++ +     +  P 
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL 375
              E   DL++   + + + R ++ E+++  L+KD+L
Sbjct: 256 NCPERVTDLMRMCWQFNPNMRPTFLEIVN--LLKDDL 290

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 131/277 (47%), Gaps = 26/277 (9%)
Query: 122 QKICLI---GEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQK 173
           +KI L+   G+GSFG V++    D+ K      VA+K +++S  S +E      E  + K
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMK 75
Query: 174 HLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI----------CVQI 222
                ++++ +         +++ E  AH  L + L   +  +E             +Q+
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TP 281
            + +   + YL++ + +HRDL  +N ++  D    + DFG  R +    +     KG  P
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 282 L-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQD-VTFPS 338
           + +MAPE + +  +  ++D+WS G + +EI  +   P++ +S   +++ +     +  P 
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL 375
              E   DL++   + +   R ++ E+++  L+KD+L
Sbjct: 256 NCPERVTDLMRMCWQFNPKMRPTFLEIVN--LLKDDL 290

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 17/221 (7%)
Query: 122 QKICLIGEGSFGKVFKAIHLD----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +++ ++G G+FG V+K I +     +K  VA+KI++++    K       E  I   + H
Sbjct: 41  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDH 99
Query: 178 PNIIKFIASHETLNEFV-LITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           P++++ +     L+  + L+T+   M    LLE   +  + I  Q+L N    +   + Y
Sbjct: 100 PHLVRLLGV--CLSPTIQLVTQL--MPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG AR +        +  G  P+ +MA E I 
Sbjct: 156 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
            R + H +D+WS G   +E+   G  P+  +    +  LL+
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 256

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V + ++   KK   VA+K++ K G    +   + +E +I   L +P I++ I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 185 ASHETLNEFVLITEFAHMSLSN--LLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
              +     +L+ E A     +  L+ +R+++  +   ++L  +   + YL     +HR+
Sbjct: 403 GVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPL-YMAPELIAERPYDHTAD 299
           L  +NVLL     A + DFG ++++       T  S    PL + APE I  R +   +D
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 521
Query: 300 LWSLGCIAYE-IHMGHPPFKTV 320
           +WS G   +E +  G  P+K +
Sbjct: 522 VWSYGVTMWEALSYGQKPYKKM 543

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 130/277 (46%), Gaps = 26/277 (9%)
Query: 122 QKICLI---GEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQK 173
           +KI L+   G+GSFG V++    D+ K      VA+K +++S  S +E      E  + K
Sbjct: 14  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMK 72
Query: 174 HLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI----------CVQI 222
                ++++ +         +++ E  AH  L + L   +  +E             +Q+
Sbjct: 73  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 132
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TP 281
            + +   + YL++ + +HRDL  +N ++  D    + DFG  R +          KG  P
Sbjct: 133 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 282 L-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQD-VTFPS 338
           + +MAPE + +  +  ++D+WS G + +EI  +   P++ +S   +++ +     +  P 
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 252
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL 375
              E   DL++   + +   R ++ E+++  L+KD+L
Sbjct: 253 NCPERVTDLMRMCWQFNPKMRPTFLEIVN--LLKDDL 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 112/255 (43%), Gaps = 29/255 (11%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-----KELSSLKQECEIQKHLAHPNII 181
           IG+G FG V K   +  K  VA+K +      G     ++    ++E  I  +L HPNI+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 182 KFIA----SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           K           + EFV   +  H     LL++   +  ++ ++++ ++   + Y+ +  
Sbjct: 87  KLYGLMHNPPRMVMEFVPCGDLYH----RLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 238 --VLHRDLKPQNVLL-----NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
             ++HRDL+  N+ L     N    A + DFG ++      H ++ + G   +MAPE I 
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ---SVHSVSGLLGNFQWMAPETIG 199
Query: 291 --ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI--LHLIRLLKTQDV--TFPSQVSETY 344
             E  Y   AD +S   I Y I  G  PF   S   +  I +++ + +  T P       
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259
Query: 345 KDLVKGLLEKDASQR 359
           +++++     D  +R
Sbjct: 260 RNVIELCWSGDPKKR 274

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 130/277 (46%), Gaps = 26/277 (9%)
Query: 122 QKICLI---GEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQK 173
           +KI L+   G+GSFG V++    D+ K      VA+K +++S  S +E      E  + K
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMK 75
Query: 174 HLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI----------CVQI 222
                ++++ +         +++ E  AH  L + L   +  +E             +Q+
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TP 281
            + +   + YL++ + +HRDL  +N ++  D    + DFG  R +          KG  P
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 282 L-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQD-VTFPS 338
           + +MAPE + +  +  ++D+WS G + +EI  +   P++ +S   +++ +     +  P 
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL 375
              E   DL++   + +   R ++ E+++  L+KD+L
Sbjct: 256 NCPERVTDLMRMCWQFNPKMRPTFLEIVN--LLKDDL 290

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 94
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + YL S + 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKF 153
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSM----AVGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKF 213
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 214 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 273
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 274 HPKAEMRPSFSELV 287

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 218 ICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM---------- 267
           +C+ I   +  A+ +LHS  ++HRDLKP N+    D V  + DFG   +M          
Sbjct: 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 268 ----AVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYE-IHMGHPPFKTVSI 322
               A  TH      GT LYM+PE I    Y H  D++SLG I +E ++      + V I
Sbjct: 225 TPMPAYATH--XGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI 282
Query: 323 LHLIRLLKTQDVTFPSQVSETYKD---LVKGLLEKDASQR 359
           +  +R LK     FP   ++ Y     +V+ +L    ++R
Sbjct: 283 ITDVRNLK-----FPLLFTQKYPQEHMMVQDMLSPSPTER 317

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 87/175 (49%), Gaps = 25/175 (14%)
Query: 222 ILSNLISALYYLHSNR-VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
           I+ +++++  Y+H+ + + HRD+KP N+L++K+G   L DFG +  M      +   +GT
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSRGT 213
Query: 281 PLYMAPELIA-ERPYDHT-ADLWSLGCIAYEIHMGHPPFK-TVSILHLIRLLKTQDVTFP 337
             +M PE  + E  Y+    D+WSLG   Y +     PF   +S++ L   ++T+++ +P
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP 273
Query: 338 --------------SQVSETYK-----DLVKGLLEKDASQRLSWPELLHHPLVKD 373
                         S  S  +      D +K  L K+ ++R++  + L H  + D
Sbjct: 274 LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V K      +  VA+K+I +   S  E     QE +    L+HP ++KF   
Sbjct: 16  LGSGQFG-VVKLGKWKGQYDVAVKMIKEGSMSEDEFF---QEAQTMMKLSHPKLVKFYGV 71
Query: 187 HETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   ++TE+      L+ L    K L  +  +++  ++   + +L S++ +HRDL 
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWSL 303
            +N L+++D    + DFG  R +    ++ +     P+ + APE+     Y   +D+W+ 
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAF 191
Query: 304 GCIAYEIH-MGHPPF 317
           G + +E+  +G  P+
Sbjct: 192 GILMWEVFSLGKMPY 206

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 76  NPHVCRLLGICLT-STVQLITQL--MPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 90
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + YL S + 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKF 149
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSM----AVGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 210 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 269
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 270 HPKAEMRPSFSELV 283

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 95
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + YL S + 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKF 154
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSM----AVGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 274
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 275 HPKAEMRPSFSELV 288

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 95
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + YL S + 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKF 154
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSM----AVGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 274
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 275 HPKAEMRPSFSELV 288

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 93
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + YL S + 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKF 152
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSM----AVGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 212
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 213 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 272
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 273 HPKAEMRPSFSELV 286

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 91/189 (48%), Gaps = 7/189 (3%)
Query: 135 VFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ-ECEIQKHLAHPNIIKFIASHETLNEF 193
           V++A     ++ VALK+ S++  S     +  Q E      L  P+++      E   + 
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQL 109
Query: 194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK 252
            +     + + L+  L ++  L+    V I+  + SAL   H+    HRD+KP+N+L++ 
Sbjct: 110 YVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169
Query: 253 DGVAMLCDFGFARSMAVGTHMLTSIK---GTPLYMAPELIAERPYDHTADLWSLGCIAYE 309
           D  A L DFG A   A     LT +    GT  Y APE  +E    + AD+++L C+ YE
Sbjct: 170 DDFAYLVDFGIA--SATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYE 227
Query: 310 IHMGHPPFK 318
              G PP++
Sbjct: 228 CLTGSPPYQ 236

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 52/238 (21%)
Query: 119 EKYQKICLIGEGSFGKVFKAI-HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           E+Y+ +  +GEG+FG+V + + H      VALKII K+    KE + L    EI      
Sbjct: 33  ERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKII-KNVEKYKEAARL----EI------ 81
Query: 178 PNIIKFIASHETLNEFVLITEF------AHMSLS---------NLLEQRKKLSETI--CV 220
            N+++ I   +  N+ + +  F       HM +S         + L+    L   I    
Sbjct: 82  -NVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVR 140
Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVL-LNKD------------------GVAMLCDF 261
            +   L  A+ +LH N++ H DLKP+N+L +N D                      + DF
Sbjct: 141 HMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDF 200
Query: 262 GFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT 319
           G   S        ++I  T  Y APE+I E  +    D+WS+GCI +E ++G   F+T
Sbjct: 201 G---SATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQT 255

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 94
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + YL S + 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKF 153
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSM----AVGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 213
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 214 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 273
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 274 HPKAEMRPSFSELV 287

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 92
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + YL S + 
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKF 151
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSM----AVGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 211
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 271
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 272 HPKAEMRPSFSELV 285

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 87
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + YL S + 
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKF 146
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSM----AVGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 147 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 206
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 207 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 266
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 267 HPKAEMRPSFSELV 280

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/277 (22%), Positives = 132/277 (47%), Gaps = 26/277 (9%)
Query: 122 QKICLI---GEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQK 173
           +KI L+   G+GSFG V++    D+ K      VA+K +++S  S +E      E  + K
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMK 75
Query: 174 HLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI----------CVQI 222
                ++++ +         +++ E  AH  L + L   +  +E             +Q+
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TP 281
            + +   + YL++ + +HR+L  +N ++  D    + DFG  R +    +     KG  P
Sbjct: 136 AAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 282 L-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQD-VTFPS 338
           + +MAPE + +  +  ++D+WS G + +EI  +   P++ +S   +++ +     +  P 
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL 375
              E   DL++   + + + R ++ E+++  L+KD+L
Sbjct: 256 NCPERVTDLMRMCWQFNPNMRPTFLEIVN--LLKDDL 290

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/277 (22%), Positives = 132/277 (47%), Gaps = 26/277 (9%)
Query: 122 QKICLI---GEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQK 173
           +KI L+   G+GSFG V++    D+ K      VA+K +++S  S +E      E  + K
Sbjct: 18  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMK 76
Query: 174 HLAHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETI----------CVQI 222
                ++++ +         +++ E  AH  L + L   +  +E             +Q+
Sbjct: 77  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 136
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TP 281
            + +   + YL++ + +HR+L  +N ++  D    + DFG  R +    +     KG  P
Sbjct: 137 AAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 282 L-YMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQD-VTFPS 338
           + +MAPE + +  +  ++D+WS G + +EI  +   P++ +S   +++ +     +  P 
Sbjct: 197 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 256
Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL 375
              E   DL++   + + + R ++ E+++  L+KD+L
Sbjct: 257 NCPERVTDLMRMCWQFNPNMRPTFLEIVN--LLKDDL 291

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 114
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + YL S + 
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKF 173
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSM----AVGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 174 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 233
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 234 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 293
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 294 HPKAEMRPSFSELV 307

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 73  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNY 129
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 130 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 189
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 190 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 221

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 101 NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 158 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 217
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 218 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 249

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 113
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + YL S + 
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKF 172
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSM----AVGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 173 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 232
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 233 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 292
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 293 HPKAEMRPSFSELV 306

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 70  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKEL-SSLKQECEIQKHLAHPNIIKFIA 185
           +GEG FG V+K  +++       K+ +    + +EL     QE ++     H N+++ + 
Sbjct: 33  MGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 186 SHETLNEFVLITEFAHMSLSNLLEQRKKLSET------ICVQILSNLISALYYLHSNRVL 239
                ++  L+  + +M   +LL++   L  T      +  +I     + + +LH N  +
Sbjct: 92  FSSDGDDLCLV--YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 149
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHT 297
           HRD+K  N+LL++   A + DFG AR+        M   I GT  YMAPE +        
Sbjct: 150 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL-RGEITPK 208
Query: 298 ADLWSLGCIAYEIHMGHP 315
           +D++S G +  EI  G P
Sbjct: 209 SDIYSFGVVLLEIITGLP 226

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 78  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 226

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 76  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 82  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 139 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 198
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 199 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 230

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 76  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 79  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 227

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 79  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 227

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 79  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 227

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 86  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 143 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 202
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 203 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 234

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 83  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 231

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 89/385 (23%), Positives = 152/385 (39%), Gaps = 68/385 (17%)
Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 71
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 72  KFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGS 131
             + +                             C      K  G L    + C      
Sbjct: 95  NLLGA-----------------------------CT-----KPGGPLMVIVEFC-----K 115
Query: 132 FGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN 191
           FG +   +     + V  K      R GK+        ++++ L      +  AS   + 
Sbjct: 116 FGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG-AIPVDLKRRLDSITSSQSSASSGFVE 174
Query: 192 EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN 251
           E  L       +  +L +    L   IC      +   + +L S + +HRDL  +N+LL+
Sbjct: 175 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSF--QVAKGMEFLASRKCIHRDLAARNILLS 232
Query: 252 KDGVAMLCDFGFARSMAVGTHMLTSIKGT-PL-YMAPELIAERPYDHTADLWSLGCIAYE 309
           +  V  +CDFG AR +      +       PL +MAPE I +R Y   +D+WS G + +E
Sbjct: 233 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 292
Query: 310 IH-MGHPPFKTVSI-------LHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS 361
           I  +G  P+  V I       L     ++  D T P ++ +T  D   G    + SQR +
Sbjct: 293 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP-EMYQTMLDCWHG----EPSQRPT 347
Query: 362 WPELLHHPLVKDNLSSEIESQNNQD 386
           + EL+ H      L + +++   QD
Sbjct: 348 FSELVEH------LGNLLQANAQQD 366

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 86/367 (23%), Positives = 145/367 (39%), Gaps = 62/367 (16%)
Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 71
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 28  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 72  KFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGS 131
             + +                             C      K  G L    + C      
Sbjct: 88  NLLGA-----------------------------CT-----KPGGPLMVIVEFC-----K 108
Query: 132 FGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN 191
           FG +   +     + V  K      R GK+        ++++ L      +  AS   + 
Sbjct: 109 FGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG-AIPVDLKRRLDSITSSQSSASSGFVE 167
Query: 192 EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN 251
           E  L       +  +L +    L   IC      +   + +L S + +HRDL  +N+LL+
Sbjct: 168 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSF--QVAKGMEFLASRKCIHRDLAARNILLS 225
Query: 252 KDGVAMLCDFGFARSMAVGTHMLTSIKGT-PL-YMAPELIAERPYDHTADLWSLGCIAYE 309
           +  V  +CDFG AR +      +       PL +MAPE I +R Y   +D+WS G + +E
Sbjct: 226 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 285
Query: 310 IH-MGHPPFKTVSI-------LHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS 361
           I  +G  P+  V I       L     ++  D T P ++ +T  D   G    + SQR +
Sbjct: 286 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP-EMYQTMLDCWHG----EPSQRPT 340
Query: 362 WPELLHH 368
           + EL+ H
Sbjct: 341 FSELVEH 347

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 89/385 (23%), Positives = 152/385 (39%), Gaps = 68/385 (17%)
Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 71
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 72  KFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGS 131
             + +                             C      K  G L    + C      
Sbjct: 97  NLLGA-----------------------------CT-----KPGGPLMVIVEFC-----K 117
Query: 132 FGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN 191
           FG +   +     + V  K      R GK+        ++++ L      +  AS   + 
Sbjct: 118 FGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG-AIPVDLKRRLDSITSSQSSASSGFVE 176
Query: 192 EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN 251
           E  L       +  +L +    L   IC      +   + +L S + +HRDL  +N+LL+
Sbjct: 177 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSF--QVAKGMEFLASRKCIHRDLAARNILLS 234
Query: 252 KDGVAMLCDFGFARSMAVGTHMLTSIKGT-PL-YMAPELIAERPYDHTADLWSLGCIAYE 309
           +  V  +CDFG AR +      +       PL +MAPE I +R Y   +D+WS G + +E
Sbjct: 235 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 294
Query: 310 IH-MGHPPFKTVSI-------LHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS 361
           I  +G  P+  V I       L     ++  D T P ++ +T  D   G    + SQR +
Sbjct: 295 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP-EMYQTMLDCWHG----EPSQRPT 349
Query: 362 WPELLHHPLVKDNLSSEIESQNNQD 386
           + EL+ H      L + +++   QD
Sbjct: 350 FSELVEH------LGNLLQANAQQD 368

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 86/367 (23%), Positives = 145/367 (39%), Gaps = 62/367 (16%)
Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIIS----KSGRSGKELSSLKQECEIQKHLAHP-NII 71
           +G G+FG+V +A    + KT   + ++    K G +  E  +L  E +I  H+ H  N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 72  KFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGS 131
             + +                             C      K  G L    + C      
Sbjct: 90  NLLGA-----------------------------CT-----KPGGPLMVIVEFC-----K 110
Query: 132 FGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN 191
           FG +   +     + V  K      R GK+        ++++ L      +  AS   + 
Sbjct: 111 FGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG-AIPVDLKRRLDSITSSQSSASSGFVE 169
Query: 192 EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN 251
           E  L       +  +L +    L   IC      +   + +L S + +HRDL  +N+LL+
Sbjct: 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSF--QVAKGMEFLASRKCIHRDLAARNILLS 227
Query: 252 KDGVAMLCDFGFARSMAVGTHMLTSIKGT-PL-YMAPELIAERPYDHTADLWSLGCIAYE 309
           +  V  +CDFG AR +      +       PL +MAPE I +R Y   +D+WS G + +E
Sbjct: 228 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 287
Query: 310 IH-MGHPPFKTVSI-------LHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS 361
           I  +G  P+  V I       L     ++  D T P ++ +T  D   G    + SQR +
Sbjct: 288 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP-EMYQTMLDCWHG----EPSQRPT 342
Query: 362 WPELLHH 368
           + EL+ H
Sbjct: 343 FSELVEH 349

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 111/255 (43%), Gaps = 29/255 (11%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-----KELSSLKQECEIQKHLAHPNII 181
           IG+G FG V K   +  K  VA+K +      G     ++    ++E  I  +L HPNI+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 182 KFIA----SHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           K           + EFV   +  H     LL++   +  ++ ++++ ++   + Y+ +  
Sbjct: 87  KLYGLMHNPPRMVMEFVPCGDLYH----RLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 238 --VLHRDLKPQNVLL-----NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
             ++HRDL+  N+ L     N    A + DF  ++      H ++ + G   +MAPE I 
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ---SVHSVSGLLGNFQWMAPETIG 199
Query: 291 --ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI--LHLIRLLKTQDV--TFPSQVSETY 344
             E  Y   AD +S   I Y I  G  PF   S   +  I +++ + +  T P       
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259
Query: 345 KDLVKGLLEKDASQR 359
           +++++     D  +R
Sbjct: 260 RNVIELCWSGDPKKR 274

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQK--HLAHPNIIKFI 184
           +G+G +G+V++       + VA+KI S      ++  S  +E E+     L H NI+ FI
Sbjct: 16  VGKGRYGEVWRGSWQG--ENVAVKIFS-----SRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 185 ASHETL----NEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLH----- 234
           AS  T      +  LIT +  M SL + L Q   L    C++I+ ++ S L +LH     
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 235 ---SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML----TSIKGTPLYMAPE 287
                 + HRDLK +N+L+ K+G   + D G A   +  T+ L        GT  YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 288 LIAERP----YD--HTADLWSLGCIAYEI 310
           ++ E      +D     D+W+ G + +E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH--LAHPNIIKFI 184
           +G+G +G+V++       + VA+KI S      ++  S  +E E+     L H NI+ FI
Sbjct: 45  VGKGRYGEVWRGSWQ--GENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFI 97
Query: 185 ASHETL----NEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLH----- 234
           AS  T      +  LIT +  M SL + L Q   L    C++I+ ++ S L +LH     
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 156
Query: 235 ---SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML----TSIKGTPLYMAPE 287
                 + HRDLK +N+L+ K+G   + D G A   +  T+ L        GT  YMAPE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 216
Query: 288 LIAERP----YD--HTADLWSLGCIAYEI 310
           ++ E      +D     D+W+ G + +E+
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH--LAHPNIIKFI 184
           +G+G +G+V++       + VA+KI S      ++  S  +E E+     L H NI+ FI
Sbjct: 16  VGKGRYGEVWRGSWQG--ENVAVKIFS-----SRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 185 ASHETL----NEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLH----- 234
           AS  T      +  LIT +  M SL + L Q   L    C++I+ ++ S L +LH     
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 235 ---SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML----TSIKGTPLYMAPE 287
                 + HRDLK +N+L+ K+G   + D G A   +  T+ L        GT  YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 288 LIAERP----YD--HTADLWSLGCIAYEI 310
           ++ E      +D     D+W+ G + +E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 78  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 226

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 76  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 83  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 231

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 44/273 (16%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKI---ISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +G+G+FG+V    H+D KK  A+K+   I K  RS K  + + ++ +      + NI+K+
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN-NIVKY 101
Query: 184 IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI------CVQILSNLISALYYLHSNR 237
                  +   LI E    SL  ++ +       I      C++IL     AL YL    
Sbjct: 102 HGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILK----ALNYLRKMS 157
Query: 238 VLHRDLKPQNVLLNK--------------DGVAM-----------LCDFGFARSMAVGTH 272
           + H DLKP+N+LL+               DG  +           L DFG A      + 
Sbjct: 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA---TFKSD 214
Query: 273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ 332
              SI  T  Y APE+I    +D ++D+WS GC+  E++ G   F+T   +  + ++++ 
Sbjct: 215 YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI 274
Query: 333 DVTFP-SQVSETYKDLVKGLLEKDASQRLSWPE 364
               P + + E  K      + KD   +L+WPE
Sbjct: 275 IQPIPKNMLYEATKTNGSKYVNKD-ELKLAWPE 306

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 109/241 (45%), Gaps = 9/241 (3%)
Query: 127 IGEGSFGKVFKAIH--LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K  +    + KTVA+KI+            L  E  + + L +P I++ I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 185 ASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E    ++L+ E A +  L+  L+Q + + +   ++++  +   + YL  +  +HRDL
Sbjct: 73  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 131
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPELIAERPYDHTADL 300
             +NVLL     A + DFG ++++    +     T  K    + APE I    +   +D+
Sbjct: 132 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 191
Query: 301 WSLGCIAYE-IHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           WS G + +E    G  P++ +    +  +L K + +  P+       DL+      D   
Sbjct: 192 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 251
Query: 359 R 359
           R
Sbjct: 252 R 252

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 109 VKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQ 167
           V++++     + ++ + +IG G+F +V         +  A+KI++K     + E+S  ++
Sbjct: 51  VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 168 ECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQI----L 223
           E ++  +     I +   + +  N   L+ E+      +LL    K  E I  ++    L
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEY--YVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGTPL 282
           + ++ A+  +H    +HRD+KP N+LL++ G   L DFG    + A GT       GTP 
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 283 YMAPELI-------AERPYDHTADLWSLGCIAYEIHMGHPPF 317
           Y++PE++           Y    D W+LG  AYE+  G  PF
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LI +   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 77  NPHVCRLLGICLT-STVQLIMQL--MPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 134 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 225

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 106/241 (43%), Gaps = 9/241 (3%)
Query: 127 IGEGSFGKVFKAIH-LDLKKTVALKIISKSGRSGKEL-SSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K  + +          I K+  +   L   L  E  + + L +P I++ I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 185 ASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E    ++L+ E A +  L+  L+Q + + +   ++++  +   + YL  +  +HRDL
Sbjct: 75  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPELIAERPYDHTADL 300
             +NVLL     A + DFG ++++    +     T  K    + APE I    +   +D+
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 193
Query: 301 WSLGCIAYE-IHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           WS G + +E    G  P++ +    +  +L K + +  P+       DL+      D   
Sbjct: 194 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 253
Query: 359 R 359
           R
Sbjct: 254 R 254

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 109/241 (45%), Gaps = 9/241 (3%)
Query: 127 IGEGSFGKVFKAIH--LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K  +    + KTVA+KI+            L  E  + + L +P I++ I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 185 ASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E    ++L+ E A +  L+  L+Q + + +   ++++  +   + YL  +  +HRDL
Sbjct: 79  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 137
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPELIAERPYDHTADL 300
             +NVLL     A + DFG ++++    +     T  K    + APE I    +   +D+
Sbjct: 138 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 197
Query: 301 WSLGCIAYE-IHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           WS G + +E    G  P++ +    +  +L K + +  P+       DL+      D   
Sbjct: 198 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 257
Query: 359 R 359
           R
Sbjct: 258 R 258

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 109/241 (45%), Gaps = 9/241 (3%)
Query: 127 IGEGSFGKVFKAIH--LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K  +    + KTVA+KI+            L  E  + + L +P I++ I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 185 ASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E    ++L+ E A +  L+  L+Q + + +   ++++  +   + YL  +  +HRDL
Sbjct: 85  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPELIAERPYDHTADL 300
             +NVLL     A + DFG ++++    +     T  K    + APE I    +   +D+
Sbjct: 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 203
Query: 301 WSLGCIAYE-IHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           WS G + +E    G  P++ +    +  +L K + +  P+       DL+      D   
Sbjct: 204 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 263
Query: 359 R 359
           R
Sbjct: 264 R 264

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 106/241 (43%), Gaps = 9/241 (3%)
Query: 127 IGEGSFGKVFKAIH-LDLKKTVALKIISKSGRSGKEL-SSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K  + +          I K+  +   L   L  E  + + L +P I++ I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 185 ASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E    ++L+ E A +  L+  L+Q + + +   ++++  +   + YL  +  +HRDL
Sbjct: 79  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 137
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPELIAERPYDHTADL 300
             +NVLL     A + DFG ++++    +     T  K    + APE I    +   +D+
Sbjct: 138 AARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDV 197
Query: 301 WSLGCIAYE-IHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           WS G + +E    G  P++ +    +  +L K + +  P+       DL+      D   
Sbjct: 198 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 257
Query: 359 R 359
           R
Sbjct: 258 R 258

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 106/241 (43%), Gaps = 9/241 (3%)
Query: 127 IGEGSFGKVFKAIH-LDLKKTVALKIISKSGRSGKEL-SSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K  + +          I K+  +   L   L  E  + + L +P I++ I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 185 ASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E    ++L+ E A +  L+  L+Q + + +   ++++  +   + YL  +  +HRDL
Sbjct: 95  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 153
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPELIAERPYDHTADL 300
             +NVLL     A + DFG ++++    +     T  K    + APE I    +   +D+
Sbjct: 154 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 213
Query: 301 WSLGCIAYE-IHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           WS G + +E    G  P++ +    +  +L K + +  P+       DL+      D   
Sbjct: 214 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 273
Query: 359 R 359
           R
Sbjct: 274 R 274

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 106/241 (43%), Gaps = 9/241 (3%)
Query: 127 IGEGSFGKVFKAIH-LDLKKTVALKIISKSGRSGKEL-SSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K  + +          I K+  +   L   L  E  + + L +P I++ I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 185 ASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E    ++L+ E A +  L+  L+Q + + +   ++++  +   + YL  +  +HRDL
Sbjct: 95  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 153
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPELIAERPYDHTADL 300
             +NVLL     A + DFG ++++    +     T  K    + APE I    +   +D+
Sbjct: 154 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 213
Query: 301 WSLGCIAYE-IHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           WS G + +E    G  P++ +    +  +L K + +  P+       DL+      D   
Sbjct: 214 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 273
Query: 359 R 359
           R
Sbjct: 274 R 274

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 113/237 (47%), Gaps = 23/237 (9%)
Query: 112 EKSNGALEK------YQKICLIGEGSFGKVFKAIHL----DLKKTVALKII-SKSGRSGK 160
           EK+N  L +       +K+ ++G G FG V K + +     +K  V +K+I  KSGR  +
Sbjct: 18  EKANKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--Q 75
Query: 161 ELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICV 220
              ++         L H +I++ +      +   L+T++  + L +LL+  ++    +  
Sbjct: 76  SFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQY--LPLGSLLDHVRQHRGALGP 132
Query: 221 QILSN----LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-HMLT 275
           Q+L N    +   +YYL  + ++HR+L  +NVLL       + DFG A  +      +L 
Sbjct: 133 QLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 192
Query: 276 SIKGTPL-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           S   TP+ +MA E I    Y H +D+WS G   +E+   G  P+  + +  +  LL+
Sbjct: 193 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 249

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 96
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + +L S + 
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKF 155
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMA----VGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 216 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 275
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 276 HPKAEMRPSFSELV 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 95
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + +L S + 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKF 154
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMA----VGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 274
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 275 HPKAEMRPSFSELV 288

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 93
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + +L S + 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKF 152
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMA----VGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 212
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 213 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 272
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 273 HPKAEMRPSFSELV 286

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 96
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + +L S + 
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKF 155
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMA----VGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 216 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 275
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 276 HPKAEMRPSFSELV 289

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 109/241 (45%), Gaps = 9/241 (3%)
Query: 127 IGEGSFGKVFKAIH--LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K  +    + KTVA+KI+            L  E  + + L +P I++ I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 185 ASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E    ++L+ E A +  L+  L+Q + + +   ++++  +   + YL  +  +HRDL
Sbjct: 93  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 151
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPELIAERPYDHTADL 300
             +NVLL     A + DFG ++++    +     T  K    + APE I    +   +D+
Sbjct: 152 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 211
Query: 301 WSLGCIAYE-IHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           WS G + +E    G  P++ +    +  +L K + +  P+       DL+      D   
Sbjct: 212 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 271
Query: 359 R 359
           R
Sbjct: 272 R 272

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LI +   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 78  NPHVCRLLGICLT-STVQLIMQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 226

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 100
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + +L S + 
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKF 159
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMA----VGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 160 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 219
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 220 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 279
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 280 HPKAEMRPSFSELV 293

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS---KSGRSGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +     +   S K    +  E  +   + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 110 NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 166
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 167 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 226
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 227 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 258

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 95
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + +L S + 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKF 154
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMA----VGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 274
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 275 HPKAEMRPSFSELV 288

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 126 LIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD    K   A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 154
Query: 183 F--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRV 238
              I      +  V++    H  L N +      + T+   +     +   + +L S + 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKF 213
Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMA----VGTHMLTSIKGTPLYMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + +
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273
Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHL-IRLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G + +E+   G PP+  V+   + + LL+ + +  P    +   +++    
Sbjct: 274 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 333
Query: 353 EKDASQRLSWPELL 366
              A  R S+ EL+
Sbjct: 334 HPKAEMRPSFSELV 347

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LI +   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 76  NPHVCRLLGICLT-STVQLIMQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LI +   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 80  NPHVCRLLGICLT-STVQLIMQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 137 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 228

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LI +   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 77  NPHVCRLLGICLT-STVQLIMQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 134 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 225

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LI +   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 79  NPHVCRLLGICLT-STVQLIMQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 227

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 45/222 (20%)
Query: 127 IGEGSFGKVFKA-----IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           IGEG+FG+VF+A     +  +    VA+K++ +   +  + +  ++E  +     +PNI+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNIV 113
Query: 182 KFIA---------------SHETLNEFV------LITEFAHMSLSNLLEQRKKLS----- 215
           K +                ++  LNEF+       +   +H  LS     R ++S     
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST----RARVSSPGPP 169
Query: 216 -----ETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AV 269
                E +C  I   + + + YL   + +HRDL  +N L+ ++ V  + DFG +R++ + 
Sbjct: 170 PLSCAEQLC--IARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 270 GTHMLTSIKGTPL-YMAPELIAERPYDHTADLWSLGCIAYEI 310
             +        P+ +M PE I    Y   +D+W+ G + +EI
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 112/232 (48%), Gaps = 18/232 (7%)
Query: 121 YQKICLIGEG--SFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           Y+ + +IG+G      V  A +    + V ++ I+    S + ++ L+ E  + K   HP
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 70
Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLL--EQRKKLSETICVQILSNLISALYYLHS 235
           NI+ + A+    NE  ++T F A+ S  +L+       ++E     IL  ++ AL Y+H 
Sbjct: 71  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 130
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM--------AVGTHMLTSIKGTPLYMAPE 287
              +HR +K  ++L++ DG   L       SM         V      S+K  P +++PE
Sbjct: 131 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP-WLSPE 189
Query: 288 LIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP 337
           ++ +  + YD  +D++S+G  A E+  GH PFK +    +  LL+  + T P
Sbjct: 190 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVP 239

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++  G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 76  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K   H NI+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-FNHQNIV 114
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSM-AVGTHMLTSIKGTPL-YMAPEL 288
             N  +HRD+  +N LL   G   VA + DFG AR +   G +        P+ +M PE 
Sbjct: 175 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 234
Query: 289 IAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
             E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 235 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 268

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K   H NI+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-FNHQNIV 137
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSM-AVGTHMLTSIKGTPL-YMAPEL 288
             N  +HRD+  +N LL   G   VA + DFG AR +   G +        P+ +M PE 
Sbjct: 198 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 257
Query: 289 IAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
             E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 258 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 17/221 (7%)
Query: 122 QKICLIGEGSFGKVFKAIHL----DLKKTVALKII-SKSGRSGKELSSLKQECEIQKHLA 176
           +K+ ++G G FG V K + +     +K  V +K+I  KSGR  +   ++         L 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLD 73
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           H +I++ +      +   L+T++  + L +LL+  ++    +  Q+L N    +   +YY
Sbjct: 74  HAHIVRLLGLCPG-SSLQLVTQY--LPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV-GTHMLTSIKGTPL-YMAPELIA 290
           L  + ++HR+L  +NVLL       + DFG A  +      +L S   TP+ +MA E I 
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
              Y H +D+WS G   +E+   G  P+  + +  +  LL+
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++  G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LIT+   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 83  NPHVCRLLGICLT-STVQLITQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 231

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 28/218 (12%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K L H NI+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-LNHQNIV 97
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGTH------MLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG AR +   ++       +  +K    +M
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 213
Query: 285 APELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            PE   E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 112/232 (48%), Gaps = 18/232 (7%)
Query: 121 YQKICLIGEG--SFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           Y+ + +IG+G      V  A +    + V ++ I+    S + ++ L+ E  + K   HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLL--EQRKKLSETICVQILSNLISALYYLHS 235
           NI+ + A+    NE  ++T F A+ S  +L+       ++E     IL  ++ AL Y+H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM--------AVGTHMLTSIKGTPLYMAPE 287
              +HR +K  ++L++ DG   L       SM         V      S+K  P +++PE
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP-WLSPE 205
Query: 288 LIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP 337
           ++ +  + YD  +D++S+G  A E+  GH PFK +    +  LL+  + T P
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVP 255

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 28/218 (12%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K L H NI+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-LNHQNIV 111
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGTH------MLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG AR +   ++       +  +K    +M
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 227
Query: 285 APELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            PE   E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 265

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LI +   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 78  NPHVCRLLGICLT-STVQLIMQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 226

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 30/235 (12%)
Query: 127 IGEGSFGKVFKAIHL------DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           +GE  FGKV+K  HL      +  + VA+K + K    G      + E  ++  L HPN+
Sbjct: 17  LGEDRFGKVYKG-HLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 181 IKFIA---------------SHETLNEFVLITEFAHMSLSNLLEQR---KKLSETICVQI 222
           +  +                SH  L+EF L+    H  + +  + R     L     V +
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEF-LVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGTP 281
           ++ + + + YL S+ V+H+DL  +NVL+       + D G  R + A   + L      P
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 282 L-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLKTQDV 334
           + +MAPE I    +   +D+WS G + +E+   G  P+   S   ++ +++ + V
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV 248

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LI +   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 78  NPHVCRLLGICLT-STVQLIMQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 226

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 50/236 (21%)
Query: 120 KYQKICLIGEGSFGKVFKAI-HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL--A 176
           +Y+ +  +GEG+FGKV + I H    + VA+KI+    R      + + E ++ +HL   
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY---CEAARSEIQVLEHLNTT 71
Query: 177 HPN----IIKFIASHETLNEFVLITEFAHMSLSNLLEQR----------KKLSETICVQI 222
            PN     ++ +   E      ++ E   +S  + +++           +K++  IC   
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC--- 128
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVL-------------LNKDGVAML------CDFGF 263
                 ++ +LHSN++ H DLKP+N+L             + +D   ++       DFG 
Sbjct: 129 -----KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG- 182
Query: 264 ARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT 319
             S        +++  T  Y APE+I    +    D+WS+GCI  E ++G   F T
Sbjct: 183 --SATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 30/235 (12%)
Query: 127 IGEGSFGKVFKAIHL------DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           +GE  FGKV+K  HL      +  + VA+K + K    G      + E  ++  L HPN+
Sbjct: 34  LGEDRFGKVYKG-HLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 181 IKFIA---------------SHETLNEFVLITEFAHMSLSNLLEQR---KKLSETICVQI 222
           +  +                SH  L+EF L+    H  + +  + R     L     V +
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEF-LVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGTP 281
           ++ + + + YL S+ V+H+DL  +NVL+       + D G  R + A   + L      P
Sbjct: 151 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 282 L-YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLKTQDV 334
           + +MAPE I    +   +D+WS G + +E+   G  P+   S   ++ +++ + V
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV 265

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++G G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LI +   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 80  NPHVCRLLGICLT-STVQLIMQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 137 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 228

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 109/228 (47%), Gaps = 16/228 (7%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G  + YQ +  +G G + +VF+AI++    T   K+  K  +  K+    ++   ++   
Sbjct: 34  GNQDDYQLVRKLGRGKYSEVFEAINI----TNNEKVAVKILKPVKKKKIKREIKILENLR 89
Query: 176 AHPNIIKF--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
             PNII    I          L+  F H++ ++  +  + L++      +  ++ AL Y 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALV--FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYC 147
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAM-LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           HS  ++HRD+KP NVL++ +   + L D+G A     G      +  +  +  PEL+ + 
Sbjct: 148 HSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPF-----KTVSILHLIRLLKTQDV 334
           + YD++ D+WSLGC+   +     PF         ++ + ++L T+D+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 254

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 109/241 (45%), Gaps = 9/241 (3%)
Query: 127 IGEGSFGKVFKAIH--LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K  +    + KTVA+KI+            L  E  + + L +P I++ I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 185 ASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E    ++L+ E A +  L+  L+Q + + +   ++++  +   + YL  +  +HRDL
Sbjct: 437 GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 495
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPELIAERPYDHTADL 300
             +NVLL     A + DFG ++++    +     T  K    + APE I    +   +D+
Sbjct: 496 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 555
Query: 301 WSLGCIAYE-IHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           WS G + +E    G  P++ +    +  +L K + +  P+       DL+      D   
Sbjct: 556 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 615
Query: 359 R 359
           R
Sbjct: 616 R 616

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 109/241 (45%), Gaps = 9/241 (3%)
Query: 127 IGEGSFGKVFKAIH--LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K  +    + KTVA+KI+            L  E  + + L +P I++ I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 185 ASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E    ++L+ E A +  L+  L+Q + + +   ++++  +   + YL  +  +HRDL
Sbjct: 438 GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 496
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHML---TSIKGTPLYMAPELIAERPYDHTADL 300
             +NVLL     A + DFG ++++    +     T  K    + APE I    +   +D+
Sbjct: 497 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 556
Query: 301 WSLGCIAYE-IHMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           WS G + +E    G  P++ +    +  +L K + +  P+       DL+      D   
Sbjct: 557 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 616
Query: 359 R 359
           R
Sbjct: 617 R 617

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K   H NI+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-FNHQNIV 103
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGTH------MLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG AR +   ++       +  +K    +M
Sbjct: 164 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 219
Query: 285 APELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            PE   E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 257

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K   H NI+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-FNHQNIV 113
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGTH------MLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG AR +   ++       +  +K    +M
Sbjct: 174 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 229
Query: 285 APELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            PE   E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 267

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K   H NI+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-FNHQNIV 97
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGTH------MLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG AR +   ++       +  +K    +M
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 213
Query: 285 APELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            PE   E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K   H NI+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-FNHQNIV 123
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGTH------MLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG AR +   ++       +  +K    +M
Sbjct: 184 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 239
Query: 285 APELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            PE   E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 277

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K   H NI+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-FNHQNIV 96
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGTH------MLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG AR +   ++       +  +K    +M
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 212
Query: 285 APELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            PE   E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K   H NI+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-FNHQNIV 96
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGTH------MLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG AR +   ++       +  +K    +M
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 212
Query: 285 APELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            PE   E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K   H NI+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-FNHQNIV 88
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGTH------MLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG AR +   ++       +  +K    +M
Sbjct: 149 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 204
Query: 285 APELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            PE   E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 242

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K   H NI+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISK-FNHQNIV 111
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGTH------MLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG AR +   ++       +  +K    +M
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 227
Query: 285 APELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            PE   E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 265

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K   H NI+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-FNHQNIV 111
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGTH------MLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG AR +   ++       +  +K    +M
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WM 227
Query: 285 APELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            PE   E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 265

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/224 (21%), Positives = 104/224 (46%), Gaps = 24/224 (10%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 81
Query: 182 KFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETIC-------------VQILSNLIS 228
           + +         ++I E   M+  +L    + L   +              +Q+   +  
Sbjct: 82  RLLGVVSQGQPTLVIMEL--MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 139
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAP 286
            + YL++N+ +HRDL  +N ++ +D    + DFG  R +    +     KG  P+ +M+P
Sbjct: 140 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 287 ELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           E + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 243

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 84/328 (25%), Positives = 136/328 (41%), Gaps = 77/328 (23%)
Query: 17  IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHP-NI 70
           +G G+FGKV +A    +KK     TVA+K++ K G +  E  +L  E +I  H+ H  N+
Sbjct: 35  LGRGAFGKVVQASAFGIKKSPTCRTVAVKML-KEGATASEYKALMTELKILTHIGHHLNV 93
Query: 71  IKFI-ASHETLNEFVLITEFAHMS-----LSKLGEPWFHN-----HCQPVKMEKSNGALE 119
           +  + A  +     ++I E+         L    + +F N     H +P K EK    LE
Sbjct: 94  VNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEP-KKEKMEPGLE 152
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           + +K                 LD   T +    S   +  K LS +++E +       P 
Sbjct: 153 QGKK---------------PRLD-SVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPI 196
Query: 180 IIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVL 239
            ++ + S+           F        L  RK      C+                   
Sbjct: 197 TMEDLISY----------SFQVARGMEFLSSRK------CI------------------- 221
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT---PL-YMAPELIAERPYD 295
           HRDL  +N+LL+++ V  +CDFG AR +      +   KG    PL +MAPE I ++ Y 
Sbjct: 222 HRDLAARNILLSENNVVKICDFGLARDIYKNPDYVR--KGDTRLPLKWMAPESIFDKIYS 279
Query: 296 HTADLWSLGCIAYEIH-MGHPPFKTVSI 322
             +D+WS G + +EI  +G  P+  V +
Sbjct: 280 TKSDVWSYGVLLWEIFSLGGSPYPGVQM 307

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 35/210 (16%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH--LAHPNIIKFI 184
           +G+G +G+V++   L   ++VA+KI S      ++  S  +E EI     L H NI+ FI
Sbjct: 16  VGKGRYGEVWRG--LWHGESVAVKIFSS-----RDEQSWFRETEIYNTVLLRHDNILGFI 68
Query: 185 ASHETL----NEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLH----- 234
           AS  T      +  LIT +  H SL + L QR+ L   + +++  +    L +LH     
Sbjct: 69  ASDMTSRNSSTQLWLITHYHEHGSLYDFL-QRQTLEPHLALRLAVSAACGLAHLHVEIFG 127
Query: 235 ---SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML----TSIKGTPLYMAPE 287
                 + HRD K +NVL+  +    + D G A   + G+  L        GT  YMAPE
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 288 LIAER-------PYDHTADLWSLGCIAYEI 310
           ++ E+        Y  T D+W+ G + +EI
Sbjct: 188 VLDEQIRTDCFESYKWT-DIWAFGLVLWEI 216

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 78
Query: 182 KFIASHETLNEFVLITEFAHM--------SLSNLLEQRKKLSE---TICVQILSNLISAL 230
           + +         ++I E            SL   +E    L+    +  +Q+   +   +
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPEL 288
            YL++N+ +HRDL  +N ++ +D    + DFG  R +    +     KG  P+ +M+PE 
Sbjct: 139 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 198
Query: 289 IAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 199 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 240

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 120/265 (45%), Gaps = 10/265 (3%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G+G FG+V+        + VA+K + K G    E  +  QE ++ K L H  +++  A 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTL-KPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAV 81
Query: 187 HETLNEFVLITEFAHMSLSNLL--EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                 +++I   +  SL + L  E  K L     V + + + S + Y+     +HRDL+
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 141
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWSL 303
             N+L+ ++ V  + DFG AR +    +        P+ + APE      +   +D+WS 
Sbjct: 142 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 201
Query: 304 GCIAYEIHM-GHPPFK-TVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS 361
           G +  E+   G  P+   V+   L ++ +   +  P +  E+  DL+     KD  +R +
Sbjct: 202 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261
Query: 362 WPELLHHPLVKDNLSSEIESQNNQD 386
           + E L   L     S+E + Q  ++
Sbjct: 262 F-EYLQAFLEDYFTSTEPQYQPGEN 285

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 10/209 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V+ A +    K VA+K +     S   + +   E  + K L H  ++K  A 
Sbjct: 196 LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 187 HETLNEFVLITEF-AHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRVLHRDL 243
             T     +ITEF A  SL + L+  +   + +   +   + +   + ++     +HRDL
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWS 302
           +  N+L++   V  + DFG AR +    +        P+ + APE I    +   +D+WS
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 370
Query: 303 LGCIAYEI-HMGHPPFKTVSILHLIRLLK 330
            G +  EI   G  P+  +S   +IR L+
Sbjct: 371 FGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 82
Query: 182 KFIASHETLNEFVLITEFAHM--------SLSNLLEQRKKLSE---TICVQILSNLISAL 230
           + +         ++I E            SL   +E    L+    +  +Q+   +   +
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPEL 288
            YL++N+ +HRDL  +N ++ +D    + DFG  R +    +     KG  P+ +M+PE 
Sbjct: 143 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 202
Query: 289 IAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 203 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 244

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 111/228 (48%), Gaps = 16/228 (7%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G  + YQ +  +G G + +VF+AI++    T   K++ K  +  K+    ++   ++   
Sbjct: 34  GNQDDYQLVRKLGRGKYSEVFEAINI----TNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 176 AHPNIIKF--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
             PNII    I          L+  F H++ ++  + R+ L++      +  ++ AL Y 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALV--FEHVNNTDFKQLRQTLTDYDIRFYMYEILKALDYC 147
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAM-LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           HS  ++HRD+KP NV+++ +   + L D+G A     G      +  +  +  PEL+ + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPF-----KTVSILHLIRLLKTQDV 334
           + YD++ D+WSLGC+   +     PF         ++ + ++L T+D+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 254

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 117/266 (43%), Gaps = 15/266 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V+   + +  K VA+K +     S   + +  +E  + K L H  +++  A 
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 187 HETLNEFVLITEF-AHMSLSNLL--EQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
                   +ITE+ A  SL + L  ++  K+     +   + +   + Y+     +HRDL
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDL 136
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWS 302
           +  NVL+++  +  + DFG AR +    +        P+ + APE I    +   +D+WS
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWS 196
Query: 303 LGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDVTFP--SQVSETYKDLVKGLLEKDASQR 359
            G + YEI   G  P+   +   ++  L +Q    P      +   D++K   ++ A +R
Sbjct: 197 FGILLYEIVTYGKIPYPGRTNADVMTAL-SQGYRMPRVENCPDELYDIMKMCWKEKAEER 255
Query: 360 LSWPELLHHPLVKDNLSSEIESQNNQ 385
              P   +   V D+  +  E Q  Q
Sbjct: 256 ---PTFDYLQSVLDDFYTATEGQYQQ 278

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 84
Query: 182 KFIASHETLNEFVLITEFAHM--------SLSNLLEQRKKLSE---TICVQILSNLISAL 230
           + +         ++I E            SL   +E    L+    +  +Q+   +   +
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPEL 288
            YL++N+ +HRDL  +N ++ +D    + DFG  R +    +     KG  P+ +M+PE 
Sbjct: 145 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 204
Query: 289 IAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 205 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 246

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 85
Query: 182 KFIASHETLNEFVLITEFAHM--------SLSNLLEQRKKLSE---TICVQILSNLISAL 230
           + +         ++I E            SL   +E    L+    +  +Q+   +   +
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPEL 288
            YL++N+ +HRDL  +N ++ +D    + DFG  R +    +     KG  P+ +M+PE 
Sbjct: 146 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 205
Query: 289 IAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 206 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 247

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 84
Query: 182 KFIASHETLNEFVLITEFAHM--------SLSNLLEQRKKLSE---TICVQILSNLISAL 230
           + +         ++I E            SL   +E    L+    +  +Q+   +   +
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPEL 288
            YL++N+ +HRDL  +N ++ +D    + DFG  R +    +     KG  P+ +M+PE 
Sbjct: 145 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 204
Query: 289 IAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 205 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 246

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 91
Query: 182 KFIASHETLNEFVLITEFAHM--------SLSNLLEQRKKLSE---TICVQILSNLISAL 230
           + +         ++I E            SL   +E    L+    +  +Q+   +   +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPEL 288
            YL++N+ +HRDL  +N ++ +D    + DFG  R +    +     KG  P+ +M+PE 
Sbjct: 152 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 211
Query: 289 IAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 212 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/224 (21%), Positives = 104/224 (46%), Gaps = 24/224 (10%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 91
Query: 182 KFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETIC-------------VQILSNLIS 228
           + +         ++I E   M+  +L    + L   +              +Q+   +  
Sbjct: 92  RLLGVVSQGQPTLVIMEL--MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAP 286
            + YL++N+ +HRDL  +N ++ +D    + DFG  R +    +     KG  P+ +M+P
Sbjct: 150 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 287 ELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           E + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 13/212 (6%)
Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLA 176
           +++KI ++  G+FG V+K + +   + V + +  K  R   S K    +  E  +   + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN----LISALYY 232
           +P++ + +    T +   LI +   M    LL+  ++  + I  Q L N    +   + Y
Sbjct: 83  NPHVCRLLGICLT-STVQLIMQL--MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIA 290
           L   R++HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I 
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 291 ERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            R Y H +D+WS G   +E+   G  P+  + 
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 231

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 113
Query: 182 KFIASHETLNEFVLITEFAHM--------SLSNLLEQRKKLSE---TICVQILSNLISAL 230
           + +         ++I E            SL   +E    L+    +  +Q+   +   +
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPEL 288
            YL++N+ +HRDL  +N ++ +D    + DFG  R +    +     KG  P+ +M+PE 
Sbjct: 174 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 233
Query: 289 IAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 234 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 275

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V+ A +    K VA+K +     S   + +   E  + K L H  ++K  A 
Sbjct: 190 LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 187 HETLNEFVLITEF-AHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRVLHRDL 243
             T     +ITEF A  SL + L+  +   + +   +   + +   + ++     +HRDL
Sbjct: 246 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSL 303
           +  N+L++   V  + DFG AR   VG      IK T    APE I    +   +D+WS 
Sbjct: 305 RAANILVSASLVCKIADFGLAR---VGAKF--PIKWT----APEAINFGSFTIKSDVWSF 355
Query: 304 GCIAYEI-HMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQRLS 361
           G +  EI   G  P+  +S   +IR L +   +  P    E   +++    +    +R  
Sbjct: 356 GILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEER-- 413
Query: 362 WPELLHHPLVKDNLSSEIESQNNQ 385
            P   +   V D+  +  ESQ  Q
Sbjct: 414 -PTFEYIQSVLDDFYTATESQXQQ 436

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 103/222 (46%), Gaps = 20/222 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 85
Query: 182 KFIASHETLNEFVLITEFAHM--------SLSNLLEQRKKLSE---TICVQILSNLISAL 230
           + +         ++I E            SL   +E    L+    +  +Q+   +   +
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPEL 288
            YL++N+ +HRDL  +N ++ +D    + DFG  R +          KG  P+ +M+PE 
Sbjct: 146 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPES 205
Query: 289 IAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 206 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 247

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 103/222 (46%), Gaps = 20/222 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 76
Query: 182 KFIASHETLNEFVLITEFAHM--------SLSNLLEQRKKLSE---TICVQILSNLISAL 230
           + +         ++I E            SL   +E    L+    +  +Q+   +   +
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPEL 288
            YL++N+ +HRDL  +N ++ +D    + DFG  R +          KG  P+ +M+PE 
Sbjct: 137 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPES 196
Query: 289 IAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 197 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 238

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 20/270 (7%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 185
           +G+G FG+V+        + VA+K + K G    E  +  QE ++ K L H  +++  A 
Sbjct: 17  LGQGCFGEVWMGTWNGTTR-VAIKTL-KPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAV 72
Query: 186 -SHETLNEFVLITEFAHMSLSNLL-----EQRKKLSETICVQILSNLISALYYLHSNRVL 239
            S E +    ++TE+  MS  +LL     E  K L     V + + + S + Y+     +
Sbjct: 73  VSEEPI---YIVTEY--MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 127
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTA 298
           HRDL+  N+L+ ++ V  + DFG AR +    +        P+ + APE      +   +
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 299 DLWSLGCIAYEIHM-GHPPFK-TVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
           D+WS G +  E+   G  P+   V+   L ++ +   +  P +  E+  DL+     KD 
Sbjct: 188 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 247
Query: 357 SQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            +R ++ E L   L     S+E + Q  ++
Sbjct: 248 EERPTF-EYLQAFLEDYFTSTEPQYQPGEN 276

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 20/270 (7%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 185
           +G+G FG+V+        + VA+K + K G    E  +  QE ++ K L H  +++  A 
Sbjct: 15  LGQGCFGEVWMGTWNGTTR-VAIKTL-KPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAV 70
Query: 186 -SHETLNEFVLITEFAHMSLSNLL-----EQRKKLSETICVQILSNLISALYYLHSNRVL 239
            S E +    ++TE+  MS  +LL     E  K L     V + + + S + Y+     +
Sbjct: 71  VSEEPI---YIVTEY--MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 125
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTA 298
           HRDL+  N+L+ ++ V  + DFG AR +    +        P+ + APE      +   +
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 185
Query: 299 DLWSLGCIAYEIHM-GHPPFK-TVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
           D+WS G +  E+   G  P+   V+   L ++ +   +  P +  E+  DL+     KD 
Sbjct: 186 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 245
Query: 357 SQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            +R ++ E L   L     S+E + Q  ++
Sbjct: 246 EERPTF-EYLQAFLEDYFTSTEPQYQPGEN 274

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 10/209 (4%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V+ A +    K VA+K +     S   + +   E  + K L H  ++K  A 
Sbjct: 23  LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 187 HETLNEFVLITEF-AHMSLSNLLEQRKKLSETI--CVQILSNLISALYYLHSNRVLHRDL 243
             T     +ITEF A  SL + L+  +   + +   +   + +   + ++     +HRDL
Sbjct: 79  V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWS 302
           +  N+L++   V  + DFG AR +    +        P+ + APE I    +   +D+WS
Sbjct: 138 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 197
Query: 303 LGCIAYEI-HMGHPPFKTVSILHLIRLLK 330
            G +  EI   G  P+  +S   +IR L+
Sbjct: 198 FGILLMEIVTYGRIPYPGMSNPEVIRALE 226

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 124 ICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           I  +G+G+FG V    +  +  +    VA+K +  SG   +     ++E +I K L    
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR--DFQREIQILKALHSDF 69
Query: 180 IIKF--IASHETLNEFVLITEF-AHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHS 235
           I+K+  ++      E  L+ E+     L + L++ R +L  +  +   S +   + YL S
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV--GTHMLTSIKGTPLYM-APELIAER 292
            R +HRDL  +N+L+  +    + DFG A+ + +     ++     +P++  APE +++ 
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 293 PYDHTADLWSLGCIAYEI 310
            +   +D+WS G + YE+
Sbjct: 190 IFSRQSDVWSFGVVLYEL 207

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 20/270 (7%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 185
           +G+G FG+V+        + VA+K + K G    E  +  QE ++ K L H  +++  A 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTL-KPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAV 81
Query: 186 -SHETLNEFVLITEFAHMSLSNLL-----EQRKKLSETICVQILSNLISALYYLHSNRVL 239
            S E +    ++TE+  MS  +LL     E  K L     V + + + S + Y+     +
Sbjct: 82  VSEEPI---YIVTEY--MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTA 298
           HRDL+  N+L+ ++ V  + DFG AR +    +        P+ + APE      +   +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 299 DLWSLGCIAYEIHM-GHPPFK-TVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
           D+WS G +  E+   G  P+   V+   L ++ +   +  P +  E+  DL+     KD 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 357 SQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            +R ++ E L   L     S+E + Q  ++
Sbjct: 257 EERPTF-EYLQAFLEDYFTSTEPQYQPGEN 285

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 124/267 (46%), Gaps = 14/267 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G+G FG+V+        + VA+K + K G    E  +  QE ++ K L H  +++  A 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTL-KPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAV 81
Query: 187 HETLNEFVLITEFAHMSLSNLL--EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                 +++I   +  SL + L  E  K L     V + + + S + Y+     +HRDL+
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 141
Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT--PL-YMAPELIAERPYDHTADLW 301
             N+L+ ++ V  + DFG AR   +  +  T+ +G   P+ + APE      +   +D+W
Sbjct: 142 AANILVGENLVCKVADFGLAR--LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 302 SLGCIAYEIHM-GHPPFK-TVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQR 359
           S G +  E+   G  P+   V+   L ++ +   +  P +  E+  DL+     KD  +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259
Query: 360 LSWPELLHHPLVKDNLSSEIESQNNQD 386
            ++ E L   L     S+E + Q  ++
Sbjct: 260 PTF-EYLQAFLEDYFTSTEPQYQPGEN 285

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 117/266 (43%), Gaps = 15/266 (5%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V+   + +  K VA+K +     S   + +  +E  + K L H  +++  A 
Sbjct: 20  LGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 187 HETLNEFVLITEF-AHMSLSNLL--EQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
                   +ITEF A  SL + L  ++  K+     +   + +   + Y+     +HRDL
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDL 135
Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADLWS 302
           +  NVL+++  +  + DFG AR +    +        P+ + APE I    +   +++WS
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWS 195
Query: 303 LGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDVTFP--SQVSETYKDLVKGLLEKDASQR 359
            G + YEI   G  P+   +   ++  L +Q    P      +   D++K   ++ A +R
Sbjct: 196 FGILLYEIVTYGKIPYPGRTNADVMSAL-SQGYRMPRMENCPDELYDIMKMCWKEKAEER 254
Query: 360 LSWPELLHHPLVKDNLSSEIESQNNQ 385
              P   +   V D+  +  E Q  Q
Sbjct: 255 ---PTFDYLQSVLDDFYTATEGQYQQ 277

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G  + Y+ +  +G G + +VF+ I+++  +    K I K  +  K+    ++   +Q  +
Sbjct: 28  GEQDDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLM 83
Query: 176 AHPNIIKF--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
             PNI+K   I   +      LI E+ + +   +L     L++      +  L+ AL Y 
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL--YPTLTDYDIRYYIYELLKALDYC 141
Query: 234 HSNRVLHRDLKPQNVLLNKDGVAM-LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           HS  ++HRD+KP NV+++ +   + L D+G A     G      +  +  +  PEL+ + 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDL 200
Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPF 317
           + YD++ D+WSLGC+   +     PF
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 123/270 (45%), Gaps = 20/270 (7%)
Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 185
           +G+G FG+V+        + VA+K + K G    E  +  QE ++ K L H  +++  A 
Sbjct: 193 LGQGCFGEVWMGTWNGTTR-VAIKTL-KPGNMSPE--AFLQEAQVMKKLRHEKLVQLYAV 248
Query: 186 -SHETLNEFVLITEFAHMSLSNLL-----EQRKKLSETICVQILSNLISALYYLHSNRVL 239
            S E +    ++TE+  MS  +LL     E  K L     V + + + S + Y+     +
Sbjct: 249 VSEEPI---YIVTEY--MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 303
Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTA 298
           HRDL+  N+L+ ++ V  + DFG  R +    +        P+ + APE      +   +
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 363
Query: 299 DLWSLGCIAYEIHM-GHPPFK-TVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
           D+WS G +  E+   G  P+   V+   L ++ +   +  P +  E+  DL+     KD 
Sbjct: 364 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 423
Query: 357 SQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            +R ++ E L   L     S+E + Q  ++
Sbjct: 424 EERPTF-EYLQAFLEDYFTSTEPQXQPGEN 452

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 124 ICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           I  +G+G+FG V    +  +  +    VA+K +  SG   +     ++E +I K L    
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR--DFQREIQILKALHSDF 72
Query: 180 IIKF--IASHETLNEFVLITEF-AHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHS 235
           I+K+  ++         L+ E+     L + L++ R +L  +  +   S +   + YL S
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYM-APELIAER 292
            R +HRDL  +N+L+  +    + DFG A+ + +    +++     +P++  APE +++ 
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 293 PYDHTADLWSLGCIAYEI 310
            +   +D+WS G + YE+
Sbjct: 193 IFSRQSDVWSFGVVLYEL 210

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 110/260 (42%), Gaps = 26/260 (10%)
Query: 126 LIGEGSFGKVFKAIHLDLKK------TVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           ++G+G FG V +A    LK+       VA+K++     +  ++    +E    K   HP+
Sbjct: 30  MLGKGEFGSVREA---QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 180 IIKFIA------SHETLNEFVLITEF-------AHMSLSNLLEQRKKLSETICVQILSNL 226
           + K +       +   L   ++I  F       A +  S + E    L     V+ + ++
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 227 ISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT-PL-YM 284
              + YL S   +HRDL  +N +L +D    + DFG +R +  G +         P+ ++
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 285 APELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIR-LLKTQDVTFPSQVSE 342
           A E +A+  Y   +D+W+ G   +EI   G  P+  +    +   L+    +  P +  E
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECME 266
Query: 343 TYKDLVKGLLEKDASQRLSW 362
              DL+      D  QR S+
Sbjct: 267 EVYDLMYQCWSADPKQRPSF 286

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 103/222 (46%), Gaps = 20/222 (9%)
Query: 127 IGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K ++++  S +E      E  + K     +++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 78
Query: 182 KFIASHETLNEFVLITEFAHM--------SLSNLLEQRKKLSE---TICVQILSNLISAL 230
           + +         ++I E            SL   +E    L+    +  +Q+   +   +
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPEL 288
            YL++N+ +HRDL  +N  + +D    + DFG  R +    +     KG  P+ +M+PE 
Sbjct: 139 AYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 198
Query: 289 IAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           + +  +   +D+WS G + +EI  +   P++ +S   ++R +
Sbjct: 199 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 240

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 104/236 (44%), Gaps = 50/236 (21%)
Query: 120 KYQKICLIGEGSFGKVFKAI-HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL--A 176
           +Y+ +  +GEG+FGKV + I H    + VA+KI+    R      + + E ++ +HL   
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY---CEAARSEIQVLEHLNTT 71
Query: 177 HPN----IIKFIASHETLNEFVLITEFAHMSLSNLLEQR----------KKLSETICVQI 222
            PN     ++ +   E      ++ E   +S  + +++           +K++  IC   
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC--- 128
Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVL-------------LNKDGVAML------CDFGF 263
                 ++ +LHSN++ H DLKP+N+L             + +D   ++       DFG 
Sbjct: 129 -----KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG- 182
Query: 264 ARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT 319
             S        +++     Y APE+I    +    D+WS+GCI  E ++G   F T
Sbjct: 183 --SATYDDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K + +      EL  L +   I K   H NI+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK-FNHQNIV 97
Query: 182 KFIA-SHETLNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILS------NLISALYYL 233
           + I  S ++L  F+L+   A   L + L E R + S+   + +L       ++     YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 234 HSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGTH------MLTSIKGTPLYM 284
             N  +HRD+  +N LL   G   VA + DFG A+ +   ++       +  +K    +M
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK----WM 213
Query: 285 APELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVS 321
            PE   E  +    D WS G + +EI  +G+ P+ + S
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 128 GEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKEL-SSLKQECEIQKHLAHPNIIKFIAS 186
           GEG FG V+K  +++       K+ +    + +EL     QE ++     H N+++ +  
Sbjct: 31  GEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 187 HETLNEFVLITEFAHMSLSNLLEQRKKLSETICV------QILSNLISALYYLHSNRVLH 240
               ++  L+  + +    +LL++   L  T  +      +I     + + +LH N  +H
Sbjct: 90  SSDGDDLCLV--YVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIH 147
Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML--TSIKGTPLYMAPELIAERPYDHTA 298
           RD+K  N+LL++   A + DFG AR+       +  + I GT  Y APE +        +
Sbjct: 148 RDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL-RGEITPKS 206
Query: 299 DLWSLGCIAYEIHMGHP 315
           D++S G +  EI  G P
Sbjct: 207 DIYSFGVVLLEIITGLP 223

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 124 ICLIGEGSFGKV----FKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           I  +G+G+FG V    +  +  +    VA+K +  SG   +     ++E +I K L    
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR--DFQREIQILKALHSDF 85
Query: 180 IIKF--IASHETLNEFVLITEF-AHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHS 235
           I+K+  ++         L+ E+     L + L++ R +L  +  +   S +   + YL S
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYM-APELIAER 292
            R +HRDL  +N+L+  +    + DFG A+ + +    +++     +P++  APE +++ 
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 293 PYDHTADLWSLGCIAYEI 310
            +   +D+WS G + YE+
Sbjct: 206 IFSRQSDVWSFGVVLYEL 223
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	549
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-97
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-21
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-89
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-20
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-89
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-20
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-88
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-84
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-19
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-82
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-19
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-81
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-18
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-80
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-14
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-74
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-17
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-73
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-16
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-72
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-15
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-72
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-17
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-72
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-15
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-71
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-15
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-70
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-16
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-69
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-14
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-67
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-17
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-66
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-14
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-66
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-17
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-66
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-65
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-64
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-16
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-63
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-63
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-17
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-63
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-13
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-63
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-63
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-63
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-62
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-13
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-62
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-15
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-62
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-12
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-62
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-12
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-62
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-15
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-61
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-11
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-61
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-14
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-61
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-61
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-12
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-60
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-60
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-14
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-60
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-15
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-60
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-08
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-60
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-14
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-60
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-13
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-59
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-13
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-59
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-59
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-59
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-14
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-59
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-14
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-59
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-59
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-14
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-59
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-14
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-59
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-11
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-58
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-13
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-58
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-08
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-58
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-13
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-58
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-58
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-58
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-58
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-13
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-58
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-57
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-57
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-14
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-57
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-12
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-57
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-13
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-57
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-57
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-56
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-10
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-56
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-10
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-56
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-08
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-56
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-14
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-56
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-11
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-56
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-13
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-56
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-55
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-55
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-14
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-55
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-13
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-54
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-11
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-54
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-10
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-54
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-54
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-12
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-54
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-13
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-53
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-06
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-53
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-11
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-53
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-14
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-53
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-12
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-53
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-12
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-53
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-14
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-53
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-09
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-53
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-09
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-53
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-09
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-52
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-52
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-52
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-13
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-51
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-51
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-50
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-05
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-50
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-49
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-05
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-49
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-12
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-49
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-49
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-49
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-05
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-47
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-11
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-47
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-10
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-47
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-11
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-47
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-47
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-11
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-47
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-11
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-46
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-11
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-46
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-04
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-46
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-46
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-46
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-46
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-04
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-46
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-46
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-46
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-10
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-45
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-10
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-45
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-11
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-45
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-45
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-45
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-44
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-44
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-44
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-44
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-44
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-44
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-43
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-10
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-43
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-43
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-42
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-04
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-42
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-42
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-11
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-42
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-42
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-42
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-10
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-40
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-40
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-07
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-40
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-04
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-40
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-07
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-40
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-04
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-40
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-39
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-10
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-39
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-39
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-09
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-38
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-38
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-09
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-38
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-37
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-07
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-37
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-07
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-37
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-07
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-37
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-37
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-07
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-37
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-07
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-36
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-36
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-06
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-35
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-06
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-35
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-34
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-34
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-06
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-33
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-31
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-30
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-30
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-05
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-29
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-29
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-04
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-29
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-08
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-08
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-07
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-28
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-27
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-05
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-07
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-06
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-08
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-07
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-07
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-26
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-09
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-09
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-06
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-09
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-06
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-26
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-06
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-07
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-07
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-09
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-05
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-06
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-06
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-25
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-06
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-07
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-10
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-25
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-08
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-08
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-08
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-06
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-25
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-05
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-08
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-05
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-07
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-05
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-25
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-06
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-05
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-08
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-08
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-24
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-05
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-09
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-08
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-08
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-06
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-23
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-04
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-06
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-23
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-07
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-23
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-07
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-09
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-06
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-08
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-07
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-20
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-18
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-17
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-17
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-16
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-14
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  298 bits (764), Expect = 4e-97
 Identities = 77/291 (26%), Positives = 137/291 (47%), Gaps = 7/291 (2%)

Query: 103 HNHCQPVKMEKSNGA---LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG 159
           H+H   V +   N     +EKY ++  IGEGSFGK       +  +   +K I+ S  S 
Sbjct: 5   HHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64

Query: 160 KELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKK--LSE 216
           KE    ++E  +  ++ HPNI+++  S E      ++ ++     L   +  +K     E
Sbjct: 65  KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE 124

Query: 217 TICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS 276
              +     +  AL ++H  ++LHRD+K QN+ L KDG   L DFG AR +     +  +
Sbjct: 125 DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184

Query: 277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT- 335
             GTP Y++PE+   +PY++ +D+W+LGC+ YE+      F+  S+ +L+  + +     
Sbjct: 185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP 244

Query: 336 FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
                S   + LV  L +++   R S   +L    +   +   +  Q   +
Sbjct: 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAE 295

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 24/89 (26%), Positives = 44/89 (49%)

Query: 2   EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 61
                ++EKY ++  IGEGSFGK       +  +   +K I+ S  S KE    ++E  +
Sbjct: 17  NLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV 76

Query: 62  QKHLAHPNIIKFIASHETLNEFVLITEFA 90
             ++ HPNI+++  S E      ++ ++ 
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYC 105

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  274 bits (703), Expect = 5e-89
 Identities = 75/274 (27%), Positives = 124/274 (45%), Gaps = 13/274 (4%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
            E Y+ +  IG GS+G+  K       K +  K +     +  E   L  E  + + L H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 178 PNIIKFIAS--HETLNEFVLITEFA-----HMSLSNLLEQRKKLSETICVQILSNLISAL 230
           PNI+++       T     ++ E+         ++   ++R+ L E   +++++ L  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 231 YYLHS-----NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
              H      + VLHRDLKP NV L+      L DFG AR +   T    +  GTP YM+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184

Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF-PSQVSETY 344
           PE +    Y+  +D+WSLGC+ YE+    PPF   S   L   ++       P + S+  
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244

Query: 345 KDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSE 378
            +++  +L      R S  E+L +PL+ ++    
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLILEHHHHH 278

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 20/85 (23%), Positives = 35/85 (41%), Gaps = 2/85 (2%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
           E Y+ +  IG GS+G+  K       K +  K +     +  E   L  E  + + L H
Sbjct: 5  AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 68 PNIIKFIAS--HETLNEFVLITEFA 90
          PNI+++       T     ++ E+ 
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYC 89

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  275 bits (705), Expect = 7e-89
 Identities = 83/308 (26%), Positives = 136/308 (44%), Gaps = 29/308 (9%)

Query: 103 HNHCQPVKMEKSNGALEK-------YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS 155
           H+H   V +   N   +        Y  +  IG G   KVF+ ++   K+  A+K ++  
Sbjct: 5   HHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLE 63

Query: 156 GRSGKELSSLKQECEIQKHLAHPN--IIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK 213
               + L S + E      L   +  II+      T     ++ E  ++ L++ L+++K 
Sbjct: 64  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS 123

Query: 214 LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-- 271
           +          N++ A++ +H + ++H DLKP N L+  DG+  L DFG A  M   T  
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTS 182

Query: 272 HMLTSIKGTPLYMAPELIAERP-----------YDHTADLWSLGCIAYEIHMGHPPF--- 317
            +  S  GT  YM PE I +                 +D+WSLGCI Y +  G  PF   
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242

Query: 318 -KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS 376
              +S LH I +    ++ FP    +  +D++K  L++D  QR+S PELL HP V+    
Sbjct: 243 INQISKLHAI-IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301

Query: 377 SEIESQNN 384
              +    
Sbjct: 302 PVNQMAKG 309

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 19/91 (20%), Positives = 36/91 (39%), Gaps = 3/91 (3%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
             Y  +  IG G   KVF+ ++   K+  A+K ++      + L S + E      L   
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86

Query: 69  N--IIKFIASHETLNEFVLITEFAHMSLSKL 97
           +  II+      T     ++ E  ++ L+  
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECGNIDLNSW 117

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  274 bits (703), Expect = 4e-88
 Identities = 79/285 (27%), Positives = 129/285 (45%), Gaps = 22/285 (7%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
             Y  +  IG G   KVF+ ++   K+  A+K ++      + L S + E      L   
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 179 N--IIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           +  II+      T     ++ E  ++ L++ L+++K +          N++ A++ +H +
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERP- 293
            ++H DLKP N L+  DG+  L DFG A  M   T   +  S  GT  YM PE I +   
Sbjct: 128 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 294 ----------YDHTADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQ 339
                         +D+WSLGCI Y +  G  PF      +S LH I +    ++ FP  
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDI 245

Query: 340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNN 384
             +  +D++K  L++D  QR+S PELL HP V+       +    
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 19/91 (20%), Positives = 36/91 (39%), Gaps = 3/91 (3%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
            Y  +  IG G   KVF+ ++   K+  A+K ++      + L S + E      L   
Sbjct: 9  RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 69 N--IIKFIASHETLNEFVLITEFAHMSLSKL 97
          +  II+      T     ++ E  ++ L+  
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGNIDLNSW 98

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  267 bits (683), Expect = 1e-84
 Identities = 78/285 (27%), Positives = 128/285 (44%), Gaps = 22/285 (7%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
             Y  +  IG G   KVF+ ++   K+  A+K ++      + L S + E      L   
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 179 N--IIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           +  II+      T     ++ E  ++ L++ L+++K +          N++ A++ +H +
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERP- 293
            ++H DLKP N L+  DG+  L DFG A  M   T   +  S  G   YM PE I +   
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 294 ----------YDHTADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQ 339
                         +D+WSLGCI Y +  G  PF      +S LH I +    ++ FP  
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDI 292

Query: 340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNN 384
             +  +D++K  L++D  QR+S PELL HP V+       +    
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 89.1 bits (221), Expect = 3e-19
 Identities = 19/91 (20%), Positives = 36/91 (39%), Gaps = 3/91 (3%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
             Y  +  IG G   KVF+ ++   K+  A+K ++      + L S + E      L   
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 69  N--IIKFIASHETLNEFVLITEFAHMSLSKL 97
           +  II+      T     ++ E  ++ L+  
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGNIDLNSW 145

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  258 bits (661), Expect = 2e-82
 Identities = 83/290 (28%), Positives = 131/290 (45%), Gaps = 10/290 (3%)

Query: 107 QPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSL 165
           + ++ +     L  ++    IG G F +V++A  L     VALK +        K  +  
Sbjct: 20  KALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADC 79

Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKK----LSETICV 220
            +E ++ K L HPN+IK+ AS    NE  ++ E A    LS +++  KK    + E    
Sbjct: 80  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139

Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
           +    L SAL ++HS RV+HRD+KP NV +   GV  L D G  R  +  T    S+ GT
Sbjct: 140 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 199

Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQV 340
           P YM+PE I E  Y+  +D+WSLGC+ YE+     PF    +       K +   +P   
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP 259

Query: 341 SETY----KDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
           S+ Y    + LV   +  D  +R     +          ++     ++  
Sbjct: 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 27/90 (30%), Positives = 42/90 (46%), Gaps = 1/90 (1%)

Query: 2   EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECE 60
           +     L  ++    IG G F +V++A  L     VALK +        K  +   +E +
Sbjct: 25  DMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEID 84

Query: 61  IQKHLAHPNIIKFIASHETLNEFVLITEFA 90
           + K L HPN+IK+ AS    NE  ++ E A
Sbjct: 85  LLKQLNHPNVIKYYASFIEDNELNIVLELA 114

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  255 bits (654), Expect = 3e-81
 Identities = 71/311 (22%), Positives = 119/311 (38%), Gaps = 7/311 (2%)

Query: 64  HLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQK 123
           H  H + +     +        +         +  E        P + E      + +Q+
Sbjct: 4   HHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFF--QQSFQR 61

Query: 124 ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIK 182
           +  +G GS+G+VFK    +  +  A+K      R  K+ +    E    + +  HP  ++
Sbjct: 62  LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121

Query: 183 FIASHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSNRVLHR 241
              + E      L TE    SL    E     L E      L + + AL +LHS  ++H 
Sbjct: 122 LEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL 181

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLW 301
           D+KP N+ L   G   L DFG    +          +G P YMAPEL+ +  Y   AD++
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGDPRYMAPELL-QGSYGTAADVF 239

Query: 302 SLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLS 361
           SLG    E+               +R        F + +S   + ++  +LE D   R +
Sbjct: 240 SLGLTILEVACNMELPHGGEGWQQLRQGY-LPPEFTAGLSSELRSVLVMMLEPDPKLRAT 298

Query: 362 WPELLHHPLVK 372
              LL  P+++
Sbjct: 299 AEALLALPVLR 309

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 1/91 (1%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA- 66
            + +Q++  +G GS+G+VFK    +  +  A+K      R  K+ +    E    + +  
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 67  HPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
           HP  ++   + E      L TE    SL + 
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQH 146

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  251 bits (643), Expect = 5e-80
 Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 32/283 (11%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
              +++I LIG G FG+VFKA H    KT  +K +  +          ++E +    L H
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDH 63

Query: 178 PNIIKFIASHETLNEFV----------------LITEFAHM-SLSNLLEQRKK--LSETI 218
            NI+ +    +  +                   +  EF    +L   +E+R+   L + +
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 219 CVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK 278
            +++   +   + Y+HS ++++RDLKP N+ L       + DFG   S+       T  K
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDGKRTRSK 182

Query: 279 GTPLYMAPELIAERPYDHTADLWSLGCIAYE-IHMGHPPFKTVSILHLIRLLKTQDVTFP 337
           GT  YM+PE I+ + Y    DL++LG I  E +H+    F+T      +R     D    
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR-----DGIIS 237

Query: 338 SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
               +  K L++ LL K    R +  E+L    V      + E
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 20/69 (28%), Positives = 32/69 (46%), Gaps = 6/69 (8%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
             +++I LIG G FG+VFKA H    KT  +K +  +          ++E +    L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKLDH 63

Query: 68 PNIIKFIAS 76
           NI+ +   
Sbjct: 64 VNIVHYNGC 72

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  237 bits (606), Expect = 8e-74
 Identities = 76/259 (29%), Positives = 128/259 (49%), Gaps = 2/259 (0%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 176
             +Y +   +G+G F K F+    D K+  A KI+ KS      +   +  E  I + LA
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 177 HPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           H +++ F    E  +   ++ E     SL  L ++RK L+E      L  ++    YLH 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           NRV+HRDLK  N+ LN+D    + DFG A  +         + GTP Y+APE+++++ + 
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
              D+WS+GCI Y + +G PPF+T  +      +K  + + P  ++     L++ +L+ D
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 279

Query: 356 ASQRLSWPELLHHPLVKDN 374
            + R +  ELL+       
Sbjct: 280 PTARPTINELLNDEFFTSG 298

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 21/85 (24%), Positives = 37/85 (43%), Gaps = 1/85 (1%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 66
             +Y +   +G+G F K F+    D K+  A KI+ KS      +   +  E  I + LA
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 67  HPNIIKFIASHETLNEFVLITEFAH 91
           H +++ F    E  +   ++ E   
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCR 124

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  233 bits (597), Expect = 6e-73
 Identities = 76/259 (29%), Positives = 128/259 (49%), Gaps = 2/259 (0%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 176
             +Y +   +G+G F K F+    D K+  A KI+ KS      +   +  E  I + LA
Sbjct: 14  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 177 HPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           H +++ F    E  +   ++ E     SL  L ++RK L+E      L  ++    YLH 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           NRV+HRDLK  N+ LN+D    + DFG A  +         + GTP Y+APE+++++ + 
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
              D+WS+GCI Y + +G PPF+T  +      +K  + + P  ++     L++ +L+ D
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 253

Query: 356 ASQRLSWPELLHHPLVKDN 374
            + R +  ELL+       
Sbjct: 254 PTARPTINELLNDEFFTSG 272

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 21/85 (24%), Positives = 37/85 (43%), Gaps = 1/85 (1%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 66
            +Y +   +G+G F K F+    D K+  A KI+ KS      +   +  E  I + LA
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 67 HPNIIKFIASHETLNEFVLITEFAH 91
          H +++ F    E  +   ++ E   
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCR 98

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  231 bits (591), Expect = 4e-72
 Identities = 62/285 (21%), Positives = 113/285 (39%), Gaps = 32/285 (11%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           L  ++ I  +G G FG VF+A +       A+K I            + +E +    L H
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEH 62

Query: 178 PNIIKFIASHETLNEFV------------LITEFAHM-SLSNLLEQRKKLS---ETICVQ 221
           P I+++  +    N               +  +     +L + +  R  +     ++C+ 
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 222 ILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------------AV 269
           I   +  A+ +LHS  ++HRDLKP N+    D V  + DFG   +M              
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL 329
                T   GT LYM+PE I    Y H  D++SLG I +E  + +P    +  +  +  +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE--LLYPFSTQMERVRTLTDV 240

Query: 330 KTQDV-TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
           +        +Q       +V+ +L     +R     ++ + + +D
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 1/76 (1%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
          L  ++ I  +G G FG VF+A +       A+K I            + +E +    L H
Sbjct: 4  LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEH 62

Query: 68 PNIIKFIASHETLNEF 83
          P I+++  +    N  
Sbjct: 63 PGIVRYFNAWLEKNTT 78

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  231 bits (592), Expect = 5e-72
 Identities = 72/275 (26%), Positives = 115/275 (41%), Gaps = 26/275 (9%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + Y  I  +GEG F  V     L      ALK I    +  ++    ++E ++ +   HP
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHP 86

Query: 179 NIIKFIASHETL----NEFVLITEFAHM-SLSNLLEQRKK----LSETICVQILSNLISA 229
           NI++ +A         +E  L+  F    +L N +E+ K     L+E   + +L  +   
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR---------SMAVGTHMLTSIKGT 280
           L  +H+    HRDLKP N+LL  +G  +L D G              A+      + + T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 281 PLYMAPELIAERPY---DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-DVTF 336
             Y APEL + + +   D   D+WSLGC+ Y +  G  P+  V        L  Q  ++ 
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

Query: 337 P--SQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
           P   + S     L+  ++  D  QR   P LL   
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 6/86 (6%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           + Y  I  +GEG F  V     L      ALK I    +  ++    ++E ++ +   HP
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHP 86

Query: 69  NIIKFIASHETL----NEFVLITEFA 90
           NI++ +A         +E  L+  F 
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFF 112

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  230 bits (589), Expect = 5e-72
 Identities = 95/277 (34%), Positives = 145/277 (52%), Gaps = 4/277 (1%)

Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECE 170
           +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+          L++E E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISA 229
           IQ HL HPNI++            LI E+A + ++   L++  K  E      ++ L +A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           L Y HS RV+HRD+KP+N+LL   G   + DFG+  S+   +   T + GT  Y+ PE+I
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMI 179

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             R +D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+ 
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239

Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            LL+ + SQR    E+L HP +  N S     QN + 
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKES 276

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 1/91 (1%)

Query: 2  EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECE 60
          +K   ALE ++    +G+G FG V+ A     K  +ALK++ K+          L++E E
Sbjct: 2  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 61 IQKHLAHPNIIKFIASHETLNEFVLITEFAH 91
          IQ HL HPNI++            LI E+A 
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAP 92

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  228 bits (583), Expect = 8e-71
 Identities = 68/300 (22%), Positives = 138/300 (46%), Gaps = 47/300 (15%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
              +++I ++G+G+FG+V KA +    +  A+K I  +    ++LS++  E  +   L H
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNH 61

Query: 178 PNIIKFIASHETLNEFV-------------LITEFAHM-SLSNLLEQRKKLSE-----TI 218
             ++++ A+      FV             +  E+    +L +L+       +      +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 219 CVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM----------- 267
             QIL     AL Y+HS  ++HRDLKP N+ +++     + DFG A+++           
Sbjct: 122 FRQILE----ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 268 ---AVGTHMLTSIKGTPLYMAPELIAERP-YDHTADLWSLGCIAYEIHMGHPPFKTVSIL 323
                 +  LTS  GT +Y+A E++     Y+   D++SLG I +E  M +P    +  +
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE--MIYPFSTGMERV 235

Query: 324 HLIRLLKTQDVTFPSQVSETY----KDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEI 379
           ++++ L++  + FP    +      K +++ L++ D ++R     LL+   +      E+
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEV 295

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 17/71 (23%), Positives = 39/71 (54%), Gaps = 3/71 (4%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
             +++I ++G+G+FG+V KA +    +  A+K I     + ++LS++  E  +   L H
Sbjct: 5  ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNH 61

Query: 68 PNIIKFIASHE 78
            ++++ A+  
Sbjct: 62 QYVVRYYAAWL 72

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  227 bits (580), Expect = 1e-70
 Identities = 81/268 (30%), Positives = 141/268 (52%), Gaps = 3/268 (1%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 176
           +E ++   L+G+GSF  V++A  +     VA+K+I K        +  ++ E +I   L 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 177 HPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQR-KKLSETICVQILSNLISALYYLH 234
           HP+I++     E  N   L+ E  H   ++  L+ R K  SE      +  +I+ + YLH
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S+ +LHRDL   N+LL ++    + DFG A  + +      ++ GTP Y++PE+     +
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
              +D+WSLGC+ Y + +G PPF T ++ + +  +   D   PS +S   KDL+  LL +
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR 249

Query: 355 DASQRLSWPELLHHPLVKDNLSSEIESQ 382
           + + RLS   +L HP +  N S++ + +
Sbjct: 250 NPADRLSLSSVLDHPFMSRNSSTKSKDE 277

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 1/85 (1%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 66
          +E ++   L+G+GSF  V++A  +     VA+K+I K        +  ++ E +I   L 
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 67 HPNIIKFIASHETLNEFVLITEFAH 91
          HP+I++     E  N   L+ E  H
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCH 94

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  222 bits (569), Expect = 5e-69
 Identities = 83/262 (31%), Positives = 129/262 (49%), Gaps = 4/262 (1%)

Query: 110 KMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQE 168
           +M K    ++ +     +G+G FG V+ A     K  +ALK++ KS          L++E
Sbjct: 5   EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64

Query: 169 CEIQKHLAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLI 227
            EIQ HL HPNI++            L+ EFA    L   L++  +  E      +  L 
Sbjct: 65  IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA 124

Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
            AL+Y H  +V+HRD+KP+N+L+   G   + DFG+  S+   +    ++ GT  Y+ PE
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRTMCGTLDYLPPE 182

Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDL 347
           +I  + +D   DLW  G + YE  +G PPF + S     R +   D+ FP  +S+  KDL
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242

Query: 348 VKGLLEKDASQRLSWPELLHHP 369
           +  LL     QRL    ++ HP
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHP 264

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 1/91 (1%)

Query: 1  MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQEC 59
          M K    ++ +     +G+G FG V+ A     K  +ALK++ KS          L++E 
Sbjct: 6  MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65

Query: 60 EIQKHLAHPNIIKFIASHETLNEFVLITEFA 90
          EIQ HL HPNI++            L+ EFA
Sbjct: 66 EIQSHLRHPNILRMYNYFHDRKRIYLMLEFA 96

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  219 bits (559), Expect = 4e-67
 Identities = 69/306 (22%), Positives = 123/306 (40%), Gaps = 49/306 (16%)

Query: 111 MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE 170
           M   + +   +    ++G+G+   VF+  H       A+K+ +      + +    +E E
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFE 59

Query: 171 IQKHLAHPNIIKFIASHE--TLNEFVLITEFAHM-SLSNLLEQRKK---LSETICVQILS 224
           + K L H NI+K  A  E  T    VLI EF    SL  +LE+      L E+  + +L 
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 225 NLISALYYLHSNRVLHRDLKPQNVLL----NKDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
           +++  + +L  N ++HR++KP N++     +   V  L DFG AR +        S+ GT
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGT 178

Query: 281 PLYMAPELIA--------ERPYDHTADLWSLGCIAYEIHMGHPPF-------KTVSILHL 325
             Y+ P++          ++ Y  T DLWS+G   Y    G  PF       +   +++ 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238

Query: 326 IRLLK------------------TQDVTFPSQVSETYKDLVK----GLLEKDASQRLSWP 363
           I   K                  + D+     +S   + L+      +LE D  +   + 
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298

Query: 364 ELLHHP 369
           +     
Sbjct: 299 QFFAET 304

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 24/92 (26%), Positives = 40/92 (43%), Gaps = 3/92 (3%)

Query: 1  MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE 60
          M   + +   +    ++G+G+   VF+  H       A+K+ +      + +    +E E
Sbjct: 1  MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFE 59

Query: 61 IQKHLAHPNIIKFIASHE--TLNEFVLITEFA 90
          + K L H NI+K  A  E  T    VLI EF 
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  218 bits (556), Expect = 2e-66
 Identities = 70/281 (24%), Positives = 128/281 (45%), Gaps = 37/281 (13%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           + +   ++ EG F  V++A  +   +  ALK +       ++  ++ QE    K L+ HP
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHP 86

Query: 179 NIIKFIASHETLN--------EFVLITEFAHMSLSNLLEQRK---KLSETICVQILSNLI 227
           NI++F ++             EF+L+TE     L   L++ +    LS    ++I     
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 228 SALYYLHSNR--VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK------- 278
            A+ ++H  +  ++HRDLK +N+LL+  G   LCDFG A +++       S +       
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 279 -----GTPLYMAPELI---AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLK 330
                 TP+Y  PE+I   +  P     D+W+LGCI Y +     PF+  + L ++    
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN--- 263

Query: 331 TQDVTFP--SQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
               + P        +  L++ +L+ +  +RLS  E++H  
Sbjct: 264 -GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 23/94 (24%), Positives = 43/94 (45%), Gaps = 11/94 (11%)

Query: 10  KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 68
           + +   ++ EG F  V++A  +   +  ALK +       ++  ++ QE    K L+ HP
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHP 86

Query: 69  NIIKFIASHETLN--------EFVLITEFAHMSL 94
           NI++F ++             EF+L+TE     L
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQL 120

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  216 bits (552), Expect = 2e-66
 Identities = 76/282 (26%), Positives = 135/282 (47%), Gaps = 15/282 (5%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + Y     +G+G+F  V + +H       A KII+    S ++   L++E  I + L HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65

Query: 179 NIIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           NI++   S +  +   L+ +   ++   L   +  R+  SE      +  ++ ++ Y HS
Sbjct: 66  NIVRLHDSIQEESFHYLVFDL--VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123

Query: 236 NRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           N ++HR+LKP+N+LL    K     L DFG A  +           GTP Y++PE++ + 
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKD 182

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLV 348
           PY    D+W+ G I Y + +G+PPF       L   +K     +PS     V+   K L+
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDN--LSSEIESQNNQDCI 388
             +L  +  +R++  + L  P + +   ++S I  Q+  DC+
Sbjct: 243 DSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCL 284

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 81.4 bits (202), Expect = 3e-17
 Identities = 21/80 (26%), Positives = 39/80 (48%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          + Y     +G+G+F  V + +H       A KII+    S ++   L++E  I + L HP
Sbjct: 6  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65

Query: 69 NIIKFIASHETLNEFVLITE 88
          NI++   S +  +   L+ +
Sbjct: 66 NIVRLHDSIQEESFHYLVFD 85

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  216 bits (552), Expect = 2e-66
 Identities = 50/281 (17%), Positives = 113/281 (40%), Gaps = 32/281 (11%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA- 176
             ++ ++  IG G FG VFK +        A+K   K      +  +  +E      L  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 177 HPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKK----LSETICVQILSNLISALY 231
           H +++++ ++    +  ++  E+ +  SL++ + +  +      E     +L  +   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAM-------------------LCDFGFARSMAVGTH 272
           Y+HS  ++H D+KP N+ +++  +                     + D G    ++    
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS---- 185

Query: 273 MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT 331
                +G   ++A E++ E   +   AD+++L           P  +     H IR  + 
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR--QG 243

Query: 332 QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
           +    P  +S+ + +L+K ++  D  +R S   L+ H ++ 
Sbjct: 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 17/92 (18%), Positives = 39/92 (42%), Gaps = 2/92 (2%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA- 66
             ++ ++  IG G FG VFK +        A+K   K      +  +  +E      L  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 67  HPNIIKFIASHETLNEFVLITEFAHM-SLSKL 97
           H +++++ ++    +  ++  E+ +  SL+  
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADA 101

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  212 bits (543), Expect = 3e-65
 Identities = 89/285 (31%), Positives = 149/285 (52%), Gaps = 11/285 (3%)

Query: 103 HNHCQPVKMEKSNGAL-EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE 161
           H+H    +     G   E+Y  +C++G+GSFG+V K      ++  A+K+I+K+    K+
Sbjct: 5   HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 162 LSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICV 220
            S++ +E E+ K L HPNI+K     E  + F ++ E      L + + +RK+ SE    
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124

Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSI 277
           +I+  + S + Y+H + ++HRDLKP+N+LL    KD    + DFG +      T M   I
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184

Query: 278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP 337
            GT  Y+APE++    YD   D+WS G I Y +  G PPF   +   +++ ++T    F 
Sbjct: 185 -GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242

Query: 338 SQ----VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSE 378
                 +S+  KDL++ +L    S R++  + L HP ++   S E
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 28/80 (35%), Positives = 49/80 (61%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           E+Y  +C++G+GSFG+V K      ++  A+K+I+K+    K+ S++ +E E+ K L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 69  NIIKFIASHETLNEFVLITE 88
           NI+K     E  + F ++ E
Sbjct: 82  NIMKLFEILEDSSSFYIVGE 101

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  210 bits (536), Expect = 6e-64
 Identities = 81/276 (29%), Positives = 140/276 (50%), Gaps = 16/276 (5%)

Query: 113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ 172
           ++    + +  + ++G G+F +VF        K  ALK I KS        SL+ E  + 
Sbjct: 3   QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVL 60

Query: 173 KHLAHPNIIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLISA 229
           K + H NI+     +E+   + L+ +    S   L + + +R   +E     ++  ++SA
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLSA 118

Query: 230 LYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
           + YLH N ++HRDLKP+N+L     ++   M+ DFG ++       ++++  GTP Y+AP
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGTPGYVAP 176

Query: 287 ELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSE 342
           E++A++PY    D WS+G I Y +  G+PPF   +   L   +K     F S     +SE
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236

Query: 343 TYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSE 378
           + KD +  LLEKD ++R +  + L HP +  N +  
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALH 272

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 21/88 (23%), Positives = 39/88 (44%), Gaps = 2/88 (2%)

Query: 3  KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ 62
          ++    + +  + ++G G+F +VF        K  ALK I KS        SL+ E  + 
Sbjct: 3  QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVL 60

Query: 63 KHLAHPNIIKFIASHETLNEFVLITEFA 90
          K + H NI+     +E+   + L+ +  
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLV 88

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  214 bits (548), Expect = 1e-63
 Identities = 85/292 (29%), Positives = 147/292 (50%), Gaps = 11/292 (3%)

Query: 103 HNHCQPVKMEKSNGAL-EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE 161
           H+H    +     G   E+Y  +C++G+GSFG+V K      ++  A+K+I+K+    K+
Sbjct: 5   HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 162 LSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICV 220
            S++ +E E+ K L HPNI+K     E  + F ++ E      L + + +RK+ SE    
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124

Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSI 277
           +I+  + S + Y+H + ++HRDLKP+N+LL    KD    + DFG +         +   
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDR 183

Query: 278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP 337
            GT  Y+APE++    YD   D+WS G I Y +  G PPF   +   +++ ++T    F 
Sbjct: 184 IGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242

Query: 338 SQ----VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQ 385
                 +S+  KDL++ +L    S R++  + L HP ++   S      +  
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLP 294

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 28/81 (34%), Positives = 49/81 (60%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           E+Y  +C++G+GSFG+V K      ++  A+K+I+K+    K+ S++ +E E+ K L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 69  NIIKFIASHETLNEFVLITEF 89
           NI+K     E  + F ++ E 
Sbjct: 82  NIMKLFEILEDSSSFYIVGEL 102

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  211 bits (539), Expect = 1e-63
 Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 9/264 (3%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + Y     +G+G+F  V + +H       A KII+    S ++   L++E  I + L HP
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88

Query: 179 NIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI++   S +  +   L+ +      L   +  R+  SE      +  ++ ++ Y HSN 
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148

Query: 238 VLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           ++HR+LKP+N+LL    K     L DFG A  +           GTP Y++PE++ + PY
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPY 207

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVKG 350
               D+W+ G I Y + +G+PPF       L   +K     +PS     V+   K L+  
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267

Query: 351 LLEKDASQRLSWPELLHHPLVKDN 374
           +L  +  +R++  + L  P + + 
Sbjct: 268 MLTVNPKKRITADQALKVPWICNR 291

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 21/82 (25%), Positives = 39/82 (47%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           + Y     +G+G+F  V + +H       A KII+    S ++   L++E  I + L HP
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88

Query: 69  NIIKFIASHETLNEFVLITEFA 90
           NI++   S +  +   L+ +  
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLV 110

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  209 bits (533), Expect = 2e-63
 Identities = 93/261 (35%), Positives = 134/261 (51%), Gaps = 10/261 (3%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E + K+  IG+GSFG+VFK I    +K VA+KII     +  E+  ++QE  +      P
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSP 80

Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
            + K+  S+    +  +I E+    S  +LLE    L ET    IL  ++  L YLHS +
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK 139

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
            +HRD+K  NVLL++ G   L DFG A  +        +  GTP +MAPE+I +  YD  
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL----KTQDVTFPSQVSETYKDLVKGLLE 353
           AD+WSLG  A E+  G PP    S LH +++L    K    T     S+  K+ V+  L 
Sbjct: 200 ADIWSLGITAIELARGEPPH---SELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 256

Query: 354 KDASQRLSWPELLHHPLVKDN 374
           K+ S R +  ELL H  +  N
Sbjct: 257 KEPSFRPTAKELLKHKFILRN 277

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 1/81 (1%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           E + K+  IG+GSFG+VFK I    +K VA+KII     +  E+  ++QE  +      P
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSP 80

Query: 69  NIIKFIASHETLNEFVLITEF 89
            + K+  S+    +  +I E+
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEY 101

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  211 bits (538), Expect = 4e-63
 Identities = 66/305 (21%), Positives = 118/305 (38%), Gaps = 49/305 (16%)

Query: 111 MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE 170
           M   + +   +    ++G+G+   VF+  H       A+K+ +      + +    +E E
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFE 59

Query: 171 IQKHLAHPNIIKFIASHE--TLNEFVLITEFAHM-SLSNLLEQRKK---LSETICVQILS 224
           + K L H NI+K  A  E  T    VLI EF    SL  +LE+      L E+  + +L 
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 225 NLISALYYLHSNRVLHRDLKPQNVLL----NKDGVAMLCDFGFARSMAVGTHMLTSIKGT 280
           +++  + +L  N ++HR++KP N++     +   V  L DFG AR +        S+ GT
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGT 178

Query: 281 PLYMAPELIA--------ERPYDHTADLWSLGCIAYEIHMGHPPF-------KTVSILHL 325
             Y+ P++          ++ Y  T DLWS+G   Y    G  PF       +   +++ 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238

Query: 326 IRLLKTQDVT----------------------FPSQVSETYKDLVKGLLEKDASQRLSWP 363
           I   K                               +      ++  +LE D  +   + 
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298

Query: 364 ELLHH 368
           +    
Sbjct: 299 QFFAE 303

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 81.8 bits (202), Expect = 7e-17
 Identities = 24/92 (26%), Positives = 40/92 (43%), Gaps = 3/92 (3%)

Query: 1  MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE 60
          M   + +   +    ++G+G+   VF+  H       A+K+ +      + +    +E E
Sbjct: 1  MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFE 59

Query: 61 IQKHLAHPNIIKFIASHE--TLNEFVLITEFA 90
          + K L H NI+K  A  E  T    VLI EF 
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  207 bits (528), Expect = 4e-63
 Identities = 84/267 (31%), Positives = 128/267 (47%), Gaps = 12/267 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + Y     IG GS+G+V  A+    +   A K I K      +    KQE EI K L HP
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD--RFKQEIEIMKSLDHP 66

Query: 179 NIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NII+   + E   +  L+ E      L   +  ++   E+   +I+ +++SA+ Y H   
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126

Query: 238 VLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           V HRDLKP+N L    + D    L DFG A     G  M T + GTP Y++P+++ E  Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-GTPYYVSPQVL-EGLY 184

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVKG 350
               D WS G + Y +  G+PPF   +   ++  ++    TFP +    VS   + L++ 
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244

Query: 351 LLEKDASQRLSWPELLHHPLVKDNLSS 377
           LL K   QR++  + L H   +  LSS
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEKQLSS 271

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 74.9 bits (185), Expect = 3e-15
 Identities = 27/80 (33%), Positives = 37/80 (46%), Gaps = 2/80 (2%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          + Y     IG GS+G+V  A+    +   A K I K      +    KQE EI K L HP
Sbjct: 9  QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD--RFKQEIEIMKSLDHP 66

Query: 69 NIIKFIASHETLNEFVLITE 88
          NII+   + E   +  L+ E
Sbjct: 67 NIIRLYETFEDNTDIYLVME 86

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  213 bits (543), Expect = 9e-63
 Identities = 87/310 (28%), Positives = 151/310 (48%), Gaps = 15/310 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E YQ++  +G G++G+V            A+KII K+  S    S L +E  + K L HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96

Query: 179 NIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+K     E    + L+ E      L + +  R K +E     I+  ++S + YLH + 
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156

Query: 238 VLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           ++HRDLKP+N+LL    KD +  + DFG +         +    GT  Y+APE++  + Y
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVL-RKKY 214

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVKG 350
           D   D+WS+G I + +  G+PPF   +   ++R ++    TF S     VSE  KDL+K 
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274

Query: 351 LLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGF-----DYCDKRRGSRKSITT 405
           +L+ D+ +R+S  + L HP +K+  S +                  + + ++ ++ ++  
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLY 334

Query: 406 IVESDSDENE 415
           +    + + E
Sbjct: 335 MASKLTSQEE 344

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 26/81 (32%), Positives = 39/81 (48%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           E YQ++  +G G++G+V            A+KII K+  S    S L +E  + K L HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96

Query: 69  NIIKFIASHETLNEFVLITEF 89
           NI+K     E    + L+ E 
Sbjct: 97  NIMKLYDFFEDKRNYYLVMEC 117

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  207 bits (528), Expect = 2e-62
 Identities = 85/266 (31%), Positives = 132/266 (49%), Gaps = 25/266 (9%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIA 185
           +GEGSF    K +H    +  A+KIISK     +  ++ ++E    K    HPNI+K   
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHE 73

Query: 186 SHETLNEFVLITEFAHMSLSNLLE---QRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
                    L+ E   ++   L E   ++K  SET    I+  L+SA+ ++H   V+HRD
Sbjct: 74  VFHDQLHTFLVMEL--LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131

Query: 243 LKPQNVLL-NKDGVA--MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTAD 299
           LKP+N+L  +++      + DFGFAR        L +   T  Y APEL+ +  YD + D
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCD 191

Query: 300 LWSLGCIAYEIHMGHPPF-------KTVSILHLIRLLKTQDVTFPS----QVSETYKDLV 348
           LWSLG I Y +  G  PF          S + +++ +K  D +F       VS+  KDL+
Sbjct: 192 LWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI 251

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDN 374
           +GLL  D ++RL    L ++  ++D 
Sbjct: 252 QGLLTVDPNKRLKMSGLRYNEWLQDG 277

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 22/73 (30%), Positives = 33/73 (45%), Gaps = 6/73 (8%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIA 75
          +GEGSF    K +H    +  A+KIISK     +  ++ ++E    K    HPNI+K   
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHE 73

Query: 76 SHETLNEFVLITE 88
                   L+ E
Sbjct: 74 VFHDQLHTFLVME 86

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  210 bits (537), Expect = 5e-62
 Identities = 85/310 (27%), Positives = 149/310 (48%), Gaps = 15/310 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 177
           ++Y+   ++G+GSFG+V         +  A+K+ISK     K    SL +E ++ K L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 178 PNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           PNI+K     E    F L+ E      L + +  RK+ SE    +I+  ++S + Y+H N
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 237 RVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           +++HRDLKP+N+LL   +KD    + DFG +         +    GT  Y+APE++    
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVL-HGT 203

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVK 349
           YD   D+WS G I Y +  G PPF   +   +++ ++    TF       VSE+ KDL++
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263

Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFD----YCDKRRGSRKSITT 405
            +L    S R+S  + L H  ++     +I                +   ++ ++ ++  
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLY 323

Query: 406 IVESDSDENE 415
           +    + ++E
Sbjct: 324 MGSKLTSQDE 333

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 75.9 bits (187), Expect = 7e-15
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 1/82 (1%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 67
           ++Y+   ++G+GSFG+V         +  A+K+ISK     K    SL +E ++ K L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 68  PNIIKFIASHETLNEFVLITEF 89
           PNI+K     E    F L+ E 
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEV 107

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  206 bits (526), Expect = 5e-62
 Identities = 89/331 (26%), Positives = 138/331 (41%), Gaps = 36/331 (10%)

Query: 104 NHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS 163
           +         S    + Y+    IG GS+    + IH       A+KII KS R   E  
Sbjct: 7   HSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-- 64

Query: 164 SLKQECEIQKHLA-HPNIIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETIC 219
               E EI      HPNII     ++      ++TE   M    L + + ++K  SE   
Sbjct: 65  ----EIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL--MKGGELLDKILRQKFFSEREA 118

Query: 220 VQILSNLISALYYLHSNRVLHRDLKPQNVLL-NKDGVA---MLCDFGFARSMAVGTHMLT 275
             +L  +   + YLH+  V+HRDLKP N+L  ++ G      +CDFGFA+ +     +L 
Sbjct: 119 SAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178

Query: 276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS------ILHLIRLL 329
           +   T  ++APE++  + YD   D+WSLG + Y +  G+ PF          IL  I   
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI--- 235

Query: 330 KTQDVTFPS----QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD-------NLSSE 378
            +   +        VS+T KDLV  +L  D  QRL+   +L HP +          L+ +
Sbjct: 236 GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQ 295

Query: 379 IESQNNQDCIGFDYCDKRRGSRKSITTIVES 409
                 +  +   Y    R     +  +  S
Sbjct: 296 DAPHLVKGAMAATYSALNRNQSPVLEPVGRS 326

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 25/81 (30%), Positives = 34/81 (41%), Gaps = 7/81 (8%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-H 67
          + Y+    IG GS+    + IH       A+KII KS R   E      E EI      H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------EIEILLRYGQH 75

Query: 68 PNIIKFIASHETLNEFVLITE 88
          PNII     ++      ++TE
Sbjct: 76 PNIITLKDVYDDGKYVYVVTE 96

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  206 bits (525), Expect = 6e-62
 Identities = 64/262 (24%), Positives = 98/262 (37%), Gaps = 17/262 (6%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +        +G GSFG+V +          A+K +              +E      L+ 
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-------VFRVEELVACAGLSS 109

Query: 178 PNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           P I+    +        +  E     SL  L++Q   L E   +  L   +  L YLH+ 
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR 169

Query: 237 RVLHRDLKPQNVLLNKDGVAM-LCDFGFARSMAVGTHMLT-----SIKGTPLYMAPELIA 290
           R+LH D+K  NVLL+ DG    LCDFG A  +       +      I GT  +MAPE++ 
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDL 347
            +P D   D+WS  C+   +  G  P+       +   I          P   +      
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 289

Query: 348 VKGLLEKDASQRLSWPELLHHP 369
           ++  L K+   R S  EL    
Sbjct: 290 IQEGLRKEPVHRASAMELRRKV 311

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 65.5 bits (160), Expect = 9e-12
 Identities = 13/82 (15%), Positives = 24/82 (29%), Gaps = 7/82 (8%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
           +        +G GSFG+V +          A+K +              +E      L+ 
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-------VFRVEELVACAGLSS 109

Query: 68  PNIIKFIASHETLNEFVLITEF 89
           P I+    +        +  E 
Sbjct: 110 PRIVPLYGAVREGPWVNIFMEL 131

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  209 bits (533), Expect = 7e-62
 Identities = 78/266 (29%), Positives = 127/266 (47%), Gaps = 12/266 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ    +G+G+F  V + + +   +  A  II+    S ++   L++E  I + L HP
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLE---QRKKLSETICVQILSNLISALYYLHS 235
           NI++   S        LI +   ++   L E    R+  SE      +  ++ A+ + H 
Sbjct: 71  NIVRLHDSISEEGHHYLIFDL--VTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128

Query: 236 NRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
             V+HR+LKP+N+LL    K     L DFG A  +           GTP Y++PE++ + 
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD 188

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLV 348
           PY    DLW+ G I Y + +G+PPF       L + +K     FPS     V+   KDL+
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 248

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDN 374
             +L  + S+R++  E L HP +   
Sbjct: 249 NKMLTINPSKRITAAEALKHPWISHR 274

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 22/82 (26%), Positives = 39/82 (47%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          E+YQ    +G+G+F  V + + +   +  A  II+    S ++   L++E  I + L HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70

Query: 69 NIIKFIASHETLNEFVLITEFA 90
          NI++   S        LI +  
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLV 92

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  206 bits (525), Expect = 1e-61
 Identities = 59/334 (17%), Positives = 101/334 (30%), Gaps = 49/334 (14%)

Query: 93  SLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKII 152
            +  +    +  + +       +    K + +  +  G    VF    ++  +  ALK+ 
Sbjct: 36  MVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVF 95

Query: 153 SKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIA-------------------------- 185
           +     S  EL  L +       L   +  +                             
Sbjct: 96  TMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQ 155

Query: 186 SHETLNEFVLITEFAHMSLSNLLE-------QRKKLSETICVQILSNLISALYYLHSNRV 238
               +  ++L+   A + L  L          R          + + LI     L S  +
Sbjct: 156 DDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGL 215

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI--AERPYDH 296
           +H    P N+ +  DG  ML D        VGT    S      Y   E +  +   + H
Sbjct: 216 VHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASS-VPVTYAPREFLNASTATFTH 272

Query: 297 TADLWSLGCIAYEIHMGHPPF-------KTVSILHLIRLLKTQDVTFPS--QVSETYKDL 347
             + W LG   Y +     PF       K       +R+  T  + F S   + +  K L
Sbjct: 273 ALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTL 332

Query: 348 VKGLLEKDASQRLSWPELLHHPLVKDNLSSEIES 381
           +   L  D  +RL   E +  P     L +EI S
Sbjct: 333 IGRFLNFDRRRRLLPLEAMETPEFL-QLQNEISS 365

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 18/121 (14%), Positives = 37/121 (30%), Gaps = 7/121 (5%)

Query: 10  KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHP 68
           K + +  +  G    VF    ++  +  ALK+ +     S  EL  L +       L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 69  NIIKFIASHETLNEFVLITEFAHMSLSKLGE----PWFHNHCQPVKMEKSNGALEKYQKI 124
           +  +       L     +   +    ++L          N+   + M  ++  LE     
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL--LLMPAASVDLELLFST 180

Query: 125 C 125
            
Sbjct: 181 L 181

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  203 bits (518), Expect = 2e-61
 Identities = 82/269 (30%), Positives = 143/269 (53%), Gaps = 15/269 (5%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY +   IG+G+ G V+ A+ +   + VA++ ++   +  KEL  +  E  + +   +P
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77

Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSE----TICVQILSNLISALYYL 233
           NI+ ++ S+   +E  ++ E+ A  SL++++ +   + E     +C + L     AL +L
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQ----ALEFL 132

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HSN+V+HRD+K  N+LL  DG   L DFGF   +       +++ GTP +MAPE++  + 
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
           Y    D+WSLG +A E+  G PP+   +    L+LI    T ++  P ++S  ++D +  
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252

Query: 351 LLEKDASQRLSWPELLHHPLVKDNLSSEI 379
            LE D  +R S  ELL H  +K       
Sbjct: 253 CLEMDVEKRGSAKELLQHQFLKIAKPLSS 281

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 20/81 (24%), Positives = 45/81 (55%), Gaps = 2/81 (2%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          +KY +   IG+G+ G V+ A+ +   + VA++ ++   +  KEL  +  E  + +   +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77

Query: 69 NIIKFIASHETLNEFVLITEF 89
          NI+ ++ S+   +E  ++ E+
Sbjct: 78 NIVNYLDSYLVGDELWVVMEY 98

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  204 bits (520), Expect = 2e-61
 Identities = 81/271 (29%), Positives = 132/271 (48%), Gaps = 19/271 (7%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
                   IGEGS G V  A      + VA+K++    +  +EL  L  E  I +   H 
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHF 102

Query: 179 NIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSE----TICVQILSNLISALY 231
           N+++   S+    E  ++ EF  +   +L++++ Q  +L+E    T+C  +L     AL 
Sbjct: 103 NVVEMYKSYLVGEELWVLMEF--LQGGALTDIVSQ-VRLNEEQIATVCEAVLQ----ALA 155

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           YLH+  V+HRD+K  ++LL  DG   L DFGF   ++       S+ GTP +MAPE+I+ 
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 215

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDVTFPSQVSETYKDLV 348
             Y    D+WSLG +  E+  G PP+ + S    +  +R      +    +VS   +D +
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL 275

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEI 379
           + +L +D  +R +  ELL HP +      E 
Sbjct: 276 ERMLVRDPQERATAQELLDHPFLLQTGLPEC 306

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 22/81 (27%), Positives = 35/81 (43%), Gaps = 2/81 (2%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
                   IGEGS G V  A      + VA+K++    +  +EL  L  E  I +   H 
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHF 102

Query: 69  NIIKFIASHETLNEFVLITEF 89
           N+++   S+    E  ++ EF
Sbjct: 103 NVVEMYKSYLVGEELWVLMEF 123

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  202 bits (517), Expect = 4e-61
 Identities = 85/283 (30%), Positives = 134/283 (47%), Gaps = 24/283 (8%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS-------SLKQECEI 171
           E Y+   ++G G    V + IH    K  A+KII  +G              +  +E +I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 172 QKHLA-HPNIIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLI 227
            + ++ HPNII+   ++ET   F L+ +   M    L + L ++  LSE    +I+  L+
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDL--MKKGELFDYLTEKVTLSEKETRKIMRALL 134

Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
             +  LH   ++HRDLKP+N+LL+ D    L DFGF+  +  G  +     GTP Y+APE
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-GTPSYLAPE 193

Query: 288 LIA------ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS--- 338
           +I          Y    D+WS G I Y +  G PPF     + ++R++ + +  F S   
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253

Query: 339 -QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
              S+T KDLV   L     +R +  E L HP  +  +  E+ 
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 8/90 (8%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS-------SLKQECEI 61
           E Y+   ++G G    V + IH    K  A+KII  +G              +  +E +I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 62  QKHLA-HPNIIKFIASHETLNEFVLITEFA 90
            + ++ HPNII+   ++ET   F L+ +  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLM 106

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  200 bits (512), Expect = 1e-60
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 15/283 (5%)

Query: 103 HNHCQPVKMEKSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE 161
           H+H    +     G ++        +G G+FG V             +K I+K  RS   
Sbjct: 5   HHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVP 63

Query: 162 LSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-----MSLSNLLEQRKKLSE 216
           +  ++ E E+ K L HPNIIK     E  +   ++ E          + +   + K LSE
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123

Query: 217 TICVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHM 273
               +++  +++AL Y HS  V+H+DLKP+N+L    +      + DFG A       H 
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183

Query: 274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD 333
             +  GT LYMAPE+  +R      D+WS G + Y +  G  PF   S+  + +    ++
Sbjct: 184 TNAA-GTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE 241

Query: 334 VTFPSQ---VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
             +  +   ++    DL+K +L KD  +R S  ++LHH   K 
Sbjct: 242 PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 22/80 (27%), Positives = 35/80 (43%), Gaps = 1/80 (1%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           + +     +G G+FG V             +K I+K  RS   +  ++ E E+ K L HP
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLKSLDHP 80

Query: 69  NIIKFIASHETLNEFVLITE 88
           NIIK     E  +   ++ E
Sbjct: 81  NIIKIFEVFEDYHNMYIVME 100

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  201 bits (513), Expect = 1e-60
 Identities = 82/271 (30%), Positives = 136/271 (50%), Gaps = 12/271 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E ++ +  +G+G+FGKV+KA + +     A K+I     S +EL     E EI     HP
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHP 76

Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSN 236
            I+K + ++    +  ++ EF    ++  ++ +  + L+E     +   ++ AL +LHS 
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA-----E 291
           R++HRDLK  NVL+  +G   L DFG +           S  GTP +MAPE++      +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDVTFPSQVSETYKDLV 348
            PYD+ AD+WSLG    E+    PP   ++   +L  I       +  PS+ S  ++D +
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEI 379
           K  L+K+   R S  +LL HP V    S++ 
Sbjct: 257 KIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 2/81 (2%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          E ++ +  +G+G+FGKV+KA + +     A K+I     S +EL     E EI     HP
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHP 76

Query: 69 NIIKFIASHETLNEFVLITEF 89
           I+K + ++    +  ++ EF
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEF 97

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  202 bits (516), Expect = 2e-60
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 24/275 (8%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS---GRSGKELSSLKQECEIQKHL 175
           + Y+   +IG+G F  V + I+ +  +  A+KI+  +      G     LK+E  I   L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLE-------QRKKLSETICVQILSNLIS 228
            HP+I++ + ++ +     ++ EF  M  ++L              SE +    +  ++ 
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEF--MDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 229 ALYYLHSNRVLHRDLKPQNVLL-NKDGVA--MLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           AL Y H N ++HRD+KP  VLL +K+  A   L  FG A  +     +     GTP +MA
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201

Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPF--KTVSILHLIRLLKTQDVTFPS----Q 339
           PE++   PY    D+W  G I + +  G  PF      +   I                 
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGI---IKGKYKMNPRQWSH 258

Query: 340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN 374
           +SE+ KDLV+ +L  D ++R++  E L+HP +K+ 
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 75.0 bits (185), Expect = 9e-15
 Identities = 21/84 (25%), Positives = 42/84 (50%), Gaps = 3/84 (3%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS---GRSGKELSSLKQECEIQKHL 65
           + Y+   +IG+G F  V + I+ +  +  A+KI+  +      G     LK+E  I   L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 66  AHPNIIKFIASHETLNEFVLITEF 89
            HP+I++ + ++ +     ++ EF
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEF 107

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  203 bits (517), Expect = 6e-60
 Identities = 43/289 (14%), Positives = 84/289 (29%), Gaps = 45/289 (15%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLA-------- 176
           ++G+       +A   +  ++  + +   + R     +  +K+E    + L         
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 177 --------------HPNIIKFIASHETLNEFVLITEFAHM------------SLSNLLEQ 210
                          P   K I       +  +++ F                L +    
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 211 RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG 270
            K L     +Q+   +I  L  LH   ++H  L+P +++L++ G   L  F         
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264

Query: 271 THML-TSIKGTPLYMAPELIAERP-----YDHTADLWSLGCIAYEIHMGHPPFKTVSILH 324
                      P   A  ++              D W+LG   Y I     P    + L 
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG 324

Query: 325 LIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
               +       P  V    + L++G L      RL   + +  P  + 
Sbjct: 325 GSEWIFRSCKNIPQPV----RALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 8/66 (12%), Positives = 22/66 (33%), Gaps = 1/66 (1%)

Query: 16  LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFI 74
           ++G+       +A   +  ++  + +   + R     +  +K+E    + L      K  
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 75  ASHETL 80
             H   
Sbjct: 145 KVHLRF 150

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  200 bits (511), Expect = 8e-60
 Identities = 80/268 (29%), Positives = 127/268 (47%), Gaps = 11/268 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 177
           + +  +  IG GSFG V+ A  +   + VA+K +S SG+   E    + +E    + L H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSN 236
           PN I++   +   +   L+ E+   S S+LLE  KK L E     +    +  L YLHS+
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA---ERP 293
            ++HRD+K  N+LL++ G+  L DFG A  M       + + GTP +MAPE+I    E  
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANSFV-GTPYWMAPEVILAMDEGQ 229

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFPSQVSETYKDLVKGL 351
           YD   D+WSLG    E+    PP   ++ +  +  +   +         SE +++ V   
Sbjct: 230 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 289

Query: 352 LEKDASQRLSWPELLHHPLVKDNLSSEI 379
           L+K    R +   LL H  V       +
Sbjct: 290 LQKIPQDRPTSEVLLKHRFVLRERPPTV 317

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 23/82 (28%), Positives = 41/82 (50%), Gaps = 1/82 (1%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 67
           + +  +  IG GSFG V+ A  +   + VA+K +S SG+   E    + +E    + L H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 68  PNIIKFIASHETLNEFVLITEF 89
           PN I++   +   +   L+ E+
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEY 135

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  199 bits (508), Expect = 9e-60
 Identities = 75/289 (25%), Positives = 131/289 (45%), Gaps = 32/289 (11%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + Y+   +IG G+   V  A     K+ VA+K I+   +    +  L +E +      HP
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE-KCQTSMDELLKEIQAMSQCHHP 73

Query: 179 NIIKFIASHETLNEFVLITEF-AHMSLSNLL--------EQRKKLSETICVQILSNLISA 229
           NI+ +  S    +E  L+ +  +  S+ +++         +   L E+    IL  ++  
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK-----GTPLYM 284
           L YLH N  +HRD+K  N+LL +DG   + DFG +  +A G  +  +       GTP +M
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193

Query: 285 APELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-------------K 330
           APE++ + R YD  AD+WS G  A E+  G  P+        +++L              
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLMLTLQNDPPSLETG 250

Query: 331 TQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEI 379
            QD     +  ++++ ++   L+KD  +R +  ELL H   +   + E 
Sbjct: 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF 299

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 18/68 (26%), Positives = 31/68 (45%), Gaps = 1/68 (1%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          + Y+   +IG G+   V  A     K+ VA+K I+   +    +  L +E +      HP
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE-KCQTSMDELLKEIQAMSQCHHP 73

Query: 69 NIIKFIAS 76
          NI+ +  S
Sbjct: 74 NIVSYYTS 81

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  204 bits (520), Expect = 2e-59
 Identities = 84/320 (26%), Positives = 144/320 (45%), Gaps = 25/320 (7%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-----------GRSGKELSSLKQ 167
           E Y K+  +G G++G+V      +     A+K+I KS               K    +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 168 ECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNL 226
           E  + K L HPNIIK     E    F L+TEF     L   +  R K  E     I+  +
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 227 ISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLY 283
           +S + YLH + ++HRD+KP+N+LL   N      + DFG +   +   + L    GT  Y
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYY 214

Query: 284 MAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ---- 339
           +APE++ ++ Y+   D+WS G I Y +  G+PPF   +   +I+ ++     F       
Sbjct: 215 IAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKN 273

Query: 340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFD----YCDK 395
           +S+  K+L+K +L  D ++R +  E L+   +K   ++  +S     C        +   
Sbjct: 274 ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGS 333

Query: 396 RRGSRKSITTIVESDSDENE 415
           ++ ++ +I  I    +   E
Sbjct: 334 QKLAQAAILFIGSKLTTLEE 353

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 28/92 (30%), Positives = 39/92 (42%), Gaps = 11/92 (11%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-----------GRSGKELSSLKQ 57
           E Y K+  +G G++G+V      +     A+K+I KS               K    +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 58  ECEIQKHLAHPNIIKFIASHETLNEFVLITEF 89
           E  + K L HPNIIK     E    F L+TEF
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  198 bits (506), Expect = 3e-59
 Identities = 89/289 (30%), Positives = 137/289 (47%), Gaps = 25/289 (8%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS------GRSGKELSSLKQECEIQ 172
           ++Y     +G G+ G+V  A      K VA+KIISK        R      +++ E EI 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 173 KHLAHPNIIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLISA 229
           K L HP IIK     +   ++ ++ E   M    L + +   K+L E  C      ++ A
Sbjct: 70  KKLNHPCIIKIKNFFDA-EDYYIVLEL--MEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126

Query: 230 LYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
           + YLH N ++HRDLKP+NVLL    +D +  + DFG ++ +   + M T   GTP Y+AP
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAP 185

Query: 287 ELIAE---RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH-LIRLLKTQDVTFPSQ--- 339
           E++       Y+   D WSLG I +    G+PPF        L   + +    F  +   
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245

Query: 340 -VSETYKDLVKGLLEKDASQRLSWPELLHHP-LVKDNLSSEIESQNNQD 386
            VSE   DLVK LL  D   R +  E L HP L  +++  + +   +++
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 294

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 7/88 (7%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS------GRSGKELSSLKQECEIQ 62
          ++Y     +G G+ G+V  A      K VA+KIISK        R      +++ E EI 
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 63 KHLAHPNIIKFIASHETLNEFVLITEFA 90
          K L HP IIK     +   ++ ++ E  
Sbjct: 70 KKLNHPCIIKIKNFFDA-EDYYIVLELM 96

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  198 bits (506), Expect = 3e-59
 Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 14/280 (5%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSS----LKQECEIQKH 174
           + Y     +G G F  V K          A K I K              +++E  I K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 175 LAHPNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYL 233
           + HPN+I     +E   + +LI E      L + L +++ L+E    + L  +++ +YYL
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 234 HSNRVLHRDLKPQNVLL----NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           HS ++ H DLKP+N++L           + DFG A  +  G     +I GTP ++APE++
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-KNIFGTPEFVAPEIV 189

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYK 345
              P    AD+WS+G I Y +  G  PF   +    +  +   +  F  +     S   K
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249

Query: 346 DLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQ 385
           D ++ LL KD  +R++  + L HP +K   + +  S+   
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKAS 289

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 21/86 (24%), Positives = 31/86 (36%), Gaps = 4/86 (4%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSS----LKQECEIQKH 64
          + Y     +G G F  V K          A K I K              +++E  I K 
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 65 LAHPNIIKFIASHETLNEFVLITEFA 90
          + HPN+I     +E   + +LI E  
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELV 96

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  199 bits (507), Expect = 4e-59
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 14/279 (5%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + ++    +G G+   V++      +K  ALK++ K+     +   ++ E  +   L+HP
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHP 108

Query: 179 NIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NIIK     ET  E  L+ E      L + + ++   SE      +  ++ A+ YLH N 
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168

Query: 238 VLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           ++HRDLKP+N+L      D    + DFG ++ +     M  ++ GTP Y APE++    Y
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM-KTVCGTPGYCAPEILRGCAY 227

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILH-LIRLLKTQDVTFPSQ----VSETYKDLVK 349
               D+WS+G I Y +  G  PF        + R +   +  F S     VS   KDLV+
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287

Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCI 388
            L+  D  +RL+  + L HP V    ++ +     Q  +
Sbjct: 288 KLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKL 326

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 21/82 (25%), Positives = 38/82 (46%), Gaps = 4/82 (4%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           + ++    +G G+   V++      +K  ALK++ K+     +   ++ E  +   L+HP
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHP 108

Query: 69  NIIKFIASHETLNEFVLITEFA 90
           NIIK     ET  E  L+ E  
Sbjct: 109 NIIKLKEIFETPTEISLVLELV 130

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  197 bits (502), Expect = 4e-59
 Identities = 80/280 (28%), Positives = 127/280 (45%), Gaps = 18/280 (6%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS----SLKQECEIQKH 174
           + Y+    +G G F  V K       K  A K I K   S          +++E  I + 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLISALY 231
           + HPNII      E   + VLI E   +S   L + L +++ L+E    Q L  ++  ++
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILEL--VSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122

Query: 232 YLHSNRVLHRDLKPQNVLL----NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
           YLHS R+ H DLKP+N++L      +    L DFG A  +  G     +I GTP ++APE
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-KNIFGTPEFVAPE 181

Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSET 343
           ++   P    AD+WS+G I Y +  G  PF   +    +  +   +  F        SE 
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241

Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQN 383
            KD ++ LL KD  +R++  + L H  +K      +  ++
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGED 281

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 24/86 (27%), Positives = 33/86 (38%), Gaps = 4/86 (4%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS----SLKQECEIQKH 64
          + Y+    +G G F  V K       K  A K I K   S          +++E  I + 
Sbjct: 5  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 65 LAHPNIIKFIASHETLNEFVLITEFA 90
          + HPNII      E   + VLI E  
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELV 90

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  197 bits (502), Expect = 5e-59
 Identities = 77/275 (28%), Positives = 126/275 (45%), Gaps = 14/275 (5%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
            ++     ++G+G++G V+    L  +  +A+K I +  R  +    L +E  + KHL H
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKH 78

Query: 178 PNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRK---KLSETICVQILSNLISALYYL 233
            NI++++ S        +  E     SLS LL  +    K +E         ++  L YL
Sbjct: 79  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138

Query: 234 HSNRVLHRDLKPQNVLLN-KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI--A 290
           H N+++HRD+K  NVL+N   GV  + DFG ++ +A       +  GT  YMAPE+I   
Sbjct: 139 HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKD 346
            R Y   AD+WSLGC   E+  G PPF    +  + +  + + K      P  +S   K 
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-VHPEIPESMSAEAKA 257

Query: 347 LVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIES 381
            +    E D  +R    +LL    +K +   +   
Sbjct: 258 FILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQ 292

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 23/91 (25%), Positives = 43/91 (47%), Gaps = 3/91 (3%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
            ++     ++G+G++G V+    L  +  +A+K I +  R  +    L +E  + KHL H
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKH 78

Query: 68  PNIIKFIASHETLNEFVLITEFAHM-SLSKL 97
            NI++++ S        +  E     SLS L
Sbjct: 79  KNIVQYLGSFSENGFIKIFMEQVPGGSLSAL 109

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  197 bits (504), Expect = 5e-59
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 42/290 (14%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFI 184
           ++GEG+  +V   I+L   +  A+KII K     +    + +E E+      H N+++ I
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS--RVFREVEMLYQCQGHRNVLELI 77

Query: 185 ASHETLNEFVLITEFAHMSLSNLLE---QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
              E  + F L+ E   M   ++L    +R+  +E     ++ ++ SAL +LH+  + HR
Sbjct: 78  EFFEEEDRFYLVFEK--MRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135

Query: 242 DLKPQNVLL-NKDGVA--MLCDFGFARSM-------AVGTHMLTSIKGTPLYMAPELI-- 289
           DLKP+N+L  + + V+   +CDF     +        + T  L +  G+  YMAPE++  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195

Query: 290 ---AERPYDHTADLWSLGCIAYEIHMGHPPF-----KTVSILHLIRLLKTQ--------- 332
                  YD   DLWSLG I Y +  G+PPF                   Q         
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255

Query: 333 -DVTFPS----QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS 377
               FP      +S   KDL+  LL +DA QRLS  ++L HP V+     
Sbjct: 256 GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 20/74 (27%), Positives = 36/74 (48%), Gaps = 3/74 (4%)

Query: 16 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFI 74
          ++GEG+  +V   I+L   +  A+KII K     +    + +E E+      H N+++ I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS--RVFREVEMLYQCQGHRNVLELI 77

Query: 75 ASHETLNEFVLITE 88
             E  + F L+ E
Sbjct: 78 EFFEEEDRFYLVFE 91

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  198 bits (505), Expect = 6e-59
 Identities = 74/312 (23%), Positives = 124/312 (39%), Gaps = 56/312 (17%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS---GRSGKELSSLKQECEIQKHL 175
           +KY     IG+GS+G V  AI    +   A+KI++K+     + K++  +K E  + K L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 176 AHPNIIKFIASHETLNEFVLITEFAH---------------------------------- 201
            HPNI +    +E      L+ E  H                                  
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 202 -------MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG 254
                                E +   I+  + SAL+YLH+  + HRD+KP+N L + + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 255 VA--MLCDFGFARSMAVGT----HMLTSIKGTPLYMAPELI--AERPYDHTADLWSLGCI 306
                L DFG ++          + +T+  GTP ++APE++      Y    D WS G +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 307 AYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLVKGLLEKDASQRLSW 362
            + + MG  PF  V+    I  +  + + F +     +S   +DL+  LL ++  +R   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

Query: 363 PELLHHPLVKDN 374
              L HP +   
Sbjct: 326 MRALQHPWISQF 337

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 3/86 (3%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS---GRSGKELSSLKQECEIQKHL 65
           +KY     IG+GS+G V  AI    +   A+KI++K+     + K++  +K E  + K L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 66  AHPNIIKFIASHETLNEFVLITEFAH 91
            HPNI +    +E      L+ E  H
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCH 111

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  197 bits (503), Expect = 6e-59
 Identities = 86/266 (32%), Positives = 136/266 (51%), Gaps = 9/266 (3%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E +  +  +GEGS+G V+KAIH +  + VA+K +        +L  + +E  I +    P
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSP 84

Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKK-LSETICVQILSNLISALYYLHSN 236
           +++K+  S+    +  ++ E+    S+S+++  R K L+E     IL + +  L YLH  
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
           R +HRD+K  N+LLN +G A L DFG A  +        ++ GTP +MAPE+I E  Y+ 
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
            AD+WSLG  A E+  G PP+  +     + +I          P   S+ + D VK  L 
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLV 264

Query: 354 KDASQRLSWPELLHHPLVKDNLSSEI 379
           K   QR +  +LL HP V+      I
Sbjct: 265 KSPEQRATATQLLQHPFVRSAKGVSI 290

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 21/81 (25%), Positives = 43/81 (53%), Gaps = 4/81 (4%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           E +  +  +GEGS+G V+KAIH +  + VA+K +        +L  + +E  I +    P
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSP 84

Query: 69  NIIKFIASHETLNEFVLITEF 89
           +++K+  S+    +  ++ E+
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEY 105

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  199 bits (509), Expect = 1e-58
 Identities = 91/283 (32%), Positives = 134/283 (47%), Gaps = 30/283 (10%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISK------SGRSGKELSSLKQECEIQ 172
           ++Y     +G G+ G+V  A      K VA++IISK      S R      +++ E EI 
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 173 KHLAHPNIIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLISA 229
           K L HP IIK     +  + + ++ E   M    L + +   K+L E  C      ++ A
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLEL--MEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251

Query: 230 LYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
           + YLH N ++HRDLKP+NVLL    +D +  + DFG ++ +   + M T   GTP Y+AP
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAP 310

Query: 287 ELIAE---RPYDHTADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPS- 338
           E++       Y+   D WSLG I +    G+PPF      VS+   I    +    F   
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI---TSGKYNFIPE 367

Query: 339 ---QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSE 378
              +VSE   DLVK LL  D   R +  E L HP ++D     
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 69.7 bits (171), Expect = 6e-13
 Identities = 26/88 (29%), Positives = 41/88 (46%), Gaps = 7/88 (7%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISK------SGRSGKELSSLKQECEIQ 62
           ++Y     +G G+ G+V  A      K VA++IISK      S R      +++ E EI 
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 63  KHLAHPNIIKFIASHETLNEFVLITEFA 90
           K L HP IIK     +  + + ++ E  
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELM 221

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  198 bits (504), Expect = 2e-58
 Identities = 44/294 (14%), Positives = 87/294 (29%), Gaps = 54/294 (18%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLA-------- 176
           ++G+       +A   +  ++  + +   + R     +  +K+E    + L         
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 177 -----------------HPNIIKFIASHETLN--EFVLITEFAHMSLSNLLE-------Q 210
                               +I+       +       +      +L    E        
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 211 RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG 270
            K L     +Q+   +I  L  LH   ++H  L+P +++L++ G   L  F         
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-- 257

Query: 271 THMLTSIKGTPLYMAPELIAER-----------PYDHTADLWSLGCIAYEIHMGHPPFKT 319
                    +  +  PEL A R               + D W+LG + Y I     P   
Sbjct: 258 --ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315

Query: 320 VSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
            + L     +       P  V    + L++G L      RL   + +  P  + 
Sbjct: 316 DAALGGSEWIFRSCKNIPQPV----RALLEGFLRYPKEDRLLPLQAMETPEYEQ 365

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 10/91 (10%), Positives = 25/91 (27%), Gaps = 3/91 (3%)

Query: 16  LIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFI 74
           ++G+       +A   +  ++  + +   + R     +  +K+E    + L      K  
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 75  ASHETLNEFVLITEFAHMSLSKLGEPWFHNH 105
             H  L               K+        
Sbjct: 140 KVH--LRFIFPFDLVKDPQKKKMIRVRLDER 168

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  197 bits (503), Expect = 2e-58
 Identities = 81/271 (29%), Positives = 132/271 (48%), Gaps = 23/271 (8%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS------SLKQECEIQ 172
           +KY    +IG G    V + +H       A+KI+  +              + ++E  I 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 173 KHLA-HPNIIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLIS 228
           + +A HP+II  I S+E+ +   L+ +   M    L + L ++  LSE     I+ +L+ 
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDL--MRKGELFDYLTEKVALSEKETRSIMRSLLE 211

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           A+ +LH+N ++HRDLKP+N+LL+ +    L DFGF+  +  G  +     GTP Y+APE+
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC-GTPGYLAPEI 270

Query: 289 I------AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS---- 338
           +          Y    DLW+ G I + +  G PPF     + ++R++      F S    
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330

Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
             S T KDL+  LL+ D   RL+  + L HP
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHP 361

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 69.0 bits (169), Expect = 9e-13
 Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 7/87 (8%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS------SLKQECEIQ 62
           +KY    +IG G    V + +H       A+KI+  +              + ++E  I 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 63  KHLA-HPNIIKFIASHETLNEFVLITE 88
           + +A HP+II  I S+E+ +   L+ +
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFD 180

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  195 bits (497), Expect = 2e-58
 Identities = 69/270 (25%), Positives = 123/270 (45%), Gaps = 23/270 (8%)

Query: 120 KYQKI-CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++ K    IG GSF  V+K +  +    VA   +     +  E    K+E E+ K L HP
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85

Query: 179 NIIKFIASHETLNE----FVLITEFAHM-SLSNLLEQRKKLSE----TICVQILSNLISA 229
           NI++F  S E+  +     VL+TE     +L   L++ K +      + C QIL      
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL----KG 141

Query: 230 LYYLHSNR--VLHRDLKPQNVLLN-KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
           L +LH+    ++HRDLK  N+ +    G   + D G A           ++ GTP +MAP
Sbjct: 142 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAP 199

Query: 287 ELIAERPYDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSET 343
           E+  E  YD + D+++ G    E+     P+   +  + ++       +  +F       
Sbjct: 200 EMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258

Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
            K++++G + ++  +R S  +LL+H   ++
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 5/85 (5%)

Query: 10  KYQKI-CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           ++ K    IG GSF  V+K +  +    VA   +     +  E    K+E E+ K L HP
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85

Query: 69  NIIKFIASHETLNE----FVLITEF 89
           NI++F  S E+  +     VL+TE 
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTEL 110

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  196 bits (500), Expect = 3e-58
 Identities = 83/283 (29%), Positives = 139/283 (49%), Gaps = 3/283 (1%)

Query: 111 MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQEC 169
           M  S   +  Y     +GEGSFGKV  A H   ++ VALK IS+   +       +++E 
Sbjct: 1   MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60

Query: 170 EIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISA 229
              K L HP+IIK      T  + V++ E+A   L + + ++K+++E    +    +I A
Sbjct: 61  SYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           + Y H ++++HRDLKP+N+LL+ +    + DFG +  M  G  + TS  G+P Y APE+I
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAPEVI 179

Query: 290 AERPYD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
             + Y     D+WS G + Y + +G  PF    I +L + + +     P  +S   + L+
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFD 391
           + ++  D  QR++  E+   P    NL   +           D
Sbjct: 240 RRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYAD 282

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 1/91 (1%)

Query: 1  MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQEC 59
          M  S   +  Y     +GEGSFGKV  A H   ++ VALK IS+   +       +++E 
Sbjct: 1  MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60

Query: 60 EIQKHLAHPNIIKFIASHETLNEFVLITEFA 90
             K L HP+IIK      T  + V++ E+A
Sbjct: 61 SYLKLLRHPHIIKLYDVITTPTDIVMVIEYA 91

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  195 bits (499), Expect = 4e-58
 Identities = 79/254 (31%), Positives = 122/254 (48%), Gaps = 3/254 (1%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG+G+F KV  A H+   + VA+KII K+  +   L  L +E  I K L HPNI+K    
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 187 HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKP 245
            ET     LI E+A    + + L    ++ E         ++SA+ Y H  R++HRDLK 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKA 142

Query: 246 QNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD-HTADLWSLG 304
           +N+LL+ D    + DFGF+    VG  +     G P Y APEL   + YD    D+WSLG
Sbjct: 143 ENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-GAPPYAAPELFQGKKYDGPEVDVWSLG 201

Query: 305 CIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPE 364
            I Y +  G  PF   ++  L   +       P  +S   ++L+K  L  +  +R +  +
Sbjct: 202 VILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQ 261

Query: 365 LLHHPLVKDNLSSE 378
           ++    +      +
Sbjct: 262 IMKDRWINAGHEED 275

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 31/74 (41%), Positives = 41/74 (55%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
          IG+G+F KV  A H+   + VA+KII K+  +   L  L +E  I K L HPNI+K    
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 77 HETLNEFVLITEFA 90
           ET     LI E+A
Sbjct: 83 IETEKTLYLIMEYA 96

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  196 bits (500), Expect = 9e-58
 Identities = 75/271 (27%), Positives = 124/271 (45%), Gaps = 12/271 (4%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V K         +A KII   G   KE   +K E  +   L H N+I+   +
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE--EVKNEISVMNQLDHANLIQLYDA 154

Query: 187 HETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
            E+ N+ VL+ E+         ++++   L+E   +  +  +   + ++H   +LH DLK
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214

Query: 245 PQNVLL-NKDGVA-MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           P+N+L  N+D     + DFG AR       +  +  GTP ++APE++         D+WS
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWS 273

Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLVKGLLEKDASQ 358
           +G IAY +  G  PF   +    +  +              +SE  K+ +  LL K+ S 
Sbjct: 274 VGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSW 333

Query: 359 RLSWPELLHHP-LVKDNLSSEIESQNNQDCI 388
           R+S  E L HP L    L S + +Q  ++  
Sbjct: 334 RISASEALKHPWLSDHKLHSRLSAQKKKNRG 364

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 24/74 (32%), Positives = 36/74 (48%), Gaps = 2/74 (2%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
           +G G FG+V K         +A KII   G   KE   +K E  +   L H N+I+   +
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE--EVKNEISVMNQLDHANLIQLYDA 154

Query: 77  HETLNEFVLITEFA 90
            E+ N+ VL+ E+ 
Sbjct: 155 FESKNDIVLVMEYV 168

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  196 bits (499), Expect = 1e-57
 Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 15/266 (5%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + Y  +  +G G+FG V + +     +    K I+      K   ++K E  I   L HP
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHP 108

Query: 179 NIIKFIASHETLNEFVLITEFAHMS----LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            +I    + E   E VLI EF  +S       +  +  K+SE   +  +      L ++H
Sbjct: 109 KLINLHDAFEDKYEMVLILEF--LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166

Query: 235 SNRVLHRDLKPQNVLL--NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
            + ++H D+KP+N++    K     + DFG A  +     +      T  + APE++   
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV-KVTTATAEFAAPEIVDRE 225

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLV 348
           P     D+W++G + Y +  G  PF     L  ++ +K  D  F       VS   KD +
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDN 374
           K LL+K+  +RL+  + L HP +K +
Sbjct: 286 KNLLQKEPRKRLTVHDALEHPWLKGD 311

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 78.2 bits (193), Expect = 9e-16
 Identities = 23/82 (28%), Positives = 35/82 (42%), Gaps = 2/82 (2%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           + Y  +  +G G+FG V + +     +    K I+      K   ++K E  I   L HP
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHP 108

Query: 69  NIIKFIASHETLNEFVLITEFA 90
            +I    + E   E VLI EF 
Sbjct: 109 KLINLHDAFEDKYEMVLILEFL 130

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  193 bits (493), Expect = 2e-57
 Identities = 76/275 (27%), Positives = 122/275 (44%), Gaps = 18/275 (6%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSS----LKQECEIQKH 174
           + Y     +G G F  V K          A K I K              +++E  I + 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLISALY 231
           + H N+I     +E   + VLI E    S   L + L Q++ LSE      +  ++  + 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELV--SGGELFDFLAQKESLSEEEATSFIKQILDGVN 129

Query: 232 YLHSNRVLHRDLKPQNVLL-NKDGVA---MLCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
           YLH+ ++ H DLKP+N++L +K+       L DFG A  +  G     +I GTP ++APE
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-KNIFGTPEFVAPE 188

Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSET 343
           ++   P    AD+WS+G I Y +  G  PF   +    +  + +    F        SE 
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248

Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSE 378
            KD ++ LL K+  +RL+  E L HP +    + +
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 20/86 (23%), Positives = 30/86 (34%), Gaps = 4/86 (4%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSS----LKQECEIQKH 64
          + Y     +G G F  V K          A K I K              +++E  I + 
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 65 LAHPNIIKFIASHETLNEFVLITEFA 90
          + H N+I     +E   + VLI E  
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELV 97

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  193 bits (493), Expect = 2e-57
 Identities = 84/304 (27%), Positives = 149/304 (49%), Gaps = 28/304 (9%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI-QKHLAH 177
             ++ + L+G G++G+V+K  H+   +  A+K++  +G    E   +KQE  + +K+  H
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHH 80

Query: 178 PNIIKFIAS------HETLNEFVLITEF-AHMSLSNLLE--QRKKLSETICVQILSNLIS 228
            NI  +  +          ++  L+ EF    S+++L++  +   L E     I   ++ 
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
            L +LH ++V+HRD+K QNVLL ++    L DFG +  +        +  GTP +MAPE+
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200

Query: 289 IA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL----KTQDVTF-PS 338
           IA     +  YD  +DLWSLG  A E+  G PP      +H +R L    +         
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNPAPRLKSK 257

Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRG 398
           + S+ ++  ++  L K+ SQR +  +L+ HP ++D  +        +D I  D   K+RG
Sbjct: 258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHI--DRTKKKRG 315

Query: 399 SRKS 402
            +  
Sbjct: 316 EKDE 319

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 18/69 (26%), Positives = 38/69 (55%), Gaps = 4/69 (5%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI-QKHLAH 67
            ++ + L+G G++G+V+K  H+   +  A+K++     +G E   +KQE  + +K+  H
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV---TGDEEEEIKQEINMLKKYSHH 80

Query: 68 PNIIKFIAS 76
           NI  +  +
Sbjct: 81 RNIATYYGA 89

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  190 bits (486), Expect = 5e-57
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 4/274 (1%)

Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECE 170
                 +  Y     +G G+FGKV    H      VA+KI+++   RS   +  +K+E +
Sbjct: 4   HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63

Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISA 229
             K   HP+IIK      T  +F ++ E+     L + + +  ++ E    ++   ++SA
Sbjct: 64  NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           + Y H + V+HRDLKP+NVLL+    A + DFG +  M+ G  + TS  G+P Y APE+I
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYAAPEVI 182

Query: 290 AERPYD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
           + R Y     D+WS G I Y +  G  PF    +  L + ++      P  ++ +   L+
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQ 382
             +L+ D  +R +  ++  H   K +L S +  +
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 1/90 (1%)

Query: 2  EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECE 60
                +  Y     +G G+FGKV    H      VA+KI+++   RS   +  +K+E +
Sbjct: 4  HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63

Query: 61 IQKHLAHPNIIKFIASHETLNEFVLITEFA 90
            K   HP+IIK      T  +F ++ E+ 
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  193 bits (492), Expect = 8e-57
 Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 18/275 (6%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS----SLKQECEIQKH 174
           + Y     +G G F  V K          A K I K              +++E  I + 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLISALY 231
           + HPNII     +E   + VLI E    S   L + L Q++ LSE      +  ++  + 
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELV--SGGELFDFLAQKESLSEEEATSFIKQILDGVN 129

Query: 232 YLHSNRVLHRDLKPQNVLL-NKDGVA---MLCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
           YLH+ ++ H DLKP+N++L +K+       L DFG A  +  G     +I GTP ++APE
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-KNIFGTPEFVAPE 188

Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSET 343
           ++   P    AD+WS+G I Y +  G  PF   +    +  +      F      Q SE 
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248

Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSE 378
            KD ++ LL K+  +RL+  E L HP +    + +
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQ 283

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 22/86 (25%), Positives = 31/86 (36%), Gaps = 4/86 (4%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS----SLKQECEIQKH 64
          + Y     +G G F  V K          A K I K              +++E  I + 
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 65 LAHPNIIKFIASHETLNEFVLITEFA 90
          + HPNII     +E   + VLI E  
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELV 97

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  198 bits (506), Expect = 8e-57
 Identities = 70/266 (26%), Positives = 120/266 (45%), Gaps = 15/266 (5%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + Y     +G G+FG V +          A K +     S KE  ++++E +    L HP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE--TVRKEIQTMSVLRHP 214

Query: 179 NIIKFIASHETLNEFVLITEFAHMS----LSNLLEQRKKLSETICVQILSNLISALYYLH 234
            ++    + E  NE V+I EF  MS       + ++  K+SE   V+ +  +   L ++H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEF--MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272

Query: 235 SNRVLHRDLKPQNVLL-NKDGVA-MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
            N  +H DLKP+N++   K      L DFG    +     +     GT  + APE+   +
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-KVTTGTAEFAAPEVAEGK 331

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLV 348
           P  +  D+WS+G ++Y +  G  PF   +    +R +K+ D          +SE  KD +
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 391

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDN 374
           + LL  D + R++  + L HP +   
Sbjct: 392 RKLLLADPNTRMTIHQALEHPWLTPG 417

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 77.6 bits (191), Expect = 3e-15
 Identities = 22/82 (26%), Positives = 36/82 (43%), Gaps = 2/82 (2%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           + Y     +G G+FG V +          A K +     S KE  ++++E +    L HP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE--TVRKEIQTMSVLRHP 214

Query: 69  NIIKFIASHETLNEFVLITEFA 90
            ++    + E  NE V+I EF 
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFM 236

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  194 bits (494), Expect = 1e-56
 Identities = 79/292 (27%), Positives = 146/292 (50%), Gaps = 32/292 (10%)

Query: 105 HCQPVKMEKSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS 163
           H +     K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    +      
Sbjct: 47  HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ 100

Query: 164 SLKQECEIQKHLA-HPNIIKFIASHETL----NEFVLITEFAHMS----LSNLLEQR-KK 213
             ++E E+    +  P+I++ +  +E L       +++ E   +      S + ++  + 
Sbjct: 101 -ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC--LDGGELFSRIQDRGDQA 157

Query: 214 LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL-NKDGVA--MLCDFGFARSMAVG 270
            +E    +I+ ++  A+ YLHS  + HRD+KP+N+L  +K   A   L DFGFA+     
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217

Query: 271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLK 330
             + T    TP Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +K
Sbjct: 218 NSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276

Query: 331 TQ----DVTFPS----QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN 374
           T+       FP+    +VSE  K L++ LL+ + +QR++  E ++HP +  +
Sbjct: 277 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 18/92 (19%), Positives = 42/92 (45%), Gaps = 13/92 (14%)

Query: 3   KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 61
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    +        ++E E+
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVEL 107

Query: 62  QKHLA-HPNIIKFIASHETL----NEFVLITE 88
               +  P+I++ +  +E L       +++ E
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  192 bits (489), Expect = 1e-56
 Identities = 75/270 (27%), Positives = 134/270 (49%), Gaps = 32/270 (11%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFI 184
           ++G G  GKV +  H    +  ALK++  S +        +QE +     +  P+I+  +
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCIL 88

Query: 185 ASHETLNE----FVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHS 235
             +E ++      ++I E   M    L         +  +E    +I+ ++ +A+ +LHS
Sbjct: 89  DVYENMHHGKRCLLIIMEC--MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146

Query: 236 NRVLHRDLKPQNVLL-NKDGVA--MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           + + HRD+KP+N+L  +K+  A   L DFGFA+      + L +   TP Y+APE++   
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPCYTPYYVAPEVLGPE 204

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPF----KTVSILHLIRLLKTQDVTFPS----QVSETY 344
            YD + D+WSLG I Y +  G PPF           + R ++     FP+    +VSE  
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264

Query: 345 KDLVKGLLEKDASQRLSWPELLHHPLVKDN 374
           K L++ LL+ D ++RL+  + ++HP +  +
Sbjct: 265 KQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 17/78 (21%), Positives = 35/78 (44%), Gaps = 12/78 (15%)

Query: 16  LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFI 74
           ++G G  GKV +  H    +  ALK++  S +        +QE +     +  P+I+  +
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCIL 88

Query: 75  ASHETLNE----FVLITE 88
             +E ++      ++I E
Sbjct: 89  DVYENMHHGKRCLLIIME 106

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  194 bits (496), Expect = 1e-56
 Identities = 65/272 (23%), Positives = 118/272 (43%), Gaps = 23/272 (8%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHP 178
            +    ++G G+ G +      D  + VA+K I       +  S   +E ++ +    HP
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILP-----ECFSFADREVQLLRESDEHP 78

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSNR 237
           N+I++  + +      +  E    +L   +EQ+         + +L    S L +LHS  
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138

Query: 238 VLHRDLKPQNVLLNKDG-----VAMLCDFGFARSMAVGTH---MLTSIKGTPLYMAPELI 289
           ++HRDLKP N+L++         AM+ DFG  + +AVG H     + + GT  ++APE++
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 290 AE---RPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDVTFPS---QVSE 342
           +E       +T D++S GC+ Y +   G  PF          LL    +           
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDV 258

Query: 343 TYKDLVKGLLEKDASQRLSWPELLHHPLVKDN 374
             ++L++ ++  D  +R S   +L HP     
Sbjct: 259 IARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 16/86 (18%), Positives = 35/86 (40%), Gaps = 7/86 (8%)

Query: 10  KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHP 68
            +    ++G G+ G +      D  + VA+K I       +  S   +E ++ +    HP
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILP-----ECFSFADREVQLLRESDEHP 78

Query: 69  NIIKFIASHETLNEFVLITEFAHMSL 94
           N+I++  + +      +  E    +L
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCAATL 104

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  190 bits (484), Expect = 5e-56
 Identities = 73/266 (27%), Positives = 118/266 (44%), Gaps = 16/266 (6%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           EKY     +G G FG V + +    KKT   K +   G    +   +K+E  I     H 
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHR 61

Query: 179 NIIKFIASHETLNEFVLITEFAHMS----LSNLLEQRKKLSETICVQILSNLISALYYLH 234
           NI+    S E++ E V+I EF  +S       +     +L+E   V  +  +  AL +LH
Sbjct: 62  NILHLHESFESMEELVMIFEF--ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 235 SNRVLHRDLKPQNVLL--NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           S+ + H D++P+N++    +     + +FG AR +  G +    +   P Y APE+    
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-RLLFTAPEYYAPEVHQHD 178

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLV 348
                 D+WSLG + Y +  G  PF   +   +I  +   + TF      ++S    D V
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDN 374
             LL K+   R++  E L HP +K  
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQK 264

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 26/82 (31%), Positives = 37/82 (45%), Gaps = 3/82 (3%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          EKY     +G G FG V + +    KKT   K +   G    +   +K+E  I     H 
Sbjct: 5  EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHR 61

Query: 69 NIIKFIASHETLNEFVLITEFA 90
          NI+    S E++ E V+I EF 
Sbjct: 62 NILHLHESFESMEELVMIFEFI 83

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  188 bits (480), Expect = 6e-56
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 29/283 (10%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-A 176
            +  + I  +G G++G V K  H+   + +A+K I  +  S +E   L  + +I      
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVD 64

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLL----EQRKKLSETICVQILSNLISALYY 232
            P  + F  +     +  +  E    SL        ++ + + E I  +I  +++ AL +
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 233 LHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFA----RSMAVGTHMLTSIKGTPLYMAPE 287
           LHS   V+HRD+KP NVL+N  G   +CDFG +      +A          G   YMAPE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA----KDIDA-GCKPYMAPE 179

Query: 288 LIA----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----- 338
            I     ++ Y   +D+WSLG    E+ +   P+   S     + L  Q V  PS     
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYD--SWGTPFQQL-KQVVEEPSPQLPA 236

Query: 339 -QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
            + S  + D     L+K++ +R ++PEL+ HP    + S   +
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTD 279

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 62.3 bits (152), Expect = 7e-11
 Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 2/91 (2%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-A 66
           +  + I  +G G++G V K  H+   + +A+K I  +  S +E   L  + +I      
Sbjct: 6  ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVD 64

Query: 67 HPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
           P  + F  +     +  +  E    SL K 
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKF 95

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  198 bits (504), Expect = 7e-56
 Identities = 74/287 (25%), Positives = 119/287 (41%), Gaps = 39/287 (13%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
            ++    +G G FG V + IH D  + VA+K   +   S K       E +I K L HPN
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73

Query: 180 IIKFIASHETLNEF------VLITEFAHM-SLSNLLEQRKK---LSETICVQILSNLISA 229
           ++      + L +       +L  E+     L   L Q +    L E     +LS++ SA
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 230 LYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
           L YLH NR++HRDLKP+N++L    +  +  + D G+A+ +  G  + T   GT  Y+AP
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAP 192

Query: 287 ELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETY-- 344
           EL+ ++ Y  T D WS G +A+E   G  PF              +       V +    
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252

Query: 345 ----------------------KDLVKGLLEKDASQRLSWPELLHHP 369
                                 +  ++ +L     QR + P+  +  
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVG 299

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 7/87 (8%)

Query: 10  KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
            ++    +G G FG V + IH D  + VA+K   +   S K       E +I K L HPN
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73

Query: 70  IIKFIASHETLNEF------VLITEFA 90
           ++      + L +       +L  E+ 
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYC 100

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  189 bits (481), Expect = 7e-56
 Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 10/266 (3%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS--GRSGKELSSLKQECEIQKHLAH 177
           KY    L+GEGS+GKV + +  +     A+KI+ K    R     +++K+E ++ + L H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 178 PNIIKF--IASHETLNEFVLITEFAHMSLSNLLE--QRKKLSETICVQILSNLISALYYL 233
            N+I+   +  +E   +  ++ E+    +  +L+    K+            LI  L YL
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIA- 290
           HS  ++H+D+KP N+LL   G   +   G A ++          + +G+P +  PE+   
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185

Query: 291 ERPYD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
              +     D+WS G   Y I  G  PF+  +I  L   +       P        DL+K
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLK 245

Query: 350 GLLEKDASQRLSWPELLHHPLVKDNL 375
           G+LE + ++R S  ++  H   +   
Sbjct: 246 GMLEYEPAKRFSIRQIRQHSWFRKKH 271

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 23/85 (27%), Positives = 45/85 (52%), Gaps = 4/85 (4%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS--GRSGKELSSLKQECEIQKHLAH 67
          KY    L+GEGS+GKV + +  +     A+KI+ K    R     +++K+E ++ + L H
Sbjct: 6  KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 68 PNIIKF--IASHETLNEFVLITEFA 90
           N+I+   +  +E   +  ++ E+ 
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYC 90

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  189 bits (482), Expect = 1e-55
 Identities = 66/383 (17%), Positives = 127/383 (33%), Gaps = 73/383 (19%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
           L  ++ I  +G G FG VF+A +       A+K I            + +E +    L H
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEH 63

Query: 68  PNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLI 127
           P I+++                           W     +  + E     L+        
Sbjct: 64  PGIVRYF------------------------NAWLETPPEKWQEEMDEIWLKDESTDW-- 97

Query: 128 GEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASH 187
                                         S   + +   +       +  N +  +   
Sbjct: 98  ---------------------------PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130

Query: 188 ETLNEFVLITEFAHM-SLSNLLEQRKKLS---ETICVQILSNLISALYYLHSNRVLHRDL 243
                  +  +     +L + + +R  L      +C+ I   +  A+ +LHS  ++HRDL
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDL 190

Query: 244 KPQNVLLNKDGVAMLCDFGFARSM------------AVGTHMLTSIKGTPLYMAPELIAE 291
           KP N+    D V  + DFG   +M                   T   GT LYM+PE I  
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF-PSQVSETYKDLVKG 350
             Y H  D++SLG I +E  + +     +  + +I  ++        +Q       +V+ 
Sbjct: 251 NNYSHKVDIFSLGLILFE--LLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQD 308

Query: 351 LLEKDASQRLSWPELLHHPLVKD 373
           +L    ++R    +++ + + ++
Sbjct: 309 MLSPSPTERPEATDIIENAIFEN 331

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  189 bits (481), Expect = 2e-55
 Identities = 72/295 (24%), Positives = 123/295 (41%), Gaps = 28/295 (9%)

Query: 103 HNHCQPVKMEKSNGALEKYQKI--------CLIGEGSFGKVFKAIHLDLKKTVALKIISK 154
           H+H   V +   N   +  +            +G G F  V + I     +  A K + K
Sbjct: 5   HHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK 64

Query: 155 SGRSGKELSSLKQECEIQKHLAH-PNIIKFIASHETLNEFVLITE-------FAHMSLSN 206
             R     + +  E  + +     P +I     +E  +E +LI E       F+      
Sbjct: 65  RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC---- 120

Query: 207 LLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGF 263
           L E  + +SE   ++++  ++  +YYLH N ++H DLKPQN+LL      G   + DFG 
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180

Query: 264 ARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL 323
           +R +     +   I GTP Y+APE++   P     D+W++G IAY +     PF      
Sbjct: 181 SRKIGHACEL-REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ 239

Query: 324 HLIRLLKTQDVTFPS----QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN 374
                +   +V +       VS+   D ++ LL K+  +R +    L H  ++  
Sbjct: 240 ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 18/75 (24%), Positives = 31/75 (41%), Gaps = 1/75 (1%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH-PNIIKFIA 75
           +G G F  V + I     +  A K + K  R     + +  E  + +     P +I    
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 76  SHETLNEFVLITEFA 90
            +E  +E +LI E+A
Sbjct: 97  VYENTSEIILILEYA 111

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  188 bits (478), Expect = 4e-55
 Identities = 74/262 (28%), Positives = 116/262 (44%), Gaps = 16/262 (6%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS------GRSGKELSSLKQECEIQK 173
           KY  +  +G G+FG V+ A+  +  K V +K I K            +L  +  E  I  
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALY 231
            + H NIIK +   E    F L+ E     + L   +++  +L E +   I   L+SA+ 
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           YL    ++HRD+K +N+++ +D    L DFG A  +  G    T   GT  Y APE++  
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-GTIEYCAPEVLMG 203

Query: 292 RPYD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
            PY     ++WSLG   Y +     PF        +       +  P  VS+    LV G
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAAIHPPYLVSKELMSLVSG 257

Query: 351 LLEKDASQRLSWPELLHHPLVK 372
           LL+    +R +  +L+  P V 
Sbjct: 258 LLQPVPERRTTLEKLVTDPWVT 279

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 25/87 (28%), Positives = 37/87 (42%), Gaps = 6/87 (6%)

Query: 10  KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS------GRSGKELSSLKQECEIQK 63
           KY  +  +G G+FG V+ A+  +  K V +K I K            +L  +  E  I  
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 64  HLAHPNIIKFIASHETLNEFVLITEFA 90
            + H NIIK +   E    F L+ E  
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKH 111

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  187 bits (476), Expect = 1e-54
 Identities = 61/321 (19%), Positives = 125/321 (38%), Gaps = 51/321 (15%)

Query: 110 KMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-------------- 155
            +++ +  +  Y+ I  + +G F K+         K  ALK   KS              
Sbjct: 22  YVKEKDKYINDYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNND 79

Query: 156 -GRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA-------HMSLSNL 207
                 +    K E +I   + +   +         +E  +I E+              +
Sbjct: 80  KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139

Query: 208 LE--QRKKLSETICVQILSNLISALYYLHSNR-VLHRDLKPQNVLLNKDGVAMLCDFGFA 264
           L+      +   +   I+ +++++  Y+H+ + + HRD+KP N+L++K+G   L DFG +
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199

Query: 265 RSMAVGTHMLTSIKGTPLYMAPELIAERP--YDHTADLWSLGCIAYEIHMGHPPFKT-VS 321
             M      +   +GT  +M PE  +          D+WSLG   Y +     PF   +S
Sbjct: 200 EYMV--DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257

Query: 322 ILHLIRLLKTQDVTFPSQ-------------------VSETYKDLVKGLLEKDASQRLSW 362
           ++ L   ++T+++ +P                     +S    D +K  L K+ ++R++ 
Sbjct: 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317

Query: 363 PELLHHPLVKDNLSSEIESQN 383
            + L H  + D    ++   +
Sbjct: 318 EDALKHEWLADTNIEDLREFS 338

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 17/105 (16%), Positives = 34/105 (32%), Gaps = 17/105 (16%)

Query: 1   MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS--------------- 45
           +++ +  +  Y+ I  + +G F K+         K  ALK   KS               
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDK 80

Query: 46  GRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA 90
                +    K E +I   + +   +         +E  +I E+ 
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM 125

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  186 bits (474), Expect = 1e-54
 Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 27/284 (9%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-A 176
            E  + +  IG G++G V K +H    + +A+K I  +    KE   L  + ++      
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSD 79

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLL-----EQRKKLSETICVQILSNLISALY 231
            P I++F  +     +  +  E    S               + E I  +I    + AL 
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 232 YLHSNR-VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           +L  N  ++HRD+KP N+LL++ G   LCDFG +  + V +   T   G   YMAPE I 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPERID 198

Query: 291 ----ERPYDHTADLWSLGCIAYEIHMGHPPFKTV----SILHLI------RLLKTQDVTF 336
                + YD  +D+WSLG   YE+  G  P+         L  +      +L  +++  F
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREF 258

Query: 337 PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
               S ++ + V   L KD S+R  + ELL HP +       +E
Sbjct: 259 ----SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVE 298

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 2/91 (2%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-A 66
            E  + +  IG G++G V K +H    + +A+K I  +    KE   L  + ++      
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSD 79

Query: 67  HPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
            P I++F  +     +  +  E    S  K 
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTSFDKF 110

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  184 bits (470), Expect = 2e-54
 Identities = 81/288 (28%), Positives = 134/288 (46%), Gaps = 39/288 (13%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS------------------------ 155
           +Y     IG+GS+G V  A + +     A+K++SK                         
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 156 GRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE--FVLITEFAH----MSLSNLLE 209
            +    +  + QE  I K L HPN++K +   +  NE    ++ E  +    M +     
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----P 129

Query: 210 QRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV 269
             K LSE        +LI  + YLH  +++HRD+KP N+L+ +DG   + DFG +     
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 270 GTHMLTSIKGTPLYMAPELIAE--RPYD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLI 326
              +L++  GTP +MAPE ++E  + +     D+W++G   Y    G  PF    I+ L 
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249

Query: 327 RLLKTQDVTFPSQ--VSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
             +K+Q + FP Q  ++E  KDL+  +L+K+   R+  PE+  HP V 
Sbjct: 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 56.1 bits (136), Expect = 8e-09
 Identities = 21/87 (24%), Positives = 34/87 (39%), Gaps = 24/87 (27%)

Query: 10  KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS------------------------ 45
           +Y     IG+GS+G V  A + +     A+K++SK                         
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 46  GRSGKELSSLKQECEIQKHLAHPNIIK 72
            +    +  + QE  I K L HPN++K
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVK 100

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  184 bits (470), Expect = 4e-54
 Identities = 71/277 (25%), Positives = 124/277 (44%), Gaps = 18/277 (6%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS----GRSGKELSSLKQECEIQKHL 175
           +YQ   L+G G FG V+  I +     VA+K + K            + +  E  + K +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 176 AH--PNIIKFIASHETLNEFVLITEFA--HMSLSNLLEQRKKLSETICVQILSNLISALY 231
           +     +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163

Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG   ++   T       GT +Y  PE I 
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD-GTRVYSPPEWIR 221

Query: 291 ERPYD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
              Y   +A +WSLG + Y++  G  PF           +    V F  +VS   + L++
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIR 275

Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
             L    S R ++ E+ +HP ++D L  +  ++ +  
Sbjct: 276 WCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH 312

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 22/87 (25%), Positives = 37/87 (42%), Gaps = 6/87 (6%)

Query: 10  KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS----GRSGKELSSLKQECEIQKHL 65
           +YQ   L+G G FG V+  I +     VA+K + K            + +  E  + K +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 66  AH--PNIIKFIASHETLNEFVLITEFA 90
           +     +I+ +   E  + FVLI E  
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERP 130

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  184 bits (469), Expect = 4e-54
 Identities = 69/266 (25%), Positives = 128/266 (48%), Gaps = 12/266 (4%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG GSFG V +A        VA+KI+ +     + ++   +E  I K L HPNI+ F+ +
Sbjct: 45  IGAGSFGTVHRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 187 HETLNEFVLITEFAHM-SLSNLL---EQRKKLSETICVQILSNLISALYYLHSNR--VLH 240
                   ++TE+    SL  LL     R++L E   + +  ++   + YLH+    ++H
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADL 300
           R+LK  N+L++K     +CDFG +R  A       S  GTP +MAPE++ + P +  +D+
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222

Query: 301 WSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV--TFPSQVSETYKDLVKGLLEKDASQ 358
           +S G I +E+     P+  ++   ++  +  +      P  ++     +++G    +  +
Sbjct: 223 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWK 282

Query: 359 RLSWPELLHH--PLVKDNLSSEIESQ 382
           R S+  ++    PL+K  +     S 
Sbjct: 283 RPSFATIMDLLRPLIKSAVPPPNRSD 308

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 3/82 (3%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
           IG GSFG V +A        VA+KI+ +     + ++   +E  I K L HPNI+ F+ +
Sbjct: 45  IGAGSFGTVHRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 77  HETLNEFVLITEFAHM-SLSKL 97
                   ++TE+    SL +L
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRL 124

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  183 bits (467), Expect = 1e-53
 Identities = 74/247 (29%), Positives = 127/247 (51%), Gaps = 4/247 (1%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 176
            E ++   ++GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L 
Sbjct: 29  PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88

Query: 177 HPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           HP  +K   + +   +      +A    L   + +     ET      + ++SAL YLH 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT--SIKGTPLYMAPELIAERP 293
             ++HRDLKP+N+LLN+D    + DFG A+ ++  +      S  GT  Y++PEL+ E+ 
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
              ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +     +DLV+ LL 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 268

Query: 354 KDASQRL 360
            DA++RL
Sbjct: 269 LDATKRL 275

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 47.2 bits (113), Expect = 7e-06
 Identities = 19/84 (22%), Positives = 37/84 (44%), Gaps = 1/84 (1%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 66
            E ++   ++GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L 
Sbjct: 29  PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88

Query: 67  HPNIIKFIASHETLNEFVLITEFA 90
           HP  +K   + +   +      +A
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYA 112

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  183 bits (467), Expect = 1e-53
 Identities = 70/275 (25%), Positives = 120/275 (43%), Gaps = 20/275 (7%)

Query: 107 QPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS----GRSGKEL 162
            P   +       +Y+   L+G+G FG VF    L  +  VA+K+I ++         + 
Sbjct: 19  PPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDS 78

Query: 163 SSLKQECEIQKHL----AHPNIIKFIASHETLNEFVLITEFAH--MSLSNLLEQRKKLSE 216
            +   E  +   +     HP +I+ +   ET   F+L+ E       L + + ++  L E
Sbjct: 79  VTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE 138

Query: 217 TICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLT 275
                    +++A+ + HS  V+HRD+K +N+L++   G A L DFG   ++        
Sbjct: 139 GPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTD 197

Query: 276 SIKGTPLYMAPELIAERPYD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV 334
              GT +Y  PE I+   Y    A +WSLG + Y++  G  PF         + +   ++
Sbjct: 198 FD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF------ERDQEILEAEL 250

Query: 335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
            FP+ VS     L++  L    S R S  E+L  P
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 22/89 (24%), Positives = 40/89 (44%), Gaps = 8/89 (8%)

Query: 10  KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS----GRSGKELSSLKQECEIQKHL 65
           +Y+   L+G+G FG VF    L  +  VA+K+I ++         +  +   E  +   +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 66  ----AHPNIIKFIASHETLNEFVLITEFA 90
                HP +I+ +   ET   F+L+ E  
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERP 120

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  185 bits (470), Expect = 1e-53
 Identities = 55/327 (16%), Positives = 115/327 (35%), Gaps = 37/327 (11%)

Query: 102 FHNHCQPVKMEKSNGAL----EKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKII 152
                  +   K         +      L+GEG+F +V++A   DL     K+   LK+ 
Sbjct: 44  TFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ 103

Query: 153 SKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQR 211
             +  +  E     Q  E  K       +KF ++H   N  VL+ E   + +L N +   
Sbjct: 104 KPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161

Query: 212 KK-----LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN-----------KDGV 255
           K      + + + +     ++  +  +H   ++H D+KP N +L                
Sbjct: 162 KNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221

Query: 256 AMLCDFGFARSMAV--GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMG 313
             L D G +  M +     + T+   T  +   E+++ +P+++  D + +    Y +  G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281

Query: 314 HPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK- 372
                             + +       + + +    +L       L   +LL   L K 
Sbjct: 282 TYMKVKNEGGECKPEGLFRRLPHL----DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337

Query: 373 --DNLSSEIESQNNQDCIGFDYCDKRR 397
              + +++I +  N+  +    C + R
Sbjct: 338 FQQHYTNKIRALRNRLIVLLLECKRSR 364

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 7/87 (8%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQK 63
           +      L+GEG+F +V++A   DL     K+   LK+   +  +  E     Q  E  K
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLK 122

Query: 64  HLAHPNIIKFIASHETLNEFVLITEFA 90
                  +KF ++H   N  VL+ E  
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELY 149

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  185 bits (471), Expect = 1e-53
 Identities = 62/314 (19%), Positives = 117/314 (37%), Gaps = 60/314 (19%)

Query: 119 EKYQKICLIGEG--SFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
             Y+ + +IG+G      V  A +    + V ++ I+    S + ++ L+ E  + K   
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 177 HPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKK--LSETICVQILSNLISALYYL 233
           HPNI+ + A+    NE  ++T F A+ S  +L+       ++E     IL  ++ AL Y+
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK-------GTPLYMAP 286
           H    +HR +K  ++L++ DG   L       SM         +            +++P
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

Query: 287 ELIAE--RPYDHTADLWSLGCIAYEIHMGHPPF--------------------------- 317
           E++ +  + YD  +D++S+G  A E+  GH PF                           
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264

Query: 318 -------------------KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
                                 +         +    +    S  +   V+  L+++   
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324

Query: 359 RLSWPELLHHPLVK 372
           R S   LL+H   K
Sbjct: 325 RPSASTLLNHSFFK 338

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 21/83 (25%), Positives = 40/83 (48%), Gaps = 2/83 (2%)

Query: 9   EKYQKICLIGEG--SFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 66
             Y+ + +IG+G      V  A +    + V ++ I+    S + ++ L+ E  + K   
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 67  HPNIIKFIASHETLNEFVLITEF 89
           HPNI+ + A+    NE  ++T F
Sbjct: 85  HPNIVPYRATFIADNELWVVTSF 107

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  187 bits (477), Expect = 2e-53
 Identities = 76/267 (28%), Positives = 132/267 (49%), Gaps = 4/267 (1%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHP 178
            Y     +G G+FGKV    H      VA+KI+++   RS   +  +++E +  K   HP
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 179 NIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           +IIK      T ++  ++ E+     L + + +  +L E    ++   ++S + Y H + 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD-H 296
           V+HRDLKP+NVLL+    A + DFG +  M+ G  + TS  G+P Y APE+I+ R Y   
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYAAPEVISGRLYAGP 195

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
             D+WS G I Y +  G  PF    +  L + +       P  ++ +   L+K +L+ D 
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDP 255

Query: 357 SQRLSWPELLHHPLVKDNLSSEIESQN 383
            +R +  ++  H   K +L   +  ++
Sbjct: 256 MKRATIKDIREHEWFKQDLPKYLFPED 282

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 1/82 (1%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHP 68
           Y     +G G+FGKV    H      VA+KI+++   RS   +  +++E +  K   HP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 69 NIIKFIASHETLNEFVLITEFA 90
          +IIK      T ++  ++ E+ 
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYV 98

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  181 bits (462), Expect = 2e-53
 Identities = 65/265 (24%), Positives = 120/265 (45%), Gaps = 8/265 (3%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 64

Query: 178 PNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+     L + +E    + E    +    L++ + YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184

Query: 295 D-HTADLWSLGCIAYEIHMGHPPF-KTVSILHLIRLLKTQDVTFP--SQVSETYKDLVKG 350
                D+WS G +   +  G  P+ +           K +        ++      L+  
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244

Query: 351 LLEKDASQRLSWPELLHHPLVKDNL 375
           +L ++ S R++ P++         L
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKPL 269

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 71.1 bits (175), Expect = 6e-14
 Identities = 24/83 (28%), Positives = 44/83 (53%), Gaps = 1/83 (1%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
          +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 6  VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 64

Query: 68 PNIIKFIASHETLNEFVLITEFA 90
           N++KF       N   L  E+ 
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYC 87

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  182 bits (464), Expect = 3e-53
 Identities = 71/275 (25%), Positives = 127/275 (46%), Gaps = 14/275 (5%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI-QKHLA 176
           +   + +  +G G+ G+V+K         +A+K + +SG   +E   +  + ++  K   
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHD 82

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHS 235
            P I++   +  T  +  +  E        L ++ +  + E I  ++   ++ ALYYL  
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 236 NR-VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI----- 289
              V+HRD+KP N+LL++ G   LCDFG +  + V         G   YMAPE I     
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERIDPPDP 201

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTV-SILHLIRLLKTQDV-TFPSQV--SETYK 345
            +  YD  AD+WSLG    E+  G  P+K   +   ++  +  ++    P  +  S  ++
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261

Query: 346 DLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
             VK  L KD  +R  + +LL H  +K   + E++
Sbjct: 262 SFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 17/91 (18%), Positives = 38/91 (41%), Gaps = 2/91 (2%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI-QKHLA 66
           +   + +  +G G+ G+V+K         +A+K + +SG   +E   +  + ++  K   
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHD 82

Query: 67  HPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
            P I++   +  T  +  +  E       KL
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKL 113

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  185 bits (472), Expect = 4e-53
 Identities = 66/294 (22%), Positives = 122/294 (41%), Gaps = 44/294 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI-QKHLAH 177
                  ++G GS G V         + VA+K +               E ++  +   H
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-----DFCDIALMEIKLLTESDDH 68

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETI-------CVQILSNLISAL 230
           PN+I++  S  T     +  E  +++L +L+E +    E +        + +L  + S +
Sbjct: 69  PNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 231 YYLHSNRVLHRDLKPQNVLL-------------NKDGVAMLCDFGFARSMAVG----THM 273
            +LHS +++HRDLKPQN+L+              ++   ++ DFG  + +  G       
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 274 LTSIKGTPLYMAPELI-------AERPYDHTADLWSLGCIAYEI-HMGHPPF-----KTV 320
           L +  GT  + APEL+        +R    + D++S+GC+ Y I   G  PF     +  
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248

Query: 321 SILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN 374
           +I+  I  L          +     DL+  +++ D  +R +  ++L HPL    
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 17/87 (19%), Positives = 32/87 (36%), Gaps = 7/87 (8%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI-QKHLAH 67
                 ++G GS G V         + VA+K +               E ++  +   H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-----DFCDIALMEIKLLTESDDH 68

Query: 68 PNIIKFIASHETLNEFVLITEFAHMSL 94
          PN+I++  S  T     +  E  +++L
Sbjct: 69 PNVIRYYCSETTDRFLYIALELCNLNL 95

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  181 bits (462), Expect = 1e-52
 Identities = 87/306 (28%), Positives = 144/306 (47%), Gaps = 42/306 (13%)

Query: 103 HNHCQPVKMEKSN---GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRS 158
           H+H   V +   N    ++EKY+ + L+GEGS+G V K  + D  + VA+K  +      
Sbjct: 6   HHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK 65

Query: 159 GKELSSLKQECEIQ--KHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK-LS 215
             +  +++   EI+  K L H N++  +   +    + L+ EF   ++ + LE     L 
Sbjct: 66  MVKKIAMR---EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLD 122

Query: 216 ETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT 275
             +  + L  +I+ + + HS+ ++HRD+KP+N+L+++ GV  LCDFGFAR++A    +  
Sbjct: 123 YQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182

Query: 276 SIKGTPLYMAPE-LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLK 330
               T  Y APE L+ +  Y    D+W++GC+  E+ MG P F   S    + H++  L 
Sbjct: 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLG 242

Query: 331 T---------------QDVTFP------------SQVSETYKDLVKGLLEKDASQRLSWP 363
                             V  P             ++SE   DL K  L  D  +R    
Sbjct: 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCA 302

Query: 364 ELLHHP 369
           ELLHH 
Sbjct: 303 ELLHHD 308

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 24/95 (25%), Positives = 47/95 (49%), Gaps = 6/95 (6%)

Query: 6   GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQ-- 62
            ++EKY+ + L+GEGS+G V K  + D  + VA+K  +        +  +++   EI+  
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR---EIKLL 78

Query: 63  KHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
           K L H N++  +   +    + L+ EF   ++   
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDD 113

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  181 bits (461), Expect = 3e-52
 Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 14/279 (5%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
            ++Y  +  IG G+FG          K+ VA+K I +     +   ++++E    + L H
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE---NVQREIINHRSLRH 75

Query: 178 PNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           PNI++F     T     +I E+A    L   +    + SE         L+S + Y HS 
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135

Query: 237 RVLHRDLKPQNVLLNKDGVAML--CDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           ++ HRDLK +N LL+      L  CDFG+++S  +      S  GTP Y+APE++  + Y
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEY 194

Query: 295 D-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTFPSQ--VSETYKDL 347
           D   AD+WS G   Y + +G  PF+        R    +      + P    +S     L
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254

Query: 348 VKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
           +  +   D + R+S PE+  H     NL +++ +++N  
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTG 293

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 22/83 (26%), Positives = 39/83 (46%), Gaps = 3/83 (3%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
           ++Y  +  IG G+FG          K+ VA+K I +     +   ++++E    + L H
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE---NVQREIINHRSLRH 75

Query: 68 PNIIKFIASHETLNEFVLITEFA 90
          PNI++F     T     +I E+A
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYA 98

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  179 bits (456), Expect = 6e-52
 Identities = 65/270 (24%), Positives = 121/270 (44%), Gaps = 8/270 (2%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 64

Query: 178 PNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+     L + +E    + E    +    L++ + YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184

Query: 295 D-HTADLWSLGCIAYEIHMGHPPF-KTVSILHLIRLLKTQDVTFP--SQVSETYKDLVKG 350
                D+WS G +   +  G  P+ +           K +        ++      L+  
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244

Query: 351 LLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
           +L ++ S R++ P++         L    +
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKPLKKGAK 274

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 24/83 (28%), Positives = 44/83 (53%), Gaps = 1/83 (1%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
          +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 6  VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 64

Query: 68 PNIIKFIASHETLNEFVLITEFA 90
           N++KF       N   L  E+ 
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYC 87

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  178 bits (453), Expect = 1e-51
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 35/286 (12%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLA 176
           +EKY+KI  IGEGS+G VFK  + D  + VA+K  +        +  +L+ E  + K L 
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLK 60

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHS 235
           HPN++  +          L+ E+   ++ + L++ ++ + E +   I    + A+ + H 
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPY 294
           +  +HRD+KP+N+L+ K  V  LCDFGFAR +   +        T  Y +PE L+ +  Y
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKT---------------QDVT 335
               D+W++GC+  E+  G P +   S    +  + + L                   V 
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 336 FP------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
            P              +S     L+KG L  D ++RL+  +LLHHP
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 65.7 bits (161), Expect = 7e-12
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 2/91 (2%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLA 66
          +EKY+KI  IGEGS+G VFK  + D  + VA+K  +        +  +L+ E  + K L 
Sbjct: 2  MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLK 60

Query: 67 HPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
          HPN++  +          L+ E+   ++   
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHE 91

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  179 bits (457), Expect = 1e-51
 Identities = 80/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFI 184
            IG+GSFGKV      D KK  A+K ++K       E+ ++ +E +I + L HP ++   
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 185 ASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
            S +   +  ++ +   +    L   L+Q     E      +  L+ AL YL + R++HR
Sbjct: 82  YSFQDEEDMFMVVDL--LLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHR 139

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP---YDHTA 298
           D+KP N+LL++ G   + DF  A  +   T  +T++ GT  YMAPE+ + R    Y    
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAAMLPRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAV 198

Query: 299 DLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
           D WSLG  AYE+  G  P+   S      ++   +T  VT+PS  S+    L+K LLE +
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPN 258

Query: 356 ASQRL-SWPELLHHPLVKD 373
             QR     ++ + P + D
Sbjct: 259 PDQRFSQLSDVQNFPYMND 277

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 43.9 bits (104), Expect = 9e-05
 Identities = 20/58 (34%), Positives = 32/58 (55%), Gaps = 1/58 (1%)

Query: 16 LIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIK 72
           IG+GSFGKV      D KK  A+K ++K       E+ ++ +E +I + L HP ++ 
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  176 bits (449), Expect = 1e-50
 Identities = 72/251 (28%), Positives = 129/251 (51%), Gaps = 5/251 (1%)

Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECE 170
            ++   L+++ +I  +G GSFG+V    H +     A+KI+ K      K++     E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 171 IQKHLAHPNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISA 229
           I + +  P ++K   S +  +   ++ E+     + + L +  + SE       + ++  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
             YLHS  +++RDLKP+N+L+++ G   + DFGFA+ +   T  L    GTP  +APE+I
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---GTPEALAPEII 210

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
             + Y+   D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270

Query: 350 GLLEKDASQRL 360
            LL+ D ++R 
Sbjct: 271 NLLQVDLTKRF 281

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 23/103 (22%), Positives = 46/103 (44%), Gaps = 6/103 (5%)

Query: 2   EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECE 60
            ++   L+++ +I  +G GSFG+V    H +     A+KI+ K      K++     E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 61  IQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFH 103
           I + +  P ++K   S +  +   ++ E+        GE + H
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG-----GEMFSH 131

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  175 bits (446), Expect = 3e-50
 Identities = 72/315 (22%), Positives = 125/315 (39%), Gaps = 61/315 (19%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
            + ++KI  +G G+ G VFK  H      +A K+I    +     + + +E ++      
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNS 90

Query: 178 PNIIKFIASHETLNEFVLITEFAHM---SLSNLLEQRKKLSETICVQILSNLISALYYLH 234
           P I+ F  +  +  E  +  E   M   SL  +L++  ++ E I  ++   +I  L YL 
Sbjct: 91  PYIVGFYGAFYSDGEISICMEH--MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148

Query: 235 SNR-VLHRDLKPQNVLLNKDGVAMLCDFGFA----RSMAVGTHMLTSIKGTPLYMAPELI 289
               ++HRD+KP N+L+N  G   LCDFG +     SMA       S  GT  YM+PE +
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA------NSFVGTRSYMSPERL 202

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQV--------- 340
               Y   +D+WS+G    E+ +G  P        L  +   Q     ++          
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262

Query: 341 -----------------------------------SETYKDLVKGLLEKDASQRLSWPEL 365
                                              S  ++D V   L K+ ++R    +L
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322

Query: 366 LHHPLVKDNLSSEIE 380
           + H  +K + + E++
Sbjct: 323 MVHAFIKRSDAEEVD 337

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 21/93 (22%), Positives = 40/93 (43%), Gaps = 6/93 (6%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
            + ++KI  +G G+ G VFK  H      +A K+I    +     + + +E ++      
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNS 90

Query: 68  PNIIKFIASHETLNEFVLITEFAHM---SLSKL 97
           P I+ F  +  +  E  +  E   M   SL ++
Sbjct: 91  PYIVGFYGAFYSDGEISICMEH--MDGGSLDQV 121

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  173 bits (440), Expect = 1e-49
 Identities = 74/248 (29%), Positives = 130/248 (52%), Gaps = 11/248 (4%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 176
           L+ +Q +  +G GSFG+V         +  A+K++ K      K++     E  +   + 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64

Query: 177 HPNIIKFIASHETLNEFVLITEFAH----MSLSNLLEQRKKLSETICVQILSNLISALYY 232
           HP II+   + +   +  +I ++       SL   L + ++    +     + +  AL Y
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL---LRKSQRFPNPVAKFYAAEVCLALEY 121

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           LHS  +++RDLKP+N+LL+K+G   + DFGFA+ +   T+ L    GTP Y+APE+++ +
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---GTPDYIAPEVVSTK 178

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL 352
           PY+ + D WS G + YE+  G+ PF   + +     +   ++ FP   +E  KDL+  L+
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 238

Query: 353 EKDASQRL 360
            +D SQRL
Sbjct: 239 TRDLSQRL 246

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 43.7 bits (104), Expect = 8e-05
 Identities = 18/83 (21%), Positives = 38/83 (45%), Gaps = 1/83 (1%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 66
          L+ +Q +  +G GSFG+V         +  A+K++ K      K++     E  +   + 
Sbjct: 5  LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64

Query: 67 HPNIIKFIASHETLNEFVLITEF 89
          HP II+   + +   +  +I ++
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDY 87

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  172 bits (437), Expect = 2e-49
 Identities = 73/253 (28%), Positives = 108/253 (42%), Gaps = 22/253 (8%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G+FG V KA      K VA+K I     S  E  +   E      + HPNI+K   +
Sbjct: 16  VGRGAFGVVCKAKWRA--KDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGA 69

Query: 187 HETLNEFVLITEFAHM-SLSNLL---EQRKKLSETICVQILSNLISALYYLHS---NRVL 239
              LN   L+ E+A   SL N+L   E     +    +         + YLHS     ++
Sbjct: 70  --CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 240 HRDLKPQNVLLNKDG-VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           HRDLKP N+LL   G V  +CDFG A  +      +T+ KG+  +MAPE+     Y    
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNKGSAAWMAPEVFEGSNYSEKC 184

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLI---RLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
           D++S G I +E+     PF  +          +           + +  + L+     KD
Sbjct: 185 DVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKD 244

Query: 356 ASQRLSWPELLHH 368
            SQR S  E++  
Sbjct: 245 PSQRPSMEEIVKI 257

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 27/82 (32%), Positives = 37/82 (45%), Gaps = 9/82 (10%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
          +G G+FG V KA      K VA+K I     S  E  +   E      + HPNI+K   +
Sbjct: 16 VGRGAFGVVCKAKWRA--KDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGA 69

Query: 77 HETLNEFVLITEFAHM-SLSKL 97
             LN   L+ E+A   SL  +
Sbjct: 70 --CLNPVCLVMEYAEGGSLYNV 89

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  171 bits (435), Expect = 2e-49
 Identities = 59/262 (22%), Positives = 112/262 (42%), Gaps = 25/262 (9%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-----ELSSLKQECEIQKHLAHPNII 181
           IG+G FG V K   +  K  VA+K +      G+     +    ++E  I  +L HPNI+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 182 KFIASHETLNEFVLITEFAHM-SLSNLL-EQRKKLSETICVQILSNLISALYYLHSNR-- 237
           K        N   ++ EF     L + L ++   +  ++ ++++ ++   + Y+ +    
Sbjct: 87  KLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144

Query: 238 VLHRDLKPQNVLLNKDG-----VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           ++HRDL+  N+ L          A + DFG ++      H ++ + G   +MAPE I   
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS---VHSVSGLLGNFQWMAPETIGAE 201

Query: 293 --PYDHTADLWSLGCIAYEIHMGHPPFKTVSILH--LIRLLKTQDV--TFPSQVSETYKD 346
              Y   AD +S   I Y I  G  PF   S      I +++ + +  T P       ++
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRN 261

Query: 347 LVKGLLEKDASQRLSWPELLHH 368
           +++     D  +R  +  ++  
Sbjct: 262 VIELCWSGDPKKRPHFSYIVKE 283

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 24/87 (27%), Positives = 36/87 (41%), Gaps = 8/87 (9%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-----ELSSLKQECEIQKHLAHPNII 71
           IG+G FG V K   +  K  VA+K +      G+     +    ++E  I  +L HPNI+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 72  KFIASHETLNEFVLITEFAHM-SLSKL 97
           K        N   ++ EF     L   
Sbjct: 87  KLYGL--MHNPPRMVMEFVPCGDLYHR 111

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  177 bits (450), Expect = 4e-49
 Identities = 83/314 (26%), Positives = 130/314 (41%), Gaps = 21/314 (6%)

Query: 81  NEFVLITEFAHMSLSK------LGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGK 134
             F  +       L +      L   +F    Q   +E      + +    ++G G FG+
Sbjct: 141 GLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGE 200

Query: 135 VFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF 193
           VF        K  A K ++K   +  K       E +I   +    I+    + ET  + 
Sbjct: 201 VFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260

Query: 194 VLITEFA-----HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNV 248
            L+            + N+ E      E   +   + ++S L +LH   +++RDLKP+NV
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320

Query: 249 LLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAY 308
           LL+ DG   + D G A  +  G        GTP +MAPEL+    YD + D ++LG   Y
Sbjct: 321 LLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLY 380

Query: 309 EIHMGHPPF----KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL---- 360
           E+     PF    + V    L + +  Q VT+P + S   KD  + LL+KD  +RL    
Sbjct: 381 EMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRD 440

Query: 361 -SWPELLHHPLVKD 373
            S   L  HPL +D
Sbjct: 441 GSCDGLRTHPLFRD 454

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  171 bits (435), Expect = 6e-49
 Identities = 72/255 (28%), Positives = 127/255 (49%), Gaps = 18/255 (7%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKSG--RSGKELSSLKQECEIQ 172
            E ++ + ++G+G +GKVF+   +    T    A+K++ K+   R+ K+ +  K E  I 
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75

Query: 173 KHLAHPNIIKFIASHETLNEFVLITEFA-------HMSLSNLLEQRKKLSETICVQILSN 225
           + + HP I+  I + +T  +  LI E+               LE+     E      L+ 
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ------LEREGIFMEDTACFYLAE 129

Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMA 285
           +  AL +LH   +++RDLKP+N++LN  G   L DFG  +       +  +  GT  YMA
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189

Query: 286 PELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYK 345
           PE++    ++   D WSLG + Y++  G PPF   +    I  +    +  P  +++  +
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249

Query: 346 DLVKGLLEKDASQRL 360
           DL+K LL+++A+ RL
Sbjct: 250 DLLKKLLKRNAASRL 264

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 43.7 bits (104), Expect = 8e-05
 Identities = 24/88 (27%), Positives = 47/88 (53%), Gaps = 5/88 (5%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKSG--RSGKELSSLKQECEIQ 62
            E ++ + ++G+G +GKVF+   +    T    A+K++ K+   R+ K+ +  K E  I 
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75

Query: 63  KHLAHPNIIKFIASHETLNEFVLITEFA 90
           + + HP I+  I + +T  +  LI E+ 
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYL 103

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  167 bits (426), Expect = 1e-47
 Identities = 86/303 (28%), Positives = 137/303 (45%), Gaps = 46/303 (15%)

Query: 108 PVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-----L 162
            V    S  ++++Y++I  +GEG++G+V+KAI     +TVA+K I    R   E      
Sbjct: 23  SVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI----RLEHEEEGVPG 78

Query: 163 SSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQI 222
           ++++ E  + K L H NII+  +     +   LI E+A   L   +++   +S  +    
Sbjct: 79  TAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSF 137

Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLN-----KDGVAMLCDFGFARSMAVGTHMLTSI 277
           L  LI+ + + HS R LHRDLKPQN+LL+     +  V  + DFG AR+  +     T  
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197

Query: 278 KGTPLYMAPE-LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKT- 331
             T  Y  PE L+  R Y  + D+WS+ CI  E+ M  P F   S    +  +  +L   
Sbjct: 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257

Query: 332 -----QDVT--------------------FPSQVSETYKDLVKGLLEKDASQRLSWPELL 366
                  VT                      + + +   DL+  +LE D  +R+S    L
Sbjct: 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317

Query: 367 HHP 369
            HP
Sbjct: 318 EHP 320

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 63.4 bits (155), Expect = 4e-11
 Identities = 30/96 (31%), Positives = 52/96 (54%), Gaps = 10/96 (10%)

Query: 7   ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-----LSSLKQECEI 61
           ++++Y++I  +GEG++G+V+KAI     +TVA+K I    R   E      ++++ E  +
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI----RLEHEEEGVPGTAIR-EVSL 86

Query: 62  QKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
            K L H NII+  +     +   LI E+A   L K 
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKY 122

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  166 bits (424), Expect = 2e-47
 Identities = 89/304 (29%), Positives = 143/304 (47%), Gaps = 43/304 (14%)

Query: 103 HNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE- 161
           H+H    +     G +EKYQK+  +GEG++G V+KA      + VALK I    R   E 
Sbjct: 5   HHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRI----RLDAED 59

Query: 162 ----LSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSE 216
                ++++ E  + K L HPNI+  I    +     L+ EF    L  +L++ +  L +
Sbjct: 60  EGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQD 118

Query: 217 TICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS 276
           +     L  L+  + + H +R+LHRDLKPQN+L+N DG   L DFG AR+  +     T 
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178

Query: 277 IKGTPLYMAPE-LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKT 331
              T  Y AP+ L+  + Y  + D+WS+GCI  E+  G P F  V+    +  +  +L T
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238

Query: 332 ---------------QDVTFPSQVSETYK-----------DLVKGLLEKDASQRLSWPEL 365
                          +  TF     + +            DL+  +L  D ++R+S  + 
Sbjct: 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298

Query: 366 LHHP 369
           ++HP
Sbjct: 299 MNHP 302

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 59.5 bits (145), Expect = 7e-10
 Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 11/98 (11%)

Query: 5   NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-----LSSLKQEC 59
            G +EKYQK+  +GEG++G V+KA      + VALK I    R   E      ++++ E 
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRI----RLDAEDEGIPSTAIR-EI 70

Query: 60  EIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
            + K L HPNI+  I    +     L+ EF    L K+
Sbjct: 71  SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKV 108

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 62.5 bits (153), Expect = 5e-11
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 10/95 (10%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-----LSSLKQECEIQ 62
          +E +QK+  IGEG++G V+KA +    + VALK I    R   E      ++++ E  + 
Sbjct: 2  MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI----RLDTETEGVPSTAIR-EISLL 56

Query: 63 KHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
          K L HPNI+K +    T N+  L+ EF H  L K 
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKF 91

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  164 bits (417), Expect = 6e-47
 Identities = 48/254 (18%), Positives = 105/254 (41%), Gaps = 19/254 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 185
           + E   G+++K         + +K++     S ++     +EC   +  +HPN++  +  
Sbjct: 18  LNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 186 -SHETLNEFVLITEFAHM-SLSNLL--EQRKKLSETICVQILSNLISALYYLHS--NRVL 239
                     LIT +    SL N+L       + ++  V+   ++   + +LH+    + 
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIP 135

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT-- 297
              L  ++V++++D  A +       S      M       P ++APE + ++P D    
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQSPGRM-----YAPAWVAPEALQKKPEDTNRR 190

Query: 298 -ADLWSLGCIAYEIHMGHPPFKTVSILHLIR--LLKTQDVTFPSQVSETYKDLVKGLLEK 354
            AD+WS   + +E+     PF  +S + +     L+    T P  +S     L+K  + +
Sbjct: 191 SADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNE 250

Query: 355 DASQRLSWPELLHH 368
           D ++R  +  ++  
Sbjct: 251 DPAKRPKFDMIVPI 264

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 15/84 (17%), Positives = 33/84 (39%), Gaps = 5/84 (5%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 75
          + E   G+++K         + +K++     S ++     +EC   +  +HPN++  +  
Sbjct: 18 LNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 76 -SHETLNEFVLITEFAHM-SLSKL 97
                    LIT +    SL  +
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNV 99

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  165 bits (420), Expect = 7e-47
 Identities = 79/294 (26%), Positives = 130/294 (44%), Gaps = 42/294 (14%)

Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
           +  +++++  +G G++  V+K ++      VALK +      G   ++++ E  + K L 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKELK 61

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQR------KKLSETICVQILSNLISAL 230
           H NI++      T N+  L+ EF    L   ++ R      + L   +       L+  L
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LI 289
            + H N++LHRDLKPQN+L+NK G   L DFG AR+  +  +  +S   T  Y AP+ L+
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI---LHLI-RLLKTQD------------ 333
             R Y  + D+WS GCI  E+  G P F   +    L LI  ++ T +            
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241

Query: 334 --VTFPSQVSETYK----------------DLVKGLLEKDASQRLSWPELLHHP 369
                  +     +                D + GLL+ +   RLS  + LHHP
Sbjct: 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 62.6 bits (153), Expect = 6e-11
 Identities = 22/91 (24%), Positives = 44/91 (48%), Gaps = 1/91 (1%)

Query: 7  ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 66
          +  +++++  +G G++  V+K ++      VALK +      G   ++++ E  + K L 
Sbjct: 3  SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKELK 61

Query: 67 HPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
          H NI++      T N+  L+ EF    L K 
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKY 92

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  165 bits (419), Expect = 8e-47
 Identities = 73/298 (24%), Positives = 124/298 (41%), Gaps = 49/298 (16%)

Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEI 171
            A  +Y+ +  IG G++G V+KA        VALK +       G  G  +S+++   E+
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR---EV 62

Query: 172 Q-----KHLAHPNIIKFI-----ASHETLNEFVLITEFAHMSLSNLLEQRKK--LSETIC 219
                 +   HPN+++ +     +  +   +  L+ E     L   L++     L     
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 122

Query: 220 VQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-LTSIK 278
             ++   +  L +LH+N ++HRDLKP+N+L+   G   L DFG AR       M LT + 
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTPVV 180

Query: 279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKT--- 331
            T  Y APE++ +  Y    D+WS+GCI  E+    P F   S    +  +  L+     
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240

Query: 332 ---------QDVTFPSQ-----------VSETYKDLVKGLLEKDASQRLSWPELLHHP 369
                        FP +           + E+   L+  +L  +  +R+S    L H 
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 62.2 bits (152), Expect = 8e-11
 Identities = 23/106 (21%), Positives = 44/106 (41%), Gaps = 17/106 (16%)

Query: 6   GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEI 61
            A  +Y+ +  IG G++G V+KA        VALK +       G  G  +S+++   E+
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR---EV 62

Query: 62  Q-----KHLAHPNIIKFI-----ASHETLNEFVLITEFAHMSLSKL 97
                 +   HPN+++ +     +  +   +  L+ E     L   
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTY 108

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  163 bits (415), Expect = 1e-46
 Identities = 69/258 (26%), Positives = 111/258 (43%), Gaps = 21/258 (8%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKII--SKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           IG G FGKV++A  +     VA+K           + + +++QE ++   L HPNII   
Sbjct: 15  IGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 185 ASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNR---VLH 240
                     L+ EFA    L+ +L   K++   I V     +   + YLH      ++H
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 241 RDLKPQNVLLNKDGVAM--------LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER 292
           RDLK  N+L+ +             + DFG AR     T M  S  G   +MAPE+I   
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYAWMAPEVIRAS 189

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV--TFPSQVSETYKDLVKG 350
            +   +D+WS G + +E+  G  PF+ +  L +   +    +    PS   E +  L++ 
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMED 249

Query: 351 LLEKDASQRLSWPELLHH 368
               D   R S+  +L  
Sbjct: 250 CWNPDPHSRPSFTNILDQ 267

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 5/84 (5%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKII--SKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 74
          IG G FGKV++A  +     VA+K           + + +++QE ++   L HPNII   
Sbjct: 15 IGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 75 ASHETLNEFVLITEFAHM-SLSKL 97
                    L+ EFA    L+++
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRV 96

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  171 bits (434), Expect = 1e-46
 Identities = 76/345 (22%), Positives = 135/345 (39%), Gaps = 24/345 (6%)

Query: 32  DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH 91
           D +K     +            +              N  + +      + F  +T   H
Sbjct: 96  DKRKACGRNLTQNFLSH-----TGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTH 150

Query: 92  MSLSK------LGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKK 145
             LS       L   +F+   Q   +E+       +++  ++G+G FG+V         K
Sbjct: 151 EYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGK 210

Query: 146 TVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA---- 200
             A K + K   +  K  +    E +I + +    ++    ++ET +   L+        
Sbjct: 211 MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 270

Query: 201 -HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLC 259
               + +    +    E   V   + +   L  LH  R+++RDLKP+N+LL+  G   + 
Sbjct: 271 LKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRIS 328

Query: 260 DFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF-- 317
           D G A  +  G  +   + GT  YMAPE++    Y  + D W+LGC+ YE+  G  PF  
Sbjct: 329 DLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

Query: 318 --KTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
             K +    + RL+K     +  + S   + L   LL KD ++RL
Sbjct: 388 RKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERL 432

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 17/93 (18%), Positives = 36/93 (38%), Gaps = 6/93 (6%)

Query: 16  LIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFI 74
           ++G+G FG+V         K  A K + K   +  K  +    E +I + +    ++   
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250

Query: 75  ASHETLNEFVLITEFA-----HMSLSKLGEPWF 102
            ++ET +   L+            +  +G+  F
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGF 283

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  163 bits (415), Expect = 1e-46
 Identities = 68/255 (26%), Positives = 119/255 (46%), Gaps = 17/255 (6%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG GSFG V+K         VA+K+++ +  + ++L + K E  + +   H NI+ F+  
Sbjct: 32  IGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 187 HETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
             T  +  ++T++    SL + L     K      + I       + YLH+  ++HRDLK
Sbjct: 89  -STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147

Query: 245 PQNVLLNKDGVAMLCDFGFARSMA--VGTHMLTSIKGTPLYMAPELIAER---PYDHTAD 299
             N+ L++D    + DFG A   +   G+H    + G+ L+MAPE+I  +   PY   +D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207

Query: 300 LWSLGCIAYEIHMGHPPFKTVSILHLIR------LLKTQDVTFPSQVSETYKDLVKGLLE 353
           +++ G + YE+  G  P+  ++    I        L        S   +  K L+   L+
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLK 267

Query: 354 KDASQRLSWPELLHH 368
           K   +R S+P +L  
Sbjct: 268 KKRDERPSFPRILAE 282

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 61.9 bits (151), Expect = 8e-11
 Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 5/82 (6%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
           IG GSFG V+K         VA+K+++ +  + ++L + K E  + +   H NI+ F+  
Sbjct: 32  IGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 77  HETLNEFVLITEF-AHMSLSKL 97
             T  +  ++T++    SL   
Sbjct: 89  -STAPQLAIVTQWCEGSSLYHH 109

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  165 bits (419), Expect = 2e-46
 Identities = 66/248 (26%), Positives = 117/248 (47%), Gaps = 4/248 (1%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEI-QKHLAHPNIIKF 183
           ++G+GSFGKVF A      +  A+K + K       ++     E  +      HP +   
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 184 IASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
             + +T      + E+ +   L   ++   K   +      + +I  L +LHS  +++RD
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRD 143

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LK  N+LL+KDG   + DFG  +   +G     +  GTP Y+APE++  + Y+H+ D WS
Sbjct: 144 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWS 203

Query: 303 LGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL-S 361
            G + YE+ +G  PF       L   ++  +  +P  + +  KDL+  L  ++  +RL  
Sbjct: 204 FGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGV 263

Query: 362 WPELLHHP 369
             ++  HP
Sbjct: 264 RGDIRQHP 271

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  163 bits (415), Expect = 2e-46
 Identities = 71/292 (24%), Positives = 131/292 (44%), Gaps = 53/292 (18%)

Query: 105 HCQPVKMEKSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS 163
           H +     K N  ++ Y+    ++G G  GKV +  +   ++  ALK++           
Sbjct: 3   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------P 55

Query: 164 SLKQECEIQKHLA-HPNIIKFIASHETL----NEFVLITEFAHMSLSNLLEQ-----RKK 213
             ++E E+    +  P+I++ +  +E L       +++ E   +    L  +      + 
Sbjct: 56  KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC--LDGGELFSRIQDRGDQA 113

Query: 214 LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVG 270
            +E    +I+ ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGF       
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------- 166

Query: 271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLK 330
                         A E      YD + D+WSLG I Y +  G+PPF +   L +   +K
Sbjct: 167 --------------AKETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211

Query: 331 TQ----DVTFPS----QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN 374
           T+       FP+    +VSE  K L++ LL+ + +QR++  E ++HP +  +
Sbjct: 212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 18/92 (19%), Positives = 41/92 (44%), Gaps = 13/92 (14%)

Query: 3  KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 61
          K N  ++ Y+    ++G G  GKV +  +   ++  ALK++             ++E E+
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVEL 63

Query: 62 QKHLA-HPNIIKFIASHETL----NEFVLITE 88
              +  P+I++ +  +E L       +++ E
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  163 bits (416), Expect = 4e-46
 Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 16/244 (6%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFI 184
           L+G+G+FGKV         +  A+KI+ K    +  E++    E  + ++  HP +    
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 185 ASHETLNEFVLITEFA-------HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
            + +T +    + E+A       H      L + +  +E       + ++SAL YLHS  
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFH------LSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFAR-SMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
           V++RD+K +N++L+KDG   + DFG  +  ++ G  M T   GTP Y+APE++ +  Y  
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGR 184

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
             D W LG + YE+  G  PF       L  L+  +++ FP  +S   K L+ GLL+KD 
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244

Query: 357 SQRL 360
            QRL
Sbjct: 245 KQRL 248

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 41.1 bits (97), Expect = 6e-04
 Identities = 18/76 (23%), Positives = 36/76 (47%), Gaps = 1/76 (1%)

Query: 16 LIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFI 74
          L+G+G+FGKV         +  A+KI+ K    +  E++    E  + ++  HP +    
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 75 ASHETLNEFVLITEFA 90
           + +T +    + E+A
Sbjct: 72 YAFQTHDRLCFVMEYA 87

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  163 bits (414), Expect = 4e-46
 Identities = 62/271 (22%), Positives = 117/271 (43%), Gaps = 24/271 (8%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG+G FG+V+          VA+++I     +  +L + K+E    +   H N++ F+ +
Sbjct: 41  IGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 187 HETLNEFVLITEFAH-MSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
             +     +IT      +L +++ + +  L      QI   ++  + YLH+  +LH+DLK
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVG-----THMLTSIKGTPLYMAPELI---------A 290
            +NV  +   V ++ DFG      V         L    G   ++APE+I          
Sbjct: 158 SKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEED 216

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFPSQVSETYKDLV 348
           + P+   +D+++LG I YE+H    PFKT     +I  + T          + +   D++
Sbjct: 217 KLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDIL 276

Query: 349 KGLLEKDASQRLSWPELLHH--PLVKDNLSS 377
                 +  +R ++ +L+     L K N   
Sbjct: 277 LFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 18/82 (21%), Positives = 37/82 (45%), Gaps = 4/82 (4%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
           IG+G FG+V+          VA+++I     +  +L + K+E    +   H N++ F+ +
Sbjct: 41  IGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 77  HETLNEFVLITEFAH-MSLSKL 97
             +     +IT      +L  +
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSV 119

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  163 bits (414), Expect = 6e-46
 Identities = 68/247 (27%), Positives = 120/247 (48%), Gaps = 16/247 (6%)

Query: 124 ICLIGEGSFGKVFKAIHLDLKKTV---ALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           + ++G+GSFGKVF    +         A+K++ K+    ++    K E +I   + HP I
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88

Query: 181 IKFIASHETLNEFVLITEFA-------HMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
           +K   + +T  +  LI +F               L +    +E      L+ L  AL +L
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTR------LSKEVMFTEEDVKFYLAELALALDHL 142

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
           HS  +++RDLKP+N+LL+++G   L DFG ++          S  GT  YMAPE++  R 
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           +  +AD WS G + +E+  G  PF+       + ++    +  P  +S   + L++ L +
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFK 262

Query: 354 KDASQRL 360
           ++ + RL
Sbjct: 263 RNPANRL 269

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  163 bits (414), Expect = 7e-46
 Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 33/284 (11%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E Y K+  +GEG++  V+K         VALK I      G   ++++ E  + K L H
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKH 59

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSN 236
            NI+       T     L+ E+    L   L+     ++       L  L+  L Y H  
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPYD 295
           +VLHRDLKPQN+L+N+ G   L DFG AR+ ++ T    +   T  Y  P+ L+    Y 
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSI---LHLI-RLLKT---------------QDVTF 336
              D+W +GCI YE+  G P F   ++   LH I R+L T               +   +
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239

Query: 337 PSQ-----------VSETYKDLVKGLLEKDASQRLSWPELLHHP 369
           P             +     DL+  LL+ +   R+S  + + HP
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 59.9 bits (146), Expect = 6e-10
 Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 1/90 (1%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
          +E Y K+  +GEG++  V+K         VALK I      G   ++++ E  + K L H
Sbjct: 1  METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKH 59

Query: 68 PNIIKFIASHETLNEFVLITEFAHMSLSKL 97
           NI+       T     L+ E+    L + 
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDKDLKQY 89

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  161 bits (410), Expect = 1e-45
 Identities = 91/288 (31%), Positives = 137/288 (47%), Gaps = 42/288 (14%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-----LSSLKQECEIQ 172
           +EKY  +  IGEG++G V+KA + +  +T ALK I    R  KE      ++++ E  I 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKI----RLEKEDEGIPSTTIR-EISIL 54

Query: 173 KHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK-KLSETICVQILSNLISALY 231
           K L H NI+K      T    VL+ E     L  LL+  +  L        L  L++ + 
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIA 290
           Y H  RVLHRDLKPQN+L+N++G   + DFG AR+  +     T    T  Y AP+ L+ 
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD------------- 333
            + Y  T D+WS+GCI  E+  G P F  VS    ++ + R+L T +             
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 334 -VTFPSQ-----------VSETYKDLVKGLLEKDASQRLSWPELLHHP 369
              F              + E+  DL+  +L+ D +QR++  + L H 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 59.1 bits (144), Expect = 7e-10
 Identities = 34/95 (35%), Positives = 48/95 (50%), Gaps = 11/95 (11%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-----LSSLKQECEIQ 62
          +EKY  +  IGEG++G V+KA + +  +T ALK I    R  KE      ++++ E  I 
Sbjct: 1  MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKI----RLEKEDEGIPSTTIR-EISIL 54

Query: 63 KHLAHPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
          K L H NI+K      T    VL+ E     L KL
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKL 89

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  161 bits (409), Expect = 1e-45
 Identities = 86/285 (30%), Positives = 133/285 (46%), Gaps = 34/285 (11%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLA 176
           ++KY+K+  IGEG++G VFKA + +  + VALK +       G   S+L+ E  + K L 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELK 59

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHS 235
           H NI++      +  +  L+ EF    L    +     L   I    L  L+  L + HS
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE-LIAERPY 294
             VLHRDLKPQN+L+N++G   L +FG AR+  +     ++   T  Y  P+ L   + Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 295 DHTADLWSLGCIAYE-IHMGHPPFKTVS----ILHLIRLLKTQD-------------VTF 336
             + D+WS GCI  E  + G P F        +  + RLL T                 +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 337 P------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
           P             +++ T +DL++ LL+ +  QR+S  E L HP
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 62.5 bits (153), Expect = 7e-11
 Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 2/91 (2%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS-KSGRSGKELSSLKQECEIQKHLA 66
          ++KY+K+  IGEG++G VFKA + +  + VALK +       G   S+L+ E  + K L 
Sbjct: 1  MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELK 59

Query: 67 HPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
          H NI++      +  +  L+ EF    L K 
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY 90

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  162 bits (412), Expect = 2e-45
 Identities = 79/290 (27%), Positives = 126/290 (43%), Gaps = 43/290 (14%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQ- 172
            ++Y+K+  +GEG F  V+KA   +  + VA+K I        + G   ++L+   EI+ 
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKL 65

Query: 173 -KHLAHPNIIKF--IASHETLNEFVLITEFAHMSLSNLLEQRK-KLSETICVQILSNLIS 228
            + L+HPNII       H+  +   L+ +F    L  +++     L+ +     +   + 
Sbjct: 66  LQELSHPNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE- 287
            L YLH + +LHRDLKP N+LL+++GV  L DFG A+S        T    T  Y APE 
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD---------- 333
           L   R Y    D+W++GCI  E+ +  P     S    +  +   L T            
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243

Query: 334 ---VTFPSQVSETYK-----------DLVKGLLEKDASQRLSWPELLHHP 369
              VTF S                  DL++GL   +   R++  + L   
Sbjct: 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 27/98 (27%), Positives = 48/98 (48%), Gaps = 13/98 (13%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKII----SKSGRSGKELSSLKQECEIQ- 62
            ++Y+K+  +GEG F  V+KA   +  + VA+K I        + G   ++L+   EI+ 
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKL 65

Query: 63  -KHLAHPNIIKF--IASHETLNEFVLITEFAHMSLSKL 97
            + L+HPNII       H+  +   L+ +F    L  +
Sbjct: 66  LQELSHPNIIGLLDAFGHK--SNISLVFDFMETDLEVI 101

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  162 bits (413), Expect = 2e-45
 Identities = 75/259 (28%), Positives = 132/259 (50%), Gaps = 19/259 (7%)

Query: 124 ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEI-QKHLAHPNII 181
           + +IG+GSFGKV  A H   +   A+K++ K      KE   +  E  +  K++ HP ++
Sbjct: 43  LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 182 KFIASHETLNEFVLITEFA-------HMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
               S +T ++   + ++        H      L++ +   E       + + SAL YLH
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYH------LQRERCFLEPRARFYAAEIASALGYLH 156

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S  +++RDLKP+N+LL+  G  +L DFG  +         ++  GTP Y+APE++ ++PY
Sbjct: 157 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY 216

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
           D T D W LG + YE+  G PPF + +   +   +  + +     ++ + + L++GLL+K
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK 276

Query: 355 DASQRLSWP----ELLHHP 369
           D ++RL       E+  H 
Sbjct: 277 DRTKRLGAKDDFMEIKSHV 295

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  160 bits (406), Expect = 9e-45
 Identities = 87/306 (28%), Positives = 142/306 (46%), Gaps = 55/306 (17%)

Query: 111 MEKSNG--ALEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALK-IISKSGRSG----- 159
           MEK     A ++Y+ +  IGEG++GKVFKA   DLK     VALK +  ++G  G     
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKAR--DLKNGGRFVALKRVRVQTGEEGMPLST 58

Query: 160 -KELSSLKQECEIQKHLAHPNIIKFI-----ASHETLNEFVLITEFAHMSLSNLLEQRKK 213
            +E++ L+      +   HPN+++       +  +   +  L+ E     L+  L++  +
Sbjct: 59  IREVAVLRH----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE 114

Query: 214 --LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT 271
             +       ++  L+  L +LHS+RV+HRDLKPQN+L+   G   L DFG AR      
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSF 172

Query: 272 HM-LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLI 326
            M LTS+  T  Y APE++ +  Y    DLWS+GCI  E+    P F+  S    +  ++
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

Query: 327 RLLKT------------QDVTFPSQVSETYK-----------DLVKGLLEKDASQRLSWP 363
            ++                  F S+ ++  +           DL+   L  + ++R+S  
Sbjct: 233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 292

Query: 364 ELLHHP 369
             L HP
Sbjct: 293 SALSHP 298

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 59.5 bits (145), Expect = 6e-10
 Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 23/114 (20%)

Query: 1   MEKSNG--ALEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALK-IISKSGRSG----- 49
           MEK     A ++Y+ +  IGEG++GKVFKA   DLK     VALK +  ++G  G     
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKAR--DLKNGGRFVALKRVRVQTGEEGMPLST 58

Query: 50  -KELSSLKQECEIQKHLAHPNIIKFI-----ASHETLNEFVLITEFAHMSLSKL 97
            +E++ L+      +   HPN+++       +  +   +  L+ E     L+  
Sbjct: 59  IREVAVLRH----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY 108

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  162 bits (412), Expect = 2e-44
 Identities = 74/240 (30%), Positives = 122/240 (50%), Gaps = 3/240 (1%)

Query: 124 ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIK 182
           + L+G+G+FGKV         +  A+KI+ K    +  E++    E  + ++  HP +  
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 183 FIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNR-VLH 240
              S +T +    + E+A+   L   L + +  SE       + ++SAL YLHS + V++
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADL 300
           RDLK +N++L+KDG   + DFG  +        + +  GTP Y+APE++ +  Y    D 
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 332

Query: 301 WSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
           W LG + YE+  G  PF       L  L+  +++ FP  +    K L+ GLL+KD  QRL
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 392

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 19/78 (24%), Positives = 37/78 (47%), Gaps = 1/78 (1%)

Query: 14  ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIK 72
           + L+G+G+FGKV         +  A+KI+ K    +  E++    E  + ++  HP +  
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 73  FIASHETLNEFVLITEFA 90
              S +T +    + E+A
Sbjct: 213 LKYSFQTHDRLCFVMEYA 230

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  159 bits (405), Expect = 2e-44
 Identities = 65/244 (26%), Positives = 113/244 (46%), Gaps = 15/244 (6%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEI-QKHLAHPNIIKF 183
           ++G+GSFGKV  A   +     A+K++ K       ++     E  I      HP + + 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 184 IASHETLNEFVLITEFA-------HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
               +T +    + EF        H      +++ ++  E       + +ISAL +LH  
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFH------IQKSRRFDEARARFYAAEIISALMFLHDK 143

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
            +++RDLK  NVLL+ +G   L DFG  +          +  GTP Y+APE++ E  Y  
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGP 203

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
             D W++G + YE+  GH PF+  +   L   +   +V +P+ + E    ++K  + K+ 
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNP 263

Query: 357 SQRL 360
           + RL
Sbjct: 264 TMRL 267

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  159 bits (404), Expect = 3e-44
 Identities = 64/270 (23%), Positives = 126/270 (46%), Gaps = 18/270 (6%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEI-QKHL 175
           L+ +  + +IG GS+ KV         +  A+K++ K      +++  ++ E  + ++  
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67

Query: 176 AHPNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP ++   +  +T +    + E+ +   L   +++++KL E       + +  AL YLH
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
              +++RDLK  NVLL+ +G   L D+G  +         ++  GTP Y+APE++    Y
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 187

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSIL---------HLIRLLKTQDVTFPSQVSETYK 345
             + D W+LG + +E+  G  PF  V            +L +++  + +  P  +S    
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 247

Query: 346 DLVKGLLEKDASQRL------SWPELLHHP 369
            ++K  L KD  +RL       + ++  HP
Sbjct: 248 SVLKSFLNKDPKERLGCHPQTGFADIQGHP 277

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  157 bits (398), Expect = 5e-44
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 33/220 (15%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQK--HLAHPNIIKF 183
            +G+G +G+V++       + VA+KI S      ++  S  +E E+     L H NI+ F
Sbjct: 15  CVGKGRYGEVWRGSWQG--ENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGF 67

Query: 184 IAS----HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNR- 237
           IAS      +  +  LIT +  M SL + L Q   L    C++I+ ++ S L +LH    
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 238 -------VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML----TSIKGTPLYMAP 286
                  + HRDLK +N+L+ K+G   + D G A   +  T+ L        GT  YMAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 287 ELIAERP------YDHTADLWSLGCIAYEIHMGHPPFKTV 320
           E++ E             D+W+ G + +E+         V
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 14/89 (15%)

Query: 16 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQK--HLAHPNIIKF 73
           +G+G +G+V++       + VA+KI S      ++  S  +E E+     L H NI+ F
Sbjct: 15 CVGKGRYGEVWRGSWQG--ENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGF 67

Query: 74 IAS----HETLNEFVLITEFAHM-SLSKL 97
          IAS      +  +  LIT +  M SL   
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDY 96

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  158 bits (402), Expect = 5e-44
 Identities = 62/244 (25%), Positives = 113/244 (46%), Gaps = 15/244 (6%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEI-QKHLAHPNIIKF 183
           ++G+GSFGKV  +      +  A+KI+ K       ++     E  +       P + + 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 184 IASHETLNEFVLITEFA-------HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            +  +T++    + E+        H      ++Q  +  E   V   + +   L++L S 
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYH------IQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
            +++RDLK  NV+L+ +G   + DFG  +          +  GTP Y+APE+IA +PY  
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 200

Query: 297 TADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDA 356
           + D W+ G + YE+  G  PF+      L + +   +V +P  +S+    + KGL+ K  
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 260

Query: 357 SQRL 360
            +RL
Sbjct: 261 GKRL 264

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  157 bits (399), Expect = 1e-43
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 52/301 (17%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQ--KH 174
           + KY+K+  IG+G+FG+VFKA H    + VALK ++ ++ + G  +++L+   EI+  + 
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQL 72

Query: 175 LAHPNIIKFI--------ASHETLNEFVLITEFAHMSLSNLLEQRK-KLSETICVQILSN 225
           L H N++  I          +       L+ +F    L+ LL     K + +   +++  
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132

Query: 226 LISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV----GTHMLTSIKGTP 281
           L++ LYY+H N++LHRD+K  NVL+ +DGV  L DFG AR+ ++      +  T+   T 
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192

Query: 282 LYMAPE-LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-I--LHLI-RLLKT----- 331
            Y  PE L+ ER Y    DLW  GCI  E+    P  +  +    L LI +L  +     
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252

Query: 332 ----------QDVTFPSQ----VSETYK---------DLVKGLLEKDASQRLSWPELLHH 368
                     + +         V +  K         DL+  LL  D +QR+   + L+H
Sbjct: 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312

Query: 369 P 369
            
Sbjct: 313 D 313

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 60.7 bits (148), Expect = 4e-10
 Identities = 29/101 (28%), Positives = 53/101 (52%), Gaps = 14/101 (13%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQ--KH 64
           + KY+K+  IG+G+FG+VFKA H    + VALK ++ ++ + G  +++L+   EI+  + 
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQL 72

Query: 65  LAHPNIIKFI--------ASHETLNEFVLITEFAHMSLSKL 97
           L H N++  I          +       L+ +F    L+ L
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL 113

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  154 bits (392), Expect = 5e-43
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 18/200 (9%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G+G FG+  K  H +  + + +K + +     +   +  +E ++ + L HPN++KFI  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 187 HETLNEFVLITEFAHM-SLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                    ITE+    +L  ++     +   +  V    ++ S + YLHS  ++HRDL 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHM--------------LTSIKGTPLYMAPELIA 290
             N L+ ++   ++ DFG AR M                      ++ G P +MAPE+I 
Sbjct: 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195

Query: 291 ERPYDHTADLWSLGCIAYEI 310
            R YD   D++S G +  EI
Sbjct: 196 GRSYDEKVDVFSFGIVLCEI 215

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 18/73 (24%), Positives = 36/73 (49%), Gaps = 2/73 (2%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
          +G+G FG+  K  H +  + + +K + +     +   +  +E ++ + L HPN++KFI  
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 77 HETLNEFVLITEF 89
                   ITE+
Sbjct: 76 LYKDKRLNFITEY 88

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  157 bits (398), Expect = 5e-43
 Identities = 62/262 (23%), Positives = 122/262 (46%), Gaps = 18/262 (6%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEI-QKHLAHPNIIKF 183
           +IG GS+ KV         +  A++++ K      +++  ++ E  + ++   HP ++  
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118

Query: 184 IASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
            +  +T +    + E+ +   L   +++++KL E       + +  AL YLH   +++RD
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 178

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWS 302
           LK  NVLL+ +G   L D+G  +         ++  GTP Y+APE++    Y  + D W+
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 238

Query: 303 LGCIAYEIHMGHPPFKTVSIL---------HLIRLLKTQDVTFPSQVSETYKDLVKGLLE 353
           LG + +E+  G  PF  V            +L +++  + +  P  +S     ++K  L 
Sbjct: 239 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLN 298

Query: 354 KDASQRL------SWPELLHHP 369
           KD  +RL       + ++  HP
Sbjct: 299 KDPKERLGCHPQTGFADIQGHP 320

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  156 bits (396), Expect = 1e-42
 Identities = 69/256 (26%), Positives = 118/256 (46%), Gaps = 17/256 (6%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 176
            E Y+ + +IG G+FG+V    H   +K  A+K++SK       + +   +E +I     
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLISALYYL 233
            P +++   + +      ++ E+  M    L NL+     + E       + ++ AL  +
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEY--MPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAI 184

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT-SIKGTPLYMAPELI--- 289
           HS   +HRD+KP N+LL+K G   L DFG    M     +   +  GTP Y++PE++   
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244

Query: 290 -AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIR--LLKTQDVTFPS--QVSETY 344
             +  Y    D WS+G   YE+ +G  PF   S++      +     +TFP    +S+  
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304

Query: 345 KDLVKGLLEKDASQRL 360
           K+L+   L  D   RL
Sbjct: 305 KNLICAFL-TDREVRL 319

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 22/102 (21%), Positives = 43/102 (42%), Gaps = 8/102 (7%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 66
            E Y+ + +IG G+FG+V    H   +K  A+K++SK       + +   +E +I     
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127

Query: 67  HPNIIKFIASHETLNEFVLITE-------FAHMSLSKLGEPW 101
            P +++   + +      ++ E          MS   + E W
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW 169

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  160 bits (406), Expect = 3e-42
 Identities = 75/276 (27%), Positives = 125/276 (45%), Gaps = 16/276 (5%)

Query: 97  LGEPWFHNHCQPVKMEKSNGA-LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS 155
           +    F   CQ   +E +    +  +    +IG G FG+V+     D  K  A+K + K 
Sbjct: 166 IESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225

Query: 156 G-RSGKELSSLKQECEI---QKHLAHPNIIKFIASHETLNEFVLITEFAHMS---LSNLL 208
             +  +  +    E  +         P I+    +  T ++   I +   M+   L   L
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL--MNGGDLHYHL 283

Query: 209 EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA 268
            Q    SE       + +I  L ++H+  V++RDLKP N+LL++ G   + D G A   +
Sbjct: 284 SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343

Query: 269 VGTHMLTSIKGTPLYMAPELIA-ERPYDHTADLWSLGCIAYEIHMGHPPF---KTVSILH 324
                  +  GT  YMAPE++     YD +AD +SLGC+ +++  GH PF   KT     
Sbjct: 344 KKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401

Query: 325 LIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRL 360
           + R+  T  V  P   S   + L++GLL++D ++RL
Sbjct: 402 IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 437

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  155 bits (393), Expect = 4e-42
 Identities = 79/297 (26%), Positives = 127/297 (42%), Gaps = 58/297 (19%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAH 177
             Y    +IG GSFG V++A   D  + VA+K ++       +EL  ++        L H
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMR-------KLDH 106

Query: 178 PNIIK----FIASHETLNEFVL--ITEFAHMSLSNLLEQRKKLSETICV--------QIL 223
            NI++    F +S E  +E  L  + ++   ++  +     +  +T+ V        Q+ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPL 282
                +L Y+HS  + HRD+KPQN+LL+ D  V  LCDFG A+ +  G     S   +  
Sbjct: 167 R----SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRY 221

Query: 283 YMAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFP 337
           Y APELI     Y  + D+WS GC+  E+ +G P F   S    ++ +I++L T      
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281

Query: 338 SQVSETYK-------------------------DLVKGLLEKDASQRLSWPELLHHP 369
            +++  Y                           L   LLE   + RL+  E   H 
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 24/96 (25%), Positives = 45/96 (46%), Gaps = 14/96 (14%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAH 67
             Y    +IG GSFG V++A   D  + VA+K ++       +EL  +       + L H
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIM-------RKLDH 106

Query: 68  PNIIK----FIASHETLNEFVL--ITEFAHMSLSKL 97
            NI++    F +S E  +E  L  + ++   ++ ++
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 142

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  152 bits (385), Expect = 5e-42
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 52/268 (19%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSS-------LKQECEIQK 173
           Y+   L+G G  G V++A     ++ VALK++S      + LSS       +++E     
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS------ETLSSDPVFRTRMQREARTAG 89

Query: 174 HLAHPNIIK-----------FIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQI 222
            L  P+++            ++         +       + L+ +L ++  L+    V I
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDM-----RLI-----NGVDLAAMLRRQGPLAPPRAVAI 139

Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT---SIKG 279
           +  + SAL   H+    HRD+KP+N+L++ D  A L DFG A   A     LT   +  G
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVG 197

Query: 280 TPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFK--TVSIL--HLIRLLKTQDVT 335
           T  YMAPE  +E    + AD+++L C+ YE   G PP++   +S++  H+      Q + 
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-----NQAIP 252

Query: 336 FPSQ----VSETYKDLVKGLLEKDASQR 359
            PS     +   +  ++   + K+   R
Sbjct: 253 RPSTVRPGIPVAFDAVIARGMAKNPEDR 280

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  153 bits (388), Expect = 6e-42
 Identities = 69/251 (27%), Positives = 127/251 (50%), Gaps = 18/251 (7%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTV---ALKIISKSG--RSGKELSSLKQECEIQKHLAH-PN 179
           ++G G++GKVF    +    T    A+K++ K+   +  K     + E ++ +H+   P 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 180 IIKFIASHETLNEFVLITEFAHMS---LSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
           ++    + +T  +  LI ++  ++   L   L QR++ +E      +  ++ AL +LH  
Sbjct: 121 LVTLHYAFQTETKLHLILDY--INGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 178

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFA-RSMAVGTHMLTSIKGTPLYMAPELI--AERP 293
            +++RD+K +N+LL+ +G  +L DFG +   +A  T       GT  YMAP+++   +  
Sbjct: 179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSETYKDLVK 349
           +D   D WSLG + YE+  G  PF       S   + R +   +  +P ++S   KDL++
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQ 298

Query: 350 GLLEKDASQRL 360
            LL KD  +RL
Sbjct: 299 RLLMKDPKKRL 309

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  158 bits (401), Expect = 9e-42
 Identities = 63/246 (25%), Positives = 116/246 (47%), Gaps = 3/246 (1%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEI-QKHL 175
           L  +  + ++G+GSFGKV  +      +  A+KI+ K       ++     E  +     
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399

Query: 176 AHPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
             P + +  +  +T++    + E+     L   ++Q  +  E   V   + +   L++L 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S  +++RDLK  NV+L+ +G   + DFG  +          +  GTP Y+APE+IA +PY
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 519

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
             + D W+ G + YE+  G  PF+      L + +   +V +P  +S+    + KGL+ K
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 579

Query: 355 DASQRL 360
              +RL
Sbjct: 580 HPGKRL 585

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  152 bits (385), Expect = 9e-42
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 33/220 (15%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQK--HLAHPNIIKF 183
            IG+G +G+V+        + VA+K+   +     E +S  +E EI +   + H NI+ F
Sbjct: 44  QIGKGRYGEVWMGKWRG--EKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGF 96

Query: 184 IAS----HETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR- 237
           IA+      +  +  LIT++  + SL + L +   L     +++  + +S L +LH+   
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 238 -------VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML----TSIKGTPLYMAP 286
                  + HRDLK +N+L+ K+G   + D G A      T+ +     +  GT  YM P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 287 ELIAER------PYDHTADLWSLGCIAYEIHMGHPPFKTV 320
           E++ E            AD++S G I +E+         V
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 24/89 (26%), Positives = 43/89 (48%), Gaps = 14/89 (15%)

Query: 16  LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQK--HLAHPNIIKF 73
            IG+G +G+V+        + VA+K+   +     E +S  +E EI +   + H NI+ F
Sbjct: 44  QIGKGRYGEVWMGKWRG--EKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGF 96

Query: 74  IAS----HETLNEFVLITEF-AHMSLSKL 97
           IA+      +  +  LIT++  + SL   
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDY 125

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  150 bits (381), Expect = 1e-40
 Identities = 80/293 (27%), Positives = 125/293 (42%), Gaps = 51/293 (17%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAH 177
             Y    +IG GSFG VF+A  ++  + VA+K ++       +EL  ++        + H
Sbjct: 40  IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMR-------IVKH 91

Query: 178 PNIIK---FIASHETLNEFV---LITEFAHMSLSNLLEQRKK----LSETICVQILSNLI 227
           PN++    F  S+    + V   L+ E+   ++        K    +   +    +  L+
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151

Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
            +L Y+HS  + HRD+KPQN+LL+   GV  L DFG A+ +  G     S   +  Y AP
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYICSRYYRAP 210

Query: 287 ELI-AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFPSQVS 341
           ELI     Y    D+WS GC+  E+  G P F   S    ++ +I++L T        ++
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270

Query: 342 ETYK-------------------------DLVKGLLEKDASQRLSWPELLHHP 369
             Y                          DL+  LLE   S RL+  E L HP
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 60.4 bits (147), Expect = 6e-10
 Identities = 23/96 (23%), Positives = 44/96 (45%), Gaps = 15/96 (15%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAH 67
             Y    +IG GSFG VF+A  ++  + VA+K ++       +EL  +       + + H
Sbjct: 40  IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIM-------RIVKH 91

Query: 68  PNIIK---FIASHETLNEFV---LITEFAHMSLSKL 97
           PN++    F  S+    + V   L+ E+   ++ + 
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRA 127

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  152 bits (385), Expect = 1e-40
 Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 18/281 (6%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 178 PNIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
            NII  +       + E   +  L+ E    +L  ++  + +L       +L  ++  + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIK 178

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           +LHS  ++HRDLKP N+++  D    + DFG AR+      M T    T  Y APE+I  
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILG 237

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIRLLKTQDVTFPSQVSETYKDL 347
             Y    D+WS+GCI  E+      F     +     +I  L T    F  ++  T ++ 
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297

Query: 348 VKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCI 388
           V+   +      L++P+L   P       SE          
Sbjct: 298 VENRPKY---AGLTFPKLF--PDSLFPADSEHNKLKASQAR 333

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 25/107 (23%), Positives = 45/107 (42%), Gaps = 7/107 (6%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
           L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 68  PNIIKFI------ASHETLNEFVLITEFAHMSLSK-LGEPWFHNHCQ 107
            NII  +       + E   +  L+ E    +L + +     H    
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 167

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  151 bits (383), Expect = 1e-40
 Identities = 69/277 (24%), Positives = 123/277 (44%), Gaps = 21/277 (7%)

Query: 102 FHNHCQPVKMEKSNG--ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RS 158
           +    +P   +        E ++ + +IG G+FG+V      +  K  A+KI++K     
Sbjct: 55  YLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK 114

Query: 159 GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMS----LSNLLEQRKKL 214
             E +  ++E ++  +     I     + +  N   L+ ++        L+ L +   +L
Sbjct: 115 RAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY--YVGGDLLTLLSKFEDRL 172

Query: 215 SETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA-RSMAVGTHM 273
            E +    L+ ++ A+  +H    +HRD+KP N+L++ +G   L DFG   + M  GT  
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232

Query: 274 LTSIKGTPLYMAPELIAERP-----YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIR- 327
            +   GTP Y++PE++         Y    D WSLG   YE+  G  PF   S++     
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292

Query: 328 -LLKTQDVTFP---SQVSETYKDLVKGLLEKDASQRL 360
            +   +   FP   + VSE  KDL++ L+      RL
Sbjct: 293 IMNHKERFQFPTQVTDVSENAKDLIRRLI-CSREHRL 328

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 17/83 (20%), Positives = 38/83 (45%), Gaps = 1/83 (1%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 66
            E ++ + +IG G+FG+V      +  K  A+KI++K       E +  ++E ++  +  
Sbjct: 73  REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132

Query: 67  HPNIIKFIASHETLNEFVLITEF 89
              I     + +  N   L+ ++
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDY 155

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  149 bits (379), Expect = 2e-40
 Identities = 73/281 (25%), Positives = 123/281 (43%), Gaps = 18/281 (6%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 178 PNIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
            NII  +       S E   +  ++ E    +L  ++  + +L       +L  ++  + 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIK 141

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           +LHS  ++HRDLKP N+++  D    + DFG AR+ A  + M+T    T  Y APE+I  
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILG 200

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIRLLKTQDVTFPSQVSETYKDL 347
             Y    D+WS+GCI  E+  G   F     +     +I  L T    F  ++  T +  
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260

Query: 348 VKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCI 388
           V+   +       S+ +L   P V     SE          
Sbjct: 261 VENRPKY---AGYSFEKLF--PDVLFPADSEHNKLKASQAR 296

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 25/107 (23%), Positives = 46/107 (42%), Gaps = 7/107 (6%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
           L++YQ +  IG G+ G V  A    L++ VA+K +S+  ++        +E  + K + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 68  PNIIKFI------ASHETLNEFVLITEFAHMSLSK-LGEPWFHNHCQ 107
            NII  +       S E   +  ++ E    +L + +     H    
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 130

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  149 bits (379), Expect = 3e-40
 Identities = 66/279 (23%), Positives = 117/279 (41%), Gaps = 23/279 (8%)

Query: 102 FHNHCQPVKMEKSNGAL--EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RS 158
           F    +P+ +      L  + ++ + +IG G+F +V         +  A+KI++K     
Sbjct: 42  FLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK 101

Query: 159 GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMS---LSNLLEQR-KKL 214
             E+S  ++E ++  +     I +   + +  N   L+ E+       L  LL +  +++
Sbjct: 102 RGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY--YVGGDLLTLLSKFGERI 159

Query: 215 SETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA-RSMAVGTHM 273
              +    L+ ++ A+  +H    +HRD+KP N+LL++ G   L DFG   +  A GT  
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219

Query: 274 LTSIKGTPLYMAPELI-------AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI 326
                GTP Y++PE++           Y    D W+LG  AYE+  G  PF   S     
Sbjct: 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279

Query: 327 RLLKTQDVTFP-----SQVSETYKDLVKGLLEKDASQRL 360
             +               V E  +D ++ LL      RL
Sbjct: 280 GKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRL 317

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 16/83 (19%), Positives = 38/83 (45%), Gaps = 1/83 (1%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 66
            + ++ + +IG G+F +V         +  A+KI++K       E+S  ++E ++  +  
Sbjct: 60  RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD 119

Query: 67  HPNIIKFIASHETLNEFVLITEF 89
              I +   + +  N   L+ E+
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEY 142

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  148 bits (374), Expect = 3e-40
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 33/220 (15%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQK--HLAHPNIIKF 183
            IG+G FG+V++       + VA+KI S       E  S  +E EI +   L H NI+ F
Sbjct: 49  SIGKGRFGEVWRGKWRG--EEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGF 101

Query: 184 IASHETLN----EFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNR- 237
           IA+    N    +  L++++    SL + L  R  ++    +++  +  S L +LH    
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 238 -------VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML----TSIKGTPLYMAP 286
                  + HRDLK +N+L+ K+G   + D G A      T  +        GT  YMAP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 287 ELIAER------PYDHTADLWSLGCIAYEIHMGHPPFKTV 320
           E++ +            AD++++G + +EI          
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 14/89 (15%)

Query: 16  LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQK--HLAHPNIIKF 73
            IG+G FG+V++       + VA+KI S       E  S  +E EI +   L H NI+ F
Sbjct: 49  SIGKGRFGEVWRGKWRG--EEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGF 101

Query: 74  IASHETLN----EFVLITEFAHM-SLSKL 97
           IA+    N    +  L++++    SL   
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDY 130

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  149 bits (377), Expect = 1e-39
 Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 33/225 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           ++Y+   LIG GS+G V +A     K+ VA+K I +      +   + +E  I   L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112

Query: 179 NIIKFI-----ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
           +++K +        E  +E  ++ E A      L      L+E     +L NL+  + Y+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL----------- 282
           HS  +LHRDLKP N L+N+D    +CDFG AR++    +  + +  +P            
Sbjct: 173 HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232

Query: 283 ----------------YMAPELI-AERPYDHTADLWSLGCIAYEI 310
                           Y APELI  +  Y    D+WS+GCI  E+
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 60.2 bits (146), Expect = 8e-10
 Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 5/94 (5%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           ++Y+   LIG GS+G V +A     K+ VA+K I +      +   + +E  I   L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112

Query: 69  NIIKFI-----ASHETLNEFVLITEFAHMSLSKL 97
           +++K +        E  +E  ++ E A     KL
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKL 146

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  150 bits (381), Expect = 4e-39
 Identities = 56/249 (22%), Positives = 106/249 (42%), Gaps = 28/249 (11%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDL-KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           Y+    I  G  G ++ A+  ++  + V LK +  SG +    +    E +    + HP+
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE-AQAMAMAERQFLAEVVHPS 140

Query: 180 IIKFIASHETLNEFVLITEFAHM------SLSNLLEQRKKLSETICV--QILSNLISALY 231
           I++     E  +       +  M      SL     Q+  ++E I    +IL     AL 
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILP----ALS 196

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGTPLYMAPELIA 290
           YLHS  +++ DLKP+N++L ++ +  L D G    + + G        GTP + APE++ 
Sbjct: 197 YLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYLY-----GTPGFQAPEIVR 250

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
             P   T D++++G     + +  P      +  L       +     +  ++Y  L++ 
Sbjct: 251 TGPTVAT-DIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYDSYGRLLRR 303

Query: 351 LLEKDASQR 359
            ++ D  QR
Sbjct: 304 AIDPDPRQR 312

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  144 bits (364), Expect = 7e-39
 Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 28/223 (12%)

Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 176
                Q + +   G FG V+KA  L+  + VA+KI     +   +    + E      + 
Sbjct: 22  QSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQN---EYEVYSLPGMK 76

Query: 177 HPNIIKFIAS----HETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALY 231
           H NI++FI +         +  LIT F    SLS+ L +   +S      I   +   L 
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLA 135

Query: 232 YLHSN----------RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKG 279
           YLH +           + HRD+K +NVLL  +  A + DFG A     G          G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195

Query: 280 TPLYMAPELI-----AERPYDHTADLWSLGCIAYEIHMGHPPF 317
           T  YMAPE++      +R      D++++G + +E+       
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 25/96 (26%), Positives = 39/96 (40%), Gaps = 10/96 (10%)

Query: 7   ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA 66
                Q + +   G FG V+KA  L+  + VA+KI     +   +    + E      + 
Sbjct: 22  QSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQN---EYEVYSLPGMK 76

Query: 67  HPNIIKFIAS----HETLNEFVLITEFAHM-SLSKL 97
           H NI++FI +         +  LIT F    SLS  
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  141 bits (357), Expect = 3e-38
 Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 8/247 (3%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAHPN 179
           Y+ +  +G G    V+ A    L   VA+K I    R  +E L   ++E      L+H N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 180 IIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           I+  I   E  + + L+ E+    +LS  +E    LS    +   + ++  + + H  R+
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT-SIKGTPLYMAPELIAERPYDHT 297
           +HRD+KPQN+L++ +    + DFG A++++  +   T  + GT  Y +PE       D  
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 298 ADLWSLGCIAYEIHMGHPPFK---TVSIL--HLIRLLKTQDVTFPSQVSETYKDLVKGLL 352
            D++S+G + YE+ +G PPF     VSI   H+   +          + ++  +++    
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRAT 252

Query: 353 EKDASQR 359
           EKD + R
Sbjct: 253 EKDKANR 259

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  143 bits (363), Expect = 5e-38
 Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 30/224 (13%)

Query: 119 EKYQKICL-IGEGSFGKVFKAIHLDLK--KTVALKIISKSGRSGKELSSLKQECEIQ--K 173
           + ++     +G G++G V+KA   D K  K  ALK I  +G S   +S+     EI   +
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSAC---REIALLR 73

Query: 174 HLAHPNIIKF--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSN------ 225
            L HPN+I    +       +  L+ ++A   L ++++  +          L        
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 226 ---LISALYYLHSNRVLHRDLKPQNVLL----NKDGVAMLCDFGFARSMAVGTHMLTSIK 278
              ++  ++YLH+N VLHRDLKP N+L+     + G   + D GFAR        L  + 
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 279 G---TPLYMAPE-LIAERPYDHTADLWSLGCIAYEIHMGHPPFK 318
               T  Y APE L+  R Y    D+W++GCI  E+    P F 
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 26/96 (27%), Positives = 44/96 (45%), Gaps = 13/96 (13%)

Query: 9   EKYQKICL-IGEGSFGKVFKAIHLDLK--KTVALKIISKSGRSGKELSSLKQECEIQ--K 63
           + ++     +G G++G V+KA   D K  K  ALK I  +G S   +S+     EI   +
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSAC---REIALLR 73

Query: 64  HLAHPNIIKF--IASHETLNEFVLITEFAHMSLSKL 97
            L HPN+I    +       +  L+ ++A   L  +
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHI 109

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  141 bits (357), Expect = 5e-38
 Identities = 62/258 (24%), Positives = 122/258 (47%), Gaps = 25/258 (9%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE--LSSLKQECEIQKHLAHP 178
           Y+   ++G G   +V  A  L   + VA+K++ ++  +         ++E +    L HP
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHP 72

Query: 179 NIIKFIASHETLNEFV----LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYL 233
            I+    + E          ++ E+   ++L +++     ++    ++++++   AL + 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT---SIKGTPLYMAPELIA 290
           H N ++HRD+KP N++++      + DFG AR++A   + +T   ++ GT  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 291 ERPYDHTADLWSLGCIAYEIHMGHPPFK---TVSIL--HLIRLLKTQDVTFPSQ----VS 341
               D  +D++SLGC+ YE+  G PPF     VS+   H+      +D   PS     +S
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-----REDPIPPSARHEGLS 247

Query: 342 ETYKDLVKGLLEKDASQR 359
                +V   L K+   R
Sbjct: 248 ADLDAVVLKALAKNPENR 265

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  141 bits (358), Expect = 1e-37
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 42/289 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88

Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       S E  N+  L+T      L+N++ + +KL++     ++  ++  L Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 147

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-AE 291
           +HS  ++HRDLKP N+ +N+D    + DFG AR  A     +T    T  Y APE++   
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA---DEMTGYVATRWYRAPEIMLNW 204

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIRLLKTQDVTF----PSQVSET 343
             Y+ T D+WS+GCI  E+  G   F     +     ++RL+ T          S+ +  
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264

Query: 344 Y-----------------------KDLVKGLLEKDASQRLSWPELLHHP 369
           Y                        DL++ +L  D+ +R++  + L H 
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 27/107 (25%), Positives = 47/107 (43%), Gaps = 8/107 (7%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88

Query: 69  NIIKFI------ASHETLNEFVLITEFAHMSLSKL--GEPWFHNHCQ 107
           N+I  +       S E  N+  L+T      L+ +   +    +H Q
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 135

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  141 bits (357), Expect = 1e-37
 Identities = 77/289 (26%), Positives = 127/289 (43%), Gaps = 43/289 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + Y     +G G++G V  AI     + VA+K +S+  +S        +E  + KH+ H 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83

Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +      +S     +F L+  F    L  ++    K SE     ++  ++  L Y
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GLKFSEEKIQYLVYQMLKGLKY 141

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-AE 291
           +HS  V+HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE+I + 
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD---AEMTGYVVTRWYRAPEVILSW 198

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIRLLKTQDVTF----PSQVSET 343
             Y+ T D+WS+GCI  E+  G   FK    L     ++++       F      + +++
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258

Query: 344 Y-----------------------KDLVKGLLEKDASQRLSWPELLHHP 369
           Y                        DL++ +LE D  +RL+  + L HP
Sbjct: 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 26/106 (24%), Positives = 45/106 (42%), Gaps = 7/106 (6%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           + Y     +G G++G V  AI     + VA+K +S+  +S        +E  + KH+ H 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83

Query: 69  NIIKFI------ASHETLNEFVLITEFAHMSLSK-LGEPWFHNHCQ 107
           N+I  +      +S     +F L+  F    L K +G  +     Q
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQ 129

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  141 bits (358), Expect = 1e-37
 Identities = 70/299 (23%), Positives = 118/299 (39%), Gaps = 50/299 (16%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---------EC 169
             Y     I  GS+G V   +  +    VA+K +  +   G+ ++ L           E 
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 170 EIQKHLAHPNIIKFI-----ASHETLNEFVLITEFAHMSLSNLLE-QRKKLSETICVQIL 223
            +  H  HPNI+             +++  L+TE     L+ ++  QR  +S       +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140

Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLY 283
            +++  L+ LH   V+HRDL P N+LL  +    +CDF  AR      +  T       Y
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-THYVTHRWY 199

Query: 284 MAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFK---TVSILHLI-RLLKT---QDVT 335
            APEL+   + +    D+WS GC+  E+      F+     + L+ I  ++ T   +DV 
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259

Query: 336 F-PSQVSETYK------------------------DLVKGLLEKDASQRLSWPELLHHP 369
              S  +  Y                         DL+  +LE +  +R+S  + L HP
Sbjct: 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 23/117 (19%), Positives = 41/117 (35%), Gaps = 19/117 (16%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---------EC 59
             Y     I  GS+G V   +  +    VA+K +  +   G+ ++ L           E 
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 60  EIQKHLAHPNIIKFI-----ASHETLNEFVLITEFAHMSLSKL----GEPWFHNHCQ 107
            +  H  HPNI+             +++  L+TE     L+++           H Q
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ 137

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  141 bits (357), Expect = 1e-37
 Identities = 71/314 (22%), Positives = 126/314 (40%), Gaps = 61/314 (19%)

Query: 112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECE 170
           E+S   ++++Q   + G+G+FG V          +VA+K +I       +EL  ++    
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ---- 71

Query: 171 IQKHLAHPNIIK-----FIASHETLNE--FVLITEFAHMSLSNLLEQRKKLSETICV--- 220
               L HPNI++     +        +    ++ E+   +L        +          
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131

Query: 221 -----QILSNLISALYYLH--SNRVLHRDLKPQNVLLNK-DGVAMLCDFGFARSMAVGTH 272
                Q++     ++  LH  S  V HRD+KP NVL+N+ DG   LCDFG A+ ++    
Sbjct: 132 KVFLFQLI----RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187

Query: 273 MLTSIKGTPLYMAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIR 327
              +   +  Y APELI   + Y    D+WS+GCI  E+ +G P F+  +       ++R
Sbjct: 188 N-VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246

Query: 328 LLKTQDVTFPSQVSETYK----------------------------DLVKGLLEKDASQR 359
           +L         +++ ++                             DL+  LL+    +R
Sbjct: 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306

Query: 360 LSWPELLHHPLVKD 373
           +   E L HP   +
Sbjct: 307 MKPYEALCHPYFDE 320

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 21/104 (20%), Positives = 44/104 (42%), Gaps = 12/104 (11%)

Query: 2   EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECE 60
           E+S   ++++Q   + G+G+FG V          +VA+K +I       +EL  ++    
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ---- 71

Query: 61  IQKHLAHPNIIK-----FIASHETLNE--FVLITEFAHMSLSKL 97
               L HPNI++     +        +    ++ E+   +L + 
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRC 115

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  140 bits (355), Expect = 3e-37
 Identities = 75/289 (25%), Positives = 127/289 (43%), Gaps = 42/289 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
             Y+ +  +G G++G V  A+       VA+K + +  +S        +E  + KH+ H 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84

Query: 179 NIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +       + +   +F L+  F    L  L+ + +KL E     ++  ++  L Y
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRY 143

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-AE 291
           +H+  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE+I   
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVILNW 200

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH----LIRLLKTQDVTFPSQV-SETYK- 345
             Y  T D+WS+GCI  E+  G   FK    L     ++++  T    F  ++ S+  K 
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260

Query: 346 -------------------------DLVKGLLEKDASQRLSWPELLHHP 369
                                    +L++ +L  DA QR++  E L HP
Sbjct: 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 24/107 (22%), Positives = 44/107 (41%), Gaps = 8/107 (7%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
             Y+ +  +G G++G V  A+       VA+K + +  +S        +E  + KH+ H 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84

Query: 69  NIIKFI------ASHETLNEFVLITEFAHMSLSKL--GEPWFHNHCQ 107
           N+I  +       + +   +F L+  F    L KL   E    +  Q
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 131

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  139 bits (352), Expect = 5e-37
 Identities = 79/318 (24%), Positives = 128/318 (40%), Gaps = 58/318 (18%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---ECEIQKH 174
              +Q   L+GEG++G V  A H    + VA+K I        +     +   E +I KH
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI----EPFDKPLFALRTLREIKILKH 65

Query: 175 LAHPNIIKFI-----ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISA 229
             H NII         S E  NE  +I E     L  ++   + LS+      +   + A
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRA 124

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYM----- 284
           +  LH + V+HRDLKP N+L+N +    +CDFG AR +       +   G    M     
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184

Query: 285 -----APELI-AERPYDHTADLWSLGCIAYEIHMGHPPFK---TVSILHLI--------- 326
                APE++     Y    D+WS GCI  E+ +  P F        L LI         
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244

Query: 327 -------------RLLKTQDVTFPSQVSETYK-------DLVKGLLEKDASQRLSWPELL 366
                          +K+  +   + + + +        DL++ +L  D ++R++  E L
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304

Query: 367 HHPLVKD--NLSSEIESQ 382
            HP ++   + + E E +
Sbjct: 305 EHPYLQTYHDPNDEPEGE 322

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 30/110 (27%), Positives = 44/110 (40%), Gaps = 14/110 (12%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---ECEIQKH 64
              +Q   L+GEG++G V  A H    + VA+K I        +     +   E +I KH
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI----EPFDKPLFALRTLREIKILKH 65

Query: 65  LAHPNIIKFI-----ASHETLNEFVLITEFAHMSLSKL--GEPWFHNHCQ 107
             H NII         S E  NE  +I E     L ++   +    +H Q
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  138 bits (348), Expect = 1e-36
 Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 40/226 (17%)

Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQK--H 174
            L+  + + LIG G +G V+K    +  + VA+K+ S +        +   E  I +   
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFA-----NRQNFINEKNIYRVPL 63

Query: 175 LAHPNIIKFIA-----SHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLIS 228
           + H NI +FI      + +   E++L+ E+    SL   L            ++  ++  
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTR 122

Query: 229 ALYYLHS---------NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--------T 271
            L YLH+           + HRDL  +NVL+  DG  ++ DFG +  +            
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182

Query: 272 HMLTSIKGTPLYMAPELIAE-------RPYDHTADLWSLGCIAYEI 310
           +   S  GT  YMAPE++                D+++LG I +EI
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 25/99 (25%), Positives = 45/99 (45%), Gaps = 15/99 (15%)

Query: 7   ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQK--H 64
            L+  + + LIG G +G V+K    +  + VA+K+ S +        +   E  I +   
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFA-----NRQNFINEKNIYRVPL 63

Query: 65  LAHPNIIKFIA-----SHETLNEFVLITEFAHM-SLSKL 97
           + H NI +FI      + +   E++L+ E+    SL K 
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY 102

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  138 bits (349), Expect = 2e-36
 Identities = 79/295 (26%), Positives = 118/295 (40%), Gaps = 42/295 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
            +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H 
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 85

Query: 179 NIIKFI-----ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
           NII         + E + +  ++ +     L  LL + + LS       L  ++  L Y+
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYI 144

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV---GTHMLTSIKGTPLYMAPELI- 289
           HS  VLHRDLKP N+LLN      +CDFG AR        T  LT    T  Y APE++ 
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFK---TVSILHLI-------------------- 326
             + Y  + D+WS+GCI  E+    P F     +  L+ I                    
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264

Query: 327 -----RLLKTQDVTFPS---QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                 L     V +            DL+  +L  +  +R+   + L HP ++ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 26/106 (24%), Positives = 43/106 (40%), Gaps = 8/106 (7%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
            +Y  +  IGEG++G V  A     K  VA+K IS          +L+ E +I     H 
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 85

Query: 69  NIIKFI-----ASHETLNEFVLITEFAHMSLSKL--GEPWFHNHCQ 107
           NII         + E + +  ++ +     L KL   +   ++H  
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 131

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  135 bits (341), Expect = 1e-35
 Identities = 78/304 (25%), Positives = 120/304 (39%), Gaps = 58/304 (19%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---ECEIQKH 174
             +Y  +  +G G  G VF A+  D  K VA+K I  +     +  S+K    E +I + 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----DPQSVKHALREIKIIRR 64

Query: 175 LAHPNIIK--------------FIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICV 220
           L H NI+K               + S   LN   ++ E+    L+N+LEQ   L E    
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHAR 123

Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAM-LCDFGFARSMA---VGTHMLTS 276
             +  L+  L Y+HS  VLHRDLKP N+ +N + + + + DFG AR M         L+ 
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183

Query: 277 IKGTPLYMAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFK---TVSILHLI-RLLKT 331
              T  Y +P L+ +   Y    D+W+ GCI  E+  G   F     +  + LI   +  
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243

Query: 332 QDVTFPSQVSETYK--------------------------DLVKGLLEKDASQRLSWPEL 365
                  ++                               D ++ +L      RL+  E 
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303

Query: 366 LHHP 369
           L HP
Sbjct: 304 LSHP 307

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 29/119 (24%), Positives = 47/119 (39%), Gaps = 24/119 (20%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---ECEIQKH 64
             +Y  +  +G G  G VF A+  D  K VA+K I  +     +  S+K    E +I + 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----DPQSVKHALREIKIIRR 64

Query: 65  LAHPNIIK--------------FIASHETLNEFVLITEFAHMSLSKL--GEPWFHNHCQ 107
           L H NI+K               + S   LN   ++ E+    L+ +    P    H +
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHAR 123

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  136 bits (345), Expect = 2e-35
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 28/221 (12%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
            + Y    LIG GS+G V+ A   + +K VA+K +++      +   + +E  I   L  
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 178 PNIIKFI-----ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
             II+             +E  ++ E A   L  L +    L+E     IL NL+    +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---------- 282
           +H + ++HRDLKP N LLN+D    +CDFG AR++                         
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204

Query: 283 ------------YMAPELI-AERPYDHTADLWSLGCIAYEI 310
                       Y APELI  +  Y  + D+WS GCI  E+
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 25/108 (23%), Positives = 42/108 (38%), Gaps = 8/108 (7%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
            + Y    LIG GS+G V+ A   + +K VA+K +++      +   + +E  I   L  
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 68  PNIIKFI-----ASHETLNEFVLITEFAHMSLSKL---GEPWFHNHCQ 107
             II+             +E  ++ E A   L KL          H +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK 132

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  132 bits (335), Expect = 2e-34
 Identities = 73/325 (22%), Positives = 127/325 (39%), Gaps = 82/325 (25%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAH 177
           +KY     +G GSFG V +   ++  K  ALK ++       +EL       +I K L H
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNREL-------DIMKVLDH 59

Query: 178 PNIIK-----------------------------------FIASHETLNEFV---LITEF 199
            NIIK                                     +     ++     +I E+
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 200 AHMSLSNLLE----QRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN-KDG 254
              +L  +L+      + +   +    +  L  A+ ++HS  + HRD+KPQN+L+N KD 
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 255 VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI-AERPYDHTADLWSLGCIAYEIHMG 313
              LCDFG A+ +        +   +  Y APEL+     Y  + DLWS+GC+  E+ +G
Sbjct: 180 TLKLCDFGSAKKLIPSEPS-VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238

Query: 314 HPPFKTVSILH----LIRLLKTQDVTFPSQVSETYK------------------------ 345
            P F   + +     +I+++ T       +++  Y                         
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298

Query: 346 -DLVKGLLEKDASQRLSWPELLHHP 369
            DL++ +L  +   R++  E + HP
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHP 323

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 22/65 (33%), Positives = 31/65 (47%), Gaps = 8/65 (12%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALK-IISKSGRSGKELSSLKQECEIQKHLAH 67
          +KY     +G GSFG V +   ++  K  ALK ++       +EL       +I K L H
Sbjct: 7  KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNREL-------DIMKVLDH 59

Query: 68 PNIIK 72
           NIIK
Sbjct: 60 VNIIK 64

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  131 bits (331), Expect = 8e-34
 Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 32/239 (13%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---ECEIQKH 174
           L KY+ +  +G+G++G V+K+I     + VA+K I  + ++    +  ++   E  I   
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN---STDAQRTFREIMILTE 64

Query: 175 L-AHPNIIKF--IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
           L  H NI+    +   +   +  L+ ++    L  ++ +   L       ++  LI  + 
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI-RANILEPVHKQYVVYQLIKVIK 123

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL--------- 282
           YLHS  +LHRD+KP N+LLN +    + DFG +RS      +  +I  +           
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183

Query: 283 ------------YMAPELI-AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRL 328
                       Y APE++     Y    D+WSLGCI  EI  G P F   S ++ +  
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 23/108 (21%), Positives = 47/108 (43%), Gaps = 11/108 (10%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ---ECEIQKH 64
           L KY+ +  +G+G++G V+K+I     + VA+K I  + ++    +  ++   E  I   
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN---STDAQRTFREIMILTE 64

Query: 65  L-AHPNIIKF--IASHETLNEFVLITEFAHMSLSKL--GEPWFHNHCQ 107
           L  H NI+    +   +   +  L+ ++    L  +         H Q
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ 112

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  127 bits (322), Expect = 4e-33
 Identities = 66/300 (22%), Positives = 122/300 (40%), Gaps = 57/300 (19%)

Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS--KSGRSGKELSSLKQECEIQK 173
           G  + YQ +  +G G + +VF+AI++   + V +KI+   K  +  +E+  L+       
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------- 85

Query: 174 HLA-HPNIIKF---IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISA 229
           +L   PNII     +    +    ++     +     L    + L++      +  ++ A
Sbjct: 86  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 142

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAM-LCDFGFARSMAVGTHMLTSIKGTPLYMAPE- 287
           L Y HS  ++HRD+KP NV+++ +   + L D+G A     G         +  +  PE 
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPEL 201

Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPF----KTVSILHLI-RLLKTQDV-----TFP 337
           L+  + YD++ D+WSLGC+   +     PF         L  I ++L T+D+      + 
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261

Query: 338 SQVSETYK----------------------------DLVKGLLEKDASQRLSWPELLHHP 369
            ++   +                             D +  LL  D   RL+  E + HP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 50.7 bits (122), Expect = 5e-07
 Identities = 21/108 (19%), Positives = 45/108 (41%), Gaps = 13/108 (12%)

Query: 6   GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS--KSGRSGKELSSLKQECEIQK 63
           G  + YQ +  +G G + +VF+AI++   + V +KI+   K  +  +E+  L       +
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-------E 85

Query: 64  HLA-HPNIIKF---IASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQ 107
           +L   PNII     +    +    ++     +    +L +       +
Sbjct: 86  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR 133

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  124 bits (313), Expect = 4e-31
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 12/217 (5%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR----SGKELSSLKQECEIQKHL 175
           +Y+ + +IG+GSFG+V KA    + + VALK++    R    + +E+  L+   +  K  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157

Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYL 233
              N+I  + +    N   +  E   M+L  L+++ K    S  +  +   +++  L  L
Sbjct: 158 TM-NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAM--LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           H NR++H DLKP+N+LL + G +   + DFG   S       + +   +  Y APE+I  
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFYRAPEVILG 273

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRL 328
             Y    D+WSLGCI  E+  G+P          +  
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 24/89 (26%), Positives = 44/89 (49%), Gaps = 5/89 (5%)

Query: 10  KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR----SGKELSSLKQECEIQKHL 65
           +Y+ + +IG+GSFG+V KA    + + VALK++    R    + +E+  L+   +  K  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157

Query: 66  AHPNIIKFIASHETLNEFVLITEFAHMSL 94
              N+I  + +    N   +  E   M+L
Sbjct: 158 TM-NVIHMLENFTFRNHICMTFELLSMNL 185

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  121 bits (306), Expect = 2e-30
 Identities = 67/335 (20%), Positives = 123/335 (36%), Gaps = 72/335 (21%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK----ELSSLKQ----ECEI 171
           +Y  +  +G G F  V+ A  +     VA+KI+       +    E+  L++    +   
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 172 QKHLAHPNIIKFIASHETLNEF----VLITEFAHMSLSNLLEQRK--KLSETICVQILSN 225
           +  +   +I+K +             V++ E    +L  L+++ +   +      QI   
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 226 LISALYYLHSN-RVLHRDLKPQNVLLNKDGVAM------LCDFGFARSMAVGTHMLTSIK 278
           L+  L Y+H    ++H D+KP+NVL+             + D G A          T+  
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTNSI 196

Query: 279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL-------HL---IRL 328
            T  Y +PE++   P+   AD+WS  C+ +E+  G   F+            H+   I L
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256

Query: 329 L----------------------------KTQDVTFPSQVSETYK----------DLVKG 350
           L                            K +       ++E YK          D +  
Sbjct: 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316

Query: 351 LLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQ 385
           +L+ D  +R     L++HP +KD L  E     ++
Sbjct: 317 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDR 351

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 25/147 (17%), Positives = 55/147 (37%), Gaps = 19/147 (12%)

Query: 10  KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK----ELSSLKQ----ECEI 61
           +Y  +  +G G F  V+ A  +     VA+KI+       +    E+  L++    +   
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 62  QKHLAHPNIIKFIASHETLNEF----VLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGA 117
           +  +   +I+K +             V++ E    +L  L +       + + +      
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK---KYEHRGIPLI----Y 132

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLK 144
           +++  K  L+G     +    IH D+K
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIK 159

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  119 bits (300), Expect = 9e-30
 Identities = 73/342 (21%), Positives = 121/342 (35%), Gaps = 82/342 (23%)

Query: 119 EKYQKICLIGEGSFGKVFKAI-HLDLKKTVALKII---SKSGRSGK-ELSSLKQECEIQK 173
           E+Y+ +  +GEG+FGKV + + H   K  VALKII    K   + + E++ LK+  E  K
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78

Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK------KLSETICVQILSNLI 227
                  +             +  E    +    L++             +  Q+     
Sbjct: 79  ENKF-LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH--- 134

Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAM-------------------LCDFGFARSMA 268
            AL +LH N++ H DLKP+N+L                           + DFG   S  
Sbjct: 135 -ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SAT 190

Query: 269 VGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRL 328
                 T+I  T  Y  PE+I E  +    D+WS+GCI +E + G   F+T      + +
Sbjct: 191 FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250

Query: 329 L---------------------KTQDVTFPSQVSETYK---------------------- 345
           +                         + +    S+                         
Sbjct: 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQL 310

Query: 346 -DLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQD 386
            DL++ +LE D +QR++  E L HP        E     +++
Sbjct: 311 FDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 17/35 (48%), Positives = 24/35 (68%), Gaps = 1/35 (2%)

Query: 9  EKYQKICLIGEGSFGKVFKAI-HLDLKKTVALKII 42
          E+Y+ +  +GEG+FGKV + + H   K  VALKII
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII 53

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  116 bits (293), Expect = 2e-29
 Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 31/232 (13%)

Query: 127 IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +GEG FGKV    +          VA+K + K    G  ++ LK+E EI ++L H NI+K
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 183 FIA--SHETLNEFVLITEFAHMSLSNLLE----QRKKLSETICVQILSNLISALYYLHSN 236
           +    + +  N   LI EF  +   +L E     + K++    ++    +   + YL S 
Sbjct: 88  YKGICTEDGGNGIKLIMEF--LPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERP 293
           + +HRDL  +NVL+  +    + DFG  +++       T          + APE + +  
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205

Query: 294 YDHTADLWSLGCIAYEI---------------HMGHPPFKTVSILHLIRLLK 330
           +   +D+WS G   +E+                M  P    +++  L+  LK
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 7/80 (8%)

Query: 17  IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
           +GEG FGKV    +          VA+K + K    G  ++ LK+E EI ++L H NI+K
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 73  FIA--SHETLNEFVLITEFA 90
           +    + +  N   LI EF 
Sbjct: 88  YKGICTEDGGNGIKLIMEFL 107

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  116 bits (292), Expect = 3e-29
 Identities = 30/248 (12%), Positives = 70/248 (28%), Gaps = 38/248 (15%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKII-SKSGRSGKELSSLKQECEIQKHLAHPN 179
           Y+ +   G     + ++A+   L + VAL  +  +       L            +  P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 180 IIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           + + +    T    +++ E+    SL  + +          ++ + +L +A    H   V
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA--IRAMQSLAAAADAAHRAGV 150

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
                 P  V ++ DG  +L                         M          +   
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA-------NPQD 183

Query: 299 DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT---QDVTFPSQ----VSETYKDLVKGL 351
           D+  +G   Y + +   P     +   +   +         P+     +      +    
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARS 243

Query: 352 LEKDASQR 359
           ++ D   R
Sbjct: 244 VQGDGGIR 251

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 9/62 (14%), Positives = 20/62 (32%), Gaps = 1/62 (1%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKII-SKSGRSGKELSSLKQECEIQKHLAHPN 69
          Y+ +   G     + ++A+   L + VAL  +  +       L            +  P 
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 70 II 71
          + 
Sbjct: 93 VA 94

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  117 bits (294), Expect = 7e-29
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 14/220 (6%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR----SGKELSSLKQECEIQKH 174
           ++Y+   LIG+GSFG+V KA     ++ VA+KII         +  E+  L+   +    
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK--LSETICVQILSNLISALYY 232
           + +  I+         N   L+ E    +L +LL       +S  +  +    + +AL +
Sbjct: 114 MKY-YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 233 LHSNR--VLHRDLKPQNVLL--NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPEL 288
           L +    ++H DLKP+N+LL   K     + DFG   S       +     +  Y +PE+
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229

Query: 289 IAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRL 328
           +   PYD   D+WSLGCI  E+H G P F   + +  +  
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 269

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 23/90 (25%), Positives = 40/90 (44%), Gaps = 5/90 (5%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR----SGKELSSLKQECEIQKH 64
           ++Y+   LIG+GSFG+V KA     ++ VA+KII         +  E+  L+   +    
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 65  LAHPNIIKFIASHETLNEFVLITEFAHMSL 94
           + +  I+         N   L+ E    +L
Sbjct: 114 MKY-YIVHLKRHFMFRNHLCLVFEMLSYNL 142

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  115 bits (289), Expect = 8e-29
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 33/233 (14%)

Query: 127 IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  L+      VA+K + +   + + L   ++E EI K L H NI+K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHS-TEEHLRDFEREIEILKSLQHDNIVK 75

Query: 183 FIA--SHETLNEFVLITEFAHMSLSNLLE----QRKKLSETICVQILSNLISALYYLHSN 236
           +             LI E+  +   +L +     ++++     +Q  S +   + YL + 
Sbjct: 76  YKGVCYSAGRRNLKLIMEY--LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERP 293
           R +HRDL  +N+L+  +    + DFG  + +          +       + APE + E  
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193

Query: 294 YDHTADLWSLGCIAYEI----------------HMGHPPFKTVSILHLIRLLK 330
           +   +D+WS G + YE+                 +G+     + + HLI LLK
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 53.1 bits (128), Expect = 8e-08
 Identities = 22/80 (27%), Positives = 37/80 (46%), Gaps = 8/80 (10%)

Query: 17 IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
          +G+G+FG V    +  L+      VA+K + +   + + L   ++E EI K L H NI+K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHS-TEEHLRDFEREIEILKSLQHDNIVK 75

Query: 73 FIA--SHETLNEFVLITEFA 90
          +             LI E+ 
Sbjct: 76 YKGVCYSAGRRNLKLIMEYL 95

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  115 bits (291), Expect = 8e-29
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 33/233 (14%)

Query: 127 IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  L+      VA+K + +   + + L   ++E EI K L H NI+K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHS-TEEHLRDFEREIEILKSLQHDNIVK 106

Query: 183 FIA--SHETLNEFVLITEFAHMSLSNLLE----QRKKLSETICVQILSNLISALYYLHSN 236
           +             LI E+  +   +L +     ++++     +Q  S +   + YL + 
Sbjct: 107 YKGVCYSAGRRNLKLIMEY--LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERP 293
           R +HRDL  +N+L+  +    + DFG  + +          +       + APE + E  
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224

Query: 294 YDHTADLWSLGCIAYEI----------------HMGHPPFKTVSILHLIRLLK 330
           +   +D+WS G + YE+                 +G+     + + HLI LLK
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 22/80 (27%), Positives = 37/80 (46%), Gaps = 8/80 (10%)

Query: 17  IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
           +G+G+FG V    +  L+      VA+K + +   + + L   ++E EI K L H NI+K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHS-TEEHLRDFEREIEILKSLQHDNIVK 106

Query: 73  FIA--SHETLNEFVLITEFA 90
           +             LI E+ 
Sbjct: 107 YKGVCYSAGRRNLKLIMEYL 126

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  115 bits (290), Expect = 1e-28
 Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 18/215 (8%)

Query: 127 IGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G+FG V+K +       +K  VA+K + +   S K    +  E  +   + +P++ +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 183 FIA--SHETLNEFVLITEFA-HMSLSN-LLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            +      T+    LIT+      L + + E +  +     +     +   + YL   R+
Sbjct: 82  LLGICLTSTV---QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIAERPYDH 296
           +HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I  R Y H
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198

Query: 297 TADLWSLGCIAYEIHM-GHPPFKTVS---ILHLIR 327
            +D+WS G   +E+   G  P+  +    I  ++ 
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 18/80 (22%), Positives = 36/80 (45%), Gaps = 10/80 (12%)

Query: 17 IGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
          +G G+FG V+K +       +K  VA+K + +   S K    +  E  +   + +P++ +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 73 FIA--SHETLNEFVLITEFA 90
           +      T+    LIT+  
Sbjct: 82 LLGICLTSTV---QLITQLM 98

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  113 bits (284), Expect = 6e-28
 Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 29/230 (12%)

Query: 127 IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +GEG FGKV    +          VA+K + K+    +  S  KQE +I + L H +IIK
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 183 FIA--SHETLNEFVLITEFAHMSLSNLLE--QRKKLSETICVQILSNLISALYYLHSNRV 238
           +             L+ E+  + L +L +   R  +     +     +   + YLH+   
Sbjct: 98  YKGCCEDAGAASLQLVMEY--VPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHY 155

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYD 295
           +HRDL  +NVLL+ D +  + DFG A+++  G       +       + APE + E  + 
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 215

Query: 296 HTADLWSLGCIAYEI---------------HMGHPPFKTVSILHLIRLLK 330
           + +D+WS G   YE+                +       +++L L  LL+
Sbjct: 216 YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 23/80 (28%), Positives = 35/80 (43%), Gaps = 7/80 (8%)

Query: 17  IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
           +GEG FGKV    +          VA+K + K+    +  S  KQE +I + L H +IIK
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 73  FIA--SHETLNEFVLITEFA 90
           +             L+ E+ 
Sbjct: 98  YKGCCEDAGAASLQLVMEYV 117

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  113 bits (284), Expect = 8e-28
 Identities = 63/326 (19%), Positives = 120/326 (36%), Gaps = 78/326 (23%)

Query: 119 EKYQKICLIGEGSFGKVFKAI-HLDLKKTVALKII------SKSGRSGKELSSLKQECEI 171
            +Y+ +  +GEG+FGKV + I H    + VA+KI+       ++ R   E+  L+     
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR--SEIQVLEHLNTT 71

Query: 172 QKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK--LSETICVQILSNLISA 229
             +      ++ +   E      ++ E   +S  + +++            ++   +  +
Sbjct: 72  DPNSTF-RCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAM-------------------LCDFGFARSMAVG 270
           + +LHSN++ H DLKP+N+L  +                        + DFG   S    
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYD 187

Query: 271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL- 329
               +++  T  Y APE+I    +    D+WS+GCI  E ++G   F T      + ++ 
Sbjct: 188 DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247

Query: 330 --------------------KTQDVTFPSQVS-----------------------ETYKD 346
                                   + +    S                       E   D
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307

Query: 347 LVKGLLEKDASQRLSWPELLHHPLVK 372
           L++ +LE D ++R++  E L HP   
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFFD 333

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 20/93 (21%), Positives = 40/93 (43%), Gaps = 10/93 (10%)

Query: 9   EKYQKICLIGEGSFGKVFKAI-HLDLKKTVALKII------SKSGRSGKELSSLKQECEI 61
            +Y+ +  +GEG+FGKV + I H    + VA+KI+       ++ R   E+  L+     
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR--SEIQVLEHLNTT 71

Query: 62  QKHLAHPNIIKFIASHETLNEFVLITEFAHMSL 94
             +      ++ +   E      ++ E   +S 
Sbjct: 72  DPNSTF-RCVQMLEWFEHHGHICIVFELLGLST 103

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  112 bits (283), Expect = 2e-27
 Identities = 75/337 (22%), Positives = 124/337 (36%), Gaps = 94/337 (27%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 177
             +  I  +G+G+FG+V    H+D KK  A+K++    R+ K+   S K E +I K + +
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV----RNIKKYTRSAKIEADILKKIQN 90

Query: 178 -----PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRK------KLSETICVQILSNL 226
                 NI+K+       +   LI E    SL  ++ +        +  +  C++IL   
Sbjct: 91  DDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILK-- 148

Query: 227 ISALYYLHSNRVLHRDLKPQNVLLNKDGVAM-------------------------LCDF 261
             AL YL    + H DLKP+N+LL+                               L DF
Sbjct: 149 --ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206

Query: 262 GFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS 321
           G        +    SI  T  Y APE+I    +D ++D+WS GC+  E++ G   F+T  
Sbjct: 207 G---CATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263

Query: 322 ILHLIRL-------------------------------LKTQDVTFPSQVSETYK----- 345
            +  + +                               L   +        +  K     
Sbjct: 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323

Query: 346 ----------DLVKGLLEKDASQRLSWPELLHHPLVK 372
                     D +  +L+ D + R S  ELL H  ++
Sbjct: 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 12/34 (35%), Positives = 21/34 (61%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKII 42
            +  I  +G+G+FG+V    H+D KK  A+K++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV 68

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  112 bits (281), Expect = 2e-27
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 15/215 (6%)

Query: 127 IGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G+FG V+K +       +K  VA+K + +   S K    +  E  +   + +P++ +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 183 FIA--SHETLNEFVLITEFA-HMSLSN-LLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            +      T+    LIT+      L + + E +  +     +     +   + YL   R+
Sbjct: 82  LLGICLTSTV---QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIAERPYDH 296
           +HRDL  +NVL+       + DFG A+ +        +  G  P+ +MA E I  R Y H
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198

Query: 297 TADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLK 330
            +D+WS G   +E+   G  P+  +    +  +L+
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 18/80 (22%), Positives = 36/80 (45%), Gaps = 10/80 (12%)

Query: 17 IGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
          +G G+FG V+K +       +K  VA+K + +   S K    +  E  +   + +P++ +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 73 FIA--SHETLNEFVLITEFA 90
           +      T+    LIT+  
Sbjct: 82 LLGICLTSTV---QLITQLM 98

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  110 bits (278), Expect = 4e-27
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 14/206 (6%)

Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IG G  G+V         +    VA+K + K+G + ++      E  I     HPNII+ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 184 IASHETLNEFVLITEFAHMSLSNLLE----QRKKLSETICVQILSNLISALYYLHSNRVL 239
                     +++TE+  M   +L         + +    V +L  + + + YL     +
Sbjct: 116 EGVVTRGRLAMIVTEY--MENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL  +NVL++ + V  + DFG +R +        +  G  +   + APE IA R +  
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233

Query: 297 TADLWSLGCIAYEIHM-GHPPFKTVS 321
            +D+WS G + +E+   G  P+  ++
Sbjct: 234 ASDVWSFGVVMWEVLAYGERPYWNMT 259

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 19/76 (25%), Positives = 32/76 (42%), Gaps = 4/76 (5%)

Query: 17  IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
           IG G  G+V         +    VA+K + K+G + ++      E  I     HPNII+ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 74  IASHETLNEFVLITEF 89
                     +++TE+
Sbjct: 116 EGVVTRGRLAMIVTEY 131

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  110 bits (276), Expect = 5e-27
 Identities = 43/218 (19%), Positives = 89/218 (40%), Gaps = 16/218 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IG+G FG V+   ++D  +     A+K +       +++ +  +E  + + L HPN++  
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 184 IA-SHETLNEFVLITEFAHMSLSNLLE----QRKKLSETICVQILSNLISALYYLHSNRV 238
           I           ++  +  M   +LL+     ++  +    +     +   + YL   + 
Sbjct: 88  IGIMLPPEGLPHVLLPY--MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF 145

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLY----MAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR +    +                A E +    +
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF 205

Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKT 331
              +D+WS G + +E+   G PP++ +    L   L  
Sbjct: 206 TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 15/78 (19%), Positives = 34/78 (43%), Gaps = 5/78 (6%)

Query: 17  IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
           IG+G FG V+   ++D  +     A+K +       +++ +  +E  + + L HPN++  
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 74  IA-SHETLNEFVLITEFA 90
           I           ++  + 
Sbjct: 88  IGIMLPPEGLPHVLLPYM 105

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  110 bits (276), Expect = 8e-27
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 15/207 (7%)

Query: 127 IGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           IG G FG+V+K +        +  VA+K + K+G + K+      E  I    +H NII+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 183 FIASHETLNEFVLITEFAHMSLSNLL----EQRKKLSETICVQILSNLISALYYLHSNRV 238
                      ++ITE+  M    L     E+  + S    V +L  + + + YL +   
Sbjct: 111 LEGVISKYKPMMIITEY--MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 168

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYD 295
           +HRDL  +N+L+N + V  + DFG +R +        +  G  +   + APE I+ R + 
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228

Query: 296 HTADLWSLGCIAYEIHM-GHPPFKTVS 321
             +D+WS G + +E+   G  P+  +S
Sbjct: 229 SASDVWSFGIVMWEVMTYGERPYWELS 255

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 22/77 (28%), Positives = 36/77 (46%), Gaps = 5/77 (6%)

Query: 17  IGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
           IG G FG+V+K +        +  VA+K + K+G + K+      E  I    +H NII+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 73  FIASHETLNEFVLITEF 89
                      ++ITE+
Sbjct: 111 LEGVISKYKPMMIITEY 127

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  109 bits (275), Expect = 1e-26
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 15/215 (6%)

Query: 127 IGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G G FG V K +       +K  V +K+I +     +   ++         L H +I++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 183 FIA--SHETLNEFVLITEFA-HMSLSN-LLEQRKKLSETICVQILSNLISALYYLHSNRV 238
            +      +L    L+T++    SL + + + R  L   + +     +   +YYL  + +
Sbjct: 80  LLGLCPGSSL---QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM 136

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKG-TPL-YMAPELIAERPYDH 296
           +HR+L  +NVLL       + DFG A  +      L   +  TP+ +MA E I    Y H
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196

Query: 297 TADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLK 330
            +D+WS G   +E+   G  P+  + +  +  LL+
Sbjct: 197 QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 16/80 (20%), Positives = 33/80 (41%), Gaps = 10/80 (12%)

Query: 17 IGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
          +G G FG V K +       +K  V +K+I +     +   ++         L H +I++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 73 FIA--SHETLNEFVLITEFA 90
           +      +L    L+T++ 
Sbjct: 80 LLGLCPGSSL---QLVTQYL 96

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  108 bits (272), Expect = 2e-26
 Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 18/219 (8%)

Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IG G FG V+    LD        A+K +        E+S    E  I K  +HPN++  
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 184 IA-SHETLNEFVLITEFA-HMSLSN-LLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
           +     +    +++  +  H  L N +  +    +    +     +   + YL S + +H
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 151

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTSIKGTPL-YMAPELIAERP 293
           RDL  +N +L++     + DFG AR M      +V       +   P+ +MA E +  + 
Sbjct: 152 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---PVKWMALESLQTQK 208

Query: 294 YDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKT 331
           +   +D+WS G + +E+   G PP+  V+   +   L  
Sbjct: 209 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 18/78 (23%), Positives = 31/78 (39%), Gaps = 5/78 (6%)

Query: 17  IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
           IG G FG V+    LD        A+K +        E+S    E  I K  +HPN++  
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 74  IA-SHETLNEFVLITEFA 90
           +     +    +++  + 
Sbjct: 92  LGICLRSEGSPLVVLPYM 109

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  109 bits (274), Expect = 2e-26
 Identities = 50/230 (21%), Positives = 91/230 (39%), Gaps = 31/230 (13%)

Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +G+G FG V +A           VA+K++     +  ++    +E    K   HP++ K 
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 184 IA------SHETLNEFVLITEFAHMSLSNLL---------EQRKKLSETICVQILSNLIS 228
           +       +   L   ++I  F  M   +L          E    L     V+ + ++  
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPF--MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------VGTHMLTSIKGTPL 282
            + YL S   +HRDL  +N +L +D    + DFG +R +        G      +K    
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK---- 204

Query: 283 YMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKT 331
           ++A E +A+  Y   +D+W+ G   +EI   G  P+  +    +   L  
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 17/83 (20%), Positives = 33/83 (39%), Gaps = 9/83 (10%)

Query: 17  IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
           +G+G FG V +A           VA+K++     +  ++    +E    K   HP++ K 
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 74  IA------SHETLNEFVLITEFA 90
           +       +   L   ++I  F 
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFM 113

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  110 bits (276), Expect = 2e-26
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 12/205 (5%)

Query: 127 IGEGSFGKVFKAI---HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +G G FG+V           + +VA+K + K G + K+      E  I     HPNII+ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 184 IASHETLNEFVLI-TEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLH 240
                T ++ V+I TE+  + SL + L +   + +    V +L  + S + YL     +H
Sbjct: 112 EGVV-TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHT 297
           RDL  +N+L+N + V  + DFG  R +        + +G  +   + +PE IA R +   
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA 230

Query: 298 ADLWSLGCIAYEIHM-GHPPFKTVS 321
           +D+WS G + +E+   G  P+  +S
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMS 255

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 23/77 (29%), Positives = 36/77 (46%), Gaps = 6/77 (7%)

Query: 17  IGEGSFGKVFKAI---HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
           +G G FG+V           + +VA+K + K G + K+      E  I     HPNII+ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 74  IASHETLNEFVLI-TEF 89
                T ++ V+I TE+
Sbjct: 112 EGVV-TKSKPVMIVTEY 127

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  109 bits (275), Expect = 2e-26
 Identities = 48/218 (22%), Positives = 87/218 (39%), Gaps = 16/218 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IG G FG V+    LD        A+K +        E+S    E  I K  +HPN++  
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 184 IA-SHETLNEFVLITEFAHMSLSNLLE----QRKKLSETICVQILSNLISALYYLHSNRV 238
           +     +    +++  +  M   +L      +    +    +     +   + +L S + 
Sbjct: 156 LGICLRSEGSPLVVLPY--MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 213

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL----YMAPELIAERPY 294
           +HRDL  +N +L++     + DFG AR M          K        +MA E +  + +
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273

Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKT 331
              +D+WS G + +E+   G PP+  V+   +   L  
Sbjct: 274 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 18/78 (23%), Positives = 31/78 (39%), Gaps = 5/78 (6%)

Query: 17  IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
           IG G FG V+    LD        A+K +        E+S    E  I K  +HPN++  
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 74  IA-SHETLNEFVLITEFA 90
           +     +    +++  + 
Sbjct: 156 LGICLRSEGSPLVVLPYM 173

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  108 bits (272), Expect = 2e-26
 Identities = 54/252 (21%), Positives = 102/252 (40%), Gaps = 29/252 (11%)

Query: 127 IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +G+G+FG V    +  L       VA+K +  SG    +    ++E +I K L    I+K
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVK 88

Query: 183 FIA-SHETLNE-FVLITEFAHMSLSNLLE----QRKKLSETICVQILSNLISALYYLHSN 236
           +   S+    +   L+ E+  +    L +     R +L  +  +   S +   + YL S 
Sbjct: 89  YRGVSYGPGRQSLRLVMEY--LPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERP 293
           R +HRDL  +N+L+  +    + DFG A+ + +        +       + APE +++  
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206

Query: 294 YDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL 352
           +   +D+WS G + YE+           +    +   +         +S   + L +G  
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA----LSRLLELLEEG-- 260

Query: 353 EKDASQRLSWPE 364
                QRL  P 
Sbjct: 261 -----QRLPAPP 267

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 20/80 (25%), Positives = 36/80 (45%), Gaps = 8/80 (10%)

Query: 17  IGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
           +G+G+FG V    +  L       VA+K +  SG    +    ++E +I K L    I+K
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVK 88

Query: 73  FIA-SHETLNE-FVLITEFA 90
           +   S+    +   L+ E+ 
Sbjct: 89  YRGVSYGPGRQSLRLVMEYL 108

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  107 bits (269), Expect = 3e-26
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 21/216 (9%)

Query: 127 IGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V + ++   KK   VA+K++ K G    +   + +E +I   L +P I++ I
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 185 A--SHETLNEFVLITEFAHMSLSNLL----EQRKKLSETICVQILSNLISALYYLHSNRV 238
                E L   +L+ E        L      +R+++  +   ++L  +   + YL     
Sbjct: 77  GVCQAEAL---MLVMEM--AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYD 295
           +HRDL  +NVLL     A + DFG ++++       T+         + APE I  R + 
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191

Query: 296 HTADLWSLGCIAYEIHM-GHPPFKTVS---ILHLIR 327
             +D+WS G   +E    G  P+K +    ++  I 
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 23/78 (29%), Positives = 40/78 (51%), Gaps = 8/78 (10%)

Query: 17 IGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 74
          +G G+FG V + ++   KK   VA+K++ K G    +   + +E +I   L +P I++ I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 75 A--SHETLNEFVLITEFA 90
               E L   +L+ E A
Sbjct: 77 GVCQAEAL---MLVMEMA 91

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  107 bits (269), Expect = 3e-26
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)

Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 184 IA--SHETLNEFVLITEFAHMSLSNLLE----QRKKLSETICVQILSNLISALYYLHSNR 237
           I   +   +    +I E    +L  L      ++  L     +     L +AL YL S R
Sbjct: 82  IGVITENPV---WIIMEL--CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 136

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMA-----VGTHMLTSIKGTPLYMAPELIAER 292
            +HRD+  +NVL++ +    L DFG +R M        +     IK    +MAPE I  R
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFR 192

Query: 293 PYDHTADLWSLGCIAYEIHM-GHPPFKTVS 321
            +   +D+W  G   +EI M G  PF+ V 
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 49.9 bits (120), Expect = 7e-07
 Identities = 22/79 (27%), Positives = 34/79 (43%), Gaps = 9/79 (11%)

Query: 17 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
          IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 74 IA--SHETLNEFVLITEFA 90
          I   +   +    +I E  
Sbjct: 82 IGVITENPV---WIIMELC 97

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  107 bits (269), Expect = 4e-26
 Identities = 57/213 (26%), Positives = 109/213 (51%), Gaps = 16/213 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 185
           +G G +G+V++ +      TVA+K + K      E     +E  + K + HPN+++ +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE--EFLKEAAVMKEIKHPNLVQLLGV 77

Query: 186 -SHETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVL 239
            + E    F +ITEF  M+  NLL+      R+++S  + + + + + SA+ YL     +
Sbjct: 78  CTRE--PPFYIITEF--MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTA 298
           HRDL  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193

Query: 299 DLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLK 330
           D+W+ G + +EI   G  P+  + +  +  LL+
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 50.3 bits (121), Expect = 6e-07
 Identities = 21/76 (27%), Positives = 38/76 (50%), Gaps = 7/76 (9%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 75
          +G G +G+V++ +      TVA+K + K      E     +E  + K + HPN+++ +  
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE--EFLKEAAVMKEIKHPNLVQLLGV 77

Query: 76 -SHETLNEFVLITEFA 90
           + E    F +ITEF 
Sbjct: 78 CTRE--PPFYIITEFM 91

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  107 bits (270), Expect = 4e-26
 Identities = 52/229 (22%), Positives = 93/229 (40%), Gaps = 30/229 (13%)

Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +GEG FG V +            VA+K +     S +E+     E    K  +HPN+I+ 
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 184 IA-----SHETLNEFVLITEFAHMSLSNLLE---------QRKKLSETICVQILSNLISA 229
           +      S + + + ++I  F  M   +L             K +     ++ + ++   
Sbjct: 102 LGVCIEMSSQGIPKPMVILPF--MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------VGTHMLTSIKGTPLY 283
           + YL +   LHRDL  +N +L  D    + DFG ++ +        G      +K    +
Sbjct: 160 MEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK----W 215

Query: 284 MAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKT 331
           +A E +A+R Y   +D+W+ G   +EI   G  P+  V    +   L  
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 20/82 (24%), Positives = 35/82 (42%), Gaps = 8/82 (9%)

Query: 17  IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
           +GEG FG V +            VA+K +     S +E+     E    K  +HPN+I+ 
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 74  IA-----SHETLNEFVLITEFA 90
           +      S + + + ++I  F 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFM 123

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  107 bits (269), Expect = 4e-26
 Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 15/213 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K  +   K    VA+KI+            L  E  + + L +P I++ I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 185 A--SHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                E+    +L+ E A    L+  L+Q + + +   ++++  +   + YL  +  +HR
Sbjct: 85  GICEAESW---MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGT--PL-YMAPELIAERPYDHTA 298
           DL  +NVLL     A + DFG ++++    +   +      P+ + APE I    +   +
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 201

Query: 299 DLWSLGCIAYEIHM-GHPPFKTVS---ILHLIR 327
           D+WS G + +E    G  P++ +    +  ++ 
Sbjct: 202 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 21/78 (26%), Positives = 34/78 (43%), Gaps = 7/78 (8%)

Query: 17 IGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 74
          +G G+FG V K  +   K    VA+KI+            L  E  + + L +P I++ I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 75 A--SHETLNEFVLITEFA 90
               E+    +L+ E A
Sbjct: 85 GICEAESW---MLVMEMA 99

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  106 bits (266), Expect = 6e-26
 Identities = 52/213 (24%), Positives = 101/213 (47%), Gaps = 22/213 (10%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 185
           IG+G FG V    +      VA+K I K+  + +       E  +   L H N+++ +  
Sbjct: 29  IGKGEFGDVMLGDYRG--NKVAVKCI-KNDATAQAF---LAEASVMTQLRHSNLVQLLGV 82

Query: 186 -SHETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVL 239
              E    ++ +TE+  M+  +L++      R  L     ++   ++  A+ YL  N  +
Sbjct: 83  IVEEKGGLYI-VTEY--MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-LTSIKGTPLYMAPELIAERPYDHTA 298
           HRDL  +NVL+++D VA + DFG  +  +         +K    + APE + E+ +   +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTKS 195

Query: 299 DLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLK 330
           D+WS G + +EI+  G  P+  + +  ++  ++
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 18/76 (23%), Positives = 33/76 (43%), Gaps = 9/76 (11%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 75
          IG+G FG V    +      VA+K I K+  + +       E  +   L H N+++ +  
Sbjct: 29 IGKGEFGDVMLGDYRG--NKVAVKCI-KNDATAQAF---LAEASVMTQLRHSNLVQLLGV 82

Query: 76 -SHETLNEFVLITEFA 90
             E    ++ +TE+ 
Sbjct: 83 IVEEKGGLYI-VTEYM 97

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  109 bits (274), Expect = 1e-25
 Identities = 65/276 (23%), Positives = 131/276 (47%), Gaps = 28/276 (10%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G +G+V++ +      TVA+K + K      E     +E  + K + HPN+++ +  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE--EFLKEAAVMKEIKHPNLVQLLGV 284

Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
                 F +ITEF  M+  NLL+      R+++S  + + + + + SA+ YL     +HR
Sbjct: 285 CTREPPFYIITEF--MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           +L  +N L+ ++ +  + DFG +R M   T+   +    P+ + APE +A   +   +D+
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402

Query: 301 WSLGCIAYEIHM-GHPPFKTVS---ILHLI----RLLKTQDVTFPSQVSETYKDLVKGLL 352
           W+ G + +EI   G  P+  +    +  L+    R+ +      P    E   +L++   
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER------PEGCPEKVYELMRACW 456

Query: 353 EKDASQRLSWPEL---LHHPLVKDNLSSEIESQNNQ 385
           + + S R S+ E+         + ++S E+E +  +
Sbjct: 457 QWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK 492

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 20/74 (27%), Positives = 36/74 (48%), Gaps = 3/74 (4%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
           +G G +G+V++ +      TVA+K + K      E     +E  + K + HPN+++ +  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE--EFLKEAAVMKEIKHPNLVQLLGV 284

Query: 77  HETLNEFVLITEFA 90
                 F +ITEF 
Sbjct: 285 CTREPPFYIITEFM 298

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  105 bits (264), Expect = 1e-25
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 16/199 (8%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G FG V        K  VA+K I + G   +E     +E E+   L+HP +++    
Sbjct: 16  IGSGQFGLVHLGY-WLNKDKVAIKTI-REGAMSEE--DFIEEAEVMMKLSHPKLVQLYGV 71

Query: 187 HETLNEFVLITEFAHMSLSNLL----EQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
                   L+TEF  M    L      QR   +    + +  ++   + YL    V+HRD
Sbjct: 72  CLEQAPICLVTEF--MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTAD 299
           L  +N L+ ++ V  + DFG  R +    +  TS  GT     + +PE+ +   Y   +D
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSD 187

Query: 300 LWSLGCIAYEIHM-GHPPF 317
           +WS G + +E+   G  P+
Sbjct: 188 VWSFGVLMWEVFSEGKIPY 206

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 47.2 bits (113), Expect = 4e-06
 Identities = 22/73 (30%), Positives = 32/73 (43%), Gaps = 4/73 (5%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
          IG G FG V        K  VA+K I + G   +E     +E E+   L+HP +++    
Sbjct: 16 IGSGQFGLVHLGY-WLNKDKVAIKTI-REGAMSEE--DFIEEAEVMMKLSHPKLVQLYGV 71

Query: 77 HETLNEFVLITEF 89
                  L+TEF
Sbjct: 72 CLEQAPICLVTEF 84

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  109 bits (275), Expect = 2e-25
 Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 25/219 (11%)

Query: 127 IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 184 IA--SHETLNEFVLITEFAHMSLSNLL----EQRKKLSETICVQILSNLISALYYLHSNR 237
           I   +   +    +I E    +L  L      ++  L     +     L +AL YL S R
Sbjct: 457 IGVITENPV---WIIMEL--CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMA-----VGTHMLTSIKGTPLYMAPELIAER 292
            +HRD+  +NVL++ +    L DFG +R M        +     IK    +MAPE I  R
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFR 567

Query: 293 PYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLK 330
            +   +D+W  G   +EI M G  PF+ V    +I  ++
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 22/79 (27%), Positives = 34/79 (43%), Gaps = 9/79 (11%)

Query: 17  IGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
           IGEG FG V + I++  +     VA+K   K+  S        QE    +   HP+I+K 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 74  IA--SHETLNEFVLITEFA 90
           I   +   +    +I E  
Sbjct: 457 IGVITENPV---WIIMELC 472

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  105 bits (265), Expect = 2e-25
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 42/241 (17%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG FGKV KA    LK      TVA+K++ K   S  EL  L  E  + K + HP++I
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 182 KFIASHETLNEFVLITEFA-HMSLSN-LLEQRKKLSETICVQILSNLISALY-------- 231
           K   +       +LI E+A + SL   L E RK     +      N  S  +        
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 232 ---------------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------VG 270
                          YL   +++HRDL  +N+L+ +     + DFG +R +         
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR 209

Query: 271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
           +     +K    +MA E + +  Y   +D+WS G + +EI  +G  P+  +    L  LL
Sbjct: 210 SQGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265

Query: 330 K 330
           K
Sbjct: 266 K 266

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 30/79 (37%), Positives = 41/79 (51%), Gaps = 6/79 (7%)

Query: 17  IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 71
           +GEG FGKV KA    LK      TVA+K++ K   S  EL  L  E  + K + HP++I
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 72  KFIASHETLNEFVLITEFA 90
           K   +       +LI E+A
Sbjct: 90  KLYGACSQDGPLLLIVEYA 108

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  105 bits (264), Expect = 3e-25
 Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 42/240 (17%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A    L K     TVA+K++ K      E  +L  E ++  +L  H NI
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 181 IKFIASHETLNEFVLITEFAHMSLSNLLE----QRKKLSETICVQI----------LSNL 226
           +  + +       ++ITE+      +LL     +R     +               L +L
Sbjct: 90  VNLLGACTIGGPTLVITEY--CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 227 ISALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------VGTHM 273
           +S  Y       +L S   +HRDL  +N+LL    +  +CDFG AR +       V  + 
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILH-LIRLLKT 331
              +K    +MAPE I    Y   +D+WS G   +E+  +G  P+  + +     +++K 
Sbjct: 208 RLPVK----WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 24/80 (30%), Positives = 40/80 (50%), Gaps = 7/80 (8%)

Query: 17  IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 70
           +G G+FGKV +A    L K     TVA+K++ K      E  +L  E ++  +L  H NI
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 71  IKFIASHETLNEFVLITEFA 90
           +  + +       ++ITE+ 
Sbjct: 90  VNLLGACTIGGPTLVITEYC 109

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  105 bits (265), Expect = 3e-25
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 36/213 (16%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV +A    L K      VA+K++ KS     E  +L  E +I  HL  H NI
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 181 IKFIA--SHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSN-------LISAL 230
           +  +   +H      ++ITE+  +  L N L ++ ++ ET     ++N       L+   
Sbjct: 113 VNLLGACTHG--GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 231 Y-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------VGTHMLTSI 277
                   +L S   +HRD+  +NVLL    VA + DFG AR +       V  +    +
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230

Query: 278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEI 310
           K    +MAPE I +  Y   +D+WS G + +EI
Sbjct: 231 K----WMAPESIFDCVYTVQSDVWSYGILLWEI 259

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 11/82 (13%)

Query: 17  IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 70
           +G G+FGKV +A    L K      VA+K++ KS     E  +L  E +I  HL  H NI
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 71  IKFIA--SHETLNEFVLITEFA 90
           +  +   +H      ++ITE+ 
Sbjct: 113 VNLLGACTHG--GPVLVITEYC 132

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  105 bits (263), Expect = 4e-25
 Identities = 48/228 (21%), Positives = 97/228 (42%), Gaps = 28/228 (12%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G+GSFG V++ +   + K      VA+K +     S +E      E  + K     +++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 182 KFIASHETLNEFVLITEFA-HMSLSN-LLEQRKKLSETICVQILS--NLISALY------ 231
           + +         ++I E      L + L   R  ++    +   S   +I          
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 232 -YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTSIKGTPLYM 284
            YL++N+ +HRDL  +N ++ +D    + DFG  R +        G   L  ++    +M
Sbjct: 152 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----WM 207

Query: 285 APELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKT 331
           +PE + +  +   +D+WS G + +EI      P++ +S   ++R +  
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 14/64 (21%), Positives = 29/64 (45%), Gaps = 6/64 (9%)

Query: 17 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 71
          +G+GSFG V++ +   + K      VA+K +     S +E      E  + K     +++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 72 KFIA 75
          + + 
Sbjct: 92 RLLG 95

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  108 bits (271), Expect = 4e-25
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 14/205 (6%)

Query: 127 IGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V + ++   KK   VA+K++ K G    +   + +E +I   L +P I++ I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 185 A--SHETLNEFVLITEFAHM-SLSN-LLEQRKKLSETICVQILSNLISALYYLHSNRVLH 240
                E L   +L+ E A    L   L+ +R+++  +   ++L  +   + YL     +H
Sbjct: 403 GVCQAEAL---MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459

Query: 241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHT 297
           R+L  +NVLL     A + DFG ++++       T+         + APE I  R +   
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519

Query: 298 ADLWSLGCIAYEIHM-GHPPFKTVS 321
           +D+WS G   +E    G  P+K + 
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMK 544

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 23/79 (29%), Positives = 40/79 (50%), Gaps = 8/79 (10%)

Query: 17  IGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 74
           +G G+FG V + ++   KK   VA+K++ K G    +   + +E +I   L +P I++ I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 75  A--SHETLNEFVLITEFAH 91
                E L   +L+ E A 
Sbjct: 403 GVCQAEAL---MLVMEMAG 418

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  103 bits (260), Expect = 4e-25
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 16/203 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V        +  VA+K+I K G   ++     QE +    L+HP ++KF   
Sbjct: 16  LGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSED--EFFQEAQTMMKLSHPKLVKFYGV 71

Query: 187 HETLNEFVLITEFAHMSLSNLL----EQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
                   ++TE+  +S   LL       K L  +  +++  ++   + +L S++ +HRD
Sbjct: 72  CSKEYPIYIVTEY--ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRD 129

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTAD 299
           L  +N L+++D    + DFG  R +    +   S  GT     + APE+     Y   +D
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSKSD 187

Query: 300 LWSLGCIAYEIHM-GHPPFKTVS 321
           +W+ G + +E+   G  P+   +
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLYT 210

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 45.6 bits (109), Expect = 2e-05
 Identities = 20/73 (27%), Positives = 33/73 (45%), Gaps = 4/73 (5%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
          +G G FG V        +  VA+K+I K G   ++     QE +    L+HP ++KF   
Sbjct: 16 LGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSED--EFFQEAQTMMKLSHPKLVKFYGV 71

Query: 77 HETLNEFVLITEF 89
                  ++TE+
Sbjct: 72 CSKEYPIYIVTEY 84

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  105 bits (263), Expect = 4e-25
 Identities = 68/237 (28%), Positives = 109/237 (45%), Gaps = 37/237 (15%)

Query: 127 IGEGSFGKVFKAIHLDLKK-------TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V  A  + + K       TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALY------ 231
           NII  + +        +I E+A   +L   L  R+         I       +       
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161

Query: 232 ----------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------VGTHMLT 275
                     YL S + +HRDL  +NVL+ ++ V  + DFG AR +         T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221

Query: 276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLKT 331
            +K    +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK 
Sbjct: 222 PVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 27/82 (32%), Positives = 43/82 (52%), Gaps = 9/82 (10%)

Query: 17  IGEGSFGKVFKAIHLDLKK-------TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 68
           +GEG+FG+V  A  + + K       TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 69  NIIKFIASHETLNEFVLITEFA 90
           NII  + +        +I E+A
Sbjct: 102 NIINLLGACTQDGPLYVIVEYA 123

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  108 bits (270), Expect = 5e-25
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 14/198 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G+G FG+V+     +    VA+K + K G    E  +  QE ++ K L H  +++  A 
Sbjct: 275 LGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAV 330

Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
             +     ++TE+  MS  +LL+       K L     V + + + S + Y+     +HR
Sbjct: 331 V-SEEPIYIVTEY--MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 387

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL+  N+L+ ++ V  + DFG AR +    +        P+ + APE      +   +D+
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447

Query: 301 WSLGCIAYEIHM-GHPPF 317
           WS G +  E+   G  P+
Sbjct: 448 WSFGILLTELTTKGRVPY 465

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 19/74 (25%), Positives = 36/74 (48%), Gaps = 5/74 (6%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
           +G+G FG+V+     +    VA+K + K G    E  +  QE ++ K L H  +++  A 
Sbjct: 275 LGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAV 330

Query: 77  HETLNEFVLITEFA 90
             +     ++TE+ 
Sbjct: 331 V-SEEPIYIVTEYM 343

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  105 bits (264), Expect = 6e-25
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 10/198 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           IG G+FG+VF          VA+K   +        +   QE  I K  +HPNI++ I  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 187 HETLNEFVLITEF-AHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLK 244
                   ++ E          L  +  +L     +Q++ +  + + YL S   +HRDL 
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240

Query: 245 PQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLY----MAPELIAERPYDHTADL 300
            +N L+ +  V  + DFG +R  A G +   +  G         APE +    Y   +D+
Sbjct: 241 ARNCLVTEKNVLKISDFGMSREEADGVY--AASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 301 WSLGCIAYEIHM-GHPPF 317
           WS G + +E    G  P+
Sbjct: 299 WSFGILLWETFSLGASPY 316

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 51.1 bits (123), Expect = 5e-07
 Identities = 19/59 (32%), Positives = 27/59 (45%), Gaps = 1/59 (1%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 75
           IG G+FG+VF          VA+K   +        +   QE  I K  +HPNI++ I 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  106 bits (266), Expect = 8e-25
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 14/198 (7%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G+G FG+V+     +    VA+K + K G    E  +  QE ++ K L H  +++  A 
Sbjct: 192 LGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAV 247

Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
             +     ++TE+  MS  +LL+       K L     V + + + S + Y+     +HR
Sbjct: 248 V-SEEPIYIVTEY--MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL-YMAPELIAERPYDHTADL 300
           DL+  N+L+ ++ V  + DFG AR +    +        P+ + APE      +   +D+
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364

Query: 301 WSLGCIAYEIHM-GHPPF 317
           WS G +  E+   G  P+
Sbjct: 365 WSFGILLTELTTKGRVPY 382

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 19/74 (25%), Positives = 36/74 (48%), Gaps = 5/74 (6%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
           +G+G FG+V+     +    VA+K + K G    E  +  QE ++ K L H  +++  A 
Sbjct: 192 LGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAV 247

Query: 77  HETLNEFVLITEFA 90
             +     ++TE+ 
Sbjct: 248 V-SEEPIYIVTEYM 260

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  103 bits (258), Expect = 9e-25
 Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 28/219 (12%)

Query: 127 IGEGSFGKVFKAI---HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 183
           +GEG FG+V++ +   H   K  VA+K   K   +         E  I K+L HP+I+K 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 184 IA--SHETLNEFVLITEFAHMSLSNLL----EQRKKLSETICVQILSNLISALYYLHSNR 237
           I     E      +I E        L       +  L     V     +  A+ YL S  
Sbjct: 79  IGIIEEEPT---WIIMEL--YPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMA-----VGTHMLTSIKGTPLYMAPELIAER 292
            +HRD+  +N+L+       L DFG +R +        +     IK    +M+PE I  R
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSPESINFR 189

Query: 293 PYDHTADLWSLGCIAYEIHM-GHPPFKTVS---ILHLIR 327
            +   +D+W      +EI   G  PF  +    ++ ++ 
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 48.3 bits (116), Expect = 2e-06
 Identities = 24/79 (30%), Positives = 35/79 (44%), Gaps = 9/79 (11%)

Query: 17 IGEGSFGKVFKAI---HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF 73
          +GEG FG+V++ +   H   K  VA+K   K   +         E  I K+L HP+I+K 
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 74 IA--SHETLNEFVLITEFA 90
          I     E      +I E  
Sbjct: 79 IGIIEEEPT---WIIMELY 94

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  103 bits (258), Expect = 1e-24
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 24/218 (11%)

Query: 127 IGEGSFGKVFKAI-HLDLKKT--VALKIISKSGRSGKELSSLK--QECEIQKHLAHPNII 181
           +G+GSFG V +        KT  VA+K + K     +  +     +E      L H N+I
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 182 KFIA--SHETLNEFVLITEFAHMSLSNLL----EQRKKLSETICVQILSNLISALYYLHS 235
           +         +    ++TE     L +LL    + +         +    +   + YL S
Sbjct: 85  RLYGVVLTPPM---KMVTEL--APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAER 292
            R +HRDL  +N+LL    +  + DFG  R++          +   +   + APE +  R
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199

Query: 293 PYDHTADLWSLGCIAYEIHM-GHPPFKTVS---ILHLI 326
            + H +D W  G   +E+   G  P+  ++   ILH I
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 43.4 bits (103), Expect = 9e-05
 Identities = 20/81 (24%), Positives = 33/81 (40%), Gaps = 11/81 (13%)

Query: 17  IGEGSFGKVFKAI-HLDLKKT--VALKIISKSGRSGKELSSLK--QECEIQKHLAHPNII 71
           +G+GSFG V +        KT  VA+K + K     +  +     +E      L H N+I
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 72  KFIA--SHETLNEFVLITEFA 90
           +         +    ++TE A
Sbjct: 85  RLYGVVLTPPM---KMVTELA 102

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  104 bits (262), Expect = 1e-24
 Identities = 68/237 (28%), Positives = 108/237 (45%), Gaps = 37/237 (15%)

Query: 127 IGEGSFGKVFKAIHLDLKK-------TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG FG+V  A  + + K       TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALY------ 231
           NII  + +        +I E+A   +L   L  R+         I       +       
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 232 ----------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------VGTHMLT 275
                     YL S + +HRDL  +NVL+ ++ V  + DFG AR +         T+   
Sbjct: 208 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 267

Query: 276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLKT 331
            +K    +MAPE + +R Y H +D+WS G + +EI  +G  P+  + +  L +LLK 
Sbjct: 268 PVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 320

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 9/82 (10%)

Query: 17  IGEGSFGKVFKAIHLDLKK-------TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 68
           +GEG FG+V  A  + + K       TVA+K++ K   + K+LS L  E E+ K +  H 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 69  NIIKFIASHETLNEFVLITEFA 90
           NII  + +        +I E+A
Sbjct: 148 NIINLLGACTQDGPLYVIVEYA 169

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  104 bits (261), Expect = 2e-24
 Identities = 72/237 (30%), Positives = 110/237 (46%), Gaps = 37/237 (15%)

Query: 127 IGEGSFGKVFKAIHLDLKK-------TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 178
           +GEG+FG+V  A  + L K        VA+K++ KS  + K+LS L  E E+ K +  H 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALY------ 231
           NII  + +        +I E+A   +L   L+ R+            N    L       
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195

Query: 232 ----------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------VGTHMLT 275
                     YL S + +HRDL  +NVL+ +D V  + DFG AR +         T+   
Sbjct: 196 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 255

Query: 276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLKT 331
            +K    +MAPE + +R Y H +D+WS G + +EI  +G  P+  V +  L +LLK 
Sbjct: 256 PVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 308

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 9/82 (10%)

Query: 17  IGEGSFGKVFKAIHLDLKK-------TVALKIISKSGRSGKELSSLKQECEIQKHLA-HP 68
           +GEG+FG+V  A  + L K        VA+K++ KS  + K+LS L  E E+ K +  H 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 69  NIIKFIASHETLNEFVLITEFA 90
           NII  + +        +I E+A
Sbjct: 136 NIINLLGACTQDGPLYVIVEYA 157

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  102 bits (256), Expect = 2e-24
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 16/199 (8%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG V        +  VA+K+I K G   ++     +E ++  +L+H  +++    
Sbjct: 32  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSED--EFIEEAKVMMNLSHEKLVQLYGV 87

Query: 187 HETLNEFVLITEFAHMSLSNLL----EQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
                   +ITE+  M+   LL    E R +      +++  ++  A+ YL S + LHRD
Sbjct: 88  CTKQRPIFIITEY--MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 145

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTAD 299
           L  +N L+N  GV  + DFG +R +    +  TS  G+     +  PE++    +   +D
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSD 203

Query: 300 LWSLGCIAYEIHM-GHPPF 317
           +W+ G + +EI+  G  P+
Sbjct: 204 IWAFGVLMWEIYSLGKMPY 222

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 17/73 (23%), Positives = 33/73 (45%), Gaps = 4/73 (5%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
           +G G FG V        +  VA+K+I K G   ++     +E ++  +L+H  +++    
Sbjct: 32  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSED--EFIEEAKVMMNLSHEKLVQLYGV 87

Query: 77  HETLNEFVLITEF 89
                   +ITE+
Sbjct: 88  CTKQRPIFIITEY 100

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  103 bits (258), Expect = 2e-24
 Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 29/230 (12%)

Query: 126 LIGEGSFGKVFKAI--HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIK 182
           +IGEG+FG+V KA      L+   A+K + K   S  +      E E+   L  HPNII 
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 183 FIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQI---------LSNLISALY- 231
            + + E      L  E+A H +L + L + + L       I            L+     
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 232 ------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM---AVGTHMLTSIKGTPL 282
                 YL   + +HRDL  +N+L+ ++ VA + DFG +R        T     ++    
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR---- 206

Query: 283 YMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLKT 331
           +MA E +    Y   +D+WS G + +EI  +G  P+  ++   L   L  
Sbjct: 207 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 56.5 bits (137), Expect = 8e-09
 Identities = 26/78 (33%), Positives = 37/78 (47%), Gaps = 4/78 (5%)

Query: 16  LIGEGSFGKVFKAI--HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIK 72
           +IGEG+FG+V KA      L+   A+K + K   S  +      E E+   L  HPNII 
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 73  FIASHETLNEFVLITEFA 90
            + + E      L  E+A
Sbjct: 91  LLGACEHRGYLYLAIEYA 108

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  102 bits (257), Expect = 3e-24
 Identities = 63/242 (26%), Positives = 102/242 (42%), Gaps = 43/242 (17%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FGKV  A    + K      VA+K++ K      E  +L  E ++   L  H NI
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSHENI 111

Query: 181 IKFIASHETLNEFVLITEFA-HMSLSN-LLEQRKKLSETICVQI---------------L 223
           +  + +        LI E+  +  L N L  +R+K SE                      
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 224 SNLISALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------VG 270
            +L+   Y       +L     +HRDL  +NVL+    V  +CDFG AR +       V 
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 231

Query: 271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILH-LIRL 328
            +    +K    +MAPE + E  Y   +D+WS G + +EI  +G  P+  + +     +L
Sbjct: 232 GNARLPVK----WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 287

Query: 329 LK 330
           ++
Sbjct: 288 IQ 289

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 22/80 (27%), Positives = 35/80 (43%), Gaps = 7/80 (8%)

Query: 17  IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 70
           +G G+FGKV  A    + K      VA+K++ K      E  +L  E ++   L  H NI
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSHENI 111

Query: 71  IKFIASHETLNEFVLITEFA 90
           +  + +        LI E+ 
Sbjct: 112 VNLLGACTLSGPIYLIFEYC 131

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  102 bits (256), Expect = 3e-24
 Identities = 65/236 (27%), Positives = 104/236 (44%), Gaps = 37/236 (15%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 180
           +G G+FG+V +A    + K     TVA+K++ K G +  E  +L  E +I  H+  H N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 181 IKFIASHETLNE-FVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALY------- 231
           +  + +        ++I EF    +LS  L  ++       V         L        
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 232 ---------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------VGTHMLTS 276
                    +L S + +HRDL  +N+LL++  V  +CDFG AR +               
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213

Query: 277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILH-LIRLLK 330
           +K    +MAPE I +R Y   +D+WS G + +EI  +G  P+  V I     R LK
Sbjct: 214 LK----WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 23/81 (28%), Positives = 41/81 (50%), Gaps = 8/81 (9%)

Query: 17  IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 70
           +G G+FG+V +A    + K     TVA+K++ K G +  E  +L  E +I  H+  H N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 71  IKFIASHETLNE-FVLITEFA 90
           +  + +        ++I EF 
Sbjct: 94  VNLLGACTKPGGPLMVIVEFC 114

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  100 bits (251), Expect = 9e-24
 Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 22/215 (10%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 185
           +G G FG+V+     +    VA+K + K G    +  +   E  + K L H  +++  A 
Sbjct: 21  LGAGQFGEVWMGY-YNGHTKVAVKSL-KQGSMSPD--AFLAEANLMKQLQHQRLVRLYAV 76

Query: 186 -SHETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVL 239
            + E      +ITE+  M   +L++        KL+    + + + +   + ++     +
Sbjct: 77  VTQE---PIYIITEY--MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL+  N+L++      + DFG AR +    +  T+ +G      + APE I    +  
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTI 189

Query: 297 TADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLK 330
            +D+WS G +  EI   G  P+  ++   +I+ L+
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 44.9 bits (107), Expect = 3e-05
 Identities = 15/59 (25%), Positives = 27/59 (45%), Gaps = 4/59 (6%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA 75
          +G G FG+V+     +    VA+K + K G    +  +   E  + K L H  +++  A
Sbjct: 21 LGAGQFGEVWMGY-YNGHTKVAVKSL-KQGSMSPD--AFLAEANLMKQLQHQRLVRLYA 75

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  102 bits (255), Expect = 1e-23
 Identities = 51/265 (19%), Positives = 94/265 (35%), Gaps = 70/265 (26%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
            +Y  I  +G G F  V+ +  +  KK VA+K++ KS     E  +   E  + K + + 
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTE--TALDEIRLLKSVRNS 93

Query: 179 NIIKFIASH--ETLNEF----------VLITEFAHMSLSNLLEQ--RKKLSETICVQILS 224
           +          + L++F           ++ E     L   + +   + L      +I+ 
Sbjct: 94  DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 225 NLISALYYLHS-NRVLHRDLKPQNVLLN-------------------------------- 251
            ++  L YLH+  R++H D+KP+N+LL+                                
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213

Query: 252 -----------------KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
                            +     + D G A          T    T  Y + E++    Y
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQTRQYRSLEVLIGSGY 270

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKT 319
           +  AD+WS  C+A+E+  G   F+ 
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEP 295

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  102 bits (256), Expect = 2e-23
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 18/200 (9%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 186
           +G G FG+V+ A   +    VA+K + K G    E  +   E  + K L H  ++K  A 
Sbjct: 196 LGAGQFGEVWMAT-YNKHTKVAVKTM-KPGSMSVE--AFLAEANVMKTLQHDKLVKLHAV 251

Query: 187 HETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVLHR 241
             T     +ITEF  M+  +LL+     +  K      +   + +   + ++     +HR
Sbjct: 252 -VTKEPIYIITEF--MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308

Query: 242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTA 298
           DL+  N+L++   V  + DFG AR +    +  T+ +G      + APE I    +   +
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKS 366

Query: 299 DLWSLGCIAYEIHM-GHPPF 317
           D+WS G +  EI   G  P+
Sbjct: 367 DVWSFGILLMEIVTYGRIPY 386

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 23/74 (31%), Positives = 34/74 (45%), Gaps = 5/74 (6%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIAS 76
           +G G FG+V+ A   +    VA+K + K G    E  +   E  + K L H  ++K  A 
Sbjct: 196 LGAGQFGEVWMAT-YNKHTKVAVKTM-KPGSMSVE--AFLAEANVMKTLQHDKLVKLHAV 251

Query: 77  HETLNEFVLITEFA 90
             T     +ITEF 
Sbjct: 252 -VTKEPIYIITEFM 264

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  100 bits (251), Expect = 2e-23
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 44/216 (20%)

Query: 125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHLAHPNIIKF 183
            LIG G FGKV+K   L     VALK  +     G +E    + E E      HP+++  
Sbjct: 45  FLIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEF---ETEIETLSFCRHPHLVSL 100

Query: 184 IASHETLNEFVLITEF-AHMSLSNLL------------EQRKKLSETICVQILSNLISA- 229
           I   +  NE +LI ++  + +L   L            EQR +    IC+       +A 
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE----ICIG------AAR 150

Query: 230 -LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKGTPLYMAP 286
            L+YLH+  ++HRD+K  N+LL+++ V  + DFG ++       TH+ T +KGT  Y+ P
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP 210

Query: 287 ELIAERPYDHT------ADLWSLGCIAYEIHMGHPP 316
           E      Y         +D++S G + +E+      
Sbjct: 211 E------YFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 41.0 bits (97), Expect = 7e-04
 Identities = 21/61 (34%), Positives = 28/61 (45%), Gaps = 5/61 (8%)

Query: 15  CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHLAHPNIIKF 73
            LIG G FGKV+K   L     VALK  +     G +E    + E E      HP+++  
Sbjct: 45  FLIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEE---FETEIETLSFCRHPHLVSL 100

Query: 74  I 74
           I
Sbjct: 101 I 101

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  102 bits (255), Expect = 2e-23
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 26/215 (12%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 185
           IG+G FG V    +      VA+K I K+  + +       E  +   L H N+++ +  
Sbjct: 201 IGKGEFGDVMLGDYRG--NKVAVKCI-KNDATAQAF---LAEASVMTQLRHSNLVQLLGV 254

Query: 186 -SHETLNEFVLITEFAHMSLSNLLE-----QRKKLSETICVQILSNLISALYYLHSNRVL 239
              E      ++TE+  M+  +L++      R  L     ++   ++  A+ YL  N  +
Sbjct: 255 IVEEK-GGLYIVTEY--MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDH 296
           HRDL  +NVL+++D VA + DFG  +  +             L   + APE + E+ +  
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKLPVKWTAPEALREKKFST 365

Query: 297 TADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLK 330
            +D+WS G + +EI+  G  P+  + +  ++  ++
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 47.7 bits (114), Expect = 6e-06
 Identities = 18/76 (23%), Positives = 32/76 (42%), Gaps = 9/76 (11%)

Query: 17  IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA- 75
           IG+G FG V    +      VA+K I K+  + +       E  +   L H N+++ +  
Sbjct: 201 IGKGEFGDVMLGDYRG--NKVAVKCI-KNDATAQAF---LAEASVMTQLRHSNLVQLLGV 254

Query: 76  -SHETLNEFVLITEFA 90
              E      ++TE+ 
Sbjct: 255 IVEEK-GGLYIVTEYM 269

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 99.4 bits (248), Expect = 7e-23
 Identities = 50/228 (21%), Positives = 89/228 (39%), Gaps = 30/228 (13%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K +     S ++      E  I     H NI+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 182 KFIASHETLNE-FVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALY-------Y 232
           + I      +    ++ E  A   L + L + +          + +L+           Y
Sbjct: 138 RCIGV-SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLC---DFGFARSM------AVGTHMLTSIKGTPLY 283
           L  N  +HRD+  +N LL   G   +    DFG AR +        G   +  +K    +
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK----W 252

Query: 284 MAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           M PE   E  +    D WS G + +EI  +G+ P+ + S   ++  + 
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 15/64 (23%), Positives = 27/64 (42%), Gaps = 6/64 (9%)

Query: 17  IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 71
           +G G+FG+V++     +        VA+K +     S ++      E  I     H NI+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 72  KFIA 75
           + I 
Sbjct: 138 RCIG 141

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 30/228 (13%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +G G+FG+V++     +        VA+K +     S ++      E  I     H NI+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 182 KFIASHETLNE-FVLITEF-AHMSLSNLL-------EQRKKLSETICVQILSNLISALYY 232
           + I      +    ++ E  A   L + L        Q   L+    + +  ++     Y
Sbjct: 97  RCIGV-SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLC---DFGFARSM------AVGTHMLTSIKGTPLY 283
           L  N  +HRD+  +N LL   G   +    DFG AR +        G   +  +K    +
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----W 211

Query: 284 MAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLLK 330
           M PE   E  +    D WS G + +EI  +G+ P+ + S   ++  + 
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 15/64 (23%), Positives = 27/64 (42%), Gaps = 6/64 (9%)

Query: 17  IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 71
           +G G+FG+V++     +        VA+K +     S ++      E  I     H NI+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 72  KFIA 75
           + I 
Sbjct: 97  RCIG 100

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 51/241 (21%), Positives = 95/241 (39%), Gaps = 42/241 (17%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           IGEG+FG+VF+A    L        VA+K++ K   S    +  ++E  +     +PNI+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPNIV 113

Query: 182 KFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQI-----------------L 223
           K +          L+ E+  +  L+  L      +                         
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 224 SNLISALY-------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA------VG 270
           +  +           YL   + +HRDL  +N L+ ++ V  + DFG +R++         
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 233

Query: 271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHLIRLL 329
            +    I+    +M PE I    Y   +D+W+ G + +EI   G  P+  ++   +I  +
Sbjct: 234 GNDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 289

Query: 330 K 330
           +
Sbjct: 290 R 290

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 56.6 bits (137), Expect = 7e-09
 Identities = 20/64 (31%), Positives = 33/64 (51%), Gaps = 6/64 (9%)

Query: 17  IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 71
           IGEG+FG+VF+A    L        VA+K++ K   S    +  ++E  +     +PNI+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPNIV 113

Query: 72  KFIA 75
           K + 
Sbjct: 114 KLLG 117

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 43/216 (19%), Positives = 93/216 (43%), Gaps = 29/216 (13%)

Query: 127 IGEGSFGKVFKAI-------HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +G+G+F K+FK +           +  V LK++ K+ R+  E  S  +   +   L+H +
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE--SFFEAASMMSKLSHKH 73

Query: 180 IIKFIASHETLNEFVLITEFAHMSLSNLL----EQRKKLSETICVQILSNLISALYYLHS 235
           ++         +E +L+ EF  +   +L     + +  ++    +++   L +A+++L  
Sbjct: 74  LVLNYGVCVCGDENILVQEF--VKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131

Query: 236 NRVLHRDLKPQNVLLNKDG--------VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
           N ++H ++  +N+LL ++            L D G + ++     +   I     ++ PE
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP----WVPPE 187

Query: 288 LIAE-RPYDHTADLWSLGCIAYEIHM-GHPPFKTVS 321
            I   +  +   D WS G   +EI   G  P   + 
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 19/81 (23%), Positives = 38/81 (46%), Gaps = 9/81 (11%)

Query: 17 IGEGSFGKVFKAI-------HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
          +G+G+F K+FK +           +  V LK++ K+ R+  E  S  +   +   L+H +
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE--SFFEAASMMSKLSHKH 73

Query: 70 IIKFIASHETLNEFVLITEFA 90
          ++         +E +L+ EF 
Sbjct: 74 LVLNYGVCVCGDENILVQEFV 94

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 41/216 (18%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GE  FGKV+K              VA+K + K    G      + E  ++  L HPN++
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 182 KFIA--SHETLNEFVLITEFAHMSLSNLLE-------------------QRKKLSETICV 220
             +   + +      +I  +   S  +L E                    +  L     V
Sbjct: 76  CLLGVVTKD--QPLSMIFSY--CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 221 QILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHML 274
            +++ + + + YL S+ V+H+DL  +NVL+       + D G  R +       +  + L
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEI 310
             I+    +MAPE I    +   +D+WS G + +E+
Sbjct: 192 LPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 53.4 bits (129), Expect = 6e-08
 Identities = 17/64 (26%), Positives = 27/64 (42%), Gaps = 6/64 (9%)

Query: 17 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 71
          +GE  FGKV+K              VA+K + K    G      + E  ++  L HPN++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 72 KFIA 75
            + 
Sbjct: 76 CLLG 79

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 39/214 (18%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG+FGKVF A   +L        VA+K + K   S       ++E E+   L H +I+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEA-SESARQDFQREAELLTMLQHQHIV 106

Query: 182 KFIASHETLNE-FVLITEFAHMSLSNLLE------------------QRKKLSETICVQI 222
           +F     T     +++ E+  M   +L                        L     + +
Sbjct: 107 RFFGVC-TEGRPLLMVFEY--MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTS 276
            S + + + YL     +HRDL  +N L+ +  V  + DFG +R +       VG   +  
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223

Query: 277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEI 310
           I+    +M PE I  R +   +D+WS G + +EI
Sbjct: 224 IR----WMPPESILYRKFTTESDVWSFGVVLWEI 253

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 21/64 (32%), Positives = 32/64 (50%), Gaps = 7/64 (10%)

Query: 17  IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 71
           +GEG+FGKVF A   +L        VA+K + K   S       ++E E+   L H +I+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEA-SESARQDFQREAELLTMLQHQHIV 106

Query: 72  KFIA 75
           +F  
Sbjct: 107 RFFG 110

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 94.2 bits (234), Expect = 3e-21
 Identities = 78/326 (23%), Positives = 128/326 (39%), Gaps = 57/326 (17%)

Query: 17  IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNI 70
           +G G+FG+V +A    + K     TVA+K++ K G +  E  +L  E +I  H+  H N+
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 71  IKFI-ASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGE 129
           +  + A  +     ++I EF       L   +  +        K+ GA  +         
Sbjct: 89  VNLLGACTKPGGPLMVIVEF--CKFGNLST-YLRSKRNEFVPYKTKGARFR--------- 136

Query: 130 GSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET 189
                   AI +DLK+ +     S+S  S   +                       S   
Sbjct: 137 -QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK------------------SLSDVE 177

Query: 190 LNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVL 249
             E         ++L +L+            Q+       + +L S + +HRDL  +N+L
Sbjct: 178 EEEAPEDLYKDFLTLEHLI--------CYSFQV----AKGMEFLASRKCIHRDLAARNIL 225

Query: 250 LNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPL---YMAPELIAERPYDHTADLWSLGCI 306
           L++  V  +CDFG AR +              L   +MAPE I +R Y   +D+WS G +
Sbjct: 226 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284

Query: 307 AYEI-HMGHPPFKTVSILH-LIRLLK 330
            +EI  +G  P+  V I     R LK
Sbjct: 285 LWEIFSLGASPYPGVKIDEEFCRRLK 310

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 36/213 (16%)

Query: 127 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 181
           +GEG+FGKVF A   +L        VA+K + K   +       ++E E+  +L H +I+
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDP-TLAARKDFQREAELLTNLQHEHIV 80

Query: 182 KFIASHETLNE-FVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALY-------- 231
           KF        +  +++ E+  H  L+  L      +  +           L         
Sbjct: 81  KFYGVC-GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 232 --------YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM------AVGTHMLTSI 277
                   YL S   +HRDL  +N L+  + +  + DFG +R +       VG H +  I
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEI 310
           +    +M PE I  R +   +D+WS G I +EI
Sbjct: 200 R----WMPPESIMYRKFTTESDVWSFGVILWEI 228

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 50.7 bits (122), Expect = 5e-07
 Identities = 21/64 (32%), Positives = 33/64 (51%), Gaps = 7/64 (10%)

Query: 17 IGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNII 71
          +GEG+FGKVF A   +L        VA+K + K   +       ++E E+  +L H +I+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDP-TLAARKDFQREAELLTNLQHEHIV 80

Query: 72 KFIA 75
          KF  
Sbjct: 81 KFYG 84

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 33/211 (15%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSL------KQECEIQKHLAHPN 179
            +GEG FG V+K   ++   TVA+K ++    +  ++++        QE ++     H N
Sbjct: 38  KMGEGGFGVVYKGY-VN-NTTVAVKKLA----AMVDITTEELKQQFDQEIKVMAKCQHEN 91

Query: 180 IIKFIASHETLNEFVLITEFAHM---SLSNLL---EQRKKLSETICVQILSNLISALYYL 233
           +++ +      ++  L+  +  M   SL + L   +    LS  +  +I     + + +L
Sbjct: 92  LVELLGFSSDGDDLCLVYVY--MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKGTPLYMAPELIAE 291
           H N  +HRD+K  N+LL++   A + DFG AR+      T M + I GT  YMAPE    
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE---- 205

Query: 292 RPYDHT-----ADLWSLGCIAYEIHMGHPPF 317
                      +D++S G +  EI  G P  
Sbjct: 206 --ALRGEITPKSDIYSFGVVLLEIITGLPAV 234

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 27/212 (12%)

Query: 125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
            ++G G FGKV+K   L     VA+K + +    G E    + E E+     H N+++  
Sbjct: 36  NILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGE-LQFQTEVEMISMAVHRNLLRLR 93

Query: 185 ASHETLNEFVLITEFAHMSLSNL-------LEQRKKLSETICVQILSNLISALYYLH--S 235
               T  E +L+  +  M+  ++        E +  L      +I       L YLH   
Sbjct: 94  GFCMTPTERLLVYPY--MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151

Query: 236 N-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG-THMLTSIKGTPLYMAPELIAERP 293
           + +++HRD+K  N+LL+++  A++ DFG A+ M    TH+ T+++GT  ++APE      
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE------ 205

Query: 294 YDHT------ADLWSLGCIAYEIHMGHPPFKT 319
           Y  T       D++  G +  E+  G   F  
Sbjct: 206 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 33/190 (17%), Positives = 66/190 (34%), Gaps = 25/190 (13%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIIS----KSGR-----------SGKELSS 164
           ++     IG G FG ++ A   +  +  A  ++     ++G            + K+   
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 165 LKQECEIQKHLAHPNIIKFIASHETLNEF-VLITEFAHMSLSNLLEQRKKLSETICVQIL 223
              E +   +L  P       +      +  ++ E   + L  +  Q     ++  +Q+ 
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157

Query: 224 SNLISALYYLHSNRVLHRDLKPQNVLL--NKDGVAMLCDFGFARS-MAVGTHM------L 274
             ++  L Y+H N  +H D+K  N+LL         L D+G +      G H        
Sbjct: 158 IRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217

Query: 275 TSIKGTPLYM 284
               GT  + 
Sbjct: 218 KGHNGTIEFT 227

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 22/201 (10%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH- 177
            +Y+    IG GSFG ++    +   + VA+K+     +       L  E +I K +   
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGG 64

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLE-QRKKLSETICVQILSNLISALYYLHSN 236
             I          +  V++ E    SL +L     +K S    + +   +IS + Y+HS 
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 237 RVLHRDLKPQNVLL---NKDGVAMLCDFGFA---RSMAVGTHML----TSIKGTPLYM-- 284
             +HRD+KP N L+    K  +  + DFG A   R      H+      ++ GT  Y   
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184

Query: 285 -APELIAERPYDHTADLWSLG 304
                I +   D   DL SLG
Sbjct: 185 NTHLGIEQSRRD---DLESLG 202

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 24/221 (10%)

Query: 111 MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE 170
           ME   G   K++    IG GSFG+++   ++   + VA+K+ +   +       L  E +
Sbjct: 1   MEPRVG--NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESK 54

Query: 171 IQKHLA-HPNIIKFIASHETLNEFVLITEFAHMSLSNLLE-QRKKLSETICVQILSNLIS 228
           I + L     I          +  VL+ +    SL +L     +KLS    + +   +I+
Sbjct: 55  IYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFA---RSMAVGTHML----TSIK 278
            + ++HS   LHRD+KP N L+          + DFG A   R  +   H+      ++ 
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174

Query: 279 GTPLYM---APELIAERPYDHTADLWSLGCIAYEIHMGHPP 316
           GT  Y        I +   D   DL SLG +      G  P
Sbjct: 175 GTARYASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSLP 212

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 7/98 (7%)

Query: 1  MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE 60
          ME   G   K++    IG GSFG+++   ++   + VA+K+ +   +       L  E +
Sbjct: 1  MEPRVG--NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESK 54

Query: 61 IQKHLA-HPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
          I + L     I          +  VL+ +    SL  L
Sbjct: 55 IYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDL 92

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 18/180 (10%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH- 177
             Y+    IGEGSFG +F+  +L   + VA+K   +   +      L+ E    K LA  
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGC 65

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSN 236
             I       +     VL+ +    SL +LL+   +K S          +++ +  +H  
Sbjct: 66  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 237 RVLHRDLKPQNVLLNKDG-----VAMLCDFGFA---RSMAVGTHML----TSIKGTPLYM 284
            +++RD+KP N L+ +       +  + DFG     R      H+      ++ GT  YM
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 33/194 (17%), Positives = 72/194 (37%), Gaps = 28/194 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHL--------DLKKTVALKIISKSGRSGKELSSLKQECE 170
            +++        + G +++A             K+  +LK+ +K GR   E +  ++  +
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 171 I--------QKHLAHPNIIKFIASHETLNEF-VLITEFAHMSLSNLLEQ--RKKLSETIC 219
                            I   +      +++  L+      SL + L+   +  LSE   
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161

Query: 220 VQILSNLISALYYLHSNRVLHRDLKPQNVLL--NKDGVAMLCDFGFARS-MAVGTHM--- 273
           +Q+   L+ AL +LH N  +H ++  +N+ +         L  +GFA      G H+   
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221

Query: 274 ---LTSIKGTPLYM 284
               +  +G   ++
Sbjct: 222 EGSRSPHEGDLEFI 235

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 77.8 bits (192), Expect = 8e-16
 Identities = 43/179 (24%), Positives = 71/179 (39%), Gaps = 18/179 (10%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH-P 178
            ++    IG G+FG++    +L   + VA+K+     R+      L  E    K L    
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGD 65

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLE-QRKKLSETICVQILSNLISALYYLHSNR 237
            I +            ++ E    SL +L +   +  S    + I   LIS + Y+HS  
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125

Query: 238 VLHRDLKPQNVLL-----NKDGVAMLCDFGFA---RSMAVGTHML----TSIKGTPLYM 284
           +++RD+KP+N L+         V  + DF  A          H+      S+ GT  YM
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 77.2 bits (189), Expect = 1e-15
 Identities = 51/260 (19%), Positives = 80/260 (30%), Gaps = 62/260 (23%)

Query: 104 NHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKII------SKSGR 157
           +   PV         EK Q+   IGEG FG+VF+ I       VA+KII        +G 
Sbjct: 6   SQKGPVPFS-HCLPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGS 62

Query: 158 SGKELSSLKQECEIQKHLA---------HPNIIKFIASH--------------------- 187
             K    +  E  I K L+             I   + H                     
Sbjct: 63  HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122

Query: 188 ---------ETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN-R 237
                       ++  ++ EF    +     + K  S      IL  L ++L    ++ R
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR 182

Query: 238 VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHT 297
             HRDL   NVLL K  +  L      +S  + +  L              ++   Y  +
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQ-------------VSIIDYTLS 229

Query: 298 ADLWSLGCIAYEIHMGHPPF 317
                   +  ++ M    F
Sbjct: 230 RLERDGIVVFCDVSMDEDLF 249

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 46.4 bits (109), Expect = 1e-05
 Identities = 25/86 (29%), Positives = 33/86 (38%), Gaps = 17/86 (19%)

Query: 7   ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKII------SKSGRSGKELSSLKQECE 60
             EK Q+   IGEG FG+VF+ I       VA+KII        +G   K    +  E  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 61  IQKHLA---------HPNIIKFIASH 77
           I K L+             I   + H
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVH 101

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 38/211 (18%), Positives = 66/211 (31%), Gaps = 40/211 (18%)

Query: 108 PVKMEKSNGALEKYQKICLIGEGSFGKVFKAI-----HLDLKKTVALKIISKSGRSGKEL 162
            V    ++ A   ++    IG+G FG ++ A       +       +K+           
Sbjct: 24  AVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN------ 77

Query: 163 SSLKQECEIQKHLAHPNIIKFIASHETLNEF-------------------VLITEFAHMS 203
             L  E +  +  A P  I+       L                       +I +     
Sbjct: 78  GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD 137

Query: 204 LSNLLE-QRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN--KDGVAMLCD 260
           L  + E   K+ S    +Q+   ++  L Y+H +  +H D+K  N+LLN        L D
Sbjct: 138 LQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVD 197

Query: 261 FGFA---RSMAVGTHML----TSIKGTPLYM 284
           +G A       V             GT  + 
Sbjct: 198 YGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.6 bits (133), Expect = 3e-08
 Identities = 87/597 (14%), Positives = 165/597 (27%), Gaps = 172/597 (28%)

Query: 1   MEKSNGALE-KYQKICLIGEGSFGKVFKAIH-LDLKKTV----ALKIISKSGRSGKELSS 54
           M+   G  + +Y+ I  + E +F   F      D+ K++     +  I  S  +      
Sbjct: 7   MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66

Query: 55  L------KQECEIQKHLA---HPNIIKFIAS--HETLNEFVLITEFAHMSLSKL--GEPW 101
           L      KQE  +QK +      N  KF+ S       +  ++T        +L      
Sbjct: 67  LFWTLLSKQEEMVQKFVEEVLRINY-KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125

Query: 102 F--HNHCQPVKMEKSNGALEKYQK---ICLIGEGSFGKVFKAIHL----DLKKTVALKI- 151
           F  +N  +     K   AL + +    + + G    GK + A+ +     ++  +  KI 
Sbjct: 126 FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF 185

Query: 152 -ISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQ 210
            ++         + L    E+ + L +     + +  +  +   L        L  LL+ 
Sbjct: 186 WLN-LKNCNSPETVL----EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240

Query: 211 RKK---L--------SETI------CVQIL--SNLISALYYLHSNRVLHRDLKPQNVLLN 251
           +     L        ++        C +IL  +       +L +    H  L   ++ L 
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSC-KILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299

Query: 252 KDGVAMLCDFGFARSMAVGTHMLTS--IKGTPLYMAPELIAERPYDH--TADLWSLGCIA 307
            D V  L      + +      L    +   P  ++  +IAE   D   T D W      
Sbjct: 300 PDEVKSL----LLKYLDCRPQDLPREVLTTNPRRLS--IIAESIRDGLATWDNWK----- 348

Query: 308 YEIHMGHPPFKTVSILHLIRL-LKTQDVTFPSQVSETYKDLVKGLLEKDA---SQRLS-- 361
              H+      T+     I   L   +   P++  + +  L   +    A   +  LS  
Sbjct: 349 ---HVNCDKLTTI-----IESSLNVLE---PAEYRKMFDRLS--VFPPSAHIPTILLSLI 395

Query: 362 WPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSITTIVESDSDENEEWVMFL 421
           W ++                                               +       +
Sbjct: 396 WFDV--------------------------------------------IKSDVMV---VV 408

Query: 422 RTCLHKLLAGSDSDTASCERSFILMLITSLRCQSCVVLGLITHILVVLIMKHEDSAHLRE 481
                  L              I  +   L+ +      L  H  +V      D  ++ +
Sbjct: 409 NKLHKYSLVEKQPKE---STISIPSIYLELKVKLENEYAL--HRSIV------DHYNIPK 457

Query: 482 CLFVFYYYYFSDSEDDMYSDADLSSDDDEDKIYDEDLVLSHSSYSTYLKKKAKREAY 538
               F          D Y              Y      SH  +  +LK     E  
Sbjct: 458 T---FDSDDLIPPYLDQY-------------FY------SHIGH--HLKNIEHPERM 490

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 2e-04
 Identities = 71/511 (13%), Positives = 148/511 (28%), Gaps = 174/511 (34%)

Query: 8   LEKYQKICLIGEGSFGK--------------------VF-------KAIHLDLKKTVAL- 39
           L   + + + G    GK                    +F        +    L+    L 
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL 206

Query: 40  KIISKSGRSGKELS-SLKQECE--------IQKHLAHPN---IIKFIASHETLNEF---- 83
             I  +  S  + S ++K            + K   + N   ++  + + +  N F    
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC 266

Query: 84  -VLI-TEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHL 141
            +L+ T F  ++         H     + ++  +  L   +      +    K       
Sbjct: 267 KILLTTRFKQVTDFLSAATTTH-----ISLDHHSMTLTPDE-----VKSLLLKYLDCRPQ 316

Query: 142 DLKKTV------ALKIISKSGRSG-------KELSSLKQECEIQKHLAH--PNIIKFIAS 186
           DL + V       L II++S R G       K ++  K    I+  L    P   +    
Sbjct: 317 DLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR--KM 374

Query: 187 HETLNEF---VLITEFAHMSLSNLLEQRKKLSETICVQILSNLI--SAL--------YYL 233
            + L+ F     I     + LS +      + ++  + +++ L   S +          +
Sbjct: 375 FDRLSVFPPSAHIPT---ILLSLIWFD---VIKSDVMVVVNKLHKYSLVEKQPKESTISI 428

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAE 291
            S   ++ +LK +      +    L             H  ++        Y  P+    
Sbjct: 429 PS---IYLELKVKL-----ENEYAL-------------HRSIVDH------YNIPK---T 458

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDL--VK 349
              D     +      Y  H+GH         HL  +   + +T    V   + D   ++
Sbjct: 459 FDSDDLIPPYLDQYF-YS-HIGH---------HLKNIEHPERMTLFRMV---FLDFRFLE 504

Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYCDKRRGSRKSITTIVES 409
             +  D++   +   +L       N   +++           Y       +  I      
Sbjct: 505 QKIRHDSTAWNASGSIL-------NTLQQLKF----------Y-------KPYIC----- 535

Query: 410 DSDENEEWVM-----FLRTCLHKLLAGSDSD 435
           D+D   E ++     FL      L+    +D
Sbjct: 536 DNDPKYERLVNAILDFLPKIEENLICSKYTD 566

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	549
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.67
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.62
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.61
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.58
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.58
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.56
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.56
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.54
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.53
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.51
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.51
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.51
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.49
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.43
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.42
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.39
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.38
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.38
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.34
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.31
3niz_A	311	Rhodanese family protein; structural genomics, str	99.31
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.3
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.3
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.29
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.29
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.29
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.29
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.29
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.28
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.27
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.26
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.25
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.25
3uqc_A	286	Probable conserved transmembrane protein; structur	99.25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.24
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.24
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.24
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.24
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.23
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.23
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.22
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.21
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.2
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.2
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.2
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.2
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.2
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.2
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.2
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.19
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.19
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.19
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.18
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.17
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.16
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.16
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.16
3bhy_A	283	Death-associated protein kinase 3; death associate	99.16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.15
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.15
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.15
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.14
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.14
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.14
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.14
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.13
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.13
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.13
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.12
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.12
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.12
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.12
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.12
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.12
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.11
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.11
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.11
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.11
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.11
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.11
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.1
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.1
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.1
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.1
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.1
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.1
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.1
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.1
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.1
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.1
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.1
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.1
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.09
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.09
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.09
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.09
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.09
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.09
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.08
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.08
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.08
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.08
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.08
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.08
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.08
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.08
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.07
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.07
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.07
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.07
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.07
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.07
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.06
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.06
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.06
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.06
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.06
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.06
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.06
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.06
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.05
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.05
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.04
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.04
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.04
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.04
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.04
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.03
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.03
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.03
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.03
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.01
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.01
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.01
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.01
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.01
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.01
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	98.99
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.98
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	98.98
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	98.98
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	98.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	98.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	98.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	98.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	98.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	98.97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	98.96
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.96
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	98.96
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	98.96
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	98.95
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	98.95
3pls_A	298	Macrophage-stimulating protein receptor; protein k	98.95
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	98.94
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	98.94
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	98.94
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	98.94
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	98.93
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	98.93
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	98.92
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	98.92
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	98.91
3q4u_A	301	Activin receptor type-1; structural genomics conso	98.91
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	98.91
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	98.91
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	98.9
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	98.9
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	98.89
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	98.89
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	98.89
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	98.89
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	98.88
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	98.88
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	98.88
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	98.87
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	98.86
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	98.86
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	98.86
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	98.85
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	98.84
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	98.84
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	98.84
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	98.83
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	98.83
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	98.83
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	98.82
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.82
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	98.82

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1e-63  Score=503.31  Aligned_cols=259  Identities=33%  Similarity=0.522  Sum_probs=222.8

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ..+++|++++.||+|+||+||+|.++.+|+.||+|++.+.... ......+.+|+++++.++|||||++++++++.+.+|
T Consensus        10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   89 (275)
T 3hyh_A           10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII   89 (275)
T ss_dssp             ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            3467899999999999999999999999999999999875432 233567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        195 LITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       195 iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||||||+|+|.+++.+++.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus        90 ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~  168 (275)
T 3hyh_A           90 MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFL  168 (275)
T ss_dssp             EEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-Ccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999876543 334


Q ss_pred             cccCCCCcccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhch
Q psy18060        275 TSIKGTPLYMAPELIAERPY-DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y-~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ++.+||+.|||||++.+..| +.++|||||||++|+|+||++||.+.+.....+.+..+.+.+|+.+|+++++||.+||+
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  248 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLI  248 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSC
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence            56789999999999998876 57999999999999999999999999999999999999999999999999999999999


Q ss_pred             hCcCCCCCHHHHhcCcccCccc
Q psy18060        354 KDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +||.+|||++|+++||||+...
T Consensus       249 ~dP~~R~s~~eil~hpw~k~~~  270 (275)
T 3hyh_A          249 VNPLNRISIHEIMQDDWFKVDL  270 (275)
T ss_dssp             SSGGGSCCHHHHHHCHHHHTTC
T ss_pred             CChhHCcCHHHHHcCcccccCC
Confidence            9999999999999999997544

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.6e-64  Score=511.66  Aligned_cols=265  Identities=29%  Similarity=0.490  Sum_probs=242.9

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ...++|++++.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|++++++++|||||++++++++.+.+|
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            345789999999999999999999999999999999976421 1223567899999999999999999999999999999


Q ss_pred             EEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc--
Q psy18060        195 LITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--  271 (549)
Q Consensus       195 iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~--  271 (549)
                      ||||||.| +|.++|.+.+.++|.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+....  
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            99999985 999999999999999999999999999999999999999999999999999999999999999875432  


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHh
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      ...++.+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+..++...|..+.+.+|+.+|+++++||.+|
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~l  268 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL  268 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHH
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHH
Confidence            23467799999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             chhCcCCCCCHHH------HhcCcccCcccchhhh
Q psy18060        352 LEKDASQRLSWPE------LLHHPLVKDNLSSEIE  380 (549)
Q Consensus       352 L~~dP~~Rps~~e------lL~Hpw~~~~~~~~~~  380 (549)
                      |++||.+|||++|      |++||||++..+..+.
T Consensus       269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  303 (311)
T ss_dssp             SCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             ccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence            9999999999987      6899999987665553

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.4e-63  Score=512.71  Aligned_cols=259  Identities=28%  Similarity=0.516  Sum_probs=233.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+..........+.+|++++++++|||||++++++++.+.+|||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            46899999999999999999999999999999999988777777788899999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        197 TEFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      ||||. |+|.++|..++  .++|.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+........
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence            99998 59999997653  5799999999999999999999999999999999999999999999999999887654444


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHhc
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dlI~~~L  352 (549)
                      .++.+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..+++..+..+.. .+|..+|+++++||.+||
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L  261 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF  261 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence            5667899999999999999999999999999999999999999999999999988887765 466789999999999999


Q ss_pred             hhCcCCCCCHHHHhcCcccCccc
Q psy18060        353 EKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       353 ~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ++||.+|||++|+|+||||+...
T Consensus       262 ~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          262 KRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             CSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             cCChhHCcCHHHHhcCHHhhcCC
Confidence            99999999999999999997644

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.2e-63  Score=504.23  Aligned_cols=263  Identities=27%  Similarity=0.438  Sum_probs=232.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEc---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .++|++++.||+|+||+||+|++.   .+++.||+|++.+..........+.+|++++++++|||||++++++++.+.+|
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            468999999999999999999874   46789999999765433333346788999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      ||||||. |+|.++|.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus       103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  182 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  182 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence            9999998 589999999999999999999999999999999999999999999999999999999999999876555455


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhch
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      .++.+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..++...+..+.+.+|+.+|+++++||.+||+
T Consensus       183 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  262 (304)
T 3ubd_A          183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFK  262 (304)
T ss_dssp             CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcc
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hCcCCCCC-----HHHHhcCcccCcccchhhh
Q psy18060        354 KDASQRLS-----WPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       354 ~dP~~Rps-----~~elL~Hpw~~~~~~~~~~  380 (549)
                      +||.+|||     ++|+++||||++..+..+.
T Consensus       263 ~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~  294 (304)
T 3ubd_A          263 RNPANRLGAGPDGVEEIKRHSFFSTIDWNKLY  294 (304)
T ss_dssp             SSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred             cCHHHCCCCCcCCHHHHHcCccccCCCHHHHH
Confidence            99999998     4799999999987665554

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-61  Score=502.48  Aligned_cols=256  Identities=30%  Similarity=0.474  Sum_probs=232.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .+.|++++.||+|+||+||+|.++.+|+.||||++......  ..+.+.+|+.+++.++|||||++++++.+.+.+||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35699999999999999999999999999999999764332  2346789999999999999999999999999999999


Q ss_pred             ecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |||+| +|.+++.+ +++++.+++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.........++
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            99985 89998875 57999999999999999999999999999999999999999999999999999987666556678


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCccCCHHHHHHHHHhch
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD---VTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~dlI~~~L~  353 (549)
                      .+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+....   ...+..+|+++++||.+||+
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  309 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  309 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence            899999999999999999999999999999999999999999999998888887653   23345789999999999999


Q ss_pred             hCcCCCCCHHHHhcCcccCcccc
Q psy18060        354 KDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      +||.+|||++|+|+||||+....
T Consensus       310 ~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          310 RDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             CChhHCcCHHHHhcCHhhcCCCC
Confidence            99999999999999999986543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.8e-60  Score=502.10  Aligned_cols=255  Identities=30%  Similarity=0.475  Sum_probs=232.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .+.|++++.||+|+||.||+|.++.+|+.||||++......  ..+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            36799999999999999999999999999999999765432  2356789999999999999999999999999999999


Q ss_pred             ecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |||.| +|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.........++
T Consensus       228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence            99985 89998865 57999999999999999999999999999999999999999999999999999987666556678


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCccCCHHHHHHHHHhch
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD---VTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~dlI~~~L~  353 (549)
                      .+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|....   ...+..+|+++++||.+||+
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  386 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  386 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence            899999999999999999999999999999999999999999999998888887653   23446799999999999999


Q ss_pred             hCcCCCCCHHHHhcCcccCccc
Q psy18060        354 KDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +||.+|||+.|+|+||||+...
T Consensus       387 ~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          387 RDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CChhHCcCHHHHhcCHHhcCCC
Confidence            9999999999999999998654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.1e-60  Score=479.49  Aligned_cols=250  Identities=26%  Similarity=0.462  Sum_probs=221.3

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee----CCEEEEE
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET----LNEFVLI  196 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~iV  196 (549)
                      |++.+.||+|+||+||+|.++.++..||+|.+..........+.+.+|++++++++|||||++++++++    .+.+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            377888999999999999999999999999998776667777889999999999999999999999865    3568999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccCCcEEEec-CCcEEEeecccceecccCcc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR--VLHRDLKPQNVLLNK-DGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IiHrDIKP~NILl~~-~g~vKL~DFGla~~~~~~~~  272 (549)
                      ||||+ |+|.+++.+.+.+++..++.|+.||+.||+|||++|  ||||||||+||||+. +|.+||+|||+|+....  .
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--~  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--S  185 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--T
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--C
Confidence            99998 699999999999999999999999999999999998  999999999999985 79999999999975432  2


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCC--CCCccCCHHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV-SILHLIRLLKTQDV--TFPSQVSETYKDLVK  349 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~dlI~  349 (549)
                      ..++.+||+.|||||++.+ +|+.++|||||||++|||+||++||.+. +...+...+..+..  .+|..+++++++||.
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  264 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  264 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence            3466789999999999875 6999999999999999999999999765 45555666655432  345678999999999


Q ss_pred             HhchhCcCCCCCHHHHhcCcccCc
Q psy18060        350 GLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      +||++||.+|||++|+|+||||++
T Consensus       265 ~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          265 GCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.8e-59  Score=484.59  Aligned_cols=252  Identities=27%  Similarity=0.354  Sum_probs=223.6

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..+.|++.+.||+|+||.||+|+++.+|+.||||++.....       ..+|+.+++.++|||||++++++.+.+.+|||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            35679999999999999999999999999999999976432       24699999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-cEEEeecccceecccCcc--
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-VAMLCDFGFARSMAVGTH--  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-~vKL~DFGla~~~~~~~~--  272 (549)
                      ||||. |+|.++|++.+.+++.+++.++.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.......  
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            99998 59999999999999999999999999999999999999999999999999998 699999999987654321  


Q ss_pred             ---cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCccCCHHHHH
Q psy18060        273 ---MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---TFPSQVSETYKD  346 (549)
Q Consensus       273 ---~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~d  346 (549)
                         .....+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+...+...+.....   .+|+.+|+++++
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~  288 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ  288 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHH
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHH
Confidence               12346899999999999999999999999999999999999999998877767777766654   357789999999


Q ss_pred             HHHHhchhCcCCCCCHHHH-------------hcCcccCccc
Q psy18060        347 LVKGLLEKDASQRLSWPEL-------------LHHPLVKDNL  375 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~el-------------L~Hpw~~~~~  375 (549)
                      ||.+||++||.+|||+.|+             |+|||+.+..
T Consensus       289 li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             HHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            9999999999999999998             5799987643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-58  Score=488.14  Aligned_cols=259  Identities=27%  Similarity=0.408  Sum_probs=228.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee------CCE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET------LNE  192 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~~  192 (549)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+..........+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999999999999999998766666666788899999999999999999998754      367


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC--
Q psy18060        193 FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--  270 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~--  270 (549)
                      +|||||||+|+|.+++.+++.+++.+++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....  
T Consensus       134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~  213 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA  213 (398)
T ss_dssp             EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-----
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcc
Confidence            899999999999999999999999999999999999999999999999999999999999999999999999876432  


Q ss_pred             --cccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----------
Q psy18060        271 --THMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF-----------  336 (549)
Q Consensus       271 --~~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~-----------  336 (549)
                        ....++.+||+.|||||++.+. .|+.++||||+|||+|||++|++||.+.+..+.+..|......+           
T Consensus       214 ~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~  293 (398)
T 4b99_A          214 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAE  293 (398)
T ss_dssp             --CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----
T ss_pred             ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhh
Confidence              2234667999999999998774 57999999999999999999999999999888877764321111           


Q ss_pred             --------------------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        337 --------------------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       337 --------------------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                                          .+.+++++.+||.+||++||.+|||++|+|+||||++...+
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p  354 (398)
T 4b99_A          294 RVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP  354 (398)
T ss_dssp             CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred             hhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence                                12468999999999999999999999999999999876443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.2e-57  Score=460.52  Aligned_cols=251  Identities=26%  Similarity=0.462  Sum_probs=204.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC------
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN------  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------  191 (549)
                      +++|++++.||+|+||+||+|.++.+|+.||||++.... .....+.+.+|++++++++|||||++++++.+.+      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            457999999999999999999999999999999997653 3445567899999999999999999999986544      


Q ss_pred             ------EEEEEEecCC-CCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeec
Q psy18060        192 ------EFVLITEFAH-MSLSNLLEQRKKL---SETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDF  261 (549)
Q Consensus       192 ------~~~iV~E~~~-gsL~~~l~~~~~l---~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DF  261 (549)
                            .+|||||||. |+|.+++..+..+   ++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence                  3799999998 5999999887654   45668899999999999999999999999999999999999999999


Q ss_pred             ccceecccCcc------------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHH
Q psy18060        262 GFARSMAVGTH------------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRL  328 (549)
Q Consensus       262 Gla~~~~~~~~------------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~-~~~~~~~  328 (549)
                      |+|+.......            ..++.+||+.|||||++.+..|+.++|||||||++|||++   ||.+.. ....+..
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~  239 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD  239 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence            99987654321            1245689999999999999999999999999999999996   886532 2233333


Q ss_pred             HhcCCCCCC---ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        329 LKTQDVTFP---SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       329 i~~~~~~~p---~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      +...  .+|   +..++.+.+||.+||++||.+|||+.|+|+||||++.
T Consensus       240 ~~~~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          240 VRNL--KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHTT--CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HhcC--CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            4433  334   3467788999999999999999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.3e-56  Score=496.88  Aligned_cols=274  Identities=26%  Similarity=0.393  Sum_probs=238.1

Q ss_pred             CCccccccc-cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC----ChHHHHHHHHHHHHHHhcCCCCe
Q psy18060        106 CQPVKMEKS-NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR----SGKELSSLKQECEIQKHLAHPNI  180 (549)
Q Consensus       106 ~~~~~~~~~-~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~~Ei~il~~l~hpnI  180 (549)
                      +++..++.. ...+++|++++.||+|+||.||+|+++.+|+.||+|++.+...    ..........++.+++.++||||
T Consensus       175 ~q~k~~e~~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~I  254 (689)
T 3v5w_A          175 CQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI  254 (689)
T ss_dssp             HHHHHHHTTCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTB
T ss_pred             HhccccccCCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCE
Confidence            344444433 5678999999999999999999999999999999999975321    11122223344666777899999


Q ss_pred             eEEEEEEeeCCEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEe
Q psy18060        181 IKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLC  259 (549)
Q Consensus       181 v~l~~~~~~~~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~  259 (549)
                      |+++++|++.+.+|||||||. |+|.++|.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+
T Consensus       255 V~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~  334 (689)
T 3v5w_A          255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS  334 (689)
T ss_dssp             CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             eEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEec
Confidence            999999999999999999998 5999999999999999999999999999999999999999999999999999999999


Q ss_pred             ecccceecccCcccccccCCCCccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcCCCC
Q psy18060        260 DFGFARSMAVGTHMLTSIKGTPLYMAPELIA-ERPYDHTADLWSLGCIAYEIHMGHPPFKT---VSILHLIRLLKTQDVT  335 (549)
Q Consensus       260 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~y~~ksDIwSlGvil~eLltG~~Pf~~---~~~~~~~~~i~~~~~~  335 (549)
                      |||+|+.....  ...+.+||+.|||||++. +..|+.++|||||||++|||++|++||.+   .+...+...+....+.
T Consensus       335 DFGlA~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~  412 (689)
T 3v5w_A          335 DLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE  412 (689)
T ss_dssp             CCTTCEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC
T ss_pred             ccceeeecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC
Confidence            99999876543  345679999999999996 46799999999999999999999999975   3456677788888889


Q ss_pred             CCccCCHHHHHHHHHhchhCcCCCCC-----HHHHhcCcccCcccchhhhh
Q psy18060        336 FPSQVSETYKDLVKGLLEKDASQRLS-----WPELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       336 ~p~~~s~~~~dlI~~~L~~dP~~Rps-----~~elL~Hpw~~~~~~~~~~~  381 (549)
                      +|..+|+++++||.+||++||.+|++     ++||++||||++..+..+..
T Consensus       413 ~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~  463 (689)
T 3v5w_A          413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL  463 (689)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHT
T ss_pred             CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHc
Confidence            99999999999999999999999998     79999999999987766643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.3e-56  Score=451.47  Aligned_cols=251  Identities=24%  Similarity=0.420  Sum_probs=221.3

Q ss_pred             cceeEEEEEecCCcEEEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ++|.+.+.||+|+||+||+|.+.     .++..||||++...  +....+.+.+|++++++++|||||++++++.+.+.+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            57999999999999999999875     35788999999753  455567899999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEe
Q psy18060        194 VLITEFAH-MSLSNLLEQR-------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLC  259 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~-------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~  259 (549)
                      |||||||+ |+|.++|.++             ..+++.++..|+.||+.||+|||+++||||||||+|||++.++.+||+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~  170 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG  170 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEEC
Confidence            99999998 6999999764             369999999999999999999999999999999999999999999999


Q ss_pred             ecccceecccCccc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CC
Q psy18060        260 DFGFARSMAVGTHM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VT  335 (549)
Q Consensus       260 DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~  335 (549)
                      |||+|+........  .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..+. .+
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~  250 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ  250 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99999866443222  233469999999999999999999999999999999998 999999999999988887765 46


Q ss_pred             CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        336 FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       336 ~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      .|+.+|+++.+||.+||+.||.+|||+.||  |+|+++
T Consensus       251 ~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          251 RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence            788999999999999999999999999999  567653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.4e-55  Score=451.27  Aligned_cols=249  Identities=23%  Similarity=0.382  Sum_probs=214.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      .+++.+.+.||+|+||+||+|.++     .++..||||++...  +....+.+.+|++++++++|||||++++++.+.+.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            357889999999999999999865     35789999999653  45566789999999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcE
Q psy18060        193 FVLITEFAH-MSLSNLLEQR---------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVA  256 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~---------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~v  256 (549)
                      +|||||||+ |+|.++|.+.               .++++.++..|+.||+.||.|||+++||||||||+||||+.++.+
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence            999999998 6999999764               358999999999999999999999999999999999999999999


Q ss_pred             EEeecccceecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-
Q psy18060        257 MLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-  332 (549)
Q Consensus       257 KL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-  332 (549)
                      ||+|||+|+......  ...+..+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.+..+..+ 
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~  277 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR  277 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999998764332  22345679999999999999999999999999999999999 99999999998888887765 


Q ss_pred             CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        333 DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       333 ~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .++.|+.+|+++.+||.+||+.||.+|||+.||+++
T Consensus       278 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            467888999999999999999999999999999764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.6e-55  Score=456.40  Aligned_cols=249  Identities=26%  Similarity=0.375  Sum_probs=206.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEc---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  193 (549)
                      .++|++.+.||+|+||+||+|.++   .+++.||+|.+.+..    ....+.+|+++++.+ .|||||++++++.+.+.+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            467999999999999999999875   467899999986543    234578899999998 699999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC-CcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~-g~vKL~DFGla~~~~~~~  271 (549)
                      |||||||+ |+|.+++.   .+++.+++.++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+......
T Consensus        96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            99999998 58999884   59999999999999999999999999999999999999987 899999999997653221


Q ss_pred             ----------------------------ccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCC-CC
Q psy18060        272 ----------------------------HMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKT-VS  321 (549)
Q Consensus       272 ----------------------------~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~-~~  321 (549)
                                                  ...++.+||++|||||++.+. .|+.++||||+||++|||++|++||.. .+
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence                                        123456899999999999775 589999999999999999999999954 34


Q ss_pred             HHHHHHHHhc--------------------------------------CC----------------CCCCccCCHHHHHH
Q psy18060        322 ILHLIRLLKT--------------------------------------QD----------------VTFPSQVSETYKDL  347 (549)
Q Consensus       322 ~~~~~~~i~~--------------------------------------~~----------------~~~p~~~s~~~~dl  347 (549)
                      ..+.+..|..                                      ..                ......+|++++||
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence            3333332211                                      00                01123578999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      |.+||+.||.+|||++|+|+||||++
T Consensus       333 l~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          333 LDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHCcCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999986

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.7e-55  Score=447.11  Aligned_cols=251  Identities=22%  Similarity=0.393  Sum_probs=221.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      ...++++.+.||+|+||+||+|...     .+++.||||++.... .....+.+.+|+.++++++|||||++++++.+.+
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            3567889999999999999999863     457889999986543 3344578999999999999999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC
Q psy18060        192 EFVLITEFAH-MSLSNLLEQR----------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG  254 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g  254 (549)
                      .++||||||+ |+|.++|..+                ..+++.++..|+.||+.||+|||+++||||||||+||||++++
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence            9999999998 6999999653                3589999999999999999999999999999999999999999


Q ss_pred             cEEEeecccceecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc
Q psy18060        255 VAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKT  331 (549)
Q Consensus       255 ~vKL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~  331 (549)
                      .+||+|||+|+......  ...+..+||+.|||||++.++.|+.++|||||||++|||+| |+.||.+.+..++...+..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~  262 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN  262 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999998764432  22345689999999999999999999999999999999998 8999999999999888877


Q ss_pred             CC-CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        332 QD-VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       332 ~~-~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +. .+.|+.+|+++.+|+.+||+.||.+|||+.||+++
T Consensus       263 ~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          263 RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            64 45778999999999999999999999999999865

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.3e-55  Score=445.47  Aligned_cols=248  Identities=24%  Similarity=0.437  Sum_probs=207.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..+++++.+.||+|+||+||+|.+.   ..||||+++....+....+.+.+|+.++++++|||||++++++.. +.++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            4567899999999999999999865   359999997766677778899999999999999999999998765 568999


Q ss_pred             EecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC--cc
Q psy18060        197 TEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--TH  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~--~~  272 (549)
                      ||||+ |+|.++|... ..+++.++..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....  ..
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence            99998 6999999764 57999999999999999999999999999999999999999999999999999866432  22


Q ss_pred             cccccCCCCcccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------CCCccCCHH
Q psy18060        273 MLTSIKGTPLYMAPELIAE---RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV------TFPSQVSET  343 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~---~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~------~~p~~~s~~  343 (549)
                      ..++.+||+.|||||++.+   .+|+.++|||||||++|||+||+.||.+.+....+..+.....      ..|+.+|++
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  269 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA  269 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence            3456789999999999964   4699999999999999999999999988665444443332221      234678999


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +.+||.+||+.||.+|||+.||+++
T Consensus       270 l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          270 MKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999987543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-54  Score=479.61  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=235.0

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ..+++|++++.||+|+||.||+|.++.+|+.||+|++....  ......+.+|+++|+.++|||||+++++|++.+.+||
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  231 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  231 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            34689999999999999999999999999999999997643  3445678999999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC--CcEEEeecccceecccCc
Q psy18060        196 ITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD--GVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~--g~vKL~DFGla~~~~~~~  271 (549)
                      |||||. |+|.++|.. ++.+++.+++.++.||+.||+|||++||+||||||+|||++.+  |.+||+|||+|+.+... 
T Consensus       232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-  310 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  310 (573)
T ss_dssp             EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred             EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence            999998 589999864 4679999999999999999999999999999999999999854  89999999999987654 


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDL  347 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl  347 (549)
                      ....+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..|......++    +.+|+++++|
T Consensus       311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl  390 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF  390 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred             CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            334567899999999999999999999999999999999999999999999999999988876665    4689999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      |.+||++||.+|||+.|+|+||||+....
T Consensus       391 i~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          391 IRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            99999999999999999999999986543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.7e-52  Score=432.52  Aligned_cols=261  Identities=31%  Similarity=0.500  Sum_probs=241.5

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ....+.+|++.+.||+|+||.||+|.+..+|+.||+|++.+..........+.+|+++++.++||||+++++++...+.+
T Consensus        10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            34557889999999999999999999999999999999987766667778889999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      |+||||+. |+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....+ .
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~  168 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-G  168 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-C
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-C
Confidence            99999997 699999999899999999999999999999999999999999999999999999999999999876544 3


Q ss_pred             cccccCCCCcccccccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHh
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYD-HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~-~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+..+...+|..+|+++.+||.+|
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  248 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRF  248 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            34667899999999999887775 89999999999999999999999999999999999999899999999999999999


Q ss_pred             chhCcCCCCCHHHHhcCcccCccc
Q psy18060        352 LEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      |+.||.+|||++|+++||||+...
T Consensus       249 L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          249 LVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             CCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             CCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999997543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.5e-53  Score=442.64  Aligned_cols=251  Identities=27%  Similarity=0.457  Sum_probs=216.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCC-CCeeEEEEEEee-
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQKHLAH-PNIIKFIASHET-  189 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~-  189 (549)
                      ..++|++.+.||+|+||+||+|.+..+     ++.||||.+.... .....+.+.+|+++++++.| ||||++++++.. 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            347899999999999999999987654     3679999997543 34556789999999999965 999999999865 


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQR----------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK  252 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~  252 (549)
                      .+.++||||||+ |+|.++|++.                ..+++..+..++.||+.||+|||+++||||||||+|||++.
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence            467899999998 6999999763                34899999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH-HHHHHH
Q psy18060        253 DGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSI-LHLIRL  328 (549)
Q Consensus       253 ~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~  328 (549)
                      ++.+||+|||+|+.......  ..++.+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+. ......
T Consensus       221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~  300 (353)
T 4ase_A          221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  300 (353)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred             CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999999999987654322  2345679999999999999999999999999999999998 9999988654 344445


Q ss_pred             HhcC-CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        329 LKTQ-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       329 i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +..+ .+..|+.+|+++.++|.+||+.||.+|||+.||++|
T Consensus       301 i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          301 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            5443 456788999999999999999999999999999988

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.7e-52  Score=430.34  Aligned_cols=264  Identities=28%  Similarity=0.489  Sum_probs=240.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      .+++|++++.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            46789999999999999999999999999999999975321 12234577899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||||++ |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.........
T Consensus        83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence            999998 5899999998999999999999999999999999999999999999999999999999999998654443445


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchh
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      .+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+......+|..+++++++||.+||++
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~  242 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK  242 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence            66789999999999999999999999999999999999999999999999999998888899999999999999999999


Q ss_pred             CcCCCC-----CHHHHhcCcccCcccchhhh
Q psy18060        355 DASQRL-----SWPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       355 dP~~Rp-----s~~elL~Hpw~~~~~~~~~~  380 (549)
                      ||.+||     +++|+++||||++..+..+.
T Consensus       243 dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~  273 (337)
T 1o6l_A          243 DPKQRLGGGPSDAKEVMEHRFFLSINWQDVV  273 (337)
T ss_dssp             STTTSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred             CHHHhcCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence            999999     89999999999987665553

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.7e-52  Score=435.44  Aligned_cols=265  Identities=26%  Similarity=0.487  Sum_probs=234.5

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF  193 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  193 (549)
                      ..+++|++++.||+|+||.||+|.++.+++.||+|++.+... .......+.+|..+++.+ +||||+++++++.+.+.+
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            456889999999999999999999999999999999975321 122345678899999988 799999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      |+||||+. |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence            99999998 58999999999999999999999999999999999999999999999999999999999999986544444


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhc
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+....+......+|..+++.+.+||.+||
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL  259 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFM  259 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            45677899999999999998999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhCcCCCCCH------HHHhcCcccCcccchhhh
Q psy18060        353 EKDASQRLSW------PELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       353 ~~dP~~Rps~------~elL~Hpw~~~~~~~~~~  380 (549)
                      ++||.+||++      +|+++||||++..+..+.
T Consensus       260 ~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~  293 (353)
T 3txo_A          260 TKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLN  293 (353)
T ss_dssp             CSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHH
T ss_pred             hhCHHHccCCcccCCHHHHhhCCcccCCCHHHHh
Confidence            9999999998      899999999987665553

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.4e-51  Score=428.83  Aligned_cols=267  Identities=26%  Similarity=0.477  Sum_probs=239.5

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNE  192 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  192 (549)
                      ...+++|++.+.||+|+||.||+|.++.+++.||+|++.+... .......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            3457889999999999999999999999999999999975321 112345677889998876 99999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +|+||||+. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            999999997 5999999998899999999999999999999999999999999999999999999999999998654444


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHh
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+......+|..+++++++||.+|
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l  252 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL  252 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHH
Confidence            44567789999999999999999999999999999999999999999999999999999888889999999999999999


Q ss_pred             chhCcCCCCCHH-HHhcCcccCcccchhhhh
Q psy18060        352 LEKDASQRLSWP-ELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       352 L~~dP~~Rps~~-elL~Hpw~~~~~~~~~~~  381 (549)
                      |+.||.+||++. ++++||||++..+..+..
T Consensus       253 L~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~  283 (345)
T 1xjd_A          253 FVREPEKRLGVRGDIRQHPLFREINWEELER  283 (345)
T ss_dssp             SCSSGGGSBTTBSCGGGSGGGTTCCHHHHHT
T ss_pred             hcCCHhHcCCChHHHHcCccccCCCHHHHhh
Confidence            999999999998 999999999877655543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-50  Score=421.95  Aligned_cols=264  Identities=24%  Similarity=0.458  Sum_probs=236.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~  194 (549)
                      .+++|++++.||+|+||.||+|.++.+++.||+|++.+... .......+.+|..+++++ +||||+++++++.+.+.+|
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   86 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF   86 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence            46789999999999999999999999999999999986543 344567788999999988 8999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      +||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++........
T Consensus        87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence            9999997 589999998889999999999999999999999999999999999999999999999999999865433344


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHhcCCCCCCccCCHHH
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT---------VSILHLIRLLKTQDVTFPSQVSETY  344 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~  344 (549)
                      ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..         .........+......+|..+++++
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~  246 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA  246 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHH
Confidence            5667899999999999999999999999999999999999999965         3445566777788888999999999


Q ss_pred             HHHHHHhchhCcCCCCCH------HHHhcCcccCcccchhhh
Q psy18060        345 KDLVKGLLEKDASQRLSW------PELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~------~elL~Hpw~~~~~~~~~~  380 (549)
                      ++||.+||++||.+||++      .|+++||||++..+..+.
T Consensus       247 ~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~  288 (345)
T 3a8x_A          247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME  288 (345)
T ss_dssp             HHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHH
T ss_pred             HHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHH
Confidence            999999999999999995      899999999987665543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.6e-51  Score=433.28  Aligned_cols=267  Identities=24%  Similarity=0.455  Sum_probs=235.9

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHL-AHPNIIKFIASHETLNE  192 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  192 (549)
                      ...+++|++++.||+|+||.||+|.++.+++.||+|++.+.... ......+.+|..++.++ +|||||++++++.+.+.
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            34578899999999999999999999999999999999865422 23345678899999877 89999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +|+||||+. |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            999999998 5899999998999999999999999999999999999999999999999999999999999998644444


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhcCCCCCCccCCH
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV---------SILHLIRLLKTQDVTFPSQVSE  342 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~  342 (549)
                      ....+.+||+.|+|||++.+..|+.++|||||||++|||++|++||...         ........+....+.+|..+++
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~  287 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV  287 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCH
Confidence            4556789999999999999999999999999999999999999999632         3445667788888899999999


Q ss_pred             HHHHHHHHhchhCcCCCCCH------HHHhcCcccCcccchhhhh
Q psy18060        343 TYKDLVKGLLEKDASQRLSW------PELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~------~elL~Hpw~~~~~~~~~~~  381 (549)
                      ++++||.+||++||.+||++      +|+++||||++..+..+..
T Consensus       288 ~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~  332 (396)
T 4dc2_A          288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ  332 (396)
T ss_dssp             HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHT
T ss_pred             HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHc
Confidence            99999999999999999995      7999999999876665543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-51  Score=420.76  Aligned_cols=262  Identities=29%  Similarity=0.529  Sum_probs=239.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      .+++|++++.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            46789999999999999999999999999999999975321 11234567889999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||||+. |+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....   ..
T Consensus        84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~~  160 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VT  160 (318)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---CB
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---cc
Confidence            999998 59999999989999999999999999999999999999999999999999999999999999987643   23


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchh
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      .+.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+......+|+.++++++++|.+||+.
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~  240 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR  240 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence            45689999999999999999999999999999999999999999999999999999888899999999999999999999


Q ss_pred             CcCCCC-----CHHHHhcCcccCcccchhhhh
Q psy18060        355 DASQRL-----SWPELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       355 dP~~Rp-----s~~elL~Hpw~~~~~~~~~~~  381 (549)
                      ||.+||     +++++++||||++..+..+..
T Consensus       241 dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~  272 (318)
T 1fot_A          241 DLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLS  272 (318)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHT
T ss_pred             CHHHcCCCcCCCHHHHhcCccccCCCHHHHHh
Confidence            999999     899999999999877665543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.5e-51  Score=410.74  Aligned_cols=258  Identities=31%  Similarity=0.492  Sum_probs=225.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.++++++||||+++++++.+.+.+++||
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            46899999999999999999999999999999999876655556678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||++++|.+.+.. ++.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...........
T Consensus        81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence            9999988877765 578999999999999999999999999999999999999999999999999999877655455566


Q ss_pred             cCCCCcccccccccCCC-CCcchhhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhcC----------------------
Q psy18060        277 IKGTPLYMAPELIAERP-YDHTADLWSLGCIAYEIHMGHPP-FKTVSILHLIRLLKTQ----------------------  332 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~-y~~ksDIwSlGvil~eLltG~~P-f~~~~~~~~~~~i~~~----------------------  332 (549)
                      ..||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+.......+...                      
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence            78999999999997765 89999999999999999987777 5666666655554321                      


Q ss_pred             -------CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        333 -------DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       333 -------~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                             ....++.+++.+++||.+||+.||.+|||++|+++||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                   0012235789999999999999999999999999999998653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.5e-51  Score=440.96  Aligned_cols=257  Identities=30%  Similarity=0.485  Sum_probs=235.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+..+|+.+|+|++............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            34779999999999999999999999999999999987766666677899999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec---CCcEEEeecccceecccCcc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK---DGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~---~g~vKL~DFGla~~~~~~~~  272 (549)
                      |||+. |+|.+.+..++.+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|+.......
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            99997 589999999999999999999999999999999999999999999999984   57899999999987765555


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLV  348 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dlI  348 (549)
                      .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+..+...+|.    .+|+++++||
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  248 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI  248 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence            556678999999999999999999999999999999999999999999999999998888766653    6899999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      .+||+.||.+|||+.|+|+||||+.
T Consensus       249 ~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          249 NKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHcCCChhHCCCHHHHhcCccccC
Confidence            9999999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.7e-51  Score=426.09  Aligned_cols=266  Identities=24%  Similarity=0.447  Sum_probs=239.5

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF  193 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  193 (549)
                      ..+++|++++.||+|+||.||+|.++.+++.||+|++.+... .......+.+|..++..+ .||||+++++++.+.+.+
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            456889999999999999999999999999999999975321 112345678899999887 899999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      |+||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence            99999997 59999999888999999999999999999999999999999999999999999999999999986544334


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhc
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L  352 (549)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+......+|..+|+++++||.+||
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL  256 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM  256 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence            45667899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhCcCCCCC-----HHHHhcCcccCcccchhhhh
Q psy18060        353 EKDASQRLS-----WPELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       353 ~~dP~~Rps-----~~elL~Hpw~~~~~~~~~~~  381 (549)
                      ++||.+||+     ++++++||||+...+..+..
T Consensus       257 ~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~  290 (353)
T 2i0e_A          257 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER  290 (353)
T ss_dssp             CSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHT
T ss_pred             hcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHh
Confidence            999999995     69999999999877665543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.9e-50  Score=422.79  Aligned_cols=258  Identities=30%  Similarity=0.470  Sum_probs=234.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ..+.|++.+.||+|+||.||+|.++.+|+.||+|++.+.....    .....+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            4467999999999999999999999999999999998754321    134678999999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC----cEEEeecccceec
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG----VAMLCDFGFARSM  267 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g----~vKL~DFGla~~~  267 (549)
                      +++||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++..
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            999999996 69999999888999999999999999999999999999999999999998877    7999999999877


Q ss_pred             ccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHH
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSET  343 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~  343 (549)
                      .... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+......++    +.+|+.
T Consensus       170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  248 (361)
T 2yab_A          170 EDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL  248 (361)
T ss_dssp             CTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred             CCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence            5442 34566899999999999999999999999999999999999999999999999999988877766    468999


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +++||.+||.+||.+|||+.|+++||||+...
T Consensus       249 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            99999999999999999999999999998654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.9e-52  Score=428.75  Aligned_cols=262  Identities=31%  Similarity=0.507  Sum_probs=232.6

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ....+.+|.+.+.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            345678899999999999999999999999999999999653211 1113467899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        193 FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +++||||++|+|.+++..++.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....+ .
T Consensus        84 ~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~  162 (336)
T 3h4j_B           84 IVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-N  162 (336)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-B
T ss_pred             EEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-c
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999876544 3


Q ss_pred             cccccCCCCcccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHh
Q psy18060        273 MLTSIKGTPLYMAPELIAERPY-DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y-~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+..+...+|..+|+++.+||.+|
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  242 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRM  242 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTT
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHH
Confidence            3456689999999999988776 789999999999999999999998876665555566666778889999999999999


Q ss_pred             chhCcCCCCCHHHHhcCcccCcccc
Q psy18060        352 LEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      |+.||.+|||++|+++||||+....
T Consensus       243 L~~dP~~Rpt~~eil~hp~~~~~~~  267 (336)
T 3h4j_B          243 IVADPMQRITIQEIRRDPWFNVNLP  267 (336)
T ss_dssp             SCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred             cCCChhHCcCHHHHHhChhhccCCc
Confidence            9999999999999999999976543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.4e-50  Score=414.26  Aligned_cols=263  Identities=32%  Similarity=0.486  Sum_probs=220.8

Q ss_pred             cccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q psy18060        111 MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL  190 (549)
Q Consensus       111 ~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  190 (549)
                      ........++|++++.||+|+||.||+|.+. +++.||+|++............+.+|+++++.++||||+++++++.+.
T Consensus        13 ~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE   91 (311)
T ss_dssp             --CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred             ceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence            3445567799999999999999999999986 489999999976554444557788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceeccc
Q psy18060        191 NEFVLITEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV  269 (549)
Q Consensus       191 ~~~~iV~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~  269 (549)
                      +.+++||||++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        92 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           92 RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            999999999999999988765 4599999999999999999999999999999999999999999999999999988765


Q ss_pred             CcccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC-----------
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT---QDV-----------  334 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~---~~~-----------  334 (549)
                      .....+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..   .+.           
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            5445566689999999999876 5689999999999999999999999987665544444321   100           


Q ss_pred             ----------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        335 ----------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       335 ----------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                      ..++.+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence                            0113468899999999999999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.4e-50  Score=421.99  Aligned_cols=262  Identities=27%  Similarity=0.481  Sum_probs=239.3

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ..+++|++++.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            356889999999999999999999999999999999975321 1123467889999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      +||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....   
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---  194 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence            9999997 699999999889999999999999999999999999999999999999999999999999999876532   


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhch
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ..+.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+..+...+|..+++++.++|.+||+
T Consensus       195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~  274 (350)
T 1rdq_E          195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ  274 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSC
T ss_pred             cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            34568999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hCcCCCCC-----HHHHhcCcccCcccchhhh
Q psy18060        354 KDASQRLS-----WPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       354 ~dP~~Rps-----~~elL~Hpw~~~~~~~~~~  380 (549)
                      .||.+||+     ++++++||||++..+..+.
T Consensus       275 ~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~  306 (350)
T 1rdq_E          275 VDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY  306 (350)
T ss_dssp             SCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHH
T ss_pred             cCHHhccCCccCCHHHHHhCcCcCCCCHHHHh
Confidence            99999998     9999999999987665443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.5e-50  Score=407.74  Aligned_cols=256  Identities=29%  Similarity=0.535  Sum_probs=228.8

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++......  ....+.+|+.+++.++||||+++++++...+.+++
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            3457899999999999999999999999999999998754332  24568899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||||+. |+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.........
T Consensus        95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence            999996 6899998764 69999999999999999999999999999999999999999999999999998776655555


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCCccCCHHHHHHHHHh
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---DVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~dlI~~~  351 (549)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...   ....|..+++.+.+||.+|
T Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  253 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (297)
T ss_dssp             CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred             CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence            6678999999999999999999999999999999999999999988877666554432   3345678999999999999


Q ss_pred             chhCcCCCCCHHHHhcCcccCcc
Q psy18060        352 LEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      |+.||.+|||+.|+++||||+..
T Consensus       254 l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          254 LEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ccCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.8e-50  Score=413.30  Aligned_cols=264  Identities=29%  Similarity=0.475  Sum_probs=227.5

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGR--SGKELSSLKQECEIQKHLAHPNIIKFIASHETL  190 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  190 (549)
                      -..++|++.+.||+|+||.||+|.+.   .+++.||+|++.+...  .......+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            34578999999999999999999985   6799999999976532  223445678899999999999999999999999


Q ss_pred             CEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceeccc
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV  269 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~  269 (549)
                      +.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            99999999997 58999999888999999999999999999999999999999999999999999999999999976544


Q ss_pred             CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK  349 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~  349 (549)
                      ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|+.+++++.+||.
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  253 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK  253 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred             CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            43344567899999999999999999999999999999999999999999999999999988888899999999999999


Q ss_pred             HhchhCcCCCC-----CHHHHhcCcccCcccchhh
Q psy18060        350 GLLEKDASQRL-----SWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       350 ~~L~~dP~~Rp-----s~~elL~Hpw~~~~~~~~~  379 (549)
                      +||+.||.+||     ++.|+++||||++..+...
T Consensus       254 ~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~  288 (327)
T 3a62_A          254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL  288 (327)
T ss_dssp             HHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHH
T ss_pred             HHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHH
Confidence            99999999999     8899999999987665544

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.1e-50  Score=420.12  Aligned_cols=259  Identities=27%  Similarity=0.481  Sum_probs=235.8

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.+.+..
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  103 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH  103 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            33445789999999999999999999999999999999987766667778899999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC---cEEEeecccceeccc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAV  269 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g---~vKL~DFGla~~~~~  269 (549)
                      |+||||+. |+|.+.+..+..+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++....
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            99999998 58999999888999999999999999999999999999999999999998654   599999999987654


Q ss_pred             CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHH
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYK  345 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  345 (549)
                      . ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+..+...+|    ..++++++
T Consensus       184 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          184 S-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             C-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             C-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            3 234556899999999999999999999999999999999999999999999888888888876665    35799999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      +||.+||+.||.+|||+.|+|+||||..
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            9999999999999999999999999964

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.4e-50  Score=421.86  Aligned_cols=267  Identities=28%  Similarity=0.484  Sum_probs=232.9

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHH-HHhcCCCCeeEEEEEEeeCCE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEI-QKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ....++|++++.||+|+||.||+|.++.+++.||+|++.+... .......+.+|..+ ++.++||||+++++++.+.+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            3456889999999999999999999999999999999976542 22334456667666 567899999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +|+||||+. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            999999998 5899999998999999999999999999999999999999999999999999999999999998654443


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHh
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      ....+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+......+|+.+++.+++||.+|
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~l  273 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL  273 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHH
T ss_pred             CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Confidence            44567789999999999999999999999999999999999999999999999999999998889999999999999999


Q ss_pred             chhCcCCCCCH----HHHhcCcccCcccchhhhh
Q psy18060        352 LEKDASQRLSW----PELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       352 L~~dP~~Rps~----~elL~Hpw~~~~~~~~~~~  381 (549)
                      |++||.+||++    .++++||||+...+..+..
T Consensus       274 L~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~  307 (373)
T 2r5t_A          274 LQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLIN  307 (373)
T ss_dssp             TCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred             cccCHHhCCCCCCCHHHHhCCccccCCCHHHHHh
Confidence            99999999997    6999999999877665543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2e-50  Score=416.02  Aligned_cols=266  Identities=30%  Similarity=0.463  Sum_probs=215.9

Q ss_pred             ccccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q psy18060        110 KMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET  189 (549)
Q Consensus       110 ~~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  189 (549)
                      ........+++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++..
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           25 SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             -------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             ccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            33445667889999999999999999999999999999999997665444445677899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe-----cCCcEEEeecccc
Q psy18060        190 LNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN-----KDGVAMLCDFGFA  264 (549)
Q Consensus       190 ~~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~-----~~g~vKL~DFGla  264 (549)
                      .+.+++||||++|+|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||++
T Consensus       105 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          105 NHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             CCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99999999999999999999999999999999999999999999999999999999999995     4456999999999


Q ss_pred             eecccCcccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---------
Q psy18060        265 RSMAVGTHMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---------  334 (549)
Q Consensus       265 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---------  334 (549)
                      +.........+...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.....         
T Consensus       185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence            8765444445566799999999999774 589999999999999999999999999887776665532100         


Q ss_pred             ---------CC------------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        335 ---------TF------------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       335 ---------~~------------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                               .+            +..+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence                     00            112689999999999999999999999999999998653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.5e-50  Score=406.84  Aligned_cols=255  Identities=34%  Similarity=0.515  Sum_probs=217.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +++|++++.||+|+||.||+|.+ .+++.||+|++............+.+|+.+++.++||||+++++++...+.+++||
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            46899999999999999999998 67899999999765433333467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.........+.
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence            99999999999864 67999999999999999999999999999999999999999999999999999876544334455


Q ss_pred             cCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CC-------------------
Q psy18060        277 IKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DV-------------------  334 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~-------------------  334 (549)
                      ..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...  ..                   
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (288)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence            679999999999976 45899999999999999999999999998876665554320  00                   


Q ss_pred             --------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        335 --------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       335 --------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                              .+++.+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                    012357899999999999999999999999999999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.7e-50  Score=412.89  Aligned_cols=260  Identities=29%  Similarity=0.491  Sum_probs=211.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+.+++|
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            35689999999999999999999999999999999976432 22335678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        197 TEFAHMSLSNLLEQR------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       197 ~E~~~gsL~~~l~~~------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      |||++|+|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus        82 ~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           82 FEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             EECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             EEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            999999999999764      35899999999999999999999999999999999999999999999999999877654


Q ss_pred             cccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C--------------
Q psy18060        271 THMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--D--------------  333 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~--------------  333 (549)
                      ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...  .              
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence            444456689999999999976 46899999999999999999999999998877766655321  0              


Q ss_pred             ------------------CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        334 ------------------VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       334 ------------------~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                                        ...+..+++++.+||.+||+.||.+|||+.|+|+||||++....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                              00122578899999999999999999999999999999876543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8e-50  Score=421.37  Aligned_cols=266  Identities=30%  Similarity=0.508  Sum_probs=236.6

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      .....++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++|||||++++++.+.+.
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3445788999999999999999999999999999999997532 112234678899999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +|+||||+. |+|..++..+..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... 
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            999999997 589999999889999999999999999999999999999999999999999999999999999876544 


Q ss_pred             ccccccCCCCcccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcCCCCCCccCCHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAE---RPYDHTADLWSLGCIAYEIHMGHPPFKT---VSILHLIRLLKTQDVTFPSQVSETYK  345 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~---~~y~~ksDIwSlGvil~eLltG~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s~~~~  345 (549)
                      ....+.+||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||..   .........+......+|..+++.+.
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~  248 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV  248 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHH
Confidence            33466789999999999964   4589999999999999999999999974   45666777777888889999999999


Q ss_pred             HHHHHhchhCcCCCCC-HHHHhcCcccCcccchhhh
Q psy18060        346 DLVKGLLEKDASQRLS-WPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps-~~elL~Hpw~~~~~~~~~~  380 (549)
                      +||.+||+.||.+||+ ++++++||||.+..+..+.
T Consensus       249 ~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~  284 (384)
T 4fr4_A          249 SLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVF  284 (384)
T ss_dssp             HHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHH
T ss_pred             HHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHH
Confidence            9999999999999998 8999999999987665543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-50  Score=410.36  Aligned_cols=254  Identities=28%  Similarity=0.470  Sum_probs=230.8

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|.+...   ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            357899999999999999999999999999999998643   23456788999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec--CCcEEEeecccceecccCcc
Q psy18060        197 TEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK--DGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~--~g~vKL~DFGla~~~~~~~~  272 (549)
                      |||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++....+. 
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            99998 4899999765 47999999999999999999999999999999999999987  7899999999998775443 


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDLV  348 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dlI  348 (549)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......++    +.+|+++.+||
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T 1tki_A          159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence            33556799999999999998899999999999999999999999999999999988888877766    36899999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+||..||.+|||+.|+|+||||++.
T Consensus       239 ~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHcCCChhHCcCHHHHhcChhhccC
Confidence            99999999999999999999999764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.5e-50  Score=431.74  Aligned_cols=265  Identities=29%  Similarity=0.491  Sum_probs=230.4

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++...+.++
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            35678999999999999999999999999999999997532 12233456788999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +||||++ |+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+.......
T Consensus       225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence            9999998 5899999998999999999999999999999998 9999999999999999999999999999986544444


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhc
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L  352 (549)
                      .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||.+||
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L  384 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL  384 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence            45677899999999999999999999999999999999999999999999999999998988999999999999999999


Q ss_pred             hhCcCCCC-----CHHHHhcCcccCcccchhhh
Q psy18060        353 EKDASQRL-----SWPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       353 ~~dP~~Rp-----s~~elL~Hpw~~~~~~~~~~  380 (549)
                      +.||.+||     |++|+++||||.+.....+.
T Consensus       385 ~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~  417 (446)
T 4ejn_A          385 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVY  417 (446)
T ss_dssp             CSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred             ccCHHHhCCCCCCCHHHHHhCccccCCCHHHHh
Confidence            99999999     99999999999987655443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-49  Score=408.50  Aligned_cols=259  Identities=29%  Similarity=0.489  Sum_probs=233.1

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.+++.++||||+++++++...+.
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            4467999999999999999999999999999999997654321    135678999999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC----cEEEeecccceec
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG----VAMLCDFGFARSM  267 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g----~vKL~DFGla~~~  267 (549)
                      +++||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++..
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            999999997 69999999888999999999999999999999999999999999999999887    8999999999877


Q ss_pred             ccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHH
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSET  343 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~  343 (549)
                      .... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......++    +.+++.
T Consensus       169 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (326)
T 2y0a_A          169 DFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL  247 (326)
T ss_dssp             CTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred             CCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHH
Confidence            5432 33556799999999999999999999999999999999999999999998888888877766655    468999


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      +.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       248 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence            999999999999999999999999999986543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.9e-50  Score=421.79  Aligned_cols=260  Identities=29%  Similarity=0.454  Sum_probs=215.5

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCC--E
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLN--E  192 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~--~  192 (549)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++.+..........+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3467899999999999999999999999999999999776566667778889999999997 999999999997544  7


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC--
Q psy18060        193 FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--  270 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~--  270 (549)
                      +|+||||++++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        86 ~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           86 VYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             EEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            899999999999999976 57999999999999999999999999999999999999999999999999999865321  


Q ss_pred             -------------------cccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy18060        271 -------------------THMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLK  330 (549)
Q Consensus       271 -------------------~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~  330 (549)
                                         ....+..+||++|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                               122345689999999999976 679999999999999999999999999988777766653


Q ss_pred             cCCC-----------------------------------------------CCCccCCHHHHHHHHHhchhCcCCCCCHH
Q psy18060        331 TQDV-----------------------------------------------TFPSQVSETYKDLVKGLLEKDASQRLSWP  363 (549)
Q Consensus       331 ~~~~-----------------------------------------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~  363 (549)
                      ....                                               ..+..+++++.+||.+||+.||.+|||++
T Consensus       245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~  324 (388)
T 3oz6_A          245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN  324 (388)
T ss_dssp             HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence            2100                                               01126789999999999999999999999


Q ss_pred             HHhcCcccCcccc
Q psy18060        364 ELLHHPLVKDNLS  376 (549)
Q Consensus       364 elL~Hpw~~~~~~  376 (549)
                      |+|+||||+....
T Consensus       325 e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          325 DALKHPFVSIFHN  337 (388)
T ss_dssp             HHTTSTTTTTTCC
T ss_pred             HHhCCHHHHHhcC
Confidence            9999999987544

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-48  Score=392.98  Aligned_cols=259  Identities=27%  Similarity=0.473  Sum_probs=235.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            34789999999999999999999999999999999987666667778899999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc---EEEeecccceecccCcc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV---AMLCDFGFARSMAVGTH  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~---vKL~DFGla~~~~~~~~  272 (549)
                      |||+. ++|.+.+..+..+++..+..++.|++.||.|||++||+||||||+||+++.++.   +||+|||++....... 
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-  162 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-  162 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence            99997 489999998899999999999999999999999999999999999999987654   9999999997765442 


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDLV  348 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dlI  348 (549)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+..+...+|    ..+++++.+||
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI  242 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHH
Confidence            33456799999999999999999999999999999999999999999999888888877766555    46899999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      .+||+.||.+|||+.|+++||||++...
T Consensus       243 ~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          243 DSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHcccChhhCCCHHHHhcCccccCChh
Confidence            9999999999999999999999976543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.4e-50  Score=409.01  Aligned_cols=244  Identities=24%  Similarity=0.335  Sum_probs=193.8

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC----EEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN----EFV  194 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~  194 (549)
                      .+|.+.+.||+|+||+||+|.+  +|+.||||++....   ......+.|+..+.+++|||||++++++...+    .+|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            4688999999999999999987  48999999996431   11223345666677889999999999987654    689


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccccccCCcEEEecCCcEEEeecccce
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN--------RVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~--------gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                      ||||||+ |+|.++|.. .++++..+..++.|++.||+|||++        |||||||||+||||+.+|.+||+|||+|+
T Consensus        78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999998 699999976 4699999999999999999999987        99999999999999999999999999998


Q ss_pred             ecccCccc----ccccCCCCcccccccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCC---------------C
Q psy18060        266 SMAVGTHM----LTSIKGTPLYMAPELIAER------PYDHTADLWSLGCIAYEIHMGHPPFKT---------------V  320 (549)
Q Consensus       266 ~~~~~~~~----~~~~~GT~~Y~APE~l~~~------~y~~ksDIwSlGvil~eLltG~~Pf~~---------------~  320 (549)
                      ........    ....+||+.|||||++.+.      .|+.++|||||||++|||+||.+||..               .
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76543322    2346899999999999754      478899999999999999999776532               1


Q ss_pred             CHHHHHHHHhcCC--CCCCcc-----CCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        321 SILHLIRLLKTQD--VTFPSQ-----VSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       321 ~~~~~~~~i~~~~--~~~p~~-----~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ........+....  +.+|..     .++.+.+|+.+||+.||.+|||+.||++.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            2334444443332  234432     33578899999999999999999999764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.9e-49  Score=400.76  Aligned_cols=259  Identities=31%  Similarity=0.525  Sum_probs=219.0

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            46899999999999999999999999999999999776666666678889999999999999999999999999999999


Q ss_pred             ecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||+++ +|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD  161 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence            99996 67788887888999999999999999999999999999999999999999999999999999877654444556


Q ss_pred             cCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------------CC
Q psy18060        277 IKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---------------------DV  334 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~---------------------~~  334 (549)
                      ..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...                     ..
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 4agu_A          162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI  241 (311)
T ss_dssp             ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred             CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence            689999999999976 67899999999999999999999999998876665544321                     00


Q ss_pred             CCC----------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        335 TFP----------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       335 ~~p----------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      +.|          +.+++.+.+||.+||+.||.+|||++|+++||||++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence            111          357889999999999999999999999999999986543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=402.06  Aligned_cols=256  Identities=30%  Similarity=0.530  Sum_probs=220.5

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh------------------------HHHHHHHHHHHH
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG------------------------KELSSLKQECEI  171 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------------------------~~~~~~~~Ei~i  171 (549)
                      ..+++|++.+.||+|+||.||+|.+..+++.||+|++.......                        .....+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            34678999999999999999999999999999999997643211                        123568899999


Q ss_pred             HHhcCCCCeeEEEEEEee--CCEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcE
Q psy18060        172 QKHLAHPNIIKFIASHET--LNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNV  248 (549)
Q Consensus       172 l~~l~hpnIv~l~~~~~~--~~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NI  248 (549)
                      ++.++||||+++++++..  .+.+++||||++ ++|.+++ ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            999999999999999976  568999999998 4676654 346799999999999999999999999999999999999


Q ss_pred             EEecCCcEEEeecccceecccCcccccccCCCCcccccccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy18060        249 LLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP---YDHTADLWSLGCIAYEIHMGHPPFKTVSILHL  325 (549)
Q Consensus       249 Ll~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~  325 (549)
                      |++.+|.+||+|||+++.............||+.|+|||++.+..   ++.++|||||||++|+|++|+.||........
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            999999999999999987765444445678999999999997755   47889999999999999999999999888888


Q ss_pred             HHHHhcCCCCCC--ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        326 IRLLKTQDVTFP--SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       326 ~~~i~~~~~~~p--~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      ...+......+|  +.+++.+.+||.+||+.||.+|||+.|+++||||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            777777666555  46899999999999999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-49  Score=426.76  Aligned_cols=265  Identities=25%  Similarity=0.418  Sum_probs=230.5

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ....++|++++.||+|+||.||+|.++.+++.||+|++.+... .......+.+|+.++..++||||+++++++.+.+.+
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            3456789999999999999999999999999999999975211 011123478899999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      |+||||+. |+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            99999996 699999987 5789999999999999999999999999999999999999999999999999997765432


Q ss_pred             -ccccccCCCCccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCc---cC
Q psy18060        272 -HMLTSIKGTPLYMAPELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFPS---QV  340 (549)
Q Consensus       272 -~~~~~~~GT~~Y~APE~l~-----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p~---~~  340 (549)
                       ...+..+||+.|+|||++.     ...|+.++|||||||++|||++|++||.+.+..+....+...  ...+|.   .+
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  309 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV  309 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence             2334568999999999986     567999999999999999999999999999988888877543  244454   48


Q ss_pred             CHHHHHHHHHhchhCcCC--CCCHHHHhcCcccCcccchhh
Q psy18060        341 SETYKDLVKGLLEKDASQ--RLSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       341 s~~~~dlI~~~L~~dP~~--Rps~~elL~Hpw~~~~~~~~~  379 (549)
                      |+++++||.+||..+|++  ||+++|+++||||++..+..+
T Consensus       310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            999999999999998888  999999999999998776655

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.4e-49  Score=427.88  Aligned_cols=258  Identities=28%  Similarity=0.446  Sum_probs=217.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC------
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------  190 (549)
                      ..++|++++.||+|+||.||+|.+..+++.||||++.+..........+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            46889999999999999999999999999999999987655566677889999999999999999999998554      


Q ss_pred             CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        191 NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       191 ~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      ..+|+||||++++|.+.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       140 ~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  217 (464)
T 3ttj_A          140 QDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  217 (464)
T ss_dssp             CEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred             CeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence            46799999999998888754  5999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------------
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-----------------  333 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-----------------  333 (549)
                       ...+..+||++|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+...-                 
T Consensus       218 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~  296 (464)
T 3ttj_A          218 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  296 (464)
T ss_dssp             -CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred             -cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence             23466789999999999999999999999999999999999999999988776666553210                 


Q ss_pred             ----------CC----CCcc-----------CCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        334 ----------VT----FPSQ-----------VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       334 ----------~~----~p~~-----------~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                                ..    +|..           .++++.+||.+||+.||.+|||++|+|+||||+.....
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~  365 (464)
T 3ttj_A          297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  365 (464)
T ss_dssp             HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence                      00    0111           15679999999999999999999999999999865543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.1e-49  Score=412.59  Aligned_cols=255  Identities=29%  Similarity=0.488  Sum_probs=223.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC---CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG---RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++....   ........+.+|+.+++.++||||+++++++...+.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            367999999999999999999999999999999986421   11123467899999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc---EEEeeccccee
Q psy18060        195 LITEFAH-MSLSNLLEQR----KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV---AMLCDFGFARS  266 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~---vKL~DFGla~~  266 (549)
                      +||||+. ++|.+.+..+    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            9999998 5898887653    35899999999999999999999999999999999999987654   99999999988


Q ss_pred             cccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCH
Q psy18060        267 MAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSE  342 (549)
Q Consensus       267 ~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~  342 (549)
                      ...........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+. .......+..+...++    +.+++
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~  261 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISE  261 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCH
Confidence            765544455678999999999999999999999999999999999999999875 4455666666665554    46899


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      ++++||.+||+.||.+|||+.|+++||||++
T Consensus       262 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          262 SAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            9999999999999999999999999999974

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.9e-49  Score=396.57  Aligned_cols=258  Identities=35%  Similarity=0.563  Sum_probs=231.2

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ...+++|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            45678999999999999999999999999999999998653211 11245688999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ++||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......  
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--  162 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  162 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence            99999998 589999999899999999999999999999999999999999999999999999999999998654432  


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhc
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+......+|..+++.+.+||.+||
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  242 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL  242 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHC
T ss_pred             cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHh
Confidence            23456799999999999999999999999999999999999999999999999988888888899999999999999999


Q ss_pred             hhCcCCCCCHHHHhcCcccCcc
Q psy18060        353 EKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       353 ~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      +.||.+|||+.|+++||||+..
T Consensus       243 ~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          243 KHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             CSSGGGSCCHHHHHHCHHHHHH
T ss_pred             ccChhhCCCHHHHhhCccccCC
Confidence            9999999999999999999754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.1e-49  Score=413.46  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=222.5

Q ss_pred             ccccccceeEEEEEecC--CcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        114 SNGALEKYQKICLIGEG--SFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G--~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      -.....+|++++.||+|  +||.||+|.+..+++.||+|++............+.+|+.+++.++|||||++++++...+
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            34556889999999999  9999999999999999999999876666667788899999999999999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        192 EFVLITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                      .+++||||+. |+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||.+....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999998 6899999876  679999999999999999999999999999999999999999999999999986543


Q ss_pred             cCc-------ccccccCCCCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------
Q psy18060        269 VGT-------HMLTSIKGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD------  333 (549)
Q Consensus       269 ~~~-------~~~~~~~GT~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~------  333 (549)
                      ...       ......+||+.|+|||++.+  ..|+.++|||||||++|+|++|+.||.+.+.......+..+.      
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            221       11233479999999999987  679999999999999999999999998755433332221111      


Q ss_pred             ----------------------------------------CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        334 ----------------------------------------VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       334 ----------------------------------------~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                                                              ..++..+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence                                                    1234568899999999999999999999999999999986


Q ss_pred             cc
Q psy18060        374 NL  375 (549)
Q Consensus       374 ~~  375 (549)
                      ..
T Consensus       340 ~~  341 (389)
T 3gni_B          340 IK  341 (389)
T ss_dssp             C-
T ss_pred             Hh
Confidence            54

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.4e-49  Score=421.23  Aligned_cols=261  Identities=26%  Similarity=0.438  Sum_probs=227.8

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ....++|++++.||+|+||.||+|.++.+++.||+|++.+... .......+.+|+.+++.++|||||++++++.+.+.+
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            3456789999999999999999999999999999999975211 001123467899999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      |+||||+. |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus       145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            99999996 589999875 5799999999999999999999999999999999999999999999999999987654322


Q ss_pred             -cccccCCCCcccccccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCC--ccCCHH
Q psy18060        273 -MLTSIKGTPLYMAPELIAERP----YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFP--SQVSET  343 (549)
Q Consensus       273 -~~~~~~GT~~Y~APE~l~~~~----y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~  343 (549)
                       ...+.+||+.|+|||++.+..    |+.++|||||||++|||++|++||.+.+.......|....  ..+|  ..+|++
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  303 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  303 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence             234678999999999997655    8899999999999999999999999999988888876542  3444  479999


Q ss_pred             HHHHHHHhchhCcCC--CCCHHHHhcCcccCcccc
Q psy18060        344 YKDLVKGLLEKDASQ--RLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~--Rps~~elL~Hpw~~~~~~  376 (549)
                      +++||.+||+.+|.+  ||+++||++||||++..+
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w  338 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  338 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence            999999999999988  999999999999997654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-49  Score=425.38  Aligned_cols=262  Identities=30%  Similarity=0.451  Sum_probs=207.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-----CCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-----LNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~  192 (549)
                      .++|++++.||+|+||.||+|.+..+++.||||++.+..........+.+|+.+++.++|||||++++++..     .+.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999999999999999997766666667789999999999999999999999843     357


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-
Q psy18060        193 FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-  271 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-  271 (549)
                      +|+|||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus       132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  211 (458)
T 3rp9_A          132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN  211 (458)
T ss_dssp             EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred             EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence            9999999999999999988899999999999999999999999999999999999999999999999999998764221 


Q ss_pred             --------------------------ccccccCCCCcccccccc-cCCCCCcchhhHHHHHHHHHHHh-----------C
Q psy18060        272 --------------------------HMLTSIKGTPLYMAPELI-AERPYDHTADLWSLGCIAYEIHM-----------G  313 (549)
Q Consensus       272 --------------------------~~~~~~~GT~~Y~APE~l-~~~~y~~ksDIwSlGvil~eLlt-----------G  313 (549)
                                                ...+..+||++|+|||++ .+..|+.++||||||||+|||++           |
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~  291 (458)
T 3rp9_A          212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR  291 (458)
T ss_dssp             CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGC
T ss_pred             cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccc
Confidence                                      123556899999999986 56679999999999999999998           7


Q ss_pred             CCCCCCCCH--------------------HHHHHHHhc---CC----------------------------CCCCccCCH
Q psy18060        314 HPPFKTVSI--------------------LHLIRLLKT---QD----------------------------VTFPSQVSE  342 (549)
Q Consensus       314 ~~Pf~~~~~--------------------~~~~~~i~~---~~----------------------------~~~p~~~s~  342 (549)
                      ++||.+.+.                    ...+..|..   .+                            ....+.+++
T Consensus       292 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  371 (458)
T 3rp9_A          292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA  371 (458)
T ss_dssp             CCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCH
T ss_pred             cccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCH
Confidence            788866541                    111111110   00                            001135699


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhcCcccCcccchhh
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~~~  379 (549)
                      ++.+||.+||+.||.+|||++|+|+||||++......
T Consensus       372 ~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~  408 (458)
T 3rp9_A          372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV  408 (458)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred             HHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence            9999999999999999999999999999998765444

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-49  Score=400.93  Aligned_cols=257  Identities=27%  Similarity=0.448  Sum_probs=215.6

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhc---CCCCeeEEEEEEeeC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS---GKELSSLKQECEIQKHL---AHPNIIKFIASHETL  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~  190 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++......   ......+.+|+.+++.+   .||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999999999999999998743311   11123456777777666   499999999998775


Q ss_pred             C-----EEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccc
Q psy18060        191 N-----EFVLITEFAHMSLSNLLEQRKK--LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGF  263 (549)
Q Consensus       191 ~-----~~~iV~E~~~gsL~~~l~~~~~--l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGl  263 (549)
                      .     .+++|||+++++|.+++.....  +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence            5     5899999999999999988654  99999999999999999999999999999999999999999999999999


Q ss_pred             ceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----C---
Q psy18060        264 ARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-----T---  335 (549)
Q Consensus       264 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-----~---  335 (549)
                      ++..... ...+...||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+.....     .   
T Consensus       167 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (308)
T 3g33_A          167 ARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  245 (308)
T ss_dssp             TTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred             ccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            9766543 233556899999999999999999999999999999999999999999888777766532100     0   


Q ss_pred             -------------------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        336 -------------------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       336 -------------------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                         .++.+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence                               113578999999999999999999999999999999753

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.7e-48  Score=417.25  Aligned_cols=263  Identities=30%  Similarity=0.458  Sum_probs=218.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-----C
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-----N  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~  191 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+++++.++||||+++++++...     +
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            45789999999999999999999999999999999987656666677889999999999999999999998766     5


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        192 EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       192 ~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      .+|+||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus       104 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  183 (432)
T 3n9x_A          104 ELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK  183 (432)
T ss_dssp             CEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred             eEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence            79999999999999999988889999999999999999999999999999999999999999999999999998765332


Q ss_pred             ----------------------ccccccCCCCcccccccc-cCCCCCcchhhHHHHHHHHHHHhC-----------CCCC
Q psy18060        272 ----------------------HMLTSIKGTPLYMAPELI-AERPYDHTADLWSLGCIAYEIHMG-----------HPPF  317 (549)
Q Consensus       272 ----------------------~~~~~~~GT~~Y~APE~l-~~~~y~~ksDIwSlGvil~eLltG-----------~~Pf  317 (549)
                                            ...+..+||++|+|||++ .+..|+.++|||||||++|||++|           .++|
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f  263 (432)
T 3n9x_A          184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF  263 (432)
T ss_dssp             ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred             cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence                                  123667899999999986 566799999999999999999984           4445


Q ss_pred             CCCC-----------------HHHHHHH------------------------HhcCCCCCC-------ccCCHHHHHHHH
Q psy18060        318 KTVS-----------------ILHLIRL------------------------LKTQDVTFP-------SQVSETYKDLVK  349 (549)
Q Consensus       318 ~~~~-----------------~~~~~~~------------------------i~~~~~~~p-------~~~s~~~~dlI~  349 (549)
                      .+.+                 ....+..                        +...+...+       +.+++++.+||.
T Consensus       264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~  343 (432)
T 3n9x_A          264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE  343 (432)
T ss_dssp             CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred             CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence            4432                 0111111                        111111111       358999999999


Q ss_pred             HhchhCcCCCCCHHHHhcCcccCcccchhh
Q psy18060        350 GLLEKDASQRLSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~Hpw~~~~~~~~~  379 (549)
                      +||+.||.+|||++|+|+||||++......
T Consensus       344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~  373 (432)
T 3n9x_A          344 SMLKFNPNKRITIDQALDHPYLKDVRKKKL  373 (432)
T ss_dssp             HHSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred             HHhcCCcccCCCHHHHhcChhhhhccCccc
Confidence            999999999999999999999987655443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-49  Score=407.24  Aligned_cols=257  Identities=28%  Similarity=0.456  Sum_probs=213.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +++|++++.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            46899999999999999999999999999999999654321 11123457999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...........
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           80 EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             cccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence            999999999988754 5999999999999999999999999999999999999999999999999999876554444556


Q ss_pred             cCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CC--C---------------
Q psy18060        277 IKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---DV--T---------------  335 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~---~~--~---------------  335 (549)
                      ..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...   +.  .               
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY  239 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence            689999999999876 66899999999999999999999999998877766655331   00  0               


Q ss_pred             ----------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        336 ----------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       336 ----------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                                .++.+++++.+||.+||+.||.+|||++|+|+||||.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence                      1124688999999999999999999999999999998643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6e-49  Score=408.27  Aligned_cols=252  Identities=31%  Similarity=0.489  Sum_probs=224.4

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~  194 (549)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|++.+....      ..+|+.++.++ .||||+++++++.+.+.+|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            3457899999999999999999999999999999999765432      24678888777 7999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC----CcEEEeecccceeccc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD----GVAMLCDFGFARSMAV  269 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~----g~vKL~DFGla~~~~~  269 (549)
                      +||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..+    +.+||+|||+++....
T Consensus        93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            9999997 5899999998899999999999999999999999999999999999998543    3599999999987765


Q ss_pred             CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcCCCCCC----ccCCH
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT---VSILHLIRLLKTQDVTFP----SQVSE  342 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~---~~~~~~~~~i~~~~~~~p----~~~s~  342 (549)
                      ......+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+   .+..+....+..+...++    +.+|+
T Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  252 (342)
T 2qr7_A          173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD  252 (342)
T ss_dssp             TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred             CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence            54455667899999999999888899999999999999999999999986   466777888877776654    46899


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      ++++||.+||..||.+|||+.++++||||.+
T Consensus       253 ~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            9999999999999999999999999999965

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6e-49  Score=404.92  Aligned_cols=252  Identities=33%  Similarity=0.515  Sum_probs=204.2

Q ss_pred             ccceeEE---EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKI---CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~---~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~  193 (549)
                      .++|++.   +.||+|+||.||+|.+..+++.||+|++.+.     ....+.+|+.+++.+. ||||+++++++.+....
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            3556665   7899999999999999999999999999652     3456788999999997 99999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC---cEEEeecccceeccc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAV  269 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g---~vKL~DFGla~~~~~  269 (549)
                      |+||||+. |+|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            99999997 59999999999999999999999999999999999999999999999998766   899999999987765


Q ss_pred             CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCCCCC----c
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-------ILHLIRLLKTQDVTFP----S  338 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~-------~~~~~~~i~~~~~~~p----~  338 (549)
                      ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+       ..+....+..+...++    .
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (325)
T 3kn6_A          162 DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK  241 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred             CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence            5555567789999999999999999999999999999999999999997643       4567777777776665    3


Q ss_pred             cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       339 ~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+|+++++||.+||+.||.+|||+.|+++||||++.
T Consensus       242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             TSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             CCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            589999999999999999999999999999999753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.8e-48  Score=407.43  Aligned_cols=256  Identities=29%  Similarity=0.466  Sum_probs=214.4

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++......   ...+.+|+.+++.++||||+++++++...+.+++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            3457899999999999999999999999999999999765432   2457899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc--EEEeecccceecccCcc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV--AMLCDFGFARSMAVGTH  272 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~--vKL~DFGla~~~~~~~~  272 (549)
                      ||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..... .
T Consensus        94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~  172 (361)
T 3uc3_A           94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S  172 (361)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-C
Confidence            999997 599999998889999999999999999999999999999999999999987765  999999999754332 2


Q ss_pred             cccccCCCCcccccccccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCCCCc--cCCHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHT-ADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFPS--QVSETYK  345 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~k-sDIwSlGvil~eLltG~~Pf~~~~----~~~~~~~i~~~~~~~p~--~~s~~~~  345 (549)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..    .......+......+|.  .+++++.
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  252 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC  252 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence            2345679999999999988887665 899999999999999999998743    35555666666655554  5899999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +||.+||+.||.+|||+.|+++||||....
T Consensus       253 ~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          253 HLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            999999999999999999999999997544

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.9e-49  Score=443.09  Aligned_cols=265  Identities=25%  Similarity=0.457  Sum_probs=240.7

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~  194 (549)
                      .+++|++++.||+|+||.||+|.++.+++.||||++.+... .......+..|..++..+ +||+|+++++++++.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            46789999999999999999999999999999999975321 112345677889999887 7999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      |||||+. |+|..++...+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+........
T Consensus       419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~  498 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  498 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred             EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence            9999997 589999999899999999999999999999999999999999999999999999999999999865444445


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhch
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ..+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++...|....+.+|..+++++++||.+||+
T Consensus       499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~  578 (674)
T 3pfq_A          499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT  578 (674)
T ss_dssp             BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSC
T ss_pred             cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence            56788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hCcCCCCCH-----HHHhcCcccCcccchhhhh
Q psy18060        354 KDASQRLSW-----PELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       354 ~dP~~Rps~-----~elL~Hpw~~~~~~~~~~~  381 (549)
                      +||.+||++     +||++||||++..+..+..
T Consensus       579 ~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~  611 (674)
T 3pfq_A          579 KHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER  611 (674)
T ss_dssp             SSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTT
T ss_pred             CCHHHCCCCCCCcHHHHhcCccccCCCHHHHHh
Confidence            999999997     9999999999877666544

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.2e-48  Score=391.05  Aligned_cols=261  Identities=29%  Similarity=0.500  Sum_probs=238.9

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .....+|.+.+.||+|+||.||+|.+..+++.+|+|++.... ........+.+|+.+++.+.||||+++++++...+..
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            345678999999999999999999999999999999997653 2344567889999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ++||||++ ++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            99999998 58999999888999999999999999999999999999999999999999999999999999987654444


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhc
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+......+|..+++.+.++|.+||
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  250 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML  250 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHc
Confidence            44556799999999999998899999999999999999999999999998888888888888889999999999999999


Q ss_pred             hhCcCCCCCHHHHhcCcccCccc
Q psy18060        353 EKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       353 ~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +.||.+|||+.|+++||||....
T Consensus       251 ~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          251 QTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             CSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             ccChhhCcCHHHHhhChheecCC
Confidence            99999999999999999997653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.1e-48  Score=403.51  Aligned_cols=257  Identities=28%  Similarity=0.409  Sum_probs=222.7

Q ss_pred             ccccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-----CCCeeEEE
Q psy18060        110 KMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-----HPNIIKFI  184 (549)
Q Consensus       110 ~~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~  184 (549)
                      .........++|++++.||+|+||.||+|.+..+++.||+|++...   .........|+.+++.+.     ||||++++
T Consensus        26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            3344445568899999999999999999999999999999999642   344567788999999996     99999999


Q ss_pred             EEEeeCCEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec----------
Q psy18060        185 ASHETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK----------  252 (549)
Q Consensus       185 ~~~~~~~~~~iV~E~~~gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~----------  252 (549)
                      +++...+..++|||+++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.          
T Consensus       103 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~  182 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV  182 (360)
T ss_dssp             EEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred             ceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence            9999999999999999889999998764  5999999999999999999999999999999999999975          


Q ss_pred             ---------------CCcEEEeecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q psy18060        253 ---------------DGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPF  317 (549)
Q Consensus       253 ---------------~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf  317 (549)
                                     ++.+||+|||+|+....   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             ECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             hcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence                           78999999999986543   234567999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHhcCCCCCCc----------------------------------------------cCCHHHHHHHHHh
Q psy18060        318 KTVSILHLIRLLKTQDVTFPS----------------------------------------------QVSETYKDLVKGL  351 (549)
Q Consensus       318 ~~~~~~~~~~~i~~~~~~~p~----------------------------------------------~~s~~~~dlI~~~  351 (549)
                      .+.+..+....+......+|.                                              ..++.+.+||.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            998877766655443222221                                              1237788999999


Q ss_pred             chhCcCCCCCHHHHhcCcccC
Q psy18060        352 LEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      |+.||.+|||+.|+|+||||+
T Consensus       340 L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          340 LQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCSSGGGSCCHHHHTTSGGGC
T ss_pred             hcCChhhCCCHHHHhcCcccC
Confidence            999999999999999999995

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-48  Score=405.78  Aligned_cols=260  Identities=31%  Similarity=0.496  Sum_probs=221.9

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee------
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET------  189 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------  189 (549)
                      ..+++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++..      
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            45688999999999999999999999999999999987655444444567899999999999999999999876      


Q ss_pred             --CCEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        190 --LNEFVLITEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       190 --~~~~~iV~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                        .+.+++||||++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  173 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  173 (351)
T ss_dssp             ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence              4568999999999988888764 5799999999999999999999999999999999999999999999999999987


Q ss_pred             cccC----cccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---
Q psy18060        267 MAVG----THMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS---  338 (549)
Q Consensus       267 ~~~~----~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~---  338 (549)
                      ....    ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+......+++   
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            6422    122345678999999999876 56899999999999999999999999998887776665432111111   


Q ss_pred             -c----------------------------CCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        339 -Q----------------------------VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       339 -~----------------------------~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                       .                            .++.+.+||.+||+.||.+|||+.|+|+||||.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence             1                            277899999999999999999999999999997643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.4e-49  Score=394.07  Aligned_cols=260  Identities=31%  Similarity=0.559  Sum_probs=203.5

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ..+++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++...+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence            3567899999999999999999999999999999999653211 112467889999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +||||++ ++|.+++..+ ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            9999997 4899999875 6799999999999999999999999999999999999999999999999999987654433


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhc
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......|..+++++.++|.+||
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  247 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL  247 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHS
T ss_pred             cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHc
Confidence            34456799999999999998899999999999999999999999988776666666666666778889999999999999


Q ss_pred             hhCcCCCCCHHHHhcCcccCccc
Q psy18060        353 EKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       353 ~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +.||.+|||+.++++||||.+..
T Consensus       248 ~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          248 RRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             CSSGGGSCCHHHHTTSTTTC---
T ss_pred             ccCHhhCCCHHHHhcCccccCCC
Confidence            99999999999999999997643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.8e-49  Score=425.80  Aligned_cols=260  Identities=28%  Similarity=0.459  Sum_probs=235.9

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ...+.+|.+.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...+.+
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3456889999999999999999999999999999999975321 112345788999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      |+||||+. |+|.+++.+++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....+ .
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~  170 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-E  170 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-C
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-c
Confidence            99999996 599999998889999999999999999999999999999999999999999999999999999877544 2


Q ss_pred             cccccCCCCcccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHh
Q psy18060        273 MLTSIKGTPLYMAPELIAERPY-DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y-~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+....|..+++++.+||.+|
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~  250 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHM  250 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHH
T ss_pred             cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHH
Confidence            3456689999999999988766 789999999999999999999999998888888998888888889999999999999


Q ss_pred             chhCcCCCCCHHHHhcCcccCccc
Q psy18060        352 LEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      |+.||.+|||+.|+++||||+...
T Consensus       251 L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          251 LQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             TCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             cCCCchhCcCHHHHHhCHHhhhcC
Confidence            999999999999999999998654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.9e-48  Score=397.03  Aligned_cols=259  Identities=29%  Similarity=0.460  Sum_probs=233.1

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.......    .....+.+|+.+++.+.||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            4567999999999999999999999999999999997654321    135678999999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC----cEEEeecccceec
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG----VAMLCDFGFARSM  267 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g----~vKL~DFGla~~~  267 (549)
                      .++||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            999999996 69999999888999999999999999999999999999999999999999888    7999999999876


Q ss_pred             ccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHH
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSET  343 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~  343 (549)
                      .... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......++    ..+++.
T Consensus       170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (321)
T 2a2a_A          170 EDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL  248 (321)
T ss_dssp             CTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred             Cccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence            5442 33456799999999999999999999999999999999999999999998888888877766655    468999


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      +.+||.+||+.||.+|||+.|+++||||.....
T Consensus       249 ~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             HHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            999999999999999999999999999986543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-49  Score=418.00  Aligned_cols=264  Identities=23%  Similarity=0.370  Sum_probs=228.5

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ....++|++++.||+|+||.||+|.++.+++.||+|++.+... .......+.+|..++..++||||+++++++.+.+.+
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            3456789999999999999999999999999999999975321 112234578899999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      |+||||+. |+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            99999996 6999999875 479999999999999999999999999999999999999999999999999998765433


Q ss_pred             c-cccccCCCCccccccccc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCC---c
Q psy18060        272 H-MLTSIKGTPLYMAPELIA-------ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFP---S  338 (549)
Q Consensus       272 ~-~~~~~~GT~~Y~APE~l~-------~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p---~  338 (549)
                      . .....+||+.|+|||++.       +..|+.++|||||||++|||++|+.||.+.+..+....+...  ...+|   .
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  296 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE  296 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence            2 234568999999999997       457899999999999999999999999999988888777642  23333   5


Q ss_pred             cCCHHHHHHHHHhchhCcCCC---CCHHHHhcCcccCcccchhh
Q psy18060        339 QVSETYKDLVKGLLEKDASQR---LSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       339 ~~s~~~~dlI~~~L~~dP~~R---ps~~elL~Hpw~~~~~~~~~  379 (549)
                      .+|+++++||.+||+ +|.+|   |+++|+++||||++..+..+
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            799999999999999 99998   58999999999998766554

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3e-48  Score=406.72  Aligned_cols=258  Identities=28%  Similarity=0.435  Sum_probs=215.1

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-----
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----  191 (549)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            467899999999999999999999999999999999876556666778899999999999999999999987654     


Q ss_pred             -EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        192 -EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       192 -~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                       .+|+||||++++|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       103 ~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          103 QDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  180 (371)
T ss_dssp             CEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred             cceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence             789999999999999886  46999999999999999999999999999999999999999999999999999866533


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC--------------
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF--------------  336 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--------------  336 (549)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......              
T Consensus       181 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  259 (371)
T 2xrw_A          181 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  259 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred             -cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence             23345689999999999999999999999999999999999999999988777666654321110              


Q ss_pred             ----------------------Cc------cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        337 ----------------------PS------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       337 ----------------------p~------~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                                            |.      ..++++++||.+||+.||.+|||++|+|+||||+.....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  328 (371)
T 2xrw_A          260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP  328 (371)
T ss_dssp             HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCH
T ss_pred             HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCc
Confidence                                  00      125789999999999999999999999999999865443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=398.83  Aligned_cols=251  Identities=26%  Similarity=0.364  Sum_probs=212.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...............|+..+..+ .||||+++++++...+.+++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            3679999999999999999999999999999999876655555555555666655555 999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus       136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~  214 (311)
T 3p1a_A          136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGE  214 (311)
T ss_dssp             EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred             EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-CCCc
Confidence            999999999998765 46999999999999999999999999999999999999999999999999999876543 2334


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCccCCHHHHHHHHHhch
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV--TFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~dlI~~~L~  353 (549)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...   ...+.....  .++..+++++.+||.+||+
T Consensus       215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  290 (311)
T 3p1a_A          215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLE  290 (311)
T ss_dssp             CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred             ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcC
Confidence            5679999999999876 699999999999999999999777655433   222333322  2345789999999999999


Q ss_pred             hCcCCCCCHHHHhcCcccCc
Q psy18060        354 KDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~~~  373 (549)
                      .||.+|||+.|+++||||++
T Consensus       291 ~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          291 PDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             SSTTTSCCHHHHHTSGGGSC
T ss_pred             CChhhCcCHHHHHhCccccC
Confidence            99999999999999999975

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-48  Score=428.84  Aligned_cols=268  Identities=28%  Similarity=0.425  Sum_probs=237.5

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      .....++|.+.+.||+|+||.||+|.++.+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            345568899999999999999999999999999999999753211 1234578899999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceec
Q psy18060        193 FVLITEFAH-MSLSNLLEQR----KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~  267 (549)
                      +|+||||+. |+|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            999999998 5899999764    36999999999999999999999999999999999999999999999999999887


Q ss_pred             ccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCCCCCCccCCHH
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSET  343 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~  343 (549)
                      ..........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.    ........+......+|..+|++
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~  419 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPA  419 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHH
Confidence            65544445568999999999999999999999999999999999999999875    45677777888888899999999


Q ss_pred             HHHHHHHhchhCcCCCCC-----HHHHhcCcccCcccchhhhh
Q psy18060        344 YKDLVKGLLEKDASQRLS-----WPELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps-----~~elL~Hpw~~~~~~~~~~~  381 (549)
                      +++||.+||++||.+||+     ++++++||||++..+..+..
T Consensus       420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~  462 (543)
T 3c4z_A          420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEA  462 (543)
T ss_dssp             HHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHT
T ss_pred             HHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHc
Confidence            999999999999999996     58999999999877665543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.2e-48  Score=388.22  Aligned_cols=255  Identities=31%  Similarity=0.507  Sum_probs=231.1

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+..++..+|+|.+.....  ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            45679999999999999999999999999999999976432  2346788999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE---ecCCcEEEeecccceecccCcc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl---~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      |||+. ++|.+++..++.+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-  163 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-  163 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence            99997 5899999988999999999999999999999999999999999999999   778899999999998766443 


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLV  348 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dlI  348 (549)
                      ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+.......+..+...+|.    .+++.+.++|
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLI  242 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred             chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHH
Confidence            33556799999999998765 899999999999999999999999999999888888888777775    6899999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      .+||+.||.+|||+.++++||||++..
T Consensus       243 ~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          243 RRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999997543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-48  Score=408.50  Aligned_cols=256  Identities=27%  Similarity=0.478  Sum_probs=228.9

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|++....  ......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            34578999999999999999999999999999999997542  3345678899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec--CCcEEEeecccceecccCc
Q psy18060        196 ITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK--DGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~--~g~vKL~DFGla~~~~~~~  271 (549)
                      ||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++......
T Consensus       126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            999997 58999987654 7999999999999999999999999999999999999974  4689999999998775442


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDL  347 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl  347 (549)
                       .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......++    ..+++++++|
T Consensus       206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  284 (387)
T 1kob_A          206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF  284 (387)
T ss_dssp             -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence             23445799999999999999999999999999999999999999999998888888877665444    4689999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      |.+||+.||.+|||+.|+|+||||+..
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          285 IKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHcCCChhHCcCHHHHhhCccccCC
Confidence            999999999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1e-48  Score=424.89  Aligned_cols=259  Identities=32%  Similarity=0.582  Sum_probs=229.3

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++.+..........+.+|+.++++++||||+++++++.+.+.+|
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            34568899999999999999999999999999999999754322234567889999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe---cCCcEEEeecccceecccC
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~---~~g~vKL~DFGla~~~~~~  270 (549)
                      +||||+. |+|.+.+..++.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+.....
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            9999997 58999999889999999999999999999999999999999999999995   4567999999999866543


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHH
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKD  346 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~d  346 (549)
                      . .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+.......+..+...++    ..+|+++++
T Consensus       178 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          178 T-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             C-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence            2 3455689999999999976 599999999999999999999999999999999988887765543    468999999


Q ss_pred             HHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        347 LVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ||.+||+.||.+|||+.|+|+||||+...
T Consensus       256 li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            99999999999999999999999998643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-48  Score=401.54  Aligned_cols=259  Identities=25%  Similarity=0.405  Sum_probs=220.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            45789999999999999999999999999999999975432 22335678999999999999999999999999999999


Q ss_pred             EecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc--cc
Q psy18060        197 TEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HM  273 (549)
Q Consensus       197 ~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~--~~  273 (549)
                      |||+.| +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......  ..
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            999975 899999888889999999999999999999999999999999999999999999999999998654322  22


Q ss_pred             ccccCCCCcccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCCC--CCccCCHHHHHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAERPY-DHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQDVT--FPSQVSETYKDLVK  349 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y-~~ksDIwSlGvil~eLltG~~Pf~~~~~~-~~~~~i~~~~~~--~p~~~s~~~~dlI~  349 (549)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.. ............  ....+++.+.+||.
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence            346689999999999987775 78999999999999999999999875542 222222222222  22578999999999


Q ss_pred             HhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        350 GLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      +||+.||.+|||+.|+++||||+....
T Consensus       244 ~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          244 KILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHccCChhhCcCHHHHhhChhhccccc
Confidence            999999999999999999999986544

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5e-48  Score=421.39  Aligned_cols=259  Identities=30%  Similarity=0.493  Sum_probs=230.0

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh-----------HHHHHHHHHHHHHHhcCCCCeeEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-----------KELSSLKQECEIQKHLAHPNIIKF  183 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-----------~~~~~~~~Ei~il~~l~hpnIv~l  183 (549)
                      ....++|++++.||+|+||.||+|.+..+++.||+|++.+.....           .....+.+|+.+++.++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            345688999999999999999999999999999999997654221           234678899999999999999999


Q ss_pred             EEEEeeCCEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC---cEEEe
Q psy18060        184 IASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG---VAMLC  259 (549)
Q Consensus       184 ~~~~~~~~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g---~vKL~  259 (549)
                      ++++.+...+|+|||||. |+|.+.+..+..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            999999999999999997 58999999989999999999999999999999999999999999999999876   69999


Q ss_pred             ecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--
Q psy18060        260 DFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP--  337 (549)
Q Consensus       260 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p--  337 (549)
                      |||+|+...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+.......+..+...++  
T Consensus       192 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          192 DFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN  269 (504)
T ss_dssp             CCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred             ECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence            999998775442 3456689999999999874 699999999999999999999999999999999999988877665  


Q ss_pred             --ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        338 --SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       338 --~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                        +.+|+++++||.+||+.||.+|||+.|+|+||||+...
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence              57899999999999999999999999999999998653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.5e-48  Score=422.70  Aligned_cols=257  Identities=32%  Similarity=0.535  Sum_probs=226.4

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ...++|++++.||+|+||.||+|.+..++..||+|++.+..........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34567999999999999999999999999999999998765444445678999999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC---CcEEEeecccceecccCc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD---GVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~---g~vKL~DFGla~~~~~~~  271 (549)
                      |||||. |+|.+.+..+..+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||+|+......
T Consensus       114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            999998 5899999988999999999999999999999999999999999999999764   459999999998776442


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDL  347 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl  347 (549)
                       .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..+....+..+...++    ..+|+.+++|
T Consensus       194 -~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  271 (494)
T 3lij_A          194 -KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL  271 (494)
T ss_dssp             -CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred             -cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence             345668999999999986 4699999999999999999999999999999999998888776654    3689999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      |.+||+.||.+|||+.|+|+||||+..
T Consensus       272 i~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          272 IKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHCCCChhhCccHHHHhcCcccccC
Confidence            999999999999999999999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-48  Score=407.99  Aligned_cols=257  Identities=28%  Similarity=0.443  Sum_probs=218.0

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC------
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------  190 (549)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+++++.++||||+++++++...      
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            34779999999999999999999999999999999976655556667889999999999999999999998765      


Q ss_pred             CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        191 NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       191 ~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      ..+|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus       103 ~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-  180 (367)
T 1cm8_A          103 TDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-  180 (367)
T ss_dssp             CCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred             ceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-
Confidence            34699999998899999876 6799999999999999999999999999999999999999999999999999987643 


Q ss_pred             cccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---------------
Q psy18060        271 THMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---------------  334 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---------------  334 (549)
                        ..+...||++|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.....               
T Consensus       181 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~  258 (367)
T 1cm8_A          181 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  258 (367)
T ss_dssp             --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             --ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence              2356689999999999877 7799999999999999999999999999887766655432100               


Q ss_pred             ----------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        335 ----------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       335 ----------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                                      ..++..++.+.+||.+||+.||.+|||+.|+|+||||......
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                            1224578999999999999999999999999999999875443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.3e-48  Score=389.84  Aligned_cols=260  Identities=32%  Similarity=0.527  Sum_probs=233.8

Q ss_pred             cccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       113 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      .....+++|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++...+
T Consensus         8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (284)
T 2vgo_A            8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK   87 (284)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence            3445568899999999999999999999999999999998653211 112357889999999999999999999999999


Q ss_pred             EEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        192 EFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       192 ~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      ..++||||+.+ +|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999974 99999998889999999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~  350 (549)
                        ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+......+|+.+++.++++|.+
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  245 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK  245 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred             --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence              234567999999999999999999999999999999999999999999988888888888888899999999999999


Q ss_pred             hchhCcCCCCCHHHHhcCcccCcc
Q psy18060        351 LLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ||+.||.+|||+.++++||||+..
T Consensus       246 ~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          246 LLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HhhcCHhhCCCHHHHhhCHHHHhh
Confidence            999999999999999999999753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.1e-48  Score=398.43  Aligned_cols=261  Identities=29%  Similarity=0.500  Sum_probs=239.0

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .....+|.+.+.||+|+||.||+|.+..+++.+|+|++.... ........+.+|+.+++.++||||+++++++.+.+..
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            345678999999999999999999999999999999997643 3345567889999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ++||||+. ++|.+++..+..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            99999998 58999999888999999999999999999999999999999999999999999999999999987754444


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhc
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......+|..+++.+.+||.+||
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  276 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML  276 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHT
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHc
Confidence            44566799999999999999999999999999999999999999999988888888888888889999999999999999


Q ss_pred             hhCcCCCCCHHHHhcCcccCccc
Q psy18060        353 EKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       353 ~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +.||.+|||+.|+++||||....
T Consensus       277 ~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          277 QTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             CSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             cCChhHCcCHHHHhcCccccCCC
Confidence            99999999999999999997654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5e-48  Score=400.41  Aligned_cols=255  Identities=29%  Similarity=0.501  Sum_probs=217.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCC--CCeeEEEEEEeeCCEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH--PNIIKFIASHETLNEFVL  195 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~i  195 (549)
                      ..+|++++.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.+.|  |||+++++++...+.+++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            467999999999999999999885 58899999998776667777889999999999976  999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--c
Q psy18060        196 ITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--M  273 (549)
Q Consensus       196 V~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--~  273 (549)
                      |||+.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.......  .
T Consensus        87 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~  165 (343)
T 3dbq_A           87 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV  165 (343)
T ss_dssp             EECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccccc
Confidence            99988889999999999999999999999999999999999999999999999996 68899999999987654322  2


Q ss_pred             ccccCCCCcccccccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhc--CCCCCCcc
Q psy18060        274 LTSIKGTPLYMAPELIAE-----------RPYDHTADLWSLGCIAYEIHMGHPPFKTV-SILHLIRLLKT--QDVTFPSQ  339 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~-----------~~y~~ksDIwSlGvil~eLltG~~Pf~~~-~~~~~~~~i~~--~~~~~p~~  339 (549)
                      ....+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||... ........+..  ....+|..
T Consensus       166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T 3dbq_A          166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI  245 (343)
T ss_dssp             ----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCC
T ss_pred             CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCccc
Confidence            345679999999999864           67899999999999999999999999874 33333333332  33456778


Q ss_pred             CCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       340 ~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus       246 ~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            89999999999999999999999999999999753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.1e-48  Score=428.76  Aligned_cols=269  Identities=26%  Similarity=0.408  Sum_probs=237.1

Q ss_pred             ccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q psy18060        112 EKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETL  190 (549)
Q Consensus       112 ~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  190 (549)
                      +......++|++.+.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++.++|||||++++++.+.
T Consensus       177 ~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  256 (576)
T 2acx_A          177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK  256 (576)
T ss_dssp             HTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence            3344567889999999999999999999999999999999975321 112245678999999999999999999999999


Q ss_pred             CEEEEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceec
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~  267 (549)
                      +.+|+||||+. |+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999997 68999998754  4999999999999999999999999999999999999999999999999999877


Q ss_pred             ccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCCCCCCccCCHH
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVSET  343 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~  343 (549)
                      .... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.    ....+...+...+..+|..+|++
T Consensus       337 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~  415 (576)
T 2acx_A          337 PEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ  415 (576)
T ss_dssp             CTTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             ccCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence            5442 335568999999999999999999999999999999999999999875    45667777777888889999999


Q ss_pred             HHHHHHHhchhCcCCCC-----CHHHHhcCcccCcccchhhhh
Q psy18060        344 YKDLVKGLLEKDASQRL-----SWPELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rp-----s~~elL~Hpw~~~~~~~~~~~  381 (549)
                      +++||.+||++||.+||     +++|+++||||++..+..+..
T Consensus       416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~  458 (576)
T 2acx_A          416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGA  458 (576)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHT
T ss_pred             HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhc
Confidence            99999999999999999     789999999999876655543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.6e-48  Score=400.08  Aligned_cols=260  Identities=31%  Similarity=0.521  Sum_probs=220.8

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      -..+++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++...+..+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            34578899999999999999999999999999999999877666666677889999999999999999999999999999


Q ss_pred             EEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      +||||+++ +|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            99999996 56666676788999999999999999999999999999999999999999999999999999876554444


Q ss_pred             ccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------C
Q psy18060        274 LTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-------------------D  333 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-------------------~  333 (549)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                   .
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            5566899999999999775 7899999999999999999999999988776655443211                   0


Q ss_pred             CCC------------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        334 VTF------------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       334 ~~~------------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ..+            .+.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            011            12578999999999999999999999999999999764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.3e-48  Score=388.03  Aligned_cols=260  Identities=28%  Similarity=0.450  Sum_probs=221.7

Q ss_pred             cccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q psy18060        111 MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL  190 (549)
Q Consensus       111 ~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  190 (549)
                      ........++|.+.+.||+|+||.||+|.+..++..+|+|++..... ......+.+|+++++.++||||+++++++.+.
T Consensus        14 ~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   92 (285)
T 3is5_A           14 LYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY   92 (285)
T ss_dssp             CEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence            33444556889999999999999999999999999999999976432 23356788999999999999999999999999


Q ss_pred             CEEEEEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE---ecCCcEEEeecc
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFG  262 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl---~~~g~vKL~DFG  262 (549)
                      +..++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            99999999998 489988854    3679999999999999999999999999999999999999   456789999999


Q ss_pred             cceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC---cc
Q psy18060        263 FARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP---SQ  339 (549)
Q Consensus       263 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p---~~  339 (549)
                      +++...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+.......+......++   ..
T Consensus       173 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (285)
T 3is5_A          173 LAELFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP  250 (285)
T ss_dssp             CCCC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CC
T ss_pred             cceecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCc
Confidence            997665432 335567999999999986 4689999999999999999999999999988888777665554433   34


Q ss_pred             CCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       340 ~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      +++++.+||.+||+.||.+|||+.|+++||||++
T Consensus       251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            7999999999999999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.8e-48  Score=422.34  Aligned_cols=258  Identities=32%  Similarity=0.533  Sum_probs=231.9

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.++++++||||+++++++...+.++
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3457899999999999999999999999999999999765432 334577899999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE---ecCCcEEEeecccceecccC
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl---~~~g~vKL~DFGla~~~~~~  270 (549)
                      +||||+. |+|.+.+..++.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+.....
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            9999997 5899999999999999999999999999999999999999999999999   46789999999999876544


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHH
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKD  346 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~d  346 (549)
                      . .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+.......+..+...++    ..+|+++++
T Consensus       183 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          183 K-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD  260 (484)
T ss_dssp             C-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred             c-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence            2 3355679999999999976 699999999999999999999999999999999998888766544    468999999


Q ss_pred             HHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        347 LVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ||.+||+.||.+|||+.|+|+||||+...
T Consensus       261 li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            99999999999999999999999997643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.3e-47  Score=399.01  Aligned_cols=254  Identities=32%  Similarity=0.495  Sum_probs=224.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ...|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            3569999999999999999999999999999999976543 334456789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||+.|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....    .
T Consensus       133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----~  208 (348)
T 1u5q_A          133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----N  208 (348)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----C
T ss_pred             EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----C
Confidence            99999999988864 567999999999999999999999999999999999999999999999999999765432    4


Q ss_pred             ccCCCCccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCccCCHHHHHHHHH
Q psy18060        276 SIKGTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT--FPSQVSETYKDLVKG  350 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~dlI~~  350 (549)
                      ...||+.|+|||++.   +..++.++|||||||++|+|++|+.||.+.+.......+......  .+..+++.+.+||.+
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  288 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS  288 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred             cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            567999999999984   567899999999999999999999999988877766665544322  345789999999999


Q ss_pred             hchhCcCCCCCHHHHhcCcccCccc
Q psy18060        351 LLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ||+.||.+|||+.++++||||....
T Consensus       289 ~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          289 CLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HcccChhhCcCHHHHhhChhhhccC
Confidence            9999999999999999999996543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.1e-47  Score=392.60  Aligned_cols=253  Identities=30%  Similarity=0.483  Sum_probs=225.6

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      .|...+.||+|+||.||+|.+..+|+.||||++.....  ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            47888899999999999999999999999999976443  2346788999999999999999999999999999999999


Q ss_pred             CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccC
Q psy18060        200 AH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK  278 (549)
Q Consensus       200 ~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~  278 (549)
                      +. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.............
T Consensus       124 ~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  202 (321)
T 2c30_A          124 LQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  202 (321)
T ss_dssp             CCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence            97 589988764 5799999999999999999999999999999999999999999999999999987765444446678


Q ss_pred             CCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCccCCHHHHHHHHHhchhC
Q psy18060        279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---TFPSQVSETYKDLVKGLLEKD  355 (549)
Q Consensus       279 GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~dlI~~~L~~d  355 (549)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.....   ..+..+++.+.++|.+||+.|
T Consensus       203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  282 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRD  282 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSS
T ss_pred             CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCC
Confidence            99999999999999999999999999999999999999999888887777765533   233468999999999999999


Q ss_pred             cCCCCCHHHHhcCcccCccc
Q psy18060        356 ASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       356 P~~Rps~~elL~Hpw~~~~~  375 (549)
                      |.+|||+.|+++||||....
T Consensus       283 p~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          283 PQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             TTTSCCHHHHHTSGGGGGCC
T ss_pred             hhhCcCHHHHhcChhhccCC
Confidence            99999999999999997643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6e-48  Score=385.68  Aligned_cols=261  Identities=29%  Similarity=0.473  Sum_probs=225.6

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            3456789999999999999999999999999999999865321 112345788999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ++|||++. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  165 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-  165 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence            99999997 5999999988899999999999999999999999999999999999999999999999999997765432 


Q ss_pred             cccccCCCCcccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHh
Q psy18060        273 MLTSIKGTPLYMAPELIAERPY-DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y-~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~  351 (549)
                      ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+......+|..+++.+.++|.+|
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  245 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHM  245 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHH
Confidence            2345579999999999988765 689999999999999999999999999888888888888888889999999999999


Q ss_pred             chhCcCCCCCHHHHhcCcccCcccc
Q psy18060        352 LEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      |+.||.+|||+.|+++||||++...
T Consensus       246 l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          246 LQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             TCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             ccCChhhCCCHHHHHhChhhccCch
Confidence            9999999999999999999976543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=399.63  Aligned_cols=254  Identities=29%  Similarity=0.473  Sum_probs=208.8

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....    ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            34567999999999999999999999999999999997542    23567889999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec---CCcEEEeecccceecccCc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK---DGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~---~g~vKL~DFGla~~~~~~~  271 (549)
                      ||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..... 
T Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-  204 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-  204 (349)
T ss_dssp             EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence            999997 599999998888999999999999999999999999999999999999975   789999999999866533 


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCCCCC----ccCCHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQDVTFP----SQVSETYKD  346 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s~~~~d  346 (549)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+......++    +.+++++.+
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  284 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD  284 (349)
T ss_dssp             --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence            2334567999999999999999999999999999999999999999766543 35566666554433    468999999


Q ss_pred             HHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        347 LVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ||.+||+.||.+|||+.|+++||||.+.
T Consensus       285 li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          285 LVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             HHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.6e-47  Score=404.37  Aligned_cols=254  Identities=29%  Similarity=0.506  Sum_probs=219.0

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC--CCCeeEEEEEEeeCCEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA--HPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~iV  196 (549)
                      .+|++.+.||+|+||.||+|.+.. ++.||||++............+.+|+.+++.+.  ||||+++++++...+.+|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            569999999999999999999875 899999999877666677788999999999996  59999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--cc
Q psy18060        197 TEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--ML  274 (549)
Q Consensus       197 ~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--~~  274 (549)
                      ||+.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.......  ..
T Consensus       135 ~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~  213 (390)
T 2zmd_A          135 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK  213 (390)
T ss_dssp             EECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------
T ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccC
Confidence            9977789999999999999999999999999999999999999999999999995 68999999999987654321  23


Q ss_pred             cccCCCCcccccccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcC--CCCCCccC
Q psy18060        275 TSIKGTPLYMAPELIAE-----------RPYDHTADLWSLGCIAYEIHMGHPPFKTV-SILHLIRLLKTQ--DVTFPSQV  340 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~-----------~~y~~ksDIwSlGvil~eLltG~~Pf~~~-~~~~~~~~i~~~--~~~~p~~~  340 (549)
                      ...+||+.|+|||++.+           ..|+.++|||||||++|+|++|+.||... .....+..+...  ...+|...
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (390)
T 2zmd_A          214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP  293 (390)
T ss_dssp             CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCS
T ss_pred             CCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccc
Confidence            45689999999999865           46899999999999999999999999875 334444444443  34567778


Q ss_pred             CHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        341 SETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       341 s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       294 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          294 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             hHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            9999999999999999999999999999999754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.4e-48  Score=387.42  Aligned_cols=256  Identities=26%  Similarity=0.439  Sum_probs=206.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++............+.++...++.+.||||+++++++...+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            45789999999999999999999999999999999976544444445555666668888999999999999999999999


Q ss_pred             EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        197 TEFAHMSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       197 ~E~~~gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      |||++|+|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  164 (290)
T 3fme_A           85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV  164 (290)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred             EehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence            99999998877754    56799999999999999999999998 99999999999999999999999999997765432


Q ss_pred             ccccccCCCCcccccccc----cCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHH-HHhcCCCCCC-ccCCHHH
Q psy18060        272 HMLTSIKGTPLYMAPELI----AERPYDHTADLWSLGCIAYEIHMGHPPFKT-VSILHLIR-LLKTQDVTFP-SQVSETY  344 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l----~~~~y~~ksDIwSlGvil~eLltG~~Pf~~-~~~~~~~~-~i~~~~~~~p-~~~s~~~  344 (549)
                       ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||.. ........ .+.......+ ..+++++
T Consensus       165 -~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (290)
T 3fme_A          165 -AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEF  243 (290)
T ss_dssp             ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHH
T ss_pred             -cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHH
Confidence             23445799999999996    566789999999999999999999999986 33333333 3333333333 4689999


Q ss_pred             HHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        345 KDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      .++|.+||+.||.+|||+.|+++||||+.
T Consensus       244 ~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          244 VDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            99999999999999999999999999974

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.3e-48  Score=384.90  Aligned_cols=258  Identities=29%  Similarity=0.519  Sum_probs=228.6

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe--eCCEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE--TLNEFV  194 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~  194 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+.++++++||||+++++++.  ....++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            467899999999999999999999999999999999877666677788999999999999999999999874  467899


Q ss_pred             EEEecCCC-CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CccccccCCcEEEecCCcEEEeecccc
Q psy18060        195 LITEFAHM-SLSNLLEQR----KKLSETICVQILSNLISALYYLHSNR-----VLHRDLKPQNVLLNKDGVAMLCDFGFA  264 (549)
Q Consensus       195 iV~E~~~g-sL~~~l~~~----~~l~e~~~~~i~~qIl~aL~yLH~~g-----IiHrDIKP~NILl~~~g~vKL~DFGla  264 (549)
                      +||||+.+ +|.+++...    ..+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            99999985 999999764    34999999999999999999999999     999999999999999999999999999


Q ss_pred             eecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCccCCHH
Q psy18060        265 RSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSET  343 (549)
Q Consensus       265 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~  343 (549)
                      +.............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..+.. .+|..++++
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (279)
T 2w5a_A          164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  243 (279)
T ss_dssp             HHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             eeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHH
Confidence            7765443333455799999999999998999999999999999999999999999988888777776654 567789999


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      +.++|.+||+.||.+|||+.|+++|||+.+.
T Consensus       244 l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          244 LNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            9999999999999999999999999999754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-48  Score=400.10  Aligned_cols=260  Identities=28%  Similarity=0.453  Sum_probs=217.5

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh---HHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG---KELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.......   .....+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999999999999999987543221   112467899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 FVLITEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      .++||||++++|..++..+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus        87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            9999999999999998765 368999999999999999999999999999999999999999999999999998775544


Q ss_pred             ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C---CCC---------
Q psy18060        272 HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--D---VTF---------  336 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~---~~~---------  336 (549)
                      ...+...||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+...  .   ..+         
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  246 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  246 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence            44566789999999999965 45899999999999999999999999998887776665431  0   000         


Q ss_pred             --------------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        337 --------------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       337 --------------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                                    ...+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                          134678999999999999999999999999999998653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.4e-47  Score=382.67  Aligned_cols=255  Identities=31%  Similarity=0.509  Sum_probs=226.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57999999999999999999999999999999997654321    13567899999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC----cEEEeecccceeccc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG----VAMLCDFGFARSMAV  269 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g----~vKL~DFGla~~~~~  269 (549)
                      +|||++. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++    .+||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999996 69999999888999999999999999999999999999999999999998877    899999999987654


Q ss_pred             CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHH
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYK  345 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  345 (549)
                      .. ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+......++    +.+++.+.
T Consensus       165 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (283)
T 3bhy_A          165 GN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK  243 (283)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             CC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence            32 23455799999999999999999999999999999999999999999998888888777665554    46899999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ++|.+||..||.+|||+.|+++||||+..
T Consensus       244 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            99999999999999999999999999754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.9e-48  Score=401.64  Aligned_cols=252  Identities=29%  Similarity=0.479  Sum_probs=222.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChH------HHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK------ELSSLKQECEIQKHLAHPNIIKFIASHETL  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  190 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++........      ....+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            45789999999999999999999999999999999987543211      234567899999999999999999999999


Q ss_pred             CEEEEEEecCC-C-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        191 NEFVLITEFAH-M-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       191 ~~~~iV~E~~~-g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                      +.+++|||++. | +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            99999999885 5 899999998899999999999999999999999999999999999999999999999999998775


Q ss_pred             cCcccccccCCCCcccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHH
Q psy18060        269 VGTHMLTSIKGTPLYMAPELIAERPY-DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDL  347 (549)
Q Consensus       269 ~~~~~~~~~~GT~~Y~APE~l~~~~y-~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dl  347 (549)
                      ... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....      .........|..+++++.+|
T Consensus       182 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~~l  254 (335)
T 3dls_A          182 RGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELMSL  254 (335)
T ss_dssp             TTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHHHH
T ss_pred             CCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHHHH
Confidence            443 3345679999999999988776 889999999999999999999997632      12334455677899999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      |.+||+.||.+|||+.++++||||++..
T Consensus       255 i~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          255 VSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             HHHHccCChhhCcCHHHHhcCccccCCc
Confidence            9999999999999999999999998643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.3e-47  Score=391.11  Aligned_cols=256  Identities=32%  Similarity=0.508  Sum_probs=216.3

Q ss_pred             ccceeEE-EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEE
Q psy18060        118 LEKYQKI-CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       118 ~~~y~~~-~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~i  195 (549)
                      .+.|++. +.||+|+||.||+|.+..+++.||+|++.....  .....+.+|+.++.++ .||||+++++++.+.+.+++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            4678885 789999999999999999999999999976432  3346788999999885 79999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc---EEEeecccceecccCc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV---AMLCDFGFARSMAVGT  271 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~---vKL~DFGla~~~~~~~  271 (549)
                      ||||+. ++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            999997 699999999889999999999999999999999999999999999999998775   9999999987653221


Q ss_pred             -------ccccccCCCCcccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCC---------------HHH
Q psy18060        272 -------HMLTSIKGTPLYMAPELIAE-----RPYDHTADLWSLGCIAYEIHMGHPPFKTVS---------------ILH  324 (549)
Q Consensus       272 -------~~~~~~~GT~~Y~APE~l~~-----~~y~~ksDIwSlGvil~eLltG~~Pf~~~~---------------~~~  324 (549)
                             ......+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+..               ...
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence                   11234569999999999875     568899999999999999999999998753               344


Q ss_pred             HHHHHhcCCCCCCc----cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        325 LIRLLKTQDVTFPS----QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       325 ~~~~i~~~~~~~p~----~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ....+..+...+|.    .+++.+++||.+||+.||.+|||+.|+++||||++..
T Consensus       249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence            56667777777663    5899999999999999999999999999999998643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.2e-48  Score=405.02  Aligned_cols=256  Identities=27%  Similarity=0.457  Sum_probs=205.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC------C
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------N  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~  191 (549)
                      .++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            4789999999999999999999999999999999977655556667888999999999999999999998653      5


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        192 EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       192 ~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      .+|+|||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  
T Consensus       108 ~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~--  184 (367)
T 2fst_X          108 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--  184 (367)
T ss_dssp             CCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred             eEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc--
Confidence            6899999998899998875 6799999999999999999999999999999999999999999999999999976543  


Q ss_pred             ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------------
Q psy18060        272 HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-----------------  333 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-----------------  333 (549)
                       ..+...||++|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+....                 
T Consensus       185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  263 (367)
T 2fst_X          185 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  263 (367)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred             -cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence             2355689999999999977 679999999999999999999999999988776665543210                 


Q ss_pred             ------CCC--------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        334 ------VTF--------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       334 ------~~~--------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                            ...        .+..++.+.+||.+||+.||.+|||+.|+|+||||.....+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence                  000        12468899999999999999999999999999999876543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.7e-47  Score=409.21  Aligned_cols=255  Identities=27%  Similarity=0.429  Sum_probs=218.2

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc------CCCCeeEEEEEEee
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL------AHPNIIKFIASHET  189 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~~~~  189 (549)
                      ....+|++++.||+|+||.||+|.+..+++.||||++...   ......+.+|+.+++.+      .||||+++++++..
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            3456799999999999999999999999999999999653   34446677888888887      57799999999999


Q ss_pred             CCEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc--EEEeecccce
Q psy18060        190 LNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV--AMLCDFGFAR  265 (549)
Q Consensus       190 ~~~~~iV~E~~~gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~--vKL~DFGla~  265 (549)
                      .+.+++|||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+
T Consensus       171 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          171 RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999999999999999998764  4999999999999999999999999999999999999999987  9999999997


Q ss_pred             ecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----------
Q psy18060        266 SMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT----------  335 (549)
Q Consensus       266 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~----------  335 (549)
                      ....   ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+......          
T Consensus       251 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~  327 (429)
T 3kvw_A          251 YEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK  327 (429)
T ss_dssp             ETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred             ecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence            6542   234568999999999999999999999999999999999999999998877665544321000          


Q ss_pred             -------------------------------------------------CCccCCHHHHHHHHHhchhCcCCCCCHHHHh
Q psy18060        336 -------------------------------------------------FPSQVSETYKDLVKGLLEKDASQRLSWPELL  366 (549)
Q Consensus       336 -------------------------------------------------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL  366 (549)
                                                                       ++...++.+.+||.+||+.||.+|||+.|+|
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L  407 (429)
T 3kvw_A          328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL  407 (429)
T ss_dssp             THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence                                                             1112478899999999999999999999999


Q ss_pred             cCcccCcccc
Q psy18060        367 HHPLVKDNLS  376 (549)
Q Consensus       367 ~Hpw~~~~~~  376 (549)
                      +||||++...
T Consensus       408 ~Hpw~~~~~~  417 (429)
T 3kvw_A          408 RHPWLRRRLP  417 (429)
T ss_dssp             TSTTTC----
T ss_pred             CChhhccCCC
Confidence            9999987543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.3e-47  Score=379.38  Aligned_cols=252  Identities=19%  Similarity=0.314  Sum_probs=216.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.++..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            35779999999999999999999999999999999987655555667788999999999 99999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC-----------------
Q psy18060        196 ITEFAH-MSLSNLLEQR----KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-----------------  253 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~-----------------  253 (549)
                      ||||+. ++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+                 
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            999997 4999999875    679999999999999999999999999999999999999844                 


Q ss_pred             --CcEEEeecccceecccCcccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy18060        254 --GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLK  330 (549)
Q Consensus       254 --g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~  330 (549)
                        +.+||+|||++......    ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+........+  ..
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~  242 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI--RQ  242 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHH--HT
T ss_pred             CceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHH--Hc
Confidence              47999999999876533    334699999999999765 6778999999999999999999887655432222  22


Q ss_pred             cCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        331 TQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       331 ~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .....+|..+++.+.++|.+||+.||.+|||+.|+++||||++.
T Consensus       243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            23345677899999999999999999999999999999999764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.2e-47  Score=382.53  Aligned_cols=262  Identities=32%  Similarity=0.538  Sum_probs=230.2

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC---C----hHHHHHHHHHHHHHHhcC-CCCeeEEEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---S----GKELSSLKQECEIQKHLA-HPNIIKFIAS  186 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~----~~~~~~~~~Ei~il~~l~-hpnIv~l~~~  186 (549)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++.....   .    ......+.+|+.+++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            3456889999999999999999999999999999999976531   1    123456789999999995 9999999999


Q ss_pred             EeeCCEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccce
Q psy18060        187 HETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       187 ~~~~~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                      +...+..++||||+. ++|.+++..+..+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence            999999999999998 5999999998899999999999999999999999999999999999999999999999999998


Q ss_pred             ecccCcccccccCCCCccccccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--
Q psy18060        266 SMAVGTHMLTSIKGTPLYMAPELIA------ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP--  337 (549)
Q Consensus       266 ~~~~~~~~~~~~~GT~~Y~APE~l~------~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p--  337 (549)
                      ...... ......||+.|+|||++.      ...++.++|||||||++|+|++|+.||...+.......+..+...++  
T Consensus       173 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (298)
T 1phk_A          173 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  251 (298)
T ss_dssp             ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             hcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence            765442 335567999999999985      45688999999999999999999999999988888888777665544  


Q ss_pred             --ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        338 --SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       338 --~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                        ..+++.+.++|.+||+.||.+|||+.|+++||||++....
T Consensus       252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence              4689999999999999999999999999999999876543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=402.42  Aligned_cols=251  Identities=29%  Similarity=0.442  Sum_probs=218.8

Q ss_pred             eEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC
Q psy18060        122 QKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH  201 (549)
Q Consensus       122 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~  201 (549)
                      ...+.||+|+||.||+|.+..+|+.||+|++....  ......+.+|+.++++++||||+++++++...+.+++||||++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            34678999999999999999999999999997643  3445678999999999999999999999999999999999997


Q ss_pred             -CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe--cCCcEEEeecccceecccCccccccc
Q psy18060        202 -MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN--KDGVAMLCDFGFARSMAVGTHMLTSI  277 (549)
Q Consensus       202 -gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~--~~g~vKL~DFGla~~~~~~~~~~~~~  277 (549)
                       ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||+++...... .....
T Consensus       170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~~  248 (373)
T 2x4f_A          170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVN  248 (373)
T ss_dssp             TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCCC
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-ccccc
Confidence             5898888654 4699999999999999999999999999999999999994  56789999999998775443 33455


Q ss_pred             CCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHHHHHhch
Q psy18060        278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDLVKGLLE  353 (549)
Q Consensus       278 ~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dlI~~~L~  353 (549)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......++    ..+++++++||.+||+
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~  328 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLI  328 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSC
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcC
Confidence            799999999999999999999999999999999999999999998888888877765554    4689999999999999


Q ss_pred             hCcCCCCCHHHHhcCcccCccc
Q psy18060        354 KDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      .||.+|||+.|+|+||||++..
T Consensus       329 ~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          329 KEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             SSGGGSCCHHHHHHSHHHHCHH
T ss_pred             CChhhCCCHHHHhcCcCcCCCc
Confidence            9999999999999999998653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.5e-47  Score=394.20  Aligned_cols=264  Identities=27%  Similarity=0.420  Sum_probs=227.0

Q ss_pred             cccccccceeEE-EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeC
Q psy18060        113 KSNGALEKYQKI-CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETL  190 (549)
Q Consensus       113 ~~~~~~~~y~~~-~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  190 (549)
                      ......++|.+. +.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.+ .||||+++++++...
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            334445678887 899999999999999999999999999987555445567889999999999 569999999999999


Q ss_pred             CEEEEEEecCCC-CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec---CCcEEEeecccc
Q psy18060        191 NEFVLITEFAHM-SLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK---DGVAMLCDFGFA  264 (549)
Q Consensus       191 ~~~~iV~E~~~g-sL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~---~g~vKL~DFGla  264 (549)
                      +.+++||||+.| +|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            999999999985 899888553  67999999999999999999999999999999999999987   789999999999


Q ss_pred             eecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccC
Q psy18060        265 RSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQV  340 (549)
Q Consensus       265 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~  340 (549)
                      +...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......++    ..+
T Consensus       182 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  260 (327)
T 3lm5_A          182 RKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV  260 (327)
T ss_dssp             EEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred             cccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhccc
Confidence            8765432 23456799999999999999999999999999999999999999999988888777766544433    468


Q ss_pred             CHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        341 SETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       341 s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                      ++.+.+||.+||+.||.+|||++|+|+||||++....
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence            9999999999999999999999999999999876443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-47  Score=401.66  Aligned_cols=251  Identities=29%  Similarity=0.468  Sum_probs=213.8

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-------
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-------  189 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-------  189 (549)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++......      ..+|+++++.++||||+++++++..       
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            356899999999999999999999999999999998754322      2379999999999999999998843       


Q ss_pred             -------------------------------CCEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Q psy18060        190 -------------------------------LNEFVLITEFAHMSLSNLLEQ----RKKLSETICVQILSNLISALYYLH  234 (549)
Q Consensus       190 -------------------------------~~~~~iV~E~~~gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH  234 (549)
                                                     ...+++||||++++|.+.+..    ...+++..++.++.||+.||.|||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           345899999999988777753    567999999999999999999999


Q ss_pred             hCCCccccccCCcEEEe-cCCcEEEeecccceecccCcccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHh
Q psy18060        235 SNRVLHRDLKPQNVLLN-KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHM  312 (549)
Q Consensus       235 ~~gIiHrDIKP~NILl~-~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLlt  312 (549)
                      ++||+||||||+|||++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus       159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence            99999999999999998 67899999999998765443 34556799999999998764 59999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcC-----------------CC------------CCCccCCHHHHHHHHHhchhCcCCCCCHH
Q psy18060        313 GHPPFKTVSILHLIRLLKTQ-----------------DV------------TFPSQVSETYKDLVKGLLEKDASQRLSWP  363 (549)
Q Consensus       313 G~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~  363 (549)
                      |++||.+.+..+.+..+...                 ..            .+|..+++++.+||.+||+.||.+|||+.
T Consensus       238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  317 (383)
T 3eb0_A          238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY  317 (383)
T ss_dssp             SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            99999998877666554320                 00            13456899999999999999999999999


Q ss_pred             HHhcCcccCcc
Q psy18060        364 ELLHHPLVKDN  374 (549)
Q Consensus       364 elL~Hpw~~~~  374 (549)
                      |+|+||||++.
T Consensus       318 e~l~hp~f~~~  328 (383)
T 3eb0_A          318 EAMAHPFFDHL  328 (383)
T ss_dssp             HHHTSGGGHHH
T ss_pred             HHhcCHHHHHH
Confidence            99999999754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4e-47  Score=386.01  Aligned_cols=254  Identities=32%  Similarity=0.540  Sum_probs=226.0

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++.....  .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            35679999999999999999999999999999999976432  2235688999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE---ecCCcEEEeecccceecccCcc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl---~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      |||+. ++|.+++..++.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||+++.....  
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--  162 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--  162 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence            99997 5999999988899999999999999999999999999999999999999   77889999999999765432  


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDLV  348 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dlI  348 (549)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..+...++    +.+++.+.+||
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  242 (304)
T 2jam_A          163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFI  242 (304)
T ss_dssp             TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred             ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence            23445699999999999999999999999999999999999999999998888888877755433    56899999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+||+.||.+|||+.|+++||||.+.
T Consensus       243 ~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          243 CHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHcCCChhHCcCHHHHhcCccccCC
Confidence            99999999999999999999999753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.4e-47  Score=380.40  Aligned_cols=253  Identities=26%  Similarity=0.451  Sum_probs=220.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee----CCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET----LNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~  193 (549)
                      ...|++.+.||+|+||.||+|.+..++..||+|.+............+.+|+.+++.++||||+++++++..    ...+
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            345899999999999999999999999999999998766667777889999999999999999999998865    3568


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccCCcEEEe-cCCcEEEeecccceeccc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR--VLHRDLKPQNVLLN-KDGVAMLCDFGFARSMAV  269 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IiHrDIKP~NILl~-~~g~vKL~DFGla~~~~~  269 (549)
                      ++||||+. ++|.+++.....+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.....
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            99999997 599999999899999999999999999999999999  99999999999998 789999999999965443


Q ss_pred             CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCC--CCCCccCCHHHHH
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV-SILHLIRLLKTQD--VTFPSQVSETYKD  346 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~-~~~~~~~~i~~~~--~~~p~~~s~~~~d  346 (549)
                      .  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||... ........+..+.  ..++...++++.+
T Consensus       185 ~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  261 (290)
T 1t4h_A          185 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  261 (290)
T ss_dssp             T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             c--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHH
Confidence            2  2345679999999998874 5899999999999999999999999874 4445555554432  2344567899999


Q ss_pred             HHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        347 LVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      +|.+||+.||.+|||+.|+++||||++
T Consensus       262 li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          262 IIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHccCChhhCCCHHHHhhCccccc
Confidence            999999999999999999999999975

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.4e-47  Score=387.07  Aligned_cols=256  Identities=26%  Similarity=0.470  Sum_probs=217.6

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ....+|++.+.||+|+||.||+|.+  +++.||+|++..........+.+.+|+.++++++||||+++++++...+.+++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            3457899999999999999999976  48899999998776667777889999999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--CccccccCCcEEEecCCcEEEeecccceeccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKK---LSETICVQILSNLISALYYLHSNR--VLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV  269 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~---l~e~~~~~i~~qIl~aL~yLH~~g--IiHrDIKP~NILl~~~g~vKL~DFGla~~~~~  269 (549)
                      ||||+. |+|.+++.....   +++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++....
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            999997 599999987654   999999999999999999999999  99999999999999999999999999976554


Q ss_pred             CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCccCCHHHHHH
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLK--TQDVTFPSQVSETYKDL  347 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dl  347 (549)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.  .....+|..+++++.++
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  271 (309)
T 3p86_A          192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI  271 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred             cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence            4333456689999999999999999999999999999999999999999998888777663  44566788999999999


Q ss_pred             HHHhchhCcCCCCCHHHHhc--CcccCc
Q psy18060        348 VKGLLEKDASQRLSWPELLH--HPLVKD  373 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~--Hpw~~~  373 (549)
                      |.+||+.||.+|||+.++++  .++++.
T Consensus       272 i~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          272 IEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            99999999999999999987  455543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.2e-47  Score=404.80  Aligned_cols=252  Identities=30%  Similarity=0.555  Sum_probs=209.0

Q ss_pred             cccccceeEE-EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHH-HhcCCCCeeEEEEEEee---
Q psy18060        115 NGALEKYQKI-CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ-KHLAHPNIIKFIASHET---  189 (549)
Q Consensus       115 ~~~~~~y~~~-~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~---  189 (549)
                      ...+++|.+. +.||+|+||.||+|.+..+++.||||++...       ..+.+|+.++ +..+||||+++++++..   
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            3456778887 7899999999999999999999999999642       3456788886 45589999999999876   


Q ss_pred             -CCEEEEEEecCCC-CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec---CCcEEEeecc
Q psy18060        190 -LNEFVLITEFAHM-SLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK---DGVAMLCDFG  262 (549)
Q Consensus       190 -~~~~~iV~E~~~g-sL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~---~g~vKL~DFG  262 (549)
                       .+.+||||||+.| +|.+++..+.  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             5678999999974 9999998754  5999999999999999999999999999999999999997   7899999999


Q ss_pred             cceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCCCCC-
Q psy18060        263 FARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL----HLIRLLKTQDVTFP-  337 (549)
Q Consensus       263 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~----~~~~~i~~~~~~~p-  337 (549)
                      +++..... ...+..+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+....    .....+..+...+| 
T Consensus       210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          210 FAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             TCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             cccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            99876533 2345678999999999999999999999999999999999999999765432    13344555555544 


Q ss_pred             ---ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        338 ---SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       338 ---~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                         ..+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence               4689999999999999999999999999999999753

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.3e-47  Score=399.98  Aligned_cols=256  Identities=29%  Similarity=0.449  Sum_probs=219.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE----
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF----  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~----  193 (549)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4789999999999999999999999999999999987666666677889999999999999999999999876654    


Q ss_pred             --EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 --VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 --~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                        ++||||++++|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  
T Consensus       121 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--  196 (371)
T 4exu_A          121 DFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--  196 (371)
T ss_dssp             CCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred             eEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc--
Confidence              9999999999988874  4599999999999999999999999999999999999999999999999999976543  


Q ss_pred             ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------
Q psy18060        272 HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV----------------  334 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~----------------  334 (549)
                       ..+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....                
T Consensus       197 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  275 (371)
T 4exu_A          197 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK  275 (371)
T ss_dssp             ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred             -CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence             2355679999999999977 7899999999999999999999999999887666655432100                


Q ss_pred             ---------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccchh
Q psy18060        335 ---------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSE  378 (549)
Q Consensus       335 ---------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~~  378 (549)
                                     ..++.+++.+.+||.+||+.||.+|||+.|+|+||||+....+.
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  334 (371)
T 4exu_A          276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE  334 (371)
T ss_dssp             HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcc
Confidence                           01235799999999999999999999999999999998755433

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.5e-47  Score=396.38  Aligned_cols=257  Identities=28%  Similarity=0.441  Sum_probs=220.0

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-----CE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-----NE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~  192 (549)
                      ..+|++++.||+|+||.||+|.+..+++.||+|++... ........+.+|++++++++||||+++++++...     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            36899999999999999999999999999999999753 3344557788999999999999999999998654     46


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        193 FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      .|+|||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       105 ~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  183 (364)
T 3qyz_A          105 VYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  183 (364)
T ss_dssp             EEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence            899999999999999876 5699999999999999999999999999999999999999999999999999987654322


Q ss_pred             ---cccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------------
Q psy18060        273 ---MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----------------  332 (549)
Q Consensus       273 ---~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~----------------  332 (549)
                         ..+..+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+...                
T Consensus       184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  263 (364)
T 3qyz_A          184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  263 (364)
T ss_dssp             BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence               1345689999999998754 55899999999999999999999999887765555444210                


Q ss_pred             ----------CCC-----CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        333 ----------DVT-----FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       333 ----------~~~-----~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                                ...     .++.+++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                      000     12457899999999999999999999999999999987644

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.9e-48  Score=396.81  Aligned_cols=258  Identities=29%  Similarity=0.478  Sum_probs=220.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC---CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG---RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .++|++.+.||+|+||.||+|.+..++..||+|++.+..   ........+.+|+.+++.++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            477999999999999999999999999999999986532   23345678899999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q psy18060        195 LITEFAH-MSLSNLLEQ----------------------------------------RKKLSETICVQILSNLISALYYL  233 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~----------------------------------------~~~l~e~~~~~i~~qIl~aL~yL  233 (549)
                      +||||+. |+|.+++..                                        ...+++..++.++.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            9999997 689998852                                        11246788899999999999999


Q ss_pred             HhCCCccccccCCcEEEecCC--cEEEeecccceecccCcc----cccccCCCCcccccccccC--CCCCcchhhHHHHH
Q psy18060        234 HSNRVLHRDLKPQNVLLNKDG--VAMLCDFGFARSMAVGTH----MLTSIKGTPLYMAPELIAE--RPYDHTADLWSLGC  305 (549)
Q Consensus       234 H~~gIiHrDIKP~NILl~~~g--~vKL~DFGla~~~~~~~~----~~~~~~GT~~Y~APE~l~~--~~y~~ksDIwSlGv  305 (549)
                      |++||+||||||+|||++.++  .+||+|||+++.......    ......||+.|+|||++.+  ..++.++|||||||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998776  899999999986643211    2345679999999999965  67899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        306 IAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       306 il~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      ++|+|++|+.||.+.+.......+......++.    .+++.+.+||.+||+.||.+|||+.|+++||||++..
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            999999999999999988888887776654442    4799999999999999999999999999999997643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-46  Score=393.56  Aligned_cols=255  Identities=31%  Similarity=0.546  Sum_probs=227.6

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC--Ch----HHHHHHHHHHHHHHhc-CCCCeeEEEEEEee
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR--SG----KELSSLKQECEIQKHL-AHPNIIKFIASHET  189 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~----~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  189 (549)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++.....  ..    .....+.+|+.+++.+ .||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            34679999999999999999999999999999999976532  11    1245678999999999 79999999999999


Q ss_pred             CCEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        190 LNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       190 ~~~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                      .+..++||||+.| +|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            9999999999985 899999988899999999999999999999999999999999999999999999999999998776


Q ss_pred             cCcccccccCCCCcccccccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----c
Q psy18060        269 VGTHMLTSIKGTPLYMAPELIAE------RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----S  338 (549)
Q Consensus       269 ~~~~~~~~~~GT~~Y~APE~l~~------~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  338 (549)
                      ... .....+||+.|+|||++.+      ..++.++|||||||++|+|++|..||...+.......+..+...++    .
T Consensus       252 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  330 (365)
T 2y7j_A          252 PGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD  330 (365)
T ss_dssp             TTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred             CCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            443 3455689999999999853      3688999999999999999999999999888888888877766554    4


Q ss_pred             cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       339 ~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      .+++.+.+||.+||+.||.+|||+.|+++||||+
T Consensus       331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            6899999999999999999999999999999996

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-47  Score=392.35  Aligned_cols=254  Identities=24%  Similarity=0.420  Sum_probs=210.7

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-----
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----  191 (549)
                      .+++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+++++.++||||+++++++.+..     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            3578999999999999999999999999999999997654 3344578899999999999999999999885543     


Q ss_pred             ----------------------------------------------------EEEEEEecCCC-CHHHHHHhcCC---CC
Q psy18060        192 ----------------------------------------------------EFVLITEFAHM-SLSNLLEQRKK---LS  215 (549)
Q Consensus       192 ----------------------------------------------------~~~iV~E~~~g-sL~~~l~~~~~---l~  215 (549)
                                                                          .+++|||||.| +|.+++..+..   .+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                38999999985 89999987654   56


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc------------ccccccCCCCcc
Q psy18060        216 ETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT------------HMLTSIKGTPLY  283 (549)
Q Consensus       216 e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~------------~~~~~~~GT~~Y  283 (549)
                      +..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......            .......||+.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            66789999999999999999999999999999999999999999999998765432            123445799999


Q ss_pred             cccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCccCCHHHHHHHHHhchhCcCCCCCH
Q psy18060        284 MAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-FPSQVSETYKDLVKGLLEKDASQRLSW  362 (549)
Q Consensus       284 ~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~dlI~~~L~~dP~~Rps~  362 (549)
                      +|||++.+..++.++|||||||++|+|++|..|+..  .......+.....+ .+...++.+.+||.+||+.||.+|||+
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  320 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA  320 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence            999999999999999999999999999998776532  22223333333221 124567889999999999999999999


Q ss_pred             HHHhcCcccCc
Q psy18060        363 PELLHHPLVKD  373 (549)
Q Consensus       363 ~elL~Hpw~~~  373 (549)
                      .|+++||||++
T Consensus       321 ~~~l~~~~f~~  331 (332)
T 3qd2_B          321 TDIIENAIFEN  331 (332)
T ss_dssp             HHHHHSTTCCC
T ss_pred             HHHhhchhhhc
Confidence            99999999975

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=385.86  Aligned_cols=259  Identities=25%  Similarity=0.465  Sum_probs=226.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEE--eeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR--SGKELSSLKQECEIQKHLAHPNIIKFIASH--ETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~~~  193 (549)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++.....  .......+.+|+.+++.++||||+++++++  ...+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            5789999999999999999999999999999999965321  123356789999999999999999999998  455678


Q ss_pred             EEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC-
Q psy18060        194 VLITEFAHMSLSNLLEQ--RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG-  270 (549)
Q Consensus       194 ~iV~E~~~gsL~~~l~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~-  270 (549)
                      ++||||+.++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... 
T Consensus        84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            99999999888888876  456999999999999999999999999999999999999999999999999999876432 


Q ss_pred             -cccccccCCCCcccccccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHH
Q psy18060        271 -THMLTSIKGTPLYMAPELIAERP--YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDL  347 (549)
Q Consensus       271 -~~~~~~~~GT~~Y~APE~l~~~~--y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dl  347 (549)
                       ........||+.|+|||++.+..  ++.++|||||||++|+|++|+.||.+.+.......+......+|..+++.+.+|
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~l  243 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDL  243 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHH
T ss_pred             cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHH
Confidence             22234557999999999997643  478999999999999999999999999999988888888888899999999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      |.+||+.||.+|||+.|+++||||+....
T Consensus       244 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          244 LKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             HHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            99999999999999999999999986544

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-47  Score=395.93  Aligned_cols=266  Identities=27%  Similarity=0.474  Sum_probs=227.3

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGR--SGKELSSLKQECEIQKHL-AHPNIIKFIASHET  189 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  189 (549)
                      ..+++|++.+.||+|+||.||+|.+.   .+++.||+|++.+...  .......+.+|+++++.+ .||||+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            34578999999999999999999984   5789999999864321  111234566789999999 69999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                      .+.+++||||+. ++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            999999999997 5999999998899999999999999999999999999999999999999999999999999998664


Q ss_pred             cC-cccccccCCCCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCCCCCCccCC
Q psy18060        269 VG-THMLTSIKGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQDVTFPSQVS  341 (549)
Q Consensus       269 ~~-~~~~~~~~GT~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s  341 (549)
                      .. .......+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...    ........+......+|..++
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  290 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccC
Confidence            32 223345679999999999975  45789999999999999999999999643    455666667777778889999


Q ss_pred             HHHHHHHHHhchhCcCCCC-----CHHHHhcCcccCcccchhhhh
Q psy18060        342 ETYKDLVKGLLEKDASQRL-----SWPELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       342 ~~~~dlI~~~L~~dP~~Rp-----s~~elL~Hpw~~~~~~~~~~~  381 (549)
                      +.+.+||.+||+.||.+||     |+.|+++||||....+..+..
T Consensus       291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~  335 (355)
T 1vzo_A          291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA  335 (355)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred             HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhh
Confidence            9999999999999999999     999999999999776555543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.5e-47  Score=376.96  Aligned_cols=259  Identities=25%  Similarity=0.405  Sum_probs=222.6

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            35789999999999999999999999999999999975432 23456789999999999999999999999999999999


Q ss_pred             EecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc--cc
Q psy18060        197 TEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HM  273 (549)
Q Consensus       197 ~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~--~~  273 (549)
                      ||++.+ +|.+++..+..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  ..
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            999985 899999888889999999999999999999999999999999999999999999999999997654322  22


Q ss_pred             ccccCCCCcccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCCC--CCccCCHHHHHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAERPY-DHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQDVT--FPSQVSETYKDLVK  349 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y-~~ksDIwSlGvil~eLltG~~Pf~~~~~~-~~~~~i~~~~~~--~p~~~s~~~~dlI~  349 (549)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .....+......  .+..+++.+.++|.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence            345679999999999987765 78999999999999999999999875432 222333332222  23578999999999


Q ss_pred             HhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        350 GLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      +||+.||.+|||+.|+++||||++...
T Consensus       244 ~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          244 KILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHCCCCchhCCCHHHHhcCccccChhh
Confidence            999999999999999999999987644

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=9.4e-47  Score=381.94  Aligned_cols=260  Identities=31%  Similarity=0.500  Sum_probs=221.2

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ....++|++.+.||+|+||.||+|.+..+++.+|+|++....  ......+.+|+.+++.++||||+++++++...+..+
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW   92 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence            345578999999999999999999999999999999986542  234567889999999999999999999999999999


Q ss_pred             EEEecCCC-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAHM-SLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~g-sL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            99999985 79888876 56799999999999999999999999999999999999999999999999999864432222


Q ss_pred             cccccCCCCcccccccc-----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCccCCHHH
Q psy18060        273 MLTSIKGTPLYMAPELI-----AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---TFPSQVSETY  344 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l-----~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~  344 (549)
                      ......||+.|+|||++     .+..++.++|||||||++|+|++|..||...+.......+.....   ..|..+++.+
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  252 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF  252 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHH
Confidence            33456799999999998     467789999999999999999999999999888777766655432   2356789999


Q ss_pred             HHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        345 KDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      .++|.+||+.||.+|||+.++++||||.....
T Consensus       253 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          253 RDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             HHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            99999999999999999999999999986544

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-48  Score=410.58  Aligned_cols=250  Identities=16%  Similarity=0.197  Sum_probs=208.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHH---HHHHhcCCCCeeEEE-------E
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQEC---EIQKHLAHPNIIKFI-------A  185 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei---~il~~l~hpnIv~l~-------~  185 (549)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+   ++++.++|||||+++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            3578999999999999999999999999999999997643 2334567888999   455566899999988       6


Q ss_pred             EEeeCC-----------------EEEEEEecCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCccc
Q psy18060        186 SHETLN-----------------EFVLITEFAHMSLSNLLEQRKKLSE-------TICVQILSNLISALYYLHSNRVLHR  241 (549)
Q Consensus       186 ~~~~~~-----------------~~~iV~E~~~gsL~~~l~~~~~l~e-------~~~~~i~~qIl~aL~yLH~~gIiHr  241 (549)
                      +++..+                 ..|+||||++|+|.+++...+.+++       ..+..++.||+.||+|||++||+||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            666553                 2789999999999999988666665       7788899999999999999999999


Q ss_pred             cccCCcEEEecCCcEEEeecccceecccCcccccccCCCCcccccccccCC-----------CCCcchhhHHHHHHHHHH
Q psy18060        242 DLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER-----------PYDHTADLWSLGCIAYEI  310 (549)
Q Consensus       242 DIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----------~y~~ksDIwSlGvil~eL  310 (549)
                      ||||+|||++.+|.+||+|||+|+....   ..+..+| +.|+|||++.+.           .|+.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999999999999999986432   3456678 999999999877           899999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        311 HMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       311 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ++|+.||.+.+.......+..    .++.+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHSSCCC------CCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHCCCCCcccccccchhhhhh----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            999999987655443333322    236789999999999999999999999999999999753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.2e-47  Score=389.71  Aligned_cols=261  Identities=23%  Similarity=0.410  Sum_probs=220.6

Q ss_pred             cccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       113 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      ......++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            344456789999999999999999999999999999999976543 3445567899999999999999999999886543


Q ss_pred             ----EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        192 ----EFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       192 ----~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                          ..|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence                3599999997 59999999989999999999999999999999999999999999999999999999999999976


Q ss_pred             cccCcc---cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----cc
Q psy18060        267 MAVGTH---MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQ  339 (549)
Q Consensus       267 ~~~~~~---~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~  339 (549)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......+    ..
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  245 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence            643321   22345799999999999999999999999999999999999999999988777666655544332    45


Q ss_pred             CCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       340 ~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      +++++.++|.+||+.||.+||++.+++.|+|++.
T Consensus       246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            8999999999999999999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.4e-46  Score=387.63  Aligned_cols=258  Identities=29%  Similarity=0.438  Sum_probs=218.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-----C
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-----N  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~  191 (549)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++...     .
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            457899999999999999999999999999999999643 3344556788999999999999999999987654     6


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        192 EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       192 ~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ..++|||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        88 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           88 EVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             CEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             eEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            7899999999999999876 579999999999999999999999999999999999999999999999999998764321


Q ss_pred             c----------cccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC----
Q psy18060        272 H----------MLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT---QD----  333 (549)
Q Consensus       272 ~----------~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~---~~----  333 (549)
                      .          ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+..   .+    
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN  246 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence            1          1234578999999998754 7799999999999999999999999998876655443321   00    


Q ss_pred             -----------------CC--------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        334 -----------------VT--------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       334 -----------------~~--------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                                       ..        .++.+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence                             00        11368999999999999999999999999999999986544

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1e-46  Score=392.46  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=221.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++... ........+.+|+.+++.++||||+++++++...+..++|
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            346799999999999999999999999999999999764 3455567889999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      |||+. ++|.+++...+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus       110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  187 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA  187 (360)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C-
T ss_pred             EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence            99997 49999999988999999999999999999999996 9999999999999999999999999998765432  23


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------------------
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRL--------------------------  328 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~--------------------------  328 (549)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......                          
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF  267 (360)
T ss_dssp             ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred             cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence            456799999999999999999999999999999999999999987665443222                          


Q ss_pred             ----------------HhcC-CCCCC-ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        329 ----------------LKTQ-DVTFP-SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       329 ----------------i~~~-~~~~p-~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                                      +... ....+ ..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                            1111 11222 34799999999999999999999999999999997543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-46  Score=385.63  Aligned_cols=253  Identities=24%  Similarity=0.410  Sum_probs=216.8

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEE-cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCC------eeEEEEEEe
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIH-LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN------IIKFIASHE  188 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~~~~  188 (549)
                      ...++|++.+.||+|+||.||+|.+ ..+++.||+|++...   ......+.+|+.+++.++|++      ++++++++.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            3457899999999999999999998 567899999999643   344567889999999886654      999999999


Q ss_pred             eCCEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec--------------
Q psy18060        189 TLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK--------------  252 (549)
Q Consensus       189 ~~~~~~iV~E~~~gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~--------------  252 (549)
                      ..+.+++||||++++|.+++..++  .+++..++.++.||+.||+|||++||+||||||+|||++.              
T Consensus        88 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           88 HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            999999999999989999998765  6899999999999999999999999999999999999987              


Q ss_pred             -----CCcEEEeecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy18060        253 -----DGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIR  327 (549)
Q Consensus       253 -----~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~  327 (549)
                           ++.+||+|||+++....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+......
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             cccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                 66899999999976543   2345679999999999999999999999999999999999999999887766554


Q ss_pred             HHhcCCCCC--------------------------------------------CccCCHHHHHHHHHhchhCcCCCCCHH
Q psy18060        328 LLKTQDVTF--------------------------------------------PSQVSETYKDLVKGLLEKDASQRLSWP  363 (549)
Q Consensus       328 ~i~~~~~~~--------------------------------------------p~~~s~~~~dlI~~~L~~dP~~Rps~~  363 (549)
                      .+......+                                            +...++.+.+||.+||+.||.+|||+.
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  324 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR  324 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence            432211111                                            123457889999999999999999999


Q ss_pred             HHhcCcccCcc
Q psy18060        364 ELLHHPLVKDN  374 (549)
Q Consensus       364 elL~Hpw~~~~  374 (549)
                      |+++||||+..
T Consensus       325 ell~hp~f~~~  335 (339)
T 1z57_A          325 EALKHPFFDLL  335 (339)
T ss_dssp             HHTTSGGGGGG
T ss_pred             HHhcCHHHHHH
Confidence            99999999753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.5e-47  Score=399.71  Aligned_cols=252  Identities=30%  Similarity=0.455  Sum_probs=211.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-----
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----  191 (549)
                      ...+|++.+.||+|+||.||+|.+..+++ +|+|.+......      ..+|+++++.++||||+++++++....     
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            35679999999999999999999988766 888887654321      236999999999999999999985443     


Q ss_pred             -EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe-cCCcEEEeecccce
Q psy18060        192 -EFVLITEFAHMSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN-KDGVAMLCDFGFAR  265 (549)
Q Consensus       192 -~~~iV~E~~~gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~-~~g~vKL~DFGla~  265 (549)
                       .+++||||+++++.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence             3889999999887666543    56799999999999999999999999999999999999999 78999999999998


Q ss_pred             ecccCcccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------
Q psy18060        266 SMAVGTHMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ------------  332 (549)
Q Consensus       266 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~------------  332 (549)
                      ....+. ......||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+....+..+...            
T Consensus       191 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          191 ILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             ECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            765443 33556799999999998764 5999999999999999999999999998876665544321            


Q ss_pred             -----CC------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        333 -----DV------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       333 -----~~------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                           ..            .+++.+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                 00            123458899999999999999999999999999999986543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.2e-47  Score=396.77  Aligned_cols=251  Identities=23%  Similarity=0.379  Sum_probs=212.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC--------CCCeeEEEEEEe
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA--------HPNIIKFIASHE  188 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~~~~~  188 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...   ......+.+|+.+++.+.        ||||+++++++.
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            457899999999999999999999999999999999643   344567889999999985        788999999987


Q ss_pred             ----eCCEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCC-------
Q psy18060        189 ----TLNEFVLITEFAHMSLSNLLEQR--KKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDG-------  254 (549)
Q Consensus       189 ----~~~~~~iV~E~~~gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g-------  254 (549)
                          ....+++||||++++|.+.+...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++       
T Consensus       112 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          112 ISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             EEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             ecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence                55689999999999988888765  4699999999999999999999999 999999999999998775       


Q ss_pred             ------------------------------------------cEEEeecccceecccCcccccccCCCCcccccccccCC
Q psy18060        255 ------------------------------------------VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER  292 (549)
Q Consensus       255 ------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~  292 (549)
                                                                .+||+|||+|+.....   .+...||+.|+|||++.+.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTS
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCC
Confidence                                                      7999999999876532   3556799999999999999


Q ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhc--C--------------------------------
Q psy18060        293 PYDHTADLWSLGCIAYEIHMGHPPFKTVS------ILHLIRLLKT--Q--------------------------------  332 (549)
Q Consensus       293 ~y~~ksDIwSlGvil~eLltG~~Pf~~~~------~~~~~~~i~~--~--------------------------------  332 (549)
                      .++.++|||||||++|+|++|+.||.+.+      .......+..  +                                
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence            99999999999999999999999997644      2222222111  0                                


Q ss_pred             --------CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        333 --------DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       333 --------~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                              ...++...++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                    11223445678899999999999999999999999999963

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.4e-46  Score=384.81  Aligned_cols=257  Identities=32%  Similarity=0.498  Sum_probs=218.1

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEc-CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc---CCCCeeEEEEEEe----
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHL-DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL---AHPNIIKFIASHE----  188 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----  188 (549)
                      ..++|++.+.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.+   .||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3478999999999999999999995 6788999999875433222223455677777666   8999999999986    


Q ss_pred             -eCCEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccce
Q psy18060        189 -TLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       189 -~~~~~~iV~E~~~gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                       .....++|||+++|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus        89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence             556789999999999999998754  49999999999999999999999999999999999999999999999999997


Q ss_pred             ecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------
Q psy18060        266 SMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD------------  333 (549)
Q Consensus       266 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~------------  333 (549)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....            
T Consensus       169 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (326)
T 1blx_A          169 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  247 (326)
T ss_dssp             CCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             cccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence            66533 23455679999999999999999999999999999999999999999988776665553210            


Q ss_pred             ---------------CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        334 ---------------VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       334 ---------------~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                     ..+++.+++.+++||.+||+.||.+|||+.|+++||||++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence                           01235689999999999999999999999999999999764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=382.01  Aligned_cols=256  Identities=33%  Similarity=0.568  Sum_probs=221.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+.....    ...+.+|+.+++.++||||+++++++...+.+++|
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            35679999999999999999999999999999999976432    35678999999999999999999999999999999


Q ss_pred             EecCCC-CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        197 TEFAHM-SLSNLLE-QRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       197 ~E~~~g-sL~~~l~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      |||+++ +|.+++. ....+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..........
T Consensus       103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR  182 (314)
T ss_dssp             EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred             eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence            999985 8999997 45679999999999999999999999999999999999999999999999999998766544444


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCccCCHHHHHHHHHh
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD---VTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~dlI~~~  351 (549)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....   ...|..+++.+.++|.+|
T Consensus       183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  262 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC  262 (314)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHH
T ss_pred             CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHH
Confidence            56679999999999999999999999999999999999999999888776665554443   233567899999999999


Q ss_pred             chhCcCCCCCHHHHhcCcccCcccc
Q psy18060        352 LEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      |..||.+|||+.++++||||+....
T Consensus       263 l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          263 LVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             TCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             ccCChhhCcCHHHHHhCHHHhcCCc
Confidence            9999999999999999999986543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.8e-46  Score=378.35  Aligned_cols=256  Identities=35%  Similarity=0.547  Sum_probs=229.0

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..+.|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.+.||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            34679999999999999999999999999999999976543 23457889999999999999999999999999999999


Q ss_pred             EecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||+++ +|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++...........
T Consensus        99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            999985 89998864 5799999999999999999999999999999999999999999999999999987765444445


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhchh
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+... ...++..+++.+.++|.+||+.
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  257 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK  257 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCS
T ss_pred             ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCC
Confidence            667999999999999999999999999999999999999999998887777666544 3446678999999999999999


Q ss_pred             CcCCCCCHHHHhcCcccCcc
Q psy18060        355 DASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       355 dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ||.+|||+.++++||||...
T Consensus       258 dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          258 EPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             SGGGSCCHHHHTTCHHHHHH
T ss_pred             ChhhCcCHHHHhhChhhhcC
Confidence            99999999999999999643

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=391.30  Aligned_cols=255  Identities=29%  Similarity=0.455  Sum_probs=218.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE-----
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE-----  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-----  192 (549)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467999999999999999999999999999999998765556666788999999999999999999999977653     


Q ss_pred             -EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 -FVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 -~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                       +++||||++++|.+++.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... 
T Consensus       103 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-  179 (353)
T 3coi_A          103 DFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-  179 (353)
T ss_dssp             CCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred             eEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence             59999999999888774  35999999999999999999999999999999999999999999999999999765432 


Q ss_pred             ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------
Q psy18060        272 HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ------------------  332 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~------------------  332 (549)
                        .+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...                  
T Consensus       180 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  257 (353)
T 3coi_A          180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK  257 (353)
T ss_dssp             ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred             --ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence              345679999999999877 67899999999999999999999999988876655544220                  


Q ss_pred             -------------CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        333 -------------DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       333 -------------~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                                   ....++.+++.+.+||.+||+.||.+|||+.|+++||||+.....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence                         011234679999999999999999999999999999999865443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.9e-46  Score=399.92  Aligned_cols=251  Identities=29%  Similarity=0.431  Sum_probs=211.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC------C
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------N  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~  191 (549)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++.....      ...+|+++++.++|||||++++++...      .
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            4569999999999999999999999999999999875432      224699999999999999999987432      2


Q ss_pred             EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC-CcEEEeeccccee
Q psy18060        192 EFVLITEFAHMSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARS  266 (549)
Q Consensus       192 ~~~iV~E~~~gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~-g~vKL~DFGla~~  266 (549)
                      .+++||||++++|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus       127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            4679999999988777653    5679999999999999999999999999999999999999965 5789999999987


Q ss_pred             cccCcccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------------
Q psy18060        267 MAVGTHMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT--------------  331 (549)
Q Consensus       267 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~--------------  331 (549)
                      ..... ......||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+..              
T Consensus       207 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          207 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             CCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             cccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            65432 33556899999999999764 799999999999999999999999999876655544422              


Q ss_pred             ---CCCC------------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        332 ---QDVT------------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       332 ---~~~~------------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                         ....            +++.+++++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence               0111            2345789999999999999999999999999999997643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.3e-47  Score=380.54  Aligned_cols=259  Identities=31%  Similarity=0.575  Sum_probs=228.9

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|++++++++||||+++++++...+..
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            34456789999999999999999999999999999999976544444567889999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC---CcEEEeecccceeccc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD---GVAMLCDFGFARSMAV  269 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~---g~vKL~DFGla~~~~~  269 (549)
                      ++|||++. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||+++....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            99999997 5899999888899999999999999999999999999999999999999764   4799999999976643


Q ss_pred             CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHH
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYK  345 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  345 (549)
                      .. ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+.......+..+...++    ..+++++.
T Consensus       177 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          177 NT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             CS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             CC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            32 22344689999999998764 89999999999999999999999999998888888877765443    46899999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ++|.+||+.||.+|||+.|+++||||++.
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            99999999999999999999999999754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3e-46  Score=378.85  Aligned_cols=255  Identities=24%  Similarity=0.426  Sum_probs=217.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++||||+++++++...+.+++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            3467999999999999999999999999999999986644 344556788999999999999999999999999999999


Q ss_pred             EEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-cc
Q psy18060        196 ITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-HM  273 (549)
Q Consensus       196 V~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-~~  273 (549)
                      ||||+.| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus        89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            9999974 999999999999999999999999999999999999999999999999999999999999997664332 22


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCccCCHHHHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT-----FPSQVSETYKDLV  348 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~dlI  348 (549)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..............     .++.+|+.+.++|
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  248 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVI  248 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHH
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHH
Confidence            33457999999999999999999999999999999999999999998877665554444322     3457899999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCccc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      .+||++||.+||+..+.+.++|.
T Consensus       249 ~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          249 LRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             HHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHhcCCHhHccccHHHHHHHHH
Confidence            99999999999966666666664

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.2e-46  Score=384.32  Aligned_cols=251  Identities=26%  Similarity=0.452  Sum_probs=211.9

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEee--CCE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHET--LNE  192 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~  192 (549)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...     ....+.+|+.+++.+. ||||+++++++..  ...
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            3457899999999999999999999999999999998643     2356889999999997 9999999999987  667


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-cEEEeecccceecccC
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-VAMLCDFGFARSMAVG  270 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-~vKL~DFGla~~~~~~  270 (549)
                      .++||||+. ++|.+++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus       108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            899999998 57888774   489999999999999999999999999999999999999777 8999999999876544


Q ss_pred             cccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHH-------------HHhcCCCC
Q psy18060        271 THMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTV-SILHLIR-------------LLKTQDVT  335 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~-~~~~~~~-------------~i~~~~~~  335 (549)
                      . ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... +......             .+......
T Consensus       185 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          185 Q-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             C-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             C-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence            3 3455679999999999977 67999999999999999999999999543 2222221             11111111


Q ss_pred             C------------------------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        336 F------------------------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       336 ~------------------------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      .                        +..+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            1                        223799999999999999999999999999999998654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=381.58  Aligned_cols=257  Identities=30%  Similarity=0.440  Sum_probs=213.1

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe--------
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE--------  188 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--------  188 (549)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++.        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            347899999999999999999999999999999998753  3455678899999999999999999998873        


Q ss_pred             ------eCCEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe-cCCcEEEeec
Q psy18060        189 ------TLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN-KDGVAMLCDF  261 (549)
Q Consensus       189 ------~~~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~-~~g~vKL~DF  261 (549)
                            ..+..++||||++|+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus        87 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             ----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             ccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence                  4468899999999999999864 6799999999999999999999999999999999999998 4679999999


Q ss_pred             ccceecccCc---ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--
Q psy18060        262 GFARSMAVGT---HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT--  335 (549)
Q Consensus       262 Gla~~~~~~~---~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~--  335 (549)
                      |+++......   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......  
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH  245 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            9998664321   12234568999999999865 77999999999999999999999999998876666554332110  


Q ss_pred             ----------------------------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        336 ----------------------------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       336 ----------------------------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                                                  .++.+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence                                        12458999999999999999999999999999999986543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=380.84  Aligned_cols=263  Identities=29%  Similarity=0.526  Sum_probs=218.8

Q ss_pred             cccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee
Q psy18060        111 MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET  189 (549)
Q Consensus       111 ~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  189 (549)
                      ........++|++.+.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.+++.+ .||||+++++++..
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            33444566889999999999999999999999999999999975432   235678999999998 89999999999876


Q ss_pred             ------CCEEEEEEecCCC-CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEee
Q psy18060        190 ------LNEFVLITEFAHM-SLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCD  260 (549)
Q Consensus       190 ------~~~~~iV~E~~~g-sL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~D  260 (549)
                            .+.+++||||+++ +|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence                  5689999999985 999999874  5799999999999999999999999999999999999999999999999


Q ss_pred             cccceecccCcccccccCCCCccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Q psy18060        261 FGFARSMAVGTHMLTSIKGTPLYMAPELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT  335 (549)
Q Consensus       261 FGla~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~  335 (549)
                      ||++..............||+.|+|||++.     +..++.++|||||||++|+|++|..||...........+......
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  252 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP  252 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence            999987654333345567999999999986     567899999999999999999999999988877776666544322


Q ss_pred             --CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        336 --FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       336 --~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                        .+..+++.+.+||.+||..||.+|||+.++++||||++...
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence              34578999999999999999999999999999999986543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.6e-47  Score=403.94  Aligned_cols=256  Identities=32%  Similarity=0.532  Sum_probs=209.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC------ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR------SGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++.+...      .......+.+|+.++++++||||+++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            5789999999999999999999999999999999976421      11222357899999999999999999999754 5


Q ss_pred             EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC---cEEEeecccceec
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG---VAMLCDFGFARSM  267 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g---~vKL~DFGla~~~  267 (549)
                      ..++||||+. |+|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+|+..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            6899999997 58999998888999999999999999999999999999999999999997654   5999999999876


Q ss_pred             ccCcccccccCCCCcccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCCCCC----cc
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAE---RPYDHTADLWSLGCIAYEIHMGHPPFKTVSI-LHLIRLLKTQDVTFP----SQ  339 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~---~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~-~~~~~~i~~~~~~~p----~~  339 (549)
                      ... ......+||+.|+|||++.+   ..|+.++|||||||++|+|++|++||..... ......+..+...++    ..
T Consensus       293 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  371 (419)
T 3i6u_A          293 GET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  371 (419)
T ss_dssp             C------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred             CCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence            543 23456789999999999853   6788999999999999999999999976532 233444555554443    35


Q ss_pred             CCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       340 ~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +++.+.+||.+||+.||.+|||++|+|+||||++..
T Consensus       372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence            899999999999999999999999999999998643

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.6e-46  Score=393.29  Aligned_cols=258  Identities=27%  Similarity=0.439  Sum_probs=218.2

Q ss_pred             cccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CC-----CeeEEE
Q psy18060        111 MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HP-----NIIKFI  184 (549)
Q Consensus       111 ~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~  184 (549)
                      ........++|++.+.||+|+||.||+|.+..+++.||||++...   ......+..|+.+++.+. |+     +|++++
T Consensus        46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            344455678999999999999999999999999999999999642   344566778899988874 55     499999


Q ss_pred             EEEeeCCEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCCccccccCCcEEEe--cCCcEEE
Q psy18060        185 ASHETLNEFVLITEFAHMSLSNLLEQR--KKLSETICVQILSNLISALYYLH--SNRVLHRDLKPQNVLLN--KDGVAML  258 (549)
Q Consensus       185 ~~~~~~~~~~iV~E~~~gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH--~~gIiHrDIKP~NILl~--~~g~vKL  258 (549)
                      +++...+.+++|||+++++|.+++...  ..+++..++.++.||+.||.|||  +.||+||||||+|||++  .++.+||
T Consensus       123 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             eeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence            999999999999999999999999875  46999999999999999999999  57999999999999995  4678999


Q ss_pred             eecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-
Q psy18060        259 CDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP-  337 (549)
Q Consensus       259 ~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p-  337 (549)
                      +|||+|+....   ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+.......| 
T Consensus       203 ~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          203 VDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             CCCTTCEETTC---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EeccCceeccc---ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99999987643   23556899999999999999999999999999999999999999999887776665543110000 


Q ss_pred             -----------------------------------cc----------------------------CCHHHHHHHHHhchh
Q psy18060        338 -----------------------------------SQ----------------------------VSETYKDLVKGLLEK  354 (549)
Q Consensus       338 -----------------------------------~~----------------------------~s~~~~dlI~~~L~~  354 (549)
                                                         +.                            .++++.+||.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                                               00                            014789999999999


Q ss_pred             CcCCCCCHHHHhcCcccCcc
Q psy18060        355 DASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       355 dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ||.+|||++|+|+||||++.
T Consensus       360 dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC-
T ss_pred             ChhhCCCHHHHhcCcccccC
Confidence            99999999999999999764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.4e-46  Score=391.41  Aligned_cols=261  Identities=23%  Similarity=0.390  Sum_probs=211.9

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC---------hHHHHHHHHHHHHHHhcCCCCeeEEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS---------GKELSSLKQECEIQKHLAHPNIIKFIA  185 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---------~~~~~~~~~Ei~il~~l~hpnIv~l~~  185 (549)
                      ....++|++.+.||+|+||.||+|.+.. +..||+|++......         ......+.+|+.+++.++||||+++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   96 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD   96 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence            3445789999999999999999999865 899999998653321         223467899999999999999999999


Q ss_pred             EEee-----CCEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEe
Q psy18060        186 SHET-----LNEFVLITEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLC  259 (549)
Q Consensus       186 ~~~~-----~~~~~iV~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~  259 (549)
                      ++..     ...+|+||||++|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             eEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence            8843     3478999999999999988764 469999999999999999999999999999999999999999999999


Q ss_pred             ecccceecccCcccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------
Q psy18060        260 DFGFARSMAVGTHMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ------  332 (549)
Q Consensus       260 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~------  332 (549)
                      |||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...      
T Consensus       177 Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          177 DFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999755433 23345679999999999876 67999999999999999999999999998876666554321      


Q ss_pred             ------------------CCC--------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        333 ------------------DVT--------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       333 ------------------~~~--------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                                        ...        .++..++.+.+||.+||+.||.+|||+.|+++||||+....+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                              001        123568899999999999999999999999999999876543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.6e-46  Score=384.38  Aligned_cols=256  Identities=27%  Similarity=0.400  Sum_probs=218.0

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCC-ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCC------eeEEEEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLK-KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN------IIKFIASH  187 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~~~  187 (549)
                      ....++|++.+.||+|+||.||+|.+..++ ..||+|++...   ......+.+|+.+++.+.|++      ++.+++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            344578999999999999999999998777 68999999643   344567888999999987665      89999999


Q ss_pred             eeCCEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE---------------
Q psy18060        188 ETLNEFVLITEFAHMSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL---------------  250 (549)
Q Consensus       188 ~~~~~~~iV~E~~~gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl---------------  250 (549)
                      ...+..++|||+++++|.+.+....  .+++..++.++.||+.||.|||++||+||||||+|||+               
T Consensus        92 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           92 NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence            9999999999999999988887754  69999999999999999999999999999999999999               


Q ss_pred             ----ecCCcEEEeecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy18060        251 ----NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI  326 (549)
Q Consensus       251 ----~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~  326 (549)
                          +.++.+||+|||+++....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.....
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                6678999999999976543   235567999999999999999999999999999999999999999988776655


Q ss_pred             HHHhcCCCCCC--------------------------------------------ccCCHHHHHHHHHhchhCcCCCCCH
Q psy18060        327 RLLKTQDVTFP--------------------------------------------SQVSETYKDLVKGLLEKDASQRLSW  362 (549)
Q Consensus       327 ~~i~~~~~~~p--------------------------------------------~~~s~~~~dlI~~~L~~dP~~Rps~  362 (549)
                      ..+......+|                                            ...++++.+||.+||+.||.+|||+
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  328 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL  328 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence            44332111111                                            1224688999999999999999999


Q ss_pred             HHHhcCcccCcccc
Q psy18060        363 PELLHHPLVKDNLS  376 (549)
Q Consensus       363 ~elL~Hpw~~~~~~  376 (549)
                      .|+++||||++...
T Consensus       329 ~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          329 AEALLHPFFAGLTP  342 (355)
T ss_dssp             HHHTTSGGGGGCCH
T ss_pred             HHHhcChhhcCCCh
Confidence            99999999987544

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.4e-47  Score=399.48  Aligned_cols=255  Identities=19%  Similarity=0.218  Sum_probs=198.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhc--CCCCeeEEE-------EEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL--AHPNIIKFI-------ASH  187 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~~  187 (549)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            4569999999999999999999999999999999987654 334556778886555555  699988865       444


Q ss_pred             eeC-----------------CEEEEEEecCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCCccccc
Q psy18060        188 ETL-----------------NEFVLITEFAHMSLSNLLEQR-KKLSETIC------VQILSNLISALYYLHSNRVLHRDL  243 (549)
Q Consensus       188 ~~~-----------------~~~~iV~E~~~gsL~~~l~~~-~~l~e~~~------~~i~~qIl~aL~yLH~~gIiHrDI  243 (549)
                      ...                 ..+||||||++|+|.+++... ..+++...      ..++.||+.||+|||++||+||||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            332                 348999999999999999874 33444445      577799999999999999999999


Q ss_pred             cCCcEEEecCCcEEEeecccceecccCcccccccCCCCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q psy18060        244 KPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFKTVS  321 (549)
Q Consensus       244 KP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~~~~  321 (549)
                      ||+|||++.+|.+||+|||+|+.....   .....||+.|+|||++.+  ..|+.++|||||||++|+|++|+.||.+..
T Consensus       221 kp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          221 TPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             SGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            999999999999999999999876432   224457799999999987  779999999999999999999999998764


Q ss_pred             HHHHH--H-----HHhcCCCCCC--ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        322 ILHLI--R-----LLKTQDVTFP--SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       322 ~~~~~--~-----~i~~~~~~~p--~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      .....  .     ........+|  +.+++.+.+||.+||+.||.+|||+.|+++||||++..
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            32110  0     0001122223  57899999999999999999999999999999997643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.8e-46  Score=388.25  Aligned_cols=260  Identities=28%  Similarity=0.401  Sum_probs=207.6

Q ss_pred             cccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       113 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      .....+++|++.+.||+|+||.||+|.+..+++.||||++......   .....++++.++.++||||+++++++...+.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            3455678999999999999999999999999999999998654322   2345677888889999999999999865433


Q ss_pred             -------EEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCCccccccCCcEEEec-CCcEEE
Q psy18060        193 -------FVLITEFAHMSLSNLLE----QRKKLSETICVQILSNLISALYYLH--SNRVLHRDLKPQNVLLNK-DGVAML  258 (549)
Q Consensus       193 -------~~iV~E~~~gsL~~~l~----~~~~l~e~~~~~i~~qIl~aL~yLH--~~gIiHrDIKP~NILl~~-~g~vKL  258 (549)
                             +++||||++++|...+.    ....+++..++.++.|++.||.|||  ++||+||||||+|||++. ++.+||
T Consensus        94 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             SCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             ccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                   88999999998776654    4567999999999999999999999  999999999999999997 899999


Q ss_pred             eecccceecccCcccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----
Q psy18060        259 CDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD----  333 (549)
Q Consensus       259 ~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~----  333 (549)
                      +|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....    
T Consensus       174 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          174 CDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             CCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            9999998765442 33456799999999998664 48999999999999999999999999988776666553210    


Q ss_pred             ----------------------------CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        334 ----------------------------VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       334 ----------------------------~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                                                  ...+...++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence                                        0111235789999999999999999999999999999987543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.1e-46  Score=382.87  Aligned_cols=256  Identities=33%  Similarity=0.518  Sum_probs=214.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC------ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR------SGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....      .......+.+|+.+++.++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            4679999999999999999999999999999999975432      1122345789999999999999999999987665


Q ss_pred             EEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc---EEEeecccceec
Q psy18060        192 EFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV---AMLCDFGFARSM  267 (549)
Q Consensus       192 ~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~---vKL~DFGla~~~  267 (549)
                       .++||||+.+ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++..
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence             8999999975 89999998889999999999999999999999999999999999999987664   999999999876


Q ss_pred             ccCcccccccCCCCccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCCCCC----cc
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQDVTFP----SQ  339 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~  339 (549)
                      ... .......||+.|+|||++.   ...++.++|||||||++|+|++|..||...... .....+..+...++    ..
T Consensus       168 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (322)
T 2ycf_A          168 GET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  246 (322)
T ss_dssp             CCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTT
T ss_pred             ccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhh
Confidence            543 2234457999999999973   567899999999999999999999999765322 23334444444332    46


Q ss_pred             CCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       340 ~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      +++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus       247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence            899999999999999999999999999999998753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8e-47  Score=390.49  Aligned_cols=261  Identities=24%  Similarity=0.426  Sum_probs=227.8

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh---------------HHHHHHHHHHHHHHhcCCC
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG---------------KELSSLKQECEIQKHLAHP  178 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---------------~~~~~~~~Ei~il~~l~hp  178 (549)
                      .....++|++.+.||+|+||.||+|.+  +++.||+|++.......               .....+.+|+.+++.++||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            344568899999999999999999998  79999999986532111               1126789999999999999


Q ss_pred             CeeEEEEEEeeCCEEEEEEecCCC-CHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcE
Q psy18060        179 NIIKFIASHETLNEFVLITEFAHM-SLSNL------LEQ--RKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNV  248 (549)
Q Consensus       179 nIv~l~~~~~~~~~~~iV~E~~~g-sL~~~------l~~--~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NI  248 (549)
                      ||+++++++...+..++||||+.+ +|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus       104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI  183 (348)
T ss_dssp             TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred             CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence            999999999999999999999985 89988      665  5679999999999999999999999 9999999999999


Q ss_pred             EEecCCcEEEeecccceecccCcccccccCCCCcccccccccCC-CCCc-chhhHHHHHHHHHHHhCCCCCCCCCH-HHH
Q psy18060        249 LLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAER-PYDH-TADLWSLGCIAYEIHMGHPPFKTVSI-LHL  325 (549)
Q Consensus       249 Ll~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~y~~-ksDIwSlGvil~eLltG~~Pf~~~~~-~~~  325 (549)
                      |++.++.+||+|||+++.....  ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||...+. ...
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             EEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            9999999999999999876443  33556799999999999877 6776 99999999999999999999998776 777


Q ss_pred             HHHHhcCCCCCC-------------------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccchh
Q psy18060        326 IRLLKTQDVTFP-------------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSE  378 (549)
Q Consensus       326 ~~~i~~~~~~~p-------------------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~~  378 (549)
                      ...+..+...+|                   ..+++++.+||.+||+.||.+|||+.|+++||||++.....
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~  333 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED  333 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHH
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHH
Confidence            778877777666                   67899999999999999999999999999999998765433

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=384.47  Aligned_cols=253  Identities=25%  Similarity=0.427  Sum_probs=211.7

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC--EE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN--EF  193 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~  193 (549)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+++++.++||||+++++++...+  ..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            345789999999999999999999999999999999975332 223466789999999999999999999987655  78


Q ss_pred             EEEEecCC-CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE----ecCCcEEEeecccce
Q psy18060        194 VLITEFAH-MSLSNLLEQRKK---LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL----NKDGVAMLCDFGFAR  265 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~---l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl----~~~g~vKL~DFGla~  265 (549)
                      ++||||+. ++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+|+
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999997 699999986543   9999999999999999999999999999999999999    677789999999998


Q ss_pred             ecccCcccccccCCCCccccccccc--------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCC
Q psy18060        266 SMAVGTHMLTSIKGTPLYMAPELIA--------ERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQD  333 (549)
Q Consensus       266 ~~~~~~~~~~~~~GT~~Y~APE~l~--------~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~----~~~~~~~i~~~~  333 (549)
                      ...... ......||+.|+|||++.        +..++.++|||||||++|+|++|+.||....    .......+..+.
T Consensus       165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             ECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             ecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            775543 334567999999999986        5779999999999999999999999996432    233333333222


Q ss_pred             C-------------------------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcc
Q psy18060        334 V-------------------------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPL  370 (549)
Q Consensus       334 ~-------------------------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw  370 (549)
                      +                         .++..+++.+.++|.+||+.||.+|||++|+|+||-
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            1                         122345678899999999999999999999999973

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.5e-46  Score=382.00  Aligned_cols=260  Identities=23%  Similarity=0.361  Sum_probs=202.6

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      -..++|++.+.||+|+||.||+|.+..++.   .||+|++..........+.+.+|+++++.++||||+++++++...+.
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345689999999999999999999887765   79999997655455667889999999999999999999999877665


Q ss_pred             E------EEEEecCCC-CHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEe
Q psy18060        193 F------VLITEFAHM-SLSNLLEQRK------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLC  259 (549)
Q Consensus       193 ~------~iV~E~~~g-sL~~~l~~~~------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~  259 (549)
                      .      ++||||+.+ +|.+++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence            4      999999984 8999987543      59999999999999999999999999999999999999999999999


Q ss_pred             ecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCC
Q psy18060        260 DFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVT  335 (549)
Q Consensus       260 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~  335 (549)
                      |||+|+.......  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+..+ ...
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~  259 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK  259 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC
Confidence            9999986644321  2233457889999999999999999999999999999999 99999998877777766554 356


Q ss_pred             CCccCCHHHHHHHHHhchhCcCCCCC-------HHHHhcCcccCccc
Q psy18060        336 FPSQVSETYKDLVKGLLEKDASQRLS-------WPELLHHPLVKDNL  375 (549)
Q Consensus       336 ~p~~~s~~~~dlI~~~L~~dP~~Rps-------~~elL~Hpw~~~~~  375 (549)
                      .|+.+++++.++|.+||+.||.+|||       +++++.|||+....
T Consensus       260 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            67889999999999999999999999       77888999997643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.9e-45  Score=375.16  Aligned_cols=260  Identities=29%  Similarity=0.482  Sum_probs=218.4

Q ss_pred             cccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC--CCCeeEEEEEEeeC
Q psy18060        113 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA--HPNIIKFIASHETL  190 (549)
Q Consensus       113 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~  190 (549)
                      ......++|++.+.||+|+||.||+|.+.. ++.||+|++............+.+|+.+++.+.  ||||+++++++...
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            334445779999999999999999998864 889999999876666677788999999999997  59999999999999


Q ss_pred             CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        191 NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       191 ~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      +.+++|||+.+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus       101 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          101 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred             CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence            9999999987789999999999999999999999999999999999999999999999996 589999999999876433


Q ss_pred             cc--cccccCCCCcccccccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcC--CC
Q psy18060        271 TH--MLTSIKGTPLYMAPELIAE-----------RPYDHTADLWSLGCIAYEIHMGHPPFKTVS-ILHLIRLLKTQ--DV  334 (549)
Q Consensus       271 ~~--~~~~~~GT~~Y~APE~l~~-----------~~y~~ksDIwSlGvil~eLltG~~Pf~~~~-~~~~~~~i~~~--~~  334 (549)
                      ..  ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.... .......+...  ..
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  259 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  259 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence            21  1234579999999999875           468899999999999999999999998753 33333333332  34


Q ss_pred             CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       335 ~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+|...++++.++|.+||+.||.+|||+.|+++||||+..
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            5677789999999999999999999999999999999753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=397.04  Aligned_cols=253  Identities=27%  Similarity=0.451  Sum_probs=194.2

Q ss_pred             cceeE-EEEEecCCcEEEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe--eCCEE
Q psy18060        119 EKYQK-ICLIGEGSFGKVFKAIHL--DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE--TLNEF  193 (549)
Q Consensus       119 ~~y~~-~~~iG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~  193 (549)
                      +.|.+ .+.||+|+||.||+|.++  .+++.||+|++......    ..+.+|+.+++.++||||+++++++.  ....+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            44666 558999999999999976  56889999999754433    35678999999999999999999984  46789


Q ss_pred             EEEEecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE----ecCCcEEEee
Q psy18060        194 VLITEFAHMSLSNLLEQR---------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL----NKDGVAMLCD  260 (549)
Q Consensus       194 ~iV~E~~~gsL~~~l~~~---------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl----~~~g~vKL~D  260 (549)
                      ++||||++++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|
T Consensus        96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A           96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            999999999999888642         249999999999999999999999999999999999999    6778999999


Q ss_pred             cccceecccCc---ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------HHHH
Q psy18060        261 FGFARSMAVGT---HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL---------HLIR  327 (549)
Q Consensus       261 FGla~~~~~~~---~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~---------~~~~  327 (549)
                      ||+|+......   ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....         ..+.
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            99998765321   22345689999999999987 45999999999999999999999999765431         2222


Q ss_pred             HHhcC-CCCC-------------------------------------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCc
Q psy18060        328 LLKTQ-DVTF-------------------------------------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHP  369 (549)
Q Consensus       328 ~i~~~-~~~~-------------------------------------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hp  369 (549)
                      .+... ..+.                                     ....++.+.+||.+||+.||.+|||++|+|+||
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp  335 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  335 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            22110 0000                                     011277899999999999999999999999999


Q ss_pred             ccCccc
Q psy18060        370 LVKDNL  375 (549)
Q Consensus       370 w~~~~~  375 (549)
                      ||.+..
T Consensus       336 ~f~~~~  341 (405)
T 3rgf_A          336 YFLEDP  341 (405)
T ss_dssp             GGTSSS
T ss_pred             hhccCC
Confidence            998653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=371.28  Aligned_cols=256  Identities=29%  Similarity=0.474  Sum_probs=213.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .+.|.....||+|+||.||+|.+..++..||+|.+....  ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            344555568999999999999999999999999997643  234567889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec-CCcEEEeecccceecccCcc
Q psy18060        198 EFAH-MSLSNLLEQRK---KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK-DGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~-~g~vKL~DFGla~~~~~~~~  272 (549)
                      |++. ++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            9997 68999998752   4679999999999999999999999999999999999998 89999999999987654333


Q ss_pred             cccccCCCCcccccccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHH-H-HHhcCCCCCCccCCHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAER--PYDHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLI-R-LLKTQDVTFPSQVSETYKDL  347 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~--~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~-~~~-~-~i~~~~~~~p~~~s~~~~dl  347 (549)
                      ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...... ... . ........+|..+++++.++
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  258 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF  258 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHH
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHH
Confidence            34556799999999999764  3899999999999999999999999764322 211 1 22334456778899999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                      |.+||+.||.+|||+.++++||||+...
T Consensus       259 i~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          259 ILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            9999999999999999999999997543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-45  Score=386.37  Aligned_cols=251  Identities=29%  Similarity=0.465  Sum_probs=220.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEc-------CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEe
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHL-------DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHE  188 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~  188 (549)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|++... ........+.+|+.+++.+ +||||+++++++.
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            4578999999999999999999875       34567999999654 3445567899999999999 8999999999999


Q ss_pred             eCCEEEEEEecCC-CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe
Q psy18060        189 TLNEFVLITEFAH-MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN  251 (549)
Q Consensus       189 ~~~~~~iV~E~~~-gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~  251 (549)
                      ..+.+|+||||+. |+|.+++....                .+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence            9999999999997 59999998754                478999999999999999999999999999999999999


Q ss_pred             cCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy18060        252 KDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRL  328 (549)
Q Consensus       252 ~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~  328 (549)
                      .+|.+||+|||+++.......  ......||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+..+....
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~  317 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  317 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999999987654321  2234567889999999999999999999999999999999 9999999888777777


Q ss_pred             HhcCC-CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        329 LKTQD-VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       329 i~~~~-~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +..+. ...|..+++++.++|.+||+.||.+|||+.|++++
T Consensus       318 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          318 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            66553 45677899999999999999999999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.3e-46  Score=380.95  Aligned_cols=258  Identities=28%  Similarity=0.453  Sum_probs=222.3

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhcC--CCCeeEEEEEE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLA--HPNIIKFIASH  187 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~--hpnIv~l~~~~  187 (549)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.+++.+.  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            3445678999999999999999999999999999999997643221    11234567999999996  59999999999


Q ss_pred             eeCCEEEEEEecCC--CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe-cCCcEEEeecccc
Q psy18060        188 ETLNEFVLITEFAH--MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN-KDGVAMLCDFGFA  264 (549)
Q Consensus       188 ~~~~~~~iV~E~~~--gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~-~~g~vKL~DFGla  264 (549)
                      ...+..++|||++.  ++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            99999999999987  68999999989999999999999999999999999999999999999999 7799999999999


Q ss_pred             eecccCcccccccCCCCcccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHH
Q psy18060        265 RSMAVGTHMLTSIKGTPLYMAPELIAERPY-DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSET  343 (549)
Q Consensus       265 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y-~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~  343 (549)
                      +.....  ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....      .+......++..++++
T Consensus       198 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~  269 (320)
T 3a99_A          198 ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSE  269 (320)
T ss_dssp             EECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHH
T ss_pred             cccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHH
Confidence            876543  2345679999999999977665 788999999999999999999997642      2334555677889999


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhcCcccCcccchhh
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~~~  379 (549)
                      +.+||.+||+.||.+|||+.|+++||||++......
T Consensus       270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~  305 (320)
T 3a99_A          270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE  305 (320)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHhhcCccCccc
Confidence            999999999999999999999999999998765433

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.5e-46  Score=386.07  Aligned_cols=254  Identities=24%  Similarity=0.367  Sum_probs=211.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-----------CCCeeEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-----------HPNIIKFIA  185 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~~  185 (549)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++...   ......+.+|+.+++.+.           ||||+++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            346899999999999999999999999999999999642   334567788999998886           899999999


Q ss_pred             EEeeCC----EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecC-----
Q psy18060        186 SHETLN----EFVLITEFAHMSLSNLLEQR--KKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKD-----  253 (549)
Q Consensus       186 ~~~~~~----~~~iV~E~~~gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~-----  253 (549)
                      ++...+    .+++|||+++++|.+++...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+     
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             HhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence            987654    78999999988999999874  4599999999999999999999998 99999999999999643     


Q ss_pred             -CcEEEeecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHH
Q psy18060        254 -GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI------LHLI  326 (549)
Q Consensus       254 -g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~------~~~~  326 (549)
                       +.+||+|||+++.....   .+...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.      ....
T Consensus       174 ~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             cceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence             37999999999876532   3455799999999999999999999999999999999999999986541      1111


Q ss_pred             HHHh------------------------------------------cCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHH
Q psy18060        327 RLLK------------------------------------------TQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPE  364 (549)
Q Consensus       327 ~~i~------------------------------------------~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~e  364 (549)
                      ..+.                                          .....+|..+++++.+||.+||+.||.+|||+.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            1111                                          1122345566789999999999999999999999


Q ss_pred             HhcCcccCcccc
Q psy18060        365 LLHHPLVKDNLS  376 (549)
Q Consensus       365 lL~Hpw~~~~~~  376 (549)
                      +|+||||++...
T Consensus       331 ll~hp~f~~~~~  342 (373)
T 1q8y_A          331 LVNHPWLKDTLG  342 (373)
T ss_dssp             HHTCGGGTTCTT
T ss_pred             HhhChhhhcccC
Confidence            999999987543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=373.87  Aligned_cols=259  Identities=27%  Similarity=0.470  Sum_probs=203.7

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ...+++|++.+.||+|+||.||+|.+..+++.||+|++............+.++..+++.++||||+++++++...+..+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            44578899999999999999999999999999999999876544444455566666788889999999999999999999


Q ss_pred             EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +||||+++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...... 
T Consensus       101 lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (318)
T 2dyl_A          101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-  179 (318)
T ss_dssp             EEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence            9999996666666554 56799999999999999999999996 99999999999999999999999999997665432 


Q ss_pred             cccccCCCCccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC-CCCC--ccCCHH
Q psy18060        273 MLTSIKGTPLYMAPELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKT-VSILHLIRLLKTQD-VTFP--SQVSET  343 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~-----~~~y~~ksDIwSlGvil~eLltG~~Pf~~-~~~~~~~~~i~~~~-~~~p--~~~s~~  343 (549)
                      ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.. .........+.... ..+|  ..++++
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (318)
T 2dyl_A          180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD  259 (318)
T ss_dssp             -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHH
T ss_pred             cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHH
Confidence            234457999999999994     56789999999999999999999999987 34455555554443 2233  358999


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      +.++|.+||+.||.+|||+.++++||||+..
T Consensus       260 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            9999999999999999999999999999753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=376.87  Aligned_cols=251  Identities=23%  Similarity=0.361  Sum_probs=218.8

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCce---EEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~---vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ...+|++.+.||+|+||.||+|.+..+++.   ||||++... ........+.+|+.+++.++||||+++++++...+..
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            457899999999999999999999866554   999999653 3455567889999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            99999997 5999999765 579999999999999999999999999999999999999999999999999998765432


Q ss_pred             c---cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHH
Q psy18060        272 H---MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKD  346 (549)
Q Consensus       272 ~---~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~d  346 (549)
                      .   ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..+ ....|..+++.+.+
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  285 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQ  285 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHH
Confidence            1   1233456888999999998899999999999999999999 99999999988888877665 44567789999999


Q ss_pred             HHHHhchhCcCCCCCHHHHhcC
Q psy18060        347 LVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +|.+||..||.+|||+.++++.
T Consensus       286 li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          286 LMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999998764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.4e-45  Score=364.18  Aligned_cols=247  Identities=23%  Similarity=0.386  Sum_probs=218.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|++......   .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            4679999999999999999999874 777999999765433   346889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-ccc
Q psy18060        198 EFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-HML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-~~~  274 (549)
                      ||++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence            9997 5899999764 468999999999999999999999999999999999999999999999999997654322 122


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhc
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ....||+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+... ....|..+++.+.+++.+||
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  244 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW  244 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHT
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHc
Confidence            34457888999999998899999999999999999999 99999999998888887765 44556778999999999999


Q ss_pred             hhCcCCCCCHHHHhcC
Q psy18060        353 EKDASQRLSWPELLHH  368 (549)
Q Consensus       353 ~~dP~~Rps~~elL~H  368 (549)
                      +.||.+|||+.++++|
T Consensus       245 ~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          245 RERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             cCCcccCcCHHHHHHH
Confidence            9999999999999876

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.6e-46  Score=377.15  Aligned_cols=260  Identities=28%  Similarity=0.482  Sum_probs=197.4

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      -..++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+..++
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            345789999999999999999999998999999999865322 2335677899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        196 ITEFAH-MSLSNLLEQ--------RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~--------~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                      ||||+. ++|.+++..        ...+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            999996 589999874        45699999999999999999999999999999999999999999999999999876


Q ss_pred             cccCc-----ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------
Q psy18060        267 MAVGT-----HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV------  334 (549)
Q Consensus       267 ~~~~~-----~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~------  334 (549)
                      .....     .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.............      
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  250 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG  250 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence            54321     11234579999999999865 5689999999999999999999999988766554443332211      


Q ss_pred             ----CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        335 ----TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       335 ----~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                          ..+..+++++.++|.+||+.||.+|||+.++++||||++...
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             ----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence                123467899999999999999999999999999999986543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-46  Score=387.50  Aligned_cols=255  Identities=21%  Similarity=0.321  Sum_probs=221.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEE-----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAI-----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      ..++|++.+.||+|+||.||+|.     +..++..||+|++... ........+.+|+.+++.++||||+++++++....
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            35789999999999999999999     4556789999998643 34455567889999999999999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC---cEEEee
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRK-------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG---VAMLCD  260 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~-------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g---~vKL~D  260 (549)
                      ..++||||+. |+|.+++...+       .+++..++.++.||+.||.|||++||+||||||+|||++.+|   .+||+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999997 59999998753       589999999999999999999999999999999999999655   599999


Q ss_pred             cccceecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCC
Q psy18060        261 FGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTF  336 (549)
Q Consensus       261 FGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~  336 (549)
                      ||+|+......  .......||+.|+|||++.+..++.++|||||||++|||++ |..||...+.......+..+. ...
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~  307 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP  307 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99997553221  22234568999999999998999999999999999999998 999999999988888877654 456


Q ss_pred             CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        337 PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       337 p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      |..+++.+.+||.+||+.||.+|||+.+|++|.|..
T Consensus       308 ~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          308 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            678999999999999999999999999999998864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=368.62  Aligned_cols=247  Identities=24%  Similarity=0.398  Sum_probs=212.1

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+..  ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            45789999999999999999999999999999999854  3456677899999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc-
Q psy18060        197 TEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-  273 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~-  273 (549)
                      |||+. ++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ 
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            99997 599999987 567999999999999999999999999999999999999999999999999999876432211 


Q ss_pred             -------------ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcCCCC
Q psy18060        274 -------------LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH-----LIRLLKTQDVT  335 (549)
Q Consensus       274 -------------~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~-----~~~~i~~~~~~  335 (549)
                                   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ......  ...
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--~~~  243 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--DRY  243 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--HHT
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--ccc
Confidence                         125679999999999999999999999999999999999999986532110     000001  112


Q ss_pred             CCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        336 FPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       336 ~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .|+.+++.+.++|.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            46778999999999999999999999999976

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.6e-45  Score=378.17  Aligned_cols=258  Identities=28%  Similarity=0.458  Sum_probs=195.2

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHH-HHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .-..++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+..|+. +++.++||||+++++++...+..
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence            3446889999999999999999999999999999999976533 333344555555 67778999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCCcEEEeecccceec
Q psy18060        194 VLITEFAHMSLSNLLEQ-----RKKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       194 ~iV~E~~~gsL~~~l~~-----~~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g~vKL~DFGla~~~  267 (549)
                      ++||||++++|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus        97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A           97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99999999999888874     56799999999999999999999999 9999999999999999999999999999776


Q ss_pred             ccCcccccccCCCCcccccccc----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCC-CCCC----
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELI----AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQD-VTFP----  337 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l----~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~-~~~~~i~~~~-~~~p----  337 (549)
                      .... ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||...... .....+..+. ..++    
T Consensus       177 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3aln_A          177 VDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE  255 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSS
T ss_pred             cccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccc
Confidence            5432 23344799999999998    4667899999999999999999999999875432 2222222221 1222    


Q ss_pred             ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        338 SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       338 ~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       256 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            3589999999999999999999999999999999753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-45  Score=376.57  Aligned_cols=253  Identities=22%  Similarity=0.369  Sum_probs=221.5

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET  189 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  189 (549)
                      ....++|++.+.||+|+||.||+|.+.     .+++.||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            334578999999999999999999987     45689999998754 344556788999999999999999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccc
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQR------------------------KKLSETICVQILSNLISALYYLHSNRVLHRDLK  244 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~------------------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIK  244 (549)
                      .+..++||||+. |+|.+++...                        ..+++.+++.++.||+.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            999999999998 5999999874                        568999999999999999999999999999999


Q ss_pred             CCcEEEecCCcEEEeecccceecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q psy18060        245 PQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVS  321 (549)
Q Consensus       245 P~NILl~~~g~vKL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~  321 (549)
                      |+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            999999999999999999997654322  12234568999999999998889999999999999999999 999999999


Q ss_pred             HHHHHHHHhcCCC-CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        322 ILHLIRLLKTQDV-TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       322 ~~~~~~~i~~~~~-~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .......+..+.. ..|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          282 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            8888887776653 5677899999999999999999999999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.8e-45  Score=380.57  Aligned_cols=255  Identities=27%  Similarity=0.447  Sum_probs=216.2

Q ss_pred             cccccccceeEEEEEecCCcEEEEEEE-----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEE
Q psy18060        113 KSNGALEKYQKICLIGEGSFGKVFKAI-----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIAS  186 (549)
Q Consensus       113 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~  186 (549)
                      ...-..++|++.+.||+|+||.||+|.     +..+++.||+|++... ........+.+|+++++.+ +||||++++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            334456889999999999999999998     5566789999999754 3445567889999999999 79999999999


Q ss_pred             EeeCC-EEEEEEecCCC-CHHHHHHhcCC---------------------------------------------------
Q psy18060        187 HETLN-EFVLITEFAHM-SLSNLLEQRKK---------------------------------------------------  213 (549)
Q Consensus       187 ~~~~~-~~~iV~E~~~g-sL~~~l~~~~~---------------------------------------------------  213 (549)
                      +...+ .+++||||+.+ +|.+++.....                                                   
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            87754 48999999985 99999987543                                                   


Q ss_pred             ---------------CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc--ccccc
Q psy18060        214 ---------------LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HMLTS  276 (549)
Q Consensus       214 ---------------l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~--~~~~~  276 (549)
                                     +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  .....
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence                           8999999999999999999999999999999999999999999999999998664322  22344


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHhc-CCCCCCccCCHHHHHHHHHhch
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSIL-HLIRLLKT-QDVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~i~~-~~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ..||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.... .....+.. .....|..+++++.++|.+||+
T Consensus       255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  334 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  334 (359)
T ss_dssp             CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            568999999999999999999999999999999998 99999876533 33333333 3456778899999999999999


Q ss_pred             hCcCCCCCHHHHhcC
Q psy18060        354 KDASQRLSWPELLHH  368 (549)
Q Consensus       354 ~dP~~Rps~~elL~H  368 (549)
                      .||.+|||+.|+++|
T Consensus       335 ~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          335 GEPSQRPTFSELVEH  349 (359)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999987

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.1e-45  Score=368.55  Aligned_cols=254  Identities=25%  Similarity=0.486  Sum_probs=209.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--------
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--------  189 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--------  189 (549)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...   ......+.+|+.+++.++||||+++++++.+        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            46799999999999999999999999999999999642   3456778999999999999999999998754        


Q ss_pred             -----CCEEEEEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecc
Q psy18060        190 -----LNEFVLITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFG  262 (549)
Q Consensus       190 -----~~~~~iV~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFG  262 (549)
                           .+..++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence                 457899999997 59999998654 58899999999999999999999999999999999999999999999999


Q ss_pred             cceecccC--------------cccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHH
Q psy18060        263 FARSMAVG--------------THMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKT-VSILHLI  326 (549)
Q Consensus       263 la~~~~~~--------------~~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~-~~~~~~~  326 (549)
                      +++.....              ........||+.|+|||++.+. .++.++|||||||++|+|++   ||.. .+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            99765421              1123455799999999999764 68999999999999999998   5543 3344555


Q ss_pred             HHHhcCCCCCC----ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        327 RLLKTQDVTFP----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       327 ~~i~~~~~~~p----~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                      ..+......+|    ...++.++++|.+||+.||.+|||+.++++||||+.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD  293 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence            55555544444    4567889999999999999999999999999999865443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.7e-45  Score=371.15  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=221.7

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET  189 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  189 (549)
                      .-..++|.+.+.||+|+||.||+|.+.     .++..||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            344678999999999999999999883     45588999998753 345566788999999999999999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCcccccc
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQRKK------------------------LSETICVQILSNLISALYYLHSNRVLHRDLK  244 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~~~------------------------l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIK  244 (549)
                      .+..++||||+. ++|.+++.....                        +++..++.++.||+.||.|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            999999999998 699999987543                        8999999999999999999999999999999


Q ss_pred             CCcEEEecCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q psy18060        245 PQNVLLNKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVS  321 (549)
Q Consensus       245 P~NILl~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~  321 (549)
                      |+|||++.++.+||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987644322  1234467889999999998889999999999999999999 999999988


Q ss_pred             HHHHHHHHhcCC-CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        322 ILHLIRLLKTQD-VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       322 ~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .......+.... ...|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          258 PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            777777666553 45677899999999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=380.88  Aligned_cols=252  Identities=30%  Similarity=0.475  Sum_probs=222.6

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCC-------CceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDL-------KKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASH  187 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~  187 (549)
                      -..++|++.+.||+|+||.||+|.+..+       +..||+|++... ........+.+|+++++.+ +||||+++++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            3457899999999999999999997543       357999999754 3455667889999999999 999999999999


Q ss_pred             eeCCEEEEEEecCC-CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE
Q psy18060        188 ETLNEFVLITEFAH-MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL  250 (549)
Q Consensus       188 ~~~~~~~iV~E~~~-gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl  250 (549)
                      ...+.+++||||+. |+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            99999999999997 59999998754                49999999999999999999999999999999999999


Q ss_pred             ecCCcEEEeecccceecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy18060        251 NKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIR  327 (549)
Q Consensus       251 ~~~g~vKL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~  327 (549)
                      +.++.+||+|||+|+......  .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~  304 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  304 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999998665332  22334567889999999999999999999999999999999 999999999888888


Q ss_pred             HHhcC-CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        328 LLKTQ-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       328 ~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .+..+ ....|..+++++.+||.+||+.||.+|||+.|++++
T Consensus       305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          305 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77665 445677899999999999999999999999999886

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.2e-45  Score=376.87  Aligned_cols=245  Identities=21%  Similarity=0.272  Sum_probs=210.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++......    ..+.+|+.+++.+ .||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            36799999999999999999999999999999998754322    3478899999999 999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc-----EEEeecccceecccC
Q psy18060        197 TEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV-----AMLCDFGFARSMAVG  270 (549)
Q Consensus       197 ~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~-----vKL~DFGla~~~~~~  270 (549)
                      |||++++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.     +||+|||+|+.....
T Consensus        84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           84 LELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             EEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence            99998899999987 468999999999999999999999999999999999999998887     999999999876433


Q ss_pred             cc-------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCCCCC---
Q psy18060        271 TH-------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV---SILHLIRLLKTQDVTFP---  337 (549)
Q Consensus       271 ~~-------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~---~~~~~~~~i~~~~~~~p---  337 (549)
                      ..       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.   +.......+.......|   
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  243 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV  243 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH
Confidence            21       124568999999999999999999999999999999999999999874   44455555433322222   


Q ss_pred             --ccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        338 --SQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       338 --~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                        ..+| ++.++|.+||+.||.+||++.+|++
T Consensus       244 ~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              2244 9999999999999999999998876

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.2e-44  Score=363.44  Aligned_cols=251  Identities=22%  Similarity=0.353  Sum_probs=217.5

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ..-..++|++++.||+|+||.||+|.+. ++..||+|++......   ...+.+|+++++.++||||+++++++.+.+..
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence            3445678999999999999999999877 4778999999765433   35678999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ++||||+. ++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            99999996 689999986 5679999999999999999999999999999999999999999999999999997654322


Q ss_pred             -ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHH
Q psy18060        272 -HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLV  348 (549)
Q Consensus       272 -~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI  348 (549)
                       .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+.... ...|...++.+.++|
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  254 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM  254 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHH
Confidence             11233457888999999998889999999999999999998 999999999888888777653 445677899999999


Q ss_pred             HHhchhCcCCCCCHHHHhcC
Q psy18060        349 KGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~H  368 (549)
                      .+||+.||.+|||+.++++|
T Consensus       255 ~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          255 YSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999999999999999887

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.2e-45  Score=384.75  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=220.2

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .-..++|.+.+.||+|+||.||+|.+..+++.||+|++... ........+.+|+++++.++||||+++++++...+.++
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence            34457899999999999999999999999999999998643 33445567889999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +||||+. |+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            9999997 69999998754 699999999999999999999999999999999999999999999999999986543321


Q ss_pred             cc--cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHH
Q psy18060        273 ML--TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLV  348 (549)
Q Consensus       273 ~~--~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI  348 (549)
                      ..  ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+..+ ..+.|..+|+.+.++|
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  348 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM  348 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            11  11235678999999998889999999999999999998 99999999888777776554 4556778999999999


Q ss_pred             HHhchhCcCCCCCHHHHhc
Q psy18060        349 KGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~  367 (549)
                      .+||+.||.+|||+.++++
T Consensus       349 ~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          349 EQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCchhCcCHHHHHH
Confidence            9999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-44  Score=359.92  Aligned_cols=248  Identities=22%  Similarity=0.349  Sum_probs=217.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++......   ...+.+|+.+++.++||||+++++++...+..++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            4578999999999999999999876 4678999999765433   35678999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-c
Q psy18060        197 TEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-M  273 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~  273 (549)
                      |||++ ++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence            99997 58999998754 599999999999999999999999999999999999999999999999999987654322 2


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHh
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGL  351 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~  351 (549)
                      .....||+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+.... ...|...++.+.++|.+|
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  241 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSC  241 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHT
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHH
Confidence            233456778999999998889999999999999999999 999999988888777776554 345667899999999999


Q ss_pred             chhCcCCCCCHHHHhcC
Q psy18060        352 LEKDASQRLSWPELLHH  368 (549)
Q Consensus       352 L~~dP~~Rps~~elL~H  368 (549)
                      |+.||.+|||+.+++++
T Consensus       242 l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          242 WHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             cCCChhhCcCHHHHHHH
Confidence            99999999999999887

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.2e-44  Score=363.52  Aligned_cols=248  Identities=20%  Similarity=0.248  Sum_probs=212.8

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++......    ..+.+|+.+++.+ .|||++++++++......++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            346799999999999999999999999999999998754322    3467899999999 89999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc-----EEEeecccceeccc
Q psy18060        196 ITEFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV-----AMLCDFGFARSMAV  269 (549)
Q Consensus       196 V~E~~~gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~-----vKL~DFGla~~~~~  269 (549)
                      ||||++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++....
T Consensus        84 v~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           84 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence            99999889999998754 5999999999999999999999999999999999999987775     99999999987654


Q ss_pred             Ccc-------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCC-----
Q psy18060        270 GTH-------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV---SILHLIRLLKTQDV-----  334 (549)
Q Consensus       270 ~~~-------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~---~~~~~~~~i~~~~~-----  334 (549)
                      ...       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.   ........+.....     
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  243 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence            321       234567999999999999999999999999999999999999999874   34444444332211     


Q ss_pred             CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       335 ~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ..++.+|+++.++|.+||+.||.+|||+.+|++.
T Consensus       244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1234789999999999999999999999998754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.7e-44  Score=362.90  Aligned_cols=250  Identities=23%  Similarity=0.392  Sum_probs=216.1

Q ss_pred             cccceeEEE-EEecCCcEEEEEEE--EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        117 ALEKYQKIC-LIGEGSFGKVFKAI--HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       117 ~~~~y~~~~-~iG~G~fg~Vy~~~--~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ...+|.+.+ .||+|+||.||+|.  ...+++.||+|++............+.+|+.+++.++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            356799998 99999999999994  466788999999976654455567899999999999999999999999 56678


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ++|||++. ++|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence            99999998 58999999988999999999999999999999999999999999999999999999999999987654322


Q ss_pred             c---ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHH
Q psy18060        273 M---LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDL  347 (549)
Q Consensus       273 ~---~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dl  347 (549)
                      .   .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+..+. ...|..+++.+.++
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  252 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL  252 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            1   223457789999999988889999999999999999999 999999998888877776553 45677899999999


Q ss_pred             HHHhchhCcCCCCCHHHHhc
Q psy18060        348 VKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~  367 (549)
                      |.+||+.||.+|||+.++++
T Consensus       253 i~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          253 MNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.6e-44  Score=362.70  Aligned_cols=251  Identities=29%  Similarity=0.419  Sum_probs=206.7

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDL---KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      -..++|++.+.||+|+||.||+|.+..+   +..+|+|.+... ........+.+|+.++++++||||+++++++. .+.
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            3457899999999999999999998654   456999988653 34455678899999999999999999999985 456


Q ss_pred             EEEEEecCCC-CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        193 FVLITEFAHM-SLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       193 ~~iV~E~~~g-sL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      .++||||+.+ +|.+++..+. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            8899999985 8999998754 6999999999999999999999999999999999999999999999999999876543


Q ss_pred             cc-cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHH
Q psy18060        271 TH-MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDL  347 (549)
Q Consensus       271 ~~-~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dl  347 (549)
                      .. ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ...+|+.+++.+.++
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  249 (281)
T 1mp8_A          170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  249 (281)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            21 1233457889999999998899999999999999999996 99999988877777766554 345778899999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcC
Q psy18060        348 VKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~H  368 (549)
                      |.+||+.||.+|||+.|++++
T Consensus       250 i~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          250 MTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999865

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-44  Score=365.60  Aligned_cols=250  Identities=25%  Similarity=0.412  Sum_probs=207.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--C
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--L  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~  190 (549)
                      ..++|++++.||+|+||.||+|.    +..+++.||+|++...  .......+.+|+.+++.++||||+++++++..  .
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            45789999999999999999998    5678999999998653  34556788999999999999999999999854  4


Q ss_pred             CEEEEEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                      ..+++||||+. ++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            56899999996 59999998754 49999999999999999999999999999999999999999999999999998765


Q ss_pred             cCcc---cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHH
Q psy18060        269 VGTH---MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL----------------HLIRLL  329 (549)
Q Consensus       269 ~~~~---~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~----------------~~~~~i  329 (549)
                      ....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......                .....+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  245 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence            4321   123345788899999999999999999999999999999999998653221                122222


Q ss_pred             h-cCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        330 K-TQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       330 ~-~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      . ....+.|..+++++.++|.+||+.||.+|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            2 23455678899999999999999999999999998753

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.4e-45  Score=375.49  Aligned_cols=254  Identities=30%  Similarity=0.517  Sum_probs=186.3

Q ss_pred             cccccccceeEEE-EEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--
Q psy18060        113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--  189 (549)
Q Consensus       113 ~~~~~~~~y~~~~-~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--  189 (549)
                      ......++|.+.+ .||+|+||.||+|.+..+++.||+|++...   .   ....+....++.+.||||+++++++..  
T Consensus        22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            3344568899965 699999999999999999999999999652   1   122233344677799999999999876  


Q ss_pred             --CCEEEEEEecCCC-CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC---CcEEEeec
Q psy18060        190 --LNEFVLITEFAHM-SLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD---GVAMLCDF  261 (549)
Q Consensus       190 --~~~~~iV~E~~~g-sL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~---g~vKL~DF  261 (549)
                        ...+++||||+.| +|.+++..+.  .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence              4568999999985 9999998764  69999999999999999999999999999999999999864   56999999


Q ss_pred             ccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCCCCC
Q psy18060        262 GFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL----IRLLKTQDVTFP  337 (549)
Q Consensus       262 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~----~~~i~~~~~~~p  337 (549)
                      |+++.....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........    ...+......+|
T Consensus       176 g~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (336)
T 3fhr_A          176 GFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP  253 (336)
T ss_dssp             TTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred             ccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence            999866532  23456799999999999988999999999999999999999999977654433    222222222222


Q ss_pred             ----ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        338 ----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       338 ----~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                          ..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence                4689999999999999999999999999999999753

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.5e-45  Score=366.66  Aligned_cols=245  Identities=20%  Similarity=0.364  Sum_probs=212.0

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCC-------ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLK-------KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET  189 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  189 (549)
                      ..++|++.+.||+|+||.||+|.+..++       ..||+|++....  ....+.+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            3468999999999999999999998877       469999986532  3445678999999999999999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc--------EEEe
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQRKK-LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV--------AMLC  259 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~~~-l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~--------vKL~  259 (549)
                      .+..++||||+. ++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.        +||+
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            999999999998 699999987655 999999999999999999999999999999999999999887        9999


Q ss_pred             ecccceecccCcccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCC
Q psy18060        260 DFGFARSMAVGTHMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVTFP  337 (549)
Q Consensus       260 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~p  337 (549)
                      |||++......    ....||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+........ .....+|
T Consensus       164 Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~~~~~  238 (289)
T 4fvq_A          164 DPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDRHQLP  238 (289)
T ss_dssp             CCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCCCC
T ss_pred             cCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hccCCCC
Confidence            99998655322    23458899999999987 779999999999999999999 55666666655544443 4455677


Q ss_pred             ccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        338 SQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       338 ~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ...++++.++|.+||+.||.+|||+.++++|
T Consensus       239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          239 APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7889999999999999999999999999887

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.2e-44  Score=357.85  Aligned_cols=246  Identities=19%  Similarity=0.350  Sum_probs=216.6

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--CE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--NE  192 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~  192 (549)
                      .-..++|++.+.||+|+||.||+|.+.  ++.+|+|++............+.+|+.++++++||||+++++++...  +.
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence            345678999999999999999999985  88999999987766677778899999999999999999999999876  77


Q ss_pred             EEEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--CccccccCCcEEEecCCcEEEeecccceec
Q psy18060        193 FVLITEFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNR--VLHRDLKPQNVLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~g--IiHrDIKP~NILl~~~g~vKL~DFGla~~~  267 (549)
                      .++||||+. |+|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+|||++.+|.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            899999998 59999998765  4899999999999999999999999  999999999999999999999999887543


Q ss_pred             ccCcccccccCCCCcccccccccCCCCCc---chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCccCCH
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAERPYDH---TADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--DVTFPSQVSE  342 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~~~y~~---ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~  342 (549)
                      .     .....||+.|+|||++.+..++.   ++|||||||++|+|++|+.||...+.......+...  ...+|..+++
T Consensus       164 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          164 Q-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             S-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             c-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence            2     23456899999999998765544   899999999999999999999998887776665443  3456788999


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .+.++|.+||+.||.+|||+.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.4e-44  Score=363.58  Aligned_cols=252  Identities=23%  Similarity=0.433  Sum_probs=221.8

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ..-..++|++.+.||+|+||.||+|.+..++..||+|.+....   .....+.+|+.+++.++||||+++++++...+..
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            3345678999999999999999999999999999999996532   3456788999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        194 VLITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      ++||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999998 5999999874  45999999999999999999999999999999999999999999999999999766543


Q ss_pred             cc-cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHH
Q psy18060        271 TH-MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDL  347 (549)
Q Consensus       271 ~~-~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dl  347 (549)
                      .. ......||+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+... ....|..+++.+.++
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  244 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL  244 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence            21 2233457889999999998899999999999999999999 99999988877776666554 445677899999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcC
Q psy18060        348 VKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~H  368 (549)
                      |.+||..||.+|||+.++++.
T Consensus       245 i~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          245 MRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhCCChhhCcCHHHHHHH
Confidence            999999999999999999763

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-45  Score=370.95  Aligned_cols=252  Identities=28%  Similarity=0.476  Sum_probs=209.9

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhc----CCCCeeEEEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHL----AHPNIIKFIAS  186 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l----~hpnIv~l~~~  186 (549)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.+++++    .||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            334578999999999999999999999999999999997643221    1223456789999998    89999999999


Q ss_pred             EeeCCEEEEEEec-CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe-cCCcEEEeeccc
Q psy18060        187 HETLNEFVLITEF-AH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN-KDGVAMLCDFGF  263 (549)
Q Consensus       187 ~~~~~~~~iV~E~-~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~-~~g~vKL~DFGl  263 (549)
                      +...+..++|||+ +. ++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            9988999999998 55 69999999988999999999999999999999999999999999999999 789999999999


Q ss_pred             ceecccCcccccccCCCCcccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCH
Q psy18060        264 ARSMAVGTHMLTSIKGTPLYMAPELIAERPY-DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSE  342 (549)
Q Consensus       264 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y-~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  342 (549)
                      ++.....  ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....      .+......+|..+++
T Consensus       187 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~  258 (312)
T 2iwi_A          187 GALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHVSP  258 (312)
T ss_dssp             CEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTSCH
T ss_pred             hhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccCCH
Confidence            9876543  2355679999999999977666 458999999999999999999997632      233456678889999


Q ss_pred             HHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        343 TYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+.++|.+||+.||.+|||+.|+++||||+..
T Consensus       259 ~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            99999999999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.6e-44  Score=365.87  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=207.8

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ....+++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence            44557889999999999999999999999999999999875432 33345778999999999999999999999999999


Q ss_pred             EEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 FVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 ~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      .++|||++.| +|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            9999999985 999999998899999999999999999999999999999999999999999999999999997654332


Q ss_pred             -ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCccCCHHHHHH
Q psy18060        272 -HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---TFPSQVSETYKDL  347 (549)
Q Consensus       272 -~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~dl  347 (549)
                       .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+.....   ..++.+|+++.++
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  268 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV  268 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence             223455799999999999999999999999999999999999999998876655554443322   2456789999999


Q ss_pred             HHHhchhCcCCCC-CHHHHhc
Q psy18060        348 VKGLLEKDASQRL-SWPELLH  367 (549)
Q Consensus       348 I~~~L~~dP~~Rp-s~~elL~  367 (549)
                      |.+||+.||.+|| |++++++
T Consensus       269 i~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          269 IARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHhccCCHHHHHHhHHHHHH
Confidence            9999999999999 7877764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.1e-44  Score=370.02  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=217.0

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceE--EEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTV--ALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNE  192 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~v--AvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  192 (549)
                      -..++|++.+.||+|+||.||+|.+..++..+  |+|.+.... .......+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            34578999999999999999999999888865  999987532 233456788999999999 99999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV  255 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~  255 (549)
                      .++||||+. ++|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence            999999997 59999998754                6999999999999999999999999999999999999999999


Q ss_pred             EEEeecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-C
Q psy18060        256 AMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-D  333 (549)
Q Consensus       256 vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~  333 (549)
                      +||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+..+ .
T Consensus       181 ~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             EEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence            999999999754322 12234467899999999998889999999999999999998 99999999988888877665 3


Q ss_pred             CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        334 VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       334 ~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ...|..+++.+.++|.+||+.||.+|||+.|++++
T Consensus       260 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            45677899999999999999999999999999886

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.1e-44  Score=364.99  Aligned_cols=252  Identities=24%  Similarity=0.406  Sum_probs=215.7

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIH-----LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET  189 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  189 (549)
                      -..++|++.+.||+|+||.||+|.+     ..+++.||+|++.... .......+.+|+.+++++ +||||+++++++..
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            3457899999999999999999985     4567899999997543 344567889999999999 99999999999999


Q ss_pred             CCEEEEEEecCCC-CHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE
Q psy18060        190 LNEFVLITEFAHM-SLSNLLEQRK------------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL  250 (549)
Q Consensus       190 ~~~~~iV~E~~~g-sL~~~l~~~~------------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl  250 (549)
                      .+..++||||+.+ +|.+++....                  .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            9999999999975 9999998754                  48999999999999999999999999999999999999


Q ss_pred             ecCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy18060        251 NKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIR  327 (549)
Q Consensus       251 ~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~  327 (549)
                      +.++.+||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+........
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            9999999999999987654322  1234457889999999998899999999999999999998 999998766433333


Q ss_pred             H-HhcC-CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        328 L-LKTQ-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       328 ~-i~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      . +... ....|..+++.+.++|.+||+.||.+|||+.|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            2 2222 334567799999999999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.5e-44  Score=357.38  Aligned_cols=247  Identities=28%  Similarity=0.495  Sum_probs=204.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ..++|++.+.||+|+||.||+|.+.  ++.+|+|++......  ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            3578999999999999999999875  889999998654322  233567889999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---CccccccCCcEEEec--------CCcEEEeecc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR---VLHRDLKPQNVLLNK--------DGVAMLCDFG  262 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IiHrDIKP~NILl~~--------~g~vKL~DFG  262 (549)
                      +||||+. ++|.+++. .+.+++..++.++.|++.||.|||++|   |+||||||+|||++.        ++.+||+|||
T Consensus        83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999997 57888875 568999999999999999999999999   899999999999986        6789999999


Q ss_pred             cceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCccC
Q psy18060        263 FARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD--VTFPSQV  340 (549)
Q Consensus       263 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~  340 (549)
                      +++......  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+....  ...|..+
T Consensus       162 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          162 LAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             C---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             ccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence            997665432  234579999999999999899999999999999999999999999988877766665443  3456789


Q ss_pred             CHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        341 SETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       341 s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ++.+.++|.+||+.||.+|||+.|+++|
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            9999999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-44  Score=355.14  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=218.0

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++......   .+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            467999999999999999999987 5778999999765433   356889999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-ccc
Q psy18060        198 EFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-HML  274 (549)
Q Consensus       198 E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-~~~  274 (549)
                      |++. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence            9997 5899999875 568999999999999999999999999999999999999999999999999997654321 122


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhc
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLL  352 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L  352 (549)
                      ....||+.|+|||++.+..++.++||||||+++|+|++ |+.||...+.......+..+ ....|..+++.+.+++.+||
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l  242 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW  242 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHc
Confidence            34467889999999998889999999999999999999 99999999888888777665 34456778999999999999


Q ss_pred             hhCcCCCCCHHHHhcC
Q psy18060        353 EKDASQRLSWPELLHH  368 (549)
Q Consensus       353 ~~dP~~Rps~~elL~H  368 (549)
                      +.||.+|||+.+++++
T Consensus       243 ~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          243 RERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.4e-44  Score=365.30  Aligned_cols=255  Identities=20%  Similarity=0.348  Sum_probs=222.2

Q ss_pred             cccccccceeEEEEEecCCcEEEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q psy18060        113 KSNGALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASH  187 (549)
Q Consensus       113 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~  187 (549)
                      ......++|++.+.||+|+||.||+|.+.     .+++.||+|.+... ........+.+|+.+++.++||||+++++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            34455678999999999999999999877     45788999998754 3344556788999999999999999999999


Q ss_pred             eeCCEEEEEEecCC-CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcE
Q psy18060        188 ETLNEFVLITEFAH-MSLSNLLEQR----------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVA  256 (549)
Q Consensus       188 ~~~~~~~iV~E~~~-gsL~~~l~~~----------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~v  256 (549)
                      ...+..++||||+. |+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence            99999999999997 5999998753          457999999999999999999999999999999999999999999


Q ss_pred             EEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC
Q psy18060        257 MLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD  333 (549)
Q Consensus       257 KL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~  333 (549)
                      ||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  257 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  257 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence            9999999976543321  1233457899999999998899999999999999999999 899999998888887776654


Q ss_pred             -CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        334 -VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       334 -~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                       ...|..+++.+.++|.+||+.||.+|||+.|+++|
T Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             34667899999999999999999999999999987

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-44  Score=372.25  Aligned_cols=253  Identities=25%  Similarity=0.395  Sum_probs=213.1

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETL  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  190 (549)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++.... .......+.+|+.+++++ .||||+++++++...
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            4578999999999999999999973     456789999997532 233456789999999999 899999999999999


Q ss_pred             CEEEEEEecCC-CCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCC
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQRK-----------------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQ  246 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~~-----------------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~  246 (549)
                      +.+++||||+. |+|.+++....                       .+++..++.++.||+.||.|||++||+||||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            99999999997 59999998653                       2799999999999999999999999999999999


Q ss_pred             cEEEecCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q psy18060        247 NVLLNKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSIL  323 (549)
Q Consensus       247 NILl~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~  323 (549)
                      |||++.++.+||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|+|+| |..||.+.+..
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            99999999999999999986654322  1234467889999999998899999999999999999998 99999887644


Q ss_pred             HHHHHH-hcC-CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcc
Q psy18060        324 HLIRLL-KTQ-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPL  370 (549)
Q Consensus       324 ~~~~~i-~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw  370 (549)
                      .....+ ... ....|..+++++.++|.+||+.||.+|||+.++++|..
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          282 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            433333 322 34456788999999999999999999999999998743

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.1e-43  Score=359.26  Aligned_cols=255  Identities=32%  Similarity=0.501  Sum_probs=207.2

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ......+|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus        27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            3446688999999999999999999999999999999997643 345566788999999999999999999999999999


Q ss_pred             EEEEEecCCC-CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceec
Q psy18060        193 FVLITEFAHM-SLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       193 ~~iV~E~~~g-sL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~  267 (549)
                      .++|||++.+ +|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999985 89999875    456999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCCC--CCccCCHH
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV--SILHLIRLLKTQDVT--FPSQVSET  343 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~--~~~~~~~~i~~~~~~--~p~~~s~~  343 (549)
                      ...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.  ........+......  .+..++++
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence            54433344567999999999999999999999999999999999999999764  344555555544322  22568999


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +.++|.+||..||.+|||+.+++++
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-44  Score=358.83  Aligned_cols=251  Identities=20%  Similarity=0.361  Sum_probs=217.3

Q ss_pred             ccceeEEE-EEecCCcEEEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        118 LEKYQKIC-LIGEGSFGKVFKAIHL--DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       118 ~~~y~~~~-~iG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||+|++... ........+.+|+.+++.++||||+++++++ ..+..+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            35677777 9999999999999854  46788999999764 3445667889999999999999999999999 455689


Q ss_pred             EEEecCCC-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAHM-SLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~g-sL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +|||++.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  165 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence            99999985 899999754 5699999999999999999999999999999999999999999999999999987654322


Q ss_pred             c---ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHH
Q psy18060        273 M---LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDL  347 (549)
Q Consensus       273 ~---~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dl  347 (549)
                      .   .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+..+. ..+|+.+++.+.++
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  245 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL  245 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHH
Confidence            1   233457899999999988889999999999999999998 999999888777777776553 56778899999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPL  370 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw  370 (549)
                      |.+||+.||.+|||+.++++|.+
T Consensus       246 i~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          246 MSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHHHH
Confidence            99999999999999999998854

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.4e-44  Score=365.61  Aligned_cols=253  Identities=22%  Similarity=0.361  Sum_probs=209.3

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-  191 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-  191 (549)
                      -..++|.+.+.||+|+||.||+|.+..   ++..||+|.+............+.+|+.++++++||||+++++++...+ 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            345789999999999999999998765   5668999999876666667788999999999999999999999987654 


Q ss_pred             ----EEEEEEecCC-CCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEee
Q psy18060        192 ----EFVLITEFAH-MSLSNLLEQ------RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCD  260 (549)
Q Consensus       192 ----~~~iV~E~~~-gsL~~~l~~------~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~D  260 (549)
                          ..++||||+. ++|.+++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence                3599999998 589999853      35699999999999999999999999999999999999999999999999


Q ss_pred             cccceecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCC
Q psy18060        261 FGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTF  336 (549)
Q Consensus       261 FGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~  336 (549)
                      ||+++......  .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+..+ ....
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  270 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ  270 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCC
Confidence            99997664332  12233467889999999999999999999999999999999 99999988877776666554 4556


Q ss_pred             CccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        337 PSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       337 p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      |..+++.+.++|.+||..||.+|||+.+++++
T Consensus       271 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77899999999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.4e-44  Score=361.14  Aligned_cols=252  Identities=25%  Similarity=0.385  Sum_probs=210.0

Q ss_pred             cccccceeEEEEEecCCcEEEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL  190 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  190 (549)
                      .-....|++.+.||+|+||.||+|.    +..+++.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            3345679999999999999999998    57789999999997543 233456789999999999999999999998776


Q ss_pred             --CEEEEEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        191 --NEFVLITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       191 --~~~~iV~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                        +.+++||||+. ++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence              67899999997 599999955 46799999999999999999999999999999999999999999999999999987


Q ss_pred             cccCcc---cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHH
Q psy18060        267 MAVGTH---MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV---------------SILHLIRL  328 (549)
Q Consensus       267 ~~~~~~---~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~---------------~~~~~~~~  328 (549)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|..|+...               ........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            654432   234456889999999999989999999999999999999999886422               12222233


Q ss_pred             Hhc-CCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        329 LKT-QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       329 i~~-~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      +.. .....|+.+++.+.++|.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            322 344567889999999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.1e-44  Score=369.51  Aligned_cols=249  Identities=22%  Similarity=0.392  Sum_probs=206.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceE----EEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTV----ALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .++|++.+.||+|+||.||+|.+..+++.+    |+|.+... ........+.+|+.++++++||||+++++++.... .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            467999999999999999999998887765    66666432 22344567899999999999999999999998766 5


Q ss_pred             EEEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +++++++. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence            67777766 799999987 4579999999999999999999999999999999999999999999999999998765432


Q ss_pred             cc--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHH
Q psy18060        272 HM--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDL  347 (549)
Q Consensus       272 ~~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dl  347 (549)
                      ..  .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+... ....|..++..+.++
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  251 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI  251 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHH
T ss_pred             ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence            21  233457889999999999999999999999999999999 99999988877776666554 345677899999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcC
Q psy18060        348 VKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~H  368 (549)
                      +.+||+.||.+|||+.|++++
T Consensus       252 i~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          252 MVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.7e-44  Score=367.60  Aligned_cols=251  Identities=29%  Similarity=0.467  Sum_probs=219.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEc-------CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEe
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHL-------DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHE  188 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~  188 (549)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|++... ........+.+|+.+++.+ +||||+++++++.
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            4578999999999999999999976       45678999998654 3455567889999999999 8999999999999


Q ss_pred             eCCEEEEEEecCC-CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe
Q psy18060        189 TLNEFVLITEFAH-MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN  251 (549)
Q Consensus       189 ~~~~~~iV~E~~~-gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~  251 (549)
                      ..+.+++||||+. |+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence            9999999999997 59999998754                389999999999999999999999999999999999999


Q ss_pred             cCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy18060        252 KDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRL  328 (549)
Q Consensus       252 ~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~  328 (549)
                      .++.+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  271 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  271 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence            999999999999987654321  2234467889999999988889999999999999999999 9999999988888777


Q ss_pred             HhcCC-CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        329 LKTQD-VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       329 i~~~~-~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +..+. ...|..+++.+.++|.+||+.||.+|||+.|++++
T Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            76553 45677899999999999999999999999999876

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.3e-44  Score=376.86  Aligned_cols=250  Identities=23%  Similarity=0.391  Sum_probs=207.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEc---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ...+|.+.+.||+|+||.||+|.+.   .++..||+|.+... ........+.+|+.++++++||||+++++++...+..
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            3467999999999999999999877   46778999998654 3455567899999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ++||||+. |+|.+++.... .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            99999996 69999998754 69999999999999999999999999999999999999999999999999998765432


Q ss_pred             cc---ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHH
Q psy18060        272 HM---LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKD  346 (549)
Q Consensus       272 ~~---~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~d  346 (549)
                      ..   .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+.......+..+ ..+.|..+++.+.+
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  281 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ  281 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHH
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHH
Confidence            11   122345788999999999999999999999999999998 99999999888888777655 23456678999999


Q ss_pred             HHHHhchhCcCCCCCHHHHhc
Q psy18060        347 LVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~  367 (549)
                      +|.+||+.||.+|||+.++++
T Consensus       282 li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          282 LMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhCcChhhCcCHHHHHH
Confidence            999999999999999999876

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.7e-44  Score=359.60  Aligned_cols=247  Identities=21%  Similarity=0.300  Sum_probs=206.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEE-EEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA-SHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~~~~iV  196 (549)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++......    ..+.+|+.+++.+.|++++..+. +....+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            46899999999999999999999999999999998764432    35788999999999887655544 45777888999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe---cCCcEEEeecccceecccCcc
Q psy18060        197 TEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       197 ~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~---~~g~vKL~DFGla~~~~~~~~  272 (549)
                      |||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.......
T Consensus        84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             EEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence            99998899999984 46799999999999999999999999999999999999994   788999999999987654322


Q ss_pred             -------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCC-----CC
Q psy18060        273 -------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDVT-----FP  337 (549)
Q Consensus       273 -------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~---~~~~~~~i~~~~~~-----~p  337 (549)
                             ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+   .......+......     ++
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  243 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence                   1245679999999999999999999999999999999999999998632   12222222222222     23


Q ss_pred             ccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        338 SQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       338 ~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ..+|+++.++|.+||+.||.+|||+.++++.
T Consensus       244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence            6789999999999999999999999998753

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.1e-44  Score=368.75  Aligned_cols=255  Identities=20%  Similarity=0.315  Sum_probs=216.7

Q ss_pred             cccceeEEEEEecCCcEEEEEEE-----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAI-----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      ..++|++.+.||+|+||.||+|.     +..++..||+|.+... ........+.+|+.+++.++||||+++++++...+
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            45789999999999999999998     5567889999998643 34455667889999999999999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC---CcEEEee
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRK-------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD---GVAMLCD  260 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~-------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~---g~vKL~D  260 (549)
                      ..++||||+. ++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence            9999999996 59999998763       48999999999999999999999999999999999999844   4699999


Q ss_pred             cccceecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCC
Q psy18060        261 FGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTF  336 (549)
Q Consensus       261 FGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~  336 (549)
                      ||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..+ ....
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~  266 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP  266 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCC
Confidence            99997553322  12234568999999999988899999999999999999998 99999999888887777655 3456


Q ss_pred             CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        337 PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       337 p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      |..+++.+.++|.+||+.||.+|||+.++++|.|..
T Consensus       267 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          267 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            678999999999999999999999999999998864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.4e-45  Score=372.79  Aligned_cols=249  Identities=22%  Similarity=0.387  Sum_probs=211.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCce----EEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKT----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .++|++.+.||+|+||.||+|.+..+++.    +|+|.+.... .......+.+|+.+++.++||||+++++++.. +..
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   89 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL   89 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence            46799999999999999999999888877    6667664332 12223456789999999999999999999864 568


Q ss_pred             EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ++||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD  169 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred             EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence            89999987 6899999764 579999999999999999999999999999999999999999999999999998765432


Q ss_pred             c--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHH
Q psy18060        272 H--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDL  347 (549)
Q Consensus       272 ~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dl  347 (549)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+... ....|..+++++.++
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  249 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMV  249 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHH
T ss_pred             ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHH
Confidence            2  2344568889999999998899999999999999999999 99999988877777766655 345667889999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcC
Q psy18060        348 VKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~H  368 (549)
                      |.+||+.||.+|||+.++++|
T Consensus       250 i~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          250 MVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-43  Score=356.13  Aligned_cols=246  Identities=24%  Similarity=0.431  Sum_probs=208.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHH-----HHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-----LSSLKQECEIQKHLAHPNIIKFIASHETLN  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  191 (549)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.........     .+.+.+|+.+++.++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            347899999999999999999999999999999998654432221     167889999999999999999999997665


Q ss_pred             EEEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccCCcEEEecCCc-----EEEeecc
Q psy18060        192 EFVLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNR--VLHRDLKPQNVLLNKDGV-----AMLCDFG  262 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g--IiHrDIKP~NILl~~~g~-----vKL~DFG  262 (549)
                        ++||||+. ++|.+.+... ..+++..+..++.|++.||.|||++|  |+||||||+|||++.++.     +||+|||
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence              68999998 6898887654 57999999999999999999999999  999999999999988776     9999999


Q ss_pred             cceecccCcccccccCCCCcccccccc--cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcC--CCCC
Q psy18060        263 FARSMAVGTHMLTSIKGTPLYMAPELI--AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI--LHLIRLLKTQ--DVTF  336 (549)
Q Consensus       263 la~~~~~~~~~~~~~~GT~~Y~APE~l--~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~--~~~~~~i~~~--~~~~  336 (549)
                      +++....   ......||+.|+|||++  ....++.++|||||||++|+|++|+.||...+.  ......+...  ...+
T Consensus       175 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T 4f0f_A          175 LSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI  251 (287)
T ss_dssp             TCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCC
T ss_pred             ccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCC
Confidence            9975442   33556799999999998  455688999999999999999999999986543  2223333332  3456


Q ss_pred             CccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        337 PSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       337 p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      |..+++.+.++|.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            7889999999999999999999999999975

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-43  Score=381.71  Aligned_cols=243  Identities=24%  Similarity=0.426  Sum_probs=212.5

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-EEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-EFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~  194 (549)
                      -..++|++.+.||+|+||.||+|.+.  ++.||||++....    ..+.+.+|+.++++++||||+++++++...+ .++
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            34678999999999999999999876  7799999997543    3457889999999999999999999976654 799


Q ss_pred             EEEecCC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        195 LITEFAH-MSLSNLLEQRKK--LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~--l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +||||+. |+|.+++..++.  +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            9999997 599999987654  799999999999999999999999999999999999999999999999999865432 


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVK  349 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~  349 (549)
                        .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+ ....|..+|+.+.++|.
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  420 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMK  420 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence              223468899999999999999999999999999999998 99999988777777766554 45677889999999999


Q ss_pred             HhchhCcCCCCCHHHHhc
Q psy18060        350 GLLEKDASQRLSWPELLH  367 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~  367 (549)
                      +||+.||.+|||+.++++
T Consensus       421 ~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          421 NCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHH
Confidence            999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=364.35  Aligned_cols=251  Identities=22%  Similarity=0.406  Sum_probs=212.8

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCC----ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLK----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ...+|.+.+.||+|+||.||+|.+..++    ..||+|++... ........+.+|+.+++.++||||+++++++...+.
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            4567999999999999999999887653    35999999754 344556678999999999999999999999999999


Q ss_pred             EEEEEecCCC-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        193 FVLITEFAHM-SLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       193 ~~iV~E~~~g-sL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      .++||||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            9999999985 999999865 67999999999999999999999999999999999999999999999999999876433


Q ss_pred             cc---cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHH
Q psy18060        271 TH---MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYK  345 (549)
Q Consensus       271 ~~---~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  345 (549)
                      ..   ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+..+ ..+.|..+++.+.
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  280 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY  280 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHH
Confidence            21   1123356889999999999999999999999999999999 99999999888888777665 3456678999999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcC
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ++|.+||+.||.+||++.+++++
T Consensus       281 ~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          281 QLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.1e-44  Score=356.52  Aligned_cols=244  Identities=27%  Similarity=0.425  Sum_probs=212.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--------
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--------  189 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--------  189 (549)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+....      ..+.+|+++++.++||||+++++++..        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            467999999999999999999999999999999997542      245789999999999999999998754        


Q ss_pred             --------CCEEEEEEecCCC-CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEE
Q psy18060        190 --------LNEFVLITEFAHM-SLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAML  258 (549)
Q Consensus       190 --------~~~~~iV~E~~~g-sL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL  258 (549)
                              ...+++||||+++ +|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence                    4558999999985 999999764  57999999999999999999999999999999999999999999999


Q ss_pred             eecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc
Q psy18060        259 CDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS  338 (549)
Q Consensus       259 ~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~  338 (549)
                      +|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...  ......+...  .++.
T Consensus       164 ~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~~~~  238 (284)
T 2a19_B          164 GDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--IISD  238 (284)
T ss_dssp             CCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--CCCT
T ss_pred             Ccchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--cccc
Confidence            9999998765442 234557999999999999999999999999999999999999987532  2233333333  3567


Q ss_pred             cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       339 ~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      .+++.+.++|.+||..||.+|||+.|+++|+|.-
T Consensus       239 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            8899999999999999999999999999998864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=371.84  Aligned_cols=251  Identities=16%  Similarity=0.170  Sum_probs=202.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcC---CCceEEEEEEecCCCChH---------HHHHHHHHHHHHHhcCCCCeeEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGK---------ELSSLKQECEIQKHLAHPNIIKFIA  185 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~---------~~~~~~~Ei~il~~l~hpnIv~l~~  185 (549)
                      .++|++.+.||+|+||.||+|.+..   ++..+|+|++........         ....+.+|+.+++.+.||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4689999999999999999999987   788999999976532111         0123567888899999999999999


Q ss_pred             EEee----CCEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC--cEEEe
Q psy18060        186 SHET----LNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG--VAMLC  259 (549)
Q Consensus       186 ~~~~----~~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g--~vKL~  259 (549)
                      ++..    ....|+||||++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             ccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence            9877    67899999999779999998888999999999999999999999999999999999999999887  99999


Q ss_pred             ecccceecccCc-------ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHh
Q psy18060        260 DFGFARSMAVGT-------HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT--VSILHLIRLLK  330 (549)
Q Consensus       260 DFGla~~~~~~~-------~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~--~~~~~~~~~i~  330 (549)
                      |||+|+......       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+  .+.........
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  275 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKT  275 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHH
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHH
Confidence            999998764321       112455799999999999999999999999999999999999999965  23332222211


Q ss_pred             cCCCCCCc---------cCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        331 TQDVTFPS---------QVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       331 ~~~~~~p~---------~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .....+|.         .+++++.++|.+||+.||.+|||+++|++.
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          276 NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            11112222         789999999999999999999999998764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.8e-44  Score=358.79  Aligned_cols=246  Identities=21%  Similarity=0.315  Sum_probs=202.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEE-EEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA-SHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~~~~iV  196 (549)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++......    ..+.+|+.+++.+.|++++..+. ++...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            46799999999999999999999999999999987654322    34678999999998877666554 45778889999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE---ecCCcEEEeecccceecccCcc
Q psy18060        197 TEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       197 ~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl---~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             EECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             EEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence            99998899999985 4679999999999999999999999999999999999999   7889999999999987654321


Q ss_pred             -------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCCC-----
Q psy18060        273 -------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI---LHLIRLLKTQDVTFP-----  337 (549)
Q Consensus       273 -------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~---~~~~~~i~~~~~~~p-----  337 (549)
                             ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.   ......+.......|     
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  243 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhh
Confidence                   22356799999999999999999999999999999999999999976432   122222222222222     


Q ss_pred             ccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        338 SQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       338 ~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ..+|+++.++|.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            568999999999999999999999999876

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.2e-44  Score=361.98  Aligned_cols=253  Identities=26%  Similarity=0.452  Sum_probs=215.0

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEe
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIH-----LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHE  188 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~  188 (549)
                      .-..++|++.+.||+|+||.||+|.+     ..+++.||+|++... ........+.+|+.+++.+ +||||+++++++.
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            34457899999999999999999985     456789999999754 3444567889999999999 7999999999987


Q ss_pred             eCC-EEEEEEecCCC-CHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE
Q psy18060        189 TLN-EFVLITEFAHM-SLSNLLEQRKK----------------LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL  250 (549)
Q Consensus       189 ~~~-~~~iV~E~~~g-sL~~~l~~~~~----------------l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl  250 (549)
                      ..+ .+++||||+.+ +|.+++.....                +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~  181 (316)
T 2xir_A          102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  181 (316)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence            654 58999999985 99999987654                8999999999999999999999999999999999999


Q ss_pred             ecCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH-HHH
Q psy18060        251 NKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSIL-HLI  326 (549)
Q Consensus       251 ~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~-~~~  326 (549)
                      +.++.+||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.... ...
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~  261 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  261 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence            9999999999999986643321  2234568899999999999999999999999999999998 99999876532 333


Q ss_pred             HHHhc-CCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        327 RLLKT-QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       327 ~~i~~-~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ..+.. .....|..+++.+.++|.+||+.||.+|||+.|+++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33333 3455677899999999999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.6e-44  Score=383.15  Aligned_cols=248  Identities=26%  Similarity=0.396  Sum_probs=196.6

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +.|.+.+.||+|+||+||.+ ...+|+.||||++...     ..+.+.+|+.+++.+ +|||||++++++.+.+.+|+||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            44667789999999999875 4456999999998652     234568899999876 8999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC-------------CcEE
Q psy18060        198 EFAHMSLSNLLEQRKKLS-------ETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-------------GVAM  257 (549)
Q Consensus       198 E~~~gsL~~~l~~~~~l~-------e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~-------------g~vK  257 (549)
                      |||+|+|.+++.......       +..+..++.||+.||+|||++||+||||||+|||++.+             +.+|
T Consensus        89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            999999999998764432       33457899999999999999999999999999999764             4899


Q ss_pred             EeecccceecccCcc----cccccCCCCcccccccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy18060        258 LCDFGFARSMAVGTH----MLTSIKGTPLYMAPELIAE-------RPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHL  325 (549)
Q Consensus       258 L~DFGla~~~~~~~~----~~~~~~GT~~Y~APE~l~~-------~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~  325 (549)
                      |+|||+|+.......    .....+||+.|+|||++.+       ..++.++|||||||++|+|++ |+.||....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            999999987654322    1234579999999999965       678999999999999999999 999997654332 


Q ss_pred             HHHHhcCCCCCC-------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        326 IRLLKTQDVTFP-------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       326 ~~~i~~~~~~~p-------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                       ..+..+...++       ..+++++.++|.+||+.||.+|||+.++++||||.+.
T Consensus       248 -~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          248 -SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             -HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             -HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence             12222222221       2456899999999999999999999999999999754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.1e-44  Score=366.73  Aligned_cols=249  Identities=22%  Similarity=0.400  Sum_probs=207.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceE----EEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTV----ALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ..+|++++.||+|+||.||+|.+..+++.+    |+|.+... ........+.+|+.+++.++||||+++++++.... .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            477999999999999999999999888876    55555432 23334567889999999999999999999998766 6


Q ss_pred             EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +++++++. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred             eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence            67777766 6999999874 579999999999999999999999999999999999999999999999999998764332


Q ss_pred             c--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHH
Q psy18060        272 H--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDL  347 (549)
Q Consensus       272 ~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dl  347 (549)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.... ...|..+++++.++
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  251 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI  251 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHH
T ss_pred             ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence            2  2233457889999999999999999999999999999999 999999988777777665543 45677899999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcC
Q psy18060        348 VKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~H  368 (549)
                      |.+||+.||.+|||+.|+++.
T Consensus       252 i~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          252 MRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-43  Score=357.39  Aligned_cols=250  Identities=26%  Similarity=0.490  Sum_probs=200.5

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .-...+|++.+.||+|+||.||+|.+.   ..+|+|++..........+.+.+|+.+++.++||||++++++. .....+
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            334577999999999999999999764   3599999987766777778899999999999999999999965 455689


Q ss_pred             EEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC--
Q psy18060        195 LITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--  270 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~--  270 (549)
                      +||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            9999998 589999964 456999999999999999999999999999999999999999999999999999765421  


Q ss_pred             cccccccCCCCccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCCC-----CCccCC
Q psy18060        271 THMLTSIKGTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI-LHLIRLLKTQDVT-----FPSQVS  341 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~-~~~~~~i~~~~~~-----~p~~~s  341 (549)
                      ........||+.|+|||++.   +..++.++|||||||++|+|++|+.||..... ......+......     .+..+|
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP  255 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCC
Confidence            22234567999999999986   66789999999999999999999999987544 4444444443322     234789


Q ss_pred             HHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        342 ETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       342 ~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +.+.+||.+||+.||.+|||+.++++.
T Consensus       256 ~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          256 KRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            999999999999999999999999753

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.7e-44  Score=364.33  Aligned_cols=249  Identities=28%  Similarity=0.493  Sum_probs=193.0

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEe--------
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHE--------  188 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~--------  188 (549)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++++. ||||+++++++.        
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            45799999999999999999999999999999998653  3445567889999999996 999999999983        


Q ss_pred             eCCEEEEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccCCcEEEecCCcEEEeeccc
Q psy18060        189 TLNEFVLITEFAHMSLSNLLEQ---RKKLSETICVQILSNLISALYYLHSNR--VLHRDLKPQNVLLNKDGVAMLCDFGF  263 (549)
Q Consensus       189 ~~~~~~iV~E~~~gsL~~~l~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g--IiHrDIKP~NILl~~~g~vKL~DFGl  263 (549)
                      ....++++|||++|+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+
T Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence            3456899999999999998875   467999999999999999999999999  99999999999999999999999999


Q ss_pred             ceecccCcc------------cccccCCCCcccccccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy18060        264 ARSMAVGTH------------MLTSIKGTPLYMAPELI---AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRL  328 (549)
Q Consensus       264 a~~~~~~~~------------~~~~~~GT~~Y~APE~l---~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~  328 (549)
                      ++.......            ......||+.|+|||++   .+..++.++|||||||++|+|++|+.||...........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            987643221            11245699999999998   567789999999999999999999999987655444332


Q ss_pred             HhcCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcc
Q psy18060        329 LKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPL  370 (549)
Q Consensus       329 i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw  370 (549)
                      .  .....+...++.+.+||.+||+.||.+|||+.|+++|-+
T Consensus       265 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          265 K--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ---CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             c--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            2  122344567888999999999999999999999998853

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.1e-43  Score=354.33  Aligned_cols=251  Identities=26%  Similarity=0.353  Sum_probs=212.2

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ...++|.+.+.||+|+||.||+|.+..   ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. .
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~   86 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P   86 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C
Confidence            345789999999999999999998654   34469999987542 345567889999999999999999999998754 4


Q ss_pred             EEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        193 FVLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      .++|||++. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            689999998 5899999775 45999999999999999999999999999999999999999999999999999766543


Q ss_pred             cc-cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHH
Q psy18060        271 TH-MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDL  347 (549)
Q Consensus       271 ~~-~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dl  347 (549)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+... ....|..+++.+.++
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  246 (281)
T 3cc6_A          167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL  246 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred             cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence            21 2234457889999999998899999999999999999998 99999877666666555443 445677899999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcC
Q psy18060        348 VKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~H  368 (549)
                      |.+||..||.+|||+.|++++
T Consensus       247 i~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          247 MTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCchhCcCHHHHHHH
Confidence            999999999999999999876

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1e-43  Score=364.83  Aligned_cols=249  Identities=26%  Similarity=0.326  Sum_probs=202.6

Q ss_pred             ccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC--
Q psy18060        114 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN--  191 (549)
Q Consensus       114 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--  191 (549)
                      ..-...+|++.+.||+|+||.||+|.+.  ++.||+|++...   ........+|+.++++++||||+++++++....  
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            3344578999999999999999999876  789999999643   233345567899999999999999999987744  


Q ss_pred             --EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCccccccCCcEEEecCCcEEE
Q psy18060        192 --EFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN----------RVLHRDLKPQNVLLNKDGVAML  258 (549)
Q Consensus       192 --~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~----------gIiHrDIKP~NILl~~~g~vKL  258 (549)
                        .+++||||+. |+|.+++.. ..+++..++.++.|++.||.|||+.          ||+||||||+|||++.++.+||
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence              4799999997 599999976 4599999999999999999999999          9999999999999999999999


Q ss_pred             eecccceecccCcc--cccccCCCCcccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCC-----------
Q psy18060        259 CDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAE-----RPYDHTADLWSLGCIAYEIHMGHPPFKTV-----------  320 (549)
Q Consensus       259 ~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~-----~~y~~ksDIwSlGvil~eLltG~~Pf~~~-----------  320 (549)
                      +|||+|+.......  ......||+.|+|||++.+     ..++.++|||||||++|+|+||+.||.+.           
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999987654322  2344679999999999976     35677899999999999999999999653           


Q ss_pred             -----CHHHHHHHHhcCCC--CCCc-----cCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        321 -----SILHLIRLLKTQDV--TFPS-----QVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       321 -----~~~~~~~~i~~~~~--~~p~-----~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                           ........+.....  .++.     ..++++.+||.+||+.||.+|||+.|+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                 22333333322221  1222     234569999999999999999999999763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.8e-43  Score=380.60  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=216.0

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .-..++|++.+.||+|+||.||+|.+.. +..||||++.....   ..+.+.+|+.+++.++|||||++++++. .+.++
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            3445789999999999999999999864 67899999976432   3567899999999999999999999986 56789


Q ss_pred             EEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        195 LITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +||||+. |+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            9999997 6999999754  378999999999999999999999999999999999999999999999999998764322


Q ss_pred             c-cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHH
Q psy18060        272 H-MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLV  348 (549)
Q Consensus       272 ~-~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI  348 (549)
                      . ......+|+.|+|||++....++.++|||||||++|||+| |+.||.+.+..+....+..+ ..+.|..+|+++.++|
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  418 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM  418 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            1 1233457788999999998899999999999999999999 99999999988888777654 3456778999999999


Q ss_pred             HHhchhCcCCCCCHHHHhc
Q psy18060        349 KGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~  367 (549)
                      .+||+.||.+|||+.+|++
T Consensus       419 ~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          419 MRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHH
Confidence            9999999999999999865

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.9e-43  Score=351.69  Aligned_cols=248  Identities=22%  Similarity=0.356  Sum_probs=215.0

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ....++|++.+.||+|+||.||+|.+. ++..||+|.+......   .+.+.+|+++++.++||||+++++++.. +..+
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   83 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence            334578999999999999999999976 4678999999764433   4578899999999999999999999864 4588


Q ss_pred             EEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        195 LITEFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +|||++. ++|.+++....  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999996 69999997543  79999999999999999999999999999999999999999999999999998765432


Q ss_pred             c-cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHH
Q psy18060        272 H-MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLV  348 (549)
Q Consensus       272 ~-~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI  348 (549)
                      . ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+..+ ....|..+++++.++|
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  243 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM  243 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHH
Confidence            2 1233457889999999988889999999999999999999 99999998888887777655 3456678999999999


Q ss_pred             HHhchhCcCCCCCHHHHhc
Q psy18060        349 KGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~  367 (549)
                      .+||..||.+|||+.++++
T Consensus       244 ~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          244 RLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhccChhhCCCHHHHHH
Confidence            9999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.6e-43  Score=363.77  Aligned_cols=253  Identities=25%  Similarity=0.409  Sum_probs=215.4

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCc-----eEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEe
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHE  188 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~  188 (549)
                      .-..++|++.+.||+|+||.||+|.+..+++     .||+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3445789999999999999999999887665     79999996543 344567889999999999 8999999999999


Q ss_pred             eCCEEEEEEecCCC-CHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC
Q psy18060        189 TLNEFVLITEFAHM-SLSNLLEQR--------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD  253 (549)
Q Consensus       189 ~~~~~~iV~E~~~g-sL~~~l~~~--------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~  253 (549)
                      ..+.+++||||+.+ +|.+++...              ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence            99999999999975 999999753              358999999999999999999999999999999999999999


Q ss_pred             CcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q psy18060        254 GVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLK  330 (549)
Q Consensus       254 g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~  330 (549)
                      +.+||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  280 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV  280 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence            9999999999986643322  1234457889999999998899999999999999999998 999998765444333332


Q ss_pred             -c-CCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        331 -T-QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       331 -~-~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                       . .....|...++.+.++|.+||+.||.+|||+.|++++
T Consensus       281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence             2 2334567789999999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.2e-43  Score=362.44  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=212.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe--eCC
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE--TLN  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~  191 (549)
                      .++|++.+.||+|+||.||+|.    +..+++.||+|++...  .....+.+.+|+++++.++||||+++++++.  ..+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            4689999999999999999998    5678999999999754  3455677899999999999999999999875  556


Q ss_pred             EEEEEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceeccc
Q psy18060        192 EFVLITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV  269 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~  269 (549)
                      .+++||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            7999999996 689999987 45699999999999999999999999999999999999999999999999999987654


Q ss_pred             Ccc---cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHhc
Q psy18060        270 GTH---MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL---------------HLIRLLKT  331 (549)
Q Consensus       270 ~~~---~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~---------------~~~~~i~~  331 (549)
                      ...   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......               .....+..
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE  259 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence            322   223456889999999999888999999999999999999999998654321               22222222


Q ss_pred             -CCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        332 -QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       332 -~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                       .....|..+++.+.++|.+||+.||.+|||+.|++++
T Consensus       260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             2345677899999999999999999999999999765

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-44  Score=381.61  Aligned_cols=250  Identities=25%  Similarity=0.397  Sum_probs=200.1

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .+|.+.+.||+|+||+|+. ....+++.||||++.....     ....+|+++++.+ +|||||++++++.+.+..||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            4599999999999999764 3445689999999965322     2346799999999 7999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec---CC--cEEEeecccceecccCc
Q psy18060        198 EFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK---DG--VAMLCDFGFARSMAVGT  271 (549)
Q Consensus       198 E~~~gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~---~g--~vKL~DFGla~~~~~~~  271 (549)
                      |+|+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.   ++  .+||+|||+|+......
T Consensus        98 E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A           98 ELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             ECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             ECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            999999999998654 4666677899999999999999999999999999999953   23  58899999998765432


Q ss_pred             ---ccccccCCCCccccccccc---CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCC---CCccCC
Q psy18060        272 ---HMLTSIKGTPLYMAPELIA---ERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVT---FPSQVS  341 (549)
Q Consensus       272 ---~~~~~~~GT~~Y~APE~l~---~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s  341 (549)
                         ...+..+||+.|+|||++.   ...++.++|||||||++|+|++ |..||...........+......   .+...+
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED  257 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHH
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccccc
Confidence               2234567999999999997   4667889999999999999999 99999766554443333322222   123356


Q ss_pred             HHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        342 ETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       342 ~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ..+.+||.+||+.||.+|||+.|+++||||...
T Consensus       258 ~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          258 VIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             HHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            778999999999999999999999999999764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-43  Score=386.14  Aligned_cols=249  Identities=23%  Similarity=0.438  Sum_probs=219.6

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      -...+|++.+.||+|+||.||+|.+..++..||||.+.....   ..+.+.+|+.++++++|||||++++++...+.++|
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            345679999999999999999999999999999999875433   34678999999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        196 ITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ||||+. |+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            999998 6999999864  4589999999999999999999999999999999999999999999999999987653321


Q ss_pred             -cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHH
Q psy18060        273 -MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVK  349 (549)
Q Consensus       273 -~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~  349 (549)
                       ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+... ....|..+++.+.+||.
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  453 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR  453 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence             1233456788999999998899999999999999999999 99999998877777666544 34567889999999999


Q ss_pred             HhchhCcCCCCCHHHHhc
Q psy18060        350 GLLEKDASQRLSWPELLH  367 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~  367 (549)
                      +||+.||.+|||+.+|++
T Consensus       454 ~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          454 ACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCcChhHCcCHHHHHH
Confidence            999999999999999975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-43  Score=354.12  Aligned_cols=249  Identities=19%  Similarity=0.362  Sum_probs=211.3

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE-E
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF-V  194 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-~  194 (549)
                      -.|.+.+.||+|+||.||+|.+..++.   .+|+|.+... ........+.+|+.+++.++||||+++++++.+.+.. +
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            357788999999999999999765554   7999998653 3445567889999999999999999999999766655 8


Q ss_pred             EEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-
Q psy18060        195 LITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-  271 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-  271 (549)
                      ++||++. ++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...... 
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            9999986 699999987 4568999999999999999999999999999999999999999999999999997654321 


Q ss_pred             ---ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHH
Q psy18060        272 ---HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKD  346 (549)
Q Consensus       272 ---~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~d  346 (549)
                         .......||+.|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+.... ...|..+++.+.+
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  259 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ  259 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHH
Confidence               22234568899999999999999999999999999999999 566677666666666655443 4566789999999


Q ss_pred             HHHHhchhCcCCCCCHHHHhcC
Q psy18060        347 LVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +|.+||+.||.+|||+.++++.
T Consensus       260 li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          260 VMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999998764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.2e-43  Score=353.61  Aligned_cols=243  Identities=24%  Similarity=0.426  Sum_probs=205.3

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-CCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-LNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~  194 (549)
                      -..++|++.+.||+|+||.||+|.+.  ++.||+|++....    ..+.+.+|+.+++.++||||+++++++.. .+..+
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   91 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence            44688999999999999999999875  8899999986532    34678899999999999999999998654 45789


Q ss_pred             EEEecCCC-CHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        195 LITEFAHM-SLSNLLEQRKK--LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       195 iV~E~~~g-sL~~~l~~~~~--l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +||||+.+ +|.+++.....  +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... 
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-  170 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  170 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence            99999985 99999987543  899999999999999999999999999999999999999999999999998765432 


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVK  349 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~  349 (549)
                        .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+.......+..+ ....|..+++.+.++|.
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  248 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK  248 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence              233468899999999998899999999999999999998 99999988877777666554 44567789999999999


Q ss_pred             HhchhCcCCCCCHHHHhc
Q psy18060        350 GLLEKDASQRLSWPELLH  367 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~  367 (549)
                      +||..||.+|||+.|+++
T Consensus       249 ~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          249 NCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHhcCChhhCCCHHHHHH
Confidence            999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=367.53  Aligned_cols=244  Identities=18%  Similarity=0.248  Sum_probs=204.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCC--------CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeE-------
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDL--------KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK-------  182 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~--------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~-------  182 (549)
                      .++|++.+.||+|+||.||+|.+..+        ++.||+|++...       ..+.+|+.+++.++||||++       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            47899999999999999999999874        889999999754       35678999999999999887       


Q ss_pred             --------EEEEEee-CCEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe
Q psy18060        183 --------FIASHET-LNEFVLITEFAHMSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN  251 (549)
Q Consensus       183 --------l~~~~~~-~~~~~iV~E~~~gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~  251 (549)
                              +++++.. .+..++||||++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD  193 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence                    5667665 7789999999977999999986  7899999999999999999999999999999999999999


Q ss_pred             cCC--cEEEeecccceecccCcc-------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-
Q psy18060        252 KDG--VAMLCDFGFARSMAVGTH-------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS-  321 (549)
Q Consensus       252 ~~g--~vKL~DFGla~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~-  321 (549)
                      .++  .+||+|||+++.......       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... 
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            998  999999999976653321       1234579999999999999999999999999999999999999998753 


Q ss_pred             -HHHHHHH---HhcCCCCCC------ccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        322 -ILHLIRL---LKTQDVTFP------SQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       322 -~~~~~~~---i~~~~~~~p------~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                       .......   +......++      ..+++++.++|.+||+.||.+|||+.++++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence             3333222   222222222      2569999999999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.9e-43  Score=355.03  Aligned_cols=252  Identities=23%  Similarity=0.367  Sum_probs=209.9

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEE-eeCC
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLK---KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASH-ETLN  191 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~  191 (549)
                      ....+|++.+.||+|+||.||+|.+..++   ..+|+|.+... ........+.+|+.++++++||||+++++++ ...+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            34467999999999999999999875443   35899998653 3445567889999999999999999999985 5566


Q ss_pred             EEEEEEecCCC-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceeccc
Q psy18060        192 EFVLITEFAHM-SLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV  269 (549)
Q Consensus       192 ~~~iV~E~~~g-sL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~  269 (549)
                      ..++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            78999999985 99999976 45689999999999999999999999999999999999999999999999999986643


Q ss_pred             Cc----ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHH
Q psy18060        270 GT----HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSET  343 (549)
Q Consensus       270 ~~----~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~  343 (549)
                      ..    ...+...||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+.... ...|..+++.
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  260 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence            22    12234567889999999999999999999999999999999 777887776666655555443 3456778999


Q ss_pred             HHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        344 YKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       344 ~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +.++|.+||+.||.+|||+.|+++.
T Consensus       261 l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          261 LYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999763

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.7e-44  Score=371.92  Aligned_cols=251  Identities=19%  Similarity=0.207  Sum_probs=199.8

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCC-----CceEEEEEEecCCCChH-HH--------HHHHHHHHHHHhcCCCCeeE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGK-EL--------SSLKQECEIQKHLAHPNIIK  182 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~-----~~~vAvK~i~~~~~~~~-~~--------~~~~~Ei~il~~l~hpnIv~  182 (549)
                      ..++|++.+.||+|+||.||+|.+..+     ++.||+|++........ +.        ....+|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            345899999999999999999998765     57899999876431100 00        12234555667778999999


Q ss_pred             EEEEEeeC----CEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe--cCCc
Q psy18060        183 FIASHETL----NEFVLITEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN--KDGV  255 (549)
Q Consensus       183 l~~~~~~~----~~~~iV~E~~~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~--~~g~  255 (549)
                      +++++...    ...+|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++  .++.
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred             EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence            99998664    458999999977999999876 6799999999999999999999999999999999999999  8899


Q ss_pred             EEEeecccceecccCcc-------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHH
Q psy18060        256 AMLCDFGFARSMAVGTH-------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSI-LHLIR  327 (549)
Q Consensus       256 vKL~DFGla~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~-~~~~~  327 (549)
                      +||+|||+|+.......       .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... .....
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            99999999987653321       11345699999999999999999999999999999999999999985321 11111


Q ss_pred             HHhc---CC-------CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        328 LLKT---QD-------VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       328 ~i~~---~~-------~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ....   ..       ...+..+|+++.+++..||+.||.+||++.+|++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          273 DSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            1100   00       0012567999999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7e-43  Score=375.88  Aligned_cols=247  Identities=23%  Similarity=0.366  Sum_probs=210.8

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      -..++|++.+.||+|+||.||+|.+.. +..||||++......   .+.+.+|+.++++++||||+++++++.. +.+++
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            345779999999999999999999875 467999999764432   3568899999999999999999999876 67899


Q ss_pred             EEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        196 ITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ||||+. |+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            999997 5999999753  5699999999999999999999999999999999999999999999999999987643321


Q ss_pred             -cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHH
Q psy18060        273 -MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVK  349 (549)
Q Consensus       273 -~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~  349 (549)
                       ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+..+ ..+.|..+|+.+.++|.
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  415 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  415 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence             1233457889999999998899999999999999999999 99999999888888777655 34567889999999999


Q ss_pred             HhchhCcCCCCCHHHHhc
Q psy18060        350 GLLEKDASQRLSWPELLH  367 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~  367 (549)
                      +||+.||.+|||+.++++
T Consensus       416 ~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          416 QCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHccCChhhCcCHHHHHH
Confidence            999999999999999876

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=359.30  Aligned_cols=247  Identities=28%  Similarity=0.425  Sum_probs=204.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe----eCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE----TLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~  193 (549)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++.    .....
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            46799999999999999999999999999999998653  3455678899999999999999999999886    23478


Q ss_pred             EEEEecCCC-CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        194 VLITEFAHM-SLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       194 ~iV~E~~~g-sL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                      ++||||+.+ +|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            999999985 99999876    4679999999999999999999999999999999999999999999999999987653


Q ss_pred             cCcc---------cccccCCCCcccccccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhc
Q psy18060        269 VGTH---------MLTSIKGTPLYMAPELIAERP---YDHTADLWSLGCIAYEIHMGHPPFKTV-----SILHLIRLLKT  331 (549)
Q Consensus       269 ~~~~---------~~~~~~GT~~Y~APE~l~~~~---y~~ksDIwSlGvil~eLltG~~Pf~~~-----~~~~~~~~i~~  331 (549)
                      ....         ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||...     .......  ..
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~  263 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--NQ  263 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--CC
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--cc
Confidence            2111         112346899999999987654   689999999999999999999999531     2211111  11


Q ss_pred             CCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        332 QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       332 ~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ...+.++.+++.+.++|.+||+.||.+|||+.+++++
T Consensus       264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            2233446789999999999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.7e-44  Score=376.62  Aligned_cols=251  Identities=25%  Similarity=0.428  Sum_probs=208.4

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC--EE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN--EF  193 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~  193 (549)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+  ..
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            345789999999999999999999999999999999975322 223466789999999999999999999987655  78


Q ss_pred             EEEEecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE----ecCCcEEEeecccce
Q psy18060        194 VLITEFAH-MSLSNLLEQRK---KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL----NKDGVAMLCDFGFAR  265 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl----~~~g~vKL~DFGla~  265 (549)
                      ++||||+. |+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+|+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999997 58999997643   39999999999999999999999999999999999999    677789999999998


Q ss_pred             ecccCcccccccCCCCcccccccccC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCC
Q psy18060        266 SMAVGTHMLTSIKGTPLYMAPELIAE--------RPYDHTADLWSLGCIAYEIHMGHPPFKTV----SILHLIRLLKTQD  333 (549)
Q Consensus       266 ~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~y~~ksDIwSlGvil~eLltG~~Pf~~~----~~~~~~~~i~~~~  333 (549)
                      ...... ......||+.|+|||++.+        ..++.++|||||||++|+|++|+.||...    ........+..+.
T Consensus       165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             ECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             EccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            765443 3355679999999999864        56889999999999999999999999642    2334444443332


Q ss_pred             CC-------------------------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        334 VT-------------------------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       334 ~~-------------------------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +.                         ++..+++.+.++|.+||+.||.+|||+.|++++
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            11                         113356788999999999999999999998664

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7e-43  Score=353.00  Aligned_cols=243  Identities=29%  Similarity=0.467  Sum_probs=197.0

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh--cCCCCeeEEEEEEee----C
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH--LAHPNIIKFIASHET----L  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~----~  190 (549)
                      ..++|++.+.||+|+||.||+|.+  +++.||+|++...     ....+..|.+++..  ++||||+++++++..    .
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            457899999999999999999987  5899999998642     23455667777766  799999999998643    3


Q ss_pred             CEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccccccCCcEEEecCCcEEEeec
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLH--------SNRVLHRDLKPQNVLLNKDGVAMLCDF  261 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH--------~~gIiHrDIKP~NILl~~~g~vKL~DF  261 (549)
                      ..+++||||+. |+|.++++ ...+++..+..++.||+.||.|||        +.||+||||||+|||++.++.+||+||
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             ceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            56899999998 59999995 457999999999999999999999        999999999999999999999999999


Q ss_pred             ccceecccCccc----ccccCCCCcccccccccCC------CCCcchhhHHHHHHHHHHHhC----------CCCCCCC-
Q psy18060        262 GFARSMAVGTHM----LTSIKGTPLYMAPELIAER------PYDHTADLWSLGCIAYEIHMG----------HPPFKTV-  320 (549)
Q Consensus       262 Gla~~~~~~~~~----~~~~~GT~~Y~APE~l~~~------~y~~ksDIwSlGvil~eLltG----------~~Pf~~~-  320 (549)
                      |+|+........    .....||+.|+|||++.+.      .++.++|||||||++|+|++|          ..||... 
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            999766543221    2345799999999999876      566899999999999999999          8898543 


Q ss_pred             ----CHHHHHHHHhc--CCCCCCc-----cCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        321 ----SILHLIRLLKT--QDVTFPS-----QVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       321 ----~~~~~~~~i~~--~~~~~p~-----~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                          ........+..  ....+|.     ..++.+.++|.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                22223222221  1222332     25678999999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.9e-43  Score=353.12  Aligned_cols=251  Identities=21%  Similarity=0.349  Sum_probs=206.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcC-CCc--eEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLD-LKK--TVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~-~~~--~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ..++|++.+.||+|+||.||+|.+.. +++  .||+|++..... .......+.+|+++++.++||||+++++++...+ 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            34689999999999999999998643 333  689999875432 2345678899999999999999999999998765 


Q ss_pred             EEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        193 FVLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      .++|||++. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            789999997 6899998764 57999999999999999999999999999999999999999999999999999876543


Q ss_pred             cc---cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCccCCHHH
Q psy18060        271 TH---MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD--VTFPSQVSETY  344 (549)
Q Consensus       271 ~~---~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~  344 (549)
                      ..   ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+.......+....  ...+..+++.+
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI  254 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHH
Confidence            22   1234467889999999998889999999999999999999 999999999888887776543  34556899999


Q ss_pred             HHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        345 KDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .++|.+||..||.+|||+.+++++
T Consensus       255 ~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          255 YNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999874

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.4e-43  Score=391.35  Aligned_cols=242  Identities=24%  Similarity=0.423  Sum_probs=210.5

Q ss_pred             EEEecCCcEEEEEEEE--cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIH--LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||.||+|.+  ..+++.||||++............+.+|++++++++|||||++++++.. +.+++||||+. 
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4899999999999954  4567899999997655555556789999999999999999999999865 45889999998 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc---cccccC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH---MLTSIK  278 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~~~  278 (549)
                      |+|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......   ..+...
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~  533 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK  533 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence            58999999988999999999999999999999999999999999999999999999999999987644321   223345


Q ss_pred             CCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHhchhCc
Q psy18060        279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       279 GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      ||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.......+..+. ...|..+++++.++|.+||+.||
T Consensus       534 ~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP  613 (635)
T 4fl3_A          534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV  613 (635)
T ss_dssp             -CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSST
T ss_pred             CceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCH
Confidence            7889999999999999999999999999999998 999999999888888776653 45678899999999999999999


Q ss_pred             CCCCCHHHHhc
Q psy18060        357 SQRLSWPELLH  367 (549)
Q Consensus       357 ~~Rps~~elL~  367 (549)
                      .+|||+.+|++
T Consensus       614 ~~RPs~~~l~~  624 (635)
T 4fl3_A          614 ENRPGFAAVEL  624 (635)
T ss_dssp             TTSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.7e-44  Score=368.25  Aligned_cols=256  Identities=23%  Similarity=0.352  Sum_probs=211.5

Q ss_pred             cccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q psy18060        111 MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL  190 (549)
Q Consensus       111 ~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  190 (549)
                      ........++|++.+.||+|+||.||+|.+. +++.||+|.+....  ......+.+|+.+++.++||||+++++++...
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            3344556788999999999999999999965 58999999886543  23456789999999999999999999999999


Q ss_pred             CEEEEEEecCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccce
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQRK----KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~~----~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                      +..++||||+. |+|.+++....    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999997 58999886543    58999999999999999999999999999999999999999999999999997


Q ss_pred             ecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHhcCC---
Q psy18060        266 SMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILH------LI-RLLKTQD---  333 (549)
Q Consensus       266 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~------~~-~~i~~~~---  333 (549)
                      ......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+..      .. .......   
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            654321  22344568999999999988899999999999999999999999997643211      11 1111111   


Q ss_pred             -------CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCc
Q psy18060        334 -------VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHP  369 (549)
Q Consensus       334 -------~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hp  369 (549)
                             ...++..++.+.+++.+||+.||.+|||+.|+++|.
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                   112334567899999999999999999999999774

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.1e-43  Score=356.90  Aligned_cols=245  Identities=27%  Similarity=0.423  Sum_probs=206.3

Q ss_pred             eeEEEEEecCCcEEEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--CCEEE
Q psy18060        121 YQKICLIGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--LNEFV  194 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~  194 (549)
                      |++++.||+|+||.||++.    +..+++.||+|++... ........+.+|+++++.++||||+++++++.+  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            5999999999999998775    4457899999999754 344556788999999999999999999999987  46889


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-  272 (549)
                      +||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus       112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  190 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY  190 (318)
T ss_dssp             EEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSE
T ss_pred             EEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccc
Confidence            9999997 5999998764 599999999999999999999999999999999999999999999999999987754322 


Q ss_pred             --cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHhc-CCC
Q psy18060        273 --MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL---------------HLIRLLKT-QDV  334 (549)
Q Consensus       273 --~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~---------------~~~~~i~~-~~~  334 (549)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|..||......               .....+.. ...
T Consensus       191 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (318)
T 3lxp_A          191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL  270 (318)
T ss_dssp             EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCC
T ss_pred             cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCC
Confidence              223456889999999999989999999999999999999999999754221               12222222 234


Q ss_pred             CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        335 TFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       335 ~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ..|..+++++.+||.+||+.||.+|||+.|+++
T Consensus       271 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          271 PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            567789999999999999999999999999984

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=353.90  Aligned_cols=241  Identities=28%  Similarity=0.450  Sum_probs=199.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.+.  ++.||+|.+...    .....+.+|++++++++||||+++++++.+  ..++|
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence            3567999999999999999999875  788999998542    345678899999999999999999998864  47899


Q ss_pred             EecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCCccccccCCcEEEecCCc-EEEeecccceecc
Q psy18060        197 TEFAH-MSLSNLLEQRK---KLSETICVQILSNLISALYYLHS---NRVLHRDLKPQNVLLNKDGV-AMLCDFGFARSMA  268 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~---~l~e~~~~~i~~qIl~aL~yLH~---~gIiHrDIKP~NILl~~~g~-vKL~DFGla~~~~  268 (549)
                      |||+. ++|.+++....   .+++..+..++.|++.||.|||+   +||+||||||+|||++.++. +||+|||+++...
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            99997 59999998765   37899999999999999999999   89999999999999999886 7999999997654


Q ss_pred             cCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHh-cCCCCCCccCCHHHH
Q psy18060        269 VGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV--SILHLIRLLK-TQDVTFPSQVSETYK  345 (549)
Q Consensus       269 ~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~--~~~~~~~~i~-~~~~~~p~~~s~~~~  345 (549)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...  ........+. ......+..+++.+.
T Consensus       158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (307)
T 2eva_A          158 TH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE  234 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHH
T ss_pred             cc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHH
Confidence            32   23456999999999999999999999999999999999999999754  2333333332 334456678999999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcC
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ++|.+||+.||.+|||+.+++++
T Consensus       235 ~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          235 SLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999999874

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.2e-42  Score=349.56  Aligned_cols=232  Identities=29%  Similarity=0.550  Sum_probs=193.9

Q ss_pred             ccccccceeEE-EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHH-HhcCCCCeeEEEEEEee--
Q psy18060        114 SNGALEKYQKI-CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ-KHLAHPNIIKFIASHET--  189 (549)
Q Consensus       114 ~~~~~~~y~~~-~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~--  189 (549)
                      ....+++|.+. +.||+|+||.||+|.+..+++.||+|++...       ....+|+.++ +.+.||||+++++++..  
T Consensus        12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            34566788888 7899999999999999999999999999642       3456788887 66699999999999877  


Q ss_pred             --CCEEEEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec---CCcEEEeec
Q psy18060        190 --LNEFVLITEFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK---DGVAMLCDF  261 (549)
Q Consensus       190 --~~~~~iV~E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~---~g~vKL~DF  261 (549)
                        ...+++||||+. |+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence              678899999997 59999998764  6999999999999999999999999999999999999998   789999999


Q ss_pred             ccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhcCCCCCC
Q psy18060        262 GFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRL----LKTQDVTFP  337 (549)
Q Consensus       262 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~----i~~~~~~~p  337 (549)
                      |+++...                      +..++.++|||||||++|+|++|+.||.+.........    +......+|
T Consensus       165 g~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  222 (299)
T 3m2w_A          165 GFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  222 (299)
T ss_dssp             TTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred             ccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence            9986432                      23478899999999999999999999987655443221    222233344


Q ss_pred             ----ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        338 ----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       338 ----~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                          ..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence                4689999999999999999999999999999999754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.5e-43  Score=362.93  Aligned_cols=259  Identities=22%  Similarity=0.336  Sum_probs=209.7

Q ss_pred             ccccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q psy18060        110 KMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET  189 (549)
Q Consensus       110 ~~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  189 (549)
                      +........++|++.+.||+|+||.||+|.+. +++.||+|++...... .....+.+|+.+++.++||||+++++++..
T Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   98 (326)
T 3uim_A           21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT   98 (326)
T ss_dssp             CTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred             cHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence            33444556688999999999999999999754 5899999998754322 122357899999999999999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCccccccCCcEEEecCCcEEEeec
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQRK----KLSETICVQILSNLISALYYLHSN---RVLHRDLKPQNVLLNKDGVAMLCDF  261 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~~----~l~e~~~~~i~~qIl~aL~yLH~~---gIiHrDIKP~NILl~~~g~vKL~DF  261 (549)
                      .+..++||||+. |+|.+++..+.    .+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+||+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df  178 (326)
T 3uim_A           99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF  178 (326)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence            999999999997 59999998653    499999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecccCc-ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHhcC
Q psy18060        262 GFARSMAVGT-HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV--------SILHLIRLLKTQ  332 (549)
Q Consensus       262 Gla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~--------~~~~~~~~i~~~  332 (549)
                      |+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...        ............
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            9998765332 2334556999999999998888999999999999999999999999521        111111111000


Q ss_pred             -----------CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcc
Q psy18060        333 -----------DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPL  370 (549)
Q Consensus       333 -----------~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw  370 (549)
                                 ...++...++.+.+++.+||+.||.+|||+.|+++|-+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                       01122344578999999999999999999999998854

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-43  Score=367.24  Aligned_cols=250  Identities=23%  Similarity=0.364  Sum_probs=202.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe-eCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDL---KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE-TLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~  193 (549)
                      ...|.+.+.||+|+||.||+|.+..+   +..+|+|.+... ........+.+|+.++++++||||+++++++. ..+..
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            34588999999999999999987543   246899988653 33445678899999999999999999999864 45678


Q ss_pred             EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ++||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            99999998 5999999865 458999999999999999999999999999999999999999999999999998654321


Q ss_pred             ----ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHH
Q psy18060        272 ----HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYK  345 (549)
Q Consensus       272 ----~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  345 (549)
                          ...+...||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+..+ ....|..+++.+.
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~  326 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  326 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence                11234467889999999999999999999999999999999 78899877655555555444 3445678999999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcC
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ++|.+||+.||.+|||+.|++++
T Consensus       327 ~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          327 EVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=362.99  Aligned_cols=244  Identities=18%  Similarity=0.258  Sum_probs=199.3

Q ss_pred             cccceeEEEEEecCCcEEEEEE-----EEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC---CCCeeEEEEEEe
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKA-----IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA---HPNIIKFIASHE  188 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~-----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~  188 (549)
                      ..++|.+.+.||+|+||.||+|     .+..+++.||+|++....     ...+..|+++++.+.   ||||+++++++.
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            4577999999999999999999     467789999999996532     345677888888886   999999999999


Q ss_pred             eCCEEEEEEecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec----------
Q psy18060        189 TLNEFVLITEFAH-MSLSNLLEQ-----RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK----------  252 (549)
Q Consensus       189 ~~~~~~iV~E~~~-gsL~~~l~~-----~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~----------  252 (549)
                      ..+..++||||+. |+|.+++..     ...+++..++.++.||+.||+|||++||+||||||+|||++.          
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence            9999999999997 699999974     457999999999999999999999999999999999999998          


Q ss_pred             -CCcEEEeecccceeccc--CcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy18060        253 -DGVAMLCDFGFARSMAV--GTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL  329 (549)
Q Consensus       253 -~g~vKL~DFGla~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i  329 (549)
                       ++.+||+|||+|+.+..  .....+..+||+.|+|||++.+..|+.++|||||||++|||+||+.||.........   
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---  294 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---  294 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---
Confidence             89999999999976542  223446678999999999999999999999999999999999999999653221000   


Q ss_pred             hcCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCc
Q psy18060        330 KTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHP  369 (549)
Q Consensus       330 ~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hp  369 (549)
                      ...... ....++.+.+++..||..+|.+|++..+.+.+.
T Consensus       295 ~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          295 PEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             ECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             echhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence            001111 113477899999999999999997655555443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=352.49  Aligned_cols=249  Identities=24%  Similarity=0.410  Sum_probs=209.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-  191 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-  191 (549)
                      ...+|++++.||+|+||.||+|.    +..+++.||+|++...  .......+.+|+.+++.++||||+++++++...+ 
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            45679999999999999999998    4668999999999753  3445678899999999999999999999886543 


Q ss_pred             -EEEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        192 -EFVLITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       192 -~~~iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                       .+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence             6899999997 5999999876 459999999999999999999999999999999999999999999999999998765


Q ss_pred             cCccc---ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHH
Q psy18060        269 VGTHM---LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL----------------HLIRLL  329 (549)
Q Consensus       269 ~~~~~---~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~----------------~~~~~i  329 (549)
                      .....   .....+|+.|+|||++.+..++.++|||||||++|+|++|..||......                .....+
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  276 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence            43221   23345788899999999888999999999999999999999998643111                112222


Q ss_pred             hc-CCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        330 KT-QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       330 ~~-~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      .. ...+.|..+++++.++|.+||+.||.+|||+.|+++
T Consensus       277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            22 234567789999999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=383.30  Aligned_cols=247  Identities=20%  Similarity=0.376  Sum_probs=208.3

Q ss_pred             cceeEEE-EEecCCcEEEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        119 EKYQKIC-LIGEGSFGKVFKAIHL--DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       119 ~~y~~~~-~iG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      +++.+.+ .||+|+||.||+|.++  .++..||||++.... .......+.+|++++++++|||||++++++.. +.+++
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  412 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML  412 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence            3455555 8999999999999876  346679999997643 23345788999999999999999999999876 56899


Q ss_pred             EEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        196 ITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      ||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus       413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred             EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence            999998 5899999754 46999999999999999999999999999999999999999999999999999876433211


Q ss_pred             ---ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHH
Q psy18060        274 ---LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLV  348 (549)
Q Consensus       274 ---~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI  348 (549)
                         .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+. ...|..+++++.++|
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  572 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALM  572 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence               122346789999999998999999999999999999998 999999988888887776653 567788999999999


Q ss_pred             HHhchhCcCCCCCHHHHhc
Q psy18060        349 KGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~  367 (549)
                      .+||..||.+|||+.++++
T Consensus       573 ~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          573 SDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHTTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHH
Confidence            9999999999999998853

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.4e-42  Score=376.15  Aligned_cols=249  Identities=22%  Similarity=0.364  Sum_probs=216.1

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .-..++|++.+.||+|+||.||+|.+.. +..||||++......   .+.+.+|++++++++||||+++++++.. +.++
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            3445789999999999999999999875 467999999765433   3568999999999999999999999876 6789


Q ss_pred             EEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        195 LITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      |||||+. |+|.+++...  ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            9999997 5999999753  569999999999999999999999999999999999999999999999999997664321


Q ss_pred             c-cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHH
Q psy18060        272 H-MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLV  348 (549)
Q Consensus       272 ~-~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI  348 (549)
                      . ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+..+ ....|..+++.+.+||
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  497 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  497 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            1 1233457788999999998899999999999999999999 99999999888888777655 3456778999999999


Q ss_pred             HHhchhCcCCCCCHHHHhcC
Q psy18060        349 KGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~H  368 (549)
                      .+||+.||.+|||+.+|++.
T Consensus       498 ~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          498 CQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHH
Confidence            99999999999999998763

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-42  Score=351.50  Aligned_cols=246  Identities=26%  Similarity=0.424  Sum_probs=197.5

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh--cCCCCeeEEEEEEeeC--
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH--LAHPNIIKFIASHETL--  190 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~--  190 (549)
                      ....++|++.+.||+|+||.||+|.+.  ++.||+|++...     .......|..++..  ++||||+++++++...  
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            344578999999999999999999876  899999998642     22334455555554  4899999999998877  


Q ss_pred             --CEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccccccCCcEEEecCCcEEEe
Q psy18060        191 --NEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN--------RVLHRDLKPQNVLLNKDGVAMLC  259 (549)
Q Consensus       191 --~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~--------gIiHrDIKP~NILl~~~g~vKL~  259 (549)
                        ..+++||||+. |+|.+++... .+++..++.++.|++.||.|||++        ||+||||||+|||++.++.+||+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence              78999999997 5999999764 799999999999999999999999        99999999999999999999999


Q ss_pred             ecccceecccCccc----ccccCCCCcccccccccCCCCCcc------hhhHHHHHHHHHHHhC----------CCCCCC
Q psy18060        260 DFGFARSMAVGTHM----LTSIKGTPLYMAPELIAERPYDHT------ADLWSLGCIAYEIHMG----------HPPFKT  319 (549)
Q Consensus       260 DFGla~~~~~~~~~----~~~~~GT~~Y~APE~l~~~~y~~k------sDIwSlGvil~eLltG----------~~Pf~~  319 (549)
                      |||+|+........    .....||+.|+|||++.+..++.+      +|||||||++|||++|          +.||..
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            99999766433221    235579999999999987766655      9999999999999999          777754


Q ss_pred             C-----CHHHHHHHHhcC--CCCCCc-----cCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        320 V-----SILHLIRLLKTQ--DVTFPS-----QVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       320 ~-----~~~~~~~~i~~~--~~~~p~-----~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .     ........+...  ...+|.     .+++++.++|.+||+.||.+|||+.|+++|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            3     222232222222  223333     466789999999999999999999999876

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=357.62  Aligned_cols=254  Identities=24%  Similarity=0.406  Sum_probs=211.9

Q ss_pred             cccccccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q psy18060        111 MEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL  190 (549)
Q Consensus       111 ~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  190 (549)
                      .....-..++|++.+.||+|+||.||+|.+..   .+|+|++............+.+|+.++++++||||+++++++...
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            34455567889999999999999999998753   599999876544333445677899999999999999999999999


Q ss_pred             CEEEEEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                      +.+++||||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            99999999997 58999998754 699999999999999999999999999999999999998 6899999999986543


Q ss_pred             cC-----cccccccCCCCcccccccccC---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC
Q psy18060        269 VG-----THMLTSIKGTPLYMAPELIAE---------RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV  334 (549)
Q Consensus       269 ~~-----~~~~~~~~GT~~Y~APE~l~~---------~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~  334 (549)
                      ..     ........||+.|+|||++.+         ..++.++|||||||++|+|++|+.||...+.......+..+..
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  260 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK  260 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence            21     122334568999999999864         4578999999999999999999999999988888777765543


Q ss_pred             CC--CccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        335 TF--PSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       335 ~~--p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ..  +..+++++.++|.+||..||.+|||+.++++.
T Consensus       261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            22  23688999999999999999999999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.8e-43  Score=373.65  Aligned_cols=251  Identities=17%  Similarity=0.190  Sum_probs=200.4

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhcCC-CCe-------------
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAH-PNI-------------  180 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~h-pnI-------------  180 (549)
                      .....|...+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.+.| +|+             
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34456899999999999999999999999999999987433 223345678899999999977 221             


Q ss_pred             --------eEEEEEEee-----CCEEEEEEecCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q psy18060        181 --------IKFIASHET-----LNEFVLITEFAHMSLSNLLEQ-------RKKLSETICVQILSNLISALYYLHSNRVLH  240 (549)
Q Consensus       181 --------v~l~~~~~~-----~~~~~iV~E~~~gsL~~~l~~-------~~~l~e~~~~~i~~qIl~aL~yLH~~gIiH  240 (549)
                              ..+...+..     ...++++|+++.++|.++++.       ...+++..+..++.||+.||+|||++||+|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                    111111111     234788999999999998852       234778889999999999999999999999


Q ss_pred             ccccCCcEEEecCCcEEEeecccceecccCcccccccCCCCcccccccc----------cCCCCCcchhhHHHHHHHHHH
Q psy18060        241 RDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI----------AERPYDHTADLWSLGCIAYEI  310 (549)
Q Consensus       241 rDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l----------~~~~y~~ksDIwSlGvil~eL  310 (549)
                      |||||+|||++.+|.+||+|||+++.....   ....+| +.|+|||++          .+..|+.++|||||||++|+|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            999999999999999999999999875533   455678 999999999          566789999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        311 HMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       311 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ++|+.||...+.......+...    ...+|+++.+||.+||+.||.+|||+.++++||||+..
T Consensus       311 ltg~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGGGGSS----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHCCCCCCCcchhhhHHHHHhh----cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            9999999876654433333222    24678999999999999999999999999999999764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.5e-42  Score=348.69  Aligned_cols=245  Identities=24%  Similarity=0.339  Sum_probs=202.4

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCC--CChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG--RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      |...+.||+|+||.||+|.+  +++.||+|.+....  ......+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44568999999999999986  48899999987543  233446788999999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc--
Q psy18060        199 FAH-MSLSNLLEQ---RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH--  272 (549)
Q Consensus       199 ~~~-gsL~~~l~~---~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~--  272 (549)
                      |+. ++|.+++..   ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            996 689999874   34699999999999999999999999999999999999999999999999999986643221  


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCC-----------CCCC
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL----HLIRLLKTQD-----------VTFP  337 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~----~~~~~i~~~~-----------~~~p  337 (549)
                      ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......    .....+....           ...+
T Consensus       191 ~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD  269 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred             cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence            2234579999999999875 4899999999999999999999999765322    1222221111           1223


Q ss_pred             ccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        338 SQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       338 ~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ...++.+.+++.+||+.||.+|||+.+++++
T Consensus       270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            4566789999999999999999999999865

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3e-42  Score=354.41  Aligned_cols=253  Identities=26%  Similarity=0.407  Sum_probs=193.7

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHH--HHhcCCCCeeEEEEEEee---
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI--QKHLAHPNIIKFIASHET---  189 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~i--l~~l~hpnIv~l~~~~~~---  189 (549)
                      .-.+++|++.+.||+|+||.||+|..  +++.||+|++....     ...+..|..+  +..+.||||+++++.+..   
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA   81 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence            34578899999999999999999976  58999999996432     2333444444  455899999999975532   


Q ss_pred             --CCEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccccccCCcEEEecCCcEE
Q psy18060        190 --LNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSN---------RVLHRDLKPQNVLLNKDGVAM  257 (549)
Q Consensus       190 --~~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~---------gIiHrDIKP~NILl~~~g~vK  257 (549)
                        ...+++||||+. |+|.+++... ..++..+..++.||+.||.|||+.         ||+||||||+|||++.++.+|
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence              336789999996 5999999765 458999999999999999999999         999999999999999999999


Q ss_pred             EeecccceecccCc--------ccccccCCCCcccccccccC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCC-C
Q psy18060        258 LCDFGFARSMAVGT--------HMLTSIKGTPLYMAPELIAE-------RPYDHTADLWSLGCIAYEIHMGHPPFKTV-S  321 (549)
Q Consensus       258 L~DFGla~~~~~~~--------~~~~~~~GT~~Y~APE~l~~-------~~y~~ksDIwSlGvil~eLltG~~Pf~~~-~  321 (549)
                      |+|||+|+......        .......||+.|+|||++.+       ..++.++|||||||++|||++|..||... .
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998764321        12234579999999999987       45778999999999999999997665321 1


Q ss_pred             -----------------HHHHHHHHhc--CCCCCCcc------CCHHHHHHHHHhchhCcCCCCCHHHHh------cCcc
Q psy18060        322 -----------------ILHLIRLLKT--QDVTFPSQ------VSETYKDLVKGLLEKDASQRLSWPELL------HHPL  370 (549)
Q Consensus       322 -----------------~~~~~~~i~~--~~~~~p~~------~s~~~~dlI~~~L~~dP~~Rps~~elL------~Hpw  370 (549)
                                       .......+..  ....+|..      +++.+.+||.+||+.||.+|||+.|++      .++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence                             1111111111  12233333      455899999999999999999999994      4677


Q ss_pred             cCccc
Q psy18060        371 VKDNL  375 (549)
Q Consensus       371 ~~~~~  375 (549)
                      -++..
T Consensus       321 ~~~~~  325 (336)
T 3g2f_A          321 ERNKS  325 (336)
T ss_dssp             CC---
T ss_pred             Hhccc
Confidence            66543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2e-41  Score=367.32  Aligned_cols=246  Identities=20%  Similarity=0.282  Sum_probs=207.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCC-CCeeEEEEEEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH-PNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~iV  196 (549)
                      .++|++.+.||+|+||.||+|.+..+++.||||++......    ..+.+|+++++.+.| ++|+.+..++...+..+||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            46899999999999999999999999999999998754432    246789999999976 5666677777888899999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEE---ecCCcEEEeecccceecccCcc
Q psy18060        197 TEFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       197 ~E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl---~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      |||++++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.......
T Consensus        82 me~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             EECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            99998899999986 5679999999999999999999999999999999999999   5889999999999987654321


Q ss_pred             -------cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCC-----CCC
Q psy18060        273 -------MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDV-----TFP  337 (549)
Q Consensus       273 -------~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~---~~~~~~~i~~~~~-----~~p  337 (549)
                             ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..   ....+..+.....     .++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~  241 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC  241 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence                   1235679999999999999999999999999999999999999998743   3333333322211     223


Q ss_pred             ccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        338 SQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       338 ~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ..+++++.+||.+||+.||.+||++.+|++
T Consensus       242 ~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          242 RGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             TTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            578999999999999999999999987764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.1e-41  Score=376.68  Aligned_cols=250  Identities=30%  Similarity=0.423  Sum_probs=214.0

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDL---KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      ..++|++.+.||+|+||.||+|.+..+   +..+|+|.+... ........+.+|+.+++.++||||+++++++.+ +..
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~  465 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV  465 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence            357799999999999999999998654   456999987643 344556788999999999999999999999854 568


Q ss_pred             EEEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ++||||+. |+|.+++..++ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~  545 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  545 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence            99999998 69999998654 69999999999999999999999999999999999999999999999999998764332


Q ss_pred             c-cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHH
Q psy18060        272 H-MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLV  348 (549)
Q Consensus       272 ~-~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI  348 (549)
                      . ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+ ...+|+.+++.+.++|
T Consensus       546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  625 (656)
T 2j0j_A          546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM  625 (656)
T ss_dssp             --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred             ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHH
Confidence            1 1233457889999999998899999999999999999997 99999999888888777655 3567888999999999


Q ss_pred             HHhchhCcCCCCCHHHHhcC
Q psy18060        349 KGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~H  368 (549)
                      .+||..||.+|||+.++++.
T Consensus       626 ~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          626 TKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.2e-41  Score=346.41  Aligned_cols=246  Identities=26%  Similarity=0.397  Sum_probs=204.3

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh--cCCCCeeEEEEEEeeCC-
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH--LAHPNIIKFIASHETLN-  191 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~-  191 (549)
                      ....++|++.+.||+|+||.||+|.+.  ++.||+|++...     ....+.+|.+++..  ++||||+++++++.... 
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            334578999999999999999999874  899999998642     34567788999888  78999999999998775 


Q ss_pred             ---EEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccccccCCcEEEecCCcEEEe
Q psy18060        192 ---EFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLH--------SNRVLHRDLKPQNVLLNKDGVAMLC  259 (549)
Q Consensus       192 ---~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH--------~~gIiHrDIKP~NILl~~~g~vKL~  259 (549)
                         .+++||||+.+ +|.+++.+ ..+++..++.++.||+.||.|||        +.||+||||||+|||++.++.+||+
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~  189 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  189 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred             ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence               79999999985 99999976 47999999999999999999999        8999999999999999999999999


Q ss_pred             ecccceecccCcc----cccccCCCCcccccccccCC------CCCcchhhHHHHHHHHHHHhC----------CCCCCC
Q psy18060        260 DFGFARSMAVGTH----MLTSIKGTPLYMAPELIAER------PYDHTADLWSLGCIAYEIHMG----------HPPFKT  319 (549)
Q Consensus       260 DFGla~~~~~~~~----~~~~~~GT~~Y~APE~l~~~------~y~~ksDIwSlGvil~eLltG----------~~Pf~~  319 (549)
                      |||+++.......    ......||+.|+|||++.+.      .++.++|||||||++|+|++|          ..||..
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~  269 (342)
T 1b6c_B          190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  269 (342)
T ss_dssp             CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence            9999987654332    23455799999999999765      344789999999999999999          789865


Q ss_pred             C-----CHHHHHHHHhcCC--CCCCc-----cCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        320 V-----SILHLIRLLKTQD--VTFPS-----QVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       320 ~-----~~~~~~~~i~~~~--~~~p~-----~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .     ........+....  ..+|.     ..++.+.++|.+||+.||.+|||+.++++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            4     3344444443332  22332     344688999999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.3e-42  Score=387.06  Aligned_cols=257  Identities=29%  Similarity=0.415  Sum_probs=209.7

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-----
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-----  189 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----  189 (549)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++..     
T Consensus        10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            34458899999999999999999999999999999998654 345566788999999999999999999998755     


Q ss_pred             -CCEEEEEEecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCc---EEEeec
Q psy18060        190 -LNEFVLITEFAH-MSLSNLLEQRK---KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGV---AMLCDF  261 (549)
Q Consensus       190 -~~~~~iV~E~~~-gsL~~~l~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~---vKL~DF  261 (549)
                       .+..++||||+. |+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence             667899999996 69999998754   6999999999999999999999999999999999999997764   999999


Q ss_pred             ccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---------HH---
Q psy18060        262 GFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIR---------LL---  329 (549)
Q Consensus       262 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~---------~i---  329 (549)
                      |+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+........         .+   
T Consensus       169 G~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          169 GYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            9998765442 3455689999999999999999999999999999999999999997653322110         00   


Q ss_pred             --hcCCC----------CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        330 --KTQDV----------TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       330 --~~~~~----------~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                        ..+..          .+++.+++.+.+||.+||..||.+|||+.|+++||||+.
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence              00111          122346789999999999999999999999999999975

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.6e-43  Score=360.01  Aligned_cols=242  Identities=26%  Similarity=0.300  Sum_probs=194.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC------ChHHHHHHHHHHHHHHhcC---------CCCee
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR------SGKELSSLKQECEIQKHLA---------HPNII  181 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~---------hpnIv  181 (549)
                      ..++|++.+.||+|+||.||+|.+  +|+.||||++.....      .......+.+|+.+++.++         |||||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            357899999999999999999988  589999999986532      2233467889999998885         88888


Q ss_pred             EEEEEEe------------------------------eCCEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q psy18060        182 KFIASHE------------------------------TLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISAL  230 (549)
Q Consensus       182 ~l~~~~~------------------------------~~~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL  230 (549)
                      ++.+.+.                              ..+.+||||||+. |++.+.+.+ +.+++..++.++.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence            8877642                              2678999999987 555555543 6789999999999999999


Q ss_pred             HHHH-hCCCccccccCCcEEEecCC--------------------cEEEeecccceecccCcccccccCCCCcccccccc
Q psy18060        231 YYLH-SNRVLHRDLKPQNVLLNKDG--------------------VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI  289 (549)
Q Consensus       231 ~yLH-~~gIiHrDIKP~NILl~~~g--------------------~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l  289 (549)
                      .||| ++||+||||||+|||++.+|                    .+||+|||+|+.....     ..+||+.|||||++
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGG
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhh
Confidence            9999 99999999999999999987                    8999999999876532     34799999999999


Q ss_pred             cCCCCCcchhhHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHhcC---CCC----CCccCCHHHHHHHHHhchhCcCCCC
Q psy18060        290 AERPYDHTADLWSLGCI-AYEIHMGHPPFKTVSI-LHLIRLLKTQ---DVT----FPSQVSETYKDLVKGLLEKDASQRL  360 (549)
Q Consensus       290 ~~~~y~~ksDIwSlGvi-l~eLltG~~Pf~~~~~-~~~~~~i~~~---~~~----~p~~~s~~~~dlI~~~L~~dP~~Rp  360 (549)
                      .+.. +.++||||||++ .+++++|..||..... ......+...   ...    .++.+|+++++||.+||++|     
T Consensus       250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----  323 (336)
T 2vuw_A          250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----  323 (336)
T ss_dssp             CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred             cCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence            8776 899999998777 7788899999954321 1122222211   111    12357899999999999977     


Q ss_pred             CHHHHh-cCcccC
Q psy18060        361 SWPELL-HHPLVK  372 (549)
Q Consensus       361 s~~elL-~Hpw~~  372 (549)
                      |++|+| +||||+
T Consensus       324 sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 SATDLLCQHSLFK  336 (336)
T ss_dssp             SHHHHHHHCGGGC
T ss_pred             CHHHHHhcCCCcC
Confidence            999999 999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.6e-39  Score=327.29  Aligned_cols=221  Identities=15%  Similarity=0.179  Sum_probs=186.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            3679999999999999999999999999999999976543 345567889999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      |||+. ++|.++++..  ....++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|             
T Consensus       110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred             EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence            99998 5899998543  4666788999999999999999999999999999999999999998443             


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHhcCCCC----CCccCCHHHHHHH
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIR---LLKTQDVT----FPSQVSETYKDLV  348 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~---~i~~~~~~----~p~~~s~~~~dlI  348 (549)
                             |++|       ++.++|||||||++|+|+||+.||.+.+....+.   ........    .++.+++++.++|
T Consensus       175 -------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  240 (286)
T 3uqc_A          175 -------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA  240 (286)
T ss_dssp             -------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHH
T ss_pred             -------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHH
Confidence                   3443       7899999999999999999999998765432110   00111111    2356899999999


Q ss_pred             HHhchhCcCCCCCHHHHhcC
Q psy18060        349 KGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~H  368 (549)
                      .+||+.||.+| |+.|+++.
T Consensus       241 ~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          241 ARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHcccCCccC-CHHHHHHH
Confidence            99999999999 99999764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-40  Score=373.12  Aligned_cols=242  Identities=22%  Similarity=0.319  Sum_probs=200.8

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcC-CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE--
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLD-LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE--  192 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--  192 (549)
                      ...++|++.+.||+|+||.||+|.+.. +++.||||++... ........+.+|+.+++.++||||+++++++...+.  
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            344789999999999999999999976 6899999998653 334556678899999999999999999999987655  


Q ss_pred             ---EEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        193 ---FVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       193 ---~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                         .||||||+.| +|.+++..  .+++.++..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++...
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence               7999999985 88887754  79999999999999999999999999999999999999875 89999999998765


Q ss_pred             cCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHH
Q psy18060        269 VGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV  348 (549)
Q Consensus       269 ~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI  348 (549)
                      ..    +...||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+......      .........++.+.++|
T Consensus       233 ~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~~l~~li  301 (681)
T 2pzi_A          233 SF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYDSYGRLL  301 (681)
T ss_dssp             CC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC------CTTCHHHHHCHHHHHHH
T ss_pred             cC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc------cccccccccCHHHHHHH
Confidence            32    456799999999998765 48999999999999999999999875311000      00000113468899999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccC
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      .+||++||.+||+..+.+.|+|+.
T Consensus       302 ~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          302 RRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             hhhccCChhhCCCHHHHHHHHHHH
Confidence            999999999999999999999875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=5.8e-35  Score=322.75  Aligned_cols=231  Identities=16%  Similarity=0.108  Sum_probs=161.0

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCC----C----hHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEEE
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR----S----GKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~----~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ...+.|+.|.+..++....|+.||+|++.+...    .    ....+.+.+|+++|+++ .||||+++++++++.+.+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            356788888888888888899999999976531    1    22345789999999999 79999999999999999999


Q ss_pred             EEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||||++| +|.++|..++.+++.   .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.........
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            9999996 899999999889875   488999999999999999999999999999999999999999998776555556


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchh
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      ++.+||+.|||||++.+. +..++|+||+|+++++|.+|..|+        ...+...    |.. ...+..+...+...
T Consensus       397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~----~~~-~~~~~~l~~~l~~~  462 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQE----PVE-RWNFVLLLALFEKK  462 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTTHHHH--------HHHHHTS----CGG-GCSHHHHHHHHHTG
T ss_pred             cCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh--------HHHhhcC----CCC-CCcHHHHHHHHhCC
Confidence            677899999999999764 678899999999998887665443        1111111    111 11244666677777


Q ss_pred             CcCCCCCHHHHhcCcccC
Q psy18060        355 DASQRLSWPELLHHPLVK  372 (549)
Q Consensus       355 dP~~Rps~~elL~Hpw~~  372 (549)
                      +|..||.......++|..
T Consensus       463 ~~~~~~~~~~~~~~~~~~  480 (569)
T 4azs_A          463 AKLPSAEQQRGATEQWII  480 (569)
T ss_dssp             GGSCCGGGSSCCHHHHHH
T ss_pred             CCCCCCChhhhccchhHH
Confidence            777777776666666653

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=4.1e-28  Score=266.48  Aligned_cols=185  Identities=17%  Similarity=0.191  Sum_probs=144.4

Q ss_pred             eEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChH------HHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        122 QKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK------ELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       122 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ...+.||+|+||.||+|.  ..+..+|+|..........      ..+.+.+|++++++++||||+++..++...+..||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            446789999999999994  4478899998755332211      13457899999999999999954444446666799


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc-
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM-  273 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~-  273 (549)
                      ||||++ ++|.+++..        +..++.|++.||.|||++||+||||||+|||++.  .+||+|||+|+........ 
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            999997 699999876        5689999999999999999999999999999998  9999999999887643221 


Q ss_pred             ------ccccCCCCcccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q psy18060        274 ------LTSIKGTPLYMAPELIAE--RPYDHTADLWSLGCIAYEIHMGHPPFK  318 (549)
Q Consensus       274 ------~~~~~GT~~Y~APE~l~~--~~y~~ksDIwSlGvil~eLltG~~Pf~  318 (549)
                            ..+.+||+.|||||++..  ..|+..+|+||.++-..+-..++.+|.
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                  246689999999999976  678899999999998888887777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=1.9e-24  Score=218.15  Aligned_cols=157  Identities=18%  Similarity=0.157  Sum_probs=121.0

Q ss_pred             ceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh----------------HHHHHHHHHHHHHHhcCCCCeeEE
Q psy18060        120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----------------KELSSLKQECEIQKHLAHPNIIKF  183 (549)
Q Consensus       120 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----------------~~~~~~~~Ei~il~~l~hpnIv~l  183 (549)
                      .|.+.+.||+|+||.||+|.+ .+|+.||+|++.......                .....+.+|+.+++.++|++++.+
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~  169 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV  169 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeE
Confidence            355669999999999999999 789999999996432211                134678899999999985555544


Q ss_pred             EEEEeeCCEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecc
Q psy18060        184 IASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFG  262 (549)
Q Consensus       184 ~~~~~~~~~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFG  262 (549)
                         +.. +..|+||||++| +|.+ +.      ......++.|++.||.|||++||+||||||+|||++ +|.+||+|||
T Consensus       170 ---~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          170 ---YAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             ---EEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             ---Eec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence               333 345999999985 8887 32      123557999999999999999999999999999999 9999999999


Q ss_pred             cceecccCcccccccCCCCcccccccccC----------CCCCcchhhHH
Q psy18060        263 FARSMAVGTHMLTSIKGTPLYMAPELIAE----------RPYDHTADLWS  302 (549)
Q Consensus       263 la~~~~~~~~~~~~~~GT~~Y~APE~l~~----------~~y~~ksDIwS  302 (549)
                      +|+.             +..++|||.+.+          ..|+..+|+|+
T Consensus       238 ~a~~-------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          238 QSVE-------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             TCEE-------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CCeE-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            9863             334789998753          34555566664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=6.9e-21  Score=189.31  Aligned_cols=138  Identities=20%  Similarity=0.173  Sum_probs=108.8

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCce--EEEEEEecCCCCh----------------------HHHHHHHHHHHHHHhcC
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSG----------------------KELSSLKQECEIQKHLA  176 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~--vAvK~i~~~~~~~----------------------~~~~~~~~Ei~il~~l~  176 (549)
                      |.+.+.||+|+||.||+|.+..+|+.  ||||++.......                      .....+.+|+.++..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            77889999999999999999777888  9999975432110                      11236788999999998


Q ss_pred             CCCe--eEEEEEEeeCCEEEEEEecCC--C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCccccccCCc
Q psy18060        177 HPNI--IKFIASHETLNEFVLITEFAH--M----SLSNLLEQRKKLSETICVQILSNLISALYYLH-SNRVLHRDLKPQN  247 (549)
Q Consensus       177 hpnI--v~l~~~~~~~~~~~iV~E~~~--g----sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH-~~gIiHrDIKP~N  247 (549)
                      |+++  +..+..    +..+|||||++  |    +|.++...   .++..+..++.|++.||.||| +.||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8754  445543    24589999995  3    56665432   345577899999999999999 9999999999999


Q ss_pred             EEEecCCcEEEeecccceec
Q psy18060        248 VLLNKDGVAMLCDFGFARSM  267 (549)
Q Consensus       248 ILl~~~g~vKL~DFGla~~~  267 (549)
                      ||++.  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99988  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=5.4e-17  Score=169.66  Aligned_cols=136  Identities=18%  Similarity=0.206  Sum_probs=99.5

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC---------------ChHH-----HHHHHHHHHHHHhcCCCCe
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---------------SGKE-----LSSLKQECEIQKHLAHPNI  180 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---------------~~~~-----~~~~~~Ei~il~~l~hpnI  180 (549)
                      |.+...||+|++|.||+|.+. +|+.||||++.....               ....     .-...+|...+.++.++++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999885 589999998753210               0000     0122457777777755554


Q ss_pred             --eEEEEEEeeCCEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC---
Q psy18060        181 --IKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG---  254 (549)
Q Consensus       181 --v~l~~~~~~~~~~~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g---  254 (549)
                        ...++.  ..  .+|||||++| +|.++.      ....+..++.||+.+|.|||+.|||||||||.|||++++|   
T Consensus       176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             SCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence              233332  22  2699999987 565432      1234567889999999999999999999999999999877   


Q ss_pred             -------cEEEeecccceec
Q psy18060        255 -------VAMLCDFGFARSM  267 (549)
Q Consensus       255 -------~vKL~DFGla~~~  267 (549)
                             .+.|+||+-+-..
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                   3899999977543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.67  E-value=4.6e-17  Score=168.50  Aligned_cols=91  Identities=29%  Similarity=0.453  Sum_probs=77.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||+|++......+.+.+.+|+++|++|+|||||+++++|++.+.+|+
T Consensus        21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            35789999999999999999999999999999999998877777777889999999999999999999999999999999


Q ss_pred             hhhhhh-ccccc
Q psy18060         86 ITEFAH-MSLSK   96 (549)
Q Consensus        86 v~ey~~-~sLsk   96 (549)
                      ||||+. ++|..
T Consensus       101 VmEy~~gg~L~~  112 (350)
T 4b9d_A          101 VMDYCEGGDLFK  112 (350)
T ss_dssp             EEECCTTCBHHH
T ss_pred             EEeCCCCCcHHH
Confidence            999996 46654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.62  E-value=2.5e-16  Score=157.89  Aligned_cols=90  Identities=33%  Similarity=0.473  Sum_probs=73.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh-hhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      .+.+|++++.||+|+||+||+|+++.+|+.||||+|++..... .....+.+|+++|++++|||||++++++++.+.+|+
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4578999999999999999999999999999999998765432 334678999999999999999999999999999999


Q ss_pred             hhhhhhccccc
Q psy18060         86 ITEFAHMSLSK   96 (549)
Q Consensus        86 v~ey~~~sLsk   96 (549)
                      ||||+.++|..
T Consensus        91 vmEy~~g~L~~  101 (275)
T 3hyh_A           91 VIEYAGNELFD  101 (275)
T ss_dssp             EEECCCEEHHH
T ss_pred             EEeCCCCCHHH
Confidence            99999877643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.61  E-value=2e-16  Score=161.23  Aligned_cols=90  Identities=23%  Similarity=0.337  Sum_probs=78.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ..++|+++++||+|+||+||+|+++.+|+.||||+|++... .....+.+.+|+++|++|+|||||+++++|++.+.+|+
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            35679999999999999999999999999999999986542 22345678999999999999999999999999999999


Q ss_pred             hhhhhh-ccccc
Q psy18060         86 ITEFAH-MSLSK   96 (549)
Q Consensus        86 v~ey~~-~sLsk   96 (549)
                      ||||+. ++|..
T Consensus       110 vmEy~~gG~L~~  121 (311)
T 4aw0_A          110 GLSYAKNGELLK  121 (311)
T ss_dssp             EECCCTTEEHHH
T ss_pred             EEecCCCCCHHH
Confidence            999995 46644

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.58  E-value=1.6e-15  Score=160.11  Aligned_cols=89  Identities=24%  Similarity=0.317  Sum_probs=78.4

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc------ccc
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET------LNE   82 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~------~~~   82 (549)
                      ++|++++.||+|+||+||+|+++.||+.||||+|++........+.+.+|+++|+.|+|||||++++++..      ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999999999999999998766655666788999999999999999999998653      467


Q ss_pred             eehhhhhhhcccccC
Q psy18060         83 FVLITEFAHMSLSKL   97 (549)
Q Consensus        83 ~~lv~ey~~~sLskl   97 (549)
                      +|+||||+.++|..+
T Consensus       134 ~~ivmE~~~g~L~~~  148 (398)
T 4b99_A          134 VYVVLDLMESDLHQI  148 (398)
T ss_dssp             EEEEEECCSEEHHHH
T ss_pred             EEEEEeCCCCCHHHH
Confidence            899999998877543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.58  E-value=1.2e-15  Score=157.71  Aligned_cols=86  Identities=26%  Similarity=0.257  Sum_probs=76.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .+.|++++.||+|+||+||+|+++.||+.||||+|++....  ..+.+.+|+++|++|+|||||+++++|++.+.+|+||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35799999999999999999999999999999999765432  2356889999999999999999999999999999999


Q ss_pred             hhhhc-ccc
Q psy18060         88 EFAHM-SLS   95 (549)
Q Consensus        88 ey~~~-sLs   95 (549)
                      ||+.+ +|.
T Consensus       151 Ey~~gg~L~  159 (346)
T 4fih_A          151 EFLEGGALT  159 (346)
T ss_dssp             CCCTTEEHH
T ss_pred             eCCCCCcHH
Confidence            99964 554

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.56  E-value=3.2e-15  Score=158.38  Aligned_cols=86  Identities=26%  Similarity=0.257  Sum_probs=76.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .+.|++++.||+|+||+||+|+++.||+.||||+|.+....  ..+.+.+|+++|+.|+|||||+++++|++.+.+|+||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            46799999999999999999999999999999999875432  3467889999999999999999999999999999999


Q ss_pred             hhhhc-ccc
Q psy18060         88 EFAHM-SLS   95 (549)
Q Consensus        88 ey~~~-sLs   95 (549)
                      ||+.+ +|.
T Consensus       228 Ey~~gG~L~  236 (423)
T 4fie_A          228 EFLEGGALT  236 (423)
T ss_dssp             ECCTTEEHH
T ss_pred             eCCCCCcHH
Confidence            99964 554

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.56  E-value=2.2e-15  Score=152.99  Aligned_cols=88  Identities=22%  Similarity=0.335  Sum_probs=72.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc------
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN------   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~------   81 (549)
                      +++|++++.||+|+||+||+|+++.+|+.||||+|++.. .....+.+.+|+++|++|+|||||+++++|.+.+      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            357999999999999999999999999999999997654 3344567899999999999999999999987544      


Q ss_pred             ------ceehhhhhhh-ccccc
Q psy18060         82 ------EFVLITEFAH-MSLSK   96 (549)
Q Consensus        82 ------~~~lv~ey~~-~sLsk   96 (549)
                            .+|++|||+. ++|..
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~  104 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKD  104 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHH
T ss_pred             ccCCCcEEEEEEecCCCCcHHH
Confidence                  3799999995 45543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.54  E-value=5.3e-15  Score=149.45  Aligned_cols=86  Identities=31%  Similarity=0.423  Sum_probs=74.9

Q ss_pred             eeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc----ccceehh
Q psy18060         11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET----LNEFVLI   86 (549)
Q Consensus        11 y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----~~~~~lv   86 (549)
                      |++.+.||+|+||+||+|.++.+|+.||||++.+........+.+.+|+++|++|+|||||+++++|++    ...+|+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            367778999999999999999999999999998776666677889999999999999999999999865    4568999


Q ss_pred             hhhhh-ccccc
Q psy18060         87 TEFAH-MSLSK   96 (549)
Q Consensus        87 ~ey~~-~sLsk   96 (549)
                      |||+. ++|..
T Consensus       108 mEy~~gg~L~~  118 (290)
T 3fpq_A          108 TELMTSGTLKT  118 (290)
T ss_dssp             EECCCSCBHHH
T ss_pred             EeCCCCCCHHH
Confidence            99995 46644

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.53  E-value=4.6e-15  Score=150.60  Aligned_cols=89  Identities=27%  Similarity=0.390  Sum_probs=73.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEEC-----CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      ..++|.+.+.||+|+||+||+|+++     .+|+.||||+++..  +....+.+.+|+++|++|+|||||++++++.+.+
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            3467999999999999999999975     36789999999753  3445578999999999999999999999999999


Q ss_pred             ceehhhhhhh-cccccC
Q psy18060         82 EFVLITEFAH-MSLSKL   97 (549)
Q Consensus        82 ~~~lv~ey~~-~sLskl   97 (549)
                      .+++||||+. ++|..+
T Consensus        89 ~~~lV~Ey~~~G~L~~~  105 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKF  105 (299)
T ss_dssp             SEEEEEECCTTCBHHHH
T ss_pred             EEEEEEEcCCCCcHHHH
Confidence            9999999995 577543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.51  E-value=1.4e-15  Score=154.60  Aligned_cols=89  Identities=27%  Similarity=0.438  Sum_probs=71.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEEC---CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      .++|++++.||+|+||+||+|++.   .+++.||||+|++..........+.+|+++|++|+|||||+++++|++.+.+|
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            468999999999999999999984   47889999999876544344457889999999999999999999999999999


Q ss_pred             hhhhhhh-ccccc
Q psy18060         85 LITEFAH-MSLSK   96 (549)
Q Consensus        85 lv~ey~~-~sLsk   96 (549)
                      +||||+. ++|..
T Consensus       103 ivmEy~~gg~L~~  115 (304)
T 3ubd_A          103 LILDFLRGGDLFT  115 (304)
T ss_dssp             EEECCCTTCEEHH
T ss_pred             EEEEcCCCCCHHH
Confidence            9999996 46643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.51  E-value=1.1e-14  Score=149.88  Aligned_cols=89  Identities=25%  Similarity=0.377  Sum_probs=75.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEEC-----CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      ..++|.+.+.||+|+||+||+|+++     .+++.||||+++..  +....+.|.+|+++|++|+|||||++++++.+..
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            3457888999999999999999975     36889999999653  3445678999999999999999999999999999


Q ss_pred             ceehhhhhhh-cccccC
Q psy18060         82 EFVLITEFAH-MSLSKL   97 (549)
Q Consensus        82 ~~~lv~ey~~-~sLskl   97 (549)
                      .+++||||+. ++|..+
T Consensus       117 ~~~lV~Ey~~~G~L~~~  133 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRF  133 (329)
T ss_dssp             SEEEEEECCTTCBHHHH
T ss_pred             EEEEEEEcCCCCcHHHH
Confidence            9999999995 576543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.51  E-value=9.9e-15  Score=148.75  Aligned_cols=90  Identities=21%  Similarity=0.406  Sum_probs=74.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEEC-----CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      ..+++++++.||+|+||+||+|++.     .+++.||||+++... .....+.|.+|+.+|++|+|||||++++++.+..
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            4567889999999999999999864     467899999996543 3334567999999999999999999999999999


Q ss_pred             ceehhhhhhh-cccccC
Q psy18060         82 EFVLITEFAH-MSLSKL   97 (549)
Q Consensus        82 ~~~lv~ey~~-~sLskl   97 (549)
                      .+++||||+. ++|..+
T Consensus       103 ~~~lV~Ey~~~G~L~~~  119 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEF  119 (308)
T ss_dssp             SCEEEEECCSSCBHHHH
T ss_pred             EEEEEEEcCCCCcHHHH
Confidence            9999999994 577553

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.49  E-value=1.7e-14  Score=148.57  Aligned_cols=83  Identities=18%  Similarity=0.149  Sum_probs=73.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..+.|++.+.||+|+||+||+|+++.+|+.||||+|++...       ..+|+.+|+.|+|||||+++++|++.+.+|+|
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            45668999999999999999999999999999999976432       24799999999999999999999999999999


Q ss_pred             hhhhh-ccccc
Q psy18060         87 TEFAH-MSLSK   96 (549)
Q Consensus        87 ~ey~~-~sLsk   96 (549)
                      |||+. ++|..
T Consensus       129 mEy~~gg~L~~  139 (336)
T 4g3f_A          129 MELLEGGSLGQ  139 (336)
T ss_dssp             ECCCTTCBHHH
T ss_pred             EeccCCCcHHH
Confidence            99996 46654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.43  E-value=1.1e-13  Score=152.60  Aligned_cols=87  Identities=24%  Similarity=0.388  Sum_probs=77.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      .+++|++++.||+|+||+||+|+++.+|+.||||+|.+..  ....+.+.+|+++|+.|+|||||+++++|++...+|++
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            4689999999999999999999999999999999997643  33456789999999999999999999999999999999


Q ss_pred             hhhhh-cccc
Q psy18060         87 TEFAH-MSLS   95 (549)
Q Consensus        87 ~ey~~-~sLs   95 (549)
                      |||+. ++|.
T Consensus       233 ~E~~~gg~L~  242 (573)
T 3uto_A          233 YEFMSGGELF  242 (573)
T ss_dssp             EECCCCCBHH
T ss_pred             EeecCCCcHH
Confidence            99985 4553

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.42  E-value=8.2e-14  Score=141.78  Aligned_cols=86  Identities=24%  Similarity=0.427  Sum_probs=72.9

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..+++++.+.||+|+||+||+|+++.   .||||+++....+....+.|.+|+++|++|+|||||++++++.+ +.+++|
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            45688999999999999999998653   59999997666666667889999999999999999999998764 568999


Q ss_pred             hhhhh-ccccc
Q psy18060         87 TEFAH-MSLSK   96 (549)
Q Consensus        87 ~ey~~-~sLsk   96 (549)
                      |||+. ++|.+
T Consensus       110 mEy~~gGsL~~  120 (307)
T 3omv_A          110 TQWCEGSSLYK  120 (307)
T ss_dssp             EECCSSCBHHH
T ss_pred             EEcCCCCCHHH
Confidence            99995 56654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.39  E-value=1.9e-13  Score=151.77  Aligned_cols=92  Identities=17%  Similarity=0.210  Sum_probs=74.8

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh-hhhhhHH---HHHHHHHhcCCCCcccccccccc
Q psy18060          4 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLK---QECEIQKHLAHPNIIKFIASHET   79 (549)
Q Consensus         4 ~~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~---~Ei~il~~l~HpnIV~l~~~~~~   79 (549)
                      .+..+++|+++++||+|+||+||+|+++.||+.||||+|++..... .....+.   +++.+++.++|||||+++++|++
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~  263 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT  263 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence            3567899999999999999999999999999999999997654211 1112233   44567777899999999999999


Q ss_pred             ccceehhhhhhh-cccc
Q psy18060         80 LNEFVLITEFAH-MSLS   95 (549)
Q Consensus        80 ~~~~~lv~ey~~-~sLs   95 (549)
                      .+.+|+||||+. ++|.
T Consensus       264 ~~~lylVmEy~~GGdL~  280 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLH  280 (689)
T ss_dssp             SSEEEEEECCCCSCBHH
T ss_pred             CCEEEEEEecCCCCcHH
Confidence            999999999996 4654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.38  E-value=5.1e-13  Score=137.06  Aligned_cols=91  Identities=35%  Similarity=0.473  Sum_probs=81.3

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          4 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         4 ~~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      .+....+|++++.||+|+||.||+|++..+|+.||||++.+........+.+.+|+++|+.++||||+++++++.+...+
T Consensus        10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            45667899999999999999999999999999999999987766666667889999999999999999999999999999


Q ss_pred             ehhhhhhh-ccc
Q psy18060         84 VLITEFAH-MSL   94 (549)
Q Consensus        84 ~lv~ey~~-~sL   94 (549)
                      ++||||+. ++|
T Consensus        90 ~lv~e~~~~~~L  101 (328)
T 3fe3_A           90 YLIMEYASGGEV  101 (328)
T ss_dssp             EEEECCCTTCBH
T ss_pred             EEEEECCCCCcH
Confidence            99999984 344

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.38  E-value=4.3e-13  Score=134.31  Aligned_cols=88  Identities=32%  Similarity=0.462  Sum_probs=79.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +++|++++.||+|+||.||+|+++.+|+.||||++............+.+|++++++++||||+++++++.+...+++||
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            47899999999999999999999999999999999876655555577889999999999999999999999999999999


Q ss_pred             hhhhcccc
Q psy18060         88 EFAHMSLS   95 (549)
Q Consensus        88 ey~~~sLs   95 (549)
                      ||+.+++.
T Consensus        81 e~~~~~l~   88 (292)
T 3o0g_A           81 EFCDQDLK   88 (292)
T ss_dssp             ECCSEEHH
T ss_pred             ecCCCCHH
Confidence            99977653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.34  E-value=6.7e-13  Score=137.74  Aligned_cols=90  Identities=24%  Similarity=0.433  Sum_probs=73.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCC-----ceEEEEEeccCCCChhhhhhHHHHHHHHHhcCC-CCcccccccccc-
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLK-----KTVALKIISKSGRSGKELSSLKQECEIQKHLAH-PNIIKFIASHET-   79 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~-   79 (549)
                      ..++|++.+.||+|+||+||+|+++.++     +.||||++.... ...+.+.+.+|+++|++++| ||||+++++|.+ 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            3468999999999999999999987543     689999997543 34455779999999999965 999999999865 


Q ss_pred             ccceehhhhhhh-cccccC
Q psy18060         80 LNEFVLITEFAH-MSLSKL   97 (549)
Q Consensus        80 ~~~~~lv~ey~~-~sLskl   97 (549)
                      ...+++||||+. ++|..+
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~  159 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTY  159 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHH
T ss_pred             CCEEEEEEEcCCCCCHHHH
Confidence            467999999995 577554

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.31  E-value=1.1e-12  Score=131.20  Aligned_cols=88  Identities=35%  Similarity=0.464  Sum_probs=76.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +++|++++.||+|+||.||+|++ .+|+.||||++............+.+|+++++.++||||+++++++.+...++++|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            47899999999999999999999 67899999999765443334467889999999999999999999999999999999


Q ss_pred             hhhhccccc
Q psy18060         88 EFAHMSLSK   96 (549)
Q Consensus        88 ey~~~sLsk   96 (549)
                      ||+.++|..
T Consensus        80 e~~~~~l~~   88 (288)
T 1ob3_A           80 EHLDQDLKK   88 (288)
T ss_dssp             ECCSEEHHH
T ss_pred             EecCCCHHH
Confidence            999877644

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.31  E-value=1.8e-12  Score=131.51  Aligned_cols=92  Identities=35%  Similarity=0.481  Sum_probs=76.7

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          4 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         4 ~~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      .+.-.++|++++.||+|+||.||+|++. +|+.||||++............+.+|++++++++||||+++++++.+...+
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            3466789999999999999999999996 489999999976554444456788999999999999999999999999999


Q ss_pred             ehhhhhhhccccc
Q psy18060         84 VLITEFAHMSLSK   96 (549)
Q Consensus        84 ~lv~ey~~~sLsk   96 (549)
                      ++||||+.++|..
T Consensus        95 ~lv~e~~~~~l~~  107 (311)
T 3niz_A           95 TLVFEFMEKDLKK  107 (311)
T ss_dssp             EEEEECCSEEHHH
T ss_pred             EEEEcCCCCCHHH
Confidence            9999999876643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.30  E-value=1.6e-12  Score=135.34  Aligned_cols=87  Identities=16%  Similarity=0.211  Sum_probs=73.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEEC---CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNE   82 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~   82 (549)
                      ..++|++++.||+|+||+||+|+++   .+++.||||++.+..    ...++.+|+++|+.+ +|||||+++++|++.+.
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            3467999999999999999999875   467899999996543    234678999999988 69999999999999999


Q ss_pred             eehhhhhhh-cccccC
Q psy18060         83 FVLITEFAH-MSLSKL   97 (549)
Q Consensus        83 ~~lv~ey~~-~sLskl   97 (549)
                      +|+||||+. ++|..+
T Consensus        95 ~~lvmE~~~g~~L~~~  110 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDI  110 (361)
T ss_dssp             EEEEEECCCCCCHHHH
T ss_pred             EEEEEeCCCcccHHHH
Confidence            999999995 455443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.30  E-value=5.4e-13  Score=135.51  Aligned_cols=84  Identities=27%  Similarity=0.331  Sum_probs=64.9

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc----cee
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN----EFV   84 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~----~~~   84 (549)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++...   .......+|+..+.+++|||||++++++.+.+    .++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            4688999999999999999987  48999999996532   11122345666667899999999999987653    589


Q ss_pred             hhhhhhh-cccccC
Q psy18060         85 LITEFAH-MSLSKL   97 (549)
Q Consensus        85 lv~ey~~-~sLskl   97 (549)
                      +||||+. ++|..+
T Consensus        78 lV~Ey~~~gsL~~~   91 (303)
T 3hmm_A           78 LVSDYHEHGSLFDY   91 (303)
T ss_dssp             EEEECCTTCBHHHH
T ss_pred             EEecCCCCCcHHHH
Confidence            9999995 576543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.29  E-value=1.7e-12  Score=138.93  Aligned_cols=90  Identities=27%  Similarity=0.376  Sum_probs=69.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccc-----cccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE-----TLNE   82 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~   82 (549)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+........+.+.+|+++|+.++|||||++++++.     ....
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            46899999999999999999999999999999999776555566678999999999999999999999983     3457


Q ss_pred             eehhhhhhhcccccC
Q psy18060         83 FVLITEFAHMSLSKL   97 (549)
Q Consensus        83 ~~lv~ey~~~sLskl   97 (549)
                      +|+||||+.++|..+
T Consensus       132 ~~lv~e~~~~~L~~~  146 (458)
T 3rp9_A          132 LYVVLEIADSDFKKL  146 (458)
T ss_dssp             EEEEECCCSEEHHHH
T ss_pred             EEEEEeccccchhhh
Confidence            899999998776543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.29  E-value=2.5e-12  Score=133.67  Aligned_cols=87  Identities=25%  Similarity=0.393  Sum_probs=78.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .++|++.+.||+|+||.||+|.++.+|+.||||++..........+.+.+|+.+++.++|||||++++++.+....++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            35799999999999999999999999999999999877666666778999999999999999999999999999999999


Q ss_pred             hhhhc-cc
Q psy18060         88 EFAHM-SL   94 (549)
Q Consensus        88 ey~~~-sL   94 (549)
                      ||+.+ +|
T Consensus       108 e~~~gg~L  115 (362)
T 2bdw_A          108 DLVTGGEL  115 (362)
T ss_dssp             CCCCSCBH
T ss_pred             ecCCCCCH
Confidence            99854 44

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.29  E-value=1.5e-12  Score=133.06  Aligned_cols=92  Identities=30%  Similarity=0.463  Sum_probs=76.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ..+++|++++.||+|+||.||+|++..+|+.||||++............+.+|++++++++||||+++++++.+...+++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            46778999999999999999999999999999999997665444445667899999999999999999999999999999


Q ss_pred             hhhhhhcccccC
Q psy18060         86 ITEFAHMSLSKL   97 (549)
Q Consensus        86 v~ey~~~sLskl   97 (549)
                      ||||+.++|..+
T Consensus       111 v~e~~~~~L~~~  122 (329)
T 3gbz_A          111 IFEYAENDLKKY  122 (329)
T ss_dssp             EEECCSEEHHHH
T ss_pred             EEecCCCCHHHH
Confidence            999998776543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.29  E-value=4.1e-12  Score=128.12  Aligned_cols=86  Identities=31%  Similarity=0.474  Sum_probs=76.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|++++++++||||+++++++.+....++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            57899999999999999999999999999999999766555445567889999999999999999999999999999999


Q ss_pred             hhhhcc
Q psy18060         88 EFAHMS   93 (549)
Q Consensus        88 ey~~~s   93 (549)
                      ||+.+.
T Consensus        82 e~~~~~   87 (311)
T 4agu_A           82 EYCDHT   87 (311)
T ss_dssp             ECCSEE
T ss_pred             EeCCCc
Confidence            998653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.29  E-value=1.2e-12  Score=134.90  Aligned_cols=94  Identities=33%  Similarity=0.389  Sum_probs=79.7

Q ss_pred             CccccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh-hhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          3 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         3 ~~~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      .......+|++.+.||+|+||.||+|.+..+|+.||||++.+..... .....+.+|+++++.++||||+++++++.+..
T Consensus         3 i~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   82 (336)
T 3h4j_B            3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT   82 (336)
T ss_dssp             -CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            34566789999999999999999999999999999999997543211 12356889999999999999999999999999


Q ss_pred             ceehhhhhhhccccc
Q psy18060         82 EFVLITEFAHMSLSK   96 (549)
Q Consensus        82 ~~~lv~ey~~~sLsk   96 (549)
                      .+++||||+.++|..
T Consensus        83 ~~~lv~E~~~g~l~~   97 (336)
T 3h4j_B           83 DIVMVIEYAGGELFD   97 (336)
T ss_dssp             EEEEEECCCCEEHHH
T ss_pred             EEEEEEECCCCcHHH
Confidence            999999999777643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.28  E-value=3.2e-12  Score=135.98  Aligned_cols=91  Identities=26%  Similarity=0.339  Sum_probs=80.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc-----c
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-----N   81 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~   81 (549)
                      ..++|++++.||+|+||.||+|+++.+|+.||||++.+........+.+.+|+++|+.++|||||++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            35789999999999999999999999999999999987655555667899999999999999999999998765     5


Q ss_pred             ceehhhhhhhcccccC
Q psy18060         82 EFVLITEFAHMSLSKL   97 (549)
Q Consensus        82 ~~~lv~ey~~~sLskl   97 (549)
                      .+|+||||+.++|..+
T Consensus       104 ~~~lv~e~~~~~L~~~  119 (432)
T 3n9x_A          104 ELYIVLEIADSDLKKL  119 (432)
T ss_dssp             CEEEEEECCSEEHHHH
T ss_pred             eEEEEEecCCcCHHHH
Confidence            6899999998877553

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.27  E-value=3.2e-12  Score=128.07  Aligned_cols=89  Identities=37%  Similarity=0.514  Sum_probs=74.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +++|++++.||+|+||.||+|+++.+|+.||||++............+.+|++++++++||||+++++++.+.+..+++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (299)
T 2r3i_A            2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   81 (299)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence            68999999999999999999999999999999999765443334467889999999999999999999999999999999


Q ss_pred             hhhhccccc
Q psy18060         88 EFAHMSLSK   96 (549)
Q Consensus        88 ey~~~sLsk   96 (549)
                      ||+.++|..
T Consensus        82 e~~~~~L~~   90 (299)
T 2r3i_A           82 EFLHQDLKK   90 (299)
T ss_dssp             ECCSEEHHH
T ss_pred             EcccCCHHH
Confidence            999877654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.27  E-value=3.8e-12  Score=136.89  Aligned_cols=89  Identities=26%  Similarity=0.375  Sum_probs=77.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc------
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------   80 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~------   80 (549)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++.+........+.+.+|+++|+.++|||||++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            46789999999999999999999999999999999987655555667889999999999999999999998654      


Q ss_pred             cceehhhhhhhcccc
Q psy18060         81 NEFVLITEFAHMSLS   95 (549)
Q Consensus        81 ~~~~lv~ey~~~sLs   95 (549)
                      ..+|+||||+.+++.
T Consensus       140 ~~~~lv~E~~~~~l~  154 (464)
T 3ttj_A          140 QDVYLVMELMDANLC  154 (464)
T ss_dssp             CEEEEEEECCSEEHH
T ss_pred             CeEEEEEeCCCCCHH
Confidence            457999999977654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.26  E-value=2.1e-12  Score=131.33  Aligned_cols=89  Identities=25%  Similarity=0.396  Sum_probs=63.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++++.||+|+||.||+|.++.+|+.||||++..... ......+.+|+++++.++|||||++++++.+.+.+++|
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            45789999999999999999999999999999999976542 22345788999999999999999999999999999999


Q ss_pred             hhhhhccccc
Q psy18060         87 TEFAHMSLSK   96 (549)
Q Consensus        87 ~ey~~~sLsk   96 (549)
                      |||+.++|..
T Consensus        82 ~e~~~~~L~~   91 (317)
T 2pmi_A           82 FEFMDNDLKK   91 (317)
T ss_dssp             EECCCCBHHH
T ss_pred             EEecCCCHHH
Confidence            9999877654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.26  E-value=5.5e-12  Score=131.16  Aligned_cols=91  Identities=25%  Similarity=0.260  Sum_probs=78.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh----hhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      ...+.|++.+.||+|+||.||+|+++.+|+.||||++.+.....    ...+.+.+|+.+|+.++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            34567999999999999999999999999999999998765322    13467889999999999999999999999999


Q ss_pred             ceehhhhhhh-ccccc
Q psy18060         82 EFVLITEFAH-MSLSK   96 (549)
Q Consensus        82 ~~~lv~ey~~-~sLsk   96 (549)
                      .+++||||+. ++|..
T Consensus        89 ~~~lv~e~~~gg~L~~  104 (361)
T 2yab_A           89 DVVLILELVSGGELFD  104 (361)
T ss_dssp             EEEEEEECCCSCBHHH
T ss_pred             EEEEEEEcCCCCcHHH
Confidence            9999999984 56543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.26  E-value=1.7e-11  Score=120.79  Aligned_cols=140  Identities=19%  Similarity=0.163  Sum_probs=110.0

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~i  195 (549)
                      .+..|.+...++.|+.+.||++...  +..+++|+.......  ....+.+|+.+++.+. +..++++++++...+..|+
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            4567889999999999999998643  688999998642111  1134788999999884 6778899999988889999


Q ss_pred             EEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q psy18060        196 ITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHS---------------------------------------  235 (549)
Q Consensus       196 V~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~---------------------------------------  235 (549)
                      |||+++| +|.+.+.     +......++.++..+|..||+                                       
T Consensus        88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            9999998 6765421     122345788899999999998                                       


Q ss_pred             --------------------CCCccccccCCcEEEecCCcEEEeecccce
Q psy18060        236 --------------------NRVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       236 --------------------~gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                                          .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                448999999999999876666799999774

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.25  E-value=6.1e-12  Score=124.65  Aligned_cols=93  Identities=23%  Similarity=0.377  Sum_probs=79.8

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccc--ccccc
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASH--ETLNE   82 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~--~~~~~   82 (549)
                      +...++|++++.||+|+||.||+|+++.+|+.||+|++..........+.+.+|++++++++||||+++++.+  .....
T Consensus         2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            3457899999999999999999999999999999999987665666667899999999999999999999987  44667


Q ss_pred             eehhhhhhh-cccccC
Q psy18060         83 FVLITEFAH-MSLSKL   97 (549)
Q Consensus        83 ~~lv~ey~~-~sLskl   97 (549)
                      ++++|||+. ++|..+
T Consensus        82 ~~lv~e~~~~~~L~~~   97 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASV   97 (279)
T ss_dssp             EEEEEECCTTEEHHHH
T ss_pred             EEEEEeCCCCCCHHHH
Confidence            999999985 466543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.25  E-value=2.7e-12  Score=132.25  Aligned_cols=88  Identities=22%  Similarity=0.387  Sum_probs=76.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.+...+++
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            46799999999999999999999999999999999976431 22234678899999999999999999999999999999


Q ss_pred             hhhhhhc-cc
Q psy18060         86 ITEFAHM-SL   94 (549)
Q Consensus        86 v~ey~~~-sL   94 (549)
                      ||||+.+ +|
T Consensus        83 v~E~~~gg~L   92 (337)
T 1o6l_A           83 VMEYANGGEL   92 (337)
T ss_dssp             EEECCTTCBH
T ss_pred             EEeCCCCCcH
Confidence            9999854 44

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.25  E-value=7.5e-12  Score=125.70  Aligned_cols=88  Identities=16%  Similarity=0.237  Sum_probs=77.5

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC-hhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .+|++.+.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            6799999999999999999999999999999999866542 344577899999999999999999999999999999999


Q ss_pred             hhhh-ccccc
Q psy18060         88 EFAH-MSLSK   96 (549)
Q Consensus        88 ey~~-~sLsk   96 (549)
                      ||+. ++|..
T Consensus       111 e~~~g~~L~~  120 (286)
T 3uqc_A          111 EWIRGGSLQE  120 (286)
T ss_dssp             ECCCEEEHHH
T ss_pred             EecCCCCHHH
Confidence            9985 45544

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.25  E-value=4.2e-12  Score=128.71  Aligned_cols=73  Identities=23%  Similarity=0.353  Sum_probs=62.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      +++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+++|++++|||||+++++|.+..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   77 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETP   77 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence            467999999999999999999999999999999997654 2334567899999999999999999999986544

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.25  E-value=7.3e-12  Score=130.92  Aligned_cols=92  Identities=24%  Similarity=0.262  Sum_probs=81.6

Q ss_pred             cccccCeeeeeeeccc--CceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          5 NGALEKYQKICLIGEG--SFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G--~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      .+...+|++++.||+|  +||.||+|+++.+|+.||||++..........+.+.+|+.+++.++|||||++++++.+.+.
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            3566789999999999  99999999999999999999998766555666788999999999999999999999999999


Q ss_pred             eehhhhhhh-ccccc
Q psy18060         83 FVLITEFAH-MSLSK   96 (549)
Q Consensus        83 ~~lv~ey~~-~sLsk   96 (549)
                      +++||||+. ++|..
T Consensus       101 ~~lv~e~~~~~~L~~  115 (389)
T 3gni_B          101 LWVVTSFMAYGSAKD  115 (389)
T ss_dssp             EEEEEECCTTCBHHH
T ss_pred             EEEEEEccCCCCHHH
Confidence            999999985 45543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.25  E-value=5.5e-12  Score=126.77  Aligned_cols=89  Identities=27%  Similarity=0.394  Sum_probs=77.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      .++|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.++++++||||+++++++.+....+++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            4689999999999999999999999999999999976543 334557789999999999999999999999999999999


Q ss_pred             hhhhhc-cccc
Q psy18060         87 TEFAHM-SLSK   96 (549)
Q Consensus        87 ~ey~~~-sLsk   96 (549)
                      |||+.+ +|..
T Consensus        90 ~e~~~g~~L~~  100 (294)
T 4eqm_A           90 MEYIEGPTLSE  100 (294)
T ss_dssp             EECCCSCBHHH
T ss_pred             EeCCCCCCHHH
Confidence            999854 6544

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.24  E-value=4.2e-12  Score=135.76  Aligned_cols=87  Identities=26%  Similarity=0.376  Sum_probs=76.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++.+........+.+.+|+++++.++|||||++++++.+...+++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            46799999999999999999999999999999999876655556678899999999999999999999999999999999


Q ss_pred             hhhhc-cc
Q psy18060         88 EFAHM-SL   94 (549)
Q Consensus        88 ey~~~-sL   94 (549)
                      ||+.+ +|
T Consensus        90 E~~~gg~L   97 (444)
T 3soa_A           90 DLVTGGEL   97 (444)
T ss_dssp             CCCBCCBH
T ss_pred             EeCCCCCH
Confidence            99854 44

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.24  E-value=5.6e-12  Score=131.83  Aligned_cols=91  Identities=23%  Similarity=0.373  Sum_probs=71.0

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC-CCCccccccccccc--cc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETL--NE   82 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~--~~   82 (549)
                      ...++|++++.||+|+||.||+|.++.+|+.||||++.+..........+.+|+.+|+.+. |||||++++++...  ..
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3467999999999999999999999999999999999766555666678889999999997 99999999998644  46


Q ss_pred             eehhhhhhhccccc
Q psy18060         83 FVLITEFAHMSLSK   96 (549)
Q Consensus        83 ~~lv~ey~~~sLsk   96 (549)
                      +|+||||+.++|..
T Consensus        86 ~~lv~e~~~~~L~~   99 (388)
T 3oz6_A           86 VYLVFDYMETDLHA   99 (388)
T ss_dssp             EEEEEECCSEEHHH
T ss_pred             EEEEecccCcCHHH
Confidence            89999999877654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.24  E-value=2.5e-12  Score=136.14  Aligned_cols=90  Identities=21%  Similarity=0.318  Sum_probs=76.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ...++|+++++||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+++.++|||||+++++|.+...+|
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            456789999999999999999999999999999999976331 1122346889999999999999999999999999999


Q ss_pred             hhhhhh-hcccc
Q psy18060         85 LITEFA-HMSLS   95 (549)
Q Consensus        85 lv~ey~-~~sLs   95 (549)
                      +||||+ .++|.
T Consensus       146 lV~E~~~gg~L~  157 (410)
T 3v8s_A          146 MVMEYMPGGDLV  157 (410)
T ss_dssp             EEECCCTTEEHH
T ss_pred             EEEeCCCCCcHH
Confidence            999998 44554

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.24  E-value=9e-12  Score=129.62  Aligned_cols=90  Identities=24%  Similarity=0.367  Sum_probs=78.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc-----
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----   81 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----   81 (549)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++.+........+.+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            467999999999999999999999999999999999876555555677889999999999999999999986654     


Q ss_pred             -ceehhhhhhhccccc
Q psy18060         82 -EFVLITEFAHMSLSK   96 (549)
Q Consensus        82 -~~~lv~ey~~~sLsk   96 (549)
                       .+++||||+.++|..
T Consensus       103 ~~~~lv~e~~~~~l~~  118 (371)
T 2xrw_A          103 QDVYIVMELMDANLCQ  118 (371)
T ss_dssp             CEEEEEEECCSEEHHH
T ss_pred             cceEEEEEcCCCCHHH
Confidence             689999999877643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.24  E-value=7.8e-12  Score=129.09  Aligned_cols=89  Identities=18%  Similarity=0.352  Sum_probs=78.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhc-CCCCccccccccccccce
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF   83 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~   83 (549)
                      ..+++|++++.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+.++.++ +|||||++++++.+...+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            457899999999999999999999999999999999987653 334556788999999987 899999999999999999


Q ss_pred             ehhhhhhhc-cc
Q psy18060         84 VLITEFAHM-SL   94 (549)
Q Consensus        84 ~lv~ey~~~-sL   94 (549)
                      |+||||+.+ +|
T Consensus        86 ~lv~e~~~gg~L   97 (345)
T 3a8x_A           86 FFVIEYVNGGDL   97 (345)
T ss_dssp             EEEECCCCSCBH
T ss_pred             EEEEeCCCCCcH
Confidence            999999853 55

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.24  E-value=4.8e-12  Score=131.70  Aligned_cols=91  Identities=24%  Similarity=0.360  Sum_probs=72.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc------
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------   80 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~------   80 (549)
                      ..++|++++.||+|+||.||+|.++.+|+.||||++.+........+.+.+|+++|+.++||||+++++++...      
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            35689999999999999999999999999999999976655555567889999999999999999999998765      


Q ss_pred             cceehhhhhhhcccccC
Q psy18060         81 NEFVLITEFAHMSLSKL   97 (549)
Q Consensus        81 ~~~~lv~ey~~~sLskl   97 (549)
                      ..+|+||+|+.++|..+
T Consensus       103 ~~~~lv~e~~~~~L~~~  119 (367)
T 1cm8_A          103 TDFYLVMPFMGTDLGKL  119 (367)
T ss_dssp             CCCEEEEECCSEEHHHH
T ss_pred             ceEEEEEecCCCCHHHH
Confidence            34699999987776543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.24  E-value=8e-12  Score=127.57  Aligned_cols=91  Identities=26%  Similarity=0.353  Sum_probs=75.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      +-.++|++++.||+|+||.||+|+++.+|+.||||++...... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            4568999999999999999999999999999999999755422 223568899999999999999999999999999999


Q ss_pred             hhhhhh-cccccC
Q psy18060         86 ITEFAH-MSLSKL   97 (549)
Q Consensus        86 v~ey~~-~sLskl   97 (549)
                      ||||+. ++|...
T Consensus        83 v~e~~~~~~L~~~   95 (323)
T 3tki_A           83 FLEYCSGGELFDR   95 (323)
T ss_dssp             EEECCTTEEGGGG
T ss_pred             EEEcCCCCcHHHH
Confidence            999985 366443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.24  E-value=7.4e-12  Score=127.84  Aligned_cols=88  Identities=27%  Similarity=0.457  Sum_probs=78.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ..+++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+++++.++||||+++++++.+....++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            46789999999999999999999999999999999997665555555678899999999999999999999999999999


Q ss_pred             hhhhhhcc
Q psy18060         86 ITEFAHMS   93 (549)
Q Consensus        86 v~ey~~~s   93 (549)
                      ||||+.+.
T Consensus       102 v~e~~~~~  109 (331)
T 4aaa_A          102 VFEFVDHT  109 (331)
T ss_dssp             EEECCSEE
T ss_pred             EEecCCcc
Confidence            99998653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.24  E-value=1e-11  Score=123.39  Aligned_cols=85  Identities=25%  Similarity=0.386  Sum_probs=77.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++..........+.+.+|+.++++++||||+++++++.+....+++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46899999999999999999999999999999999876666666678899999999999999999999999999999999


Q ss_pred             hhhhc
Q psy18060         88 EFAHM   92 (549)
Q Consensus        88 ey~~~   92 (549)
                      ||+.+
T Consensus        85 e~~~~   89 (284)
T 3kk8_A           85 DLVTG   89 (284)
T ss_dssp             CCCCS
T ss_pred             ecCCC
Confidence            99853

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.23  E-value=3.1e-12  Score=132.18  Aligned_cols=86  Identities=26%  Similarity=0.439  Sum_probs=74.5

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC---ChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ++|++.+.||+|+||.||+|.++.+|+.||||++.+...   .....+.+.+|+.+++.++|||||++++++.+...+++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            569999999999999999999999999999999965321   11234678899999999999999999999999999999


Q ss_pred             hhhhhh-ccc
Q psy18060         86 ITEFAH-MSL   94 (549)
Q Consensus        86 v~ey~~-~sL   94 (549)
                      ||||+. ++|
T Consensus       104 v~e~~~g~~L  113 (351)
T 3c0i_A          104 VFEFMDGADL  113 (351)
T ss_dssp             EEECCSSCBH
T ss_pred             EEeCCCCCCH
Confidence            999986 455

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.23  E-value=4.1e-12  Score=133.30  Aligned_cols=89  Identities=25%  Similarity=0.397  Sum_probs=77.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ..+++|++++.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+++|+.++|||||+++++|.+...++
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457899999999999999999999999999999999976431 2234467889999999999999999999999999999


Q ss_pred             hhhhhhh-ccc
Q psy18060         85 LITEFAH-MSL   94 (549)
Q Consensus        85 lv~ey~~-~sL   94 (549)
                      +||+|+. ++|
T Consensus        92 lv~e~~~gg~L  102 (384)
T 4fr4_A           92 MVVDLLLGGDL  102 (384)
T ss_dssp             EEECCCTTEEH
T ss_pred             EEEecCCCCcH
Confidence            9999984 344

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.23  E-value=6e-12  Score=126.80  Aligned_cols=89  Identities=21%  Similarity=0.369  Sum_probs=77.0

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++.......  .+.+.+|+.+++.++||||+++++++.+...+++
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            45678999999999999999999999999999999997654322  3568899999999999999999999999999999


Q ss_pred             hhhhh-hccccc
Q psy18060         86 ITEFA-HMSLSK   96 (549)
Q Consensus        86 v~ey~-~~sLsk   96 (549)
                      ||||+ .++|..
T Consensus        95 v~e~~~~~~L~~  106 (297)
T 3fxz_A           95 VMEYLAGGSLTD  106 (297)
T ss_dssp             EEECCTTCBHHH
T ss_pred             EEECCCCCCHHH
Confidence            99998 445543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.23  E-value=9.3e-12  Score=126.26  Aligned_cols=90  Identities=28%  Similarity=0.397  Sum_probs=78.0

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ....++|++.+.||+|+||.||+|++  +|+.||||++..........+.+.+|++++++++||||+++++++.+...++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            34567899999999999999999987  4789999999876655666678999999999999999999999999999999


Q ss_pred             hhhhhhhc-cccc
Q psy18060         85 LITEFAHM-SLSK   96 (549)
Q Consensus        85 lv~ey~~~-sLsk   96 (549)
                      +||||+.+ +|..
T Consensus       111 lv~e~~~~~~L~~  123 (309)
T 3p86_A          111 IVTEYLSRGSLYR  123 (309)
T ss_dssp             EEEECCTTCBHHH
T ss_pred             EEEecCCCCcHHH
Confidence            99999854 6543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.22  E-value=9.9e-12  Score=129.42  Aligned_cols=91  Identities=25%  Similarity=0.398  Sum_probs=73.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc------
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------   80 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~------   80 (549)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+++|+.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            34789999999999999999999999999999999976655555567888999999999999999999988653      


Q ss_pred             cceehhhhhhhcccccC
Q psy18060         81 NEFVLITEFAHMSLSKL   97 (549)
Q Consensus        81 ~~~~lv~ey~~~sLskl   97 (549)
                      ..++++++++.++|..+
T Consensus       107 ~~~~lv~e~~~~~L~~~  123 (367)
T 2fst_X          107 NDVYLVTHLMGADLNNI  123 (367)
T ss_dssp             CCCEEEEECCCEECC--
T ss_pred             CeEEEEecccCCCHHHH
Confidence            56789999987777554

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.22  E-value=4.1e-12  Score=129.73  Aligned_cols=89  Identities=21%  Similarity=0.340  Sum_probs=76.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+...+++
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            46899999999999999999999999999999999976432 11234668899999999999999999999999999999


Q ss_pred             hhhhhhc-ccc
Q psy18060         86 ITEFAHM-SLS   95 (549)
Q Consensus        86 v~ey~~~-sLs   95 (549)
                      ||||+.+ +|.
T Consensus        84 v~e~~~gg~L~   94 (318)
T 1fot_A           84 IMDYIEGGELF   94 (318)
T ss_dssp             EECCCCSCBHH
T ss_pred             EEeCCCCCCHH
Confidence            9999853 553

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.22  E-value=7.5e-12  Score=131.88  Aligned_cols=89  Identities=17%  Similarity=0.350  Sum_probs=75.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhc-CCCCccccccccccccce
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF   83 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~   83 (549)
                      ..+++|+++++||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.++.++ +|||||+++++|.+...+
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            356789999999999999999999999999999999987643 233456688999999887 899999999999999999


Q ss_pred             ehhhhhhhc-cc
Q psy18060         84 VLITEFAHM-SL   94 (549)
Q Consensus        84 ~lv~ey~~~-sL   94 (549)
                      ++||||+.+ +|
T Consensus       129 ~lV~E~~~gg~L  140 (396)
T 4dc2_A          129 FFVIEYVNGGDL  140 (396)
T ss_dssp             EEEEECCTTCBH
T ss_pred             EEEEEcCCCCcH
Confidence            999999854 44

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.22  E-value=7.3e-12  Score=128.84  Aligned_cols=90  Identities=30%  Similarity=0.455  Sum_probs=76.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc------
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET------   79 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~------   79 (549)
                      ...++|++++.||+|+||.||+|+++.+|+.||||++............+.+|+++++.++||||+++++++.+      
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            45689999999999999999999999999999999997665444444577899999999999999999999876      


Q ss_pred             --ccceehhhhhhhcccc
Q psy18060         80 --LNEFVLITEFAHMSLS   95 (549)
Q Consensus        80 --~~~~~lv~ey~~~sLs   95 (549)
                        .+.+++||||+.++|.
T Consensus        94 ~~~~~~~lv~e~~~~~l~  111 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEHDLA  111 (351)
T ss_dssp             ---CEEEEEEECCSEEHH
T ss_pred             cCCceEEEEEeccCCCHH
Confidence              3468999999976553

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.22  E-value=1e-11  Score=124.62  Aligned_cols=90  Identities=26%  Similarity=0.356  Sum_probs=71.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh------------------------hhhhhHHHHHHH
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG------------------------KELSSLKQECEI   61 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~------------------------~~~~~~~~Ei~i   61 (549)
                      ..+++|++.+.||+|+||.||+|+++.+|+.||||++.+.....                        ...+.+.+|+++
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            34689999999999999999999999999999999997654211                        123568899999


Q ss_pred             HHhcCCCCcccccccccc--ccceehhhhhhh-cccc
Q psy18060         62 QKHLAHPNIIKFIASHET--LNEFVLITEFAH-MSLS   95 (549)
Q Consensus        62 l~~l~HpnIV~l~~~~~~--~~~~~lv~ey~~-~sLs   95 (549)
                      |+.++||||+++++++.+  ...+++||||+. ++|.
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~  126 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM  126 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSC
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHH
Confidence            999999999999999876  567899999985 3443

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.22  E-value=1.2e-11  Score=128.40  Aligned_cols=86  Identities=27%  Similarity=0.348  Sum_probs=75.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++++.||+|+||.||+|+++.+|+.||||++.+....   .+.+.+|+.+++.++|||||++++++.+...+++|
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            357899999999999999999999999999999999765432   24678999999999999999999999999999999


Q ss_pred             hhhhh-cccc
Q psy18060         87 TEFAH-MSLS   95 (549)
Q Consensus        87 ~ey~~-~sLs   95 (549)
                      |||+. ++|.
T Consensus        95 ~e~~~~~~L~  104 (361)
T 3uc3_A           95 MEYASGGELY  104 (361)
T ss_dssp             EECCCSCBHH
T ss_pred             EEeCCCCCHH
Confidence            99984 4553

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.21  E-value=1.2e-11  Score=124.77  Aligned_cols=89  Identities=21%  Similarity=0.355  Sum_probs=78.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++...  .....+.+.+|+++++.++||||+++++++.+....++
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence            3567999999999999999999999999999999998543  34455788999999999999999999999999999999


Q ss_pred             hhhhhhc-cccc
Q psy18060         86 ITEFAHM-SLSK   96 (549)
Q Consensus        86 v~ey~~~-sLsk   96 (549)
                      ||||+.+ +|..
T Consensus        85 v~e~~~~~~L~~   96 (310)
T 3s95_A           85 ITEYIKGGTLRG   96 (310)
T ss_dssp             EEECCTTCBHHH
T ss_pred             EEEecCCCcHHH
Confidence            9999854 6544

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.21  E-value=1.8e-11  Score=126.15  Aligned_cols=90  Identities=26%  Similarity=0.378  Sum_probs=78.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc-----
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE-----   82 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~-----   82 (549)
                      .++|.+.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            468999999999999999999999999999999997765555556778999999999999999999999877654     


Q ss_pred             -eehhhhhhhcccccC
Q psy18060         83 -FVLITEFAHMSLSKL   97 (549)
Q Consensus        83 -~~lv~ey~~~sLskl   97 (549)
                       ++++|+|+.++|...
T Consensus       103 ~~~lv~e~~~~~l~~~  118 (353)
T 3coi_A          103 DFYLVMPFMQTDLQKI  118 (353)
T ss_dssp             CCEEEEECCSEEGGGT
T ss_pred             eEEEEeccccCCHHHH
Confidence             489999998877654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.21  E-value=1.1e-11  Score=128.11  Aligned_cols=88  Identities=27%  Similarity=0.406  Sum_probs=77.1

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC-hhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +.|+.++.||+|+||.||+|++..+|+.||||++...... ....+.+.+|++++++++|||||++++++.+....++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4599999999999999999999999999999999765433 334467899999999999999999999999999999999


Q ss_pred             hhhhccccc
Q psy18060         88 EFAHMSLSK   96 (549)
Q Consensus        88 ey~~~sLsk   96 (549)
                      ||+.+++..
T Consensus       134 e~~~g~l~~  142 (348)
T 1u5q_A          134 EYCLGSASD  142 (348)
T ss_dssp             ECCSEEHHH
T ss_pred             ecCCCCHHH
Confidence            999776543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.21  E-value=9.2e-12  Score=123.30  Aligned_cols=90  Identities=19%  Similarity=0.309  Sum_probs=78.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccccccceehh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      .++|++++.||+|+||.||+|.++.+|+.||||++............+.+|+.++..+ +||||+++++++.+....+++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            4679999999999999999999999999999999987655444556788999999999 899999999999999999999


Q ss_pred             hhhhhc-ccccC
Q psy18060         87 TEFAHM-SLSKL   97 (549)
Q Consensus        87 ~ey~~~-sLskl   97 (549)
                      |||+.+ +|..+
T Consensus        90 ~e~~~~~~L~~~  101 (289)
T 1x8b_A           90 NEYCNGGSLADA  101 (289)
T ss_dssp             EECCTTCBHHHH
T ss_pred             EEecCCCcHHHH
Confidence            999854 76543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.21  E-value=5.4e-12  Score=133.65  Aligned_cols=91  Identities=19%  Similarity=0.224  Sum_probs=78.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ...++|+++++||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.++..++||||++++++|++.+.+|
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            456789999999999999999999999999999999976432 2234456889999999999999999999999999999


Q ss_pred             hhhhhh-hccccc
Q psy18060         85 LITEFA-HMSLSK   96 (549)
Q Consensus        85 lv~ey~-~~sLsk   96 (549)
                      +||||+ .++|..
T Consensus       138 lVmE~~~gg~L~~  150 (412)
T 2vd5_A          138 LVMEYYVGGDLLT  150 (412)
T ss_dssp             EEECCCCSCBHHH
T ss_pred             EEEcCCCCCcHHH
Confidence            999998 445543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.21  E-value=7.2e-12  Score=129.84  Aligned_cols=89  Identities=22%  Similarity=0.373  Sum_probs=74.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhc-CCCCccccccccccccce
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF   83 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~   83 (549)
                      ..+++|+++++||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+++.+ +||||+++++++.+...+
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            456899999999999999999999999999999999976432 223446688999999988 699999999999999999


Q ss_pred             ehhhhhhhc-cc
Q psy18060         84 VLITEFAHM-SL   94 (549)
Q Consensus        84 ~lv~ey~~~-sL   94 (549)
                      |+||||+.+ +|
T Consensus       100 ~lv~E~~~gg~L  111 (353)
T 3txo_A          100 FFVMEFVNGGDL  111 (353)
T ss_dssp             EEEEECCCSCBH
T ss_pred             EEEEeCCCCCcH
Confidence            999999853 44

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.20  E-value=1.8e-11  Score=124.82  Aligned_cols=86  Identities=30%  Similarity=0.426  Sum_probs=75.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|.+....   .....+.+|+.+++.++||||+++++++.+...++++
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            3578999999999999999999999999999999996432   3345688999999999999999999999999999999


Q ss_pred             hhhhhc-ccc
Q psy18060         87 TEFAHM-SLS   95 (549)
Q Consensus        87 ~ey~~~-sLs   95 (549)
                      |||+.+ +|.
T Consensus        80 ~e~~~g~~L~   89 (321)
T 1tki_A           80 FEFISGLDIF   89 (321)
T ss_dssp             ECCCCCCBHH
T ss_pred             EEeCCCCCHH
Confidence            999854 553

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.20  E-value=3.9e-12  Score=129.72  Aligned_cols=88  Identities=26%  Similarity=0.364  Sum_probs=73.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +++|++++.||+|+||.||+|+++.+|+.||||++...... .....+.+|+++++.++||||+++++++.+...+++||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            47899999999999999999999999999999999754322 22234567999999999999999999999999999999


Q ss_pred             hhhhccccc
Q psy18060         88 EFAHMSLSK   96 (549)
Q Consensus        88 ey~~~sLsk   96 (549)
                      ||+.++|..
T Consensus        80 e~~~~~l~~   88 (324)
T 3mtl_A           80 EYLDKDLKQ   88 (324)
T ss_dssp             ECCSEEHHH
T ss_pred             cccccCHHH
Confidence            999876644

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.20  E-value=7.2e-12  Score=129.69  Aligned_cols=90  Identities=22%  Similarity=0.376  Sum_probs=77.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ..+++|++++.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+++|+.++||||+++++++.+...+|
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            567899999999999999999999999999999999976432 1223467889999999999999999999999999999


Q ss_pred             hhhhhhh-cccc
Q psy18060         85 LITEFAH-MSLS   95 (549)
Q Consensus        85 lv~ey~~-~sLs   95 (549)
                      +||||+. ++|.
T Consensus       118 lv~e~~~gg~L~  129 (350)
T 1rdq_E          118 MVMEYVAGGEMF  129 (350)
T ss_dssp             EEEECCTTCBHH
T ss_pred             EEEcCCCCCcHH
Confidence            9999984 4553

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.20  E-value=1.5e-11  Score=125.68  Aligned_cols=89  Identities=25%  Similarity=0.294  Sum_probs=76.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh----hhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      .+.|++.+.||+|+||.||+|+++.+|+.||||++.+.....    ...+.+.+|+.+|+.++||||+++++++.+...+
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            457999999999999999999999999999999998754321    1346788999999999999999999999999999


Q ss_pred             ehhhhhhh-ccccc
Q psy18060         84 VLITEFAH-MSLSK   96 (549)
Q Consensus        84 ~lv~ey~~-~sLsk   96 (549)
                      ++||||+. ++|..
T Consensus        90 ~lv~e~~~~~~L~~  103 (326)
T 2y0a_A           90 ILILELVAGGELFD  103 (326)
T ss_dssp             EEEEECCCSCBHHH
T ss_pred             EEEEEcCCCCCHHH
Confidence            99999984 46543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.20  E-value=8.7e-12  Score=134.87  Aligned_cols=86  Identities=31%  Similarity=0.428  Sum_probs=71.0

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE   88 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~e   88 (549)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+..........+.+|+.+++.++|||||++++++.+...+++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46999999999999999999999999999999998765444445678899999999999999999999999999999999


Q ss_pred             hhhc-cc
Q psy18060         89 FAHM-SL   94 (549)
Q Consensus        89 y~~~-sL   94 (549)
                      |+.+ +|
T Consensus       117 ~~~~g~L  123 (494)
T 3lij_A          117 CYKGGEL  123 (494)
T ss_dssp             CCCSCBH
T ss_pred             cCCCCcH
Confidence            9853 44

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.20  E-value=2e-11  Score=127.06  Aligned_cols=90  Identities=24%  Similarity=0.360  Sum_probs=78.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccce----
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF----   83 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~----   83 (549)
                      .++|++.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4689999999999999999999999999999999987655555567889999999999999999999999876654    


Q ss_pred             --ehhhhhhhcccccC
Q psy18060         84 --VLITEFAHMSLSKL   97 (549)
Q Consensus        84 --~lv~ey~~~sLskl   97 (549)
                        +++|+|+.++|...
T Consensus       121 ~~~lv~e~~~~~l~~~  136 (371)
T 4exu_A          121 DFYLVMPFMQTDLQKI  136 (371)
T ss_dssp             CCEEEEECCCEEHHHH
T ss_pred             eEEEEEccccccHHHH
Confidence              89999988776543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.20  E-value=1.4e-11  Score=122.59  Aligned_cols=91  Identities=20%  Similarity=0.210  Sum_probs=74.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++++.||+|+||.||+|++..+|+.||||++..........+.+.++..+++.++||||+++++++.+....++
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            45679999999999999999999999999999999997654333333445555566788999999999999999999999


Q ss_pred             hhhhhhccccc
Q psy18060         86 ITEFAHMSLSK   96 (549)
Q Consensus        86 v~ey~~~sLsk   96 (549)
                      +|||+.++|..
T Consensus        84 v~e~~~~~l~~   94 (290)
T 3fme_A           84 CMELMDTSLDK   94 (290)
T ss_dssp             EEECCSEEHHH
T ss_pred             EEehhccchHH
Confidence            99999877643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.19  E-value=6.6e-12  Score=135.50  Aligned_cols=85  Identities=33%  Similarity=0.591  Sum_probs=75.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .++|++++.||+|+||.||+|+++.+|+.||||++.+..........+.+|+++|++++|||||++++++.+...+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            46799999999999999999999999999999999764432334567889999999999999999999999999999999


Q ss_pred             hhhhc
Q psy18060         88 EFAHM   92 (549)
Q Consensus        88 ey~~~   92 (549)
                      +|+.+
T Consensus       101 e~~~~  105 (486)
T 3mwu_A          101 ELYTG  105 (486)
T ss_dssp             CCCCS
T ss_pred             EcCCC
Confidence            99853

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.19  E-value=6.8e-12  Score=133.92  Aligned_cols=91  Identities=20%  Similarity=0.251  Sum_probs=77.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ...++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.++..++|||||+++++|.+...+|
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            456789999999999999999999999999999999976432 1123345889999999999999999999999999999


Q ss_pred             hhhhhh-hccccc
Q psy18060         85 LITEFA-HMSLSK   96 (549)
Q Consensus        85 lv~ey~-~~sLsk   96 (549)
                      +||||+ .++|..
T Consensus       151 lV~Ey~~gg~L~~  163 (437)
T 4aw2_A          151 LVMDYYVGGDLLT  163 (437)
T ss_dssp             EEECCCTTCBHHH
T ss_pred             EEEecCCCCcHHH
Confidence            999998 456543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.19  E-value=8.6e-12  Score=126.18  Aligned_cols=92  Identities=18%  Similarity=0.290  Sum_probs=77.0

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      ..-.++|++.+.||+|+||.||+|+++.+|+.||||++..... .......+.+|++++++++||||+++++++......
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            3456789999999999999999999999999999999976543 334456789999999999999999999998766544


Q ss_pred             ----ehhhhhhh-ccccc
Q psy18060         84 ----VLITEFAH-MSLSK   96 (549)
Q Consensus        84 ----~lv~ey~~-~sLsk   96 (549)
                          ++||||+. ++|..
T Consensus        88 ~~~~~lv~e~~~g~~L~~  105 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRD  105 (311)
T ss_dssp             EEEEEEEEECCCEEEHHH
T ss_pred             CcccEEEEecCCCCCHHH
Confidence                99999984 56644

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.19  E-value=1.8e-11  Score=132.65  Aligned_cols=88  Identities=33%  Similarity=0.431  Sum_probs=72.9

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh-----------hhhhhHHHHHHHHHhcCCCCcccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-----------KELSSLKQECEIQKHLAHPNIIKFIA   75 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIV~l~~   75 (549)
                      ..++|++++.||+|+||.||+|+++.+++.||||++.+.....           ...+.+.+|+.+|++++|||||++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999999999999999997654221           23467889999999999999999999


Q ss_pred             ccccccceehhhhhhhc-cc
Q psy18060         76 SHETLNEFVLITEFAHM-SL   94 (549)
Q Consensus        76 ~~~~~~~~~lv~ey~~~-sL   94 (549)
                      ++.+...+++||||+.+ +|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L  133 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGEL  133 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBH
T ss_pred             EEEcCCEEEEEEecCCCCcH
Confidence            99999999999999854 54

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.18  E-value=9.1e-12  Score=122.42  Aligned_cols=91  Identities=16%  Similarity=0.314  Sum_probs=78.5

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc--cc
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--NE   82 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~   82 (549)
                      ....++|++.+.||+|+||.||+|++.  |+.||||++..........+.+.+|+.++++++||||+++++++.+.  ..
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence            356789999999999999999999985  78999999987665666667899999999999999999999999876  77


Q ss_pred             eehhhhhhh-cccccC
Q psy18060         83 FVLITEFAH-MSLSKL   97 (549)
Q Consensus        83 ~~lv~ey~~-~sLskl   97 (549)
                      .+++|||+. ++|..+
T Consensus        84 ~~lv~e~~~~~~L~~~   99 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNV   99 (271)
T ss_dssp             CEEEEECCTTCBHHHH
T ss_pred             eEeeecccCCCcHHHH
Confidence            899999986 466543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.18  E-value=9.2e-12  Score=128.69  Aligned_cols=91  Identities=21%  Similarity=0.325  Sum_probs=75.4

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhc-CCCCccccccccccccc
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNE   82 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~   82 (549)
                      ...+++|++.++||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.++..+ +||||+++++++++...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            3467899999999999999999999999999999999976431 122345678899999877 89999999999999999


Q ss_pred             eehhhhhhh-cccc
Q psy18060         83 FVLITEFAH-MSLS   95 (549)
Q Consensus        83 ~~lv~ey~~-~sLs   95 (549)
                      +|+||||+. ++|.
T Consensus        93 ~~lv~E~~~gg~L~  106 (345)
T 1xjd_A           93 LFFVMEYLNGGDLM  106 (345)
T ss_dssp             EEEEEECCTTCBHH
T ss_pred             EEEEEeCCCCCcHH
Confidence            999999985 4553

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.17  E-value=2.2e-11  Score=124.35  Aligned_cols=90  Identities=21%  Similarity=0.271  Sum_probs=76.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCc---eEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      ..++|++.+.||+|+||.||+|.++.+|+   .||||++.... .....+.+.+|+++++.++||||+++++++.+....
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            35679999999999999999999987665   49999997543 344556789999999999999999999999999999


Q ss_pred             ehhhhhhhc-ccccC
Q psy18060         84 VLITEFAHM-SLSKL   97 (549)
Q Consensus        84 ~lv~ey~~~-sLskl   97 (549)
                      ++||||+.+ +|..+
T Consensus       126 ~lv~e~~~~~~L~~~  140 (325)
T 3kul_A          126 MIVTEYMENGSLDTF  140 (325)
T ss_dssp             EEEEECCTTCBHHHH
T ss_pred             EEEeeCCCCCcHHHH
Confidence            999999854 66543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.17  E-value=2.5e-11  Score=122.95  Aligned_cols=88  Identities=24%  Similarity=0.328  Sum_probs=74.5

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..............+|+..+..+ +||||+++++++.+...+++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            569999999999999999999999999999999876655544455566677666655 8999999999999999999999


Q ss_pred             hhhhccccc
Q psy18060         88 EFAHMSLSK   96 (549)
Q Consensus        88 ey~~~sLsk   96 (549)
                      ||+.++|..
T Consensus       137 e~~~~~L~~  145 (311)
T 3p1a_A          137 ELCGPSLQQ  145 (311)
T ss_dssp             ECCCCBHHH
T ss_pred             eccCCCHHH
Confidence            999776643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.17  E-value=2.4e-11  Score=124.19  Aligned_cols=89  Identities=27%  Similarity=0.437  Sum_probs=69.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEEC---CCCceEEEEEeccCCC--ChhhhhhHHHHHHHHHhcCCCCccccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGR--SGKELSSLKQECEIQKHLAHPNIIKFIASHETL   80 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~---~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~   80 (549)
                      ...++|++++.||+|+||.||+|++.   .+|+.||||++.+...  .......+.+|+.+|+.++||||+++++++.+.
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            34678999999999999999999985   6899999999986542  223345678999999999999999999999999


Q ss_pred             cceehhhhhhh-ccc
Q psy18060         81 NEFVLITEFAH-MSL   94 (549)
Q Consensus        81 ~~~~lv~ey~~-~sL   94 (549)
                      ..+++||||+. ++|
T Consensus        94 ~~~~lv~e~~~~~~L  108 (327)
T 3a62_A           94 GKLYLILEYLSGGEL  108 (327)
T ss_dssp             SCEEEEEECCTTEEH
T ss_pred             CEEEEEEeCCCCCcH
Confidence            99999999985 454

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.17  E-value=1.9e-11  Score=124.20  Aligned_cols=90  Identities=23%  Similarity=0.243  Sum_probs=77.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh----hhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      ..++|++.+.||+|+||.||+|+++.+|+.||||++.+.....    ...+.+.+|+.++++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3457999999999999999999999999999999997754321    134678899999999999999999999999999


Q ss_pred             eehhhhhhh-ccccc
Q psy18060         83 FVLITEFAH-MSLSK   96 (549)
Q Consensus        83 ~~lv~ey~~-~sLsk   96 (549)
                      .+++|||+. ++|..
T Consensus        90 ~~lv~e~~~~~~L~~  104 (321)
T 2a2a_A           90 VVLILELVSGGELFD  104 (321)
T ss_dssp             EEEEECCCCSCBHHH
T ss_pred             EEEEEEcCCCCcHHH
Confidence            999999984 45543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.16  E-value=1.3e-11  Score=126.29  Aligned_cols=89  Identities=31%  Similarity=0.442  Sum_probs=76.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCC---CChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG---RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.+..   ......+.+.+|+++++.++||||+++++++.+....+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            357999999999999999999999999999999997542   12345577899999999999999999999999999999


Q ss_pred             hhhhhhh-ccccc
Q psy18060         85 LITEFAH-MSLSK   96 (549)
Q Consensus        85 lv~ey~~-~sLsk   96 (549)
                      +||||+. ++|..
T Consensus       105 lv~e~~~gg~L~~  117 (345)
T 3hko_A          105 LVMELCHGGHLLD  117 (345)
T ss_dssp             EEEECCCSCBHHH
T ss_pred             EEEeCCCCCcHHH
Confidence            9999984 45543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.16  E-value=2.7e-11  Score=122.14  Aligned_cols=91  Identities=32%  Similarity=0.427  Sum_probs=77.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCC-CChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ....+|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++.+.+....+
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            35678999999999999999999999999999999997644 23445677899999999999999999999999999999


Q ss_pred             hhhhhhhc-cccc
Q psy18060         85 LITEFAHM-SLSK   96 (549)
Q Consensus        85 lv~ey~~~-sLsk   96 (549)
                      ++|+|+.+ +|..
T Consensus       109 lv~e~~~~~~L~~  121 (310)
T 2wqm_A          109 IVLELADAGDLSR  121 (310)
T ss_dssp             EEEECCCSCBHHH
T ss_pred             EEEecCCCCCHHH
Confidence            99999864 6544

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.16  E-value=2.6e-11  Score=126.47  Aligned_cols=88  Identities=24%  Similarity=0.303  Sum_probs=76.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++.+.||+|+||.||+|+++.+|+.||||++... ......+.+.+|+++|++++|||||++++++.+...+++|
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            456899999999999999999999999999999999643 3344456788999999999999999999999999999999


Q ss_pred             hhhhh-cccc
Q psy18060         87 TEFAH-MSLS   95 (549)
Q Consensus        87 ~ey~~-~sLs   95 (549)
                      |||+. ++|.
T Consensus       191 ~e~~~~g~L~  200 (377)
T 3cbl_A          191 MELVQGGDFL  200 (377)
T ss_dssp             EECCTTCBHH
T ss_pred             EEcCCCCCHH
Confidence            99985 4554

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.16  E-value=2.3e-11  Score=120.74  Aligned_cols=88  Identities=28%  Similarity=0.349  Sum_probs=76.1

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh----hhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+.....    ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57999999999999999999999999999999997654321    13467889999999999999999999999999999


Q ss_pred             hhhhhhh-ccccc
Q psy18060         85 LITEFAH-MSLSK   96 (549)
Q Consensus        85 lv~ey~~-~sLsk   96 (549)
                      ++|||+. ++|..
T Consensus        85 lv~e~~~~~~L~~   97 (283)
T 3bhy_A           85 LILELVSGGELFD   97 (283)
T ss_dssp             EEEECCCSCBHHH
T ss_pred             EEEeecCCCcHHH
Confidence            9999984 55543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.16  E-value=2.1e-11  Score=125.45  Aligned_cols=91  Identities=27%  Similarity=0.453  Sum_probs=70.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh---hhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG---KELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      ...++|++++.||+|+||.||+|+++.+|+.||||++.......   ...+.+.+|+++++.++||||+++++++.+...
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            45678999999999999999999999999999999997643221   123568899999999999999999999999999


Q ss_pred             eehhhhhhhccccc
Q psy18060         83 FVLITEFAHMSLSK   96 (549)
Q Consensus        83 ~~lv~ey~~~sLsk   96 (549)
                      .++||||+.++|..
T Consensus        87 ~~lv~e~~~~~l~~  100 (346)
T 1ua2_A           87 ISLVFDFMETDLEV  100 (346)
T ss_dssp             CEEEEECCSEEHHH
T ss_pred             eEEEEEcCCCCHHH
Confidence            99999999876643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.16  E-value=2.4e-11  Score=121.29  Aligned_cols=84  Identities=33%  Similarity=0.612  Sum_probs=75.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .++|++++.||+|+||.||+|+++.+|+.||||++.+........+.+.+|++++++++||||+++++++.+....++++
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            45799999999999999999999999999999999765544445577899999999999999999999999999999999


Q ss_pred             hhhh
Q psy18060         88 EFAH   91 (549)
Q Consensus        88 ey~~   91 (549)
                      +++.
T Consensus       101 e~~~  104 (287)
T 2wei_A          101 ELYT  104 (287)
T ss_dssp             CCCC
T ss_pred             EccC
Confidence            9874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.15  E-value=2.3e-11  Score=131.00  Aligned_cols=84  Identities=31%  Similarity=0.446  Sum_probs=74.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC-hhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++.+.... ....+.+.+|+.++++++|||||++++++.+...+++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            35799999999999999999999999999999999776532 23456789999999999999999999999999999999


Q ss_pred             hhhhh
Q psy18060         87 TEFAH   91 (549)
Q Consensus        87 ~ey~~   91 (549)
                      |+|+.
T Consensus       105 ~e~~~  109 (484)
T 3nyv_A          105 GEVYT  109 (484)
T ss_dssp             ECCCC
T ss_pred             EecCC
Confidence            99874

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.15  E-value=3.1e-11  Score=122.39  Aligned_cols=90  Identities=27%  Similarity=0.340  Sum_probs=74.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc--ce
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN--EF   83 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~   83 (549)
                      ..-++|++.+.||+|+||.||+|+++.+|+.||||++..... ....+.+.+|+++++.++||||+++++++....  ..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            345689999999999999999999999999999999975432 122456789999999999999999999886654  78


Q ss_pred             ehhhhhhh-ccccc
Q psy18060         84 VLITEFAH-MSLSK   96 (549)
Q Consensus        84 ~lv~ey~~-~sLsk   96 (549)
                      ++||||+. ++|..
T Consensus        85 ~lv~e~~~~~~L~~   98 (319)
T 4euu_A           85 VLIMEFCPCGSLYT   98 (319)
T ss_dssp             EEEEECCTTCBHHH
T ss_pred             EEEEeCCCCCCHHH
Confidence            99999985 56644

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.15  E-value=2e-11  Score=121.15  Aligned_cols=88  Identities=33%  Similarity=0.456  Sum_probs=76.4

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh-hhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          4 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         4 ~~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      .+-.+++|++.+.||+|+||.||+|.+..+++.||||++.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            3567889999999999999999999999999999999996543211 223568899999999999999999999999999


Q ss_pred             eehhhhhhh
Q psy18060         83 FVLITEFAH   91 (549)
Q Consensus        83 ~~lv~ey~~   91 (549)
                      .+++|+|+.
T Consensus        84 ~~lv~e~~~   92 (279)
T 3fdn_A           84 VYLILEYAP   92 (279)
T ss_dssp             EEEEECCCT
T ss_pred             EEEEEecCC
Confidence            999999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.15  E-value=2.8e-11  Score=120.79  Aligned_cols=87  Identities=24%  Similarity=0.324  Sum_probs=75.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.+... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            3579999999999999999999999999999999976542 223467889999999999999999999999999999999


Q ss_pred             hhhhc-ccc
Q psy18060         88 EFAHM-SLS   95 (549)
Q Consensus        88 ey~~~-sLs   95 (549)
                      ||+.+ +|.
T Consensus       100 e~~~~~~L~  108 (285)
T 3is5_A          100 ETCEGGELL  108 (285)
T ss_dssp             CCCSCCBHH
T ss_pred             EeCCCCcHH
Confidence            99854 543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.14  E-value=2.5e-11  Score=120.76  Aligned_cols=90  Identities=22%  Similarity=0.386  Sum_probs=78.3

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          4 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         4 ~~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      .....++|++.+.||+|+||.||+|.++.+++.||||++....   ...+.+.+|+++++.++||||+++++++.+...+
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            3456678999999999999999999999999999999996532   2346788999999999999999999999999999


Q ss_pred             ehhhhhhh-ccccc
Q psy18060         84 VLITEFAH-MSLSK   96 (549)
Q Consensus        84 ~lv~ey~~-~sLsk   96 (549)
                      ++||||+. ++|..
T Consensus        85 ~~v~e~~~~~~L~~   98 (288)
T 3kfa_A           85 YIITEFMTYGNLLD   98 (288)
T ss_dssp             EEEEECCTTEEHHH
T ss_pred             EEEEEcCCCCcHHH
Confidence            99999986 56644

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.14  E-value=2.7e-11  Score=125.97  Aligned_cols=89  Identities=20%  Similarity=0.250  Sum_probs=73.6

Q ss_pred             ccCeeeeeeecccCceEEEEEE-----ECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAI-----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      .++|++++.||+|+||.||+|+     +..+++.||||+++... .......+.+|+.++++++|||||++++++.+...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            4679999999999999999999     44577899999996433 33444678899999999999999999999999999


Q ss_pred             eehhhhhhh-cccccC
Q psy18060         83 FVLITEFAH-MSLSKL   97 (549)
Q Consensus        83 ~~lv~ey~~-~sLskl   97 (549)
                      .++||||+. ++|..+
T Consensus       149 ~~lv~e~~~~g~L~~~  164 (367)
T 3l9p_A          149 RFILLELMAGGDLKSF  164 (367)
T ss_dssp             CEEEEECCTTEEHHHH
T ss_pred             CEEEEEeCCCCCHHHH
Confidence            999999984 466543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.14  E-value=4.7e-11  Score=119.42  Aligned_cols=89  Identities=26%  Similarity=0.375  Sum_probs=77.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ....+|++.+.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            345689999999999999999999999999999999976543 3345567889999999999999999999999999999


Q ss_pred             hhhhhhh-ccc
Q psy18060         85 LITEFAH-MSL   94 (549)
Q Consensus        85 lv~ey~~-~sL   94 (549)
                      ++|||+. ++|
T Consensus        92 lv~e~~~~~~L  102 (294)
T 2rku_A           92 VVLELCRRRSL  102 (294)
T ss_dssp             EEEECCTTCBH
T ss_pred             EEEecCCCCCH
Confidence            9999986 344

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.14  E-value=2.7e-11  Score=125.05  Aligned_cols=89  Identities=22%  Similarity=0.265  Sum_probs=78.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            3568999999999999999999999999999999997653 344456789999999999999999999999999999999


Q ss_pred             hhhhhc-cccc
Q psy18060         87 TEFAHM-SLSK   96 (549)
Q Consensus        87 ~ey~~~-sLsk   96 (549)
                      |||+.+ +|..
T Consensus       110 ~e~~~~~~L~~  120 (360)
T 3eqc_A          110 MEHMDGGSLDQ  120 (360)
T ss_dssp             ECCCTTCBHHH
T ss_pred             EECCCCCCHHH
Confidence            999954 6654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.14  E-value=3.1e-11  Score=121.61  Aligned_cols=89  Identities=27%  Similarity=0.406  Sum_probs=70.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccc---------
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASH---------   77 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~---------   77 (549)
                      -.++|++++.||+|+||.||+|.+..+|+.||||++...  +....+.+.+|++++++++||||+++++++         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            346899999999999999999999999999999999754  334456788999999999999999998876         


Q ss_pred             -----ccccceehhhhhhhcccccC
Q psy18060         78 -----ETLNEFVLITEFAHMSLSKL   97 (549)
Q Consensus        78 -----~~~~~~~lv~ey~~~sLskl   97 (549)
                           .+....+++|||+.++|..+
T Consensus        87 ~~~~~~~~~~~~lv~e~~~~~L~~~  111 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYMETDLANV  111 (320)
T ss_dssp             ----CCSCSEEEEEEECCSEEHHHH
T ss_pred             ccccccccCceeEEeeccCCCHHHH
Confidence                 34467889999988776543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.14  E-value=3.7e-11  Score=118.63  Aligned_cols=91  Identities=26%  Similarity=0.353  Sum_probs=77.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      +-.++|++++.||+|+||.||+|.++.+|+.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            3457899999999999999999999999999999999754322 234678899999999999999999999999999999


Q ss_pred             hhhhhhc-ccccC
Q psy18060         86 ITEFAHM-SLSKL   97 (549)
Q Consensus        86 v~ey~~~-sLskl   97 (549)
                      +|||+.+ +|...
T Consensus        83 v~e~~~~~~L~~~   95 (276)
T 2yex_A           83 FLEYCSGGELFDR   95 (276)
T ss_dssp             EEECCTTEEGGGG
T ss_pred             EEEecCCCcHHHH
Confidence            9999853 66443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.14  E-value=1.6e-11  Score=132.39  Aligned_cols=91  Identities=24%  Similarity=0.310  Sum_probs=78.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC-hhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ....+|++.+.||+|+||.||+|++..+|+.||||++.+.... ......+.+|+.+|+.++||||+++++++.+...++
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3567899999999999999999999999999999999764321 123457889999999999999999999999999999


Q ss_pred             hhhhhh-hccccc
Q psy18060         85 LITEFA-HMSLSK   96 (549)
Q Consensus        85 lv~ey~-~~sLsk   96 (549)
                      +||||+ .++|..
T Consensus        93 lv~E~~~gg~L~~  105 (476)
T 2y94_A           93 MVMEYVSGGELFD  105 (476)
T ss_dssp             EEEECCSSEEHHH
T ss_pred             EEEeCCCCCcHHH
Confidence            999998 456644

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.14  E-value=5.5e-11  Score=124.80  Aligned_cols=88  Identities=26%  Similarity=0.397  Sum_probs=76.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++....  ......+.+|+++|+.++|||||++++++.+...+++|
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            4568999999999999999999999999999999997543  23345788999999999999999999999999999999


Q ss_pred             hhhhh-ccccc
Q psy18060         87 TEFAH-MSLSK   96 (549)
Q Consensus        87 ~ey~~-~sLsk   96 (549)
                      |||+. ++|..
T Consensus       127 ~E~~~gg~L~~  137 (387)
T 1kob_A          127 LEFLSGGELFD  137 (387)
T ss_dssp             EECCCCCBHHH
T ss_pred             EEcCCCCcHHH
Confidence            99985 45543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.14  E-value=3.8e-11  Score=125.31  Aligned_cols=68  Identities=34%  Similarity=0.424  Sum_probs=56.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET   79 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~   79 (549)
                      ...++|++++.||+|+||.||+|++..+|+.||||++.....      ...+|+++|+.++|||||+++++|..
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~   71 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYT   71 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeee
Confidence            456789999999999999999999999999999999965432      22379999999999999999998843

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.13  E-value=2.4e-11  Score=120.39  Aligned_cols=91  Identities=26%  Similarity=0.437  Sum_probs=77.3

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC-hhhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      ...+++|++.+.||+|+||.||+|++..+|+.||||++.+.... ....+.+.+|+++++.++||||+++++++.+....
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            35678999999999999999999999999999999999754321 12246788999999999999999999999999999


Q ss_pred             ehhhhhhh-cccc
Q psy18060         84 VLITEFAH-MSLS   95 (549)
Q Consensus        84 ~lv~ey~~-~sLs   95 (549)
                      +++|||+. ++|.
T Consensus        87 ~lv~e~~~~~~L~   99 (278)
T 3cok_A           87 YLVLEMCHNGEMN   99 (278)
T ss_dssp             EEEEECCTTEEHH
T ss_pred             EEEEecCCCCcHH
Confidence            99999985 3553

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.13  E-value=3.5e-11  Score=120.42  Aligned_cols=89  Identities=27%  Similarity=0.353  Sum_probs=73.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEE----ECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc-
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-   80 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-   80 (549)
                      -..++|++++.||+|+||.||+|+    +..+|+.||||++...  .....+.+.+|+++++.++||||+++++++... 
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            345789999999999999999999    5678999999999653  344456789999999999999999999988553 


Q ss_pred             -cceehhhhhhh-ccccc
Q psy18060         81 -NEFVLITEFAH-MSLSK   96 (549)
Q Consensus        81 -~~~~lv~ey~~-~sLsk   96 (549)
                       ..+++||||+. ++|..
T Consensus        85 ~~~~~lv~e~~~~~~L~~  102 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRD  102 (295)
T ss_dssp             HTSCEEEEECCTTCBHHH
T ss_pred             CCceEEEEEeCCCCCHHH
Confidence             45899999984 46654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.13  E-value=5.6e-11  Score=121.64  Aligned_cols=88  Identities=26%  Similarity=0.383  Sum_probs=77.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            45679999999999999999999999999999999976543 33455678999999999999999999999999999999


Q ss_pred             hhhhhh-ccc
Q psy18060         86 ITEFAH-MSL   94 (549)
Q Consensus        86 v~ey~~-~sL   94 (549)
                      +|||+. ++|
T Consensus       119 v~e~~~~~~L  128 (335)
T 2owb_A          119 VLELCRRRSL  128 (335)
T ss_dssp             EECCCTTCBH
T ss_pred             EEecCCCCCH
Confidence            999986 344

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.13  E-value=2.4e-11  Score=133.74  Aligned_cols=90  Identities=18%  Similarity=0.214  Sum_probs=77.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ...++|+++++||+|+||.||+|+++.+|+.||||++.+... .......+.+|+++|+.++|||||++++++.+...++
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            456789999999999999999999999999999999976432 1123356789999999999999999999999999999


Q ss_pred             hhhhhhh-cccc
Q psy18060         85 LITEFAH-MSLS   95 (549)
Q Consensus        85 lv~ey~~-~sLs   95 (549)
                      +||||+. ++|.
T Consensus       261 lVmEy~~gg~L~  272 (576)
T 2acx_A          261 LVLTLMNGGDLK  272 (576)
T ss_dssp             EEECCCCSCBHH
T ss_pred             EEEEcCCCCcHH
Confidence            9999984 4553

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.13  E-value=1.7e-11  Score=128.06  Aligned_cols=89  Identities=25%  Similarity=0.394  Sum_probs=67.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHH-HHhcCCCCccccccccccccce
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEI-QKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~i-l~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      ...++|+++++||+|+||+||+|+++.+++.||||++.+... .......+.+|..+ ++.++|||||++++++.+...+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence            456789999999999999999999999999999999987653 22334567778776 4678999999999999999999


Q ss_pred             ehhhhhhhc-cc
Q psy18060         84 VLITEFAHM-SL   94 (549)
Q Consensus        84 ~lv~ey~~~-sL   94 (549)
                      |+||||+.+ +|
T Consensus       115 ~lv~E~~~gg~L  126 (373)
T 2r5t_A          115 YFVLDYINGGEL  126 (373)
T ss_dssp             EEEEECCCSCBH
T ss_pred             EEEEeCCCCCcH
Confidence            999999854 44

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.13  E-value=3.6e-11  Score=122.75  Aligned_cols=90  Identities=23%  Similarity=0.426  Sum_probs=76.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEEC-----CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      ..++|++++.||+|+||.||+|++.     .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            4578999999999999999999997     456899999997543 3444567899999999999999999999999999


Q ss_pred             ceehhhhhhhc-ccccC
Q psy18060         82 EFVLITEFAHM-SLSKL   97 (549)
Q Consensus        82 ~~~lv~ey~~~-sLskl   97 (549)
                      .++++|||+.+ +|..+
T Consensus       124 ~~~lv~e~~~~~~L~~~  140 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEF  140 (343)
T ss_dssp             SCEEEEECCTTCBHHHH
T ss_pred             ceEEEEecCCCCcHHHH
Confidence            99999999854 66543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.12  E-value=4.6e-11  Score=119.23  Aligned_cols=88  Identities=31%  Similarity=0.403  Sum_probs=75.7

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc----cccee
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET----LNEFV   84 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----~~~~~   84 (549)
                      ..|++.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.+++.++||||+++++++..    ...++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34889999999999999999999999999999998766666667789999999999999999999998765    45689


Q ss_pred             hhhhhhh-ccccc
Q psy18060         85 LITEFAH-MSLSK   96 (549)
Q Consensus        85 lv~ey~~-~sLsk   96 (549)
                      +||||+. ++|..
T Consensus       106 lv~e~~~~~~L~~  118 (290)
T 1t4h_A          106 LVTELMTSGTLKT  118 (290)
T ss_dssp             EEEECCCSCBHHH
T ss_pred             EEEEecCCCCHHH
Confidence            9999984 36543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.12  E-value=3.8e-11  Score=125.01  Aligned_cols=89  Identities=30%  Similarity=0.430  Sum_probs=75.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEEC-------CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHL-------DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHE   78 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~   78 (549)
                      ..++|++.+.||+|+||.||+|++.       .++..||||++.... .....+.+.+|+.+|+.+ +|||||++++++.
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            3468999999999999999999975       345679999997543 344567899999999999 8999999999999


Q ss_pred             cccceehhhhhhhc-cccc
Q psy18060         79 TLNEFVLITEFAHM-SLSK   96 (549)
Q Consensus        79 ~~~~~~lv~ey~~~-sLsk   96 (549)
                      +...+++||||+.+ +|..
T Consensus       158 ~~~~~~lv~e~~~~g~L~~  176 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLRE  176 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHH
T ss_pred             cCCCEEEEEEcCCCCCHHH
Confidence            99999999999854 6644

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.12  E-value=1.9e-11  Score=125.56  Aligned_cols=85  Identities=29%  Similarity=0.423  Sum_probs=73.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh------hhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG------KELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      .++|++++.||+|+||.||+|+++.+|+.||||++.+.....      .....+.+|+.+++.++||||+++++++.+..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            457999999999999999999999999999999998764321      13346778999999999999999999999999


Q ss_pred             ceehhhhhhhc
Q psy18060         82 EFVLITEFAHM   92 (549)
Q Consensus        82 ~~~lv~ey~~~   92 (549)
                      .++++|+|+..
T Consensus       103 ~~~lv~e~~~~  113 (335)
T 3dls_A          103 FFQLVMEKHGS  113 (335)
T ss_dssp             EEEEEEECCTT
T ss_pred             EEEEEEEeCCC
Confidence            99999998743

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.12  E-value=8e-11  Score=121.93  Aligned_cols=88  Identities=25%  Similarity=0.285  Sum_probs=75.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc-----cc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-----NE   82 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~   82 (549)
                      .++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|++++++++||||+++++++...     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            358999999999999999999999999999999997532 334456788999999999999999999988654     46


Q ss_pred             eehhhhhhhccccc
Q psy18060         83 FVLITEFAHMSLSK   96 (549)
Q Consensus        83 ~~lv~ey~~~sLsk   96 (549)
                      ++++|+++.++|..
T Consensus       105 ~~iv~e~~~~~L~~  118 (364)
T 3qyz_A          105 VYIVQDLMETDLYK  118 (364)
T ss_dssp             EEEEEECCSEEHHH
T ss_pred             EEEEEcccCcCHHH
Confidence            89999998877654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.12  E-value=1.8e-11  Score=126.98  Aligned_cols=90  Identities=19%  Similarity=0.317  Sum_probs=75.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhc-CCCCccccccccccccce
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF   83 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~   83 (549)
                      ..+++|+++++||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.++..+ +||||+++++++++...+
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            356899999999999999999999999999999999976432 122346688999999887 799999999999999999


Q ss_pred             ehhhhhhhc-ccc
Q psy18060         84 VLITEFAHM-SLS   95 (549)
Q Consensus        84 ~lv~ey~~~-sLs   95 (549)
                      |+||||+.+ +|.
T Consensus        97 ~lv~E~~~gg~L~  109 (353)
T 2i0e_A           97 YFVMEYVNGGDLM  109 (353)
T ss_dssp             EEEEECCCSCBHH
T ss_pred             EEEEeCCCCCcHH
Confidence            999999853 553

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.12  E-value=7.4e-11  Score=116.39  Aligned_cols=86  Identities=27%  Similarity=0.383  Sum_probs=74.0

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++++.||+|+||.||+|++.. ++.||||++.......   +.+.+|++++++++||||+++++++.+....++
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             eChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence            345789999999999999999999874 6789999997654332   468899999999999999999999999999999


Q ss_pred             hhhhhhc-ccc
Q psy18060         86 ITEFAHM-SLS   95 (549)
Q Consensus        86 v~ey~~~-sLs   95 (549)
                      +|||+.+ +|.
T Consensus        83 v~e~~~~~~L~   93 (269)
T 4hcu_A           83 VFEFMEHGCLS   93 (269)
T ss_dssp             EEECCTTCBHH
T ss_pred             EEEeCCCCcHH
Confidence            9999853 554

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.12  E-value=2.8e-11  Score=132.52  Aligned_cols=90  Identities=19%  Similarity=0.231  Sum_probs=77.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC-hhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ...++|+++++||+|+||.||+|+++.+|+.||||++.+.... ....+.+.+|+++|+.++|||||+++++|.+...+|
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            4567899999999999999999999999999999999765321 123457889999999999999999999999999999


Q ss_pred             hhhhhhh-cccc
Q psy18060         85 LITEFAH-MSLS   95 (549)
Q Consensus        85 lv~ey~~-~sLs   95 (549)
                      +||||+. ++|.
T Consensus       262 lVmE~~~gg~L~  273 (543)
T 3c4z_A          262 LVMTIMNGGDIR  273 (543)
T ss_dssp             EEECCCTTCBHH
T ss_pred             EEEEeccCCCHH
Confidence            9999985 4553

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.12  E-value=5e-11  Score=120.03  Aligned_cols=91  Identities=32%  Similarity=0.423  Sum_probs=77.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEEC-----CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL   80 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~   80 (549)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||||++.... .....+.+.+|+++++.++||||+++++++.+.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            45578999999999999999999983     456899999997543 445567889999999999999999999999999


Q ss_pred             cceehhhhhhh-cccccC
Q psy18060         81 NEFVLITEFAH-MSLSKL   97 (549)
Q Consensus        81 ~~~~lv~ey~~-~sLskl   97 (549)
                      ...+++|||+. ++|..+
T Consensus        99 ~~~~lv~e~~~~~~L~~~  116 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGF  116 (314)
T ss_dssp             SSCEEEEECCTTCBHHHH
T ss_pred             CceEEEEeecCCCCHHHH
Confidence            99999999985 566543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.12  E-value=6.7e-11  Score=121.47  Aligned_cols=91  Identities=21%  Similarity=0.279  Sum_probs=78.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCC--CCccccccccccccce
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH--PNIIKFIASHETLNEF   83 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIV~l~~~~~~~~~~   83 (549)
                      ..-.+|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+|..++|  |||+++++++.+...+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            34467999999999999999999985 58999999998766666666788999999999986  9999999999999999


Q ss_pred             ehhhhhhhcccccC
Q psy18060         84 VLITEFAHMSLSKL   97 (549)
Q Consensus        84 ~lv~ey~~~sLskl   97 (549)
                      ++|||+..++|..+
T Consensus        85 ~lv~e~~~~~L~~~   98 (343)
T 3dbq_A           85 YMVMECGNIDLNSW   98 (343)
T ss_dssp             EEEECCCSEEHHHH
T ss_pred             EEEEeCCCCCHHHH
Confidence            99999877776543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.11  E-value=5.4e-11  Score=117.77  Aligned_cols=86  Identities=33%  Similarity=0.403  Sum_probs=75.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      -.++|++.+.||+|+||.||+|.++.+++.||+|++.+....  ..+.+.+|++++++++||||+++++++.+....++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            346799999999999999999999999999999999765432  246788999999999999999999999999999999


Q ss_pred             hhhhhc-cc
Q psy18060         87 TEFAHM-SL   94 (549)
Q Consensus        87 ~ey~~~-sL   94 (549)
                      |||+.+ +|
T Consensus        85 ~e~~~~~~L   93 (277)
T 3f3z_A           85 MELCTGGEL   93 (277)
T ss_dssp             EECCCSCBH
T ss_pred             EeccCCCcH
Confidence            999843 44

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.11  E-value=1.5e-10  Score=112.99  Aligned_cols=134  Identities=18%  Similarity=0.095  Sum_probs=97.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCC--eeEEEEEEeeCCEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN--IIKFIASHETLNEFVL  195 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~i  195 (549)
                      ...+.+....+.|..+.||++.. .+|..+++|+.....     ...+.+|+.+++.+.+.+  +++++++....+..++
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            34455544444666799999854 457789999975431     234678899988885444  5678888887778999


Q ss_pred             EEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q psy18060        196 ITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNR-------------------------------------  237 (549)
Q Consensus       196 V~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~g-------------------------------------  237 (549)
                      |||+++| +|.  ..   ..+   ...++.+++..|..||+..                                     
T Consensus        93 v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           93 LLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            9999987 553  11   122   2356677778888888643                                     


Q ss_pred             ---------------------CccccccCCcEEEecCCcEEEeecccce
Q psy18060        238 ---------------------VLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       238 ---------------------IiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                                           ++|+|++|.|||++.++.+.|+|||.+.
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                 9999999999999877667799999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.11  E-value=6.5e-11  Score=125.42  Aligned_cols=88  Identities=28%  Similarity=0.377  Sum_probs=71.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC------ChhhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR------SGKELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      .++|++.+.||+|+||.||+|.++.+++.||||++.+...      .......+.+|+++|++++|||||++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            4689999999999999999999999999999999976431      11223458899999999999999999998854 4


Q ss_pred             ceehhhhhhhc-cccc
Q psy18060         82 EFVLITEFAHM-SLSK   96 (549)
Q Consensus        82 ~~~lv~ey~~~-sLsk   96 (549)
                      ..++||||+.+ +|..
T Consensus       213 ~~~lv~e~~~~g~L~~  228 (419)
T 3i6u_A          213 DYYIVLELMEGGELFD  228 (419)
T ss_dssp             EEEEEEECCTTCBGGG
T ss_pred             ceEEEEEcCCCCcHHH
Confidence            57899999853 5543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.11  E-value=1e-10  Score=119.97  Aligned_cols=90  Identities=29%  Similarity=0.364  Sum_probs=75.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc-----
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-----   80 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----   80 (549)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+++++.++||||+++++++...     
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            34578999999999999999999999999999999996432 333456788999999999999999999876543     


Q ss_pred             cceehhhhhhhccccc
Q psy18060         81 NEFVLITEFAHMSLSK   96 (549)
Q Consensus        81 ~~~~lv~ey~~~sLsk   96 (549)
                      ...+++|+|+.++|..
T Consensus        87 ~~~~lv~e~~~~~L~~  102 (353)
T 2b9h_A           87 NEVYIIQELMQTDLHR  102 (353)
T ss_dssp             CCEEEEECCCSEEHHH
T ss_pred             ceEEEEEeccCccHHH
Confidence            6789999999877654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.11  E-value=5.1e-11  Score=120.83  Aligned_cols=91  Identities=19%  Similarity=0.292  Sum_probs=65.0

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCc---eEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      ...++|++.+.||+|+||.||+|+++.++.   .||||++..........+.+.+|++++++++||||+++++++.+...
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            445689999999999999999999887765   89999997765455566789999999999999999999999877665


Q ss_pred             e------ehhhhhhhc-cccc
Q psy18060         83 F------VLITEFAHM-SLSK   96 (549)
Q Consensus        83 ~------~lv~ey~~~-sLsk   96 (549)
                      .      +++|+|+.+ +|..
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~  120 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHA  120 (323)
T ss_dssp             -----CEEEEEECCTTCBHHH
T ss_pred             ccCCCccEEEEEeccCCcHHH
Confidence            4      899998854 5543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.11  E-value=8.1e-11  Score=117.92  Aligned_cols=85  Identities=27%  Similarity=0.410  Sum_probs=72.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++++.||+|+||.||+|++..+|+.||+|++.....  ...+.+.+|+++++.++||||+++++++.+....++
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            345689999999999999999999999999999999975432  234678899999999999999999999999999999


Q ss_pred             hhhhhhc
Q psy18060         86 ITEFAHM   92 (549)
Q Consensus        86 v~ey~~~   92 (549)
                      +|||+.+
T Consensus        94 v~e~~~~  100 (302)
T 2j7t_A           94 MIEFCPG  100 (302)
T ss_dssp             EEECCTT
T ss_pred             EEEeCCC
Confidence            9999854

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.11  E-value=6e-11  Score=120.37  Aligned_cols=91  Identities=26%  Similarity=0.427  Sum_probs=77.3

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          4 SNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         4 ~~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      .....++|++.+.||+|+||.||+|++. +|+.||||++.....  ...+.+.+|+++++.++||||+++++++.+.+..
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            3456789999999999999999999965 689999999875432  3356788999999999999999999999999999


Q ss_pred             ehhhhhhh-cccccC
Q psy18060         84 VLITEFAH-MSLSKL   97 (549)
Q Consensus        84 ~lv~ey~~-~sLskl   97 (549)
                      ++||||+. ++|..+
T Consensus       111 ~lv~e~~~~~~L~~~  125 (321)
T 2qkw_B          111 ILIYKYMENGNLKRH  125 (321)
T ss_dssp             EEEEECCTTCBTGGG
T ss_pred             EEEEEcCCCCcHHHH
Confidence            99999985 466543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.11  E-value=6.2e-11  Score=122.35  Aligned_cols=85  Identities=26%  Similarity=0.360  Sum_probs=68.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++.+.||+|+||.||+|+++.+++.||||++....    ..+.+.+|+++++.++||||+++++++.+....++|
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            3456999999999999999999999999999999997543    234677899999999999999999999999999999


Q ss_pred             hhhhh-cccc
Q psy18060         87 TEFAH-MSLS   95 (549)
Q Consensus        87 ~ey~~-~sLs   95 (549)
                      |||+. ++|.
T Consensus       127 ~e~~~~~~L~  136 (349)
T 2w4o_A          127 LELVTGGELF  136 (349)
T ss_dssp             ECCCCSCBHH
T ss_pred             EEeCCCCCHH
Confidence            99985 4553

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.11  E-value=3.8e-11  Score=123.73  Aligned_cols=81  Identities=31%  Similarity=0.365  Sum_probs=70.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccccccceehh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      .++|++.+.||+|+||.||+|.++.+|+.||||++.+...      ...+|++++.++ +||||+++++++.+...+|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            4579999999999999999999999999999999976542      234688888887 799999999999999999999


Q ss_pred             hhhhhc-cc
Q psy18060         87 TEFAHM-SL   94 (549)
Q Consensus        87 ~ey~~~-sL   94 (549)
                      |||+.+ +|
T Consensus        95 ~E~~~gg~L  103 (342)
T 2qr7_A           95 TELMKGGEL  103 (342)
T ss_dssp             ECCCCSCBH
T ss_pred             EeCCCCCcH
Confidence            999853 44

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.11  E-value=3.8e-11  Score=122.44  Aligned_cols=86  Identities=22%  Similarity=0.189  Sum_probs=75.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccccccceehh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      -++|++.+.||+|+||.||+|++..+|+.||||++.....    ...+.+|+.+++.| +||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            3689999999999999999999999999999999975432    24578999999999 899999999999999999999


Q ss_pred             hhhhhcccccC
Q psy18060         87 TEFAHMSLSKL   97 (549)
Q Consensus        87 ~ey~~~sLskl   97 (549)
                      |||+.++|..+
T Consensus        84 ~e~~~~~L~~~   94 (330)
T 2izr_A           84 LELLGPSLEDL   94 (330)
T ss_dssp             EECCCCBHHHH
T ss_pred             EEeCCCCHHHH
Confidence            99997777654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.10  E-value=7.4e-11  Score=117.39  Aligned_cols=86  Identities=28%  Similarity=0.381  Sum_probs=72.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChh-----hhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-----ELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      ..++|++.+.||+|+||.||+|++..+++.||||++........     ..+.+.+|+.++++++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            45789999999999999999999999999999999976543221     1257889999999999999999999987655


Q ss_pred             ceehhhhhhh-ccc
Q psy18060         82 EFVLITEFAH-MSL   94 (549)
Q Consensus        82 ~~~lv~ey~~-~sL   94 (549)
                        +++|||+. ++|
T Consensus        97 --~lv~e~~~~~~L  108 (287)
T 4f0f_A           97 --RMVMEFVPCGDL  108 (287)
T ss_dssp             --EEEEECCTTCBH
T ss_pred             --eEEEEecCCCCH
Confidence              68899885 455

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.10  E-value=6.5e-11  Score=128.23  Aligned_cols=87  Identities=23%  Similarity=0.421  Sum_probs=76.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++.+.||+|+||.||+|.++.+++.||||++.....   ..+.+.+|+.+|++++|||||++++++.+...+++|
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            45679999999999999999999999999999999975433   246788999999999999999999999999999999


Q ss_pred             hhhhh-ccccc
Q psy18060         87 TEFAH-MSLSK   96 (549)
Q Consensus        87 ~ey~~-~sLsk   96 (549)
                      |||+. ++|..
T Consensus       295 ~E~~~~g~L~~  305 (495)
T 1opk_A          295 TEFMTYGNLLD  305 (495)
T ss_dssp             EECCTTCBHHH
T ss_pred             EEccCCCCHHH
Confidence            99985 56543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.10  E-value=4.4e-11  Score=119.08  Aligned_cols=89  Identities=22%  Similarity=0.318  Sum_probs=76.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCC-------ceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLK-------KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET   79 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~   79 (549)
                      ..++|++.+.||+|+||.||+|+++.++       +.||+|++.+..  ....+.+.+|+++++.++||||+++++++.+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            4578999999999999999999998877       479999996543  2344678999999999999999999999999


Q ss_pred             ccceehhhhhhh-cccccC
Q psy18060         80 LNEFVLITEFAH-MSLSKL   97 (549)
Q Consensus        80 ~~~~~lv~ey~~-~sLskl   97 (549)
                      ....++||||+. ++|..+
T Consensus        84 ~~~~~lv~e~~~~~~L~~~  102 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTY  102 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHH
T ss_pred             CCCCEEEEECCCCCCHHHH
Confidence            999999999996 566543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.10  E-value=3.3e-11  Score=120.90  Aligned_cols=87  Identities=25%  Similarity=0.410  Sum_probs=72.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC--ChhhhhhHHHHHHHHHhcCCCCcccccccc--ccccce
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR--SGKELSSLKQECEIQKHLAHPNIIKFIASH--ETLNEF   83 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~--~~~~~~   83 (549)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.+...  .....+.+.+|+++++.++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            5789999999999999999999999999999999976431  122346789999999999999999999988  556689


Q ss_pred             ehhhhhhhccc
Q psy18060         84 VLITEFAHMSL   94 (549)
Q Consensus        84 ~lv~ey~~~sL   94 (549)
                      +++|||+.+++
T Consensus        84 ~lv~e~~~~~l   94 (305)
T 2wtk_C           84 YMVMEYCVCGM   94 (305)
T ss_dssp             EEEEECCSEEH
T ss_pred             EEEehhccCCH
Confidence            99999987664

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.10  E-value=1.7e-11  Score=130.86  Aligned_cols=86  Identities=22%  Similarity=0.380  Sum_probs=66.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      .+++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            45789999999999999999999999999999999976431 22344567899999999999999999999999999999


Q ss_pred             hhhhhhc
Q psy18060         86 ITEFAHM   92 (549)
Q Consensus        86 v~ey~~~   92 (549)
                      ||||+.+
T Consensus       226 v~e~~~~  232 (446)
T 4ejn_A          226 VMEYANG  232 (446)
T ss_dssp             EECCCSS
T ss_pred             EEeeCCC
Confidence            9999854

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.10  E-value=5.4e-11  Score=124.79  Aligned_cols=87  Identities=22%  Similarity=0.330  Sum_probs=76.1

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC--CCCccccccccccccceehh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA--HPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~~~~~~lv   86 (549)
                      .+|++++.||+|+||.||+|.+.. |+.||||++.+........+.+.+|+.+|+.|.  |||||++++++.....+++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            459999999999999999999875 899999999876656666678999999999996  59999999999999999999


Q ss_pred             hhhhhccccc
Q psy18060         87 TEFAHMSLSK   96 (549)
Q Consensus        87 ~ey~~~sLsk   96 (549)
                      ||+..++|..
T Consensus       135 ~E~~~~~L~~  144 (390)
T 2zmd_A          135 MECGNIDLNS  144 (390)
T ss_dssp             EECCSEEHHH
T ss_pred             EecCCCCHHH
Confidence            9977776644

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.10  E-value=7.5e-11  Score=119.23  Aligned_cols=91  Identities=19%  Similarity=0.277  Sum_probs=76.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ..+++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            456789999999999999999999999999999999976543 2333467889999999999999999999999999999


Q ss_pred             hhhhhhhc-cccc
Q psy18060         85 LITEFAHM-SLSK   96 (549)
Q Consensus        85 lv~ey~~~-sLsk   96 (549)
                      +++||+.+ +|..
T Consensus       111 lv~e~~~~~~L~~  123 (309)
T 2h34_A          111 VDMRLINGVDLAA  123 (309)
T ss_dssp             EEEECCCCEEHHH
T ss_pred             EEEEecCCCCHHH
Confidence            99999853 5543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.10  E-value=6.7e-11  Score=120.28  Aligned_cols=90  Identities=22%  Similarity=0.302  Sum_probs=74.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHH-HHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECE-IQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ...++|++++.||+|+||.||+|.++.+|+.||||++..... ......+.+|+. +++.++||||+++++++.+.+..+
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            345789999999999999999999999999999999976532 333445666666 677789999999999999999999


Q ss_pred             hhhhhhhccccc
Q psy18060         85 LITEFAHMSLSK   96 (549)
Q Consensus        85 lv~ey~~~sLsk   96 (549)
                      ++|||+.++|..
T Consensus        98 lv~e~~~~~l~~  109 (327)
T 3aln_A           98 ICMELMSTSFDK  109 (327)
T ss_dssp             EEECCCSEEHHH
T ss_pred             EEEeecCCChHH
Confidence            999999877543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.10  E-value=4.4e-11  Score=119.01  Aligned_cols=90  Identities=31%  Similarity=0.418  Sum_probs=76.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh-hhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-KELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ...++|++.+.||+|+||.||+|++..+++.||||++.+..... .....+.+|+++++.++||||+++++++.+....+
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence            45789999999999999999999999999999999996543211 12356889999999999999999999999999999


Q ss_pred             hhhhhhhc-ccc
Q psy18060         85 LITEFAHM-SLS   95 (549)
Q Consensus        85 lv~ey~~~-sLs   95 (549)
                      ++|||+.+ +|.
T Consensus        91 lv~e~~~~~~L~  102 (284)
T 2vgo_A           91 LMLEFAPRGELY  102 (284)
T ss_dssp             EEECCCTTEEHH
T ss_pred             EEEEeCCCCcHH
Confidence            99999853 553

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.10  E-value=3.4e-11  Score=125.62  Aligned_cols=90  Identities=22%  Similarity=0.321  Sum_probs=75.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEEC---CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      ..++|++.+.||+|+||.||+|+++   .++..||||++.... .....+.+.+|+.+|++++||||+++++++.+...+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            3457999999999999999999987   467789999997543 344557799999999999999999999999999999


Q ss_pred             ehhhhhhh-cccccC
Q psy18060         84 VLITEFAH-MSLSKL   97 (549)
Q Consensus        84 ~lv~ey~~-~sLskl   97 (549)
                      ++||||+. ++|..+
T Consensus       122 ~lv~e~~~~~sL~~~  136 (373)
T 2qol_A          122 MIVTEYMENGSLDSF  136 (373)
T ss_dssp             EEEEECCTTCBHHHH
T ss_pred             EEEEeCCCCCcHHHH
Confidence            99999984 566543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.10  E-value=8e-11  Score=118.42  Aligned_cols=86  Identities=27%  Similarity=0.339  Sum_probs=72.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++.+.||+|+||.||+|+++.+|+.||||++......  ..+.+.+|+.+++.++||||+++++++.+....+++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            446899999999999999999999999999999999764321  235678999999999999999999999999999999


Q ss_pred             hhhhh-ccc
Q psy18060         87 TEFAH-MSL   94 (549)
Q Consensus        87 ~ey~~-~sL   94 (549)
                      |||+. ++|
T Consensus        85 ~e~~~~~~L   93 (304)
T 2jam_A           85 MQLVSGGEL   93 (304)
T ss_dssp             ECCCCSCBH
T ss_pred             EEcCCCccH
Confidence            99985 354

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.10  E-value=8.9e-11  Score=118.50  Aligned_cols=86  Identities=28%  Similarity=0.335  Sum_probs=73.3

Q ss_pred             ccCeeee-eeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccccccceeh
Q psy18060          8 LEKYQKI-CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         8 ~~~y~~~-~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~l   85 (549)
                      .+.|++. ++||+|+||.||+|.++.+|+.||||++.+...  .....+.+|++++.++ +||||+++++++.+.+.+++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            3568885 789999999999999999999999999976532  2346788999999884 79999999999999999999


Q ss_pred             hhhhhh-cccc
Q psy18060         86 ITEFAH-MSLS   95 (549)
Q Consensus        86 v~ey~~-~sLs   95 (549)
                      ||||+. ++|.
T Consensus        89 v~e~~~~~~L~   99 (316)
T 2ac3_A           89 VFEKMRGGSIL   99 (316)
T ss_dssp             EEECCTTCBHH
T ss_pred             EEEcCCCCcHH
Confidence            999985 5554

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.09  E-value=7.4e-11  Score=123.82  Aligned_cols=90  Identities=27%  Similarity=0.351  Sum_probs=75.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc--cee
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN--EFV   84 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~   84 (549)
                      .-++|++.+.||+|+||.||+|+++.+|+.||||++..... ....+.+.+|+++++.++||||+++++++.+..  ..+
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            34689999999999999999999999999999999975432 123456789999999999999999999987654  679


Q ss_pred             hhhhhhh-cccccC
Q psy18060         85 LITEFAH-MSLSKL   97 (549)
Q Consensus        85 lv~ey~~-~sLskl   97 (549)
                      +||||+. ++|..+
T Consensus        86 lv~e~~~~g~L~~~   99 (396)
T 4eut_A           86 LIMEFCPCGSLYTV   99 (396)
T ss_dssp             EEECCCTTEEHHHH
T ss_pred             EEEecCCCCCHHHH
Confidence            9999985 566554

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.09  E-value=9.6e-11  Score=118.31  Aligned_cols=87  Identities=25%  Similarity=0.296  Sum_probs=72.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccc----cccce
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE----TLNEF   83 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~----~~~~~   83 (549)
                      .++|++++.||+|+||.||+|+++.+|+.||||++...  .....+.+.+|+++++.++||||+++++++.    .....
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            45799999999999999999999999999999999653  2344567889999999999999999999886    34578


Q ss_pred             ehhhhhhhc-cccc
Q psy18060         84 VLITEFAHM-SLSK   96 (549)
Q Consensus        84 ~lv~ey~~~-sLsk   96 (549)
                      +++|+|+.+ +|..
T Consensus       106 ~lv~e~~~~~~L~~  119 (317)
T 2buj_A          106 WLLLPFFKRGTLWN  119 (317)
T ss_dssp             EEEEECCTTCBHHH
T ss_pred             EEEEEeCCCCcHHH
Confidence            999999865 6543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.09  E-value=9.3e-11  Score=117.23  Aligned_cols=91  Identities=30%  Similarity=0.404  Sum_probs=76.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC---Ch----hhhhhHHHHHHHHHhcC-CCCcccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR---SG----KELSSLKQECEIQKHLA-HPNIIKFIASH   77 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~---~~----~~~~~~~~Ei~il~~l~-HpnIV~l~~~~   77 (549)
                      .-.++|++.+.||+|+||.||+|.++.+|+.||||++.....   ..    ...+.+.+|+++++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            456889999999999999999999999999999999976541   11    22456889999999996 99999999999


Q ss_pred             ccccceehhhhhhh-ccccc
Q psy18060         78 ETLNEFVLITEFAH-MSLSK   96 (549)
Q Consensus        78 ~~~~~~~lv~ey~~-~sLsk   96 (549)
                      .+....+++|||+. ++|..
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~  113 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFD  113 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHH
T ss_pred             ccCCeEEEEEeccCCCcHHH
Confidence            99999999999985 45543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.09  E-value=1.3e-10  Score=116.59  Aligned_cols=88  Identities=31%  Similarity=0.425  Sum_probs=76.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..+.|++++.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+.+++.++||||+++++++.+....+++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            34679999999999999999999999999999999976543 23456789999999999999999999999999999999


Q ss_pred             hhhhhc-ccc
Q psy18060         87 TEFAHM-SLS   95 (549)
Q Consensus        87 ~ey~~~-sLs   95 (549)
                      |||+.+ +|.
T Consensus        99 ~e~~~~~~L~  108 (303)
T 3a7i_A           99 MEYLGGGSAL  108 (303)
T ss_dssp             EECCTTEEHH
T ss_pred             EEeCCCCcHH
Confidence            999854 544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.09  E-value=1.5e-10  Score=115.03  Aligned_cols=87  Identities=20%  Similarity=0.262  Sum_probs=71.3

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ....++|++++.||+|+||.||+|.+. ++..||||++.......   +.+.+|+++++.++||||+++++++.+....+
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence            345678999999999999999999887 46789999997654332   46889999999999999999999999999999


Q ss_pred             hhhhhhh-cccc
Q psy18060         85 LITEFAH-MSLS   95 (549)
Q Consensus        85 lv~ey~~-~sLs   95 (549)
                      ++|||+. ++|.
T Consensus        96 lv~e~~~~~~L~  107 (283)
T 3gen_A           96 IITEYMANGCLL  107 (283)
T ss_dssp             EEECCCTTCBHH
T ss_pred             EEEeccCCCcHH
Confidence            9999984 4554

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.09  E-value=7.6e-11  Score=119.67  Aligned_cols=87  Identities=30%  Similarity=0.369  Sum_probs=69.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC------hhhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS------GKELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      .++|++.+.||+|+||.||+|.++.+|+.||||++.+....      ......+.+|+++++.++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            46799999999999999999999999999999999764321      122346889999999999999999999986654


Q ss_pred             ceehhhhhhh-cccc
Q psy18060         82 EFVLITEFAH-MSLS   95 (549)
Q Consensus        82 ~~~lv~ey~~-~sLs   95 (549)
                       .++||||+. ++|.
T Consensus        89 -~~lv~e~~~~~~L~  102 (322)
T 2ycf_A           89 -YYIVLELMEGGELF  102 (322)
T ss_dssp             -EEEEEECCTTEETH
T ss_pred             -eEEEEecCCCCcHH
Confidence             899999985 3553

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.08  E-value=1.3e-10  Score=118.33  Aligned_cols=91  Identities=29%  Similarity=0.421  Sum_probs=76.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCc-----eEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCcccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET   79 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~   79 (549)
                      ...++|++.+.||+|+||.||+|.+..+|+     .||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            345689999999999999999999987665     79999997543 334456789999999999 89999999999999


Q ss_pred             ccceehhhhhhhc-ccccC
Q psy18060         80 LNEFVLITEFAHM-SLSKL   97 (549)
Q Consensus        80 ~~~~~lv~ey~~~-sLskl   97 (549)
                      ...+++||||+.+ +|..+
T Consensus       122 ~~~~~lv~e~~~~g~L~~~  140 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNF  140 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHH
T ss_pred             CCceEEEEecCCCCcHHHH
Confidence            9999999999854 66543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.08  E-value=4e-11  Score=122.82  Aligned_cols=90  Identities=22%  Similarity=0.266  Sum_probs=76.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChh---------------hhhhHHHHHHHHHhcCCCCc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK---------------ELSSLKQECEIQKHLAHPNI   70 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~---------------~~~~~~~Ei~il~~l~HpnI   70 (549)
                      ...++|++++.||+|+||.||+|.+  +|+.||||++........               ..+.+.+|+.++++++||||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            3457999999999999999999999  899999999975432111               11678899999999999999


Q ss_pred             cccccccccccceehhhhhhhc-ccccC
Q psy18060         71 IKFIASHETLNEFVLITEFAHM-SLSKL   97 (549)
Q Consensus        71 V~l~~~~~~~~~~~lv~ey~~~-sLskl   97 (549)
                      +++++++.+.+..++||||+.+ +|..+
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~  133 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKF  133 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEE
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHH
Confidence            9999999999999999999965 77654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.08  E-value=1.6e-10  Score=113.78  Aligned_cols=87  Identities=24%  Similarity=0.299  Sum_probs=74.2

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      +-..++|++++.||+|+||.||+|.+. ++..||||++.......   ..+.+|++++++++||||+++++++.+....+
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            445678999999999999999999887 46789999997654332   46889999999999999999999999999999


Q ss_pred             hhhhhhh-cccc
Q psy18060         85 LITEFAH-MSLS   95 (549)
Q Consensus        85 lv~ey~~-~sLs   95 (549)
                      ++|||+. ++|.
T Consensus        80 lv~e~~~~~~L~   91 (268)
T 3sxs_A           80 IVTEYISNGCLL   91 (268)
T ss_dssp             EEEECCTTCBHH
T ss_pred             EEEEccCCCcHH
Confidence            9999984 4453

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.08  E-value=8.1e-11  Score=118.66  Aligned_cols=89  Identities=17%  Similarity=0.272  Sum_probs=67.8

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      +..+++|++++.||+|+||.||+|.++.+|+.||||++..........+.+.++..+++.++||||+++++++.+....+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            45678999999999999999999999999999999999765433333334455556788889999999999999999999


Q ss_pred             hhhhhhhcc
Q psy18060         85 LITEFAHMS   93 (549)
Q Consensus        85 lv~ey~~~s   93 (549)
                      ++|||+...
T Consensus       101 lv~e~~~~~  109 (318)
T 2dyl_A          101 IAMELMGTC  109 (318)
T ss_dssp             EEECCCSEE
T ss_pred             EEEeccCCc
Confidence            999998443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.08  E-value=2.4e-11  Score=126.64  Aligned_cols=90  Identities=8%  Similarity=0.113  Sum_probs=69.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHH---HHHHhcCCCCcccccccc------
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQEC---EIQKHLAHPNIIKFIASH------   77 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei---~il~~l~HpnIV~l~~~~------   77 (549)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+   ++|++++|||||++++.+      
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            4679999999999999999999999999999999986542 334557788999   556666899999998444      


Q ss_pred             -cccc-----------------ceehhhhhhhcccccC
Q psy18060         78 -ETLN-----------------EFVLITEFAHMSLSKL   97 (549)
Q Consensus        78 -~~~~-----------------~~~lv~ey~~~sLskl   97 (549)
                       .+.+                 ..+++|||+.++|..+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~  189 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF  189 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHH
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHH
Confidence             3322                 3788899888777554

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.08  E-value=1.2e-10  Score=118.70  Aligned_cols=84  Identities=25%  Similarity=0.273  Sum_probs=72.8

Q ss_pred             CeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhhhh
Q psy18060         10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF   89 (549)
Q Consensus        10 ~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~ey   89 (549)
                      .|+..+.||+|+||.||+|+++.+|+.||||++......  ..+.+.+|+.+++.++||||+++++.+......+++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            378888999999999999999999999999999765432  235688999999999999999999999999999999999


Q ss_pred             hh-cccc
Q psy18060         90 AH-MSLS   95 (549)
Q Consensus        90 ~~-~sLs   95 (549)
                      +. ++|.
T Consensus       124 ~~~~~L~  130 (321)
T 2c30_A          124 LQGGALT  130 (321)
T ss_dssp             CCSCBHH
T ss_pred             CCCCCHH
Confidence            84 3443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.08  E-value=9.4e-11  Score=120.55  Aligned_cols=91  Identities=24%  Similarity=0.377  Sum_probs=74.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEE-----ECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCcccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAI-----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET   79 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~   79 (549)
                      ...++|++.+.||+|+||.||+|+     +..+++.||||++.... .....+.+.+|++++.++ +|||||++++++.+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            345789999999999999999999     45677999999997543 344456789999999999 79999999999877


Q ss_pred             cc-ceehhhhhhh-cccccC
Q psy18060         80 LN-EFVLITEFAH-MSLSKL   97 (549)
Q Consensus        80 ~~-~~~lv~ey~~-~sLskl   97 (549)
                      .. .++++|||+. ++|..+
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~  117 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTY  117 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHH
T ss_pred             CCCceEEEEEecCCCcHHHH
Confidence            54 4899999985 466543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.08  E-value=7.4e-11  Score=120.06  Aligned_cols=91  Identities=20%  Similarity=0.234  Sum_probs=72.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEE-----ECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAI-----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL   80 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~   80 (549)
                      ...++|++++.||+|+||.||+|+     +..+++.||||++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            345689999999999999999999     55678899999996443 334456788999999999999999999999999


Q ss_pred             cceehhhhhh-hcccccC
Q psy18060         81 NEFVLITEFA-HMSLSKL   97 (549)
Q Consensus        81 ~~~~lv~ey~-~~sLskl   97 (549)
                      ...+++|||+ .++|..+
T Consensus       106 ~~~~lv~e~~~~~~L~~~  123 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSF  123 (327)
T ss_dssp             SSCEEEEECCTTEEHHHH
T ss_pred             CCcEEEEecCCCCcHHHH
Confidence            9999999998 4566543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.08  E-value=6.5e-11  Score=117.00  Aligned_cols=90  Identities=28%  Similarity=0.349  Sum_probs=76.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            456799999999999999999999999999999999965432 1123457889999999999999999999999999999


Q ss_pred             hhhhhhh-cccc
Q psy18060         85 LITEFAH-MSLS   95 (549)
Q Consensus        85 lv~ey~~-~sLs   95 (549)
                      ++|||+. ++|.
T Consensus        88 lv~e~~~~~~L~   99 (276)
T 2h6d_A           88 MVMEYVSGGELF   99 (276)
T ss_dssp             EEEECCCSCBHH
T ss_pred             EEEeccCCCcHH
Confidence            9999985 4554

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.08  E-value=6.3e-11  Score=118.68  Aligned_cols=88  Identities=33%  Similarity=0.424  Sum_probs=70.6

Q ss_pred             ccCeeeeeeecccCceEEEEEE----ECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc--c
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL--N   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~   81 (549)
                      ...|++++.||+|+||.||+|+    +..+|+.||||++.... .....+.+.+|+++++.++||||+++++++.+.  .
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            3469999999999999999999    56789999999997543 223446788999999999999999999998766  6


Q ss_pred             ceehhhhhhhc-cccc
Q psy18060         82 EFVLITEFAHM-SLSK   96 (549)
Q Consensus        82 ~~~lv~ey~~~-sLsk   96 (549)
                      .++++|||+.+ +|..
T Consensus        99 ~~~lv~e~~~~~~L~~  114 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKE  114 (302)
T ss_dssp             CEEEEEECCTTCBHHH
T ss_pred             eEEEEEEeCCCCcHHH
Confidence            68999999854 6644

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.07  E-value=1.8e-11  Score=125.19  Aligned_cols=83  Identities=33%  Similarity=0.465  Sum_probs=66.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC------ChhhhhhHHHHHHHHHhcC---------------
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR------SGKELSSLKQECEIQKHLA---------------   66 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~---------------   66 (549)
                      .++|++++.||+|+||.||+|++  +|+.||||++.+...      .....+.+.+|+.+|+.++               
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  689999999987642      1223467889999999887               


Q ss_pred             -----------CCCcccccccccc-------------ccceehhhhhhhc
Q psy18060         67 -----------HPNIIKFIASHET-------------LNEFVLITEFAHM   92 (549)
Q Consensus        67 -----------HpnIV~l~~~~~~-------------~~~~~lv~ey~~~   92 (549)
                                 |||||+++++|.+             ...+++||||+.+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~  146 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG  146 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC
Confidence                       6666777776665             6778999998743

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.07  E-value=1.3e-10  Score=119.65  Aligned_cols=88  Identities=30%  Similarity=0.399  Sum_probs=76.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC-----CCCcccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-----HPNIIKFIASHETLN   81 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIV~l~~~~~~~~   81 (549)
                      ..++|++++.||+|+||.||+|++..+|+.||||++...   ......+.+|+.+++.+.     |||||++++++....
T Consensus        33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            346899999999999999999999999999999999642   233456778999999986     999999999999999


Q ss_pred             ceehhhhhhhcccccC
Q psy18060         82 EFVLITEFAHMSLSKL   97 (549)
Q Consensus        82 ~~~lv~ey~~~sLskl   97 (549)
                      .+++||+++.++|..+
T Consensus       110 ~~~lv~e~~~~~L~~~  125 (360)
T 3llt_A          110 HMCLIFEPLGPSLYEI  125 (360)
T ss_dssp             EEEEEECCCCCBHHHH
T ss_pred             eeEEEEcCCCCCHHHH
Confidence            9999999997777543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.07  E-value=6.3e-11  Score=119.40  Aligned_cols=90  Identities=27%  Similarity=0.423  Sum_probs=70.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC---hhhhhhHHHHHHHHHhcC---CCCccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS---GKELSSLKQECEIQKHLA---HPNIIKFIASHETL   80 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~Ei~il~~l~---HpnIV~l~~~~~~~   80 (549)
                      ..++|++++.||+|+||.||+|+++.+|+.||||++......   ......+.+|+.+++.+.   ||||+++++++.+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999999999999999999754321   112345678888877665   99999999998665


Q ss_pred             c-----ceehhhhhhhccccc
Q psy18060         81 N-----EFVLITEFAHMSLSK   96 (549)
Q Consensus        81 ~-----~~~lv~ey~~~sLsk   96 (549)
                      .     .++++|+++.++|..
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~  107 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQDLRT  107 (308)
T ss_dssp             CSSSEEEEEEEEECCCCBHHH
T ss_pred             CCCCceeEEEEehhhhcCHHH
Confidence            4     488999998877654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.07  E-value=1.4e-10  Score=114.23  Aligned_cols=89  Identities=27%  Similarity=0.420  Sum_probs=69.8

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC--hhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS--GKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      +...++|++.+.||+|+||.||+|.+.  |+.||||++......  ....+.+.+|+++++.++||||+++++++.+...
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            345679999999999999999999985  789999999765422  2234678899999999999999999999999999


Q ss_pred             eehhhhhhh-cccc
Q psy18060         83 FVLITEFAH-MSLS   95 (549)
Q Consensus        83 ~~lv~ey~~-~sLs   95 (549)
                      .+++|||+. ++|.
T Consensus        81 ~~lv~e~~~~~~L~   94 (271)
T 3dtc_A           81 LCLVMEFARGGPLN   94 (271)
T ss_dssp             CEEEEECCTTEEHH
T ss_pred             eEEEEEcCCCCCHH
Confidence            999999984 4443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.07  E-value=9.2e-11  Score=119.62  Aligned_cols=89  Identities=22%  Similarity=0.281  Sum_probs=75.3

Q ss_pred             cCeeee-eeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC-CCCccccccccccccceehh
Q psy18060          9 EKYQKI-CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         9 ~~y~~~-~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~lv   86 (549)
                      +.|.+. +.||+|+||.||+|+++.+|+.||||++.+..........+.+|+.++..+. ||||+++++++.+...+++|
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            347776 8999999999999999999999999999875544444567889999999985 69999999999999999999


Q ss_pred             hhhhhc-ccccC
Q psy18060         87 TEFAHM-SLSKL   97 (549)
Q Consensus        87 ~ey~~~-sLskl   97 (549)
                      |||+.+ +|..+
T Consensus       108 ~e~~~~~~L~~~  119 (327)
T 3lm5_A          108 LEYAAGGEIFSL  119 (327)
T ss_dssp             EECCTTEEGGGG
T ss_pred             EEecCCCcHHHH
Confidence            999854 55443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.07  E-value=1.4e-10  Score=118.47  Aligned_cols=91  Identities=30%  Similarity=0.405  Sum_probs=75.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEEC-------CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCcccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHL-------DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASH   77 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~   77 (549)
                      ...++|++.+.||+|+||.||+|++.       .+++.||||++.... .....+.+.+|+++++.+ +||||+++++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            34578999999999999999999986       467789999997543 344567789999999999 899999999999


Q ss_pred             ccccceehhhhhhhc-ccccC
Q psy18060         78 ETLNEFVLITEFAHM-SLSKL   97 (549)
Q Consensus        78 ~~~~~~~lv~ey~~~-sLskl   97 (549)
                      .+...+++||||+.+ +|..+
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~  131 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREY  131 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHH
T ss_pred             ccCCceEEEEECCCCCcHHHH
Confidence            999999999999854 66543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.07  E-value=1.5e-10  Score=117.34  Aligned_cols=91  Identities=24%  Similarity=0.458  Sum_probs=76.3

Q ss_pred             CccccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCcccccccccc--
Q psy18060          3 KSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET--   79 (549)
Q Consensus         3 ~~~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~--   79 (549)
                      ......++|++++.||+|+||.||+|++..+|+.||||++.....   ....+.+|+.+++++ +||||+++++++..  
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            344567889999999999999999999999999999999975432   235688999999999 79999999999866  


Q ss_pred             ----ccceehhhhhhhc-cccc
Q psy18060         80 ----LNEFVLITEFAHM-SLSK   96 (549)
Q Consensus        80 ----~~~~~lv~ey~~~-sLsk   96 (549)
                          ...++++|||+.+ +|..
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~  116 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTD  116 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHH
T ss_pred             CccccceEEEEEEcCCCCcHHH
Confidence                4578999999854 6644

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.06  E-value=1.5e-10  Score=117.48  Aligned_cols=86  Identities=27%  Similarity=0.411  Sum_probs=73.1

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC-CCCcccccccc--------cc
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASH--------ET   79 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~--------~~   79 (549)
                      .+|++.+.||+|+||.||+|+++.+|+.||||++....  ....+.+.+|+.++.++. ||||+++++++        ..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            47999999999999999999999999999999996542  334467889999999996 99999999887        44


Q ss_pred             ccceehhhhhhhccccc
Q psy18060         80 LNEFVLITEFAHMSLSK   96 (549)
Q Consensus        80 ~~~~~lv~ey~~~sLsk   96 (549)
                      ...++++|+|+.++|..
T Consensus       106 ~~~~~lv~e~~~g~L~~  122 (337)
T 3ll6_A          106 QAEFLLLTELCKGQLVE  122 (337)
T ss_dssp             SEEEEEEEECCSEEHHH
T ss_pred             CceEEEEEEecCCCHHH
Confidence            55689999999887644

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.06  E-value=9.4e-11  Score=118.22  Aligned_cols=86  Identities=27%  Similarity=0.482  Sum_probs=69.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++....    ..+.+.+|+.+++.++||||+++++.+.+....+++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            3567999999999999999999999999999999997543    235688999999999999999999999999999999


Q ss_pred             hhhhhc-cccc
Q psy18060         87 TEFAHM-SLSK   96 (549)
Q Consensus        87 ~ey~~~-sLsk   96 (549)
                      |||+.+ +|..
T Consensus       103 ~e~~~~~~L~~  113 (314)
T 3com_A          103 MEYCGAGSVSD  113 (314)
T ss_dssp             EECCTTEEHHH
T ss_pred             eecCCCCCHHH
Confidence            999854 5543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.06  E-value=7.6e-11  Score=117.60  Aligned_cols=86  Identities=22%  Similarity=0.402  Sum_probs=72.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc--------
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--------   79 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--------   79 (549)
                      .++|++++.||+|+||.||+|++..+|+.||||++...   ....+.+.+|+.+++.++||||+++++.+.+        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            35799999999999999999999999999999999642   3345678899999999999999999988744        


Q ss_pred             -----ccceehhhhhhh-ccccc
Q psy18060         80 -----LNEFVLITEFAH-MSLSK   96 (549)
Q Consensus        80 -----~~~~~lv~ey~~-~sLsk   96 (549)
                           ....+++|||+. ++|..
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~  104 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYD  104 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHH
T ss_pred             cccccCCceEEEEecCCCCCHHH
Confidence                 467899999985 46654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.06  E-value=1e-10  Score=120.58  Aligned_cols=90  Identities=22%  Similarity=0.365  Sum_probs=73.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh---------hhhhhHHHHHHHHHhcCCCCccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG---------KELSSLKQECEIQKHLAHPNIIKFIAS   76 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~---------~~~~~~~~Ei~il~~l~HpnIV~l~~~   76 (549)
                      ...++|++.+.||+|+||.||+|.+.. |+.||||++.......         ...+.+.+|++++++++||||++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            456789999999999999999999865 8999999996643221         123678999999999999999999998


Q ss_pred             cc-----cccceehhhhhhhccccc
Q psy18060         77 HE-----TLNEFVLITEFAHMSLSK   96 (549)
Q Consensus        77 ~~-----~~~~~~lv~ey~~~sLsk   96 (549)
                      +.     ....+++||||+.++|..
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~l~~  122 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRTDLAQ  122 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSEEHHH
T ss_pred             EEeccCCCcceEEEEEccCCCCHHH
Confidence            83     344689999999876644

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.06  E-value=8.9e-11  Score=118.84  Aligned_cols=92  Identities=21%  Similarity=0.320  Sum_probs=77.2

Q ss_pred             cccccCeeeeeeecccCceEEEEEEEC-----CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET   79 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~   79 (549)
                      ....++|++.+.||+|+||.||+|.++     .+++.||||++.... .......+.+|+++++.++||||+++++++.+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            445678999999999999999999887     467899999997543 33445678899999999999999999999999


Q ss_pred             ccceehhhhhhh-cccccC
Q psy18060         80 LNEFVLITEFAH-MSLSKL   97 (549)
Q Consensus        80 ~~~~~lv~ey~~-~sLskl   97 (549)
                      ....+++|||+. ++|..+
T Consensus       100 ~~~~~lv~e~~~~~~L~~~  118 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSY  118 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHH
T ss_pred             CCccEEEEEeCCCCcHHHH
Confidence            999999999985 466543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.06  E-value=1.5e-10  Score=116.51  Aligned_cols=91  Identities=26%  Similarity=0.324  Sum_probs=76.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEE-----CCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCcccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIH-----LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET   79 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~   79 (549)
                      ...++|++.+.||+|+||.||+|++     ..+++.||||++.... .....+.+.+|+++++++ +||||+++++++.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            3456899999999999999999985     4577899999997543 334457789999999999 89999999999999


Q ss_pred             ccceehhhhhhhc-ccccC
Q psy18060         80 LNEFVLITEFAHM-SLSKL   97 (549)
Q Consensus        80 ~~~~~lv~ey~~~-sLskl   97 (549)
                      ....+++|||+.+ +|..+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~  117 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNF  117 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHH
T ss_pred             CCCcEEEEecCCCCCHHHH
Confidence            9999999999854 66543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.06  E-value=1.4e-10  Score=121.04  Aligned_cols=80  Identities=31%  Similarity=0.499  Sum_probs=65.3

Q ss_pred             eeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhhhhhh-
Q psy18060         13 KICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-   91 (549)
Q Consensus        13 ~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~ey~~-   91 (549)
                      ..++||+|+||.||+|.+..+|+.||||++....  ....+.+.+|+++|+.++|||||++++++.+...+++||||+. 
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            3678999999999999999999999999997643  2345678999999999999999999999999999999999985 


Q ss_pred             ccc
Q psy18060         92 MSL   94 (549)
Q Consensus        92 ~sL   94 (549)
                      ++|
T Consensus       171 ~~L  173 (373)
T 2x4f_A          171 GEL  173 (373)
T ss_dssp             CEE
T ss_pred             CcH
Confidence            355

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.06  E-value=1.1e-10  Score=119.34  Aligned_cols=90  Identities=24%  Similarity=0.386  Sum_probs=73.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEEC-----CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETL   80 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~   80 (549)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            4568999999999999999999973     456789999997543 233456789999999999 899999999999999


Q ss_pred             cceehhhhhhh-cccccC
Q psy18060         81 NEFVLITEFAH-MSLSKL   97 (549)
Q Consensus        81 ~~~~lv~ey~~-~sLskl   97 (549)
                      ...+++|||+. ++|..+
T Consensus       122 ~~~~lv~e~~~~g~L~~~  139 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNY  139 (344)
T ss_dssp             SSCEEEEECCTTCBHHHH
T ss_pred             CccEEEEecCCCCcHHHH
Confidence            99999999985 476543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.05  E-value=9.6e-11  Score=120.51  Aligned_cols=86  Identities=24%  Similarity=0.324  Sum_probs=61.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc---
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE---   82 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~---   82 (549)
                      ..+++|++.+.||+|+||.||+|+++.+|+.||||++.....   ......+|++.++.++||||+++++++.....   
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            456789999999999999999999999999999999865432   12355678888899999999999999865443   


Q ss_pred             ----eehhhhhhhccc
Q psy18060         83 ----FVLITEFAHMSL   94 (549)
Q Consensus        83 ----~~lv~ey~~~sL   94 (549)
                          ++++|||+.++|
T Consensus        97 ~~~~~~lv~e~~~~~l  112 (360)
T 3e3p_A           97 RDIYLNVVMEYVPDTL  112 (360)
T ss_dssp             TCEEEEEEEECCSCBH
T ss_pred             cceeEEEEeecccccH
Confidence                889999987765

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.05  E-value=1.5e-10  Score=120.86  Aligned_cols=89  Identities=29%  Similarity=0.444  Sum_probs=75.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCC-------ceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCcccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLK-------KTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET   79 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~   79 (549)
                      .++|++.+.||+|+||.||+|++..++       +.||||++... ........+.+|+++++.+ +|||||++++++.+
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            468999999999999999999986433       57999999754 3444567889999999999 89999999999999


Q ss_pred             ccceehhhhhhhc-ccccC
Q psy18060         80 LNEFVLITEFAHM-SLSKL   97 (549)
Q Consensus        80 ~~~~~lv~ey~~~-sLskl   97 (549)
                      ...+++||||+.+ +|..+
T Consensus       147 ~~~~~lv~e~~~~g~L~~~  165 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREY  165 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHH
T ss_pred             CCceEEEEEecCCCcHHHH
Confidence            9999999999954 66543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.04  E-value=1.4e-10  Score=117.37  Aligned_cols=90  Identities=30%  Similarity=0.454  Sum_probs=73.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEEC-CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc---CCCCccccccccc----
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHL-DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL---AHPNIIKFIASHE----   78 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIV~l~~~~~----   78 (549)
                      ..++|++++.||+|+||.||+|++. .+|+.||||++............+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999995 6789999999976543333334677888888776   8999999999886    


Q ss_pred             -cccceehhhhhhhccccc
Q psy18060         79 -TLNEFVLITEFAHMSLSK   96 (549)
Q Consensus        79 -~~~~~~lv~ey~~~sLsk   96 (549)
                       .....+++|||+.++|..
T Consensus        89 ~~~~~~~lv~e~~~~~L~~  107 (326)
T 1blx_A           89 DRETKLTLVFEHVDQDLTT  107 (326)
T ss_dssp             SSEEEEEEEEECCSCBHHH
T ss_pred             CCCceEEEEEecCCCCHHH
Confidence             567799999999877654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.04  E-value=1.1e-10  Score=119.25  Aligned_cols=83  Identities=29%  Similarity=0.346  Sum_probs=71.3

Q ss_pred             ccCeeee---eeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC-CCCccccccccccccce
Q psy18060          8 LEKYQKI---CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEF   83 (549)
Q Consensus         8 ~~~y~~~---~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~   83 (549)
                      .++|++.   +.||+|+||.||+|.++.+|+.||||++.+.     ....+.+|+.+++.+. ||||+++++++.+....
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            3567775   7899999999999999999999999999653     2346778999999997 99999999999999999


Q ss_pred             ehhhhhhhc-ccc
Q psy18060         84 VLITEFAHM-SLS   95 (549)
Q Consensus        84 ~lv~ey~~~-sLs   95 (549)
                      ++||||+.+ +|.
T Consensus        82 ~lv~e~~~~~~L~   94 (325)
T 3kn6_A           82 FLVMELLNGGELF   94 (325)
T ss_dssp             EEEECCCCSCBHH
T ss_pred             EEEEEccCCCcHH
Confidence            999999854 553

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.04  E-value=2.6e-10  Score=111.88  Aligned_cols=87  Identities=28%  Similarity=0.371  Sum_probs=74.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++.......   +.+.+|+++++.++||||+++++++.+....++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence            45678999999999999999999987 57889999997654332   568899999999999999999999999999999


Q ss_pred             hhhhhh-ccccc
Q psy18060         86 ITEFAH-MSLSK   96 (549)
Q Consensus        86 v~ey~~-~sLsk   96 (549)
                      +|||+. ++|..
T Consensus        81 v~e~~~~~~L~~   92 (267)
T 3t9t_A           81 VTEFMEHGCLSD   92 (267)
T ss_dssp             EECCCTTCBHHH
T ss_pred             EEeCCCCCcHHH
Confidence            999985 45543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.04  E-value=1e-10  Score=115.74  Aligned_cols=82  Identities=28%  Similarity=0.438  Sum_probs=70.0

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc---------
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET---------   79 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~---------   79 (549)
                      .+|++++.||+|+||.||+|++..+|+.||||++....      +.+.+|+++++.++||||+++++++..         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            57999999999999999999999999999999997542      356789999999999999999998754         


Q ss_pred             -------ccceehhhhhhhc-cccc
Q psy18060         80 -------LNEFVLITEFAHM-SLSK   96 (549)
Q Consensus        80 -------~~~~~lv~ey~~~-sLsk   96 (549)
                             ...++++|||+.+ +|..
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~  109 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQ  109 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHH
T ss_pred             ccccccCcceEEEEEeccCCCCHHH
Confidence                   4558899999864 6644

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.04  E-value=1.4e-10  Score=115.59  Aligned_cols=87  Identities=24%  Similarity=0.402  Sum_probs=72.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .++|....+||+|+||.||+|.+..+++.||||++.....  ...+.+.+|+.+++.++||||+++++++.+....+++|
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            3455566699999999999999999999999999976532  23467889999999999999999999999999999999


Q ss_pred             hhhh-ccccc
Q psy18060         88 EFAH-MSLSK   96 (549)
Q Consensus        88 ey~~-~sLsk   96 (549)
                      ||+. ++|..
T Consensus        99 e~~~~~~L~~  108 (295)
T 2clq_A           99 EQVPGGSLSA  108 (295)
T ss_dssp             ECCSEEEHHH
T ss_pred             EeCCCCCHHH
Confidence            9984 56544

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.03  E-value=1.4e-10  Score=115.92  Aligned_cols=90  Identities=26%  Similarity=0.338  Sum_probs=71.5

Q ss_pred             ccccCeeeee-eecccCceEEEEEEE--CCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          6 GALEKYQKIC-LIGEGSFGKVFKAIH--LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         6 ~~~~~y~~~~-~IG~G~fG~V~~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      ...++|++.+ .||+|+||.||+|.+  ..+++.||||++..........+.+.+|+++++.++||||+++++++ ....
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            4456899988 999999999999954  56789999999976554444457799999999999999999999998 5567


Q ss_pred             eehhhhhhh-ccccc
Q psy18060         83 FVLITEFAH-MSLSK   96 (549)
Q Consensus        83 ~~lv~ey~~-~sLsk   96 (549)
                      .+++|+|+. ++|..
T Consensus        92 ~~lv~e~~~~~~L~~  106 (291)
T 1xbb_A           92 WMLVMEMAELGPLNK  106 (291)
T ss_dssp             EEEEEECCTTEEHHH
T ss_pred             cEEEEEeCCCCCHHH
Confidence            889999985 45543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.03  E-value=1.1e-10  Score=123.58  Aligned_cols=81  Identities=25%  Similarity=0.338  Sum_probs=67.3

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc------ccc
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET------LNE   82 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~------~~~   82 (549)
                      .+|++.+.||+|+||.||+|+++.+|+.||||++....      ....+|+++|+.++|||||+++++|..      ...
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            46999999999999999999999999999999996532      123479999999999999999988743      234


Q ss_pred             eehhhhhhhcccc
Q psy18060         83 FVLITEFAHMSLS   95 (549)
Q Consensus        83 ~~lv~ey~~~sLs   95 (549)
                      +++||||+.+++.
T Consensus       128 ~~lv~e~~~~~l~  140 (420)
T 1j1b_A          128 LNLVLDYVPETVY  140 (420)
T ss_dssp             EEEEEECCCEEHH
T ss_pred             EEeehhcccccHH
Confidence            7789999876553

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.03  E-value=2.4e-10  Score=116.06  Aligned_cols=80  Identities=26%  Similarity=0.432  Sum_probs=70.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC-CCCcccccccccc--ccce
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHET--LNEF   83 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~--~~~~   83 (549)
                      ..++|++++.||+|+||.||+|++..+|+.||||++....     .+.+.+|+++++.++ ||||+++++++.+  ....
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            4578999999999999999999999999999999996432     356889999999997 9999999999877  5678


Q ss_pred             ehhhhhhh
Q psy18060         84 VLITEFAH   91 (549)
Q Consensus        84 ~lv~ey~~   91 (549)
                      +++|+|+.
T Consensus       109 ~lv~e~~~  116 (330)
T 3nsz_A          109 ALVFEHVN  116 (330)
T ss_dssp             EEEEECCC
T ss_pred             EEEEeccC
Confidence            99999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.03  E-value=2.2e-10  Score=115.53  Aligned_cols=92  Identities=22%  Similarity=0.321  Sum_probs=71.2

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECC---CCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      ....++|++.+.||+|+||.||+|.+..   +++.||||++..........+.+.+|+.++++++||||+++++++.+..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            3455789999999999999999998765   5568999999876656666678999999999999999999999987654


Q ss_pred             -----ceehhhhhhhc-cccc
Q psy18060         82 -----EFVLITEFAHM-SLSK   96 (549)
Q Consensus        82 -----~~~lv~ey~~~-sLsk   96 (549)
                           ..+++|+|+.+ +|..
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~  130 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHT  130 (313)
T ss_dssp             -----CEEEEEECCTTCBHHH
T ss_pred             ccCCcccEEEEecccCCCHHH
Confidence                 35899998853 5543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.01  E-value=4.3e-11  Score=119.72  Aligned_cols=90  Identities=23%  Similarity=0.275  Sum_probs=59.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++..... ......+.+|+.+++.++||||+++++++...+..++
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            345789999999999999999999999999999999965432 2234568899999999999999999999999999999


Q ss_pred             hhhhhh-ccccc
Q psy18060         86 ITEFAH-MSLSK   96 (549)
Q Consensus        86 v~ey~~-~sLsk   96 (549)
                      +|||+. ++|..
T Consensus        91 v~e~~~~~~L~~  102 (303)
T 2vwi_A           91 VMKLLSGGSVLD  102 (303)
T ss_dssp             EEECCTTCBHHH
T ss_pred             EehhccCCchHH
Confidence            999984 46544

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.01  E-value=2.1e-10  Score=116.65  Aligned_cols=88  Identities=22%  Similarity=0.265  Sum_probs=73.3

Q ss_pred             cccCeeeeeeecccCceEEEEEE----ECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccc--cc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAI----HLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE--TL   80 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~--~~   80 (549)
                      ..++|++++.||+|+||.||+|+    +..+|+.||||++...  .....+.+.+|+++++.++||||+++++++.  +.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            35689999999999999999999    4678899999999754  3344567899999999999999999999875  45


Q ss_pred             cceehhhhhh-hccccc
Q psy18060         81 NEFVLITEFA-HMSLSK   96 (549)
Q Consensus        81 ~~~~lv~ey~-~~sLsk   96 (549)
                      ..+++||||+ .++|..
T Consensus        99 ~~~~lv~e~~~~~~L~~  115 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRD  115 (327)
T ss_dssp             CEEEEEEECCTTCBHHH
T ss_pred             ceEEEEEeecCCCCHHH
Confidence            6689999998 455544

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.01  E-value=1.2e-10  Score=118.49  Aligned_cols=87  Identities=30%  Similarity=0.330  Sum_probs=70.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc----
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN----   81 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~----   81 (549)
                      -..++|++.+.||+|+||.||+|++.  |+.||||++....   .......+|+.++++++|||||++++++.+..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            34578999999999999999999876  7899999996532   23345667999999999999999999987754    


Q ss_pred             ceehhhhhhhc-ccccC
Q psy18060         82 EFVLITEFAHM-SLSKL   97 (549)
Q Consensus        82 ~~~lv~ey~~~-sLskl   97 (549)
                      .+++||||+.+ +|..+
T Consensus        96 ~~~lv~e~~~~g~L~~~  112 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDF  112 (322)
T ss_dssp             EEEEEEECCTTCBHHHH
T ss_pred             eEEEEEecCCCCCHHHH
Confidence            36999999854 66543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.01  E-value=2.8e-10  Score=116.37  Aligned_cols=89  Identities=25%  Similarity=0.368  Sum_probs=73.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCC----ceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLK----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      ..++|++.+.||+|+||.||+|.++.++    ..||||++.... .......+.+|+++++.++||||+++++++.+...
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            4567999999999999999999987654    359999997543 34445678999999999999999999999999999


Q ss_pred             eehhhhhhhc-cccc
Q psy18060         83 FVLITEFAHM-SLSK   96 (549)
Q Consensus        83 ~~lv~ey~~~-sLsk   96 (549)
                      .++||||+.+ +|..
T Consensus       121 ~~lv~e~~~~~~L~~  135 (333)
T 1mqb_A          121 MMIITEYMENGALDK  135 (333)
T ss_dssp             EEEEEECCTTEEHHH
T ss_pred             cEEEEeCCCCCcHHH
Confidence            9999999854 6644

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.01  E-value=8.9e-11  Score=119.17  Aligned_cols=89  Identities=21%  Similarity=0.297  Sum_probs=72.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++.+.||+|+||.||+|++. +|+.||||++...... .....+.+|+++++.++||||+++++++.+....++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred             HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence            45678999999999999999999854 6899999999765422 222468899999999999999999999999999999


Q ss_pred             hhhhhhc-cccc
Q psy18060         86 ITEFAHM-SLSK   96 (549)
Q Consensus        86 v~ey~~~-sLsk   96 (549)
                      ||+|+.+ +|..
T Consensus       105 v~e~~~~~~L~~  116 (326)
T 3uim_A          105 VYPYMANGSVAS  116 (326)
T ss_dssp             EEECCTTCBHHH
T ss_pred             EEEeccCCCHHH
Confidence            9999854 5543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.01  E-value=2.7e-10  Score=119.77  Aligned_cols=84  Identities=29%  Similarity=0.448  Sum_probs=64.8

Q ss_pred             cCeee-eeeecccCceEEEEEEEC--CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccc--ccccce
Q psy18060          9 EKYQK-ICLIGEGSFGKVFKAIHL--DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASH--ETLNEF   83 (549)
Q Consensus         9 ~~y~~-~~~IG~G~fG~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~--~~~~~~   83 (549)
                      +.|++ .++||+|+||.||+|+++  .+++.||||++......    ..+.+|+.+|+.|+|||||++++++  .....+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            34776 558999999999999977  57899999999754332    3577999999999999999999999  457789


Q ss_pred             ehhhhhhhccccc
Q psy18060         84 VLITEFAHMSLSK   96 (549)
Q Consensus        84 ~lv~ey~~~sLsk   96 (549)
                      ++||||+.++|..
T Consensus        96 ~lv~e~~~~~l~~  108 (405)
T 3rgf_A           96 WLLFDYAEHDLWH  108 (405)
T ss_dssp             EEEEECCSEEHHH
T ss_pred             EEEEeCCCCCHHH
Confidence            9999999877643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.00  E-value=1.7e-10  Score=117.41  Aligned_cols=90  Identities=28%  Similarity=0.356  Sum_probs=74.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceE--EEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccccccce
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTV--ALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEF   83 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~v--AiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~   83 (549)
                      ..++|++.+.||+|+||.||+|+++.+|+.+  |||.+.... .....+.+.+|+++++++ +||||+++++++.+...+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            4578999999999999999999999988865  999996532 233446788999999999 899999999999999999


Q ss_pred             ehhhhhhh-cccccC
Q psy18060         84 VLITEFAH-MSLSKL   97 (549)
Q Consensus        84 ~lv~ey~~-~sLskl   97 (549)
                      +++|||+. ++|..+
T Consensus       102 ~lv~e~~~~~~L~~~  116 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDF  116 (327)
T ss_dssp             EEEECCCTTCBHHHH
T ss_pred             EEEEecCCCCCHHHH
Confidence            99999984 466543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.00  E-value=2.7e-10  Score=118.44  Aligned_cols=85  Identities=18%  Similarity=0.278  Sum_probs=73.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC--------CCCccccccccc-
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA--------HPNIIKFIASHE-   78 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIV~l~~~~~-   78 (549)
                      .++|++++.||+|+||.||+|++..+|+.||||++...   ....+.+.+|+.+++.++        ||||+++++.+. 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            36899999999999999999999999999999999643   334467889999999885        888999999987 


Q ss_pred             ---cccceehhhhhhhcccc
Q psy18060         79 ---TLNEFVLITEFAHMSLS   95 (549)
Q Consensus        79 ---~~~~~~lv~ey~~~sLs   95 (549)
                         +...+++||+|+.+++.
T Consensus       113 ~~~~~~~~~lv~e~~~~~l~  132 (397)
T 1wak_A          113 SGVNGTHICMVFEVLGHHLL  132 (397)
T ss_dssp             EETTEEEEEEEECCCCCBHH
T ss_pred             cCCCCceEEEEEeccCccHH
Confidence               66789999999977654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.00  E-value=2.4e-10  Score=115.45  Aligned_cols=90  Identities=21%  Similarity=0.289  Sum_probs=77.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC--CCCcccccccccccccee
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA--HPNIIKFIASHETLNEFV   84 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~~~~~~   84 (549)
                      .-++|++++.||+|+||.||+|.+. +|+.||||++............+.+|++++.+++  ||||+++++++.+...++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            4467999999999999999999986 4899999999876655556678999999999997  599999999999999999


Q ss_pred             hhhhhhhcccccC
Q psy18060         85 LITEFAHMSLSKL   97 (549)
Q Consensus        85 lv~ey~~~sLskl   97 (549)
                      ++||+..++|..+
T Consensus       105 lv~e~~~~~L~~~  117 (313)
T 3cek_A          105 MVMECGNIDLNSW  117 (313)
T ss_dssp             EEECCCSEEHHHH
T ss_pred             EEEecCCCcHHHH
Confidence            9999877776543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.00  E-value=4.3e-10  Score=116.69  Aligned_cols=87  Identities=25%  Similarity=0.380  Sum_probs=74.1

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC--Ch----hhhhhHHHHHHHHHhc-CCCCcccccccccccc
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR--SG----KELSSLKQECEIQKHL-AHPNIIKFIASHETLN   81 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~--~~----~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~   81 (549)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++.....  ..    ...+.+.+|+.+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            469999999999999999999999999999999976542  11    1245688999999999 7999999999999999


Q ss_pred             ceehhhhhhhc-ccc
Q psy18060         82 EFVLITEFAHM-SLS   95 (549)
Q Consensus        82 ~~~lv~ey~~~-sLs   95 (549)
                      ..++||||+.+ +|.
T Consensus       174 ~~~lv~e~~~g~~L~  188 (365)
T 2y7j_A          174 FMFLVFDLMRKGELF  188 (365)
T ss_dssp             EEEEEECCCTTCBHH
T ss_pred             EEEEEEEeCCCCcHH
Confidence            99999999864 553

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=98.99  E-value=3.4e-10  Score=115.20  Aligned_cols=88  Identities=27%  Similarity=0.354  Sum_probs=72.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEE----CCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc-
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIH----LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-   81 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-   81 (549)
                      ..++|++++.||+|+||.||+|++    ..+|+.||||++....  ....+.+.+|+++++.++||||+++++++.... 
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            445799999999999999999994    5689999999997542  344567899999999999999999999876543 


Q ss_pred             -ceehhhhhhh-ccccc
Q psy18060         82 -EFVLITEFAH-MSLSK   96 (549)
Q Consensus        82 -~~~lv~ey~~-~sLsk   96 (549)
                       .+++||||+. ++|..
T Consensus       117 ~~~~lv~e~~~~~~L~~  133 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRD  133 (326)
T ss_dssp             -CCEEEECCCTTCBHHH
T ss_pred             CceEEEEECCCCCCHHH
Confidence             6899999985 46644

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.98  E-value=1.2e-09  Score=112.88  Aligned_cols=140  Identities=16%  Similarity=0.196  Sum_probs=103.8

Q ss_pred             EEEEEecCCcEEEEEEEEcCCCceEEEEEEe--cCCCChHHHHHHHHHHHHHHhcC--CCCeeEEEEEEeeC---CEEEE
Q psy18060        123 KICLIGEGSFGKVFKAIHLDLKKTVALKIIS--KSGRSGKELSSLKQECEIQKHLA--HPNIIKFIASHETL---NEFVL  195 (549)
Q Consensus       123 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~--~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~~i  195 (549)
                      .++.++.|.++.||++...  +..+++|+..  .... ......+.+|..+++.+.  +..+++++.++.+.   +..|+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            4678899999999998754  4678888765  3211 122346788999999986  45578889888766   34789


Q ss_pred             EEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q psy18060        196 ITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHS---------------------------------------  235 (549)
Q Consensus       196 V~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~---------------------------------------  235 (549)
                      |||+++| .+.+.  ....++..+...++.+++.+|..||+                                       
T Consensus       119 vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          119 IMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999987 44321  12347788888999999999999997                                       


Q ss_pred             -------------------CCCccccccCCcEEEecCCc--EEEeecccceec
Q psy18060        236 -------------------NRVLHRDLKPQNVLLNKDGV--AMLCDFGFARSM  267 (549)
Q Consensus       236 -------------------~gIiHrDIKP~NILl~~~g~--vKL~DFGla~~~  267 (549)
                                         .+++|+|++|.|||++.++.  +.|.||+.+..-
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                               35899999999999997753  689999988643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=98.98  E-value=5e-10  Score=119.65  Aligned_cols=85  Identities=21%  Similarity=0.341  Sum_probs=71.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc-cee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-EFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~   84 (549)
                      ...++|++.+.||+|+||.||+|.+.  |+.||||+++...    ..+.+.+|+++|++++|||||++++++.... .++
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            34678999999999999999999886  6899999997543    3467889999999999999999999875544 799


Q ss_pred             hhhhhhh-ccccc
Q psy18060         85 LITEFAH-MSLSK   96 (549)
Q Consensus        85 lv~ey~~-~sLsk   96 (549)
                      +||||+. ++|..
T Consensus       264 iv~e~~~~g~L~~  276 (450)
T 1k9a_A          264 IVTEYMAKGSLVD  276 (450)
T ss_dssp             EEEECCTTCBHHH
T ss_pred             EEEEecCCCcHHH
Confidence            9999985 46643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=98.98  E-value=2.4e-10  Score=118.60  Aligned_cols=90  Identities=19%  Similarity=0.196  Sum_probs=61.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhc--CCCCccccccccc------
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL--AHPNIIKFIASHE------   78 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l--~HpnIV~l~~~~~------   78 (549)
                      ..+|++.+.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|++++..|  +||||++++..+.      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3459999999999999999999999999999999987654 334456778886555444  6999988664442      


Q ss_pred             -cc-----------------cceehhhhhhhcccccC
Q psy18060         79 -TL-----------------NEFVLITEFAHMSLSKL   97 (549)
Q Consensus        79 -~~-----------------~~~~lv~ey~~~sLskl   97 (549)
                       ..                 ..+++||||+.++|..+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~  177 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL  177 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHH
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHH
Confidence             11                 44899999998877654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=98.98  E-value=6.8e-10  Score=110.26  Aligned_cols=90  Identities=27%  Similarity=0.349  Sum_probs=72.8

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCC---CceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDL---KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      ....++|++.+.||+|+||.||+|.+..+   +..||||++.... .....+.+.+|+.++++++||||+++++++. .+
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   88 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence            44567899999999999999999998754   4579999986543 3444567899999999999999999999885 45


Q ss_pred             ceehhhhhhhc-cccc
Q psy18060         82 EFVLITEFAHM-SLSK   96 (549)
Q Consensus        82 ~~~lv~ey~~~-sLsk   96 (549)
                      ..++||||+.+ +|..
T Consensus        89 ~~~lv~e~~~~~~L~~  104 (281)
T 1mp8_A           89 PVWIIMELCTLGELRS  104 (281)
T ss_dssp             SCEEEEECCTTEEHHH
T ss_pred             ccEEEEecCCCCCHHH
Confidence            68899999853 5543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=98.97  E-value=6.9e-10  Score=111.46  Aligned_cols=84  Identities=19%  Similarity=0.376  Sum_probs=70.6

Q ss_pred             ccccCeeee-eeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHH-HhcCCCCcccccccccc----
Q psy18060          6 GALEKYQKI-CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ-KHLAHPNIIKFIASHET----   79 (549)
Q Consensus         6 ~~~~~y~~~-~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIV~l~~~~~~----   79 (549)
                      ...++|.++ ++||+|+||.||+|.++.+|+.||||++...       ..+.+|+.++ +.++||||+++++++.+    
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   86 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG   86 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence            456789998 7899999999999999999999999999642       3567888888 56689999999999876    


Q ss_pred             ccceehhhhhhhc-cccc
Q psy18060         80 LNEFVLITEFAHM-SLSK   96 (549)
Q Consensus        80 ~~~~~lv~ey~~~-sLsk   96 (549)
                      ...+++||||+.+ +|..
T Consensus        87 ~~~~~lv~e~~~~~~L~~  104 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFS  104 (299)
T ss_dssp             EEEEEEEECCCCSCBHHH
T ss_pred             CceEEEEEeecCCCcHHH
Confidence            7789999999854 6643

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=98.97  E-value=4.1e-10  Score=112.34  Aligned_cols=87  Identities=26%  Similarity=0.282  Sum_probs=75.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccccccceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++.....    ...+.+|+.+++.+ +||||+++++++.+....++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            44679999999999999999999999999999999965432    24578899999999 79999999999999999999


Q ss_pred             hhhhhhcccccC
Q psy18060         86 ITEFAHMSLSKL   97 (549)
Q Consensus        86 v~ey~~~sLskl   97 (549)
                      +|||+.++|..+
T Consensus        84 v~e~~~~~L~~~   95 (298)
T 1csn_A           84 VIDLLGPSLEDL   95 (298)
T ss_dssp             EEECCCCBHHHH
T ss_pred             EEEecCCCHHHH
Confidence            999997777654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=98.97  E-value=6.2e-10  Score=118.23  Aligned_cols=86  Identities=28%  Similarity=0.443  Sum_probs=73.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc------CCCCcccccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL------AHPNIIKFIASHETLN   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l------~HpnIV~l~~~~~~~~   81 (549)
                      ..+|++++.||+|+||.||+|.+..+|+.||||++...   ......+.+|+++++.+      +||||+++++.+....
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            45799999999999999999999999999999999643   23345677899988877      6789999999999999


Q ss_pred             ceehhhhhhhccccc
Q psy18060         82 EFVLITEFAHMSLSK   96 (549)
Q Consensus        82 ~~~lv~ey~~~sLsk   96 (549)
                      .++++|||+.++|..
T Consensus       173 ~~~lv~e~~~~~L~~  187 (429)
T 3kvw_A          173 HICMTFELLSMNLYE  187 (429)
T ss_dssp             EEEEEECCCCCBHHH
T ss_pred             eEEEEEeccCCCHHH
Confidence            999999999877654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=98.97  E-value=5.2e-10  Score=111.84  Aligned_cols=91  Identities=21%  Similarity=0.296  Sum_probs=71.5

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCC---ceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccc-ccc
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLK---KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASH-ETL   80 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-~~~   80 (549)
                      .+....|++.+.||+|+||.||+|.+..++   ..||+|.+.... .....+.+.+|+.++++++||||+++++++ ...
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            344567999999999999999999976433   468999997533 344557789999999999999999999984 556


Q ss_pred             cceehhhhhhhc-cccc
Q psy18060         81 NEFVLITEFAHM-SLSK   96 (549)
Q Consensus        81 ~~~~lv~ey~~~-sLsk   96 (549)
                      ...+++|+|+.+ +|..
T Consensus       100 ~~~~~v~e~~~~~~L~~  116 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRN  116 (298)
T ss_dssp             SCCEEEEECCTTCBHHH
T ss_pred             CceEEEEeCCCCCCHHH
Confidence            678999999864 6644

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=98.97  E-value=4.6e-10  Score=113.38  Aligned_cols=83  Identities=29%  Similarity=0.369  Sum_probs=69.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++.+.||+|+||.||+|++.  ++.||||++...    ...+.+.+|++++++++||||+++++++.+  ..++
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l   76 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL   76 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence            34678999999999999999999885  688999999642    234678899999999999999999998874  4789


Q ss_pred             hhhhhh-ccccc
Q psy18060         86 ITEFAH-MSLSK   96 (549)
Q Consensus        86 v~ey~~-~sLsk   96 (549)
                      ||||+. ++|..
T Consensus        77 v~e~~~~~~L~~   88 (307)
T 2eva_A           77 VMEYAEGGSLYN   88 (307)
T ss_dssp             EEECCTTCBHHH
T ss_pred             EEEcCCCCCHHH
Confidence            999985 46644

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=98.96  E-value=2.4e-10  Score=128.38  Aligned_cols=88  Identities=19%  Similarity=0.343  Sum_probs=74.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhc-CCCCcccccccccccccee
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~   84 (549)
                      .+++|+++++||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|..+ +||||+.+++++++...+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            46789999999999999999999999999999999976431 223346778899999887 6999999999999999999


Q ss_pred             hhhhhhhc-cc
Q psy18060         85 LITEFAHM-SL   94 (549)
Q Consensus        85 lv~ey~~~-sL   94 (549)
                      +||||+.+ +|
T Consensus       419 lV~E~~~gg~L  429 (674)
T 3pfq_A          419 FVMEYVNGGDL  429 (674)
T ss_dssp             EEEECCCSCBH
T ss_pred             EEEeCcCCCcH
Confidence            99999853 44

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.96  E-value=1.1e-09  Score=110.51  Aligned_cols=181  Identities=18%  Similarity=0.214  Sum_probs=120.8

Q ss_pred             EEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCC--eeEEEEEEeeCC---EEEEEEe
Q psy18060        125 CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPN--IIKFIASHETLN---EFVLITE  198 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpn--Iv~l~~~~~~~~---~~~iV~E  198 (549)
                      +.++.|....||++.     ..+++|+...    ......+.+|..+++.+ .+..  +++.+......+   ..|+||+
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            458999999999862     5688998642    23456788999999887 3333  455655544333   3478999


Q ss_pred             cCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q psy18060        199 FAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHS------------------------------------------  235 (549)
Q Consensus       199 ~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~------------------------------------------  235 (549)
                      +++| +|.....  ..++..+...++.|++..|..||+                                          
T Consensus        97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            9998 5554322  357777888888899998888886                                          


Q ss_pred             ----------------CCCccccccCCcEEEec--CCcEEEeecccceecccCcccccccCCCCcccccccccC-----C
Q psy18060        236 ----------------NRVLHRDLKPQNVLLNK--DGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE-----R  292 (549)
Q Consensus       236 ----------------~gIiHrDIKP~NILl~~--~g~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~  292 (549)
                                      ..++|+|++|.||+++.  .+.+.|+||+.+....+..+..... ....-..|+....     +
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~-~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLM-EDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTC-CTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHH-hhccccCHHHHHHHHHHcC
Confidence                            13699999999999998  4567899999986543221110000 0000023332210     0


Q ss_pred             CC---------CcchhhHHHHHHHHHHHhCCCCC
Q psy18060        293 PY---------DHTADLWSLGCIAYEIHMGHPPF  317 (549)
Q Consensus       293 ~y---------~~ksDIwSlGvil~eLltG~~Pf  317 (549)
                      ..         ..-.+.|++|.++|.+.+|..||
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            01         12268999999999999998876

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=98.96  E-value=7e-10  Score=109.83  Aligned_cols=87  Identities=23%  Similarity=0.348  Sum_probs=71.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++++.||+|+||.||+|.+. +++.||||++......   .+.+.+|+++++.++||||+++++++.+ +..++
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            44578999999999999999999976 4678999999754432   3578899999999999999999998864 45889


Q ss_pred             hhhhh-hcccccC
Q psy18060         86 ITEFA-HMSLSKL   97 (549)
Q Consensus        86 v~ey~-~~sLskl   97 (549)
                      +|+|+ .++|..+
T Consensus        85 v~e~~~~~~L~~~   97 (279)
T 1qpc_A           85 ITEYMENGSLVDF   97 (279)
T ss_dssp             EEECCTTCBHHHH
T ss_pred             EEecCCCCCHHHH
Confidence            99998 4566544

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=98.96  E-value=5.9e-10  Score=112.19  Aligned_cols=91  Identities=24%  Similarity=0.372  Sum_probs=73.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEE-----CCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCcccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIH-----LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET   79 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~   79 (549)
                      ...++|++.+.||+|+||.||+|++     ..+++.||||++.... .....+.+.+|++++..+ +||||+++++++..
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            3456899999999999999999985     3567899999997543 334456789999999999 69999999999876


Q ss_pred             cc-ceehhhhhhh-cccccC
Q psy18060         80 LN-EFVLITEFAH-MSLSKL   97 (549)
Q Consensus        80 ~~-~~~lv~ey~~-~sLskl   97 (549)
                      .. .++++|||+. ++|..+
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~  122 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTY  122 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHH
T ss_pred             CCCceEEEEEcCCCCcHHHH
Confidence            54 5899999985 466543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=98.95  E-value=2.1e-10  Score=118.56  Aligned_cols=89  Identities=22%  Similarity=0.438  Sum_probs=73.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEEC---CCCceEEEEEeccCCC--ChhhhhhHHHHHHHHHhc-CCCCccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGR--SGKELSSLKQECEIQKHL-AHPNIIKFIASHETL   80 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~---~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~   80 (549)
                      ..++|++++.||+|+||.||+|++.   .+|+.||||++++...  .....+.+.+|+++|+.+ +||||+++++++.+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            3478999999999999999999985   5899999999975432  112335677899999999 699999999999999


Q ss_pred             cceehhhhhhhc-ccc
Q psy18060         81 NEFVLITEFAHM-SLS   95 (549)
Q Consensus        81 ~~~~lv~ey~~~-sLs   95 (549)
                      ..+++||||+.+ +|.
T Consensus       132 ~~~~lv~e~~~~~~L~  147 (355)
T 1vzo_A          132 TKLHLILDYINGGELF  147 (355)
T ss_dssp             TEEEEEECCCCSCBHH
T ss_pred             ceEEEEeecCCCCCHH
Confidence            999999999853 553

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=98.95  E-value=3.4e-10  Score=114.81  Aligned_cols=85  Identities=32%  Similarity=0.405  Sum_probs=69.4

Q ss_pred             eeeeeeecccCceEEEEEEE----CCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc--cccee
Q psy18060         11 YQKICLIGEGSFGKVFKAIH----LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--LNEFV   84 (549)
Q Consensus        11 y~~~~~IG~G~fG~V~~~~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~   84 (549)
                      |++++.||+|+||.||+|.+    ..+|+.||||++... ......+.+.+|+++++.++||||+++++++.+  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            59999999999999988865    457899999999754 334455778999999999999999999999876  45689


Q ss_pred             hhhhhhhc-cccc
Q psy18060         85 LITEFAHM-SLSK   96 (549)
Q Consensus        85 lv~ey~~~-sLsk   96 (549)
                      +||||+.+ +|..
T Consensus       112 lv~e~~~~~~L~~  124 (318)
T 3lxp_A          112 LVMEYVPLGSLRD  124 (318)
T ss_dssp             EEECCCTTCBHHH
T ss_pred             EEEecccCCcHHH
Confidence            99999853 6544

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=98.95  E-value=1e-09  Score=109.51  Aligned_cols=85  Identities=21%  Similarity=0.355  Sum_probs=68.9

Q ss_pred             CeeeeeeecccCceEEEEEEECCCCc---eEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccce-eh
Q psy18060         10 KYQKICLIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF-VL   85 (549)
Q Consensus        10 ~y~~~~~IG~G~fG~V~~~~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~-~l   85 (549)
                      .|+..+.||+|+||.||+|.+..+++   .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            46777999999999999999866554   79999997533 334557889999999999999999999999776655 88


Q ss_pred             hhhhh-hcccc
Q psy18060         86 ITEFA-HMSLS   95 (549)
Q Consensus        86 v~ey~-~~sLs   95 (549)
                      +++|+ .++|.
T Consensus       101 v~e~~~~~~L~  111 (298)
T 3pls_A          101 LLPYMCHGDLL  111 (298)
T ss_dssp             EECCCTTCBHH
T ss_pred             EEecccCCCHH
Confidence            88887 44553

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=98.94  E-value=5.4e-10  Score=110.68  Aligned_cols=85  Identities=21%  Similarity=0.351  Sum_probs=69.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc-cccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-LNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~   84 (549)
                      ...++|++.+.||+|+||.||+|.+.  |+.||||++....    ..+.+.+|+++++.++||||+++++++.+ ...++
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   91 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence            45678999999999999999999875  7899999996532    34578899999999999999999998644 45789


Q ss_pred             hhhhhhhc-cccc
Q psy18060         85 LITEFAHM-SLSK   96 (549)
Q Consensus        85 lv~ey~~~-sLsk   96 (549)
                      ++|||+.+ +|..
T Consensus        92 lv~e~~~~~~L~~  104 (278)
T 1byg_A           92 IVTEYMAKGSLVD  104 (278)
T ss_dssp             EEECCCTTEEHHH
T ss_pred             EEEecCCCCCHHH
Confidence            99999864 6644

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=98.94  E-value=6.8e-10  Score=118.72  Aligned_cols=86  Identities=23%  Similarity=0.369  Sum_probs=71.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++.....   .+.+.+|+++|++++||||+++++++.+ ..+++|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            44679999999999999999999976 467999999765432   3568899999999999999999999876 678999


Q ss_pred             hhhhh-cccccC
Q psy18060         87 TEFAH-MSLSKL   97 (549)
Q Consensus        87 ~ey~~-~sLskl   97 (549)
                      |||+. ++|..+
T Consensus       257 ~e~~~~gsL~~~  268 (452)
T 1fmk_A          257 TEYMSKGSLLDF  268 (452)
T ss_dssp             ECCCTTCBHHHH
T ss_pred             ehhhcCCCHHHH
Confidence            99985 466543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=98.94  E-value=6.9e-10  Score=110.78  Aligned_cols=84  Identities=26%  Similarity=0.425  Sum_probs=70.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      .-.+|++.+.||+|+||.||+|++..   .||||++..........+.+.+|++++++++||||+++++.. .....+++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            44689999999999999999998653   599999987665666677899999999999999999999854 55668899


Q ss_pred             hhhhh-ccc
Q psy18060         87 TEFAH-MSL   94 (549)
Q Consensus        87 ~ey~~-~sL   94 (549)
                      |+|+. ++|
T Consensus        98 ~e~~~~~~L  106 (289)
T 3og7_A           98 TQWCEGSSL  106 (289)
T ss_dssp             EECCCEEEH
T ss_pred             EEecCCCcH
Confidence            99985 444

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=98.94  E-value=1e-09  Score=117.33  Aligned_cols=85  Identities=26%  Similarity=0.347  Sum_probs=71.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++....   ..+.+.+|+++|+.++|||||++++++. ...+++|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            45679999999999999999999864 67899999976433   2467899999999999999999999886 5678999


Q ss_pred             hhhhh-ccccc
Q psy18060         87 TEFAH-MSLSK   96 (549)
Q Consensus        87 ~ey~~-~sLsk   96 (549)
                      |||+. ++|..
T Consensus       261 ~e~~~~g~L~~  271 (454)
T 1qcf_A          261 TEFMAKGSLLD  271 (454)
T ss_dssp             ECCCTTCBHHH
T ss_pred             EeecCCCcHHH
Confidence            99985 46643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=98.93  E-value=1.1e-09  Score=115.22  Aligned_cols=84  Identities=19%  Similarity=0.351  Sum_probs=68.9

Q ss_pred             ccccCeeee-eeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHH-hcCCCCcccccccccc----
Q psy18060          6 GALEKYQKI-CLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQK-HLAHPNIIKFIASHET----   79 (549)
Q Consensus         6 ~~~~~y~~~-~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~-~l~HpnIV~l~~~~~~----   79 (549)
                      ...++|.+. ++||+|+||+||+|.++.+|+.||||++...       ..+.+|+.++. .++||||+++++++..    
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            346778887 7899999999999999999999999999632       35678888874 4589999999998865    


Q ss_pred             ccceehhhhhhh-ccccc
Q psy18060         80 LNEFVLITEFAH-MSLSK   96 (549)
Q Consensus        80 ~~~~~lv~ey~~-~sLsk   96 (549)
                      ...+++||||+. ++|..
T Consensus       131 ~~~~~lv~E~~~gg~L~~  148 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFS  148 (400)
T ss_dssp             EEEEEEEEECCCSEEHHH
T ss_pred             CcEEEEEEEeCCCCcHHH
Confidence            667999999985 46643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=98.93  E-value=1.6e-09  Score=107.98  Aligned_cols=89  Identities=21%  Similarity=0.338  Sum_probs=72.0

Q ss_pred             ccccCeeeee-eecccCceEEEEEEEC--CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          6 GALEKYQKIC-LIGEGSFGKVFKAIHL--DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         6 ~~~~~y~~~~-~IG~G~fG~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      ...++|.+.. .||+|+||.||+|.++  .+++.||||++.... .....+.+.+|+++++.++||||+++++++ ....
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            4456788887 9999999999999864  467889999997643 344567789999999999999999999998 4556


Q ss_pred             eehhhhhhhc-cccc
Q psy18060         83 FVLITEFAHM-SLSK   96 (549)
Q Consensus        83 ~~lv~ey~~~-sLsk   96 (549)
                      .+++|||+.+ +|..
T Consensus        84 ~~lv~e~~~~~~L~~   98 (287)
T 1u59_A           84 LMLVMEMAGGGPLHK   98 (287)
T ss_dssp             EEEEEECCTTEEHHH
T ss_pred             cEEEEEeCCCCCHHH
Confidence            8999999854 5543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=98.92  E-value=5.6e-10  Score=117.12  Aligned_cols=80  Identities=28%  Similarity=0.418  Sum_probs=65.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc------
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN------   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~------   81 (549)
                      ..+|++.++||+|+||.||+|++..+++ ||+|++.....      ...+|+++|+.++|||||++++++....      
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            3569999999999999999999988766 99999865332      2237999999999999999999985433      


Q ss_pred             ceehhhhhhhccc
Q psy18060         82 EFVLITEFAHMSL   94 (549)
Q Consensus        82 ~~~lv~ey~~~sL   94 (549)
                      .+++||||+.+++
T Consensus       112 ~~~lv~e~~~~~l  124 (394)
T 4e7w_A          112 FLNLVLEYVPETV  124 (394)
T ss_dssp             EEEEEEECCSEEH
T ss_pred             EEEEEeeccCccH
Confidence            3889999997654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=98.92  E-value=7.4e-10  Score=124.56  Aligned_cols=88  Identities=20%  Similarity=0.329  Sum_probs=73.7

Q ss_pred             cCeeeeeeecccCceEEEEEEECC-CCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc-----
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLD-LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE-----   82 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~-----   82 (549)
                      ++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|++++++++|||||++++++.....     
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            789999999999999999999986 78999999986543 33445678899999999999999999999987665     


Q ss_pred             eehhhhhhh-cccccC
Q psy18060         83 FVLITEFAH-MSLSKL   97 (549)
Q Consensus        83 ~~lv~ey~~-~sLskl   97 (549)
                      .|+||||+. ++|...
T Consensus       159 ~~lv~E~~~g~~L~~~  174 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRS  174 (681)
T ss_dssp             EEEEEECCCCEECC--
T ss_pred             eEEEEEeCCCCcHHHH
Confidence            799999995 566543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=98.91  E-value=5.9e-10  Score=112.31  Aligned_cols=88  Identities=27%  Similarity=0.425  Sum_probs=65.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh----hhhhhHHHHHHHHHhc----CCCCcccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHL----AHPNIIKFIASHET   79 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l----~HpnIV~l~~~~~~   79 (549)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++.......    .....+.+|+.++.++    +||||+++++++.+
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            457999999999999999999999999999999997654321    1234567899999998    89999999999999


Q ss_pred             ccceehhhhh-h-hcccc
Q psy18060         80 LNEFVLITEF-A-HMSLS   95 (549)
Q Consensus        80 ~~~~~lv~ey-~-~~sLs   95 (549)
                      .+..++++++ + .++|.
T Consensus       110 ~~~~~~v~e~~~~~~~L~  127 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLF  127 (312)
T ss_dssp             ---CEEEEECCSSEEEHH
T ss_pred             CCeEEEEEEecCCCCCHH
Confidence            8999999987 3 34543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=98.91  E-value=7.8e-10  Score=110.51  Aligned_cols=84  Identities=32%  Similarity=0.466  Sum_probs=66.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHh--cCCCCcccccccccc----c
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH--LAHPNIIKFIASHET----L   80 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIV~l~~~~~~----~   80 (549)
                      ..++|++++.||+|+||.||+|++  +|+.||||++...     ....+.+|.+++..  ++||||+++++.+.+    .
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            456899999999999999999988  5899999998643     22455677777776  799999999988543    4


Q ss_pred             cceehhhhhhhc-ccccC
Q psy18060         81 NEFVLITEFAHM-SLSKL   97 (549)
Q Consensus        81 ~~~~lv~ey~~~-sLskl   97 (549)
                      ..++++|||+.+ +|..+
T Consensus        79 ~~~~lv~e~~~~g~L~~~   96 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDY   96 (301)
T ss_dssp             EEEEEEECCCTTCBHHHH
T ss_pred             ceeEEehhhccCCCHHHH
Confidence            568999999864 66543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=98.91  E-value=1e-09  Score=110.28  Aligned_cols=81  Identities=22%  Similarity=0.309  Sum_probs=67.8

Q ss_pred             eeeeecccCceEEEEEEECCCCceEEEEEeccCCC--ChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhhhhh
Q psy18060         13 KICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR--SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA   90 (549)
Q Consensus        13 ~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~ey~   90 (549)
                      ..+.||+|+||.||+|.+  +++.||||++.....  .....+.+.+|+.+++.++||||+++++++.+....+++|+|+
T Consensus        35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  112 (307)
T 2nru_A           35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM  112 (307)
T ss_dssp             TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence            348999999999999986  578999999976432  2334567899999999999999999999999999999999998


Q ss_pred             h-cccc
Q psy18060         91 H-MSLS   95 (549)
Q Consensus        91 ~-~sLs   95 (549)
                      . ++|.
T Consensus       113 ~~~~L~  118 (307)
T 2nru_A          113 PNGSLL  118 (307)
T ss_dssp             TTCBHH
T ss_pred             CCCcHH
Confidence            4 4554

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=98.91  E-value=8.8e-10  Score=112.31  Aligned_cols=86  Identities=23%  Similarity=0.400  Sum_probs=62.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceE----EEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTV----ALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      ..++|++++.||+|+||.||+|++..+|+.+    |+|.+.... .....+.+.+|+.++++++||||+++++++.+.. 
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            3568999999999999999999998888755    777775432 2233467889999999999999999999998765 


Q ss_pred             eehhhhhh-hccc
Q psy18060         83 FVLITEFA-HMSL   94 (549)
Q Consensus        83 ~~lv~ey~-~~sL   94 (549)
                      .+++++++ .++|
T Consensus        91 ~~~v~e~~~~g~L  103 (327)
T 3poz_A           91 VQLITQLMPFGCL  103 (327)
T ss_dssp             EEEEEECCTTCBH
T ss_pred             eEEEEEecCCCcH
Confidence            56667665 3444

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=98.90  E-value=8.3e-10  Score=112.32  Aligned_cols=87  Identities=20%  Similarity=0.369  Sum_probs=69.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCce----EEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKT----VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      ..++|++++.||+|+||.||+|+++.+|+.    ||+|.+.... .....+.+.+|+.++++++||||+++++++. ...
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            456899999999999999999999988876    6777765432 2223356778999999999999999999886 456


Q ss_pred             eehhhhhhh-cccc
Q psy18060         83 FVLITEFAH-MSLS   95 (549)
Q Consensus        83 ~~lv~ey~~-~sLs   95 (549)
                      .++||+|+. ++|.
T Consensus        89 ~~~v~e~~~~~~L~  102 (325)
T 3kex_A           89 LQLVTQYLPLGSLL  102 (325)
T ss_dssp             EEEEEECCTTCBSH
T ss_pred             cEEEEEeCCCCCHH
Confidence            888999874 4553

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=98.89  E-value=4.6e-10  Score=115.54  Aligned_cols=83  Identities=16%  Similarity=0.083  Sum_probs=66.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCC--------CceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccc----
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDL--------KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIA----   75 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~----   75 (549)
                      -++|++.+.||+|+||.||+|+++.+        ++.||||++.+.       +.+.+|+++++.++|||||++++    
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            36899999999999999999999874        889999999753       35779999999999999998543    


Q ss_pred             -----------cccc-ccceehhhhhhhcccccC
Q psy18060         76 -----------SHET-LNEFVLITEFAHMSLSKL   97 (549)
Q Consensus        76 -----------~~~~-~~~~~lv~ey~~~sLskl   97 (549)
                                 .+.. ....++||||+.++|..+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~  147 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA  147 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHH
T ss_pred             CCccCccchhhccccCCcEEEEEecCCCcCHHHH
Confidence                       3333 567899999997777654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=98.89  E-value=6.9e-10  Score=112.73  Aligned_cols=90  Identities=27%  Similarity=0.368  Sum_probs=74.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh----hhhhhHHHHHHHHHhcC--CCCcccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLA--HPNIIKFIASHET   79 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~   79 (549)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++.......    ...+.+.+|+.+++.++  ||||+++++.+.+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            44568999999999999999999999999999999997654322    12245678999999996  5999999999999


Q ss_pred             ccceehhhhhhh--cccc
Q psy18060         80 LNEFVLITEFAH--MSLS   95 (549)
Q Consensus        80 ~~~~~lv~ey~~--~sLs   95 (549)
                      ....+++++++.  ++|.
T Consensus       120 ~~~~~lv~e~~~~~~~L~  137 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLF  137 (320)
T ss_dssp             SSEEEEEEECCSSEEEHH
T ss_pred             CCcEEEEEEcCCCCccHH
Confidence            999999999875  4443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=98.89  E-value=2e-09  Score=117.73  Aligned_cols=85  Identities=24%  Similarity=0.366  Sum_probs=71.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++......   .+.+.+|+++|++|+|||||++++++.+ ..+++|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            45679999999999999999999976 467999999765432   3568899999999999999999999876 678999


Q ss_pred             hhhhh-ccccc
Q psy18060         87 TEFAH-MSLSK   96 (549)
Q Consensus        87 ~ey~~-~sLsk   96 (549)
                      |||+. ++|..
T Consensus       340 ~e~~~~gsL~~  350 (535)
T 2h8h_A          340 TEYMSKGSLLD  350 (535)
T ss_dssp             ECCCTTEEHHH
T ss_pred             eehhcCCcHHH
Confidence            99985 46644

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=98.88  E-value=8.2e-10  Score=114.21  Aligned_cols=86  Identities=22%  Similarity=0.267  Sum_probs=69.1

Q ss_pred             cccCeeeeeeecccCceEEEEE-----EECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC---CCCccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKA-----IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA---HPNIIKFIASHE   78 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~-----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIV~l~~~~~   78 (549)
                      ..++|++.+.||+|+||.||+|     .+..+++.||||++....     ...+.+|++++..++   ||||+.+++.+.
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            3467999999999999999999     467789999999996532     245677888888887   999999999999


Q ss_pred             cccceehhhhhhh-cccccC
Q psy18060         79 TLNEFVLITEFAH-MSLSKL   97 (549)
Q Consensus        79 ~~~~~~lv~ey~~-~sLskl   97 (549)
                      ..+..++||||+. ++|..+
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~  157 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNA  157 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHH
T ss_pred             cCCCcEEEEeccCCCcHHHH
Confidence            9999999999985 566543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=98.88  E-value=1.7e-09  Score=107.22  Aligned_cols=89  Identities=29%  Similarity=0.338  Sum_probs=71.6

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECC---CCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      ....++|++.+.||+|+||.||+|.+..   ++..||||.+.+.. .....+.+.+|+.+++.++||||+++++++.+. 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   85 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-   85 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence            3456789999999999999999998754   34569999997643 334457789999999999999999999998754 


Q ss_pred             ceehhhhhhh-cccc
Q psy18060         82 EFVLITEFAH-MSLS   95 (549)
Q Consensus        82 ~~~lv~ey~~-~sLs   95 (549)
                      ..+++|+|+. ++|.
T Consensus        86 ~~~~v~e~~~~~~L~  100 (281)
T 3cc6_A           86 PTWIIMELYPYGELG  100 (281)
T ss_dssp             SCEEEEECCTTCBHH
T ss_pred             CCEEEEecCCCCCHH
Confidence            5688999875 3543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=98.88  E-value=3e-10  Score=126.69  Aligned_cols=90  Identities=27%  Similarity=0.318  Sum_probs=72.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc------
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET------   79 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~------   79 (549)
                      ....+|++.+.||+|+||.||+|.++.+|+.||||++... ......+.+.+|+++++.++||||+++++++..      
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            3457899999999999999999999999999999999654 344455778999999999999999999988765      


Q ss_pred             ccceehhhhhh-hccccc
Q psy18060         80 LNEFVLITEFA-HMSLSK   96 (549)
Q Consensus        80 ~~~~~lv~ey~-~~sLsk   96 (549)
                      ....++||||+ .++|..
T Consensus        90 ~~~~~LVmEy~~ggsL~~  107 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRK  107 (676)
T ss_dssp             TSSCCCEEECCSSCBHHH
T ss_pred             CCeEEEEEEeCCCCCHHH
Confidence            67789999999 456644

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=98.87  E-value=5.6e-10  Score=114.65  Aligned_cols=90  Identities=18%  Similarity=0.138  Sum_probs=67.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECC---CCceEEEEEeccCCCCh-h--------hhhhHHHHHHHHHhcCCCCcccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLD---LKKTVALKIISKSGRSG-K--------ELSSLKQECEIQKHLAHPNIIKFIA   75 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~---~~~~vAiK~i~~~~~~~-~--------~~~~~~~Ei~il~~l~HpnIV~l~~   75 (549)
                      .++|++.+.||+|+||.||+|++..   ++..||||++....... .        ....+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3579999999999999999999987   78999999997653211 0        1123668889999999999999999


Q ss_pred             cccc----ccceehhhhhhhcccccC
Q psy18060         76 SHET----LNEFVLITEFAHMSLSKL   97 (549)
Q Consensus        76 ~~~~----~~~~~lv~ey~~~sLskl   97 (549)
                      ++.+    ....+++|||+.++|..+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~~~~L~~~  141 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERLGIDLQKI  141 (345)
T ss_dssp             EEEEESSSCEEEEEEEECEEEEHHHH
T ss_pred             ccccccCCCcEEEEEEeccCCCHHHH
Confidence            9877    778999999997787654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=98.86  E-value=1.7e-09  Score=111.51  Aligned_cols=88  Identities=19%  Similarity=0.269  Sum_probs=73.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC-----------CCCcccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-----------HPNIIKFIA   75 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIV~l~~   75 (549)
                      ...+|++++.||+|+||.||+|++..+|+.||||++...   ......+.+|+++++.++           ||||+++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            346899999999999999999999999999999999643   233456788999998886           899999999


Q ss_pred             cccccc----ceehhhhhhhcccccC
Q psy18060         76 SHETLN----EFVLITEFAHMSLSKL   97 (549)
Q Consensus        76 ~~~~~~----~~~lv~ey~~~sLskl   97 (549)
                      .+....    .++++|+++.++|..+
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~~L~~~  119 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVLGENLLAL  119 (373)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHH
T ss_pred             HhhccCCCCceEEEEEecCCCCHHHH
Confidence            987654    7899999987777553

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=98.86  E-value=1.4e-09  Score=110.13  Aligned_cols=86  Identities=22%  Similarity=0.400  Sum_probs=73.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEE-CCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCC------ccccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIH-LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN------IIKFIASHETL   80 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn------IV~l~~~~~~~   80 (549)
                      .++|++++.||+|+||.||+|.+ ..+|+.||||++...   ....+.+.+|+++++.++|+|      |+++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            46899999999999999999998 568899999999643   234467889999999887765      99999999999


Q ss_pred             cceehhhhhhhccccc
Q psy18060         81 NEFVLITEFAHMSLSK   96 (549)
Q Consensus        81 ~~~~lv~ey~~~sLsk   96 (549)
                      ..+++||||+.++|..
T Consensus        90 ~~~~lv~e~~~~~l~~  105 (339)
T 1z57_A           90 GHICIVFELLGLSTYD  105 (339)
T ss_dssp             TEEEEEEECCCCBHHH
T ss_pred             CcEEEEEcCCCCCHHH
Confidence            9999999999777654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=98.86  E-value=2.2e-09  Score=109.52  Aligned_cols=82  Identities=23%  Similarity=0.418  Sum_probs=65.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceE----EEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTV----ALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      ..++|++++.||+|+||.||+|++..+|+.|    |+|.+.... .....+.+.+|+.+++.++||||+++++++.+.. 
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            3578999999999999999999999888765    666664332 2234467889999999999999999999988765 


Q ss_pred             eehhhhhh
Q psy18060         83 FVLITEFA   90 (549)
Q Consensus        83 ~~lv~ey~   90 (549)
                      .+++++++
T Consensus        91 ~~~v~~~~   98 (327)
T 3lzb_A           91 VQLITQLM   98 (327)
T ss_dssp             EEEEECCC
T ss_pred             ceEEEEec
Confidence            56666665

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=98.85  E-value=5.2e-10  Score=112.88  Aligned_cols=90  Identities=22%  Similarity=0.402  Sum_probs=75.0

Q ss_pred             cccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          5 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         5 ~~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ....++|++.+.||+|+||.||+|.+..   .||+|++..........+.+.+|+.++++++||||+++++++.+...++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            3456889999999999999999999864   4999999765544444466788999999999999999999999999999


Q ss_pred             hhhhhhh-cccccC
Q psy18060         85 LITEFAH-MSLSKL   97 (549)
Q Consensus        85 lv~ey~~-~sLskl   97 (549)
                      ++|+|+. ++|..+
T Consensus       106 iv~e~~~~~~L~~~  119 (319)
T 2y4i_B          106 IITSLCKGRTLYSV  119 (319)
T ss_dssp             EECBCCCSEEHHHH
T ss_pred             EEeecccCCcHHHH
Confidence            9999985 455443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=98.84  E-value=2.4e-09  Score=106.70  Aligned_cols=87  Identities=24%  Similarity=0.257  Sum_probs=72.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccc-ccccceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASH-ETLNEFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-~~~~~~~l   85 (549)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++.....    ...+.+|+.+++.++|++++..+..+ ......++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            34689999999999999999999999999999999875432    23578999999999999887766554 56677899


Q ss_pred             hhhhhhcccccC
Q psy18060         86 ITEFAHMSLSKL   97 (549)
Q Consensus        86 v~ey~~~sLskl   97 (549)
                      +|||+.++|..+
T Consensus        83 v~e~~~~~L~~~   94 (296)
T 3uzp_A           83 VMELLGPSLEDL   94 (296)
T ss_dssp             EEECCCCBHHHH
T ss_pred             EEEecCCCHHHH
Confidence            999997777543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=98.84  E-value=1.6e-09  Score=107.62  Aligned_cols=87  Identities=24%  Similarity=0.296  Sum_probs=62.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEECC-CCc--eEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLD-LKK--TVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~-~~~--~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      ..++|++++.||+|+||.||+|++.. +++  .||||++..... .....+.+.+|++++++++||||+++++++.+.. 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            35689999999999999999998753 333  699999976543 2344577899999999999999999999987755 


Q ss_pred             eehhhhhhh-ccc
Q psy18060         83 FVLITEFAH-MSL   94 (549)
Q Consensus        83 ~~lv~ey~~-~sL   94 (549)
                      .+++++|+. ++|
T Consensus        95 ~~~v~e~~~~~~L  107 (291)
T 1u46_A           95 MKMVTELAPLGSL  107 (291)
T ss_dssp             CEEEEECCTTCBH
T ss_pred             ceeeEecccCCCH
Confidence            888999875 344

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=98.84  E-value=1.4e-09  Score=110.86  Aligned_cols=82  Identities=33%  Similarity=0.450  Sum_probs=68.6

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHh--cCCCCcccccccccccc----c
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH--LAHPNIIKFIASHETLN----E   82 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIV~l~~~~~~~~----~   82 (549)
                      ++|++.+.||+|+||.||+|++  +|+.||||++...     ....+.+|++++..  ++||||+++++++....    .
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            5799999999999999999998  4899999999643     23467789999887  78999999999987765    7


Q ss_pred             eehhhhhhhc-ccccC
Q psy18060         83 FVLITEFAHM-SLSKL   97 (549)
Q Consensus        83 ~~lv~ey~~~-sLskl   97 (549)
                      ++++|||+.+ +|..+
T Consensus       115 ~~lv~e~~~~g~L~~~  130 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDY  130 (342)
T ss_dssp             EEEEECCCTTCBHHHH
T ss_pred             eEEEEeecCCCcHHHH
Confidence            8999999865 66543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=98.83  E-value=1.4e-09  Score=115.74  Aligned_cols=82  Identities=22%  Similarity=0.204  Sum_probs=67.9

Q ss_pred             CeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccccccceehhhh
Q psy18060         10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFVLITE   88 (549)
Q Consensus        10 ~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~lv~e   88 (549)
                      .|...++||+|+||+||.+. ..+|+.||||++....     .+.+.+|+++|+++ +|||||++++++.+...++++||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            45557889999999998754 4579999999996532     24577899999876 89999999999999999999999


Q ss_pred             hhhcccccC
Q psy18060         89 FAHMSLSKL   97 (549)
Q Consensus        89 y~~~sLskl   97 (549)
                      |+.++|..+
T Consensus        90 ~~~gsL~~~   98 (434)
T 2rio_A           90 LCNLNLQDL   98 (434)
T ss_dssp             CCSEEHHHH
T ss_pred             cCCCCHHHH
Confidence            998877554

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=98.83  E-value=3.1e-09  Score=118.54  Aligned_cols=80  Identities=29%  Similarity=0.444  Sum_probs=65.8

Q ss_pred             eeecccCceEEEEEEE--CCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhhhhhh-
Q psy18060         15 CLIGEGSFGKVFKAIH--LDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-   91 (549)
Q Consensus        15 ~~IG~G~fG~V~~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~ey~~-   91 (549)
                      +.||+|+||.||+|.+  +.+++.||||+++.........+.+.+|+++|++++|||||++++++.+ ...++||||+. 
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999955  4667899999997655444455789999999999999999999998864 45889999985 


Q ss_pred             cccc
Q psy18060         92 MSLS   95 (549)
Q Consensus        92 ~sLs   95 (549)
                      ++|.
T Consensus       454 g~L~  457 (635)
T 4fl3_A          454 GPLN  457 (635)
T ss_dssp             EEHH
T ss_pred             CCHH
Confidence            4453

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=98.83  E-value=3.1e-09  Score=110.74  Aligned_cols=87  Identities=28%  Similarity=0.378  Sum_probs=73.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC-CCC-----ccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPN-----IIKFIASHETL   80 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hpn-----IV~l~~~~~~~   80 (549)
                      ..++|++.+.||+|+||.||+|+++.+|+.||||++...   ......+.+|+.++..++ |+|     |+++++.+...
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            457899999999999999999999999999999999643   233456778999988885 554     88899999989


Q ss_pred             cceehhhhhhhccccc
Q psy18060         81 NEFVLITEFAHMSLSK   96 (549)
Q Consensus        81 ~~~~lv~ey~~~sLsk   96 (549)
                      ..+++||||+.++|..
T Consensus       129 ~~~~lv~e~~~~~L~~  144 (382)
T 2vx3_A          129 NHLCLVFEMLSYNLYD  144 (382)
T ss_dssp             TEEEEEEECCCCBHHH
T ss_pred             CceEEEEecCCCCHHH
Confidence            9999999999877654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=98.82  E-value=2.7e-09  Score=118.61  Aligned_cols=84  Identities=21%  Similarity=0.376  Sum_probs=67.4

Q ss_pred             Ceeeee-eecccCceEEEEEEEC--CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060         10 KYQKIC-LIGEGSFGKVFKAIHL--DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus        10 ~y~~~~-~IG~G~fG~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ++.+.+ .||+|+||.||+|.++  .++..||||+++... .....+.+.+|+++|+.++|||||++++++.+ +.+++|
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            455555 7999999999999876  356689999997643 23345678999999999999999999999876 568999


Q ss_pred             hhhhhc-ccc
Q psy18060         87 TEFAHM-SLS   95 (549)
Q Consensus        87 ~ey~~~-sLs   95 (549)
                      |||+.+ +|.
T Consensus       414 ~E~~~~g~L~  423 (613)
T 2ozo_A          414 MEMAGGGPLH  423 (613)
T ss_dssp             EECCTTCBHH
T ss_pred             EEeCCCCcHH
Confidence            999853 554

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=98.82  E-value=1.6e-09  Score=112.86  Aligned_cols=86  Identities=22%  Similarity=0.335  Sum_probs=69.2

Q ss_pred             CeeeeeeecccCceEEEEEEECCCC---ceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccc-ccccceeh
Q psy18060         10 KYQKICLIGEGSFGKVFKAIHLDLK---KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASH-ETLNEFVL   85 (549)
Q Consensus        10 ~y~~~~~IG~G~fG~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-~~~~~~~l   85 (549)
                      .|++.+.||+|+||.||+|.+..++   ..||||.+... ......+.+.+|+.++++++|||||++++++ ......++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            4788999999999999999986433   46899998653 3334567899999999999999999999985 45567899


Q ss_pred             hhhhhhc-cccc
Q psy18060         86 ITEFAHM-SLSK   96 (549)
Q Consensus        86 v~ey~~~-sLsk   96 (549)
                      ||||+.+ +|..
T Consensus       169 v~e~~~~g~L~~  180 (373)
T 3c1x_A          169 VLPYMKHGDLRN  180 (373)
T ss_dssp             EEECCTTCBHHH
T ss_pred             EEECCCCCCHHH
Confidence            9999854 6644

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	549
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-74
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-15
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-72
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-17
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-71
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-17
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-71
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-17
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-70
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-17
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-69
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-16
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-68
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-17
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-67
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-17
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-67
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-17
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-66
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-17
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-65
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-14
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-65
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-16
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-16
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-64
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-15
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-63
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-14
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-63
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-17
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-63
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-15
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-63
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-12
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-61
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-13
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-60
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-17
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-59
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-15
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-59
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-13
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-58
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-12
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-57
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-18
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-57
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-14
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-56
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-15
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-13
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-13
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-55
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-15
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-54
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-12
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-54
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-14
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-14
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-53
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-12
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-53
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-17
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-53
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-15
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-12
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-52
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-13
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-52
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-14
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-52
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-11
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-52
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-16
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-13
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-12
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-51
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-14
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-12
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-12
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-49
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-12
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-49
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-16
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-12
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-48
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-11
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-48
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-13
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-12
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-11
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-46
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-13
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-11
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-46
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-12
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-45
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-14
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-10
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-45
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-13
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-44
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-12
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-09
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-38
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-09
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-37
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-19
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-05

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (601), Expect = 1e-74
 Identities = 91/262 (34%), Positives = 140/262 (53%), Gaps = 4/262 (1%)

Query: 117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKEL-SSLKQECEIQKHL 175
           ALE ++    +G+G FG V+ A     K  +ALK++ K+      +   L++E EIQ HL
Sbjct: 4   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63

Query: 176 AHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HPNI++            LI E+A   ++   L++  K  E      ++ L +AL Y H
Sbjct: 64  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S RV+HRD+KP+N+LL   G   + DFG++      +   T++ GT  Y+ PE+I  R +
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIEGRMH 181

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
           D   DLWSLG + YE  +G PPF+  +     + +   + TFP  V+E  +DL+  LL+ 
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241

Query: 355 DASQRLSWPELLHHPLVKDNLS 376
           + SQR    E+L HP +  N S
Sbjct: 242 NPSQRPMLREVLEHPWITANSS 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.9 bits (181), Expect = 3e-15
 Identities = 29/87 (33%), Positives = 45/87 (51%), Gaps = 1/87 (1%)

Query: 7  ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKEL-SSLKQECEIQKHL 65
          ALE ++    +G+G FG V+ A     K  +ALK++ K+      +   L++E EIQ HL
Sbjct: 4  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63

Query: 66 AHPNIIKFIASHETLNEFVLITEFAHM 92
           HPNI++            LI E+A +
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPL 90

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 6e-72
 Identities = 79/271 (29%), Positives = 135/271 (49%), Gaps = 9/271 (3%)

Query: 107 QPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSL 165
           QP K        E ++   ++GEGSF  V  A  L   +  A+KI+ K       ++  +
Sbjct: 1   QPRKKRP-----EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV 55

Query: 166 KQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILS 224
            +E ++   L HP  +K   + +   +      +A +  L   + +     ET      +
Sbjct: 56  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 115

Query: 225 NLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKGTPL 282
            ++SAL YLH   ++HRDLKP+N+LLN+D    + DFG A+ ++         S  GT  
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

Query: 283 YMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSE 342
           Y++PEL+ E+    ++DLW+LGCI Y++  G PPF+  +   + + +   +  FP +   
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235

Query: 343 TYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
             +DLV+ LL  DA++RL   E+  +  +K 
Sbjct: 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.7 bits (196), Expect = 4e-17
 Identities = 19/83 (22%), Positives = 37/83 (44%), Gaps = 1/83 (1%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLAH 67
          E ++   ++GEGSF  V  A  L   +  A+KI+ K       ++  + +E ++   L H
Sbjct: 8  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 68 PNIIKFIASHETLNEFVLITEFA 90
          P  +K   + +   +      +A
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYA 90

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (584), Expect = 1e-71
 Identities = 76/259 (29%), Positives = 134/259 (51%), Gaps = 5/259 (1%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +KY +   IG+G+ G V+ A+ +   + VA++ ++   +  KEL  +  E  + +   +P
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           NI+ ++ S+   +E  ++ E+        +     + E     +    + AL +LHSN+V
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTA 298
           +HRD+K  N+LL  DG   L DFGF   +       +++ GTP +MAPE++  + Y    
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 299 DLWSLGCIAYEIHMGHPPFK---TVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
           D+WSLG +A E+  G PP+     +  L+LI    T ++  P ++S  ++D +   L+ D
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257

Query: 356 ASQRLSWPELLHHPLVKDN 374
             +R S  ELL H  +K  
Sbjct: 258 VEKRGSAKELLQHQFLKIA 276

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 20/83 (24%), Positives = 45/83 (54%), Gaps = 2/83 (2%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           +KY +   IG+G+ G V+ A+ +   + VA++ ++   +  KEL  +  E  + +   +P
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77

Query: 69  NIIKFIASHETLNEFVLITEFAH 91
           NI+ ++ S+   +E  ++ E+  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLA 100

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 8e-71
 Identities = 76/266 (28%), Positives = 125/266 (46%), Gaps = 13/266 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E Y+ +  IG GS+G+  K       K +  K +     +  E   L  E  + + L HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 179 NIIKFIAS--HETLNEFVLITEFA-HMSLSNLL----EQRKKLSETICVQILSNLISALY 231
           NI+++       T     ++ E+     L++++    ++R+ L E   +++++ L  AL 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 232 YLH-----SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
             H      + VLHRDLKP NV L+      L DFG AR +   T    +  GTP YM+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 287 ELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSETYK 345
           E +    Y+  +D+WSLGC+ YE+    PPF   S   L   ++       P + S+   
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243

Query: 346 DLVKGLLEKDASQRLSWPELLHHPLV 371
           +++  +L      R S  E+L +PL+
Sbjct: 244 EIITRMLNLKDYHRPSVEEILENPLI 269

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.5 bits (193), Expect = 7e-17
 Identities = 20/84 (23%), Positives = 35/84 (41%), Gaps = 2/84 (2%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          E Y+ +  IG GS+G+  K       K +  K +     +  E   L  E  + + L HP
Sbjct: 4  EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 69 NIIKFIAS--HETLNEFVLITEFA 90
          NI+++       T     ++ E+ 
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYC 87

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  226 bits (577), Expect = 6e-70
 Identities = 75/284 (26%), Positives = 133/284 (46%), Gaps = 12/284 (4%)

Query: 107 QPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLK 166
           QPV+++  +  L+ Y     +G G+FG V +          A K +     S KE  +++
Sbjct: 15  QPVEIKHDH-VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE--TVR 71

Query: 167 QECEIQKHLAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLL-EQRKKLSETICVQILS 224
           +E +    L HP ++    + E  NE V+I EF     L   + ++  K+SE   V+ + 
Sbjct: 72  KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR 131

Query: 225 NLISALYYLHSNRVLHRDLKPQNVLLN--KDGVAMLCDFGFARSMAVGTHMLTSIKGTPL 282
            +   L ++H N  +H DLKP+N++    +     L DFG    +     +  +  GT  
Sbjct: 132 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAE 190

Query: 283 YMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----S 338
           + APE+   +P  +  D+WS+G ++Y +  G  PF   +    +R +K+ D        S
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 250

Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQ 382
            +SE  KD ++ LL  D + R++  + L HP +    +   +SQ
Sbjct: 251 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 2/83 (2%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
           L+ Y     +G G+FG V +          A K +     S KE  ++++E +    L H
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE--TVRKEIQTMSVLRH 82

Query: 68  PNIIKFIASHETLNEFVLITEFA 90
           P ++    + E  NE V+I EF 
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFM 105

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (570), Expect = 1e-69
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 12/271 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + ++ I  +G+G+FGKV+KA + +     A K+I    +S +EL     E +I     HP
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHP 69

Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSN 236
           NI+K + +    N   ++ EF    ++  ++ + ++ L+E+    +    + AL YLH N
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA-----E 291
           +++HRDLK  N+L   DG   L DFG +           S  GTP +MAPE++      +
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD---VTFPSQVSETYKDLV 348
           RPYD+ AD+WSLG    E+    PP   ++ + ++  +   +   +  PS+ S  +KD +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249

Query: 349 KGLLEKDASQRLSWPELLHHPLVKDNLSSEI 379
           K  LEK+   R +  +LL HP V  + +  I
Sbjct: 250 KKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 25/86 (29%), Positives = 43/86 (50%), Gaps = 2/86 (2%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          + ++ I  +G+G+FGKV+KA + +     A K+I    +S +EL     E +I     HP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHP 69

Query: 69 NIIKFIASHETLNEFVLITEFAHMSL 94
          NI+K + +    N   ++ EF     
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGA 95

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  221 bits (565), Expect = 4e-68
 Identities = 79/294 (26%), Positives = 133/294 (45%), Gaps = 15/294 (5%)

Query: 101 WFHNHCQPVKMEKSNGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK 160
           W     QPV++++ +   + Y  +  +G G+FG V + +     +    K I+      K
Sbjct: 12  WKKYVPQPVEVKQGS-VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK 70

Query: 161 ELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRK-KLSETI 218
              ++K E  I   L HP +I    + E   E VLI EF     L + +     K+SE  
Sbjct: 71  Y--TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE 128

Query: 219 CVQILSNLISALYYLHSNRVLHRDLKPQNVLL--NKDGVAMLCDFGFARSMAVGTHMLTS 276
            +  +      L ++H + ++H D+KP+N++    K     + DFG A  +     ++  
Sbjct: 129 VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKV 187

Query: 277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF 336
              T  + APE++   P     D+W++G + Y +  G  PF     L  ++ +K  D  F
Sbjct: 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 247

Query: 337 P----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK---DNLSSEIESQN 383
                S VS   KD +K LL+K+  +RL+  + L HP +K    NL+S I S  
Sbjct: 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 301

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 80.9 bits (199), Expect = 3e-17
 Identities = 23/83 (27%), Positives = 35/83 (42%), Gaps = 2/83 (2%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
            + Y  +  +G G+FG V + +     +    K I+      K   ++K E  I   L H
Sbjct: 28  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHH 85

Query: 68  PNIIKFIASHETLNEFVLITEFA 90
           P +I    + E   E VLI EF 
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFL 108

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 2e-67
 Identities = 66/265 (24%), Positives = 121/265 (45%), Gaps = 8/265 (3%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 62

Query: 178 PNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            N++KF       N   L  E+     L + +E    + E    +    L++ + YLH  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKGTPLYMAPELIAERPY 294
            + HRD+KP+N+LL++     + DFG A          +L  + GT  Y+APEL+  R +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 295 DHTA-DLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDVTFPSQVSETYKDLVKG 350
                D+WS G +   +  G  P+   S     +     K   +    ++      L+  
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242

Query: 351 LLEKDASQRLSWPELLHHPLVKDNL 375
           +L ++ S R++ P++         L
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPL 267

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.1 bits (197), Expect = 2e-17
 Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 1/85 (1%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
          +E +  +  +GEG++G+V  A++   ++ VA+KI+    R+     ++K+E  I K L H
Sbjct: 4  VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNH 62

Query: 68 PNIIKFIASHETLNEFVLITEFAHM 92
           N++KF       N   L  E+   
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSG 87

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  217 bits (554), Expect = 4e-67
 Identities = 78/271 (28%), Positives = 124/271 (45%), Gaps = 11/271 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 177
           + +  +  IG GSFG V+ A  +   + VA+K +S SG+   E    + +E    + L H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNL-LEQRKKLSETICVQILSNLISALYYLHSN 236
           PN I++   +   +   L+ E+   S S+L    +K L E     +    +  L YLHS+
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA---ERP 293
            ++HRD+K  N+LL++ G+  L DFG A  M        S  GTP +MAPE+I    E  
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYWMAPEVILAMDEGQ 190

Query: 294 YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF--PSQVSETYKDLVKGL 351
           YD   D+WSLG    E+    PP   ++ +  +  +   +         SE +++ V   
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250

Query: 352 LEKDASQRLSWPELLHHPLVKDNLSSEIESQ 382
           L+K    R +   LL H  V       +   
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 27/92 (29%), Positives = 45/92 (48%), Gaps = 1/92 (1%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE-LSSLKQECEIQKHLAH 67
           + +  +  IG GSFG V+ A  +   + VA+K +S SG+   E    + +E    + L H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 68  PNIIKFIASHETLNEFVLITEFAHMSLSKLGE 99
           PN I++   +   +   L+ E+   S S L E
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 106

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  214 bits (546), Expect = 7e-66
 Identities = 80/272 (29%), Positives = 144/272 (52%), Gaps = 10/272 (3%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + Y    ++G G+F +V  A     +K VA+K I+K    GKE  S++ E  +   + HP
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHP 67

Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR 237
           NI+     +E+     LI +      L + + ++   +E    +++  ++ A+ YLH   
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 238 VLHRDLKPQNVLL---NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           ++HRDLKP+N+L    ++D   M+ DFG ++    G+ +L++  GTP Y+APE++A++PY
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-VLSTACGTPGYVAPEVLAQKPY 186

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLVKG 350
               D WS+G IAY +  G+PPF   +   L   +   +  F S     +S++ KD ++ 
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246

Query: 351 LLEKDASQRLSWPELLHHPLVKDNLSSEIESQ 382
           L+EKD  +R +  + L HP +  + + +    
Sbjct: 247 LMEKDPEKRFTCEQALQHPWIAGDTALDKNIH 278

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 24/82 (29%), Positives = 40/82 (48%), Gaps = 1/82 (1%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          + Y    ++G G+F +V  A     +K VA+K I+K    GKE  S++ E  +   + HP
Sbjct: 9  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHP 67

Query: 69 NIIKFIASHETLNEFVLITEFA 90
          NI+     +E+     LI +  
Sbjct: 68 NIVALDDIYESGGHLYLIMQLV 89

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 1e-65
 Identities = 67/260 (25%), Positives = 124/260 (47%), Gaps = 4/260 (1%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKEL--SSLKQECEIQKHL 175
           +E +    ++G+GSFGKVF A      +  A+K + K      +    ++ ++  +    
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 176 AHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
            HP +     + +T      + E+     L   ++   K   +      + +I  L +LH
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
           S  +++RDLK  N+LL+KDG   + DFG  +   +G     +  GTP Y+APE++  + Y
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK 354
           +H+ D WS G + YE+ +G  PF       L   ++  +  +P  + +  KDL+  L  +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240

Query: 355 DASQRLS-WPELLHHPLVKD 373
           +  +RL    ++  HPL ++
Sbjct: 241 EPEKRLGVRGDIRQHPLFRE 260

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.1 bits (171), Expect = 8e-14
 Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 2/86 (2%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKEL--SSLKQECEIQKHL 65
          +E +    ++G+GSFGKVF A      +  A+K + K      +    ++ ++  +    
Sbjct: 1  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 66 AHPNIIKFIASHETLNEFVLITEFAH 91
           HP +     + +T      + E+ +
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLN 86

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (542), Expect = 4e-65
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 12/265 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           EKY     +G G FG V + +    KKT   K +   G    +   +K+E  I     H 
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHR 61

Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSN 236
           NI+    S E++ E V+I EF   + +   +     +L+E   V  +  +  AL +LHS+
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 237 RVLHRDLKPQNVLL--NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPY 294
            + H D++P+N++    +     + +FG AR +  G +    +   P Y APE+      
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-RLLFTAPEYYAPEVHQHDVV 180

Query: 295 DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYKDLVKG 350
               D+WSLG + Y +  G  PF   +   +I  +   + TF  +    +S    D V  
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 351 LLEKDASQRLSWPELLHHPLVKDNL 375
           LL K+   R++  E L HP +K  +
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKI 265

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 26/82 (31%), Positives = 37/82 (45%), Gaps = 3/82 (3%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          EKY     +G G FG V + +    KKT   K +      G +   +K+E  I     H 
Sbjct: 5  EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHR 61

Query: 69 NIIKFIASHETLNEFVLITEFA 90
          NI+    S E++ E V+I EF 
Sbjct: 62 NILHLHESFESMEELVMIFEFI 83

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 5e-65
 Identities = 70/308 (22%), Positives = 128/308 (41%), Gaps = 49/308 (15%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           + ++KI  +G G+ G VFK  H      +A K+I    +     + + +E ++      P
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSP 64

Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHS-N 236
            I+ F  +  +  E  +  E     SL  +L++  ++ E I  ++   +I  L YL   +
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDH 296
           +++HRD+KP N+L+N  G   LCDFG +  +     M  S  GT  YM+PE +    Y  
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYSV 182

Query: 297 TADLWSLGCIAYEIHMGHPPF-----KTVSILHLIRLLKTQDVTFP-------------- 337
            +D+WS+G    E+ +G  P      K + ++   ++      T P              
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242

Query: 338 -------------------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
                                       S  ++D V   L K+ ++R    +L+ H  +K
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302

Query: 373 DNLSSEIE 380
            + + E++
Sbjct: 303 RSDAEEVD 310

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.6 bits (193), Expect = 1e-16
 Identities = 18/81 (22%), Positives = 35/81 (43%), Gaps = 1/81 (1%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          + ++KI  +G G+ G VFK  H      +A K+I    +     + + +E ++      P
Sbjct: 6  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSP 64

Query: 69 NIIKFIASHETLNEFVLITEF 89
           I+ F  +  +  E  +  E 
Sbjct: 65 YIVGFYGAFYSDGEISICMEH 85

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 3e-64
 Identities = 66/269 (24%), Positives = 120/269 (44%), Gaps = 16/269 (5%)

Query: 115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH 174
           +G   K+     IG GSF  V+K +  +    VA   +     +  E    K+E E+ K 
Sbjct: 7   DGRFLKFDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 64

Query: 175 LAHPNIIKFIASHETL----NEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISA 229
           L HPNI++F  S E+        VL+TE     +L   L++ K +   +       ++  
Sbjct: 65  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKG 124

Query: 230 LYYLHSN--RVLHRDLKPQNVLLN-KDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAP 286
           L +LH+    ++HRDLK  N+ +    G   + D G A           ++ GTP +MAP
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAP 182

Query: 287 ELIAERPYDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSET 343
           E+  E  YD + D+++ G    E+     P+   +  + ++       +  +F       
Sbjct: 183 EMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241

Query: 344 YKDLVKGLLEKDASQRLSWPELLHHPLVK 372
            K++++G + ++  +R S  +LL+H   +
Sbjct: 242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.3 bits (177), Expect = 9e-15
 Identities = 37/144 (25%), Positives = 57/144 (39%), Gaps = 13/144 (9%)

Query: 5   NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH 64
           +G   K+     IG GSF  V+K +  +    VA   +     +  E    K+E E+ K 
Sbjct: 7   DGRFLKFDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 64

Query: 65  LAHPNIIKFIASHETL----NEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEK 120
           L HPNI++F  S E+        VL+TE   M+   L           +K+         
Sbjct: 65  LQHPNIVRFYDSWESTVKGKKCIVLVTEL--MTSGTLKTYLKRFKVMKIKV-----LRSW 117

Query: 121 YQKICLIGEGSFGKVFKAIHLDLK 144
            ++I    +    +    IH DLK
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLK 141

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 5e-63
 Identities = 74/263 (28%), Positives = 126/263 (47%), Gaps = 7/263 (2%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLA 176
           +  +  + L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++  
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 177 HPNIIKFIASHETLNEFVLITEF-AHMSLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           HP +     + +T +    + E+     L   L + +  +E       + ++SAL YLHS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
             V++RD+K +N++L+KDG   + DFG  +        + +  GTP Y+APE++ +  Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
              D W LG + YE+  G  PF       L  L+  +++ FP  +S   K L+ GLL+KD
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243

Query: 356 ASQRLSWP-----ELLHHPLVKD 373
             QRL        E++ H     
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFLS 266

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.5 bits (177), Expect = 2e-14
 Identities = 18/83 (21%), Positives = 38/83 (45%), Gaps = 1/83 (1%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK-ELSSLKQECEIQKHLA 66
          +  +  + L+G+G+FGKV         +  A+KI+ K     K E++    E  + ++  
Sbjct: 4  MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 67 HPNIIKFIASHETLNEFVLITEF 89
          HP +     + +T +    + E+
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEY 86

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  206 bits (526), Expect = 6e-63
 Identities = 77/273 (28%), Positives = 144/273 (52%), Gaps = 10/273 (3%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 176
           L+ +Q +  +G GSFG+V         +  A+K++ K      K++     E  +   + 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 177 HPNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHS 235
           HP II+   + +   +  +I ++     L +LL + ++    +     + +  AL YLHS
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
             +++RDLKP+N+LL+K+G   + DFGFA+ +     +  ++ GTP Y+APE+++ +PY+
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
            + D WS G + YE+  G+ PF   + +     +   ++ FP   +E  KDL+  L+ +D
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239

Query: 356 ASQRL-----SWPELLHHPLVKDNLSSEIESQN 383
            SQRL        ++ +HP  K+ +  ++ S+N
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRN 272

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 79.4 bits (195), Expect = 7e-17
 Identities = 24/138 (17%), Positives = 50/138 (36%), Gaps = 10/138 (7%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 66
           L+ +Q +  +G GSFG+V         +  A+K++ K      K++     E  +   + 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 67  HPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICL 126
           HP II+   + +   +  +I ++        G   F    +  +           +    
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIE------GGELFSLLRKSQRFPNPVAKFYAAEVCLA 116

Query: 127 IGEGSFGKVFKAIHLDLK 144
           +       +   I+ DLK
Sbjct: 117 LEYLHSKDI---IYRDLK 131

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 6e-63
 Identities = 67/263 (25%), Positives = 123/263 (46%), Gaps = 17/263 (6%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
            +      IG GSFG V+K         VA+K+++ +  + ++L + K E  + +   H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSN 236
           NI+ F+  + T  +  ++T++    SL + L     K      + I       + YLH+ 
Sbjct: 65  NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV--GTHMLTSIKGTPLYMAPELI---AE 291
            ++HRDLK  N+ L++D    + DFG A   +   G+H    + G+ L+MAPE+I    +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------SQVSETYK 345
            PY   +D+++ G + YE+  G  P+  ++    I  +  +    P      S   +  K
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243

Query: 346 DLVKGLLEKDASQRLSWPELLHH 368
            L+   L+K   +R  +P++L  
Sbjct: 244 RLMAECLKKKRDERPLFPQILAS 266

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.1 bits (179), Expect = 6e-15
 Identities = 20/82 (24%), Positives = 41/82 (50%), Gaps = 4/82 (4%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           +      IG GSFG V+K         VA+K+++ +  + ++L + K E  + +   H 
Sbjct: 8  GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 69 NIIKFIASHETLNEFVLITEFA 90
          NI+ F+  + T  +  ++T++ 
Sbjct: 65 NILLFMG-YSTAPQLAIVTQWC 85

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  205 bits (523), Expect = 7e-63
 Identities = 84/273 (30%), Positives = 132/273 (48%), Gaps = 20/273 (7%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ-------ECEI 171
           E Y+   ++G G    V + IH    K  A+KII  +G        +++       E +I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 172 QKHLA-HPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISA 229
            + ++ HPNII+   ++ET   F L+ +      L + L ++  LSE    +I+  L+  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 230 LYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           +  LH   ++HRDLKP+N+LL+ D    L DFGF+  +  G   L  + GTP Y+APE+I
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEII 181

Query: 290 A------ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----Q 339
                     Y    D+WS G I Y +  G PPF     + ++R++ + +  F S     
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241

Query: 340 VSETYKDLVKGLLEKDASQRLSWPELLHHPLVK 372
            S+T KDLV   L     +R +  E L HP  +
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 65.1 bits (158), Expect = 3e-12
 Identities = 24/90 (26%), Positives = 42/90 (46%), Gaps = 8/90 (8%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQ-------ECEI 61
          E Y+   ++G G    V + IH    K  A+KII  +G        +++       E +I
Sbjct: 3  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 62 QKHLA-HPNIIKFIASHETLNEFVLITEFA 90
           + ++ HPNII+   ++ET   F L+ +  
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLM 92

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  202 bits (514), Expect = 9e-61
 Identities = 71/263 (26%), Positives = 131/263 (49%), Gaps = 10/263 (3%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 176
           L+++ +I  +G GSFG+V    H +     A+KI+ K      K++     E  I + + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 177 HPNIIKFIASHETLNEFVLITEFAHMS-LSNLLEQRKKLSETICVQILSNLISALYYLHS 235
            P ++K   S +  +   ++ E+     + + L +  + SE       + ++    YLHS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
             +++RDLKP+N+L+++ G   + DFGFA+ +        ++ GTP  +APE+I  + Y+
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWTLCGTPEALAPEIILSKGYN 216

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEKD 355
              D W+LG + YE+  G+PPF     + +   + +  V FPS  S   KDL++ LL+ D
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276

Query: 356 ASQRL-----SWPELLHHPLVKD 373
            ++R         ++ +H     
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFAT 299

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 70.2 bits (171), Expect = 1e-13
 Identities = 20/86 (23%), Positives = 40/86 (46%), Gaps = 1/86 (1%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-RSGKELSSLKQECEIQKHLA 66
           L+++ +I  +G GSFG+V    H +     A+KI+ K      K++     E  I + + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 67  HPNIIKFIASHETLNEFVLITEFAHM 92
            P ++K   S +  +   ++ E+   
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAG 125

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 8e-60
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 14/268 (5%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISK----SGRSGKELSSLKQECEIQKH 174
           + Y     +G G F  V K          A K I K    S R G     +++E  I K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 175 LAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
           + HPN+I     +E   + +LI E      L + L +++ L+E    + L  +++ +YYL
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 234 HSNRVLHRDLKPQNVLLNKDGVA----MLCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
           HS ++ H DLKP+N++L    V      + DFG A  +  G     +I GTP ++APE++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-KNIFGTPEFVAPEIV 188

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYK 345
              P    AD+WS+G I Y +  G  PF   +    +  +   +  F  +     S   K
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248

Query: 346 DLVKGLLEKDASQRLSWPELLHHPLVKD 373
           D ++ LL KD  +R++  + L HP +K 
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.6 bits (193), Expect = 9e-17
 Identities = 25/107 (23%), Positives = 40/107 (37%), Gaps = 6/107 (5%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISK----SGRSGKELSSLKQECEIQKH 64
           + Y     +G G F  V K          A K I K    S R G     +++E  I K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 65  LAHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKM 111
           + HPN+I     +E   + +LI E   ++  +L +          + 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILEL--VAGGELFDFLAEKESLTEEE 114

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  196 bits (500), Expect = 1e-59
 Identities = 63/267 (23%), Positives = 122/267 (45%), Gaps = 13/267 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSGKELSSLKQECEIQKHLAH 177
           ++Y+   ++G G   +V  A  L L + VA+K++     R        ++E +    L H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 178 PNIIKFIASHETLNE----FVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           P I+    + E          ++ E+   ++L +++     ++    ++++++   AL +
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPELI 289
            H N ++HRD+KP N++++      + DFG AR++A          ++ GT  Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ----VSETYK 345
                D  +D++SLGC+ YE+  G PPF   S + +      +D   PS     +S    
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 346 DLVKGLLEKDASQRLSWPELLHHPLVK 372
            +V   L K+   R      +   LV+
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLVR 273

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 75.2 bits (184), Expect = 1e-15
 Identities = 18/87 (20%), Positives = 36/87 (41%), Gaps = 5/87 (5%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKS-GRSGKELSSLKQECEIQKHLAH 67
          ++Y+   ++G G   +V  A  L L + VA+K++     R        ++E +    L H
Sbjct: 7  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 68 PNIIKFIASHETLNE----FVLITEFA 90
          P I+    + E          ++ E+ 
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYV 93

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 5e-59
 Identities = 72/275 (26%), Positives = 125/275 (45%), Gaps = 18/275 (6%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHL 175
           +YQ   L+G G FG V+  I +     VA+K + K   S        + +  E  + K +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 176 --AHPNIIKFIASHETLNEFVLITEFAHM--SLSNLLEQRKKLSETICVQILSNLISALY 231
                 +I+ +   E  + FVLI E       L + + +R  L E +       ++ A+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 232 YLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA 290
           + H+  VLHRD+K +N+L++ + G   L DFG    +     + T   GT +Y  PE I 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIR 182

Query: 291 ERPY-DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVK 349
              Y   +A +WSLG + Y++  G  PF+          +    V F  +VS   + L++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQRVSSECQHLIR 236

Query: 350 GLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNN 384
             L    S R ++ E+ +HP ++D L  +  ++ +
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 271

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.0 bits (168), Expect = 1e-13
 Identities = 23/92 (25%), Positives = 37/92 (40%), Gaps = 6/92 (6%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHL 65
          +YQ   L+G G FG V+  I +     VA+K + K   S        + +  E  + K +
Sbjct: 5  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 66 --AHPNIIKFIASHETLNEFVLITEFAHMSLS 95
                +I+ +   E  + FVLI E       
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQD 96

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 1e-58
 Identities = 80/323 (24%), Positives = 158/323 (48%), Gaps = 27/323 (8%)

Query: 113 KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 171
           K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++ +E+    +  + 
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ- 63

Query: 172 QKHLAHPNIIKFIASHETL----NEFVLITEFA-HMSLSNLLEQR--KKLSETICVQILS 224
                 P+I++ +  +E L       +++ E      L + ++ R  +  +E    +I+ 
Sbjct: 64  -----CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118

Query: 225 NLISALYYLHSNRVLHRDLKPQNVLLNK---DGVAMLCDFGFARSMAVGTHMLTSIKGTP 281
           ++  A+ YLHS  + HRD+KP+N+L      + +  L DFGFA+       + T    TP
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTP 177

Query: 282 LYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ----DVTFP 337
            Y+APE++    YD + D+WSLG I Y +  G+PPF +   L +   +KT+       FP
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237

Query: 338 ----SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDYC 393
               S+VSE  K L++ LL+ + +QR++  E ++HP +  +        +    +  D  
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK- 296

Query: 394 DKRRGSRKSITTIVESDSDENEE 416
           ++    ++ +T+ + +   + E+
Sbjct: 297 ERWEDVKEEMTSALATMRVDYEQ 319

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.1 bits (158), Expect = 4e-12
 Identities = 17/93 (18%), Positives = 42/93 (45%), Gaps = 11/93 (11%)

Query: 3  KSNGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEI 61
          K N  ++ Y+    ++G G  GKV +  +   ++  ALK++    ++ +E+    +  + 
Sbjct: 5  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ- 63

Query: 62 QKHLAHPNIIKFIASHETL----NEFVLITEFA 90
                P+I++ +  +E L       +++ E  
Sbjct: 64 -----CPHIVRIVDVYENLYAGRKCLLIVMECL 91

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 3e-57
 Identities = 88/288 (30%), Positives = 130/288 (45%), Gaps = 32/288 (11%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQR--KKLSETICVQILSNLISALYYLHS 235
           PNI+K +    T N+  L+ EF H  L   ++      +   +    L  L+  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYD 295
           +RVLHRDLKPQN+L+N +G   L DFG AR+  V     T    T  Y APE++    Y 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 296 HTA-DLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----------------- 337
            TA D+WSLGCI  E+      F   S +  +  +     T                   
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240

Query: 338 ------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                         + E  + L+  +L  D ++R+S    L HP  +D
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.4 bits (205), Expect = 2e-18
 Identities = 33/90 (36%), Positives = 49/90 (54%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
          +E +QK+  IGEG++G V+KA +    + VALK I     +    S+  +E  + K L H
Sbjct: 1  MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 68 PNIIKFIASHETLNEFVLITEFAHMSLSKL 97
          PNI+K +    T N+  L+ EF H  L K 
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKF 90

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  193 bits (490), Expect = 4e-57
 Identities = 73/270 (27%), Positives = 121/270 (44%), Gaps = 16/270 (5%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSL----KQECEIQK 173
           +  +    +IG G FG+V+     D  K  A+K + K     K+  +L    +    +  
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 174 HLAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYY 232
               P I+    +  T ++   I +      L   L Q    SE       + +I  L +
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +H+  V++RDLKP N+LL++ G   + D G A           +  GT  YMAPE++ + 
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHASVGTHGYMAPEVLQKG 180

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFPSQVSETYKDLV 348
             YD +AD +SLGC+ +++  GH PF   KT     + R+  T  V  P   S   + L+
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240

Query: 349 KGLLEKDASQRLSWP-----ELLHHPLVKD 373
           +GLL++D ++RL        E+   P  + 
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 72.5 bits (177), Expect = 2e-14
 Identities = 17/88 (19%), Positives = 34/88 (38%), Gaps = 4/88 (4%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSL----KQECEIQK 63
          +  +    +IG G FG+V+     D  K  A+K + K     K+  +L    +    +  
Sbjct: 3  MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 64 HLAHPNIIKFIASHETLNEFVLITEFAH 91
              P I+    +  T ++   I +  +
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMN 90

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 1e-56
 Identities = 72/284 (25%), Positives = 119/284 (41%), Gaps = 33/284 (11%)

Query: 123 KICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE---LSSLKQECEIQKHLAHPN 179
           K+  +GEG F  V+KA   +  + VA+K I    RS  +     +  +E ++ + L+HPN
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 180 IIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRV 238
           II  + +    +   L+ +F        + +    L+ +     +   +  L YLH + +
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121

Query: 239 LHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE-RPYDHT 297
           LHRDLKP N+LL+++GV  L DFG A+S        T    T  Y APEL+   R Y   
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 298 ADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP-------------------- 337
            D+W++GCI  E+ +  P     S L  +  +     T                      
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241

Query: 338 --------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                   S   +   DL++GL   +   R++  + L      +
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.9 bits (183), Expect = 2e-15
 Identities = 23/83 (27%), Positives = 41/83 (49%), Gaps = 3/83 (3%)

Query: 13 KICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKE---LSSLKQECEIQKHLAHPN 69
          K+  +GEG F  V+KA   +  + VA+K I    RS  +     +  +E ++ + L+HPN
Sbjct: 2  KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 70 IIKFIASHETLNEFVLITEFAHM 92
          II  + +    +   L+ +F   
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMET 84

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-56
 Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 12/254 (4%)

Query: 127 IGEGSFGKVFKAIHLDLK--KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V K  +   K  KTVA+KI+            L  E  + + L +P I++ I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 185 ASHETLNEFVLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDL 243
              E    ++L+ E A +  L+  L+Q + + +   ++++  +   + YL  +  +HRDL
Sbjct: 75  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133

Query: 244 KPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPELIAERPYDHTADL 300
             +NVLL     A + DFG ++++          T  K    + APE I    +   +D+
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 193

Query: 301 WSLGCIAYEI-HMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLLEKDASQ 358
           WS G + +E    G  P++ +    +  +L K + +  P+       DL+      D   
Sbjct: 194 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 253

Query: 359 RLSWPEL---LHHP 369
           R  +  +   L + 
Sbjct: 254 RPGFAAVELRLRNY 267

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.2 bits (166), Expect = 3e-13
 Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 3/78 (3%)

Query: 17 IGEGSFGKVFKAIHLDLK--KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 74
          +G G+FG V K  +   K  KTVA+KI+            L  E  + + L +P I++ I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 75 ASHETLNEFVLITEFAHM 92
             E    ++L+ E A +
Sbjct: 75 GICEA-ESWMLVMEMAEL 91

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 6e-56
 Identities = 61/257 (23%), Positives = 115/257 (44%), Gaps = 15/257 (5%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +++ + +  IG+G FG V    +      VA+K I           +   E  +   L H
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKND----ATAQAFLAEASVMTQLRH 59

Query: 178 PNIIKFI-ASHETLNEFVLITEFA-HMSLSNLLEQRKK--LSETICVQILSNLISALYYL 233
            N+++ +    E      ++TE+    SL + L  R +  L     ++   ++  A+ YL
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERP 293
             N  +HRDL  +NVL+++D VA + DFG  +     +    + K    + APE + E+ 
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKK 176

Query: 294 YDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGL 351
           +   +D+WS G + +EI   G  P+  + +  ++ R+ K   +  P        +++K  
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNC 236

Query: 352 LEKDASQRLSWPELLHH 368
              DA+ R S+ +L   
Sbjct: 237 WHLDAAMRPSFLQLREQ 253

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.6 bits (162), Expect = 8e-13
 Identities = 17/83 (20%), Positives = 34/83 (40%), Gaps = 7/83 (8%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
          +++ + +  IG+G FG V    +      VA+K I           +   E  +   L H
Sbjct: 6  MKELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKND----ATAQAFLAEASVMTQLRH 59

Query: 68 PNIIKFI-ASHETLNEFVLITEF 89
           N+++ +    E      ++TE+
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEY 82

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  186 bits (473), Expect = 1e-55
 Identities = 86/287 (29%), Positives = 130/287 (45%), Gaps = 32/287 (11%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           +EKY  +  IGEG++G V+KA + +  +T ALK I          S+  +E  I K L H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK-LSETICVQILSNLISALYYLHSN 236
            NI+K      T    VL+ E     L  LL+  +  L        L  L++ + Y H  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA-ERPYD 295
           RVLHRDLKPQN+L+N++G   + DFG AR+  +     T    T  Y AP+++   + Y 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 296 HTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-------------------------- 329
            T D+WS+GCI  E+  G P F  VS    +  +                          
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 330 ---KTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                   +F   + E+  DL+  +L+ D +QR++  + L H   K+
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 74.9 bits (183), Expect = 1e-15
 Identities = 30/87 (34%), Positives = 42/87 (48%), Gaps = 1/87 (1%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
          +EKY  +  IGEG++G V+KA + +  +T ALK I          S+  +E  I K L H
Sbjct: 1  MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 68 PNIIKFIASHETLNEFVLITEFAHMSL 94
           NI+K      T    VL+ E     L
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDL 86

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 4e-54
 Identities = 58/271 (21%), Positives = 119/271 (43%), Gaps = 16/271 (5%)

Query: 127 IGEGSFGKVFKAIHLDLKK--TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 184
           +G G+FG V + ++   KK   VA+K++ + G    +   + +E +I   L +P I++ I
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ-GTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 185 ASHETLNEFVLITEFA-HMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRD 242
              +     +L+ E A    L   L  +R+++  +   ++L  +   + YL     +HRD
Sbjct: 76  GVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 134

Query: 243 LKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPELIAERPYDHTAD 299
           L  +NVLL     A + DFG ++++          ++ K    + APE I  R +   +D
Sbjct: 135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 194

Query: 300 LWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKT-QDVTFPSQVSETYKDLVKGLLEKDAS 357
           +WS G   +E    G  P+K +    ++  ++  + +  P +       L+         
Sbjct: 195 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWE 254

Query: 358 QRLSWPEL---LHHPLVKDNLSSEIESQNNQ 385
            R  +  +   +       +L+S++E  ++ 
Sbjct: 255 DRPDFLTVEQRMRACYY--SLASKVEGHHHH 283

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.6 bits (154), Expect = 9e-12
 Identities = 20/76 (26%), Positives = 39/76 (51%), Gaps = 4/76 (5%)

Query: 17 IGEGSFGKVFKAIHLDLKK--TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFI 74
          +G G+FG V + ++   KK   VA+K++ + G    +   + +E +I   L +P I++ I
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ-GTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 75 ASHETLNEFVLITEFA 90
             +     +L+ E A
Sbjct: 76 GVCQA-EALMLVMEMA 90

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 7e-54
 Identities = 56/255 (21%), Positives = 109/255 (42%), Gaps = 9/255 (3%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           +    +  +G G FG V        +  VA+K+I +   S  E     +E ++  +L+H 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEF---IEEAKVMMNLSHE 59

Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLE-QRKKLSETICVQILSNLISALYYLHSN 236
            +++            +ITE+     L N L   R +      +++  ++  A+ YL S 
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA-VGTHMLTSIKGTPLYMAPELIAERPYD 295
           + LHRDL  +N L+N  GV  + DFG +R +           K    +  PE++    + 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 296 HTADLWSLGCIAYEI-HMGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLE 353
             +D+W+ G + +EI  +G  P++  +       + +   +  P   SE    ++     
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH 239

Query: 354 KDASQRLSWPELLHH 368
           + A +R ++  LL +
Sbjct: 240 EKADERPTFKILLSN 254

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.3 bits (169), Expect = 7e-14
 Identities = 17/84 (20%), Positives = 34/84 (40%), Gaps = 4/84 (4%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          +    +  +G G FG V        +  VA+K+I +   S  E     +E ++  +L+H 
Sbjct: 4  KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEF---IEEAKVMMNLSHE 59

Query: 69 NIIKFIASHETLNEFVLITEFAHM 92
           +++            +ITE+   
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMAN 83

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (461), Expect = 9e-54
 Identities = 64/274 (23%), Positives = 128/274 (46%), Gaps = 12/274 (4%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
                    +G G +G+V++ +      TVA+K + +     +E     +E  + K + H
Sbjct: 16  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF---LKEAAVMKEIKH 72

Query: 178 PNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQ--RKKLSETICVQILSNLISALYYLH 234
           PN+++ +        F +ITEF  + +L + L +  R+++S  + + + + + SA+ YL 
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-HMLTSIKGTPLYMAPELIAERP 293
               +HRDL  +N L+ ++ +  + DFG +R M   T       K    + APE +A   
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192

Query: 294 YDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGL 351
           +   +D+W+ G + +EI   G  P+  + +  +  LL K   +  P    E   +L++  
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252

Query: 352 LEKDASQRLSWPEL---LHHPLVKDNLSSEIESQ 382
            + + S R S+ E+         + ++S E+E +
Sbjct: 253 WQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 286

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 72.1 bits (176), Expect = 2e-14
 Identities = 19/87 (21%), Positives = 37/87 (42%), Gaps = 3/87 (3%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
                   +G G +G+V++ +      TVA+K + +     +E     +E  + K + H
Sbjct: 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKH 72

Query: 68 PNIIKFIASHETLNEFVLITEFAHMSL 94
          PN+++ +        F +ITEF     
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGN 99

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (461), Expect = 1e-53
 Identities = 81/293 (27%), Positives = 133/293 (45%), Gaps = 39/293 (13%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHL-DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA- 176
           ++Y+ +  IGEG++GKVFKA  L +  + VALK +           S  +E  + +HL  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 177 --HPNIIKFI-----ASHETLNEFVLITEFAHMSLSNLLEQRKK--LSETICVQILSNLI 227
             HPN+++       +  +   +  L+ E     L+  L++  +  +       ++  L+
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 228 SALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPE 287
             L +LHS+RV+HRDLKPQN+L+   G   L DFG AR  +    + TS+  T  Y APE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPE 185

Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT------------ 335
           ++ +  Y    DLWS+GCI  E+    P F+  S +  +  +                  
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 336 ---------------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                          F + + E  KDL+   L  + ++R+S    L HP  +D
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.5 bits (156), Expect = 5e-12
 Identities = 29/140 (20%), Positives = 52/140 (37%), Gaps = 7/140 (5%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHL-DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA- 66
           ++Y+ +  IGEG++GKVFKA  L +  + VALK +           S  +E  + +HL  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 67  --HPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKI 124
             HPN+++                             + +      +         +Q +
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 125 CLIGEGSFGKVFKAIHLDLK 144
             +    F    + +H DLK
Sbjct: 127 RGL---DFLHSHRVVHRDLK 143

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-53
 Identities = 79/288 (27%), Positives = 127/288 (44%), Gaps = 32/288 (11%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           ++KY+K+  IGEG++G VFKA + +  + VALK +          SS  +E  + K L H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 178 PNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHSN 236
            NI++      +  +  L+ EF               L   I    L  L+  L + HS 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIA-ERPYD 295
            VLHRDLKPQN+L+N++G   L +FG AR+  +     ++   T  Y  P+++   + Y 
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 296 HTADLWSLGCIAYEIHMG-HPPFKTVSILHLIRLLKTQDVTFPS---------------- 338
            + D+WS GCI  E+     P F    +   ++ +     T                   
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 339 -------------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                        +++ T +DL++ LL+ +  QR+S  E L HP   D
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.2 bits (199), Expect = 1e-17
 Identities = 34/137 (24%), Positives = 56/137 (40%), Gaps = 9/137 (6%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
           ++KY+K+  IGEG++G VFKA + +  + VALK +          SS  +E  + K L H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 68  PNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLI 127
            NI++      +  +  L+ EF    L K  +    +    +        L+        
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 128 GEGSFGKVFKAIHLDLK 144
                      +H DLK
Sbjct: 121 N---------VLHRDLK 128

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 3e-53
 Identities = 83/310 (26%), Positives = 135/310 (43%), Gaps = 47/310 (15%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           + KY+K+  IG+G+FG+VFKA H    + VALK +           +  +E +I + L H
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68

Query: 178 PNIIKFIASHETL--------NEFVLITEFAHMSLSNL-LEQRKKLSETICVQILSNLIS 228
            N++  I    T             L+ +F    L+ L      K + +   +++  L++
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 229 ALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT----HMLTSIKGTPLYM 284
            LYY+H N++LHRD+K  NVL+ +DGV  L DFG AR+ ++      +  T+   T  Y 
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 285 APELIA-ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQV--- 340
            PEL+  ER Y    DLW  GCI  E+    P  +  +  H + L+     +   +V   
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 341 -----------------------------SETYKDLVKGLLEKDASQRLSWPELLHHP-L 370
                                             DL+  LL  D +QR+   + L+H   
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308

Query: 371 VKDNLSSEIE 380
             D + S+++
Sbjct: 309 WSDPMPSDLK 318

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.7 bits (185), Expect = 1e-15
 Identities = 32/137 (23%), Positives = 60/137 (43%), Gaps = 1/137 (0%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
           + KY+K+  IG+G+FG+VFKA H    + VALK +           +  +E +I + L H
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68

Query: 68  PNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLI 127
            N++  I    T        + +   +    E         V ++ +   +++  ++ L 
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 128 GEGSFGKVFKAIHLDLK 144
           G     +  K +H D+K
Sbjct: 129 GLYYIHR-NKILHRDMK 144

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-52
 Identities = 58/277 (20%), Positives = 114/277 (41%), Gaps = 18/277 (6%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E  +    +G+G FG+V+        + VA+K +     S +      QE ++ K L H 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAF---LQEAQVMKKLRHE 72

Query: 179 NIIKFIASHETLNEFVLITEFAHMSLSNLL---EQRKKLSETICVQILSNLISALYYLHS 235
            +++  A   +     ++TE+            E  K L     V + + + S + Y+  
Sbjct: 73  KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG-THMLTSIKGTPLYMAPELIAERPY 294
              +HRDL+  N+L+ ++ V  + DFG AR +           K    + APE      +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191

Query: 295 DHTADLWSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G +  E+   G  P+  +    ++ ++ +   +  P +  E+  DL+    
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 251

Query: 353 EKDASQRLSWPEL---LHHPLVKDNLSSEIESQNNQD 386
            K+  +R ++  L   L         S+E + Q  ++
Sbjct: 252 RKEPEERPTFEYLQAFLEDYFT----STEPQYQPGEN 284

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.1 bits (158), Expect = 3e-12
 Identities = 24/136 (17%), Positives = 51/136 (37%), Gaps = 12/136 (8%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           E  +    +G+G FG+V+        + VA+K +     S +      QE ++ K L H 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKKLRHE 72

Query: 69  NIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIG 128
            +++  A   +     ++TE+        G        +  K  +    ++   +I    
Sbjct: 73  KLVQLYAVV-SEEPIYIVTEYMSK-----GSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126

Query: 129 EGSFGKVFKAIHLDLK 144
              + +    +H DL+
Sbjct: 127 A--YVERMNYVHRDLR 140

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 1e-52
 Identities = 75/328 (22%), Positives = 127/328 (38%), Gaps = 47/328 (14%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 180
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNI 75

Query: 181 IK----FIASHETLNEFVLITEFAHMS------LSNLLEQRKKLSETICVQILSNLISAL 230
           ++    F +S E  +E  L     ++         +    ++ L        +  L  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAM-LCDFGFARSMAVGTHMLTSIKGTPLYMAPELI 289
            Y+HS  + HRD+KPQN+LL+ D   + LCDFG A+ +  G   ++ I          + 
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195

Query: 290 AERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL-------------------- 329
               Y  + D+WS GC+  E+ +G P F   S +  +  +                    
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255

Query: 330 ---------KTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
                          F  +       L   LLE   + RL+  E   H    +     ++
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 315

Query: 381 SQNNQDCIG-FDYCDKRRGSRKSITTIV 407
             N +D    F++  +   S   + TI+
Sbjct: 316 LPNGRDTPALFNFTTQELSSNPPLATIL 343

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.9 bits (165), Expect = 5e-13
 Identities = 25/91 (27%), Positives = 42/91 (46%), Gaps = 10/91 (10%)

Query: 11  YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI 70
           Y    +IG GSFG V++A   D  + VA+K + +  R         +E +I + L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNI 75

Query: 71  IK----FIASHETLNEFVLITEFAHMSLSKL 97
           ++    F +S E  +E  L     ++  +  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 106

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 3e-52
 Identities = 58/255 (22%), Positives = 109/255 (42%), Gaps = 9/255 (3%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
            +   +  IG G FG V     L+ K  VA+K I +   S ++     +E E+   L+HP
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDF---IEEAEVMMKLSHP 60

Query: 179 NIIKFIASHETLNEFVLITEFAHM-SLSNLLEQRKKL-SETICVQILSNLISALYYLHSN 236
            +++            L+ EF     LS+ L  ++ L +    + +  ++   + YL   
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA-VGTHMLTSIKGTPLYMAPELIAERPYD 295
            V+HRDL  +N L+ ++ V  + DFG  R +        T  K    + +PE+ +   Y 
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 296 HTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKT-QDVTFPSQVSETYKDLVKGLLE 353
             +D+WS G + +E+   G  P++  S   ++  + T   +  P   S     ++    +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240

Query: 354 KDASQRLSWPELLHH 368
           +    R ++  LL  
Sbjct: 241 ERPEDRPAFSRLLRQ 255

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.9 bits (173), Expect = 2e-14
 Identities = 23/98 (23%), Positives = 37/98 (37%), Gaps = 5/98 (5%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
            +   +  IG G FG V     L+ K  VA+K I +   S ++     +E E+   L+HP
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDF---IEEAEVMMKLSHP 60

Query: 69  NIIKFIASHETLNEFVLITEFAHM-SLSKLGEPWFHNH 105
            +++            L+ EF     LS          
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF 98

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 5e-52
 Identities = 71/275 (25%), Positives = 134/275 (48%), Gaps = 19/275 (6%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKS--GRSGKELSSLKQECEIQ 172
           +E ++ + ++G G++GKVF    +    T    A+K++ K+   +  K     + E ++ 
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 173 KHLAH-PNIIKFIASHETLNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISAL 230
           +H+   P ++    + +T  +  LI ++ +   L   L QR++ +E      +  ++ AL
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142

Query: 231 YYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSM-AVGTHMLTSIKGTPLYMAPELI 289
            +LH   +++RD+K +N+LL+ +G  +L DFG ++   A  T       GT  YMAP+++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 290 --AERPYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFPSQVSET 343
              +  +D   D WSLG + YE+  G  PF           + R +   +  +P ++S  
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262

Query: 344 YKDLVKGLLEKDASQRLSWP-----ELLHHPLVKD 373
            KDL++ LL KD  +RL        E+  H   + 
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.7 bits (154), Expect = 1e-11
 Identities = 18/91 (19%), Positives = 45/91 (49%), Gaps = 6/91 (6%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKS--GRSGKELSSLKQECEIQ 62
           +E ++ + ++G G++GKVF    +    T    A+K++ K+   +  K     + E ++ 
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 63  KHLAH-PNIIKFIASHETLNEFVLITEFAHM 92
           +H+   P ++    + +T  +  LI ++ + 
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYING 113

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 8e-52
 Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 42/302 (13%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
             Y+ +  +G G++G V  A+       VA+K + +  +S        +E  + KH+ H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 179 NIIKFIASHET------LNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYY 232
           N+I  +             +F L+  F    L  L++  +KL E     ++  ++  L Y
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRY 136

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE- 291
           +H+  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE+I   
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNW 193

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ------------ 339
             Y  T D+WS+GCI  E+  G   FK    L  ++ +     T P++            
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253

Query: 340 -------------------VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIE 380
                               S    +L++ +L  DA QR++  E L HP  +    +E E
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 313

Query: 381 SQ 382
            Q
Sbjct: 314 PQ 315

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.4 bits (187), Expect = 9e-16
 Identities = 22/95 (23%), Positives = 39/95 (41%), Gaps = 6/95 (6%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
             Y+ +  +G G++G V  A+       VA+K + +  +S        +E  + KH+ H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 69  NIIKFIASHET------LNEFVLITEFAHMSLSKL 97
           N+I  +             +F L+  F    L KL
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL 112

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 9e-52
 Identities = 55/254 (21%), Positives = 107/254 (42%), Gaps = 11/254 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E  + +  +G G FG+V+   +    K VA+K + +   S         E  + K L H 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF---LAEANLMKQLQHQ 68

Query: 179 NIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRK--KLSETICVQILSNLISALYYLHS 235
            +++  A         +ITE+  + SL + L+     KL+    + + + +   + ++  
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML-TSIKGTPLYMAPELIAERPY 294
              +HRDL+  N+L++      + DFG AR +    +      K    + APE I    +
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187

Query: 295 DHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLL 352
              +D+WS G +  EI   G  P+  ++   +I+ L +   +  P    E    L++   
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247

Query: 353 EKDASQRLSWPELL 366
           ++    R ++  L 
Sbjct: 248 KERPEDRPTFDYLR 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.5 bits (167), Expect = 2e-13
 Identities = 19/86 (22%), Positives = 34/86 (39%), Gaps = 5/86 (5%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
          E  + +  +G G FG+V+   +    K VA+K + +   S         E  + K L H 
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA---FLAEANLMKQLQHQ 68

Query: 69 NIIKFIASHETLNEFVLITEFAHMSL 94
           +++  A         +ITE+     
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGS 93

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-51
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 36/285 (12%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQK 173
           E  +   ++G G+FGKV  A    + KT     VA+K++ +   S  E  +L  E ++  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMT 95

Query: 174 HLA-HPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKK------------------ 213
            L  H NI+  + +        LI E+  +  L N L  +++                  
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 214 -----LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA 268
                L+    +     +   + +L     +HRDL  +NVL+    V  +CDFG AR + 
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 269 VG--THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIH-MGHPPFKTVSILHL 325
                 +  + +    +MAPE + E  Y   +D+WS G + +EI  +G  P+  + +   
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275

Query: 326 IRLLKTQDVTF--PSQVSETYKDLVKGLLEKDASQRLSWPELLHH 368
              L         P   +E    +++     D+ +R S+P L   
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.3 bits (161), Expect = 2e-12
 Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 7/88 (7%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKT-----VALKIISKSGRSGKELSSLKQECEIQK 63
           E  +   ++G G+FGKV  A    + KT     VA+K++ +   S  E  +L  E ++  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMT 95

Query: 64  HLA-HPNIIKFIASHETLNEFVLITEFA 90
            L  H NI+  + +        LI E+ 
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYC 123

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 4e-51
 Identities = 76/295 (25%), Positives = 112/295 (37%), Gaps = 42/295 (14%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
            +Y  +  IGEG++G V  A     K  VA+K IS             +E +I     H 
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT-YCQRTLREIKILLRFRHE 66

Query: 179 NIIKFI-----ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
           NII         + E + +  L+T      L  LL + + LS       L  ++  L Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYI 125

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT---HMLTSIKGTPLYMAPELIA 290
           HS  VLHRDLKP N+LLN      +CDFG AR           LT    T  Y APE++ 
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 291 -ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP------------ 337
             + Y  + D+WS+GCI  E+    P F     L  +  +     +              
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 338 -------------------SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                                      DL+  +L  +  +R+   + L HP ++ 
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.0 bits (173), Expect = 6e-14
 Identities = 26/94 (27%), Positives = 37/94 (39%), Gaps = 6/94 (6%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
            +Y  +  IGEG++G V  A     K  VA+K IS             +E +I     H 
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT-YCQRTLREIKILLRFRHE 66

Query: 69  NIIKFI-----ASHETLNEFVLITEFAHMSLSKL 97
           NII         + E + +  L+T      L KL
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL 100

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-50
 Identities = 54/256 (21%), Positives = 105/256 (41%), Gaps = 8/256 (3%)

Query: 121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISK---SGRSGKELSSLKQECEIQKHLAH 177
           ++KI ++G G+FG V+K + +   + V + +  K      S K    +  E  +   + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 178 PNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKL-SETICVQILSNLISALYYLHSN 236
           P++ + +    T    ++        L + + + K        +     +   + YL   
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 237 RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKGTPLYMAPELIAERPY 294
           R++HRDL  +NVL+       + DFG A+ +      +     K    +MA E I  R Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190

Query: 295 DHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDLVKGLL 352
            H +D+WS G   +E+   G  P+  +    +  +L K + +  P   +     ++    
Sbjct: 191 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCW 250

Query: 353 EKDASQRLSWPELLHH 368
             DA  R  + EL+  
Sbjct: 251 MIDADSRPKFRELIIE 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.4 bits (156), Expect = 7e-12
 Identities = 16/87 (18%), Positives = 37/87 (42%), Gaps = 3/87 (3%)

Query: 11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISK---SGRSGKELSSLKQECEIQKHLAH 67
          ++KI ++G G+FG V+K + +   + V + +  K      S K    +  E  +   + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 68 PNIIKFIASHETLNEFVLITEFAHMSL 94
          P++ + +    T    ++        L
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCL 97

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 1e-49
 Identities = 53/263 (20%), Positives = 99/263 (37%), Gaps = 13/263 (4%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKE-LSSLKQECEIQK 173
            +  + +  +G+GSFG V +            VA+K +     S  E +    +E     
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 174 HLAHPNIIKFIASHETLNEFVLITEFAHMS--LSNLLEQRKKLSETICVQILSNLISALY 231
            L H N+I+      T     ++TE A +   L  L + +         +    +   + 
Sbjct: 67  SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPEL 288
           YL S R +HRDL  +N+LL    +  + DFG  R++        M    K    + APE 
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185

Query: 289 IAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDVTF--PSQVSETYK 345
           +  R + H +D W  G   +E+   G  P+  ++   ++  +  +      P    +   
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245

Query: 346 DLVKGLLEKDASQRLSWPELLHH 368
           +++          R ++  L   
Sbjct: 246 NVMVQCWAHKPEDRPTFVALRDF 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.0 bits (155), Expect = 6e-12
 Identities = 20/87 (22%), Positives = 34/87 (39%), Gaps = 5/87 (5%)

Query: 8  LEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKE-LSSLKQECEIQK 63
           +  + +  +G+GSFG V +            VA+K +     S  E +    +E     
Sbjct: 7  EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 64 HLAHPNIIKFIASHETLNEFVLITEFA 90
           L H N+I+      T     ++TE A
Sbjct: 67 SLDHRNLIRLYGVVLT-PPMKMVTELA 92

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  170 bits (432), Expect = 2e-49
 Identities = 65/263 (24%), Positives = 113/263 (42%), Gaps = 13/263 (4%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKH 174
           +   +   +IG G FG+V         K    VA+K + KSG + K+      E  I   
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQ 83

Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHM-SLSNLLEQR-KKLSETICVQILSNLISALYY 232
             HPN+I            ++ITEF    SL + L Q   + +    V +L  + + + Y
Sbjct: 84  FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS-----IKGTPLYMAPE 287
           L     +HRDL  +N+L+N + V  + DFG +R +   T   T       K    + APE
Sbjct: 144 LADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203

Query: 288 LIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIR-LLKTQDVTFPSQVSETYK 345
            I  R +   +D+WS G + +E+   G  P+  ++   +I  + +   +  P        
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263

Query: 346 DLVKGLLEKDASQRLSWPELLHH 368
            L+    +KD + R  + ++++ 
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVNT 286

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 66.7 bits (162), Expect = 1e-12
 Identities = 24/88 (27%), Positives = 35/88 (39%), Gaps = 4/88 (4%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKH 64
           +   +   +IG G FG+V         K    VA+K + KSG + K+      E  I   
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQ 83

Query: 65  LAHPNIIKFIASHETLNEFVLITEFAHM 92
             HPN+I            ++ITEF   
Sbjct: 84  FDHPNVIHLEGVVTKSTPVMIITEFMEN 111

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-49
 Identities = 67/292 (22%), Positives = 121/292 (41%), Gaps = 40/292 (13%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 179 NIIKFIASHETLNEF-----VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
           N+I  +              V +      +  N + + +KL++     ++  ++  L Y+
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE-R 292
           HS  ++HRDLKP N+ +N+D    + DFG AR        +T    T  Y APE++    
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 194

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQ------------- 339
            Y+ T D+WS+GCI  E+  G   F     +  ++L+     T  ++             
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254

Query: 340 ------------------VSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                              +    DL++ +L  D+ +R++  + L H     
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.2 bits (194), Expect = 1e-16
 Identities = 21/100 (21%), Positives = 39/100 (39%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
           E+YQ +  +G G++G V  A        VA+K +S+  +S        +E  + KH+ H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 69  NIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQP 108
           N+I  +             +   ++     +      CQ 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 3e-49
 Identities = 72/257 (28%), Positives = 111/257 (43%), Gaps = 8/257 (3%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKHL 175
           E+ +    IGEG FG V + I++  +     VA+K       S        QE    +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQF 65

Query: 176 AHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLH 234
            HP+I+K I        ++++       L + L+ R   L     +     L +AL YL 
Sbjct: 66  DHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 235 SNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS-IKGTPLYMAPELIAERP 293
           S R +HRD+  +NVL++ +    L DFG +R M   T+   S  K    +MAPE I  R 
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185

Query: 294 YDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGL 351
           +   +D+W  G   +EI M G  PF+ V    +I R+   + +  P     T   L+   
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 245

Query: 352 LEKDASQRLSWPELLHH 368
              D S+R  + EL   
Sbjct: 246 WAYDPSRRPRFTELKAQ 262

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.6 bits (154), Expect = 8e-12
 Identities = 21/99 (21%), Positives = 38/99 (38%), Gaps = 4/99 (4%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKHL 65
           E+ +    IGEG FG V + I++  +     VA+K       S        QE    +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQF 65

Query: 66  AHPNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHN 104
            HP+I+K I        ++++       L    +   ++
Sbjct: 66  DHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS 104

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (424), Expect = 3e-48
 Identities = 57/282 (20%), Positives = 112/282 (39%), Gaps = 35/282 (12%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQK 173
              + +  IGEG+FG+VF+A    L        VA+K++ +   S    +  ++E  +  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMA 71

Query: 174 HLAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKK------------------- 213
              +PNI+K +          L+ E+  +  L+  L                        
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 214 -----LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA 268
                LS    + I   + + + YL   + +HRDL  +N L+ ++ V  + DFG +R++ 
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 269 VG--THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHL 325
                    +      +M PE I    Y   +D+W+ G + +EI   G  P+  ++   +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251

Query: 326 IRLLKTQDV-TFPSQVSETYKDLVKGLLEKDASQRLSWPELL 366
           I  ++  ++   P        +L++    K  + R S+  + 
Sbjct: 252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 63.7 bits (154), Expect = 1e-11
 Identities = 22/95 (23%), Positives = 43/95 (45%), Gaps = 7/95 (7%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQK 63
              + +  IGEG+FG+VF+A    L        VA+K++ +   S    +  ++E  +  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMA 71

Query: 64  HLAHPNIIKFIASHETLNEFVLITEFA-HMSLSKL 97
              +PNI+K +          L+ E+  +  L++ 
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 106

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (423), Expect = 4e-48
 Identities = 52/282 (18%), Positives = 100/282 (35%), Gaps = 27/282 (9%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y+    IG GSFG ++    +   + VA+K+         +   L  E +I K +    
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGV 63

Query: 180 IIKFI-ASHETLNEFVLITEFAHMSLSNL-LEQRKKLSETICVQILSNLISALYYLHSNR 237
            I  I       +  V++ E    SL +L     +K S    + +   +IS + Y+HS  
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 238 VLHRDLKPQNVLLNKDG---VAMLCDFGFARSMAVGT-------HMLTSIKGTPLYMAPE 287
            +HRD+KP N L+       +  + DFG A+                 ++ GT  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 288 LIAERPYDHTADLWSLGCIAYEIHMGHPPFKT---VSILHLIRLLKTQDVTFP-----SQ 339
                      DL SLG +    ++G  P++     +       +  + ++ P       
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243

Query: 340 VSETYKDLVKGLLEKDASQRLSWP---ELLHHPLVKDNLSSE 378
               +   +          +  +    +L  +   +   S +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 66.8 bits (162), Expect = 9e-13
 Identities = 21/89 (23%), Positives = 35/89 (39%), Gaps = 5/89 (5%)

Query: 10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 69
          +Y+    IG GSFG ++    +   + VA+K+         +   L  E +I K +    
Sbjct: 8  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGV 63

Query: 70 IIKFI-ASHETLNEFVLITEFAHMSLSKL 97
           I  I       +  V++ E    SL  L
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDL 92

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-47
 Identities = 58/259 (22%), Positives = 116/259 (44%), Gaps = 12/259 (4%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLD----LKKTVALKIISKSGRSGKELSSLKQECEIQKH 174
               +  +IG G FG+V+K +        +  VA+K + K+G + K+      E  I   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQ 65

Query: 175 LAHPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKK--LSETICVQILSNLISALYY 232
            +H NII+           ++ITE+      +   + K    S    V +L  + + + Y
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 233 LHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG---THMLTSIKGTPLYMAPELI 289
           L +   +HRDL  +N+L+N + V  + DFG +R +      T+  +  K    + APE I
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 290 AERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLL-KTQDVTFPSQVSETYKDL 347
           + R +   +D+WS G + +E+   G  P+  +S   +++ +     +  P         L
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245

Query: 348 VKGLLEKDASQRLSWPELL 366
           +    +++ ++R  + +++
Sbjct: 246 MMQCWQQERARRPKFADIV 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.1 bits (155), Expect = 7e-12
 Identities = 22/88 (25%), Positives = 38/88 (43%), Gaps = 5/88 (5%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLD----LKKTVALKIISKSGRSGKELSSLKQECEIQKH 64
              +  +IG G FG+V+K +        +  VA+K + K+G + K+      E  I   
Sbjct: 7  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQ 65

Query: 65 LAHPNIIKFIASHETLNEFVLITEFAHM 92
           +H NII+           ++ITE+   
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMEN 93

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 5e-47
 Identities = 66/273 (24%), Positives = 117/273 (42%), Gaps = 24/273 (8%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLD--LKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
               +   +IGEG+FG+V KA      L+   A+K + +   S  +      E E+   L
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKL 67

Query: 176 A-HPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQR----------------KKLSET 217
             HPNII  + + E      L  E+A H +L + L +                   LS  
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 218 ICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSI 277
             +   +++   + YL   + +HRDL  +N+L+ ++ VA + DFG +R   V     T  
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-TMG 186

Query: 278 KGTPLYMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIR-LLKTQDVT 335
           +    +MA E +    Y   +D+WS G + +EI  +G  P+  ++   L   L +   + 
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246

Query: 336 FPSQVSETYKDLVKGLLEKDASQRLSWPELLHH 368
            P    +   DL++    +   +R S+ ++L  
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.5 bits (151), Expect = 3e-11
 Identities = 34/147 (23%), Positives = 54/147 (36%), Gaps = 11/147 (7%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLD--LKKTVALKIISKSGRSGKELSSLKQECEIQKHL 65
               +   +IGEG+FG+V KA      L+   A+K + +   S  +      E E+   L
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKL 67

Query: 66  A-HPNIIKFIASHETLNEFVLITEFA-HMSLSKL--GEPWFHNHCQPVKMEKSNGALEKY 121
             HPNII  + + E      L  E+A H +L                     +   L   
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 122 QKICLIGEGSFGKVF----KAIHLDLK 144
           Q +    + + G  +    + IH DL 
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLA 154

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  163 bits (414), Expect = 2e-46
 Identities = 67/299 (22%), Positives = 118/299 (39%), Gaps = 47/299 (15%)

Query: 116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 175
           G  + YQ +  +G G + +VF+AI++   + V +KI+        +   +K+E +I ++L
Sbjct: 32  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENL 86

Query: 176 A-HPNIIKFIASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLH 234
              PNII      +          F H++ ++  +  + L++      +  ++ AL Y H
Sbjct: 87  RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 146

Query: 235 SNRVLHRDLKPQNVLL-NKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE-R 292
           S  ++HRD+KP NV++ ++     L D+G A     G         +  +  PEL+ + +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPELLVDYQ 205

Query: 293 PYDHTADLWSLGCIAYEIHMGHPPFK----TVSILHLI---------------------- 326
            YD++ D+WSLGC+   +     PF         L  I                      
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 327 ------------RLLKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD 373
                       R  +         VS    D +  LL  D   RL+  E + HP    
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 67.9 bits (165), Expect = 5e-13
 Identities = 22/93 (23%), Positives = 43/93 (46%), Gaps = 6/93 (6%)

Query: 6   GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL 65
           G  + YQ +  +G G + +VF+AI++   + V +KI+        +   +K+E +I ++L
Sbjct: 32  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENL 86

Query: 66  A-HPNIIKFIASHETLNEFVLITEFAHMSLSKL 97
              PNII      +          F H++ +  
Sbjct: 87  RGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 119

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-46
 Identities = 56/255 (21%), Positives = 106/255 (41%), Gaps = 13/255 (5%)

Query: 126 LIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 182
           +IG G FG V+    LD        A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 92

Query: 183 FI-ASHETLNEFVLITEFAHMSLSNLLE--QRKKLSETICVQILSNLISALYYLHSNRVL 239
            +     +    +++  +            +    +    +     +   + +L S + +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152

Query: 240 HRDLKPQNVLLNKDGVAMLCDFGFARSMAVG----THMLTSIKGTPLYMAPELIAERPYD 295
           HRDL  +N +L++     + DFG AR M        H  T  K    +MA E +  + + 
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212

Query: 296 HTADLWSLGCIAYEI-HMGHPPFKTVSILHLI-RLLKTQDVTFPSQVSETYKDLVKGLLE 353
             +D+WS G + +E+   G PP+  V+   +   LL+ + +  P    +   +++     
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWH 272

Query: 354 KDASQRLSWPELLHH 368
             A  R S+ EL+  
Sbjct: 273 PKAEMRPSFSELVSR 287

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.3 bits (153), Expect = 1e-11
 Identities = 27/133 (20%), Positives = 47/133 (35%), Gaps = 13/133 (9%)

Query: 16  LIGEGSFGKVFKAIHLDLKKT---VALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIK 72
           +IG G FG V+    LD        A+K +++    G E+S    E  I K  +HPN++ 
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLS 92

Query: 73  FI-ASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLIGEGS 131
            +     +    +++  +              N  +      +   L  +      G   
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGD-------LRNFIRNETHNPTVKDLIGFGLQVAKGM-K 144

Query: 132 FGKVFKAIHLDLK 144
           F    K +H DL 
Sbjct: 145 FLASKKFVHRDLA 157

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  160 bits (406), Expect = 8e-46
 Identities = 57/296 (19%), Positives = 106/296 (35%), Gaps = 32/296 (10%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 178
             Y+    IGEGSFG +F+  +L   + VA+K   +      +   L+ E    K LA  
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGC 60

Query: 179 NIIKFI-ASHETLNEFVLITEFAHMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSN 236
             I  +    +     VL+ +    SL +LL+   +K S          +++ +  +H  
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 237 RVLHRDLKPQNVLLNK-----DGVAMLCDFGFAR-------SMAVGTHMLTSIKGTPLYM 284
            +++RD+KP N L+ +       +  + DFG  +          +      ++ GT  YM
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 285 APELIAERPYDHTADLWSLGCIAYEIHMGHPPF---KTVSILHLIRLLKTQDVTFP---- 337
           +      R      DL +LG +      G  P+   K  +       +  +  + P    
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240

Query: 338 -SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLSSEIESQNNQDCIGFDY 392
            +   E +   +             +  L      +   S  +E  N  +   FD+
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYL------QGLFSKVLERLNTTEDENFDW 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 64.4 bits (156), Expect = 5e-12
 Identities = 24/90 (26%), Positives = 37/90 (41%), Gaps = 5/90 (5%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHP 68
            Y+    IGEGSFG +F+  +L   + VA+K   +      +   L+ E    K LA  
Sbjct: 5  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGC 60

Query: 69 NIIKFI-ASHETLNEFVLITEFAHMSLSKL 97
            I  +    +     VL+ +    SL  L
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDL 90

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (409), Expect = 1e-45
 Identities = 70/304 (23%), Positives = 118/304 (38%), Gaps = 51/304 (16%)

Query: 118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 177
           L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 178 PNIIKFI------ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALY 231
            NII  +       + E   +  L+ E   M  +     + +L       +L  ++  + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGIK 133

Query: 232 YLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE 291
           +LHS  ++HRDLKP N+++  D    + DFG AR+    + M+T    T  Y APE+I  
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 192

Query: 292 RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRL----------------------- 328
             Y    D+WS+GCI  E+      F     +                            
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252

Query: 329 -------------------LKTQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHP 369
                              L   D       +   +DL+  +L  D ++R+S  + L HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312

Query: 370 LVKD 373
            +  
Sbjct: 313 YINV 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.5 bits (174), Expect = 5e-14
 Identities = 33/137 (24%), Positives = 53/137 (38%), Gaps = 6/137 (4%)

Query: 8   LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH 67
           L++YQ +  IG G+ G V  A    L + VA+K +S+  ++        +E  + K + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 68  PNIIKFIASHETLNEFVLITEFAHMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQKICLI 127
            NII  +             +   +      E    N CQ ++ME  +  +       L 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLV-----MELMDANLCQVIQMELDHERMSYLLYQMLC 130

Query: 128 GEGSFGKVFKAIHLDLK 144
           G          IH DLK
Sbjct: 131 GIKHLHSAGI-IHRDLK 146

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 2e-45
 Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 30/279 (10%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLKK-------TVALKIISKSGRSGKELSSLKQECEI 171
           ++      +GEG+FG+V  A  + L K        VA+K++ KS  + K+LS L  E E+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEM 71

Query: 172 QKHLA-HPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRK----------------K 213
            K +  H NII  + +        +I E+A   +L   L+ R+                +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 214 LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM 273
           LS    V     +   + YL S + +HRDL  +NVL+ +D V  + DFG AR +    + 
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 274 LTS--IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLK 330
             +   +    +MAPE + +R Y H +D+WS G + +EI  +G  P+  V +  L +LLK
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 331 T-QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH 368
               +  PS  +     +++       SQR ++ +L+  
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.9 bits (144), Expect = 2e-10
 Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 9/90 (10%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDLKK-------TVALKIISKSGRSGKELSSLKQECEI 61
           ++      +GEG+FG+V  A  + L K        VA+K++ KS  + K+LS L  E E+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEM 71

Query: 62  QKHLA-HPNIIKFIASHETLNEFVLITEFA 90
            K +  H NII  + +        +I E+A
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYA 101

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 8e-45
 Identities = 61/279 (21%), Positives = 115/279 (41%), Gaps = 31/279 (11%)

Query: 119 EKYQKICLIGEGSFGKVFKA-----IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQK 173
            +      +G G+FGKV +A     I  D   TVA+K++  S     E  +L  E ++  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLS 81

Query: 174 HLA-HPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRK------------------K 213
           +L  H NI+  + +       ++ITE+  +  L N L +++                   
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 214 LSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--T 271
           L     +     +   + +L S   +HRDL  +N+LL    +  +CDFG AR +      
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLK 330
            +  + +    +MAPE I    Y   +D+WS G   +E+  +G  P+  + +      + 
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

Query: 331 TQDV--TFPSQVSETYKDLVKGLLEKDASQRLSWPELLH 367
            +      P        D++K   + D  +R ++ +++ 
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.7 bits (167), Expect = 2e-13
 Identities = 36/151 (23%), Positives = 61/151 (40%), Gaps = 16/151 (10%)

Query: 9   EKYQKICLIGEGSFGKVFKA-----IHLDLKKTVALKIISKSGRSGKELSSLKQECEIQK 63
            +      +G G+FGKV +A     I  D   TVA+K++  S     E  +L  E ++  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLS 81

Query: 64  HLA-HPNIIKFIASHETLNEFVLITEFA-----HMSLSKLGEPWFHNHCQPVKMEKSNGA 117
           +L  H NI+  + +       ++ITE+         L +  + +  +   P  ME    A
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 118 LEKYQKICLIGEGSFGKVF----KAIHLDLK 144
           L+    +    + + G  F      IH DL 
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 4e-44
 Identities = 54/291 (18%), Positives = 122/291 (41%), Gaps = 28/291 (9%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQK 173
           EK      +G+GSFG V++ +   +     +  VA+K ++++  S +E      E  + K
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMK 78

Query: 174 HLAHPNIIKFIASHETLNEFVLITEFA-HMSLSNLLEQRKK----------LSETICVQI 222
                ++++ +         ++I E      L + L   +            S +  +Q+
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 223 LSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THMLTSIKGT 280
              +   + YL++N+ +HRDL  +N ++ +D    + DFG  R +               
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 281 PLYMAPELIAERPYDHTADLWSLGCIAYEI-HMGHPPFKTVSILHLIRLLKTQDV-TFPS 338
             +M+PE + +  +   +D+WS G + +EI  +   P++ +S   ++R +    +   P 
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258

Query: 339 QVSETYKDLVKGLLEKDASQRLSWPELLH------HPLVKDNLSSEIESQN 383
              +   +L++   + +   R S+ E++        P  ++ +S     +N
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE-VSFYYSEEN 308

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.7 bits (159), Expect = 3e-12
 Identities = 26/146 (17%), Positives = 55/146 (37%), Gaps = 15/146 (10%)

Query: 9   EKYQKICLIGEGSFGKVFKAIHLDL-----KKTVALKIISKSGRSGKELSSLKQECEIQK 63
           EK      +G+GSFG V++ +   +     +  VA+K ++++  S +E      E  + K
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMK 78

Query: 64  HLAHPNIIKFIASHETLNEFVLITEFA-HMSLSKLGEPWFHNHCQPVKMEKSNGALEKYQ 122
                ++++ +         ++I E      L      +  +    +            +
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS----YLRSLRPAMANNPVLAPPSLSK 134

Query: 123 KICLIGEGSFGKVF----KAIHLDLK 144
            I + GE + G  +    K +H DL 
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLA 160

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 6e-44
 Identities = 61/278 (21%), Positives = 117/278 (42%), Gaps = 28/278 (10%)

Query: 119 EKYQKICLIGEGSFGKVFKAIHLDLK-----KTVALKIISKSGRSGKELSSLKQECEIQK 173
           ++ +    +G G+FG+V +A    +      +TVA+K++ +     +  + + +   +  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 174 HLAHPNIIKFI-ASHETLNEFVLITEFA-HMSLSNLLEQRKK----------------LS 215
              H N++  + A  +     ++I EF    +LS  L  ++                 L+
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 216 ETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HM 273
               +     +   + +L S + +HRDL  +N+LL++  V  +CDFG AR +        
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGH-PPFKTVSILHLI--RLLK 330
               +    +MAPE I +R Y   +D+WS G + +EI      P+  V I      RL +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252

Query: 331 TQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH 368
              +  P   +      +      + SQR ++ EL+ H
Sbjct: 253 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.4 bits (135), Expect = 3e-09
 Identities = 12/83 (14%), Positives = 37/83 (44%), Gaps = 5/83 (6%)

Query: 9  EKYQKICLIGEGSFGKVFKAIHLDLK-----KTVALKIISKSGRSGKELSSLKQECEIQK 63
          ++ +    +G G+FG+V +A    +      +TVA+K++ +     +  + + +   +  
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 64 HLAHPNIIKFIASHETLNEFVLI 86
             H N++  + +       +++
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMV 95

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 3e-38
 Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 55/287 (19%)

Query: 127 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ--KHLAHPNIIKFI 184
           IG+G FG+V++       + VA+KI S      +E  S  +E EI     L H NI+ FI
Sbjct: 11  IGKGRFGEVWRGKWRG--EEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFI 63

Query: 185 ASHE----TLNEFVLITEFA-HMSLSNLLEQRKKLSETICVQILSNLISALYYLHS---- 235
           A+      T  +  L++++  H SL + L  R  ++    +++  +  S L +LH     
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 236 ----NRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML----TSIKGTPLYMAPE 287
                 + HRDLK +N+L+ K+G   + D G A      T  +        GT  YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 288 LIAER------PYDHTADLWSLGCIAYEIHMGHPPFK-----------------TVSILH 324
           ++ +            AD++++G + +EI                         +V  + 
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 325 LIRLLKTQDVTFPS-----QVSETYKDLVKGLLEKDASQRLSWPELL 366
            +   +      P+     +       +++     + + RL+   + 
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.6 bits (133), Expect = 5e-09
 Identities = 25/81 (30%), Positives = 40/81 (49%), Gaps = 13/81 (16%)

Query: 17 IGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQ--KHLAHPNIIKFI 74
          IG+G FG+V++       + VA+KI S      +E  S  +E EI     L H NI+ FI
Sbjct: 11 IGKGRFGEVWRGKWRG--EEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFI 63

Query: 75 ASHE----TLNEFVLITEFAH 91
          A+      T  +  L++++  
Sbjct: 64 AADNKDNGTWTQLWLVSDYHE 84

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  138 bits (347), Expect = 6e-37
 Identities = 59/328 (17%), Positives = 114/328 (34%), Gaps = 72/328 (21%)

Query: 120 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN 179
           +Y  +  +G G F  V+ A  +     VA+KI+       +   + + E ++ + +   +
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDAD 70

Query: 180 IIK---------------FIASHETLNEFVLITEFA--HMSLSNLLEQRKKLSETICVQI 222
             K               F          V++ E    ++       + + +      QI
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130

Query: 223 LSNLISALYYLHSNR-VLHRDLKPQNVLLNKDG-VAMLCDFGFAR--SMAVGTHMLTSIK 278
              L+  L Y+H    ++H D+KP+NVL+        L     A   +        T+  
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFK-------TVSILHLIRLLK- 330
            T  Y +PE++   P+   AD+WS  C+ +E+  G   F+       T    H+ ++++ 
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250

Query: 331 ----------------------------------------TQDVTFPSQVSETYKDLVKG 350
                                                   T+   F    ++   D +  
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310

Query: 351 LLEKDASQRLSWPELLHHPLVKDNLSSE 378
           +L+ D  +R     L++HP +KD L  E
Sbjct: 311 MLQLDPRKRADAGGLVNHPWLKDTLGME 338

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.7 bits (206), Expect = 3e-19
 Identities = 27/194 (13%), Positives = 56/194 (28%), Gaps = 29/194 (14%)

Query: 126 LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS--------SLKQECEIQKHLAH 177
           L+GEG    VF            +K       S K++                       
Sbjct: 7   LMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 178 PNIIKF----IASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYL 233
             + K     +          ++ E          ++  ++      ++L  ++  +   
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDA------KELYRVRVENPDEVLDMILEEVAKF 119

Query: 234 HSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAE-- 291
           +   ++H DL   NVL++++G+  + DF  +  +              L      I    
Sbjct: 120 YHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG------EEGWREILERDVRNIITYF 172

Query: 292 -RPYDHTADLWSLG 304
            R Y    D+ S  
Sbjct: 173 SRTYRTEKDINSAI 186

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 41.3 bits (96), Expect = 9e-05
 Identities = 11/100 (11%), Positives = 19/100 (19%), Gaps = 13/100 (13%)

Query: 16  LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELS--------SLKQECEIQKHLAH 67
           L+GEG    VF            +K       S K++                       
Sbjct: 7   LMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 68  PNIIKF----IASHETLNEFVLITEFAHMSLSKLGEPWFH 103
             + K     +          ++ E               
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENP 105

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	549
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.6
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.59
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.58
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.58
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.55
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.55
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.55
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.55
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.54
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.54
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.54
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.54
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.53
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.53
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.53
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.53
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.52
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.52
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.51
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.51
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.51
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.5
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.5
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.49
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.49
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.48
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.46
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.46
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.46
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.45
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.44
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.43
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.42
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.41
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.41
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.39
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.38
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.38
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.37
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.37
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.37
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.36
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.36
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.36
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.35
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.34
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.34
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.34
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.34
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.33
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.32
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.32
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.3
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.3
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.29
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.24
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.23
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.22
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.17
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.12
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	98.84
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	98.47
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.11
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.65
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.53
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.75
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.06
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	94.74

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-61  Score=482.38  Aligned_cols=256  Identities=35%  Similarity=0.563  Sum_probs=236.2

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ..+++|++++.||+|+||+||+|.++.+++.||+|++.+... .......+.+|+++++.++|||||++++++.+.+.+|
T Consensus         3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            346889999999999999999999999999999999975321 1123467889999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccc
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHM  273 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~  273 (549)
                      ||||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....  .
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~  160 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--R  160 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--C
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--c
Confidence            9999998 599999999999999999999999999999999999999999999999999999999999999766533  2


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhch
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ....+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+....+....+.+|+.+|+++++||.+||+
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  240 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK  240 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTC
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHcc
Confidence            35568999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hCcCCCCCHHHHhcCcccCc
Q psy18060        354 KDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~~~  373 (549)
                      +||.+|||++|+|+||||+.
T Consensus       241 ~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         241 HNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             SSGGGSCCHHHHHTCHHHHH
T ss_pred             CCHhHCcCHHHHHcCcCcCC
Confidence            99999999999999999964

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-60  Score=489.32  Aligned_cols=263  Identities=28%  Similarity=0.493  Sum_probs=242.7

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      .+++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.++|||||++++++++.+.+|+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            46789999999999999999999999999999999976421 12235678899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      |||||. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.........
T Consensus        83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence            999998 5899999999999999999999999999999999999999999999999999999999999998766555556


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchh
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+...+...+..+.+.+|+.+|+++++||.+||++
T Consensus       163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~  242 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK  242 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccC
Confidence            67899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCCC-----HHHHhcCcccCcccchhh
Q psy18060        355 DASQRLS-----WPELLHHPLVKDNLSSEI  379 (549)
Q Consensus       355 dP~~Rps-----~~elL~Hpw~~~~~~~~~  379 (549)
                      ||.+||+     ++|+++||||++..+..+
T Consensus       243 dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l  272 (337)
T d1o6la_         243 DPKQRLGGGPSDAKEVMEHRFFLSINWQDV  272 (337)
T ss_dssp             STTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             CchhhcccccccHHHHHcCcccccCCHHHH
Confidence            9999995     899999999988655444

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-60  Score=478.03  Aligned_cols=263  Identities=30%  Similarity=0.504  Sum_probs=236.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      .++|++++.||+|+||+||+|.++.+|+.||||++.+... .......+.+|++++++++|||||++++++.+.+.+|+|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            4679999999999999999999999999999999975321 122346789999999999999999999999999999999


Q ss_pred             EecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc--cc
Q psy18060        197 TEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HM  273 (549)
Q Consensus       197 ~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~--~~  273 (549)
                      ||||.| +|.+++..++.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+......  ..
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~  166 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR  166 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence            999984 899999999999999999999999999999999999999999999999999999999999998775332  23


Q ss_pred             ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhch
Q psy18060        274 LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      .++.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+...+...+....+.+|+.+|+++++||.+||+
T Consensus       167 ~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  246 (288)
T d1uu3a_         167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV  246 (288)
T ss_dssp             ---CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSC
T ss_pred             cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHcc
Confidence            45678999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hCcCCCCCHHH------HhcCcccCcccchhhh
Q psy18060        354 KDASQRLSWPE------LLHHPLVKDNLSSEIE  380 (549)
Q Consensus       354 ~dP~~Rps~~e------lL~Hpw~~~~~~~~~~  380 (549)
                      +||.+|||++|      +++||||++..+..+.
T Consensus       247 ~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~  279 (288)
T d1uu3a_         247 LDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  279 (288)
T ss_dssp             SSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             CCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence            99999999987      6889999876655554

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-60  Score=472.11  Aligned_cols=254  Identities=30%  Similarity=0.529  Sum_probs=219.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--CCEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--LNEFVL  195 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i  195 (549)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.....+....+.+.+|++++++++|||||++++++.+  .+.+||
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            478999999999999999999999999999999998877777777889999999999999999999998854  566899


Q ss_pred             EEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----CccccccCCcEEEecCCcEEEeecccce
Q psy18060        196 ITEFAH-MSLSNLLEQ----RKKLSETICVQILSNLISALYYLHSNR-----VLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~----~~~l~e~~~~~i~~qIl~aL~yLH~~g-----IiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                      |||||+ |+|.+++.+    +..+++..++.++.||+.||+|||++|     |+||||||+|||++.+|.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999998 589999864    467999999999999999999999976     9999999999999999999999999998


Q ss_pred             ecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCccCCHHH
Q psy18060        266 SMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV-TFPSQVSETY  344 (549)
Q Consensus       266 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~  344 (549)
                      .........++.+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..+....+..+.. .+|..+|+++
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  242 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL  242 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence            876655555678899999999999999999999999999999999999999999999998888877664 4677899999


Q ss_pred             HHHHHHhchhCcCCCCCHHHHhcCccc
Q psy18060        345 KDLVKGLLEKDASQRLSWPELLHHPLV  371 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~~elL~Hpw~  371 (549)
                      ++||.+||+.||.+|||++|+++|||+
T Consensus       243 ~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         243 NEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            999999999999999999999999996

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-59  Score=474.00  Aligned_cols=253  Identities=29%  Similarity=0.540  Sum_probs=228.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++++.||+|+||+||+|.++.+|+.||||++......  ..+.+.+|+.++++++|||||++++++.+.+.+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            35799999999999999999999999999999999764332  2467899999999999999999999999999999999


Q ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |||. |+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...........
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            9998 589887765 57999999999999999999999999999999999999999999999999999987665555667


Q ss_pred             cCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCCccCCHHHHHHHHHhch
Q psy18060        277 IKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ---DVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      .+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+.......+...   ....|+.+|+++++||.+||+
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  255 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence            78999999999999999999999999999999999999999998877766655433   344567899999999999999


Q ss_pred             hCcCCCCCHHHHhcCcccCc
Q psy18060        354 KDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       354 ~dP~~Rps~~elL~Hpw~~~  373 (549)
                      +||.+|||+.|+|+||||+.
T Consensus       256 ~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         256 MDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             SSTTTSCCHHHHTTCGGGGG
T ss_pred             CChhHCcCHHHHhcCHhhCC
Confidence            99999999999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-60  Score=473.15  Aligned_cols=259  Identities=25%  Similarity=0.405  Sum_probs=221.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      .+++|++++.||+|+||+||+|.++.+|+.||||++..... ....+.+.+|++++++++|||||++++++.+.+.+|||
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            35789999999999999999999999999999999976532 23345688999999999999999999999999999999


Q ss_pred             EecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc--cc
Q psy18060        197 TEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT--HM  273 (549)
Q Consensus       197 ~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~--~~  273 (549)
                      ||||.| +|.+++.+++.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......  ..
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            999985 899999888899999999999999999999999999999999999999999999999999998765432  23


Q ss_pred             ccccCCCCcccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCCC--CCccCCHHHHHHHH
Q psy18060        274 LTSIKGTPLYMAPELIAERPY-DHTADLWSLGCIAYEIHMGHPPFKTVSIL-HLIRLLKTQDVT--FPSQVSETYKDLVK  349 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~~~y-~~ksDIwSlGvil~eLltG~~Pf~~~~~~-~~~~~i~~~~~~--~p~~~s~~~~dlI~  349 (549)
                      .++.+||+.|||||++.+..+ +.++|||||||++|+|+||++||...... .....+......  .++.+|+++++||.
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  241 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence            456789999999999988776 67899999999999999999999765432 223333333222  23578999999999


Q ss_pred             HhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        350 GLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      +||+.||.+|||++|+|+||||+....
T Consensus       242 ~~L~~dP~~R~t~~eil~hpwf~~~l~  268 (271)
T d1nvra_         242 KILVENPSARITIPDIKKDRWYNKPLK  268 (271)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence            999999999999999999999986543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-59  Score=470.99  Aligned_cols=256  Identities=32%  Similarity=0.544  Sum_probs=228.0

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      +.|++++.||+|+||.||+|.++.+++.||+|++....  ....+.+.+|++++++++|||||++++++.+.+.+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            46999999999999999999999999999999997643  3445678899999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        199 FAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       199 ~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      ||. |+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..........+
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            998 589998765 457999999999999999999999999999999999999999999999999999876544344456


Q ss_pred             cCCCCccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCccCCHHHHHHH
Q psy18060        277 IKGTPLYMAPELIA-----ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV---TFPSQVSETYKDLV  348 (549)
Q Consensus       277 ~~GT~~Y~APE~l~-----~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~dlI  348 (549)
                      .+||+.|||||++.     +..|+.++|||||||++|+|+||++||.+.+..+....+..+..   ..|+.+|+++++||
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li  249 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL  249 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            78999999999983     46689999999999999999999999999888877777766543   34568999999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                      .+||++||.+|||++|+|+||||+....
T Consensus       250 ~~~L~~dp~~R~t~~ell~hp~~~~~~~  277 (288)
T d2jfla1         250 KKCLEKNVDARWTTSQLLQHPFVTVDSN  277 (288)
T ss_dssp             HHHSCSSTTTSCCHHHHTTSGGGCCCCC
T ss_pred             HHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            9999999999999999999999975433

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-58  Score=473.95  Aligned_cols=261  Identities=29%  Similarity=0.529  Sum_probs=239.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ++++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+++.++|||||++++++.+.+.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            46789999999999999999999999999999999975321 12235678899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      |||||. |+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....   ..
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---~~  158 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VT  158 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---CB
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc---cc
Confidence            999998 47999999999999999999999999999999999999999999999999999999999999987653   33


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchh
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      ++.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+..+...+|+.+|++++++|.+||++
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  238 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR  238 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCC-----CHHHHhcCcccCcccchhhh
Q psy18060        355 DASQRL-----SWPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       355 dP~~Rp-----s~~elL~Hpw~~~~~~~~~~  380 (549)
                      ||.+|+     |++++++||||++..+..+.
T Consensus       239 dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~  269 (316)
T d1fota_         239 DLSQRLGNLQNGTEDVKNHPWFKEVVWEKLL  269 (316)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGSSCCHHHHH
T ss_pred             CHHhccccchhhHHHHHcCcccccCCHHHHH
Confidence            999996     89999999999987665553

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=473.25  Aligned_cols=262  Identities=26%  Similarity=0.486  Sum_probs=236.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHH-HhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQ-KHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      +++|++++.||+|+||+||+|.++.+|+.||||++.+... .......+..|..++ +.++|||||++++++.+.+.+||
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            4689999999999999999999999999999999975321 112234556666665 46899999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      |||||. |+|.+++..+..+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.........
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            999998 5899999999999999999999999999999999999999999999999999999999999998776555556


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchh
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      +..+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+..+.+.+|+.+|+++++||.+||++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~  240 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR  240 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhccc
Confidence            66789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCCCHH-HHhcCcccCcccchhh
Q psy18060        355 DASQRLSWP-ELLHHPLVKDNLSSEI  379 (549)
Q Consensus       355 dP~~Rps~~-elL~Hpw~~~~~~~~~  379 (549)
                      ||.+|||+. |+++||||++.....+
T Consensus       241 dP~~R~s~~~~l~~hpff~~~~~~~l  266 (320)
T d1xjda_         241 EPEKRLGVRGDIRQHPLFREINWEEL  266 (320)
T ss_dssp             SGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred             CCCCCcCHHHHHHhCchhccCCHHHH
Confidence            999999995 8999999987654444

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-58  Score=470.87  Aligned_cols=255  Identities=30%  Similarity=0.545  Sum_probs=214.5

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..+.|++.+.||+|+||+||+|.++.+++.||||++.+..... ....+.+|+.++++++|||||++++++.+.+.+|||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3466999999999999999999999999999999998654332 235678999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe---cCCcEEEeecccceecccCcc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN---KDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~---~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ||||+ |+|.++|..++.+++.+++.++.||+.||+|||++||+||||||+|||+.   .+|.+||+|||+|+...... 
T Consensus        86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-  164 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-  164 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence            99998 69999999999999999999999999999999999999999999999995   47899999999998765442 


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDLV  348 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dlI  348 (549)
                      ...+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+.......+......++    +.+|+++++||
T Consensus       165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  244 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI  244 (307)
T ss_dssp             --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHH
Confidence            34567899999999999999999999999999999999999999999999988888887765543    57899999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                      .+||++||.+|||++|+++||||++
T Consensus       245 ~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         245 RHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHccCCHhHCcCHHHHhcCHhhCC
Confidence            9999999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=460.00  Aligned_cols=256  Identities=30%  Similarity=0.506  Sum_probs=233.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC----hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS----GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+....    ....+.+.+|++++++++|||||++++++.+.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            36799999999999999999999999999999999765422    22357889999999999999999999999999999


Q ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC----cEEEeecccceecc
Q psy18060        194 VLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG----VAMLCDFGFARSMA  268 (549)
Q Consensus       194 ~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g----~vKL~DFGla~~~~  268 (549)
                      |||||||. |+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.+|    .+||+|||+|+...
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            99999998 58999999999999999999999999999999999999999999999998876    59999999998876


Q ss_pred             cCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHH
Q psy18060        269 VGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETY  344 (549)
Q Consensus       269 ~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~  344 (549)
                      .+. ...+..||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+......++    +.+|+++
T Consensus       169 ~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  247 (293)
T d1jksa_         169 FGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA  247 (293)
T ss_dssp             TSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred             CCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHH
Confidence            543 34566899999999999999999999999999999999999999999999999999888877665    5789999


Q ss_pred             HHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        345 KDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      ++||.+||+.||.+|||++|+|+||||++.
T Consensus       248 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         248 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999854

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8e-58  Score=474.16  Aligned_cols=261  Identities=28%  Similarity=0.482  Sum_probs=239.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      .+++|++++.||+|+||.||+|.++.+|+.||||++.+... .......+.+|+++++.++|||||++++++.+.+.+++
T Consensus        39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence            46789999999999999999999999999999999975321 12234678899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccc
Q psy18060        196 ITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHML  274 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~  274 (549)
                      ||||+. |+|..++.+++.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....   .
T Consensus       119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~  195 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---T  195 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---B
T ss_pred             ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---c
Confidence            999988 589999999999999999999999999999999999999999999999999999999999999877533   3


Q ss_pred             cccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHhchh
Q psy18060        275 TSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLVKGLLEK  354 (549)
Q Consensus       275 ~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI~~~L~~  354 (549)
                      .+.+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+.......+..+.+.+|..+|+++.+||++||++
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  275 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred             ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhh
Confidence            55689999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCC-----CHHHHhcCcccCcccchhhh
Q psy18060        355 DASQRL-----SWPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       355 dP~~Rp-----s~~elL~Hpw~~~~~~~~~~  380 (549)
                      ||.+|+     |++++++||||++..+..+.
T Consensus       276 dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~  306 (350)
T d1rdqe_         276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIY  306 (350)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGTTCCHHHHH
T ss_pred             CHHhccccccccHHHHHcCccccCCCHHHHH
Confidence            999995     99999999999987655443

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-57  Score=454.45  Aligned_cols=249  Identities=26%  Similarity=0.462  Sum_probs=219.7

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee----CCEEEEE
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET----LNEFVLI  196 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~iV  196 (549)
                      |++.+.||+|+||+||+|.+..+++.||+|.+..........+.+.+|++++++++|||||++++++..    ...+|||
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            477789999999999999999999999999998766666777889999999999999999999999865    3568999


Q ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccCCcEEEe-cCCcEEEeecccceecccCcc
Q psy18060        197 TEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNR--VLHRDLKPQNVLLN-KDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IiHrDIKP~NILl~-~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ||||+ |+|.+++.+...+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+.....  
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--  168 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--  168 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence            99998 599999999999999999999999999999999998  99999999999997 4789999999999764432  


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCC--CCCccCCHHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTV-SILHLIRLLKTQDV--TFPSQVSETYKDLVK  349 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~dlI~  349 (549)
                      ...+.+||+.|||||++.+ +|+.++|||||||++|||++|+.||.+. +...+.+.+..+..  .++..+++++++||.
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  247 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  247 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHH
Confidence            3456789999999999875 5999999999999999999999999765 45555566655432  345678999999999


Q ss_pred             HhchhCcCCCCCHHHHhcCcccC
Q psy18060        350 GLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      +||++||++|||++|+|+||||+
T Consensus       248 ~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         248 GCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999995

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-57  Score=465.00  Aligned_cols=252  Identities=30%  Similarity=0.471  Sum_probs=225.1

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +.|+.++.||+|+||+||+|.+..+|+.||||++...... ....+.+.+|++++++++|||||++++++.+.+.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4599999999999999999999999999999999876543 344567899999999999999999999999999999999


Q ss_pred             ecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |||.| +|..++..++.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....    ...
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~~  170 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANS  170 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BCC
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----CCc
Confidence            99985 5666677788999999999999999999999999999999999999999999999999999976543    245


Q ss_pred             cCCCCcccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCccCCHHHHHHHHHh
Q psy18060        277 IKGTPLYMAPELIAE---RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT--FPSQVSETYKDLVKGL  351 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~---~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~dlI~~~  351 (549)
                      .+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+.+..+.+..+......  .+..+|+++++||.+|
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~  250 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            689999999999864   46899999999999999999999999998888877776655432  3456899999999999


Q ss_pred             chhCcCCCCCHHHHhcCcccCcc
Q psy18060        352 LEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       352 L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      |++||.+|||++|+|+||||...
T Consensus       251 L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             TCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CcCChhHCcCHHHHHhCHHhcCC
Confidence            99999999999999999999754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.6e-57  Score=469.17  Aligned_cols=256  Identities=26%  Similarity=0.444  Sum_probs=232.4

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ..+++|++++.||+|+||.||+|.++.+|+.||||++....  ....+.+.+|++++++++|||||++++++.+.+.+||
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45789999999999999999999999999999999997543  3445788999999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec--CCcEEEeecccceecccCc
Q psy18060        196 ITEFAH-MSLSNLLE-QRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK--DGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       196 V~E~~~-gsL~~~l~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~--~g~vKL~DFGla~~~~~~~  271 (549)
                      |||||. |+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.  +|.+||+|||+|+......
T Consensus       101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            999998 58999985 4567999999999999999999999999999999999999964  5789999999998776543


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDL  347 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl  347 (549)
                       ...+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+......++    +.+|+++++|
T Consensus       181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  259 (350)
T d1koaa2         181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF  259 (350)
T ss_dssp             -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred             -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence             34567899999999999999999999999999999999999999999999999998888776655    4689999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      |.+||++||.+|||++|+|+||||++.
T Consensus       260 i~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         260 IRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-58  Score=469.44  Aligned_cols=254  Identities=27%  Similarity=0.455  Sum_probs=218.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++++.||+|+||+||+|.++.+|+.||+|++.... .......+.+|+.+++.++|||||++++++.+.+.+||||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            467999999999999999999999999999999997643 3344567899999999999999999999999999999999


Q ss_pred             ecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        198 EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSN-RVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       198 E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      ||+.| +|.+++.+++.+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+|+.....  ..+
T Consensus        84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~  161 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN  161 (322)
T ss_dssp             ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--TC-
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--ccc
Confidence            99985 8999999999999999999999999999999974 9999999999999999999999999999866432  345


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------------------------------
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL------------------------------  325 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~------------------------------  325 (549)
                      +.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+....                              
T Consensus       162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T d1s9ja_         162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG  241 (322)
T ss_dssp             --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred             cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence            67899999999999999999999999999999999999999976542211                              


Q ss_pred             ------------HHHHhcC-CCCCC-ccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        326 ------------IRLLKTQ-DVTFP-SQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       326 ------------~~~i~~~-~~~~p-~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                  ...+... +..+| ..+|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                        1111111 11222 2468999999999999999999999999999999753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.1e-57  Score=468.34  Aligned_cols=256  Identities=27%  Similarity=0.479  Sum_probs=232.0

Q ss_pred             ccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        116 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       116 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ...++|++++.||+|+||.||+|.++.+|+.||||++.+..  ......+.+|+.++++++|||||++++++.+.+.+||
T Consensus        26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i  103 (352)
T d1koba_          26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  103 (352)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34578999999999999999999999999999999997643  3345678899999999999999999999999999999


Q ss_pred             EEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEe--cCCcEEEeecccceecccCc
Q psy18060        196 ITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLN--KDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~--~~g~vKL~DFGla~~~~~~~  271 (549)
                      |||||. |+|.+.+... .++++.+++.|+.||+.||+|||++||+||||||+|||++  .+|.+||+|||+|+......
T Consensus       104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            999998 5898887654 4699999999999999999999999999999999999998  56899999999998876543


Q ss_pred             ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----SQVSETYKDL  347 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl  347 (549)
                       ......||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+.......+......+|    +.+|+++++|
T Consensus       184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  262 (352)
T d1koba_         184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF  262 (352)
T ss_dssp             -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence             34566899999999999999999999999999999999999999999999999988888776655    4689999999


Q ss_pred             HHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        348 VKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       348 I~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      |.+||++||.+|||++|+|+||||+..
T Consensus       263 i~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         263 IKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3e-56  Score=447.79  Aligned_cols=256  Identities=32%  Similarity=0.541  Sum_probs=230.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh-------HHHHHHHHHHHHHHhcC-CCCeeEEEEEEee
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-------KELSSLKQECEIQKHLA-HPNIIKFIASHET  189 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~  189 (549)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+.....       ...+.+.+|+.+++++. |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999999999999999998754321       12346789999999996 9999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecc
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMA  268 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~  268 (549)
                      .+.+|||||||. |+|.++|..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            999999999997 5999999999999999999999999999999999999999999999999999999999999998876


Q ss_pred             cCcccccccCCCCccccccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----c
Q psy18060        269 VGTHMLTSIKGTPLYMAPELIA------ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFP----S  338 (549)
Q Consensus       269 ~~~~~~~~~~GT~~Y~APE~l~------~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  338 (549)
                      ... ..+...||+.|+|||++.      ...++.++||||+||++|+|++|+.||.+.+.......+..+...++    +
T Consensus       162 ~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (277)
T d1phka_         162 PGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  240 (277)
T ss_dssp             TTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            543 345678999999999985      34578999999999999999999999999999988888887765444    3


Q ss_pred             cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        339 QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       339 ~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+|+++++||.+||++||.+|||++|+|+||||++.
T Consensus       241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            799999999999999999999999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.8e-56  Score=463.12  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=227.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR----SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      ++++|++++.||+|+||.||+|.++.+|+.||||++.+...    .........+++++++.++|||||++++++.+.+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            46789999999999999999999999999999999975321    11112222344667777789999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +|||||||. |+|.++|.++..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... 
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            999999998 689999999999999999999999999999999999999999999999999999999999999877543 


Q ss_pred             ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCCCCccCCHHHHHH
Q psy18060        272 HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQDVTFPSQVSETYKDL  347 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~dl  347 (549)
                       .....+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.+   .......+......+|+.+|+++++|
T Consensus       161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (364)
T d1omwa3         161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL  239 (364)
T ss_dssp             -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHH
T ss_pred             -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHH
Confidence             3355689999999999964 579999999999999999999999997643   44555566667778889999999999


Q ss_pred             HHHhchhCcCCCCC-----HHHHhcCcccCcccchhhh
Q psy18060        348 VKGLLEKDASQRLS-----WPELLHHPLVKDNLSSEIE  380 (549)
Q Consensus       348 I~~~L~~dP~~Rps-----~~elL~Hpw~~~~~~~~~~  380 (549)
                      |.+||++||.+|||     ++|+++||||++..+..+.
T Consensus       240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~  277 (364)
T d1omwa3         240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVF  277 (364)
T ss_dssp             HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHH
T ss_pred             HHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHh
Confidence            99999999999999     7999999999987655443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=455.51  Aligned_cols=254  Identities=28%  Similarity=0.473  Sum_probs=231.3

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++++.||+|+||+||+|.++.+|+.||+|++....   .....+.+|+++++.++|||||++++++++.+.+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            3578999999999999999999999999999999997643   3345678999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC--CcEEEeecccceecccCcc
Q psy18060        197 TEFAH-MSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD--GVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~--g~vKL~DFGla~~~~~~~~  272 (549)
                      ||||+ |+|.++|..++ .+++.+++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++...... 
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-  158 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence            99998 58999998765 79999999999999999999999999999999999999854  489999999998775443 


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS----QVSETYKDLV  348 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dlI  348 (549)
                      ......||+.|+|||.+.+..|+.++|||||||++|+|++|.+||.+.+..+....|......+|.    .+|+++++||
T Consensus       159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T d1tkia_         159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence            345567999999999999999999999999999999999999999999999999999888877764    6899999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                      .+||++||.+|||++|+++||||+..
T Consensus       239 ~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-56  Score=448.39  Aligned_cols=258  Identities=33%  Similarity=0.502  Sum_probs=221.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +++|++++.||+|+||+||+|.+..+|+.||||++............+.+|++++++++|||||++++++.+.+.+|+||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            47899999999999999999999999999999999765444444567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCccccc
Q psy18060        198 EFAHMSLSNLLEQ--RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLT  275 (549)
Q Consensus       198 E~~~gsL~~~l~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~  275 (549)
                      ||+++++...+..  ...+++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..........
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence            9999887777654  35699999999999999999999999999999999999999999999999999987766555566


Q ss_pred             ccCCCCcccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------------CCC
Q psy18060        276 SIKGTPLYMAPELIAERP-YDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD------------------VTF  336 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~-y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~------------------~~~  336 (549)
                      ...||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+.......+....                  ..+
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF  240 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence            778999999999987655 5789999999999999999999999988776665542210                  001


Q ss_pred             -----------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        337 -----------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       337 -----------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                                 .+.+|+++++||.+||++||.+|||++|+|+||||++..
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence                       124689999999999999999999999999999998653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-56  Score=449.41  Aligned_cols=252  Identities=29%  Similarity=0.450  Sum_probs=214.0

Q ss_pred             EEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChH---HHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEec
Q psy18060        123 KICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGK---ELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEF  199 (549)
Q Consensus       123 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~  199 (549)
                      .++.||+|+||+||+|.++.+|+.||||++........   ....+.+|+.++++++|||||++++++...+.+||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            57899999999999999999999999999875432221   234678999999999999999999999999999999999


Q ss_pred             CCCCHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccccC
Q psy18060        200 AHMSLSNL-LEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTSIK  278 (549)
Q Consensus       200 ~~gsL~~~-l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~  278 (549)
                      +.|++... +..+..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..........+.+
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            99755444 44466799999999999999999999999999999999999999999999999999987765555556678


Q ss_pred             CCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------------------CC-
Q psy18060        279 GTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDV--------------------TF-  336 (549)
Q Consensus       279 GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~--------------------~~-  336 (549)
                      ||+.|||||++.+ ..|+.++|||||||++|||+||.+||.+.+..+.+..+.....                    .. 
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            9999999999865 5689999999999999999999999999988877766542100                    00 


Q ss_pred             -------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        337 -------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       337 -------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                             .+.+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence                   12468999999999999999999999999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-56  Score=443.27  Aligned_cols=251  Identities=29%  Similarity=0.471  Sum_probs=220.2

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhcC--CCCeeEEEEEEeeCCE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLA--HPNIIKFIASHETLNE  192 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~  192 (549)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++.+.....    .....+.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999999999999999997643221    11123568999999986  8999999999999999


Q ss_pred             EEEEEecCCC--CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC-CcEEEeecccceeccc
Q psy18060        193 FVLITEFAHM--SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD-GVAMLCDFGFARSMAV  269 (549)
Q Consensus       193 ~~iV~E~~~g--sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~-g~vKL~DFGla~~~~~  269 (549)
                      +|+|||++.+  ++.+++.++..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            9999999864  788999999999999999999999999999999999999999999999855 7999999999987543


Q ss_pred             CcccccccCCCCcccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHH
Q psy18060        270 GTHMLTSIKGTPLYMAPELIAERPY-DHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPSQVSETYKDLV  348 (549)
Q Consensus       270 ~~~~~~~~~GT~~Y~APE~l~~~~y-~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dlI  348 (549)
                      .  ..++.+||+.|||||++.+..+ +.++|||||||++|+|+||+.||.+.+      .+..+...+|+.+|+++++||
T Consensus       164 ~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~~li  235 (273)
T d1xwsa_         164 T--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLI  235 (273)
T ss_dssp             S--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHHH
T ss_pred             c--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHHHHH
Confidence            3  3456789999999999987665 677999999999999999999997632      345567788899999999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCcccCcccch
Q psy18060        349 KGLLEKDASQRLSWPELLHHPLVKDNLSS  377 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hpw~~~~~~~  377 (549)
                      .+||++||.+|||++|+|+||||++...+
T Consensus       236 ~~~L~~dp~~R~s~~eil~hp~~~~~~~p  264 (273)
T d1xwsa_         236 RWCLALRPSDRPTFEEIQNHPWMQDVLLP  264 (273)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             HHHccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence            99999999999999999999999876543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-55  Score=449.16  Aligned_cols=251  Identities=29%  Similarity=0.554  Sum_probs=214.6

Q ss_pred             cccccceeEEE-EEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh-cCCCCeeEEEEEEee---
Q psy18060        115 NGALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKH-LAHPNIIKFIASHET---  189 (549)
Q Consensus       115 ~~~~~~y~~~~-~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~---  189 (549)
                      ...+++|.++. .||+|+||.||+|.+..+++.||||++.+.       ..+.+|+.++.+ .+|||||+++++|++   
T Consensus         7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1           7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            34567899875 699999999999999999999999999642       356789988655 589999999999876   


Q ss_pred             -CCEEEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec---CCcEEEeecc
Q psy18060        190 -LNEFVLITEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK---DGVAMLCDFG  262 (549)
Q Consensus       190 -~~~~~iV~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~---~g~vKL~DFG  262 (549)
                       .+.+|||||||+ |+|.++|.++  ..+++.+++.|+.||+.||+|||++||+||||||+|||++.   .+.+||+|||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence             467899999998 5999999875  46999999999999999999999999999999999999985   4679999999


Q ss_pred             cceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCCCCCc
Q psy18060        263 FARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHL----IRLLKTQDVTFPS  338 (549)
Q Consensus       263 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~----~~~i~~~~~~~p~  338 (549)
                      +|+...... .....+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+....    ...+......+|.
T Consensus       160 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         160 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             TCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             eeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            998776543 34567899999999999999999999999999999999999999977653333    3334445555553


Q ss_pred             ----cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        339 ----QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       339 ----~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                          .+|+++++||.+||++||.+|||+.|+++||||.+
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence                58999999999999999999999999999999964

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.4e-54  Score=436.78  Aligned_cols=255  Identities=34%  Similarity=0.504  Sum_probs=216.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +++|++++.||+|+||+||+|.++ +|+.||||++............+.+|+.++++++|||||++++++...+..+++|
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            478999999999999999999986 6899999999765544444578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~gsL~~~l-~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      |++.+++...+ ..++.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||.|............
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence            99997655555 55778999999999999999999999999999999999999999999999999999876655444455


Q ss_pred             cCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C--------------------
Q psy18060        277 IKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--D--------------------  333 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--~--------------------  333 (549)
                      ..||+.|+|||.+.+ ..++.++|||||||++|||++|++||.+.+..+.+..+...  .                    
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T d1ob3a_         160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (286)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence            679999999999865 45799999999999999999999999988877766554210  0                    


Q ss_pred             -------CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCc
Q psy18060        334 -------VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKD  373 (549)
Q Consensus       334 -------~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~  373 (549)
                             ..+++.+++.+.+||++||++||++|||+.|+|+||||++
T Consensus       240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                   0123457899999999999999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=438.88  Aligned_cols=256  Identities=32%  Similarity=0.500  Sum_probs=214.8

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCC-CceEEEEEEecCCCChHHHHHHHHHHHHHHhc---CCCCeeEEEEEEee----
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDL-KKTVALKIISKSGRSGKELSSLKQECEIQKHL---AHPNIIKFIASHET----  189 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~----  189 (549)
                      .++|++++.||+|+||+||+|.+..+ ++.||||++............+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999999765 66799999875433322233456777776665   79999999998853    


Q ss_pred             -CCEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeeccccee
Q psy18060        190 -LNEFVLITEFAHMSLSNLLEQ--RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARS  266 (549)
Q Consensus       190 -~~~~~iV~E~~~gsL~~~l~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~  266 (549)
                       ...++++||++.+++......  ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence             346899999999876554443  45699999999999999999999999999999999999999999999999999976


Q ss_pred             cccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------
Q psy18060        267 MAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--------------  332 (549)
Q Consensus       267 ~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--------------  332 (549)
                      .... ......+||+.|||||++.+.+|+.++|||||||++|||++|++||.+.+..+.+..+...              
T Consensus       166 ~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  244 (305)
T d1blxa_         166 YSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  244 (305)
T ss_dssp             CCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             hccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence            5543 3446678999999999999999999999999999999999999999999887776665321              


Q ss_pred             -------------CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        333 -------------DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       333 -------------~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                   ...+++.+++.+++||.+||++||.+|||+.|+|+||||++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                         001334679999999999999999999999999999999863

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-54  Score=430.80  Aligned_cols=246  Identities=24%  Similarity=0.421  Sum_probs=213.1

Q ss_pred             EEEecCCcEEEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEecCC-
Q psy18060        125 CLIGEGSFGKVFKAIHL--DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-  201 (549)
Q Consensus       125 ~~iG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~-  201 (549)
                      +.||+|+||+||+|.++  .+++.||||++.....+....+.+.+|++++++++|||||++++++.. +..+||||||+ 
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            57999999999999864  456789999997655555566789999999999999999999999865 45789999998 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc---cccccC
Q psy18060        202 MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH---MLTSIK  278 (549)
Q Consensus       202 gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~~~  278 (549)
                      |+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.......   ......
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~  171 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK  171 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence            58999999999999999999999999999999999999999999999999999999999999987654322   123457


Q ss_pred             CCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhchhCc
Q psy18060        279 GTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLEKDA  356 (549)
Q Consensus       279 GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~~dP  356 (549)
                      ||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++...+..+ .++.|..+|+++.+||.+||+.||
T Consensus       172 gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp  251 (277)
T d1xbba_         172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV  251 (277)
T ss_dssp             CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSST
T ss_pred             CCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCH
Confidence            9999999999999999999999999999999998 99999999988888887765 456788999999999999999999


Q ss_pred             CCCCCHHHH---hcCccc
Q psy18060        357 SQRLSWPEL---LHHPLV  371 (549)
Q Consensus       357 ~~Rps~~el---L~Hpw~  371 (549)
                      .+|||+++|   |+|+|+
T Consensus       252 ~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         252 ENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             TTSCCHHHHHHHHHHHHH
T ss_pred             hHCcCHHHHHHHhhCHHh
Confidence            999999998   466664

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.7e-53  Score=424.74  Aligned_cols=255  Identities=24%  Similarity=0.422  Sum_probs=215.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC----E
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLN----E  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~  192 (549)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.+... +......+.+|+++++.++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            3679999999999999999999999999999999986543 4455678899999999999999999999987654    4


Q ss_pred             EEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      +|||||||. ++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.++......
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            899999998 5899999999999999999999999999999999999999999999999999999999999987654322


Q ss_pred             ---ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----CccCCHHH
Q psy18060        272 ---HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTF----PSQVSETY  344 (549)
Q Consensus       272 ---~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~  344 (549)
                         ....+.+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+..+....+.......    ++.+|+++
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  245 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL  245 (277)
T ss_dssp             -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred             ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence               23455689999999999999999999999999999999999999999999888877766655433    35789999


Q ss_pred             HHHHHHhchhCcCCCCCHHHHhcCcccC
Q psy18060        345 KDLVKGLLEKDASQRLSWPELLHHPLVK  372 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~~elL~Hpw~~  372 (549)
                      .+||.+||++||.+||+..+.+.|+|.+
T Consensus       246 ~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         246 DAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            9999999999999999544555677753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=439.51  Aligned_cols=254  Identities=28%  Similarity=0.450  Sum_probs=216.0

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC------
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN------  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------  191 (549)
                      .++|++++.||+|+||+||+|.++.+|+.||||++.+...+....+.+.+|+++|+.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999999999999999999876666666778999999999999999999999987654      


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        192 EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       192 ~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      .+|+|||||+++|..+++ ++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....  
T Consensus        97 ~~~lv~e~~~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~--  173 (346)
T d1cm8a_          97 DFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--  173 (346)
T ss_dssp             CCEEEEECCSEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred             eEEEEEecccccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC--
Confidence            579999999777877765 56899999999999999999999999999999999999999999999999999987653  


Q ss_pred             ccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------------
Q psy18060        272 HMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQD-----------------  333 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~-----------------  333 (549)
                       ..+...||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+....                 
T Consensus       174 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (346)
T d1cm8a_         174 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK  252 (346)
T ss_dssp             -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred             -ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence             3466789999999999876 457899999999999999999999999887666554432210                 


Q ss_pred             --------------CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        334 --------------VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       334 --------------~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                                    ...++.+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                          012245789999999999999999999999999999998654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-53  Score=428.26  Aligned_cols=248  Identities=23%  Similarity=0.434  Sum_probs=218.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||+||+|.++.+++.||||++.....   ..+.+.+|++++++++|||||++++++.+.+.++||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            45689999999999999999999999999999999875443   345689999999999999999999999999999999


Q ss_pred             EecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-
Q psy18060        197 TEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-  272 (549)
                      ||||. |+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....... 
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence            99998 6899999764  5689999999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGH-PPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~-~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~  350 (549)
                      ..+...||+.|||||++.+..|+.++|||||||++|||++|. +||.+.+.......+..+ .+.+|+.+|+++.+||.+
T Consensus       172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  251 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA  251 (287)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHH
Confidence            223446899999999999999999999999999999999965 456667777776666544 456778899999999999


Q ss_pred             hchhCcCCCCCHHHHhc
Q psy18060        351 LLEKDASQRLSWPELLH  367 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~  367 (549)
                      ||+.||.+|||+.||++
T Consensus       252 cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         252 CWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHH
Confidence            99999999999999965

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=423.18  Aligned_cols=258  Identities=30%  Similarity=0.459  Sum_probs=225.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      +++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            46899999999999999999999999999999999876666666788999999999999999999999999999999999


Q ss_pred             ecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcccccc
Q psy18060        198 EFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTHMLTS  276 (549)
Q Consensus       198 E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  276 (549)
                      +++.| +|..++..++.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+...........
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence            99986 67777788889999999999999999999999999999999999999999999999999999887665555556


Q ss_pred             cCCCCcccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhcC----------------------
Q psy18060        277 IKGTPLYMAPELIAERP-YDHTADLWSLGCIAYEIHMGHPPF-KTVSILHLIRLLKTQ----------------------  332 (549)
Q Consensus       277 ~~GT~~Y~APE~l~~~~-y~~ksDIwSlGvil~eLltG~~Pf-~~~~~~~~~~~i~~~----------------------  332 (549)
                      ..+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+..+....+...                      
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence            67889999999987654 689999999999999999999885 555555555544210                      


Q ss_pred             -------CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        333 -------DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       333 -------~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                             ....+..+++.+.+||.+||++||.+|||++|+|+||||++..
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                   0112345789999999999999999999999999999998654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=422.96  Aligned_cols=251  Identities=22%  Similarity=0.357  Sum_probs=218.7

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.++ ++..||||++......   .+.+.+|+.++++++|||||++++++.+ +.+++|
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            3478999999999999999999976 4788999999765433   3568999999999999999999998755 557899


Q ss_pred             EecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-c
Q psy18060        197 TEFAH-MSLSNLLEQR--KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-H  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-~  272 (549)
                      |||+. |+|.+++...  .++++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...... .
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            99998 6898877543  369999999999999999999999999999999999999999999999999998875433 2


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~  350 (549)
                      ..+...||+.|||||++.+..|+.++|||||||++|||+| |.+||...+..+....+..+ ....|+.+|+++.+||.+
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  245 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL  245 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHH
Confidence            3345679999999999998899999999999999999999 56677788888888877665 455678899999999999


Q ss_pred             hchhCcCCCCCHHHHhc--CcccC
Q psy18060        351 LLEKDASQRLSWPELLH--HPLVK  372 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~--Hpw~~  372 (549)
                      ||+.||.+|||+.||++  |+||.
T Consensus       246 cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         246 CWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHhhhhhh
Confidence            99999999999999998  78874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-53  Score=419.22  Aligned_cols=246  Identities=23%  Similarity=0.389  Sum_probs=208.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++++.||+|+||.||+|.+.. ++.||||++......   .+.+.+|++++++++|||||++++++...+.+++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            579999999999999999999864 678999999764433   3568999999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-ccc
Q psy18060        199 FAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-MLT  275 (549)
Q Consensus       199 ~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~~  275 (549)
                      |+. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... ...
T Consensus        81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            998 6899988754 5689999999999999999999999999999999999999999999999999987654322 223


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhch
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ...||+.|||||++.+..|+.++|||||||++|||+| |.+||...+..+....+..+ ....|..+++++.+||.+||+
T Consensus       161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~  240 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK  240 (263)
T ss_dssp             ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHcc
Confidence            4579999999999999999999999999999999999 67888888888888887665 345677899999999999999


Q ss_pred             hCcCCCCCHHHHhcC
Q psy18060        354 KDASQRLSWPELLHH  368 (549)
Q Consensus       354 ~dP~~Rps~~elL~H  368 (549)
                      .||.+|||++||++|
T Consensus       241 ~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         241 ERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CCHhHCcCHHHHHHH
Confidence            999999999999987

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=425.74  Aligned_cols=247  Identities=26%  Similarity=0.462  Sum_probs=207.6

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~  197 (549)
                      .++|++.+.||+|+||+||+|...   ..||||++.....+....+.+.+|+.++++++|||||++++++.. +.++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            467899999999999999999754   359999998766666777889999999999999999999998754 5689999


Q ss_pred             ecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC--ccc
Q psy18060        198 EFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG--THM  273 (549)
Q Consensus       198 E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~--~~~  273 (549)
                      |||+ |+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....  ...
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~  162 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ  162 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence            9998 6999999764 56999999999999999999999999999999999999999999999999999876532  223


Q ss_pred             ccccCCCCcccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhcCCC-----CCCccCCHHH
Q psy18060        274 LTSIKGTPLYMAPELIAE---RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLI-RLLKTQDV-----TFPSQVSETY  344 (549)
Q Consensus       274 ~~~~~GT~~Y~APE~l~~---~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~-~~i~~~~~-----~~p~~~s~~~  344 (549)
                      .++..||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.+..... ..+..+..     ..+..+|+++
T Consensus       163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l  242 (276)
T d1uwha_         163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM  242 (276)
T ss_dssp             ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHH
T ss_pred             ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHH
Confidence            456789999999999864   45899999999999999999999999886654433 33433321     2356789999


Q ss_pred             HHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        345 KDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       345 ~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .+||.+||+.||.+|||+.||+++
T Consensus       243 ~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         243 KRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-52  Score=426.41  Aligned_cols=250  Identities=24%  Similarity=0.391  Sum_probs=209.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .++|++.+.||+|+||+||+|.++.+++   .||||.+... ......+.+.+|++++++++|||||++++++...+.++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            4679999999999999999999987765   4888887543 34555678999999999999999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +|||||. |+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus       104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            9999998 5899988774 5699999999999999999999999999999999999999999999999999987654322


Q ss_pred             c-----ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHH
Q psy18060        273 M-----LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYK  345 (549)
Q Consensus       273 ~-----~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  345 (549)
                      .     .....||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+....+..+ .++.|..+|+++.
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  263 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH  263 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHH
Confidence            1     122457999999999999999999999999999999998 89999999998888887665 3566778999999


Q ss_pred             HHHHHhchhCcCCCCCHHHHhcC
Q psy18060        346 DLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       346 dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      +||.+||+.||.+|||+.||+++
T Consensus       264 ~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         264 QLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999998765

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-53  Score=430.15  Aligned_cols=260  Identities=30%  Similarity=0.487  Sum_probs=215.0

Q ss_pred             cccccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-----
Q psy18060        115 NGALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-----  189 (549)
Q Consensus       115 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----  189 (549)
                      ...+++|++++.||+|+||+||+|++..+|+.||||++............+.+|++++++++||||+++++++..     
T Consensus         6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            345789999999999999999999999999999999987665544555678899999999999999999998744     


Q ss_pred             ---CCEEEEEEecCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccce
Q psy18060        190 ---LNEFVLITEFAHMSLSNLL-EQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       190 ---~~~~~iV~E~~~gsL~~~l-~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                         .+.+|+|||++.+++...+ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence               3468999999997655544 445789999999999999999999999999999999999999999999999999997


Q ss_pred             ecccCc----ccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc--
Q psy18060        266 SMAVGT----HMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVTFPS--  338 (549)
Q Consensus       266 ~~~~~~----~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~~p~--  338 (549)
                      ......    ....+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+.......+......+++  
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            665322    223445799999999998764 6899999999999999999999999988877766655331111110  


Q ss_pred             ------------------------------cCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcc
Q psy18060        339 ------------------------------QVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDN  374 (549)
Q Consensus       339 ------------------------------~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~  374 (549)
                                                    ..++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence                                          137788999999999999999999999999999853

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=422.95  Aligned_cols=252  Identities=21%  Similarity=0.376  Sum_probs=218.2

Q ss_pred             cceeEEEE-EecCCcEEEEEEEEcCC--CceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        119 EKYQKICL-IGEGSFGKVFKAIHLDL--KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       119 ~~y~~~~~-iG~G~fg~Vy~~~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      +++.+... ||+|+||.||+|.++.+  +..||||++... ......+.+.+|++++++++|||||++++++.. +.+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            45777775 99999999999987644  457999999754 345566789999999999999999999999865 46899


Q ss_pred             EEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-
Q psy18060        196 ITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-  272 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-  272 (549)
                      |||||+ |+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... 
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  165 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  165 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence            999998 589998765 46799999999999999999999999999999999999999999999999999987754322 


Q ss_pred             --cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHH
Q psy18060        273 --MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLV  348 (549)
Q Consensus       273 --~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI  348 (549)
                        ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..+....+..+ .+++|+.+|+++.+||
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  245 (285)
T d1u59a_         166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALM  245 (285)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence              2234578999999999998999999999999999999998 99999998888888877765 3567889999999999


Q ss_pred             HHhchhCcCCCCCHHHH---hcCcccC
Q psy18060        349 KGLLEKDASQRLSWPEL---LHHPLVK  372 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~el---L~Hpw~~  372 (549)
                      .+||+.||.+|||+.+|   |+|+|+.
T Consensus       246 ~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         246 SDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999887   6677763

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=434.72  Aligned_cols=250  Identities=25%  Similarity=0.414  Sum_probs=213.4

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCc-----eEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCC
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLN  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~  191 (549)
                      .++|++.+.||+|+||+||+|.+..+++     .||+|.+.... .......+.+|+.+++++ +|||||++++++.+.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            3679999999999999999999876554     69999986543 233446788999999998 8999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCc
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRK-----------------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQN  247 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~-----------------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~N  247 (549)
                      .+|+|||||+ |+|.++|..+.                       .+++..++.++.||+.||+|||++|||||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            9999999998 69999997643                       48999999999999999999999999999999999


Q ss_pred             EEEecCCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy18060        248 VLLNKDGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILH  324 (549)
Q Consensus       248 ILl~~~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~  324 (549)
                      ||++.++.+||+|||+|+.......  ...+..||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+...
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~  274 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  274 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987654332  2235568999999999999999999999999999999997 899998876555


Q ss_pred             HHHHHhcC--CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        325 LIRLLKTQ--DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       325 ~~~~i~~~--~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .+..+...  .++.|..+|+++++||.+||+.||.+|||++||++|
T Consensus       275 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            44444333  345678899999999999999999999999999876

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=431.33  Aligned_cols=251  Identities=29%  Similarity=0.429  Sum_probs=212.6

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee------CCE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET------LNE  192 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~~  192 (549)
                      -+|+.+++||+|+||+||+|++..+|+.||||++.+....      ..+|++++++++|||||++++++..      ..+
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            3699999999999999999999999999999999765322      2479999999999999999998843      335


Q ss_pred             EEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-cEEEeecccceec
Q psy18060        193 FVLITEFAHMSLSNLLE----QRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-VAMLCDFGFARSM  267 (549)
Q Consensus       193 ~~iV~E~~~gsL~~~l~----~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-~vKL~DFGla~~~  267 (549)
                      +|||||||++++...+.    ....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            89999999987655553    356799999999999999999999999999999999999999876 8999999999877


Q ss_pred             ccCcccccccCCCCcccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------
Q psy18060        268 AVGTHMLTSIKGTPLYMAPELIAE-RPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ--------------  332 (549)
Q Consensus       268 ~~~~~~~~~~~GT~~Y~APE~l~~-~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~--------------  332 (549)
                      .... ...+.+||+.|+|||.+.+ ..|+.++|||||||++|||++|++||...+..+.+..+...              
T Consensus       174 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         174 VRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             cCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            6543 3455689999999998865 57899999999999999999999999988876665554310              


Q ss_pred             ---CCC------------CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        333 ---DVT------------FPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       333 ---~~~------------~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                         ...            ..+.+++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence               001            12357899999999999999999999999999999986543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=414.60  Aligned_cols=246  Identities=22%  Similarity=0.376  Sum_probs=220.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEEEe
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE  198 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV~E  198 (549)
                      ++|++.+.||+|+||+||+|+++ +++.||||++.+....   .+.+.+|+.++++++|||||++++++.+.+.+++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            57899999999999999999985 6789999999875543   3568999999999999999999999999999999999


Q ss_pred             cCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-ccc
Q psy18060        199 FAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-MLT  275 (549)
Q Consensus       199 ~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~~  275 (549)
                      |+. |+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... ...
T Consensus        80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            997 688888654 56799999999999999999999999999999999999999999999999999986654322 234


Q ss_pred             ccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHHhch
Q psy18060        276 SIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKGLLE  353 (549)
Q Consensus       276 ~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~~L~  353 (549)
                      ...||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..+ ....|...++++.+||.+||+
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~  239 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH  239 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTC
T ss_pred             ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHcc
Confidence            4679999999999999999999999999999999998 89999999999988888775 445778899999999999999


Q ss_pred             hCcCCCCCHHHHhcC
Q psy18060        354 KDASQRLSWPELLHH  368 (549)
Q Consensus       354 ~dP~~Rps~~elL~H  368 (549)
                      .||.+|||+++|++|
T Consensus       240 ~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         240 EKADERPTFKILLSN  254 (258)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CCHhHCcCHHHHHHH
Confidence            999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=425.67  Aligned_cols=256  Identities=30%  Similarity=0.452  Sum_probs=214.5

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-----CEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL-----NEF  193 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~  193 (549)
                      ++|++++.||+|+||+||+|.+..+|+.||||++.+.. .......+.+|+.+++.++||||+++++++...     ..+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            57999999999999999999999999999999997643 345567788999999999999999999998654     347


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-
Q psy18060        194 VLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-  272 (549)
Q Consensus       194 ~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-  272 (549)
                      |++|++++|+|.+++.. +++++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....... 
T Consensus        87 ~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~  165 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  165 (345)
T ss_dssp             EEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             EEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence            88888888899999975 4799999999999999999999999999999999999999999999999999987644321 


Q ss_pred             --cccccCCCCccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------
Q psy18060        273 --MLTSIKGTPLYMAPELIA-ERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQ-----------------  332 (549)
Q Consensus       273 --~~~~~~GT~~Y~APE~l~-~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~-----------------  332 (549)
                        .....+||+.|+|||++. +..|+.++||||+||++|+|++|+.||.+.+...........                 
T Consensus       166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T d1pmea_         166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA  245 (345)
T ss_dssp             CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence              234567999999999984 456799999999999999999999999987765554433110                 


Q ss_pred             -------C----C---CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        333 -------D----V---TFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       333 -------~----~---~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                             .    .   ...+.+++++++||.+||++||.+|||++|+|+||||+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                   0    0   012357889999999999999999999999999999986544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=431.41  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=211.9

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe------eC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE------TL  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------~~  190 (549)
                      .+++|++++.||+|+||+||+|.++.+|+.||||++.+...+......+.+|+.++++++|||||++++++.      ..
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            457899999999999999999999999999999999877666667778999999999999999999999985      34


Q ss_pred             CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccC
Q psy18060        191 NEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVG  270 (549)
Q Consensus       191 ~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~  270 (549)
                      +.+|+|||||.|++.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus        95 ~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             CEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             ceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            6899999999988877664  57999999999999999999999999999999999999999999999999998776544


Q ss_pred             cccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------------
Q psy18060        271 THMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKT-------------------  331 (549)
Q Consensus       271 ~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~-------------------  331 (549)
                       ...+..+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.......+..                   
T Consensus       173 -~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (355)
T d2b1pa1         173 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred             -cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence             334566899999999999999999999999999999999999999998876655544321                   


Q ss_pred             ---CCCCC--------------------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCcccc
Q psy18060        332 ---QDVTF--------------------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNLS  376 (549)
Q Consensus       332 ---~~~~~--------------------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~~  376 (549)
                         .....                    +...|+++.+||++||+.||++||||+|+|+||||+....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~  319 (355)
T d2b1pa1         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  319 (355)
T ss_dssp             HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence               10000                    0124678999999999999999999999999999987544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-52  Score=424.17  Aligned_cols=265  Identities=27%  Similarity=0.478  Sum_probs=226.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhcCC-CCeeEEEEEEeeC
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGR--SGKELSSLKQECEIQKHLAH-PNIIKFIASHETL  190 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~  190 (549)
                      .+++|++++.||+|+||+||+|.+.   .+|+.||||++.+...  .....+.+.+|++++++++| |||+++++++.+.
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            4688999999999999999999874   4689999999865321  12233567889999999966 8999999999999


Q ss_pred             CEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceeccc
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAV  269 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~  269 (549)
                      ..++++|||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            99999999998 58999999999999999999999999999999999999999999999999999999999999987643


Q ss_pred             C-cccccccCCCCcccccccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCCCCccCCH
Q psy18060        270 G-THMLTSIKGTPLYMAPELIAER--PYDHTADLWSLGCIAYEIHMGHPPFKTVS----ILHLIRLLKTQDVTFPSQVSE  342 (549)
Q Consensus       270 ~-~~~~~~~~GT~~Y~APE~l~~~--~y~~ksDIwSlGvil~eLltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~  342 (549)
                      . .....+..||+.|+|||.+.+.  .++.++|||||||+||+|++|+.||.+.+    ...+.+........+|..+|+
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  261 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  261 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence            3 2234556899999999999654  47889999999999999999999997653    444455555667778889999


Q ss_pred             HHHHHHHHhchhCcCCCC-----CHHHHhcCcccCcccchhhhh
Q psy18060        343 TYKDLVKGLLEKDASQRL-----SWPELLHHPLVKDNLSSEIES  381 (549)
Q Consensus       343 ~~~dlI~~~L~~dP~~Rp-----s~~elL~Hpw~~~~~~~~~~~  381 (549)
                      ++.+||.+||++||.+||     |++|+++||||++.....+..
T Consensus       262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~  305 (322)
T d1vzoa_         262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA  305 (322)
T ss_dssp             HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred             HHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHh
Confidence            999999999999999999     589999999998765544443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=412.70  Aligned_cols=248  Identities=29%  Similarity=0.425  Sum_probs=206.5

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLK---KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  195 (549)
                      ++|++.+.||+|+||.||+|.+..++   ..||||.+... ........+.+|+.++++++|||||++++++.+ +.+|+
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            67999999999999999999987654   45888887543 345556789999999999999999999999864 56899


Q ss_pred             EEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc-
Q psy18060        196 ITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH-  272 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~-  272 (549)
                      ||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+....... 
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~  164 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  164 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence            999998 578887765 45799999999999999999999999999999999999999999999999999987654322 


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLVKG  350 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI~~  350 (549)
                      ..+...||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+....+..+. .++|+.+|+++.+||.+
T Consensus       165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  244 (273)
T d1mp8a_         165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK  244 (273)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            2345578999999999999999999999999999999998 899999998888888777664 56788999999999999


Q ss_pred             hchhCcCCCCCHHHHhcC
Q psy18060        351 LLEKDASQRLSWPELLHH  368 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~H  368 (549)
                      ||+.||.+|||+.||++|
T Consensus       245 cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         245 CWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHH
Confidence            999999999999999876

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-51  Score=410.10  Aligned_cols=249  Identities=22%  Similarity=0.399  Sum_probs=208.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCC----ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLK----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF  193 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  193 (549)
                      .+.|++.+.||+|+||.||+|.++.++    ..||||.+... ........+.+|++++++++|||||++++++.+.+.+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            357999999999999999999987654    46999999654 3445566789999999999999999999999999999


Q ss_pred             EEEEecCCC-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        194 VLITEFAHM-SLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~g-sL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      ++||||+.+ ++.+.+... ..+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence            999999985 677777654 679999999999999999999999999999999999999999999999999998764432


Q ss_pred             c---cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHH
Q psy18060        272 H---MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMG-HPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKD  346 (549)
Q Consensus       272 ~---~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~d  346 (549)
                      .   ......||+.|||||++.+..|+.++|||||||++|||++| .+|+...+..+....+..+ .++.|..+|+++.+
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  244 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ  244 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHH
T ss_pred             ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHH
Confidence            1   22345689999999999999999999999999999999985 5666777777777777655 34567789999999


Q ss_pred             HHHHhchhCcCCCCCHHHHhc
Q psy18060        347 LVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL~  367 (549)
                      +|.+||+.||.+|||+.||++
T Consensus       245 li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         245 LMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHCcCCHhHCcCHHHHHH
Confidence            999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=418.71  Aligned_cols=249  Identities=22%  Similarity=0.391  Sum_probs=208.8

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      .+|++++.||+|+||+||+|.+..+|+    .||+|.+... .+....+.+.+|+.++++++|||||++++++.+.+. +
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-Q   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE-E
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-e
Confidence            469999999999999999999988876    4777877543 233445788999999999999999999999987665 4


Q ss_pred             EEEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFA-HMSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~-~gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ++||++ +|+|.+.+..+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            555555 57888887664 6799999999999999999999999999999999999999999999999999987654322


Q ss_pred             c--ccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHH
Q psy18060        273 M--LTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQD-VTFPSQVSETYKDLV  348 (549)
Q Consensus       273 ~--~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dlI  348 (549)
                      .  .....||+.|||||++.++.|+.++|||||||++|||+| |.+||.+.+..++...+..+. ++.|+.+|+++.++|
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li  246 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM  246 (317)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHH
T ss_pred             cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence            2  234568999999999999999999999999999999998 899999988777777776654 567788999999999


Q ss_pred             HHhchhCcCCCCCHHHHhcCc
Q psy18060        349 KGLLEKDASQRLSWPELLHHP  369 (549)
Q Consensus       349 ~~~L~~dP~~Rps~~elL~Hp  369 (549)
                      .+||+.||.+|||+.||++|.
T Consensus       247 ~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         247 VKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhCCCChhhCcCHHHHHHHH
Confidence            999999999999999999884

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-52  Score=427.41  Aligned_cols=254  Identities=28%  Similarity=0.463  Sum_probs=215.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee------CC
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET------LN  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~  191 (549)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+...+......+.+|+++++.++|||||++++++..      .+
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999999999999999998776666677788999999999999999999999853      23


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc
Q psy18060        192 EFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       192 ~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~  271 (549)
                      .+++++++++|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|....   
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~---  172 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---  172 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT---
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC---
Confidence            4667777777899998864 579999999999999999999999999999999999999999999999999997654   


Q ss_pred             ccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---------------
Q psy18060        272 HMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLLKTQDVT---------------  335 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i~~~~~~---------------  335 (549)
                      ....+..||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+......               
T Consensus       173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  252 (348)
T d2gfsa1         173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  252 (348)
T ss_dssp             GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred             cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence            234566799999999987665 4689999999999999999999999998877666655322111               


Q ss_pred             --------C--------CccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        336 --------F--------PSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       336 --------~--------p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                              .        ...+++++++||.+||+.||.+|||+.|+|+||||++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence                    1        125789999999999999999999999999999998653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-51  Score=410.69  Aligned_cols=252  Identities=22%  Similarity=0.354  Sum_probs=212.4

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ..++|++.+.||+|+||.||+|.++.+ +.||||++......   .+.+.+|+.++++++|||||++++++.+ +.+++|
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence            357899999999999999999998765 56999999765443   3568999999999999999999999855 557899


Q ss_pred             EecCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCc-c
Q psy18060        197 TEFAH-MSLSNLLEQ--RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGT-H  272 (549)
Q Consensus       197 ~E~~~-gsL~~~l~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~-~  272 (549)
                      |||+. |+|..++..  .+.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...... .
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            99998 578888754  3579999999999999999999999999999999999999999999999999998765332 2


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMG-HPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~  350 (549)
                      ..+...||+.|+|||++.+..++.++|||||||++|||++| .+|+.+....+....+..+ ..+.|+.+|+++++||.+
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  249 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ  249 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHH
Confidence            23446799999999999999999999999999999999995 6666777777777777654 456788999999999999


Q ss_pred             hchhCcCCCCCHHHHhc--CcccCc
Q psy18060        351 LLEKDASQRLSWPELLH--HPLVKD  373 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~--Hpw~~~  373 (549)
                      ||+.||.+|||+++|++  ++||..
T Consensus       250 cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         250 CWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HcccCHhHCcCHHHHHHHHhhhhcC
Confidence            99999999999999987  888864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-50  Score=415.35  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=208.2

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEee--CCEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHET--LNEF  193 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~~  193 (549)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+..     .+.+.+|+.+++.+. ||||+++++++..  ...+
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            3468999999999999999999999999999999996532     356789999999995 9999999999874  4569


Q ss_pred             EEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCC-cEEEeecccceecccCc
Q psy18060        194 VLITEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDG-VAMLCDFGFARSMAVGT  271 (549)
Q Consensus       194 ~iV~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g-~vKL~DFGla~~~~~~~  271 (549)
                      ++|||||.+ +|..+   .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999985 67654   35799999999999999999999999999999999999999765 69999999998776543


Q ss_pred             ccccccCCCCcccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHh-------------cCC---
Q psy18060        272 HMLTSIKGTPLYMAPELIAER-PYDHTADLWSLGCIAYEIHMGHPPFKTVSI-LHLIRLLK-------------TQD---  333 (549)
Q Consensus       272 ~~~~~~~GT~~Y~APE~l~~~-~y~~ksDIwSlGvil~eLltG~~Pf~~~~~-~~~~~~i~-------------~~~---  333 (549)
                       .....+||+.|+|||.+.+. .|+.++||||+||++|+|++|+.||..... ......+.             ...   
T Consensus       185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         185 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             -cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence             34667899999999998764 579999999999999999999999976532 22111110             000   


Q ss_pred             ---------------------CCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcCcccCccc
Q psy18060        334 ---------------------VTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHHPLVKDNL  375 (549)
Q Consensus       334 ---------------------~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~Hpw~~~~~  375 (549)
                                           ...+..+++++.+||++||++||.+|||++|+|+||||++..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                 001134789999999999999999999999999999998643

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-50  Score=407.35  Aligned_cols=249  Identities=22%  Similarity=0.369  Sum_probs=218.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      .++|++++.||+|+||+||+|+.+     .+++.||||++... ........+.+|+.++++++||||+++++++...+.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            457999999999999999999875     35678999998653 345556789999999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCc
Q psy18060        193 FVLITEFAH-MSLSNLLEQRK------------------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQN  247 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~~------------------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~N  247 (549)
                      .+++||++. |+|.+++....                        .+++..+..|+.||+.||+|||++|||||||||+|
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N  170 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN  170 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence            999999997 68999997532                        38899999999999999999999999999999999


Q ss_pred             EEEecCCcEEEeecccceecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCHHH
Q psy18060        248 VLLNKDGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGH-PPFKTVSILH  324 (549)
Q Consensus       248 ILl~~~g~vKL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~-~Pf~~~~~~~  324 (549)
                      ||++.++.+||+|||+|+......  ...++..||+.|+|||++.+..|+.++|||||||++|||++|. +||.+.+..+
T Consensus       171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e  250 (301)
T d1lufa_         171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE  250 (301)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence            999999999999999998664332  2234567999999999999999999999999999999999985 7899999999


Q ss_pred             HHHHHhcCCC-CCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        325 LIRLLKTQDV-TFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       325 ~~~~i~~~~~-~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ....+..+.. ..|..+|+++.+||.+||+.||.+|||+.||++
T Consensus       251 ~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9888877754 467789999999999999999999999999954

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=408.32  Aligned_cols=250  Identities=26%  Similarity=0.436  Sum_probs=201.7

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee-C
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET-L  190 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-~  190 (549)
                      .++|++.+.||+|+||.||+|.+..     +++.||||++.... .....+.+.+|..++.++ +|||||.+++++.. .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            3679999999999999999999754     35689999986543 344456677777777766 78999999998755 4


Q ss_pred             CEEEEEEecCC-CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecC
Q psy18060        191 NEFVLITEFAH-MSLSNLLEQR----------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKD  253 (549)
Q Consensus       191 ~~~~iV~E~~~-gsL~~~l~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~  253 (549)
                      +.+++|||||+ |+|.+++..+                ..+++.++..++.||+.||+|||++||+||||||+|||++.+
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence            56899999998 6899999754                248999999999999999999999999999999999999999


Q ss_pred             CcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHH-HHHHH
Q psy18060        254 GVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMG-HPPFKTVSILH-LIRLL  329 (549)
Q Consensus       254 g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG-~~Pf~~~~~~~-~~~~i  329 (549)
                      |.+||+|||+|+.......  ..+...||+.|||||++.+..|+.++|||||||++|||+|| .+||.+.+... ....+
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~  250 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  250 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999986643322  23456799999999999999999999999999999999986 56887765433 33334


Q ss_pred             hc-CCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        330 KT-QDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       330 ~~-~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .. ..+..|+.+|+++.++|.+||+.||.+|||+.||++|
T Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33 3456778899999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=402.69  Aligned_cols=247  Identities=21%  Similarity=0.347  Sum_probs=204.1

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCC-C--ceEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDL-K--KTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~-~--~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  194 (549)
                      ++|++++.||+|+||.||+|..... +  ..||||++.+... .....+.+.+|+.++++++|||||++++++.+. .++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            6799999999999999999986533 2  3689999876442 334457889999999999999999999999764 678


Q ss_pred             EEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        195 LITEFAH-MSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      +||||+. |+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~  166 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD  166 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence            9999998 688877665 45799999999999999999999999999999999999999999999999999987654322


Q ss_pred             ---cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCC--CCCccCCHHHHH
Q psy18060        273 ---MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQDV--TFPSQVSETYKD  346 (549)
Q Consensus       273 ---~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~d  346 (549)
                         ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....+.....  +.|+.+|+++.+
T Consensus       167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~  246 (273)
T d1u46a_         167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN  246 (273)
T ss_dssp             EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHH
T ss_pred             cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHH
Confidence               2234468889999999999999999999999999999998 8999999999999888866643  456789999999


Q ss_pred             HHHHhchhCcCCCCCHHHHh
Q psy18060        347 LVKGLLEKDASQRLSWPELL  366 (549)
Q Consensus       347 lI~~~L~~dP~~Rps~~elL  366 (549)
                      +|.+||..||.+|||+.||+
T Consensus       247 li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         247 VMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHH
Confidence            99999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=401.31  Aligned_cols=243  Identities=24%  Similarity=0.425  Sum_probs=207.1

Q ss_pred             cccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEe-eCCEEEE
Q psy18060        117 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE-TLNEFVL  195 (549)
Q Consensus       117 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~i  195 (549)
                      ..++|++++.||+|+||.||+|..+  |..||||++++..    ..+.+.+|++++++++|||||++++++. ..+.+|+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence            4578999999999999999999985  7789999996542    3356889999999999999999999884 4566899


Q ss_pred             EEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc
Q psy18060        196 ITEFAH-MSLSNLLEQRK--KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH  272 (549)
Q Consensus       196 V~E~~~-gsL~~~l~~~~--~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~  272 (549)
                      ||||+. |+|.++|.+++  .+++..++.|+.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++.....  
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence            999997 58999997643  5899999999999999999999999999999999999999999999999999865432  


Q ss_pred             cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHHHHHH
Q psy18060        273 MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLLKTQ-DVTFPSQVSETYKDLVKG  350 (549)
Q Consensus       273 ~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~~  350 (549)
                       .....+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..+....+..+ .+++|+.+++++.+||.+
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  235 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN  235 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence             244568999999999998999999999999999999998 79999998888888887653 456788899999999999


Q ss_pred             hchhCcCCCCCHHHHhcC
Q psy18060        351 LLEKDASQRLSWPELLHH  368 (549)
Q Consensus       351 ~L~~dP~~Rps~~elL~H  368 (549)
                      ||..||.+|||+.+++++
T Consensus       236 cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         236 CWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HcccCHhHCcCHHHHHHH
Confidence            999999999999999874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-50  Score=407.33  Aligned_cols=249  Identities=25%  Similarity=0.374  Sum_probs=215.9

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCce--EEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCCEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKT--VALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNEFV  194 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~  194 (549)
                      .++|++.+.||+|+||.||+|.++.++..  ||||.+.... .....+.+.+|+++++++ +|||||++++++.+.+.++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            47899999999999999999999988774  6777775432 233456789999999998 7999999999999999999


Q ss_pred             EEEecCC-CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEE
Q psy18060        195 LITEFAH-MSLSNLLEQR----------------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAM  257 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~----------------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vK  257 (549)
                      +||||++ |+|.++|..+                ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence            9999998 6999999754                5699999999999999999999999999999999999999999999


Q ss_pred             EeecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcC-CCC
Q psy18060        258 LCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMG-HPPFKTVSILHLIRLLKTQ-DVT  335 (549)
Q Consensus       258 L~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG-~~Pf~~~~~~~~~~~i~~~-~~~  335 (549)
                      |+|||+|+...... ......||+.|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..++...+..+ .++
T Consensus       168 l~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~  246 (309)
T d1fvra_         168 IADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE  246 (309)
T ss_dssp             ECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred             Eccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            99999997654332 22345699999999999999999999999999999999996 5689999999998888665 566


Q ss_pred             CCccCCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        336 FPSQVSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       336 ~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      .|..+|+++++||.+||+.||++|||+.||++|
T Consensus       247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            778899999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-49  Score=400.37  Aligned_cols=249  Identities=30%  Similarity=0.486  Sum_probs=214.2

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCC-------ceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEee
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLK-------KTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET  189 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  189 (549)
                      .++|++++.||+|+||.||+|+...++       ..||||++.+.. .......+.+|...+.++ +|||||++++++.+
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            478999999999999999999876554       469999997643 445567788888888888 89999999999999


Q ss_pred             CCEEEEEEecCC-CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec
Q psy18060        190 LNEFVLITEFAH-MSLSNLLEQRK----------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK  252 (549)
Q Consensus       190 ~~~~~iV~E~~~-gsL~~~l~~~~----------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~  252 (549)
                      .+.+++||||+. |+|.++|..+.                .+++.+++.++.||+.||+|||++|||||||||+|||++.
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  170 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence            999999999998 68999997653                4899999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy18060        253 DGVAMLCDFGFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLL  329 (549)
Q Consensus       253 ~g~vKL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i  329 (549)
                      +|.+||+|||+++.......  ......||+.|+|||.+.++.|+.++|||||||++|||++ |.+||.+.+.......+
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i  250 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  250 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            99999999999987754322  2344678999999999999999999999999999999998 79999999988888877


Q ss_pred             hcC-CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        330 KTQ-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       330 ~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ..+ .+..|..+|+.+.+||.+||+.||.+|||+.||++
T Consensus       251 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            665 45677889999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=398.04  Aligned_cols=249  Identities=20%  Similarity=0.350  Sum_probs=219.5

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE  192 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  192 (549)
                      .++|++.+.||+|+||.||+|.+..     ++..||||++.+. ........+.+|++++++++|||||++++++...+.
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            4789999999999999999998753     3578999999754 344556678999999999999999999999999999


Q ss_pred             EEEEEecCC-CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeec
Q psy18060        193 FVLITEFAH-MSLSNLLEQR----------KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDF  261 (549)
Q Consensus       193 ~~iV~E~~~-gsL~~~l~~~----------~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DF  261 (549)
                      .++||||+. |+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF  177 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF  177 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence            999999997 6899988643          34789999999999999999999999999999999999999999999999


Q ss_pred             ccceecccCcc--cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcCC-CCCC
Q psy18060        262 GFARSMAVGTH--MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMG-HPPFKTVSILHLIRLLKTQD-VTFP  337 (549)
Q Consensus       262 Gla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG-~~Pf~~~~~~~~~~~i~~~~-~~~p  337 (549)
                      |+|+.......  ..+...||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+....+..+. +..|
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p  257 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP  257 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            99987654322  23445689999999999999999999999999999999998 58999999999888877654 4567


Q ss_pred             ccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        338 SQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       338 ~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      +.+|+.+.++|.+||+.||.+|||+.+|++
T Consensus       258 ~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         258 DNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            889999999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=395.38  Aligned_cols=249  Identities=24%  Similarity=0.414  Sum_probs=214.3

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCC
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLN  191 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~  191 (549)
                      .++|++.+.||+|+||.||+|.+.     .+++.||||++.... .......+.+|+.+++.+ +|||||++++++.+.+
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            478999999999999999999863     456789999997643 345566889999999999 6999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec
Q psy18060        192 EFVLITEFAH-MSLSNLLEQRK------------------KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK  252 (549)
Q Consensus       192 ~~~iV~E~~~-gsL~~~l~~~~------------------~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~  252 (549)
                      .+++|||||+ |+|.+++....                  .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~  180 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH  180 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence            9999999998 58999987643                  5899999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccceecccCc--ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy18060        253 DGVAMLCDFGFARSMAVGT--HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHM-GHPPFKTVSILHLIRLL  329 (549)
Q Consensus       253 ~g~vKL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~i  329 (549)
                      ++.+||+|||+++......  ...+..+||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+....+..+
T Consensus       181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~  260 (311)
T d1t46a_         181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM  260 (311)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred             cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999998765432  22345679999999999999999999999999999999998 67777776654444333


Q ss_pred             -hcC-CCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        330 -KTQ-DVTFPSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       330 -~~~-~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                       ..+ ....|..+|+.+.+||.+||+.||.+|||+.||++
T Consensus       261 i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             332 34566789999999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.4e-48  Score=389.17  Aligned_cols=250  Identities=20%  Similarity=0.286  Sum_probs=204.5

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCC-eeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPN-IIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++......    ..+..|+++++.++|+| |+.+..++.+.+..++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            4699999999999999999999999999999998765332    24678999999997666 555667778888999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec---CCcEEEeecccceecccCc--
Q psy18060        198 EFAHMSLSNLLEQ-RKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK---DGVAMLCDFGFARSMAVGT--  271 (549)
Q Consensus       198 E~~~gsL~~~l~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~---~g~vKL~DFGla~~~~~~~--  271 (549)
                      ||++++|...+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+......  
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            9999988877765 467999999999999999999999999999999999999864   4579999999998765332  


Q ss_pred             -----ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hcC-----CCCCCc
Q psy18060        272 -----HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSILHLIRLL---KTQ-----DVTFPS  338 (549)
Q Consensus       272 -----~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~~~~~~i---~~~-----~~~~p~  338 (549)
                           ....+..||+.|||||++.+..|+.++|||||||++|||+||+.||...........+   ...     ...+++
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK  242 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhcc
Confidence                 1234568999999999999999999999999999999999999999876543332211   111     112345


Q ss_pred             cCCHHHHHHHHHhchhCcCCCCCHHH---HhcCcccC
Q psy18060        339 QVSETYKDLVKGLLEKDASQRLSWPE---LLHHPLVK  372 (549)
Q Consensus       339 ~~s~~~~dlI~~~L~~dP~~Rps~~e---lL~Hpw~~  372 (549)
                      .+|+++.+||.+||+.||.+||++.+   +|+|+|.+
T Consensus       243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            78999999999999999999999864   56777654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=388.52  Aligned_cols=246  Identities=22%  Similarity=0.332  Sum_probs=204.8

Q ss_pred             eEEEEEecCCcEEEEEEEEcCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-CCEEEEEE
Q psy18060        122 QKICLIGEGSFGKVFKAIHLDLK---KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-LNEFVLIT  197 (549)
Q Consensus       122 ~~~~~iG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iV~  197 (549)
                      ...++||+|+||+||+|.+..++   ..||||++.+. .+......+.+|++++++++|||||++++++.. ....++||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            34678999999999999987654   35899998653 355667889999999999999999999998765 56899999


Q ss_pred             ecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccceecccCcc---
Q psy18060        198 EFAH-MSLSNLLEQR-KKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFARSMAVGTH---  272 (549)
Q Consensus       198 E~~~-gsL~~~l~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla~~~~~~~~---  272 (549)
                      |||+ |+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++.......   
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            9998 5898888754 4578889999999999999999999999999999999999999999999999987653321   


Q ss_pred             -cccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcC-CCCCCccCCHHHHHHHH
Q psy18060        273 -MLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKT-VSILHLIRLLKTQ-DVTFPSQVSETYKDLVK  349 (549)
Q Consensus       273 -~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~dlI~  349 (549)
                       ......||+.|+|||.+.+..++.++||||||+++|||+||..||.. .+..+....+..+ .+..|+.+++++.+||.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence             22345789999999999999999999999999999999997777654 3444445554443 45577889999999999


Q ss_pred             HhchhCcCCCCCHHHHhcC
Q psy18060        350 GLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       350 ~~L~~dP~~Rps~~elL~H  368 (549)
                      +||+.||++|||+.||++|
T Consensus       269 ~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.7e-46  Score=379.35  Aligned_cols=245  Identities=20%  Similarity=0.264  Sum_probs=207.3

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCC-CCeeEEEEEEeeCCEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH-PNIIKFIASHETLNEFVLIT  197 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~iV~  197 (549)
                      ++|++.+.||+|+||+||+|++..+|+.||||++......    ..+.+|+++++.+.| ||++.+++++......++||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            5799999999999999999999999999999998664322    246788899999965 89999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEec-----CCcEEEeecccceecccCc
Q psy18060        198 EFAHMSLSNLLEQRK-KLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNK-----DGVAMLCDFGFARSMAVGT  271 (549)
Q Consensus       198 E~~~gsL~~~l~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~-----~g~vKL~DFGla~~~~~~~  271 (549)
                      ||++++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+......
T Consensus        81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             EecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            999999999997754 6999999999999999999999999999999999999974     5789999999998764321


Q ss_pred             -------ccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCC-----CCC
Q psy18060        272 -------HMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVS---ILHLIRLLKTQD-----VTF  336 (549)
Q Consensus       272 -------~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~---~~~~~~~i~~~~-----~~~  336 (549)
                             ....+.+||+.|||||++.+..++.++|||||||++|||+||+.||.+..   .......+....     ..+
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL  240 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence                   12345689999999999999999999999999999999999999997543   333333332211     123


Q ss_pred             CccCCHHHHHHHHHhchhCcCCCCCHHHHhc
Q psy18060        337 PSQVSETYKDLVKGLLEKDASQRLSWPELLH  367 (549)
Q Consensus       337 p~~~s~~~~dlI~~~L~~dP~~Rps~~elL~  367 (549)
                      ++.+|+++.+++..|+..+|.+||+++.+.+
T Consensus       241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            3578999999999999999999999877643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=375.17  Aligned_cols=244  Identities=24%  Similarity=0.337  Sum_probs=192.7

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC----EEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN----EFV  194 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~  194 (549)
                      ++|.+.+.||+|+||.||+|+.  +|+.||||++....   ......+.|+..+.+++|||||++++++...+    .++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            5789999999999999999986  48899999986431   11222334555566789999999999987653    689


Q ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCccccccCCcEEEecCCcEEEeecccce
Q psy18060        195 LITEFAH-MSLSNLLEQRKKLSETICVQILSNLISALYYLHS--------NRVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       195 iV~E~~~-gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~--------~gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                      +||||+. |+|.++|++. ++++..+..++.|++.||.|||+        +||+||||||+||||+.+|.+||+|||+++
T Consensus        78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            9999997 6999999764 79999999999999999999996        599999999999999999999999999998


Q ss_pred             ecccCcc----cccccCCCCcccccccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCC---------------C
Q psy18060        266 SMAVGTH----MLTSIKGTPLYMAPELIAER------PYDHTADLWSLGCIAYEIHMGHPPFKT---------------V  320 (549)
Q Consensus       266 ~~~~~~~----~~~~~~GT~~Y~APE~l~~~------~y~~ksDIwSlGvil~eLltG~~Pf~~---------------~  320 (549)
                      .......    ......||+.|||||++.+.      .++.++|||||||++|||+||..||..               .
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            7754332    22456799999999998754      367899999999999999999887732               1


Q ss_pred             CHHHHHHHHhcCCC--CCCcc-----CCHHHHHHHHHhchhCcCCCCCHHHHhcC
Q psy18060        321 SILHLIRLLKTQDV--TFPSQ-----VSETYKDLVKGLLEKDASQRLSWPELLHH  368 (549)
Q Consensus       321 ~~~~~~~~i~~~~~--~~p~~-----~s~~~~dlI~~~L~~dP~~Rps~~elL~H  368 (549)
                      ........+.....  .+|..     .+..+.+++.+||+.||.+|||+.||+++
T Consensus       237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            23333333333322  23332     23468899999999999999999999764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.1e-45  Score=377.83  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=198.1

Q ss_pred             cceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-----------CCCeeEEEEEE
Q psy18060        119 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-----------HPNIIKFIASH  187 (549)
Q Consensus       119 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~~~~  187 (549)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+.   ....+.+.+|+++++.+.           ||||+++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            4599999999999999999999999999999999753   233456788999888775           57899998887


Q ss_pred             ee--CCEEEEEEecCC--CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccCCcEEEecCC------
Q psy18060        188 ET--LNEFVLITEFAH--MSLSNLLE--QRKKLSETICVQILSNLISALYYLHS-NRVLHRDLKPQNVLLNKDG------  254 (549)
Q Consensus       188 ~~--~~~~~iV~E~~~--gsL~~~l~--~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIiHrDIKP~NILl~~~g------  254 (549)
                      ..  ....+++|+++.  ++......  ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++      
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence            53  456667777654  33333332  34679999999999999999999998 8999999999999998765      


Q ss_pred             cEEEeecccceecccCcccccccCCCCcccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHH--
Q psy18060        255 VAMLCDFGFARSMAVGTHMLTSIKGTPLYMAPELIAERPYDHTADLWSLGCIAYEIHMGHPPFKTVSIL------HLI--  326 (549)
Q Consensus       255 ~vKL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~y~~ksDIwSlGvil~eLltG~~Pf~~~~~~------~~~--  326 (549)
                      .++++|||.|+....   .....+||+.|+|||++.+..|+.++||||+||++++|++|+.||...+..      ...  
T Consensus       170 ~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         170 QIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            399999999976543   235567999999999999999999999999999999999999999754321      111  


Q ss_pred             --HHHh--------------------------------------cCCCCCCccCCHHHHHHHHHhchhCcCCCCCHHHHh
Q psy18060        327 --RLLK--------------------------------------TQDVTFPSQVSETYKDLVKGLLEKDASQRLSWPELL  366 (549)
Q Consensus       327 --~~i~--------------------------------------~~~~~~p~~~s~~~~dlI~~~L~~dP~~Rps~~elL  366 (549)
                        ..+.                                      .....+++..++++.+||.+||+.||.+|||++|+|
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence              0000                                      001112234578899999999999999999999999


Q ss_pred             cCcccCcccc
Q psy18060        367 HHPLVKDNLS  376 (549)
Q Consensus       367 ~Hpw~~~~~~  376 (549)
                      +||||++...
T Consensus       327 ~Hp~f~~~~~  336 (362)
T d1q8ya_         327 NHPWLKDTLG  336 (362)
T ss_dssp             TCGGGTTCTT
T ss_pred             cCcccCCCCC
Confidence            9999986543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=7.8e-25  Score=205.65  Aligned_cols=166  Identities=17%  Similarity=0.131  Sum_probs=121.9

Q ss_pred             eeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCC----------------hHHHHHHHHHHHHHHhcCCCCeeEEE
Q psy18060        121 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS----------------GKELSSLKQECEIQKHLAHPNIIKFI  184 (549)
Q Consensus       121 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----------------~~~~~~~~~Ei~il~~l~hpnIv~l~  184 (549)
                      +.+.+.||+|+||+||+|.+. +|+.||||++.....+                ........+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            457899999999999999885 5899999987532110                01123445788899999999999988


Q ss_pred             EEEeeCCEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccCCcEEEecCCcEEEeecccc
Q psy18060        185 ASHETLNEFVLITEFAHMSLSNLLEQRKKLSETICVQILSNLISALYYLHSNRVLHRDLKPQNVLLNKDGVAMLCDFGFA  264 (549)
Q Consensus       185 ~~~~~~~~~~iV~E~~~gsL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIiHrDIKP~NILl~~~g~vKL~DFGla  264 (549)
                      ++..    .+++||++++...      ..+++..+..++.|++.||.|||++||+||||||+|||+++++ ++|+|||+|
T Consensus        81 ~~~~----~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a  149 (191)
T d1zara2          81 AWEG----NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS  149 (191)
T ss_dssp             EEET----TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTC
T ss_pred             EecC----CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCc
Confidence            7642    2689999987422      2355666788999999999999999999999999999998654 899999999


Q ss_pred             eecccCcccccccCCCCccccc--c---cccCCCCCcchhhHHHHHH
Q psy18060        265 RSMAVGTHMLTSIKGTPLYMAP--E---LIAERPYDHTADLWSLGCI  306 (549)
Q Consensus       265 ~~~~~~~~~~~~~~GT~~Y~AP--E---~l~~~~y~~ksDIwSlGvi  306 (549)
                      .....+...        .|...  +   ......|+.++|+||+.--
T Consensus       150 ~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         150 VEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             EETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             ccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            766433210        11111  1   0123568899999997543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=2.9e-16  Score=156.77  Aligned_cols=87  Identities=37%  Similarity=0.513  Sum_probs=75.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +++|++++.||+|+||+||+|+++.+|+.||||++++........+.+.+|+++|++++|||||+++++|.+.+.+|+||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            57999999999999999999999999999999999765544444578899999999999999999999999999999999


Q ss_pred             hhhhccc
Q psy18060         88 EFAHMSL   94 (549)
Q Consensus        88 ey~~~sL   94 (549)
                      ||+.+++
T Consensus        81 e~~~~~~   87 (298)
T d1gz8a_          81 EFLHQDL   87 (298)
T ss_dssp             ECCSEEH
T ss_pred             eecCCch
Confidence            9987654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=4.3e-16  Score=153.38  Aligned_cols=90  Identities=22%  Similarity=0.372  Sum_probs=78.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc--ccceeh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET--LNEFVL   85 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~l   85 (549)
                      .++|++++.||+|+||+||+|+++.||+.||||++.+...+..+.+.+.+|+++|++++|||||++++++.+  .+.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            578999999999999999999999999999999998877666677889999999999999999999999854  566899


Q ss_pred             hhhhhh-cccccC
Q psy18060         86 ITEFAH-MSLSKL   97 (549)
Q Consensus        86 v~ey~~-~sLskl   97 (549)
                      ||||+. ++|..+
T Consensus        83 vmEy~~~g~L~~~   95 (269)
T d2java1          83 VMEYCEGGDLASV   95 (269)
T ss_dssp             EEECCTTEEHHHH
T ss_pred             EEecCCCCcHHHH
Confidence            999995 466543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=5.3e-16  Score=152.97  Aligned_cols=90  Identities=27%  Similarity=0.363  Sum_probs=76.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      -.++|++++.||+|+||+||+|+++.+|+.||||++++.... ...+.+.+|+++|++++|||||++++++.+.+.+|+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            357899999999999999999999999999999999765432 2345789999999999999999999999999999999


Q ss_pred             hhhhh-cccccC
Q psy18060         87 TEFAH-MSLSKL   97 (549)
Q Consensus        87 ~ey~~-~sLskl   97 (549)
                      |||+. ++|..+
T Consensus        82 mEy~~gg~L~~~   93 (271)
T d1nvra_          82 LEYCSGGELFDR   93 (271)
T ss_dssp             EECCTTEEGGGG
T ss_pred             EeccCCCcHHHH
Confidence            99996 477543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=1e-15  Score=152.40  Aligned_cols=89  Identities=25%  Similarity=0.294  Sum_probs=77.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh----hhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      -++|++++.||+|+||+||+|+++.+|+.||||++++.....    ...+.+.+|+++|++|+|||||+++++|++.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            457999999999999999999999999999999998764322    2346789999999999999999999999999999


Q ss_pred             ehhhhhhh-ccccc
Q psy18060         84 VLITEFAH-MSLSK   96 (549)
Q Consensus        84 ~lv~ey~~-~sLsk   96 (549)
                      |+||||+. ++|..
T Consensus        89 ~iv~E~~~gg~L~~  102 (293)
T d1jksa_          89 ILILELVAGGELFD  102 (293)
T ss_dssp             EEEEECCCSCBHHH
T ss_pred             EEEEEcCCCccccc
Confidence            99999986 45543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.55  E-value=1.1e-15  Score=153.39  Aligned_cols=84  Identities=27%  Similarity=0.414  Sum_probs=75.7

Q ss_pred             CeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC-hhhhhhHHHHHHHHHhcCCCCccccccccccccceehhhh
Q psy18060         10 KYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE   88 (549)
Q Consensus        10 ~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~e   88 (549)
                      .|+.++.||+|+||+||+|+++.+|+.||||++++.... ....+.+.+|+++|++|+|||||++++++.+.+.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            599999999999999999999999999999999876543 3345678999999999999999999999999999999999


Q ss_pred             hhhcc
Q psy18060         89 FAHMS   93 (549)
Q Consensus        89 y~~~s   93 (549)
                      |+.++
T Consensus        96 ~~~~g  100 (309)
T d1u5ra_          96 YCLGS  100 (309)
T ss_dssp             CCSEE
T ss_pred             ecCCC
Confidence            98654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=8.7e-16  Score=150.71  Aligned_cols=89  Identities=33%  Similarity=0.462  Sum_probs=77.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC-hhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS-GKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+++|+.++|||||++++++.+.+.+|+
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence            468999999999999999999999999999999999765422 2234578899999999999999999999999999999


Q ss_pred             hhhhhh-cccc
Q psy18060         86 ITEFAH-MSLS   95 (549)
Q Consensus        86 v~ey~~-~sLs   95 (549)
                      ||||+. ++|.
T Consensus        84 vmEy~~~g~L~   94 (263)
T d2j4za1          84 ILEYAPLGTVY   94 (263)
T ss_dssp             EEECCTTCBHH
T ss_pred             EEeecCCCcHH
Confidence            999986 3553

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=1.9e-15  Score=150.25  Aligned_cols=86  Identities=28%  Similarity=0.455  Sum_probs=76.5

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE   88 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~e   88 (549)
                      +.|++++.||+|+||+||+|+++.+|+.||||++++..  ....+.+.+|+++|++++|||||++++++.+.+.+++|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            56999999999999999999999999999999997653  3345788999999999999999999999999999999999


Q ss_pred             hhh-ccccc
Q psy18060         89 FAH-MSLSK   96 (549)
Q Consensus        89 y~~-~sLsk   96 (549)
                      |+. ++|..
T Consensus        90 y~~~g~L~~   98 (288)
T d2jfla1          90 FCAGGAVDA   98 (288)
T ss_dssp             CCTTEEHHH
T ss_pred             cCCCCcHHH
Confidence            985 45543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=9.2e-16  Score=152.55  Aligned_cols=90  Identities=23%  Similarity=0.337  Sum_probs=78.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+++|++++|||||+++++|.+.+.+|+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            34689999999999999999999999999999999976432 22334678999999999999999999999999999999


Q ss_pred             hhhhhh-ccccc
Q psy18060         86 ITEFAH-MSLSK   96 (549)
Q Consensus        86 v~ey~~-~sLsk   96 (549)
                      ||||+. ++|..
T Consensus        86 vmEy~~gg~L~~   97 (288)
T d1uu3a_          86 GLSYAKNGELLK   97 (288)
T ss_dssp             EECCCTTEEHHH
T ss_pred             EEEccCCCCHHH
Confidence            999986 46644

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=1.9e-15  Score=152.44  Aligned_cols=87  Identities=30%  Similarity=0.450  Sum_probs=76.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      -.++|++++.||+|+||+||+|.++.+|+.||||++++..   .+...+.+|+++|+.++|||||+++++|++.+.+|+|
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            3578999999999999999999999999999999997643   2335688999999999999999999999999999999


Q ss_pred             hhhhh-ccccc
Q psy18060         87 TEFAH-MSLSK   96 (549)
Q Consensus        87 ~ey~~-~sLsk   96 (549)
                      |||+. ++|..
T Consensus        80 mE~~~gg~L~~   90 (321)
T d1tkia_          80 FEFISGLDIFE   90 (321)
T ss_dssp             ECCCCCCBHHH
T ss_pred             EecCCCCcHHH
Confidence            99996 35543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.54  E-value=8.9e-16  Score=154.02  Aligned_cols=90  Identities=26%  Similarity=0.351  Sum_probs=73.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ..-+.|++++.||+|+||+||+|+++.+|+.||||+|.+..... ....+.+|+++|++++|||||++++++.+.+.+|+
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34467999999999999999999999999999999998765432 23567899999999999999999999999999999


Q ss_pred             hhhhhh-ccccc
Q psy18060         86 ITEFAH-MSLSK   96 (549)
Q Consensus        86 v~ey~~-~sLsk   96 (549)
                      ||||+. ++|..
T Consensus        85 vmE~~~gg~L~~   96 (307)
T d1a06a_          85 IMQLVSGGELFD   96 (307)
T ss_dssp             EECCCCSCBHHH
T ss_pred             EEeccCCCcHHH
Confidence            999996 57654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=1.2e-15  Score=155.09  Aligned_cols=86  Identities=21%  Similarity=0.380  Sum_probs=77.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      .+++|+++++||+|+||+||+|+++.||+.||||+|++... .....+.+.+|+++|+.++|||||+++++|++...+|+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            57899999999999999999999999999999999986542 22345678899999999999999999999999999999


Q ss_pred             hhhhhhc
Q psy18060         86 ITEFAHM   92 (549)
Q Consensus        86 v~ey~~~   92 (549)
                      ||||+.+
T Consensus        83 v~ey~~g   89 (337)
T d1o6la_          83 VMEYANG   89 (337)
T ss_dssp             EEECCTT
T ss_pred             ceeccCC
Confidence            9999853

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=1.7e-15  Score=152.78  Aligned_cols=90  Identities=22%  Similarity=0.278  Sum_probs=79.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++++... ....+.+.+|+++|++++|||||+++++|.+...+++|
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            45789999999999999999999999999999999976532 33446789999999999999999999999999999999


Q ss_pred             hhhhh-cccccC
Q psy18060         87 TEFAH-MSLSKL   97 (549)
Q Consensus        87 ~ey~~-~sLskl   97 (549)
                      |||+. ++|..+
T Consensus        83 mEy~~gg~L~~~   94 (322)
T d1s9ja_          83 MEHMDGGSLDQV   94 (322)
T ss_dssp             EECCTTEEHHHH
T ss_pred             EEcCCCCcHHHH
Confidence            99986 466543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=2.5e-15  Score=149.75  Aligned_cols=86  Identities=22%  Similarity=0.390  Sum_probs=76.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+....  ..+.+.+|+++|++++|||||+++++|.+.+.+|+||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            35799999999999999999999999999999999765432  2357899999999999999999999999999999999


Q ss_pred             hhhhc-ccc
Q psy18060         88 EFAHM-SLS   95 (549)
Q Consensus        88 ey~~~-sLs   95 (549)
                      ||+.+ +|.
T Consensus        97 Ey~~gg~L~  105 (293)
T d1yhwa1          97 EYLAGGSLT  105 (293)
T ss_dssp             ECCTTCBHH
T ss_pred             EecCCCcHH
Confidence            99854 553

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.53  E-value=1.3e-15  Score=153.39  Aligned_cols=86  Identities=21%  Similarity=0.346  Sum_probs=76.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            46789999999999999999999999999999999976432 22335678899999999999999999999999999999


Q ss_pred             hhhhhhc
Q psy18060         86 ITEFAHM   92 (549)
Q Consensus        86 v~ey~~~   92 (549)
                      ||||+.+
T Consensus        82 vmE~~~g   88 (316)
T d1fota_          82 IMDYIEG   88 (316)
T ss_dssp             EECCCCS
T ss_pred             EeeecCC
Confidence            9999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.53  E-value=3e-15  Score=148.68  Aligned_cols=87  Identities=23%  Similarity=0.406  Sum_probs=76.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++.+.||+|+||+||+|+++.+|+.||||++++...   ..+.+.+|+++|++++|||||++++++.+.+.+++
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            345689999999999999999999999999999999976543   24578999999999999999999999999999999


Q ss_pred             hhhhhh-cccc
Q psy18060         86 ITEFAH-MSLS   95 (549)
Q Consensus        86 v~ey~~-~sLs   95 (549)
                      +|||+. ++|.
T Consensus        91 v~E~~~~g~l~  101 (287)
T d1opja_          91 ITEFMTYGNLL  101 (287)
T ss_dssp             EEECCTTCBHH
T ss_pred             EeecccCcchH
Confidence            999996 4543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.53  E-value=3.9e-15  Score=152.02  Aligned_cols=89  Identities=24%  Similarity=0.379  Sum_probs=78.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++.+..  ....+.+.+|+++|++|+|||||++++++.+.+.+|+
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34678999999999999999999999999999999997643  3345678999999999999999999999999999999


Q ss_pred             hhhhhh-ccccc
Q psy18060         86 ITEFAH-MSLSK   96 (549)
Q Consensus        86 v~ey~~-~sLsk   96 (549)
                      ||||+. ++|..
T Consensus       101 vmE~~~gg~L~~  112 (350)
T d1koaa2         101 IYEFMSGGELFE  112 (350)
T ss_dssp             EECCCCSCBHHH
T ss_pred             EEEcCCCCCHHH
Confidence            999985 46643

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.52  E-value=2.8e-15  Score=148.34  Aligned_cols=86  Identities=35%  Similarity=0.442  Sum_probs=76.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +++|++++.||+|+||+||+|+++ +|+.||||+++.........+++.+|+++|++++|||||+++++|.+.+..++++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            579999999999999999999996 7899999999776544444578999999999999999999999999999999999


Q ss_pred             hhhhccc
Q psy18060         88 EFAHMSL   94 (549)
Q Consensus        88 ey~~~sL   94 (549)
                      +++.+++
T Consensus        80 e~~~~~~   86 (286)
T d1ob3a_          80 EHLDQDL   86 (286)
T ss_dssp             ECCSEEH
T ss_pred             Eeehhhh
Confidence            9986543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=5.1e-15  Score=151.27  Aligned_cols=89  Identities=26%  Similarity=0.387  Sum_probs=76.9

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccc------cc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE------TL   80 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~------~~   80 (549)
                      .+++|+++++||+|+||+||+|+++.||+.||||++++...+.....++.+|+.+|++++|||||+++++|.      +.
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            357899999999999999999999999999999999877666666678999999999999999999999985      34


Q ss_pred             cceehhhhhhhcccc
Q psy18060         81 NEFVLITEFAHMSLS   95 (549)
Q Consensus        81 ~~~~lv~ey~~~sLs   95 (549)
                      ..+|+||||+.+++.
T Consensus        95 ~~~~iv~Ey~~~~l~  109 (355)
T d2b1pa1          95 QDVYLVMELMDANLC  109 (355)
T ss_dssp             CEEEEEEECCSEEHH
T ss_pred             ceeEEEEeccchHHH
Confidence            678999999977653

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=3.8e-15  Score=151.51  Aligned_cols=90  Identities=23%  Similarity=0.350  Sum_probs=72.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc-----
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----   81 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----   81 (549)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++++...+....+.+.+|+++|++++|||||+++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            457899999999999999999999999999999999876666666778999999999999999999999986654     


Q ss_pred             -ceehhhhhhhccccc
Q psy18060         82 -EFVLITEFAHMSLSK   96 (549)
Q Consensus        82 -~~~lv~ey~~~sLsk   96 (549)
                       .+|+||||+..+|..
T Consensus        96 ~~~~lv~e~~~~~l~~  111 (346)
T d1cm8a_          96 TDFYLVMPFMGTDLGK  111 (346)
T ss_dssp             CCCEEEEECCSEEHHH
T ss_pred             ceEEEEEecccccHHH
Confidence             579999998766544

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.51  E-value=6.3e-15  Score=150.55  Aligned_cols=87  Identities=26%  Similarity=0.400  Sum_probs=76.9

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehh
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLI   86 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv   86 (549)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++++..  ....+.+.+|+++|++|+|||||+++++|++...+|+|
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4567999999999999999999999999999999997653  23346788999999999999999999999999999999


Q ss_pred             hhhhh-cccc
Q psy18060         87 TEFAH-MSLS   95 (549)
Q Consensus        87 ~ey~~-~sLs   95 (549)
                      |||+. ++|.
T Consensus       105 mE~~~gg~L~  114 (352)
T d1koba_         105 LEFLSGGELF  114 (352)
T ss_dssp             EECCCCCBHH
T ss_pred             EEcCCCChHH
Confidence            99996 4553

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=6.8e-15  Score=145.50  Aligned_cols=85  Identities=32%  Similarity=0.461  Sum_probs=77.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      +++|++++.||+|+||+||+|+++.+|+.||||++++.........++.+|+.+|+.++|||||+++++|.+....++++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            57999999999999999999999999999999999776655556678999999999999999999999999999999999


Q ss_pred             hhhhc
Q psy18060         88 EFAHM   92 (549)
Q Consensus        88 ey~~~   92 (549)
                      +++.+
T Consensus        81 ~~~~~   85 (292)
T d1unla_          81 EFCDQ   85 (292)
T ss_dssp             ECCSE
T ss_pred             eeccc
Confidence            88754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=8.8e-15  Score=143.96  Aligned_cols=85  Identities=32%  Similarity=0.436  Sum_probs=73.6

Q ss_pred             eeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc----ccceehh
Q psy18060         11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET----LNEFVLI   86 (549)
Q Consensus        11 y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----~~~~~lv   86 (549)
                      |++.+.||+|+||+||+|+++.+|+.||||++........+.+.+.+|+++|++++|||||+++++|++    ...+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            367778999999999999999999999999998766666667789999999999999999999999865    4568999


Q ss_pred             hhhhhc-ccc
Q psy18060         87 TEFAHM-SLS   95 (549)
Q Consensus        87 ~ey~~~-sLs   95 (549)
                      |||+.+ +|.
T Consensus        91 mE~~~~g~L~  100 (270)
T d1t4ha_          91 TELMTSGTLK  100 (270)
T ss_dssp             EECCCSCBHH
T ss_pred             EeCCCCCcHH
Confidence            999854 553

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.50  E-value=1.2e-14  Score=143.64  Aligned_cols=89  Identities=28%  Similarity=0.390  Sum_probs=77.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh-------hhhhhHHHHHHHHHhcC-CCCcccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG-------KELSSLKQECEIQKHLA-HPNIIKFIASHET   79 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~   79 (549)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++.....       ...+.+.+|+.+|++|+ |||||++++++++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999999999999999998765321       12346889999999997 9999999999999


Q ss_pred             ccceehhhhhhh-ccccc
Q psy18060         80 LNEFVLITEFAH-MSLSK   96 (549)
Q Consensus        80 ~~~~~lv~ey~~-~sLsk   96 (549)
                      .+.+|+||||+. ++|..
T Consensus        82 ~~~~~ivmE~~~~g~L~~   99 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFD   99 (277)
T ss_dssp             SSEEEEEEECCTTCBHHH
T ss_pred             CcceEEEEEcCCCchHHH
Confidence            999999999995 46653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.49  E-value=1.2e-14  Score=143.08  Aligned_cols=84  Identities=20%  Similarity=0.306  Sum_probs=73.3

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccc----ce
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLN----EF   83 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~----~~   83 (549)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++++... +....+.+.+|+++|+.++|||||++++++.+..    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            569999999999999999999999999999999987654 3444567999999999999999999999987654    38


Q ss_pred             ehhhhhhhc
Q psy18060         84 VLITEFAHM   92 (549)
Q Consensus        84 ~lv~ey~~~   92 (549)
                      |+||||+.+
T Consensus        87 ~lvmE~~~g   95 (277)
T d1o6ya_          87 YIVMEYVDG   95 (277)
T ss_dssp             EEEEECCCE
T ss_pred             EEEEECCCC
Confidence            899999863

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=6.6e-15  Score=146.65  Aligned_cols=83  Identities=29%  Similarity=0.461  Sum_probs=68.3

Q ss_pred             eeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh---hhhhhHHHHHHHHHhcCCCCccccccccccccceehhhh
Q psy18060         12 QKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG---KELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITE   88 (549)
Q Consensus        12 ~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~e   88 (549)
                      +.+++||+|+||+||+|+++.+|+.||||+|++.....   ...+.+.+|+++|++++|||||++++++.+.+.+|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            46789999999999999999999999999997654322   123568899999999999999999999999999999999


Q ss_pred             hhhccc
Q psy18060         89 FAHMSL   94 (549)
Q Consensus        89 y~~~sL   94 (549)
                      |+.+++
T Consensus        81 ~~~~~~   86 (299)
T d1ua2a_          81 FMETDL   86 (299)
T ss_dssp             CCSEEH
T ss_pred             hhcchH
Confidence            987643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=1.5e-14  Score=141.21  Aligned_cols=84  Identities=20%  Similarity=0.287  Sum_probs=73.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .++|++++.||+|+||+||+|+++ +++.||||++++.....   +.+.+|++++++++|||||++++++.+.+.+++||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            468999999999999999999986 67899999998765433   46889999999999999999999999999999999


Q ss_pred             hhhh-cccc
Q psy18060         88 EFAH-MSLS   95 (549)
Q Consensus        88 ey~~-~sLs   95 (549)
                      ||+. ++|.
T Consensus        79 Ey~~~g~l~   87 (258)
T d1k2pa_          79 EYMANGCLL   87 (258)
T ss_dssp             ECCTTEEHH
T ss_pred             EccCCCcHH
Confidence            9985 5554

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=1.1e-14  Score=146.72  Aligned_cols=89  Identities=21%  Similarity=0.345  Sum_probs=74.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHH-hcCCCCccccccccccccceeh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQK-HLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~-~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      +++|+++++||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.++. .++|||||++++++++.+.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            4789999999999999999999999999999999976432 1223456777887765 6899999999999999999999


Q ss_pred             hhhhhhc-cccc
Q psy18060         86 ITEFAHM-SLSK   96 (549)
Q Consensus        86 v~ey~~~-sLsk   96 (549)
                      ||||+.+ +|..
T Consensus        81 vmEy~~~g~L~~   92 (320)
T d1xjda_          81 VMEYLNGGDLMY   92 (320)
T ss_dssp             EEECCTTCBHHH
T ss_pred             EEeecCCCcHHH
Confidence            9999864 5543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.46  E-value=1.2e-14  Score=148.45  Aligned_cols=87  Identities=23%  Similarity=0.388  Sum_probs=76.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ..+++|++++.||+|+||.||+|+++.||+.||||++++... .....+.+.+|+++|+.++|||||++++++.+...++
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence            457899999999999999999999999999999999976432 2234567889999999999999999999999999999


Q ss_pred             hhhhhhhc
Q psy18060         85 LITEFAHM   92 (549)
Q Consensus        85 lv~ey~~~   92 (549)
                      ++|+|+.+
T Consensus       118 ~v~e~~~~  125 (350)
T d1rdqe_         118 MVMEYVAG  125 (350)
T ss_dssp             EEEECCTT
T ss_pred             cccccccc
Confidence            99999853

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=3.1e-14  Score=139.25  Aligned_cols=85  Identities=27%  Similarity=0.380  Sum_probs=73.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhh
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~   87 (549)
                      .++|++++.||+|+||.||+|+++ +++.||||++++.....   +.+.+|++++++++|||||++++++.+.+.+++||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            468999999999999999999987 46789999997654433   56889999999999999999999999999999999


Q ss_pred             hhhh-ccccc
Q psy18060         88 EFAH-MSLSK   96 (549)
Q Consensus        88 ey~~-~sLsk   96 (549)
                      ||+. ++|..
T Consensus        80 E~~~~g~L~~   89 (263)
T d1sm2a_          80 EFMEHGCLSD   89 (263)
T ss_dssp             ECCTTCBHHH
T ss_pred             EecCCCcHHH
Confidence            9984 45544

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=2.6e-14  Score=145.14  Aligned_cols=90  Identities=26%  Similarity=0.402  Sum_probs=75.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc------c
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL------N   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~------~   81 (549)
                      .++|++++.||+|+||+||+|+++.+|+.||||+|++...+....+++.+|+++|++|+|||||++++++...      .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            5789999999999999999999999999999999987766666667889999999999999999999988532      3


Q ss_pred             ceehhhhhhhcccccC
Q psy18060         82 EFVLITEFAHMSLSKL   97 (549)
Q Consensus        82 ~~~lv~ey~~~sLskl   97 (549)
                      ..++++++..++|..+
T Consensus        97 ~~~i~~~~~gg~L~~~  112 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNI  112 (348)
T ss_dssp             CCEEEEECCSEEHHHH
T ss_pred             eEEEEEeecCCchhhh
Confidence            3556666656676543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=3.4e-14  Score=142.52  Aligned_cols=89  Identities=30%  Similarity=0.456  Sum_probs=73.0

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc------
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET------   79 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~------   79 (549)
                      ...++|++++.||+|+||+||+|+++.+|+.||||++.+..........+.+|+++|++++||||+++++++..      
T Consensus         7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            45789999999999999999999999999999999997765555556778999999999999999999988744      


Q ss_pred             --ccceehhhhhhhccc
Q psy18060         80 --LNEFVLITEFAHMSL   94 (549)
Q Consensus        80 --~~~~~lv~ey~~~sL   94 (549)
                        ...++++|+|+.+.+
T Consensus        87 ~~~~~~~iv~e~~~~~~  103 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDL  103 (318)
T ss_dssp             ----CEEEEEECCCEEH
T ss_pred             ccCceEEEEEeccCCCc
Confidence              345889999986554

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.43  E-value=5.5e-14  Score=140.15  Aligned_cols=89  Identities=26%  Similarity=0.322  Sum_probs=73.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCc---eEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKK---TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      ..+.|++.++||+|+||+||+|+++.+|+   .||||++.... .....+.+.+|+++|++++|||||++++++.+.+.+
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            35679999999999999999999987775   58999986543 444567799999999999999999999999999999


Q ss_pred             ehhhhhhh-ccccc
Q psy18060         84 VLITEFAH-MSLSK   96 (549)
Q Consensus        84 ~lv~ey~~-~sLsk   96 (549)
                      ++||||+. ++|..
T Consensus       103 ~iv~Ey~~~g~L~~  116 (299)
T d1jpaa_         103 MIITEFMENGSLDS  116 (299)
T ss_dssp             EEEEECCTTEEHHH
T ss_pred             EEEEEecCCCccee
Confidence            99999995 45543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.42  E-value=4.9e-14  Score=144.52  Aligned_cols=90  Identities=18%  Similarity=0.228  Sum_probs=73.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh----hhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      .+++|+++++||+|+||.||+|+++.||+.||||+|.+.....    .......+|+++++.++|||||+++++|.+.+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            4789999999999999999999999999999999997643211    111223345677778899999999999999999


Q ss_pred             eehhhhhhh-ccccc
Q psy18060         83 FVLITEFAH-MSLSK   96 (549)
Q Consensus        83 ~~lv~ey~~-~sLsk   96 (549)
                      +|+||||+. ++|..
T Consensus        82 ~~ivmE~~~gg~L~~   96 (364)
T d1omwa3          82 LSFILDLMNGGDLHY   96 (364)
T ss_dssp             EEEEECCCCSCBHHH
T ss_pred             EEEEEEecCCCcHHH
Confidence            999999996 45543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=1.1e-13  Score=136.81  Aligned_cols=86  Identities=23%  Similarity=0.329  Sum_probs=72.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCC----ceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLK----KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN   81 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~   81 (549)
                      ...+.|++.++||+|+||.||+|.++.++    ..||||+++... .......+.+|+++|++++|||||++++++.+..
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            34568999999999999999999987655    479999996543 3444567899999999999999999999999999


Q ss_pred             ceehhhhhhhc
Q psy18060         82 EFVLITEFAHM   92 (549)
Q Consensus        82 ~~~lv~ey~~~   92 (549)
                      .++++|||+.+
T Consensus        83 ~~~~v~e~~~~   93 (283)
T d1mqba_          83 PMMIITEYMEN   93 (283)
T ss_dssp             SEEEEEECCTT
T ss_pred             ceEEEEEeccc
Confidence            99999999854

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=1.1e-13  Score=135.89  Aligned_cols=86  Identities=23%  Similarity=0.341  Sum_probs=71.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++.+.||+|+||.||+|+++ +++.||||+++.....   .+.+.+|+++|++++|||||++++++.+ +.+++
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            34578999999999999999999986 4788999999765433   3568999999999999999999998755 56799


Q ss_pred             hhhhhh-ccccc
Q psy18060         86 ITEFAH-MSLSK   96 (549)
Q Consensus        86 v~ey~~-~sLsk   96 (549)
                      ||||+. ++|..
T Consensus        85 v~Ey~~~g~L~~   96 (272)
T d1qpca_          85 ITEYMENGSLVD   96 (272)
T ss_dssp             EEECCTTCBHHH
T ss_pred             EEEeCCCCcHHH
Confidence            999985 45544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.39  E-value=1.2e-13  Score=140.40  Aligned_cols=88  Identities=28%  Similarity=0.318  Sum_probs=70.7

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccc-----ce
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLN-----EF   83 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~   83 (549)
                      ++|++++.||+|+||+||+|+++.+|+.||||+|++.. .....+.+.+|+++|++|+|||||++++++....     .+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            57999999999999999999999999999999997643 3344567899999999999999999999886543     36


Q ss_pred             ehhhhhhhcccccC
Q psy18060         84 VLITEFAHMSLSKL   97 (549)
Q Consensus        84 ~lv~ey~~~sLskl   97 (549)
                      ++++++..++|.++
T Consensus        87 ~l~~~~~~g~L~~~  100 (345)
T d1pmea_          87 YLVTHLMGADLYKL  100 (345)
T ss_dssp             EEEEECCCEEHHHH
T ss_pred             EEEEeecCCchhhh
Confidence            67777777777654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=7.3e-14  Score=137.31  Aligned_cols=85  Identities=27%  Similarity=0.388  Sum_probs=73.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCCh----hhhhhHHHHHHHHHhcC--CCCcccccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSG----KELSSLKQECEIQKHLA--HPNIIKFIASHETLN   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~~~   81 (549)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.....    ....++.+|+.+|++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            468999999999999999999999999999999998654321    12244678999999997  999999999999999


Q ss_pred             ceehhhhhhhc
Q psy18060         82 EFVLITEFAHM   92 (549)
Q Consensus        82 ~~~lv~ey~~~   92 (549)
                      .+++||||+.+
T Consensus        83 ~~~lv~e~~~~   93 (273)
T d1xwsa_          83 SFVLILERPEP   93 (273)
T ss_dssp             EEEEEEECCSS
T ss_pred             eEEEEEEeccC
Confidence            99999999753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.38  E-value=2.2e-13  Score=137.20  Aligned_cols=86  Identities=26%  Similarity=0.431  Sum_probs=72.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcC-CCCcccccccccc--ccce
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHET--LNEF   83 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~--~~~~   83 (549)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++++..     .+.+.+|+++|+++. ||||++++++|..  ...+
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            4568999999999999999999999999999999996532     356789999999996 9999999999864  4568


Q ss_pred             ehhhhhhh-cccccC
Q psy18060         84 VLITEFAH-MSLSKL   97 (549)
Q Consensus        84 ~lv~ey~~-~sLskl   97 (549)
                      ++||||+. ++|..+
T Consensus       108 ~~v~e~~~~~~L~~~  122 (328)
T d3bqca1         108 ALVFEHVNNTDFKQL  122 (328)
T ss_dssp             EEEEECCCSCBGGGT
T ss_pred             eEEEeecCCCcHHHH
Confidence            99999985 455544

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=3.9e-13  Score=132.98  Aligned_cols=90  Identities=21%  Similarity=0.362  Sum_probs=72.2

Q ss_pred             ccccCeeeeee-ecccCceEEEEEEECCC--CceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccc
Q psy18060          6 GALEKYQKICL-IGEGSFGKVFKAIHLDL--KKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNE   82 (549)
Q Consensus         6 ~~~~~y~~~~~-IG~G~fG~V~~~~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~   82 (549)
                      ...++|.+.++ ||+|+||+||+|.++.+  +..||||++++.. .....+.+.+|+++|++++|||||++++++.+ +.
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            34567888885 99999999999988644  4579999997543 44556789999999999999999999999865 46


Q ss_pred             eehhhhhhh-cccccC
Q psy18060         83 FVLITEFAH-MSLSKL   97 (549)
Q Consensus        83 ~~lv~ey~~-~sLskl   97 (549)
                      +++||||+. ++|..+
T Consensus        83 ~~lvmE~~~~g~L~~~   98 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKF   98 (285)
T ss_dssp             EEEEEECCTTEEHHHH
T ss_pred             EEEEEEeCCCCcHHHH
Confidence            899999996 466543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=1.6e-13  Score=135.24  Aligned_cols=87  Identities=24%  Similarity=0.381  Sum_probs=73.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++.+.||+|+||.||+|+++   ..||||+++....+....+.+.+|+++|++++|||||++++++.+ ..+++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            34678999999999999999999764   359999998766556667889999999999999999999997654 56899


Q ss_pred             hhhhhh-ccccc
Q psy18060         86 ITEFAH-MSLSK   96 (549)
Q Consensus        86 v~ey~~-~sLsk   96 (549)
                      ||||+. ++|..
T Consensus        81 v~Ey~~~g~L~~   92 (276)
T d1uwha_          81 VTQWCEGSSLYH   92 (276)
T ss_dssp             EEECCCEEEHHH
T ss_pred             EEecCCCCCHHH
Confidence            999996 56644

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=1.9e-13  Score=133.65  Aligned_cols=85  Identities=21%  Similarity=0.343  Sum_probs=69.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccc-ccccee
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHE-TLNEFV   84 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-~~~~~~   84 (549)
                      ..+++|++++.||+|+||.||+|+++  |+.||||++++..    ..+.+.+|+++|++++|||||++++++. +.+.++
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            45789999999999999999999985  6789999996543    2356889999999999999999999875 456789


Q ss_pred             hhhhhhh-ccccc
Q psy18060         85 LITEFAH-MSLSK   96 (549)
Q Consensus        85 lv~ey~~-~sLsk   96 (549)
                      +||||+. ++|..
T Consensus        78 lv~ey~~~g~L~~   90 (262)
T d1byga_          78 IVTEYMAKGSLVD   90 (262)
T ss_dssp             EEECCCTTEEHHH
T ss_pred             EEEeccCCCCHHH
Confidence            9999984 45544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=2e-13  Score=138.98  Aligned_cols=80  Identities=26%  Similarity=0.371  Sum_probs=67.9

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc------ccc
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET------LNE   82 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~------~~~   82 (549)
                      -+|+.+++||+|+||+||+|+++.+|+.||||++.+...      ...+|+++|++++|||||+++++|..      ...
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            369999999999999999999999999999999976432      23479999999999999999998843      334


Q ss_pred             eehhhhhhhccc
Q psy18060         83 FVLITEFAHMSL   94 (549)
Q Consensus        83 ~~lv~ey~~~sL   94 (549)
                      +++||||+.+++
T Consensus        94 ~~lv~Ey~~~~~  105 (350)
T d1q5ka_          94 LNLVLDYVPETV  105 (350)
T ss_dssp             EEEEEECCSEEH
T ss_pred             EEEEEeccCCcc
Confidence            789999997654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=2.1e-13  Score=138.13  Aligned_cols=85  Identities=19%  Similarity=0.357  Sum_probs=71.2

Q ss_pred             ccccCeeeee-eecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCcccccccccc----
Q psy18060          6 GALEKYQKIC-LIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET----   79 (549)
Q Consensus         6 ~~~~~y~~~~-~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~----   79 (549)
                      ..+++|+++. +||+|+||+||+|+++.||+.||||++++.       ..+.+|++++.++ +|||||+++++|++    
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            4578999975 699999999999999999999999999642       3567899987654 89999999999865    


Q ss_pred             ccceehhhhhhh-cccccC
Q psy18060         80 LNEFVLITEFAH-MSLSKL   97 (549)
Q Consensus        80 ~~~~~lv~ey~~-~sLskl   97 (549)
                      ...+|+||||+. ++|..+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~   99 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSR   99 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHH
T ss_pred             CCEEEEEEECCCCCcHHHH
Confidence            467999999996 577543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.36  E-value=2.2e-13  Score=135.68  Aligned_cols=90  Identities=23%  Similarity=0.377  Sum_probs=76.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECC-----CCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL   80 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~   80 (549)
                      ...++|++++.||+|+||+||+|+++.     +++.||||+++... .....+.+.+|+++|++++||||+++++++.+.
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            345689999999999999999999863     56789999997543 344456799999999999999999999999999


Q ss_pred             cceehhhhhh-hccccc
Q psy18060         81 NEFVLITEFA-HMSLSK   96 (549)
Q Consensus        81 ~~~~lv~ey~-~~sLsk   96 (549)
                      ..++++|+|+ +++|..
T Consensus        89 ~~~~~v~e~~~~g~L~~  105 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNE  105 (301)
T ss_dssp             SSCEEEEECCTTCBHHH
T ss_pred             CceEEEEEecCCCcHHH
Confidence            9999999998 455544

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.35  E-value=3.8e-13  Score=135.03  Aligned_cols=84  Identities=24%  Similarity=0.423  Sum_probs=63.6

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCc----eEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccccccee
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKK----TVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFV   84 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~   84 (549)
                      ++|+++++||+|+||+||+|.++.+|+    .||+|+++... +....+.+.+|+++|++++|||||++++++.+.. .+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-ee
Confidence            579999999999999999999998886    58888886433 2334567899999999999999999999998765 44


Q ss_pred             hhhhhh-hccc
Q psy18060         85 LITEFA-HMSL   94 (549)
Q Consensus        85 lv~ey~-~~sL   94 (549)
                      ++++++ .++|
T Consensus        87 ~v~e~~~~~~l   97 (317)
T d1xkka_          87 LITQLMPFGCL   97 (317)
T ss_dssp             EEEECCTTCBH
T ss_pred             EEEEeccCCcc
Confidence            555544 4444

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=2.8e-13  Score=134.84  Aligned_cols=87  Identities=30%  Similarity=0.447  Sum_probs=70.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCC-CceEEEEEeccCCCChhhhhhHHHHHHHHHhc---CCCCccccccccc----
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDL-KKTVALKIISKSGRSGKELSSLKQECEIQKHL---AHPNIIKFIASHE----   78 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIV~l~~~~~----   78 (549)
                      ..++|++++.||+|+||+||+|+++.+ ++.||||++++..........+.+|+.+|+.|   +|||||+++++|.    
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            347899999999999999999999766 56799999976554433345677898888766   7999999999884    


Q ss_pred             -cccceehhhhhhhcc
Q psy18060         79 -TLNEFVLITEFAHMS   93 (549)
Q Consensus        79 -~~~~~~lv~ey~~~s   93 (549)
                       ....++++|+++.++
T Consensus        85 ~~~~~~~~~~e~~~~~  100 (305)
T d1blxa_          85 DRETKLTLVFEHVDQD  100 (305)
T ss_dssp             SSEEEEEEEEECCSCB
T ss_pred             ccCceEEEEEEeccCC
Confidence             345689999998654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=4.8e-13  Score=132.33  Aligned_cols=82  Identities=22%  Similarity=0.348  Sum_probs=69.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceeh
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVL   85 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~l   85 (549)
                      ...++|++.+.||+|+||.||+|+++.+ +.||||+++......   +.+.+|+.+|++++|||||++++++.+ +.+++
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence            3467899999999999999999999865 569999997654432   568899999999999999999999865 56899


Q ss_pred             hhhhhhc
Q psy18060         86 ITEFAHM   92 (549)
Q Consensus        86 v~ey~~~   92 (549)
                      ||||+.+
T Consensus        89 v~Ey~~~   95 (285)
T d1fmka3          89 VTEYMSK   95 (285)
T ss_dssp             EECCCTT
T ss_pred             EEEecCC
Confidence            9999853

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=3e-13  Score=133.29  Aligned_cols=81  Identities=30%  Similarity=0.454  Sum_probs=64.0

Q ss_pred             eeecccCceEEEEEEEC--CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccceehhhhhhh-
Q psy18060         15 CLIGEGSFGKVFKAIHL--DLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEFVLITEFAH-   91 (549)
Q Consensus        15 ~~IG~G~fG~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~lv~ey~~-   91 (549)
                      +.||+|+||+||+|.++  .+++.||||+++....+....+.+.+|+++|++++|||||++++++.+ +..++||||+. 
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            47999999999999865  456789999997655444556789999999999999999999999865 45789999985 


Q ss_pred             ccccc
Q psy18060         92 MSLSK   96 (549)
Q Consensus        92 ~sLsk   96 (549)
                      ++|..
T Consensus        92 g~L~~   96 (277)
T d1xbba_          92 GPLNK   96 (277)
T ss_dssp             EEHHH
T ss_pred             CcHHH
Confidence            46644

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=3.6e-13  Score=134.64  Aligned_cols=90  Identities=21%  Similarity=0.314  Sum_probs=75.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECC-----CCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETL   80 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~   80 (549)
                      ...++|++.+.||+|+||.||+|.++.     +++.||||++++.. ...+...+.+|++++++++|||||++++++...
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            445789999999999999999999863     35789999997543 444556789999999999999999999999999


Q ss_pred             cceehhhhhhh-ccccc
Q psy18060         81 NEFVLITEFAH-MSLSK   96 (549)
Q Consensus        81 ~~~~lv~ey~~-~sLsk   96 (549)
                      ...++||||+. ++|..
T Consensus        96 ~~~~lv~e~~~~g~l~~  112 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKS  112 (308)
T ss_dssp             SSCEEEEECCTTCBHHH
T ss_pred             CceeEEEeecCCCCHHH
Confidence            99999999984 45543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=5.2e-13  Score=134.47  Aligned_cols=89  Identities=26%  Similarity=0.413  Sum_probs=72.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEECCCCc-----eEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCcccccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLDLKK-----TVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLN   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~   81 (549)
                      .++|++.++||+|+||+||+|+++.+++     .||+|++.... .......+.+|+.+|+++ +|||||++++++.+.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            4689999999999999999999976654     69999996543 233456788999999998 8999999999999999


Q ss_pred             ceehhhhhhh-cccccC
Q psy18060         82 EFVLITEFAH-MSLSKL   97 (549)
Q Consensus        82 ~~~lv~ey~~-~sLskl   97 (549)
                      .+++||||+. ++|..+
T Consensus       115 ~~~lv~Ey~~~g~L~~~  131 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNY  131 (325)
T ss_dssp             SCEEEEECCTTCBHHHH
T ss_pred             eEEEEEEcCCCCcHHHH
Confidence            9999999995 566543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.32  E-value=6.4e-13  Score=130.36  Aligned_cols=84  Identities=27%  Similarity=0.389  Sum_probs=69.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCC---ceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLK---KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      ..++|++.+.||+|+||.||+|++..++   ..||||.++... .....+.+.+|+++|++++|||||++++++.+ +.+
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~   82 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV   82 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence            3468999999999999999999987654   468999986543 34455779999999999999999999999864 678


Q ss_pred             ehhhhhhhc
Q psy18060         84 VLITEFAHM   92 (549)
Q Consensus        84 ~lv~ey~~~   92 (549)
                      ++||||+.+
T Consensus        83 ~iv~E~~~~   91 (273)
T d1mp8a_          83 WIIMELCTL   91 (273)
T ss_dssp             EEEEECCTT
T ss_pred             EEEEEeccC
Confidence            999999853

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.32  E-value=3.2e-13  Score=135.03  Aligned_cols=91  Identities=27%  Similarity=0.331  Sum_probs=73.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEECCCCc--eEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccccccc
Q psy18060          6 GALEKYQKICLIGEGSFGKVFKAIHLDLKK--TVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLNE   82 (549)
Q Consensus         6 ~~~~~y~~~~~IG~G~fG~V~~~~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~   82 (549)
                      ...++|++.++||+|+||.||+|+++.+|.  .||||+++... .....+.+.+|+++|+++ +|||||++++++.+.+.
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            356799999999999999999999998886  46788875433 233456789999999998 79999999999999999


Q ss_pred             eehhhhhhh-cccccC
Q psy18060         83 FVLITEFAH-MSLSKL   97 (549)
Q Consensus        83 ~~lv~ey~~-~sLskl   97 (549)
                      +++||||+. ++|..+
T Consensus        86 ~~iV~ey~~~g~L~~~  101 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDF  101 (309)
T ss_dssp             EEEEECCCTTCBHHHH
T ss_pred             eEEEEEecCCCcHHHH
Confidence            999999985 566553

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.30  E-value=1e-12  Score=131.37  Aligned_cols=87  Identities=28%  Similarity=0.343  Sum_probs=73.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEEC-----CCCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCcccccccccccc
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHL-----DLKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHETLN   81 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~   81 (549)
                      .++|++.+.||+|+||.||+|+++     .+++.||||++++.. .......+.+|+.+++.+ +|||||++++++.+..
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            478999999999999999999874     466799999997654 334556789999999999 6999999999999999


Q ss_pred             ceehhhhhhh-cccc
Q psy18060         82 EFVLITEFAH-MSLS   95 (549)
Q Consensus        82 ~~~lv~ey~~-~sLs   95 (549)
                      .++++|||+. ++|.
T Consensus       101 ~~~lvmE~~~~g~l~  115 (311)
T d1t46a_         101 PTLVITEYCCYGDLL  115 (311)
T ss_dssp             SCEEEEECCTTEEHH
T ss_pred             EEEEEEEcCCCCCHH
Confidence            9999999995 4443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.30  E-value=5.5e-13  Score=131.05  Aligned_cols=83  Identities=22%  Similarity=0.285  Sum_probs=60.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEECC-CC--ceEEEEEeccCCC-ChhhhhhHHHHHHHHHhcCCCCccccccccccccce
Q psy18060          8 LEKYQKICLIGEGSFGKVFKAIHLD-LK--KTVALKIISKSGR-SGKELSSLKQECEIQKHLAHPNIIKFIASHETLNEF   83 (549)
Q Consensus         8 ~~~y~~~~~IG~G~fG~V~~~~~~~-~~--~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~   83 (549)
                      .++|++++.||+|+||.||+|++.. ++  ..||||++.+... .....+.+.+|+++|++++|||||++++++.+ ..+
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            4679999999999999999998753 33  3789999976653 23345678999999999999999999999976 467


Q ss_pred             ehhhhhhh
Q psy18060         84 VLITEFAH   91 (549)
Q Consensus        84 ~lv~ey~~   91 (549)
                      ++||||+.
T Consensus        86 ~lv~e~~~   93 (273)
T d1u46a_          86 KMVTELAP   93 (273)
T ss_dssp             EEEEECCT
T ss_pred             heeeeeec
Confidence            89999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=2.8e-13  Score=136.45  Aligned_cols=85  Identities=22%  Similarity=0.471  Sum_probs=72.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEEC---CCCceEEEEEeccCCC--ChhhhhhHHHHHHHHHhcCC-CCccccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHL---DLKKTVALKIISKSGR--SGKELSSLKQECEIQKHLAH-PNIIKFIASHETL   80 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~---~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~   80 (549)
                      .+++|++++.||+|+||+||+|++.   .+|+.||||++++...  +....+.+.+|+++|++++| |||+++++.+++.
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            4688999999999999999999984   4789999999976542  22234668899999999976 8999999999999


Q ss_pred             cceehhhhhhh
Q psy18060         81 NEFVLITEFAH   91 (549)
Q Consensus        81 ~~~~lv~ey~~   91 (549)
                      ..++++|||+.
T Consensus       102 ~~~~~v~e~~~  112 (322)
T d1vzoa_         102 TKLHLILDYIN  112 (322)
T ss_dssp             TEEEEEECCCC
T ss_pred             Cceeeeeeccc
Confidence            99999999974

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=2.8e-12  Score=127.49  Aligned_cols=89  Identities=29%  Similarity=0.442  Sum_probs=69.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEECCCC-------ceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCccccccccc
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLDLK-------KTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHE   78 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~   78 (549)
                      ..++|++++.||+|+||.||+|++..++       ..||||++++.. .......+.+|..++.++ +|||||++++++.
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            4578999999999999999999987654       479999997643 344556788999999888 7999999999999


Q ss_pred             cccceehhhhhhh-ccccc
Q psy18060         79 TLNEFVLITEFAH-MSLSK   96 (549)
Q Consensus        79 ~~~~~~lv~ey~~-~sLsk   96 (549)
                      +...+++||||+. ++|..
T Consensus        90 ~~~~~~~v~e~~~~g~l~~  108 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLRE  108 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHH
T ss_pred             cCCeEEEEEEccCCCcHHH
Confidence            9999999999985 45544

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.23  E-value=4.5e-12  Score=126.74  Aligned_cols=78  Identities=23%  Similarity=0.350  Sum_probs=64.2

Q ss_pred             eeeecccCceEEEEEEECCCC---ceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccccccccc-ccceehhhhh
Q psy18060         14 ICLIGEGSFGKVFKAIHLDLK---KTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKFIASHET-LNEFVLITEF   89 (549)
Q Consensus        14 ~~~IG~G~fG~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~lv~ey   89 (549)
                      .++||+|+||+||+|++..++   ..||||++++. .+....+.+.+|+++|++++|||||++++++.+ ....++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            578999999999999987644   36899999753 345566789999999999999999999998764 5678999999


Q ss_pred             hhc
Q psy18060         90 AHM   92 (549)
Q Consensus        90 ~~~   92 (549)
                      +.+
T Consensus       111 ~~~  113 (311)
T d1r0pa_         111 MKH  113 (311)
T ss_dssp             CTT
T ss_pred             eec
Confidence            863

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.22  E-value=4.6e-12  Score=125.51  Aligned_cols=84  Identities=27%  Similarity=0.300  Sum_probs=73.0

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCC-CCccccccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH-PNIIKFIASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~lv~   87 (549)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++....    ...+.+|+++++.|.| |||+.+++.+.+....++||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            589999999999999999999999999999999865432    2356789999999975 89999999999999999999


Q ss_pred             hhhhccccc
Q psy18060         88 EFAHMSLSK   96 (549)
Q Consensus        88 ey~~~sLsk   96 (549)
                      ||+.++|..
T Consensus        81 e~~~~~l~~   89 (293)
T d1csna_          81 DLLGPSLED   89 (293)
T ss_dssp             ECCCCBHHH
T ss_pred             EecCCCHHH
Confidence            998777654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.17  E-value=1.2e-11  Score=122.63  Aligned_cols=83  Identities=23%  Similarity=0.251  Sum_probs=68.6

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCCCCcccc-ccccccccceehhh
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNIIKF-IASHETLNEFVLIT   87 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l-~~~~~~~~~~~lv~   87 (549)
                      ++|++++.||+|+||+||+|+++.+|+.||||++......    ..+.+|+++++.++|+|+|.+ ..++.+....++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            4799999999999999999999999999999998764322    357789999999987776655 45567778889999


Q ss_pred             hhhhcccc
Q psy18060         88 EFAHMSLS   95 (549)
Q Consensus        88 ey~~~sLs   95 (549)
                      +|+.+++.
T Consensus        83 e~~~~~l~   90 (299)
T d1ckia_          83 ELLGPSLE   90 (299)
T ss_dssp             ECCCCBHH
T ss_pred             EEcCCchh
Confidence            99876654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.12  E-value=1.4e-11  Score=122.50  Aligned_cols=82  Identities=30%  Similarity=0.380  Sum_probs=63.1

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHH--HHHHHhcCCCCcccccccccccc----c
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQE--CEIQKHLAHPNIIKFIASHETLN----E   82 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E--i~il~~l~HpnIV~l~~~~~~~~----~   82 (549)
                      +.|.+.+.||+|+||.||+|++  +|+.||||+++...     .+...+|  +..++.++|||||++++++.+.+    .
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            5788999999999999999986  58999999996432     2333344  44556789999999999986543    5


Q ss_pred             eehhhhhh-hcccccC
Q psy18060         83 FVLITEFA-HMSLSKL   97 (549)
Q Consensus        83 ~~lv~ey~-~~sLskl   97 (549)
                      +++||||+ .++|..+
T Consensus        76 ~~lv~Ey~~~g~L~~~   91 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDY   91 (303)
T ss_dssp             EEEEEECCTTCBHHHH
T ss_pred             EEEEEecccCCCHHHH
Confidence            89999998 4466543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.00  E-value=1.5e-10  Score=114.56  Aligned_cols=90  Identities=24%  Similarity=0.401  Sum_probs=68.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEECC-----CCceEEEEEeccCCCChhhhhhHHHHHHHHHhc-CCCCcccccccccc-
Q psy18060          7 ALEKYQKICLIGEGSFGKVFKAIHLD-----LKKTVALKIISKSGRSGKELSSLKQECEIQKHL-AHPNIIKFIASHET-   79 (549)
Q Consensus         7 ~~~~y~~~~~IG~G~fG~V~~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~-   79 (549)
                      ..++|++++.||+|+||+||+|+++.     +++.||||+++... ...+.+.+.+|+.++.++ +|||||.+++.+.+ 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            34789999999999999999999764     45789999997543 334456778888888777 68999999988654 


Q ss_pred             ccceehhhhhhh-cccccC
Q psy18060         80 LNEFVLITEFAH-MSLSKL   97 (549)
Q Consensus        80 ~~~~~lv~ey~~-~sLskl   97 (549)
                      ...++++|||+. ++|..+
T Consensus        90 ~~~~~iv~E~~~~g~L~~~  108 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTY  108 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHH
T ss_pred             CCeEEEEEEecCCCcHHHH
Confidence            456899999985 566543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.84  E-value=1.1e-09  Score=110.65  Aligned_cols=68  Identities=19%  Similarity=0.320  Sum_probs=55.6

Q ss_pred             cCeeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCChhhhhhHHHHHHHHHhcCC-----------CCcccccccc
Q psy18060          9 EKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH-----------PNIIKFIASH   77 (549)
Q Consensus         9 ~~y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-----------pnIV~l~~~~   77 (549)
                      .+|+++++||+|+||+||+|+++.+|+.||||++++..   ...+.+.+|+++++.++|           ||||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            36999999999999999999999999999999997532   223567789999888765           6677777776


Q ss_pred             cc
Q psy18060         78 ET   79 (549)
Q Consensus        78 ~~   79 (549)
                      ..
T Consensus        90 ~~   91 (362)
T d1q8ya_          90 NH   91 (362)
T ss_dssp             EE
T ss_pred             ee
Confidence            44

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=98.47  E-value=1e-07  Score=87.23  Aligned_cols=77  Identities=18%  Similarity=0.103  Sum_probs=55.3

Q ss_pred             eeeeeeecccCceEEEEEEECCCCceEEEEEeccCCCC----------------hhhhhhHHHHHHHHHhcCCCCccccc
Q psy18060         11 YQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRS----------------GKELSSLKQECEIQKHLAHPNIIKFI   74 (549)
Q Consensus        11 y~~~~~IG~G~fG~V~~~~~~~~~~~vAiK~i~~~~~~----------------~~~~~~~~~Ei~il~~l~HpnIV~l~   74 (549)
                      +.+.+.||+|+||.||+|++. +|+.||||+++....+                ........+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            357889999999999999985 6899999987542211                01122356788899999999999877


Q ss_pred             cccccccceehhhhhhhc
Q psy18060         75 ASHETLNEFVLITEFAHM   92 (549)
Q Consensus        75 ~~~~~~~~~~lv~ey~~~   92 (549)
                      +..    ..+++|+++.+
T Consensus        81 ~~~----~~~lvme~~~~   94 (191)
T d1zara2          81 AWE----GNAVLMELIDA   94 (191)
T ss_dssp             EEE----TTEEEEECCCC
T ss_pred             Eec----CCEEEEEeecc
Confidence            542    23678887753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.11  E-value=6.5e-06  Score=78.05  Aligned_cols=139  Identities=19%  Similarity=0.181  Sum_probs=89.1

Q ss_pred             ccceeEEEEEecCCcEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCEEEEE
Q psy18060        118 LEKYQKICLIGEGSFGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVLI  196 (549)
Q Consensus       118 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iV  196 (549)
                      ++.|+..+..+.++.+.||+..  ..++.+.+|+.......  ....+.+|...++.+. +--+++++.+....+..++|
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv   88 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence            4567777765556667899875  34667888987643211  1224567888877763 33357788888888899999


Q ss_pred             EecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q psy18060        197 TEFAHM-SLSNLLEQRKKLSETICVQILSNLISALYYLHS----------------------------------------  235 (549)
Q Consensus       197 ~E~~~g-sL~~~l~~~~~l~e~~~~~i~~qIl~aL~yLH~----------------------------------------  235 (549)
                      |++.+| ++.+....     ......++.++...+..||+                                        
T Consensus        89 ~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            999987 45433211     01111223333333333331                                        


Q ss_pred             -------------C------CCccccccCCcEEEecCCcEEEeecccce
Q psy18060        236 -------------N------RVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       236 -------------~------gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                                   .      .++|+|+.|.|||+++++.+-|.||+.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                         1      27899999999999877666799999774

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.65  E-value=5.3e-05  Score=76.69  Aligned_cols=77  Identities=13%  Similarity=0.085  Sum_probs=47.6

Q ss_pred             EEEEecCCcEEEEEEEEcCCCceEEEEEEecCC-----CChHHHHHHHHHHHHHHhcC---CCCeeEEEEEEeeCCEEEE
Q psy18060        124 ICLIGEGSFGKVFKAIHLDLKKTVALKIISKSG-----RSGKELSSLKQECEIQKHLA---HPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       124 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-----~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~i  195 (549)
                      .+.||.|....||++....+++.+++|.-....     ..+........|...++.+.   ...+++++.+.  .+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            567899999999999888778899999754211     11112234456777776652   23466777654  334578


Q ss_pred             EEecCCC
Q psy18060        196 ITEFAHM  202 (549)
Q Consensus       196 V~E~~~g  202 (549)
                      |||++++
T Consensus       109 vmE~L~~  115 (392)
T d2pula1         109 VMEDLSH  115 (392)
T ss_dssp             EECCCTT
T ss_pred             EEeccCC
Confidence            9999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.53  E-value=0.00024  Score=66.36  Aligned_cols=134  Identities=13%  Similarity=0.044  Sum_probs=79.1

Q ss_pred             EEecCC-cEEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCC--CCeeEEEEEEeeCCEEEEEEecCCC
Q psy18060        126 LIGEGS-FGKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAH--PNIIKFIASHETLNEFVLITEFAHM  202 (549)
Q Consensus       126 ~iG~G~-fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~iV~E~~~g  202 (549)
                      .+..|. -+.||+... ..+..+.+|.......     ..+..|...++.+..  -.+++++.+..+.+..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            344444 467898865 3466788898654321     235677777776632  2357788888888888999999875


Q ss_pred             -CHHH-------H-------HHh-c------CCCC--HHHHH-----HH---------------HHHHHHHHHHHHhC--
Q psy18060        203 -SLSN-------L-------LEQ-R------KKLS--ETICV-----QI---------------LSNLISALYYLHSN--  236 (549)
Q Consensus       203 -sL~~-------~-------l~~-~------~~l~--e~~~~-----~i---------------~~qIl~aL~yLH~~--  236 (549)
                       ++..       .       +.+ +      ..+.  .....     .+               .......+..+...  
T Consensus        91 ~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  170 (255)
T d1nd4a_          91 QDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP  170 (255)
T ss_dssp             EETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred             cccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCC
Confidence             3211       1       111 0      0000  00000     00               00112233444332  


Q ss_pred             -----CCccccccCCcEEEecCCcEEEeecccce
Q psy18060        237 -----RVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       237 -----gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                           .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       171 ~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         171 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                 37999999999999987667899999774

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.75  E-value=0.023  Score=56.46  Aligned_cols=71  Identities=18%  Similarity=0.089  Sum_probs=47.2

Q ss_pred             EEEEecCCcEEEEEEEEcC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeCCEEEE
Q psy18060        124 ICLIGEGSFGKVFKAIHLD-------LKKTVALKIISKSGRSGKELSSLKQECEIQKHLA-HPNIIKFIASHETLNEFVL  195 (549)
Q Consensus       124 ~~~iG~G~fg~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~i  195 (549)
                      ++.|+.|-.-.+|++....       .++.|.+++.... .   ......+|..+++.+. +.-.+++++++.+    .+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            4678889999999987653       2345666665422 1   1234567888888874 3334578887753    47


Q ss_pred             EEecCCC
Q psy18060        196 ITEFAHM  202 (549)
Q Consensus       196 V~E~~~g  202 (549)
                      ||||..|
T Consensus       119 I~efi~g  125 (395)
T d1nw1a_         119 LEEYIPS  125 (395)
T ss_dssp             EECCCCE
T ss_pred             EEEEecc
Confidence            8898865

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.06  E-value=0.028  Score=53.68  Aligned_cols=30  Identities=40%  Similarity=0.496  Sum_probs=26.6

Q ss_pred             CCCccccccCCcEEEecCCcEEEeecccce
Q psy18060        236 NRVLHRDLKPQNVLLNKDGVAMLCDFGFAR  265 (549)
Q Consensus       236 ~gIiHrDIKP~NILl~~~g~vKL~DFGla~  265 (549)
                      .|+||+|+.+.||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            379999999999999988777899999774

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=94.74  E-value=0.072  Score=51.15  Aligned_cols=66  Identities=6%  Similarity=0.076  Sum_probs=40.6

Q ss_pred             EEEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCCe--eEEE-----EEEeeCCEEEEEEecCCC
Q psy18060        133 GKVFKAIHLDLKKTVALKIISKSGRSGKELSSLKQECEIQKHLAHPNI--IKFI-----ASHETLNEFVLITEFAHM  202 (549)
Q Consensus       133 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnI--v~l~-----~~~~~~~~~~iV~E~~~g  202 (549)
                      ..||++... +|..|++|+......+.   ..+..|...+..|...++  +...     ..+......+.++++++|
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            579998764 58889999986543333   456678887776632222  1111     123445667888888764